PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Wang, C; Ohe, K				Wang, C; Ohe, K			A CORBA-based object framework with patient identification translation and dynamic linking - Methods for exchanging patient data	METHODS OF INFORMATION IN MEDICINE			English	Article						CORBA; object framework; patient ID translation; dynamic link; exchange of patient data	CLINICAL INFORMATION; DECISION-SUPPORT; ECG STORAGE; SYSTEM; VALIDATION; MODEL	Exchanging and integration of patient data across heterogeneous databases and institutional boundaries offers many problems. We focused on two issues: (1) how to identify identical patients between different systems and institutions while lacking universal patient identifiers; and (2) how to link patient data across heterogeneous databases and institutional boundaries. To solve these problems, we created a patient identification (ID) translation model and a dynamic linking method in the Common Object Request Broker Architecture (CORBA) environment. The algorithm for the patient ID translation is based on patient attribute matching plus computer-based human checking; the method for dynamic linking is temporal mapping. By implementing these methods into computer systems with help of the distributed object computing technology, we built a prototype of a CORBA-based object framework in which the patient ID translation and dynamic linking methods were embedded. Our experiments with a Web based user interface using the object framework and dynamic linking through the object framework were successful. These methods are important for exchanging and integrating patient data across heterogeneous databases and institutional boundaries.	Tokyo Univ Hosp, Hosp Comp Ctr, Bunkyo Ku, Tokyo 113, Japan	Wang, C (reprint author), Tokyo Univ Hosp, Hosp Comp Ctr, Bunkyo Ku, 7 Hongo, Tokyo 113, Japan.	wan@hcc.h.u-tokyo.ac.jp					ACKERMAN MJ, 1994, J AM MED INFORM ASSN, V1, P1; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233; CIMINO JJ, 1995, J AM MED INFORM ASSN, V2, P273; FRIEDMAN C, 1992, COMPUT BIOMED RES, V25, P486, DOI 10.1016/0010-4809(92)90005-U; DAS AK, 1994, METHOD INFORM MED, V33, P358; CARPENTER PC, 1993, SCAMC, P49; Combi C, 1995, METHOD INFORM MED, V34, P458; Dierks C, 1993, Med Law, V12, P547; *EUR COMM STAND, 1993, STAND COMM PROT COMP; FINGAR P, 1996, NEXT GENERATION COMP; Forslund D W, 1997, Proc AMIA Annu Fall Symp, P364; FURNELL SM, 1995, MEDINFO, P675; GOLABEK JK, 1997, NASHV HANL BELF INC, P37; GREENES RA, 1996, AMIA YB MED INFORMAT, P76; HAMMOND WE, 1996, 16 JOINT C MED INF J, P22; Johansson B, 1996, METHOD INFORM MED, V35, P302; KAHN MG, 1991, METHOD INFORM MED, V30, P4; KAHN MG, 1991, COMPUT BIOMED RES, V24, P401, DOI 10.1016/0010-4809(91)90016-P; Keravnou ET, 1996, ARTIF INTELL MED, V8, P235, DOI 10.1016/0933-3657(95)00035-6; Kohane I S, 1996, Proc AMIA Annu Fall Symp, P608; LOWE HJ, 1995, SCAMC P, P441; *MIN HLTH WELF JAP, 1997, PROSP MED LEG INF SO; MURRAY CL, 1995, MEDINFO, P1637; *OBJ MAN GROUP, CORBASERVICES COMM O; Ohe K, 1998, ST HEAL T, V52, P962; PYLE IC, 1996, DICT COMPUTING; SALMON P, 1996, SCAMC, P463; VANBEMMEL JH, 1997, HDB MED INFORMATICS; VANBEMMEL JH, 1990, METHOD INFORM MED, V29, P261; Wang C, 1996, METHOD INFORM MED, V35, P35; WANG C, 1997, JAPAN J MED INFORMAT, V17, P111; Wang C, 1996, J Med Syst, V20, P35, DOI 10.1007/BF02260872; Wang C, 1997, Proc AMIA Annu Fall Symp, P27	33	6	6	SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN	STUTTGART	HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY	0026-1270			METHOD INFORM MED	Methods Inf. Med.	MAR	1999	38	1					56	65				10	Computer Science, Information Systems; Health Care Sciences & Services; Medical Informatics	Computer Science; Health Care Sciences & Services; Medical Informatics	180MQ	WOS:000079390100009		
J	Karima, R; Matsumoto, S; Higashi, H; Matsushima, K				Karima, R; Matsumoto, S; Higashi, H; Matsushima, K			The molecular pathogenesis of endotoxic shock and organ failure	MOLECULAR MEDICINE TODAY			English	Review							TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; RESPIRATORY-DISTRESS-SYNDROME; MULTICENTER CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; SEPTIC SHOCK; SEVERE SEPSIS; DOUBLE-BLIND; MONOCLONAL-ANTIBODY; BACTERIAL-INFECTION	Sepsis is still associated with a high mortality rate, Septic shock and sequential multiple organ failure have a strong correlation with poor outcome. Lipopolysaccharide (LPS) plays a pivotal role in the initiation of host responses to Gram-negative infection. A number of mediators, such as cytokines, nitric oxide and eicosanoids, are responsible far most of the manifestations caused by LPS, and circulatory failure, leukocyte-induced tissue injury and coagulation disorder appear to be critical determinants in the development of sequential organ failure. Although several anti-LPS or anti-cytokine clinical trials have been attempted, none of them has so far been successful.	Univ Tokyo, Fac Med, Bunkyo Ku, Dept Mol Prevent Med, Tokyo 113, Japan	Karima, R (reprint author), Univ Tokyo, Fac Med, Bunkyo Ku, Dept Mol Prevent Med, Hongo 7-3-1, Tokyo 113, Japan.	krm@m.u-tokyo.ac.jp					SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; XU H, 1994, J EXP MED, V180, P95, DOI 10.1084/jem.180.1.95; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Abraham E, 1998, LANCET, V351, P929; DHAINAUT JFA, 1994, CRIT CARE MED, V22, P1720; BONE RC, 1995, CRIT CARE MED, V23, P994, DOI 10.1097/00003246-199506000-00003; Yang RB, 1998, NATURE, V395, P284; Sen CK, 1996, FASEB J, V10, P709; Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; WATANABE SI, 1995, INT IMMUNOL, V7, P1037, DOI 10.1093/intimm/7.7.1037; Abraham E, 1997, JAMA-J AM MED ASSOC, V277, P1531, DOI 10.1001/jama.277.19.1531; Levi M, 1997, EUR J CLIN INVEST, V27, P3, DOI 10.1046/j.1365-2362.1997.570614.x; Bates DW, 1997, J INFECT DIS, V176, P1538; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; ADERKA D, 1992, J EXP MED, V175, P323, DOI 10.1084/jem.175.2.323; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; STANDIFORD TJ, 1995, J IMMUNOL, V155, P1515; Johnson K, 1998, J IMMUNOL, V160, P5130; Kitchens RL, 1998, J IMMUNOL, V160, P1920; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Stouthard JML, 1996, THROMB HAEMOSTASIS, V76, P738; SABHARWAL AK, 1995, AM J RESP CRIT CARE, V151, P758; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Abraham E, 1996, CRIT CARE MED, V24, P10, DOI 10.1097/00003246-199601000-00005; Zisman DA, 1997, J CLIN INVEST, V99, P2832, DOI 10.1172/JCI119475; Opal SM, 1997, CRIT CARE MED, V25, P1115, DOI 10.1097/00003246-199707000-00010; TONNETTI L, 1995, EUR J IMMUNOL, V25, P1559, DOI 10.1002/eji.1830250614; Jack RS, 1997, NATURE, V389, P742, DOI 10.1038/39622; SZABO C, 1994, P NATL ACAD SCI USA, V91, P12472, DOI 10.1073/pnas.91.26.12472; Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; Hierholzer C, 1998, J EXP MED, V187, P917, DOI 10.1084/jem.187.6.917; LEVI M, 1994, J CLIN INVEST, V93, P114, DOI 10.1172/JCI116934; BONE RC, 1992, CRIT CARE MED, V20, P864; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Camerota AJ, 1998, J INFECT DIS, V177, P668; Carvalho GL, 1997, SURGERY, V122, P60, DOI 10.1016/S0039-6060(97)90265-8; COBB JP, 1992, J EXP MED, V176, P1175, DOI 10.1084/jem.176.4.1175; Cohen J, 1996, CRIT CARE MED, V24, P1431, DOI 10.1097/00003246-199609000-00002; Eisele B, 1998, INTENS CARE MED, V24, P663, DOI 10.1007/s001340050642; Fein AM, 1997, JAMA-J AM MED ASSOC, V277, P482, DOI 10.1001/jama.277.6.482; GENG Y, 1993, J IMMUNOL, V151, P6692; GERARD C, 1993, J EXP MED, V177, P547, DOI 10.1084/jem.177.2.547; Habib A, 1997, J IMMUNOL, V158, P3845; INGALLS RR, 1995, J EXP MED, V181, P1473, DOI 10.1084/jem.181.4.1473; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; *NAT COMM EV CENT, 1994, ARCH INTERN MED, V154, P2484; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Salat C, 1996, SHOCK, V6, P233, DOI 10.1097/00024382-199610000-00001; STANDIFORD TJ, 1995, J IMMUNOL, V155, P2222; Szabó C, 1995, New Horiz, V3, P2; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; WENZEL RP, 1992, NEW ENGL J MED, V326, P1151, DOI 10.1056/NEJM199204233261710; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619	60	239	270	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1357-4310			MOL MED TODAY	Mol. Med. Today	MAR	1999	5	3					123	132		10.1016/S1357-4310(98)01430-0		10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	180YE	WOS:000079412800010		
J	Si, YM; Okuno, M				Si, YM; Okuno, M			Regulation of microtubule sliding by a 36-kDa phosphoprotein in hamster sperm flagella	MOLECULAR REPRODUCTION AND DEVELOPMENT			English	Article						sperm motility; protein phosphorylation; Ca2+; cAMP	CAMP-DEPENDENT PHOSPHORYLATION; SEA-URCHIN SPERMATOZOA; CYCLIC-NUCLEOTIDES; PROTEIN-PHOSPHORYLATION; ADENYLATE-CYCLASE; FIBROUS SHEATH; 22S DYNEIN; MOTILITY; ACTIVATION; CALCIUM	Cyclic AMP has been shown essential for activation of sperm motility. When immotile hamster caudal epididymal spermatozoa were suspended in a Ca2+-deficient solution, they showed a sluggish motility. Spermatozoa were demembranated and transferred to an ATP-containing reactivation solution. Demembranated spermatozoa did not exhibit reactivated flagellar movement unless cAMP was added. Conversely, when the immotile epididymal spermatozoa were suspended in a Ca2+-containing solution, they were immediately activated to display a vigorous motility; demembranated spermatozoa also exhibited reactivated flagellar movement in the reactivation solution without cAMP. Further investigation of microtubule sliding properties revealed that the effects of Ca2+ on live spermatozoa were identical with the effects of cAMP on demembranated spermatozoa both in microtubule sliding velocity and sliding disintegration pattern. Moreover, a 36-kDa flagellar protein was found to be phosphorylated in a cAMP-dependent manner and coupled to the motility activation. A polyclonal antibody against this protein was developed and showed specific immunolocalization and significant inhibitory effects on microtubule sliding disintegration. These results indicate that extracellular Ca2+ owes its effect to triggering intracellular cAMP production, and cAMP-dependent phosphorylation of a 36-kDa phosphoprotein activates hamster sperm motility through regulation of microtubule sliding properties. Mel. Reprod. Dev. 52:328-334, 1999. (C) 1999 Wiley-Liss, Inc.	Univ Tokyo, Coll Arts & Sci, Dept Biol, Tokyo 153, Japan	Si, YM (reprint author), Temple Univ, Sch Med, Dept Anat & Cell Biol, 3400 N Broad St, Philadelphia, PA 19140 USA.						BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302; MORTON B, 1974, BIOCHEM BIOPH RES CO, V56, P372, DOI 10.1016/0006-291X(74)90852-3; KING SM, 1985, P NATL ACAD SCI USA, V82, P4717, DOI 10.1073/pnas.82.14.4717; BARKALOW K, 1994, J CELL BIOL, V126, P727, DOI 10.1083/jcb.126.3.727; MORISAWA M, 1982, NATURE, V295, P703, DOI 10.1038/295703a0; TASH JS, 1983, BIOL REPROD, V28, P75, DOI 10.1095/biolreprod28.1.75; MOHRI H, 1980, EXP CELL RES, V127, P191, DOI 10.1016/0014-4827(80)90426-7; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; TAKAHASHI D, 1985, CELL STRUCT FUNCT, V10, P327; HAMASAKI T, 1991, P NATL ACAD SCI USA, V88, P7918, DOI 10.1073/pnas.88.18.7918; BRAUN T, 1975, J CYCLIC NUCL PROT, V1, P271; BROKAW CJ, 1985, ANN NY ACAD SCI, V438, P132; GAGNON C, 1994, MOL BIOL CELL, V5, P1051; Garbers D L, 1980, Adv Cyclic Nucleotide Res, V13, P251; GARBERS DL, 1971, BIOCHEMISTRY-US, V10, P1825; GARBERS DL, 1971, BIOL REPROD, V5, P336; GREENGARD P, 1978, SCIENCE, V199, P146, DOI 10.1126/science.22932; HAYASHI H, 1987, J BIOL CHEM, V262, P16692; HYNE RV, 1979, BIOL REPROD, V21, P1135, DOI 10.1095/biolreprod21.5.1135; ISHIDA K, 1987, DEV GROWTH DIFFER, V29, P47; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MORTON B, 1973, BIOL REPROD, V9, P71; OKUNO M, 1981, J CELL BIOL, V91, P689, DOI 10.1083/jcb.91.3.689; OKUNO M, 1982, BIOL FUNCTIONS MICRO, P151; OPRESKO LK, 1983, GAMETE RES, V8, P201, DOI 10.1002/mrd.1120080302; SI Y, 1994, CAIRNS AUSTR 7 INT S; Si Y., 1997, Biology of Reproduction, V56, P173; SI YM, 1995, BIOL REPROD, V53, P1081, DOI 10.1095/biolreprod53.5.1081; SI YM, 1995, J EXP ZOOL, V273, P355, DOI 10.1002/jez.1402730409; SI YM, 1993, EXP CELL RES, V208, P170, DOI 10.1006/excr.1993.1235; SI YM, 1993, MOL REPROD DEV, V36, P89, DOI 10.1002/mrd.1080360113; TASH JS, 1984, CELL, V38, P551, DOI 10.1016/0092-8674(84)90509-9; TASH JS, 1989, CELL MOTIL CYTOSKEL, V14, P332, DOI 10.1002/cm.970140303; TASH JS, 1986, J CELL BIOL, V103, P649, DOI 10.1083/jcb.103.2.649; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4358; Yanagimachi R., 1994, P189; YANO Y, 1980, J CELL SCI, V44, P169	37	13	15	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	1040-452X			MOL REPROD DEV	Mol. Reprod. Dev.	MAR	1999	52	3					328	334		10.1002/(SICI)1098-2795(199903)52:3<328::AID-MRD11>3.0.CO;2-N		7	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	Biochemistry & Molecular Biology; Cell Biology; Developmental Biology; Reproductive Biology	162FD	WOS:000078334100011		
J	Fukuda, M; Hashimoto, O; Nagakubo, S; Hata, A				Fukuda, M; Hashimoto, O; Nagakubo, S; Hata, A			A family with arm atonic variant of paroxysmal kinesigenic choreoathetosis and hypercalcitoninemia	MOVEMENT DISORDERS			English	Article						paroxysmal kinesigenic choreoathetosis; atonic seizure; hypercalcitoninemia		We report a family with an incompletely atonic variant of paroxysmal kinesigenic choreoathetosis (PKC). Three members of the family experienced attacks of muscle weakness which resembled the choreoathetotic attacks that occur in PKC in terms of their kinesigenicity and duration, clarity of consciousness during the attacks, good therapeutic response to low doses of phenytoin, and familial transmission, but differed from choreoathetotic attacks in PKC in that they were atonic. All three affected individuals were hypercalcitoninemic.	Univ Tokyo, Fac Med, Dept Neuropsychiat, Bunkyo Ku, Tokyo 1138655, Japan; Katsushikabashi Hosp, Tokyo, Japan	Fukuda, M (reprint author), Univ Tokyo, Fac Med, Dept Neuropsychiat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						LANCE JW, 1977, ANN NEUROL, V2, P285, DOI 10.1002/ana.410020405; Mount LA, 1940, ARCH NEURO PSYCHIATR, V44, P841; KERTESZ AZ, 1967, NEUROLOGY, V17, P680; ASOU K, 1985, SHONIKA RINSHO, V38, P355; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; BURUMA OJS, 1986, HDB CLIN NEUROLOGY, V5, P349; GOODENOUGH DJ, 1978, ARCH NEUROL-CHICAGO, V35, P827; GOWERS WR, 1964, EPILEPSY OTHER CHRON, P175; Inamura H, 1967, Seishin Shinkeigaku Zasshi, V69, P57; KAWAHARA R, 1979, SEISHIN IGAKU, V21, P999; KINAST M, 1980, PEDIATRICS, V65, P74; MARUI N, 1993, SEISHIN IGAKU, V35, P473	12	4	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-3185			MOVEMENT DISORD	Mov. Disord.	MAR	1999	14	2					342	344		10.1002/1531-8257(199903)14:2<342::AID-MDS1022>3.0.CO;2-7		3	Clinical Neurology	Neurosciences & Neurology	243LP	WOS:000082999400022		
J	Hoummady, M; Fujita, H				Hoummady, M; Fujita, H			Micromachines for nanoscale science and technology	NANOTECHNOLOGY			English	Article							SCANNING TUNNELING MICROSCOPY; FORCE MICROSCOPY	The field of micromachines is maturing in terms of fabrication technologies, reproducibility and reliability. Different development principles and applications are investigated for a wide range of dimensions from millimetric to nanometric. One promising approach is to make micromachined tools for sensing, handling and manipulating on the nanoscale with high precision. A few examples are presented, including an integrated scanning tunnelling microscope, a monolithic nanoscanner and a high-frequency atomic force microscope nanocantilever. The integration of nanostructures and micromachines will lead to the development of smart nanosystems allowing for future manufacturability.	Inst Microtech Franche Comte, CNRS, Lab Phys & Metrol Oscillateurs, FR 0067 CNRS, F-25044 Besancon, France; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Hoummady, M (reprint author), Inst Microtech Franche Comte, CNRS, Lab Phys & Metrol Oscillateurs, FR 0067 CNRS, 32 Ave Observ, F-25044 Besancon, France.						AKAMINE S, 1990, SENSOR ACTUATOR, V21, P964; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Walters DA, 1996, REV SCI INSTRUM, V67, P3583, DOI 10.1063/1.1147177; BINNIG G, 1982, HELV PHYS ACTA, V55, P726; BINNIG G, 1986, REV SCI INSTRUM, V57, P1688, DOI 10.1063/1.1139196; Ataka M., 1993, Journal of Microelectromechanical Systems, V2, DOI 10.1109/84.273089; CAMPITELLI A, 1998, EUR C NAN NAN HINDSG; Collins PG, 1997, SCIENCE, V278, P100, DOI 10.1126/science.278.5335.100; DANEL JS, 1990, SENSOR ACTUAT A-PHYS, V21, P971; FUJII T, 1997, P ANN C IEEE CHIC IL, V19, P2571; Hoummady M, 1997, SMART MATER STRUCT, V6, P647, DOI 10.1088/0964-1726/6/6/001; Hoummady M, 1997, J VAC SCI TECHNOL B, V15, P1556, DOI 10.1116/1.589399; Hoummady M, 1997, J VAC SCI TECHNOL B, V15, P1539, DOI 10.1116/1.589395; Han J, 1997, NANOTECHNOLOGY, V8, P95, DOI 10.1088/0957-4484/8/3/001; Kobayashi D., 1996, Transactions of the Institute of Electrical Engineers of Japan, Part E, V116-E; KOBAYASHI D, 1992, P IEEE WORKSH MEMS T, V5, P214; Kobayashi D., 1996, Transactions of the Institute of Electrical Engineers of Japan, Part E, V116-E; TOSHIYOSHI H, 1995, J MICRO ELECT MECH S, V4, P29; Wada Y, 1997, SURF SCI, V386, P265, DOI 10.1016/S0039-6028(97)00318-X; WASHIZU M, 1990, INTEGRATED MICRO MOT, P417; Washizu M, 1996, DECH MONOG, V132, P177; Yao J. J., 1992, Journal of Microelectromechanical Systems, V1, DOI 10.1109/84.128051	23	16	16	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0957-4484			NANOTECHNOLOGY	Nanotechnology	MAR	1999	10	1					29	33		10.1088/0957-4484/10/1/007		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Science & Technology - Other Topics; Materials Science; Physics	182YH	WOS:000079525400007		
J	Miyatake, N; Shikata, K; Wada, J; Sugimoto, H; Takahashi, S; Makino, H				Miyatake, N; Shikata, K; Wada, J; Sugimoto, H; Takahashi, S; Makino, H			Differential distribution of insulin-like growth factor-1 and insulin-like growth factor binding proteins in experimental diabetic rat kidney	NEPHRON			English	Article						insulin-like growth factor-1; insulin-like growth factor binding proteins diabetic rat; glomerular hypertrophy; streptozotocin	GLOMERULAR-FILTRATION-RATE; INITIAL RENAL GROWTH; I MESSENGER-RNA; IGF-I; PLASMA-FLOW; GENE-EXPRESSION; CELL-CULTURES; SHORT-TERM; HORMONE; SIZE	Insulin-like growth factor-1 (IGF-1) is a peptide growth factor, and its activity is modulated by interaction with the family of IGF binding proteins (IGFBP-1 to 6). IGF-1 is detected in rat kidney and has metabolic and growth effects. To explore the possible involvement of IGFBPs in glomerular hypertrophy in streptozotocin (STZ)-induced diabetic rat, the immunolocalization of IGF-1 and IGFBPs were investigated. IGF-1 was gradually increased in the glomeruli of diabetic rats and correlated with glomerular hypertrophy. IGFBP-1 was transiently increased at 1 week after the STZ injection and declined to control level during the following period. In contrast, IGFBP-4 was increased in the diabetic glomeruli throughout the observation period. With insulin treatment, the levels of IGF-1, IGFBP-1 and 4 were normalized and glomerular hypertrophy was prevented. Initial glomerular hypertrophy of diabetic nephropathy is a related IGF-1 action, which may be modulated by IGFBP-1 and 4.	Okayama Univ, Sch Med, Dept Med 3, Okayama 7008558, Japan; Univ Tokyo, Grad Sch Agr & Life Sc, Dept Appl Anim Sci, Tokyo, Japan	Miyatake, N (reprint author), Okayama Univ, Sch Med, Dept Med 3, 2-5-1 Shikata Cho, Okayama 7008558, Japan.		WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170			CHRISTIANSEN JS, 1981, DIABETOLOGIA, V20, P451; MOHAN S, 1989, P NATL ACAD SCI USA, V86, P8338, DOI 10.1073/pnas.86.21.8338; BACH LA, 1992, GROWTH REGULAT, V2, P30; LATOUR D, 1990, MOL ENDOCRINOL, V4, P1806; RECHLER MM, 1993, VITAM HORM, V47, P1, DOI 10.1016/S0083-6729(08)60444-6; Matsuda M, 1996, LAB INVEST, V75, P403; JENSEN PK, 1981, DIABETOLOGIA, V21, P409; BACH LA, 1992, DIABETES METAB REV, V8, P229; BACH LA, 1992, DIABETES, V41, P499, DOI 10.2337/diabetes.41.4.499; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; CAMACHOHUBNER C, 1991, J CELL PHYSIOL, V148, P281, DOI 10.1002/jcp.1041480214; CHEN TL, 1991, ENDOCRINOLOGY, V128, P2489; CHRISTIANSEN JS, 1982, KIDNEY INT, V21, P683, DOI 10.1038/ki.1982.81; CLEMMONS DR, 1992, GROWTH REGULAT, V2, P80; CULOUSCOU JM, 1991, CANCER RES, V51, P2813; DEVROEDE MA, 1986, J CLIN INVEST, V77, P602, DOI 10.1172/JCI112343; DOI T, 1988, AM J PATHOL, V131, P398; FAGIN JA, 1989, DIABETES, V38, P428, DOI 10.2337/diabetes.38.4.428; FLOEGE J, 1992, KIDNEY INT, V41, P297, DOI 10.1038/ki.1992.42; FLYVBJERG A, 1990, ACTA ENDOCRINOL-COP, V122, P374; FLYVBJERG A, 1988, DIABETOLOGIA, V31, P310; FLYVBJERG A, 1992, AM J PHYSIOL, V262, pE956; FLYVBJERG A, 1990, DIABETOLOGIA, V33, P334, DOI 10.1007/BF00404636; FOWLKES J, 1992, ENDOCRINOLOGY, V131, P2071, DOI 10.1210/en.131.5.2071; GULER HP, 1989, P NATL ACAD SCI USA, V86, P2868, DOI 10.1073/pnas.86.8.2868; GULER HP, 1988, P NATL ACAD SCI USA, V85, P4889, DOI 10.1073/pnas.85.13.4889; IRWIN JC, 1995, J CLIN ENDOCR METAB, V80, P619, DOI 10.1210/jc.80.2.619; KANZAKI S, 1994, ENDOCRINOLOGY, V134, P383, DOI 10.1210/en.134.1.383; KOBAYASHI S, 1991, AM J PHYSIOL, V261, pF22; LANDAU D, 1995, ENDOCRINOLOGY, V136, P1835, DOI 10.1210/en.136.5.1835; LUO JM, 1991, MOL CELL BIOCHEM, V103, P41; MARSHALL SM, 1991, DIABETOLOGIA, V34, P632, DOI 10.1007/BF00400992; MATEJKA GL, 1992, HISTOCHEMISTRY, V97, P173, DOI 10.1007/BF00267308; MEYERS SE, 1993, ENOCRINOLOGY, V133, P1525; MICHELS LD, 1981, J LAB CLIN MED, V98, P869; MOGENSEN CE, 1973, DIABETES, V22, P706; MOGENSEN CE, 1971, SCAND J CLIN LAB INV, V28, P91, DOI 10.3109/00365517109090667; PARKER A, 1995, ENDOCRINOLOGY, V136, P2470, DOI 10.1210/en.136.6.2470; PHILLIP M, 1994, J MOL ENDOCRINOL, V12, P215; Price GJ, 1997, J MOL ENDOCRINOL, V18, P5, DOI 10.1677/jme.0.0180005; PRICE GJ, 1995, KIDNEY INT, V48, P402, DOI 10.1038/ki.1995.308; RITVOS O, 1988, ENDOCRINOLOGY, V122, P2150; Rodgers BD, 1995, P SOC EXP BIOL MED, V210, P234; SEYERHANSEN K, 1976, CLIN SCI MOL MED, V51, P551; Sugimoto H, 1996, NEPHRON, V72, P648; SUIKKARI AM, 1988, J CLIN ENDOCR METAB, V67, P1225; UI M, 1989, ENDOCRINOLOGY, V125, P912	47	13	17	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-2766			NEPHRON	Nephron	MAR	1999	81	3					317	323		10.1159/000045299		7	Urology & Nephrology	Urology & Nephrology	172UC	WOS:000078942300011		
J	Voit, T; Cohn, RD; Sperner, J; Leube, B; Sorokin, L; Toda, T; Herrmann, R				Voit, T; Cohn, RD; Sperner, J; Leube, B; Sorokin, L; Toda, T; Herrmann, R			Merosin-positive congenital muscular dystrophy with transient brain dysmyelination, pontocerebellar hypoplasia and mental retardation	NEUROMUSCULAR DISORDERS			English	Article						congenital muscular dystrophies; laminin alpha 2 chain deficient; LAMA2 gene	ENMC INTERNATIONAL WORKSHOP; CENTRAL-NERVOUS-SYSTEM; SKELETAL-MUSCLE; WALKER-WARBURG; EXPRESSION; CHAIN; LOCALIZATION; DEFICIENCY; INVOLVEMENT; NETHERLANDS	The congenital muscular dystrophies (CMDs) are a heterogeneous group of disorders. Among these, the laminin alpha 2 chain 'merosin' deficient CMD is caused by mutations of the LAMA2 gene on chr 6q2 and Fukuyama CMD is linked to chr 9q31. We report a 7-year-old boy who was born to consanguineous healthy parents. His motor and mental development were slow. Creatine kinase (CK) was elevated (2.100 U/l), and the muscle biopsy was dystrophic. He sat unsupported at 12 months and took his first steps at 3 years of age. At 6 years of age he could walk up to 500 m. He was mentally retarded and spoke single words only. At 1 year, MR imaging of the brain showed abnormal increased periventricular T2-signal, consistent with dysmyelination as well as pontocerebellar hypoplasia and several cerebellar cysts. The pattern of gyration was normal. Follow-up at 4 years showed normalization of the previously abnormal periventricular T2-signal. Immunohistochemical analysis of the skeletal muscle showed normal expression of laminin alpha 2 for a C-terminal antibody and antibodies to the 300 and 150 kDa fragments, as well as of laminins alpha 5, beta 1, beta 2 and gamma 1. The boy has two healthy younger brothers. Linkage analysis excluded the candidate loci on chromosomes 6q2 and 9q31. As such, the patient's data are suggestive of a new form of laminin alpha 2 positive CMD characterized by transient brain dysmyelination, pontocerebellar hypoplasia and mental retardation. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Essen Gesamthsch, Dept Pediat & Pediat Neurol, D-45122 Essen, Germany; Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Univ Erlangen Nurnberg, Inst Expt Med, D-91054 Erlangen, Germany; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	Voit, T (reprint author), Univ Essen Gesamthsch, Dept Pediat & Pediat Neurol, Hufelandstr 55, D-45122 Essen, Germany.	thomas.voit@uni-essen.de					PHILPOT J, 1995, NEUROMUSCULAR DISORD, V5, P301, DOI 10.1016/0960-8966(94)00069-L; Kobayashi K, 1998, NATURE, V394, P388; TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351; DOBYNS WB, 1985, AM J MED GENET, V22, P157, DOI 10.1002/ajmg.1320220118; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; WARBURG M, 1976, HUM HERED, V26, P137, DOI 10.1159/000152795; Voit T, 1998, BRAIN DEV-JPN, V20, P65, DOI 10.1016/S0387-7604(97)00094-6; SCHULER F, 1995, J CELL SCI, V108, P3795; Ullrich O, 1930, Z GESAMTE NEUROL PSY, V126, P171, DOI 10.1007/BF02864097; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Echenne B, 1997, NEUROMUSCULAR DISORD, V7, P187, DOI 10.1016/S0960-8966(97)00452-5; Arancio O, 1988, Ital J Neurol Sci, V9, P485, DOI 10.1007/BF02337167; Cohn RD, 1998, NEUROLOGY, V51, P94; Cohn RD, 1997, NEUROMUSCULAR DISORD, V7, P373, DOI 10.1016/S0960-8966(97)00072-2; DeStefano N, 1996, BRAIN DEV-JPN, V18, P323, DOI 10.1016/0387-7604(96)00029-0; Dubowitz V, 1997, NEUROMUSCULAR DISORD, V7, P539; DUBOWITZ V, 1995, NEUROMUSCULAR DISORD, V5, P253, DOI 10.1016/0960-8966(95)90011-X; Dubowitz V, 1996, NEUROMUSCULAR DISORD, V6, P295, DOI 10.1016/0960-8966(96)00358-6; Fardeau M, 1996, REV NEUROL, V152, P11; Fukuyama Y, 1960, PAEDIATR U TOKYO, V4, P5; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; HelblingLeclerc A, 1995, CR ACAD SCI III-VIE, V318, P1245; Herrmann R, 1996, EUR J PEDIATR, V155, P968, DOI 10.1007/BF02282889; HILLAIRE D, 1994, HUM MOL GENET, V3, P1657, DOI 10.1093/hmg/3.9.1657; KNUBLEY WA, 1988, DEV MED CHILD NEUROL, V30, P378; Miyake M, 1997, GENOMICS, V40, P284, DOI 10.1006/geno.1996.4584; Oexle K, 1996, NEUROPEDIATRICS, V27, P32, DOI 10.1055/s-2007-973744; Osawa M, 1997, DEVEL NEUR, V13, P31; RANTA S, 1995, NEUROMUSCULAR DISORD, V3, P221; Santavuori P, 1977, NEUROPADIATRIE, V8, P550; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; Topaloglu H, 1998, NEUROMUSCULAR DISORD, V8, P169, DOI 10.1016/S0960-8966(98)00013-3; TREVISAN CP, 1995, EUR NEUROL, V35, P230, DOI 10.1159/000117134; Ullrich O, 1930, MONATSSCHR KINDERH, V47, P502; VOIT T, 1995, NEUROPEDIATRICS, V26, P148, DOI 10.1055/s-2007-979745; Walker AE, 1942, ARCH NEUROL PSYCHIAT, V48, P13	37	15	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-8966			NEUROMUSCULAR DISORD	Neuromusc. Disord.	MAR	1999	9	2					95	101		10.1016/S0960-8966(98)00091-1		7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	184TP	WOS:000079629800006		
J	Katsukawa, T; Lee, Y; Matsumiya, Y				Katsukawa, T; Lee, Y; Matsumiya, Y			Spawning Per Recruit analysis for female snow crab Chionoecetes opilio in the sea off Kyoto prefecture	NIPPON SUISAN GAKKAISHI			Japanese	Article								Analysis of Spawning Per Recruit (SPR) has been used to evaluate the effect of the fishing mortality on the spawning ability of the stock. We analyzed fishery data on snow crab Chionoecetes opilio by using this technique. This stock is managed by seasonal protected area. Before the protected area was introduced, the stock was at about 1.1% of the maximum possible spawning stock biomass per recruit. By the protected area, %SPR of this species has improved to 4.2%, nearly four times larger than before. We also examined the effect of changing the fishing gear from Danish seines to traps. Since traps are more selective, we can decrease bycatch mortality by using a trap instead of a Danish seine. Our analysis suggested that we can enhance %SPR to 13.8% by using traps.	Univ Tokyo, Ocean Res Inst, Dept Populat Dynam Marine Organisms, Nakano Ku, Tokyo 1648639, Japan	Katsukawa, T (reprint author), Univ Tokyo, Ocean Res Inst, Dept Populat Dynam Marine Organisms, Nakano Ku, Minamidai, Tokyo 1648639, Japan.						CLARK WG, 1991, CAN J FISH AQUAT SCI, V48, P734, DOI 10.1139/f91-088; Clark W.G., 1993, P INT S MAN STRAT EX, P233; Gabriel W.L., 1989, North American Journal of Fisheries Management, V9, P383, DOI 10.1577/1548-8675(1989)009<0383:AOSSBP>2.3.CO;2; Mace Pamela M., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V120, P101; PRAGER M H, 1987, North American Journal of Fisheries Management, V7, P403, DOI 10.1577/1548-8659(1987)7<403:ULFTCM>2.0.CO;2	5	4	4	JAPAN SOC SCI FISHERIES SCI	TOKYO	C/O TOKYO UNIV FISHERIES, 5-7, 4-CHOME, KONAN, MINATO-KU, TOKYO, 108, JAPAN	0021-5392			NIPPON SUISAN GAKK	Nippon Suisan Gakkaishi	MAR	1999	65	2					288	293				6	Fisheries	Fisheries	195YL	WOS:000080280200016		
J	Zhang, J				Zhang, J			Boundedness and blow-up behavior for reaction-diffusion systems in a bounded domain	NONLINEAR ANALYSIS-THEORY METHODS & APPLICATIONS			English	Article						reaction-diffusion system; boundedness; blow-up	LINEAR PARABOLIC-SYSTEMS; QUASILINEAR EQUATIONS; POPULATION-DYNAMICS; GLOBAL EXISTENCE		Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 153, Japan; Sichuan Normal Univ, Dept Math, Chengdu 610068, Peoples R China	Zhang, J (reprint author), Univ Tokyo, Dept Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 153, Japan.						AMANN H, 1986, ARCH RATION MECH AN, V92, P153; PAO CV, 1982, J MATH ANAL APPL, V87, P165, DOI 10.1016/0022-247X(82)90160-3; ESCOBEDO M, 1993, ANN MAT PUR APPL, V165, P315, DOI 10.1007/BF01765854; YAMADA Y, 1990, SIAM J MATH ANAL, V21, P327, DOI 10.1137/0521018; CARISTI G, 1994, J DIFFER EQUATIONS, V113, P265, DOI 10.1006/jdeq.1994.1124; DEURING P, 1987, MATH Z, V194, P375, DOI 10.1007/BF01162244; ESCOBEDO M, 1995, ARCH RATION MECH AN, V129, P47, DOI 10.1007/BF00375126; FILO J, 1995, NONLINEAR ANAL-THEOR, V24, P1597, DOI 10.1016/0362-546X(94)00093-W; GALAKTIONOV VA, 1983, DIFF EQUAT+, V19, P1558; GALAKTIONOV VA, 1985, DIFF EQUAT+, V21, P1049; JONG UK, 1984, NONLINEAR ANAL TMA, V8, P1121; LEUNG A, 1980, J MATH ANAL APPL, V73, P204, DOI 10.1016/0022-247X(80)90028-1; Lu G, 1993, J DIFFER EQUATIONS, V104, P147; REDLINGER R, 1995, J DIFFER EQUATIONS, V118, P219, DOI 10.1006/jdeq.1995.1073; ROSSI JD, 1995, COMMUN PART DIFF EQ, V20, P1991, DOI 10.1080/03605309508821160; RUAN W, 1990, NONLINEAR ANAL-THEOR, V14, P1051, DOI 10.1016/0362-546X(90)90068-R; RUAN WH, 1995, J DIFFER EQUATIONS, V117, P411, DOI 10.1006/jdeq.1995.1059; Samarskii AA, 1995, BLOWUP QUASILINEAR P; SENBA T, 1990, NONLINEAR ANAL-THEOR, V14, P789, DOI 10.1016/0362-546X(90)90107-R; YAGI A, 1993, NONLINEAR ANAL-THEOR, V21, P603, DOI 10.1016/0362-546X(93)90004-C; YAMADA Y, 1995, NONLINEAR ANAL-THEOR, V24, P1395, DOI 10.1016/0362-546X(94)E0088-X	21	13	22	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0362-546X			NONLINEAR ANAL-THEOR	Nonlinear Anal.-Theory Methods Appl.	MAR	1999	35	7					833	844		10.1016/S0362-546X(97)00706-2		12	Mathematics, Applied; Mathematics	Mathematics	156CD	WOS:000077983100003		
J	Al-Shehbaz, IA; Arai, K; Ohba, H				Al-Shehbaz, IA; Arai, K; Ohba, H			A new species of Hemilophia (Brassicaceae) from China	NOVON			English	Article								Hemilophia sessilifolia is described and illustrated. Its relationship to the other species of Hemilophia is discussed.	Missouri Bot Gardens, St Louis, MO 63166 USA; Karuizawa Bot Garden, Karuizawa, Nagano, Japan; Univ Tokyo, Univ Museum, Dept Bot, Tokyo 113, Japan	Al-Shehbaz, IA (reprint author), Missouri Bot Gardens, POB 299, St Louis, MO 63166 USA.							0	0	0	MISSOURI BOTANICAL GARDEN	ST LOUIS	2345 TOWER GROVE AVENUE, ST LOUIS, MO 63110 USA	1055-3177			NOVON	Novon	SPR	1999	9	1					8	10		10.2307/3392106		3	Plant Sciences	Plant Sciences	178YA	WOS:000079295700003		
J	Inoue, K; Nagai, Y; Saito, H; Nagashima, Y; Hyodo, T; Muramatsu, S; Nagai, S				Inoue, K; Nagai, Y; Saito, H; Nagashima, Y; Hyodo, T; Muramatsu, S; Nagai, S			A position-sensitive scintillation detector for two-dimensional angular correlation of annihilation radiation using metal-package position-sensitive photomultiplier tubes	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article						gamma-ray detector; BGO array; position-sensitive photomultiplier tube; positron annihilation; 2D-ACAR	APPARATUS	We have constructed and tested a prototype of a new position sensitive gamma-ray detector which consists of an array of 2.6 x 2.6 x 18 mm(3) EGO scintillator blocks, a light guide, and four metal-package position-sensitive photomultiplier tubes (R5900-00-C8) recently developed by Hamamatsu Photonics Co. Ltd. Scalability of the detector of this type makes it possible to construct a larger detector using many PS-PMTs, which will be useful for the two-dimensional angular correlation of annihilation radiation apparatus. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Arts & Sci, Inst Phys, Meguro Ku, Tokyo 1538902, Japan; Hamamatsu Photon Co Ltd, Toyooka Village, Shizuoka 4380126, Japan	Inoue, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Inst Phys, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.		Nagai, Yasuyoshi/A-8995-2011; Inoue, Koji/H-1814-2011				BERKO S, 1977, PHYS LETT A, V63, P335, DOI 10.1016/0375-9601(77)90922-7; Hyodo T, 1997, MATER SCI FORUM, V255-2, P488; KYUSHIMA H, 1994, IEEE T NUCL SCI, V41, P725, DOI 10.1109/23.322796; MILLS AP, 1997, P 7 INT S ADV NUCL E, P500; Nagai Y, 1996, NUCL INSTRUM METH A, V378, P629, DOI 10.1016/0168-9002(96)00424-X; WATANABE M, 1995, IEEE T NUCL SCI, V42, P1090, DOI 10.1109/23.467743; WEST RN, 1995, ACTA PHYS POL A, V88, P249; WEST RN, 1981, J PHYS E SCI INSTRUM, V14, P478, DOI 10.1088/0022-3735/14/4/021	8	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	MAR 1	1999	423	2-3					364	368		10.1016/S0168-9002(98)01266-2		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	173JF	WOS:000078976800020		
J	Inoue, Y; Ohtake, T; Yokoyama, I; Yoshikawa, K; Ohtomo, K				Inoue, Y; Ohtake, T; Yokoyama, I; Yoshikawa, K; Ohtomo, K			Deadtime correction in measurement of fractional renal accumulation of Tc-99(m)-MAG3	NUCLEAR MEDICINE COMMUNICATIONS			English	Article							GLOMERULAR-FILTRATION RATE; CAMERA; TC-99M-DTPA; CHILDREN; CLEARANCE; TECHNETIUM-99M-DTPA; QUANTIFICATION; RENOGRAPHY	Fractional renal accumulation of a radiotracer is often used to measure renal function with camera-based methods. We evaluated the effect of deadtime count loss on the calculation of fractional renal accumulation of Tc-99(m)-mercaptoacetyltriglycine (Tc-99(m)-MAG3). In 15 patients, dynamic renal scintigraphy was performed after the injection of 250 MBq of Tc-99(m)-MAG3. A reference source was placed on the periphery of the field of view of the gamma camera to monitor the loss of counts in dynamic imaging. The activity in the syringe was also counted with the camera to measure the injected dose, and the deadtime count loss in the syringe was computed from the observed count rate and deadtime in imaging a point source. Fractional renal accumulation, the ratio of renal accumulation on dynamic imaging to the injected dose, was assessed with and without correction for deadtime loss. Fractional renal accumulation was overestimated by 4.1% with no deadtime correction, when the value after correction for loss in both syringe counts and dynamic imaging was used as a standard. It was underestimated by 4.0% with correction for syringe counts only The results suggest that correction for count loss only in measuring the injected dose does not lead to a significant improvement in the accuracy of estimating renal function with camera-based methods. ((C) 1999 Lippincott Williams & Wilkins).	Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo 1088639, Japan	Inoue, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						SHORE RM, 1984, RADIOLOGY, V151, P627; ARNOLD JE, 1974, J NUCL MED, V15, P412; DOBBELIER A, 1990, NUCL MED COMMUN, V12, P27; FLEMING JS, 1987, EUR J NUCL MED, V13, P250; FREEDMAN GS, 1972, RADIOLOGY, V104, P713; GATES GF, 1991, CLIN NUCL MED, V16, P73, DOI 10.1097/00003072-199102000-00001; GATES GF, 1982, AM J ROENTGENOL, V138, P565; GOATES JJ, 1990, J NUCL MED, V31, P424; HEYMAN S, 1988, J UROLOGY, V140, P780; Inoue Y, 1997, EUR J NUCL MED, V24, P1418, DOI 10.1007/s002590050169; Inoue Y, 1998, Radiat Med, V16, P149; Inoue Y, 1998, EUR J NUCL MED, V25, P1232, DOI 10.1007/s002590050289; Itoh K, 1996, J NUCL MED, V37, P71; MADSEN MT, 1986, MED PHYS, V13, P344, DOI 10.1118/1.595874; NIELSEN SP, 1977, J NUCL MED, V18, P112; REHLING M, 1985, EUR J NUCL MED, V11, P1, DOI 10.1007/BF00440952; SCHLEGEL JU, 1979, J UROLOGY, V122, P447; SORENSON JA, 1976, J NUCL MED, V17, P137; Taylor A, 1997, RADIOLOGY, V204, P47; TAYLOR A, 1993, J NUCL MED, V34, P1766; YAP HK, 1985, ACTA PAEDIATR SCAND, V74, P579, DOI 10.1111/j.1651-2227.1985.tb11033.x; ZUBAL IG, 1992, J NUCL MED, V33, P1712	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0143-3636			NUCL MED COMMUN	Nucl. Med. Commun.	MAR	1999	20	3					267	272		10.1097/00006231-199903000-00010		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	208BR	WOS:000080970800010		
J	Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T				Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T		CP-PACS Collaboration	Quenched light hadron spectrum with the Wilson quark action: Final results from CP-PACS	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		CHIRAL PERTURBATION-THEORY; APPROXIMATION; QCD	We report the final results of the CP-PACS calculation for the quenched light hadron spectrum with the Wilson quark action. Our data support the presence of quenched chiral singularities, and this motivates us to use mass formulae based on quenched chiral perturbation theory in order to extrapolate hadron masses to the physical point. Hadron masses and decay constants in the continuum limit show unambiguous systematic deviations from experiment. We also report the results for light quark masses.	Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan; Univ Tsukuba, Ctr Computat Phys, Ibaraki, Osaka 3058577, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; High Energy Accelerator Res Org KEK, Ibaraki, Osaka 3050801, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan.		Ukawa, Akira/A-6549-2011				BERNARD CW, 1992, PHYS REV D, V46, P853, DOI 10.1103/PhysRevD.46.853; Booth M, 1997, PHYS REV D, V55, P3092, DOI 10.1103/PhysRevD.55.3092; BUTLER F, 1994, NUCL PHYS B, V430, P179, DOI 10.1016/0550-3213(94)90654-8; *CP PACS COLL, 1998, NUCL PHYS B PS A, V60, P14; *CP PACS COLL, 1998, NUCL PHYS B S, V63, P161; Labrenz JN, 1996, PHYS REV D, V54, P4595, DOI 10.1103/PhysRevD.54.4595; SHARPE SR, 1992, PHYS REV D, V46, P3146, DOI 10.1103/PhysRevD.46.3146	7	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						189	191		10.1016/S0920-5632(99)85018-X		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000017		
J	Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T				Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T		CP-PACS Collaboration	Full QCD light hadron spectrum from the CP-PACS	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO			We report on an on-going two-flavor full QCD study on CP-PACS using an RG-improved gauge action and a tadpole-improved SW quark action. Runs are made for three lattice spacings a(-1) approximate to 0.9, 1.3, and 2.5 GeV on 12(3) x 24, 16(3) x 32, and 24(3) x 48 lattices. Four sea quark masses having m(PS)/m(V) approximate to 0.8-0.6 are simulated, for each of which hadron masses are evaluated for valence quark masses corresponding to m(PS)/m(V) approximate to 0.8-0.5. Results for hadron and light quark masses are presented and compared with those obtained in quenched QCD.	Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan; Univ Tsukuba, Ctr Computat Phys, Ibaraki, Osaka 3058577, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; High Energy Accelerator Res Org KEK, Ibaraki, Osaka 3050801, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan.		Ukawa, Akira/A-6549-2011				Bhattacharya T, 1998, NUCL PHYS B-PROC SUP, V63, P95, DOI 10.1016/S0920-5632(97)00701-9; *CP PACS COLL, 1998, NUCL PHYS B PS A, V60, P335; *CP PACS COLL, 1998, NUCL PHYS B PS A, V60, P14; *CP PACS COLL, 1998, NUCL PHYS B S, V63, P161; *CP PACS COLL, 1998, NUCL PHYS B S, V63, P221; Eicker N, 1997, PHYS LETT B, V407, P290, DOI 10.1016/S0370-2693(97)00718-1; Yoshie T, 1998, NUCL PHYS B-PROC SUP, V63, P3, DOI 10.1016/S0920-5632(97)00690-7	7	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						192	194		10.1016/S0920-5632(99)85019-1		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000018		
J	Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T				Aoki, S; Boyd, G; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T		CP-PACS Collaboration	The static quark potential in full QCD	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO			We report results on the static quark potential in two-flavor full QCD. The calculation is performed for three values of lattice spacing a(-1) approximate to 0.9, 1.3 and 2.5 GeV on 12(3) x 24, 16(3) x 32 and 24(3) x 48 lattices respectively, at sea quark masses corresponding to m(pi)/m(p) approximate to 0.8-0.6. An RG-improved gauge action and a tadpole-improved SW clover quark action are employed. We discuss scaling of m(p)/root sigma and effects of dynamical quarks on the potential.	Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan; Univ Tsukuba, Ctr Computat Phys, Ibaraki, Osaka 3058577, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; High Energy Accelerator Res Org KEK, Ibaraki, Osaka 3050801, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Ibaraki, Osaka 3058571, Japan.		Ukawa, Akira/A-6549-2011				*CP PACS COLL, 1998, NUCL PHYS B S, V63, P221; ELKHADRA AX, 1992, PHYS REV LETT, V69, P729, DOI 10.1103/PhysRevLett.69.729; *SESAM TCHIL COLL, 1998, NUCL PHYS B S, V63, P209; *UKQCD, 1998, NUCL PHYS B S, V63, P227	4	26	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						216	218		10.1016/S0920-5632(99)85027-0		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000026		
J	Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yamada, N; Yoshie, T				Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yamada, N; Yoshie, T		JLQCD Collaboration	Non-perturbative renormalization factors of bilinear quark operators for Kogut-Susskind fermions and light quark masses in quenched QCD	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		ANOMALOUS DIMENSION	Light quark masses are computed for Kogut-Susskind fermions by evaluating non-perturbatively the renormalization factor for bilinear quark operators. Calculations are carried out in the quenched approximation at beta = 6.0, 6.2, and 6.4. For the average up and down quark mass we find m<(MS)over bar>(2GeV) = 4.15(27)MeV in the continuum limit, which is significantly larger than 3.51(20)MeV (q(*) = 1/a) or 3.40(21)MeV (q(*) = pi/a) obtained with the one-loop perturbative renormalization factor.	Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan; Univ Tsukuba, Ctr Computat Phys, Tsukuba, Ibaraki 3058577, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan.		Ukawa, Akira/A-6549-2011				Vermaseren JAM, 1997, PHYS LETT B, V405, P327, DOI 10.1016/S0370-2693(97)00660-6; Chetyrkin KG, 1997, PHYS LETT B, V404, P161, DOI 10.1016/S0370-2693(97)00535-2; MARTINELLI G, 1995, NUCL PHYS B, V445, P81, DOI 10.1016/0550-3213(95)00126-D; FRANCO E, HEPPH9803491; GUPTA R, 1998, NUCL PHYS B S, V63, P95; *JLQCD COLL, 1997, NUCL PHYS B S, V53, P209; vanRitbergen T, 1997, PHYS LETT B, V400, P379, DOI 10.1016/S0370-2693(97)00370-5	7	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						279	281		10.1016/S0920-5632(99)85047-6		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000046		
J	Tsutsui, N; Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Ukawa, A; Yamada, N; Yoshie, T				Tsutsui, N; Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Ukawa, A; Yamada, N; Yoshie, T		JLQCD Collaboration	Hadron matrix elements for nucleon decay with the Wilson quark action	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		PROTON-DECAY; OPERATORS	We report preliminary results of our study of matrix elements of baryon number violating operators which appear in the low-energy effective Lagrangian of (SUSY-)Grand Unified Theories. The calculation is performed on a 32(3) x 80 lattice at beta = 6.1 using Wilson fermions in the quenched approximation. Our calculation is independent of details of (SUSY-)GUT models and covers all interesting decay modes.	Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan; Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Univ Tsukuba, Ctr Computat Phys, Tsukuba, Ibaraki 3058577, Japan	Tsutsui, N (reprint author), Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan.		Ukawa, Akira/A-6549-2011				WEINBERG S, 1979, PHYS REV LETT, V43, P1566, DOI 10.1103/PhysRevLett.43.1566; CHADHA S, 1983, NUCL PHYS B, V229, P105, DOI 10.1016/0550-3213(83)90355-3; GAVELA MB, 1989, NUCL PHYS B, V312, P269, DOI 10.1016/0550-3213(89)90297-6; WILCZEK F, 1979, PHYS REV LETT, V43, P1571, DOI 10.1103/PhysRevLett.43.1571; CLAUDSON M, 1982, NUCL PHYS B, V195, P297, DOI 10.1016/0550-3213(82)90401-1; BOWLER KC, 1988, NUCL PHYS B, V296, P4321; HARA Y, 1986, PHYS REV D, V34, P3399, DOI 10.1103/PhysRevD.34.3399; *PART DAT GROUP, 1998, EUR PHYS J C, V3, P614; RICHARDS DG, 1987, NUCL PHYS B, V286, P683, DOI 10.1016/0550-3213(87)90459-7	9	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						297	299		10.1016/S0920-5632(99)85053-1		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000052		
J	Ishikawa, KI; Yamada, N; Aoki, S; Fukugita, M; Hashimoto, S; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Matsufuru, H; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yoshie, T				Ishikawa, KI; Yamada, N; Aoki, S; Fukugita, M; Hashimoto, S; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Matsufuru, H; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yoshie, T		JLQCD Collaboration	Scaling behavior of f(B) with NRQCD	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		MESON DECAY CONSTANTS; HEAVY-LIGHT MESONS; LATTICE QCD; B-MESON	We investigate the scaling behavior of the B meson decay constant f(B) and f(Bs), at beta=5.7, 5.9, 6.1, employing the NRQCD heavy quark action and the clover light quark action. Mixing effect from dimension-4 operator in the heavy-light axial-vector current is studied, and we find that the a dependence of f(B) is significantly reduced. Our preliminary result for the decay constants in the quenched approximation is f(B)=162((+35)(-18)) MeV, f(Bs)=190((+40)(-19)) MeV, and f(Bs)/f(B)=1.18((+6)(-6)).	Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan; Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Univ Tsukuba, Ctr Computat Phys, Tsukuba, Ibaraki 3058577, Japan; Univ Heidelberg, Inst Theoret Phys, D-6900 Heidelberg, Germany	Ishikawa, KI (reprint author), Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan.		Ukawa, Akira/A-6549-2011				ElKhadra AX, 1997, PHYS REV D, V55, P3933, DOI 10.1103/PhysRevD.55.3933; Aoki S, 1998, PHYS REV LETT, V80, P5711, DOI 10.1103/PhysRevLett.80.5711; El-Khadra AX, 1998, PHYS REV D, V58; GOCHKELER M, 1998, PHYS REV D, V57, P5562; Hein J, 1998, NUCL PHYS B-PROC SUP, V63, P347, DOI 10.1016/S0920-5632(97)00765-2; HERNANDEZ OF, 1994, PHYS REV D, V50, P495, DOI 10.1103/PhysRevD.50.495; Khan AA, 1998, PHYS LETT B, V427, P132; Khan AA, 1997, PHYS REV D, V56, P7012, DOI 10.1103/PhysRevD.56.7012; Morningstar CJ, 1998, PHYS REV D, V57, P6741, DOI 10.1103/PhysRevD.57.6741	9	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						363	365		10.1016/S0920-5632(99)85074-9		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000073		
J	Aoki, S; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T				Aoki, S; Burkhalter, R; Ejiri, S; Fukugita, M; Hashimoto, S; Iwasaki, Y; Kanaya, K; Kaneko, T; Kuramashi, Y; Nagai, K; Okawa, M; Shanahan, HP; Ukawa, A; Yoshie, T		CP-PACS Collaboration	Heavy quark physics in N-f=2 QCD	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		CHIRAL PERTURBATION-THEORY; DECAY CONSTANTS; LIGHT MESONS; FERMIONS	We present a preliminary analysis of the heavy-heavy spectrum and heavy-light decay constants in full QCD, using a tadpole-improved SW quark action and an RG-improved gauge action on a 16(3) x 32 lattice with four sea quark masses corresponding to m(pi)/m(p) approximate to 0.8, 0.75, 0.7, 0.6 and a(-1) approximate to 1.3 GeV. We focus particularly on the effect of sea quarks on these observables.	Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan; Univ Tsukuba, Ctr Computat Phys, Tsukuba, Ibaraki 3058577, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Tsukuba, Ibaraki 3058571, Japan.		Ukawa, Akira/A-6549-2011				Sharpe SR, 1996, PHYS REV D, V53, P5125, DOI 10.1103/PhysRevD.53.5125; ElKhadra AX, 1997, PHYS REV D, V55, P3933, DOI 10.1103/PhysRevD.55.3933; AOKI S, HEPLAT9802034; BERNARD C, IN PRESS PHYS REV LE; BERNARD CW, 1994, PHYS REV D, V49, P2536, DOI 10.1103/PhysRevD.49.2536; BOOTH MJ, 1995, PHYS REV D, V51, P2338, DOI 10.1103/PhysRevD.51.2338; Collins S, 1997, PHYS REV D, V55, P1630, DOI 10.1103/PhysRevD.55.1630; El-Khadra A. X., 1993, Nuclear Physics B, Proceedings Supplements, V30, DOI 10.1016/0920-5632(93)90247-4; Glassner U, 1996, PHYS LETT B, V383, P98, DOI 10.1016/0370-2693(96)00700-9	9	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						375	377		10.1016/S0920-5632(99)85078-6		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000077		
J	Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yamada, N; Yoshie, T				Aoki, S; Fukugita, M; Hashimoto, S; Ishikawa, KI; Ishizuka, N; Iwasaki, Y; Kanaya, K; Kaneda, T; Kaya, S; Kuramashi, Y; Okawa, M; Onogi, T; Tominaga, S; Tsutsui, N; Ukawa, A; Yamada, N; Yoshie, T		JLQCD Collaboration	Phase structure of lattice QCD at finite temperature for 2+1 flavors of Kogut-Susskind quarks	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		TRANSITION	We report on a study of the finite-temperature chiral transition on an N-t = 4 lattice for 2 + 1 flavors of Kogut-Susskind quarks. We find the point of physical quark masses to lie in the region of crossover, in agreement with results of previous studies. Results of a detailed examination of the m(v,d) = m(s) case indicate vanishing of the screening mass of sigma meson at the end point of the first-order transition.	Univ Tsukuba, Inst Phys, Tokyo 1888571, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; KEK, High Energy Accelerator Res Org, Ibaraki, Osaka 3050801, Japan; Hiroshima Univ, Dept Phys, Hiroshima 7398526, Japan; Univ Tsukuba, Ctr Computat Phys, Ibaraki, Osaka 3058577, Japan	Aoki, S (reprint author), Univ Tsukuba, Inst Phys, Tokyo 1888571, Japan.		Ukawa, Akira/A-6549-2011				PISARSKI RD, 1984, PHYS REV D, V29, P338, DOI 10.1103/PhysRevD.29.338; BROWN FR, 1990, PHYS REV LETT, V65, P2491, DOI 10.1103/PhysRevLett.65.2491; GAVAI RV, 1987, PHYS REV LETT, V58, P2519, DOI 10.1103/PhysRevLett.58.2519; GAVIN S, 1994, PHYS REV D, V49, pR3079; Gottlieb S., 1991, Nuclear Physics B, Proceedings Supplements, V20, DOI 10.1016/0920-5632(91)90919-6; Iwasaki Y, 1996, PHYS REV D, V54, P7010, DOI 10.1103/PhysRevD.54.7010; KOGUT JB, 1991, PHYS LETT B, V263, P101, DOI 10.1016/0370-2693(91)91714-7	7	37	37	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						459	461		10.1016/S0920-5632(99)85104-4		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000103		
J	Hotta, T; Nishimura, J; Tsuchiya, A				Hotta, T; Nishimura, J; Tsuchiya, A			Dynamical properties of large N reduced model of Yang-Mills theory	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		IIB MATRIX MODEL	We study the large N reduced model of D-dimensional Yang-Mills theory with special attention to the dynamical aspects related to the eigenvalues of the N x N matrices, which correspond to the space-time coordinates in the IIB matrix model. We define a quantity which represents the uncertainty of the space-time coordinates and show that it is of the same order as the extent of the space time, which means that the classical space-time picture is maximally broken. The absence of the SSB of the Lorentz invariance is also shown.	Univ Tokyo, Inst Phys, Meguro Ku, Tokyo 1539802, Japan; Nagoya Univ, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Osaka Univ, Grad Sch Sci, Dept Phys, Osaka 5600043, Japan	Hotta, T (reprint author), Univ Tokyo, Inst Phys, Meguro Ku, 4-6-1 Komaba, Tokyo 1539802, Japan.						Ishibashi N, 1997, NUCL PHYS B, V498, P467, DOI 10.1016/S0550-3213(97)00290-3; EGUCHI T, 1982, PHYS REV LETT, V48, P1063, DOI 10.1103/PhysRevLett.48.1063; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Aoki H, 1998, PROG THEOR PHYS, V99, P713, DOI 10.1143/PTP.99.713; Fukuma M, 1998, NUCL PHYS B, V510, P158, DOI 10.1016/S0550-3213(97)00584-1; HOTTA T, UNPUB; NISHIMURA J, UNPUB	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						810	812		10.1016/S0920-5632(99)85211-6		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000210		
J	Nakajima, T; Nishimura, J				Nakajima, T; Nishimura, J			Numerical studies of the double scaling limit in a large N reduced model	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	XVIth International Symposium on Lattice Field Theory (Lattice 98)	JUL 13-18, 1998	UNIV COLORADO, BOULDER, COLORADO	IBM Corp, Univ Colorado, Dept Physics, Council Res & Creative Work, US Natl Sci Fdn, US DOE	UNIV COLORADO		GAUGE-THEORY; STRINGS	We study the two-dimensional Eguchi-Kawai model as a toy model of the IIB matrix model, which has been recently proposed as a nonperturbative definition of the type IIB superstring theory. While the planar limit of the model is known to reproduce the two-dimensional Yang-Mills theory, we find through Monte Carlo simulation that the model allows a different large N limit, which can be considered as the double scaling limit in matrix models.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan; Nagoya Univ, Dept Phys, Nagoya, Aichi 46401, Japan	Nakajima, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan.						GROSS DJ, 1980, PHYS REV D, V21, P446, DOI 10.1103/PhysRevD.21.446; BREZIN E, 1990, PHYS LETT B, V236, P144, DOI 10.1016/0370-2693(90)90818-Q; Ishibashi N, 1997, NUCL PHYS B, V498, P467, DOI 10.1016/S0550-3213(97)00290-3; EGUCHI T, 1982, PHYS REV LETT, V48, P1063, DOI 10.1103/PhysRevLett.48.1063; DOUGLAS MR, 1990, NUCL PHYS B, V335, P635, DOI 10.1016/0550-3213(90)90522-F; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; GROSS DJ, 1990, PHYS REV LETT, V64, P127, DOI 10.1103/PhysRevLett.64.127; DAS SR, 1987, REV MOD PHYS, V59, P235, DOI 10.1103/RevModPhys.59.235; Nakajima T, 1998, NUCL PHYS B, V528, P355, DOI 10.1016/S0550-3213(98)00472-6	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	73						813	815		10.1016/S0920-5632(99)85212-8		3	Physics, Particles & Fields	Physics	205KW	WOS:000080821000211		
J	Minowa, M; Moriyama, S; Inoue, Y; Namba, T; Takasu, Y; Yamamoto, A				Minowa, M; Moriyama, S; Inoue, Y; Namba, T; Takasu, Y; Yamamoto, A			The Tokyo axion helioscope experiment	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	5th IFT Workshop on Axions	MAR 13-15, 1998	GAINESVILLE, FLORIDA	Univ Florida Dept Phys, UF Coll Liberal Arts & Sci, UF Off Res & Grad Educ, Natl High Magnet Field Lab, US DOE			SOLAR AXIONS; CP	A preliminary result of the solar axion search experiment at the University of Tokyo is presented. We searched for axions which could be produced in the solar core by exploiting the axion helioscope. The helioscope consists of a superconducting magnet with field strength of 4 Tesla over 2.3 meters. From the absence of the axion signal we set a 95 % confidence level upper limit on the axion coupling to two photons g(a gamma gamma) < 6.0 x 10(-10)GeV(-1) for the axion mass m(a) < 0.03 eV. This is the first solar axion search experiment whose sensitivity to g(a gamma gamma) exceeds the limit inferred from the solar age consideration.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Sci, Res Ctr Early Universe, RESCEU,Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Int Ctr Particle Phys, ICEPP, Bunkyo Ku, Tokyo 1130033, Japan; High Energy Accelerator Res Org, Ibaraki, Osaka 3050801, Japan	Minowa, M (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						KIM JE, 1979, PHYS REV LETT, V43, P103, DOI 10.1103/PhysRevLett.43.103; WEINBERG S, 1978, PHYS REV LETT, V40, P223, DOI 10.1103/PhysRevLett.40.223; DINE M, 1981, PHYS LETT B, V104, P199, DOI 10.1016/0370-2693(81)90590-6; KIM JE, 1987, PHYS REP, V150, P1, DOI 10.1016/0370-1573(87)90017-2; LAZARUS DM, 1992, PHYS REV LETT, V69, P2333, DOI 10.1103/PhysRevLett.69.2333; SIKIVIE P, 1983, PHYS REV LETT, V51, P1415, DOI 10.1103/PhysRevLett.51.1415; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; VANBIBBER K, 1989, PHYS REV D, V39, P2089, DOI 10.1103/PhysRevD.39.2089; AVIGNONE FT, ASTROPH9708008; CRESWICK RJ, HEPPH9708210; MORIYAMA S, COMMUNICATION; YAMAMOTO A, 1997, KEKPREPRINT97202; YAMAMOTO A, 1997, INPRESS P 15 INT C M; ZHITNITSKII AP, 1980, SOV J NUCL PHYS+, V31, P260	14	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	72						171	175		10.1016/S0920-5632(98)00520-9		5	Physics, Particles & Fields	Physics	185EY	WOS:000079656200026		
J	Moriyama, S				Moriyama, S			Proposal to search for a monochromatic component of solar axions using Fe-57	NUCLEAR PHYSICS B-PROCEEDINGS SUPPLEMENTS			English	Article; Proceedings Paper	5th IFT Workshop on Axions	MAR 13-15, 1998	GAINESVILLE, FLORIDA	Univ Florida Dept Phys, UF Coll Liberal Arts & Sci, UF Off Res & Grad Educ, Natl High Magnet Field Lab, US DOE			SPIN STRUCTURE-FUNCTION; STRUCTURE-FUNCTION G1(X); PRECISION-MEASUREMENT; CP CONSERVATION; SCATTERING; PROTON; INVARIANCE; DEUTERON; DETECTOR	An experimental method is introduced to search for almost monochromatic solar axions. In this method, we can search for solar axions by exploiting the axion-quark coupling, not relying on the axion-photon coupling at all. A recent experimental result of Krcmar is presented.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Moriyama, S (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ABE K, 1995, PHYS REV LETT, V75, P25, DOI 10.1103/PhysRevLett.75.25; ADAMS D, 1994, PHYS LETT B, V329, P399, DOI 10.1016/0370-2693(94)90793-5; ADEVA B, 1993, PHYS LETT B, V302, P533, DOI 10.1016/0370-2693(93)90438-N; Altarelli G, 1997, NUCL PHYS B, V496, P337, DOI 10.1016/S0550-3213(97)00201-0; ABE K, 1995, PHYS REV LETT, V74, P346, DOI 10.1103/PhysRevLett.74.346; CHANG SY, 1993, PHYS LETT B, V316, P51, DOI 10.1016/0370-2693(93)90656-3; MORIYAMA S, 1995, PHYS REV LETT, V75, P3222, DOI 10.1103/PhysRevLett.75.3222; PECCEI RD, 1977, PHYS REV D, V16, P1791, DOI 10.1103/PhysRevD.16.1791; KIM JE, 1979, PHYS REV LETT, V43, P103, DOI 10.1103/PhysRevLett.43.103; RESSELL MT, 1991, PHYS REV D, V44, P3001, DOI 10.1103/PhysRevD.44.3001; PASCHOS EA, 1994, PHYS LETT B, V323, P367, DOI 10.1016/0370-2693(94)91233-5; Anthony PL, 1996, PHYS REV D, V54, P6620, DOI 10.1103/PhysRevD.54.6620; DINE M, 1981, PHYS LETT B, V104, P199, DOI 10.1016/0370-2693(81)90590-6; Adams D, 1997, PHYS REV D, V56, P5330, DOI 10.1103/PhysRevD.56.5330; LAZARUS DM, 1992, PHYS REV LETT, V69, P2333, DOI 10.1103/PhysRevLett.69.2333; SIKIVIE P, 1983, PHYS REV LETT, V51, P1415, DOI 10.1103/PhysRevLett.51.1415; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; VANBIBBER K, 1989, PHYS REV D, V39, P2089, DOI 10.1103/PhysRevD.39.2089; SHIFMAN MA, 1980, NUCL PHYS B, V166, P493, DOI 10.1016/0550-3213(80)90209-6; ANTHONY PL, 1993, PHYS REV LETT, V71, P959, DOI 10.1103/PhysRevLett.71.959; AVIGNONE FT, UNPUB PHYS LETT B; HAXTON WC, 1991, PHYS REV LETT, V66, P2557, DOI 10.1103/PhysRevLett.66.2557; Hisano J, 1997, PHYS REV D, V55, P411, DOI 10.1103/PhysRevD.55.411; HOOGEVEEN F, 1992, PHYS LETT B, V286, P165, DOI 10.1016/0370-2693(92)90175-4; KRCMAR M, IRBZEF9801; MORIYAMA S, UNPUB PHYS LETT B; MOROI T, HEPPH9804291; ZHITNITSKII AP, 1980, SOV J NUCL PHYS+, V31, P260	28	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-5632			NUCL PHYS B-PROC SUP	Nucl. Phys. B-Proc. Suppl.	MAR	1999	72						183	186		10.1016/S0920-5632(98)00522-2		4	Physics, Particles & Fields	Physics	185EY	WOS:000079656200028		
J	Tamaki, Y; Araie, M; Nagahara, M; Tomita, K				Tamaki, Y; Araie, M; Nagahara, M; Tomita, K			Acute effects of cigarette smoking on tissue circulation in human optic nerve head and choroid-retina	OPHTHALMOLOGY			English	Article; Proceedings Paper	12th International Congress of Eye Research	OCT   01, 1996	YOKOHAMA, JAPAN				LASER SPECKLE PHENOMENON; BLOOD-FLOW; 2-DIMENSIONAL MEASUREMENT; INTRAOCULAR-PRESSURE; DOPPLER FLOWMETRY; NICOTINE; VISUALIZATION; PHOTOGRAPHY; METABOLISM; NONCONTACT	Objective: To study the acute effects of cigarette smoking on tissue circulation in the human optic nerve head (ONH) and choroid-retina, Design: Nonrandomized, comparative trial (sequential self-controlled). Participants: Nine healthy habitual smokers (age, 28 +/- 4 years; number of cigarettes smoked per day, 27 +/- 10; length of smoking history, 10 +/- 4 years; mean +/- standard deviation). Intervention: Using the laser speckle method, normalized blur (NB) value, a quantitative index of tissue blood velocity, was measured every 0.125 second and averaged over three pulses across an area located in the temporal site of the ONH free of visible surface vessels (NBONH) and across an area located halfway between the macula and the ONH with no discrete vessels visible (NBch-ret). NBONH, NBch-ret, and intraocular pressure (IOP) in one randomly chosen eye, and blood pressure (BP) and pulse rate (PR) were measured before and 1, 5, 10, 15, 20, 25, 30, 45, 60, and 90 minutes after sham smoking using a short drinking straw as a cigarette substitute (control). One week later, NBONH, NBch-ret, and IOP in the same eye, and BP and PR were measured after cigarette smoking according to the same time schedule as in the control experiment, Main Outcome Measures: NBONH and NBch-ret. Results: In the control experiment, all parameters examined showed no significant change during the experimental period. Differences in NBONH and NBch-ret before and after actual smoking were significantly greater than those in the control experiment (analysis of variance, P = 0.0000, 0.0000), BP and PR were significantly increased between 1 and 30 minutes after actual smoking as compared with control data, while IOP showed no significant change at any time of measurement. Conclusions: These results indicated that cigarette smoking increased tissue blood velocity in the ONH and possibly in the choroid in habitual smokers.	Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 113, Japan; Tokyo Metropolitan Geriatr Hosp, Eye Clin, Tokyo 173, Japan; Tokyo Kosei Nenkin Hosp, Eye Clin, Tokyo, Japan	Araie, M (reprint author), Univ Tokyo, Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Alm A, 1992, ADLERS PHYSL EYE, P198; BENOWITZ NL, 1982, J PHARMACOL EXP THER, V221, P368; SARIN CL, 1974, JAMA-J AM MED ASSOC, V229, P1327, DOI 10.1001/jama.229.10.1327; BRIERS JD, 1982, INVEST OPHTH VIS SCI, V22, P255; MORGADO PB, 1994, OPHTHALMOLOGY, V101, P1220; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; ROJANAPONGPUN P, 1993, GRAEF ARCH CLIN EXP, V231, P371, DOI 10.1007/BF00919642; ARMITAGE AK, 1975, BRIT MED J, V4, P313; GEIJER C, 1979, INVEST OPHTH VIS SCI, V18, P1030; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; RIVA CE, 1992, EXP EYE RES, V55, P499, DOI 10.1016/0014-4835(92)90123-A; BALL K, 1974, LANCET, V2, P822; FIELDING JE, 1985, NEW ENGL J MED, V313, P491, DOI 10.1056/NEJM198508223130807; HANS FJ, 1993, AM J PHYSIOL, V265, pH2142; Isono Hiroaki, 1997, Nippon Ganka Gakkai Zasshi, V101, P684; KOELLE JS, 1993, LASER MED SCI, V8, P49, DOI 10.1007/BF02559756; LEB G, 1970, J PHARMACOL EXP THER, V173, P138; LEHTOVIRTA P, 1978, BRIT J OBSTET GYNAEC, V85, P729, DOI 10.1111/j.1471-0528.1978.tb15592.x; MJOS OD, 1973, SCAND J CLIN LAB INV, V32, P75, DOI 10.3109/00365517309082453; Nagahara Miyuki, 1997, Nippon Ganka Gakkai Zasshi, V101, P173; ROBINSON F, 1985, INVEST OPHTH VIS SCI, V26, P609; SHONAT RD, 1992, INVEST OPHTH VIS SCI, V33, P3174; SOSSI N, 1983, ARCH OPHTHALMOL-CHIC, V101, P98; Tamaki Y, 1996, CURR EYE RES, V15, P543, DOI 10.3109/02713689609000765; WENNMALM A, 1982, CLIN PHYSIOL, V2, P529, DOI 10.1111/j.1475-097X.1982.tb00059.x	28	20	20	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0161-6420			OPHTHALMOLOGY	Ophthalmology	MAR	1999	106	3					564	569		10.1016/S0161-6420(99)90117-3		6	Ophthalmology	Ophthalmology	171NU	WOS:000078870800032		
J	Iwamoto, S; Kageshima, H; Yuasa, T; Nishioka, M; Someya, T; Arakawa, Y; Fukutani, K; Shimura, T; Kuroda, K				Iwamoto, S; Kageshima, H; Yuasa, T; Nishioka, M; Someya, T; Arakawa, Y; Fukutani, K; Shimura, T; Kuroda, K			Resonant photorefractive effect in InGaAs/GaAs multiple quantum wells	OPTICS LETTERS			English	Article							GAAS	Semi-insulating InGaAs/GaAs multiple quantum wells are fabricated by metal-organic vapor-phase epitaxy and proton implantation. Two-wave mixing gain and four-wave mixing diffraction efficiency are measured at wavelengths of 0.91-0.94 mu m in the Franz-Keldysh geometry. We observe a large photorefractive effect caused by the excitonic electro-optic effect. The maximum diffraction efficiency reaches similar to 1.5 x 10(-4). (C) 1999 Optical Society of America.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Iwamoto, S (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan.	iwamoto@cc.iis.u-tokyo.ac.jp	Someya, Takao/H-3052-2015	Someya, Takao/0000-0003-3051-1138			Ding Y, 1997, OPT LETT, V22, P718, DOI 10.1364/OL.22.000718; PARTOVI A, 1993, OPT LETT, V18, P906, DOI 10.1364/OL.18.000906; WANG QN, 1993, J APPL PHYS, V74, P4254, DOI 10.1063/1.354438; Basu P.K., 1997, THEORY OPTICAL PROCE, P392; DeMatos C, 1997, APPL PHYS LETT, V70, P3591, DOI 10.1063/1.119242; DEMOTOS C, 1996, APPL PHYS LETT, V68, P3576; DYMENT JC, 1973, J APPL PHYS, V44, P207, DOI 10.1063/1.1661863; GORDY E, 1957, J BIOL CHEM, V227, P285; MARZIN JY, 1985, PHYS REV B, V31, P8298, DOI 10.1103/PhysRevB.31.8298; Miao J, 1997, APPL PHYS LETT, V70, P847, DOI 10.1063/1.118222; NIKI S, 1989, APPL PHYS LETT, V55, P1339, DOI 10.1063/1.101649; NOLTE DD, 1995, PHOTOREFRACTIVE EFFE, pCH7; WANG Q, 1992, J OPT SOC AM B, V9, P1926; WANG QN, 1991, APPL PHYS LETT, V59, P256, DOI 10.1063/1.105613; ZENDELSON Y, 1988, IEEE T BIOMED ENG, V35, P798	15	10	10	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592			OPT LETT	Opt. Lett.	MAR 1	1999	24	5					321	323		10.1364/OL.24.000321		3	Optics	Optics	173GW	WOS:000078973600017		
J	Ozeki, H; Matsuzaki, M; Murofushi, T				Ozeki, H; Matsuzaki, M; Murofushi, T			Vestibular evoked myogenic potentials in patients with bilateral profound hearing loss	ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES			English	Article						vestibule; saccule; evoked response; vestibulocollic; profound hearing loss; caloric tests	GUINEA-PIG; NEURONS; RESPONSES; MUSCLES; CLICKS; NERVE	We report vestibular evoked myogenic potentials (VEMPs) in 3 patients with bilateral profound hearing loss in order to confirm that they are not of cochlear origin, All of the 3 patients (31-year-old man, 67-year-old man and 47-year-old woman) had bilateral profound hearing loss. They were diagnosed as having congenital hearing loss, bilateral Meniere's disease and inner ear syphilis. Their pure-tone hearing ranged from 81 dB HL to nearly total hearing loss. Stimulation by click (95 dB nHL) evoked biphasic myogenic responses (p13-n23) on the sternocleidomastoid muscle ipsilateral to the stimulated ear. The ear in which the stimulation did not evoke biphasic myogenic responses did not have a caloric response either, These results suggested that VEMPs are not likely of cochlear origin but of vestibular origin.	Univ Tokyo, Fac Med, Dept Otolaryngol, Tokyo 113, Japan	Ozeki, H (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol, 7-3-1 Hongo, Tokyo 113, Japan.						Murofushi T, 1998, ARCH OTOLARYNGOL, V124, P509; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; MCCUE MP, 1994, J NEUROSCI, V14, P6058; McCue MP, 1997, AM J OTOL, V18, P355; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; Murofushi T, 1996, ARCH OTOLARYNGOL, V122, P845; FerberViart C, 1997, ACTA OTO-LARYNGOL, V117, P472, DOI 10.3109/00016489709113424; Murofushi T, 1996, EXP BRAIN RES, V111, P149; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; ROBERTSON DD, 1995, J OTOLARYNGOL, V24, P3; SHOJAKU H, 1996, EQUILIBRIUM RES, V55, P538	12	18	19	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-1569			ORL J OTO-RHINO-LARY	ORL-J. Oto-Rhino-Laryngol. Relat. Spec.	MAR-APR	1999	61	2					80	83		10.1159/000027646		4	Otorhinolaryngology	Otorhinolaryngology	186HX	WOS:000079723800005		
J	Naito, R; Hayashida, T; Mochizuki, M; Kojima, H; Kaga, K				Naito, R; Hayashida, T; Mochizuki, M; Kojima, H; Kaga, K			Auditory brainstem response and neuropathology in a case of systemic T-cell lymphoma with intracranial metastasis	ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES			English	Article						auditory brainstem response; systemic T-cell lymphoma; pathological findings; brainstem damage	NON-HODGKINS LYMPHOMA; CENTRAL NERVOUS-SYSTEM; STEM; INVOLVEMENT; CNS	A 58-year-old male with systemic T-cell lymphoma involving the brainstem eccentrically, showed varying abnormal auditory brainstem responses (ABRs), The initial ABR demonstrated a prolonged V wave peak latency and an I-V IPL on admission. Four months later, all waves were absent bilaterally. Neuropathological examination at autopsy revealed that most of the nuclei and tracts associated with the auditory system were destroyed by lymphoid cell infiltration. It suggested that in the early stages of this disease, lymphoid cells could have involved the lower brainstem and, subsequently, in the advanced stages invaded the inferior colliculus.	Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, Tokyo 1130033, Japan	Naito, R (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						BUCHWALD JS, 1975, SCIENCE, V189, P382, DOI 10.1126/science.1145206; HASHIMOTO I, 1981, BRAIN, V104, P841, DOI 10.1093/brain/104.4.841; BRISBANE JU, 1983, AM J CLIN PATHOL, V79, P285; FUNAI H, 1994, ORL J OTO-RHINO-LARY, V56, P340; HERMAN TS, 1979, CANCER, V43, P390, DOI 10.1002/1097-0142(197901)43:1<390::AID-CNCR2820430155>3.0.CO;2-U; HOLTE H, 1987, CANCER, V60, P2521, DOI 10.1002/1097-0142(19871115)60:10<2521::AID-CNCR2820601029>3.0.CO;2-N; Kaga K, 1993, Acta Otolaryngol Suppl, V503, P99; LAW IP, 1975, CANCER, V36, P225, DOI 10.1002/1097-0142(197507)36:1<225::AID-CNCR2820360125>3.0.CO;2-A; LEVITT LJ, 1980, CANCER, V45, P545, DOI 10.1002/1097-0142(19800201)45:3<545::AID-CNCR2820450322>3.0.CO;2-6; MOLLER AR, 1981, ELECTROEN CLIN NEURO, V52, P18, DOI 10.1016/0013-4694(81)90184-X; MORGELLO S, 1989, NEUROLOGY, V39, P1190; PINKUS GS, 1979, AM J CLIN PATHOL, V72, P540; RECHT L, 1988, AM J MED, V84, P425, DOI 10.1016/0002-9343(88)90262-8; SCHAITKIN B, 1993, CURR OPIN OTOLARYNGO, V1, P79; STOCKARD JJ, 1977, MAYO CLIN PROC, V52, P761	15	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0301-1569			ORL J OTO-RHINO-LARY	ORL-J. Oto-Rhino-Laryngol. Relat. Spec.	MAR-APR	1999	61	2					108	112		10.1159/000027651		5	Otorhinolaryngology	Otorhinolaryngology	186HX	WOS:000079723800010		
J	Murakawa, Y; Yamashita, T; Kanese, Y; Omata, M				Murakawa, Y; Yamashita, T; Kanese, Y; Omata, M			Effect of a Class III antiarrhythmic drug on the configuration of dose response curve for defibrillation	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						defibrillation; defibrillation threshold; antiarrhythmic drug	ENERGY-REQUIREMENTS; VENTRICULAR DEFIBRILLATION; CANINE MODEL; WAVE-FORMS; THRESHOLD; DOGS; SHOCK; FIBRILLATION; CARDIOVERSION; TACHYCARDIA	Antiarrhythmic agents with a Class III action are known to increase defibrillation efficacy. We investigated whether a Class III drug simply shifts the dose-response curve for defibrillation or more extensively alters the curve. Forty-five dogs were divided into four groups according to the shock waveform and the presence or absence of treatment with a novel Class III drug, MS-551 (2 mg/kg: bolus, + 0.02 mg/kg per min). In addition to the conventional transcardiac DFT, dose-response curves were obtained by fitting the results of 40 fibrillation-defibrillation sequences at five shock strengths to a logistic model. MS-551 significantly decreased DFT regardless of the shock waveform (control vs MS-551 = 306 +/- 79 V vs 229 +/- 72 V [monophasic shock, P < 0.05] or 227 +/- 42 V vs 176 +/- 26 V [biphasic shock, P <. 0.005]). The dose-response curves in dogs treated with MS-551 had a gentler slope than those without treatment, and the ratio of the voltages corresponding to 50% and 90% defibrillation success (V90/V50) was significantly greater in the MS-551 group (monophasic: 1.21 +/- 0.06 vs 1.62 +/- 0.42 [P < 0.005], biphasic: 1.20 +/- 0.05 vs 1.37 +/- 0.18 [P < 0.01]). The V90/DFT ratio was also significantly larger in the MS-551 group (monophasic: 1.22 +/- 0.12 vs 1.66 +/- 0.37 [P < 0.001]; biphasic: 1.19 +/- 0.11 vs 1.44 +/- 0.79 [P < 0.005]). Thus, this Class III drug decreased the shock strength corresponding to relatively higher success rate (similar to 90%) less markedly than that for moderate success rate (similar to 50%). These results suggest that a Class III drug does not simply shift the dose response curve in proportion to the change in DFT, but more extensively alters its configuration.	Univ Tokyo, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan	Murakawa, Y (reprint author), Univ Tokyo, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ECHT DS, 1989, CIRCULATION, V79, P1106; TSUCHIHASHI K, 1991, J CARDIOVASC PHARM, V18, P445, DOI 10.1097/00005344-199109000-00018; NAKAYA H, 1993, BRIT J PHARMACOL, V109, P157; BABBS CF, 1980, J ELECTROCARDIOL, V13, P73, DOI 10.1016/S0022-0736(80)80013-6; BABBS CF, 1978, AM HEART J, V95, P331, DOI 10.1016/0002-8703(78)90364-2; CARLISLE EJF, 1988, J ELECTROCARDIOL, V21, P337, DOI 10.1016/0022-0736(88)90110-0; DAVY JM, 1987, AM HEART J, V113, P77, DOI 10.1016/0002-8703(87)90012-3; DEALE OC, 1990, AM J PHYSIOL, V259, pH1544; Dorian P, 1996, CAN J CARDIOL, V12, P399; DORIAN P, 1986, J AM COLL CARDIOL, V8, P327; DORIAN P, 1991, CIRCULATION, V83, P614; DORIAN P, 1994, CAN J CARDIOL, V10, P193; ELLINGBOE JW, 1992, J MED CHEM, V35, P705, DOI 10.1021/jm00082a011; FAIN ES, 1986, CIRCULATION, V73, P1334; FEESER SA, 1990, CIRCULATION, V82, P2128; FRAME LH, 1988, J AM COLL CARDIOL, V12, P746; GLINER BE, 1990, PACE, V13, P326, DOI 10.1111/j.1540-8159.1990.tb02046.x; GWILT M, 1992, EUR J PHARMACOL, V215, P137, DOI 10.1016/0014-2999(92)90021-U; HSIA PW, 1990, PACE, V13, P1326, DOI 10.1111/j.1540-8159.1990.tb02031.x; JACKMAN WM, 1982, CIRCULATION, V66, P187; JONES DL, 1991, CIRC RES, V69, P45; KERBER RE, 1983, AM J PHYSIOL, V244, pH825; LI HG, 1994, J AM COLL CARDIOL, V24, P703; MURAKAWA Y, 1997, J AM COLL CARDIOL, V21, P102; Murakawa Y, 1996, J CARDIOVASC ELECTR, V7, P603, DOI 10.1111/j.1540-8167.1996.tb00568.x; MURAKAWA Y, 1989, AM HEART J, V117, P1065, DOI 10.1016/0002-8703(89)90863-6; NACCARELLI GV, 1995, CARDIAC ELECTROPHYSI, P1426; PETERS W, 1991, AM HEART J, V122, P1355, DOI 10.1016/0002-8703(91)90577-5; SATO R, 1995, J PHARMACOL EXP THER, V274, P469; SINGH BN, 1993, AM J CARDIOL, V72, pF18, DOI 10.1016/0002-9149(93)90960-K; UJHELYI MR, 1995, CIRCULATION, V92, P1644; WESLEY RC, 1993, AM J PHYSIOL, V264, pH1269	32	4	4	FUTURA PUBL CO	ARMONK	135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418 USA	0147-8389			PACE	PACE-Pacing Clin. Electrophysiol.	MAR	1999	22	3					479	486		10.1111/j.1540-8159.1999.tb00476.x		8	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	178EK	WOS:000079253200010		
J	Buss, DM; Shackelford, TK; Kirkpatrick, LA; Choe, JC; Lim, HK; Hasegawa, M; Hasegawa, T; Bennett, K				Buss, DM; Shackelford, TK; Kirkpatrick, LA; Choe, JC; Lim, HK; Hasegawa, M; Hasegawa, T; Bennett, K			Jealousy and the nature of beliefs about infidelity: Tests of competing hypotheses about sex differences in the United States, Korea, and Japan	PERSONAL RELATIONSHIPS			English	Article							EVOLUTIONARY; PERSPECTIVE; PSYCHOLOGY	The different adaptive problems faced by men and women over evolutionary history led evolutionary psychologists to hypothesize and discover sex differences in jealousy as a function of infidelity type. An alternative hypothesis proposes that beliefs about the conditional probabilities of sexual and emotional infidelity account for these sex differences Four studies tested these hypotheses Study 1 tested the hypotheses in an American sample (N = 1,122) by rendering the types of infidelity mutually exclusive. Study 2 tested the hypotheses in an American sample (N = 234) by asking participants to identify which aspect of infidelity was more upsetting when both forms occurred, and by using regression to identify the unique contributions of sex and beliefs. Study 3 replicated Study 2 in a Korean sample (N = 190). Study 4 replicated Study 2 in a Japanese sample (N = 316). Across the studies, the evolutionary hypothesis, but not the belief hypothesis, accounted for sex differences in jealousy when the types of infidelity are rendered mutually exclusive; sex differences in which aspect of infidelity is more upsetting when both occur; significant variance attributable to sex, after controlling for beliefs; sex-differentiated patterns of beliefs; and the cross-cultural prevalence of all these sex differences.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Florida Atlantic Univ, Boca Raton, FL 33431 USA; Coll William & Mary, Williamsburg, VA 23187 USA; Seoul Natl Univ, Seoul 151, South Korea; Univ Tokyo, Tokyo, Japan; Univ New Mexico, Albuquerque, NM 87131 USA	Buss, DM (reprint author), Univ Texas, Dept Psychol, Austin, TX 78712 USA.						MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; DeSteno DA, 1996, PSYCHOL SCI, V7, P367, DOI 10.1111/j.1467-9280.1996.tb00391.x; BUSS DM, 1992, PSYCHOL SCI, V3, P251, DOI 10.1111/j.1467-9280.1992.tb00038.x; DALY M, 1982, ETHOL SOCIOBIOL, V3, P11, DOI 10.1016/0162-3095(82)90027-9; TOWNSEND JM, 1995, ARCH SEX BEHAV, V24, P173, DOI 10.1007/BF01541580; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Buss DM, 1997, J PERS SOC PSYCHOL, V72, P346, DOI 10.1037/0022-3514.72.2.346; TOOBY J, 1990, ETHOL SOCIOBIOL, V11, P375, DOI 10.1016/0162-3095(90)90017-Z; Buunk BP, 1996, PSYCHOL SCI, V7, P359, DOI 10.1111/j.1467-9280.1996.tb00389.x; Shackelford TK, 1996, PERS SOC PSYCHOL B, V22, P1151, DOI 10.1177/01461672962211006; BETZIG L, 1989, CURR ANTHROPOL, V30, P654, DOI 10.1086/203798; Buss D. M., 1994, EVOLUTION DESIRE; BUSS DM, 1989, J PERS SOC PSYCHOL, V56, P735, DOI 10.1037//0022-3514.56.5.735; BUSS DM, 1998, UNPUB EMOTIONAL REAC; Buss DM, 1996, PSYCHOL SCI, V7, P373, DOI 10.1111/j.1467-9280.1996.tb00392.x; BUSS DM, 1995, PSYCHOL INQ, V6, P1, DOI 10.1207/s15327965pli0601_1; Daly Martin, 1988, HOMICIDE; Geary DC, 1995, ETHOL SOCIOBIOL, V16, P255; Gelman S. A., 1994, MAPPING MIND; Symons D., 1979, EVOLUTION HUMAN SEXU; Tooby J., 1992, ADAPTED MIND EVOLUTI, P19; Triandis Harry C., 1995, INDIVIDUALISM COLLEC; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1111/J.1420-9101.2008.01540.X; WIEDERMAN MW, 1993, ETHOL SOCIOBIOL, V14, P115, DOI 10.1016/0162-3095(93)90011-6	24	123	125	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	1350-4126			PERS RELATIONSHIP	Pers. Relat.	MAR	1999	6	1					125	150		10.1111/j.1475-6811.1999.tb00215.x		26	Communication; Psychology, Social	Communication; Psychology	175FZ	WOS:000079083900008		
J	Yamaguchi, M; Morigaki, K				Yamaguchi, M; Morigaki, K			Effect of hydrogen dilution on the optical properties of hydrogenated amorphous silicon prepared by plasma deposition	PHILOSOPHICAL MAGAZINE B-PHYSICS OF CONDENSED MATTER STATISTICAL MECHANICS ELECTRONIC OPTICAL AND MAGNETIC PROPERTIES			English	Article							PHOTOTHERMAL DEFLECTION SPECTROSCOPY; ALPHA-SI-H; MICROCRYSTALLINE SILICON; ABSORPTION EDGE; SILANE; DEFECTS; FILMS	A series of experimental studies has been made on the effect of the dilution of silane with hydrogen on optical properties of hydrogenated amorphous silicon films (a-Si:H) prepared by plasma deposition as functions of the gas-volume ratio gamma (= [SiH(4)]/([SiH(4)] + [H(2)])) and the substrate temperature T(s). The effect of hydrogen dilution has been discussed in terms of the obtained values of the deposition rate R(d), the optical gap E(g), the Urbach energy E(u), the defect density N(d), the hydrogen content C(H) and the refractive index n(0) and their correlations between them and the hydrogen-bonding configuration estimated from infrared absorption spectra. Its effect strongly depends on T(s) and decreases N(d) and E(u) from gamma = 100% to about 20%. The effect for reducing them is discussed in terms of the surface-limited optimal growth model containing the hydrogen dilution effect. On decreasing gamma from about 10%, both N(d) and E(u) increase in spite of the decrease in R(d). This result is due to the onset of the formation of microcrystalline phase and is discussed in terms of the 'selective etching' model. An a-Si:H film with E(u) less than 50 meV is prepared at our optimal growth conditions: gamma approximate to 20% and T(s) x 200 degrees C.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Hiroshima Inst Technol, Dept Elect Engn, Saeki Ku, Hiroshima 7315193, Japan	Yamaguchi, M (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.						MATSUDA A, 1983, J NON-CRYST SOLIDS, V59-6, P767, DOI 10.1016/0022-3093(83)90284-3; YAMAGUCHI M, 1991, J NON-CRYST SOLIDS, V137, P57, DOI 10.1016/S0022-3093(05)80056-0; Morigaki K, 1998, J NON-CRYST SOLIDS, V227, P338, DOI 10.1016/S0022-3093(98)00072-6; STREET RA, 1989, PHYS REV B, V40, P6236, DOI 10.1103/PhysRevB.40.6236; SHANKS H, 1980, PHYS STATUS SOLIDI B, V100, P43, DOI 10.1002/pssb.2221000103; GUHA S, 1981, J APPL PHYS, V52, P859, DOI 10.1063/1.328849; JACKSON WB, 1982, PHYS REV B, V25, P5559, DOI 10.1103/PhysRevB.25.5559; CODY GD, 1981, PHYS REV LETT, V47, P1480, DOI 10.1103/PhysRevLett.47.1480; KAWASE M, 1994, JPN J APPL PHYS 1, V33, P3830, DOI 10.1143/JJAP.33.3830; Cabarrocas P. Roca i, 1993, J NONCRYST SOLIDS, V164-166, P37; CHOO KY, 1975, J PHYS CHEM-US, V79, P1752, DOI 10.1021/j100584a002; Fritsche H., 1977, P 7 INT C AM LIQ SEM, P3; GANGULY G, 1993, J NONCRYST SOLIDS, V164, P31, DOI 10.1016/0022-3093(93)90485-G; HAYASHI T, 1997, SEM AM SEM JAP ADV I, P183; IMURA T, 1984, JPN J APPL PHYS 1, V23, P179, DOI 10.1143/JJAP.23.179; KUMEDA M, 1982, JPN J APPL PHYS, V22, pL194; LEE SM, 1989, PHILOS MAG B, V60, P547, DOI 10.1080/13642818908205927; Matsuda A, 1986, JPN J APPL PHYS, V25, P54; MEILING H, 1990, PHILOS MAG B, V62, P19, DOI 10.1080/13642819008205531; MIRESHGHI A, 1995, JPN J APPL PHYS 1, V34, P3012, DOI 10.1143/JJAP.34.3012; MISHIMA Y, 1982, PHILOS MAG B, V46, P1, DOI 10.1080/13642818208246419; SAKKA T, 1989, APPL PHYS LETT, V55, P1068, DOI 10.1063/1.101707; SMITH ZE, 1987, PHYS REV LETT, V59, P688, DOI 10.1103/PhysRevLett.59.688; Solomon I., 1993, J NONCRYST SOLIDS, V164-166, P989, DOI 10.1016/0022-3093(93)91164-X; Spear W.E., 1981, J PHYS-PARIS, V42, pC4; Tsai C.C., 1988, AMORPHOUS SILICON RE, P123; USUI S, 1979, J NON-CRYST SOLIDS, V34, P1, DOI 10.1016/0022-3093(79)90002-4; VARHUE WJ, 1989, THIN SOLID FILMS, V169, P179, DOI 10.1016/0040-6090(89)90699-8; Williamson D.L., 1995, MATER RES SOC S P, V377, P251; WINER K, 1990, PHYS REV B, V41, P12150, DOI 10.1103/PhysRevB.41.12150; XU X, 1996, J NONCRYST SOLIDS, V198, P60, DOI 10.1016/0022-3093(95)00657-5; YAMASAKI S, 1987, PHILOS MAG B, V56, P79, DOI 10.1080/13642818708211226; YATABE K, 1989, PHILOS MAG B, V60, P73, DOI 10.1080/13642818908228815; YONEZAWA F, 1983, J NON-CRYST SOLIDS, V59-6, P69, DOI 10.1016/0022-3093(83)90527-6; YONEZAWA F, 1984, KOTAI BUTSURI, V20, P521	35	32	32	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0141-8637			PHILOS MAG B	Philos. Mag. B-Phys. Condens. Matter Stat. Mech. Electron. Opt. Magn. Prop.	MAR	1999	79	3					387	405		10.1080/13642819908206415		19	Materials Science, Multidisciplinary; Mechanics; Physics, Applied; Physics, Condensed Matter	Materials Science; Mechanics; Physics	175GN	WOS:000079085200002		
J	Yoshihara, A; Soe, WH; Yamamoto, R				Yoshihara, A; Soe, WH; Yamamoto, R			Brillouin scattering from TiN/ZrN superlattices	PHYSICA B			English	Article; Proceedings Paper	9th International Conference on Phonon Scattering in Condensed Matter (PHONONS 98)	JUL 26-31, 1998	LANCASTER, ENGLAND	Engn & Phys Sci Res Council, European Commiss, Int Union Pure & Appl Phys, US Army European Res Off, Lancaster Univ Dept Phys, Inst Phys, European Phys Soc		Brillouin scattering; Rayleigh surface wave; TiN/ZrN superlattices	ELASTIC PROPERTIES	The Rayleigh surface wave velocity of transition-metal nitride TiN/ZrN superlattices on MgO (0 0 1) substrates has been measured by Brillouin scattering. The superlattices were covered with a 20 nm thick Al layer to enhance the scattering efficiency. The Rayleigh wave velocity was independent of the modulation period between 30 and 0.6 nm and found to be 4.4 +/- 0.1 km/s. (C) 1999 Elsevier Science B.V. All rights reserved.	Ishinomaki Senshu Univ, Dept Basic Sci, Miyagi 9868580, Japan; Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan	Yoshihara, A (reprint author), Ishinomaki Senshu Univ, Dept Basic Sci, Miyagi 9868580, Japan.	yosihara@isenshu-u.ac.jp					GRIMSDITCH M, 1985, PHYS REV B, V31, P6818, DOI 10.1103/PhysRevB.31.6818; BAHDRA R, 1989, APPL PHYS LETT, V54, P1409; FARNELL GW, 1972, PHYSICAL ACOUSTICS, V6, pCH2; GRIMSDITCH M, 1990, PHYS REV B, V42, P2923, DOI 10.1103/PhysRevB.42.2923; GRIMSDITCH MH, 1988, LIGHT SCATTERING SOL, V5; KOSOLAPOVA TY, 1990, HDB HIGH TEMPERATURE, P46; MENG WJ, 1990, PHYS REV B, V42, P4881, DOI 10.1103/PhysRevB.42.4881; MIRKARIMI PB, 1992, J APPL PHYS, V71, P4955, DOI 10.1063/1.350644; YOSHIHARA A, 1994, JPN J APPL PHYS 1, V33, P3100, DOI 10.1143/JJAP.33.3100	9	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	1999	263						70	72		10.1016/S0921-4526(98)01302-7		3	Physics, Condensed Matter	Physics	180AN	WOS:000079362700016		
J	Kawashima, H; Shirahama, K; Kono, K				Kawashima, H; Shirahama, K; Kono, K			Fluctuation properties of third sound transmission in random media	PHYSICA B			English	Article; Proceedings Paper	9th International Conference on Phonon Scattering in Condensed Matter (PHONONS 98)	JUL 26-31, 1998	LANCASTER, ENGLAND	Engn & Phys Sci Res Council, European Commiss, Int Union Pure & Appl Phys, US Army European Res Off, Lancaster Univ Dept Phys, Inst Phys, European Phys Soc		third sound; transmission spectrum; weak localization; fluctuation		We have studied the fluctuation properties in the localization of third sound propagating in one-dimensional random lattices. The spectrum shows substantial suppression due to the weak localization effect. A large fluctuation is observed in the suppressed region. The properties of this fluctuation are analyzed in terms of the weak localization theory. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Kawashima, H (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Roppongi 7-22-1, Tokyo 1068666, Japan.		Kono, Kimitoshi/H-3329-2012	Kono, Kimitoshi/0000-0002-4446-4419			KONO K, 1992, PHYS REV LETT, V69, P1185, DOI 10.1103/PhysRevLett.69.1185; NISHIGUCHI N, 1993, PHYS REV B, V48, P14426, DOI 10.1103/PhysRevB.48.14426; NISHIGUCHI N, COMMUNICATIONS	3	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	1999	263						373	375		10.1016/S0921-4526(98)01238-1		3	Physics, Condensed Matter	Physics	180AN	WOS:000079362700104		
J	Kuroe, H; Seto, H; Sekine, T; Isobe, M; Ueda, Y				Kuroe, H; Seto, H; Sekine, T; Isobe, M; Ueda, Y			Spin-Peierls transition in alpha '-NaV2O5 observed by Raman scattering	PHYSICA B			English	Article; Proceedings Paper	9th International Conference on Phonon Scattering in Condensed Matter (PHONONS 98)	JUL 26-31, 1998	LANCASTER, ENGLAND	Engn & Phys Sci Res Council, European Commiss, Int Union Pure & Appl Phys, US Army European Res Off, Lancaster Univ Dept Phys, Inst Phys, European Phys Soc		alpha '-NaV2O5; Raman scattering; Fano effect; spin-Peierls transition	COMPOUND; NAV2O5	The spin-Peierls transition and the Fano effect in alpha'-Na1-deltaV2O5 (delta = 0, 0.01 and 0.1) have been studied by means of Raman scattering. The origins of five new peaks and a broad band which appear only below T-SP and the crystal structure below T-SP are discussed. When the temperature and the Na+-ion deficiency increase, the Fano asymmetry observed at 531 cm(-1) weakens because the transition probability of the phonon-phonon decay channel increases and the phonon-electronic excitation interaction decreases. (C) 1999 Elsevier Science B.V. All rights reserved.	Sophia Univ, Dept Phys, Chiyoda Ku, Tokyo 1028554, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan	Kuroe, H (reprint author), Sophia Univ, Dept Phys, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.		Isobe, Masahiko/B-5616-2015				Fujii Y, 1997, J PHYS SOC JPN, V66, P326, DOI 10.1143/JPSJ.66.326; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; CARPY A, 1975, ACTA CRYSTALLOGR B, V31, P1481, DOI 10.1107/S0567740875005468; Isobe M, 1996, J PHYS SOC JPN, V65, P1178, DOI 10.1143/JPSJ.65.1178; KLEIN MV, 1982, TOP APPL PHYS, V8, P169; Kuroe H, 1998, J PHYS SOC JPN, V67, P2881, DOI 10.1143/JPSJ.67.2881; Kuroe H, 1998, J MAGN MAGN MATER, V177, P679, DOI 10.1016/S0304-8853(97)00940-2; Ohama T, 1997, J PHYS SOC JPN, V66, P3008, DOI 10.1143/JPSJ.66.3008; Sekine T, 1998, J PHYS SOC JPN, V67, P1440, DOI 10.1143/JPSJ.67.1440; Sekine T, 1998, J MAGN MAGN MATER, V177, P691, DOI 10.1016/S0304-8853(97)00961-X; YOSHIHAMA T, 1997, PHYSICA B, V234, P539; Yoshihama T., 1998, Journal of the Physical Society of Japan, V67	12	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	1999	263						803	805		10.1016/S0921-4526(98)01291-5		3	Physics, Condensed Matter	Physics	180AN	WOS:000079362700220		
J	Kuroe, H; Seto, H; Sekine, T; Masuda, T; Tsukada, I; Uchinokura, K				Kuroe, H; Seto, H; Sekine, T; Masuda, T; Tsukada, I; Uchinokura, K			Raman scattering in Zn-, Si- and Mg-doped CuGeO3	PHYSICA B			English	Article; Proceedings Paper	9th International Conference on Phonon Scattering in Condensed Matter (PHONONS 98)	JUL 26-31, 1998	LANCASTER, ENGLAND	Engn & Phys Sci Res Council, European Commiss, Int Union Pure & Appl Phys, US Army European Res Off, Lancaster Univ Dept Phys, Inst Phys, European Phys Soc		CuGeO3; Raman scattering; doping effect; spin-Peierls transition	SPIN-PEIERLS TRANSITION; COMPOUND CUGEO3; FLUCTUATIONS	The dopant-concentration dependence of the folded phonon at 368 cm(-1) in the spin-Peierls (SP) system CuGeO3 has been studied by Raman scattering. With increasing dopant concentration, the Raman spectrum from the folded phonon weakens in intensity and broadens. In the weakly doped samples, the sharp folded phonon is observed at low temperatures, giving evidence for the coexistence of the SP and antiferromagnetic (AF) orders. In the 4% Si-doped sample, a broad Raman band probably reflecting the one-phonon density of states is observed in the AF phase, indicating the existence of the uniform AF phase. In the 2.1% Zn-doped sample, the 368 cm(-1) broad peak is superimposed on the broad band. This concentration is near the critical concentration between the dimerized AF and uniform AF phases. The intensity of the folded phonon in the ME-doped sample is stronger than those in Zn- and Si-doped samples. The luminescence emitted by the phonon cascade process is observed in the 8.1% Mg-doped sample. (C) 1999 Elsevier Science B.V. All rights reserved.	Sophia Univ, Dept Phys, Chiyoda Ku, Tokyo 1028854, Japan; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Kuroe, H (reprint author), Sophia Univ, Dept Phys, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028854, Japan.						HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; Hirota K, 1995, PHYS REV B, V52, P15412, DOI 10.1103/PhysRevB.52.15412; KUROE H, 1995, PHYS REV B, V51, P16098; Kuroe H, 1998, J MAGN MAGN MATER, V177, P679, DOI 10.1016/S0304-8853(97)00940-2; Kuroe H, 1996, PHYSICA B, V219-20, P104, DOI 10.1016/0921-4526(95)00664-8; Lemmens P, 1997, PHYS REV B, V55, P15076, DOI 10.1103/PhysRevB.55.15076; NISHI M, 1995, PHYSICA B, V213, P275, DOI 10.1016/0921-4526(95)00128-V; POUGET JP, 1994, PHYS REV LETT, V72, P4073; Sekine T, 1998, J PHYS SOC JPN, V67, P1440, DOI 10.1143/JPSJ.67.1440; Sekine T, 1998, J MAGN MAGN MATER, V177, P691, DOI 10.1016/S0304-8853(97)00961-X; Weiden M, 1997, PHYS REV B, V55, P15067, DOI 10.1103/PhysRevB.55.15067	11	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	1999	263						825	828		10.1016/S0921-4526(98)01294-0		4	Physics, Condensed Matter	Physics	180AN	WOS:000079362700227		
J	Hieda, M; Suzuki, M; Torii, K; Yano, H; Wada, N				Hieda, M; Suzuki, M; Torii, K; Yano, H; Wada, N			Mechanical responses of helium films adsorbed on two-dimensional mesoporous hectorite	PHYSICA B-CONDENSED MATTER			English	Article; Proceedings Paper	9th International Conference on Phonon Scattering in Condensed Matter (PHONONS 98)	JUL 26-31, 1998	LANCASTER, ENGLAND	Engn & Phys Sci Res Council, European Commiss, Int Union Pure & Appl Phys, US Army European Res Off, Lancaster Univ Dept Phys, Inst Phys, European Phys Soc		helium film; hectorite; ultrasonic measurement; slippage	FRICTION	The mechanical responses of physisorbed films to the vibration of a substrate were investigated by measuring the sound velocity and attenuation of a two-dimensional mesoporous hectorite. The sound velocity of a hectorite pellet adsorbed by both (4)He and (3)He submonolayer films increased drastically at low temperatures accompanied by the attenuation. The most plausible explanation for this behavior is that helium films decouple from the vibrating substrate at low temperatures. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Electrocommun, Div Nat Sci, Chofu, Tokyo 1828585, Japan; Tohoku Natl Ind Res Inst, Miyagi Ku, Sendai, Miyagi 9838551, Japan; Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Suzuki, M (reprint author), Univ Electrocommun, Div Nat Sci, Chofu, Tokyo 1828585, Japan.	suzuki@phys.uec.ac.jp					BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; Daly C, 1996, PHYS REV LETT, V76, P803, DOI 10.1103/PhysRevLett.76.803; KRIM J, 1991, PHASE TRANSITION   S, V2, P169; MOHANDAS P, 1995, J LOW TEMP PHYS, V101, P481, DOI 10.1007/BF00753341; TORII K, 1991, STUD SURF SCI CATAL, V60, P81; WADA N, 1995, PHYS REV B, V52, P1167, DOI 10.1103/PhysRevB.52.1167	6	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4526			PHYSICA B	Physica B	MAR	1999	263						370	372		10.1016/S0921-4526(98)01388-X		3	Physics, Condensed Matter	Physics	180AN	WOS:000079362700103		
J	Fujiwara, N; Yasuoka, H; Ueda, Y				Fujiwara, N; Yasuoka, H; Ueda, Y			Spin fluctuation nearby magnetically unstable point in Li1-xZnxV2O4	PHYSICAL REVIEW B			English	Article							METAL-INSULATOR-TRANSITION; RELAXATION; OXIDE; HEAT	Nuclear magnetic resonance (NMR) for Li-7 nuclei was performed in vanadium spinel Li-1_xZnxV2O4 (0 less than or equal to x less than or equal to 0.4) from 4.2 to 300 K. The relaxation rate (1/T-1) and the linewidth for a paramagnetic metal LiV2O4 take the maximum at 50 and 20 K, respectively, whereas those for x not equal 0 samples show monotonous increase with decreasing temperature toward a spin glass order which appears at about 15 K. These qualitative differences with respect to Zn concentration were investigated in relation to a metal nearby the ferromagnetically unstable point. [S0163-1829(99)05109-7].	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan	Fujiwara, N (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan.						AMAKO Y, 1990, J PHYS SOC JPN, V59, P2241, DOI 10.1143/JPSJ.59.2241; ROGERS DB, 1967, SOLID STATE COMMUN, V5, P263, DOI 10.1016/0038-1098(67)90269-4; Kondo S, 1997, PHYS REV LETT, V78, P3729, DOI 10.1103/PhysRevLett.78.3729; KADOWAKI K, 1986, SOLID STATE COMMUN, V58, P507, DOI 10.1016/0038-1098(86)90785-4; FUJIMORI A, 1988, PHYS REV B, V38, P7889, DOI 10.1103/PhysRevB.38.7889; Fujiwara N, 1998, PHYS REV B, V57, P3539, DOI 10.1103/PhysRevB.57.3539; FUJIWARA N, 1997, PHYSICA B, V59, P237; HIOKI T, 1977, J PHYS SOC JPN, V43, P1200, DOI 10.1143/JPSJ.43.1200; Ishigaki A, 1996, J PHYS SOC JPN, V65, P376, DOI 10.1143/JPSJ.65.376; Ishigaki A, 1996, J PHYS SOC JPN, V65, P3402, DOI 10.1143/JPSJ.65.3402; Johnston DC, 1999, PHYS REV B, V59, P2627, DOI 10.1103/PhysRevB.59.2627; KAWAKAMI K, 1986, J PHYS SOC JPN, V55, P3174, DOI 10.1143/JPSJ.55.3174; Kondo S, 1999, PHYS REV B, V59, P2609, DOI 10.1103/PhysRevB.59.2609; KONTANI M, 1975, J PHYS SOC JPN, V39, P665, DOI 10.1143/JPSJ.39.665; Lomer W. M., 1962, P PHYS SOC LOND, V80, P1380; Mahajan AV, 1998, PHYS REV B, V57, P8890, DOI 10.1103/PhysRevB.57.8890; Moriya T., 1985, SPRINGER SERIES SOLI, V56; MORRISH AH, 1965, PHYSICAL PRINCIPLES; MUHTAR F, 1998, J PHYS SOC JPN, V7, P119; NIZIOL S, 1973, PHYS STATUS SOLIDI A, V18, pK11, DOI 10.1002/pssa.2210180145; Onoda M, 1997, PHYS REV B, V56, P3760, DOI 10.1103/PhysRevB.56.3760; REUTER B, 1967, NATURWISSENSCHAFTEN, V54, P164; SAJI H, 1966, J PHYS SOC JPN, V21, P255, DOI 10.1143/JPSJ.21.255; Selwood P. W., 1956, MAGNETOCHEMISTRY; UEDA K, 1975, J PHYS SOC JPN, V38, P32, DOI 10.1143/JPSJ.38.32; Ueda Y, 1997, J PHYS SOC JPN, V66, P778, DOI 10.1143/JPSJ.66.778; URANO T, COMMUNICATION; YASUOKA H, 1978, J PHYS SOC JPN, V44, P842, DOI 10.1143/JPSJ.44.842	28	12	12	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	1999	59	9					6294	6300		10.1103/PhysRevB.59.6294		7	Physics, Condensed Matter	Physics	178EX	WOS:000079254300048		
J	Sato, K; Takahashi, Y; Uchiyama, H; Kanazawa, I; Tamura, R; Kimura, K; Komori, F; Suzuki, R; Ohdaira, T; Takeuchi, S				Sato, K; Takahashi, Y; Uchiyama, H; Kanazawa, I; Tamura, R; Kimura, K; Komori, F; Suzuki, R; Ohdaira, T; Takeuchi, S			Positron-annihilation studies of stable Al-based icosahedral quasicrystals	PHYSICAL REVIEW B			English	Article							QUASI-CRYSTALS; LIFETIME SPECTRA; IDEAL STRUCTURE; ALLOYS; PHASE; CU; SYSTEMS; NEUTRON; PROGRAM	The positron-annihilation lifetime spectra in the Al-Pd-Re alloy system, the positron-annihilation Doppler-broadening spectra by slow variable monoenergetic positron beam in Al70.7Pd21.34Re7.96 and Al71.5Pd20.3Mn8.2 alloys, and positron-annihilation lifetime spectra by slow positron beam in Al71.5Pd20.3Mn8.2 were measured. These measurements indicate that every sample contains a dense distribution of structural vacancy-type sites. This result is consistent with our previous expectation of the relationship between the presence of vacant centers in clusters and the stability of icosahedral quasicrystals. Furthermore, the structural vacancy densities in icosahedral quasicrystals of Al70.7Pd21.34Re7.96 and Al71.5Pd20.3Mn8.2 have been estimated to be 7.7x10(20) and 5.0x10(20) cm(-3), respectively. [S0163-1829(99)08109-6].	Tokyo Gakugei Univ, Dept Phys, Koganei, Tokyo 184, Japan; Univ Tokyo, Dept Mat Sci, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan; Electrotech Lab, Quantum Radiat Div, Tsukuba, Ibaraki 305, Japan; Tokyo Univ Sci, Dept Mat Sci & Technol, Noda, Chiba 278, Japan	Sato, K (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						AERS GC, 1995, APPL SURF SCI, V85, P196, DOI 10.1016/0169-4332(94)00332-7; KIRKEGAARD P, 1981, COMPUT PHYS COMMUN, V23, P307, DOI 10.1016/0010-4655(81)90006-0; ELSER V, 1985, PHYS REV LETT, V55, P2883, DOI 10.1103/PhysRevLett.55.2883; BOUDARD M, 1992, J PHYS-CONDENS MAT, V4, P10149, DOI 10.1088/0953-8984/4/50/007; CORNIERQUIQUANDON M, 1991, PHYS REV B, V44, P2071, DOI 10.1103/PhysRevB.44.2071; GHOSH VJ, 1995, APPL SURF SCI, V85, P187, DOI 10.1016/0169-4332(94)00331-9; GHOSH VJ, 1994, AIP C P, V303, P937; Hamada E, 1997, MATER SCI FORUM, V255-2, P451; Hiraga K, 1997, J PHYS SOC JPN, V66, P3700, DOI 10.1143/JPSJ.66.3700; HONDA Y, 1994, JPN J APPL PHYS 1, V33, P4929, DOI 10.1143/JJAP.33.4929; Kanazawa I, 1997, PHYS REV LETT, V79, P2269, DOI 10.1103/PhysRevLett.79.2269; KANAZAWA I, 1992, MATER SCI FORUM, V105, P1093; KANAZAWA I, 1994, PHYS REV B, V49, P3573, DOI 10.1103/PhysRevB.49.3573; Kimura K, 1995, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON QUASICRYSTALS, P730; KIRKEGAA.P, 1974, COMPUT PHYS COMMUN, V7, P401, DOI 10.1016/0010-4655(74)90070-8; KIZUKA T, 1989, PHYS REV B, V40, P796, DOI 10.1103/PhysRevB.40.796; MOGENSEN OE, 1982, POSITRON ANNIHILATIO, P763; NIEMINEN RM, 1979, TOP CURR PHYS, V12, P145; OHATA T, 1990, PHYS REV B, V42, P6730, DOI 10.1103/PhysRevB.42.6730; PIERCE FS, 1994, PHYS REV LETT, V73, P2220, DOI 10.1103/PhysRevLett.73.2220; SATO K, 1997, P 6 INT C QUAS, P425; SAWADA H, 1997, P 6 INT C QUAS, P329; SUZUKI R, 1991, JPN J APPL PHYS 2, V30, pL532, DOI 10.1143/JJAP.30.L532; YAMAMOTO A, 1994, MATER SCI FORUM, V150, P211; YAMAMOTO A, 1992, PHYS REV B, V45, P5217, DOI 10.1103/PhysRevB.45.5217	25	37	37	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	1999	59	10					6712	6716		10.1103/PhysRevB.59.6712		5	Physics, Condensed Matter	Physics	177WG	WOS:000079233600025		
J	Mushnikov, NV; Goto, T; Kamishima, K; Yamada, H; Andreev, AV; Shiokawa, Y; Iwao, A				Mushnikov, NV; Goto, T; Kamishima, K; Yamada, H; Andreev, AV; Shiokawa, Y; Iwao, A			Magnetic properties of the 5f itinerant electron metamagnet UCoAl under high pressure	PHYSICAL REVIEW B			English	Article							FERROMAGNETISM; LU(CO1-XALX)2; SYSTEM; NI; CO	The magnetization and susceptibility of single-crystalline UCoAl were measured under high pressures to P = 1.2 GPa. A sharp metamagnetic transition was observed only in magnetic fields along the c axis. The critical field is B-c = 0.65 T at P = 0 GPa, which increases with pressure and temperature. The susceptibility for ambient pressure shows a broad maximum at T-max = 20 K. The value of T-max increases with pressure. A theory of the itinerant metamagnetic transition has been generalized for the case of anisotropic spin fluctuations. The observed pressure dependence of the inverse susceptibility at T-max, the temperature T-0 for the disappearance of the metamagnetic transition, and the temperature dependence of B-c can be explained with this theory. [S0163-1829(99)04409-4].	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Shinshu Univ, Fac Sci, Matsumoto, Nagano 3908621, Japan; Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; Charles Univ, Dept Met Phys, CR-12116 Prague 2, Czech Republic; Inst Met Phys, Ekaterinburg 620219, Russia; Acad Sci Czech Republ, Inst Phys, CZ-18040 Prague 8, Czech Republic	Mushnikov, NV (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.		Andreev, Alexander/B-6057-2011; Kamishima, Kenji/B-2738-2012; Mushnikov, Nikolay/K-9076-2013	Mushnikov, Nikolay/0000-0002-6354-2558			Andreev A. V., 1985, Soviet Physics - Solid State, V27; Andreev A.F., UNPUB; ANDREEV AV, 1995, J ALLOY COMPD, V224, P117, DOI 10.1016/0925-8388(95)01549-3; ANDREEV AV, 1990, PHYS MET METALLOGR, V69, P68; ANDREEV AV, IN PRESS J MAGN MAGN; Andreev AV, 1998, J ALLOY COMPD, V269, P34, DOI 10.1016/S0925-8388(98)00143-1; Andreev AV, 1997, PHYSICA B, V239, P88, DOI 10.1016/S0921-4526(97)00384-0; Andreev AV, 1997, J MAGN MAGN MATER, V169, P229, DOI 10.1016/S0304-8853(96)00755-X; WULFF M, 1990, PHYSICA B, V163, P331, DOI 10.1016/0921-4526(90)90203-7; Andreev AV, 1997, PHYS REV B, V55, P5847, DOI 10.1103/PhysRevB.55.5847; Cuong TD, 1996, J MAGN MAGN MATER, V157, P694, DOI 10.1016/0304-8853(95)01048-3; ERIKSSON O, 1989, J PHYS-CONDENS MAT, V1, P4005, DOI 10.1088/0953-8984/1/25/012; GABELKO IL, 1991, J MAGN MAGN MATER, V94, P287, DOI 10.1016/0304-8853(91)90089-S; GOTO T, 1994, J APPL PHYS, V76, P6682, DOI 10.1063/1.358167; Goto T, 1997, PHYS REV B, V56, P14019, DOI 10.1103/PhysRevB.56.14019; IIJIMA M, 1990, J PHYS-CONDENS MAT, V2, P10069, DOI 10.1088/0953-8984/2/50/012; Moriya T., 1985, SPIN FLUCTUATIONS IT; MORIYA T, 1986, J PHYS SOC JPN, V55, P357, DOI 10.1143/JPSJ.55.357; SAKAKIBARA T, 1990, J MAGN MAGN MATER, V90-1, P131; SECHOVSKY V, 1986, PHYSICA B & C, V142, P283, DOI 10.1016/0378-4363(86)90023-9; SHIMIZU M, 1982, J PHYS-PARIS, V43, P155, DOI 10.1051/jphys:01982004301015500; YAMADA H, 1993, PHYS REV B, V47, P11211, DOI 10.1103/PhysRevB.47.11211	22	70	70	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	1999	59	10					6877	6885		10.1103/PhysRevB.59.6877		9	Physics, Condensed Matter	Physics	177WG	WOS:000079233600044		
J	Startseva, T; Timusk, T; Puchkov, AV; Basov, DN; Mook, HA; Okuya, M; Kimura, T; Kishio, K				Startseva, T; Timusk, T; Puchkov, AV; Basov, DN; Mook, HA; Okuya, M; Kimura, T; Kishio, K			Temperature evolution of the pseudogap state in the infrared response of underdoped La2-xSrxCuO4	PHYSICAL REVIEW B			English	Article							T-C SUPERCONDUCTORS; OPTICAL CONDUCTIVITY; CHARGE DYNAMICS; SPIN DYNAMICS; CUO2 PLANE; AXIS; LA1.85SR0.15CUO4; RESISTIVITY; YBA2CU3O7-Y; TRANSPORT	The ab-plane optical spectra of two single crystals of underdoped La2-xSrxCuO4 were investigated. The reflectivity of La1.87Sr0.13CuO4 has been measured in the frequency range 30-9000 cm(-1) (0.004-1 eV) both parallel and perpendicular to the CuO2 planes, whereas La1.86Sr0.14CuO4 was studied only in the ab plane. The extended Drude model shows that the frequency-dependent effective scattering rate 1/tau(omega,T) is strongly suppressed below the high-frequency straight-line extrapolation, a signature of the pseudogap state. This suppression can be seen from temperatures below the superconducting transition up to 400 K. In the case of underdoped LSCO the straight-line extrapolation is temperature independent below 200 K, whereas above 200 K there is a strong temperature dependence of the high-frequency 1/tau(omega,T). The out-of-plane direction is also examined for evidence of the pseudogap state. [S0163-1829(99)08009-1].	McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tokyo, Dept Appl Chem, Tokyo 113, Japan	Startseva, T (reprint author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.						ALLEN PB, 1971, PHYS REV B, V3, P305, DOI 10.1103/PhysRevB.3.305; Renner C, 1998, PHYS REV LETT, V80, P149, DOI 10.1103/PhysRevLett.80.149; UCHIDA S, 1991, PHYS REV B, V43, P7942, DOI 10.1103/PhysRevB.43.7942; Puchkov AV, 1996, J PHYS-CONDENS MAT, V8, P10049, DOI 10.1088/0953-8984/8/48/023; TAKAGI H, 1992, PHYS REV LETT, V69, P2975, DOI 10.1103/PhysRevLett.69.2975; CHEONG SW, 1991, PHYS REV LETT, V67, P1791, DOI 10.1103/PhysRevLett.67.1791; GOTZE W, 1972, PHYS REV B, V6, P1226, DOI 10.1103/PhysRevB.6.1226; HWANG HY, 1994, PHYS REV LETT, V72, P2636, DOI 10.1103/PhysRevLett.72.2636; AEPPLI G, 1987, PHYS REV B, V35, P7129, DOI 10.1103/PhysRevB.35.7129; Tolpygo SK, 1996, PHYS REV B, V53, P12454, DOI 10.1103/PhysRevB.53.12454; Basov DN, 1996, PHYS REV LETT, V77, P4090, DOI 10.1103/PhysRevLett.77.4090; BASOV DN, 1995, PHYS REV B, V52, P13141; BATLOGG B, 1994, PHYSICA C, V235, P130, DOI 10.1016/0921-4534(94)91330-7; BUCHER B, 1993, PHYS REV LETT, V70, P2012, DOI 10.1103/PhysRevLett.70.2012; GAO F, 1993, PHYS REV B, V47, P1036, DOI 10.1103/PhysRevB.47.1036; GOLD A, 1982, PHYS REV B, V25, P3519, DOI 10.1103/PhysRevB.25.3519; HOMES CC, 1995, PHYSICA C, V254, P265, DOI 10.1016/0921-4534(95)00579-X; HOMES CC, 1993, PHYS REV LETT, V71, P1645, DOI 10.1103/PhysRevLett.71.1645; ITO T, 1993, PHYS REV LETT, V70, P3995, DOI 10.1103/PhysRevLett.70.3995; KIMURA T, 1992, PHYSICA C, V192, P247, DOI 10.1016/0921-4534(92)90767-7; MARSHALL DS, 1999, PHYSICA C, V263, P208; MASON TE, 1992, PHYS REV LETT, V68, P1414, DOI 10.1103/PhysRevLett.68.1414; MILLIS AJ, 1993, PHYS REV LETT, V70, P2810, DOI 10.1103/PhysRevLett.70.2810; ORENSTEIN J, 1988, PHYS REV LETT, V60, P968, DOI 10.1103/PhysRevLett.60.968; Puchkov AV, 1996, PHYS REV LETT, V77, P1853, DOI 10.1103/PhysRevLett.77.1853; Puchkov AV, 1996, PHYS REV LETT, V77, P3212, DOI 10.1103/PhysRevLett.77.3212; Quijada MA, 1995, PHYS REV B, V52, P15485, DOI 10.1103/PhysRevB.52.15485; REEDYK M, 1992, PHYS REV LETT, V69, P2705, DOI 10.1103/PhysRevLett.69.2705; STARTSEVA T, UNPUB; TAJIMA S, 1990, PHYSICA C, V168, P117, DOI 10.1016/0921-4534(90)90113-S; Tanner D. B., 1992, PHYSICAL PROPERTIES, VIII, P363; TAO HJ, 1987, PHYSICA B C, V282, P1507; THOMAS GA, 1992, PHYS REV B, V45, P2474, DOI 10.1103/PhysRevB.45.2474; TIMUSK T, IN PRESS REP PROG PH; Uchida S, 1996, PHYS REV B, V53, P14558, DOI 10.1103/PhysRevB.53.14558; YAGIL Y, 1994, PHYSICA C, V235, P1143, DOI 10.1016/0921-4534(94)91796-5; ZHANG HB, 1994, PHYSICA C, V234, P185, DOI 10.1016/0921-4534(94)90071-X	37	52	52	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	MAR 1	1999	59	10					7184	7190		10.1103/PhysRevB.59.7184		7	Physics, Condensed Matter	Physics	177WG	WOS:000079233600078		
J	Chikira, Y; Haba, N; Mimura, Y				Chikira, Y; Haba, N; Mimura, Y			Sliding singlet mechanism with gauge mediated supersymmetry breaking	PHYSICAL REVIEW D			English	Article							DESTABILIZING DIVERGENCES; SUPERGRAVITY; ENERGY; MODELS; HIGGS; MASS	The sliding singlet mechanism is one of the most interesting solutions of the triplet-doublet splitting problem. We analyze this mechanism in the gauge mediated supersymmetry breaking scenario. We show that the sliding singlet mechanism does not work in the naive gauge mediation scenario because of the singlet linear terms derived from gravity, although the F term is much smaller than the one in the gravity mediation scenario. We also consider an extension in order for the sliding singlet mechanism to work. [S0556-2821(99)05703-3].	Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1520033, Japan; Mie Univ, Fac Engn, Tsu, Mie 5140008, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan	Chikira, Y (reprint author), Tokyo Inst Technol, Dept Phys, Meguro Ku, Oh Okayama, Tokyo 1520033, Japan.	ychikira@th.phys.titech.ac.jp; haba@phen.mie-u.ac.jp; mimura@icrr.u-tokyo.ac.jp					Agashe K, 1997, NUCL PHYS B, V507, P3, DOI 10.1016/S0550-3213(97)00569-5; JAIN V, 1995, PHYS LETT B, V351, P481, DOI 10.1016/0370-2693(95)00373-S; GRINSTEIN B, 1982, NUCL PHYS B, V206, P387, DOI 10.1016/0550-3213(82)90275-9; WITTEN E, 1981, PHYS LETT B, V105, P267, DOI 10.1016/0370-2693(81)90885-6; DINE M, 1993, PHYS REV D, V48, P1277, DOI 10.1103/PhysRevD.48.1277; ALVAREZGAUME L, 1983, NUCL PHYS B, V221, P495, DOI 10.1016/0550-3213(83)90591-6; INOUE K, 1982, PROG THEOR PHYS, V68, P927, DOI 10.1143/PTP.68.927; GEORGI H, 1982, PHYS LETT B, V108, P283, DOI 10.1016/0370-2693(82)91193-5; INOUE K, 1986, PROG THEOR PHYS, V75, P664, DOI 10.1143/PTP.75.664; BABU KS, 1993, PHYS REV D, V48, P5354, DOI 10.1103/PhysRevD.48.5354; ANSELM AA, 1988, PHYS LETT B, V200, P331, DOI 10.1016/0370-2693(88)90781-2; ALVAREZGAUME L, 1982, NUCL PHYS B, V207, P96, DOI 10.1016/0550-3213(82)90138-9; INOUE K, 1984, PROG THEOR PHYS, V71, P413, DOI 10.1143/PTP.71.413; NILLES HP, 1983, PHYS LETT B, V124, P337, DOI 10.1016/0370-2693(83)91467-3; Dine M, 1996, PHYS REV D, V53, P2658, DOI 10.1103/PhysRevD.53.2658; IBANEZ LE, 1983, NUCL PHYS B, V218, P514, DOI 10.1016/0550-3213(83)90378-4; BAGGER J, 1993, PHYS REV LETT, V71, P2380, DOI 10.1103/PhysRevLett.71.2380; IBANEZ L, 1982, PHYS LETT B, V110, P215; LAHANAS AB, 1983, PHYS LETT B, V124, P341, DOI 10.1016/0370-2693(83)91468-5; Kolda C, 1998, PHYS REV LETT, V80, P5263, DOI 10.1103/PhysRevLett.80.5263; IBANEZ L, 1982, PHYS LETT B, V118, P73, DOI 10.1016/0370-2693(82)90604-9; Ansel'm A. A., 1988, Soviet Physics - JETP, V67; BAGGER J, 1995, NUCL PHYS B, V455, P59, DOI 10.1016/0550-3213(95)00463-3; Barr SM, 1998, PHYS REV D, V57, P190, DOI 10.1103/PhysRevD.57.190; Berezhiani Z., 1989, SOV PHYS LEBEDEV I R, V5, P55; Ciafaloni P, 1997, NUCL PHYS B, V494, P41, DOI 10.1016/S0550-3213(97)00138-7; Ciafaloni P, 1997, PHYS LETT B, V404, P83, DOI 10.1016/S0370-2693(97)00513-3; COWAN G, 1997, SPEC CERN PART PHYS; de Gouvea A, 1998, PHYS REV D, V57, P5676, DOI 10.1103/PhysRevD.57.5676; DIMOPOULOS S, 1982, NSFITP8207; DIMOPOULOS S, 1982, PHYS LETT B, V117, P287, DOI 10.1016/0370-2693(82)90720-1; DINE M, 1982, P 6 J HOPK WORKSH FL; DINE M, 1982, PHYS LETT B, V110, P227, DOI 10.1016/0370-2693(82)91241-2; GIUDICE GF, HEPPH9801271; GIUDICE GF, HEPPH9602207; MASIERO A, 1982, PHYS LETT B, V115, P380, DOI 10.1016/0370-2693(82)90522-6; NANOPOULOS DV, 1982, PHYS LETT B, V113, P151, DOI 10.1016/0370-2693(82)90413-0; NAPPI CR, 1982, PHYS LETT B, V113, P175, DOI 10.1016/0370-2693(82)90418-X; NEMESCHANSKY D, 1984, NUCL PHYS B, V234, P379, DOI 10.1016/0550-3213(84)90069-5; Nilles HP, 1997, PHYS LETT B, V412, P69, DOI 10.1016/S0370-2693(97)01042-3; POLCHINSKI J, 1982, PHYS REV D, V26, P3661, DOI 10.1103/PhysRevD.26.3661; SEN A, 1984, PHYS LETT B, V148, P65, DOI 10.1016/0370-2693(84)91612-5	42	1	1	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	MAR 1	1999	59	5							055002			6	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	173BN	WOS:000078961200044		
J	Nagao, M; Seto, H				Nagao, M; Seto, H			Small-angle neutron scattering study of a pressure-induced phase transition in a ternary microemulsion composed of AOT, D2O, and n-decane	PHYSICAL REVIEW E			English	Article							INDUCED STRUCTURAL-CHANGES; SYSTEMS; MICROSTRUCTURE; EVOLUTION; BEHAVIOR; REGION	A small-angle neutron scattering experiment was carried out in order to investigate a pressure-induced phase transition in an AOT (dioctyl sulfosuccinate sodium salt)/water/n-decane system. The samples, 20.9%, 22.4%, and 23.0% of AOT, dissolved in an equal volume fraction of water and oil, are known to be a dense water-in-oil droplet structure at ambient temperature and pressure. With increasing pressure, a structural phase transition was observed. At higher pressure, the systems turned into two phases; a lamellar phase at the lower part of the cell and a bicontinuous phase at the upper part. A pressure dependence of the mean repeat distance for each structure was obtained. The disorder parameter both in the water-in-oil droplet structure at lower pressure and in the bicontinuous structure at higher pressure followed a unique function. [S1063-651X(99)04103-3].	Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Naka, Ibaraki 3191106, Japan; Hiroshima Univ, Fac Integrated Arts & Sci, Higashihiroshima 7398521, Japan	Nagao, M (reprint author), Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, 106-1 Shirakata, Naka, Ibaraki 3191106, Japan.						JAHN W, 1988, J PHYS CHEM-US, V92, P2294, DOI 10.1021/j100319a039; HELFRICH W, 1978, Z NATURFORSCH A, V33, P305; DEGENNES PG, 1982, J PHYS CHEM-US, V86, P2294, DOI 10.1021/j100210a011; CHEN SH, 1990, J CHEM PHYS, V93, P1907, DOI 10.1063/1.459068; KAHLWEIT M, 1987, J COLLOID INTERF SCI, V118, P436, DOI 10.1016/0021-9797(87)90480-2; TEUBNER M, 1987, J CHEM PHYS, V87, P3195, DOI 10.1063/1.453006; CHEN SH, 1993, J MOL STRUCT, V296, P259, DOI 10.1016/0022-2860(93)80141-H; LEE DD, 1994, PHYS REV LETT, V73, P106, DOI 10.1103/PhysRevLett.73.106; BODEN N, 1989, STRUCTURE DYNAMICS S, P433; CAMETTI C, 1990, PHYS REV LETT, V64, P1461, DOI 10.1103/PhysRevLett.64.1461; Chen SH, 1997, J APPL CRYSTALLOGR, V30, P755, DOI 10.1107/S0021889897001635; Choi SM, 1997, PROG COLL POL SCI S, V106, P14, DOI 10.1007/BF01189485; EASTOE J, 1990, J CHEM SOC FARADAY T, V86, P2883, DOI 10.1039/ft9908602883; EASTOE J, 1994, J CHEM SOC FARADAY T, V90, P3121, DOI 10.1039/ft9949003121; EASTOE J, 1994, J CHEM SOC FARADAY T, V90, P487, DOI 10.1039/ft9949000487; EKWALL P, 1970, J COLLOID INTERF SCI, V33, P215, DOI 10.1016/0021-9797(70)90024-X; FULTON JL, 1988, J PHYS CHEM-US, V92, P2903, DOI 10.1021/j100321a039; Ghosh SK, 1997, PROG COLL POL SCI S, V106, P98, DOI 10.1007/BF01189500; Ghosh SK, 1998, JPN J APPL PHYS 1, V37, P919, DOI 10.1143/JJAP.37.919; GOMPPER G, 1990, PHYS REV B, V41, P9148, DOI 10.1103/PhysRevB.41.9148; HELFRICH W, 1973, PHYS LETT A, VA 43, P409, DOI 10.1016/0375-9601(73)90396-4; ITO Y, 1995, PHYSICA B, V213, P889, DOI 10.1016/0921-4526(95)00314-Y; KAHLWEIT M, 1985, ANGEW CHEM INT EDIT, V24, P654, DOI 10.1002/anie.198506541; KALER EW, 1983, J CHEM PHYS, V79, P5685, DOI 10.1063/1.445689; Komura S, 1996, J CHEM PHYS, V105, P3264, DOI 10.1063/1.471842; KOTLARCHYK M, 1992, PHYS REV A, V46, P928, DOI 10.1103/PhysRevA.46.928; KOTLARCHYK M, 1984, PHYS REV A, V29, P2054, DOI 10.1103/PhysRevA.29.2054; KOTLARCHYK M, 1984, PHYS REV LETT, V53, P941, DOI 10.1103/PhysRevLett.53.941; KUNIEDA H, 1979, J COLLOID INTERF SCI, V70, P577, DOI 10.1016/0021-9797(79)90065-1; LANGEVIN D, 1988, ACCOUNTS CHEM RES, V21, P255, DOI 10.1021/ar00151a001; NAGAO M, 1998, PHYSICA B, V241, P970; NAGAO M, IN PRESS SLOW DYNMAI; Nagao M, 1997, PROG COLL POL SCI S, V106, P86, DOI 10.1007/BF01189498; NALLET F, 1990, J PHYS-PARIS, V51, P2333, DOI 10.1051/jphys:0199000510200233300; Roux D., 1994, MICELLES MEMBRANES M; Takeno H, 1997, POLYM J, V29, P931, DOI 10.1295/polymj.29.931	36	25	25	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1063-651X			PHYS REV E	Phys. Rev. E	MAR	1999	59	3	B				3169	3176		10.1103/PhysRevE.59.3169		8	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	177WF	WOS:000079233500014		
J	Tribelsky, MI				Tribelsky, MI			Statistical properties of chaos at onset of electroconvection in a homeotropically aligned nematic layer	PHYSICAL REVIEW E			English	Article							SPATIOTEMPORAL CHAOS; LIQUID-CRYSTALS; INSTABILITY; CONVECTION	The recently discovered chaos at the onset of electroconvection in a homeotropically aligned nematic layer caused by slow random long-wavelength modulations of a roll pattern is discussed. The temporal autocorrelation function for components of the order parameter is expressed in terms of probability density for random drift velocity of the pattern. It is shown that despite the fact that the problem has at least two different characteristic times associated with the slow pattern dynamics, only one of them enters into the autocorrelation function. [S1063-651X(99)12003-8].	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 153, Japan; Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Tribelsky, MI (reprint author), Fukui Univ, Fac Engn, Dept Appl Phys, Bunkyo 3-9-1, Fukui 9108507, Japan.	tribel@scroll.apphy.fukui-u.ac.jp	Tribelsky, Michael/H-4216-2011				Dennin M, 1996, SCIENCE, V272, P388, DOI 10.1126/science.272.5260.388; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Chandrasekhar S., 1977, LIQUID CRYSTALS; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; Dennin M, 1996, PHYS REV LETT, V76, P319, DOI 10.1103/PhysRevLett.76.319; Dennin M, 1995, MOL CRYST LIQ CRYS A, V261, P337, DOI 10.1080/10587259508033480; HERTRICH A, 1992, J PHYS II, V2, P1915; Hidaka Y, 1997, J PHYS SOC JPN, V66, P3329, DOI 10.1143/JPSJ.66.3329; HU YC, 1995, PHYS REV LETT, V74, P5040, DOI 10.1103/PhysRevLett.74.5040; Kai S, 1996, J PHYS CHEM-US, V100, P19007, DOI 10.1021/jp961539f; LANDAU LD, 1989, STAT PHYSICS 1; RICHTER H, 1995, EUROPHYS LETT, V30, P37, DOI 10.1209/0295-5075/30/1/007; RICHTER H, 1995, PHYS REV E, V51, P5886, DOI 10.1103/PhysRevE.51.5886; Rossberg AG, 1996, PHYS REV LETT, V76, P4729, DOI 10.1103/PhysRevLett.76.4729; Toth P, 1998, PHYS REV E, V58, P1983, DOI 10.1103/PhysRevE.58.1983; TRIBELSKY MI, 1966, BUSSEI KENKYU KYOTO, V66, P592	16	6	6	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1063-651X			PHYS REV E	Phys. Rev. E	MAR	1999	59	3	B				3729	3732		10.1103/PhysRevE.59.3729		4	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	177WF	WOS:000079233500082		
J	Fukuda, Y; Hayakawa, T; Ichihara, E; Inoue, K; Ishihara, K; Ishino, H; Itow, Y; Kajita, T; Kameda, J; Kasuga, S; Kobayashi, K; Kobayashi, Y; Koshio, Y; Miura, M; Nakahata, M; Nakayama, S; Okada, A; Okumura, K; Sakurai, N; Shiozawa, M; Suzuki, Y; Takeuchi, Y; Totsuka, Y; Yamada, S; Earl, M; Habig, A; Kearns, E; Messier, MD; Scholberg, K; Stone, JL; Sulak, LR; Walter, CW; Goldhaber, M; Barszczak, T; Casper, D; Gajewski, W; Halverson, PG; Hsu, J; Kropp, WR; Price, LR; Reines, F; Smy, M; Sobel, HW; Vagins, MR; Ganezer, KS; Keig, WE; Ellsworth, RW; Tasaka, S; Flanagan, JW; Kibayashi, A; Learned, JG; Matsuno, S; Stenger, VJ; Takemori, D; Ishii, T; Kanzaki, J; Kobayashi, T; Mine, S; Nakamura, K; Nishikawa, K; Oyama, Y; Sakai, A; Sakuda, M; Sasaki, O; Echigo, S; Kohama, M; Suzuki, AT; Haines, TJ; Blaufuss, E; Kim, BK; Sanford, R; Svoboda, R; Chen, ML; Conner, Z; Goodman, JA; Sullivan, GW; Hill, J; Jung, CK; Martens, K; Mauger, C; McGrew, C; Sharkey, E; Viren, B; Yanagisawa, C; Doki, W; Miyano, K; Okazawa, H; Saji, C; Takahata, M; Nagashima, Y; Takita, M; Yamaguchi, T; Yoshida, M; Kim, SB; Etoh, M; Fujita, K; Hasegawa, A; Hasagawa, T; Hatakeyama, S; Iwamoto, T; Koga, M; Maruyama, T; Ogawa, H; Shirai, J; Suzuki, A; Tsushima, F; Koshiba, M; Iwamoto, T; Koga, M; Maruyama, T; Ogawa, H; Shirai, J; Suzuki, A; Tsushima, F; Koshiba, M; Nemoto, M; Nishijima, K; Futagami, T; Hayato, Y; Kanaya, Y; Kaneyuki, K; Watanabe, Y; Kielczewska, D; Doyle, RA; George, JS; Stachyra, AL; Wai, LL; Wilkes, RJ; Young, KK				Fukuda, Y; Hayakawa, T; Ichihara, E; Inoue, K; Ishihara, K; Ishino, H; Itow, Y; Kajita, T; Kameda, J; Kasuga, S; Kobayashi, K; Kobayashi, Y; Koshio, Y; Miura, M; Nakahata, M; Nakayama, S; Okada, A; Okumura, K; Sakurai, N; Shiozawa, M; Suzuki, Y; Takeuchi, Y; Totsuka, Y; Yamada, S; Earl, M; Habig, A; Kearns, E; Messier, MD; Scholberg, K; Stone, JL; Sulak, LR; Walter, CW; Goldhaber, M; Barszczak, T; Casper, D; Gajewski, W; Halverson, PG; Hsu, J; Kropp, WR; Price, LR; Reines, F; Smy, M; Sobel, HW; Vagins, MR; Ganezer, KS; Keig, WE; Ellsworth, RW; Tasaka, S; Flanagan, JW; Kibayashi, A; Learned, JG; Matsuno, S; Stenger, VJ; Takemori, D; Ishii, T; Kanzaki, J; Kobayashi, T; Mine, S; Nakamura, K; Nishikawa, K; Oyama, Y; Sakai, A; Sakuda, M; Sasaki, O; Echigo, S; Kohama, M; Suzuki, AT; Haines, TJ; Blaufuss, E; Kim, BK; Sanford, R; Svoboda, R; Chen, ML; Conner, Z; Goodman, JA; Sullivan, GW; Hill, J; Jung, CK; Martens, K; Mauger, C; McGrew, C; Sharkey, E; Viren, B; Yanagisawa, C; Doki, W; Miyano, K; Okazawa, H; Saji, C; Takahata, M; Nagashima, Y; Takita, M; Yamaguchi, T; Yoshida, M; Kim, SB; Etoh, M; Fujita, K; Hasegawa, A; Hasagawa, T; Hatakeyama, S; Iwamoto, T; Koga, M; Maruyama, T; Ogawa, H; Shirai, J; Suzuki, A; Tsushima, F; Koshiba, M; Iwamoto, T; Koga, M; Maruyama, T; Ogawa, H; Shirai, J; Suzuki, A; Tsushima, F; Koshiba, M; Nemoto, M; Nishijima, K; Futagami, T; Hayato, Y; Kanaya, Y; Kaneyuki, K; Watanabe, Y; Kielczewska, D; Doyle, RA; George, JS; Stachyra, AL; Wai, LL; Wilkes, RJ; Young, KK		Super-Kamiokande Collaboration	Constraints on neutrino oscillation parameters from the measurement of day-night solar neutrino fluxes at Super-Kamiokande	PHYSICAL REVIEW LETTERS			English	Article							MODEL; SUN; MATTER	A search for day-night variations in the solar neutrino flux resulting from neutrino oscillations has been carried out using the 504 day sample of solar neutrino data obtained at Super-Kamiokande, The absence of a significant day-night variation has set an absolute: Bur independent exclusion region in the two neutrino oscillation parameter space. [S0031-9007(99)08599-3].	Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; Boston Univ, Dept Phys, Boston, MA 02215 USA; Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; Calif State Univ Dominguez Hills, Dept Phys, Carson, CA 90747 USA; George Mason Univ, Dept Phys, Fairfax, VA 22030 USA; Gifu Univ, Dept Phys, Gifu 5011193, Japan; Univ Hawaii, Dept Phys & Astron, Honolulu, HI 96822 USA; High Energy Accelerator Res Org KEK, Inst Particle & Nucl Studies, Ibaraki, Osaka 3050801, Japan; Kobe Univ, Dept Phys, Kobe, Hyogo 6578501, Japan; Univ Calif Los Alamos Natl Lab, Dept Phys, Los Alamos, NM 87544 USA; Louisiana State Univ, Dept Phys & Astron, Baton Rouge, LA 70803 USA; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Niigata Univ, Dept Phys, Niigata 9502181, Japan; Osaka Univ, Dept Phys, Osaka 5600043, Japan; Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea; Tohoku Univ, Dept Phys, Sendai, Miyagi 9808578, Japan; Univ Tokyo, Tokyo 1130033, Japan; Tokai Univ, Dept Phys, Kanagawa 2591292, Japan; Tokyo Inst Technol, Dept Phys, Meguro Ku, Tokyo 1528551, Japan; Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; Univ Washington, Dept Phys, Seattle, WA 98195 USA	Fukuda, Y (reprint author), Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan.		Takeuchi, Yasuo/A-4310-2011; Nakamura, Kenzo/F-7174-2010; Sobel, Henry/A-4369-2011; Suzuki, Yoichiro/F-7542-2010; Martens, Kai/A-4323-2011; Wilkes, R.Jeffrey/E-6011-2013; Kim, Soo-Bong/B-7061-2014; Sakurai, Nobuyuki/M-5009-2014; Ishino, Hirokazu/C-1994-2015; Koshio, Yusuke/C-2847-2015	Sakurai, Nobuyuki/0000-0002-1002-217X; Ishino, Hirokazu/0000-0002-8623-4080; Koshio, Yusuke/0000-0003-0437-8505			Fukuda Y, 1996, PHYS REV LETT, V77, P1683, DOI 10.1103/PhysRevLett.77.1683; MIKHEEV SP, 1985, SOV J NUCL PHYS+, V42, P913; ABDURASHITOV JN, 1994, PHYS LETT B, V328, P234, DOI 10.1016/0370-2693(94)90454-5; WOLFENSTEIN L, 1978, PHYS REV D, V17, P2369, DOI 10.1103/PhysRevD.17.2369; Fukuda Y, 1998, PHYS REV LETT, V81, P1158, DOI 10.1103/PhysRevLett.81.1158; TURCKCHIEZE S, 1993, ASTROPHYS J, V408, P347, DOI 10.1086/172592; ANSELMANN P, 1995, PHYS LETT B, V342, P440, DOI 10.1016/0370-2693(94)01586-2; BAHCALL JN, 1995, REV MOD PHYS, V67, P1; Bahcall JN, 1997, PHYS REV C, V56, P2839, DOI 10.1103/PhysRevC.56.2839; Bahcall JN, 1997, PHYS REV C, V56, P3391, DOI 10.1103/PhysRevC.56.3391; Bahcall JN, 1998, PHYS LETT B, V433, P1, DOI 10.1016/S0370-2693(98)00657-1; Bahcall JN, 1996, PHYS REV C, V54, P411, DOI 10.1103/PhysRevC.54.411; Bahcall JN, 1997, PHYS REV LETT, V78, P171, DOI 10.1103/PhysRevLett.78.171; Cleveland BT, 1998, ASTROPHYS J, V496, P505, DOI 10.1086/305343; Dar A, 1996, ASTROPHYS J, V468, P933, DOI 10.1086/177748; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; FOGLI GL, 1995, ASTROPART PHYS, V3, P185, DOI 10.1016/0927-6505(94)00041-Z; GAVRIN V, 1999, IN PRESS NUCL PH B S; KIRSTEN T, NEUTRINO 98; NAKAHATA M, IN PRESS; SACKMANN IJ, 1990, ASTROPHYS J, V360, P727, DOI 10.1086/169158; SHI X, 1994, PHYS REV D, V50, P2414, DOI 10.1103/PhysRevD.50.2414	22	385	387	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	MAR 1	1999	82	9					1810	1814		10.1103/PhysRevLett.82.1810		5	Physics, Multidisciplinary	Physics	171RC	WOS:000078877000003		
J	Kato, H; Kawai, M; Yoshinobu, J				Kato, H; Kawai, M; Yoshinobu, J			Switching in the molecular orientation ruled by steric repulsion of adsorbed CO on Pd(110)	PHYSICAL REVIEW LETTERS			English	Article							ELECTRON-STIMULATED DESORPTION; ADSORPTION SITE; CARBON-MONOXIDE; NI(110); SURFACE; RECONSTRUCTION; ESDIAD; LAYERS; RAIRS	The molecular orientation of CO adsorbed on Pd(110) changes anisotropically depending on the ordered structures. The tilted geometry of CO is identified, using high-resolution electron energy-loss spectroscopy, based on the observation of hindered rotational vibrations in the dipole-scattering spectra in which the assignments are determined by the energy shifts of a series of CO isotopomers. With increasing coverage, the orientation of CO switches from the upright geometry to the tilted geometry first along the Pd row and then perpendicular to the row. The tilted geometry is controlled by how the nearest-neighbor CO-CO repulsion is reduced. [S0031-9007(99)08575-0].	RIKEN, Inst Phys & Chem Res, Tokyo 3510198, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Kawai, M (reprint author), RIKEN, Inst Phys & Chem Res, 2-1 Hirosawa, Tokyo 3510198, Japan.		Kato, Hiroyuki/H-2640-2014				Ahner J, 1996, J CHEM PHYS, V105, P6553, DOI 10.1063/1.472464; ALVEY MD, 1986, SURF SCI, V165, P447, DOI 10.1016/0039-6028(86)90819-8; CHESTERS MA, 1985, SURF SCI, V164, P425, DOI 10.1016/0039-6028(85)90757-5; BLYHOLDER G, 1964, J PHYS CHEM-US, V68, P2772, DOI 10.1021/j100792a006; HENDERSON MA, 1989, J CHEM PHYS, V91, P7245, DOI 10.1063/1.457292; Graham AP, 1998, J CHEM PHYS, V108, P7825, DOI 10.1063/1.476219; LOCATELLI A, 1994, PHYS REV LETT, V73, P90, DOI 10.1103/PhysRevLett.73.90; HU P, 1994, CHEM PHYS LETT, V230, P501, DOI 10.1016/0009-2614(94)01184-2; RAVAL R, 1990, CHEM PHYS LETT, V167, P391, DOI 10.1016/0009-2614(90)85019-9; Bertino MF, 1997, SURF SCI, V385, pL984, DOI 10.1016/S0039-6028(97)00430-5; HAHNER G, 1990, APPL PHYS A-MATER, V51, P208, DOI 10.1007/BF00324003; HAQ S, 1992, SURF SCI, V275, P170, DOI 10.1016/0039-6028(92)90791-4; HU P, 1991, SURF SCI, V249, P1, DOI 10.1016/0039-6028(91)90827-F; KATO H, IN PRESS SURF SCI; lbach H., 1982, ELECT ENERGY LOSS SP; PERSSON BNJ, 1992, SURF SCI REP, V15, P1, DOI 10.1016/0167-5729(92)90012-Z; Ramprasad R, 1996, SURF SCI, V360, P31, DOI 10.1016/0039-6028(96)00600-0; RAVAL R, 1989, SURF SCI, V211, P61, DOI 10.1016/0039-6028(89)90754-1; RICHARDSON NV, 1987, VIB SPECTROSC, P39; RIEDL W, 1985, SURF SCI, V163, P39, DOI 10.1016/0039-6028(85)90846-5; SOMOLJAI GAA, 1994, INTRO SURFACE CHEM C; UVDAL P, 1988, SURF SCI, V202, P167, DOI 10.1016/0039-6028(88)90067-2; VANDERPOL A, 1990, J CHEM PHYS, V92, P7498, DOI 10.1063/1.458185; VOIGTLANDER B, 1990, SURF SCI, V225, P151, DOI 10.1016/0039-6028(90)90433-9	24	31	31	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	MAR 1	1999	82	9					1899	1902		10.1103/PhysRevLett.82.1899		4	Physics, Multidisciplinary	Physics	171RC	WOS:000078877000025		
J	Tomita, H; Abe, K				Tomita, H; Abe, K			Numerical simulation of the Rayleigh-Benard convection of air in a box of a large aspect ratio	PHYSICS OF FLUIDS			English	Article							TURBULENT CONVECTION; TRANSITION; FLOW	The Rayleigh-Binard convection in a box of a large aspect ratio is investigated using direct numerical simulation. The range of the Rayleigh number (Ra) is 2500 less than or equal to Ra less than or equal to 10000. When Ra less than or equal to 6000, nearly straight roll convection is observed, and the average roll diameter increases linearly with Ra. When Ra greater than or similar to 6000, traveling waves are superimposed on the convection rolls. The gradient of increase in the average roll diameter for Ra greater than or similar to 6000 is smaller than that for Ra less than or similar to 6000. The average curvature of the roll axis increases rapidly when Ra greater than or similar to 6000. (C) 1999 American Institute of Physics. [S1070-6631(99)02603-3].	Univ Tokyo, Grad Sch Engn, Abe Lab, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, Coll Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Tomita, H (reprint author), Univ Tokyo, Grad Sch Engn, Abe Lab, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.						GROTZBACH G, 1983, J COMPUT PHYS, V49, P241, DOI 10.1016/0021-9991(83)90125-0; CLEVER RM, 1974, J FLUID MECH, V65, P625, DOI 10.1017/S0022112074001571; MOENG CH, 1990, J ATMOS SCI, V47, P1149, DOI 10.1175/1520-0469(1990)047<1149:VVSITB>2.0.CO;2; LEONARD BP, 1979, COMPUT METHOD APPL M, V19, P59, DOI 10.1016/0045-7825(79)90034-3; EIDSON TM, 1985, J FLUID MECH, V158, P245, DOI 10.1017/S0022112085002634; Kerr RM, 1996, J FLUID MECH, V310, P139, DOI 10.1017/S0022112096001760; LIPPS FB, 1976, J FLUID MECH, V75, P113, DOI 10.1017/S0022112076000141; ARTER W, 1988, PHYS FLUIDS, V31, P2474, DOI 10.1063/1.866601; BROWN W, 1973, J FLUID MECH, V60, P539, DOI 10.1017/S0022112073000339; CLEVER RM, 1987, J FLUID MECH, V176, P711; CLEVER RM, 1978, Z ANGEW MATH PHYS, V29, P711, DOI 10.1007/BF01601497; GROTZBACH G, 1982, J FLUID MECH, V119, P27, DOI 10.1017/S0022112082001256; KRISHNAM.R, 1973, J FLUID MECH, V60, P285, DOI 10.1017/S0022112073000170; KRISHNAM.R, 1970, J FLUID MECH, V42, P295, DOI 10.1017/S0022112070001271; KRISHNAM.R, 1970, J FLUID MECH, V42, P309, DOI 10.1017/S0022112070001283; Willis G E, 1970, J FLUID MECH, V44, P661, DOI 10.1017/S0022112070002070; WILLIS GE, 1972, J FLUID MECH, V54, P351, DOI 10.1017/S0022112072000722; WONG VC, 1994, PHYS FLUIDS, V6, P1016, DOI 10.1063/1.868335	18	4	4	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	1070-6631			PHYS FLUIDS	Phys. Fluids	MAR	1999	11	3					743	745		10.1063/1.869944		3	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	169XA	WOS:000078773700023		
J	Haruta, M; Murata, M; Kadokura, H; Homma, S				Haruta, M; Murata, M; Kadokura, H; Homma, S			Immunological and molecular comparison of polyphenol oxidase in Rosaceae fruit trees	PHYTOCHEMISTRY			English	Article						Pyrus pyrifolia (Japanese pear); Pyrus communis (pear); Prunus persica (peach); Eriobotrya japonica (Japanese loquat); Pseudocydonia sinensis (Chinese quince); Rosaceae; polyphenol oxidase; enzymatic browning	CHLOROGENIC ACID OXIDASE; APPLE; PURIFICATION; CLONING; PLANTS; DNA	An antibody raised against apple polyphenol oxidase (PPO) cross-reacted with PPOs from Japanese pear (Pyrus pyrifolia). pear (Pyrus communis), peach (Prunus persica); Chinese quince (Pseudocydonia sinensis) and Japanese loquat (Eriobotrya japonica). Core fragments (681 bp) of the corresponding PPO genes were amplified and characterized. The deduced protein sequences showed identities of 85.3 to 97.5%. Chlorogenic acid oxidase activity of these PPOs showed higher activities when assayed :ir pH4 than at pH6. These results indicate that PPOs in Rosaceae plants are structurally and enzymatically similar. (C) 1999 Elsevier Science Ltd. All rights reserved.	Ochanomizu Univ, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 1120012, Japan; Univ Tokyo, Dept Biotechnol, Tokyo 113, Japan	Murata, M (reprint author), Ochanomizu Univ, Dept Nutr & Food Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1120012, Japan.						MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; VanGelder CWG, 1997, PHYTOCHEMISTRY, V45, P1309, DOI 10.1016/S0031-9422(97)00186-6; FELTON GW, 1992, J CHEM ECOL, V18, P571, DOI 10.1007/BF00987820; Bucheli CS, 1996, PLANT MOL BIOL, V31, P1233, DOI 10.1007/BF00040840; Goldman MHS, 1998, PLANT MOL BIOL, V36, P479, DOI 10.1023/A:1005914918284; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; DRY IB, 1994, PLANT MOL BIOL, V26, P495, DOI 10.1007/BF00039560; FLURKEY WH, 1980, J FOOD BIOCHEM, V4, P29, DOI 10.1111/j.1745-4514.1980.tb00875.x; GEYKEMA WPJ, 1984, NATURE, V309, P23; Haruta M, 1998, BIOSCI BIOTECH BIOCH, V62, P358, DOI 10.1271/bbb.62.358; HEIMDAL H, 1994, J AGR FOOD CHEM, V42, P1428, DOI 10.1021/jf00043a008; HUNT MD, 1993, PLANT MOL BIOL, V21, P59, DOI 10.1007/BF00039618; LANKER T, 1988, PHYTOCHEMISTRY, V27, P3731, DOI 10.1016/0031-9422(88)83007-3; LAX AR, 1995, ACS S SER, V600; LERCH K, 1995, ACS SYM SER, V600, P64; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; MURATA M, 1992, BIOSCI BIOTECH BIOCH, V56, P1705; MURATA M, 1995, J AGR FOOD CHEM, V43, P1115, DOI 10.1021/jf00053a001; MURATA M, 1993, J AGR FOOD CHEM, V41, P1385, DOI 10.1021/jf00033a008; NEWMAN SM, 1993, PLANT MOL BIOL, V21, P1035, DOI 10.1007/BF00023601; ROBINSON SP, 1992, PLANT PHYSIOL, V99, P317, DOI 10.1104/pp.99.1.317; Sambrook J., 1989, MOL CLONING LAB MANU; Sheptovitsky YG, 1996, BIOCHEMISTRY-US, V35, P16255, DOI 10.1021/bi9613842; SODERHALL I, 1995, PHYTOCHEMISTRY, V39, P33, DOI 10.1016/0031-9422(94)00918-J; Tono T., 1986, Journal of the Agricultural Chemical Society of Japan, V60, P705; WISEMANN KW, 1985, PLANT PHYSIOL, V78, P256	28	29	37	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9422			PHYTOCHEMISTRY	Phytochemistry	MAR	1999	50	6					1021	1025		10.1016/S0031-9422(98)00633-5		5	Biochemistry & Molecular Biology; Plant Sciences	Biochemistry & Molecular Biology; Plant Sciences	192KG	WOS:000080077100017		
J	Lee, KT; Suzuki, T; Yamakawa, T; Kodama, T; Igarashi, Y; Shimomura, K				Lee, KT; Suzuki, T; Yamakawa, T; Kodama, T; Igarashi, Y; Shimomura, K			Production of tropane alkaloids by transformed root cultures of Atropa belladonna in stirred bioreactors with a stainless steel net	PLANT CELL REPORTS			English	Article						Atropa belladonna; transformed root cultures; scale-up; tropane alkaloids; modified stirred bioreactors	AGROBACTERIUM-RHIZOGENES; HAIRY ROOTS; HYOSCYAMINE; SELECTION; REACTOR; GROWTH	A scale up of transformed root cultures of Atropa belladonna from a 300-ml flask to a 30-1 tank was accomplished without any reduction in alkaloid productivity. Cutting treatment of seed cultures showed no distinct effect on root growth, morphology, and alkaloid content in conical flasks during 1 month of culture. Randomly cut roots thus grown were further cultivated in 3-1 and 30-1 modified stirred bioreactors for a scale-up culture. After 1 month of culture, 1490 mg of tropane alkaloids was produced by a 30-1 culture of A. belladonna transformed roots. These roots contained the same level of atropine (5.4 mg/g dw) as the roots of this plant grown in the field for 12 months and still contained a considerable amount of other alkaloids including 1.6 mg/g dw of 6-beta-hydroxyhyoscyamine, 0.9 mg/g dw of scopolamine, and 2.0 mg/g dw of lit-torine.	Univ Tokyo, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Dept Biotechnol, Tokyo 1138657, Japan; Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan; Natl Inst Hlth Sci, Tsukuba Med Plant Res Stn, Tsukuba, Ibaraki 3050843, Japan	Yamakawa, T (reprint author), Univ Tokyo, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan.			LEE, KUNG-TA/0000-0003-1386-6586			HILTON MG, 1990, APPL MICROBIOL BIOT, V33, P132; JUNG G, 1987, PLANT SCI, V50, P145, DOI 10.1016/0168-9452(87)90151-8; KAMADA H, 1986, PLANT CELL REP, V5, P239, DOI 10.1007/BF00269811; Falk LR, 1996, BIOTECHNOL LETT, V18, P1099, DOI 10.1007/BF00129739; JAZIRI M, 1994, PLANT CELL TISS ORG, V38, P257, DOI 10.1007/BF00033885; Kawamura M, 1996, J FERMENT BIOENG, V82, P618, DOI 10.1016/S0922-338X(97)81266-4; KWOK KH, 1995, BIOTECHNOL PROGR, V11, P429, DOI 10.1021/bp00034a010; Lee KT, 1998, PHYTOCHEMISTRY, V49, P2343, DOI 10.1016/S0031-9422(97)01074-1; MEDINABOLIVAR F, 1995, PLANT PHYSIOL, V108, P1553; MURANAKA T, 1992, APPL MICROBIOL BIOT, V37, P554; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; PAYNE J, 1987, Planta Medica, V53, P474, DOI 10.1055/s-2006-962776; RAMAKRISHNAN D, 1994, BIOTECHNOL TECH, V8, P639; ROBINS RJ, 1993, ALKALOIDS, V44, P116; SHIMOMURA K, 1991, PHYTOCHEMISTRY, V30, P2275, DOI 10.1016/0031-9422(91)83629-Y; Woo SH, 1997, PLANT CELL TISS ORG, V48, P131, DOI 10.1023/A:1005725519740; Woo SH, 1996, J CHEM TECH BIOTECHN, V66, P355; Yamada Y., 1997, PLANT BIOTECHNOL, V14, P1; YUKIMUNE Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1443	19	16	18	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0721-7714			PLANT CELL REP	Plant Cell Reports	MAR	1999	18	7-8					567	571				5	Plant Sciences	Plant Sciences	178TH	WOS:000079282200008		
J	Sakai, A; Miyazawa, Y; Saito, C; Nagata, N; Takano, H; Hirano, HY; Kuroiwa, T				Sakai, A; Miyazawa, Y; Saito, C; Nagata, N; Takano, H; Hirano, HY; Kuroiwa, T			Amyloplast formation in cultured tobacco cells. III - Determination of the timing of gene expression necessary for starch accumulation	PLANT CELL REPORTS			English	Article						ADP-glucose starch glycosyl transferase amyloplast; BY-2; Nicotiana tabacum; transcription/translation inhibitors		When BY-2 cultured tobacco (Nicotiana tabacum L.) cells were transferred to auxin-depleted culture medium containing cytokinin (benzyladenine, 1 mg/l), the starch content per cell started increasing from 18 h of culture and amyloplasts had formed by 48 h. Pulse-treatment of the cells with actinomycin D and cycloheximide for the first 12 h (or longer) of culture significantly decreased the cellular starch content after 48 h, whereas the starch content did not decrease significantly when the cells were re leased from the inhibition within 6 h. This suggests that nuclear gene expression necessary for amyloplast formation begins 6-12 h after the transfer. Immunoblotting analysis of the accumulation of ADP-glucose starch glycosyl transferase (starch synthase) supported this inference.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Lab Plant Breeding & Genet, Tokyo 1138657, Japan	Sakai, A (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan.		Saito, Chieko/F-5755-2013; Hirano, Hiro-Yuki/G-4928-2014; 	Saito, Chieko/0000-0002-4374-5120; Hirano, Hiro-Yuki/0000-0001-7364-8893; Takano, Hiroyoshi/0000-0003-4720-5057			DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; HIRANO HY, 1991, PLANT CELL PHYSIOL, V32, P989; Kirk JT, 1978, PLASTIDS THEIR CHEM, V2nd; NAGATA T, 1981, MOL GEN GENET, V184, P161; Sakai Atsushi, 1997, Cytologia (Tokyo), V62, P295; SAKAI A, 1992, PLANT PHYSIOL, V100, P1062, DOI 10.1104/pp.100.2.1062; Sakai A, 1996, PLANT CELL REP, V15, P601, DOI 10.1007/BF00232461; SUGIURA M, 1992, PLANT MOL BIOL, V19, P149, DOI 10.1007/BF00015612	8	6	7	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0721-7714			PLANT CELL REP	Plant Cell Reports	MAR	1999	18	7-8					589	594				6	Plant Sciences	Plant Sciences	178TH	WOS:000079282200012		
J	Kuriyama, H; Takano, H; Suzuki, L; Uchida, H; Kawano, S; Kuroiwa, H; Kuroiwa, T				Kuriyama, H; Takano, H; Suzuki, L; Uchida, H; Kawano, S; Kuroiwa, H; Kuroiwa, T			Characterization of Chlamydomonas reinhardtii zygote-specific cDNAs that encode novel proteins containing ankyrin repeats and WW domains	PLANT PHYSIOLOGY			English	Article							CELL-CYCLE CONTROL; ALTERNATIVELY SPLICED FORMS; DNA-BINDING SUBUNIT; MATING-TYPE LOCUS; NF-KAPPA-B; CHLOROPLAST DNA; ENDOPLASMIC-RETICULUM; MATERNAL INHERITANCE; MICROSCOPIC EVIDENCE; REL ONCOGENE	Genes that are expressed only in the young zygote are considered to be of great importance in the development of an isogamous green alga, Chlamydomonas reinhardtii. Clones representing the Zys3 gene were isolated from a cDNA library prepared using zygotes at 10 min after fertilization. Sequencing of Zys3 cDNA clones resulted in the isolation of two related molecular species. One of them encoded a protein that contained two kinds of protein-to-protein interaction motifs known as ankyrin repeats and WW domains. The other clone lacked the ankyrin repeats but was otherwise identical. These mRNA species began to accumulate simultaneously in cells beginning 10 min after fertilization, and reached maximum levels at about 4 h, after which time levels decreased markedly. Genomic DNA gel-blot analysis indicated that Zys3 was a single-copy gene. The Zys3 proteins exhibited parallel expression to the Zys3 mRNAs at first, appearing 2 h after mating, and reached maximum levels at more than 6 h, but persisted to at least 1 d. Immunocytochemical analysis revealed their localization in the endoplasmic reticulum, which suggests a role in the morphological changes of the endoplasmic reticulum or in the synthesis and transport of proteins to the Golgi apparatus or related vesicles.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Hyg & Oncol, Tokyo 113, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 305, Japan; Kyoritsu Womens Jr Coll, Dept Biol, Tokyo 102, Japan	Kuriyama, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan.	kuriyam2@gol.com		Takano, Hiroyoshi/0000-0003-4720-5057			AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; Devarajan P, 1996, J CELL BIOL, V133, P819, DOI 10.1083/jcb.133.4.819; ZHANG H, 1992, PLANT CELL, V4, P1575, DOI 10.1105/tpc.4.12.1575; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Staehelin LA, 1997, PLANT J, V11, P1151, DOI 10.1046/j.1365-313X.1997.11061151.x; LAMARCO K, 1991, SCIENCE, V253, P789, DOI 10.1126/science.1876836; Zhou DX, 1997, J CELL BIOL, V136, P621, DOI 10.1083/jcb.136.3.621; Chang YJ, 1996, J ENHANC HEAT TRANSF, V3, P15; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Hart MJ, 1996, EMBO J, V15, P2997; NOZAKI H, 1994, J PHYCOL, V30, P279, DOI 10.1111/j.0022-3646.1994.00279.x; SUDOL M, 1995, J BIOL CHEM, V270, P14733; PETERS LL, 1995, J CELL BIOL, V130, P313, DOI 10.1083/jcb.130.2.313; FERRIS PJ, 1994, CELL, V76, P1135, DOI 10.1016/0092-8674(94)90389-1; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; KUROIWA T, 1991, INT REV CYTOL, V128, P1, DOI 10.1016/S0074-7696(08)60496-9; QUADER H, 1987, EUR J CELL BIOL, V44, P17; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; YOCHEM J, 1989, CELL, V58, P553, DOI 10.1016/0092-8674(89)90436-4; SANGER F, 1981, SCIENCE, V214, P1205, DOI 10.1126/science.7302589; KIRK MM, 1985, CELL, V41, P419, DOI 10.1016/S0092-8674(85)80015-5; AVES SJ, 1985, EMBO J, V4, P457; ARMBRUST EV, 1993, CELL, V74, P801, DOI 10.1016/0092-8674(93)90460-8; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; BOURNE S, 1993, SIGHT SOUND, V3, P72; BOURS V, 1990, NATURE, V348, P76, DOI 10.1038/348076a0; CAVALIER.T, 1970, NATURE, V228, P333, DOI 10.1038/228333a0; CAVALIERSMITH T, 1976, PROTOPLASMA, V87, P297, DOI 10.1007/BF01624002; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; FERRIS PJ, 1987, MOL CELL BIOL, V7, P2360; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; GILBERT SF, 1988, DEV BIOL, P522; GOODENOUGH UW, 1995, ANNU REV PLANT PHYS, V46, P21; Graham LE, 1993, ORIGIN LAND PLANTS; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; ITADANI H, 1994, PLANT MOL BIOL, V24, P249, DOI 10.1007/BF00040593; JOHNSON KA, 1990, CELL, V62, P615, DOI 10.1016/0092-8674(90)90105-N; JONES RL, 1980, PLANTA, V150, P70, DOI 10.1007/BF00385617; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; KUROIWA T, 1982, NATURE, V298, P481, DOI 10.1038/298481a0; KUROIWA T, 1983, P JPN ACAD B-PHYS, V59, P182, DOI 10.2183/pjab.59.182; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORENZ M, 1995, CELL BIOL INT, V19, P625, DOI 10.1006/cbir.1995.1110; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; MATTERS GL, 1992, MOL GEN GENET, V232, P81, DOI 10.1007/BF00299140; MINAMI SA, 1978, J CELL BIOL, V77, P165, DOI 10.1083/jcb.77.1.165; NAKAMURA S, 1988, PLANT SCI, V56, P129, DOI 10.1016/0168-9452(88)90026-X; OHTA N, 1992, PLANT CELL PHYSIOL, V33, P657; Sambrook J., 1989, MOL CLONING LAB MANU; SNELL WJ, 1982, EXP CELL RES, V138, P109, DOI 10.1016/0014-4827(82)90096-9; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; UCHIDA H, 1993, CURR GENET, V24, P296, DOI 10.1007/BF00336779; WEGENER D, 1991, PLANT MOL BIOL, V16, P937, DOI 10.1007/BF00016066; WOESSNER JP, 1989, PLANT CELL, V1, P901; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; YOUNGBLOM J, 1984, MOL CELL BIOL, V4, P2686	62	17	18	AMER SOC PLANT PHYSIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889			PLANT PHYSIOL	Plant Physiol.	MAR	1999	119	3					873	884		10.1104/pp.119.3.873		12	Plant Sciences	Plant Sciences	175PA	WOS:000079102000007		
J	Nakagawa, H				Nakagawa, H			Valuation of default swap with affine-type hazard rate	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article									Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 1538914, Japan							AONUMA K, 1998, VALUATION CREDIT DEF; DAVIS M, 1997, VALUATION POTENTIAL; DUFFIE D, 1994, MODELING TERM STRUCT; Duffie D., 1996, DYNAMIC ASSET PRICIN; Kusuoka S., 1999, ADV MATH EC, V1, P69; Laperyre B., 1996, INTRO STOCHASTIC CAL	6	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	MAR	1999	75	3					43	46				4	Mathematics	Mathematics	186XL	WOS:000079756100008		
J	Masuda, A				Masuda, A			Characteristics of rare-earth elements extraction from tholeiitic basalt by hydrochloric acid nitric acid mixture - Polymorphic effect of sesquioxides of lanthanides	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						polymorphism; REE; extraction; tholeiitic basalt; hydrochloric acid nitric acid mixture; crystal structure; sesquioxide; valency		The interesting features that rare-earth elements (REE) exhibit in HCl-HNO3 acid extraction from powdered tholeiitic basalt are reported here. Cerium which can be oxidized to tetravalent shows the highest extraction percentage. The lower extractability of Eu compared with Sm and Gd is attributed to the high chemical resistance of feldspar in which divalent Eu is preferentially incorporated Based on the extractability, the stable trivalent rare-earth elements, La, Nd, Sm, Gd, Dy, Er, Yb and Lu are divided into three subgroups; {La, Nd}, {Sm}, and {Gd, Dy, Er, Yb, Lu}. This differentiation of the stable trivalent REE is inferred to be related to the polymorphic crystal structures of A-, B- and C-type sesquioxides of REE. Barium shows an extractability identical with that of La-Nd subgroup.	Chinese Acad Sci, Inst Geochem, Guiyang 550002, Guizhou, Peoples R China; Univ Tokyo, Fac Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Masuda, A (reprint author), COLGA, 449-1 Shimo Yasumatsu, Tokorozawa, Saitama 3590024, Japan.						HOEKSTRA HR, 1966, INORG CHEM, V5, P754, DOI 10.1021/ic50039a013; MACDONALD GA, 1963, GEOL SOC AM BULL, V74, P1071, DOI 10.1130/0016-7606(1963)74[1071:PPOEHM]2.0.CO;2; MASUDA A, 1968, J GEOPHYS RES, V73, P5425, DOI 10.1029/JB073i016p05425; MASUDA A, 1966, GEOCHEM J, V1, P11; MASUDA A, 1968, GEOCHEM J, V2, P111; MORGAN JW, 1965, J GEOPHYS RES, V70, P4724, DOI 10.1029/JZ070i018p04724; SCHNETZL.CC, 1970, GEOCHIM COSMOCHIM AC, V34, P331, DOI 10.1016/0016-7037(70)90110-9; SCHNETZL.CC, 1967, ANAL CHEM, V39, P1888, DOI 10.1021/ac50157a073; TOWELL DG, 1965, J GEOPHYS RES, V70, P3485, DOI 10.1029/JZ070i014p03485; WARSHAW I, 1961, J PHYS CHEM-US, V65, P2048, DOI 10.1021/j100828a030	10	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	1999	75	3					46	48		10.2183/pjab.75.46		3	Multidisciplinary Sciences	Science & Technology - Other Topics	186XJ	WOS:000079755900002		
J	Ui-Tei, K; Takamiya, M; Nagano, M; Suzuki, H; Suzuki, A; Kataoka, H; Miyata, Y				Ui-Tei, K; Takamiya, M; Nagano, M; Suzuki, H; Suzuki, A; Kataoka, H; Miyata, Y			Purification of a novel substance from skeletal muscles with motoneuron survival activity: It is non-peptidergic	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						survival activity; non-peptide; spinal motoneuron; skeletal muscle; chick embryo	NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; SPINAL-CORD; NEURONS; CYTOKINES; REDUCTION	We purified a novel substance with survival activity for spinal motoneurons from skeletal muscles of chick embryos. The purification procedure using various column chromatographies was described. The purified substance showed a maximum UV absorbance at 258 nm, which suggests that it is non-peptidergic in nature. This is the first report to show that a non-peptidergic substance exhibits the survival activity on spinal motoneurons. A possible candidate for the substance was discussed.	Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, Tokyo 1138602, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Miyata, Y (reprint author), Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.						HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Suzuki H, 1998, J COMP NEUROL, V402, P303; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; KORSCHING S, 1993, J NEUROSCI, V13, P2739; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; KATAOKA H, 1991, AGR BIOL CHEM TOKYO, V55, P73; APPEL SH, 1981, ANN NEUROL, V10, P499, DOI 10.1002/ana.410100602; Greensmith L, 1996, TRENDS NEUROSCI, V19, P450, DOI 10.1016/S0166-2236(96)20034-7; HALL AK, 1992, TRENDS NEUROSCI, V15, P35, DOI 10.1016/0166-2236(92)90022-Z; Hamburger V, 1982, NEUROSCI COMMENT, V1, P39; HAMBURGER V, 1958, AM J ANAT, V102, P365, DOI 10.1002/aja.1001020303; Hefti F., 1993, NEUROTROPHIC FACTORS, P25; HOLLYDAY M, 1976, J COMP NEUROL, V170, P311, DOI 10.1002/cne.901700304; KUNO M, 1995, SYNAPSE FUNCTION PLA, P145; LUVEL E, 1997, TINS, V18, P196; MCMANAMAN JL, 1988, J BIOL CHEM, V263, P5890; MIYATA Y, 1986, J NEUROSCI, V6, P2012; OPPENHEIM RW, 1982, J COMP NEUROL, V210, P174, DOI 10.1002/cne.902100208; PRESTIGE MC, 1967, J EMBRYOL EXP MORPH, V18, P359; SMITH RG, 1986, J NEUROSCI, V6, P439; Takamiya M, 1999, P JPN ACAD B-PHYS, V75, P59, DOI 10.2183/pjab.75.59	22	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	1999	75	3					54	58		10.2183/pjab.75.54		5	Multidisciplinary Sciences	Science & Technology - Other Topics	186XJ	WOS:000079755900004		
J	Takamiya, M; Ui-Tei, K; Nagano, M; Suzuki, H; Suzuki, A; Miyata, Y; Kataoka, H				Takamiya, M; Ui-Tei, K; Nagano, M; Suzuki, H; Suzuki, A; Miyata, Y; Kataoka, H			Identification of RNA as a substance responsible for the survival of chick spinal motoneurons in vitro	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						RNA; spinal cord; neuron; chick embryo; H-1-NMR	INVITRO; DEATH	In our preceding paper, we presented the purification of a chick embryo's muscle-derived substance that prevented spinal neurons from undergoing cell death in vitro. In this study, characterization of this substance by H-1-NMR spectroscopic analysis and enzymatic inactivation experiments revealed that the substance responsible for the survival of cultured spinal neurons was RNA. For further characterization a modified purification procedure was devised on the basis of the substance being RNA. The finally purified substance showed lambda(max) at 258 nm and prevented enriched populations of spinal motoneurons from undergoing cell death in, vitro, in the same way as the crude muscle extract. These results suggested a novel role of RNA as an intercellular signaling molecule.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Nippon Med Sch, Dept Pharmacol, Bunkyo Ku, Tokyo 1138602, Japan	Kataoka, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						[Anonymous], 1996, MERCK INDEX; SMITH RG, 1985, J CELL BIOL, V101, P1608, DOI 10.1083/jcb.101.4.1608; OPPENHEIM RW, 1988, SCIENCE, V240, P919, DOI 10.1126/science.3363373; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; POUCHERT CJ, 1974, ALDRICH LIBR NMR SPE; SMITH RG, 1986, J NEUROSCI, V6, P439; Ui-Tei K, 1999, P JPN ACAD B-PHYS, V75, P54, DOI 10.2183/pjab.75.54; Wuthrich K., 1986, NMR PROTEINS NUCL AC	8	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	1999	75	3					59	63		10.2183/pjab.75.59		5	Multidisciplinary Sciences	Science & Technology - Other Topics	186XJ	WOS:000079755900005		
J	Tateno, M; Koike, H; Amano, N; Ohfuku, Y; Suzuki, M				Tateno, M; Koike, H; Amano, N; Ohfuku, Y; Suzuki, M			Archaebacterial ribosome is a chimera of eubacterial-type RNAs and eukaryotic-type proteins.	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						genome analysis; bacterial evolution; translation; ribosome; endosymbiogenesis	ORIGIN; EVOLUTION; ARCHAEAL; SEQUENCE; GENES; ROOT; DNA	The three types of archaebacterial ribosomal RNAs, 5S, 16S, and 23S, have been studied in terms of their closest homologues of the non-archaebacterial origin, the numbers of close homologues of eukaryotic and eubacterial organisms, and the insertion and deletion of bases. It is concluded that all the ribosomal RNAs are of eubacterial-type. In contrast, archaebacterial ribosomal proteins have been identified to compose a population that possesses characteristics of eukaryotic-type. Thus the archaebacterial ribosome is a chimera of the eubacterial-type RNAs and the eukaryotic-type proteins.	AIST, NIBHT, CREST, Ctr Struct Biol, Tsukuba, Ibaraki 3050046, Japan; Univ Tsukuba, Doctoral Program Med Sci, Tsukuba, Ibaraki 3050006, Japan; Univ Tsukuba, Doctral Program Agr Sci, Tsukuba, Ibaraki 3050006, Japan; Univ Tokyo, Grad Sch Human & Environm Sci, Meguro Ku, Tokyo 1530041, Japan	Suzuki, M (reprint author), AIST, NIBHT, CREST, Ctr Struct Biol, 1-1 Higashi, Tsukuba, Ibaraki 3050046, Japan.						GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; DOOLITTLE WF, 1994, P NATL ACAD SCI USA, V91, P6721, DOI 10.1073/pnas.91.15.6721; Koonin EV, 1997, MOL MICROBIOL, V25, P619, DOI 10.1046/j.1365-2958.1997.4821861.x; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; BROWN JR, 1995, P NATL ACAD SCI USA, V92, P2441, DOI 10.1073/pnas.92.7.2441; BROWN JW, 1989, CRIT REV MICROBIOL, V16, P287, DOI 10.3109/10408418909105479; DOOLITTLE WF, 1998, CURR BIOL, V8, pE209; DOUY M, 1989, NATURE, V339, P145; GRAY MW, 1989, ANNU REV CELL BIOL, V5, P25; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Koike H, 1999, P JPN ACAD B-PHYS, V75, P37, DOI 10.2183/pjab.75.37; Margulis L., 1970, ORIGIN EUKARYOTIC CE; Ohfuku Y, 1998, P JPN ACAD B-PHYS, V74, P90, DOI 10.2183/pjab.74.90; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Stein JL, 1996, P NATL ACAD SCI USA, V93, P6228, DOI 10.1073/pnas.93.13.6228; STOSSER G, 1999, NUCLEIC ACIDS RES, V27, P18; SUCHOW JM, 1999, P JAPAN ACAD B, V75, P10; SUGAWARA H, 1999, NUCLEIC ACIDS RES, V27, P18; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yamasaki T, 1998, P JPN ACAD B-PHYS, V74, P227, DOI 10.2183/pjab.74.227	24	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	MAR	1999	75	3					64	69		10.2183/pjab.75.64		6	Multidisciplinary Sciences	Science & Technology - Other Topics	186XJ	WOS:000079755900006		
J	Hasegawa, S; Tong, X; Takeda, S; Sato, N; Nagao, T				Hasegawa, S; Tong, X; Takeda, S; Sato, N; Nagao, T			Structures and electronic transport on silicon surfaces	PROGRESS IN SURFACE SCIENCE			English	Review							SCANNING-TUNNELING-MICROSCOPY; X-RAY-DIFFRACTION; ROOM-TEMPERATURE ADSORPTION; ION-SCATTERING-SPECTROSCOPY; SCHOTTKY-BARRIER FORMATION; COVERED SI(111) SURFACES; CORE-LEVEL SHIFTS; ELECTRICAL-CONDUCTION; STATE BAND; SI(111)-ROOT-3X-ROOT-3-AG SURFACE	By utilizing a variety of surface superstructures formed on silicon surfaces and atomic layers grown on them, close correlations between the atomic-scale structures and electrical conduction phenomena at the surfaces have been revealed. State-of-art techniques for analyzing and controlling atomic/electronic structures of surfaces are leading to an understanding of the novel electronic transport properties at surfaces. For example, the electrical conduction through surface-state bands, which are inherent in the surface superstructure, has been confirmed in in-situ measurements. An important,phenomenon has also been found, where adatoms donate carriers into the surface-state band, resulting in a remarkable enhancement in electrical conductance. The nucleation of the adatoms diminishes such a doping effect. Furthermore, electrical conduction through atomic layers grown on the surfaces, whose growth structures are sensitive to the substrate surface structures, will be also discussed. In this review, we emphasize that the surface electronic transport properties are closely related to the atomic structures and atomistic dynamics on surfaces. The ultimate two-dimensional electron systems, consisting of the surface-state bands and grown atomic layers, are expected to provide a new stage in surface physics, as well as a precursory stage leading to atomic-scale electronics devices. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; JST, CREST, Kawaguchi, Saitama 3320012, Japan	Hasegawa, S (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.	shuji@surface.phys.s.u-tokyo.ac.jp	Hasegawa, Shuji/F-8059-2010; Takeda, Sakura/B-3101-2011; NAGAO, Tadaaki/H-2582-2011				ABUKAWA T, 1995, SURF SCI, V325, P33, DOI 10.1016/0039-6028(94)00693-8; AIYAMA T, 1979, SURF SCI, V82, pL585, DOI 10.1016/0039-6028(79)90214-0; ANDO T, 1982, P BIENN C EL PROP 2, V113; ANDO T, 1978, P BIENN C EL PROP 2, V73; ANDO T, 1984, P BIENN C EL PROP 2, V142; ANDO T, 1990, P BIENN C EL PROP PR, V229; ANDO T, 1986, P BIENN C EL PROP 2, V170; ANDO T, 1980, P BIENN C EL PROP 2, V98; ANDO T, 1988, P BIENN C EL PROP 2, V196; HIGASHIYAMA K, 1986, JPN J APPL PHYS 2, V25, pL117, DOI 10.1143/JJAP.25.L117; KAWAJI M, 1979, APPL PHYS LETT, V34, P748, DOI 10.1063/1.90659; DAIMON H, 1990, SURF SCI, V235, P142, DOI 10.1016/0039-6028(90)90789-B; Nagao T, 1998, PHYS REV B, V57, P10100, DOI 10.1103/PhysRevB.57.10100; Plass R, 1997, SURF SCI, V380, P497, DOI 10.1016/S0039-6028(97)00029-0; LIPSON H, 1974, J PHYS C SOLID STATE, V7, P12, DOI 10.1088/0022-3719/7/1/010; SCHULTE FK, 1976, SURF SCI, V55, P427, DOI 10.1016/0039-6028(76)90250-8; BRAICOVICH L, 1980, J VAC SCI TECHNOL, V17, P1005, DOI 10.1116/1.570581; NOGAMI J, 1987, PHYS REV B, V36, P6221, DOI 10.1103/PhysRevB.36.6221; Heike S, 1998, PHYS REV LETT, V81, P890, DOI 10.1103/PhysRevLett.81.890; FINNEY MS, 1992, SURF SCI, V277, P330, DOI 10.1016/0039-6028(92)90772-X; Tong X, 1998, PHYS REV B, V57, P9015, DOI 10.1103/PhysRevB.57.9015; JOHANSSON LSO, 1989, PHYS REV LETT, V63, P2092, DOI 10.1103/PhysRevLett.63.2092; TERSOFF J, 1985, PHYS REV B, V31, P805, DOI 10.1103/PhysRevB.31.805; VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002; Takeda S, 1998, SURF SCI, V415, P264, DOI 10.1016/S0039-6028(98)00473-7; HIRAYAMA H, 1988, APPL SURF SCI, V33-4, P193, DOI 10.1016/0169-4332(88)90306-6; LANDER JJ, 1964, SURF SCI, V2, P553, DOI 10.1016/0039-6028(64)90099-8; KEVAN SD, 1987, PHYS REV B, V36, P5809, DOI 10.1103/PhysRevB.36.5809; COLLINS IR, 1995, SURF SCI, V325, P45, DOI 10.1016/0039-6028(94)00735-7; Hasegawa T, 1996, SURF SCI, V357, P858, DOI 10.1016/0039-6028(96)00278-6; ANDO T, 1982, REV MOD PHYS, V54, P437, DOI 10.1103/RevModPhys.54.437; Sato N, 1999, PHYS REV B, V59, P2035, DOI 10.1103/PhysRevB.59.2035; MARKS LD, 1995, PHYS REV LETT, V75, P2172, DOI 10.1103/PhysRevLett.75.2172; DING YG, 1992, SURF SCI, V275, pL691, DOI 10.1016/0039-6028(92)90785-5; NICHOLLS JM, 1985, PHYS REV B, V32, P1333, DOI 10.1103/PhysRevB.32.1333; HASEGAWA T, 1990, J VAC SCI TECHNOL A, V8, P241, DOI 10.1116/1.577075; PARK SI, 1988, J MICROSC-OXFORD, V152, P727; INO S, 1977, JPN J APPL PHYS, V16, P891, DOI 10.1143/JJAP.16.891; OFNER H, 1993, PHYS REV B, V48, P10940, DOI 10.1103/PhysRevB.48.10940; Kraft J, 1997, PHYS REV B, V55, P5384, DOI 10.1103/PhysRevB.55.5384; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329; TAKAYANAGI K, 1985, SURF SCI, V164, P367, DOI 10.1016/0039-6028(85)90753-8; MARGARITONDO G, 1976, PHYS REV B, V14, P5396, DOI 10.1103/PhysRevB.14.5396; ROWE JE, 1974, PHYS REV LETT, V32, P421, DOI 10.1103/PhysRevLett.32.421; KOHMOTO S, 1988, APPL SURF SCI, V33-4, P45, DOI 10.1016/0169-4332(88)90286-3; JALOCHOWSKI M, 1988, PHYS REV B, V38, P5272, DOI 10.1103/PhysRevB.38.5272; KAWAZU A, 1988, PHYS REV B, V37, P2704, DOI 10.1103/PhysRevB.37.2704; NOGAMI J, 1990, PHYS REV LETT, V65, P1611, DOI 10.1103/PhysRevLett.65.1611; PERSSON BNJ, 1986, PHYS REV B, V34, P5916, DOI 10.1103/PhysRevB.34.5916; Okuda T, 1997, APPL SURF SCI, V121, P89, DOI 10.1016/S0169-4332(97)00263-8; HASEGAWA S, 1987, SURF SCI, V186, P138, DOI 10.1016/S0039-6028(87)80039-0; CHESTER M, 1991, SURF SCI, V256, P135, DOI 10.1016/0039-6028(91)91209-G; Nagao T, 1998, APPL SURF SCI, V130, P47, DOI 10.1016/S0169-4332(98)00023-3; Okuda T, 1996, J ELECTRON SPECTROSC, V80, P229, DOI 10.1016/0368-2048(96)02963-5; AVOURIS P, 1994, J VAC SCI TECHNOL B, V12, P1447, DOI 10.1116/1.587314; Avouris P, 1997, NATO ADV SCI I E-APP, V333, P1; BABA S, 1980, JPN J APPL PHYS, V19, pL571, DOI 10.1143/JJAP.19.L571; BASKI AA, 1990, PHYS REV B, V41, P10247, DOI 10.1103/PhysRevB.41.10247; BAUER E, 1991, SURF SCI, V250, pL379; BISWAS R, 1994, PHYS REV B, V50, P10932, DOI 10.1103/PhysRevB.50.10932; BOLMONT D, 1984, SURF SCI, V137, P280, DOI 10.1016/0039-6028(84)90689-7; BULLOCK EL, 1990, PHYS REV B, V41, P1703, DOI 10.1103/PhysRevB.41.1703; CollazoDavila C, 1997, SURF REV LETT, V4, P65, DOI 10.1142/S0218625X97000110; Collazo-Davila C, 1998, PHYS REV LETT, V80, P1678, DOI 10.1103/PhysRevLett.80.1678; COUTTS JT, 1974, ELECT CONDUCTION THI; CUSACK NE, 1987, PHYSICS STRUCTURALLY; DAIMON H, 1985, SURF SCI, V164, P320, DOI 10.1016/0039-6028(85)90715-0; Datta S., 1995, ELECT TRANSPORT MESO; Di Nardo N. J., 1994, NANOSCALE CHARACTERI; DING YG, 1991, PHYS REV LETT, V67, P1454, DOI 10.1103/PhysRevLett.67.1454; ENDO A, 1993, JPN J APPL PHYS 1, V32, P4718, DOI 10.1143/JJAP.32.4718; ENDO A, 1993, SURF SCI, V293, P165, DOI 10.1016/0039-6028(93)90311-7; ERWIN SC, 1995, PHYS REV LETT, V75, P1973, DOI 10.1103/PhysRevLett.75.1973; FAN WC, 1990, PHYS REV B, V41, P3592, DOI 10.1103/PhysRevB.41.3592; Frankl D.R., 1967, ELECT PROPERTIES SEM; GASPAROV VA, 1996, PHYS LOW-DIMENS STR, V1, P53; GOTOH Y, 1978, JPN J APPL PHYS, V17, P2097, DOI 10.1143/JJAP.17.2097; HANEMAN D, 1987, REP PROG PHYS, V50, P1045, DOI 10.1088/0034-4885/50/8/003; HANSSON GV, 1986, SURF SCI, V168, P105, DOI 10.1016/0039-6028(86)90840-X; HASEGAWA S, 1993, INT J MOD PHYS B, V7, P3817, DOI 10.1142/S0217979293003504; Hasegawa S, 1997, SURF SCI, V386, P322, DOI 10.1016/S0039-6028(97)00331-2; HASEGAWA S, 1993, SURF SCI, V283, P438, DOI 10.1016/0039-6028(93)91016-I; HASEGAWA S, 1998, SURF REV LETT, V3, P803; Hasegawa S, 1997, ADV COLLOID INTERFAC, V71-2, P125; HASEGAWA S, 1994, NANOSTRUCTURES QUANT, P104; HASEGAWA S, 1992, PHYS REV LETT, V68, P1192, DOI 10.1103/PhysRevLett.68.1192; Hasegawa S, 1995, PHASE TRANSIT, V53, P87, DOI 10.1080/01411599508200391; HASEGAWA S, 1993, THIN SOLID FILMS, V228, P113, DOI 10.1016/0040-6090(93)90576-B; HASEGAWA Y, 1996, SURF SCI, V358, P32; He L., 1985, JPN J APPL PHYS, V24, P928, DOI 10.1143/JJAP.24.928; HEIMANN P, 1979, SURF SCI, V85, P263, DOI 10.1016/0039-6028(79)90249-8; HEIMANN P, 1977, J PHYS C SOLID STATE, V10, pL17, DOI 10.1088/0022-3719/10/1/004; HENZLER M, 1975, SURFACE PHYSICS MAT, V1, P241; Henzler M, 1998, PHYS REV B, V58, P10046, DOI 10.1103/PhysRevB.58.10046; HEUN S, 1993, J PHYS-CONDENS MAT, V5, P2913, DOI 10.1088/0953-8984/5/18/013; Hibino H, 1996, PHYS REV B, V54, P5763, DOI 10.1103/PhysRevB.54.5763; Hill IG, 1997, PHYS REV B, V56, P15725, DOI 10.1103/PhysRevB.56.15725; HIMPSEL FJ, 1983, PHYS REV B, V28, P7014, DOI 10.1103/PhysRevB.28.7014; HIMPSEL FJ, 1990, P INT SCH PHYS, V108, P203; Hiraki A., 1984, SURF SCI REP, V3, P357; HOMMA I, 1991, STRUCTURE SURFACES, V3, P610; HONG HW, 1992, PHYS REV LETT, V68, P507, DOI 10.1103/PhysRevLett.68.507; HORIKOSHI K, 1999, UNPUB PHYS REV B; HORIO Y, 1989, SURF SCI, V219, P128, DOI 10.1016/0039-6028(89)90204-5; ICHIMIYA A, 1987, SURF SCI, V191, pL765, DOI 10.1016/0167-2584(87)90887-5; Ichimiya A., 1994, Surface Review and Letters, V1, DOI 10.1142/S0218625X94000023; INO S, 1980, JPN J APPL PHYS, V19, P1277, DOI 10.1143/JJAP.19.1277; INO S, 1988, REFLECTION HIGH ENER, P3; IZUMI K, 1989, JPN J APPL PHYS 1, V28, P1742, DOI 10.1143/JJAP.28.1742; JALOCHOWSKI M, 1989, SURF SCI, V213, P556, DOI 10.1016/0039-6028(89)90312-9; JALOCHOWSKI M, 1992, PHYS REV B, V45, P13607, DOI 10.1103/PhysRevB.45.13607; JALOCHOWSKI M, 1988, PHYS REV B, V37, P8622, DOI 10.1103/PhysRevB.37.8622; JENTZSCH F, 1989, J APPL PHYS, V66, P5901, DOI 10.1063/1.343615; Jiang CS, 1996, PHYS REV B, V54, P10389, DOI 10.1103/PhysRevB.54.10389; Jiang CS, 1997, SURF SCI, V376, P69, DOI 10.1016/S0039-6028(96)01569-5; JOYCE BA, 1986, SURF SCI, V168, P423, DOI 10.1016/0039-6028(86)90873-3; KANE EO, 1966, PHYS REV, V146, P558, DOI 10.1103/PhysRev.146.558; Kang MH, 1998, PHYS REV B, V58, P13359, DOI 10.1103/PhysRevB.58.R13359; KATAYAMA M, 1991, PHYS REV LETT, V66, P2762, DOI 10.1103/PhysRevLett.66.2762; KELLY MK, 1986, J VAC SCI TECHNOL A, V4, P1396, DOI 10.1116/1.573578; KELLY MK, 1985, PHYS REV B, V32, P2693, DOI 10.1103/PhysRevB.32.2693; KIKUCHI M, 1996, BUTURI, V51, P21; KIMBERLIN KR, 1995, J VAC SCI TECHNOL A, V13, P462, DOI 10.1116/1.579380; KINOSHITA T, 1987, J PHYS SOC JPN, V56, P4015, DOI 10.1143/JPSJ.56.4015; Kittel C, 1976, INTRO SOLID STATE PH; KONO S, 1987, PHYS REV LETT, V58, P1555, DOI 10.1103/PhysRevLett.58.1555; LARSON PK, 1988, REFLECTION HIGH ENER; LELAY G, 1983, SURF SCI, V132, P169, DOI 10.1016/0039-6028(83)90537-X; LIEHR M, 1987, J APPL PHYS, V61, P4619, DOI 10.1063/1.338372; Lifshits V G, 1994, SURFACE PHASES SILIC; Lijadi M, 1996, SURF SCI, V357, P51, DOI 10.1016/0039-6028(96)00056-8; Lim H, 1995, PHYS REV B, V52, P17231, DOI 10.1103/PhysRevB.52.17231; Lottermoser L, 1998, PHYS REV LETT, V80, P3980, DOI 10.1103/PhysRevLett.80.3980; Luth H., 1993, SURFACES INTERFACES; Many A., 1965, SEMICONDUCTOR SURFAC; MEYER G, 1994, APPL PHYS LETT, V64, P3560, DOI 10.1063/1.111197; MEYER G, 1995, SURF SCI, V331, P600, DOI 10.1016/0039-6028(95)00325-8; MOLODTSOV SL, 1992, SURF SCI, V269, P988, DOI 10.1016/0039-6028(92)91381-K; Monch W., 1995, SEMICONDUCTOR SURFAC; Nakajima Y, 1997, PHYS REV B, V56, P6782, DOI 10.1103/PhysRevB.56.6782; Nakajima Y, 1996, PHYS REV B, V54, P14134, DOI 10.1103/PhysRevB.54.14134; Natori A, 1996, SURF SCI, V357, P47, DOI 10.1016/0039-6028(96)00055-6; NEDDERMEYER H, 1990, CRIT REV SOLID STATE, V16, P309, DOI 10.1080/10408439008242185; NOGAMI J, 1988, J VAC SCI TECHNOL B, V6, P1479, DOI 10.1116/1.584200; NOGAMI J, 1994, SURF SCI, V306, P81, DOI 10.1016/0039-6028(94)91187-8; NORTHRUP JE, 1984, PHYS REV LETT, V53, P683, DOI 10.1103/PhysRevLett.53.683; OHNISHI H, 1994, JPN J APPL PHYS 1, V33, P3683, DOI 10.1143/JJAP.33.3683; Petersen CL, 1997, SURF SCI, V377, P676, DOI 10.1016/S0039-6028(96)01470-7; QIAN GX, 1986, J VAC SCI TECHNOL B, V4, P1079, DOI 10.1116/1.583546; QIAN GX, 1987, PHYS REV B, V35, P1288, DOI 10.1103/PhysRevB.35.1288; Riviere JC, 1990, SURFACE ANAL TECHNIQ; Ryzhkov SV, 1998, PHYS LOW-DIMENS STR, V7-8, P1; Ryzhkov SV, 1998, PHYS LOW-DIMENS STR, V7-8, P109; SAHIMI M, 1984, J PHYS A-MATH GEN, V17, pL601, DOI 10.1088/0305-4470/17/11/009; SAMSAVAR A, 1990, PHYS REV B, V42, P9245, DOI 10.1103/PhysRevB.42.9245; Saranin AA, 1997, PHYS REV B, V56, P1017, DOI 10.1103/PhysRevB.56.1017; Saranin AA, 1997, SURF SCI, V388, P299, DOI 10.1016/S0039-6028(97)00414-7; Saranin AA, 1998, SURF SCI, V398, P60, DOI 10.1016/S0039-6028(98)80011-3; Saranin AA, 1997, JPN J APPL PHYS 1, V36, P3814, DOI 10.1143/JJAP.36.3814; SATO T, 1992, JEOL APPL NOTE SCANN; SCHAD R, 1992, APPL PHYS A-MATER, V55, P231, DOI 10.1007/BF00348390; SEEGER K, 1996, SEMICONDUCTOR PHYSIC; SPIEGEL K, 1967, SURF SCI, V7, P125, DOI 10.1016/0039-6028(67)90121-5; Stauffer D., 1992, INTRO PERCOLATION TH; STROSCIO JA, 1993, SANNING TUNNELING MI; STTOSCH H, 1988, PHYS REV LETT, V61, P5126; SUMITOMO K, 1989, APPL SURF SCI, V41-2, P112, DOI 10.1016/0169-4332(89)90042-1; SURNEV SL, 1995, J VAC SCI TECHNOL A, V13, P1389, DOI 10.1116/1.579569; SUURMEIJER EPTM, 1993, APPL SURF SCI, V70-1, P452, DOI 10.1016/0169-4332(93)90559-T; SZE SM, 1981, PHYSICS SEMICONDUCTO; TAKAHASHI S, 1991, SURF SCI, V242, P73, DOI 10.1016/0039-6028(91)90245-N; TAKAHASHI T, 1991, SURF SCI, V242, P54; TAKAHASHI T, 1993, SURF SCI, V282, P17, DOI 10.1016/0039-6028(93)90607-L; TAKAHASHI T, 1988, JPN J APPL PHYS 2, V27, pL753, DOI 10.1143/JJAP.27.L753; TAKEDA S, IN PRESS; TONG X, 1999, UNPUB PHYS REV B; TONG X, IN PRESS; TONG X, 1999, UNPUB JAP J APPL PHY; Tong X, 1997, PHYS REV B, V55, P1310, DOI 10.1103/PhysRevB.55.1310; Tong X, 1998, SURF SCI, V408, P146, DOI 10.1016/S0039-6028(98)00185-X; TSUNO T, 1989, THESIS U TOKYO; Van der Pauw L.J., 1958, Philips Research Reports, V13; VANLOENEN EJ, 1987, PHYS REV LETT, V58, P373, DOI 10.1103/PhysRevLett.58.373; Viernow J, 1998, PHYS REV B, V57, P2321, DOI 10.1103/PhysRevB.57.2321; WAN KJ, 1992, PHYS REV B, V45, P9509, DOI 10.1103/PhysRevB.45.9509; WAN KJ, 1992, PHYS REV B, V46, P13635, DOI 10.1103/PhysRevB.46.13635; WATANABE S, 1991, PHYS REV B, V44, P8330, DOI 10.1103/PhysRevB.44.8330; WATSON KG, 1974, PHYS REP, V12, P75; WEITERING HH, 1992, PHYS REV B, V45, P9126, DOI 10.1103/PhysRevB.45.9126; Yagi Y, 1996, SURF SCI, V356, P47, DOI 10.1016/0039-6028(96)00021-0; YASUNAGA H, 1986, JPN J APPL PHYS 2, V25, pL400, DOI 10.1143/JJAP.25.L400; YEH JJ, 1993, PHYS REV LETT, V70, P3768, DOI 10.1103/PhysRevLett.70.3768; YEOM HW, UNPUB SCIENCE; YOUMANS JM, 1978, J PHYS C SOLID STATE, V11, P4098; YOUNG CE, 1961, J APPL PHYS, V32, P329, DOI 10.1063/1.1736007; YUHARA J, 1992, J VAC SCI TECHNOL A, V10, P334, DOI 10.1116/1.578053; ZHANG ZH, 1995, PHYS REV B, V52, P10760, DOI 10.1103/PhysRevB.52.10760; Zhang ZH, 1997, PHYS REV B, V55, P9983, DOI 10.1103/PhysRevB.55.9983; ZUO JK, 1991, APPL SURF SCI, V48-9, P366, DOI 10.1016/0169-4332(91)90359-R	199	158	161	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0079-6816			PROG SURF SCI	Prog. Surf. Sci.	MAR-APR	1999	60	5-8					89	257		10.1016/S0079-6816(99)00008-8		169	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	219BP	WOS:000081588300001		
J	Tokitoh, N				Tokitoh, N			New aspects in the chemistry of multiple-bonds to heteroatoms	PURE AND APPLIED CHEMISTRY			English	Article; Proceedings Paper	5th International Conference on Heteroatom Chemistry (ICHAC-5)	JUL 05-10, 1998	UNIV WESTERN ONTARIO, ONTARIO, CANADA	IUPAC, Univ Western Ontario, Int Council Main Grp Chem, Organic Div Canadian Soc Chem, Petroleum Res Fund Amer Chem Soc, UWO Book Store, Gelest Inc, Stream Chem Inc, Merck Frosst Canada Inc, Boehringer Ingelheim, Ltd/Bio-Mega Res Div, JOhn LabattLtd	UNIV WESTERN ONTARIO		KINETICALLY STABILIZED SILANETHIONE; PHOSPHORUS DOUBLE-BOND; CRYSTAL-STRUCTURE; COMPOUND; REACTIVITY; DIPHOSPHENES; SILICON; DIBISMUTHENE; DISTIBENE; DIARSENE	The recent applications of an extremely bulky and efficient steric protection group, 2,4,6-tris[bis(trimethylsilyl)methyl]phe (denoted as Tbt in this article) to the kinetic stabilization of a variety of multiple-bonds to heteroatoms are described. The main topics are as follows: (i) the first isolation and characterization of stable antimony-antimony double-bond compound (distibene) and its bismuth analogue (dibismuthene), long-sought doubly bonded compounds between heavier group 15 elements, and (ii) the successful synthesis of stable silabenzene and 2-silanaphthalene, the first examples of stable silaaromatics.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan	Tokitoh, N (reprint author), Kyushu Univ, Inst Fundamental Res Organ Chem, Fukuoka 812, Japan.						MARKL G, 1988, ANGEW CHEM INT EDIT, V27, P963, DOI 10.1002/anie.198809631; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; TOKITOH N, 1993, J AM CHEM SOC, V115, P2065, DOI 10.1021/ja00058a078; CALDERAZZO F, 1984, J CHEM SOC DALTON, P2365, DOI 10.1039/dt9840002365; TOKITOH N, 1993, J AM CHEM SOC, V115, P8855, DOI 10.1021/ja00072a055; ASHE AJ, 1983, ORGANOMETALLICS, V2, P1859, DOI 10.1021/om50006a027; TSUMURAYA T, 1991, ANGEW CHEM INT EDIT, V30, P902, DOI 10.1002/anie.199109021; YOSHIFUJI M, 1981, J AM CHEM SOC, V103, P4587, DOI 10.1021/ja00405a054; RAABE G, 1985, CHEM REV, V85, P419, DOI 10.1021/cr00069a005; Saito M, 1997, J AM CHEM SOC, V119, P11124, DOI 10.1021/ja972221j; Tokitoh N, 1997, SCIENCE, V277, P78, DOI 10.1126/science.277.5322.78; COWLEY AH, 1983, J AM CHEM SOC, V105, P5506, DOI 10.1021/ja00354a069; SUZUKI H, 1994, J AM CHEM SOC, V116, P11578, DOI 10.1021/ja00104a052; Tokitoh N, 1997, J AM CHEM SOC, V119, P6951, DOI 10.1021/ja9710924; Suzuki H, 1998, J AM CHEM SOC, V120, P11096, DOI 10.1021/ja980783c; Schleyer PV, 1996, J AM CHEM SOC, V118, P6317, DOI 10.1021/ja960582d; BARRAU J, 1990, CHEM REV, V90, P283, DOI 10.1021/cr00099a010; Brook A.G., 1996, ADV ORGANOMET CHEM, V39, P71, DOI 10.1016/S0065-3055(08)60466-9; BURGER H, 1983, J MOL STRUCT, V98, P265, DOI 10.1016/0022-2860(83)90124-2; COWLEY AH, 1984, INORG CHEM, V23, P2582, DOI 10.1021/ic00185a010; COWLEY AH, 1983, J AM CHEM SOC, V105, P1655, DOI 10.1021/ja00344a041; Daly J. J., 1964, J CHEM SOC, P6147, DOI 10.1039/jr9640006147; KALINOWSKI HO, 1986, CARBON 13 NMR SPECTR; Kano N, 1997, ORGANOMETALLICS, V16, P4237, DOI 10.1021/om9705564; Kano N, 1997, CHEM LETT, P277, DOI 10.1246/cl.1997.277; KWAK YW, 1994, B KOR CHEM SOC, V15, P410; MARKL G, 1979, ANGEW CHEM INT EDIT, V18, P789, DOI 10.1002/anie.197907891; MATSUMOTO T, 1994, ANGEW CHEM INT EDIT, V33, P2316, DOI 10.1002/anie.199423161; NAGASE S, 1990, J CHEM SOC CHEM COMM, P1724, DOI 10.1039/c39900001724; Nagase S., 1994, CHEM ORGANIC ARSENIC, P1, DOI [10.1002/0470023473.ch1, DOI 10.1002/0470023473.CHL]; Raabe G., 1989, CHEM ORGANIC SILICON, P1102; Raabe G., 1989, CHEM ORGANIC SILICON, P1015, DOI 10.1002/0470025107.ch17; RANAIVONJATOVO H, 1987, PHOSPHORUS SULFUR, V31, P81, DOI 10.1080/03086648708079345; Stone F. G. A., 1996, ADV ORGANOMETALLIC C, V39; Tokitoh N, 1995, CHEM LETT, P1087, DOI 10.1246/cl.1995.1087; Tokitoh N, 1998, J AM CHEM SOC, V120, P433, DOI 10.1021/ja973295y; Tokitoh N, 1997, J AM CHEM SOC, V119, P2337, DOI 10.1021/ja963517c; UEKUSA H, 1996, MOL CRYST LIQ CRYST, V279, P285, DOI 10.1080/10587259608042197; WEBER L, 1992, CHEM REV, V92, P1839, DOI 10.1021/cr00016a008; YOSHIFUJI M, 1990, MULTIPLE BONDS LOW C, P321; YOSHIFUJI M, 1983, J AM CHEM SOC, V105, P2495, DOI 10.1021/ja00346a077	41	40	40	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0033-4545			PURE APPL CHEM	Pure Appl. Chem.	MAR	1999	71	3					495	502		10.1351/pac199971030495		8	Chemistry, Multidisciplinary	Chemistry	241HW	WOS:000082877700017		
J	Uematsu, M; Sonderegger, M; Shioda, A; Tahara, K; Fukui, T; Hama, Y; Kojima, T; Wong, JR; Kusano, S				Uematsu, M; Sonderegger, M; Shioda, A; Tahara, K; Fukui, T; Hama, Y; Kojima, T; Wong, JR; Kusano, S			Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker	RADIOTHERAPY AND ONCOLOGY			English	Article						radiotherapy; stereotactic; frameless; fractionated; treatment unit; geometrical errors	FRACTIONATED RADIOTHERAPY; IMMOBILIZATION SYSTEM; BRAIN-TUMORS; IRRADIATION; FIXATION	To evaluate quantitative positioning errors of frameless stereotactic radiation therapy with a fusion of computed tomography (CT) and linear accelerator unit, Z-type CT markers were attached to patients, and CT images were obtained before and after daily treatment. In 40 verification tests, geometrical errors were never more than 1 mm. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Natl Def Med Coll, Div Radiat Oncol, Tokorozawa, Saitama 359, Japan; Univ Tokyo, Dept Precis Machinery Engn, Bunkyo Ku, Tokyo 113, Japan; Morristown Mem Hosp, Dept Radiat Oncol, Morristown, NJ 07962 USA	Sonderegger, M (reprint author), Natl Def Med Coll, Div Radiat Oncol, 3-2 Namiki, Tokorozawa, Saitama 359, Japan.						Uematsu M, 1996, INT J RADIAT ONCOL, V35, P587, DOI 10.1016/S0360-3016(96)80022-8; Uematsu M, 1998, CANCER-AM CANCER SOC, V82, P1062, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G; Bova FJ, 1997, INT J RADIAT ONCOL, V38, P875, DOI 10.1016/S0360-3016(97)00055-2; DELANNES M, 1991, INT J RADIAT ONCOL, V21, P749; DUNBAR SF, 1994, INT J RADIAT ONCOL, V30, P531; GILL SS, 1991, INT J RADIAT ONCOL, V20, P599; GRAHAM JD, 1991, RADIOTHER ONCOL, V21, P60, DOI 10.1016/0167-8140(91)90342-E; HARIZ MI, 1986, APPL NEUROPHYSIOL, V49, P347; HARIZ MI, 1990, RADIOTHER ONCOL, V17, P57, DOI 10.1016/0167-8140(90)90049-3; HODAPP N, 1994, ACT NEUR S, V62, P101; KOOY HM, 1994, INT J RADIAT ONCOL, V30, P685; LAING RW, 1993, BRIT J RADIOL, V66, P1020; LAITINEN LV, 1985, SURG NEUROL, V23, P3559; LOEFFLER JS, 1993, STEREOTACTIC SURG RA, P307; LYMAN JT, 1989, INT J RADIAT ONCOL, V16, P1615; PILIPUF MN, 1995, J NEUROSURG, V82, P1082, DOI 10.3171/jns.1995.82.6.1082; Rosenthal SJ, 1995, INT J RADIAT ONCOL, V33, P1239, DOI 10.1016/0360-3016(95)02009-8; Varlotto JM, 1996, INT J RADIAT ONCOL, V36, P141, DOI 10.1016/S0360-3016(96)00237-4; Willner J, 1997, RADIOTHER ONCOL, V45, P83, DOI 10.1016/S0167-8140(97)00135-7	19	32	33	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0167-8140			RADIOTHER ONCOL	Radiother. Oncol.	MAR	1999	50	3					337	339		10.1016/S0167-8140(99)00037-7		3	Oncology; Radiology, Nuclear Medicine & Medical Imaging	Oncology; Radiology, Nuclear Medicine & Medical Imaging	193GT	WOS:000080128100011		
J	Teramoto, S; Ouchi, Y				Teramoto, S; Ouchi, Y			Does an inhaled beta-adrenergic or anticholinergic agent improve gas exchange at rest and during exercise in patients with COPD?	RESPIRATORY MEDICINE			English	Letter							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; DYSPNEA; DRUG; CAPACITY		Tokyo Univ Hosp, Dept Geriatr Med, Tokyo, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr Med, Tokyo, Japan.						Belman MJ, 1996, AM J RESP CRIT CARE, V153, P967; GROSS NJ, 1987, AM REV RESPIR DIS, V136, P1091; IGARASHI T, 1993, JAP J THORACIC DIS, V31, P32; PATKAS D, 1998, RESP MED, V92, P1116; RamirezVenegas A, 1997, CHEST, V112, P336, DOI 10.1378/chest.112.2.336; TERAMOTO S, 1995, AGE AGEING, V24, P278, DOI 10.1093/ageing/24.4.278; Teramoto S, 1996, INTERNAL MED, V35, P772, DOI 10.2169/internalmedicine.35.772; TERAMOTO S, 1992, CHEST, V102, P1362, DOI 10.1378/chest.102.5.1362; TERAMOTO S, 1993, CHEST, V103, P1774, DOI 10.1378/chest.103.6.1774; Teramoto S, 1996, CHEST, V109, P1666, DOI 10.1378/chest.109.6.1666-a	10	0	0	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0954-6111			RESP MED	Respir. Med.	MAR	1999	93	3					222	223		10.1016/S0954-6111(99)90014-8		2	Cardiac & Cardiovascular Systems; Respiratory System	Cardiovascular System & Cardiology; Respiratory System	169UH	WOS:000078766800015		
J	Ueda, K; Harii, K; Asato, H; Yoshimura, K; Yamada, A				Ueda, K; Harii, K; Asato, H; Yoshimura, K; Yamada, A			Evaluation of muscle graft using facial nerve on the affected side as a motor source in the treatment of facial paralysis	SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY			English	Article						facial paralysis; muscle graft; affected facial nerve	TRANSPLANTATION; PALSY	To acquire symmetry of the cheek when smiling, we carried out 39 free vascularised grafts of the muscle, the motor nerve of which was sutured to a stump of the ipsilateral facial nerve, for 39 patients with facial paralysis. We used two methods: an as healthy and fresh as possible facial nerve stump (method 1A, n = 17), or an incompletely affected stump (method 1B, n = 22). The results are classified into grade 1 to 5 indicating increasing efficiency of muscle function. All patients who had method 1A and 14 patients who had method 1B were evaluated grade 4 or better. Both an incompletely affected facial nerve stump and the proximal stump of a facial nerve that had previously been resected have sufficient function to provide contraction in the grafted muscle.	Jichi Med Sch, Div Plast Surg, Minami Kawachi, Tochigi 32904, Japan; Univ Tokyo, Dept Plast Surg, Tokyo, Japan; Tohoku Univ, Div Plast Surg, Sendai, Miyagi 980, Japan	Ueda, K (reprint author), Jichi Med Sch, Div Plast Surg, 3311-1 Yakushiji, Minami Kawachi, Tochigi 32904, Japan.		Yoshimura, Kotaro/C-8524-2009				ALDSKOGI.H, 1974, NEUROBIOLOGY, V4, P132; HARII K, 1976, PLAST RECONSTR SURG, V57, P133, DOI 10.1097/00006534-197602000-00001; HARRISON DH, 1985, PLAST RECONSTR SURG, V75, P206, DOI 10.1097/00006534-198502000-00011; MANKTELOW RT, 1984, CLIN PLAST SURG, V11, P215; FALCO NA, 1990, PLAST RECONSTR SURG, V85, P1; CHUANG DCC, 1995, BRIT J PLAST SURG, V48, P1, DOI 10.1016/0007-1226(95)90021-7; FOWLER E P Jr, 1963, Acta Otolaryngol, V56, P113, DOI 10.3109/00016486309127395; FRY FJ, 1972, J COMP NEUROL, V144, P1, DOI 10.1002/cne.901440102; GARCIA E, 1989, PEDIATR NEUROL, V5, P262; GRANT G, 1968, EXPERIENTIA, V24, P169, DOI 10.1007/BF02146967; HALL A, 1951, AMA ARCH OTOLARYNGOL, V54, P475; HARII K, 1988, Microsurgery, V9, P169, DOI 10.1002/micr.1920090302; HARII K, 1991, PARALYZED FACE, P178; HARII K, 1984, S CLIN FRONT REC MIC, P159; JONGKEES LBW, 1954, ACTA OTO-LARYNGOL, V44, P336, DOI 10.3109/00016485409128715; KANAYA F, 1991, J HAND SURG-AM, V16A, P851; KETTEL K, 1963, Laryngoscope, V73, P837; KUMAGAMI H, 1968, PRACT OTOLOGICA KYOT, V61, P1853; OBRIEN BM, 1980, BRIT J PLAST SURG, V33, P202, DOI 10.1016/0007-1226(80)90013-2; PARK S, 1988, FACIAL NERVE RES JPN, V8, P29; POWEL T, 1964, J ANAT, V98, P29; PROCTOR B, 1976, T AM ACAD OPHTHALMOL, V82, P70; SADE J, 1972, ARCHIV OTOLARYNGOL, V95, P406; Saito H, 1994, Acta Otolaryngol Suppl, V510, P77; SANGER JR, 1991, MICROSURG, V12, P361, DOI 10.1002/micr.1920120508; TERZIS J, 1991, PLAST RECONSTR SURG, V83, P767; WILLIAM P, 1971, J ANAT, P397; YOSHIMURA K, 1994, J JPN PRS, V14, P131	28	4	5	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0284-4311			SCAND J PLAST RECONS	Scand. J. Plast. Reconstr. Surg. Hand Surg.	MAR	1999	33	1					47	57				11	Surgery	Surgery	217LE	WOS:000081500100008		
J	Toh-e, A				Toh-e, A			Structure and function of the yeast 26S proteasome	SEIKAGAKU			Japanese	Review							RABBIT RETICULOCYTE LYSATE; ATP-DEPENDENT ACTIVATOR; HIGH-MOLECULAR-WEIGHT; SACCHAROMYCES-CEREVISIAE; 20S PROTEASOME; CDNA CLONING; UBIQUITIN; SUBUNIT; PURIFICATION; COMPLEX		Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan							LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; NISOGI H, 1992, EXP CELL RES, V200, P48, DOI 10.1016/S0014-4827(05)80070-9; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442; OMURA S, 1991, J ANTIBIOT, V44, P113; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Barhite S, 1998, BBA-MOL CELL RES, V1402, P95, DOI 10.1016/S0167-4889(97)00141-9; Baumeister W, 1997, CURR OPIN STRUC BIOL, V7, P273, DOI 10.1016/S0959-440X(97)80036-X; DeMartino GN, 1996, J BIOL CHEM, V271, P3112; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; EMORI Y, 1991, MOL CELL BIOL, V11, P344; Ferrell K, 1996, FEBS LETT, V381, P143, DOI 10.1016/0014-5793(96)00101-9; Fraser RA, 1997, J BIOL CHEM, V272, P7122; FRIEDMAN H, 1994, P NATL ACAD SCI USA, V91, P2031, DOI 10.1073/pnas.91.6.2031; Fujimuro M, 1998, FEBS LETT, V423, P149, DOI 10.1016/S0014-5793(98)00084-2; Fujimuro M, 1998, BIOCHEM BIOPH RES CO, V251, P818, DOI 10.1006/bbrc.1998.9560; GANOTH D, 1988, J BIOL CHEM, V263, P12412; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HILT W, 1995, MOL BIOL REP, V21, P3, DOI 10.1007/BF00990964; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOUGH R, 1987, J BIOL CHEM, V262, P8303; KOMINAMI K, 1995, EMBO J, V14, P3105; Kominami K, 1997, MOL BIOL CELL, V8, P171; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; MA CP, 1994, J BIOL CHEM, V269, P3539; MCCUSKER JH, 1988, GENETICS, V119, P303; NELSON MK, 1993, GENETICS, V134, P159; PERTERS JM, 1994, TRENDS BIOCHEM SCI, V19, P377; Russell SJ, 1996, J BIOL CHEM, V271, P32810; Tokumoto T, 1997, J CELL BIOL, V138, P1313, DOI 10.1083/jcb.138.6.1313; Tsurumi C, 1996, EUR J BIOCHEM, V239, P912, DOI 10.1111/j.1432-1033.1996.0912u.x; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; WAG W, 1996, P NATL ACAD SCI USA, V93, P8236; Watanabe TK, 1998, GENOMICS, V50, P241, DOI 10.1006/geno.1998.5301; Xu BE, 1997, MOL BIOL CELL, V8, P1649; Yokota K, 1996, MOL BIOL CELL, V7, P853; YOSHIMURA T, 1993, J STRUCT BIOL, V111, P200, DOI 10.1006/jsbi.1993.1050	49	1	1	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0037-1017			SEIKAGAKU	Seikagaku	MAR	1999	71	3					173	181				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	182MD	WOS:000079502000001		
J	Shibasaki, Y; Ishihara, H; Oka, Y; Yazaki, Y				Shibasaki, Y; Ishihara, H; Oka, Y; Yazaki, Y			Phosphatidylinositol 5-kinases	SEIKAGAKU			Japanese	Article							DEFINES; PATHWAY; FAMILY		Univ Tokyo, Dept Internal Med 3, Bunkyo Ku, Tokyo 1130033, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Yamaguchi 7558512, Japan							BORONENKOV IV, 1995, J BIOL CHEM, V270, P2881; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Loijens JC, 1996, J BIOL CHEM, V271, P32937; Rao VD, 1998, CELL, V94, P829, DOI 10.1016/S0092-8674(00)81741-9; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578; Ishihara H, 1996, J BIOL CHEM, V271, P23611; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Davis JN, 1997, MOL CELL BIOL, V17, P7398; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Whiteford CC, 1997, BIOCHEM J, V323, P597; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756	15	0	0	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0037-1017			SEIKAGAKU	Seikagaku	MAR	1999	71	3					193	197				5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	182MD	WOS:000079502000003		
J	Wu, XW; Oshima, Y; Koda, S				Wu, XW; Oshima, Y; Koda, S			Effects of temperature and O-2 pressure on laser-induced partial oxidation of cyclohexane in the liquid phase	SEKIYU GAKKAISHI-JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			Japanese	Article						excimer laser; cyclohexane; oxygen; oxidation; radical reaction; reaction mechanism		Laser-induced partial oxidation of cyclohexane in the liquid phase was carried out in order to investigate the effect of reaction temperature and oxygen pressure on product selectivities and quantum yield. The total amount of the products slightly increased with increase of oxygen partial pressure, and cyclohexanone was the only product whose yield showed a dependence on the oxygen pressure. The quantum yield gradually decreased with increase of oxygen partial pressure, and it became constant with oxygen pressure above 2.0 MPa. The quantum yield was also dependent on the reaction temperature, and the activation energy of the overall reaction was estimated to be 16 +/- 4 kJ/mol. At higher temperatures, the yield of cyclohexanol was relatively high, and the quantum yield was close to unity. Based on these results, a plausible reaction mechanism was proposed, in which the radical-radical reactions play an important role in the product distribution and quantum yield. Although a radical chain reaction with high quantum yield could not be achieved in this system, the author's knowledge of the chemistry at high radical concentrations could be applied to a novel reaction-control technique.	Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Wu, XW (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						LUHRING P, 1989, J CHEM ENG DATA, V250, P34; OSHIMA Y, 1989, SEKIYU GAKKAISHI, V32, P59; OSHIMA Y, 1994, 6 INT S ADV NUCL EN, P409; OSHIMA Y, 1996, SEKIYU GAKKAISHI, V39, P222; OSHIMA Y, 1989, SEKIYU GAKKAISHI, V32, P216; WILD JD, 1978, CHEM ENG J BIOCH ENG, V15, P209	6	0	0	JAPAN PETROLEUM INST	TOKYO	COSMO HIRAKAWA-CHO BLDG, 3-14, 1-CHOME HIRAKAWA-CHO, CHIYODA-KU, TOKYO, 102, JAPAN	0582-4664			SEKIYU GAKKAISHI	Sekiyu Gakkaishi	MAR	1999	42	2					114	119				6	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	186DR	WOS:000079712400006		
J	Kim, ES; Usami, N; Shiraki, Y				Kim, ES; Usami, N; Shiraki, Y			Selective epitaxial growth of dot structures on patterned Si substrates by gas source molecular beam epitaxy	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article							CHEMICAL VAPOR-DEPOSITION; ISLAND FORMATION; GE; WIRES; PHOTOLUMINESCENCE; LUMINESCENCE; SI1-XGEX/SI; ALLOYS	Selective epitaxial growth of Ge dot structures is investigated to obtain highly regular dot arrays with excellent size uniformity in the nanoscale. The dot structures are grown in patterned fine windows ranging in diameter from 650 to 90 nm on Si(100) substrates covered with SiO2 masks. The dimensions and number of the dots grown in a window significantly change depending on window size, growth temperature and time and the thickness of the Si buffer layer. These growth characteristics are considered to be induced by the Stranski-Krastanov growth mode and migration mechanism of Ge atoms on Si substrates. It is noted that Ge dots whose diameter is much smaller than the pattern size are formed with high uniformity and that the position is precisely controlled by SEG. The Ge dot structures are found to give rise to prominent luminescence with well separated phonon replicas and the energy position systematically changes when the growth conditions are varied.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan	Kim, ES (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.	shiraki@photonics.rcast.u-tokyo.ac.jp	Usami, Noritaka/C-1720-2009				AHN TM, 1976, J PHYS CHEM SOLIDS, V37, P771, DOI 10.1016/0022-3697(76)90046-9; SUNAMURA H, 1995, APPL PHYS LETT, V66, P3024, DOI 10.1063/1.114265; Goldfarb I, 1997, PHYS REV B, V56, P10459, DOI 10.1103/PhysRevB.56.10459; WEBER J, 1989, PHYS REV B, V40, P5683, DOI 10.1103/PhysRevB.40.5683; Arai J, 1997, APPL PHYS LETT, V70, P2981, DOI 10.1063/1.118763; BRUNNER J, 1994, APPL PHYS LETT, V64, P994, DOI 10.1063/1.110929; CHAKRAVE.BK, 1967, J PHYS CHEM SOLIDS, V28, P2401, DOI 10.1016/0022-3697(67)90026-1; COLGAN EG, 1994, APPL PHYS LETT, V64, P2952, DOI 10.1063/1.111423; Goldfarb I, 1997, PHYS REV LETT, V78, P3959, DOI 10.1103/PhysRevLett.78.3959; HARTMANN A, 1995, J APPL PHYS, V77, P1959, DOI 10.1063/1.358830; HIRAYAMA H, 1990, APPL PHYS LETT, V56, P1107, DOI 10.1063/1.102582; Kim ES, 1997, J CRYST GROWTH, V175, P519, DOI 10.1016/S0022-0248(96)00991-8; Kim ES, 1998, APPL PHYS LETT, V72, P1617, DOI 10.1063/1.121131; NOBLE DB, 1990, APPL PHYS LETT, V56, P51, DOI 10.1063/1.103176; RACANELLI M, 1991, APPL PHYS LETT, V58, P2096, DOI 10.1063/1.104998; SCHMIDT G, 1994, SOLID STATE ELECTRON, V37, P587, DOI 10.1016/0038-1101(94)90253-4; USAMI N, 1993, APPL PHYS LETT, V63, P2789, DOI 10.1063/1.110335; VESCAN L, 1994, SEMICOND SCI TECH, V9, P387, DOI 10.1088/0268-1242/9/4/009; VESCAN L, 1995, MATER SCI TECH-LOND, V11, P421; WADO H, 1995, J CRYST GROWTH, V150, P969, DOI 10.1016/0022-0248(95)80084-P; ZHONG YL, 1990, APPL PHYS LETT, V57, P2092, DOI 10.1063/1.103951	21	22	22	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0268-1242			SEMICOND SCI TECH	Semicond. Sci. Technol.	MAR	1999	14	3					257	265		10.1088/0268-1242/14/3/009		9	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	174VR	WOS:000079057300009		
J	Nishiyama, M; Shiomi, Y; Suzuki, S; Marumoto, T				Nishiyama, M; Shiomi, Y; Suzuki, S; Marumoto, T			Suppression of growth of Ralstonia solanacearum, tomato bacterial wilt agent, on/in tomato seedlings cultivated in a suppressive soil	SOIL SCIENCE AND PLANT NUTRITION			English	Article						disease suppressive soil; Ralstonia solanacearum; rhizoplane; soilborne plant disease; tomato bacterial wilt	SOILBORNE PLANT-PATHOGENS; PSEUDOMONAS-SOLANACEARUM	To identify the sites responsible for the suppressiveness of tomato bacterial wilt in a suppressive soil, population dynamics of Ralstonia solanacearum in non-rhizosphere soil, roots and stems of tomato plants was compared between a wilt-conducive soil and a suppressive soil both of which were artificially infested with the pathogenic strain SL8, Rhizobacteria were recovered as two fractions; root fraction-1 obtained after four washings in water, which was assumed to correspond to the rhizoplane, and root fraction-2 that was macerated after the washings and was assumed to be the fraction corresponding to the part inside of the roots and the firmly attached cells to the rhizoplane, In the conducive soil, all the tomato seedlings wilted while none wilted in the suppressive soil during the 31-d period of cultivation after transplanting to soils infested with the pathogen at an initial density of 10(3) cfu per g dry soil, The number of pathogens in the conducive soil increased first in root fraction-1, then in root fraction-2 and in stems up to 10(8)-10(10) cfu per g wet plant tissue during the 16-d period of cultivation after transplanting, In contrast, in the suppressive soil, the number of pathogens remained below 10(6) cfu per g tissue both in the two root fractions and in stems for 40 d, Survival rate of the pathogen inoculated into the tomato-free soils was higher in the suppressive soil than in the conducive soil, These results suggest that prior multiplication in root fraction-1 at a density above 10(6) cfu per g root is necessary for the pathogen to multiply in root fraction-2 and stems at a density above 10(6) cfu per g for the occurrence of wilt, and that the primary site for suppressiveness of the disease in tomato plants cultivated in the suppressive soil in this report was located in root fraction-1.	Yamaguchi Univ, Fac Agr, Yamaguchi 7538515, Japan	Nishiyama, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.						MARTIN JP, 1950, SOIL SCI, V69, P215, DOI 10.1097/00010694-195003000-00006; Handelsman J, 1996, PLANT CELL, V8, P1855; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; YABUUCHI E, 1995, MICROBIOL IMMUNOL, V39, P897; VASSE J, 1995, MOL PLANT MICROBE IN, V8, P241, DOI 10.1094/MPMI-8-0241; KING EO, 1954, J LAB CLIN MED, V44, P301; Bailey DJ, 1997, NEW PHYTOL, V136, P359, DOI 10.1046/j.1469-8137.1997.00774.x; FURUYA N, 1991, Annals of the Phytopathological Society of Japan, V57, P363; Gilligan C. A., 1997, New Phytologist, V136, P343, DOI 10.1046/j.1469-8137.1997.00768.x; HARA H, 1991, Annals of the Phytopathological Society of Japan, V57, P24; HARTMAN GL, 1994, BACTERIAL WILT, P157; HO WC, 1988, SOIL BIOL BIOCHEM, V20, P489, DOI 10.1016/0038-0717(88)90063-6; Koga Kazuharu, 1997, Annals of the Phytopathological Society of Japan, V63, P304; LHARA H, 1983, B OKAYAMA TOBACCO EX, V42, P127; Mulya Karden, 1996, Annals of the Phytopathological Society of Japan, V62, P134; Nakaho Kazuhiro, 1997, Annals of the Phytopathological Society of Japan, V63, P83; SCHROTH MN, 1982, SCIENCE, V216, P1376, DOI 10.1126/science.216.4553.1376; *SOIL MICR SOC JAP, 1992, METH SOIL MICR, P379; Someya T., 1995, SOIL MICROORGANISMS, V46, P61; Takaki S, 1992, SOIL MICROORG, V39, P35; Toyota K, 1996, SOIL BIOL BIOCHEM, V28, P1489, DOI 10.1016/S0038-0717(96)00157-5; TRIGALET A, 1986, PHYSIOL MOL PLANT P, V28, P423; WELLER DM, 1988, ANNU REV PHYTOPATHOL, V26, P379, DOI 10.1146/annurev.py.26.090188.002115; YAMAZAKI H, 1995, HORTSCIENCE, V30, P91; Yamazaki H., 1998, Japanese Journal of Soil Science and Plant Nutrition, V69, P76	25	13	15	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	MAR	1999	45	1					79	87				9	Plant Sciences; Environmental Sciences; Soil Science	Plant Sciences; Environmental Sciences & Ecology; Agriculture	176AG	WOS:000079128000006		
J	Matsumoto, S				Matsumoto, S			Fundamentals and practices of soil bioremediation	SOIL SCIENCE AND PLANT NUTRITION			English	Article; Proceedings Paper	International Seminar on Use Plants for Environmental Remediation	SEP   20, 1997	TOKYO, JAPAN				PAUCIMOBILIS STRAIN SS86; SPHINGOMONAS-PAUCIMOBILIS; BACTERIUM	Many kinds of hazardous waste have contaminated soils as the result of diversify of human life styles. Once soil environments have been contaminated by slightly and hazardous organic materials, ranges of its contamination enlarge spatially by the diffusion and penetration, and finally lead to the pollution of groundwater that will be requested for us the most difficult remediations techniques to put into practice. It is very important, therefore, to decompose these hazardous materials in short periods while they remain in soil ecosystem. Soil microorganisms playing a major part in the decomposition of these materials, we have to arrange their living circumstances in soil ecosystem. However, natural soil environment for microorganisms provide not always a suitable condition to produce the biochemical reaction, for example soil physical structure are too fragile when soil get wet and also they have not a uniform pore but a wide variation in size. For the selection of suitable microhabitates, several kinds of materials coated with nutrients were examined by burying in soil. The material with a uniform and suitable size for the fixation of a soil microorganism gave a typical growth curve of a single cell multiplication when it was dug up from the soil after two months. On the other hand, the materials with large and wide variation size did not give a typical growth curve of a single cell multiplication. This fact shows the possibility of selection of specific kinds of microorganisms from soil and promotion of the biochemical reaction through their vigorous fixation in microhabitates. Some kinds of charcoals and burned diatomaceous earth will be estimated as low cost and suitable materials for microhabitates. In this paper, a soil bioremediation technique for the oil-contaminated soil will be introduced mainly, and also the execution of improved river water quality using microhabitates technique will be shown partly.	Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	Matsumoto, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.						ALLISON LE, 1947, SOIL SCI, V63, P439; HATTORI T, 1988, REP I AGR RES TOHOKU, V37, P69; Hattori T., 1992, Bulletin of Japanese Society of Microbial Ecology, V7, P69; Hattori T., 1973, MICROBIAL LIFE SOIL; MATSUMOTO M, 1993, KAGAKU KOGAKU RONBUN, V19, P1; MATSUMOTO S, 1997, CONCEPTION EXECUTION, P3; MATSUMOTO S, 1997, KAGAKU SEIBUTSU, V15, P243; NISHIYAMA M, 1993, SOIL BIOL BIOCHEM, V25, P769, DOI 10.1016/0038-0717(93)90120-Z; NISHIYAMA M, 1992, FEMS MICROBIOL ECOL, V101, P145, DOI 10.1016/0168-6445(92)90010-S; Senoo K, 1997, SOIL SCI PLANT NUTR, V43, P463; SENOO K, 1992, FEMS MICROBIOL ECOL, V86, P311, DOI 10.1016/0378-1097(92)90795-P; STANIER RY, 1980, INTRO MICROBIAL WORL	12	3	4	JAPANESE SOC SOIL SCIENCE PLANT NUTRITION	TOKYO	BUSINESS CENTER ACAD SOC JAPAN 16-9, HONKOMAGOME 5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0038-0768			SOIL SCI PLANT NUTR	Soil Sci. Plant Nutr.	MAR	1999	45	1					237	251				15	Agronomy; Soil Science	Agriculture	176AG	WOS:000079128000020		
J	Honma, I; Hirakawa, S; Yamada, K; Bae, JM				Honma, I; Hirakawa, S; Yamada, K; Bae, JM			Synthesis of organic/inorganic nanocomposites protonic conducting membrane through sol-gel processes	SOLID STATE IONICS			English	Article						organic/inorganic composites; silica/PEO hybrid materials; monododecylphosphate; protonic conducting membrane; solid polymer electrolytes	STRUCTURE PROPERTY BEHAVIOR; ELECTROLYTE FUEL-CELLS; POLY(TETRAMETHYLENE OXIDE); POLYMER ELECTROLYTES; PHOSPHOTUNGSTIC ACID; STATE; PERFORMANCE	High temperature protonic conducting polymer membranes provide new technological applications in the electrochemical devices including electrochromic displays, chemical sensors, fuel cells and others. Organic/inorganic nanocomposites membranes, consisting of SiO2/PEO (Polyethylene Oxides) hybrids, are a remarkable family of isotropic, amorphous polymer materials, which have been synthesized through sol-gel processes. The hybrid membrane doped with acidic surfactant molecules shows good protonic conductivities at high temperatures above 100 degrees C. The membrane was found to be thermally stable at high temperatures because of the inorganic SiO2 framework in the composites matrix. (C) 1999 Elsevier Science B.V. All rights reserved.	AIST, Electrotech Lab, Div Energy, Tsukuba, Ibaraki 305, Japan; Tokyo Univ Agr & Technol, Tokyo, Japan; Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 113, Japan; New Energy & Ind Technol Dev Org, Tsukuba, Ibaraki, Japan	Honma, I (reprint author), AIST, Electrotech Lab, Div Energy, Tsukuba, Ibaraki 305, Japan.	ihonma@etl.go.jp	Bae, joongmyeon/C-1608-2011				Giordano N, 1997, ELECTROCHIM ACTA, V42, P1645, DOI 10.1016/S0013-4686(96)00279-4; Leventis N, 1997, CHEM MATER, V9, P2621, DOI 10.1021/cm970261g; Scherer GG, 1997, SOLID STATE IONICS, V94, P249, DOI 10.1016/S0167-2738(96)00616-9; Kreuer KD, 1998, ELECTROCHIM ACTA, V43, P1281, DOI 10.1016/S0013-4686(97)10031-7; Loy DA, 1996, CHEM MATER, V8, P656, DOI 10.1021/cm950067z; IWAHARA H, 1993, J ELECTROCHEM SOC, V140, P1687, DOI 10.1149/1.2221624; IWAHARA H, 1990, J ELECTROCHEM SOC, V137, P462, DOI 10.1149/1.2086463; Kreuer KD, 1997, SOLID STATE IONICS, V97, P1, DOI 10.1016/S0167-2738(97)00082-9; IWAHARA H, 1995, SOLID STATE IONICS, V77, P289, DOI 10.1016/0167-2738(95)00051-7; HUANG HH, 1989, POLYMER, V30, P2001, DOI 10.1016/0032-3861(89)90286-3; Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a; Kobayashi T, 1998, SOLID STATE IONICS, V106, P219, DOI 10.1016/S0167-2738(97)00512-2; Sumner JJ, 1998, J ELECTROCHEM SOC, V145, P107, DOI 10.1149/1.1838220; Goward GR, 1998, ELECTROCHIM ACTA, V43, P1307, DOI 10.1016/S0013-4686(97)10035-4; Quartarone E, 1998, SOLID STATE IONICS, V110, P1, DOI 10.1016/S0167-2738(98)00114-3; GAUTIERLUNEAU I, 1992, ELECTROCHIM ACTA, V37, P1615, DOI 10.1016/0013-4686(92)80122-3; Fontanella JJ, 1998, ELECTROCHIM ACTA, V43, P1289, DOI 10.1016/S0013-4686(97)10032-9; Edmondson CA, 1998, ELECTROCHIM ACTA, V43, P1295, DOI 10.1016/S0013-4686(97)10033-0; Kuver A, 1998, ELECTROCHIM ACTA, V43, P2527, DOI 10.1016/S0013-4686(97)10114-1; Carr SW, 1997, CHEM MATER, V9, P1751, DOI 10.1021/cm960499p; CHARBOUILLOT Y, 1988, J NON-CRYST SOLIDS, V103, P325, DOI 10.1016/0022-3093(88)90212-8; Depre L, 1998, ELECTROCHIM ACTA, V43, P1301, DOI 10.1016/S0013-4686(97)10034-2; Giordano N, 1996, ELECTROCHIM ACTA, V41, P397, DOI 10.1016/0013-4686(95)00316-9; GLASER RH, 1988, POLYM BULL, V19, P51; GUPTA B, 1993, SOLID STATE IONICS, V61, P213, DOI 10.1016/0167-2738(93)90356-8; LASSEGUES JC, 1989, SOLID STATE IONICS, V35, P17, DOI 10.1016/0167-2738(89)90007-6; NOUEL M, 1998, ELECTROCHIM ACTA, V43, P2381; OGATA N, 1995, KOUBUNNSI, V44, P72; OGATA N, 1990, SENNIGAKKAISI, V46, P52; Ostrovskii DI, 1997, SOLID STATE IONICS, V97, P315, DOI 10.1016/S0167-2738(97)00079-9; Ponomareva VG, 1998, SOLID STATE IONICS, V106, P137, DOI 10.1016/S0167-2738(97)00482-7; POPALL M, 1992, ELECTROCHIM ACTA, V37, P1593, DOI 10.1016/0013-4686(92)80118-6; PRZYLUSKI J, 1991, SYNTHETIC MET, V45, P323, DOI 10.1016/0379-6779(91)91788-C; RAVAINE D, 1986, J NON-CRYST SOLIDS, V82, P210, DOI 10.1016/0022-3093(86)90133-X; RODRIGUES DE, 1992, CHEM MATER, V4, P1437, DOI 10.1021/cm00024a055; SANCHEZ JY, 1993, POLYM ADVAN TECHNOL, V4, P99, DOI 10.1002/pat.1993.220040207; SCHERBAN T, 1989, SOLID STATE IONICS, V35, P189, DOI 10.1016/0167-2738(89)90029-5; Staiti P, 1997, INT J HYDROGEN ENERG, V22, P809, DOI 10.1016/S0360-3199(96)00222-4; Tian D, 1997, CHEM MATER, V9, P871, DOI 10.1021/cm960514q; Vaivars G, 1997, SOLID STATE IONICS, V97, P365, DOI 10.1016/S0167-2738(97)00049-0; Yoshida M, 1996, CHEM MATER, V8, P235, DOI 10.1021/cm950331o	41	123	134	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	MAR	1999	118	1-2					29	36		10.1016/S0167-2738(98)00450-0		8	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	167HF	WOS:000078625900004		
J	Metzner, C; Yusa, G; Sakaki, H				Metzner, C; Yusa, G; Sakaki, H			Modelling inter-dot Coulomb interaction effects in field effect transistors with an embedded quantum dot layer	SUPERLATTICES AND MICROSTRUCTURES			English	Article						quantum dots; dot-dot-interaction; Coulomb gap	P-I SUPERLATTICES; IMPURITY BANDS; DISORDERED SYSTEMS; CLASSICAL-THEORY; INAS DOTS; ELECTRON; GAP; SIMULATION; INGAAS; GAAS	By a computer simulation we study the real space and energy distributions of OD electrons bound in a planar array of quantum dots, including both intra-dot charging and inter-dot Coulomb interaction effects, size fluctuations, as well as the screening by a parallel gas of 2D electrons. It is demonstrated that the mutual Coulomb shifts between different dots cause pronounced many-body correlation effects and in-plane potential fluctuations, which can be significant for experiments such as capacitance and tunneling spectroscopy. In addition we investigate the influence of charged dot scattering on the mobility of a conducting channel parallel to the dot layer. (C) 1999 Academic Press.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan	Metzner, C (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.		Metzner, Claus/D-9707-2013				MOISON JM, 1994, APPL PHYS LETT, V64, P196, DOI 10.1063/1.111502; DAVIES JH, 1984, PHYS REV B, V29, P4260, DOI 10.1103/PhysRevB.29.4260; LEONARD D, 1993, APPL PHYS LETT, V63, P3203, DOI 10.1063/1.110199; DREXLER H, 1994, PHYS REV LETT, V73, P2252, DOI 10.1103/PhysRevLett.73.2252; BARANOVSKII SD, 1979, J PHYS C SOLID STATE, V12, P1023, DOI 10.1088/0022-3719/12/6/015; EFROS AL, 1976, J PHYS C SOLID STATE, V9, P2021, DOI 10.1088/0022-3719/9/11/012; MEDEIROSRIBEIRO G, 1995, APPL PHYS LETT, V66, P1767, DOI 10.1063/1.113361; METZNER C, 1992, SUPERLATTICE MICROST, V12, P101, DOI 10.1016/0749-6036(92)90230-3; METZNER C, 1992, PHYS REV B, V46, P4128, DOI 10.1103/PhysRevB.46.4128; MOBIUS A, 1992, PHYS REV B, V45, P11568, DOI 10.1103/PhysRevB.45.11568; SAKAKI H, 1995, APPL PHYS LETT, V67, P3444, DOI 10.1063/1.115274; SAKAKI H, 1992, SURF SCI, V267, P623, DOI 10.1016/0039-6028(92)91212-T; SCHMIDT T, 1993, PHYS REV B, V47, P10633, DOI 10.1103/PhysRevB.47.10633; Schonhut J, 1996, SOLID STATE ELECTRON, V40, P701, DOI 10.1016/0038-1101(95)00346-0; Shklovskii B. I., 1984, ELECT PROPERTIES DOP, V45; Yusa G, 1996, ELECTRON LETT, V32, P491, DOI 10.1049/el:19960293	16	6	6	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	MAR	1999	25	3					537	549		10.1006/spmi.1996.0228		13	Physics, Condensed Matter	Physics	178KN	WOS:000079265000007		
J	Yoshimoto, Y; Tsukada, M				Yoshimoto, Y; Tsukada, M			First principles study on the geometry and stability of the Ge atom in initial Ge growth on the Si(001) surface	SURFACE SCIENCE			English	Article						density functional calculations; germanium; silicon; surface diffusion; surface relaxation and reconstruction	DIMER GROWTH; STATE	Based on generalized gradient approximation (GGA) density functional calculations, the optimized structures of the Si(001)-Ge surfaces, where Ge atoms partially replace Si atoms, are determined. The significant floating up of the Ge atom at the up-atom dimer site suggested by an X-ray photoelectron diffraction experiment at 0.1 ML is not reproduced. The relative concentration of the Ge in the third and the fourth layers to that in the first layer is found to be 10-15%, which is of the same order as suggested experimentally. The coverage dependence of the penetration is also evaluated. The possibility of a Ge-Si mixed dimer ca 0.1 ML is studied taking into account the stabilization of the initial and the final states forming dimers or dimer rows. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Yoshimoto, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Tsukada, Masaru/E-5182-2010				Borovsky B, 1997, PHYS REV LETT, V78, P4229, DOI 10.1103/PhysRevLett.78.4229; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; Yamauchi J, 1996, PHYS REV B, V54, P5586, DOI 10.1103/PhysRevB.54.5586; Brocks G, 1996, PHYS REV LETT, V76, P2362, DOI 10.1103/PhysRevLett.76.2362; Chen X, 1997, PHYS REV B, V55, pR7319; CHO JH, 1994, PHYS REV B, V50, P17139, DOI 10.1103/PhysRevB.50.17139; GELL M, 1989, APPL PHYS LETT, V55, P484, DOI 10.1063/1.101860; Ikeda A, 1997, SURF SCI, V385, P200, DOI 10.1016/S0039-6028(97)00275-6; ISMAIL K, 1992, IEEE ELECTR DEVICE L, V13, P229, DOI 10.1109/55.145036; Jenkins SJ, 1997, SURF SCI, V377, P887, DOI 10.1016/S0039-6028(96)01505-1; MURAKAMI E, 1990, JPN J APPL PHYS 2, V29, pL1059; PATTHEY L, 1995, PHYS REV LETT, V75, P2538, DOI 10.1103/PhysRevLett.75.2538; PATTON GL, 1990, IEEE ELECTR DEVICE L, V11, P171, DOI 10.1109/55.61782; SASAKI M, 1994, APPL SURF SCI, V82-3, P387, DOI 10.1016/0169-4332(94)90246-1; TROULLIER N, 1991, PHYS REV B, V43, P1993, DOI 10.1103/PhysRevB.43.1993; Yamasaki T, 1996, PHYS REV LETT, V76, P2949, DOI 10.1103/PhysRevLett.76.2949; YOEM HW, 1997, SURF SCI, V381, pL533	18	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028			SURF SCI	Surf. Sci.	MAR 1	1999	423	1					32	42		10.1016/S0039-6028(98)00887-5		11	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	180FF	WOS:000079374600012		
J	Yamada, T; Hisanaga, M; Nakajima, Y; Kanehiro, H; Aomatsu, Y; Ko, S; Kin, T; Nishio, K; Sho, H; Nagao, M; Harada, A; Matsushima, K; Nakano, H				Yamada, T; Hisanaga, M; Nakajima, Y; Kanehiro, H; Aomatsu, Y; Ko, S; Kin, T; Nishio, K; Sho, H; Nagao, M; Harada, A; Matsushima, K; Nakano, H			The serum interleukin 8 level reflects hepatic mitochondrial redox state in hyperthermochemohypoxic isolated liver perfusion with use of a venovenous bypass	SURGERY			English	Article							NEUTROPHIL CHEMOTACTIC FACTOR; TUMOR-NECROSIS-FACTOR; KETONE-BODY RATIO; GENE-EXPRESSION; CYTO-TOXICITY; INFLAMMATORY CYTOKINES; REPERFUSION INJURY; PRINGLE MANEUVER; REACTIVE OXYGEN; MITOMYCIN-C	Background. We have recently developed a simple method of hyperthermochemohypoxic isolated liver perfusion (HILP) as a regional therapy for unrecognized liz,er micrometastases. However little is known about the influence of HILP on cytokine production and liver function. We investigated the influence of HILP on interleukin 8 (IL-8) production and the hepatic mitochondrial function and assessed the relationship, between these 2 parameters. We also measured the serum tumor necrosis factor-alpha (TNF-alpha) and interleukin 1 beta (IL-1 beta) levels to examine the involvement of HILP-induced cytokines in the tumor response. Methods. Sixteen patients with metastatic liver tumors runs randomly assigned to undergo hc;hepatectomy with HILP (group A, n = 9) or hepatectomy alone (group, B, n = 7). The isolated liver was perfused for 30 minutes with Ringer's lactate solution containing chemotherapeutic agents warmed to 42 degrees C to 43 degrees C without oxygenation. Results. The serum IL-8 levels in group A were markedly increased, with peaks at 3 hours after reperfusion, which was significantly higher than levels in group B (P <.01). In group A the arterial ketone body ratio, which reflects the hepatic mitochondrial redox state, decreased during perfusion and was gradually restored to the preperfusion level 1 hour after reperfusion. However in group B it decreased during hepatectomy but rapidly recovered 5 minutes after, hepatectomy. There was a significant negative correlation between the peak serum IL-8 level and the initial velocity of arterial ketone body ratio recovery for the first 5 minutes after reperfusion r = -0.83 P <.001). The serum TNF-alpha and IL-1 beta were temporarily detected only in 3 of 9 patients in group A. Conclusions. We have shown that HILP resulted in a augmented IL-8 release but not TNF-alpha and IL-1 beta and that the serum IL-8 level reflects the hepatic mitochondrial redox state. These findings suggest that IL-8 production may be associated with hepatic mitochondrial impairment during ischemia. This work may contribute to new therapeutic strategies not only for. hepatic ischemia reperfusion injury but also for metastatic liver tumors.	Nara Med Univ, Dept Surg 1, Nara 6348521, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 113, Japan	Nakano, H (reprint author), Nara Med Univ, Dept Surg 1, 840 Shijo Cho, Nara 6348521, Japan.						PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; MUKAIDA N, 1990, J BIOL CHEM, V265, P21128; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; GRACE PA, 1994, BRIT J SURG, V81, P637, DOI 10.1002/bjs.1800810504; DEFORGE LE, 1993, J BIOL CHEM, V268, P25568; WALLNER KE, 1987, CANCER RES, V47, P493; Bradham CA, 1997, HEPATOLOGY, V25, P1128, DOI 10.1002/hep.510250514; STRIETER RM, 1989, SCIENCE, V243, P1467, DOI 10.1126/science.2648570; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Harada A, 1996, MOL MED TODAY, V2, P482; CAESAR J, 1961, CLIN SCI, V21, P43; DEFORGE LE, 1992, J IMMUNOL, V148, P2133; Adams DH, 1997, LANCET, V349, P490, DOI 10.1016/S0140-6736(96)07524-1; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; MATSUSHIMA K, 1988, J EXP MED, V167, P1883, DOI 10.1084/jem.167.6.1883; Zwacka RM, 1998, NAT MED, V4, P698, DOI 10.1038/nm0698-698; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; BODDIE AW, 1979, J SURG RES, V26, P447, DOI 10.1016/0022-4804(79)90033-7; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; HAMAZOE R, 1991, J SURG ONCOL, V48, P127, DOI 10.1002/jso.2930480211; HERMAN TS, 1988, CANCER RES, V48, P2342; HORIKAWA M, 1994, WORLD J SURG, V18, P845; JAESCHKE H, 1989, BIOCHEM BIOPH RES CO, V160, P140, DOI 10.1016/0006-291X(89)91632-X; Kita Y, 1996, DIGEST DIS SCI, V41, P2459, DOI 10.1007/BF02100143; KO YC, 1992, J IMMUNOL METHODS, V149, P227, DOI 10.1016/0022-1759(92)90254-Q; Kurokawa T, 1996, J SURG RES, V66, P1, DOI 10.1006/jsre.1996.0363; MARUBAYASHI S, 1991, SURGERY, V110, P537; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; MCCURRY KR, 1993, J SURG RES, V55, P49, DOI 10.1006/jsre.1993.1107; METINKO AP, 1992, J CLIN INVEST, V90, P791, DOI 10.1172/JCI115953; Mueller AR, 1996, TRANSPLANTATION, V62, P1118, DOI 10.1097/00007890-199610270-00017; Nakajima Y, 1998, RECENT RES CANCER, V147, P28; NITTA N, 1988, LIFE SCI, V42, P1973, DOI 10.1016/0024-3205(88)90496-1; Oldhafer KJ, 1998, SURGERY, V123, P622, DOI 10.1067/msy.1998.87441; OZAKI N, 1993, SURGERY, V113, P403; OZAWA K, 1992, MED TRIBUNE; Remick DG, 1996, J LEUKOCYTE BIOL, V59, P471; RHODES RS, 1980, SURG GYNECOL OBSTET, V150, P347; SUZUKI YJ, 1994, J IMMUNOL, V153, P5008; TAKI Y, 1990, TRANSPLANTATION, V49, P535, DOI 10.1097/00007890-199003000-00012; TEICHER BA, 1981, CANCER RES, V41, P1096; THORNTON AJ, 1990, J IMMUNOL, V144, P2609; Villarete LH, 1996, AM J PATHOL, V149, P1685; WANG LQ, 1994, BRIT J SURG, V81, P1775, DOI 10.1002/bjs.1800811222; West M A, 1996, New Horiz, V4, P168; WILLIAMSON DH, 1974, METHOD ENZYMAT AN, P1836; WILLIAMS.DH, 1967, BIOCHEM J, V103, P514	48	8	9	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0039-6060			SURGERY	Surgery	MAR	1999	125	3					304	314		10.1067/msy.1999.95725		11	Surgery	Surgery	171UX	WOS:000078883400009		
J	Kawamura, YJ; Sugamata, Y; Yoshino, K; Abo, Y; Nara, S; Sumita, T; Setoyama, R; Kiribuchi, Y; Kawano, N				Kawamura, YJ; Sugamata, Y; Yoshino, K; Abo, Y; Nara, S; Sumita, T; Setoyama, R; Kiribuchi, Y; Kawano, N			Endoscopic resection for submucosally invasive colorectal cancer - Is it feasible?	SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES			English	Article						submucosally invasive cancer; colon; endoscopic resection; polypectomy	CARCINOMA; POLYPS; SURVEILLANCE; POLYPECTOMY; COLONOSCOPY; MANAGEMENT	Background: Recent advances in colonoscopy have resulted in an increasing number of endoscopic resections of colorectal neoplasms. However, endoscopic resection of submucosal invasive cancer remains a controversial issue. Methods: The subjects for this study were the surgically treated patients with submucosal invasive colorectal cancer; These patients were classified into two groups: those with versus those without preoperative endoscopic resection. Clinicopathologic features and prognosis were compared and analyzed. Results: Fifty patients underwent surgery for submucosally invasive colorectal cancer. Numbers of patients with and without preoperative endoscopic resection were 22 and 28, respectively. in 36.4% of the patients, endoscopic resections were incomplete. Two patients in whom the preoperative endoscopic resections had revealed a positive cancer margin, had nodal metastasis. One of these patients also developed hepatic metastasis. Endoscopic findings such as diameter and shape were not indicative of either lymphatic or vascular invasion. There were no morbidities or mortalities associated with endoscopic resection or surgery. Conclusions: Preoperative endoscopic resection for colorectal submucosal cancer is feasible, provided the resection is complete. The indications for surgical treatment should be determined after pathologic examination.	Sanraku Hosp, Dept Surg, Chiyoda Ku, Tokyo 1010062, Japan	Kawamura, YJ (reprint author), Univ Tokyo, Sch Med, Dept Surg 1, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						WALSH RM, 1992, GASTROINTEST ENDOSC, V38, P303; Kudo SE, 1996, GASTROINTEST ENDOSC, V44, P8, DOI 10.1016/S0016-5107(96)70222-5; MORSON BC, 1977, GUT, V18, P1045, DOI 10.1136/gut.18.12.1045; HACKELSBERGER A, 1995, ENDOSCOPY, V27, P153, DOI 10.1055/s-2007-1005654; TANAKA S, 1995, J GASTROENTEROL, V30, P710, DOI 10.1007/BF02349636; VOLK EE, 1995, GASTROENTEROLOGY, V109, P1801, DOI 10.1016/0016-5085(95)90746-7; BINMEOELLER KF, 1996, GASTROINTEST ENDOSC, V43, P83; DEHYLE P, 1972, ENDOSCOPY, V5, P38; DEHYLE P, 1971, ENDOSCOPY, V3, P103; Iishi H, 1996, GASTROINTEST ENDOSC, V44, P594, DOI 10.1016/S0016-5107(96)70015-9; *JAP SOC CANC COL, 1993, GEN RUL CLIN PATH ST; JUHL G, 1990, WORLD J SURG, V14, P255; Kewenter J, 1996, DIS COLON RECTUM, V39, P676, DOI 10.1007/BF02056949; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; MAKELA JT, 1995, ARCH SURG-CHICAGO, V130, P1062; PATCHETT SE, 1993, BRIT J SURG, V80, P1330, DOI 10.1002/bjs.1800801038; SIVAK MV, 1984, GASTROINTEST ENDOSC, V30, P1, DOI 10.1016/S0016-5107(84)72282-6; STREKALOVSKY VP, 1989, ENDOSCOPY, V21, P75, DOI 10.1055/s-2007-1012904; TADA M, 1978, GASTROINTEST ENDOSC, V24, P146, DOI 10.1016/S0016-5107(78)73489-9; WAYE JD, 1982, ENDOSCOPY, V14, P79, DOI 10.1055/s-2007-1021585	20	19	19	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0930-2794			SURG ENDOSC-ULTRAS	Surg. Endosc.-Ultrason. Interv. Tech.	MAR	1999	13	3					224	227		10.1007/s004649900949		4	Surgery	Surgery	175KB	WOS:000079091400004		
J	Furukawa, H; Yabe, T; Akaza, T; Tadokoro, K; Tohma, S; Inoue, T; Tokunaga, K; Yamamoto, K; Geraghty, DE; Juji, T				Furukawa, H; Yabe, T; Akaza, T; Tadokoro, K; Tohma, S; Inoue, T; Tokunaga, K; Yamamoto, K; Geraghty, DE; Juji, T			Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient	TISSUE ANTIGENS			English	Article						HLA-E; TAP1; cell surface expression; HLA class I deficiency; bare lymphocyte syndrome	ANTIGEN; PEPTIDES	It was recently revealed from studies on TAP-deficient cell lines that HLA-E molecules are associated with nonamer peptides derived from certain HLA class I leader sequences and are expressed on the cell surface in a TAP-dependent manner, We have previously reported a homozygous TAP1 gene mutation in a HLA class I-deficient patient, In the present report, we demonstrate HLA-E molecule expression on the surface of the peripheral blood mononuclear cells (PBMC) of the TAP1-deficient patient, The HLA-E expression level on the monocytes of the patient was as high as that in healthy donors, whereas the HLA-E expression level on the lymphocytes of the patient was slightly lower. On the other hand, HLA-E expression was not detected on KMW-B2 cells, an Epstein-Barr virus (EBV)-transformed B-cell line derived from the lymphocytes of the TAP1-deficient patient. These data suggest the existence of TAP-dependent and independent pathways for the surface expression of HLA-E molecules.	Japanese Red Cross, Cent Blood Ctr, Dept Res, Shibuya Ku, Tokyo 1500012, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo, Japan; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; Univ Tokyo, Fac Med, Dept Med & Phys Therapy, Bunkyo Ku, Tokyo, Japan	Yabe, T (reprint author), Japanese Red Cross, Cent Blood Ctr, Dept Res, Shibuya Ku, 4-1-31 Hino, Tokyo 1500012, Japan.	t-yabe@info.cbc.jrc.or.jp					ALDRICH CJ, 1992, J IMMUNOL, V149, P3773; Lee N, 1998, J IMMUNOL, V160, P4951; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; ALDRICH CJ, 1994, CELL, V79, P649, DOI 10.1016/0092-8674(94)90550-9; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; Llano M, 1998, EUR J IMMUNOL, V28, P2854, DOI 10.1002/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Lee N, 1998, P NATL ACAD SCI USA, V95, P5199, DOI 10.1073/pnas.95.9.5199; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Furukawa H, 1999, HUM IMMUNOL, V60, P32, DOI 10.1016/S0198-8859(98)00097-4; FURUKAWA H, 1999, IN PRESS J CLIN INVE; GERAGHTY DE, 1992, HUM IMMUNOL, V33, P174, DOI 10.1016/0198-8859(92)90069-Y; Tompkins SM, 1998, J EXP MED, V188, P961	13	14	15	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-2815			TISSUE ANTIGENS	Tissue Antigens	MAR	1999	53	3					292	295		10.1034/j.1399-0039.1999.530310.x		4	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	177QM	WOS:000079222100010		
J	Yano, K; Karube, I				Yano, K; Karube, I			Molecularly imprinted polymers for biosensor applications	TRAC-TRENDS IN ANALYTICAL CHEMISTRY			English	Article						biosensors; molecularly imprinted polymers; chloramphenicol; optical detection	OPTICAL-DETECTION; SENSORS; SYSTEM	Molecular imprinting, which allows the formation of specific recognition sites in polymer matrices, is now applied widely for developing robust sensors for industry, diagnostics, and environmental analysis. In these sensors, molecularly imprinted polymers are coupled with appropriate transducers for the quantitative detection. This article describes recent trends and some examples of sensors based on molecular imprinting. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	karube@bio.rcast.u-tokyo.ac.jp					KRIZ D, 1995, ANAL CHIM ACTA, V300, P71, DOI 10.1016/0003-2670(94)00368-V; KRIZ D, 1995, ANAL CHEM, V67, P2142, DOI 10.1021/ac00109a037; Cheong SH, 1997, MACROMOLECULES, V30, P1317, DOI 10.1021/ma961014l; ANDERSSON LI, 1990, J CHROMATOGR, V516, P323, DOI 10.1016/S0021-9673(01)89274-8; Piletsky SA, 1996, ANAL LETT, V29, P157; WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121; Piletsky SA, 1998, MACROMOLECULES, V31, P2137, DOI 10.1021/ma970818d; HEDBORG E, 1993, SENSOR ACTUAT A-PHYS, V37-8, P796, DOI 10.1016/0924-4247(93)80134-3; Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163; Turkewitsch P, 1998, ANAL CHEM, V70, P2025, DOI 10.1021/ac980003i; CHEN C-Y, 1992, Current Opinion in Biotechnology, V3, P31, DOI 10.1016/0958-1669(92)90122-Y; Chen GH, 1997, NAT BIOTECHNOL, V15, P354, DOI 10.1038/nbt0497-354; Cheong SH, 1998, J POLYM SCI POL CHEM, V36, P1725, DOI 10.1002/(SICI)1099-0518(199808)36:11<1725::AID-POLA5>3.0.CO;2-Q; Cooper M.E., 1997, POLYM PREPRINTS, V38, P209; Dickert FL, 1998, ADV MATER, V10, P149, DOI 10.1002/(SICI)1521-4095(199801)10:2<149::AID-ADMA149>3.0.CO;2-2; Jenkins AL, 1997, ANAL COMMUN, V34, P221, DOI 10.1039/a704220e; KARUBE I, 1995, TRAC-TREND ANAL CHEM, V14, P295, DOI 10.1016/0165-9936(95)97055-6; Lai EPC, 1998, CAN J CHEM, V76, P265, DOI 10.1139/cjc-76-3-265; Levi R, 1997, ANAL CHEM, V69, P2017, DOI 10.1021/ac960983b; Lulka MF, 1997, ANAL LETT, V30, P2301; Matsui J, 1998, ANAL COMMUN, V35, P225, DOI 10.1039/a803404d; McNiven S, 1998, ANAL CHIM ACTA, V365, P69, DOI 10.1016/S0003-2670(98)00096-8; Kriz Dario, 1995, Biomimetics, V3, P81; PILETSKY SA, 1994, SENSOR ACTUAT B-CHEM, V19, P629, DOI 10.1016/0925-4005(93)01216-Q; Piletsky SA, 1997, ANAL LETT, V30, P445; PILETSKY SA, 1995, BIOSENS BIOELECTRON, V10, P959, DOI 10.1016/0956-5663(95)99233-B; SHEA KJ, 1994, TRENDS POLYM SCI, V2, P66; Steinke JHG, 1996, MACROMOLECULES, V29, P407, DOI 10.1021/ma9505033; Takeuchi T, 1996, ACTA POLYM, V47, P471, DOI 10.1002/actp.1996.010471101	29	117	127	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0165-9936	1879-3142		TRAC-TREND ANAL CHEM	Trac-Trends Anal. Chem.	MAR	1999	18	3					199	204		10.1016/S0165-9936(98)00119-8		6	Chemistry, Analytical	Chemistry	174RD	WOS:000079047600018		
J	Horie, S; Tobisu, KI; Fujimoto, H; Doi, N; Kakizoe, T				Horie, S; Tobisu, KI; Fujimoto, H; Doi, N; Kakizoe, T			Urinary incontinence after non-nerve-sparing radical prostatectomy with neoadjuvant androgen deprivation	UROLOGY			English	Article							RETROPUBIC PROSTATECTOMY; CONTINENCE	Objectives. The impact of non-nerve-sparing retropubic radical prostatectomy (RRP) for prostate cancer combined with neoadjuvant androgen deprivation on urinary control is not well documented. We examined the incidence and severity of urinary incontinence after such therapy and determined the etiologic factors causing this complication. Methods. We examined the postoperative continence status of 104 consecutive patients admitted to the National Cancer Center Hospital who underwent RRP with wide resection of the pelvic nerves after neoadjuvant androgen deprivation. Incontinence was scored according to the number of pads used daily by the patient for urinary leakage. The severity of incontinence was analyzed according to patient age, weight of resected specimen, status of cancer stage, duration of neoadjuvant androgen blockade therapy, preoperative length of membranous urethra, and duration of urethral catheterization after surgery. We also measured the configuration and diameter of the reconstructed bladder neck by retrograde cystourethrography. Results. In 104 patients examined, the percentage of patients who became dry postoperatively was 22% at 1 month, 47% at 3 months, 69% at 6 months, and 78% at 1 year. Of 81 patients who became dry postoperatively at any interval, 22 (27%) became continent within 1 month of RRP, 49 (61%) were continent within 3 months, 71 (88%) became continent by 6 months, and another 10 (12%) became continent between 6 and 12 months postoperatively. Of 48 patients who were followed up for more than I year and for whom continence status at 1 month after surgery was available, all patients who used 1 to 2 pads per day (13 of 13) at 1 month after surgery regained continence by 1 year after surgery. However, only 62% of patients (16 of 26) who required more than 3 pads per day at 1 month after surgery became dry by 1 year after surgery. Only age (older than 70 years) and large prostate size (weight of surgical specimen more than 40 g) temporarily influenced the recovery of urinary continence after surgery. Dilation of the bladder neck evaluated by retrograde cystourethrography was prominent in severely incontinent patients in the immediate postoperative period. Conclusions. Our experience in patients who undergo non-nerve-sparing RRP after neoadjuvant androgen deprivation closely matches published surveys of patient-reported complications. Postoperative incontinence is not a major contraindication for non-nerve-sparing RRP after neoadjuvant endocrine therapy. Dilation of the bladder neck affected the recovery from incontinence, highlighting the importance of adequate reconstruction of the bladder neck. (C) 1999, Elsevier Science Inc. All rights reserved.	Natl Canc Ctr Hosp, Serv Urol, Tokyo, Japan	Horie, S (reprint author), Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						CATALONA WJ, 1993, J UROLOGY, V150, P905; MYERS RP, 1987, J UROLOGY, V138, P543; MORGAN WR, 1993, UROLOGY, V41, P113, DOI 10.1016/0090-4295(93)90159-8; Eastham JA, 1996, J UROLOGY, V156, P1707, DOI 10.1016/S0022-5347(01)65488-0; Gaker DL, 1996, J UROLOGY, V156, P445, DOI 10.1016/S0022-5347(01)65875-0; Shelfo SW, 1998, UROLOGY, V51, P73, DOI 10.1016/S0090-4295(97)00463-9; STEINER MS, 1991, J UROLOGY, V145, P512; CONNOLLY JA, 1995, BRIT J UROL, V75, P766, DOI 10.1111/j.1464-410X.1995.tb07388.x; ODONNELL PD, 1990, UROLOGY, V36, P511, DOI 10.1016/0090-4295(90)80189-T; ODONNELL PD, 1989, J UROLOGY, V142, P1227; PRESTI JC, 1990, J UROLOGY, V143, P975; RUUTU M, 1984, CLIN RADIOL, V35, P485, DOI 10.1016/S0009-9260(84)80066-5; STEINER MS, 1993, J UROLOGY, V150, P407; Walsh PC, 1992, CAMPBELLS UROLOGY, V3, P2865	14	17	17	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0090-4295			UROLOGY	UROLOGY	MAR	1999	53	3					561	567		10.1016/S0090-4295(98)00541-X		7	Urology & Nephrology	Urology & Nephrology	177DW	WOS:000079193000022		
J	Tsushima, Y; Jang, HK; Izumiya, Y; Cai, JS; Kato, K; Miyazawa, T; Kai, C; Takahashi, E; Mikami, T				Tsushima, Y; Jang, HK; Izumiya, Y; Cai, JS; Kato, K; Miyazawa, T; Kai, C; Takahashi, E; Mikami, T			Gene arrangement and RNA transcription of the BamHI fragments K and M2 within the non-oncogenic Marek's disease virus serotype 2 unique long genome region	VIRUS RESEARCH			English	Article						MDVZ BaHI-M2 DNA; MDV2 BamHI-K DNA; putative MDV specific glycoprotein; nucleotide sequence	DNA-SEQUENCE ANALYSIS; NUCLEOTIDE-SEQUENCE; MDV SEROTYPE-2; RECOMBINANT BACULOVIRUS; EQUINE HERPESVIRUS-1; 3 SEROTYPES; IDENTIFICATION; TYPE-1; EXPRESSION; ICP27	We determined the nucleotide sequence of a 6593 bp fragment of the Marek's disease virus serotype 2 (MDV2) unique long region located in the right part of genomic BamHI-M2 and the adjacent part of BamHI-K fragments. Within this region five complete open reading frames (ORFs) were identified whose deduced amino acid sequences exhibited homology to the UL53 (glycoprotein K), UL54 (immediate early regulatory protein ICP27), and UL55 gene products of herpes simplex virus type 1 (HSV-1). Homologue to the HSV-1 UL56 was not detected. However, we identified a gene between the MDV2 UL54 and UL55 genes with homology to the first ORF (ORF-1) of equine herpesvirus type 1 and corresponding gene identified in pseudorabies virus. Two adjacent ORFs contained in the BamHI-K fragment, ORF 873s and ORF 873, were found by computer analysis to have the properties of an intron encoding a glycoprotein: ORF 873s encodes a 84 amino acid polypeptide with a stretch of a hydrophobic signal sequence in the C-terminus, and ORF 873 encodes a 873 amino acid polypeptide with a transmembrane domain and putative three N-linked glycosylation sites. All the identified genes were confirmed to be transcribed with 3'-coterminal transcripts and/or a unique transcript in the virus-infected cells. Especially, 3.5 kb mRNA of ORF 873s and ORF 873 are transcribed from a potential promoter region of ORF 873s, and splice donor and acceptor sites are used to splice the mRNA after cleavage of a 113 bp-nucleotide sequence. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	Mikami, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						TELFORD EAR, 1992, VIROLOGY, V189, P304, DOI 10.1016/0042-6822(92)90706-U; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; HARDY WR, 1994, J VIROL, V68, P7790; BAUMEISTER J, 1995, J VIROL, V69, P5560; BUCKMASTER AE, 1988, J GEN VIROL, V69, P2033, DOI 10.1099/0022-1317-69-8-2033; CHODOSH LA, 1988, CELL, V53, P11, DOI 10.1016/0092-8674(88)90483-7; HIRAI K, 1986, ARCH VIROL, V89, P113, DOI 10.1007/BF01309883; Izumiya Y, 1998, J GEN VIROL, V79, P1997; Jang HK, 1996, ARCH VIROL, V141, P2207, DOI 10.1007/BF01718226; Jang HK, 1996, J VET MED SCI, V58, P1057; Jang HK, 1997, VIRUS RES, V48, P111, DOI 10.1016/S0168-1702(96)01432-3; KITAZAWA T, 1993, J VET MED SCI, V55, P985; KYTE J, 1982, J MOL BIOL, V157, P15; MCGEOCH DJ, 1988, J GEN VIROL, V69, P1531, DOI 10.1099/0022-1317-69-7-1531; MORIUCHI M, 1995, VIROLOGY, V208, P376, DOI 10.1006/viro.1995.1164; ONO M, 1994, VIROLOGY, V201, P142, DOI 10.1006/viro.1994.1275; ONO M, 1992, VIROLOGY, V191, P459, DOI 10.1016/0042-6822(92)90210-G; REN DL, 1994, VIROLOGY, V204, P242, DOI 10.1006/viro.1994.1528; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; Rosser EJ, 1993, ADV VET DERMATOLOGY, V2, P33; Schwyzer M, 1996, VET MICROBIOL, V53, P17, DOI 10.1016/S0378-1135(96)01231-X; Shimojima Y, 1997, J VET MED SCI, V59, P629, DOI 10.1292/jvms.59.629; Shimojima Y, 1997, VIRUS GENES, V14, P81, DOI 10.1023/A:1007943624997; SILVA RF, 1991, AVIAN DIS, V35, P487, DOI 10.2307/1591212; SMITH GD, 1995, VIROLOGY, V207, P205, DOI 10.1006/viro.1995.1067; SUN Y, 1994, VIROLOGY, V199, P448, DOI 10.1006/viro.1994.1143	26	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-1702			VIRUS RES	Virus Res.	MAR	1999	60	1					101	110		10.1016/S0168-1702(99)00010-6		10	Virology	Virology	186NX	WOS:000079736800010		
J	Shimoyama, S; Shimizu, N; Kaminishi, M				Shimoyama, S; Shimizu, N; Kaminishi, M			Type-oriented intraoperative and adjuvant chemotherapy and survival after curative resection of advanced gastric cancer	WORLD JOURNAL OF SURGERY			English	Article							LYMPH-NODE; CARCINOMA; 1-(2-TETRAHYDROFURYL)-5-FLUOROURACIL; 5-FLUOROURACIL; THERAPY; SURGERY; URACIL; DRUGS	Recent observations and our experience that histologic types of gastric cancer related significantly to patterns of recurrence prompted us to develop intraoperative and postoperative chemotherapy based on the preoperatively diagnosed histologic types of canter and to evaluate its effectiveness by a prospective randomized trial. This chemotherapy regimen consisted of the intraoperative administration of mitomycin C (MMC) and postoperative administration of cisplatin (80 mg/patient, day 14), and tegaful and uracil (UFT) (300-600 mg/day for 2 years). Patients viith a diffuse type of cancer were randomly assigned to one of three treatment groups: no intraoperative chemotherapy and UFT 300 mg/day (P0 group, n = 16); intraoperative chemotherapy and UFT 300 mg/day (P1 group, n = 13); or UFT 600 mg/day (P2 group, n = 17. Patients with an intestinal type of cancer were randomly assigned to one of three treatment groups: H0 (n = 17), H1 (n = 12), and H2 (n = 12); each group was subjected to the same protocols as the P0, P1, and FZ groups, respectively, except for the MMC administration route. MMC (10 mg/patient) was administered intraoperatively into the intraperitoneal cavity (P1 and P2 groups) or the portal vein (H1 and H2 groups). All patients underwent curative resection. Background factors did not differ significantly among the treatment groups. The overall survival rates were progressively worsened in the order of P2, P1, and P0 or H2, H1, and H0, respectively. The survival rate of the P2 group was statistically higher than that of the P0 group (p < 0.05). The intermediate-term survival rate of the P2 group or H2 group was significantly higher than that of the P0 group (p < 0.05) or H0 group (p < 0.05), respectively. These results suggest the effectiveness of this therapy and the possible eradication of potential micrometastatic foci outside the surgical field by the direct administration of chemotherapeutic agents to the predicted recurrence site.	Univ Tokyo, Dept Surg 3, Bunkyo Ku, Tokyo 1128688, Japan	Shimoyama, S (reprint author), Univ Tokyo, Dept Surg 3, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						*AM JOINT COMM CAN, 1988, MAN STAG CANC, P69; MAEHARA Y, 1991, SURGERY, V110, P820; MARUYAMA K, 1987, WORLD J SURG, V11, P418; ENGSTROM PF, 1985, CANCER, V55, P1868, DOI 10.1002/1097-0142(19850501)55:9<1868::AID-CNCR2820550904>3.0.CO;2-B; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; AJANI JA, 1991, CANCER, V68, P1501, DOI 10.1002/1097-0142(19911001)68:7<1501::AID-CNCR2820680706>3.0.CO;2-L; ARIMA S, 1989, JPN J SURG, V19, P177, DOI 10.1007/BF02471582; FUJII S, 1979, GANN, V70, P209; HANAUE H, 1987, CANCER, V59, P1571, DOI 10.1002/1097-0142(19870501)59:9<1571::AID-CNCR2820590907>3.0.CO;2-9; HIGGINS GA, 1983, CANCER, V52, P1105, DOI 10.1002/1097-0142(19830915)52:6<1105::AID-CNCR2820520629>3.0.CO;2-Z; *JAP RES SOC GASTR, 1995, JAP CLASS GASTR CARC, P2; KAIBARA N, 1987, CANCER, V60, P136, DOI 10.1002/1097-0142(19870701)60:1<136::AID-CNCR2820600125>3.0.CO;2-X; KOGA S, 1987, J SURG ONCOL, V36, P239, DOI 10.1002/jso.2930360405; KOGA S, 1978, AM J SURG, V136, P317, DOI 10.1016/0002-9610(78)90284-2; KUSUMOTO H, 1988, EUR J SURG ONCOL, V14, P685; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P3; LAWRENCE WT, 1980, SEMIN ONCOL, V7, P400; LEICHMAN L, 1984, CANCER, V53, P18, DOI 10.1002/1097-0142(19840101)53:1<18::AID-CNCR2820530105>3.0.CO;2-J; MAEHARA Y, 1987, EUR J SURG ONCOL, V13, P203; MAEHARA Y, 1990, AM J SURG, V160, P79; Moriguchi S, 1992, Surg Oncol, V1, P341, DOI 10.1016/0960-7404(92)90034-I; NODA S, 1980, Japanese Journal of Surgery, V10, P277, DOI 10.1007/BF02468788; Papaioannou A N, 1986, Recent Results Cancer Res, V103, P142; SHIMOYAMA S, 1994, J SURG ONCOL, V57, P164, DOI 10.1002/jso.2930570306	24	19	19	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0364-2313			WORLD J SURG	World J.Surg.	MAR	1999	23	3					284	292				9	Surgery	Surgery	166EF	WOS:000078562700015		
J	Itoh, M; Aoyama, T; Yamamura, Y; Nakajima, K; Nakamura, K; Kotaki, H; Matsuyama, T; Saitoh, T; Kami, M; Chiba, S; Hirai, H; Yazaki, Y; Iga, T				Itoh, M; Aoyama, T; Yamamura, Y; Nakajima, K; Nakamura, K; Kotaki, H; Matsuyama, T; Saitoh, T; Kami, M; Chiba, S; Hirai, H; Yazaki, Y; Iga, T			Effects of the rational use of corticosteroids eye drops for the prevention of ocular toxicity in high-dose cytosine arabinoside therapy	YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN			Japanese	Article						high-dose cytosine arabinoside therapy; ocular toxicity; corticosteroid eye drops; rational use; eye washing	SYSTEMIC CYTARABINE; CORNEAL TOXICITY; KERATITIS; LEUKEMIA	Although the use of corticosteroid (CS) eye drops or the use of eye washing by artificial tears was effective for the prevention of ocular toxicity such as keratitis and photophobia in the high-dose cytosine arabinoside (Ara-C) therapy, the toxicity was not prevented perfectly. We studied the effects of the rational use of CS eye drops, and the combined use of CS eye drops and eye washing by physiological saline in order to prevent the ocular toxicity. Before the study, the instillation of 0.1% sodium bethamethazone phosphate (BM) eye drops was carried out at 4-6 times per day during the high-dose Ara-C therapy, and continued for several days after the high-dose Ara-C therapy. However, the rational use of "eyelid closure" and "naso-lacrimal occlusion" after the instillation was not performed Consequently, the ocular toxicity was observed in 3 (19%) of 16 cases of the patients. When the instillation of BM eye drops at 4 times per day was carried out rationally according to the consultation of pharmacist during the high-dose Ara-C therapy and for additional 10 days after the therapy, no ocular toxicity was observed in all cases (0 of 6 cases). Furthermore, the combined use of eye washing by physiological saline and instillation of BM eye drops was effective for the decrease of the risk of ocular toxicity, because no ocular toxicity was observed in the high-dose Ara-C therapy (0 of 34 cases). Our procedure in this study would be effective for the prevention of ocular toxicity in the high-dose Ara-C therapy.	Univ Tokyo, Dept Pharm, Res Hosp, Inst Med Sci,Minato Ku, Tokyo 1080071, Japan; Tokyo Univ Hosp, Fac Med, Dept Cell Therapy & Transplantat Med, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Fac Med, Dept Pharm, Bunkyo Ku, Tokyo 1138655, Japan	Itoh, M (reprint author), Tokyo Univ Hosp, Fac Med, Dept Pharm, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						HOPEN G, 1981, AM J OPHTHALMOL, V91, P500; HERZIG RH, 1983, BLOOD, V62, P361; GRESSEL MG, 1982, LANCET, V2, P273; BARLETTA JP, 1992, AM J OPHTHALMOL, V113, P587; BOOS J, 1993, INT J CLIN PHARM TH, V31, P593; BURNS LJ, 1992, SEMIN ONCOL, V19, P492; FRIEDLAND S, 1993, ANN OPHTHALMOL, V25, P290; GOCOCO KO, 1992, CANCER, V69, P2866, DOI 10.1002/1097-0142(19920601)69:11<2866::AID-CNCR2820691137>3.0.CO;2-N; HANDE KR, 1982, CLIN PHARMACOL THER, V31, P669; HIDDEMANN W, 1991, ANN HEMATOL, V62, P119, DOI 10.1007/BF01702925; HIGA GM, 1991, CANCER, V68, P1691, DOI 10.1002/1097-0142(19911015)68:8<1691::AID-CNCR2820680805>3.0.CO;2-W; KAUFMAN HE, 1964, ARCH OPHTHALMOL-CHIC, V72, P535; LASS JH, 1982, AM J OPHTHALMOL, V94, P617; PROOIJEN RV, 1977, CLIN PHARMACOL THER, V21, P744; RITCH PS, 1983, CANCER, V51, P430, DOI 10.1002/1097-0142(19830201)51:3<430::AID-CNCR2820510313>3.0.CO;2-5; Tweigeri T, 1996, CANCER, V78, P1359; ZIMMERMANN TJ, 1984, ARCH OPHTHALMOL-CHIC, V84, P551	17	3	3	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0031-6903			YAKUGAKU ZASSHI	Yakugaku Zasshi-J. Pharm. Soc. Jpn.	MAR	1999	119	3					229	235				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	173CT	WOS:000078964200005		
J	Katsuraya, K; Nakashima, H; Yamamoto, N; Uryu, T				Katsuraya, K; Nakashima, H; Yamamoto, N; Uryu, T			Synthesis of sulfated oligosaccharide glycosides having high anti-HIV activity and the relationship between activity and chemical structure	CARBOHYDRATE RESEARCH			English	Article						laminara-oligosaccharides; sulfated sugars; anti-HIV activity; hydrophobicity; oligosaccharide glycosides	IMMUNODEFICIENCY-VIRUS-INFECTION; CURDLAN SULFATE; LAMINARA-OLIGOSACCHARIDES; ALKYL OLIGOSACCHARIDES; ANTITHROMBIN-III; CD4 LYMPHOCYTES; POTENT; AIDS; INVITRO; INHIBITION	Sulfated laminara-oligosaccharide glycosides having high anti-human immunodeficiency virus (HIV) activities were synthesized from laminara-tetraose, -pentaose and -hexaose. The oligosaccharide glycosides were synthesized by treating peracetylated beta-oligosaccharides with various alcohols and Lewis acid catalysts. The effects of the number of glucose residues and the alkyl chain-length on anti-HIV activity were examined. The anti-HIV activity of sulfated dodecyl laminara-pentaosides and -hexaosides increased with increasing degree of sulfation (DS) and the pentaoside having an almost fully-sulfated saccharide portion had the highest activity, whereas for the hexaoside a somewhat lower DS manifested the highest activity. Sulfated laminara-oligosaccharide glycosides having fluoroalkyl-containing aglycons of high hydrophobicity showed potent inhibitory effects against HIV infection, in contrast, hydrophilic substituents containing oligo(ethyleneoxy) groups as aglycons in the sulfated oligosaccharides did not show high anti-HIV activity. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan; Kagoshima Univ, Sch Dent, Kagoshima 890, Japan; Tokyo Med & Dent Univ, Sch Med, Bunkyo Ku, Tokyo 113, Japan	Uryu, T (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 106, Japan.						LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; CONDRA JH, 1995, NATURE, V374, P569, DOI 10.1038/374569a0; PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; DECLERCQ E, 1986, J MED CHEM, V29, P1561, DOI 10.1021/jm00159a001; GORDON M, 1994, J MED, V25, P163; HATANAKA K, 1987, J MED CHEM, V30, P810, DOI 10.1021/jm00388a011; HATANAKA K, 1989, JPN J CANCER RES, V80, P95; Jeon KJ, 1997, MACROMOLECULES, V30, P1997, DOI 10.1021/ma961392q; KANEKO Y, 1990, BIOCHEM PHARMACOL, V39, P793; KATSURAYA K, 1994, CARBOHYD RES, V260, P51, DOI 10.1016/0008-6215(94)80021-9; KATSURAYA K, 1995, MACROMOLECULES, V28, P6697, DOI 10.1021/ma00124a001; KATSURAYA K, 1994, MACROMOLECULES, V27, P6695, DOI 10.1021/ma00101a001; LINDAHL U, 1983, J BIOL CHEM, V258, P9826; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MITSUYA H, 1988, SCIENCE, V240, P646, DOI 10.1126/science.2452480; NAKASHIMA H, 1987, JPN J CANCER RES, V78, P1164; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SINAY P, 1984, CARBOHYD RES, V132, pC5, DOI 10.1016/0008-6215(84)85236-2; TORII M, 1986, MICROBIOL IMMUNOL, V30, P261; UENO R, 1987, LANCET, V2, P461; URYU T, 1992, BIOCHEM PHARMACOL, V43, P2385, DOI 10.1016/0006-2952(92)90317-C; Uryu T, 1997, MACROMOL SYMP, V120, P147, DOI 10.1002/masy.19971200116; VILLANUEVA GB, 1984, J BIOL CHEM, V259, P2531; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; YOSHIDA O, 1988, BIOCHEM PHARMACOL, V37, P2887, DOI 10.1016/0006-2952(88)90272-9; YOSHIDA T, 1990, MACROMOLECULES, V23, P3717, DOI 10.1021/ma00218a001	28	42	55	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0008-6215			CARBOHYD RES	Carbohydr. Res.	FEB 28	1999	315	3-4					234	242		10.1016/S0008-6215(98)00315-2		9	Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	207ND	WOS:000080942200004		
J	Kasai, H; Takahashi, N				Kasai, H; Takahashi, N			Multiple kinetic components and the Ca2+ requirements of exocytosis	PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES			English	Article; Proceedings Paper	Symposium on Molecular and Cellular Aspects of Exocytosis	JUN 24-25, 1998	MILAN, ITALY			caged-Ca2+ compounds; PC12 cell; beta-cell; acinar cell; secretion	ADRENAL CHROMAFFIN CELLS; PROTEIN-KINASE-C; NEUROENDOCRINE CELLS; TRANSMITTER RELEASE; SECRETORY GRANULES; CYTOSOLIC CA-2+; CALCIUM INFLUX; ACINAR-CELLS; CAGED CA2+; FUSION	The use of caged-Ca2+ compounds to stimulate Ca2+-dependent exocytosis has substantially increased our understanding of this complex process. By this approach, the existence of multiple kinetic components of exocytosis has been established. These components may correspond to a series of sequential steps that lead to a single fusion-ready state (sequential mechanism) or, alternatively, to heterogeneity in secretory vesicles or in fusion-ready states (parallel mechanism). It is suggested that both of these mechanisms can underlie exocytosis of a single type of vesicle (mixed sequential-parallel mechanism). Studies with caged-Ca2+ compounds have also indicated that the Ca2+ requirement for exocytosis is substantially greater than that suggested by conventional methodologies. This discrepancy is mainly attributable to the underestimation, by imaging studies with high-affinity Ca2+ indicators (due to dye saturation), of the local increases in cytosolic Ca2+ concentration that trigger the exocytosis of individual vesicles. The effects of local saturation of such indicators are explored by means of a simple theory.	Univ Tokyo, Fac Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan	Kasai, H (reprint author), Univ Tokyo, Fac Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan.			Kasai, Haruo/0000-0003-2327-9027			AHNERTHILGER G, 1987, BIOCHEMISTRY-US, V26, P7842, DOI 10.1021/bi00398a046; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751; ZUCKER RS, 1986, P NATL ACAD SCI USA, V83, P3032, DOI 10.1073/pnas.83.9.3032; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; SMITH SJ, 1993, J PHYSIOL-LONDON, V472, P573; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; HEINEMANN C, 1994, BIOPHYS J, V67, P2546; Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; BOKVIST K, 1995, EMBO J, V14, P50; BURGOYNE RD, 1991, BIOCHIM BIOPHYS ACTA, V1071, P174, DOI 10.1016/0304-4157(91)90024-Q; Calakos N, 1996, PHYSIOL REV, V76, P1; CHEEK TR, 1989, FEBS LETT, V247, P429, DOI 10.1016/0014-5793(89)81385-7; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; KASAI H, 1999, IN PRESS TRENDS NEUR; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Oberhauser AF, 1996, BIOPHYS J, V71, P1131; OKAZAKI K, 1994, J BIOL CHEM, V269, P6149; PRALONG WF, 1988, FEBS LETT, V242, P79, DOI 10.1016/0014-5793(88)80989-X; ROE MW, 1990, CELL CALCIUM, V11, P63, DOI 10.1016/0143-4160(90)90060-8; SIMON SM, 1985, BIOPHYS J, V48, P485; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; TAKAHASHI N, 1999, UNPUB P NATL ACAD SC; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; TOESCU EC, 1992, EMBO J, V11, P1623; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9	40	12	12	ROYAL SOC LONDON	LONDON	6 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND	0962-8436			PHILOS T ROY SOC B	Philos. Trans. R. Soc. Lond. Ser. B-Biol. Sci.	FEB 28	1999	354	1381					331	335		10.1098/rstb.1999.0384		5	Biology	Life Sciences & Biomedicine - Other Topics	171LB	WOS:000078864200010		
J	Teramoto, S; Matsuse, T; Ouchi, Y				Teramoto, S; Matsuse, T; Ouchi, Y			Increased cytokines and pamidronate-induced bone pain in adults with cystic fibrosis	LANCET			English	Letter							ALPHA		Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111; Haworth CS, 1998, LANCET, V352, P1753, DOI 10.1016/S0140-6736(05)79826-3; NANES MS, 1991, ENDOCRINOLOGY, V128, P2577; Teramoto S, 1997, CHEST, V112, P574, DOI 10.1378/chest.112.2.574; THEIBAUD D, 1997, CALCIFIED TISSUE INT, V61, P386	5	11	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					750	750		10.1016/S0140-6736(05)76114-6		1	Medicine, General & Internal	General & Internal Medicine	173DR	WOS:000078966400049		
J	Matsumura, T; Kami, M; Saito, T; Sakamaki, H; Hirai, H				Matsumura, T; Kami, M; Saito, T; Sakamaki, H; Hirai, H			Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood	LANCET			English	Letter									Univ Tokyo, Fac Med, Dept Haematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Metropolitan Komagome Hosp, Dept Haematol, Tokyo, Japan	Kami, M (reprint author), Univ Tokyo, Fac Med, Dept Haematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan.						Preudhomme C, 1997, LEUKEMIA, V11, P294, DOI 10.1038/sj.leu.2400567; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Tobal K, 1996, BLOOD, V88, P3704	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	FEB 27	1999	353	9154					752	752		10.1016/S0140-6736(05)76119-5		1	Medicine, General & Internal	General & Internal Medicine	173DR	WOS:000078966400054		
J	Yamashita, H; Nakamura, A; Noguchi, N; Niki, E; Kuhn, H				Yamashita, H; Nakamura, A; Noguchi, N; Niki, E; Kuhn, H			Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals	FEBS LETTERS			English	Article						lipoxygenase; low density lipoprotein; lipid peroxidation; plasma	LIPID-PROTEIN ADDUCTS; RETICULOCYTE LIPOXYGENASE; MAMMALIAN LIPOXYGENASES; ATHEROSCLEROTIC LESIONS; MESSENGER-RNA; OXYGENATION; ATHEROGENESIS; PEROXIDATION; CHOLESTEROL; ESTERS	It is generally accepted that the oxidation of pentadiene structures of polyunsaturated lipids by lipoxygenase (LOX) is regio- and enantio-specific, while the free radical-mediated lipid peroxidation gives stereo-random racemic products. It was confirmed that the oxidation of human tom density lipoprotein (LDL) by 15-LOX from rabbit reticulocytes gave phosphatidylcholine (PC) and cholesteryl ester (CE) hydroperoxides regio-, stereo- and enantio-specifically. 15-LOX also oxidized human plasma to give specific PC and CE hydroperoxides in spite of the presence of high concentrations of antioxidants. More CE hydroperoxides were formed than PC hydroperoxides from LDL, but the reverse order was observed for plasma oxidation, The SIR ratio of the hydroperoxides decreased during long time incubation but remained significantly larger than one, while free radical-mediated oxidation of LDL and plasma gave racemic products. (C) 1999 Federation of European Biochemical Societies.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan; Humboldt Univ, Clinicum Charite, Inst Biochem, D-10115 Berlin, Germany	Niki, E (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.						KUHN H, 1994, J EXP MED, V179, P1903, DOI 10.1084/jem.179.6.1903; BELKNER J, 1991, FEBS LETT, V279, P110, DOI 10.1016/0014-5793(91)80263-3; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; Kuhn H, 1997, J CLIN INVEST, V99, P888, DOI 10.1172/JCI119253; Upston JM, 1997, J BIOL CHEM, V272, P30067, DOI 10.1074/jbc.272.48.30067; FOLCIK VA, 1995, J CLIN INVEST, V96, P504, DOI 10.1172/JCI118062; Heinecke JW, 1997, CURR OPIN LIPIDOL, V8, P268, DOI 10.1097/00041433-199710000-00005; OLEARY VJ, 1992, BIOCHEM J, V282, P631; YLAHERTTUALA S, 1990, P NATL ACAD SCI USA, V87, P6959, DOI 10.1073/pnas.87.18.6959; Rubbo H, 1995, ARCH BIOCHEM BIOPHYS, V324, P15, DOI 10.1006/abbi.1995.9935; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; YLAHERTTUALA S, 1995, J CLIN INVEST, V95, P2692, DOI 10.1172/JCI117971; Upston JM, 1996, J LIPID RES, V37, P2650; Belkner J, 1998, J BIOL CHEM, V273, P23225, DOI 10.1074/jbc.273.36.23225; KUHN H, 1990, J BIOL CHEM, V265, P18351; KUHN H, 1993, BIOCHIM BIOPHYS ACTA, V1169, P80, DOI 10.1016/0005-2760(93)90085-N; Noguchi N, 1998, FREE RADICAL BIO MED, V24, P259, DOI 10.1016/S0891-5849(97)00230-X; BELKNER J, 1993, EUR J BIOCHEM, V213, P251, DOI 10.1111/j.1432-1033.1993.tb17755.x; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; KUHN H, 1994, J LIPID RES, V35, P1749; Kuhn H, 1997, CURR OPIN LIPIDOL, V8, P111; Lass A, 1996, BIOCHEM J, V314, P577; LEHMANN WD, 1994, FREE RADICAL BIO MED, V16, P241, DOI 10.1016/0891-5849(94)90149-X; MANALLY AK, 1990, J IMMUNOL, V145, P254; MURRAY JJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P514, DOI 10.1016/0003-9861(88)90156-7; NEUJIL J, 1998, BIOCHEMISTRY-US, V37, P9203; NOGUCHI N, 1993, BIOCHIM BIOPHYS ACTA, V1168, P348; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; SPARROW CP, 1988, J LIPID RES, V29, P745; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; YAMAMOTO S, 1991, FREE RADICAL BIO MED, V10, P149, DOI 10.1016/0891-5849(91)90008-Q; YLAHERTTUALA S, 1991, J CLIN INVEST, V87, P1146, DOI 10.1172/JCI115111	32	26	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 26	1999	445	2-3					287	290		10.1016/S0014-5793(99)00137-4		4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	175YC	WOS:000079122800014		
J	Shiratsuchi, A; Kawasaki, Y; Ikemoto, M; Arai, H; Nakanishi, Y				Shiratsuchi, A; Kawasaki, Y; Ikemoto, M; Arai, H; Nakanishi, Y			Role of class B scavenger receptor type I in phagocytosis of apoptotic rat spermatogenic cells by Sertoli cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; MALE GERM-CELLS; SR-BI; TESTICULAR CELLS; PRIMARY CULTURE; TESTIS; PHOSPHATIDYLSERINE; RECOGNITION; SURFACE; DIFFERENTIATION	Rat Sertoli cells phagocytose apoptotic spermatogenic cells, which consist mostly of spermatocytes, in primary culture by recognizing phosphatidylserine (PS) exposed on the surface of degenerating spermatogenic cells. We compared the mode of phagocytosis using spermatogenic cells at different stages of spermatogenesis. Spermatogenic cells were separated into several groups based on their ploidy, with purities of 60-90%. When the fractionated spermatogenic cell populations were subjected to a phagocytosis assay, cells with ploidies of In, 2n, and 4n were almost equally phagocytosed by Sertoli cells, AU the cell populations exposed PS on the cell surface, and phagocytosis of all cell populations was similarly inhibited by the addition of PS-containing liposomes, Class B scavenger receptor type I (SR-BI), a candidate for the PS receptor, was detected in Sertoli cells. Overexpression of the rat SR-BI cDNA increased the PS-mediated phagocytic activity of Sertoli cell-derived cell lines. Moreover, phagocytosis of spermatogenic cells by Sertoli cells was inhibited in the presence of an anti-SR-BI antibody. Finally, the addition of high density lipoprotein, a ligand specific for SR-BI, decreased both phagocytosis of spermatogenic cells and incorporation of PS-containing liposomes by Sertoli cells. In conclusion, SR-BI functions at least partly as a PS receptor, enabling Sertoli cells to recognize and phagocytose apoptotic spermatogenic cells at all stages of differentiation.	Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan; Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9200934, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan	Nakanishi, Y (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.	nakanaka@kenroku.kanazawa-u.ac.jp	Nakanishi, Yoshinobu/D-4602-2014; Shiratsuchi, Akiko/D-8391-2015	Nakanishi, Yoshinobu/0000-0002-8767-3587; Shiratsuchi, Akiko/0000-0002-7811-4409			Allan D.J., 1987, P229; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Fukasawa M, 1996, EXP CELL RES, V222, P246, DOI 10.1006/excr.1996.0030; HUCKINS C, 1978, ANAT REC, V190, P905, DOI 10.1002/ar.1091900410; MIETHING A, 1992, CELL TISSUE RES, V267, P583, DOI 10.1007/BF00319381; Oka K, 1998, P NATL ACAD SCI USA, V95, P9535, DOI 10.1073/pnas.95.16.9535; Martin SJ, 1996, J BIOL CHEM, V271, P28753; JOKINEN EV, 1994, J BIOL CHEM, V269, P26411; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; KOOPMAN G, 1994, BLOOD, V84, P1415; DYM M, 1994, P NATL ACAD SCI USA, V91, P11287, DOI 10.1073/pnas.91.24.11287; CasciolaRosen L, 1996, P NATL ACAD SCI USA, V93, P1624, DOI 10.1073/pnas.93.4.1624; ALLAN DJ, 1992, CELL PROLIFERAT, V25, P241, DOI 10.1111/j.1365-2184.1992.tb01399.x; SHIKONE T, 1994, BIOL REPROD, V51, P865, DOI 10.1095/biolreprod51.5.865; FADOK VA, 1992, J IMMUNOL, V148, P2207; Rigotti A, 1997, CURR OPIN LIPIDOL, V8, P181, DOI 10.1097/00041433-199706000-00009; Webb NR, 1998, J BIOL CHEM, V273, P15241, DOI 10.1074/jbc.273.24.15241; Zwaal RFA, 1997, BLOOD, V89, P1121; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; RUSSELL LD, 1977, ANAT REC, V187, P347, DOI 10.1002/ar.1091870307; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; Varban ML, 1998, P NATL ACAD SCI USA, V95, P4619, DOI 10.1073/pnas.95.8.4619; Wyllie A H, 1980, Int Rev Cytol, V68, P251; SAVILL J, 1993, IMMUNOL TODAY, V14, P131, DOI 10.1016/0167-5699(93)90215-7; BENNETT MR, 1995, CIRC RES, V77, P1136; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Ren Y, 1998, CELL DEATH DIFFER, V5, P563, DOI 10.1038/sj.cdd.4400407; Dunkel L, 1997, CELL DEATH DIFFER, V4, P171, DOI 10.1038/sj.cdd.4400234; MATHER JP, 1982, ANN NY ACAD SCI, V383, P44, DOI 10.1111/j.1749-6632.1982.tb23161.x; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25; Shiratsuchi A, 1997, J BIOL CHEM, V272, P2354; Braun RE, 1998, NAT GENET, V18, P202, DOI 10.1038/ng0398-202; Byers S., 1993, SERTOLI CELL, P461; CALLARD GV, 1995, DEV GENET, V16, P140, DOI 10.1002/dvg.1020160207; CHEMES H, 1986, ENDOCRINOLOGY, V119, P1673; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Grandjean V, 1997, DEV BIOL, V184, P165, DOI 10.1006/dbio.1997.8518; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; KERR JB, 1992, J REPROD FERTIL, V95, P825; KIKUCHI H, 1993, BIOCHIM BIOPHYS ACTA, V1162, P171, DOI 10.1016/0167-4838(93)90144-G; Martin Seamus J., 1996, P107; Mizuno K, 1996, CELL DEATH DIFFER, V3, P119; Mizutani T, 1997, BIOCHEM BIOPH RES CO, V234, P499, DOI 10.1006/bbrc.1997.6646; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551; NAGAO Y, 1989, IN VITRO CELL DEV B, V25, P1088; PINEAU C, 1991, CELL TISSUE RES, V264, P589, DOI 10.1007/BF00319048; Sambrook J., 1989, MOL CLONING LAB MANU; Savill J, 1997, BRIT MED BULL, V53, P491; SHIRATSUCHI A, 1998, BIOCHEM BIOPH RES CO, V246, P649; TAMARU M, 1990, BIOCHIM BIOPHYS ACTA, V1049, P331, DOI 10.1016/0167-4781(90)90106-C; TOKUDA N, 1992, J UROLOGY, V147, P278; UEYAMA H, 1984, MOL CELL BIOL, V4, P1073; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102	62	111	113	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 26	1999	274	9					5901	5908		10.1074/jbc.274.9.5901		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	170KG	WOS:000078804400085		
J	Takahashi, N; Sasagawa, N; Suzuki, K; Ishiura, S				Takahashi, N; Sasagawa, N; Suzuki, K; Ishiura, S			Synthesis of long trinucleotide repeats in vitro	NEUROSCIENCE LETTERS			English	Article						trinucleotide repeats; polymerase chain reaction; repeat expansion; myotonic dystrophy; CTG repeats	INTRANUCLEAR INCLUSIONS; MYOTONIC-DYSTROPHY; EXPANSION; PROTEIN; EXPRESSION; DISEASE; GENE	More than a dozen diseases have been associated with the expansion of trinucleotide repeats. Most of these expanding repeats are GC-rich (CGG/CCG or CTG/CAG), but it is difficult to amplify GC-rich repeat DNA from patient samples by the polymerase chain reaction. We invented a pair of methods to synthesize long trinucleotide repeats in vitro by polymerase extension utilizing a thermal cycler. A combination of the two methods, termed the non-template PCR method and SLIP (Synthesis of Long Iterative Polynucleotide) method, produced (CTG/CAG)(190) repeat DNA, We expect that these two methods will contribute to studies of all diseases associated with tri-nucleotide repeat expansion, since they can be applied to any type of repeat DNA. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol Biol, Lab Mol Struct & Funct,Bunkyo Ku, Tokyo 1130032, Japan	Ishiura, S (reprint author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cishiura@komaba.ecc.u-tokyo.ac.jp					Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ashley CT, 1995, ANNU REV GENET, V29, P703; Ohshima K, 1997, J BIOL CHEM, V272, P16798, DOI 10.1074/jbc.272.27.16798; Sasagawa N, 1996, BBA-MOL BASIS DIS, V1315, P112, DOI 10.1016/0925-4439(95)00101-8; YOUNG AB, 1998, SCI AM MOL NEUROLOGY, V415, P35	12	14	14	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	FEB 26	1999	262	1					45	48		10.1016/S0304-3940(99)00031-2		4	Neurosciences	Neurosciences & Neurology	170MT	WOS:000078810000012		
J	Yanagisawa, J; Yanagi, Y; Masuhiro, Y; Suzawa, M; Watanabe, M; Kashiwagi, K; Toriyabe, T; Kawabata, M; Miyazono, K; Kato, S				Yanagisawa, J; Yanagi, Y; Masuhiro, Y; Suzawa, M; Watanabe, M; Kashiwagi, K; Toriyabe, T; Kawabata, M; Miyazono, K; Kato, S			Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators	SCIENCE			English	Article							D ENDOCRINE SYSTEM; NUCLEAR-RECEPTOR; MAD PROTEINS; HISTONE ACETYLTRANSFERASE; SUPERFAMILY; ACTIVATION; BINDING; PHOSPHORYLATION; METABOLISM; CBP/P300	Cell proliferation and differentiation are regulated by growth regulatory factors such as transforming growth factor-beta (TGF-beta) and the liphophilic hormone vitamin D. TGF-beta causes activation of SMAD proteins acting as coactivators or transcription factors in the nucleus. Vitamin D controls transcription of target genes through the vitamin D receptor (VDR). Smad3, one of the SMAD proteins downstream in the TGF-beta signaling pathway, was found in mammalian cells to act as a coactivator specific for Ligand-induced transactivation of VDR by forming a complex with a member of the steroid receptor coactivator-l protein family in the nucleus. Thus, Smad3 may mediate cross-talk between vitamin D and TGF-beta signaling pathways.	Japan Sci & Technol, CREST, Kawaguchi, Saitama 332, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japanese Fdn Canc Res, Inst Canc, Dept Biochem, Toshima Ku, Tokyo 1708455, Japan; Japan Soc Promot Sci, Res Future Program, Toshima Ku, Tokyo 1708455, Japan	Kato, S (reprint author), Japan Sci & Technol, CREST, 4-1-8 Honcho, Kawaguchi, Saitama 332, Japan.	uskato@hongo.ecc.u-tokyo.ac.jp					Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; DeLuca H F, 1986, Adv Exp Med Biol, V196, P361; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Heery DM, 1997, NATURE, V387, P733; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Imamura T, 1997, NATURE, V389, P622; ONATE SA, 1995, SCIENCE, V270, P1354; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Torchia J, 1997, NATURE, V387, P677; Baker JC, 1996, GENE DEV, V10, P1880, DOI 10.1101/gad.10.15.1880; Massague J, 1996, CELL, V85, P947, DOI 10.1016/S0092-8674(00)81296-9; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Kim J, 1997, NATURE, V388, P304; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Spencer TE, 1997, NATURE, V389, P194; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; KAMEL Y, 1997, CELL, V85, P403; KATO S, 1995, MOL CELL BIOL, V15, P5858; Kawasaki H, 1998, NATURE, V393, P284; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; NORMAN AW, 1982, ENDOCR REV, V3, P331; STERN PH, 1997, VITAMIN D, P343; SUZUKI A, 1997, DEV BIOL, V184, P207; Takeshita A, 1998, J BIOL CHEM, V273, P14738, DOI 10.1074/jbc.273.24.14738; WALTERS MR, 1992, ENDOCR REV, V13, P719, DOI 10.1210/er.13.4.719; YANAGISAWA J, UNPUB; YAO T, 1997, P NATL ACAD SCI USA, V93, P10626; Zhang Y, 1997, CURR BIOL, V7, P270, DOI 10.1016/S0960-9822(06)00123-0	44	354	368	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	1999	283	5406					1317	1321		10.1126/science.283.5406.1317		5	Multidisciplinary Sciences	Science & Technology - Other Topics	171AM	WOS:000078839900039		
J	Shirai, R; Morita, K; Nishikawa, A; Nakatsu, N; Fukui, Y; Morisaki, N; Hashimoto, Y				Shirai, R; Morita, K; Nishikawa, A; Nakatsu, N; Fukui, Y; Morisaki, N; Hashimoto, Y			The structural requirement of phosphatidylinositols as substrate of phosphatidylinositol 3-kinase	TETRAHEDRON LETTERS			English	Article						carboxylic acids and derivatives; enzymes and enzyme reactions; inositols; phosphoric acids and derivatives	MYO-INOSITOL 3,4,5-TRISPHOSPHATE; PLECKSTRIN HOMOLOGY DOMAINS; FAST-ATOM-BOMBARDMENT; PROTEIN-KINASE-C; PHOSPHOINOSITIDE 3-KINASE; FAMILY MEMBERS; ACTIVATION; ALPHA; PROTOONCOGENE; PHOSPHOLIPIDS	Synthetic distearate phosphatidylinositol (PI) was not phosphorylated by PI 3-kinase. The fatty acids at glycerol sn-2 must be as short as octanoic acid or less to act as a substrate of PI 3-kinase. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Shirai, R (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Fukui, Yasuhisa/E-8806-2010				Akimoto K, 1996, EMBO J, V15, P788; Aneja SG, 1997, TETRAHEDRON LETT, V38, P803, DOI 10.1016/S0040-4039(96)02486-0; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859; Rameh LE, 1997, J BIOL CHEM, V272, P22059, DOI 10.1074/jbc.272.35.22059; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; Carpenter CL, 1996, BBA-REV CANCER, V1288, pM11, DOI 10.1016/0304-419X(96)00018-2; CRONHOLM T, 1992, BIOCHEM J, V287, P925; ESTEVEZ VA, 1991, J AM CHEM SOC, V113, P9885, DOI 10.1021/ja00026a043; FUKUI Y, 1989, ONCOGENE RES, V4, P283; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; Gaffney PRJ, 1997, BIOORG MED CHEM LETT, V7, P3171, DOI 10.1016/S0960-894X(97)10166-4; GOU DM, 1994, J CHEM SOC CHEM COMM, P2125, DOI 10.1039/c39940002125; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; JENSEN NJ, 1987, LIPIDS, V22, P480, DOI 10.1007/BF02540363; Jiang T, 1998, J BIOL CHEM, V273, P11017, DOI 10.1074/jbc.273.18.11017; MURPHY RC, 1994, MASS SPECTROM REV, V13, P57, DOI 10.1002/mas.1280130105; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; REDDY KK, 1995, J ORG CHEM, V60, P3385, DOI 10.1021/jo00116a023; SAWADA T, 1995, BIOORG MED CHEM LETT, V5, P2263, DOI 10.1016/0960-894X(95)00394-9; SHERMAN WR, 1985, BIOMED MASS SPECTROM, V12, P409, DOI 10.1002/bms.1200120810; Shirai R, 1998, TETRAHEDRON LETT, V39, P9485, DOI 10.1016/S0040-4039(98)02151-0; TOKER A, 1994, J BIOL CHEM, V269, P32358; Wang DS, 1996, J ORG CHEM, V61, P5905, DOI 10.1021/jo960602u; WATANABE Y, 1995, TETRAHEDRON, V51, P8969, DOI 10.1016/0040-4020(95)00515-A	33	7	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 26	1999	40	9					1693	1696		10.1016/S0040-4039(99)00004-0		4	Chemistry, Organic	Chemistry	167GQ	WOS:000078624500022		
J	Chae, YK; Egashira, Y; Shimogaki, Y; Sugawara, K; Komiyama, H				Chae, YK; Egashira, Y; Shimogaki, Y; Sugawara, K; Komiyama, H			Experimental and numerical analysis of rapid reaction to initiate the radical chain reactions in WSix CVD (vol 320, pg 151, 1998)	THIN SOLID FILMS			English	Correction									Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 113, Japan; Nihon Univ, Coll Engn, Dept Comp Sci, Tokyo 113, Japan	Chae, YK (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		Shimogaki, Yukihiro/B-9803-2008	Shimogaki, Yukihiro/0000-0002-1186-8636			Chae YK, 1998, THIN SOLID FILMS, V320, P151, DOI 10.1016/S0040-6090(97)01080-8	1	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	FEB 26	1999	340	1-2					317	317		10.1016/S0040-6090(99)00090-5		1	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	179WM	WOS:000079353000055		
J	Sakurada, K; Iwase, H; Takatori, T; Nagao, M; Nakajima, M; Niijima, H; Matsuda, Y; Kobayashi, M				Sakurada, K; Iwase, H; Takatori, T; Nagao, M; Nakajima, M; Niijima, H; Matsuda, Y; Kobayashi, M			Identification of cis-9,10-methylenehexadecanoic acid in submitochondrial particles of bovine heart	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						cyclopropane fatty acid; bovine; human; mitochondria; phospholipase A(2)		Submitochondrial particles of bovine heart were hydrolyzed by phospholipase Al and the products were analyzed by liquid chromatography electrospray ionization-mass spectrometry. We found a fatty acid with a molecular mass of 268 Da and a retention time longer than that of linoleic acid. Next, we synthesized organically cis-9,10-methylenehexadecanoic acid, which has a molecular mass similar to that of the extracted fatty acid, and characterized its high performance liquid chromatography and gas chromatography-mass spectrometry profiles. Using these data we were able to identify endogenous cis-9,10-methylenehexadecanoic acid in rat and human heart and liver tissues that had been hydrolyzed by phospholipase A(2). This fatty acid was not detected in tissue extracts that had not been hydrolyzed by phospholipase A(2). Similar amounts of cis-9,10-methylenehexadecanoic acid were measured in tissue extracts after total hydrolysis. These results suggest that cis-9, 10-methylenehexadecanoic acid is a fatty acid component, in the sn-2 position, of phospholipids in some mammalian tissue. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan	Sakurada, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Forens Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						MCGARRITY JT, 1981, CAN J MICROBIOL, V27, P835; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; FURUKAWA J, 1968, TETRAHEDRON, V24, P53, DOI 10.1016/0040-4020(68)89007-6; MARR AG, 1962, J BACTERIOL, V84, P1260; CRONAN JE, 1968, J BACTERIOL, V95, P2054; CRONAN JE, 1974, BIOCHIM BIOPHYS ACTA, V348, P63, DOI 10.1016/0005-2760(74)90093-9; CROWFOOD PD, 1971, BIOCHIM BIOPHYS ACTA, V218, P555; GRETER J, 1979, J BIOL CHEM, V254, P2807; HAEST CWM, 1969, CHEM PHYS LIPIDS, V3, P413, DOI 10.1016/0009-3084(69)90048-6; HOFMANN K, 1952, J BIOL CHEM, V195, P473; KANEMASA Y, 1991, MICROBIOL IMMUNOL, V35, P77; KANESHIRO T, 1961, J BIOL CHEM, V236, P2615; KEENAN RW, 1968, ANAL BIOCHEM, V23, P555, DOI 10.1016/0003-2697(68)90246-7; KNIVETT VA, 1965, BIOCHEM J, V96, P771; LAW JH, 1963, BIOCHIM BIOPHYS ACTA, V70, P143, DOI 10.1016/0926-6542(63)90023-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCGARRITY JT, 1975, BIOCHIM BIOPHYS ACTA, V398, P258, DOI 10.1016/0005-2760(75)90141-1; MEYER H, 1966, J BIOL CHEM, V241, P5000; OHLROGGE JB, 1976, BIOCHIM BIOPHYS ACTA, V431, P257, DOI 10.1016/0005-2760(76)90146-6; OUDEJANS RC, 1971, BIOCHEMISTRY-US, V10, P4938, DOI 10.1021/bi00802a016; Simmons H. E., 1958, J AM CHEM SOC, V80, P5323, DOI 10.1021/ja01552a080; YANO I, 1972, LIPIDS, V7, P30, DOI 10.1007/BF02531266	23	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	FEB 25	1999	1437	2					214	222		10.1016/S1388-1981(99)00016-5		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	177EJ	WOS:000079194200011		
J	Takami, A; Kurita, H; Koda, S				Takami, A; Kurita, H; Koda, S			Laser-induced size reduction of noble metal particles	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							COLLOIDAL GOLD; NANOPARTICLES; IRRADIATION; DYNAMICS; LIGHT	Irradiation of a pulsed Nd:YAG laser at 532 nm to gold particles of less than 50 nm in aqueous solution was found to cause the shape change and size reduction of the particles. Typically, the nonspherical gold particles between 20 and 50 nm in diameter disappeared, whereas the number of gold particles of spherical shape less than 10 nm increased. The size reduction ceased after 5 min irradiation. The maximum diameter in the size distribution decreased to ca. 10 nm when the laser fluence was increased up to nearly 800 mJ cm(-2). The temperature of the gold particles was estimated from the absorbed laser energy by the particles and was found to rise as high as the boiling point of gold; these results were supported by the measurements of the blackbody radiation from the particles. The shape change and size reduction are considered to occur through melting and vaporization of the gold particles. The high temperature, which causes melting and vaporization, is a result of the strong absorption of the laser energy by the particles and the low heat transfer to the surrounding water.	Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Koda, S (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.						TAKAGI M, 1954, J PHYS SOC JPN, V9, P359, DOI 10.1143/JPSJ.9.359; Kamat PV, 1998, J PHYS CHEM B, V102, P3123, DOI 10.1021/jp980009b; SATOH N, 1994, J PHYS CHEM-US, V98, P2143, DOI 10.1021/j100059a029; Hodak JH, 1998, J CHEM PHYS, V108, P9210, DOI 10.1063/1.476374; ECKSTEIN H, 1993, Z PHYS D ATOM MOL CL, V26, P239; Ahmadi TS, 1996, J PHYS CHEM-US, V100, P8053, DOI 10.1021/jp960484e; Mehendale SC, 1997, OPT COMMUN, V133, P273, DOI 10.1016/S0030-4018(96)00431-2; Takeuchi Y, 1997, J PHYS CHEM B, V101, P1322, DOI 10.1021/jp963107a; BLOEMER MJ, 1990, J OPT SOC AM B, V7, P790, DOI 10.1364/JOSAB.7.000790; Buffat D.A., 1976, PHYS REV A, V13, P2289; HOHEISEL W, 1993, PHYS REV B, V48, P17463, DOI 10.1103/PhysRevB.48.17463; INCROPERA FP, 1996, FUNDAMENATLS HEAT MA; Kreibig U., 1995, OPTICAL PROPERTIES M; Kurita H, 1998, APPL PHYS LETT, V72, P789, DOI 10.1063/1.120894; Logunov SL, 1997, J PHYS CHEM B, V101, P3713, DOI 10.1021/jp962923f; Takami A, 1996, JPN J APPL PHYS 2, V35, pL781, DOI 10.1143/JJAP.35.L781; van de Hulst H C, 1981, LIGHT SCATTERING SMA	17	340	342	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1089-5647			J PHYS CHEM B	J. Phys. Chem. B	FEB 25	1999	103	8					1226	1232		10.1021/jp983503o		7	Chemistry, Physical	Chemistry	174BT	WOS:000079014800005		
J	Sakurai, H; Lukyanov, SM; Notani, M; Aoi, N; Beaumel, D; Fukuda, N; Hirai, M; Ideguchi, E; Imai, N; Ishihara, M; Iwasaki, H; Kubo, T; Kusaka, K; Kumagai, H; Nakamura, T; Penionzhkevich, YE; Teranishi, T; Watanabe, YX; Yoneda, K; Yoshida, A				Sakurai, H; Lukyanov, SM; Notani, M; Aoi, N; Beaumel, D; Fukuda, N; Hirai, M; Ideguchi, E; Imai, N; Ishihara, M; Iwasaki, H; Kubo, T; Kusaka, K; Kumagai, H; Nakamura, T; Penionzhkevich, YE; Teranishi, T; Watanabe, YX; Yoneda, K; Yoshida, A			Evidence for particle stability of F-31 and particle instability of N-25 and O-28	PHYSICS LETTERS B			English	Article							NEUTRON-RICH NUCLEI; N = 20; MASS MEASUREMENTS; ISOTOPES; FRAGMENTATION; SEARCH	The neutron drip line up to fluorine has been investigated by the projectile fragmentation of a 94.1 A MeV Ar-40 beam at the fragment separator RIPS at RIKEN. A new neutron-rich isotope, F-31, has been observed for the first time while clear evidence for the particle instability of N-24,N-25, O-27,O-28 and F-30 has been obtained. The sudden change in stability from oxygen to fluorine may demonstrate the onset of deformation for the neutron-rich fluorine isotopes. (C) 1999 Elsevier Science B.V. All rights reserved.	RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan; Joint Inst Nucl Res, Flerov Lab Nucl React, Dubna 141980, Moscow Region, Russia; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan; Tokyo Inst Technol, Dept Appl Phys, Meguro Ku, Tokyo 152, Japan; Inst Phys Nucl, F-91406 Orsay, France	Sakurai, H (reprint author), RIKEN, Inst Phys & Chem Res, 2-1 Hirosawa, Wako, Saitama 35101, Japan.		Teranishi, Takashi/D-2166-2012; SAKURAI, HIROYOSHI/G-5085-2014; Nakamura, Takashi/N-5390-2015				WARBURTON EK, 1990, PHYS REV C, V41, P1147, DOI 10.1103/PhysRevC.41.1147; Kruppa AT, 1997, PHYS REV LETT, V79, P2217, DOI 10.1103/PhysRevLett.79.2217; CAMPI X, 1975, NUCL PHYS A, V251, P193, DOI 10.1016/0375-9474(75)90065-2; Fauerbach M, 1996, PHYS REV C, V53, P647, DOI 10.1103/PhysRevC.53.647; DETRAZ C, 1989, ANNU REV NUCL PART S, V39, P407, DOI 10.1146/annurev.ns.39.120189.002203; FUKUNISHI M, 1992, PHYS LETT B, V292, P279; GUILLEMAUDMUELLER D, 1990, PHYS REV C, V41, P937, DOI 10.1103/PhysRevC.41.937; GUILLEMAUDMUELLER D, 1989, Z PHYS A-HADRON NUCL, V332, P189, DOI 10.1007/BF01289774; HAUSTEIN PE, 1988, ATOM DATA NUCL DATA, V39, P185, DOI 10.1016/0092-640X(88)90019-8; KUBO T, 1992, NUCL INSTRUM METH B, V70, P309, DOI 10.1016/0168-583X(92)95947-P; MOLLER P, 1995, ATOM DATA NUCL DATA, V59, P185, DOI 10.1006/adnd.1995.1002; MOTOBAYASHI T, 1996, PHYS LETT B, V346, P9; NAYAK R, 1978, NUCL PHYS A, V304, P64, DOI 10.1016/0375-9474(78)90096-9; ORR NA, 1991, PHYS LETT B, V258, P29, DOI 10.1016/0370-2693(91)91203-8; PATRA SK, 1991, PHYS LETT B, V273, P13, DOI 10.1016/0370-2693(91)90545-2; Pfaff R, 1996, PHYS REV C, V53, P1753, DOI 10.1103/PhysRevC.53.1753; POVES A, 1994, NUCL PHYS A, V571, P221, DOI 10.1016/0375-9474(94)90058-2; POVES A, 1994, Z PHYS A-HADRON NUCL, V347, P227, DOI 10.1007/BF01289788; REN ZZ, 1995, PHYS REV C, V52, pR20, DOI 10.1103/PhysRevC.52.R20; Sakurai H, 1996, PHYS REV C, V54, pR2802; SUMMERER K, 1990, PHYS REV C, V42, P2546, DOI 10.1103/PhysRevC.42.2546; Tarasov O, 1997, PHYS LETT B, V409, P64, DOI 10.1016/S0370-2693(97)00901-5; WINGER JA, 1992, NUCL INSTRUM METH B, V70, P380, DOI 10.1016/0168-583X(92)95954-P; ZHOU XG, 1991, PHYS LETT B, V260, P285, DOI 10.1016/0370-2693(91)91613-Z	24	191	192	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	FEB 25	1999	448	3-4					180	184		10.1016/S0370-2693(99)00015-5		5	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	174XF	WOS:000079061200004		
J	Kikukawa, Y; Yamada, A				Kikukawa, Y; Yamada, A			Weak coupling expansion of massless QCD with a Ginsparg-Wilson fermion and axial U(1) anomaly	PHYSICS LETTERS B			English	Article						overlap Dirac operator; the Ginsparg-Wilson relation; axial anomaly	CHIRAL GAUGE-THEORIES; LATTICE; OVERLAP	We discuss the weak coupling expansion of massless QCD with the Dirac operator which is derived by Neuberger based on the overlap formalism and satisfies the Ginsparg-Wilson relation. The axial U(1) anomaly associated to the chiral transformation proposed by Luscher is calculated as an application and is shown to have the correct form of the topological charge density for perturbative backgrounds. The coefficient of the anomaly is evaluated as a winding number related to a certain five-dimensional fermion propagator. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; Univ Tokyo, Dept Phys, Tokyo 113, Japan	Kikukawa, Y (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.						NARAYANAN R, 1994, NUCL PHYS B, V412, P574, DOI 10.1016/0550-3213(94)90393-X; Narayanan R, 1997, NUCL PHYS B, V506, P373, DOI 10.1016/S0550-3213(97)00544-0; KAPLAN DB, 1992, PHYS LETT B, V288, P342, DOI 10.1016/0370-2693(92)91112-M; NARAYANAN R, 1995, NUCL PHYS B, V443, P305, DOI 10.1016/0550-3213(95)00111-5; GIBBS PE, 1986, PHYS LETT B, V172, P53, DOI 10.1016/0370-2693(86)90215-7; GINSPARG PH, 1982, PHYS REV D, V25, P2649, DOI 10.1103/PhysRevD.25.2649; Neuberger H, 1998, PHYS LETT B, V417, P141, DOI 10.1016/S0370-2693(97)01368-3; Neuberger H, 1998, PHYS REV D, V57, P5417, DOI 10.1103/PhysRevD.57.5417; Bietenholz W., 1994, Nuclear Physics B, Proceedings Supplements, V34, DOI 10.1016/0920-5632(94)90434-0; Bietenholz W., 1997, Nuclear Physics B, Proceedings Supplements, V53, DOI 10.1016/S0920-5632(96)00818-3; CHIU TW, HEPLAT9804016; COSTE A, 1989, NUCL PHYS B, V323, P631, DOI 10.1016/0550-3213(89)90127-2; DEGRAND T, 1995, NUCL PHYS B, V454, P587, DOI 10.1016/0550-3213(95)00458-5; GOLTERMAN MFL, 1993, PHYS LETT B, V301, P219, DOI 10.1016/0370-2693(93)90692-B; HASENFRATS P, HEPLAT9801021; HASENFRATZ P, 1994, NUCL PHYS B, V414, P78; KIKUKAWA Y, HEPLAT9705024; Kikukawa Y, 1998, NUCL PHYS B, V513, P735, DOI 10.1016/S0550-3213(97)00779-7; LUSCHER M, HEPLAT9802011; Narayanan R, 1997, NUCL PHYS B, V508, P371, DOI 10.1016/S0550-3213(97)00630-5; NARAYANAN R, 1993, PHYS REV LETT, V71, P3251, DOI 10.1103/PhysRevLett.71.3251; Narayanan R, 1998, NUCL PHYS B-PROC SUP, V63, P555, DOI 10.1016/S0920-5632(97)00832-3; NEUBERGER H, HEPLAT9802033; NEUBERGER H, HEPLAT9801031; RandjbarDaemi S, 1997, PHYS LETT B, V402, P134, DOI 10.1016/S0370-2693(97)00450-4; SHAMIR Y, 1994, NUCL PHYS B, V417, P167, DOI 10.1016/0550-3213(94)90542-8; SHAMIR Y, 1993, NUCL PHYS B, V406, P90, DOI 10.1016/0550-3213(93)90162-I; SO H, 1985, PROG THEOR PHYS, V74, P585, DOI 10.1143/PTP.74.585; SO H, 1985, PROG THEOR PHYS, V73, P582; WIESE UJ, 1993, PHYS LETT B, V315, P417, DOI 10.1016/0370-2693(93)91634-Y; Yamada A, 1998, NUCL PHYS B, V514, P399, DOI 10.1016/S0550-3213(97)00760-8; YAMADA A, IN PRESS NUCL PHYS B; Yamada A, 1998, PHYS REV D, V57, P1433, DOI 10.1103/PhysRevD.57.1433	33	88	88	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	FEB 25	1999	448	3-4					265	274		10.1016/S0370-2693(99)00021-0		10	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	174XF	WOS:000079061200016		
J	Sakuraba, A; Kono, M				Sakuraba, A; Kono, M			Effect of the inner core on the numerical solution of the magnetohydrodynamic dynamo	PHYSICS OF THE EARTH AND PLANETARY INTERIORS			English	Article; Proceedings Paper	8th Scientific Assembly of the International-Association-of-Geomagnetism-and-Aeronomy	AUG 04-15, 1997	UPPSALA, SWEDEN	Int Assoc Geomagnetism & Aeron		inner core; Archaean; magnetohydrodynamic dynamo	ROTATING SPHERICAL-SHELL; EARTHS CORE; THERMAL-CONVECTION; FIELD GENERATION; GEODYNAMO MODEL; DIPOLE FIELD; SIMULATION; EVOLUTION; MAGNETISM; PLANETS	We report two simulation results of the magnetohydrodynamic dynamo applied to rapidly rotating spherical systems using fully nonlinear equations under Boussinesq approximation. Calculations were carried out under the same parameter conditions but for a spherical shell and a sphere. We assume that a uniform internal heat source distributed in the whole sphere drives the convection and dynamo and that the physical properties of the inner core are identical to those of the fluid outer core except for its rigidity. This treatment enables us to compare two cases under the same condition, except the existence of the inner core. Magnetic field is effectively generated by strong velocity shear and helicity of the fluid near the top (and bottom) boundaries. A stable axial dipole field develops in the case of the spherical shell because of the steady field generation at both the outer and inner boundaries, while the magnetic field in the sphere fluctuates with time from lack of the bottom boundary before it reaches the dipole dominant state at last. This result suggests that the Earth's magnetic field may be stabilized as the inner core grows, even though the total energy input is the same. This study provides a first step to interpret the paleointensity data from the Archaean when there was a transition due to the growth of the inner core. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Earth & Planetary Phys, Bunkyo Ku, Tokyo 1130033, Japan	Sakuraba, A (reprint author), Univ Tokyo, Dept Earth & Planetary Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	sakuraba@geoph.s.u-tokyo.ac.jp	SAKURABA, ATARU/G-4889-2014				PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; GLATZMAIER GA, 1984, J COMPUT PHYS, V55, P461, DOI 10.1016/0021-9991(84)90033-0; BUSSE FH, 1970, J FLUID MECH, V44, P441, DOI 10.1017/S0022112070001921; Kuang WL, 1997, NATURE, V389, P371; HOLLERBACH R, 1993, NATURE, V365, P541, DOI 10.1038/365541a0; HOLLERBACH R, 1995, PHYS EARTH PLANET IN, V87, P171, DOI 10.1016/0031-9201(94)02965-E; GLATZMAIER GA, 1995, NATURE, V377, P203, DOI 10.1038/377203a0; Song XD, 1996, NATURE, V382, P221, DOI 10.1038/382221a0; Kageyama A, 1997, PHYS REV E, V55, P4617, DOI 10.1103/PhysRevE.55.4617; SUN ZP, 1993, SCIENCE, V260, P661, DOI 10.1126/science.260.5108.661; Labrosse S, 1997, PHYS EARTH PLANET IN, V99, P1, DOI 10.1016/S0031-9201(96)03207-4; Buffett BA, 1996, J GEOPHYS RES-SOL EA, V101, P7989, DOI 10.1029/95JB03539; Glatzmaier GA, 1996, SCIENCE, V274, P1887, DOI 10.1126/science.274.5294.1887; KAGEYAMA A, 1995, PHYS PLASMAS, V2, P1421, DOI 10.1063/1.871485; JONES CA, 1995, PHYS EARTH PLANET IN, V92, P119, DOI 10.1016/0031-9201(95)03068-8; BRAGINSKY SI, 1995, GEOPHYS ASTRO FLUID, V79, P1, DOI 10.1080/03091929508228992; VERHOOGEN J, 1961, GEOPHYS J ROY ASTR S, V4, P276, DOI 10.1111/j.1365-246X.1961.tb06819.x; Ardes M, 1997, PHYS EARTH PLANET IN, V99, P55, DOI 10.1016/S0031-9201(96)03200-1; ZHANG KK, 1987, GEOPHYS ASTRO FLUID, V39, P119, DOI 10.1080/03091928708208809; Braginsky S. I., 1964, GEOMAGN AERON+, V4, P698; CANDE SC, 1992, J GEOPHYS RES-SOL EA, V97, P13917, DOI 10.1029/92JB01202; Canuto C, 1987, SPECTRAL METHODS FLU; CHANDRASEKHAR S., 1961, HYDRODYNAMIC HYDROMA; ELSASSER WM, 1946, PHYS REV, V69, P106, DOI 10.1103/PhysRev.69.106; GLATZMAIER GA, 1995, PHYS EARTH PLANET IN, V91, P63, DOI 10.1016/0031-9201(95)03049-3; Glatzmaier GA, 1996, PHYSICA D, V97, P81, DOI 10.1016/0167-2789(96)00100-5; HALE CJ, 1987, NATURE, V329, P233, DOI 10.1038/329233a0; HOLLERBACH R, 1994, P ROY SOC LOND A MAT, V444, P333, DOI 10.1098/rspa.1994.0023; HOLLERBACH R, 1993, PHYS EARTH PLANET IN, V75, P317, DOI 10.1016/0031-9201(93)90007-V; KAGEYAMA A, 1993, PHYS FLUIDS B-PLASMA, V5, P2793, DOI 10.1063/1.860668; Kageyama A, 1997, PLASMA PHYS CONTR F, V39, P83; Kono M., 1995, EARTHS CENTRAL PART, P75; KRAUSE F, 1967, THESIS U JENA; KRISHNAM.R, 1968, J FLUID MECH, V33, P445, DOI 10.1017/S0022112068001436; Moffatt H. K., 1978, MAGNETIC FIELD GENER; NAKAJIMA T, 1993, J GEOMAGN GEOELECTR, V45, P1575; ROBERTS PH, 1968, PHILOS TR R SOC S-A, V263, P93, DOI 10.1098/rsta.1968.0007; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; STEWARTS.K, 1966, J FLUID MECH, V26, P131, DOI 10.1017/S0022112066001137; Su WJ, 1996, SCIENCE, V274, P1883, DOI 10.1126/science.274.5294.1883; ZHANG KK, 1988, GEOPHYS ASTRO FLUID, V44, P33, DOI 10.1080/03091928808208877	41	79	79	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0031-9201			PHYS EARTH PLANET IN	Phys. Earth Planet. Inter.	FEB 25	1999	111	1-2					105	121		10.1016/S0031-9201(98)00150-2		17	Geochemistry & Geophysics	Geochemistry & Geophysics	171XX	WOS:000078890800010		
J	Nakamura, T; Oka, M; Aizawa, K; Soda, H; Fukuda, M; Terashi, K; Ikeda, K; Mizuta, Y; Noguchi, Y; Kimura, Y; Tsuruo, T; Kohno, S				Nakamura, T; Oka, M; Aizawa, K; Soda, H; Fukuda, M; Terashi, K; Ikeda, K; Mizuta, Y; Noguchi, Y; Kimura, Y; Tsuruo, T; Kohno, S			Direct interaction between a quinoline derivative, MS-209, and multidrug resistance protein (MRP) in human gastric cancer cells	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							DECREASED DRUG ACCUMULATION; ANION TRANSPORTER CMOAT; HUMAN LUNG-CANCER; P-GLYCOPROTEIN; EXPORT CARRIER; TUMOR-CELLS; GENE; GLUTATHIONE; EXPRESSION; OVEREXPRESSION	MS-209 is a novel quinoline derivative reversing P-glycoprotein-mediated multidrug resistance (MDR). We investigated the interaction between MS-209 and multidrug resistance protein (MRP) in MRP-overexpressing human gastric cancer cells. me measured [H-3]leukotriene C-4 uptake into the membrane vesicles of the cells and intracellular calcein and [H-3]vincristine accumulation with or without MS-209. In muti-drug-resistant MKN45R0.8 cells selected by doxorubicin, MS-209 dose dependently reduced MRP-mediated [H-3]leukotriene C-4 uptake and increased calcein accumulation. In both resistant and unselected cell lines expressing the MRP gene, MS-209 increased [H-3]vincristine accumulation in proportion with the level of MRP mRNA expression and enhanced the cytotoxicity of etoposide, doxorubicin, and vincristine. The reversal effects correlated with the level of MRP mRNA expression in these cells. Our results indicate that MS-209 effectively reverses intrinsic and acquired MRP-mediated MDR of gastric cancer cells by interacting directly with MRP. (C) 1999 Academic Press.	Nagasaki Univ, Sch Med, Dept Internal Med 2, Nagasaki 8528501, Japan; Niigata Univ, Sch Med, Dept Surg 1, Niigata 9518122, Japan; Mitsui Pharmaceut, Inst Biol Sci, Chiba 2970017, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Oka, M (reprint author), Nagasaki Univ, Sch Med, Dept Internal Med 2, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.						FELLER N, 1995, BRIT J CANCER, V72, P543, DOI 10.1038/bjc.1995.371; Legrand O, 1998, BLOOD, V91, P4480; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Taniguchi K, 1996, CANCER RES, V56, P4124; FORD JM, 1993, CYTOTECHNOLOGY, V12, P171, DOI 10.1007/BF00744664; ZAMAN GJR, 1995, P NATL ACAD SCI USA, V92, P7690, DOI 10.1073/pnas.92.17.7690; Narasaki F, 1996, ANTICANCER RES, V16, P2079; Barrand MA, 1997, GEN PHARMACOL, V28, P639, DOI 10.1016/S0306-3623(96)00284-4; SATO W, 1995, CANCER CHEMOTH PHARM, V35, P271, DOI 10.1007/BF00689444; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; LAM BK, 1992, P NATL ACAD SCI USA, V89, P11598, DOI 10.1073/pnas.89.23.11598; WILSON WH, 1995, J CLIN ONCOL, V13, P1995; HOLLO Z, 1994, BBA-BIOMEMBRANES, V1191, P384, DOI 10.1016/0005-2736(94)90190-2; VERSANTVOORT CHM, 1993, BRIT J CANCER, V68, P939, DOI 10.1038/bjc.1993.458; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Flens MJ, 1996, AM J PATHOL, V148, P1237; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Berger W, 1997, INT J CANCER, V73, P84; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chuman Y, 1996, BIOCHEM BIOPH RES CO, V226, P158, DOI 10.1006/bbrc.1996.1326; CLYNES M, 1993, CYTOTECHNOLOGY, V12, P1; CORDONCARDO C, 1990, J HISTOCHEM CYTOCHEM, V38, P1277; FAIRCHILD CR, 1987, CANCER RES, V47, P5141; FUKAZAWA N, 1989, Patent No. 363212; JEDLITSCHKY G, 1994, CANCER RES, V54, P4833; Kavallaris M, 1997, ANTI-CANCER DRUG, V8, P17, DOI 10.1097/00001813-199701000-00002; Keppler D, 1996, Prog Liver Dis, V14, P55; Koike K, 1997, CANCER RES, V57, P5475; LEIER I, 1994, EUR J BIOCHEM, V220, P599, DOI 10.1111/j.1432-1033.1994.tb18661.x; Loe D. W., 1996, European Journal of Cancer, V32A, P945, DOI 10.1016/0959-8049(96)00046-9; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER M, 1994, P NATL ACAD SCI USA, V91, P13033, DOI 10.1073/pnas.91.26.13033; Narasaki F, 1997, BIOCHEM BIOPH RES CO, V240, P606, DOI 10.1006/bbrc.1997.7703; Pulaski L, 1996, EUR J BIOCHEM, V241, P644, DOI 10.1111/j.1432-1033.1996.00644.x; Tomonaga M, 1996, JPN J CANCER RES, V87, P1263	36	40	44	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 24	1999	255	3					618	624		10.1006/bbrc.1999.0245		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	173FP	WOS:000078970800013		
J	Fujita, A; Mitsuhashi, T				Fujita, A; Mitsuhashi, T			Differential regulation of ligand-dependent and ligand-independent functions of the mouse retinoid X receptor beta by alternative splicing	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							VITAMIN-D-RECEPTOR; NUCLEAR RECEPTOR; BINDING DOMAIN; RXR-ALPHA; ACID; RAR; IDENTIFICATION; HETERODIMERS; PROMOTERS; CLONING	RXR is involved in two distinct signal transduction pathways. RXR activates transcription Ligand-dependently on RXRE and behaves as a positive heterodimer partner with permissive receptors; while it behaves as a ligand-independent silent partner with nonpermissive receptors. We studied the functions of a unique isoform of mouse RXR beta 2 (mRXR beta 2E) which has an in-frame four-amino-acid insertion in the ligand binding domain. mRXR beta 2E did not bind 9-cis RA with high affinity and did not activate transcription on RXRE. However, mRXR beta 2E formed heterodimers with TR, VDR, RAR, and LXR, and enhanced transcriptional activity of the nonpermissive VDR to the same extent as mRXR beta 2. With the permissive LXR, mRXR beta 2E did not show 9-cis RA-dependent transactivation and inhibited mRXR beta 2 activity. Thus, although mRXR beta 2E can perform ligand-independent functions of RXR, it cannot mediate the ligand-dependent functions of RXR, indicating that alternative splicing plays an important role in the differential regulation of these two important functions of (C) 1999 Academic Press.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 1138655, Japan	Mitsuhashi, T (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mitsuhashi-3im@h.u-tokyo.ac.jp					LEID M, 1992, CELL, V68, P377, DOI 10.1016/0092-8674(92)90478-U; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; JONES BB, 1995, MOL CELL BIOL, V15, P5226; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; EPPLEN C, 1992, MAMM GENOME, V3, P472, DOI 10.1007/BF00356161; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; LEBLANC BP, 1995, GENE DEV, V9, P1811, DOI 10.1101/gad.9.15.1811; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MADER S, 1993, EMBO J, V12, P5029; Mahajna J, 1997, DNA CELL BIOL, V16, P463, DOI 10.1089/dna.1997.16.463; MANGELSDORF DJ, 1991, CELL, V66, P555, DOI 10.1016/0092-8674(81)90018-0; MITSUHASHI T, 1988, P NATL ACAD SCI USA, V85, P5804, DOI 10.1073/pnas.85.16.5804; MITSUHASHI T, 1987, J BIOL CHEM, V262, P3993; NAGATA T, 1994, GENE, V142, P183, DOI 10.1016/0378-1119(94)90259-3; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259	22	7	7	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 24	1999	255	3					625	630		10.1006/bbrc.1999.0243		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	173FP	WOS:000078970800014		
J	Yazu, M; Adachi, H; Sutoh, K				Yazu, M; Adachi, H; Sutoh, K			Novel Dictyostelium unconventional myosin MyoK is a class I myosin with the longest loop-1 insert and the shortest tail	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							HEAVY-CHAIN GENE; ACTIN-BINDING SITE; P21-ACTIVATED KINASE; DISCOIDEUM; SEQUENCE; MUTANTS; DISRUPTION; EXPRESSION; ISOFORM; DOMAIN	We have identified and sequenced a novel unconventional myosin termed MyoK in Dictyostelium. Like class XIV myosins, MyoK has a very short and basic tail and lacks light chain-binding IQ motifs. In contrast, a phylogenetic analysis of the motor domain (head) clearly indicated that MyoK belongs to class I myosins. Surprisingly, at the loop-1 site of the head, an insert of 142 amino acid residues was found, the longest in all myosins so far sequenced. The insert was rich in Gly and Pro and could serve as a secondary actin-binding site, as is the case with those present in the tail of some class I myosins. The expression of the MyoK transcript was stimulated at very early stages of Dictyostelium development. The growth and terminal developmental phenotype of the Dictyostelium cell were not affected by the myoK(-) mutation, suggesting the existence of myosin(s) with functions overlapping those of MyoK. (C) 1999 Academic Press.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Sutoh, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						Adachi H, 1997, J CELL BIOL, V137, P891, DOI 10.1083/jcb.137.4.891; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Heintzelman MB, 1997, J MOL BIOL, V271, P139, DOI 10.1006/jmbi.1997.1167; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P11767; WATTS DJ, 1970, BIOCHEM J, V119, P171; BAIN G, 1991, MOL GEN GENET, V226, P59, DOI 10.1007/BF00273587; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Brzeska H, 1997, P NATL ACAD SCI USA, V94, P1092, DOI 10.1073/pnas.94.4.1092; Brzeska H, 1996, J BIOL CHEM, V271, P27056; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Fujiwara M, 1997, BIOCHEM BIOPH RES CO, V236, P75, DOI 10.1006/bbrc.1997.6907; Hammer JA, 1996, J BIOL CHEM, V271, P7120; JUNG G, 1994, FEBS LETT, V342, P197, DOI 10.1016/0014-5793(94)80500-8; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; JUNG G, 1993, J BIOL CHEM, V268, P14981; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; JUNG G, 1989, P NATL ACAD SCI USA, V86, P6186, DOI 10.1073/pnas.86.16.6186; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Lee SF, 1996, J BIOL CHEM, V271, P27044; Novak KD, 1998, MOL BIOL CELL, V9, P75; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; PETERSON MD, 1995, J CELL SCI, V108, P1093; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.physiol.53.1.653; PUTA F, IN PRESS FOLIA BIOL; ROSENFELD SS, 1994, BIOCHEMISTRY-US, V33, P2322, DOI 10.1021/bi00174a045; Sambrook J., 1989, MOL CLONING LAB MANU; Sasaki N, 1998, J BIOL CHEM, V273, P20334, DOI 10.1074/jbc.273.32.20334; SCHWARZ EC, IN PRESS CELL BIOCH; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Temesvari LA, 1996, J CELL SCI, V109, P663; TITUS MA, 1989, CELL REGUL, V1, P55; TITUS MA, 1993, MOL BIOL CELL, V4, P233; TITUS MA, 1994, P NATL ACAD SCI USA, V91, P9446, DOI 10.1073/pnas.91.20.9446; URRUTIA RA, 1993, BIOCHIM BIOPHYS ACTA, V1173, P225, DOI 10.1016/0167-4781(93)90185-G; UYEDA TQP, 1997, DICTYOSTELIUM MODEL, P43; VIEIRA J, 1987, METHOD ENZYMOL, V153, P3; WARRICK HM, 1986, P NATL ACAD SCI USA, V83, P9433, DOI 10.1073/pnas.83.24.9433	46	16	17	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 24	1999	255	3					711	716		10.1006/bbrc.1999.0264		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	173FP	WOS:000078970800029		
J	Seki, S; Yoshida, Y; Tagawa, S; Asai, K				Seki, S; Yoshida, Y; Tagawa, S; Asai, K			Electronic structure of radical anions and cations of polysilanes with structural defects	MACROMOLECULES			English	Article							HIGH POLYMERS; ORGANOPOLYSILANE; PHOTODEGRADATION; LITHOGRAPHY; TRANSPORT; RESISTS	The electronic structure of a charged polysilane molecule is studied. The transient absorption spectroscopy was carried out for radical cations and anions of aryl-substituted polysilane molecules with, Si-based defects by means of the nanosecond pulse radiolysis technique, Radical cations and anions of polysilanes displayed near-UV and IR absorption maxima at ca. 3.2-3.4 and 0.5-1 eV, respectively. They are:ascribed to interband and subband transitions of polaron states and/or charge resonance states (CR) between sigma-conjugated segments. The transition energy of the bands was strongly affected by the defects; showing a remarkable blue shift in IR absorption. The energy of the IR absorption band was interpreted as the degree of electron-phonon coupling, The energy rapidly increased from ca. 0.5 eV with an increase in the defect density and saturated at ca. 0.85 eV for radical cations and 0.95 eV for radical anions, It indicated that excess electrons and holes relatively localized at the defect structures, whereas the charges were delocalized in a conjugated segment in linear polysilanes.	Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan; Univ Tokyo, Fac Engn, Bunkyo Ku, Tokyo 1138654, Japan	Seki, S (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Ibaraki, Osaka 5670047, Japan.		Seki, Shu/E-5346-2010; Tagawa, Seiichi/B-8078-2010	Seki, Shu/0000-0001-7851-4405; 			WEST R, 1981, J AM CHEM SOC, V103, P7352, DOI 10.1021/ja00414a061; TAYLOR GN, 1981, J VAC SCI TECHNOL, V19, P872, DOI 10.1116/1.571226; FUJIKI M, 1992, CHEM PHYS LETT, V198, P177, DOI 10.1016/0009-2614(92)90067-W; MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006; STOLKA M, 1987, J POLYM SCI POL CHEM, V25, P823, DOI 10.1002/pola.1987.080250307; WEST R, 1975, SCIENCE, V189, P179, DOI 10.1126/science.189.4198.179; KEPLER RG, 1987, PHYS REV B, V35, P2818, DOI 10.1103/PhysRevB.35.2818; TREFONAS P, 1983, J POLYM SCI POL LETT, V21, P823, DOI 10.1002/pol.1983.130211008; BAN H, 1987, MACROMOLECULES, V20, P1775, DOI 10.1021/ma00174a011; BAN H, 1988, MACROMOLECULES, V21, P45, DOI 10.1021/ma00179a010; CARBERRY E, 1969, J AM CHEM SOC, V91, P5446, DOI 10.1021/ja01048a008; FUJINO M, 1987, CHEM PHYS LETT, V136, P451, DOI 10.1016/0009-2614(87)80285-3; HOFER DC, 1984, P SOC PHOTO-OPT INST, V469, P16; KAJAR F, 1986, J APPL PHYS, V60, P3040; KIRA M, 1979, J ORGANOMET CHEM, V164, P277, DOI 10.1016/S0022-328X(00)81691-5; KUMADA M, 1968, ADV ORGANOMET CHEM, V6, P80; PHILLPOT SR, 1987, PHYS LETT, V31, P43; PITT CG, 1977, HOMOATOMIC RINGS CHA; POLLARD WB, 1982, PHYS REV B, V26, P3172, DOI 10.1103/PhysRevB.26.3172; RICE MJ, 1979, PHYS LETT A, V71, P152, DOI 10.1016/0375-9601(79)90905-8; RICE MJ, 1987, PHYS REV LETT, V58, P937, DOI 10.1103/PhysRevLett.58.937; SEKI S, 1993, RADIAT PHYS CHEM, V47, P217; SEKI S, UNPUB PHILOS MAG B; Seki S, 1998, J PHYS CHEM B, V102, P8367, DOI 10.1021/jp981412l; SU WP, 1979, PHYS REV LETT, V58, P937; TAKEDA K, 1987, PHYS REV B, V36, P8129, DOI 10.1103/PhysRevB.36.8129; TREFONAS P, 1985, J AM CHEM SOC, V107, P2737, DOI 10.1021/ja00295a028; vanWalree CA, 1996, MACROMOLECULES, V29, P7362, DOI 10.1021/ma960407h; ZEIGLER JM, 1985, P SOC PHOTO-OPT INST, V539, P166	29	67	68	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	FEB 23	1999	32	4					1080	1086		10.1021/ma981241i		7	Polymer Science	Polymer Science	170KK	WOS:000078804700015		
J	Murase, S; Horie, K				Murase, S; Horie, K			Large photoinduced refractive index changes of transparent polymer films containing photoeliminable diazo and azido groups	MACROMOLECULES			English	Article							REVERSIBLE OPTICAL STORAGE; POLY(METHYL METHACRYLATE); AZO POLYMERS; BIREFRINGENCE; CIRCUITS	We measured photoinduced refractive index changes of polymer films containing various compounds, such as alpha-diazoketone derivatives, azide derivatives, and others which induce the loss of nitrogen molecules during photoirradiation. PMMA films containing 20 wt % of 2-diazo-1-indanone (2DI) and beta-azidostyrene (beta-AS) showed large refractive index changes of 0.015 during photolysis, keeping transparency throughout the entire visible region. The fact that the chemical structure of the substituents at alpha-position of the diazo group and hence the resonance effect do not affect the photoinduced changes in refractive indices much indicates the major contribution of the elimination effect of nitrogen molecules to the refractive index changes. Azide derivatives except for beta-AS showed small refractive index changes which may be related to the chemical structure of the photoproducts. Discussion is given on the estimation of the molar refraction and the contribution of the changes in electronic structure and in density to the refractive index of the systems.	Univ Tokyo, Fac Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 113, Japan	Horie, K (reprint author), Univ Tokyo, Fac Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						NATANSOHN A, 1992, MACROMOLECULES, V25, P5531, DOI 10.1021/ma00046a064; HURD CD, 1955, J AM CHEM SOC, V77, P5359, DOI 10.1021/ja01625a047; ROCHON P, 1992, APPL PHYS LETT, V60, P4, DOI 10.1063/1.107369; TANIO N, 1994, JPN J APPL PHYS 1, V33, P1550, DOI 10.1143/JJAP.33.1550; TIEN PK, 1971, APPL OPTICS, V10, P2395, DOI 10.1364/AO.10.002395; Morino S, 1997, ACS SYM SER, V672, P260; NATANSOHN A, 1992, MACROMOLECULES, V25, P2268, DOI 10.1021/ma00034a031; Eldada L, 1996, J LIGHTWAVE TECHNOL, V14, P1704, DOI 10.1109/50.507948; KUROKAWA T, 1980, APPL OPTICS, V19, P3124, DOI 10.1364/AO.19.003124; Pham VP, 1997, JPN J APPL PHYS 1, V36, P429, DOI 10.1143/JJAP.36.429; FRANKE H, 1984, APPL OPTICS, V23, P2729; BEESON KW, 1991, APPL PHYS LETT, V58, P1955, DOI 10.1063/1.105030; BEESON KW, 1991, ACS SYM SER, V455, P303; CAMPBELL CD, 1967, J CHEM SOC C, P742; CAVA MP, 1958, J AM CHEM SOC, V80, P2257, DOI 10.1021/ja01542a055; CHANDROS.EA, 1974, APPL PHYS LETT, V24, P72, DOI 10.1063/1.1655099; DIETRICH SMC, 1968, J AM CHEM SOC, V90, P1923; GROSS A, 1963, CHEM BER, V96, P399; HUCKERNP, 1995, PROCESSES PHOTOREACT, P369; IMAMURA K, 1968, TETRAHEDRON LTT, V31, P3499; KARDINAHL T, 1995, APPL PHYS LETT, V67, P795; KAWATSUKI N, 1994, J APPL POLYM SCI, V53, P973, DOI 10.1002/app.1994.070530712; Kinoshita K, 1997, APPL PHYS LETT, V70, P2940, DOI 10.1063/1.118750; KIRME W, 1958, LIEBIGS ANN CHEM, V4, P614; KIRMSE W, 1960, CHEM BER-RECL, V93, P2353, DOI 10.1002/cber.19600931029; LIEBER E, 1963, CAN J CHEM, V41, P926, DOI 10.1139/v63-131; MCGUINESS M, 1990, TETRAHEDRON LETT, V31, P4987, DOI 10.1016/S0040-4039(00)97785-2; Meeten G. H., 1989, OPTICAL PROPERTIES P; MORINO S, 1995, J PHYS CHEM-US, V99, P10280, DOI 10.1021/j100025a032; Morino S., 1994, J PHOTOPOLYM SCI TEC, V7, P121, DOI 10.2494/photopolymer.7.121; Murase S, 1997, MACROMOLECULES, V30, P8088, DOI 10.1021/ma971077j; REISER A., 1989, PHOTOREACTIVE POLYM; SPANGLER RJ, 1977, J ORG CHEM, V42, P1697, DOI 10.1021/jo00430a007; TOMLINSO.WJ, 1972, APPL OPTICS, V11, P533, DOI 10.1364/AO.11.000533; Toriumi A, 1997, OPT LETT, V22, P555, DOI 10.1364/OL.22.000555; 1993, KAGAKU BINRAN	36	26	26	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	FEB 23	1999	32	4					1103	1110		10.1021/ma9815511		8	Polymer Science	Polymer Science	170KK	WOS:000078804700018		
J	Iijima, M; Nagasaki, Y; Okada, T; Kato, M; Kataoka, K				Iijima, M; Nagasaki, Y; Okada, T; Kato, M; Kataoka, K			Core-polymerized reactive micelles from heterotelechelic amphiphilic block copolymers	MACROMOLECULES			English	Article							HETEROBIFUNCTIONAL POLY(ETHYLENE OXIDE); POLY(ALPHA-METHYLSTYRENE-B-METHYL METHACRYLATE) MICELLES; PRIMARY AMINO GROUP; ONE END; ORGANIZED-POLYMERIZATION; SELECTIVE SOLVENT; HYDROXYL GROUP; CROSS-LINKING; DIBLOCK MACROMONOMERS; FORMYL GROUP	Amphiphilic poly(ethylene glycol)-b-polylactide (PEG/PLA) copolymers with an aldehyde group at one end and a methacryloyl group at the other chain end were synthesized by anionic polymerization. The efficiencies of the functionalization at both ends were almost quantitative. The amphiphilic block copolymers formed micelles in aqueous media. Acetal groups on the micelle! surface were quantitatively converted to aldehyde groups by an acid treatment. The end methacryloyl group located in the core of the micelle was polymerized effectively to form core-shell-type nanoparticles having reactive aldehyde groups on the surface. The, size of the reactive nanoparticle was 20-30 nm which was constant with temperatures up to 60 DC. The stability of the micelle was also confirmed by a sodium dodecyl sulfate (SDS) treatment. When SDS was added to the nanosphere solution to 20 mg/mL, the particle was not collapsed. The particle was stable enough even in organic solvents. This functionalized micelle having high stability is not only expected to have wide utilities in biomedical applications (including drug delivery, diagnosis, and surface modification through the coupling of bioactive substances) but also to be of great interest as a novel supramolecular architecture.	Sci Univ Tokyo, Dept Mat Sci & Technol, Noda, Chiba 2788510, Japan; Univ Tokyo, Dept Mat Sci, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Nagasaki, Y (reprint author), Sci Univ Tokyo, Dept Mat Sci & Technol, Yamazaki 2641, Noda, Chiba 2788510, Japan.		Kataoka, Kazunori/K-7108-2012	Kataoka, Kazunori/0000-0002-8591-413X			Henselwood F, 1997, MACROMOLECULES, V30, P488, DOI 10.1021/ma961401v; TUZAR Z, 1976, ADV COLLOID INTERFAC, V6, P201, DOI 10.1016/0001-8686(76)80009-7; Liu GJ, 1996, MACROMOLECULES, V29, P5508, DOI 10.1021/ma9604653; CAMMAS S, 1995, BIOCONJUGATE CHEM, V6, P226, DOI 10.1021/bc00032a011; Guo A, 1996, MACROMOLECULES, V29, P2487, DOI 10.1021/ma951354r; Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035; HENSELWOOD F, IN PRESS MACROMOLECU; ISHIZU K, 1992, POLYM-PLAST TECHNOL, V31, P607, DOI 10.1080/03602559208017772; ISHIZU K, 1993, J POLYM SCI POL CHEM, V31, P3073, DOI 10.1002/pola.1993.080311223; ISHIZU K, 1993, POLYMER, V34, P3929, DOI 10.1016/0032-3861(93)90522-C; ISHIZU K, 1991, POLYM COMMUN, V32, P386; ISHIZU K, 1993, J POLYM SCI POL CHEM, V31, P661, DOI 10.1002/pola.1993.080310309; Kim J., UNPUB; KIM YJ, 1994, POLYM BULL, V33, P1, DOI 10.1007/BF00313466; Lehn J.-M., 1996, COMPREHENSIVE SUPRAM; Liu GJ, 1997, MACROMOL SYMP, V113, P233, DOI 10.1002/masy.19971130120; Liu GJ, 1996, MACROMOLECULES, V29, P220, DOI 10.1021/ma9503930; NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P702, DOI 10.1021/bc00036a007; Nagasaki Y, 1997, MACROMOLECULES, V30, P6489, DOI 10.1021/ma9705026; NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012; RIESS G, 1985, ENCY POLYM SCI TECHN; SAITO R, 1994, POLYMER, V35, P1747, DOI 10.1016/0032-3861(94)90850-8; SAITO R, 1992, POLYMER, V33, P1712, DOI 10.1016/0032-3861(92)91071-9; SAITO R, 1990, POLYMER, V31, P679, DOI 10.1016/0032-3861(90)90289-B; SAITO R, 1991, POLYMER, V32, P2258, DOI 10.1016/0032-3861(91)90056-O; SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040; Webber S. E., 1996, NATO ASI SERIES E, V327	29	176	185	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	FEB 23	1999	32	4					1140	1146		10.1021/ma9815962		7	Polymer Science	Polymer Science	170KK	WOS:000078804700024		
J	Ishikuro, H; Hiramoto, T				Ishikuro, H; Hiramoto, T			On the origin of tunneling barriers in silicon single electron and single hole transistors	APPLIED PHYSICS LETTERS			English	Article							ROOM-TEMPERATURE; SI; FABRICATION	To clarify the channel potential profiles, Coulomb blockades of single electron and single hole tunneling in Si nanosize narrow channel metal-oxide-semiconductor field-effect transistors are intensively studied. Devices with both n(+) and p(+) source/drain contacts were fabricated on silicon-on-insulator substrates. Transport properties of a hole system as well as an electron system induced in the same channel were investigated. It is found from the experimental results that potential fluctuations in the channel act as tunnel barriers for both electrons and holes. Lateral quantum confinement effects or silicon oxide (SiOx) are thought to be the cause of tunnel barriers. (C) 1999 American Institute of Physics. [S0003-6951(99)03108- 3].	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Univ Tokyo, VLSI Design & Educ Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Ishikuro, H (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						LEOBANDUNG E, 1995, APPL PHYS LETT, V67, P2338, DOI 10.1063/1.114337; TAKAHASHI Y, 1995, ELECTRON LETT, V31, P136, DOI 10.1049/el:19950082; Zhuang L, 1998, APPL PHYS LETT, V72, P1205, DOI 10.1063/1.121014; AubertonHerve AJ, 1997, IEICE T ELECTRON, VE80C, P358; Fujiwara A, 1997, PHYS REV LETT, V78, P1532, DOI 10.1103/PhysRevLett.78.1532; Hiramoto T, 1996, JPN J APPL PHYS 1, V35, P6664, DOI 10.1143/JJAP.35.6664; Hiramoto T, 1996, PHYSICA B, V227, P95, DOI 10.1016/0921-4526(96)00363-8; Hirayama Y, 1996, J APPL PHYS, V80, P588, DOI 10.1063/1.362722; Ishikuro H, 1996, APPL PHYS LETT, V68, P3585, DOI 10.1063/1.116645; Ishikuro H, 1997, APPL PHYS LETT, V71, P3691, DOI 10.1063/1.120483; Sakamoto T, 1998, APPL PHYS LETT, V72, P795, DOI 10.1063/1.120896	11	61	61	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 22	1999	74	8					1126	1128		10.1063/1.123464		3	Physics, Applied	Physics	168HG	WOS:000078685700024		
J	Shimazawa, R; Takayama, H; Kato, F; Kato, M; Hashimoto, Y				Shimazawa, R; Takayama, H; Kato, F; Kato, M; Hashimoto, Y			Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article							DP-IV; BOROPRO; MECHANISM; POTENT; CD26	A novel series of nonpeptide small-molecular dipeptidyl peptidase IV (DPP-M inhibitors with an N-phenylphthalimide skeleton has been developed. Some of the compounds, including 4-amino-(2,6-dimethylphenyl)phthalimides (7), 4- and 5-hydroxy-(2,6-diethylphenyl)phthalimide (11 and 14), 4-hydroxy-(2,6-diisopropylphenyl)phthalimide (12), and thiocarbonyl analogs of (2,6-diisopropylphenyl)phthalimide and their 4,5,6,7-tetrafluorinated derivative (18, 19 and 20), were more potent than the well-known DPP-IV-specific inhibitor, Pro-boroPro (PBP). Among them, 18 was revealed to be a DPP-TV-specific inhibitor, while the others also showed inhibitory activity toward another peptidase, aminopeptidase N (APN). (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Ishihara Sangyo Kaisha Ltd, Cent Res Inst, R&D Grp Pharmaceut, Shiga 5250025, Japan	Hashimoto, Y (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118; Lambeir AM, 1996, BBA-GEN SUBJECTS, V1290, P76, DOI 10.1016/0304-4165(96)00012-8; Ashworth DM, 1996, BIOORG MED CHEM LETT, V6, P1163, DOI 10.1016/0960-894X(96)00190-4; DEMUTH HU, 1993, FEBS LETT, V320, P23, DOI 10.1016/0014-5793(93)81649-K; FLENTKE GR, 1991, P NATL ACAD SCI USA, V88, P1556, DOI 10.1073/pnas.88.4.1556; GUTHEIL WG, 1993, BIOCHEMISTRY-US, V32, P8723, DOI 10.1021/bi00085a001; MARGUET D, 1993, ADV NEUROIMMUNOL, V3, P209, DOI 10.1016/S0960-5428(05)80022-1; Miyachi H, 1998, J MED CHEM, V41, P263, DOI 10.1021/jm970624o; Miyachi H, 1997, J MED CHEM, V40, P2858, DOI 10.1021/jm970109q; SCHON E, 1987, EUR J IMMUNOL, V17, P1821, DOI 10.1002/eji.1830171222; SHIMAZAWA R, 1999, IN PRESS J SYN ORG C; SHIMAZAWA R, UNPUB BIOL PHARM B; SUBRAMANYAM M, 1993, J IMMUNOL, V150, P2544; SUDMEIER JL, 1994, BIOCHEMISTRY-US, V33, P12427, DOI 10.1021/bi00207a009; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572	15	28	32	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 22	1999	9	4					559	562		10.1016/S0960-894X(99)00034-7		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	172NM	WOS:000078930700013		
J	Hosokawa, K; Shimomura, T; Frusawa, H; Kimura, Y; Ito, K; Hayakawa, R				Hosokawa, K; Shimomura, T; Frusawa, H; Kimura, Y; Ito, K; Hayakawa, R			Two-dimensional spectroscopy of electric birefringence relaxation in frequency domain: Measurement method for second-order nonlinear after-effect function	JOURNAL OF CHEMICAL PHYSICS			English	Article							KERR-EFFECT RELAXATION; DC BIAS FIELD; POLY-ELECTROLYTE; TRANSIENT; DYNAMICS; POLARIZABILITY; EQUATION	A new measurement method for second-order nonlinear after-effect function has been developed. Theoretical calculation starting from a general time-evolution equation connects nonlinear responses in time domain and frequency domain and thus gives the nonlinear response to applied external field of arbitrary form. In addition, it turns out in the frequency domain that the dc component of a second-order nonlinear response function corresponds to a linear response function. For example, the dc component of the electric birefringence relaxation is equivalent to the dielectric relaxation. This simple relation indicates an advantage of a frequency-domain measurement for nonlinear responses. As an example, the electric birefringence relaxation is measured in two-dimensional frequency domain for aqueous solution of sodium poly(styrenesulfonate) to confirm the validity of the theoretical results. (C) 1999 American Institute of Physics. [S0021-9606(99)51308-1].	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Hosokawa, K (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.		Shimomura, Takeshi/B-9993-2013	Shimomura, Takeshi/0000-0001-9580-1019			MANDEL M, 1984, ANNU REV PHYS CHEM, V35, P75, DOI 10.1146/annurev.physchem.35.1.75; OOKUBO N, 1989, MACROMOLECULES, V22, P1359, DOI 10.1021/ma00193a059; Coffey W., 1985, ADV CHEM PHYS, V63, P69, DOI 10.1002/9780470142875.ch2; COFFEY WT, 1978, CHEM PHYS LETT, V54, P519, DOI 10.1016/0009-2614(78)85275-0; Coffey WT, 1996, PHYS REV E, V54, P6462, DOI 10.1103/PhysRevE.54.6462; COFFEY WT, 1978, P ROY IRISH ACAD A, V78, P17; DEGIORGIO V, 1990, PHYS REV LETT, V64, P1043, DOI 10.1103/PhysRevLett.64.1043; Dejardin JL, 1997, J CHEM PHYS, V106, P5824, DOI 10.1063/1.473249; Dejardin JL, 1996, PHYS REV E, V54, P2982, DOI 10.1103/PhysRevE.54.2982; Dejardin J.-L., 1995, DYNAMIC KERR EFFECT; Dejardin JL, 1998, J CHEM PHYS, V108, P3081, DOI 10.1063/1.475705; Dejardin JL, 1997, J CHEM PHYS, V107, P508, DOI 10.1063/1.474412; DEJARDIN JL, 1995, PHYS REV E, V52, P4646, DOI 10.1103/PhysRevE.52.4646; ELIAS JG, 1981, MACROMOLECULES, V14, P410, DOI 10.1021/ma50003a034; HAYAKAWA R, 1981, POLYM PREPR JPN, V33, P1796; KALYMYKOV YP, 1997, PHYS REV E, V55, P2509; KRAMER U, 1991, MACROMOLECULES, V24, P256; KUBO R, 1991, STAT PHYSICS, V2; MORITA A, 1986, PHYS REV A, V34, P1499, DOI 10.1103/PhysRevA.34.1499; MORITA A, 1987, PHYS REV A, V35, P2690, DOI 10.1103/PhysRevA.35.2690; NAFAILE CR, 1984, MACROMOLECULES, V17, P1187; NAKADA O, 1960, J PHYS SOC JPN, V15, P2280, DOI 10.1143/JPSJ.15.2280; Oizumi J, 1996, J CHEM PHYS, V104, P9137, DOI 10.1063/1.471446; OKONSKI CT, 1976, MOL ELECTROOPTICS 1; OOKUBO N, 1981, JPN J APPL PHYS, V20, P801, DOI 10.1143/JJAP.20.801; OOKUBO N, 1980, JPN J APPL PHYS, V19, P2271, DOI 10.1143/JJAP.19.2271; OOKUBO N, 1988, FERROELECTRICS, V86, P19, DOI 10.1080/00150198808227001; Perrin F, 1934, J PHYS-PARIS, V5, P497, DOI 10.1051/jphysrad:01934005010049700; RIDLER PJ, 1997, IEEE T MAGN, V33, P5; Schetzen M., 1980, VOLTERRA WIENER THEO; SHIMOMURA T, 1994, PHYS REV LETT, V72, P2073, DOI 10.1103/PhysRevLett.72.2073; SZABO A, 1986, J CHEM PHYS, V85, P7472, DOI 10.1063/1.451336; TRICOT M, 1982, MACROMOLECULES, V15, P854, DOI 10.1021/ma00231a032; WILKINSON RS, 1973, BIOPOLYMERS, V15, P1555; Yasuda K, 1996, J PHYS CHEM-US, V100, P5892, DOI 10.1021/jp952738m	35	18	18	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	FEB 22	1999	110	8					4101	4108		10.1063/1.478250		8	Physics, Atomic, Molecular & Chemical	Physics	168AX	WOS:000078668900058		
J	Okawa, Y; Yoneya, T				Okawa, Y; Yoneya, T			Equations of motion and Galilei invariance in D-particle dynamics	NUCLEAR PHYSICS B			English	Article						superstring; supergravity; matrix models		As a continuation of our previous work on the multi-body forces of D-particles in supergravity and Matrix theory, we investigate the problem of motion. We show that the scattering of D-particles including recoil derived in Matrix theory is precisely reproduced by supergravity with the discrete light-cone prescription up to the second order in Ii-dimensional Newton constant. An intimate connection of recoil and Galilei invariance in supergravity is pointed out and elucidated. (C) 1999 Elsevier Science B.V.	Univ Tokyo, Inst Phys, Tokyo 153, Japan	Okawa, Y (reprint author), Univ Tokyo, Inst Phys, 4-6-1 Komaba, Tokyo 153, Japan.						Becker K, 1998, PHYS REV D, V57, P6464, DOI 10.1103/PhysRevD.57.6464; Green MB, 1997, PHYS LETT B, V409, P177, DOI 10.1016/S0370-2693(97)00931-3; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Douglas MR, 1997, PHYS LETT B, V402, P36, DOI 10.1016/S0370-2693(97)00424-3; Okawa Y, 1999, NUCL PHYS B, V538, P67, DOI 10.1016/S0550-3213(98)00700-7; Barrio M, 1998, J HIGH ENERGY PHYS; Becker K, 1997, PHYS REV D, V56, pR3174; BILAL A, HEPTH9805070; DANIELSSON UH, HEPTH9807071; DINE M, HEPTH9805007; Dine M, 1998, PHYS LETT B, V425, P77, DOI 10.1016/S0370-2693(98)00153-1; Douglas MR, 1998, PHYS LETT B, V425, P71, DOI 10.1016/S0370-2693(98)00114-2; ECHOLS R, HEPTH9806109; Fabbrichesi M, 1998, J HIGH ENERGY PHYS; FABBRICHESI M, HEPTH9806166; Ganor OJ, 1998, NUCL PHYS B, V511, P243, DOI 10.1016/S0550-3213(97)00654-8; Harvey JA, 1998, NUCL PHYS B-PROC SUP, V68, P113, DOI 10.1016/S0920-5632(98)00145-5; HELLERMAN S, HEPTH9711037; KESKIVAKKURI E, HEPTH9712013; Kraus P, 1998, PHYS LETT B, V419, P73, DOI 10.1016/S0370-2693(97)01501-3; MCARTHUR IN, HEPTH9806082; MCCARTHY J, HEPTH9806136; Morales JF, 1998, PHYS LETT B, V417, P233, DOI 10.1016/S0370-2693(97)01422-6; Morales JF, 1998, NUCL PHYS B, V534, P223, DOI 10.1016/S0550-3213(98)00609-9; PLEFKA J, HEPTH9806081; TAYLOR W, HEPTH9806006	26	33	33	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	FEB 22	1999	541	1-2					163	178		10.1016/S0550-3213(98)00769-X		16	Physics, Particles & Fields	Physics	168YN	WOS:000078720900008		
J	Hosaka, N; Tachibana, H; Shiga, N; Matsumoto, M; Tokura, Y				Hosaka, N; Tachibana, H; Shiga, N; Matsumoto, M; Tokura, Y			Photoinduced phase transformation in polythiophene	PHYSICAL REVIEW LETTERS			English	Article							SOLID-STATE; POLY(3-ALKYLTHIOPHENE); THERMOCHROMISM; POLY(3-HEXYLTHIOPHENE); TRANSITION	The thermally restorable photoswitching between the spectroscopically distinct two phases has been observed for thin films of poly(3-alkylthiophene) with regioregular alkyl sidegroups. The primary process of the photoinduced phase transition is completed within a duration of the exciting laser pulse (5 ns), in which photogenerated electron-hole pairs on the polymer backbone with the density above a critical value appear to trigger a self-activated process for the phase conversion. Such a fast photoswitching of the electronic and/or structural state may be applied as well to many other conjugated polymers with optoelectronic functionality.	Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan; Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3058562, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 3058565, Japan	Hosaka, N (reprint author), Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan.		Tokura, Yoshinori/C-7352-2009				MCCULLOUGH RD, 1993, J ORG CHEM, V58, P904, DOI 10.1021/jo00056a024; WINOKUR MJ, 1989, SYNTHETIC MET, V28, pC419; NAGAOSA N, 1989, PHYS REV B, V39, P4472, DOI 10.1103/PhysRevB.39.4472; KOSHIHARA S, 1992, PHYS REV LETT, V68, P1148, DOI 10.1103/PhysRevLett.68.1148; SALANECK WR, 1988, J CHEM PHYS, V89, P4613, DOI 10.1063/1.454802; TASHIRO K, 1991, J POLYM SCI POL PHYS, V29, P1223, DOI 10.1002/polb.1991.090291007; Corish J, 1997, J PHYS CHEM B, V101, P10075, DOI 10.1021/jp971734+; Durr H., 1990, STUDIES ORGANIC CHEM, V40; HANAMURA E, 1987, SOLID STATE COMMUN, V62, P5, DOI 10.1016/0038-1098(87)90072-X; IMRY Y, 1975, J PHYS C SOLID STATE, V8, P567, DOI 10.1088/0022-3719/8/5/005; Leclerc M, 1996, MACROMOL CHEM PHYSIC, V197, P2077, DOI 10.1002/macp.1996.021970701; MCCULLOUGH RD, 1992, J CHEM SOC CHEM COMM, P70, DOI 10.1039/c39920000070; Meille SV, 1997, MACROMOLECULES, V30, P7898, DOI 10.1021/ma970655t; Sakurai K, 1997, PHYS REV B, V56, P9552, DOI 10.1103/PhysRevB.56.9552; Sugimoto R., 1986, CHEM EXPRESS, V1, P635; YOSHINO K, 1988, JPN J APPL PHYS 2, V27, pL716, DOI 10.1143/JJAP.27.L716	16	43	43	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 22	1999	82	8					1672	1675		10.1103/PhysRevLett.82.1672		4	Physics, Multidisciplinary	Physics	168WA	WOS:000078715100016		
J	Willox, R; Ohta, Y; Gilson, CR; Tokihiro, T; Satsuma, J				Willox, R; Ohta, Y; Gilson, CR; Tokihiro, T; Satsuma, J			Quadrilateral lattices and eigenfunction potentials for N-component KP hierarchies	PHYSICS LETTERS A			English	Article						discrete systems; integrable surfaces; Darboux transformations; exact solutions	SURFACES	The (charged) free fermion formulation of the N-component KP hierarchies is used for the description of quadrilateral lattices in terms of multicomponent KP eigenfunction potentials. Tan functions for these hierarchies are explicitly calculated, giving rise to Grammian and Casorati determinant solutions to the (discretized) Darboux or Laplace equations describing the lattices. An example of localized tau functions and eigenfunction potentials is given. (C) 1999 Published by Elsevier Science B.V.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan; Free Univ Brussels, Dienst Theoret Natuurkunde, B-1050 Brussels, Belgium; Hiroshima Univ, Fac Engn, Dept Appl Math, Higashihiroshima 7398527, Japan; Univ Glasgow, Dept Math, Glasgow G12 8QW, Lanark, Scotland	Willox, R (reprint author), Univ Tokyo, Grad Sch Math Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538914, Japan.						MIWA T, 1982, P JPN ACAD A-MATH, V58, P9; Bogdanov LV, 1998, J MATH PHYS, V39, P4701, DOI 10.1063/1.532531; Bobenko A I, 1994, HARMONIC MAPS INTEGR; BOBENKO AI, IN PRESS DISCRETE IN; BOGDANOV LV, 1995, J PHYS A-MATH GEN, V28, pL173, DOI 10.1088/0305-4470/28/5/005; Darboux G, 1896, LECONS THEORIE GEN S; DATE E, 1982, J PHYS SOC JPN, V51, P4116, DOI 10.1143/JPSJ.51.4116; DOLIWA A, 9712017 SOLV INT; DOLIWA A, SOLVINT9803015; Doliwa A, 1997, PHYS LETT A, V233, P365, DOI 10.1016/S0375-9601(97)00456-8; EISENHART LP, 1923, TRANSFORMATIONS SURF; JIMBO M, 1983, PUBL RES I MATH SCI, V19, P943, DOI 10.2977/prims/1195182017; Kac V. G., 1993, IMPORTANT DEV SOLITO, P302; KONOPELCHENKO BG, 1997, 3 DIMENSIONAL INTEGR; Konopelchenko BG, 1996, STUD APPL MATH, V96, P9; LIU QP, SOLVINT9709007; Manas M, 1997, PHYS LETT A, V232, P99, DOI 10.1016/S0375-9601(97)00341-1; MIWA T, 1993, SOLITON NO SURI; Bobenko A, 1996, J REINE ANGEW MATH, V475, P187; Willox R, 1998, INVERSE PROBL, V14, P745, DOI 10.1088/0266-5611/14/3/022	20	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	FEB 22	1999	252	3-4					163	172		10.1016/S0375-9601(98)00939-6		10	Physics, Multidisciplinary	Physics	170UK	WOS:000078825100009		
J	Uryu, K; Eriguchi, Y				Uryu, K; Eriguchi, Y			Newtonian models for black hole gaseous star close binary systems	MONTHLY NOTICES OF THE ROYAL ASTRONOMICAL SOCIETY			English	Article						black hole physics; hydrodynamics; instabilities; methods : numerical binaries : close; stars : rotation	NEUTRON-STARS; HYDRODYNAMIC INSTABILITY; COMPACT BINARIES; GENERAL-RELATIVITY; EQUILIBRIUM; COALESCENCE; POLYTROPES; EVOLUTION; APPROXIMATION; STABILITY	Circularly orbiting black hole-gaseous star close binary systems are examined by using numerically exact stationary configurations in the framework of Newtonian gravity. We have chosen a polytropic star for the fluid component of the binary system and considered two ideal situations: (i) a synchronously rotating star and (ii) an irrotationally rotating star. They correspond to a rotating star under the influence of viscosity and to that in the inviscid Limit, respectively. By analysing the stationary sequences of binary systems with small separations, we can discuss the final stages of black hole-gaseous star close binary systems. Our computational results show that the binary systems reach the Roche(-Riemann) limit states or the Roche lobe filling states without suffering from hydrodynamical instability caused by the tidal force for a certain realistic parameter range of the mass ratio and the polytropic index. Moreover, some of these stable Roche(-Riemann) limits or Roche lobe filling states survive even under the general relativistic effect. Therefore, at the final stage of the evolution, which is caused by the emission of gravitational waves, Roche lobe overflow is another possibility in addition to the merging of a black hole and a star. For a sufficiently stiff equation of state (the polytropic index N greater than or similar to 0.3-0.7, depending on the mass ratio), the turning point, which corresponds to the secular instability limit for the synchronous binary case and the dynamical instability limit for the irrotational binary case, disappears on the solution sequence. Therefore, even for a realistic parameter range, our results are different from the semi-analytic results computed by the ellipsoidal approximation in which the turning point always appears.	Int Ctr Theoret Phys, I-34100 Trieste, Italy; SISSA, I-34013 Trieste, Italy; Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Meguro Ku, Tokyo 1538902, Japan	Uryu, K (reprint author), Int Ctr Theoret Phys, Str Costiera 11, I-34100 Trieste, Italy.						AIZENMAN ML, 1968, ASTROPHYS J, V153, P511, DOI 10.1086/149683; LAI D, 1993, ASTROPHYS J SUPPL S, V88, P205, DOI 10.1086/191822; ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; CUTLER C, 1993, PHYS REV LETT, V70, P2984, DOI 10.1103/PhysRevLett.70.2984; Kluzniak W, 1998, ASTROPHYS J, V494, pL53, DOI 10.1086/311151; Shibata M, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.024012; OSTRIKER JP, 1968, ASTROPHYS J, V151, P1075, DOI 10.1086/149506; BILDSTEN L, 1992, ASTROPHYS J, V400, P175, DOI 10.1086/171983; Teukolsky SA, 1998, ASTROPHYS J, V504, P442, DOI 10.1086/306082; Asada H, 1998, PHYS REV D, V57, P7292, DOI 10.1103/PhysRevD.57.7292; Baumgarte TW, 1998, PHYS REV D, V57, P7299, DOI 10.1103/PhysRevD.57.7299; Bonazzola S, 1997, PHYS REV D, V56, P7740, DOI 10.1103/PhysRevD.56.7740; Chandrasekhar S., 1969, ELLIPSOIDAL FIGURES; ERIGUCHI Y, 1990, ASTRON ASTROPHYS, V231, P61; HACHISU I, 1986, ASTROPHYS J SUPPL S, V62, P461, DOI 10.1086/191148; HACHISU I, 1984, PUBL ASTRON SOC JPN, V36, P239; HACHISU I, 1984, PUBL ASTRON SOC JPN, V36, P259; KIDDER LE, 1992, CLASSICAL QUANT GRAV, V9, pL125, DOI 10.1088/0264-9381/9/9/004; KOCHANEK CS, 1992, ASTROPHYS J, V398, P234, DOI 10.1086/171851; LAI D, 1993, ASTROPHYS J, V406, pL63, DOI 10.1086/186787; LAI D, 1994, ASTROPHYS J, V423, P344, DOI 10.1086/173812; LAI D, 1994, ASTROPHYS J, V420, P811, DOI 10.1086/173606; LEE WH, 1998, ASTROPH9808185; MILLER BD, 1974, ASTROPHYS J, V187, P609, DOI 10.1086/152671; MINO Y, 1997, PROG THEOR PHYS SUPP, V1, P183; Misner C.W., 1970, GRAVITATION; New KCB, 1997, ASTROPHYS J, V490, P311, DOI 10.1086/304861; Oohara K, 1997, PROG THEOR PHYS SUPP, P183; Paczynski B., 1991, Acta Astronomica, V41; Portegies Zwart S, 1998, ASTROPHYS J, V503, pL53, DOI 10.1086/311522; RASIO FA, 1992, ASTROPHYS J, V401, P226, DOI 10.1086/172055; RASIO FA, 1994, ASTROPHYS J, V432, P242, DOI 10.1086/174566; Ruffert M, 1997, ASTRON ASTROPHYS, V321, P991; Shapiro S. L., 1983, BLACK HOLES WHITE DW; Shibata M, 1997, PHYS REV D, V55, P6019, DOI 10.1103/PhysRevD.55.6019; Shibata M, 1997, PROG THEOR PHYS, V98, P1081, DOI 10.1143/PTP.98.1081; Taniguchi K, 1996, PROG THEOR PHYS, V96, P693, DOI 10.1143/PTP.96.693; Tassoul J.-L., 1978, THEORY ROTATING STAR; Uryu K, 1996, MON NOT R ASTRON SOC, V282, P653; Uryu K, 1998, MON NOT R ASTRON SOC, V296, pL1; Uryu  K, 1998, ASTROPHYS J SUPPL S, V118, P563, DOI 10.1086/313146; Uryu K, 1998, MON NOT R ASTRON SOC, V299, P575, DOI 10.1046/j.1365-8711.1998.01795.x	42	30	30	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0035-8711			MON NOT R ASTRON SOC	Mon. Not. Roy. Astron. Soc.	FEB 21	1999	303	2					329	342		10.1046/j.1365-8711.1999.02224.x		14	Astronomy & Astrophysics	Astronomy & Astrophysics	175QY	WOS:000079107500019		
J	Boi, P; Tonna, G; Dalu, G; Nakajima, T; Olivieri, B; Pompei, A; Campanelli, M; Rao, R				Boi, P; Tonna, G; Dalu, G; Nakajima, T; Olivieri, B; Pompei, A; Campanelli, M; Rao, R			Calibration and data elaboration procedure for sky irradiance measurements	APPLIED OPTICS			English	Article							SIZE DISTRIBUTION; BRIGHTNESS MEASUREMENTS; SOLAR; AEROSOLS	The problems encountered in the elaboration of measurements of direct and sky diffuse solar irradiance are the following: (1) to carry out the calibration for the direct irradiance, which consists in determining the direct irradiance at the upper limit of the atmosphere; (2) to carry out the calibration for the diffuse irradiance, which consists in determining the solid viewing angle of the sky radiometer; (3) to determine the input parameters, namely, ground albedo, real and imaginary parts of the aerosol refractive index, and aerosol radius range; and (4) to determine from the optical data the columnar aerosol optical depth and volume radius distribution. With experimental data and numerical simulations a procedure is shown that enables one to carry out the two calibrations needed for the sky radiometer, to determine a best estimate of the input parameters, and, finally, to obtain the average features of the atmospheric aerosols. An interesting finding is that inversion of only data of diffuse irradiance yields the same accuracy of result as data of both diffuse and direct irradiance; in this case, only calibration of the solid viewing angle of the sky radiometer is needed, thus shortening the elaboration procedure. Measurements were carried out in the Western Mediterranean Sea (Italy), in Tokyo (Japan), and in Ushuaia (Tierra del Fuego, Argentina), data were elaborated with a new software package, the Skyrad code. based on an efficient radiative transfer scheme, (C) 1999 Optical Society of America.	Univ Cagliari, Dept Phys, I-09124 Cagliari, Italy; Italian Natl Res Council, Inst Atmospher Phys, Tor Vergata Res Area, I-00133 Rome, Italy; CNR, Area Ric Cagliari, I-09125 Cagliari, Italy; Univ Tokyo, Ctr Climate Syst Res, Maguro Ku, Tokyo 153, Japan; Chinese Acad Sci, Anhui Inst Opt & Fine Mech, Hefei 230031, Peoples R China	Boi, P (reprint author), Univ Cagliari, Dept Phys, Via Osped 72, I-09124 Cagliari, Italy.	monica@atmos.ifa.rm.cnr.it	Nakajima, Teruyuki/H-2370-2013; 	Nakajima, Teruyuki/0000-0002-9042-504X; CAMPANELLI, MONICA/0000-0001-6505-8164			Amato U, 1996, J GEOPHYS RES-ATMOS, V101, P19267, DOI 10.1029/95JD02603; KAUFMAN YJ, 1994, J GEOPHYS RES-ATMOS, V99, P10341, DOI 10.1029/94JD00229; TANRE D, 1990, INT J REMOTE SENS, V11, P659; KASTEN F, 1989, APPL OPTICS, V28, P4735, DOI 10.1364/AO.28.004735; Nakajima T, 1996, APPL OPTICS, V35, P2672, DOI 10.1364/AO.35.002672; Dalu G, 1995, J GEOPHYS RES-ATMOS, V100, P26135, DOI 10.1029/95JD02598; KING MD, 1979, J ATMOS SCI, V36, P163, DOI 10.1175/1520-0469(1979)036<0163:DOTGAA>2.0.CO;2; MOORTHY KK, 1991, J APPL METEOROL, V30, P844, DOI 10.1175/1520-0450(1991)030<0844:SDOCAE>2.0.CO;2; NAKAJIMA T, 1986, APPL OPTICS, V25, P4374; REAGAN JA, 1992, IEEE T GEOSCI REMOTE, V30, P825, DOI 10.1109/36.158879; TANAKA M, 1986, APPL OPTICS, V25, P1170; TOMASI C, 1983, J CLIM APPL METEOROL, V22, P1707, DOI 10.1175/1520-0450(1983)022<1707:SOTRBW>2.0.CO;2; TONNA G, 1995, APPL OPTICS, V34, P4486, DOI 10.1364/AO.34.004486	13	22	22	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	FEB 20	1999	38	6					896	907		10.1364/AO.38.000896		12	Optics	Optics	169GQ	WOS:000078739500002		
J	Suginohara, M; Suginohara, T; Spergel, DN				Suginohara, M; Suginohara, T; Spergel, DN			Detecting z > 10 objects through carbon, nitrogen, and oxygen emission lines	ASTROPHYSICAL JOURNAL			English	Article						cosmology, theory; early universe; galaxies, formation; intergalactic medium; radio lines, general	COLD DARK-MATTER; C-I; GALAXIES; REIONIZATION; UNIVERSE; CLUSTERS; QUASAR	By redshift z = 10, star formation in the first objects should have produced considerable amounts of carbon, nitrogen, and oxygen. The submillimeter lines of C, N, and O redshift into the millimeter and centimeter bands (0.5 mm-1.2 cm), where they may be detectable. High spectral resolution observations could potentially detect inhomogeneities in C, N, and O emission, and see the first objects forming at high redshift. We calculate expected intensity fluctuations and discuss frequency and angular resolution required to detect them. For C II emission, we estimate the intensity using two independent methods: the line-emission coefficient argument and the luminosity-density argument. We find they are in good agreement. At 1 + z similar to 10, the typical protogalaxy has a velocity dispersion of 30 km s(-1) and an angular size of 1 ". If C II is the dominant coolant, then we estimate a characteristic line strength of similar to 0.1 K km s(-1) We also discuss other atomic lines and estimate their signal. Observations with a frequency resolution of 10(-3) can detect moderately nonlinear fluctuations of amplitude 2 x 10(-5) times the microwave background. If the intensity fluctuations are detected, they will probe matter density inhomogeneity, chemical evolution, and ionization history at high redshifts.	Princeton Univ, Dept Astrophys Sci, Princeton, NJ 08544 USA	Suginohara, M (reprint author), Univ Tokyo, Dept Phys, 7-3-1 Hongo, Tokyo 113, Japan.		Spergel, David/A-4410-2011				SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; HOLLENBACH D, 1989, ASTROPHYS J, V342, P306, DOI 10.1086/167595; COUCHMAN HMP, 1986, MON NOT R ASTRON SOC, V221, P53; Kitayama T, 1996, ASTROPHYS J, V469, P480, DOI 10.1086/177797; Dey A, 1998, ASTROPHYS J, V498, pL93, DOI 10.1086/311331; Young K, 1997, ASTROPHYS J, V482, pL101, DOI 10.1086/310677; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Malhotra S, 1997, ASTROPHYS J, V491, pL27, DOI 10.1086/311044; ISRAEL FP, 1995, ASTRON ASTROPHYS, V302, P343; PRESS WH, 1974, ASTROPHYS J, V187, P425, DOI 10.1086/152650; Franx M, 1997, ASTROPHYS J, V486, pL75, DOI 10.1086/310844; Tegmark M, 1997, ASTROPHYS J, V474, P1, DOI 10.1086/303434; Adelberger KL, 1998, ASTROPHYS J, V505, P18, DOI 10.1086/306162; Dalcanton JJ, 1997, ASTROPHYS J, V482, P659, DOI 10.1086/304182; Gnedin NY, 1997, ASTROPHYS J, V486, P581, DOI 10.1086/304548; BARNES J, 1987, ASTROPHYS J, V319, P575, DOI 10.1086/165480; Barvainis R, 1997, ASTROPHYS J, V484, P695, DOI 10.1086/304382; FUKUGITA M, 1994, MON NOT R ASTRON SOC, V269, P563; KATZ N, 1998, UNPUB APJ; LEVIN JJ, 1992, ASTROPHYS J, V389, P464, DOI 10.1086/171223; MIZUTANI K, 1994, ASTROPHYS J SUPPL S, V91, P613, DOI 10.1086/191950; SCHNEIDER DP, 1991, ASTRON J, V102, P837, DOI 10.1086/115914; Stutzki J, 1997, ASTROPHYS J, V477, pL33, DOI 10.1086/310514; Thielemann F.-K., 1993, ORIGIN EVOLUTION ELE, P297; WIESE WL, 1966, NSRDSNBS4 US DEP COM; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; YAMAMOTO S, 1991, ASTROPHYS J, V370, pL103, DOI 10.1086/185987	28	17	17	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 20	1999	512	2	1				547	552		10.1086/306787		6	Astronomy & Astrophysics	Astronomy & Astrophysics	187VP	WOS:000079809000004		
J	Pochanart, P; Hirokawa, J; Kajii, Y; Akimoto, H; Nakao, M				Pochanart, P; Hirokawa, J; Kajii, Y; Akimoto, H; Nakao, M			Influence of regional-scale anthropogenic activity in northeast Asia on seasonal variations of surface ozone and carbon monoxide observed at Oki, Japan	JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES			English	Article							LONG-TERM TRENDS; TROPOSPHERIC OZONE; MACE-HEAD; UNITED-STATES; AIR MASSES; TRANSPORT; 19TH-CENTURY; CLIMATOLOGY; EMISSIONS; ATLANTIC	Surface O-3 and CO measurements were carried out at Oki, Japan during March 1994 to February 1996 in order to elucidate the processes determining temporal variations of O-3 and CO in the northeast Asian Pacific rim region. The isentropic trajectory analysis was applied to sort out the influences of the air mass exchange under the Asian monsoon system and the regional-scale photochemical buildup of O-3. The trajectories were categorized into five groups which cover background and regionally polluted air masses. The seasonal cycles of O-3 and CO in the background continental air mass revealed spring maximum-summer minimum with averaged concentrations ranging from 32 and 120 ppb to 45 and 208 ppb, respectively. In contrast,, O-3 concentrations in the regionally polluted continental air mass ranged from 44 to 57 ppb and showed a winter minimum and a spring-summer-autumn broad maximum, which was characterized by photochemical O-3 production due to anthropogenic activities in northeast Asia. CO concentrations in the same air mass showed a spring maximum of 271 ppb and a summer-autumn minimum of 180 ppb. The photochemical buildup of O-3 resulting from anthropogenic activities in this region was estimated to be 21 ppb in summer, while its production was insignificant, an average 3 ppb, in winter. A comparison between data in northeast Asia and in Europe shows many similarities, supporting the contention that photochemical buildup of O-3 from large-scale precursor emissions in both regions is very significant.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Shimane Prefectural Inst Publ Hlth & Environm Sci, Matsue, Shimane 69001, Japan	Pochanart, P (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	pakpong@atmchem.rcast.u-tokyo.ac.jp; hirokawa@atmchem.rcast.u-tokyo.ac.jp; kajii@atmchem.rcast.u-tokyo.ac.jp; akimoto@atmchem.rcast.u-tokyo.ac.jp	Hirokawa, Jun/H-8018-2012				AKIMOTO H, 1994, ATMOS ENVIRON, V28, P213, DOI 10.1016/1352-2310(94)90096-5; Akimoto H., 1994, CHEM ATMOSPHERE ITS, P261; ANFOSSI D, 1991, J GEOPHYS RES-ATMOS, V96, P17349, DOI 10.1029/91JD01474; Akimoto H, 1996, J GEOPHYS RES-ATMOS, V101, P1999, DOI 10.1029/95JD00025; Simmonds PG, 1997, J ATMOS CHEM, V28, P45, DOI 10.1023/A:1005817916497; CHIN M, 1994, J GEOPHYS RES-ATMOS, V99, P14565, DOI 10.1029/94JD00907; Fehsenfeld FC, 1996, J GEOPHYS RES-ATMOS, V101, P28877, DOI 10.1029/2006JD007829; LIU SC, 1987, J GEOPHYS RES-ATMOS, V92, P4191, DOI 10.1029/JD092iD04p04191; OLTMANS SJ, 1994, ATMOS ENVIRON, V28, P9, DOI 10.1016/1352-2310(94)90019-1; MARENCO A, 1994, J GEOPHYS RES-ATMOS, V99, P16617, DOI 10.1029/94JD00021; STAEHELIN J, 1994, ATMOS ENVIRON, V28, P75, DOI 10.1016/1352-2310(94)90024-8; Lee S, 1998, GEOPHYS RES LETT, V25, P1637, DOI 10.1029/98GL01224; Jaffe DA, 1996, J GEOPHYS RES-ATMOS, V101, P2037, DOI 10.1029/95JD01699; Kley D, 1997, J ATMOS CHEM, V28, P1, DOI 10.1023/A:1005807600764; VOLZ A, 1988, NATURE, V332, P240, DOI 10.1038/332240a0; MOODY JL, 1995, J GEOPHYS RES-ATMOS, V100, P7179, DOI 10.1029/94JD02830; Derwent RG, 1998, ATMOS ENVIRON, V32, P145, DOI 10.1016/S1352-2310(97)00338-5; NOVELLI PC, 1992, J GEOPHYS RES-ATMOS, V97, P20731; Bazhanov V, 1997, J ATMOS CHEM, V28, P61, DOI 10.1023/A:1005839313307; BEEKMANN M, 1994, J GEOPHYS RES-ATMOS, V99, P12841, DOI 10.1029/94JD00228; BOJKOV RD, 1986, J CLIM APPL METEOROL, V25, P343, DOI 10.1175/1520-0450(1986)025<0343:SODTSH>2.0.CO;2; Crutzen P. J, 1988, TROPOSPHERIC OZONE, P3; DERWENT RG, 1994, ATMOS ENVIRON, V28, P2623, DOI 10.1016/1352-2310(94)90436-7; DIANOVKLOKOV VI, 1989, J ATMOS CHEM, V8, P153, DOI 10.1007/BF00053720; HARRIS JM, 1990, J GEOPHYS RES-ATMOS, V95, P13651, DOI 10.1029/JD095iD09p13651; Harris JM, 1997, J GEOPHYS RES-ATMOS, V102, P8781, DOI 10.1029/97JD00238; HAYASHIDAAMANO S, 1991, J GEOPHYS RES-ATMOS, V96, P15469, DOI 10.1029/91JD01392; Jaffe D, 1997, J GEOPHYS RES-ATMOS, V102, P28627, DOI 10.1029/96JD02750; Kajii Y, 1997, J GEOPHYS RES-ATMOS, V102, P28637, DOI 10.1029/97JD02013; Kajii Y, 1998, GEOPHYS RES LETT, V25, P3505, DOI 10.1029/98GL02602; KATO N, 1992, ATMOS ENVIRON A-GEN, V26, P2997, DOI 10.1016/0960-1686(92)90291-R; KLEY D, 1994, ATMOS ENVIRON, V28, P149, DOI 10.1016/1352-2310(94)90030-2; Kunz H, 1997, J ATMOS CHEM, V28, P77, DOI 10.1023/A:1005867229466; LAURILA T, 1994, ATMOS ENVIRON, V28, P103, DOI 10.1016/1352-2310(94)90026-4; LEVY H, 1985, J GEOPHYS RES-ATMOS, V90, P3753, DOI 10.1029/JD090iD02p03753; LOGAN JA, 1985, J GEOPHYS RES-ATMOS, V90, P10463, DOI 10.1029/JD090iD06p10463; LOGAN JA, 1981, J GEOPHYS RES-OC ATM, V86, P7210, DOI 10.1029/JC086iC08p07210; LOGAN JA, 1994, J GEOPHYS RES, V99, P25555; LOW PS, 1990, J GEOPHYS RES-ATMOS, V95, P22441, DOI 10.1029/JD095iD13p22441; MERRILL JT, 1985, J GEOPHYS RES-ATMOS, V90, P2927, DOI 10.1029/JD090iD07p12927; Merrill JT, 1996, J GEOPHYS RES-ATMOS, V101, P1679, DOI 10.1029/95JD01226; MUKAI H, 1996, ATMOS ENVIRON, V30, P3914; NARITA D, 1998, IN PRESS CHEMOSPHERE; NOVELLI PC, 1997, IGAC INT S ATM CHEM; OGAWA T, 1985, J METEOROL SOC JPN, V63, P937; Oltmans SJ, 1996, J GEOPHYS RES-ATMOS, V101, P29179, DOI 10.1029/96JD01713; OLTMANS SJ, 1992, NATURE, V358, P392, DOI 10.1038/358392a0; PARRISH DD, 1991, J GEOPHYS RES-ATMOS, V96, P9309, DOI 10.1029/91JD00047; PENKETT SA, 1993, J GEOPHYS RES-ATMOS, V98, P2865, DOI 10.1029/92JD02162; PENKETT SA, 1986, NATURE, V319, P655, DOI 10.1038/319655a0; RIDLEY B, 1993, NORMALIZATION NO CO; Simmonds PG, 1996, ATMOS ENVIRON, V30, P4041, DOI 10.1016/1352-2310(96)00055-6; Solberg S, 1997, J ATMOS CHEM, V28, P111, DOI 10.1023/A:1005766612853; SUNWOO Y, 1994, ATMOS ENVIRON, V28, P25, DOI 10.1016/1352-2310(94)90020-5; TSURUTA H, 1989, OZONE ATMOSPHERE, P433	55	99	102	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-897X			J GEOPHYS RES-ATMOS	J. Geophys. Res.-Atmos.	FEB 20	1999	104	D3					3621	3631		10.1029/1998JD100071		11	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	168RN	WOS:000078706600015		
J	Aoyagi, P; Lee, JF; Katsurai, M				Aoyagi, P; Lee, JF; Katsurai, M			Analytical solution to the FDTD scalar-wave equation	MICROWAVE AND OPTICAL TECHNOLOGY LETTERS			English	Article						finite-difference time-domain (FDTD) method; wave equation; Yee algorithm numerical dispersion; sampling error; analytical solution		A general analytical solution to the finite-difference time-domain (FDTD) scalar-wave equation is derived in terms of its initial conditions using Fourier analysis. The fundamental sources of FDTD modeling error, namely, phase and sampling errors, are demonstrated by comparing this expression with a corresponding analytical solution to the continuous scalar-wave equation. A detailed analysis of the phase error is given which proves mathematically why increasing the time step will decrease error rather than increase it. This explanation, in turn, is used to conclude that the FDTD approximation will, in general, suffer from less numerical dispersion than a frequency-domain finite-difference approximation of the same order. In addition, it is shown that sources can exist implicitly in the FDTD scalar-wave formulation, even though no such sources are explicitly defined. By accounting for these implicit sources, the equivalence between the FDTD scalar-wave equation and the Yee algorithm is demonstrated. (C) 1999 John Wiley & Sons, Inc.	Hitachi Ltd, Prod Engn Res Lab, Totsuka Ku, Yokohama, Kanagawa 244, Japan; Worcester Polytech Inst, Dept Elect & Comp Engn, Worcester, MA 01609 USA; Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 113, Japan	Aoyagi, P (reprint author), Hitachi Ltd, Prod Engn Res Lab, Totsuka Ku, 292 Yoshida Cho, Yokohama, Kanagawa 244, Japan.		Lee, Jin-Fa/A-9436-2008				TAFLOVE A, 1975, IEEE T MICROW THEORY, V23, P623, DOI 10.1109/TMTT.1975.1128640; CANGELLARIS AC, 1991, IEEE T ANTENN PROPAG, V39, P1518, DOI 10.1109/8.97384; Kunz K. S., 1993, FINITE DIFFERENCE TI; MEI KK, 1991, IEEE T ANTENN PROPAG, V39, P1518; Oppenheim A., 1983, SIGNALS SYSTEMS; Taflove A., 1995, COMPUTATIONAL ELECTR; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302	7	0	0	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0895-2477			MICROW OPT TECHN LET	Microw. Opt. Technol. Lett.	FEB 20	1999	20	4					240	245				6	Engineering, Electrical & Electronic; Optics	Engineering; Optics	162TC	WOS:000078362000006		
J	Rabara, M; Takeuchi, T; Miya, K				Rabara, M; Takeuchi, T; Miya, K			Systematic study of angular hysteresis of critical current density in Bi2Sr2Ca2Cu3Ox tapes	PHYSICA C			English	Article						Bi-2223 superconductor; critical current density; angular hysteresis; magnetic field and temperature dependence; trapping flux	TRANSPORT CRITICAL-CURRENT; SHEATHED BI-2223 TAPES; MAGNETIC-FIELD; DEPENDENCE; TEMPERATURE; ANISOTROPY; FLUX; SUPERCONDUCTORS; TEXTURE	The angular dependence of the critical current density for Bi-2223 tapes was experimentally evaluated. Observed asymmetric behavior of J(c) with respect to applied field direction was investigated and the influences of the magnetic field and the temperature on the hysteresis amplitude were analyzed. The results unveil vanishing of hysteresis with increase of the magnetic field as well as with the temperature. The data of the angular hysteresis were re-plotted with the normal component B-n = Bsin theta and compared with hysteresis for one orientation of applied magnetic field (B (perpendicular to) tape plane). Evident correlation between the two confirms that J(c) is governed by the perpendicular component of applied field. It also suggests similar origin of the hysteresis, which is trapping flux inside the grains. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Sch Engn, Tokai, Ibaraki 3191106, Japan; Natl Res Inst Met, Tsukuba, Ibaraki 305, Japan	Rabara, M (reprint author), Univ Tokyo, Sch Engn, 2-22 Shirane, Tokai, Ibaraki 3191106, Japan.						DYACHENKO AI, 1993, PHYSICA C, V213, P167, DOI 10.1016/0921-4534(93)90773-J; EVETTS JE, 1988, CRYOGENICS, V28, P641, DOI 10.1016/0011-2275(88)90147-6; CHADDAH P, 1989, PHYSICA C, V159, P570, DOI 10.1016/0921-4534(89)91287-2; DOU SX, 1992, APPL PHYS LETT, V60, P2929, DOI 10.1063/1.106823; FASTAMPA R, 1994, PHYS REV B, V49, P15959, DOI 10.1103/PhysRevB.49.15959; FullerMora WW, 1996, PHYS REV B, V54, P11977, DOI 10.1103/PhysRevB.54.11977; HENSEL B, 1993, PHYSICA C, V205, P329, DOI 10.1016/0921-4534(93)90399-B; HU QY, 1995, PHYSICA C, V252, P211, DOI 10.1016/0921-4534(95)00474-2; Kobayashi S, 1996, PHYSICA C, V258, P336, DOI 10.1016/0921-4534(95)00832-2; KRAMER EJ, 1973, J APPL PHYS, V44, P1360, DOI 10.1063/1.1662353; List FA, 1997, PHYSICA C, V275, P220, DOI 10.1016/S0921-4534(96)00714-9; MAWATARI Y, 1995, CRYOGENICS, V35, P161, DOI 10.1016/0011-2275(95)93989-D; MORRIS RC, 1972, PHYS REV B, V5, P895, DOI 10.1103/PhysRevB.5.895; MUKAI H, 1993, SUMITOMO DENKI, V143, P67; Muller KH, 1997, PHYS REV B, V55, P630, DOI 10.1103/PhysRevB.55.630; MURAKAMI Y, 1996, ADV CRYO ENG, V42, P529; NEUMULLER HW, 1990, CRYOGENICS, V30, P639, DOI 10.1016/0011-2275(90)90300-2; Oota A, 1996, PHYSICA C, V268, P295, DOI 10.1016/0921-4534(96)00418-2; Rabara M, 1998, PHYSICA C, V305, P285, DOI 10.1016/S0921-4534(98)00348-7; TINKHAM M, 1963, PHYS REV, V129, P2413, DOI 10.1103/PhysRev.129.2413; WILLIS JO, 1994, ADV CRYOG ENG, V40, P9; YOSHIDA Y, 1998, APPL ELECT MECH, V13, P75; YOSHIDA Y, 1998, CRYOGENIC ENG, V33, P15	23	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4534			PHYSICA C	Physica C	FEB 20	1999	313	3-4					213	218		10.1016/S0921-4534(99)00008-8		6	Physics, Applied	Physics	175QR	WOS:000079106700006		
J	Furukawa, Y; Matsumori, A; Ohashi, N; Shioi, T; Ono, K; Harada, A; Matsushima, K; Sasayama, S				Furukawa, Y; Matsumori, A; Ohashi, N; Shioi, T; Ono, K; Harada, A; Matsushima, K; Sasayama, S			Anti-monocyte chemoattractant protein-1 monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries	CIRCULATION RESEARCH			English	Article						monocyte chemoattractant protein-1 monocyte chemotactic and activating factor; angioplasty; restenosis; macrophage; smooth muscle cell	SMOOTH-MUSCLE CELLS; JE GENE ENCODES; VASCULAR INJURY; GROWTH-FACTOR; CORONARY ANGIOPLASTY; PROLIFERATION; EXPRESSION; MIGRATION; RESTENOSIS; MCP-1	Monocyte chemoattractant protein-1 (MCP-1)/monocyte chemotactic and activating factor (MCAF) has been suggested to promote atherogenesis, The effects of in vivo neutralization of MCP-1 in a rat model were examined in an effort to clarify the role of MCP-I in the development of neointimal hyperplasia, Competitive polymerase chain reaction analysis revealed maximum MCP-1 mRNA expression at 4 hours after carotid arterial injury. Increased immunoreactivities of MCP-1 were also detected at 2 and 8 hours after injury. Either anti-MCP-l antibody or nonimmunized goat IgG (10 mg/kg) was then administered every 12 hours to rats that had undergone carotid arterial injury. Treatment with 3 consecutive doses of anti-MCP-l antibody within 24 hours (experiment 1) and every 12 hours for 5 days (experiment 2) significantly inhibited neointimal hyperplasia at day 14, resulting in a 27.8% reduction of the mean intima/media ratio (P<0.05) in experiment 1 and a 43.6% reduction (P<0.01) in experiment 2. This effect was still apparent at day 56 (55.6% inhibition; P<0.05). The number of vascular smooth muscle cells in the neointima at day 4 was significantly reduced by anti-MCP-l treatment, demonstrating the important role of MCP-1 in early neointimal lesion formation. However, recombinant MCP-1 did not stimulate chemotaxis of vascular smooth muscle cells in an in vitro migration assay. These results suggest that MCP-1 promotes neointimal hyperplasia in early neointimal lesion formation and that neutralization of MCP-1 before, and immediately after, arterial injury may be effective in preventing restenosis after angioplasty. Further studies are needed to clarify the mechanism underlying the promotion of neointimal hyperplasia by MCP-1.	Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068397, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 113, Japan	Matsumori, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Kawaracho, Kyoto 6068397, Japan.						ABE K, 1995, BRAIN RES, V683, P251, DOI 10.1016/0006-8993(95)00272-R; SERRUYS PW, 1988, CIRCULATION, V77, P361; FERNS GAA, 1991, SCIENCE, V253, P1129, DOI 10.1126/science.1653454; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; BERLINER JA, 1995, CIRCULATION, V91, P2488; TAUB DD, 1995, J CLIN INVEST, V95, P1370, DOI 10.1172/JCI117788; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; TAUBMAN MB, 1992, CIRC RES, V70, P314; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; BENDECK MP, 1994, CIRC RES, V75, P539; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; DAEMEN MJAP, 1991, CIRC RES, V68, P450; Wada T, 1996, FASEB J, V10, P1418; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; PIETERSMA A, 1995, CIRCULATION, V91, P1320; CLOWES AW, 1983, LAB INVEST, V49, P327; Yoshida Y, 1997, ANN NY ACAD SCI, V811, P459, DOI 10.1111/j.1749-6632.1997.tb52027.x; HANCOCK WW, 1994, AM J PATHOL, V145, P1008; ASAHARA T, 1995, CIRCULATION, V91, P2793; ROBINSON EA, 1989, P NATL ACAD SCI USA, V86, P1850, DOI 10.1073/pnas.86.6.1850; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/0022-1759(80)90211-2; FERNS GAA, 1991, AM J PATHOL, V138, P1045; FINGERLE J, 1989, P NATL ACAD SCI USA, V86, P8412, DOI 10.1073/pnas.86.21.8412; FUSTER V, 1995, THROMB HAEMOSTASIS, V74, P552; Hayes IM, 1998, ARTERIOSCL THROM VAS, V18, P397; HOLMES DR, 1984, AM J CARDIOL, V53, pC77, DOI 10.1016/0002-9149(84)90752-5; IKEDA U, 1993, ATHEROSCLEROSIS, V104, P61, DOI 10.1016/0021-9150(93)90176-U; IKEDA U, 1995, AM J PHYSIOL-HEART C, V268, pH1021; LIBBY P, 1991, LAB INVEST, V64, P5; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; MARMUR JD, 1990, CIRCULATION, V82, P698; MITSUKA M, 1993, CIRC RES, V73, P269; OKADA H, 1992, JPN J PHARMACOL, V59, P255; Ono K, 1998, CORONARY ARTERY DIS, V9, P5, DOI 10.1097/00019501-199809010-00002; PASTORE CJ, 1995, CIRC RES, V77, P519; Porreca E, 1997, J VASC RES, V34, P58; ROLLINS BJ, 1989, MOL CELL BIOL, V9, P4687; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; VALENTE AJ, 1988, BIOCHEMISTRY-US, V27, P4162, DOI 10.1021/bi00411a039; WENZEL UO, 1995, CIRC RES, V77, P503; Xu L., 1996, FASEB Journal, V10, pA1334; YOSHIMURA T, 1991, BIOCHEM BIOPH RES CO, V174, P504, DOI 10.1016/0006-291X(91)91445-I; Zempo N, 1996, ARTERIOSCL THROM VAS, V16, P28	50	174	195	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7330			CIRC RES	Circ.Res.	FEB 19	1999	84	3					306	314				9	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	168GQ	WOS:000078683700007		
J	Hirabayashi, T; Kume, K; Hirose, K; Yokomizo, T; Iino, M; Itoh, H; Shimizu, T				Hirabayashi, T; Kume, K; Hirose, K; Yokomizo, T; Iino, M; Itoh, H; Shimizu, T			Critical duration of intracellular Ca2+ response required for continuous translocation and activation of cytosolic phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; NUCLEAR-ENVELOPE; FACTOR RECEPTOR; SUBCELLULAR-LOCALIZATION; PROTEIN-KINASE; MAP KINASE; CALCIUM; PHOSPHORYLATION; CELLS; EXPRESSION	When cells are exposed to certain external stimuli, arachidonic acid (AA) is released from the membrane and serves as a precursor of various types of eicosanoids. A Ca2+-regulated cytosolic phospholipase A(2) (cPLA(2)) plays a dominant role in the release of AA. To closely examine the relation between Ca2+ response and AA release by stimulation of G protein-coupled receptors, we established several lines of Chinese hamster ovary cells expressing platelet-activating factor receptor or leukotriene B-4 receptor. Measurement of intracellular Ca2+ concentration ([Ca2+](i)) demonstrated that cell lines capable of releasing AA. elicited a sustained [Ca2+](i) increase when stimulated by agonists. The prolonged [Ca2+](i) elevation is the result of Ca2+ entry, because this elevation was blocked by EGTA treatment or in the presence of Ca2+ channel blockers (SKF 96365 and methoxyverapamil). cPLA(2) fused with a green fluorescent protein (cPLA(2)-GFP) translocated from the cytosol to the perinuclear region in response to increases in [Ca2+](i). When EGTA was added shortly after [Ca2+](i) increase, the cPLA(2)-GFP returned to the cytosol, without liberating AA. After a prolonged [Ca2+](i) increase, even by EGTA treatment, the enzyme was not readily redistributed to the cytosol. Thus, we propose that a critical time length of [Ca2+](i) elevation is required for continuous membrane localization and full activation of cPLA(2).	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Shimizu, T (reprint author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; KRAMER RM, 1993, J BIOL CHEM, V268, P26796; Schievella AR, 1995, J BIOL CHEM, V270, P30749; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; VIAL D, 1995, J NEUROCHEM, V64, P2765; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; IRVINE RF, 1982, BIOCHEM J, V204, P3; GOETZL EJ, 1995, FASEB J, V9, P1051; KRUMP E, 1995, BIOCHEM J, V310, P681; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Serhan CN, 1996, FASEB J, V10, P1147; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; GUSOVSKY F, 1993, J BIOL CHEM, V268, P7768; Nalefski EA, 1996, PROTEIN SCI, V5, P2375; Uozumi N, 1997, NATURE, V390, P618; BROOKS RC, 1989, J BIOL CHEM, V264, P20147; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; GLOVER S, 1995, J BIOL CHEM, V270, P15359; HONDA Z, 1994, J BIOL CHEM, V269, P2307; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Ishii I, 1997, J BIOL CHEM, V272, P7846; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; KLEY N, 1987, J BIOL CHEM, V262, P4083; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; Miyakawa T, 1998, BIOCHEM J, V329, P107; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; NarayFejesToth A, 1996, J BIOL CHEM, V271, P15436; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; PENROSE JF, 1995, AM J RESP CRIT CARE, V152, P283; PetersGolden M, 1996, BIOCHEM J, V318, P797; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; SAKANAKA C, 1994, BIOCHEM BIOPH RES CO, V205, P18, DOI 10.1006/bbrc.1994.2623; STEPHENS L, 1993, J BIOL CHEM, V268, P17162; TAKANO T, 1994, J BIOL CHEM, V269, P22453; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; XU XX, 1994, J BIOL CHEM, V269, P31693; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506	44	138	139	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 19	1999	274	8					5163	5169		10.1074/jbc.274.8.5163		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	168NB	WOS:000078698200091		
J	Kubo, Y; Tsunehiro, T; Nishikawa, S; Nakai, M; Ikeda, E; Toh-e, A; Morishima, N; Shibata, T; Endo, T				Kubo, Y; Tsunehiro, T; Nishikawa, S; Nakai, M; Ikeda, E; Toh-e, A; Morishima, N; Shibata, T; Endo, T			Two distinct mechanisms operate in the reactivation of heat-denatured proteins by the mitochondrial Hsp70/Mdj1p/Yge1p chaperone system	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Hsp70; Ssc1p; Mdj1p; molecular chaperone; yeast	DNAJ HOMOLOG; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; BIOCHEMICAL-PROPERTIES; MOLECULAR CHAPERONES; ATP HYDROLYSIS; REACTION CYCLE; HSP70; GRPE; IMPORT	The yeast mitochondrial Hsp70, Ssc1p, functions as a molecular chaperone with its partner proteins, Mdj1p (DnaJ homologue) and Yge1p (GrpE homologue). We have purified a mature form of Ssc1p from yeast mitochondria and those of Mdj1p and Yge1p from Escherichia coli overexpresser cells. With these purified components of the mitochondrial Hsp70 chaperone system, we have succeeded in reconstituting their chaperone functions in the protection of firefly luciferase against thermal damage in vitro. Heat-denatured luciferase is prevented from irreversible aggregation and is maintained in a refolding-competent state by Ssc1p and/or Mdj1p at 42 degrees C. Luciferase denatured at 42 degrees C is actively reactivated by Ssc1p, Mdj1p and/or Yge1p after lowering the temperature to 25 degrees C. The reactivation process of heat-denatured luciferase shows two-phase kinetics. The slow refolding process requires either Ssc1p or Mdj1p at 42 degrees C but the presence of Ssc1p, Mdj1p and Yge1p, and ATP hydrolysis, is essential at 25 degrees C. The slow refolding of luciferase involves multiple rounds of formation and dissociation of the complex between luciferase and Mdj1p/Ssc1p. On the other hand, the fast refolding process is most enhanced when luciferase is incubated with Ssc1p alone at 42 degrees C, and it requires neither the assistance of Mdj1p and Yge1p nor ATP hydrolysis. We have observed a similar two-pathway reactivation of heat-denatured luciferase by the bacterial Hsp70 and the yeast cytosolic Hsp70 systems. (C) 1999 Academic Press.	Nagoya Univ, Fac Sci, Dept Chem, Nagoya, Aichi 4648602, Japan; Univ Tokyo, Grad Sch Sci, Dept Plant Sci, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	Endo, T (reprint author), Nagoya Univ, Fac Sci, Dept Chem, Nagoya, Aichi 4648602, Japan.						Rassow J, 1997, TRENDS CELL BIOL, V7, P129; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Deloche O, 1997, J BIOL CHEM, V272, P28539, DOI 10.1074/jbc.272.45.28539; SCHRODER H, 1993, EMBO J, V12, P4137; CYR DM, 1992, J BIOL CHEM, V267, P20927; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; PripBuus C, 1996, FEBS LETT, V380, P142, DOI 10.1016/0014-5793(96)00049-X; Minami Y, 1996, J BIOL CHEM, V271, P19617; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; KANG PJ, 1990, NATURE, V348, P137, DOI 10.1038/348137a0; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Azem A, 1997, J BIOL CHEM, V272, P20901, DOI 10.1074/jbc.272.33.20901; BOLLIGER L, 1994, EMBO J, V13, P1998; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; CRAIG EA, 1994, BIOL HEAT SHOCK PROT, P31; DAUM G, 1982, J BIOL CHEM, V257, P3028; Dekker PJT, 1997, J MOL BIOL, V270, P321, DOI 10.1006/jmbi.1997.1131; Deloche O, 1996, J BIOL CHEM, V271, P23960; Endo T, 1996, J BIOL CHEM, V271, P4161; ENDO T, 1997, MOL CHAPERONES LIFE, P435; ENDO T, 1995, FEBS LETT, V359, P93, DOI 10.1016/0014-5793(95)00015-2; FINK AL, 1997, MOL CHAPERONES LIFE, P123; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; GOTTESMAN ME, 1980, J MOL BIOL, V140, P57, DOI 10.1016/0022-2836(80)90356-3; HA JH, 1997, MOL CHAPERONES LIFE, P95; Herbst R, 1998, BIOCHEMISTRY-US, V37, P6586, DOI 10.1021/bi972928i; Horst M, 1997, EMBO J, V16, P1842, DOI 10.1093/emboj/16.8.1842; Horst M, 1996, PROTEIN SCI, V5, P759; IKEDA E, 1994, FEBS LETT, V339, P265, DOI 10.1016/0014-5793(94)80428-1; LALORAYA S, 1994, P NATL ACAD SCI USA, V91, P6481, DOI 10.1073/pnas.91.14.6481; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; McKay DB, 1994, BIOL HEAT SHOCK PROT, P153; Miao BJ, 1997, J MOL BIOL, V265, P541, DOI 10.1006/jmbi.1996.0762; MORISHIMA N, 1990, J BIOL CHEM, V265, P15189; NAKAI M, 1993, J BIOL CHEM, V268, P24262; NAKAI M, 1994, BIOCHEM BIOPH RES CO, V200, P435, DOI 10.1006/bbrc.1994.1468; ROWLEY N, 1994, CELL, V77, P249, DOI 10.1016/0092-8674(94)90317-4; VESTWEBER D, 1988, J CELL BIOL, V107, P2037, DOI 10.1083/jcb.107.6.2037; WESTERMANN B, 1995, EMBO J, V14, P3452; Westermann B, 1997, J MOL BIOL, V272, P477, DOI 10.1006/jmbi.1997.1267; ZYLICZ M, 1985, J BIOL CHEM, V260, P7591	43	25	26	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836			J MOL BIOL	J. Mol. Biol.	FEB 19	1999	286	2					447	464		10.1006/jmbi.1998.2465		18	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	169QL	WOS:000078760000012		
J	Maeyama, K; Iwasawa, N				Maeyama, K; Iwasawa, N			W(CO)(5)center dot THF-catalyzed electrocyclizations of aromatic enynes via vinylidene intermediates	JOURNAL OF ORGANIC CHEMISTRY			English	Article							CATALYZED CYCLIZATIONS; COMPLEXES; CARBENES		Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Iwasawa, N (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.						Tokunaga M, 1998, ANGEW CHEM INT EDIT, V37, P2867, DOI 10.1002/(SICI)1521-3773(19981102)37:20<2867::AID-ANIE2867>3.0.CO;2-E; Merlic CA, 1996, J AM CHEM SOC, V118, P11319, DOI 10.1021/ja962684+; McDonald FE, 1997, TETRAHEDRON LETT, V38, P7691, DOI 10.1016/S0040-4039(97)10007-7; BRUCE MI, 1991, CHEM REV, V91, P197, DOI 10.1021/cr00002a005; QUAYLE P, 1995, TETRAHEDRON LETT, V36, P8087, DOI 10.1016/0040-4039(95)01681-7; MCDONALD FE, 1994, J AM CHEM SOC, V116, P9363, DOI 10.1021/ja00099a077; BRUCE MI, 1983, ADV ORGANOMET CHEM, V22, P59; BRUNEAU C, 1997, J CHEM SOC CHEM COMM, P507; CLARK PD, 1981, CAN J CHEM, V59, P227, DOI 10.1139/v81-037; CLARK PD, 1981, CAN J CHEM, V59, P1297, DOI 10.1139/v81-190; Maeyama K, 1998, J AM CHEM SOC, V120, P1928, DOI 10.1021/ja973317g; McDonald FE, 1997, TETRAHEDRON, V53, P11061, DOI 10.1016/S0040-4020(97)00366-9; NARASIMHAN NS, 1975, TETRAHEDRON, V31, P1005, DOI 10.1016/0040-4020(75)80118-9; Ohe K, 1996, ANGEW CHEM INT EDIT, V35, P1823, DOI 10.1002/anie.199618231; Trost BM, 1996, CHEM BER, V129, P1313, DOI 10.1002/cber.19961291102	15	84	84	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	FEB 19	1999	64	4					1344	1346		10.1021/jo981361o		3	Chemistry, Organic	Chemistry	170UV	WOS:000078826200046		
J	Okada, Y; Hirokawa, N				Okada, Y; Hirokawa, N			A processive single-headed motor: Kinesin superfamily protein KIF1A	SCIENCE			English	Article							STIMULATED ATP HYDROLYSIS; MICROTUBULE INTERACTION; MOLECULES; MECHANISM; MOVEMENT; DOMAINS; NECK; MICROSCOPY; KINETICS; MYOSIN	A single kinesin molecule can move "processively" along a microtubule for more than 1 micrometer before detaching from it. The prevailing explanation far this processive movement is the "walking model," which envisions that each of two motor domains (heads) of the kinesin molecule binds coordinately to the microtubule. This implies that each kinesin molecule must have two heads to "walk" and that a single-headed kinesin could not move processively. Here, a motor-domain construct of KIF1A, a single-headed kinesin superfamily protein, was shown to move processively along the microtubule for more than 1 micrometer. The movement along the microtubules was stochastic and fitted a biased Brownian-movement model.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Tokyo 1130033, Japan	Hirokawa, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Hongo, Tokyo 1130033, Japan.		Okada, Yasushi/N-5067-2015	Okada, Yasushi/0000-0003-2601-3689			Amos LA, 1997, CURR OPIN CELL BIOL, V9, P4, DOI 10.1016/S0955-0674(97)80145-7; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Tripet B, 1997, J BIOL CHEM, V272, P8946; Kull FJ, 1996, NATURE, V380, P550; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Ma YZ, 1997, J BIOL CHEM, V272, P724; Tucker C, 1997, J BIOL CHEM, V272, P9481; Ma YZ, 1997, J BIOL CHEM, V272, P717; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Hancock WO, 1998, J CELL BIOL, V140, P1395, DOI 10.1083/jcb.140.6.1395; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Inoue Y, 1997, P NATL ACAD SCI USA, V94, P7275, DOI 10.1073/pnas.94.14.7275; Jiang W, 1997, J BIOL CHEM, V272, P5616; Jiang W, 1997, J BIOL CHEM, V272, P7626; MA YZ, 1995, BIOCHEMISTRY-US, V34, P13242, DOI 10.1021/bi00040a040; NAKATA T, 1993, BIOPHYS J, V65, P2504; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; SCHNAPP BJ, 1990, P NATL ACAD SCI USA, V87, P10053, DOI 10.1073/pnas.87.24.10053	34	286	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	1999	283	5405					1152	1157		10.1126/science.283.5405.1152		6	Multidisciplinary Sciences	Science & Technology - Other Topics	169GD	WOS:000078738400048		
J	Kobayashi, S; Peng, G; Fukuyama, T				Kobayashi, S; Peng, G; Fukuyama, T			Efficient total syntheses of (+/-)-vincadifformine and (-)-tabersonine	TETRAHEDRON LETTERS			English	Article							HYDROSTANNATION; PALLADIUM	Stereocontrolled biomimetic total syntheses of the title compounds art: described. Our syntheses feature a highly efficient preparation of the key intermediate II using our novel indole synthesis methodology. A novel amine protecting protocol hy means of 2,4-dinitrobenzenesulfonamides has been developed to ensure the formation of the elusive secodine (3) as well as secodine-type intermediate (4) under very mild conditions. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, CREST, Grad Sch Pharmaceut Sci, Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 113, Japan; Rice Univ, Dept Chem, Houston, TX 77251 USA	Fukuyama, T (reprint author), Univ Tokyo, CREST, Grad Sch Pharmaceut Sci, Japan Sci & Technol Corp,Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						FUKUYAMA T, 1995, TETRAHEDRON LETT, V36, P6373, DOI 10.1016/0040-4039(95)01316-A; ZHANG HX, 1990, J ORG CHEM, V55, P1857, DOI 10.1021/jo00293a035; WENKERT E, 1962, J AM CHEM SOC, V84, P98, DOI 10.1021/ja00860a023; COCHRAN JC, 1990, TETRAHEDRON LETT, V31, P6621, DOI 10.1016/S0040-4039(00)97130-2; DAUMAS M, 1989, SYNTHESIS-STUTTGART, P64; FUKUYAMA T, 1994, J AM CHEM SOC, V116, P3127, DOI 10.1021/ja00086a054; FUKUYAMA T, 1980, J AM CHEM SOC, V102, P2122, DOI 10.1021/ja00526a076; KUEHNE ME, 1982, J ORG CHEM, V47, P1335, DOI 10.1021/jo00346a034; KUEHNE ME, 1985, J ORG CHEM, V50, P924, DOI 10.1021/jo00207a002; MITSUNOBU O, 1992, ORG REACTIONS, V42, P335; SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467; STILLE JK, 1987, J AM CHEM SOC, V109, P813, DOI 10.1021/ja00237a029; ZIEGLER FE, 1969, J AM CHEM SOC, V91, P2342, DOI 10.1021/ja01037a026	13	51	52	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 19	1999	40	8					1519	1522		10.1016/S0040-4039(98)02667-7		4	Chemistry, Organic	Chemistry	165GU	WOS:000078513400026		
J	Kawamura, M; Kobayashi, S				Kawamura, M; Kobayashi, S			Lithium perchlorate-accelerated Baylis-Hillman reactions	TETRAHEDRON LETTERS			English	Article								The coupling of alpha,beta-unsaturated carbonyl compounds with aldehydes (the Baylis-Hillman reaction) was accelerated in the presence of a catalytic amount of 1,4-diazabicyclo[2,2,2]octane (DABCO) and lithium perchlorate in ether. A preliminary kinetic study revealed that the relative rate of the reaction using LiClO4 in ether was 8.0 x 10(2) times faster than that of the reaction without LiClO4. (C) 1999 Elsevier Science Ltd.	Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 1130033, Japan; Sci Univ Tokyo, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1620825, Japan	Kobayashi, S (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, CREST, Japan Sci & Technol Corp,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				AGGARWAL V, 1996, J CHEM SOC CHEM COMM, P2713; DREWES SE, 1988, TETRAHEDRON, V44, P4653, DOI 10.1016/S0040-4020(01)86168-8; Basavaiah D, 1996, TETRAHEDRON, V52, P8001, DOI 10.1016/0040-4020(96)00154-8; GRIECO PA, 1991, J AM CHEM SOC, V113, P5488, DOI 10.1021/ja00014a069; MORITA K, 1968, B CHEM SOC JPN, V41, P2815, DOI 10.1246/bcsj.41.2815; Baylis A. B., 1972, German patent, Patent No. 2155113; FORT Y, 1992, TETRAHEDRON, V48, P6371, DOI 10.1016/S0040-4020(01)88227-2; IMAGAWA T, 1984, SYNTHETIC COMMUN, V14, P1267, DOI 10.1080/00397918408076808; KATAOKA T, 1998, J CHEM SOC CHEM COMM, P197; MUKAIYAMA T, 1984, CHEM LETT, P907, DOI 10.1246/cl.1984.907	10	116	116	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 19	1999	40	8					1539	1542		10.1016/S0040-4039(98)02705-1		4	Chemistry, Organic	Chemistry	165GU	WOS:000078513400031		
J	Asakura, K; Noguchi, Y; Iwasawa, Y				Asakura, K; Noguchi, Y; Iwasawa, Y			Stepwise synthesis and structure analysis of Mo dimers in NaY zeolite	JOURNAL OF PHYSICAL CHEMISTRY B			English	Article							ABSORPTION FINE-STRUCTURE; X-RAY PHOTOELECTRON; MOLYBDENUM HEXACARBONYL; THERMAL STABILITIES; METAL-CLUSTERS; CATALYSTS; PHOTOTOPOTAXY; SPECTROSCOPY; RESONANCE; CAGES	Mo dimers were prepared in the supercage of NaY zeolite by cycles of saturated adsorption of Mo(CO)(6) at room temperature and subsequent thermal decomposition at 573 K. The obtained samples were characterized by temperature-programmed desorption, extended X-ray absorption fine structure (EXAFS), X-ray photoelectron spectra, and X-ray fluorescence. Two Mo(CO)(6) molecules per supercage were immobilized in each process. After the thermal decomposition of the adsorbed Mo(CO)(6) in the supercage, the resultant Mo(1)/NaY could accept two more Mo(CO)(6) molecules per supercage. Mo loading was found to increase linearly by two Mo(CO)(6) molecules in a supercage per one deposition cycle, and was saturated with eight Mo atoms per supercage after the four cycles. EXAFS analysis revealed that Mo(II) oxocarbide dimer species [Mo-2(C)(O)(x)] with the Mo-Mo distance of 0.285 nm was formed in the supercage by the 573 K thermal decomposition of the adsorbed Mo(CO)(6). The structures of Mo oxocarbide dimers were invariant regardless of the Mo loading.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Res Ctr Spectrochem, Bunkyo Ku, Tokyo 1130033, Japan	Iwasawa, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	iwasawa@chem.s.u-tokyo.ac.jp	Asakura, Kiyotaka/G-6052-2010	Asakura, Kiyotaka/0000-0003-1077-5996			ABDO S, 1983, J PHYS CHEM-US, V87, P1722, DOI 10.1021/j100233a016; ABDO S, 1983, J PHYS CHEM-US, V87, P1713, DOI 10.1021/j100233a015; CID R, 1984, J CATAL, V89, P478, DOI 10.1016/0021-9517(84)90324-5; ANDERSSON SLT, 1989, J PHYS CHEM-US, V93, P4913, DOI 10.1021/j100349a047; McCarthy TJ, 1997, CATAL LETT, V43, P11, DOI 10.1023/A:1018942623229; STERN EA, 1993, PHYS REV B, V48, P9825, DOI 10.1103/PhysRevB.48.9825; FIERRO JLG, 1987, J CATAL, V108, P334, DOI 10.1016/0021-9517(87)90182-5; Asakura K., 1996, XRAY ABSORPTION FINE, P33; CODDINGTON JM, 1990, J CHEM SOC FARADAY T, V86, P1015, DOI 10.1039/ft9908601015; DJAJANTI SD, 1995, ZEOLITES REFINED TOO; HOWE RF, 1972, J CHEM SOC FARAD T 1, V68, P2266, DOI 10.1039/f19726802266; HOWE RF, 1976, INORG CHEM, V15, P486, DOI 10.1021/ic50156a056; ICHIKAWA M, 1992, ADV CATAL, V38, P283, DOI 10.1016/S0360-0564(08)60009-7; IWASAWA Y, 1987, ADV CATAL, V35, P187, DOI 10.1016/S0360-0564(08)60094-2; JELINEK R, 1992, J AM CHEM SOC, V114, P4907, DOI 10.1021/ja00038a068; Kosugi N., 1996, XRAY ABSORPTION FINE, P60; Kozlov A, 1997, CHEM LETT, P313, DOI 10.1246/cl.1997.313; Kozlov A, 1998, J CHEM SOC FARADAY T, V94, P809, DOI 10.1039/a706679a; MAEZAWA A, 1988, CHEM LETT, P241, DOI 10.1246/cl.1988.241; MOLLER K, 1991, J PHYS CHEM-US, V95, P5276, DOI 10.1021/j100166a066; MONTOVANI E, 1977, J MOL CATAL, V3, P385; Muller BR, 1996, J CHEM SOC FARADAY T, V92, P1633, DOI 10.1039/ft9969201633; OCHOA R, 1996, CHEM TRANSITION META, P489; OKAMOTO Y, 1993, CATAL LETT, V20, P49, DOI 10.1007/BF00772596; OKAMOTO Y, 1991, J PHYS CHEM-US, V95, P3702; OKAMOTO Y, 1988, J CHEM SOC FARAD T 1, V84, P851, DOI 10.1039/f19888400851; OZIN GA, 1994, MACROMOL SYMP, V80, P45, DOI 10.1002/masy.19940800105; OZIN GA, 1992, ACCOUNTS CHEM RES, V25, P553, DOI 10.1021/ar00024a002; OZIN GA, 1990, J PHYS CHEM-US, V94, P7556, DOI 10.1021/j100382a046; OZKAR S, 1990, J AM CHEM SOC, V112, P9575, DOI 10.1021/ja00182a016; SACHTLER WMH, 1992, NEW FRONTIR CATALYSI, V10, P271; SMITH J, 1974, J CATAL, V34, P191, DOI 10.1016/0021-9517(74)90027-X; SWARTZ WE, 1971, ANAL CHEM, V43, P1774, DOI 10.1021/ac60307a020; Thomas J. M., 1997, PRINCIPLES PRACTICE; YONG YS, 1986, J CHEM SOC FARAD T 1, V82, P2887; ZAKHAROV VY, 1977, REACT KINET CATAL L, V6, P133	36	26	26	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1089-5647			J PHYS CHEM B	J. Phys. Chem. B	FEB 18	1999	103	7					1051	1058		10.1021/jp983343g		8	Chemistry, Physical	Chemistry	176KN	WOS:000079150400002		
J	Kushiro, T; Shibuya, M; Ebizuka, Y				Kushiro, T; Shibuya, M; Ebizuka, Y			Chimeric triterpene synthase. A possible model for multifunctional triterpene synthase	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ENCODING LANOSTEROL SYNTHASE; RAT OXIDOSQUALENE CYCLASE; MOLECULAR-CLONING; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL EXPRESSION; CYCLOARTENOL SYNTHASE; CDNA; 2,3-OXIDOSQUALENE; BIOSYNTHESIS; YEAST	Two triterpene synthases, beta-amyrin synthase (EC 5.4.99.-) from Panax ginseng and lupeol synthase (EC 5.4.99.-) from Arabidopsis thaliana, were used to construct a series of chimeric proteins between these two enzymes in order to investigate the region Important for product specificity. Functional expression in yeast and analysis of the synthase products have revealed that chimera 1, in which the N-terminal half is beta-amyrin synthase and the C-terminal half is lupeol synthase, produced both beta-amyrin and lupeol in a 3:1 ratio. By dividing the whole sequence into four regions, all the possible combinations of the two synthases were constructed. Among them, chimera 7, in which only region B (the second quarter from the N-terminus) is beta-amyrin synthase, produced beta-amyrin and lupeol in a 4:1 ratio, indicating the importance of region B in beta-amyrin formation. Another chimera, which was created by the mixed PCR method, produced beta-amyrin and lupeol in a 1:4 ratio, indicating that the sequence which is important for product distribution lies within 80 amino acid residues in region B. The incorporation experiment of [1,2-C-13(2)]acetate showed that, during the formation of lupeol, the final proton abstraction takes place from either of the two gem-dimethyl groups in a 1:1 ratio. This is the first demonstration of the scrambling of methyl groups during the biosynthesis of any terpenoids. On the other hand, no scrambling of methyl groups was observed during beta-amyrin formation, indicating that the isopropyl group of the lupenyl cation must be held tightly by beta-amyrin synthase protein.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Ebizuka, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ABE I, 1995, P NATL ACAD SCI USA, V92, P9274, DOI 10.1073/pnas.92.20.9274; ABE I, 1994, J BIOL CHEM, V269, P802; ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; PORALLA K, 1994, TRENDS BIOCHEM SCI, V19, P157, DOI 10.1016/0968-0004(94)90276-3; SUNG CK, 1995, BIOL PHARM BULL, V18, P1459; CROTEAU R, 1987, CHEM REV, V87, P929, DOI 10.1021/cr00081a004; Corey EJ, 1997, J AM CHEM SOC, V119, P1277, DOI 10.1021/ja963227w; SEO S, 1988, J AM CHEM SOC, V110, P1740, DOI 10.1021/ja00214a013; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Steele CL, 1998, J BIOL CHEM, V273, P2078, DOI 10.1074/jbc.273.4.2078; GOLLUB EG, 1977, J BIOL CHEM, V252, P2846; BAKER CH, 1995, BIOCHEM BIOPH RES CO, V213, P154, DOI 10.1006/bbrc.1995.2110; SHI Z, 1994, P NATL ACAD SCI USA, V91, P7370, DOI 10.1073/pnas.91.15.7370; Corey EJ, 1997, J AM CHEM SOC, V119, P1289, DOI 10.1021/ja963228o; SEO S, 1975, TETRAHEDRON LETT, P7; Back KW, 1996, P NATL ACAD SCI USA, V93, P6841, DOI 10.1073/pnas.93.13.6841; BUNTEL CJ, 1992, J AM CHEM SOC, V114, P9711, DOI 10.1021/ja00050a090; Corey EJ, 1996, BIOCHEM BIOPH RES CO, V219, P327, DOI 10.1006/bbrc.1996.0232; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; COREY EJ, 1994, P NATL ACAD SCI USA, V91, P2211, DOI 10.1073/pnas.91.6.2211; DAS MC, 1983, PHYTOCHEMISTRY, V22, P1071, DOI 10.1016/0031-9422(83)80198-8; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GOODWIN TW, 1980, BIOSYNTHESIS ISOPREN, P443; KUSANO M, 1995, BIOL PHARM BULL, V18, P195; Morita M, 1997, BIOL PHARM BULL, V20, P770; NES WD, 1994, ACS S SERIES, V562; Rose M.D., 1990, METHODS YEAST GENETI; Shiojima K, 1996, CHEM PHARM BULL, V44, P509	28	38	39	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 17	1999	121	6					1208	1216		10.1021/ja983012h		9	Chemistry, Multidisciplinary	Chemistry	168CY	WOS:000078674500013		
J	Maki, K; Ikura, T; Hayano, T; Takahashi, N; Kuwajima, K				Maki, K; Ikura, T; Hayano, T; Takahashi, N; Kuwajima, K			Effects of proline mutations on the folding of staphylococcal nuclease	BIOCHEMISTRY			English	Article							FLOW CIRCULAR-DICHROISM; MOLTEN GLOBULE INTERMEDIATE; ALPHA-LACTALBUMIN; PROLYL ISOMERIZATION; RIBONUCLEASE-A; CHYMOTRYPSIN INHIBITOR-2; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; DENATURED STATE; RAPID FORMATION	Effects of proline isomerizations on the equilibrium unfolding and kinetic refolding of staphylococcal nuclease were studied by circular dichroism in the peptide region (225 nm) and fluorescence spectra of a tryptophan residue. For this purpose, four single mutants (P11A, P31A, P42A, and P56A) and four multiple mutants (P11A/P47T/P117G, P11A/P31A/P47T/P117G, P11A/P31A/P42A/P47T/P117G, and P11A/P31A/P42A/P47T/P56A/P117G) were constructed. These mutants, together with the single and double mutants for Pro(47) and Pro(117) constructed in our previous study, cover all six proline sites of the nuclease. The P11A, P31A, and P42A mutations did not change the stability of the protein remarkably, while the P56A mutation increased protein stability to a small extent by 0.5 kcal/mol. The refolding kinetics of the protein were, however, affected remarkably by three of the mutations, namely, P11A, P31A, and P56A. Most notably, the amplitude of the slow phase of the triphasic refolding kinetics of the nuclease observed by stopped-flow circular dichroism decreased by increasing the number of the proline mutations; the slow phase disappeared completely in the proline-free mutant (P11A/P31A/P42A/P47T/P56A/P117G). The kinetic refolding reactions of the wild-type protein assessed in the presence of Escherichia coli cyclophilin A showed that the slow phase was accelerated by cyclophilin, indicating that the slow phase was rate-limited by cis-trans isomerization of the proline residues. Although the fast and middle phases of the refolding kinetics were not affected by cyclophilin, the amplitude of the middle phase decreased when the number of the proline mutations increased; the percent amplitudes for the wild-type protein and the proline-free mutants were 43 and 13%, respectively. In addition to these three phases detected with stopped-flow circular dichroism, a very fast phase of refolding was observed with stopped-flow fluorescence, which had a shorter dead time (3.6 ms) than the stopped-flow circular dichroism. The following conclusions were drawn. (1) The effects of the P11A, P31A, and P56A mutations on the refolding kinetics indicate that the isomerizations of the three proline residues are rate-limiting, suggesting that the structures around these residues (Pro(11), Pro(31), and Pro(56)) may be organized at an early stage of refolding. (2) The fast phase corresponds to the refolding of the native proline isomer, and the middle phase whose amplitude has decreased when the number of proline mutations was increased may correspond to the slow refolding of non-native proline isomers. The occurrence of the fast- and slow-refolding reactions together with the slow phase rate-limited by the proline isomerization suggests that there are parallel folding pathways for the native and non-native proline isomers, (3) The middle phase did not completely disappear in the proline-free mutant. This suggests that the slow-folding isomer is produced not only by the proline isomerizations but also by another conformational event that is not related to the prolines. (4) The very fast phase detected with the fluorescent measurements suggests that there is an intermediate at a very early stage of kinetic refolding.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Tonen KK, Corp Res & Dev Lab, Ohi, Saitama 3568505, Japan; Tokyo Univ Agr & Technol, Tokyo 1838509, Japan	Kuwajima, K (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Ikura, Teikichi/N-1490-2015	Ikura, Teikichi/0000-0003-2377-5434			KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; TUCKER PW, 1978, MOL CELL BIOCHEM, V22, P67, DOI 10.1007/BF00496235; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; EVANS PA, 1987, NATURE, V329, P266, DOI 10.1038/329266a0; MATTHEWS CR, 1993, ANNU REV BIOCHEM, V62, P653, DOI 10.1146/annurev.bi.62.070193.003253; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; HAYANO T, 1991, BIOCHEMISTRY-US, V30, P3041, DOI 10.1021/bi00226a009; Dodge RW, 1996, BIOCHEMISTRY-US, V35, P1548, DOI 10.1021/bi952348q; HYNES TR, 1991, PROTEINS, V10, P92, DOI 10.1002/prot.340100203; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202; Arai M, 1996, FOLD DES, V1, P275, DOI 10.1016/S1359-0278(96)00041-7; BALDWIN RL, 1975, ANNU REV BIOCHEM, V44, P453, DOI 10.1146/annurev.bi.44.070175.002321; FOX RO, 1986, NATURE, V320, P192, DOI 10.1038/320192a0; GREEN SM, 1992, BIOCHEMISTRY-US, V31, P5717, DOI 10.1021/bi00140a005; HAYANO T, 1995, THESIS U TOKYO BUNKY; IKEGUCHI M, 1986, BIOCHEMISTRY-US, V25, P6965, DOI 10.1021/bi00370a034; Ikura T, 1997, BIOCHEMISTRY-US, V36, P6529, DOI 10.1021/bi963174v; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10436, DOI 10.1021/bi00107a011; JACOBS MD, 1994, P NATL ACAD SCI USA, V91, P449, DOI 10.1073/pnas.91.2.449; KALNIN NN, 1995, PROTEINS, V23, P163, DOI 10.1002/prot.340230206; KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023; KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020; KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010; KUWAJIMA K., 1996, CIRCULAR DICHROISM C; KUWAJIMA K, 1991, FEBS LETT, V290, P135, DOI 10.1016/0014-5793(91)81243-2; Kuwajima K, 1996, FASEB J, V10, P102; KUWAJIMA K, 1987, FEBS LETT, V221, P115, DOI 10.1016/0014-5793(87)80363-0; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; NAKANO T, 1993, BIOCHEMISTRY-US, V32, P2534, DOI 10.1021/bi00061a010; Pace C N, 1986, Methods Enzymol, V131, P266; SCHMID FX, 1992, PROTEIN FOLDING; SCHULTZ DA, 1992, PROTEIN SCI, V1, P917; SUGAWARA T, 1991, BIOCHEMISTRY-US, V30, P2698, DOI 10.1021/bi00224a018; Tan YJ, 1997, J MOL BIOL, V269, P611, DOI 10.1006/jmbi.1997.1043; Veeraraghavan S, 1997, BIOCHEMISTRY-US, V36, P15134, DOI 10.1021/bi971357r; Walkenhorst William F., 1997, Biochemistry, V36, P5795, DOI 10.1021/bi9700476; ZIMMERLE CT, 1989, BIOCHEM J, V258, P381	45	48	52	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	FEB 16	1999	38	7					2213	2223		10.1021/bi981962+		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	175VZ	WOS:000079117500029		
J	Yoshida, K; Shimomura, T; Ito, K; Hayakawa, R				Yoshida, K; Shimomura, T; Ito, K; Hayakawa, R			Inclusion complex formation of cyclodextrin and polyaniline	LANGMUIR			English	Letter							N-METHYLPYRROLIDONE WATER; SPECTROSCOPY; DIFFUSION; SYSTEMS	Inclusion complex formation between polyaniline with emeraldine base and beta-cyclodextrin has been studied by the frequency-domain electric birefringence (FEB) spectroscopy in a solution of N-methyl-2-pyrrolidone (NMP) and by scanning tunneling microscopy (STM). The FEB results show that polyaniline in the solution with cyclodextrin changes its conformation from coil to rod at low temperature (below 275 K), and some rodlike images are observed on a substrate by STM. These results suggest that cyclodextrins are threaded onto polyaniline and confine the conformation of the polymer chain to a rodlike one. Furthermore, it is found that the threaded cyclodextrins prevent the chemical oxidation, i.e., doping of polyaniline by iodine. This indicates formation of a new inclusion complex, a conjugated conducting polymer covered by insulated cyclic molecules, namely, "insulated molecular wire".	Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Ito, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan.		Shimomura, Takeshi/B-9993-2013	Shimomura, Takeshi/0000-0001-9580-1019			AMBROSONE L, 1995, J CHEM SOC FARADAY T, V91, P1339, DOI 10.1039/ft9959101339; Anderson S, 1998, J CHEM SOC PERK T 1, P2383, DOI 10.1039/a802680g; FRENCH D, 1949, J AM CHEM SOC, V71, P353, DOI 10.1021/ja01169a100; OOKUBO N, 1989, MACROMOLECULES, V22, P1359, DOI 10.1021/ma00193a059; HARADA A, 1992, NATURE, V356, P325, DOI 10.1038/356325a0; CAO Y, 1990, SYNTHETIC MET, V35, P319, DOI 10.1016/0379-6779(90)90216-8; CHEN GS, 1995, J CHEM ENG DATA, V40, P1005, DOI 10.1021/je00020a062; Garcia B, 1997, J PHYS CHEM B, V101, P7991, DOI 10.1021/jp9626374; GUARINO G, 1985, J CHEM ENG DATA, V30, P366, DOI 10.1021/je00041a039; Harada A., 1990, MACROMOLECULES, V23, P2823; HOTTA S, IN PRESS ELECT PROPE; LEWIS EA, 1973, J CHEM SOC PERK T 2, P2081, DOI 10.1039/p29730002081; OKONSKI CT, 1976, MOL ELECTROOPTICS 1; Okumura Y, 1998, PHYS REV LETT, V80, P5003, DOI 10.1103/PhysRevLett.80.5003; Philp D, 1996, ANGEW CHEM INT EDIT, V35, P1155; SHIMOMURA T, 1994, PHYS REV LETT, V72, P2073, DOI 10.1103/PhysRevLett.72.2073; Yoshida K., UNPUB	17	159	162	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	FEB 16	1999	15	4					910	913		10.1021/la9812471		4	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	168GB	WOS:000078682400004		
J	Tsukamoto, N; Kobayashi, N; Azuma, S; Yamamoto, T; Inoue, J				Tsukamoto, N; Kobayashi, N; Azuma, S; Yamamoto, T; Inoue, J			Two differently regulated nuclear factor kappa B activation pathways triggered by the cytoplasmic tail of CD40	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						tumor necrosis factor receptor-associated factor; nuclear factor kappa B-inducing kinase; protein-protein interaction	NECROSIS-FACTOR RECEPTOR; ANTI-CD40 MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCING PROTEINS; CROSS-LINKING; IGE SYNTHESIS; FACTOR FAMILY; DOMAIN; CELLS; EXPRESSION; LIGAND	CD40 signaling modulates the immune response at least in part by activation of nuclear factor kappa B (NF kappa B). It has been shown that two distinct domains in the CD40 cytoplasmic tail (cyt), namely cyt-N and cyt-C, independently activate NF kappa B. Although four members of the tumor necrosis factor receptor-associated factor (TRAF) family, including TRAF2, TRAF3, TRAF5, and TRAF6, bind to the CD40 cyt, how each TRAF protein contributes to the NF kappa B activation by CD40 is not clear. Here we report that TRAF2, TRAF3, and TRAF5 bind cyt-C, whereas TRAF6 binds cyt-N. cyt-N is conserved poorly between human and mouse CD40, while cyt-C is highly conserved. However, single aa substitution of Glu-235 in cyt-N of human CD40 with Ala abolishes the binding of TRAF6 to cyt-N and NF kappa B activation by cyt-N. Conservation of this Glu between mouse and human CD40 strongly suggests that TRAF6 could link cyt-N to signals essential for CD40-mediated immune response. Furthermore, NF kappa B activation by cyt-C is inhibited by a kinase-negative form of NF kappa B-inducing kinase more efficiently than that by cyt-N, consistent with the result that NF kappa B activation by TRAF2 and TRAF5 is inhibited by a kinase-negative farm of NF kappa B-inducing kinase more efficiently than that by TRAF6. These results indicate that NF kappa B activating signals emanating from cyt-N and cyt-C are mediated by the different members of the TRAF family and could be regulated in a distinct manner.	Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan	Inoue, J (reprint author), Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; HU HM, 1994, J BIOL CHEM, V269, P30069; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; TSUBATA T, 1993, NATURE, V364, P645, DOI 10.1038/364645a0; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Lee SY, 1996, P NATL ACAD SCI USA, V93, P9699, DOI 10.1073/pnas.93.18.9699; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Bennett SRM, 1998, NATURE, V393, P478; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; SATO T, 1995, FEBS LETT, V358, P113, DOI 10.1016/0014-5793(94)01406-Q; Devergne O, 1996, MOL CELL BIOL, V16, P7098; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; Ishida T, 1996, P NATL ACAD SCI USA, V93, P9437, DOI 10.1073/pnas.93.18.9437; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Nakano H, 1998, P NATL ACAD SCI USA, V95, P3537, DOI 10.1073/pnas.95.7.3537; BARRETT TB, 1991, J IMMUNOL, V146, P1722; Ishida T, 1996, J BIOL CHEM, V271, P28745; SHIIO Y, 1992, P NATL ACAD SCI USA, V89, P5206, DOI 10.1073/pnas.89.12.5206; INUI S, 1990, EUR J IMMUNOL, V20, P1747, DOI 10.1002/eji.1830200819; BEUTLER B, 1994, SCIENCE, V264, P667, DOI 10.1126/science.8171316; BJORCK P, 1993, IMMUNOLOGY, V78, P218; Burlinson EL, 1996, EUR J IMMUNOL, V26, P1069, DOI 10.1002/eji.1830260517; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; DEFRANCE T, 1992, EUR J IMMUNOL, V22, P2831, DOI 10.1002/eji.1830221112; FARIS M, 1994, J EXP MED, V179, P1923, DOI 10.1084/jem.179.6.1923; Gedrich RW, 1996, J BIOL CHEM, V271, P12852; HERBOMEL P, 1984, CELL, V39, P653, DOI 10.1016/0092-8674(84)90472-0; HOLLENBAUGH D, 1994, IMMUNOL REV, V138, P23, DOI 10.1111/j.1600-065X.1994.tb00845.x; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; SCHRIEVER F, 1989, J EXP MED, V169, P2043, DOI 10.1084/jem.169.6.2043; TORRES RM, 1992, J IMMUNOL, V148, P620; UCKUN FM, 1991, J BIOL CHEM, V266, P17478	41	77	78	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 16	1999	96	4					1234	1239		10.1073/pnas.96.4.1234		6	Multidisciplinary Sciences	Science & Technology - Other Topics	168ND	WOS:000078698400015		
J	Kai, E; Sawata, S; Ikebukuro, K; Iida, T; Honda, T; Karube, I				Kai, E; Sawata, S; Ikebukuro, K; Iida, T; Honda, T; Karube, I			Detection of PCR products in solution using surface plasmon resonance	ANALYTICAL CHEMISTRY			English	Article							POLYMERASE-CHAIN-REACTION; ELECTROCHEMICAL GENE DETECTION; REAL-TIME DETECTION; HEPATITIS-C VIRUS; DNA-HYBRIDIZATION; BIOSENSOR TECHNOLOGY; CRYSTAL-STRUCTURE; BINDING-PROTEIN; AMPLIFIED DNA; SENSOR	Polymerase chain reaction (PCR) products were detected using a now injection-type sensor based on surface plasmon resonance. Asymmetric PCR was used to amplify the target DNA sequence, and two products with different length were produced. The novelty of our DNA detection system was that our target DNA was double stranded but the probe binding site, located in the 3'-terminus, was single stranded. This avoids the formation of intra- and intermolecular complexes. This novel design permitted us not only to detect PCR product but also to develop a rapid detection system for the detection of the verotoxin 2 gene of Escherichia coli O157:H7.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Natl Space Dev Agcy Japan, Tsukuba, Ibaraki 3050047, Japan; Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Suita, Osaka 5650871, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			Abel AP, 1996, ANAL CHEM, V68, P2905, DOI 10.1021/ac960071+; GRAHAM CR, 1992, BIOSENS BIOELECTRON, V7, P487, DOI 10.1016/0956-5663(92)80005-V; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; MARMUR J, 1962, J MOL BIOL, V5, P109, DOI 10.1016/S0022-2836(62)80066-7; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; Rivetti C, 1998, J MOL BIOL, V280, P41, DOI 10.1006/jmbi.1998.1830; Bianchi N, 1997, CLIN DIAGN VIROL, V8, P199, DOI 10.1016/S0928-0197(97)00025-1; NILSSON P, 1995, ANAL BIOCHEM, V224, P400, DOI 10.1006/abio.1995.1057; BIABCHI N, 1994, J VIROL METHODS, V47, P321; BIANCHI N, 1994, INT J ONCOL, V4, P903; Bier FF, 1996, BIOSENS BIOELECTRON, V11, P669, DOI 10.1016/0956-5663(96)83300-8; EGGERDING FA, 1991, J CLIN MICROBIOL, V29, P945; Gotoh M, 1995, DNA Res, V2, P285, DOI 10.1093/dnares/2.6.285; HAMELIN R, 1993, ONCOGENE, V8, P2213; HASHIMOTO K, 1994, ANAL CHIM ACTA, V286, P219, DOI 10.1016/0003-2670(94)80163-0; HASHIMOTO K, 1993, SUPRAMOL CHEM, V2, P265, DOI 10.1080/10610279308029816; HOLZENBERGER M, 1993, PCR METH APPL, V3, P107; JONSSON U, 1992, ADV BIOSENSORS, V2, P291; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; LIN Z, 1993, MICROBIOL IMMUNOL, V37, P451; Morris T, 1996, J CLIN MICROBIOL, V34, P2933; PerryOKeefe H, 1996, P NATL ACAD SCI USA, V93, P14670, DOI 10.1073/pnas.93.25.14670; PERRYOKEEFE H, 1996, P NATL ACAD SCI US, V93; Pertl B, 1997, AM J OBSTET GYNECOL, V177, P899, DOI 10.1016/S0002-9378(97)70292-8; Petronis A, 1996, AM J MED GENET, V67, P85, DOI 10.1002/(SICI)1096-8628(19960216)67:1<85::AID-AJMG15>3.0.CO;2-L; PIUNNO PAE, 1995, ANAL CHEM, V67, P2635, DOI 10.1021/ac00111a022; SCULLY SP, 1990, MOL CELL PROBE, V4, P485, DOI 10.1016/0890-8508(90)90007-M; SU HB, 1995, ANAL CHEM, V67, P1010, DOI 10.1021/ac00101a033; WATTS HJ, 1995, ANAL CHEM, V67, P4283, DOI 10.1021/ac00119a013	31	78	86	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	FEB 15	1999	71	4					796	800		10.1021/ac9807161		5	Chemistry, Analytical	Chemistry	166UG	WOS:000078595100005		
J	Shimada, T; Sakurada, T; Koma, A				Shimada, T; Sakurada, T; Koma, A			Selective epitaxial growth of organic molecules on patterned alkali halide substrates	APPLIED PHYSICS LETTERS			English	Article							FILMS	Selective epitaxial growth of organic materials is found and analyzed. It is observed during the molecular beam epitaxy of organic molecules and charge transfer complexes on ionic surfaces. The selectivity comes from lattice matching condition on critical nuclei formation in contrast to compound semiconductors for which covalent chemical bonding plays essential roles. It can be utilized to fabricate micropatterns of crystalline organic materials accompanied by lithography processes of alkali halides using NH3 plasma. Feasibility of building three-dimensional microstructures has also been shown, which is readily applicable to make photonic crystals from optically functional organic materials. (C) 1999 American Institute of Physics. [S0003-6951(99)02507-3].	Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 113, Japan	Shimada, T (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	shimada@chem.s.u-tokyo.ac.jp	敏宏, 島田/F-2068-2013	敏宏, 島田/0000-0001-5122-1063			DULCEY CS, 1991, SCIENCE, V252, P551, DOI 10.1126/science.2020853; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; KOSHIHARA S, 1990, PHYS REV B, V42, P6853, DOI 10.1103/PhysRevB.42.6853; Eberl K., 1995, LOW DIMENSIONAL STRU; MARKOV IV, 1995, CRYSTAL GROWTH BEGIN, pCH2; Ohno H, 1996, JPN J APPL PHYS 2, V35, pL512, DOI 10.1143/JJAP.35.L512; SAIKI K, 1997, APPL SURF SCI, V114, P9; SEKIGUCHI A, 1991, APPL PHYS LETT, V59, P2466, DOI 10.1063/1.105997; SUHARA T, 1991, IEEE PHOTONIC TECH L, V3, P241, DOI 10.1109/68.79767; Suzuki A, 1996, JPN J APPL PHYS 2, V35, pL254, DOI 10.1143/JJAP.35.L254	10	6	6	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 15	1999	74	7					941	943		10.1063/1.123416		3	Physics, Applied	Physics	166JA	WOS:000078571400015		
J	Sekine, N; Yamanaka, K; Hirakawa, K; Vosseburger, M; Haring-Bolivar, P; Kurz, H				Sekine, N; Yamanaka, K; Hirakawa, K; Vosseburger, M; Haring-Bolivar, P; Kurz, H			Observation of terahertz radiation from higher-order two-dimensional plasmon modes in GaAs/AlGaAs single quantum wells	APPLIED PHYSICS LETTERS			English	Article							FAR-INFRARED-EMISSION; 2-DIMENSIONAL PLASMONS; INVERSION-LAYERS; ELECTRONS	We have observed terahertz (THz) radiation from higher-order two-dimensional (2D) plasmon modes in GaAs/AlGaAs single quantum wells by time-resolved THz emission spectroscopy. Up to fifth-order plasmon modes are clearly resolved and the observed mode frequencies are in excellent agreement with theory. Relaxation times of the 2D plasmon modes are found to be almost independent of the plasmon wave vector accessible in the present experiment. (C) 1999 American Institute of Physics. [S0003-6951(99)03707-9].	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Rhein Westfal TH Aachen, Inst Halbleitertech 2, D-52056 Aachen, Germany; Japan Sci & Technol Corp, CREST, Toshima Ku, Tokyo 1710031, Japan	Sekine, N (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.		Haring Bolivar, Peter/C-9436-2012	Haring Bolivar, Peter/0000-0001-5875-556X			ALLEN SJ, 1977, PHYS REV LETT, V38, P980, DOI 10.1103/PhysRevLett.38.980; TSUI DC, 1980, SOLID STATE COMMUN, V35, P875, DOI 10.1016/0038-1098(80)91043-1; HIRAKAWA K, 1995, APPL PHYS LETT, V67, P2326, DOI 10.1063/1.114333; SMITH PR, 1988, IEEE J QUANTUM ELECT, V24, P255, DOI 10.1109/3.121; BATKE E, 1985, PHYS REV LETT, V54, P2367, DOI 10.1103/PhysRevLett.54.2367; GOMIK E, 1983, UNPUB 7 INT C INFR M; GRIMES CC, 1976, PHYS REV LETT, V36, P145, DOI 10.1103/PhysRevLett.36.145; Hirakawa K, 1996, SURF SCI, V361, P368, DOI 10.1016/0039-6028(96)00423-2; HOPFEL R, 1982, SURF SCI, V113, P118, DOI 10.1016/0039-6028(82)90571-4; HOPFEL RA, 1982, PHYS REV LETT, V49, P1667, DOI 10.1103/PhysRevLett.49.1667; OKISU N, 1986, APPL PHYS LETT, V48, P776, DOI 10.1063/1.96718; SEKINE N, UNPUB; Vosseburger MV, 1996, J OPT SOC AM B, V13, P1045, DOI 10.1364/JOSAB.13.001045; ZHENG L, 1990, PHYS REV B, V41, P8493, DOI 10.1103/PhysRevB.41.8493	14	30	30	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 15	1999	74	7					1006	1008		10.1063/1.123437		3	Physics, Applied	Physics	166JA	WOS:000078571400037		
J	Zhang, Y; Zhang, YY; Ogata, M; Chen, P; Harada, A; Hashimoto, S; Matsushima, K				Zhang, Y; Zhang, YY; Ogata, M; Chen, P; Harada, A; Hashimoto, S; Matsushima, K			Transforming growth factor-beta 1 polarizes murine hematopoietic progenitor cells to generate Langerhans cell-like dendritic cells through a monocyte/macrophage differentiation pathway	BLOOD			English	Article							NECROSIS-FACTOR-ALPHA; COLONY-STIMULATING-FACTOR; CORD-BLOOD DIFFERENTIATE; CLASS-II TRANSACTIVATOR; LIGAND-TREATED MICE; FACTOR-BETA; MONOCLONAL-ANTIBODY; ANTIGEN EXPRESSION; TNF-ALPHA; IN-VITRO	We have recently demonstrated that CD11b(-/dull)CD11c(+) and CD11b(+hi)CD11c(+) dendritic cell (DC) precursor subsets represent two distinct DC differentiation pathways from murine bone marrow lineage-phenotype negative (Lin(-))c-kit(+) hematopoietic progenitor cells (HPCs) stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF) + stem cell factor (SCF) + tumor necrosis factor alpha (TNF alpha). We show here that transforming growth factor-beta 1 (TGF-beta 1) significantly inhibits the generation of these CD11b(-/dull)CD11c(+) and CD11b(+hi)CD11c(+) DC precursors. Phenotypically, this inhibitory effect was accompanied by markedly suppressed expression of la and CD86 antigens as well as major histocompatibility complex (MHC) class II transactivator (CIITA) and CC-chemokine receptor 7 (CCR7) mRNAs in Lin(-)c-kit(+) HPC cultures stimulated with GM-CSF + SCF + TNF alpha at day 6. TGF-beta 1 could also suppress mature DC differentiation from CD11b(+hi)CD11c(+) DC precursors, but not the differentiation from CD11b(-/dull)CD11c(+) DC precursors. In the absence of TNF alpha, TGF-beta 1 markedly suppressed the expression of CIITA and CCR7 mRNAs in GM-CSF + SGF-stimulated Lin(-)c-kit(+) HPCs at either day 6 or day 12 and induced the differentiation solely into monocytes/macrophages as evident in morphology, active phagocytic, and endocytic activities. These cells expressed high levels of F4/80 and E-cadherin antigens, but low or undetectable levels of la, CD86, and CD40 molecules. However, upon the stimulation with TNF alpha + GM-CSF, these cells could further differentiate into mature DCs expressing high levels of la and E-cadherin, characteristics for Langerhans cells (LCs), and gained the capacity of enhancing allogenic MLR. Taken together, all of these findings suggest that TGF-beta 1 polarizes murine HPCs to generate LC-like DCs through a monocyte/macrophage differentiation pathway. (C) 1999 by The American Society of Hematology.	Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Sch Med, CREST, Tokyo 113, Japan	Matsushima, K (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	koujim@m.u-tokyo.ac.jp					Henderson RA, 1997, J IMMUNOL, V159, P635; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; GEISER AG, 1993, P NATL ACAD SCI USA, V90, P9944, DOI 10.1073/pnas.90.21.9944; BORKOWSKI TA, 1994, EUR J IMMUNOL, V24, P2767, DOI 10.1002/eji.1830241129; Wong BR, 1997, J EXP MED, V186, P2075, DOI 10.1084/jem.186.12.2075; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Sitnicka E, 1996, BLOOD, V88, P82; SCHWEICKART VL, 1994, GENOMICS, V23, P643, DOI 10.1006/geno.1994.1553; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; ODOHERTY U, 1994, IMMUNOLOGY, V82, P487; WITMERPACK MD, 1993, J CELL SCI, V104, P1021; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Vremec D, 1997, J IMMUNOL, V159, P565; Caux C, 1997, BLOOD, V90, P1458; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Strobl H, 1996, J IMMUNOL, V157, P1499; Piskurich JF, 1998, J IMMUNOL, V160, P233; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Pulendran B, 1997, J IMMUNOL, V159, P2222; Enk AH, 1997, INT J CANCER, V73, P309, DOI 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Borkowski TA, 1996, J EXP MED, V184, P2417, DOI 10.1084/jem.184.6.2417; Sozzani S, 1998, J IMMUNOL, V161, P1083; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826; KRAAL G, 1986, J EXP MED, V163, P981, DOI 10.1084/jem.163.4.981; Pierre P, 1997, NATURE, V388, P787; NESTLE FO, 1993, J IMMUNOL, V151, P6535; Dubois B, 1997, J EXP MED, V185, P941, DOI 10.1084/jem.185.5.941; Nandan D, 1997, J IMMUNOL, V158, P1095; Ardavin C, 1997, IMMUNOL TODAY, V18, P350, DOI 10.1016/S0167-5699(97)01090-6; BARRACK ER, 1997, PROSTATE, V31, P51; Brauner R, 1997, J THORAC CARDIOV SUR, V114, P923, DOI 10.1016/S0022-5223(97)70006-0; Caux C, 1996, BLOOD, V87, P2376; CELADA A, 1992, J IMMUNOL, V148, P1102; Chaux P, 1996, LAB INVEST, V74, P975; CHILDS CB, 1982, P NATL ACAD SCI-BIOL, V79, P5312, DOI 10.1073/pnas.79.17.5312; COHEN PJ, 1994, EUR J IMMUNOL, V24, P315, DOI 10.1002/eji.1830240206; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; FLORESROMO L, 1997, J EXP MED, V185, P3411; GOEDDEL DV, 1986, COLD SPRING HARB SYM, V51, P597; Knoefel B, 1997, J INTERF CYTOK RES, V17, P95, DOI 10.1089/jir.1997.17.95; Koli K, 1996, ADV CANCER RES, V70, P63, DOI 10.1016/S0065-230X(08)60872-6; Langerhans P., 1868, VIRCHOWS ARCH PATHOL, V44, P325, DOI 10.1007/BF01959006; Lu LN, 1997, TRANSPLANTATION, V64, P1808, DOI 10.1097/00007890-199712270-00031; MCCARTNEYFRANCIS NL, 1994, J LEUKOCYTE BIOL, V55, P401; NISHIKAWA S, 1991, EMBO J, V10, P2111; Park JA, 1997, CANCER GENE THER, V4, P42; Qin LH, 1996, HUM GENE THER, V7, P1981, DOI 10.1089/hum.1996.7.16-1981; Steinman R M, 1991, ANNU REV IMMUNOL, V9, P271; SWIGGARD WJ, 1995, CELL IMMUNOL, V165, P302, DOI 10.1006/cimm.1995.1218; Yamaguchi Y, 1997, STEM CELLS, V15, P144; YOUNG JM, 1996, J EXP MED, V182, P1111; Zhang Y, 1998, BLOOD, V92, P118; Zhang Y, 1997, BLOOD, V90, P4842	62	64	67	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 15	1999	93	4					1208	1220				13	Hematology	Hematology	166CT	WOS:000078559200010		
J	Eguchi, M; Eguchi-Ishimae, M; Tojo, A; Morishita, K; Suzuki, K; Sato, Y; Kudoh, S; Tanaka, K; Setoyama, M; Nagamura, F; Asano, S; Kamada, N				Eguchi, M; Eguchi-Ishimae, M; Tojo, A; Morishita, K; Suzuki, K; Sato, Y; Kudoh, S; Tanaka, K; Setoyama, M; Nagamura, F; Asano, S; Kamada, N			Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)	BLOOD			English	Article							IN-SITU HYBRIDIZATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ETS-VARIANT GENE-6; TYROSINE KINASE; CHROMOSOMAL TRANSLOCATION; TEL GENE; PROTEIN; EXPRESSION; DOMAIN	Chromosome translocations involving band 12p13 are known to be involved in a variety of hematologic malignancies, some of them resulting in rearrangement of the ETV6/TEL gene. Applying the fluorescence in situ hybridization (FISH) method, we found a cryptic translocation t(12;15)(p13;q25) in an adult acute myeloid leukemia (AML) patient. Hybridization with cosmid probes showed that the ETV6 gene was rearranged in this translocation. A patient-specific cDNA library was screened with ETV6 cDNA, and a novel fusion transcript was identified between the ETV6 and TRKC/NTRK3 gene located on 15q25. TRKC is a receptor tyrosine kinase that is activated by neurotrophin-3 (NT-3). It is known to be expressed broadly in neural tissues but not in hematologic cells, so far. ETV6-TRKC chimeric transcript encoded the pointed (PNT) domain of the ETV6 gene that fused to the protein-tyrosine kinase (PTK) domain of the TRKC gene. Two types of fusion transcript were determined, one that included the entire PTK domain of TRKC and the other in which the 3'-terminal 462 bp of TRKC was truncated within the PTK domain. Western blot analysis showed the expression of both chimeric proteins of 52 and 38 kD in size. Our results suggest that chimeric PTK expressed in the leukemic cells may contribute to cellular transformation by abnormally activating TRK signaling pathways. Moreover, this is the first report on truncated neurotrophin receptors associated in leukemia. (C) 1999 by The American Society of Hematology.	Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Canc Cytogenet, Minato Ku, Hiroshima 7348553, Japan; Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Biochem & Biophys, Minato Ku, Hiroshima 7348553, Japan; Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan; Natl Canc Ctr, Res Inst, Div Biol, Tokyo 104, Japan; Int Med Ctr Japan, Inst Res, Div Intractable Dis, Tokyo, Japan	Kamada, N (reprint author), Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Canc Cytogenet, Minato Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.						MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; Tsoulfas P, 1996, J BIOL CHEM, V271, P5691; Greco A, 1997, GENE CHROMOSOME CANC, V19, P112, DOI 10.1002/(SICI)1098-2264(199706)19:2<112::AID-GCC7>3.3.CO;2-U; Carroll M, 1996, P NATL ACAD SCI USA, V93, P14845, DOI 10.1073/pnas.93.25.14845; Peeters P, 1997, BLOOD, V90, P2535; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; Baens M, 1996, GENOME RES, V6, P404, DOI 10.1101/gr.6.5.404; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; CHEVALIER S, 1994, BLOOD, V83, P1479; GOLUB TR, 1994, CELL, V77, P307, DOI 10.1016/0092-8674(94)90322-0; ICHIKAWA H, 1994, CANCER RES, V54, P2865; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; JEON IS, 1995, ONCOGENE, V10, P1229; Golub TR, 1996, MOL CELL BIOL, V16, P4107; Arif M, 1997, JPN J CANCER RES, V88, P420; BAFFA R, 1995, P NATL ACAD SCI USA, V92, P4922, DOI 10.1073/pnas.92.11.4922; BOHLANDER SK, 1994, CYTOGENET CELL GENET, V65, P108, DOI 10.1159/000133612; BUIJS A, 1995, ONCOGENE, V10, P151; DECHANT G, 1993, J NEUROSCI, V13, P2610; GOLUB TR, 1995, P NATL ACAD SCI USA, V92, P4917, DOI 10.1073/pnas.92.11.4917; Jousset C, 1997, EMBO J, V16, P69, DOI 10.1093/emboj/16.1.69; LAMBALLE F, 1993, EMBO J, V12, P3083; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; MCGREGOR LM, 1994, GENOMICS, V22, P267, DOI 10.1006/geno.1994.1383; Mitelman F., 1995, INT SYSTEM HUMAN CYT; PAPADOPOULOS P, 1995, CANCER RES, V55, P34; Peeters P, 1997, CANCER RES, V57, P564; Poirel H, 1997, ONCOGENE, V14, P349, DOI 10.1038/sj.onc.1200829; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROMANA SP, 1995, BLOOD, V85, P3662; Sato Y, 1997, BLOOD, V90, P4886; SEGAL RA, 1994, P NATL ACAD SCI USA, V91, P12867, DOI 10.1073/pnas.91.26.12867; Setoyama M, 1998, BLOOD, V92, P1454; Suto Y, 1997, GENE CHROMOSOME CANC, V18, P254, DOI 10.1002/(SICI)1098-2264(199704)18:4<254::AID-GCC3>3.0.CO;2-#; Yamashiro DJ, 1996, ONCOGENE, V12, P37; ZUCMAN J, 1993, EMBO J, V12, P4481	37	159	163	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 15	1999	93	4					1355	1363				9	Hematology	Hematology	166CT	WOS:000078559200026		
J	Osada, T; Sakamoto, M; Nagawa, H; Yamamoto, J; Matsuno, Y; Iwamatsu, A; Muto, T; Hirohashi, S				Osada, T; Sakamoto, M; Nagawa, H; Yamamoto, J; Matsuno, Y; Iwamatsu, A; Muto, T; Hirohashi, S			Acquisition of glutamine synthetase expression in human hepatocarcinogenesis - Relation to disease recurrence and possible regulation by ubiquitin-dependent proteolysis	CANCER			English	Article						glutamine synthetase; ubiquitin; hepatocellular carcinoma; amino acid sequencing; two-dimensional gel electrophoresis; immunohistochemistry	SHORT-LIVED PROTEIN; MAJOR ENERGY-SOURCE; HEPATOCELLULAR-CARCINOMA; ADENOMATOUS HYPERPLASIA; ORNITHINE AMINOTRANSFERASE; HETEROGENEOUS DISTRIBUTION; MAMMALIAN-CELLS; MESSENGER-RNA; METABOLISM; AMMONIA	BACKGROUND. The authors previously reported increased ubiquitin (Ub) immuno-reactivity in hepatocellular carcinomas (HCCs) and suggested a possible correlation between changes in ubiquitinated protein levels and multistep hepatocarcinogenesis. The current study was performed to identify one of these ubiquitinated proteins (42 kDa) and to analyze the clinical significance of its accumulation. METHODS, The protein was purified using two-dimensional gel electrophoresis and identified by amino acid sequence analysis. The authors studied the expression of this protein in 101 HCCs and 23 precancerous lesions by immunohistochemical methods and in 26 HCCs by immunoblot analysis. A survival analysis was performed on patients with advanced HCC using the Kaplan-Meier method with approximate chi-square statistics for the log rank test. RESULTS. The target protein for ubiquitination was identified as glutamine synthetase (GS). Accumulation of GS was found in 19 of 49 advanced HCCs (38.8%) by immunohistochemical methods and in 9 of 16 (56.3%) by immunoblot analysis, whereas the frequency was much lower in early HCCs (12.9% and 33.3%, respectively) and precancerous lesions (4.3% by immunostaining). In the Ub immunoblot analysis of strongly GS positive specimens, an intense 42-kDa ubiquitinated band was observed. Nine of 21 (42.9%) nodule-in-nodule type HCCs showed a GS positive, high-grade component within a GS negative, low-grade component, indicating the acquisition of GS expression during progression. Among 23 patients with a single advanced HCC nodule, the relapse free survival time was significantly shorter in the GS positive group than in the GS negative group. CONCLUSIONS, The results of this study demonstrate the acquisition of GS expression during hepatocarcinogenesis and the possible regulation of GS enzyme activity by a Ub-dependent proteolytic system. Moreover, GS might play a significant role in promoting the metastatic potential of HCC. (C) 1999 American Cancer Society.	Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, Tokyo 104, Japan; Univ Tokyo, Dept Surg, Div Surg Oncol, Bunkyo Ku, Tokyo, Japan; Natl Canc Ctr Hosp, Dept Surg, Chuo Ku, Tokyo, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanagawa, Japan	Hirohashi, S (reprint author), Natl Canc Ctr, Res Inst, Div Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 104, Japan.		Sakamoto, Michiie/N-2917-2015				SAKAMOTO M, 1991, HUM PATHOL, V22, P172, DOI 10.1016/0046-8177(91)90039-R; MOORMAN AFM, 1989, HEPATOLOGY, V9, P367, DOI 10.1002/hep.1840090305; REITZER LJ, 1979, J BIOL CHEM, V254, P2669; MEIJER AJ, 1990, PHYSIOL REV, V70, P701; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; EGUCHI A, 1992, HEPATOLOGY, V15, P843, DOI 10.1002/hep.1840150516; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; KAISER S, 1988, EUR J CLIN INVEST, V18, P535, DOI 10.1111/j.1365-2362.1988.tb01053.x; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; ZIELKE HR, 1984, FED PROC, V43, P121; CENCIARELLI C, 1992, SCIENCE, V257, P795, DOI 10.1126/science.1323144; MATSUNO T, 1992, CANCER RES, V52, P1192; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; HERSHKO A, 1980, P NATL ACAD SCI-BIOL, V77, P1783, DOI 10.1073/pnas.77.4.1783; PARRYBILLINGS M, 1991, INT J BIOCHEM, V23, P933, DOI 10.1016/0020-711X(91)90082-X; SHAPIRO BM, 1970, ANNU REV MICROBIOL, V24, P501, DOI 10.1146/annurev.mi.24.100170.002441; EAGLE H, 1955, SCIENCE, V122, P501, DOI 10.1126/science.122.3168.501; GEBHARDT R, 1983, EMBO J, V2, P567; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHRISTA L, 1994, GASTROENTEROLOGY, V106, P1312; CROOK RB, 1978, BIOCHEM J, V176, P47; FREIKOPF A, 1976, BIOCHEM BIOPH RES CO, V72, P1195, DOI 10.1016/S0006-291X(76)80257-4; GEBHARDT R, 1988, FEBS LETT, V241, P89, DOI 10.1016/0014-5793(88)81037-8; GEBHARDT R, 1994, ADV ENZYME REGUL, V34, P27, DOI 10.1016/0065-2571(94)90007-8; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; GEBHARDT R, 1989, CARCINOGENESIS, V10, P1917, DOI 10.1093/carcin/10.10.1917; Gaasbeek Janzen J W, 1987, J Histochem Cytochem, V35, P49; GIBSON W, 1983, ANAL BIOCHEM, V132, P171, DOI 10.1016/0003-2697(83)90443-8; HAUSSINGER D, 1985, J HEPATOL, V1, P3, DOI 10.1016/S0168-8278(85)80063-5; HIROHASHI S, 1992, PRIMARY LIVER CANC J, P25; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; Iwaya K, 1997, JPN J CANCER RES, V88, P273; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KULKA RG, 1973, J BIOL CHEM, V248, P6738; KUO FC, 1991, MOL CELL BIOL, V11, P6050; KUO FC, 1991, P NATL ACAD SCI USA, V88, P9468, DOI 10.1073/pnas.88.21.9468; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOUIE M, 1978, J BIOL CHEM, V253, P6119; Lovry O.H., 1951, J BIOL CHEM, V193, P265; MATSUNO T, 1985, INT J BIOCHEM, V17, P1369, DOI 10.1016/0020-711X(85)90062-X; MILMAN G, 1975, J BIOL CHEM, V250, P1393; MOORMAN AFM, 1988, J HISTOCHEM CYTOCHEM, V36, P751; MORI S, 1993, J BIOL CHEM, V268, P577; Nishibori H, 1996, CANCER RES, V56, P2752; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Osada T, 1997, J HEPATOL, V26, P1266, DOI 10.1016/S0168-8278(97)80461-8; PARAG HA, 1987, EMBO J, V6, P55; Schlesinger DH, 1975, NATURE, V255, P42304; SCHOLS L, 1990, HISTOCHEMISTRY, V94, P49; SMITH DD, 1988, P NATL ACAD SCI USA, V85, P160, DOI 10.1073/pnas.85.1.160; THEIMER W, 1968, KLIN WOCHENSCHR, V46, P49, DOI 10.1007/BF01725304; TIEMEIER DC, 1972, J BIOL CHEM, V247, P5722; TSUDA H, 1988, GASTROENTEROLOGY, V95, P1664; WOOLFOLK CA, 1967, ARCH BIOCHEM BIOPHYS, V118, P736, DOI 10.1016/0003-9861(67)90412-2	55	35	37	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0008-543X			CANCER	Cancer	FEB 15	1999	85	4					819	831		10.1002/(SICI)1097-0142(19990215)85:4<819::AID-CNCR9>3.0.CO;2-E		13	Oncology	Oncology	165ZX	WOS:000078552700009		
J	Nishiyama, K; Fukuda, A; Morita, K; Tokuda, H				Nishiyama, K; Fukuda, A; Morita, K; Tokuda, H			Membrane deinsertion of SecA underlying proton motive force-dependent stimulation of protein translocation	EMBO JOURNAL			English	Article						E-coli; protein translocation; proton motive force; SecA cycle	ESCHERICHIA-COLI TRANSLOCASE; DISTINCT ATP-BINDING; PREPROTEIN TRANSLOCATION; CYTOPLASMIC MEMBRANE; INVITRO TRANSLOCATION; SECRETORY PROTEINS; INNER MEMBRANE; WILD-TYPE; VESICLES; EXPORT	The proton motive force (PMF) renders protein translocation across the Escherichia coli membrane highly efficient, although the underlying mechanism has not been clarified. The membrane insertion and deinsertion of SecA coupled to ATP binding and hydrolysis, respectively, are thought to drive the translocation. We report here that PMF significantly decreases the level of membrane-inserted SecA, The prlA4 mutation of SecY, which causes efficient protein translocation in the absence of PMF, was found to reduce the membrane-inserted SecA irrespective of the presence or absence of PMF, The PMF-dependent decrease in the membrane-inserted SecA caused an increase in the amount of SecA released into the extra-membrane milieu, indicating that PMF deinserts SecA from the membrane. The PMF-dependent deinsertion reduced the amount of SecA required for maximal translocation activity. Neither ATP hydrolysis nor exchange with external SecA was required for the PMF-dependent deinsertion of SecA, These results indicate that the SecA deinsertion is a limiting step of protein translocation and is accelerated by PMF, efficient protein translocation thereby being caused in the presence of PMF.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Tokuda, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Nouwen N, 1996, P NATL ACAD SCI USA, V93, P5953, DOI 10.1073/pnas.93.12.5953; TANI K, 1989, J BIOL CHEM, V264, P18582; CHEN LL, 1985, P NATL ACAD SCI USA, V82, P4384, DOI 10.1073/pnas.82.13.4384; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Hanada M, 1996, FEBS LETT, V381, P25, DOI 10.1016/0014-5793(96)00066-X; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; GARDEL C, 1990, EMBO J, V9, P3209; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; TANI K, 1990, J BIOL CHEM, V265, P17341; AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; AKITA M, 1990, J BIOL CHEM, V265, P8164; WALKER JE, 1982, EMBO J, V1, P945; Price A, 1996, J BIOL CHEM, V271, P31580; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50; ARKOWITZ RA, 1994, EMBO J, V13, P954; SHIOZUKA K, 1990, J BIOL CHEM, V265, P18843; DeRosier DJ, 1998, CELL, V93, P17, DOI 10.1016/S0092-8674(00)81141-1; MITCHELL C, 1993, MOL MICROBIOL, V10, P483, DOI 10.1111/j.1365-2958.1993.tb00921.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Chen XC, 1996, J BIOL CHEM, V271, P29698; DRIESSEN AJM, 1994, J MEMBRANE BIOL, V142, P145; DRIESSEN AJM, 1992, EMBO J, V11, P847; DRIESSEN AJM, 1991, P NATL ACAD SCI USA, V88, P2471, DOI 10.1073/pnas.88.6.2471; Duong F, 1997, CELL, V91, P567, DOI 10.1016/S0092-8674(00)80444-4; Eichler J, 1997, P NATL ACAD SCI USA, V94, P5574, DOI 10.1073/pnas.94.11.5574; EISENBACH M, 1990, MOL MICROBIOL, V4, P161, DOI 10.1111/j.1365-2958.1990.tb00584.x; GELLER BL, 1986, P NATL ACAD SCI USA, V83, P4219, DOI 10.1073/pnas.83.12.4219; HANADA M, 1994, J BIOL CHEM, V269, P23625; Ito K, 1996, GENES CELLS, V1, P337, DOI 10.1046/j.1365-2443.1996.34034.x; KATO M, 1993, J BIOL CHEM, V268, P3586; KAWASAKI H, 1989, FEBS LETT, V242, P431, DOI 10.1016/0014-5793(89)80516-2; KAWASAKI S, 1993, J BIOL CHEM, V268, P8193; KIM YJ, 1994, CELL, V78, P845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; MATSUYAMA S, 1993, EMBO J, V12, P265; MULLER CW, 1992, J MOL BIOL, V224, P159, DOI 10.1016/0022-2836(92)90582-5; Ramamurthy V, 1997, J BIOL CHEM, V272, P23239, DOI 10.1074/jbc.272.37.23239; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; SCHATZ PJ, 1990, ANNU REV GENET, V24, P215; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; TANI K, 1991, FEBS LETT, V285, P127, DOI 10.1016/0014-5793(91)80741-K; TOKUDA H, 1994, FEBS LETT, V346, P65, DOI 10.1016/0014-5793(94)00317-3; VANDERWOLK JPW, 1995, J BIOL CHEM, V270, P18975; van der Wolk JPW, 1998, EMBO J, V17, P3631, DOI 10.1093/emboj/17.13.3631; WEISS JB, 1988, P NATL ACAD SCI USA, V85, P8978, DOI 10.1073/pnas.85.23.8978; YAMADA H, 1989, J BIOL CHEM, V264, P18577; YAMADA H, 1989, J BIOL CHEM, V264, P1723; YAMANE K, 1987, J BIOL CHEM, V262, P2358	57	62	64	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0261-4189			EMBO J	Embo J.	FEB 15	1999	18	4					1049	1058		10.1093/emboj/18.4.1049		10	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	173ZG	WOS:000079009200025		
J	Horinouchi, M; Sano, M; Taniuchi, T; Shimizu, M				Horinouchi, M; Sano, M; Taniuchi, T; Shimizu, M			Effects of changes in leaf height and shoot density on the abundance of two fishes, Rudarius ercodes and Acentrogobius pflaumii, in a Zostera bed	ICHTHYOLOGICAL RESEARCH			English	Article						habitat complexity; seagrass bed; filefish; streaked goby	SEAGRASS; EELGRASS; DECAPODS; ECOLOGY; COMMUNITIES; PREY; ASSEMBLAGES; RECRUITMENT; PREDATION; SELECTION	The effects of changes in the structural complexity of a seagrass habitat on the densities of filefish (Rudarius ercodes) and streaked gobies (Acentrogobius pflaumii), were investigated by conducting a 9 month field experiment in a Zostera marina bed at Moroiso Bay, Aburatsubo, central Japan. The experimental design included a control and 7 treatments where leaf height or shoot densities were reduced. During the period of high density of filefish, the species was more abundant in quadrats with longer leaves and denser shoots, but this tendency was not observed during the period of low density. File-fish did not frequent the quadrat cleared of seagrass or the area of sandy substratum surrounding the experimental seagrass bed at any time. The abundance of streaked gobies did not differ significantly among 8 experimental quadrats, although the species seldom appeared over the surrounding sandy substratum. The results suggested that filefish, unlike gobies, were attracted to factors associated with the Zoster a leaves, such as epiphytic prey and/or the complex living space.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Nihon Univ, Coll Bioresources Sci, Dept Marine Sci & Resources, Fujisawa, Kanagawa 2520813, Japan	Horinouchi, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1138657, Japan.						ADAMS SM, 1976, J EXP MAR BIOL ECOL, V22, P269, DOI 10.1016/0022-0981(76)90007-1; AKIHITO, 1984, FISHES JAPANESE ARCH, P230; SOGARD SM, 1992, MAR ECOL PROG SER, V85, P35, DOI 10.3354/meps085035; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111<255:PIBLBA>2.0.CO;2; ANDERSON TW, 1994, MAR ECOL PROG SER, V113, P279, DOI 10.3354/meps113279; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; WORTHINGTON DG, 1992, MAR BIOL, V112, P139, DOI 10.1007/BF00349737; BELL JD, 1986, J EXP MAR BIOL ECOL, V104, P275; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P53, DOI 10.1016/0022-0981(95)00083-6; BELL JD, 1986, OECOLOGIA, V68, P205, DOI 10.1007/BF00384788; BECKLEY LE, 1983, S AFR J ZOOL, V18, P15; BELL JD, 1986, J EXP MAR BIOL ECOL, V104, P249, DOI 10.1016/0022-0981(86)90109-7; BELL JD, 1989, BIOL SEAGRASSES, P536; CONNOLLY RM, 1994, J EXP MAR BIOL ECOL, V184, P99, DOI 10.1016/0022-0981(94)90168-6; CONNOLLY RM, 1994, AUST J MAR FRESH RES, V45, P1033; Heck KL, 1980, ESTUARINE PERSPECTIV, P449; HORINOUCHI M, 1997, THESIS U TOKYO TOKYO; ISHIDA Y, 1983, B JPN SOC SCI FISH, V49, P547; Kikuchi T., 1966, Publications Amakusa Marine Biological Laboratory, V1, P1; KIKUCHI T, 1974, AQUACULTURE, V4, P145, DOI 10.1016/0044-8486(74)90030-1; KURITA Y, 1991, NIPPON SUISAN GAKK, V57, P1293; LEBER KM, 1985, ECOLOGY, V66, P1951, DOI 10.2307/2937391; Levin P, 1997, OECOLOGIA, V112, P55, DOI 10.1007/s004420050283; LEVIN PS, 1994, ENVIRON BIOL FISH, V40, P271, DOI 10.1007/BF00002517; MATSUURA K, 1984, FISHES JAPANESE ARCH, P345; Mori Keiichro, 1995, Bulletin of the National Research Institute of Fisheries Science, V7, P277; ORTH RJ, 1980, ESTUARIES, V3, P278, DOI 10.2307/1352083; SOGARD SM, 1989, J EXP MAR BIOL ECOL, V133, P15, DOI 10.1016/0022-0981(89)90155-X; STONER AW, 1983, J CRUSTACEAN BIOL, V3, P505, DOI 10.2307/1547947; STONER AW, 1980, MAR ECOL PROG SER, V3, P105, DOI 10.3354/meps003105; STONER AW, 1983, FISH B-NOAA, V81, P837	31	3	5	ICHTHYOLOGICAL SOC JAPAN	TOKYO	BUSINESS CENTER ACADEMIC SOC JAPAN, 5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113, JAPAN	1341-8998			ICHTHYOL RES	Ichthyol. Res.	FEB 15	1999	46	1					49	56		10.1007/BF02674947		8	Zoology	Zoology	179JH	WOS:000079322900006		
J	Harada, Y; Mizobe, Y; Hidai, M				Harada, Y; Mizobe, Y; Hidai, M			Synthesis and structures of tungsten ferrocenyldiazoalkane complexes derived from a dinitrogen complex. Part 58. Preparation and properties of molybdenum and tungsten dinitrogen complexes	INORGANICA CHIMICA ACTA			English	Article						crystal structures; tungsten complexes; dinitrogen complexes; diazoalkane complexes; ferrocenyl complexes	DIAZOALKANE COMPLEXES; CHEMISTRY	Reaction of the hydrazido(2-) complex cis, mer-[WCl2(NNH2)(PMe2Ph)(3)], derived from a dinitrogen complex cis-[W(N-2)(2)(PMe2Ph)(4)], with formylferrocene or acetylferrocene gave ferrocenyldiazoalkane complexes cis, mer-[WCl2(NN=CRFc)(PMe2Ph)(3)] (2: R = H, Me; Fc = (eta(5)-C5H4)Fe(eta(5)-C5H5)). Treatment of 2 with pi-acceptor ligands L such as CO, CH2=CH2, p-MeC6H4CHO, p-MeC6H4C=CH and (BuNC)-N-t afforded a series of ferrocenyldiazoalkane complexes cis, trans-[WCl2(NN=CRFc)(L)(PMe2Ph)(2)] (4), while upon treatment with CH2Cl2 2 gave the W(V) complexes mer, trans-[WCl3(NN=CRFc)(PMe2Ph)(2)] (5). The X-ray analyses have been undertaken to determine the detailed structures for 2a (R = H) and 5b (R = Me). (C) 1999 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Hidai, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.						HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; AOSHIMA T, 1992, J ORGANOMET CHEM, V435, P85, DOI 10.1016/0022-328X(92)83462-Q; BEVAN PC, 1978, J ORGANOMET CHEM, V160, P165, DOI 10.1016/S0022-328X(00)91210-5; CHATT J, 1978, J CHEM SOC DALTON, P1766, DOI 10.1039/dt9780001766; Harada Y, 1998, B CHEM SOC JPN, V71, P183, DOI 10.1246/bcsj.71.183; Harada Y., UNPUB; HIDAI M, 1993, MOLYBDENUM ENZYMES C, pCH22; HIDAI M, 1978, J AM CHEM SOC, V100, P5740, DOI 10.1021/ja00486a026; Hidai M, 1996, B CHEM SOC JPN, V69, P819, DOI 10.1246/bcsj.69.819; HOULTON A, 1992, J CHEM SOC DALTON, P2235, DOI 10.1039/dt9920002235; HOULTON A, 1993, ACTA CRYSTALLOGR C, V49, P682, DOI 10.1107/S0108270192009363; MIZOBE Y, 1980, B CHEM SOC JPN, V53, P1781, DOI 10.1246/bcsj.53.1781; MIZOBE Y, 1981, J ORGANOMET CHEM, V204, P377; OSHITA H, 1993, J ORGANOMET CHEM, V461, P43, DOI 10.1016/0022-328X(93)83272-W	14	3	3	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0020-1693			INORG CHIM ACTA	Inorg. Chim. Acta	FEB 15	1999	285	2					336	340		10.1016/S0020-1693(98)00361-2		5	Chemistry, Inorganic & Nuclear	Chemistry	169KJ	WOS:000078746700029		
J	Mori, K; Okada, T; Takagi, Y; Takada, Y; Mizoguchi, T				Mori, K; Okada, T; Takagi, Y; Takada, Y; Mizoguchi, T			Oxidation and disproportionation of wustite studied by Mossbauer spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS PART 2-LETTERS			English	Letter						wustite; iron oxides; oxidation; disproportionation; Mossbauer spectroscopy; logarithmic time dependence	FE1-XO	Oxidation of wustite (Fe1-deltaO) in air and disproportionation into alpha-Fe and Fe3O4 in a vacuum-sealed tube at temperatures below the transition temperature (843 K) were studied by Mossbauer spectroscopy. The observed discontinuity of weight increase during oxidation in air indicates a two-step process, i.e., the first is the oxidation of Fe1-deltaO to Fe3O4 and the second, that of Fe3O4 to alpha-Fe2O3. The change in the fraction of components by annealing in a vacuum-sealed tube depends linearly on the logarithm of the annealing time. The process is interpreted as having a wide distribution of effective thermal activation energy.	Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan; Nippon Steel Corp Ltd, Adv Technol Res Labs Futtsu, Chiba 2938511, Japan; Nippon Steel Corp Ltd, Proc Technol Res Labs, Chiba 2938511, Japan	Mori, K (reprint author), Univ Tokyo, Dept Nucl Engn, Fac Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						ANAND HR, 1973, PHYS REV B, V8, P3112, DOI 10.1103/PhysRevB.8.3112; PATTEKJANCZYK A, 1986, MATER RES BULL, V21, P1083, DOI 10.1016/0025-5408(86)90224-2; STREET R, 1949, P PHYS SOC LOND A, V62, P562, DOI 10.1088/0370-1298/62/9/303; GOHY C, 1982, PHYS STATUS SOLIDI A, V74, P583, DOI 10.1002/pssa.2210740225; BIRKS N, 1983, INTRO HIGH TEMPERATU, P66; CHECHERS.LF, 1973, PHYS STATUS SOLIDI A, V19, pK177, DOI 10.1002/pssa.2210190261; GREENWOO.NN, 1972, J CHEM SOC DALTON, P110, DOI 10.1039/dt9720000110; GREENWOO.NN, 1972, J CHEM SOC DALTON, P122, DOI 10.1039/dt9720000122; GREENWOO.NN, 1972, J CHEM SOC DALTON, P116, DOI 10.1039/dt9720000116; HAUFFE K, 1965, OXID MET, P144; HENTSCHE.B, 1970, Z NATURFORSCH PT A, VA 25, P1996; HRYNKIEW.HU, 1972, PHYS STATUS SOLIDI A, V9, P611, DOI 10.1002/pssa.2210090225; KOFSTAD P, 1966, CORROSION MONOGRAPH, P112; Odqvist FKG, 1974, MATH THEORY CREEP CR; PATTEKJANCZYK A, 1990, SOLID STATE IONICS, V38, P171, DOI 10.1016/0167-2738(90)90417-P; ROMANOV VP, 1972, PHYS STATUS SOLIDI B, V49, pK183, DOI 10.1002/pssb.2220490267; ROMANOV VP, 1973, PHYS STATUS SOLIDI A, V15, P721, DOI 10.1002/pssa.2210150244; Schieber MM., 1967, EXPT MAGNETOCHEMISTR; TOKUMITSU K, 1998, SPRING M JAP I MET 1	19	2	2	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 2	Jpn. J. Appl. Phys. Part 2 - Lett.	FEB 15	1999	38	2B					L189	L191		10.1143/JJAP.38.L189		3	Physics, Applied	Physics	182EX	WOS:000079486800013		
J	Matsuo, A; Nagatomo, K				Matsuo, A; Nagatomo, K			A note on free bosonic vertex algebra and its conformal vectors	JOURNAL OF ALGEBRA			English	Article							OPERATOR-ALGEBRAS; SUPERALGEBRAS	We classify all the Heisenberg and conformal vectors and we determine the full. automorphism group of the free bosonic vertex algebra without gradation. To describe it we introduce a notion of inner automorphisms of a vertex algebra. (C) 1999 Academic Press.	Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan; Osaka Univ, Grad Sch Sci, Dept Math, Osaka 5600043, Japan	Matsuo, A (reprint author), Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan.						BELAVIN AA, 1984, NUCL PHYS B, V241, P333, DOI 10.1016/0550-3213(84)90052-X; Li HS, 1996, J PURE APPL ALGEBRA, V109, P143, DOI 10.1016/0022-4049(95)00079-8; BORCHERDS RE, 1986, P NATL ACAD SCI USA, V83, P3068, DOI 10.1073/pnas.83.10.3068; BORCHERDS RE, 1992, INVENT MATH, V109, P405, DOI 10.1007/BF01232032; Dong C., 1993, PROGR MATH, V112; FRENKEL E, 1995, COMMUN MATH PHYS, V170, P337, DOI 10.1007/BF02108332; Frenkel I. B., 1988, VERTEX OPERATOR ALGE; FRENKEL IB, 1993, MEM AM MAT SOC, V104; Goddard P., 1989, ADV SERIES MATH PHYS, V7, P556; Kac V. G., 1996, U LECT SERIES, V10; Li H.-S., 1996, CONT MATH, V193, P203; LIAN BH, 1994, COMMUN MATH PHYS, V163, P307, DOI 10.1007/BF02102011; LIAN BH, 1995, J PURE APPL ALGEBRA, V100, P117, DOI 10.1016/0022-4049(95)00053-Y; MATSUO A, HEPTH9706118	14	5	5	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-8693			J ALGEBRA	J. Algebra	FEB 15	1999	212	2					395	418		10.1006/jabr.1998.7638		24	Mathematics	Mathematics	170VG	WOS:000078827300001		
J	Usami, N; Leo, K; Shiraki, Y				Usami, N; Leo, K; Shiraki, Y			Optical characterization of strain-induced structural modification in SiGe-based heterostructures	JOURNAL OF APPLIED PHYSICS			English	Article							NEIGHBORING CONFINEMENT STRUCTURE; MOLECULAR-BEAM EPITAXY; QUANTUM-WELLS; RADIATIVE RECOMBINATION; PHOTOLUMINESCENCE; LUMINESCENCE; SILICON; SI(100); GROWTH; GE	We demonstrate that strain-induced structural modifications in SiGe-based heterostructures can be nondestructively probed by photoluminescence spectroscopy with several different excitation wavelengths. Owing to the indirect band structure of SiGe-based semiconductors, an appropriate choice of excitation energy leads to drastic change of the generation depth of photocarriers and allows to probe different part of the samples in the growth direction. By using this technique, we show that thin strained quantum wells on relaxed SiGe are almost free from threading dislocations and most of them are confined in composition-graded SiGe buffer layer. Furthermore, we show that the accumulation of strain in pure Ge/Si multiple quantum wells causes breakdown of the layer-by-layer growth mode at certain critical number of wells. (C) 1999 American Institute of Physics. [S0021-8979(99)01604-7].	Tech Univ Dresden, Inst Angew Photophys, D-01062 Dresden, Germany; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Usami, N (reprint author), Tech Univ Dresden, Inst Angew Photophys, Mommsenstr 13, D-01062 Dresden, Germany.		Usami, Noritaka/C-1720-2009; Leo, Karl/L-1125-2013				SCHITTENHELM P, 1995, APPL PHYS LETT, V67, P1292, DOI 10.1063/1.114401; SUNAMURA H, 1995, APPL PHYS LETT, V66, P3024, DOI 10.1063/1.114265; SOREF RA, 1993, P IEEE, V81, P1687, DOI 10.1109/5.248958; VAN DE WALLE CG, 1986, PHYS REV B, V34, P5621, DOI 10.1103/PhysRevB.34.5621; Brunner K, 1996, APPL PHYS LETT, V69, P1279, DOI 10.1063/1.117391; FITZGERALD EA, 1991, APPL PHYS LETT, V59, P811, DOI 10.1063/1.105351; FUKATSU S, 1993, J VAC SCI TECHNOL B, V12, P1156; FUKATSU S, 1994, J CRYST GROWTH, V136, P315, DOI 10.1016/0022-0248(94)90432-4; ISMAIL K, 1994, PHYS REV LETT, V73, P3447, DOI 10.1103/PhysRevLett.73.3447; Kasper E., 1995, PROPERTIES STRAINED; Kishimoto Y, 1996, APPL PHYS LETT, V69, P635, DOI 10.1063/1.117931; MURAKAMI E, 1990, JPN J APPL PHYS 2, V29, pL1059; SAUER R, 1985, APPL PHYS A-MATER, V36, P1, DOI 10.1007/BF00616453; STURM JC, 1991, PHYS REV LETT, V66, P1362, DOI 10.1103/PhysRevLett.66.1362; Sunamura H, 1997, THIN SOLID FILMS, V294, P336, DOI 10.1016/S0040-6090(96)09292-9; Sunamura H, 1998, J VAC SCI TECHNOL B, V16, P1595, DOI 10.1116/1.589945; SUNAMURA H, 1993, APPL PHYS LETT, V63, P1651, DOI 10.1063/1.110725; USAMI N, 1995, APPL PHYS LETT, V67, P524, DOI 10.1063/1.115176; Usami N, 1997, SEMICOND SCI TECH, V12, P1596, DOI 10.1088/0268-1242/12/12/009	19	15	15	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0021-8979			J APPL PHYS	J. Appl. Phys.	FEB 15	1999	85	4					2363	2366		10.1063/1.369550		4	Physics, Applied	Physics	163JV	WOS:000078403000054		
J	Mizuno, N; Nozaki, C; Kiyoto, I; Misono, M				Mizuno, N; Nozaki, C; Kiyoto, I; Misono, M			Selective oxidation of alkenes catalyzed by di-iron-substituted silicotungstate with highly efficient utilization of hydrogen peroxide	JOURNAL OF CATALYSIS			English	Article						di-iron-substituted silicotungstate; epoxidation; high efficiency; hydrogen peroxide	TERT-BUTYL HYDROPEROXIDE; SATURATED-HYDROCARBONS; INDUCED ACTIVATION; KETONIZATION; EPOXIDATION; CLEAVAGE; OLEFINS; ACETONITRILE; PORPHYRINS; COMPLEXES	Oxidation reactions of alkenes with hydrogen peroxide were catalyzed by di-iron-substituted silicotungstate, gamma-SiW10{Fe(OH2)}(2) O-38(6-), with a high efficiency of hydrogen peroxide utilization. The efficiency of hydrogen peroxide utilization reached up to ca. 100% for the epoxidation of cyclooctene catalyzed by the di-iron-substituted silicotungstate. Not only cyclooctene but also 2-octene and cyclohexene were oxidized with a high efficiency of hydrogen peroxide utilization. The gamma-SiW10{Fe(OH2)}(2)O-38(6-) silicotungstate showed the highest efficiency of hydrogen peroxide utilization and conversion among di-transition-metal- and iron-substituted silicotungstates. (C) 1999 Academic Press.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Mizuno, N (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.						Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; CLERICI MG, 1991, APPL CATAL, V68, P249; Zhang X, 1997, INORG CHEM, V36, P4381, DOI 10.1021/ic970391r; Mizuno N, 1998, J AM CHEM SOC, V120, P9267, DOI 10.1021/ja980006c; BATTIONI P, 1988, J AM CHEM SOC, V110, P8462, DOI 10.1021/ja00233a023; MEUNIER B, 1992, CHEM REV, V92, P1411, DOI 10.1021/cr00014a008; CORMA A, 1995, J CATAL, V152, P18, DOI 10.1006/jcat.1995.1055; NAM WW, 1991, J AM CHEM SOC, V113, P7052, DOI 10.1021/ja00018a062; ISHII Y, 1988, J ORG CHEM, V53, P3587, DOI 10.1021/jo00250a032; Barton DHR, 1996, TETRAHEDRON LETT, V37, P1133, DOI 10.1016/0040-4039(96)00001-9; BARTON DHR, 1993, TETRAHEDRON LETT, V34, P567, DOI 10.1016/S0040-4039(00)61621-0; Collman J.P., 1987, PRINCIPLES APPL ORGA; DTOIA C, 1997, TETRAHEDRON LETT, V38, P3727; HILL CL, 1995, COORDIN CHEM REV, V143, P407, DOI 10.1016/0010-8545(95)01141-B; ISHII Y, 1990, REV HETEROATOM CHEM, V3, P121; Jappar N, 1998, J CATAL, V180, P132, DOI 10.1006/jcat.1998.2266; MIZUNO N, IN PRESS J CATAL; NAM W, 1989, NEW J CHEM, V13, P677; Notari B, 1996, ADV CATAL, V41, P253, DOI 10.1016/S0360-0564(08)60042-5; Sheldon R. A., 1993, TOP CURR CHEM, V164, P23; Sheldon R. A., 1981, METAL CATALYZED OXID; SHEU C, 1990, J AM CHEM SOC, V112, P1936, DOI 10.1021/ja00161a045; SOBKOWIAK A, 1992, PROG INORG CHEM, V40, P291, DOI 10.1002/9780470166413.ch4; SUGIMOTO H, 1985, J ORG CHEM, V50, P1784, DOI 10.1021/jo00210a053; THELLEND A, 1994, J CHEM SOC CHEM COMM, P1035, DOI 10.1039/c39940001035; TRAYLOR TG, 1993, J AM CHEM SOC, V115, P2775, DOI 10.1021/ja00060a027; Vogel AI, 1978, TXB QUANTITATIVE INO	27	24	26	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517			J CATAL	J. Catal.	FEB 15	1999	182	1					285	288		10.1006/jcat.1998.2369		4	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	170XA	WOS:000078831300032		
J	Takatsuka, K; Seko, C				Takatsuka, K; Seko, C			Concept of interbasin mixing and extension of the Lyapunov exponent in multiple potential-basin dynamics as in structural isomerization of clusters	JOURNAL OF CHEMICAL PHYSICS			English	Article							CYLINDRICAL MANIFOLDS; ATOMIC CLUSTERS; PHASE-SPACE; SURFACES; CHAOS	For Hamilton dynamics on a potential that has multiple local basins as in structural isomerization reaction of clusters, a notion of interbasin mixing is introduced that is responsible for Markov-type stochastic appearance of molecular structures. An extension of the Lyapunov exponent to quantify the time scale to reach interbasin mixing is proposed. The present dynamics also serves as a prototype of multichannel chemical reactions. (C) 1999 American Institute of Physics. [S0021-9606(99)52007-2].	Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan; Nagoya Univ, Grad Sch Human Informat, Nagoya, Aichi 4648601, Japan	Takatsuka, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan.						AMAR FG, 1986, J CHEM PHYS, V85, P5943, DOI 10.1063/1.451506; FAIR JR, 1995, J PHYS CHEM-US, V99, P14707, DOI 10.1021/j100040a019; BENETTIN G, 1976, PHYS REV A, V14, P2338, DOI 10.1103/PhysRevA.14.2338; KLAFTER J, 1994, PHYS REV E, V49, P4873, DOI 10.1103/PhysRevE.49.4873; OHMINE I, 1993, CHEM REV, V93, P2545, DOI 10.1021/cr00023a011; HINDE RJ, 1992, J CHEM PHYS, V96, P1376, DOI 10.1063/1.462173; HINDE RJ, 1993, J CHEM PHYS, V99, P2942, DOI 10.1063/1.465201; DELEON N, 1992, J CHEM PHYS, V96, P285, DOI 10.1063/1.462516; BERRY RS, 1993, CHEM REV, V93, P2379, DOI 10.1021/cr00023a003; Wales DJ, 1996, SCIENCE, V271, P925, DOI 10.1126/science.271.5251.925; ZASLAVSKY GM, 1993, PHYS REV E, V48, P1683, DOI 10.1103/PhysRevE.48.1683; Ball KD, 1996, SCIENCE, V271, P963, DOI 10.1126/science.271.5251.963; Berry RS, 1996, INT J QUANTUM CHEM, V58, P657; BRAIER PA, 1990, J CHEM PHYS, V93, P8745, DOI 10.1063/1.459263; DELEON N, 1991, J CHEM PHYS, V94, P8310, DOI 10.1063/1.460116; DELEON N, 1992, J CHEM PHYS, V94, P8329; JELLINEK J, 1986, J CHEM PHYS, V84, P2783, DOI 10.1063/1.450303; KUBO R, 1998, STAT PHYSICS, V2; Mainz DT, 1996, MOL PHYS, V88, P709, DOI 10.1080/00268979650026244; NAYAK SK, 1995, PHYS REV E, V51, P3376, DOI 10.1103/PhysRevE.51.3376; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P539; Richards F. M., 1991, Scientific American, V264; Seko C, 1998, J CHEM PHYS, V109, P4768, DOI 10.1063/1.477088; Seko C, 1998, J CHEM PHYS, V108, P4924, DOI 10.1063/1.475901; Seko C, 1996, J CHEM PHYS, V104, P8613, DOI 10.1063/1.471550; SLESINGER MF, 1993, NATURE, V363, P31; Steinfeld J.I., 1989, CHEM KINETICS DYNAMI; Takatsuka K, 1996, J CHEM PHYS, V105, P10356, DOI 10.1063/1.472965; Yanao T., UNPUB	29	14	14	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	FEB 15	1999	110	7					3263	3266		10.1063/1.478191		4	Physics, Atomic, Molecular & Chemical	Physics	164DA	WOS:000078446100001		
J	Togo, T; Morisawa, M				Togo, T; Morisawa, M			Mechanisms for blocking polyspermy in oocytes of the oyster Crassostrea gigas	JOURNAL OF EXPERIMENTAL ZOOLOGY			English	Article							ELECTRICALLY MEDIATED BLOCK; MUSSEL MYTILUS-EDULIS; URECHIS-CAUPO; EGGS; FERTILIZATION; ACTIVATION; MATURATION	We showed here the mechanisms to black polyspermy in the oocyte of the oyster Crassostrea gigas. When the fertilized monospermic oocytes were inseminated again with high sperm-oocyte ratio 15 min after the initial insemination, sperm could not penetrate into the oocytes; the oocytes were still monospermic. Insemination in low-sodium artificial seawater induced polyspermy, suggesting the occurrence of a fast polyspermy block caused by depolarization of the plasma membrane at fertilization. Requirement of external sodium ion for blocking polyspermy continued for 15 min after fertilization. Release of proteases from oocytes at fertilization was not observed. Electron microscopic observations showed that re-inseminated sperm could undergo acrosome reaction and bind to the fertilized oocytes, but acrosomal process did not fuse with the oocyte plasma membrane. These results suggest that blockage of contact or fusion of the plasma membrane between sperm and oocyte acts as a slow polyspermy block in Crassostrea. (C) 1999 Wiley-Liss, Inc.	Univ Tokyo, Misaki Marine Biol Stn, Kanagawa 2380225, Japan	Togo, T (reprint author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	togot@socrates.berkeley.edu					ALLIEGRO MC, 1983, J EXP ZOOL, V227, P127, DOI 10.1002/jez.1402270117; GOULDSOMERO M, 1979, J CELL BIOL, V82, P426, DOI 10.1083/jcb.82.2.426; KURAISHI R, 1988, Bulletin of the Marine Biological Station of Asamushi, V18, P57; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; GREY RD, 1982, DEV BIOL, V89, P475, DOI 10.1016/0012-1606(82)90335-9; BRAWLEY SH, 1991, DEV BIOL, V144, P94, DOI 10.1016/0012-1606(91)90482-I; CROSS NL, 1980, DEV BIOL, V75, P187, DOI 10.1016/0012-1606(80)90154-2; DESILETS J, 1995, INVERTEBR REPROD DEV, V27, P115, DOI 10.1080/07924259.1995.9672441; ECKBERG WR, 1984, J EXP ZOOL, V233, P253; FINKEL T, 1980, GAMETE RES, V3, P299, DOI 10.1002/mrd.1120030312; GOUDEAU H, 1989, DEV BIOL, V133, P348, DOI 10.1016/0012-1606(89)90039-0; GOUDEAU H, 1994, DEV BIOL, V166, P489, DOI 10.1006/dbio.1994.1332; GOUDEAU H, 1989, BOD MAR LAB, P61; HORVATH PM, 1993, MOL REPROD DEV, V34, P65, DOI 10.1002/mrd.1080340111; IWAO Y, 1989, DEV BIOL, V134, P438, DOI 10.1016/0012-1606(89)90116-4; JAFFE LA, 1976, NATURE, V261, P68, DOI 10.1038/261068a0; JAFFE LA, 1980, DEV GROWTH DIFFER, V22, P503; JAFFE LA, 1983, PHYSL EXCITABLE CELL, P211; Jaffe LA, 1985, BIOL FERTILIZATION, P223; KOBAYASHI W, 1994, DEV BIOL, V161, P552, DOI 10.1006/dbio.1994.1053; LAMBERT CC, 1989, DEVELOPMENT, V105, P415; LONGO FJ, 1993, BIOL BULL, V185, P197, DOI 10.2307/1542000; LONGO FJ, 1976, AM ZOOL, V16, P375; LONGO FJ, 1983, MOLLUSCA, V3, P49; MIYAZAKI S, 1979, DEV BIOL, V70, P327, DOI 10.1016/0012-1606(79)90031-9; OSANAI K, 1985, Bulletin of the Marine Biological Station of Asamushi, V18, P1; PAUL M, 1976, J EXP ZOOL, V196, P105, DOI 10.1002/jez.1401960110; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STEPHANO JL, 1988, AQUACULTURE, V73, P295; Togo T, 1997, DEV BIOL, V182, P219, DOI 10.1006/dbio.1996.8483; Togo T, 1995, BIOL BULL-US, V189, P330, DOI 10.2307/1542150; KLINE D, 1985, J EXP ZOOL, V236, P45, DOI 10.1002/jez.1402360107; ZIOMEK CA, 1975, SCIENCE, V189, P139, DOI 10.1126/science.1173469	33	12	13	WILEY-LISS	HOBOKEN	DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA	0022-104X			J EXP ZOOL	J. Exp. Zool.	FEB 15	1999	283	3					307	314		10.1002/(SICI)1097-010X(19990215)283:3<307::AID-JEZ8>3.3.CO;2-E		8	Zoology	Zoology	161JT	WOS:000078286000008		
J	Borrell, V; Del Rio, JA; Alcantara, S; Derer, M; Martinez, A; D'Arcangelo, G; Nakajima, K; Mikoshiba, K; Derer, P; Curran, T; Soriano, E				Borrell, V; Del Rio, JA; Alcantara, S; Derer, M; Martinez, A; D'Arcangelo, G; Nakajima, K; Mikoshiba, K; Derer, P; Curran, T; Soriano, E			Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections	JOURNAL OF NEUROSCIENCE			English	Article						Reelin; Cajal-Retzius cells; synaptic specificity; neuronal connections; hippocampus; reeler mutant mouse	CAJAL-RETZIUS CELLS; POSTNATAL MURINE HIPPOCAMPUS; AXON GUIDANCE; IN-VIVO; ORGANOTYPIC CULTURES; CORTICAL DEVELOPMENT; SYNAPTIC ACTIVITY; PIONEER NEURONS; GENE FAMILY; ORGANIZATION	Here we examine the role of Reelin, an extracellular protein involved in neuronal migration, in the formation of hippocampal connections. Both at prenatal and postnatal stages, the general laminar and topographic distribution of entorhinal projections is preserved in the hippocampus of reeler mutant mice, in the absence of Reelin. However, developing and adult entorhinal afferents show severe alterations, including increased numbers of misrouted fibers and the formation of abnormal patches of termination from the medial and lateral entorhinal cortices. At perinatal stages, single entorhinal axons in reeler mice are grouped into thick bundles, and they have decreased axonal branching and decreased extension of axon collaterals. We also show that the number of entorhino-hippocampal synapses is lower in reeler mice than in control animals during development. Studies performed in mixed entorhino-hippocampal cocultures combining slices from reeler and wild-type mice indicate that these abnormalities are caused by the lack of Reelin in the target hippocampus. These findings imply that Reelin fulfills a modulatory role during the formation of layer-specific and topographic connections in the hippocampus. They also suggest that Reelin promotes maturation of single fibers and synaptogenesis by entorhinal afferents.	Univ Barcelona, Fac Biol, Dept Anim & Plant Cell Biol, Barcelona 08028, Spain; Univ Paris 06, Dev Neurobiol Lab, F-75005 Paris, France; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Jikei Univ, Sch Med, Res Ctr Med Sci, Dept Mol Neurobiol,Inst DNA Med,Minato Ku, Tokyo 1058461, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 108, Japan	Soriano, E (reprint author), Univ Barcelona, Fac Biol, Dept Anim & Plant Cell Biol, Av Diagonal 645, Barcelona 08028, Spain.		Alcantara, Soledad/K-3648-2014; Nakajima, Kazunori/L-3396-2013; Curran, Tom/C-1164-2008; Curran, Tom/D-7515-2011; 	Alcantara, Soledad/0000-0003-3313-2715; Curran, Tom/0000-0003-1444-7551; Del Rio, Jose Antonio/0000-0002-5214-4909			Amaral David G., 1995, P443; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Forster E, 1998, DEVELOPMENT, V125, P3399; DelRio JA, 1996, J NEUROSCI, V16, P6896; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; DArcangelo G, 1997, J NEUROSCI, V17, P23; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Gotz M, 1997, EUR J NEUROSCI, V9, P496, DOI 10.1111/j.1460-9568.1997.tb01627.x; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Martinez A, 1998, J NEUROSCI, V18, P7336; FROTSCHER M, 1993, P NATL ACAD SCI USA, V90, P10400, DOI 10.1073/pnas.90.21.10400; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; HIROTSUNE S, 1995, NAT GENET, V10, P77, DOI 10.1038/ng0595-77; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Alcantara S, 1996, EUR J NEUROSCI, V8, P1329, DOI 10.1111/j.1460-9568.1996.tb01595.x; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Culotti JG, 1996, CURR OPIN NEUROBIOL, V6, P81, DOI 10.1016/S0959-4388(96)80012-2; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; SWANSON LW, 1978, J COMP NEUROL, V181, P681, DOI 10.1002/cne.901810402; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Alcantara S, 1998, J NEUROSCI, V18, P7779; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341; Faissner A, 1997, CELL TISSUE RES, V290, P331, DOI 10.1007/s004410050938; Goldowitz D, 1997, J NEUROSCI, V17, P8767; Nakajima K, 1997, P NATL ACAD SCI USA, V94, P8196, DOI 10.1073/pnas.94.15.8196; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Super H, 1998, J NEUROSCI, V18, P4616; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; STEWARD O, 1976, J COMP NEUROL, V169, P347, DOI 10.1002/cne.901690306; Brennan C, 1997, DEVELOPMENT, V124, P655; Chedotal A, 1998, DEVELOPMENT, V125, P4313; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; DELECEA L, 1994, MOL BRAIN RES, V25, P286, DOI 10.1016/0169-328X(94)90164-3; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; EDMUNDS SM, 1982, J NEUROCYTOL, V11, P427, DOI 10.1007/BF01257987; Fujisawa H, 1997, CELL TISSUE RES, V290, P465, DOI 10.1007/s004410050954; Goffinet AM, 1997, NATURE, V389, P668, DOI 10.1038/39453; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; Holt CE, 1998, CURR OPIN NEUROBIOL, V8, P98, DOI 10.1016/S0959-4388(98)80013-5; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; MARINPADILLA M, 1982, ANAT EMBRYOL, V164, P161, DOI 10.1007/BF00318504; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Rice DS, 1998, DEVELOPMENT, V125, P3719; RUTH RE, 1982, J COMP NEUROL, V209, P69, DOI 10.1002/cne.902090107; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406; STANFIELD BB, 1979, J COMP NEUROL, V185, P461, DOI 10.1002/cne.901850304; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Super H, 1998, BRAIN RES REV, V27, P40, DOI 10.1016/S0165-0173(98)00005-8; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; WINSLOW JW, 1995, NEURON, V14, P973, DOI 10.1016/0896-6273(95)90335-6	70	122	127	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 15	1999	19	4					1345	1358				14	Neurosciences	Neurosciences & Neurology	166XP	WOS:000078603500018		
J	Umemori, H; Kadowaki, Y; Hirosawa, K; Yoshida, Y; Hironaka, K; Okano, H; Yamamoto, T				Umemori, H; Kadowaki, Y; Hirosawa, K; Yoshida, Y; Hironaka, K; Okano, H; Yamamoto, T			Stimulation of myelin basic protein gene transcription by Fyn tyrosine kinase for myelination	JOURNAL OF NEUROSCIENCE			English	Article						myelination; Fyn tyrosine kinase; myelin basic protein; transactivation; developmental regulation; knock-out mouse	DNA-BINDING PROTEIN; MUTANT MICE; PROMOTER; EXPRESSION; FAMILY; REPEAT; CELLS; SITE; PHOSPHORYLATION; EFFICIENT	Myelin is synthesized about the time of birth. The Src-family tyrosine kinase Fyn is involved in the initial events of myelination. Fyn is present in myelin-forming cells and is activated through stimulation of cell surface receptors such as large myelin-associated glycoprotein (L-MAG). Here we show that Fyn stimulates transcription of the myelin basic protein (MBP) gene for myelination. MBP is a major component of the myelin membrane. In 4-week-old Fyn-deficient mice, MBP is significantly reduced, and electron microscopic analysis showed that myelination is delayed, compared with wild-type mice. The Fyn-deficient mice had thinner, more irregular myelin than the wild-type. We found that Fyn stimulates the promoter activity of the MBP gene by approximately sevenfold. The region responsible for the transactivation by Fyn is located between nucleotides -675 and -647 with respect to the transcription start site. Proteins binding to this region were found by gel shift study, and the binding activity correlates with Fyn activity during myelination. These results suggest that transactivation of the MBP gene by Fyn is important for myelination.	Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neuroanat, Suita, Osaka 5650871, Japan; Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Suita, Osaka 5650871, Japan	Yamamoto, T (reprint author), Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan.		Okano, Hideyuki/J-5973-2013				Cao XM, 1996, MOL CELL BIOL, V16, P1595; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466; ASIPU A, 1994, GENE, V150, P227, DOI 10.1016/0378-1119(94)90431-6; DEVINEBEACH K, 1990, J BIOL CHEM, V265, P13830; HAAS S, 1995, J CELL BIOL, V130, P1171, DOI 10.1083/jcb.130.5.1171; HAQUE NS, 1994, J BIOL CHEM, V269, P31149; HOUHASHI N, 1995, INT IMMUNOL, V7, P1851; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; INOUE T, 1990, J BIOL CHEM, V265, P19065; KADOWAKI Y, 1995, P NATL ACAD SCI USA, V92, P4432, DOI 10.1073/pnas.92.10.4432; KADOWAKI Y, 1992, BIOCHEM BIOPH RES CO, V183, P492, DOI 10.1016/0006-291X(92)90509-J; KAMHOLZ J, 1988, J NEUROSCI RES, V21, P62, DOI 10.1002/jnr.490210110; MAHONEY CW, 1992, J BIOL CHEM, V267, P19396; MIKOSHIBA K, 1991, ANNU REV NEUROSCI, V14, P201, DOI 10.1146/annurev.neuro.14.1.201; MIURA M, 1989, GENE, V75, P31; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; OKANO H, 1987, J NEUROCHEM, V48, P470, DOI 10.1111/j.1471-4159.1987.tb04116.x; SHIOTA C, 1991, J NEUROCHEM, V56, P818, DOI 10.1111/j.1471-4159.1991.tb01997.x; STEIN B, 1993, MOL CELL BIOL, V13, P3964; TAKEUCHI M, 1993, J BIOL CHEM, V268, P27413; TAMURA TA, 1989, MOL CELL BIOL, V9, P3122; UCHIUMI F, 1992, MOL CELL BIOL, V12, P3784; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; Yoon CS, 1996, CELL TISSUE RES, V284, P77, DOI 10.1007/s004410050568	28	80	82	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 15	1999	19	4					1393	1397				5	Neurosciences	Neurosciences & Neurology	166XP	WOS:000078603500022		
J	Horibata, T; Oi, M; Onishi, N; Ansari, A				Horibata, T; Oi, M; Onishi, N; Ansari, A			Band structures of Os-182 studied by GCM based on 3D-CHFB	NUCLEAR PHYSICS A			English	Article						generator coordinate method; cranked HFB; tilted axis rotation; band crossing; backbending; wobbling motion	NUCLEAR ROTATIONS; STATES; HFB	Band structure properties of Os-182 investigated through a particle number and angular momentum constrained generator coordinate (GCM) calculation based on self-consistent three-dimensional cranking solutions. From the analysis of the wave function of the lowest GCM solution, we confirm that this nucleus shows a tilted rotational motion in its yrast states, at least with the present set of force parameters of the pairing-plus-quadrupole interaction Hamiltonian. A close examination of the behaviour of the other GCM solutions reveals a sign of a possible occurrence of multi-band crossing in the nucleus. We have also found a new potential curve along the prime meridian on the globe of the J = 18 (h) over bar sphere. Along this new solution the characters of proton and neutron gap parameters get interchanged. Namely, Delta(p) almost vanishes while Delta(n) grows to a finite value close to the one corresponding to the principal axis rotation (PAR), A state in the new solution curve at the PAR point turns out to have almost the same characteristic features of an yrare s-band state which is located just above the g-band in our calculation. This fact suggests a new type of seesaw vibrational mode of the proton and the neutron pairing, occurring through a wobbling motion. This mode is considered to bridge the g-band states and the s-band states in the backbending region, (C) 1999 Elsevier Science B.V.	Aomori Univ, Dept Informat Syst Engn, Aomori 0300943, Japan; Inst Phys & Chem Res, Cyclotron Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Coll Arts & Sci, Inst Phys, Meguro Ku, Tokyo 1538902, Japan; Inst Phys, Bhubaneswar 751005, Orissa, India	Horibata, T (reprint author), Aomori Univ, Dept Informat Syst Engn, Aomori 0300943, Japan.						CHOWDHURY P, 1988, NUCL PHYS A, V485, P136, DOI 10.1016/0375-9474(88)90526-X; KUTSAROVA T, 1995, NUCL PHYS A, V587, P111, DOI 10.1016/0375-9474(94)00819-9; HILL DL, 1953, PHYS REV, V89, P1102, DOI 10.1103/PhysRev.89.1102; HARA K, 1982, NUCL PHYS A, V385, P14, DOI 10.1016/0375-9474(82)90486-9; BONCHE P, 1990, NUCL PHYS A, V510, P466, DOI 10.1016/0375-9474(90)90062-Q; ONISHI N, 1986, NUCL PHYS A, V456, P279; WALKER PM, 1993, PHYS LETT B, V309, P17, DOI 10.1016/0370-2693(93)91496-A; GUSTAFSO.C, 1967, ARK FYS, V36, P613; HORIBATA T, 1994, PHYS LETT B, V325, P283, DOI 10.1016/0370-2693(94)90011-6; HORIBATA T, 1997, RIKEN ACCEL PROG REP, V30, P20; HORIBATA T, 1997, RIKEN ACCEL PROG REP, V31, P22; HORIBATA T, 1995, PHYS LETT B, V355, P433, DOI 10.1016/0370-2693(95)00687-G; HORIBATA T, UNPUB J PHYS G; Horibata T, 1996, NUCL PHYS A, V596, P251, DOI 10.1016/0375-9474(95)00421-1; KERMAN AK, 1981, NUCL PHYS A, V361, P179, DOI 10.1016/0375-9474(81)90475-9; LIPKIN HJ, 1960, ANN PHYS-NEW YORK, V12, P425; MEYER J, 1995, NUCL PHYS A, V588, P597, DOI 10.1016/0375-9474(95)00055-6; Nogami Y., 1964, PHYS REV B, V134, P313; OI M, 1997, PHYS LETT B, V418, P1; Ring P., 1980, NUCL MANY BODY PROBL; WALKER PM, 1993, P FUT NUCL SPECTR CR; WUST E, 1985, NUCL PHYS A, V435, P477, DOI 10.1016/0375-9474(85)90474-9; ZHENG DC, 1992, PHYS REV C, V46, P1355, DOI 10.1103/PhysRevC.46.1355	23	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9474			NUCL PHYS A	Nucl. Phys. A	FEB 15	1999	646	3					277	295		10.1016/S0375-9474(98)00642-3		19	Physics, Nuclear	Physics	166JC	WOS:000078571600001		
J	Basu-Mallick, B				Basu-Mallick, B			Symmetries and exact solutions of some integrable Haldane-Shastry-like spin chains	NUCLEAR PHYSICS B			English	Article						Haldane-Shastry model; Yangian algebra; anyon; Dunkl operator; quantum group	CALOGERO-SUTHERLAND MODEL; DYNAMICAL CORRELATION-FUNCTIONS; INVERSE-SQUARE EXCHANGE; LONG-RANGE INTERACTIONS; YANG-BAXTER EQUATION; W-INFINITY ALGEBRA; FRACTIONAL STATISTICS; QUANTUM-SYSTEMS; SPECTRUM; STATES	Here we construct some integrable Haldane-Shastry (HS) like spin chains, which exhibit multi-parameter deformed or non-standard variants of Y(gl(M)) Yangian symmetry. By projecting the eigenstates of Dunkl operators in a suitable way, we also derive a class of exact eigenfunctions for such spin chains and subsequently conjecture that these exact eigenfunctions would lead to the highest weight states (HWS) associated with multi-parameter deformed or non-standard variants of Y(gl(M)) Yangian algebra. By using this conjecture, and acting descendent operator on the HWS associated with a non-standard Y(gl(2)) Yangian algebra, we are able to find out the complete set of eigenvalues and eigenfunctions for the related MS-like spin-1/2 chain. It turns out that some additional energy levels, which are forbidden due to a selection rule in the case of SU(2) HS model, interestingly appear in the spectrum of the above mentioned MS-like spin chain with non-standard Y(gl(2)) symmetry. (C) 1999 Elsevier Science B.V.	Univ Tokyo, Fac Sci, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	Basu-Mallick, B (reprint author), Univ Tokyo, Fac Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.						Albertini G, 1997, NUCL PHYS B, V493, P541, DOI 10.1016/S0550-3213(97)00078-3; ALCARAZ FC, 1990, J STAT PHYS, V58, P45, DOI 10.1007/BF01020284; LESAGE F, 1995, NUCL PHYS B, V435, P585, DOI 10.1016/0550-3213(94)00453-L; UJINO H, 1992, J PHYS SOC JPN, V61, P3425, DOI 10.1143/JPSJ.61.3425; SHASTRY BS, 1988, PHYS REV LETT, V60, P639, DOI 10.1103/PhysRevLett.60.639; CALOGERO F, 1969, J MATH PHYS, V10, P2191, DOI 10.1063/1.1664820; HALDANE FDM, 1992, PHYS REV LETT, V69, P2021, DOI 10.1103/PhysRevLett.69.2021; GWA LH, 1992, PHYS REV A, V46, P844, DOI 10.1103/PhysRevA.46.844; MAJID S, 1993, MATH PROC CAMBRIDGE, V113, P45, DOI 10.1017/S0305004100075769; HALDANE FDM, 1988, PHYS REV LETT, V60, P635, DOI 10.1103/PhysRevLett.60.635; BERNARD D, 1993, J PHYS A-MATH GEN, V26, P5219, DOI 10.1088/0305-4470/26/20/010; OLSHANETSKY MA, 1983, PHYS REP, V94, P313, DOI 10.1016/0370-1573(83)90018-2; AZUMA H, 1994, PHYS LETT B, V331, P107, DOI 10.1016/0370-2693(94)90949-0; BasuMallick B, 1996, PHYS LETT A, V211, P339, DOI 10.1016/0375-9601(96)00008-4; Basu-Mallick B, 1998, NUCL PHYS B, V509, P705, DOI 10.1016/S0550-3213(97)00686-X; BasuMallick B, 1996, NUCL PHYS B, V482, P713, DOI 10.1016/S0550-3213(96)00544-5; BasuMallick B, 1997, INT J MOD PHYS A, V12, P945, DOI 10.1142/S0217751X97000700; Chari V., 1994, GUIDE QUANTUM GROUPS; DRINFELD VG, 1987, ICM P BERK, P798; FRAHM H, 1993, J PHYS A-MATH GEN, V26, pL473, DOI 10.1088/0305-4470/26/10/002; Fukui T, 1996, PHYS REV LETT, V76, P4242, DOI 10.1103/PhysRevLett.76.4242; HA ZNC, 1992, B AM PHYS SOC, V37, P646; HA ZNC, 1994, PHYS REV LETT, V73, P1574, DOI 10.1103/PhysRevLett.73.1574; HA ZNC, 1995, NUCL PHYS B, V435, P604, DOI 10.1016/0550-3213(94)00537-O; Haldane F, 1994, P 16 TAN S KASH JAP; HIKAMI K, 1994, PHYS REV LETT, V73, P1191, DOI 10.1103/PhysRevLett.73.1191; HIKAMI K, 1993, J PHYS SOC JPN, V62, P4203, DOI 10.1143/JPSJ.62.4203; KAWAKAMI N, 1992, PHYS REV B, V46, P1005, DOI 10.1103/PhysRevB.46.1005; KUNDU A, CONDMAT9710033; MAJID S, 1995, J MATH PHYS, V36, P7081, DOI 10.1063/1.531344; MURTHY MVN, 1994, PHYS REV LETT, V73, P3331, DOI 10.1103/PhysRevLett.73.3331; PERK JHH, 1990, ADV SERIES MATH PHYS, V10, P326; POLYCHRONAKOS AP, 1994, NUCL PHYS B, V419, P553, DOI 10.1016/0550-3213(94)90344-1; SUTHERLAND B, 1993, PHYS REV LETT, V71, P5, DOI 10.1103/PhysRevLett.71.5; SIMONS BD, 1993, NUCL PHYS B, V409, P487, DOI 10.1016/0550-3213(93)90540-6; STOLIN A, TRITAMAT1996JU11; STONE M, 1994, INT J MOD PHYS B, V8, P2539, DOI 10.1142/S0217979294001020; SUTHERLA.B, 1972, PHYS REV A-GEN PHYS, V5, P1372, DOI 10.1103/PhysRevA.5.1372; SUTHERLA.B, 1967, PHYS REV LETT, V19, P588, DOI 10.1103/PhysRevLett.19.588; UJINO H, 1995, J PHYS SOC JPN, V64, P39, DOI 10.1143/JPSJ.64.39; YANG CP, 1967, PHYS REV LETT, V19, P586, DOI 10.1103/PhysRevLett.19.586	41	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	FEB 15	1999	540	3					679	704		10.1016/S0550-3213(98)00784-6		26	Physics, Particles & Fields	Physics	168DW	WOS:000078676900006		
J	Higuchi, S				Higuchi, S			Hamiltonian cycles on random lattices of arbitrary genus	NUCLEAR PHYSICS B			English	Article						random graph; random lattice; Hamiltonian cycle; self-avoiding walk; compact polymer	PACKED LOOP MODEL; HONEYCOMB LATTICE; PLANAR DIAGRAMS; QUANTUM-GRAVITY; RANDOM SURFACES; POLYMERS; WALKS	A Hamiltonian cycle of a graph is a closed path that visits every vertex once and only once. It has been difficult to count the number of Hamiltonian cycles on regular lattices with periodic boundary conditions, e.g. lattices on a torus, due to the presence of winding modes. In this paper, the exact number of Hamiltonian cycles on a random trivalent fat graph drawn faithfully on a torus is obtained. This result is further extended to the case of random graphs drawn on surfaces of an arbitrary genus. The conformational exponent gamma is found to depend on the genus linearly. (C) 1999 Elsevier Science B.V.	Univ Tokyo, Dept Pure & Appl Sci, Tokyo 1538902, Japan	Higuchi, S (reprint author), Univ Tokyo, Dept Pure & Appl Sci, Tokyo 1538902, Japan.						DISTLER J, 1989, NUCL PHYS B, V321, P509, DOI 10.1016/0550-3213(89)90354-4; Kondev J, 1998, PHYS REV LETT, V81, P2922, DOI 10.1103/PhysRevLett.81.2922; BLOTE HWJ, 1994, PHYS REV LETT, V72, P1372, DOI 10.1103/PhysRevLett.72.1372; BREZIN E, 1978, COMMUN MATH PHYS, V59, P35, DOI 10.1007/BF01614153; DUPLANTIER B, 1987, NUCL PHYS B, V290, P291, DOI 10.1016/0550-3213(87)90190-8; CHAN HS, 1989, MACROMOLECULES, V22, P4559, DOI 10.1021/ma00202a031; KOSTOV IK, 1987, PHYS LETT B, V189, P118, DOI 10.1016/0370-2693(87)91281-0; AMBJORN J, 1993, NUCL PHYS B, V404, P127, DOI 10.1016/0550-3213(93)90476-6; Jacobsen JL, 1998, NUCL PHYS B, V532, P635, DOI 10.1016/S0550-3213(98)00571-9; Doniach S, 1996, J CHEM PHYS, V105, P1601, DOI 10.1063/1.472031; LIEB EH, 1967, PHYS REV LETT, V18, P692, DOI 10.1103/PhysRevLett.18.692; DAVID F, 1988, MOD PHYS LETT A, V3, P1651, DOI 10.1142/S0217732388001975; KNIZHNIK VG, 1988, MOD PHYS LETT A, V3, P819, DOI 10.1142/S0217732388000982; KAZAKOV VA, 1985, PHYS LETT B, V157, P295, DOI 10.1016/0370-2693(85)90669-0; AMBJORN J, 1995, NUCL PHYS B, V449, P681; Kondev J, 1996, J PHYS A-MATH GEN, V29, P6489, DOI 10.1088/0305-4470/29/20/007; KAZAKOV VA, 1989, MOD PHYS LETT A, V4, P2125, DOI 10.1142/S0217732389002392; BANKS T, 1990, PHYS LETT B, V238, P279, DOI 10.1016/0370-2693(90)91736-U; Batchelor MT, 1996, J PHYS A-MATH GEN, V29, pL399, DOI 10.1088/0305-4470/29/16/001; BATCHELOR MT, 1994, PHYS REV LETT, V73, P2646, DOI 10.1103/PhysRevLett.73.2646; BESSIS D, 1980, ADV APPL MATH, V109, P1; CAMACHO CJ, 1993, PHYS REV LETT, V71, P2505, DOI 10.1103/PhysRevLett.71.2505; DAVID F, 1985, NUCL PHYS B, V257, P45, DOI 10.1016/0550-3213(85)90335-9; DESCLOIZEAUX J, 1987, POLYM SOLUTION THEIR; DUPLANTIER B, 1990, NUCL PHYS B, V340, P491, DOI 10.1016/0550-3213(90)90456-N; DUPLANTIER B, 1988, PHYS REV LETT, V61, P1433, DOI 10.1103/PhysRevLett.61.1433; Eynard B, 1998, NUCL PHYS B, V528, P523, DOI 10.1016/S0550-3213(98)00391-5; Ginsparg P. H., HEPTH9304011; Higuchi S, 1998, MOD PHYS LETT A, V13, P727, DOI 10.1142/S0217732398000784; Higuchi S, 1998, PHYS REV E, V58, P128, DOI 10.1103/PhysRevE.58.128; Hooft G. 't, 1974, NUCL PHYS          B, V75, P46, DOI 10.1016/0550-3213(74)90154-0; KASTELEYN PW, 1963, PHYSICA, V29, P1329; Mehta M. L., 1991, RANDOM MATRICES REVI; ORLAND H, 1985, J PHYS LETT-PARIS, V46, pL353; SCHMALZ TG, 1984, J PHYS A-MATH GEN, V17, P445, DOI 10.1088/0305-4470/17/2/029; SUZUKI J, 1988, J PHYS SOC JPN, V57, P687, DOI 10.1143/JPSJ.57.687	36	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	FEB 15	1999	540	3					731	741				11	Physics, Particles & Fields	Physics	168DW	WOS:000078676900008		
J	Li, XQ; Nakayama, H; Arakawa, Y				Li, XQ; Nakayama, H; Arakawa, Y			Phonon bottleneck in quantum dots: Role of lifetime of the confined optical phonons	PHYSICAL REVIEW B			English	Article							ULTRAFAST ENERGY RELAXATION; MULTIPHONON PROCESSES; ELECTRON RELAXATION; EXCITON RELAXATION; BOX SYSTEMS; PHOTOLUMINESCENCE; LUMINESCENCE; TEMPERATURE; SCATTERING; THRESHOLD	The phonon bottleneck in quantum dots is reexamined theoretically within the intrinsic phonon scattering mechanism. In the coupled-mode-equation formalism, an analytical solution is derived for the carrier relaxation. The result shows that, due to the anharmonic coupling of the confined LO phonon to the bulk acoustic phonons, the carrier relaxation rate is higher than 10(10) s(-1) in a wide detuning range of tens of meV around the LO phonon energy, which differs remarkably from the original phonon bottleneck prediction. [S0163-1829(99)04107-7].	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Li, XQ (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 106, Japan.						EFROS AL, 1995, SOLID STATE COMMUN, V93, P281; Heitz R, 1997, PHYS REV B, V56, P10435, DOI 10.1103/PhysRevB.56.10435; SERCEL PC, 1995, PHYS REV B, V51, P14532, DOI 10.1103/PhysRevB.51.14532; Schroeter DF, 1996, PHYS REV B, V54, P1486, DOI 10.1103/PhysRevB.54.1486; Steer MJ, 1996, PHYS REV B, V54, P17738, DOI 10.1103/PhysRevB.54.17738; BOCKELMANN U, 1990, PHYS REV B, V42, P8947, DOI 10.1103/PhysRevB.42.8947; ASADA M, 1986, IEEE J QUANTUM ELECT, V22, P1915, DOI 10.1109/JQE.1986.1073149; BENISTY H, 1991, PHYS REV B, V44, P10945, DOI 10.1103/PhysRevB.44.10945; BOCKELMANN U, 1992, PHYS REV B, V46, P15574, DOI 10.1103/PhysRevB.46.15574; ARAKAWA Y, 1986, IEEE J QUANTUM ELECT, V22, P1887, DOI 10.1109/JQE.1986.1073185; BRUNNER K, 1992, PHYS REV LETT, V69, P3216, DOI 10.1103/PhysRevLett.69.3216; ARAKAWA Y, 1982, APPL PHYS LETT, V40, P939, DOI 10.1063/1.92959; BENISTY H, 1995, PHYS REV B, V51, P13281, DOI 10.1103/PhysRevB.51.13281; Bockelmann U, 1997, PHYS REV B, V55, P4456, DOI 10.1103/PhysRevB.55.4456; BOCKELMANN U, 1993, PHYS REV B, V48, P17637, DOI 10.1103/PhysRevB.48.17637; INOSHITA T, 1992, PHYS REV B, V46, P7260, DOI 10.1103/PhysRevB.46.7260; Li XQ, 1997, PHYS REV B, V56, P10423, DOI 10.1103/PhysRevB.56.10423; LI XQ, IN PRESS SOLID STATE; Li XQ, 1998, PHYS REV B, V57, P12285, DOI 10.1103/PhysRevB.57.12285; LIPSANEN H, 1995, PHYS REV B, V51, P13868, DOI 10.1103/PhysRevB.51.13868; Mukai K, 1996, PHYS REV B, V54, pR5243; Ohnesorge B, 1996, PHYS REV B, V54, P11532, DOI 10.1103/PhysRevB.54.11532; OSHINOWO J, 1994, APPL PHYS LETT, V65, P1421, DOI 10.1063/1.112070; RUSTAGI KC, 1976, SOLID STATE COMMUN, V18, P673, DOI 10.1016/0038-1098(76)91757-9; Vollmer M, 1996, PHYS REV B, V54, P17292; WANG G, 1994, APPL PHYS LETT, V64, P2815, DOI 10.1063/1.111434; WANG PD, 1994, SURF SCI, V305, P585, DOI 10.1016/0039-6028(94)90958-X; Woggon U, 1996, PHYS REV B, V54, P17681, DOI 10.1103/PhysRevB.54.17681	28	147	147	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	1999	59	7					5069	5073		10.1103/PhysRevB.59.5069		5	Physics, Condensed Matter	Physics	169YZ	WOS:000078778800085		
J	Roche, S; Saito, R				Roche, S; Saito, R			Effects of magnetic field and disorder on the electronic properties of carbon nanotubes	PHYSICAL REVIEW B			English	Article								The electronic properties of carbon nanotubes are investigated in the presence of a magnetic field perpendicular to the nanotube axis and disorder introduced through site-energy randomness. The magnetic field is shown to induce a metal-insulator transition for the metallic (9,0),(12,0)... nanotubes in the absence of disorder. It is also shown that semiconducting nanotubes can become metallic with increasing magnetic strength. The low disorder limit preserved the electronic structure whereas the metal-insulator transition remains even in the strong disorder limit. These results may find experimental confirmation with tunneling spectroscopy measurements. [S0163-1829(99)03907-7].	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138654, Japan; Univ Electrocommun, Dept Elect Engn, Chofu, Tokyo 1828585, Japan	Roche, S (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.		Saito, Riichiro/B-1132-2008; Roche, Stephan/B-1116-2012	Roche, Stephan/0000-0003-0323-4665			Wong SS, 1998, NATURE, V394, P52; Roche S, 1997, PHYS REV LETT, V79, P2518, DOI 10.1103/PhysRevLett.79.2518; Menon M, 1997, PHYS REV LETT, V79, P4453, DOI 10.1103/PhysRevLett.79.4453; Roche S, 1999, PHYS REV B, V59, P2284, DOI 10.1103/PhysRevB.59.2284; TURCHI P, 1982, J PHYS C SOLID STATE, V15, P2891, DOI 10.1088/0022-3719/15/13/017; AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Charlier JC, 1996, PHYS REV B, V53, P11108, DOI 10.1103/PhysRevB.53.11108; Langer L, 1996, PHYS REV LETT, V76, P479, DOI 10.1103/PhysRevLett.76.479; Tans SJ, 1998, NATURE, V393, P49; Chico L, 1998, PHYS REV LETT, V81, P1278, DOI 10.1103/PhysRevLett.81.1278; HAYDOCK R, 1984, SPRINGER SERIES SOLI, V58, P216; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Mayou D, 1998, MATER RES SOC SYMP P, V491, P231; ROCHE S, UNPUB; ROHRER H, 1998, NANOELECTRONICS NANO; Saito R, 1998, PHYSICAL PROPERTIES; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139	18	43	44	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	1999	59	7					5242	5246		10.1103/PhysRevB.59.5242		5	Physics, Condensed Matter	Physics	169YZ	WOS:000078778800105		
J	Imamura, H; Maksym, PA; Aoki, H				Imamura, H; Maksym, PA; Aoki, H			Vertically coupled double quantum dots in magnetic fields	PHYSICAL REVIEW B			English	Article							INTERACTING ELECTRONS; HALL SYSTEM; STATE; SPECTROSCOPY; WELL	Ground- and excited-state properties of vertically coupled double quantum dots are studied by exact diagonalization. Magic-number total angular moment that minimize the total energy are found to reflect a crossover between electron configurations dominated by intralayer correlation and those dominated by interlayer correlation. The position of the crossover is governed by the strength of the interlayer electron tunneling and magnetic field. The magic numbers should have an observable effect on the far-infrared optical-absorption spectrum, since Kohn's theorem [Phys. Rev. 123, 1242 (1961)] does not hold when the confinement potential is different for two dots. This is indeed confirmed here from a numerical calculation that includes Landau-level mixing. Our results take full account off the effect of spin degrees of freedom. A key feature is that the total spin S of the system and the magic-number angular momentum are intimately linked because of strong electron correlation. Thus S jumps hand in hand with the total angular momentum as the magnetic field is varied. One important consequence of this is that the spin blockade (an inhibition of single-electron tunneling) should occur in some magnetic field regions because of a spin selection rule,Owing to the flexibility arising from the presence of both intralayer and interlayer correlations, the spin blockade is easier to realize in double dots than in single dots. [S0163-1829 (99)04408-2].	Tohoku Univ, CREST, Sendai, Miyagi 9808577, Japan; Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Imamura, H (reprint author), Tohoku Univ, CREST, Sendai, Miyagi 9808577, Japan.		Aoki, Hideo/A-2525-2009	Aoki, Hideo/0000-0002-7332-9355			BOEBINGER GS, 1990, PHYS REV LETT, V64, P1793, DOI 10.1103/PhysRevLett.64.1793; JOHNSON NF, 1995, J PHYS-CONDENS MAT, V7, P965, DOI 10.1088/0953-8984/7/6/005; LAUGHLIN RB, 1983, PHYS REV B, V27, P3383, DOI 10.1103/PhysRevB.27.3383; MEURER B, 1992, PHYS REV LETT, V68, P1371, DOI 10.1103/PhysRevLett.68.1371; MACDONALD AH, 1990, PHYS REV LETT, V65, P775, DOI 10.1103/PhysRevLett.65.775; WEINMANN D, 1995, PHYS REV LETT, V74, P984, DOI 10.1103/PhysRevLett.74.984; Tarucha S, 1996, PHYS REV LETT, V77, P3613, DOI 10.1103/PhysRevLett.77.3613; Eto M, 1997, JPN J APPL PHYS 1, V36, P3924, DOI 10.1143/JJAP.36.3924; SUEN YW, 1992, PHYS REV LETT, V68, P1379, DOI 10.1103/PhysRevLett.68.1379; KOHN W, 1961, PHYS REV, V123, P1242, DOI 10.1103/PhysRev.123.1242; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P1383, DOI 10.1103/PhysRevLett.68.1383; ASHOORI RC, 1992, PHYS REV LETT, V68, P3088, DOI 10.1103/PhysRevLett.68.3088; MOON K, 1995, PHYS REV B, V51, P5138, DOI 10.1103/PhysRevB.51.5138; MAKSYM PA, 1990, PHYS REV LETT, V65, P108, DOI 10.1103/PhysRevLett.65.108; ASHOORI RC, 1993, PHYS REV LETT, V71, P613, DOI 10.1103/PhysRevLett.71.613; Austing DG, 1997, JPN J APPL PHYS 1, V36, P1667, DOI 10.1143/JJAP.36.1667; CHAKRABORTY T, 1995, QUANTUM HALL EFFECT; CHO KK, 1991, PROG THEOR PHYS SUPP, P225; Darwin CG, 1931, P CAMB PHILOS SOC, V27, P86; Das Sarma S., 1997, PERSPECTIVES QUANTUM; Fock V., 1928, Z PHYS, V47, P466, DOI DOI 10.1017/S0305004100009373; GALEJS RJ, 1987, PHYS REV B, V35, P6240, DOI 10.1103/PhysRevB.35.6240; GIRVIN SM, 1983, PHYS REV B, V28, P4506, DOI 10.1103/PhysRevB.28.4506; Imamura H, 1998, PHYS REV B, V57, pR4257, DOI 10.1103/PhysRevB.57.R4257; Imamura H, 1998, PHYSICA B, V249, P214, DOI 10.1016/S0921-4526(98)00101-X; Imamura H, 1996, PHYS REV B, V53, P12613, DOI 10.1103/PhysRevB.53.12613; JOHNSTON D, 1989, HIST POLIT THOUGHT, V10, P647; KELLER O, 1995, PHYS REV B, V52, P4670, DOI 10.1103/PhysRevB.52.4670; MAKSYM PA, 1996, P 23 INT C PHYS SEM, P1613; Maksym PA, 1996, PHYS REV B, V53, P10871, DOI 10.1103/PhysRevB.53.10871; MERKT U, 1993, PHYSICA B, V189, P165, DOI 10.1016/0921-4526(93)90158-3; NAKAJIMA T, 1995, PHYS REV B, V51, P7874, DOI 10.1103/PhysRevB.51.7874; NAKAJIMA T, 1995, PHYS REV B, V52, P13780, DOI 10.1103/PhysRevB.52.13780; PALACIOS JJ, 1995, PHYS REV B, V51, P1769, DOI 10.1103/PhysRevB.51.1769; PERNBOOM JAA, 1981, PHYS REP, V78, P173; Prange R.E., 1990, QUANTUM HALL EFFECT; Reinert F, 1998, PHYS REV B, V58, P12808, DOI 10.1103/PhysRevB.58.12808; STONE M, 1992, PHYS REV B, V45, P14156, DOI 10.1103/PhysRevB.45.14156; Tanaka Y, 1996, PHYS REV B, V53, P3901, DOI 10.1103/PhysRevB.53.3901; WAGNER M, 1992, PHYS REV B, V45, P1951, DOI 10.1103/PhysRevB.45.1951; YOSHIOKA D, 1989, PHYS REV B, V39, P1932, DOI 10.1103/PhysRevB.39.1932	41	46	47	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	1999	59	8					5817	5825		10.1103/PhysRevB.59.5817		9	Physics, Condensed Matter	Physics	173AZ	WOS:000078959900071		
J	Oiwa, A; Endo, A; Katsumoto, S; Iye, Y; Ohno, H; Munekata, H				Oiwa, A; Endo, A; Katsumoto, S; Iye, Y; Ohno, H; Munekata, H			Magnetic and transport properties of the ferromagnetic semiconductor heterostructures (In,Mn)As/(Ga,Al)Sb	PHYSICAL REVIEW B			English	Article							III-V SEMICONDUCTORS	We have investigated the magnetic and transport properties of (In,Mn)As thin films grown on a (Ga,Al)Sb layer. Strong perpendicular magnetic anisotropy is observed for the (In,Mn)As layer, the thickness of which is less than the critical value required for relaxation of lattice-mismatch-induced strain. The anomalous Hall coefficient is found to be approximately proportional to the square of resistivity in the low-field region. Large negative magnetoresistance is found to occur over a magnetic field range significantly wider than that for the ferromagnetic hysteresis loop. [S0163-1829 (98)04344-6].	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan; Tohoku Univ, Res Inst Elect Commun, Aoba Ku, Sendai, Miyagi 9808577, Japan; Tokyo Inst Technol, Imaging Sci & Engn Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Oiwa, A (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.		Ohno, Hideo/E-6453-2010; Oiwa, Akira/E-8349-2012; Oiwa, Akira/J-1521-2014				MUNEKATA H, 1989, PHYS REV LETT, V63, P1849, DOI 10.1103/PhysRevLett.63.1849; Ohno H, 1996, APPL PHYS LETT, V69, P363, DOI 10.1063/1.118061; OHNO H, 1992, PHYS REV LETT, V68, P2664, DOI 10.1103/PhysRevLett.68.2664; CHANG LL, 1980, SURF SCI, V98, P70, DOI 10.1016/0039-6028(80)90477-X; HURD CM, 1980, HALL EFFECT ITS APPL, P3; LUO LF, 1989, APPL PHYS LETT, V55, P2033; Munekata H, 1997, J APPL PHYS, V81, P4862, DOI 10.1063/1.364889; MUNEKATA H, 1995, P 22 INT C PHYS SEM, P2517; MUNEKATA H, 1993, APPL PHYS LETT, V63, P2929, DOI 10.1063/1.110276; MUNEKATA H, 1995, MAT SCI ENG B-SOLID, V31, P151, DOI 10.1016/0921-5107(94)08021-6; Neel L., 1949, ANN GEOPHYS, V5, P99; OHNO H, 1995, P 22 INT C PHYS SEM, P2605; Oiwa A, 1997, SOLID STATE COMMUN, V103, P209, DOI 10.1016/S0038-1098(97)00178-6; Shen A, 1997, APPL SURF SCI, V113, P183, DOI 10.1016/S0169-4332(96)00865-3	14	72	73	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 15	1999	59	8					5826	5831		10.1103/PhysRevB.59.5826		6	Physics, Condensed Matter	Physics	173AZ	WOS:000078959900072		
J	Kawasaki, M; Yanagida, T				Kawasaki, M; Yanagida, T			Primordial black hole formation in supergravity	PHYSICAL REVIEW D			English	Article							INFLATION; CONSTRAINTS; GRAVITINO; MATTER; COSMOLOGY; SPECTRUM; DWARFS	We study a double inflation model (a preinflation + a new inflation) in supergravity and discuss the formation of primordial black holes which may be identified with massive compact halo objects (MACHOs) observed in the halo of our galaxy. The preinflation drives an inflaton for the new inflation close to the origin through supergravity effects and the new inflation naturally occurs. If the total e-fold number of the new inflation is smaller than similar to 60, both inflations produce cosmologically relevant density fluctuations. If the coherent inflaton oscillation after the preinflation continues until the beginning of the new inflation, density fluctuations on small cosmological scales can be set suitably large to produce black holes MACHOs of masses similar to 1M(.) in a wide region of parameter space in the double inflation model. [S0556-2821(99)03402-5].	Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Univ Tokyo, RESCEU, Tokyo 1130033, Japan	Kawasaki, M (reprint author), Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan.		Yanagida, Tsutomu/A-4394-2011				Adams FC, 1996, ASTROPHYS J, V468, P586, DOI 10.1086/177717; ALOCK C, 1997, ASTROPHYS J, V486, P697; ALOCK C, 1993, NATURE, V365, P621; AFFLECK I, 1985, NUCL PHYS B, V249, P361, DOI 10.1016/0550-3213(85)90021-5; NILLES HP, 1984, PHYS REP, V110, P1, DOI 10.1016/0370-1573(84)90008-5; ALBRECHT A, 1982, PHYS REV LETT, V48, P1220, DOI 10.1103/PhysRevLett.48.1220; KHLOPOV MY, 1984, PHYS LETT B, V138, P265, DOI 10.1016/0370-2693(84)91656-3; CARR BJ, 1975, ASTROPHYS J, V201, P1, DOI 10.1086/153853; MOROI T, 1993, PHYS LETT B, V303, P289, DOI 10.1016/0370-2693(93)91434-O; ELLIS J, 1984, PHYS LETT B, V145, P181, DOI 10.1016/0370-2693(84)90334-4; ELLIS J, 1992, NUCL PHYS B, V373, P399, DOI 10.1016/0550-3213(92)90438-H; BAHCALL JN, 1994, ASTROPHYS J, V435, pL51, DOI 10.1086/187592; Bennett C. L., 1996, ASTROPHYS J LETT, V464, P1; DVALI G, 1994, PHYS REV LETT, V73, P1886, DOI 10.1103/PhysRevLett.73.1886; ENQUVIST K, 1988, NUCL PHYS B, V303, P713; Graff DS, 1996, ASTROPHYS J, V456, pL49, DOI 10.1086/309850; Green AM, 1997, PHYS REV D, V56, P7559, DOI 10.1103/PhysRevD.56.7559; Green AM, 1997, PHYS REV D, V56, P6166, DOI 10.1103/PhysRevD.56.6166; GUIDICE GF, HEPPH9801271; Izawa KI, 1997, PHYS LETT B, V411, P249, DOI 10.1016/S0370-2693(97)01040-X; Izawa KI, 1997, PHYS LETT B, V393, P331, DOI 10.1016/S0370-2693(96)01638-3; KAWASAKI M, 1995, PROG THEOR PHYS, V93, P879; KUMEKAWA K, 1994, PROG THEOR PHYS, V92, P437; Linde A, 1997, PHYS REV D, V56, pR1841; LINDE AD, 1990, PARTICLE PHYSICS INF; Lyth D.H., HEPPH9807278; Nakamura T, 1997, ASTROPHYS J, V487, pL139, DOI 10.1086/310886; Panagiotakopoulos C, 1997, PHYS REV D, V55, pR7335; Rubakov V. A., 1996, SOV PHYS USP, V166, P493; WHITE M, 1995, MON NOT R ASTRON SOC, V276, pL69; Yokoyama J, 1997, ASTRON ASTROPHYS, V318, P673; YOSHIMURA K, 1995, PHYS REV LETT, V75, P3792, DOI 10.1103/PhysRevLett.75.3792	32	37	37	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	FEB 15	1999	59	4							043512	10.1103/PhysRevD.59.043512		7	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	189ZY	WOS:000079938100018		
J	Sigl, G; Lee, S; Bhattacharjee, P; Yoshida, S				Sigl, G; Lee, S; Bhattacharjee, P; Yoshida, S			Probing grand unified theories with cosmic-ray, gamma-ray, and neutrino astrophysics	PHYSICAL REVIEW D			English	Article							HIGH-ENERGY NEUTRINOS; UNIFICATION SCALE PHYSICS; ZATSEPIN-KUZMIN CUTOFF; TOPOLOGICAL DEFECTS; DARK-MATTER; SPECTRUM; LIMITS; PROPAGATION; PARTICLES; FLUX	We explore scenarios where the highest energy cosmic rays are produced by new particle physics near the grand unification scale. Using detailed numerical simulations of extragalactic nucleon, gamma-ray, and neutrino propagation, we show the existence of an interesting parameter range for which such scenarios may explain part of the data and are consistent with all observational constraints. A combination of proposed observatories for ultra-high energy cosmic rays, neutrino telescopes of greater than or similar to few kilometer scale, and gamma-ray astrophysics instruments, should be able to test these scenarios. In particular, for neutrino masses in the eV range, exclusive neutrino decay modes of superheavy particles can give rise to neutrino fluxes comparable to those predicted in models of active galactic nuclei. [S0556-2821(99)06202-5].	Univ Chicago, Enrico Fermi Inst, Dept Astron & Astrophys, Chicago, IL 60637 USA; NASA, Goddard Space Flight Ctr, High Energy Astrophys Lab, Greenbelt, MD 20771 USA; Indian Inst Astrophys, Bangalore 560034, Karnataka, India; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan	Sigl, G (reprint author), Univ Chicago, Enrico Fermi Inst, Dept Astron & Astrophys, Chicago, IL 60637 USA.						AHARONIAN FA, 1992, PHYS REV D, V46, P4188, DOI 10.1103/PhysRevD.46.4188; ALSEADY M, 1996, P INT S EXTR HIGH EN, P191; Berezinsky V, 1997, PHYS REV LETT, V79, P4302, DOI 10.1103/PhysRevLett.79.4302; WEILER T, 1982, PHYS REV LETT, V49, P234, DOI 10.1103/PhysRevLett.49.234; Yoshida S, 1997, ASTROPHYS J, V479, P547, DOI 10.1086/303923; Protheroe RJ, 1996, ASTROPART PHYS, V4, P253, DOI 10.1016/0927-6505(95)00039-9; HILL CT, 1983, NUCL PHYS B, V224, P469, DOI 10.1016/0550-3213(83)90386-3; Bhattacharjee P, 1998, PHYS REV LETT, V80, P3698, DOI 10.1103/PhysRevLett.80.3698; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Sreekumar P, 1998, ASTROPHYS J, V494, P523, DOI 10.1086/305222; PUGET JL, 1976, ASTROPHYS J, V205, P638, DOI 10.1086/154321; ARNOWITT R, 1992, PHYS REV LETT, V69, P725, DOI 10.1103/PhysRevLett.69.725; Birkel M, 1998, ASTROPART PHYS, V9, P297, DOI 10.1016/S0927-6505(98)00028-0; GREISEN K, 1966, PHYS REV LETT, V16, P748, DOI 10.1103/PhysRevLett.16.748; Chung DJH, 1998, PHYS REV LETT, V81, P4048, DOI 10.1103/PhysRevLett.81.4048; Kuzmin VA, 1998, PHYS ATOM NUCL+, V61, P1028; Takeda M, 1998, PHYS REV LETT, V81, P1163, DOI 10.1103/PhysRevLett.81.1163; Berezinsky V, 1998, PHYS LETT B, V434, P61, DOI 10.1016/S0370-2693(98)00728-X; KRONBERG PP, 1994, REP PROG PHYS, V57, P325, DOI 10.1088/0034-4885/57/4/001; BIRD DJ, 1994, ASTROPHYS J, V424, P491, DOI 10.1086/173906; Salamon MH, 1998, ASTROPHYS J, V493, P547, DOI 10.1086/305134; Kuzmin VA, 1998, JETP LETT+, V68, P271, DOI 10.1134/1.567858; Epele LN, 1998, J HIGH ENERGY PHYS; BIRD DJ, 1993, PHYS REV LETT, V71, P3401, DOI 10.1103/PhysRevLett.71.3401; WEILER T, 1984, ASTROPHYS J, V285, P495, DOI 10.1086/162524; BHATTACHARJEE P, 1995, PHYS REV D, V51, P4079, DOI 10.1103/PhysRevD.51.4079; Biller SD, 1998, PHYS REV LETT, V80, P2992, DOI 10.1103/PhysRevLett.80.2992; ARNOWITT R, 1994, PHYS REV D, V49, P1479, DOI 10.1103/PhysRevD.49.1479; BALTRUSAITIS RM, 1985, PHYS REV D, V31, P2192, DOI 10.1103/PhysRevD.31.2192; Berezinsky V, 1997, PHYS REV LETT, V79, P5202, DOI 10.1103/PhysRevLett.79.5202; Berezinsky V, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.103515; BHATTACHARJEE P, 1992, PHYS REV LETT, V69, P567, DOI 10.1103/PhysRevLett.69.567; BHATTACHARJEE P, 1990, PHYS LETT B, V246, P365, DOI 10.1016/0370-2693(90)90615-D; BIRD DJ, 1995, ASTROPHYS J, V441, P144, DOI 10.1086/175344; Capelle KS, 1998, ASTROPART PHYS, V8, P321, DOI 10.1016/S0927-6505(97)00059-5; Chi X., 1993, ASTROPART PHYS, V1, P129; Chi XY, 1993, ASTROPART PHYS, V1, P239; Chung DJH, 1999, PHYS REV D, V59; CLARK TA, 1970, NATURE, V228, P847, DOI 10.1038/228847a0; COPPI PS, 1997, ASTROPHYS J LETT, V487, P9; CORBATO SC, 1992, NUCL PHYS B        S, V28, P36, DOI 10.1016/0920-5632(92)90106-3; Cronin J. W., 1992, NUCL PHYS B        S, V28, P213, DOI 10.1016/0920-5632(92)90134-E; DOKSHITZER YL, 1991, BASIC PERTURBATIVE Q; ELBERT JW, 1995, ASTROPHYS J, V441, P151, DOI 10.1086/175345; GHANDI R, 1998, PHYS REV D, V58, P3009; Ghandi R., 1996, ASTROPART PHYS, V5, P81; GILL AJ, 1994, PHYS REV D, V50, P3660, DOI 10.1103/PhysRevD.50.3660; HALZEN F, 1995, ASTROPART PHYS, V3, P151, DOI 10.1016/0927-6505(94)00038-5; HAYASHIDA M, 1996, P INT S EXTR HIGH EN, P205; HAYASHIDA N, 1994, PHYS REV LETT, V73, P3491, DOI 10.1103/PhysRevLett.73.3491; HILLAS AM, 1984, ANNU REV ASTRON ASTR, V22, P425, DOI 10.1146/annurev.aa.22.090184.002233; LAWRENCE MA, 1991, J PHYS G NUCL PARTIC, V17, P733, DOI 10.1088/0954-3899/17/5/019; Lee S, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.043004; MOORE JN, HEPH9808336; NANOPOULOS DV, HEPPH9809546; ORMES JF, 1997, UNPUB P 25 INT COSM, V5, P273; PEEBLES PJE, 1993, PRINCIPLES PHYSICAL; Protheroe RJ, 1996, PHYS REV LETT, V77, P3708, DOI 10.1103/PhysRevLett.77.3708; Protheroe RJ, 1996, ASTROPART PHYS, V6, P45, DOI 10.1016/S0927-6505(96)00041-2; Rhode W, 1996, ASTROPART PHYS, V4, P217, DOI 10.1016/0927-6505(95)00038-0; SIGL G, 1995, SCIENCE, V270, P1977, DOI 10.1126/science.270.5244.1977; Sigl G, 1994, ASTROPART PHYS, V2, P401, DOI 10.1016/0927-6505(94)90029-9; Sigl G, 1995, PHYS REV D, V52, P6682, DOI 10.1103/PhysRevD.52.6682; Sigl G, 1997, PHYS LETT B, V392, P129, DOI 10.1016/S0370-2693(96)01534-1; STECKER FW, IN PRESS ASTROPHYS L; TAKAHASHI Y, 1996, P INT S EXTR HIGH EN, P310; Teshima M., 1992, NUCL PHYS B        S, V28, P169, DOI 10.1016/0920-5632(92)90124-B; Vincent G, 1998, PHYS REV LETT, V80, P2277, DOI 10.1103/PhysRevLett.80.2277; WAXMAN E, IN PRESS PHYS REV D; WEILER TJ, HEPPH9710431; WICHOSKI UF, HEPPH9805419; Yoshida S, 1994, ASTROPART PHYS, V2, P187, DOI 10.1016/0927-6505(94)90041-8; YOSHIDA S, IN PRESS PHYS REV LE; YOSHIDA S, 1995, ASTROPART PHYS, V3, P105, DOI 10.1016/0927-6505(94)00036-3; Halzen F, 1997, ASTROPHYS J, V488, P669, DOI 10.1086/304741; ZATSEPIN GT, 1966, PISMA ESKP TEOR FIZ, V14, P114; 1996, P INT S EXTR HIGH EN	77	86	87	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1550-7998	1550-2368		PHYS REV D	Phys. Rev. D	FEB 15	1999	59	4							043504			8	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	189ZY	WOS:000079938100010		
J	Sato, T; Gou, FJ; Koresawa, S; Kasahara, J; Tanaka, K; Honda, S; Yokota, T; Nakamura, K; Naito, H; Ishikawa, Y; Hirasawa, T				Sato, T; Gou, FJ; Koresawa, S; Kasahara, J; Tanaka, K; Honda, S; Yokota, T; Nakamura, K; Naito, H; Ishikawa, Y; Hirasawa, T			Seismic observations at a seismic gap in the eastern margin of the Japan Sea using ocean bottom seismometers	TECTONOPHYSICS			English	Article						seismicity; seismic gap; the Japan Sea; ocean bottom seismometers	HYPOCENTER; TRENCH	The eastern margin of the Japan Sea is a nascent convergent plate boundary. Previous studies proposed the existence of a seismic gap along this boundary between 39 degrees N and 40 degrees N. The trend of this gap is reported by Ohtake (Island Are 4, 156-165, 1995) to be north-northwest to south-southeast, but by Ishikawa (Gekkan Kaiyo, Suppl. 7, 102-107, 1994) and Matsuzawa (Prog. Abstr., Seismol. Sec. Jpn. 2, B92, 1995) to be north-northeast to south-southwest. During one month ocean bottom seismic observations were conducted using nine ocean bottom seismometers to investigate seismicity in and around the seismic gap area in detail. The observations revealed that the earthquake epicentral distribution had an echelon shape and could be divided into three soups. These groups have a north-northeast to south-southwest trend. This trend is consistent with the fault system in this area, which was formed by the back-are spreading in the Early to Middle Miocene. This suggests that previously formed tectonic structures affect the present seismo-tectonics and that this area has weak planes with a north-northeast to south-southwest trend. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Earthquake Res Inst, Tokyo 113, Japan; Japan Meteorol Agcy, Tokyo, Japan; Meteorol Res Inst, Tsukuba, Ibaraki 305, Japan; Tohoku Univ, Fac Sci, Sendai, Miyagi 980, Japan	Sato, T (reprint author), Univ Tokyo, Earthquake Res Inst, 7-3-1 Hongo, Tokyo 113, Japan.						HIRATA N, 1989, GEOPHYS J INT, V98, P55, DOI 10.1111/j.1365-246X.1989.tb05513.x; HIRATA N, 1987, PHYS EARTH PLANET IN, V47, P50, DOI 10.1016/0031-9201(87)90066-5; ISHIKAWA Y, 1994, GEKKAN KAIYO S, V7, P102; KASAHARA J, 1997, J MAR ACOUSTICS SOC, V24, P39; KASAHARA J, 1995, J MAR ACOUST SOC JPN, V22, P45; Kasahara J, 1997, ISL ARC, V6, P267, DOI 10.1111/j.1440-1738.1997.tb00177.x; MATSUURA M, 1984, J PHYS EARTH, V32, P469; MATSUZAWA T, 1995, PROG ABSTR SEISM SOC, V2, pB92; NAKAMURA K, 1983, B EARTHQ RES I TOKYO, V58, P711; NISHIZAWA A, 1996, PROG ABSTR SEISM SOC, V2, pB32; Ohtake M., 1995, ISL ARC, V4, P156, DOI 10.1111/j.1440-1738.1995.tb00140.x; Okamura Y., 1995, ISL ARC, V4, P166, DOI DOI 10.1111/J.1440-1738.1995.TB00141.X; SATO T, 1997, TECTONOPHYSICS, V271, P285, DOI 10.1016/S0040-1951(96)00251-X; Tamaki K., 1992, P OCEAN DRILLING PRO, V127/128, P1333; Tsumura K., 1967, B EARTHQ RES I TOKYO, V45, P7	15	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0040-1951			TECTONOPHYSICS	Tectonophysics	FEB 15	1999	302	1-2					1	7		10.1016/S0040-1951(98)00274-1		7	Geochemistry & Geophysics	Geochemistry & Geophysics	174DH	WOS:000079018500001		
J	Terada, S; Yokoyama, T; Sakano, M; Kiguchi, M; Kitajima, Y; Ohta, T				Terada, S; Yokoyama, T; Sakano, M; Kiguchi, M; Kitajima, Y; Ohta, T			Asymmetric surface structure of SO2 on Pd(111) studied by total-reflection X-ray absorption fine structure spectroscopy	CHEMICAL PHYSICS LETTERS			English	Article							SULFUR-DIOXIDE ADSORPTION; ELECTRONIC-PROPERTIES; AG(110) SURFACE; PT(111); NEXAFS; XPS; UPS	S K-edge surface X-ray absorption fine structure measurements reveal that SO, is adsorbed on Pd(lll) with the molecular plane normal to the surface, via the S atom and one of the O atoms. This is in clear contrast to the SO2/Ni cases where the molecule lies flat on the surfaces. Inequivalent intramolecular S-O bonds are clearly identified with the distances of 1.43 Angstrom for the upright one and 1.48 Angstrom for the surface-parallel one. The total-reflection measurements play an important role in discriminating between the two S-O bond lengths with asymmetric surface structure. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Ibaraki, Osaka 3050801, Japan	Ohta, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	ohta@chem.s.u-tokyo.ac.jp	Yokoyama, Toshihiko/F-9298-2011; Kiguchi, Manabu/F-2856-2013				ZEBISCH P, 1993, SURF SCI, V295, P295, DOI 10.1016/0039-6028(93)90276-P; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; YOKOYAMA T, 1995, SURF SCI, V324, P25, DOI 10.1016/0039-6028(94)00692-X; Adachi J, 1998, CHEM PHYS LETT, V294, P559, DOI 10.1016/S0009-2614(98)00909-9; SUN YM, 1994, SURF SCI, V319, P34, DOI 10.1016/0039-6028(94)90567-3; Polcik M, 1997, SURF SCI, V381, pL568, DOI 10.1016/S0039-6028(97)00060-5; TERADA S, 1995, SURF SCI, V336, P55, DOI 10.1016/0039-6028(95)00514-5; BURKE ML, 1988, SURF SCI, V194, P223, DOI 10.1016/0039-6028(94)91257-2; PETTIFOR DG, 1977, J PHYS F MET PHYS, V7, P613, DOI 10.1088/0305-4608/7/4/013; Wilson K, 1997, SURF SCI, V372, P279, DOI 10.1016/S0039-6028(96)01107-7; REHR JJ, 1991, J AM CHEM SOC, V113, P5135, DOI 10.1021/ja00014a001; ARLINGHAUS FJ, 1980, PHYS REV B, V21, P2055, DOI 10.1103/PhysRevB.21.2055; FUNABASHI M, 1989, REV SCI INSTRUM, V60, P2505, DOI 10.1063/1.1140713; GAY JG, 1980, PHYS REV B, V21, P1559; GUITIERREZSOSA A, 1996, SURF SCI LETT, V364, pL519; Koningsberger D., 1988, XRAY ABSORPTION PRIN; OHTA T, 1986, NUCL INSTRUM METH A, V246, P373, DOI 10.1016/0168-9002(86)90111-7; OUTKA DA, 1986, LANGMUIR, V2, P406, DOI 10.1021/la00070a005; OUTKA DA, 1984, SURF SCI, V137, P242, DOI 10.1016/0039-6028(84)90687-3; PAPACONSTANTOPO.PA, 1978, INT J QUANTUM CHEM S, V12, P497; PETTIFOR DG, 1987, SOLID STATE PHYS, V40, P43; Stohr J., 1992, NEXAFS SPECTROSCOPY; SZE KH, 1987, CHEM PHYS, V115, P433, DOI 10.1016/0301-0104(87)80055-1; Terada S, 1998, SURF SCI, V414, P107, DOI 10.1016/S0039-6028(98)00495-6; Terada S, 1997, J PHYS IV, V7, P703, DOI 10.1051/jp4:1997211; YOKOYAMA T, 1995, SURF SCI, V334, P88, DOI 10.1016/0039-6028(95)00498-X; YOKOYAMA T, 1993, EXAFS ANAL PROGRAM E	27	17	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	FEB 12	1999	300	5-6					645	650		10.1016/S0009-2614(98)01404-3		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	166BE	WOS:000078555700020		
J	Nagata, Y; Homma, H; Lee, JA; Imai, K				Nagata, Y; Homma, H; Lee, JA; Imai, K			D-aspartate stimulation of testosterone synthesis in rat Leydig cells	FEBS LETTERS			English	Article						D-aspartate; testosterone; steroidogenesis; Leydig cell; human chorionic gonadotropin; glutamate transporter	D-AMINO ACIDS; POSTNATAL CHANGES; PINEAL-GLAND; D-SERINE; GLUTAMATE TRANSPORTER; BRAIN; ENZYME; LOCALIZATION; EXPRESSION; ENDOCRINE	D-Aspartate increases human chorionic gonadotropin-induced testosterone production in purified rat Leydig cells. L-Aspartate, D-,L-glutamate or D-,L-asparagine could not substitute for D-aspartate and this effect was independent of glutamate receptor activation. Testosterone production was enhanced only in cells cultured,vith D-aspartate for more than 3 h, The increased production of testosterone nas well correlated with the amounts of D-aspartate incorporated into the Leydig cells, and L-cysteine sulfinic acid, an inhibitor of D-aspartate uptake, suppressed both testosterone production and intracellular D-aspartate levels. D-Aspartate therefore is presumably taken up into cells to increase steroidogenesis, Intracellular D-aspartate probably acts on cholesterol translocation into the inner mitochondrial membrane, the rate-limiting process in steroidogenesis. (C) 1999 Federation of European Biochemical Societies.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Homma, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Sakai K, 1998, ARCH BIOCHEM BIOPHYS, V351, P96, DOI 10.1006/abbi.1997.0539; HASHIMOTO A, 1995, EUR J NEUROSCI, V7, P1657, DOI 10.1111/j.1460-9568.1995.tb00687.x; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lee JA, 1997, BIOCHEM BIOPH RES CO, V231, P505, DOI 10.1006/bbrc.1996.5902; MARCUS GJ, 1985, STEROIDS, V46, P975, DOI 10.1016/S0039-128X(85)80005-2; Sakai K, 1998, BRAIN RES, V808, P65, DOI 10.1016/S0006-8993(98)00599-X; DUNLOP DS, 1986, BIOCHEM BIOPH RES CO, V141, P27, DOI 10.1016/S0006-291X(86)80329-1; HASHIMOTO A, 1993, J NEUROCHEM, V61, P348, DOI 10.1111/j.1471-4159.1993.tb03575.x; SAEZ JM, 1994, ENDOCR REV, V15, P574, DOI 10.1210/er.15.5.574; MORI H, 1995, NEUROPHARMACOLOGY, V34, P1219, DOI 10.1016/0028-3908(95)00109-J; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; DAniello A, 1996, LIFE SCI, V59, P97, DOI 10.1016/0024-3205(96)00266-4; Ishio S, 1998, NEUROSCI LETT, V249, P143, DOI 10.1016/S0304-3940(98)00414-5; IMAI K, 1995, BIOMED CHROMATOGR, V9, P106, DOI 10.1002/bmc.1130090211; Long ZQ, 1998, FEBS LETT, V434, P231, DOI 10.1016/S0014-5793(98)00986-7; Imai K, 1996, BIOMED CHROMATOGR, V10, P303, DOI 10.1002/(SICI)1099-0801(199611)10:6<303::AID-BMC624>3.0.CO;2-B; Sakai K, 1997, BIOCHEM BIOPH RES CO, V235, P433, DOI 10.1006/bbrc.1997.6783; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Takigawa Y, 1998, BIOCHEM BIOPH RES CO, V248, P641, DOI 10.1006/bbrc.1998.8971; NEIDLE A, 1990, LIFE SCI, V46, P1517, DOI 10.1016/0024-3205(90)90424-P; GOVITRAPONG P, 1988, NEUROCHEM INT, V13, P223, DOI 10.1016/0197-0186(88)90058-7; D'Aniello A, 1998, NEUROSCI LETT, V250, P131, DOI 10.1016/S0304-3940(98)00451-0; Di Fiore MM, 1998, J ENDOCRINOL, V157, P199, DOI 10.1677/joe.0.1570199; DUFAU ML, 1988, ANNU REV PHYSIOL, V50, P483; RUSSELL LD, 1995, TISSUE CELL, V27, P129, DOI 10.1016/S0040-8166(95)80016-6; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; MATHER JP, 1981, STEROIDS, V38, P35, DOI 10.1016/0039-128X(81)90019-2; Papadopoulos V, 1998, P SOC EXP BIOL MED, V217, P130; SATO K, 1993, NEUROENDOCRINOLOGY, V58, P77, DOI 10.1159/000126515; Schlatt S, 1997, EUR J ENDOCRINOL, V137, P107, DOI 10.1530/eje.0.1370107; Sharpe Richard M., 1994, P1363; Stocco DM, 1998, P SOC EXP BIOL MED, V217, P123; SUN XR, 1993, ENDOCRINOLOGY, V132, P186, DOI 10.1210/en.132.1.186; Thomson M, 1998, HORM METAB RES, V30, P16, DOI 10.1055/s-2007-978825; VANHAREN L, 1992, MOL CELL ENDOCRINOL, V87, P57, DOI 10.1016/0303-7207(92)90233-V; VANVELDHOVEN PP, 1991, BIOCHIM BIOPHYS ACTA, V1073, P203, DOI 10.1016/0304-4165(91)90203-S	38	106	107	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 12	1999	444	2-3					160	164		10.1016/S0014-5793(99)00045-9		5	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	168ZN	WOS:000078723200004		
J	Lee, HS; Cho, MY; Lee, KM; Kwon, TH; Homma, K; Natori, S; Lee, BL				Lee, HS; Cho, MY; Lee, KM; Kwon, TH; Homma, K; Natori, S; Lee, BL			The pro-phenoloxidase of coleopteran insect, Tenebrio molitor, larvae was activated during cell clump cell adhesion of insect cellular defense reactions	FEBS LETTERS			English	Article						insect immunity; pro-phenoloxidase; cell clump; phenoloxidase; defense protein	INDUCIBLE ANTIBACTERIAL PROTEIN; MOLECULAR-CLONING; HOLOTRICHIA-DIOMPHALIA; PHENOL OXIDASE; CDNA CLONING; PURIFICATION; PROENZYME	To characterize the proteins involved in cell clump/cell adhesion of insect cellular defense reactions, me induced the cell clump/cell adhesion reaction in vitro with the hemolymph of larvae of the coleopteran insect, Tenebrio molitor. The 72 kDa protein was specifically enriched in the residues of cell clump/cell adhesion and was purified to homogeneity. A cDNA clone for the 72 kDa protein was isolated. We found that the 72 kDa protein was an activated phenoloxidase from Tenebrio pro-phenoloxidase, We suggest that activated phenoloxidase is involved in the cell clump/cell adhesion reaction as well as in the synthesis of melanin, (C) 1999 Federation of European Biochemical Societies.	Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Lee, BL (reprint author), Pusan Natl Univ, Coll Pharm, Jangjeon Dong, Pusan 609735, South Korea.	brlee@hyowon.pusan.ac.kr					HALL M, 1995, P NATL ACAD SCI USA, V92, P7764, DOI 10.1073/pnas.92.17.7764; FUJIMOTO K, 1995, P NATL ACAD SCI USA, V92, P7769, DOI 10.1073/pnas.92.17.7769; Lee SY, 1998, EUR J BIOCHEM, V257, P615, DOI 10.1046/j.1432-1327.1998.2570615.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; KAWABATA T, 1995, P NATL ACAD SCI USA, V92, P7774, DOI 10.1073/pnas.92.17.7774; ASPAN A, 1995, P NATL ACAD SCI USA, V92, P939, DOI 10.1073/pnas.92.4.939; Asgari S, 1998, P NATL ACAD SCI USA, V95, P3690, DOI 10.1073/pnas.95.7.3690; Ashida M., 1990, P239; Ashida Masaaki, 1998, P135; Cho WL, 1998, INSECT MOL BIOL, V7, P31, DOI 10.1046/j.1365-2583.1998.71049.x; GAGEN SJ, 1976, J INVERTEBR PATHOL, V28, P17, DOI 10.1016/0022-2011(76)90066-5; LEE HY, 1998, BIOCHEM J, V334, P99; LEE SY, 1998, EUR J BIOCHEM, V254, P90; LEE SY, 1995, BIOL PHARM BULL, V18, P1049; LEE SY, 1995, BIOL PHARM BULL, V18, P457; LEE SY, 1994, J BIOCHEM-TOKYO, V115, P82; Lee WJ, 1998, INSECT MOL BIOL, V7, P41, DOI 10.1046/j.1365-2583.1998.71047.x; LEGENDRE N, 1988, BIOTECHNIQUES, V6, P154; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MCCAULEY R, 1973, MOL CELL BIOCHEM, V1, P73, DOI 10.1007/BF01659940; MOON HJ, 1994, J BIOCHEM-TOKYO, V116, P53; Park DS, 1997, INSECT BIOCHEM MOLEC, V27, P983, DOI 10.1016/S0965-1748(97)00081-7; Ratcliffe N.A., 1979, P331, DOI 10.1017/CBO9780511759987.014; Soderhall Kenneth, 1996, P229	24	29	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	FEB 12	1999	444	2-3					255	259		10.1016/S0014-5793(99)00067-8		5	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	168ZN	WOS:000078723200024		
J	Tanaka, K; Horiguchi, K; Yoshida, T; Takeda, M; Fujisawa, H; Takeuchi, K; Umeda, M; Kato, S; Ihara, S; Nagata, S; Fukui, Y				Tanaka, K; Horiguchi, K; Yoshida, T; Takeda, M; Fujisawa, H; Takeuchi, K; Umeda, M; Kato, S; Ihara, S; Nagata, S; Fukui, Y			Evidence that a phosphatidylinositol 3,4,5-trisphosphate-binding protein can function in nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE THYMUS; KINASE-B; 3-KINASE; CELLS; ACTIVATION; ALPHA; PURIFICATION; RECEPTOR; SYSTEM; BRAIN	PIP3BP is a phosphatidylinositol 3,4,5-trisphosphate-binding protein (PIP3BP) abundant in brain, containing a zinc: finger motif and two pleckstrin homology (PH) domains. Staining of rat brain cells with anti-PIP3BP antibody and determination of localization of PIP3BP fused to the green fluorescent protein (GFP-PIP3BP) revealed that PIP3BP was targeted to the nucleus. Targeting was dependent on a putative nuclear localization signal in PIP3BP. Generation of PIP3 in the nucleus was detected in H2O2-treated 293T cells, nerve growth factor (NGF)-treated PC12 cells, and platelet-derived growth factor (PDGF)-treated NIH 3T3 cells. Translocation of phosphatidylinositol 3-kinase (PI 3-kinase) to the nucleus and enhanced activity of PI 3-kinase in the nucleus fraction were observed after H2O2 treatment of 293T cells, suggesting that PI 3-kinase can be activated in the nucleus as well as in the membrane after appropriate stimulation of the cells, Go-expression of the constitutively active PI 3-kinase with PIP3BP resulted in exportation of the protein from the nucleus to the cytoplasm, suggesting that PIP3BP can function as a PIP3-binding protein in the intact cells. These results imply that there may be an unknown function of PI 3-kinase in the nucleus.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Biol Chem Lab,Bunkyo Ku, Tokyo 1130032, Japan; Inst Environm Toxicol, Div Toxicol, Mitsukaido, Ibaraki 3030043, Japan; Tokyo Metropolitan Inst Med Sci, Dept Inflammat Res, Bunkyo Ku, Tokyo 1138613, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Fukui, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Biol Chem Lab,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	ayfukui@hongo.ecc.u-tokyo.ac.jp	Fukui, Yasuhisa/E-8806-2010; Yoshida, Toshinori/B-7255-2015				Akimoto K, 1996, EMBO J, V15, P788; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; NAGATA S, 1991, HYBRIDOMA, V10, P317, DOI 10.1089/hyb.1991.10.317; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; HammondsOdie LP, 1996, J BIOL CHEM, V271, P18859; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Klarlund JK, 1998, J BIOL CHEM, V273, P1859, DOI 10.1074/jbc.273.4.1859; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Venkateswarlu K, 1998, BIOCHEM J, V335, P139; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; FUKUI Y, 1991, ONCOGENE, V6, P407; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; HAYASHI H, 1993, J BIOL CHEM, V268, P7107; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Kabuyama Y, 1996, EUR J BIOCHEM, V238, P350, DOI 10.1111/j.1432-1033.1996.0350z.x; Kita Y, 1998, J CELL SCI, V111, P907; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; SHIBASAKI F, 1991, J BIOL CHEM, V266, P8108; STEPHENS LR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P27, DOI 10.1016/0167-4889(93)90072-W; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Yoshida T, 1998, TOXICOL PATHOL, V26, P411	30	105	106	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 12	1999	274	7					3919	3922		10.1074/jbc.274.7.3919		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	166KQ	WOS:000078575500001		
J	Kose, S; Imamoto, N; Tachibana, T; Yoshida, M; Yoneda, Y				Kose, S; Imamoto, N; Tachibana, T; Yoshida, M; Yoneda, Y			beta-subunit of nuclear pore-targeting complex (importin-beta) can be exported from the nucleus in a Ran-independent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMATURE CHROMOSOME CONDENSATION; PROTEIN IMPORT; BINDING PROTEIN; GTPASE ACTIVITY; MESSENGER-RNA; LEPTOMYCIN-B; LIVING CELLS; RCC1; TRANSPORT; SIGNAL	The nuclear export of importin-alpha is mediated by GAS, which is related to importin-beta, whereas the mechanism for the export of importin-beta remains unclear. In this study, we demonstrate that the nuclear export of importin-beta is mediated by the nuclear pore complex-binding domain of this molecule, Insensitivity to leptomycin B indicates that its export is not mediated by a leucine-rich nuclear export signal-specific receptor, CRM1. Furthermore, the nuclear export of importin-a was not inhibited by co-injection with a GTPase-deficient Ran mutant (G19V), The cell line tsBN2 contains a temperature-sensitive point mutation in the RCC1 gene, which encodes a guanine nucleotide exchange factor of Ran. At the nonpermissive temperature, importin-beta was exported from the nucleus of these cells, even when Ran-GAP1, a GTPase-activating protein for Ran, was co-injected. These results not only provide support for the view that Ran-dependent GTP hydrolysis is not required for the nuclear export of importin-beta but also indicate that nuclear RanGTP is not essential for its export. As a result, we propose: that importin-beta can be recycled from the nucleus alone in a Ran-independent manner.	Osaka Univ, Sch Med, Dept Anat & Cell Biol, Suita, Osaka 5650871, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1130033, Japan	Yoneda, Y (reprint author), Osaka Univ, Sch Med, Dept Anat & Cell Biol, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	yyoneda@anat3.med.osaka-u.ac.jp	Imamoto, Naoko/A-7458-2015; Yoshida, Minoru/C-8049-2014	Imamoto, Naoko/0000-0002-2886-3022; 			Gorlich D, 1997, CURR OPIN CELL BIOL, V9, P412, DOI 10.1016/S0955-0674(97)80015-4; ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; BISCHOFF FR, 1995, P NATL ACAD SCI USA, V92, P1749, DOI 10.1073/pnas.92.5.1749; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P5584; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Sekimoto T, 1996, J BIOL CHEM, V271, P31017; IMAMOTO N, 1995, EMBO J, V14, P3617; IMAMOTO N, 1995, J BIOL CHEM, V270, P8559; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Chi NC, 1996, J CELL BIOL, V135, P559, DOI 10.1083/jcb.135.3.559; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; NISHI K, 1994, J BIOL CHEM, V269, P6320; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; Fukuda M, 1997, EMBO J, V16, P1901, DOI 10.1093/emboj/16.8.1901; OHTSUBO M, 1989, J CELL BIOL, V109, P1389, DOI 10.1083/jcb.109.4.1389; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; NISHITANI H, 1991, EMBO J, V10, P1555; DAVIS LI, 1995, ANNU REV BIOCHEM, V64, P865, DOI 10.1146/annurev.bi.64.070195.004245; IMAMOTO N, 1995, FEBS LETT, V368, P415; Iovine MK, 1997, J CELL BIOL, V137, P797, DOI 10.1083/jcb.137.4.797; Lounsbury KM, 1996, J BIOL CHEM, V271, P32834; NISHIMOTO T, 1978, CELL, V15, P475, DOI 10.1016/0092-8674(78)90017-X; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; REN MD, 1993, J CELL BIOL, V120, P313, DOI 10.1083/jcb.120.2.313; Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842; Rush MG, 1996, BIOESSAYS, V18, P103, DOI 10.1002/bies.950180206; Tachibana T, 1996, FEBS LETT, V397, P177, DOI 10.1016/S0014-5793(96)01180-5; TACHIBANA T, 1994, J BIOL CHEM, V269, P24542; UCHIDA S, 1990, MOL CELL BIOL, V10, P577; YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7	46	46	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 12	1999	274	7					3946	3952		10.1074/jbc.274.7.3946		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	166KQ	WOS:000078575500008		
J	Tandai-Hiruma, M; Endo, T; Kobata, A				Tandai-Hiruma, M; Endo, T; Kobata, A			Detection of novel carbohydrate binding activity of interleukin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAMM-HORSFALL GLYCOPROTEIN; ASPARAGINE-LINKED OLIGOSACCHARIDES; HUMAN-PREGNANCY URINE; SUGAR CHAINS; N-ACETYLGALACTOSAMINE; MONOCLONAL-ANTIBODY; STRUCTURAL-ANALYSIS; UROMODULIN; LECTIN; PROTEIN	Tamm-Horsfall glycoprotein (THGP) and the oligosaccharide fraction liberated from THGP by hydrazinolysis inhibited tetanus toroid-induced T cell proliferation. Intact THGP showed approximately 100-fold more inhibitory activity than the free oligosaccharides. After fractionating the oligosaccharides by anion-exchange column chromatography, the inhibitory activity could be detected in a sialidase-resistant acidic oligosaccharide fraction (fraction AR). The inhibitory activity of fraction AR was not observed when the fraction was added to the T cell culture medium 24 h after the addition of tetanus toroid. Increased concentration of interleukin (IL) 1 beta and decreased concentration of IL-2 were observed in the T cell culture medium after the addition of fraction AR. The oligosaccharides in fraction AR also inhibited the growth of an IL-1-dependent cell line, D10-G4. These results strongly suggested that the oligosaccharides in fraction AR bind to IL-1 beta and suppress its cytokine activity. IL-1 beta actually bound to the fraction AR immobilized on an amino-bonded thin layer plate. Fractionation of the oligosaccharides indicated that only oligosaccharides containing an N-acetylgalactosamine residue and a sulfate residue bound specifically to IL-1 beta. Removal of either the sulfate residue or the N-acetylgalactosamine residue from the oligosaccharides abolished both the proliferation-inhibition and IL-1 beta binding activities. Since IL-1 beta did not bind to thyroid-stimulating hormone, which has the sulfate group at C-4 of the N-acetylgalactosamine residue in its N-linked sugar chains, the binding of IL-1 beta toward oligosaccharides in fraction AR was considered to be highly specific.	Univ Tokyo, Inst Med Sci, Dept Biochem, Minato Ku, Tokyo 1080071, Japan	Endo, T (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Glycobiol, Itabashi Ku, Tokyo 1730015, Japan.	endo@tmig.or.jp					ABBONDANZA A, 1980, BIOCHEM J, V187, P525; ADLER W H, 1970, Journal of Experimental Medicine, V131, P1049, DOI 10.1084/jem.131.6.1049; TAMM I, 1950, P SOC EXP BIOL MED, V74, P108; TADANO K, 1982, J BIOL CHEM, V257, P1482; MUCHMORE AV, 1985, SCIENCE, V229, P479, DOI 10.1126/science.2409603; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; KOBATA A, 1992, EUR J BIOCHEM, V209, P483, DOI 10.1111/j.1432-1033.1992.tb17313.x; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; BOLTON AE, 1973, BIOCHEM J, V133, P529; BROWN KM, 1986, P NATL ACAD SCI USA, V83, P9119, DOI 10.1073/pnas.83.23.9119; DALLOLIO F, 1988, CARBOHYD RES, V178, P327, DOI 10.1016/0008-6215(88)80123-X; DALLOLIO F, 1991, CELL IMMUNOL, V137, P303, DOI 10.1016/0008-8749(91)90081-L; DEWAARD P, 1991, J BIOL CHEM, V266, P4237; DOWER SK, 1985, J EXP MED, V162, P501, DOI 10.1084/jem.162.2.501; Fukushima K, 1997, J BIOL CHEM, V272, P10579; HARD K, 1992, EUR J BIOCHEM, V209, P895, DOI 10.1111/j.1432-1033.1992.tb17362.x; KAYE J, 1984, J IMMUNOL, V133, P1339; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Li Y.-T., 1972, METHOD ENZYMOL, V28, P702; MAKITA A, 1963, JPN J EXP MED, V33, P361; MOONEN P, 1988, FEBS LETT, V226, P314, DOI 10.1016/0014-5793(88)81446-7; MUCHMORE AV, 1987, J IMMUNOL, V138, P2541; MUCHMORE AV, 1990, J LEUKOCYTE BIOL, V48, P457; MUCHMORE AV, 1986, J BIOL CHEM, V261, P3404; MUCHMORE AV, 1987, J IMMUNOL, V138, P2547; OHBAYASHI H, 1989, ANAL BIOCHEM, V182, P200, DOI 10.1016/0003-2697(89)90579-4; PENNICA D, 1987, SCIENCE, V236, P83, DOI 10.1126/science.3453112; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785; SERAFINICESSI F, 1979, BIOCHEM J, V183, P381; SMAGULA RM, 1990, GLYCOCONJUGATE J, V7, P609, DOI 10.1007/BF01189081; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; WILLIAMS J, 1984, CARBOHYD RES, V134, P141, DOI 10.1016/0008-6215(84)85029-6; YAMAKAWA T, 1962, J BIOCHEM-TOKYO, V52, P226; YAMASHITA K, 1983, J BIOL CHEM, V258, P4144	36	9	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 12	1999	274	7					4459	4466		10.1074/jbc.274.7.4459		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	166KQ	WOS:000078575500074		
J	Terada, T; Ito, Y; Shirouzu, M; Tateno, M; Hashimoto, K; Kigawa, T; Ebisuzaki, T; Takio, K; Shibata, T; Yokoyama, S; Smith, BO; Laue, ED; Cooper, JA				Terada, T; Ito, Y; Shirouzu, M; Tateno, M; Hashimoto, K; Kigawa, T; Ebisuzaki, T; Takio, K; Shibata, T; Yokoyama, S; Smith, BO; Laue, ED; Cooper, JA			Nuclear magnetic resonance and molecular dynamics studies on the interactions of the Ras-binding domain of Raf-1 with wild-type and mutant Ras proteins	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Ras-binding domain; Ras; Raf-l; nuclear magnetic resonance; molecular dynamics simulation	NUCLEOTIDE DISSOCIATION STIMULATOR; 3-DIMENSIONAL NMR-SPECTROSCOPY; CYSTEINE-RICH REGION; GTP-GAMMA-S; HA-RAS; CONFORMATIONAL CHANGE; SIGNAL-TRANSDUCTION; BACKBONE ASSIGNMENT; TERMINAL REGION; EFFECTOR-REGION	The Ras protein and its homolog, Rap1A, have an identical "effector region" (residues 32-40) preceded by Asp30-Glu31 and Glu30-Lys31, respectively. in the complex of the "Ras-like" E30D/K31E mutant Rap1A with the Ras-binding domain (RBD), residues 51-131 of Raf-1, Glu31 in Rap1A forms a tight salt bridge with Lys84 in Raf-1. However, we have recently found that Raf-1 RED binding of Ras is indeed reduced by the E31K mutation, but is not affected by the E31A mutation. Here, the "Rap1A-like" D30E/E31K mutant of Ras was prepared and shown to bind the Raf-1 RED less strongly than wild-type Ras, but slightly more tightly than the E31K mutant. The backbone H-1, C-13, and N-15 magnetic resonances of the Raf-1 RED were assigned in complexes with the wild-type and D30E/E31K mutant Ras proteins in the guanosine 5'-O-(beta,gamma-imidotriphosphate)-bound form. The Lys84 residue in the Raf-1 RED exhibited a large change in chemical shift upon binding wild-type Ras, suggesting that Lys84 interacts with wild-type Ras. The D30E/E31K mutant of Ras caused nearly the same perturbations in Raf-1 chemical shifts, including that of Lys84. We hypothesized that Glu31 in Ras may not be the major salt bridge partner of Lys84 in Raf-1. A molecular dynamics simulation of a model structure of the Raf-1 RBD.Ras.GTP complex suggested that Lys84 in Raf-1 might instead form a tight salt bridge with Asp33 in Ras. Consistent with this, the D33A mutation in Ras greatly reduced its Raf-1 RED binding activity. We conclude that the major salt bridge partner of Lys84 in Raf-1 may be Asp33 in Ras. (C) 1999 Academic Press.	RIKEN, Inst Phys & Chem Res, Cellular Signaling Lab, Wako, Saitama 3510198, Japan; RIKEN, Inst Phys & Chem Res, Div Biomol Charecterizat, Wako, Saitama 3510198, Japan; RIKEN, Inst Phys & Chem Res, Cellular & Mol Biol Lab, Wako, Saitama 3510198, Japan; RIKEN, Inst Phys & Chem Res, Sci Computat Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, Cambridge CB2 1QW, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Yokoyama, S (reprint author), RIKEN, Inst Phys & Chem Res, Cellular Signaling Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yokoyama@y-sun.biochem.s.u.-tokyo.ac.jp	Kigawa, Takanori/A-7679-2010; Ebisuzaki, Toshikazu/N-6998-2014; Smith, Brian/J-1899-2015; Ito, Yutaka/P-2604-2015; 	Kigawa, Takanori/0000-0003-0146-9719; Ebisuzaki, Toshikazu/0000-0002-3918-1166; Smith, Brian/0000-0003-3363-4168; Ito, Yutaka/0000-0002-1030-4660; Laue, Ernest/0000-0002-7476-4148			ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KIKUCHI A, 1994, MOL CELL BIOL, V14, P7483; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413; Herrmann C, 1996, J BIOL CHEM, V271, P6794; BRTVA TR, 1995, J BIOL CHEM, V270, P9809; YAMASAKI K, 1989, BIOCHEM BIOPH RES CO, V162, P1054, DOI 10.1016/0006-291X(89)90780-8; AVRUCH J, 1994, TRENDS BIOCHEM SCI, V19, P279, DOI 10.1016/0968-0004(94)90005-1; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; PAI EF, 1990, EMBO J, V9, P2351; PIZON V, 1988, ONCOGENE, V3, P201; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; Hu CD, 1997, J BIOL CHEM, V272, P11702, DOI 10.1074/jbc.272.18.11702; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; CHUANG E, 1994, MOL CELL BIOL, V14, P5318; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.biochem.56.1.779; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOUME HR, 1991, NATURE, V349, P117; BRUNGER AT, 1992, XPLOR MANUAL VERSION; CAMPBELLBURK SL, 1993, HDB EXP PHARM, V108, P213; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Drugan JK, 1996, J BIOL CHEM, V271, P233; EMERSON SD, 1994, BIOCHEMISTRY-US, V33, P7745, DOI 10.1021/bi00191a001; EMERSON SD, 1995, BIOCHEMISTRY-US, V34, P6911, DOI 10.1021/bi00021a001; Ewald PP, 1921, ANN PHYS-BERLIN, V64, P253; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FRISCH MJ, 1995, GAUSSIAN 94 REV A 1; GHOSH SJ, 1994, J BIOL CHEM, V269, P10000; HA JM, 1989, BIOCHEMISTRY-US, V28, P8411, DOI 10.1021/bi00447a021; HERMANN C, 1995, J BIOL CHEM, V270, P2901; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Hu CD, 1995, J BIOL CHEM, V270, P30274; HU JS, 1993, BIOCHEMISTRY-US, V32, P6763, DOI 10.1021/bi00077a031; Hu JS, 1997, BIOCHEMISTRY-US, V36, P5045, DOI 10.1021/bi963010e; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; ITO A, 1995, FEBS LETT, V368, P183, DOI 10.1016/0014-5793(95)00643-N; Ito Y, 1997, BIOCHEMISTRY-US, V36, P9109, DOI 10.1021/bi970296u; KANAI T, 1987, JPN J CANCER RES, V78, P1314; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; LAUE ED, 1986, J MAGN RESON, V68, P14, DOI 10.1016/0022-2364(86)90312-4; MARION D, 1989, J MAGN RESON, V84, P425, DOI 10.1016/0022-2364(89)90391-0; MARKUS MA, 1994, J MAGN RESON SER B, V105, P192, DOI 10.1006/jmrb.1994.1122; MARSHALL MS, 1991, MOL CELL BIOL, V11, P3997; Matsuo H, 1996, J MAGN RESON SER B, V110, P112, DOI 10.1006/jmrb.1996.0018; Matsuo H, 1996, J MAGN RESON SER B, V111, P194, DOI 10.1006/jmrb.1996.0082; MILLER AF, 1993, BIOCHEMISTRY-US, V32, P7367, DOI 10.1021/bi00080a006; MILLER AF, 1992, BIOCHEMISTRY-US, V31, P10208, DOI 10.1021/bi00157a007; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Mott HR, 1996, P NATL ACAD SCI USA, V93, P8312, DOI 10.1073/pnas.93.16.8312; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; MUTO Y, 1993, J BIOMOL NMR, V3, P165; Nassar Nicolas, 1995, Nature (London), V375, P554, DOI 10.1038/375554a0; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; PEARLMAN DA, 1995, AMBER 4 1; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; SATOH T, 1987, MOL CELL BIOL, V7, P4553; SCHEFFLER JE, 1994, J BIOL CHEM, V269, P22340; SHIROUZU M, 1992, ONCOGENE, V7, P475; Shirouzu M, 1998, J BIOL CHEM, V273, P7737, DOI 10.1074/jbc.273.13.7737; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; YAMASAKI K, 1992, J BIOMOL NMR, V2, P71, DOI 10.1007/BF02192801; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P6464, DOI 10.1021/ja00093a069; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	74	29	34	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836			J MOL BIOL	J. Mol. Biol.	FEB 12	1999	286	1					219	232		10.1006/jmbi.1998.2472		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	168PT	WOS:000078702000017		
J	Iizasa, K; Fiske, RS; Ishizuka, O; Yuasa, M; Hashimoto, J; Ishibashi, J; Naka, J; Horii, Y; Fujiwara, Y; Imai, A; Koyama, S				Iizasa, K; Fiske, RS; Ishizuka, O; Yuasa, M; Hashimoto, J; Ishibashi, J; Naka, J; Horii, Y; Fujiwara, Y; Imai, A; Koyama, S			A Kuroko-type polymetallic sulfide deposit in a submarine silicic caldera	SCIENCE			English	Article							EAST PACIFIC RISE; IZU-OGASAWARA ARC; NORTHWESTERN PACIFIC; FLOOR SEDIMENTS; RIDGE; BASIN; GOLD	Manned submersible studies have delineated a large and actively growing Kuroko-type volcanogenic massive sulfide deposit 400 kilometers south of Tokyo in Myojin Knell submarine caldera, The sulfide body is Located on the caldera floor at a depth of 1210 to 1360 meters, has an area of 400 by 400 by 30 meters, and is notably rich in gold and silver. The discovery of a Large Kuroko-type polymetallic sulfide deposit in this are-front caldera raises the possibility that the numerous unexplored submarine silicic calderas elsewhere might have similar deposits.	Smithsonian Inst, Washington, DC 20560 USA; Geol Survey Japan, Ibaraki, Osaka 3058567, Japan; Japan Marine Sci & Technol Ctr 2 15, Yokosuka, Kanagawa 2370061, Japan; Univ Tokyo, Tokyo 1330033, Japan; Tokyo Metropolitan Fisheries Stn, Tokyo 1001511, Japan	Fiske, RS (reprint author), Smithsonian Inst, MRC-119, Washington, DC 20560 USA.	rfiske@volcano.si.edu					FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2154; FOUQUET Y, 1988, MAR GEOL, V84, P145, DOI 10.1016/0025-3227(88)90098-9; HALBACH P, 1989, NATURE, V338, P496, DOI 10.1038/338496a0; HANNINGTON M, 1991, MAR GEOL, V101, P217, DOI 10.1016/0025-3227(91)90073-D; HANNINGTON MD, 1988, NATURE, V333, P64, DOI 10.1038/333064a0; Ohmoto H, 1996, ORE GEOL REV, V10, P135, DOI 10.1016/0169-1368(95)00021-6; REES CE, 1978, GEOCHIM COSMOCHIM AC, V42, P377, DOI 10.1016/0016-7037(78)90268-5; BODNAR RJ, 1984, ECON GEOL, V79, P141; CRAWFORD AM, 1984, MAR MINING, V4, P337; EMBLEY RW, 1988, CAN MINERAL, V26, P517; FISKE RS, 1995, P JAMSTEC S DEEP SEA, V11, P315; FOUQUET Y, 1993, ECON GEOL BULL SOC, V88, P2018; IIZASA K, 1993, MAR GEOL, V112, P271, DOI 10.1016/0025-3227(93)90173-S; Iizasa K, 1995, MAR GEORESOUR GEOTEC, V13, P339; ISHIBASHI J, 1992, CHIKYU, V14, P489; MURAKAMI F, 1997, J GEOGR, V106, P70; Ohmoto H., 1983, EC GEOL MON, V5, P1; Ohmoto H., 1979, GEOCHEMISTRY HYDROTH, P509; SINGER DA, 1986, US GEOL SURV B, V1693, P190; UEDA A, 1984, GEOCHIM COSMOCHIM AC, V48, P1837, DOI 10.1016/0016-7037(84)90037-1; Watanabe K, 1994, RESOUR GEOL, V44, P133; YUASA M, 1991, J GEOGR, V100, P458; Yuasa M., 1995, B VOLCANOL SOC JPN, V40, P277	23	84	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	1999	283	5404					975	977		10.1126/science.283.5404.975		3	Multidisciplinary Sciences	Science & Technology - Other Topics	166KM	WOS:000078574800045		
J	Eto, K; Tsubamoto, Y; Terauchi, Y; Sugiyama, T; Kishimoto, T; Takahashi, N; Yamauchi, N; Kubota, N; Murayama, S; Aizawa, S; Akanuma, Y; Aizawa, S; Kasai, H; Yazaki, Y; Kadowaki, T				Eto, K; Tsubamoto, Y; Terauchi, Y; Sugiyama, T; Kishimoto, T; Takahashi, N; Yamauchi, N; Kubota, N; Murayama, S; Aizawa, S; Akanuma, Y; Aizawa, S; Kasai, H; Yazaki, Y; Kadowaki, T			Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion	SCIENCE			English	Article							PANCREATIC BETA-CELLS; CYTOSOLIC CA2+; ISLETS; RELEASE; DEHYDROGENASE; NUCLEOTIDES; GLYCOLYSIS; CHANNELS	Glucose metabolism in glycolysis and in mitochondria is pivotal to glucose-induced insulin secretion from pancreatic beta cells. One or more factors derived from glycolysis other than pyruvate appear to be required for the generation of mitochondrial signals that Lead to insulin secretion. The electrons of the glycolysis-derived reduced form of nicotinamide adenine dinucleotide (NADH) are transferred to mitochondria through the NADH shuttle system. By abolishing the NADH shuttle function, glucose-induced increases in NADH autofluorescence, mitochondrial membrane potential, and adenosine triphosphate content were reduced and glucose-induced insulin secretion was abrogated. The NADH shuttle evidently couples glycolysis with activation of mitochondrial energy metabolism to trigger insulin secretion.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan; Shinshu Univ, Sch Med, Dept Geriatr Endocrinol & Metab, Matsumoto, Nagano 390, Japan; Asahi Life Fdn, Inst Diabet Care & Res, Chiyoda Ku, Tokyo 100, Japan; Kumamoto Univ, Sch Med, Dept Morphogenesis, Inst Mol Embryol & Genet, Kumamoto 862, Japan	Kadowaki, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.			Kasai, Haruo/0000-0003-2327-9027			Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; ERECINSKA M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P273, DOI 10.1016/0005-2728(92)90084-F; Maechler P, 1997, EMBO J, V16, P3833, DOI 10.1093/emboj/16.13.3833; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; MALAISSE WJ, 1987, BIOCHIM BIOPHYS ACTA, V927, P190, DOI 10.1016/0167-4889(87)90134-0; MALAISSE WJ, 1979, METABOLISM, V28, P373, DOI 10.1016/0026-0495(79)90111-2; DUCHEN MR, 1993, BIOCHEM J, V294, P35; ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Mertz RJ, 1996, J BIOL CHEM, V271, P4838; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; DUKES ID, 1994, J BIOL CHEM, V269, P10979; ETO K, UNPUB; GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5; HAMAKAWA N, 1995, CELL CALCIUM, V17, P21, DOI 10.1016/0143-4160(95)90099-3; HEDESKOV CJ, 1987, BIOCHEM J, V241, P161; Litsky ML, 1997, BIOCHEMISTRY-US, V36, P7071, DOI 10.1021/bi970180y; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MALAISSE WJ, 1982, ENDOCRINOLOGY, V111, P392; PRALONG WF, 1990, EMBO J, V9, P53; SENER A, 1978, BIOCHEM J, V176, P217; Wollheim C.B., 1996, DIABETES REV, V4, P276; Zawalich WS, 1997, J BIOL CHEM, V272, P3527	27	273	277	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	1999	283	5404					981	985		10.1126/science.283.5404.981		5	Multidisciplinary Sciences	Science & Technology - Other Topics	166KM	WOS:000078574800047		
J	Sasaki, M; Noguchi, T; Tachibana, K				Sasaki, M; Noguchi, T; Tachibana, K			Synthesis of the FGH ring fragment of ciguatoxin	TETRAHEDRON LETTERS			English	Article						metathesis; oxepanes; polyethers; radicals and radical reactions	CLOSING METATHESIS; ENANTIOSELECTIVE SYNTHESIS; OXONENE RING; SUB-UNITS; CONSTRUCTION; STRATEGY; OXEPENE; SYSTEMS; MOIETY; PART	Stereoselective synthesis of the FGH ring fragment of ciguatoxin is described. The key steps in the present synthesis are an intramolecular radical cyclization to construct oxepane ring G and ring-closing metathesis reaction to construct hexahydrooxonin ring F. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Sasaki, M (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Hongo, Tokyo 1130033, Japan.						Alvarez E, 1996, TETRAHEDRON LETT, V37, P2865, DOI 10.1016/0040-4039(96)00408-X; Schwab P, 1996, J AM CHEM SOC, V118, P100, DOI 10.1021/ja952676d; Clark JS, 1997, TETRAHEDRON LETT, V38, P127; Crimmins MT, 1997, J ORG CHEM, V62, P7548; Clark JS, 1997, TETRAHEDRON LETT, V38, P123; Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6; MURATA M, 1990, J AM CHEM SOC, V112, P4380, DOI 10.1021/ja00167a040; YASUMOTO T, 1993, CHEM REV, V93, P1897, DOI 10.1021/cr00021a011; Delgado M, 1997, TETRAHEDRON LETT, V38, P6299, DOI 10.1016/S0040-4039(97)01412-3; Atsuta H, 1997, SYNLETT, P307; CHARETTE AB, 1993, SYNLETT, P81; Clark JS, 1998, TETRAHEDRON LETT, V39, P8321, DOI 10.1016/S0040-4039(98)01825-5; FUKUZAWA S, 1995, SYNLETT, P1077; Inoue M, 1997, TETRAHEDRON LETT, V38, P1611, DOI 10.1016/S0040-4039(97)00125-1; Inoue M, 1998, ANGEW CHEM INT EDIT, V37, P965, DOI 10.1002/(SICI)1521-3773(19980420)37:7<965::AID-ANIE965>3.0.CO;2-P; Ishihara K, 1996, SYNLETT, P839; Isobe M, 1996, CHEM LETT, P473, DOI 10.1246/cl.1996.473; KOTSUKI H, 1990, TETRAHEDRON LETT, V31, P4609, DOI 10.1016/S0040-4039(00)97688-3; LAMBET A, 1987, FEBS LETT, V219, P355; MARUOKA K, 1983, J AM CHEM SOC, V105, P2831, DOI 10.1021/ja00347a052; NICOLAOU KC, 1990, TETRAHEDRON, V46, P4517, DOI 10.1016/S0040-4020(01)85579-4; Oishi T, 1998, CHEM COMMUN, P1041, DOI 10.1039/a801678j; Oishi T, 1996, SYNLETT, P1165; Oishi T, 1997, CHEM COMMUN, P1289, DOI 10.1039/a702158e; Oka T, 1996, TETRAHEDRON, V52, P12091, DOI 10.1016/0040-4020(96)00700-4; OSIHI T, 1997, SYNLETT, P980; Sasaki M, 1998, TETRAHEDRON LETT, V39, P2783, DOI 10.1016/S0040-4039(98)00338-4; SATAKE M, 1997, J AM CHEM SOC, V119, P1135; Oishi T, 1997, CHEM LETT, P845, DOI 10.1246/cl.1997.845	29	80	81	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 12	1999	40	7					1337	1340		10.1016/S0040-4039(98)02606-9		4	Chemistry, Organic	Chemistry	162NK	WOS:000078353000029		
J	Kobayashi, S; Furuta, T; Sugita, K; Okitsu, O; Oyamada, H				Kobayashi, S; Furuta, T; Sugita, K; Okitsu, O; Oyamada, H			Polymer-supported acylhydrazones. Use in Sc(OTf)(3)-catalyzed Mannich-type reactions providing an efficient method for the preparation of diverse pyrazolone derivatives	TETRAHEDRON LETTERS			English	Article							SOLID-PHASE SYNTHESIS; DRUG DISCOVERY; COMBINATORIAL TECHNOLOGIES; ORGANIC-SYNTHESIS; LIBRARIES; CHEMISTRY	Polymer-supported acylhydrazones, prepared from polystyrene resin (1%-divinylbenzene), reacted with ketene silyl acetals in the presence of a catalytic amount of scandium triflate (Sc(OTf)(3)), to afford the corresponding beta-hydrazinoesters, which were cyclized and cleaved from the support simultaneously by treatment with a base to produce diverse pyrazolone derivatives. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, CREST,Japan Sci & Technol Corp, Tokyo 1130033, Japan; Sci Univ Tokyo, Fac Sci, Dept Appl Chem, Shinjuku Ku, Tokyo 1620825, Japan	Kobayashi, S (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, CREST,Japan Sci & Technol Corp, Hongo, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Thompson LA, 1996, CHEM REV, V96, P555, DOI 10.1021/cr9402081; Balkenhohl F., 1996, ANGEW CHEM INT EDIT, V35, P2288, DOI 10.1002/anie.199622881; FARRALL MJ, 1976, J ORG CHEM, V41, P3877, DOI 10.1021/jo00886a023; Fruchtel JS, 1996, ANGEW CHEM INT EDIT, V35, P17, DOI 10.1002/anie.199600171; GREEN J, 1995, J ORG CHEM, V60, P4287, DOI 10.1021/jo00118a056; JUNG G, 1996, COMBINATORIAL PEOTID; KOBAYASHI S, IN PRESS CHEM SOC RE; Kobayashi S, 1998, SYNLETT, P1019; Kobayashi S, 1997, TETRAHEDRON LETT, V38, P4251, DOI 10.1016/S0040-4039(97)00857-5; LOWE G, 1995, CHEM SOC REV, V24, P309, DOI 10.1039/cs9952400309; Obrecht D., 1998, SOLID SUPPORTED COMB; Oyamada H, 1998, SYNLETT, P249; TERRETT NK, 1995, TETRAHEDRON, V51, P8135, DOI 10.1016/0040-4020(95)00467-M; Terrett N. K., 1998, COMBINATORIAL CHEM; Tietze LF, 1997, BIOORG MED CHEM LETT, V7, P1303, DOI 10.1016/S0960-894X(97)00209-6	17	44	44	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	FEB 12	1999	40	7					1341	1344		10.1016/S0040-4039(98)02607-0		4	Chemistry, Organic	Chemistry	162NK	WOS:000078353000030		
J	Murashige, S; Aihara, K; Komuro, M				Murashige, S; Aihara, K; Komuro, M			Bifurcation and resonance of a mathematical model for non-linear motion of a flooded ship in waves	JOURNAL OF SOUND AND VIBRATION			English	Article							CAPSIZE	A flooded ship can exhibit undesirable non-linear roll motion even in waves of moderate amplitude. In order to understand the mechanism of this non-linear phenomenon, the nan-linearly coupled dynamics of a ship and flood water are considered using a mathematical model for the simplified motion of a flooded ship in regular beam waves. This paper describes bifurcation and resonance of this coupled system. A bifurcation diagram shows that large-amplitude subharmonic motion exists in a wide range of parameters, and that the Hopf bifurcation is observed due to the dynamic effects of flood water. Resonance frequencies can be determined by linearization of this model. Comparison between the resonance points and the bifurcation curves suggests that non-linear resonances of this model can bring about large-amplitude subharmonic motion, even if it is in the non-resonant state of the linearized system. (C) 1999 Academic Press.	Univ Tokyo, Grad Sch Engn, Dept Math Engn & Informat Phys, Tokyo, Japan	Murashige, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Math Engn & Informat Phys, Tokyo, Japan.						KAWAKAMI H, 1984, IEEE T CIRCUITS SYST, V31, P248, DOI 10.1109/TCS.1984.1085495; Falzarano JM, 1992, INT J BIFURCAT CHAOS, V2, P101, DOI 10.1142/S0218127492000100; KAN H, 1994, NONLINEARITY CHAOS E, P418; MURASHIGE S, 1997, P 1997 INT S NONL TH, V1, P497; MURASHIGE S, IN PRESS P ROYAL S A; Murashige S, 1998, INT J BIFURCAT CHAOS, V8, P619, DOI 10.1142/S0218127498000413; Nayfeh A H, 1979, NONLINEAR OSCILLATIO; Nayfeh A.H., 1973, J HYDRONAUT, V7, P145, DOI 10.2514/3.62949; SOLIMAN MS, 1991, APPL OCEAN RES, V13, P82, DOI 10.1016/S0141-1187(05)80065-3; Thompson J. M. T., 1997, APPL MECH REV, V50, P307; Thompson JMT, 1996, P ROY SOC A-MATH PHY, V452, P2527, DOI 10.1098/rspa.1996.0135; VIRGIN LN, 1987, APPL OCEAN RES, V9, P89, DOI 10.1016/0141-1187(87)90011-3	12	6	8	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-460X			J SOUND VIB	J. Sound Vibr.	FEB 11	1999	220	1					155	170		10.1006/jsvi.1998.1956		16	Acoustics; Engineering, Mechanical; Mechanics	Acoustics; Engineering; Mechanics	164DT	WOS:000078447700008		
J	Mori, C; Uritani, A; Miyahara, H; Iguchi, T; Shiroya, S; Kobayashi, K; Takada, E; Fleming, RF; Dewaraja, YK; Stuenkel, D; Knoll, GF				Mori, C; Uritani, A; Miyahara, H; Iguchi, T; Shiroya, S; Kobayashi, K; Takada, E; Fleming, RF; Dewaraja, YK; Stuenkel, D; Knoll, GF			Measurement of neutron and gamma-ray intensity distributions with an optical fiber-scintillator detector	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	9th Symposium on Radiation Measurements and Applications	MAY 11-14, 1998	ANN ARBOR, MICHIGAN				PROPORTIONAL COUNTER	On the tip of an optical fiber, a very small amount of ZnS(Ag) scintillator mixed with neutron converter and adhesive paste was painted, which can be inserted into a narrow space and moved by a fiber-driving unit controlled with a personal computer. The presented method made it possible to measure neutron flux distributions in critical assemblies, research reactors or other neutron facilities with position resolution of less than 1 mm and in 10 min or so over a meter. As neutron converter, Li-6 and U-235 are good for thermal neutrons and Th-232 is useful for fast neutrons. When a neutron converter is not used, the method can be applied to the measurement of gamma-ray intensity distribution. (C) 1999 Elsevier Science B.V. All rights reserved.	Nagoya Univ, Dept Nucl Engn, Nagoya, Aichi 4648603, Japan; Kyoto Univ, Inst Res Reactor, Kyoto 606, Japan; Univ Tokyo, Tokyo, Japan; Univ Michigan, Ann Arbor, MI 48109 USA	Mori, C (reprint author), Nagoya Univ, Dept Nucl Engn, Nagoya, Aichi 4648603, Japan.						MORI C, 1994, J NUCL SCI TECHNOL, V31, P248, DOI 10.3327/jnst.31.248; MORI C, 1992, NUCL INSTRUM METH A, V312, P189, DOI 10.1016/0168-9002(92)90151-S; URITANI A, 1995, J NUCL SCI TECHNOL, V32, P719	3	17	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	FEB 11	1999	422	1-3					129	132		10.1016/S0168-9002(98)01088-2		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	171MY	WOS:000078868800027		
J	Kurahashi, T; Takahashi, H; Nakazawa, M				Kurahashi, T; Takahashi, H; Nakazawa, M			Radiation digital signal processing using smoothing spline	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	9th Symposium on Radiation Measurements and Applications	MAY 11-14, 1998	ANN ARBOR, MICHIGAN					The noise component in digitized signal data greatly affects the result of numerical waveform processings. The effectiveness of the smoothing spline method has been examined by obtaining the distributions of calculated rise-time value. During the comparison of the distributions with the Savitzky-Golay method, the better suppression of the noise component was observed by applying the smoothing spline method. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1138656, Japan	Kurahashi, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHOENBERG IJ, 1964, P NATL ACAD SCI USA, V52, P947, DOI 10.1073/pnas.52.4.947; TAKAHASHI H, 1994, NUCL INSTRUM METH A, V353, P164, DOI 10.1016/0168-9002(94)91628-4; Whittaker E.T., 1923, P EDINBURGH MATH SOC, V41, P63, DOI DOI 10.1017/S001309150000359X	4	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	FEB 11	1999	422	1-3					385	387		10.1016/S0168-9002(98)00988-7		3	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	171MY	WOS:000078868800077		
J	Fujiwara, M; Akimune, H; Daito, I; Fujimura, H; Fujita, Y; Hatanaka, K; Ikegami, H; Katayama, I; Nagayama, K; Matsuoka, N; Morinobu, S; Noro, T; Yoshimura, M; Sakaguchi, H; Sakemi, Y; Tamii, A; Yosoi, M				Fujiwara, M; Akimune, H; Daito, I; Fujimura, H; Fujita, Y; Hatanaka, K; Ikegami, H; Katayama, I; Nagayama, K; Matsuoka, N; Morinobu, S; Noro, T; Yoshimura, M; Sakaguchi, H; Sakemi, Y; Tamii, A; Yosoi, M			Magnetic spectrometer Grand Raiden	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	9th Symposium on Radiation Measurements and Applications	MAY 11-14, 1998	ANN ARBOR, MICHIGAN			magnetic spectrometer; Grand Raiden; ion-optical properties		A high-resolution magnetic spectrometer called "Grand Raiden" is operated at the RCNP ring cyclotron facility in Osaka for nuclear physics studies at intermediate energies. This magnetic spectrometer has excellent ion-optical properties. In the design of the spectrometer, the second-order dispersion matching condition has been taken into account, and almost all the aberration terms such as (x\theta(3)), (x\theta phi(2)), (x\theta(2)delta) and (x\theta delta(2)) in a third-order matrix calculation are optimized. A large magnetic rigidity of the spectrometer (K = 1400 MeV) gives a great advantage to measure the charge-exchange (He-3, t) reactions at 450 MeV. The ability of the high-resolution measurement has been demonstrated. Various coincidence measurements are performed to study the nuclear structures of highly excited states through decay properties of nuclear levels following nuclear reactions at intermediate energies. (C) 1999 Elsevier Science B.V. All rights reserved.	Osaka Univ, Nucl Phys Res Ctr, Osaka 5670047, Japan; Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan; Univ Tokyo, Ctr Nucl Study, Tokyo 1880002, Japan; Kyushu Univ, Dept Phys, Fukuoka 8120053, Japan; Kyoto Univ, Dept Phys, Kyoto 6068224, Japan; Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan	Fujiwara, M (reprint author), Osaka Univ, Nucl Phys Res Ctr, Mihogaoka 10-1, Osaka 5670047, Japan.						ENGE HA, 1970, P INT C MAG TECHN HA, P366; FUJIWARA M, 1989, RCNP ANN REPORT, P201; FUJIWARA M, 1987, RCNP ANN REPORT, P160; FUJIWARA M, 1989, P INT S HEAV ION RES, P283; FUJIWARA M, 1987, RCNP ANN REPORT, P169; FUJIWARA M, 1988, RCNP ANN REPORT, P206; KOWALASKI S, 1986, RAYTRACE MANUAL; Morinobu S., COMMUNICATION; Noro T., 1991, RCNP ANN REPORT, P177; STEPHENSON EJ, 1990, C PHYS C, V6, P85; Tamii A, 1996, IEEE T NUCL SCI, V43, P2488, DOI 10.1109/23.539396; YOSOI M, 1987, RCNP ANN REPORT, P166	12	212	212	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	FEB 11	1999	422	1-3					484	488		10.1016/S0168-9002(98)01009-2		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	171MY	WOS:000078868800095		
J	Takahashi, H; Amemiya, K; Kaizuka, Y; Nakazawa, M; Yasuda, N; Yamamoto, M; Sakai, T; Kamiya, T; Okada, S				Takahashi, H; Amemiya, K; Kaizuka, Y; Nakazawa, M; Yasuda, N; Yamamoto, M; Sakai, T; Kamiya, T; Okada, S			High resolution imaging for charged particles using CR-39 and atomic force microscopy	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	9th Symposium on Radiation Measurements and Applications	MAY 11-14, 1998	ANN ARBOR, MICHIGAN					Recently Atomic Force Microscopy (AFM) has been used for a readout of Solid State Nuclear Track Detectors (SSNTD). In this technique, the SSNTD is etched for very short time and scanned by an AFM to observe track etch pits. Etch pits of several hundred nm in diameter can be observed. We applied this technique to charged particle imaging using CR-39. CR-39 plates were etched for about 5 min in 27% NaOH solution at 70 degrees C. Then very small etch pits were measured. A typical diameter of etch pits was below 1 mu m and a typical etch pit depth was about several hundred nm. The obtained image has demonstrated a position resolution of less than 100 nm. Ion microbeam profiles were also measured by the system. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; Japan Atom Energy Res Inst, Takasaki, Gumma 37012, Japan	Takahashi, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; DRNDIC M, 1994, NUCL INSTRUM METH B, V93, P52, DOI 10.1016/0168-583X(94)95456-9; Havancsak K, 1997, RADIAT MEAS, V28, P65, DOI 10.1016/S1350-4487(97)00041-3; Yamamoto M, 1997, RADIAT MEAS, V28, P227, DOI 10.1016/S1350-4487(97)00073-5; Yasuda N, 1998, NUCL INSTRUM METH B, V142, P111, DOI 10.1016/S0168-583X(98)00267-5	5	2	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	FEB 11	1999	422	1-3					751	755		10.1016/S0168-9002(98)01030-4		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	171MY	WOS:000078868800146		
J	Dan, S; Naito, M; Seimiya, H; Kizaki, A; Mashima, T; Tsuruo, T				Dan, S; Naito, M; Seimiya, H; Kizaki, A; Mashima, T; Tsuruo, T			Activation of c-Abl tyrosine kinase requires caspase activation and is not involved in JNK/SAPK activation during apoptosis of human monocytic leukemia U937 cells	ONCOGENE			English	Article						c-Abl; JNK1/SAPK; caspase; apoptosis	DEPENDENT PROTEIN-KINASE; DNA-DAMAGE; IONIZING-RADIATION; CELLULAR-RESPONSE; STRESS-RESPONSE; P53; 1-BETA-D-ARABINOFURANOSYLCYTOSINE; PHOSPHORYLATION; RESISTANCE; SUBSTRATE	Genotoxic stress triggers the activation of several sensor molecules, such as p53, JNK1/SAPK and c-Abl, and occasionally promotes the cells to apoptosis, We previously reported that JNK1/SAPK regulates genotoxic stress-induced apoptosis in p53-negative U937 cells by activating caspases, c-Abl is expected to act upstream of JNK1/SAPK activation upon treatment with genotoxic stressors, but its involvement in apoptosis development is still unclear. We herein investigated the kinase activities of c-Abl and JNK1/SAPK during apoptosis elicited by genotoxic anticancer drugs and tumor necrosis factor (TNF) in U937 cells and their apoptosis-resistant variant UK711 cells. We found that the activation of JNK1/SAPK and c-Abl correlated well with apoptosis development in these cell lines. Unexpectedly, however, the JNK1/SAPK activation preceded the c-Abl activation. Moreover, the caspase inhibitor Z-Asp suppressed c-Abl activation and the onset of apoptosis but not the JNK1/SAPK activation. Interestingly, c-Abl tyrosine kinase inhibition by CGP 57148 reduced apoptosis without interfering with JNK1/SAPK activation. These results indicate that c-Abl acts not upstream of JNK1/SAPK but downstream of caspases during the development of p53-independent apoptosis and is possibly involved in accelerating execution of the cell death pathway.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1708455, Japan	Tsuruo, T (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Shafman T, 1997, NATURE, V387, P520, DOI 10.1038/387520a0; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; Yuan ZM, 1996, J BIOL CHEM, V271, P26457; Buchdunger E, 1996, CANCER RES, V56, P100; REN RB, 1994, GENE DEV, V8, P783, DOI 10.1101/gad.8.7.783; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; KATAOKA S, 1994, EXP CELL RES, V215, P199, DOI 10.1006/excr.1994.1332; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Enari M, 1998, NATURE, V391, P43; Yuan ZM, 1997, P NATL ACAD SCI USA, V94, P1437, DOI 10.1073/pnas.94.4.1437; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Mashima T, 1995, BIOCHEM BIOPH RES CO, V217, P1185, DOI 10.1006/bbrc.1995.2894; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kharbanda S, 1997, NATURE, V386, P732, DOI 10.1038/386732a0; KASTAN MB, 1991, CANCER RES, V51, P6304; LEE JM, 1993, P NATL ACAD SCI USA, V90, P5742, DOI 10.1073/pnas.90.12.5742; Han ZY, 1996, J BIOL CHEM, V271, P25035; DEKLEIN A, 1982, NATURE, V300, P765; Sakahira H, 1998, NATURE, V391, P96; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; GUNJI H, 1991, CANCER RES, V51, P741; Huang YY, 1997, ONCOGENE, V15, P1947, DOI 10.1038/sj.onc.1201376; Kharbanda S, 1996, P NATL ACAD SCI USA, V93, P6898, DOI 10.1073/pnas.93.14.6898; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; McConnell KR, 1997, J IMMUNOL, V158, P2083; Pandey P, 1996, J BIOL CHEM, V271, P23775; Seimiya H, 1997, J BIOL CHEM, V272, P4631; Song QZ, 1996, EMBO J, V15, P3238; Teraoka H, 1996, FEBS LETT, V393, P1, DOI 10.1016/0014-5793(96)00842-3	32	25	26	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 11	1999	18	6					1277	1283		10.1038/sj.onc.1202423		7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	165FW	WOS:000078510900003		
J	Iwamoto, K				Iwamoto, K			On the radio-to-X-ray light curves of SN 1998bw and GRB 980425	ASTROPHYSICAL JOURNAL			English	Article						gamma rays : bursts; supernovae : general; supernovae : individual (SN 1998bw)		We calculate radio-to-X-ray light curves for afterglows caused by nonthermal emission from a highly relativistic blast wave, which is inferred from the gamma-ray flux detected in GRB 980425 and from the very bright radio emission detected in SN 1998bw. We find that the observed gamma-ray and radio light curves are roughly reproduced by the synchrotron emission from a relativistic fireball. The optical flux predicted for the nonthermal emission is well below that of the thermal emission observed for SN 1998bw so that it will not be seen at least for a few years. The model predicts the X-ray flux just above the detection limit of BeppoSAX for the epoch when it was pointed to the field of GRB 980425. Therefore, the nondetection of X-ray and optical afterglows is consistent with the model. The models presented here are consistent with the physical association between SN 1998bw and GRB 980425 and lend further support to the idea that this object might correspond to an event similar to the "hypernova" or "collapsar"-events in which the collapse of a massive star forms a rotating black hole surrounded by a disk of the remnant stellar mantle.	Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Iwamoto, K (reprint author), Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan.						Iwamoto K, 1998, NATURE, V395, P672; Wijers RAMJ, 1997, MON NOT R ASTRON SOC, V288, pL51; BLANDFORD RD, 1976, PHYS FLUIDS, V19, P1130, DOI 10.1063/1.861619; Kulkarni SR, 1998, NATURE, V395, P663, DOI 10.1038/27139; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Galama TJ, 1998, NATURE, V395, P670, DOI 10.1038/27150; Rees MJ, 1998, ASTROPHYS J, V496, pL1, DOI 10.1086/311244; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433; MACFADYEN A, 1998, UNPUB APJ; NAKAMURA T, 1998, UNPUB; Paczynski B, 1998, ASTROPHYS J, V494, pL45, DOI 10.1086/311148; PIAN E, 1998, 61 GCN; PIAN E, 1998, 69 GCN; PIRAN T, 1997, SOME UNSOLVED PROBLE, P343; WOOSLEY SE, 1998, IN PRESS APJ	15	20	20	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 10	1999	512	1	2				L47	L50		10.1086/311867		4	Astronomy & Astrophysics	Astronomy & Astrophysics	178DP	WOS:000079251300013		
J	Nose, M; Tsukada, I; Uchinokura, K				Nose, M; Tsukada, I; Uchinokura, K			Bilayer fabrication and B-site cation interdiffusion in the Bi-Sr-Ca-Cu-O/Bi-Sr-Co-O system	PHYSICA C			English	Article						Bi-Sr-Ca-Cu-O; Bi-Sr-Co-O; molecular beam epitaxy; bilayer	SUPERCONDUCTING PROPERTIES; THIN-FILMS; SUPERLATTICES; JUNCTIONS	The bilayer system of Bi2Sr2Can - 1CunOy and Bi2Sr2CoO6.25 + 8 thin films grown by molecular beam epitaxy was investigated by X-ray diffraction, reflection high-energy electron diffraction, and d.c, resistivity measurement. We found that a diffusion behavior is qualitatively different among Bi2Sr2Can - 1CunOy/Bi2Sr2CoO6.25 + 8 bilayers (n = 1, 2, 3). In the case of the Bi2Sr2CoO6.25 + 8/Bi2Sr2CuO6 + 8 bilayer, it was revealed that Cu in Bi2Sr2CuOy and Co in Bi2Sr2CoO6.25 + 8 interdiffused and the film became a solid solution of Bi2Sr2(Cu1-xCox)O-y. On the other hand, in the cases of Bi2Sr2CaCu2O8 + 6/Bi2Sr2CoO6.25 + (8) and Bi2Sr2Ca2Cu3O10 + 8/Bi2Sr2CoO6.25 + 8 bilayers, substitution of Co for Cu was drastically suppressed and the bilayers show superconductivity. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Nose, M (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						TERASHIMA T, 1991, PHYS REV LETT, V67, P1362, DOI 10.1103/PhysRevLett.67.1362; BOEKHOLT M, 1992, PHYSICA C, V198, P33, DOI 10.1016/0921-4534(92)90262-B; ECKSTEIN JN, 1995, IEEE T APPL SUPERCON, V5, P1680, DOI 10.1109/77.402899; HASHIMOTO T, 1992, APPL PHYS LETT, V60, P1756, DOI 10.1063/1.107208; LI ZZ, 1994, PHYS REV LETT, V72, P4033, DOI 10.1103/PhysRevLett.72.4033; MATSUSHIMA T, 1990, SOLID STATE COMMUN, V76, P1201, DOI 10.1016/0038-1098(90)90060-O; Migita S, 1997, APPL PHYS LETT, V71, P3712, DOI 10.1063/1.120490; MIZUNO K, 1991, JPN J APPL PHYS 2, V30, pL1559; Nose M, 1996, CZECH J PHYS, V46, P1323; ROGERS CT, 1989, APPL PHYS LETT, V55, P2032, DOI 10.1063/1.102340; TARASCON JM, 1989, PHYS REV B, V39, P11587, DOI 10.1103/PhysRevB.39.11587; TRISCONE JM, 1990, PHYS REV LETT, V64, P804, DOI 10.1103/PhysRevLett.64.804; Tsukada I, 1996, P SOC PHOTO-OPT INS, V2697, P306, DOI 10.1117/12.250247; Tsukada I, 1997, PHYSICA C, V282, P687, DOI 10.1016/S0921-4534(97)00498-X; Tsukada I, 1996, J APPL PHYS, V80, P5691, DOI 10.1063/1.363568; Zou ZG, 1997, JPN J APPL PHYS 2, V36, pL18, DOI 10.1143/JJAP.36.L18	16	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0921-4534			PHYSICA C	Physica C	FEB 10	1999	313	1-2					98	104		10.1016/S0921-4534(98)00707-2		7	Physics, Applied	Physics	170NB	WOS:000078811100014		
J	Tanaka, I; Kamiya, I; Sakaki, H; Qureshi, N; Allen, SJ; Petroff, PM				Tanaka, I; Kamiya, I; Sakaki, H; Qureshi, N; Allen, SJ; Petroff, PM			Imaging and probing electronic properties of self-assembled InAs quantum dots by atomic force microscopy with conductive tip	APPLIED PHYSICS LETTERS			English	Article							ENERGY-LEVELS; GAAS; ISLANDS; PHOTOLUMINESCENCE; SURFACES	Atomic force microscopy with a conductive probe has been used to study both the topography and the electronic properties of 10-nm-scale self-assembled InAs quantum dots (QDs) grown by molecular beam epitaxy on n-type GaAs. The current flowing through the conductive probe normal to the sample surface is measured for imaging local conductance, while the deflection of cantilever is optically detected for disclosing geometrical structure. The conductance on InAs QDs is found to be much larger than that on the wetting layer, allowing imaging of QDs through measurements of local current. We attribute this change in conductance to the local modification of surface band bending associated with surface states on InAs QD surface. Mechanisms of electron transport through QDs are discussed based on current-voltage characteristics measured on QDs of various sizes. (C) 1999 American Institute of Physics. [S0003-6951(99)03206-4].	Japan Sci & Technol Corp, Quantum Transit Project, Meguro Ku, Tokyo 1530041, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Calif Santa Barbara, QUEST, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Ctr Terahertz Sci & Technol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	Tanaka, I (reprint author), Wakayama Univ, Dept Chem & Mat Sci, 930 Sakaedani, Wakayama 6408510, Japan.		Kamiya, Itaru/M-9596-2014	Kamiya, Itaru/0000-0003-0105-5188			ANAND S, 1996, J VAC SCI TECHNOL B, V14, P2795; Houze F, 1996, APPL PHYS LETT, V69, P1975; TUNG RT, 1992, PHYS REV B, V45, P13509, DOI 10.1103/PhysRevB.45.13509; Kobayashi NP, 1996, APPL PHYS LETT, V68, P3299, DOI 10.1063/1.116580; MARZIN JY, 1994, PHYS REV LETT, V73, P716, DOI 10.1103/PhysRevLett.73.716; LEONARD D, 1993, APPL PHYS LETT, V63, P3203, DOI 10.1063/1.110199; Rubin ME, 1996, PHYS REV LETT, V77, P5268, DOI 10.1103/PhysRevLett.77.5268; DURR CS, 1997, MSS8 SANT BARB; FAFARD S, 1994, APPL PHYS LETT, V65, P1388, DOI 10.1063/1.112060; HEINTS R, 1996, APPL PHYS LETT, V68, P361; Kamiya I, 1998, PHYSICA E, V2, P637, DOI 10.1016/S1386-9477(98)00130-1; KAWAJI S, 1996, J PHOTOGR SCI, V21, P336; LEONARD D, 1994, PHYS REV B, V50, P11687, DOI 10.1103/PhysRevB.50.11687; MEDEIROSRIBEIRO G, 1995, APPL PHYS LETT, V66, P1767, DOI 10.1063/1.113361; SAKAKI H, 1992, SURF SCI, V267, P623, DOI 10.1016/0039-6028(92)91212-T; Toda Y, 1996, APPL PHYS LETT, V69, P827, DOI 10.1063/1.117905	16	89	92	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 8	1999	74	6					844	846		10.1063/1.123402		3	Physics, Applied	Physics	163RL	WOS:000078419200024		
J	Takahashi, J; Hosokawa, T; Masuda, H; Kaneko, T; Kobayashi, K; Saito, S; Utsumi, Y				Takahashi, J; Hosokawa, T; Masuda, H; Kaneko, T; Kobayashi, K; Saito, S; Utsumi, Y			Abiotic synthesis of amino acids by x-ray irradiation of simple inorganic gases	APPLIED PHYSICS LETTERS			English	Article							INTERSTELLAR DUST; PRIMITIVE EARTH; ATMOSPHERES; CARBON	1-2 keV x-ray irradiation was carried out using a synchrotron radiation source on simulated primitive earth environment: a gas mixture of carbon monoxide, nitrogen, and water at atmospheric pressure. High-speed liquid chromatography of the hydrolyzed product solution detected amino acids. The amount of amino acids increased with the total energy absorbed by the gas molecules, and the antipodal optical isomers were generated in almost equal quantities. These imply that the precursors for amino acids were produced through x-ray-induced photolysis of inorganic molecules followed by recombination and polymerization into bio-organic compounds. These results suggest that prebiotic formation of amino acids is possible in primitive earth atmosphere by x ray as well as cosmic ray. (C) 1999 American Institute of Physics. [S0003-6951(99)00906-7].	NTT, Syst Elect Labs, Kanagawa 2430198, Japan; Yokohama Natl Univ, Dept Chem & Biotechnol, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; Univ Tokyo, Inst Cosm Ray Res, Tokyo 1888502, Japan; NTT, Basic Res Labs, Kanagawa 2430198, Japan	Takahashi, J (reprint author), NTT, Syst Elect Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.			Kaneko, Takeo/0000-0002-8904-1030; Kobayashi, Kensei/0000-0003-2951-1341			HENKE BL, 1993, ATOM DATA NUCL DATA, V54, P181, DOI 10.1006/adnd.1993.1013; BRIGGS R, 1992, ORIGINS LIFE EVOL B, V22, P287, DOI 10.1007/BF01810858; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; Kobayashi K, 1998, ORIGINS LIFE EVOL B, V28, P155, DOI 10.1023/A:1006561217063; BARNUN A, 1983, J GEOPHYS RES-OC ATM, V88, P6662, DOI 10.1029/JC088iC11p06662; GREENBERG JM, 1994, J BIOL PHYS, V20, P61; KASTING JF, 1990, ORIGINS LIFE EVOL B, V20, P199, DOI 10.1007/BF01808105; SAGAN C, 1971, SCIENCE, V173, P417, DOI 10.1126/science.173.3995.417; KOBAYASHI K, 1990, ORIGINS LIFE EVOL B, V20, P99, DOI 10.1007/BF01808270; MASUDA H, 1998, VIVA ORIGINO, V26, P51; Miyakawa S, 1998, APPL PHYS LETT, V72, P990, DOI 10.1063/1.120617; SCHLESINGER G, 1983, J MOL EVOL, V19, P376, DOI 10.1007/BF02101642; SHIBAYAMA A, 1989, REV SCI INSTRUM, V60, P1779, DOI 10.1063/1.1140952; TAKAHASHI J, 1992, THIN SOLID FILMS, V218, P40, DOI 10.1016/0040-6090(92)90901-M; Takahashi J, 1998, J SYNCHROTRON RADIAT, V5, P548, DOI 10.1107/S0909049597017585	15	20	20	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 8	1999	74	6					877	879		10.1063/1.123396		3	Physics, Applied	Physics	163RL	WOS:000078419200035		
J	Hosoyama, H; Shigemori, H; Tomida, A; Tsuruo, T; Kobayashi, J				Hosoyama, H; Shigemori, H; Tomida, A; Tsuruo, T; Kobayashi, J			Modulation of multidrug resistance in tumor cells by taxinine derivatives	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article						biologically active compounds; glycopeptides/glycoproteins; molecular design; taxoids	TAXUS-CUSPIDATA; TAXOIDS; VINCRISTINE	Among a series of taxinine (1) and its designed derivatives (2 similar to 33), two taxoids (29 and 33) increased cellular accumulation of vincristine in multidrug-resistant tumor cells more potently than verapamil, while the activities of eight taxoids (11, 14 similar to 16, 22, and 30 similar to 32) were comparable with that of verapamil. These results reveal that some taxinine derivatives are good modifiers of multidrug resistance in tumor cells. (C) 1999 Elsevier Science Ltd. All rights reserved.	Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Hosoyama, H (reprint author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan.		Kobayashi, Jun'ichi/A-4253-2012				BATHINI Y, 1994, SYNTHETIC COMMUN, V24, P1513, DOI 10.1080/00397919408010151; Hosoyama H, 1998, TETRAHEDRON, V54, P2521, DOI 10.1016/S0040-4020(98)00018-0; Kobayashi J, 1998, HETEROCYCLES, V47, P1111; Kobayashi J, 1998, BIOORG MED CHEM LETT, V8, P1555, DOI 10.1016/S0960-894X(98)00262-5; Kobayashi J, 1997, BIOORG MED CHEM LETT, V7, P393, DOI 10.1016/S0960-894X(97)00029-2; KOBAYASHI J, 1995, TETRAHEDRON, V51, P5971, DOI 10.1016/0040-4020(95)00255-7; Morita H, 1997, TETRAHEDRON, V53, P4621, DOI 10.1016/S0040-4020(97)00200-7; NAITO M, 1988, J BIOL CHEM, V263, P11887; RIORDAN JR, 1985, PHARMACOL THERAPEUT, V28, P51, DOI 10.1016/0163-7258(85)90082-8; Sako M, 1998, CHEM PHARM BULL, V46, P1135; Sako M, 1998, J CHEM SOC PERK T 1, P417, DOI 10.1039/a707146i; TWENTYMAN PR, 1988, ANTICANCER RES, V8, P985	12	32	35	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 8	1999	9	3					389	394		10.1016/S0960-894X(99)00009-8		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	168TB	WOS:000078707800018		
J	Ichinose, K; Surti, C; Taguchi, T; Malpartida, F; Booker-Milburn, KI; Stephenson, GR; Ebizuka, Y; Hopwood, DA				Ichinose, K; Surti, C; Taguchi, T; Malpartida, F; Booker-Milburn, KI; Stephenson, GR; Ebizuka, Y; Hopwood, DA			Proof that the actVI genetic region of Streptomyces coelicolor A3(2) is involved in stereospecific pyran ring formation in the biosynthesis of actinorhodin	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article							CLONING; CLUSTER	Pyran ring formation in the biosynthesis of actinorhodin in Streptomyces coelicolor A3(2) was studied using the act cluster deficient strain, CH999, carrying pRM5-based plasmids harbouring combinations of the actVI genes. The strain, CH999/pIJ5660 (pRM5 + actVI-ORF1), produced a chiral intermediate, (S)-DNPA, suggesting that the actVI-ORF1 product is a reductase determining the C-3 stereochemical centre. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ E Anglia, Sch Chem Sci, Norwich NR4 7TJ, Norfolk, England; Consejo Super Invest Cient, Ctr Nacl Biotecnol, Madrid 28049, Spain; John Innes Ctr Plant Sci Res, Dept Genet, Norwich NR4 7UH, Norfolk, England	Ichinose, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.		Malpartida, Francisco/D-2563-2009				RUDD BAM, 1979, J GEN MICROBIOL, V114, P35; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; BARTEL PL, 1990, J BACTERIOL, V172, P4816; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; MCDANIEL R, 1993, SCIENCE, V262, P1546, DOI 10.1126/science.8248802; OMURA S, 1986, ANTIMICROB AGENTS CH, V29, P13; BROCKMANN H, 1955, CHEM BER, V88, P228; CHATER KF, 1983, GENE, V26, P67, DOI 10.1016/0378-1119(83)90037-9; CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8; COLE SP, 1987, J ANTIBIOT, V40, P340; FERNANDEZMORENO MA, 1994, J BIOL CHEM, V269, P24854; GORSTALLMAN CP, 1981, J ORG CHEM, V46, P455, DOI 10.1021/jo00315a046; Hopwood DA, 1985, GENETIC MANIPULATION; ICHINOSE K, 1998, IN PRESS ACTINOMYCET, V12; MALPARTIDA F, 1986, MOL GEN GENET, V205, P66, DOI 10.1007/BF02428033; O'Hagan D., 1991, POLYKETIDE METABOLIT; YOUNGLESON JS, 1989, J BACTERIOL, V171, P6800	17	35	40	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 8	1999	9	3					395	400		10.1016/S0960-894X(99)00011-6		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	168TB	WOS:000078707800019		
J	Min, YK; Asami, T; Fujioka, S; Murofushi, N; Yamaguchi, I; Yoshida, S				Min, YK; Asami, T; Fujioka, S; Murofushi, N; Yamaguchi, I; Yoshida, S			New lead compounds for brassinosteroid biosynthesis inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article							TRACHEARY-ELEMENT DIFFERENTIATION; PLANT-GROWTH; BRASSINOLIDE; METABOLISM; CELLS	The first brassinosteroid biosynthesis inhibitor is reported. Among newly synthesized triazole derivatives, 4-(4-chlorophenyl)-2-phenyl-3-(1,2,4-triazoyl)butan-2-ol (6) was found to inhibit the growth of cress seedlings, and this inhibition was recovered by the treatment of brassinolide, suggesting that compound 6 primarily inhibits brassinosteroid biosynthesis. (C) 1999 Elsevier Science Ltd. All rights reserved.	RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 113, Japan	Asami, T (reprint author), RIKEN, Inst Phys & Chem Res, 2-1 Hirosawa, Wako, Saitama 35101, Japan.						Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980; YOPP JH, 1981, PHYSIOL PLANTARUM, V53, P445, DOI 10.1111/j.1399-3054.1981.tb02729.x; Fujioka S, 1997, PLANT CELL, V9, P1951; Yokota T, 1997, TRENDS PLANT SCI, V2, P137, DOI 10.1016/S1360-1385(97)01017-0; Clouse SD, 1998, ANNU REV PLANT PHYS, V49, P427, DOI 10.1146/annurev.arplant.49.1.427; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Azpiroz R, 1998, PLANT CELL, V10, P219; IWASAKI T, 1991, PLANT CELL PHYSIOL, V32, P1007; IZUMI K, 1984, PLANT CELL PHYSIOL, V25, P611; Sakurai A, 1997, BIOSCI BIOTECH BIOCH, V61, P757; Fujioka S, 1997, PHYSIOL PLANTARUM, V100, P710, DOI 10.1034/j.1399-3054.1997.1000335.x; JonesHeld S, 1996, J PLANT GROWTH REGUL, V15, P63, DOI 10.1007/BF00192933; MANDAVA N, 1989, ANNU REV PLANT PHYS, V39, P23; Rademacher W., 1989, Target sites of herbicide action., P127; RADEMACHER W, 1991, GIBBERELLINS, P296; SCHLAGNHAUFER CD, 1991, J PLANT PHYSIOL, V138, P191; YOKOTA T, 1991, GIBBERELLIN, P39	17	50	52	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	FEB 8	1999	9	3					425	430		10.1016/S0960-894X(99)00008-6		6	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	168TB	WOS:000078707800024		
J	Shimizu, S; Ikeguchi, M; Nakamura, S; Shimizu, K				Shimizu, S; Ikeguchi, M; Nakamura, S; Shimizu, K			Size dependence of transfer free energies: A hard-sphere-chain-based formalism	JOURNAL OF CHEMICAL PHYSICS			English	Article							SOLVATION FREE-ENERGIES; FLORY-HUGGINS THEORY; MOLECULAR-SIZE; SOLUTES; MODELS; COEFFICIENTS; PARAMETERS; SOLUBILITY; WATER; SHAPE	The main purpose of this paper is to present a theoretical scheme which describes the solvation and transfer free energies of small molecules and relate them to solvent contributions in the biomolecular processes. Several proposals, based originally on Flory-Huggins theory, have been made recently that there is a non-negligible solute's volume-proportional term in solvation free energy and the term should be subtracted to obtain solute/solvent contact free energy for biochemical applications. These proposals have resulted in the revision of the magnitude of the hydrophobic effect in biomolecules. The validity has been controversial, since the existence, physical origin, and magnitude of the volume-proportional term have been model dependent. In this paper, we cleared up this problem by using an accurate fused-hard sphere model and a perturbation scheme in which the compensation between the repulsive and attractive interactions has been clarified. The solvation free energy is shown to be dependent on the solute's surface area and curvature: the volume-proportional term is shown to be negligibly small. This disproves the basic assumption of the previous theories whose purpose is to "correct'' the magnitude of the solvation free energy by subtracting volume-proportional terms. The relationship of our theory to previous theories is also discussed. (C) 1999 American Institute of Physics. [S0021-9606(99)50106-2].	Univ Tokyo, Dept Biotechnol, Bioinformat Engn Lab, Bunkyo Ku, Tokyo 1138657, Japan	Shimizu, S (reprint author), Univ Tokyo, Dept Biotechnol, Bioinformat Engn Lab, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	seishi@bi.a.u-tokyo.ac.jp					RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; FAUCHERE JL, 1983, EUR J MED CHEM, V18, P369; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; HORTON N, 1992, PROTEIN SCI, V1, P169; LEBOWITZ JL, 1961, PHYS REV, V122, P1675, DOI 10.1103/PhysRev.122.1675; REISS H, 1959, J CHEM PHYS, V31, P369, DOI 10.1063/1.1730361; BARKER JA, 1976, REV MOD PHYS, V48, P587, DOI 10.1103/RevModPhys.48.587; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; SHARP KA, 1991, BIOCHEMISTRY-US, V30, P9686, DOI 10.1021/bi00104a017; ABRAHAM MH, 1994, J PHARM SCI, V83, P1085, DOI 10.1002/jps.2600830806; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; LEO A, 1971, CHEM REV, V71, P525, DOI 10.1021/cr60274a001; EISENBERG D, 1989, CHEM SCRIPTA, V29A, P217; WERTHEIM MS, 1987, J CHEM PHYS, V87, P7323, DOI 10.1063/1.453326; Ben-Naim A, 1997, J PHYS CHEM B, V101, P11221, DOI 10.1021/jp970257s; Ben-Naim A., 1992, STAT THERMODYNAMICS; BenNaim A, 1997, J PHYS CHEM B, V101, P10535, DOI 10.1021/jp962811o; BENNAIM A, 1993, J PHYS CHEM-US, V97, P10829, DOI 10.1021/j100143a050; BENNAIM A, 1994, CURR OPIN STRUC BIOL, V4, P264, DOI 10.1016/S0959-440X(94)90318-2; Chan HS, 1997, ANNU REV BIOPH BIOM, V26, P425, DOI 10.1146/annurev.biophys.26.1.425; CHAN HS, 1994, J CHEM PHYS, V101, P7007, DOI 10.1063/1.468327; CHAPMAN WG, 1988, MOL PHYS, V65, P191; CUMMINGS MD, 1995, PROTEIN SCI, V4, P2087; DEYOUNG LR, 1990, J PHYS CHEM-US, V94, P801, DOI 10.1021/j100365a054; DEYOUNG LR, 1998, BIOCHEM J, V27, P5281; DICKMAN R, 1986, J CHEM PHYS, V85, P4108, DOI 10.1063/1.450881; Evans R., 1992, FUNDAMENTALS INHOMOG, P85; Flory P.J., 1953, PRINCIPLES POLYM CHE; GIESEN DJ, 1994, J PHYS CHEM-US, V98, P4141, DOI 10.1021/j100066a038; HILDEBRAND JH, 1947, J CHEM PHYS, V15, P225, DOI 10.1063/1.1746484; HOLTZER A, 1994, BIOPOLYMERS, V34, P315, DOI 10.1002/bip.360340303; HOLTZER A, 1992, BIOPOLYMERS, V32, P711, DOI 10.1002/bip.360320611; KUMAR SK, 1995, J PHYS CHEM-US, V99, P8382, DOI 10.1021/j100020a076; LEBOWITZ JL, 1964, PHYS REV, V133, pA895, DOI 10.1103/PhysRev.133.A895; LEE B, 1994, BIOPHYS CHEM, V51, P263, DOI 10.1016/0301-4622(94)00047-6; LIDE DR, 1996, CRC HDB CHEM PHYSICS; MATUBAYASI N, 1994, J PHYS CHEM-US, V98, P10640, DOI 10.1021/j100092a040; NEFF RO, 1973, J PHYS CHEM-US, V77, P413, DOI 10.1021/j100622a021; OOI T, 1987, P NATL ACAD SCI USA, V84, P30836; PIEROTTI RA, 1965, J PHYS CHEM-US, V69, P281, DOI 10.1021/j100885a043; SanchezRuiz JM, 1996, EUR BIOPHYS J BIOPHY, V24, P261; SANCHEZRUIZ JM, 1995, J PHYS CHEM-US, V99, P12076, DOI 10.1021/j100032a004; Sharp KA, 1996, J PHYS CHEM-US, V100, P14166, DOI 10.1021/jp960668t; Shimizu S, 1998, CHEM PHYS LETT, V284, P235, DOI 10.1016/S0009-2614(97)01381-X; Shimizu S, 1997, CHEM PHYS LETT, V268, P93, DOI 10.1016/S0009-2614(97)00165-6; SHIMIZU S, UNPUB; Shimizu S, 1998, CHEM PHYS LETT, V282, P79, DOI 10.1016/S0009-2614(97)01147-0; SINANOGLU O, 1981, J CHEM PHYS, V75, P463; SODA K, 1994, J PHYS SOC JPN, V63, P814, DOI 10.1143/JPSJ.63.814; TUNON I, 1994, J PHYS CHEM-US, V98, P377, DOI 10.1021/j100053a001; Vega C, 1996, J CHEM PHYS, V104, P701, DOI 10.1063/1.470867; VONFREYBERG B, 1993, J MOL BIOL, V233, P275, DOI 10.1006/jmbi.1993.1506	52	28	28	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	FEB 8	1999	110	6					2971	2982		10.1063/1.477940		12	Physics, Atomic, Molecular & Chemical	Physics	163AJ	WOS:000078379800028		
J	El-Nahas, AM; Hirao, K				El-Nahas, AM; Hirao, K			A theoretical study on 2-hydroxypyrazine and 2,3-dihydroxypyrazine: tautomerism, intramolecular hydrogen bond, solvent effects	JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM			English	Article						ab initio; DFT; solvent effects; tautomerism; hydroxypyrazine; dihydroxypyrazine; intramolecular hydrogen bond	GAS-PHASE; PROTON-TRANSFER; EQUILIBRIA; ABINITIO; 2-PYRIDONE; AM1; 1,2-DIHYDROXYBENZENE; SOLVATION; ENERGIES; URACIL	Density functional theory and ab initio calculations have been carried out to investigate the stability of different tautomers of 2-hydroxy and 2,3-dihydroxypyrazine in the gas phase as well as in different media. Intramolecular hydrogen bond has been also considered. Effect of electron correlation on geometries is taken into account at MP2 and density functional approach at B3LYP level. Energy calculations at different levels up to CISD/6-31++G(d,p)//MP2/6-31+G* are reported for accurate estimation of conformational stability. The data obtained indicate 2-hydroxypyrazine to be more stable than its 2-keto tautomer by about 3 kcal/mol in the gas phase, while in solution the stability order is reversed. For 2,3-dihydroxypyrazine, the intramolecular hydrogen bonded hydroxyoxo and the alpha-diketo tautomers are the most stable species at all theoretical levels in the gas phase. The stability of hydroxyoxo and diketo tautomers is significantly increased in solution due to their higher dipole moments. The data obtained for both 2-hydroxypyrazine and 2,3-dihydroxypyrazine are in a good agreement with experimental foundations. (C) 1999 Elsevier Science B.V. All rights reserved.	Menoufia Univ, Fac Sci, Dept Chem, Shibin Al Kawm, Egypt; Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	El-Nahas, AM (reprint author), Menoufia Univ, Fac Sci, Dept Chem, Shibin Al Kawm, Egypt.	science@shebin.eun.eg					STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Chung G, 1997, J PHYS CHEM A, V101, P9415, DOI 10.1021/jp971464v; HATHERLEY LD, 1993, J PHYS CHEM-US, V97, P46, DOI 10.1021/j100103a011; DIETRICH SW, 1976, J AM CHEM SOC, V98, P8310, DOI 10.1021/ja00442a002; WONG MW, 1992, J AM CHEM SOC, V114, P1645, DOI 10.1021/ja00031a017; LAPINSKI L, 1992, J PHYS CHEM-US, V96, P6250, DOI 10.1021/j100194a030; Onsager L, 1936, J AM CHEM SOC, V58, P1486, DOI 10.1021/ja01299a050; OYLER NA, 1993, J PHYS CHEM-US, V97, P11122, DOI 10.1021/j100144a037; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; BEAK P, 1976, J AM CHEM SOC, V98, P171, DOI 10.1021/ja00417a027; BEAK P, 1977, ACCOUNTS CHEM RES, V10, P186, DOI 10.1021/ar50113a006; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BOUGHTON JW, 1993, INT J QUANTUM CHEM, V47, P49, DOI 10.1002/qua.560470104; BROWN RS, 1980, J AM CHEM SOC, V102, P1174, DOI 10.1021/ja00523a050; CIEPLAK P, 1987, J AM CHEM SOC, V109, P6283, DOI 10.1021/ja00255a010; CONTRERAS JG, 1992, BOL SOC CHIL QUIM, V37, P7; CRADOCK S, 1988, J AM CHEM SOC, V110, P2758, DOI 10.1021/ja00217a011; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Elguero J., 1976, TAUTOMERISM HETEROCY; ELNAHAS AM, 1998, J CHEM RES, V222, P1014; ELNAHAS AM, UNPUB; Fabian W.M.F., 1990, J MOL STRUC-THEOCHEM, V206, P295, DOI 10.1016/0166-1280(90)85144-C; FABIAN WMF, 1990, J PHYS ORG CHEM, V3, P332, DOI 10.1002/poc.610030510; FIELD MJ, 1987, J CHEM SOC PERK T 2, P617, DOI 10.1039/p29870000617; FRANK J, 1976, J CHEM SOC PERK T 2, P1428, DOI 10.1039/p29760001428; Frisch M.J., 1995, GAUSSIAN 94 USERS RE; FRISCH MJ, 1995, GAUSSIAN 94; FUJIMOTO A, 1990, B CHEM SOC JPN, V63, P2292, DOI 10.1246/bcsj.63.2292; HA TK, 1993, J AM CHEM SOC, V115, P11939, DOI 10.1021/ja00078a036; HARRIHARAN PC, 1973, THEOR CHIM ACTA, V28, P213; KARELSON M, 1990, INT J QUANTUM CHEM, V37, P1, DOI 10.1002/qua.560370102; KARELSON MM, 1989, J ORG CHEM, V54, P6030, DOI 10.1021/jo00287a012; KARMAS G, 1953, J AM CHEM SOC, V75, P5517, DOI 10.1021/ja01118a016; KARMAS G, 1952, J AM CHEM SOC, V74, P1580, DOI 10.1021/ja01126a070; KATRITZKY AR, 1989, J MOL STRUCT THEOCHE, V184, P179, DOI 10.1016/0166-1280(89)85143-7; KUZUYA M, 1985, J CHEM SOC PERK T 2, P1423, DOI 10.1039/p29850001423; KWAITOWSKI JS, 1986, ADV QUANTUM CHEM, V18, P85; LAMANNA G, 1989, J MOL STRUC-THEOCHEM, V188, P199; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MIERTUS S, 1981, CHEM PHYS, V55, P1117; NARINDER U, 1987, J MOL STRUCT THEOCHE, V151, P259; NEDJAR B, 1978, J HETEROCYCLIC CHEM, V15, P1153; ONDA M, 1987, J MOL STRUCT, V159, P243, DOI 10.1016/0022-2860(87)80042-X; Plesset M. S., 1934, PHYS REV, V46, P618; POPLE JA, 1976, INT J QUANTUM CHEM, P1; Reichardt Ch., 1988, SOLVENT SOLVENT EFFE; ROOTHAAN CCJ, 1951, REV MOD PHYS, V23, P69, DOI 10.1103/RevModPhys.23.69; Sato N, 1997, J CHEM RES-S, P250, DOI 10.1039/a701579h; SATO N, 1997, J CHEM SOC P1, V1, P3167; SATO N, 1996, COMPREHENSIVE HETERO, V6, P241; TOBIAS S, 1982, TETRAHEDRON LETT, V23, P4785, DOI 10.1016/S0040-4039(00)85713-5; VENTURA ON, 1984, THEOR CHIM ACTA, V64, P229, DOI 10.1007/BF00551009	52	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-1280			J MOL STRUC-THEOCHEM	Theochem-J. Mol. Struct.	FEB 8	1999	459	1-3					229	237		10.1016/S0166-1280(98)00270-X		9	Chemistry, Physical	Chemistry	166AL	WOS:000078554000024		
J	Harada, Y; Mizobe, Y; Hidai, M				Harada, Y; Mizobe, Y; Hidai, M			Condensation of triketones with tungsten hydrazido(2-) complexes derived from a dinitrogen complex: formation of mononuclear or dinuclear diazoalkane complexes	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						diazoalkane complex; tungsten complex; nitrogen fixation; X-ray structure	MOLYBDENUM; CHEMISTRY; FIXATION	The tungsten hydrazido(2-) complex cis,mer-[WCl(2)(NNH(2))(PMe(2)Ph)(3)], readily derived from a dinitrogen complex cis-[W(N(2))(2)(PMe(2)Ph)(4)], reacted with 1,3,5-triketones RCOCH(2)COCH(2)COPh (R = Me, Ph) to give the diazoalkane complexes cis,mer-[WCl(2)(NN=CRCH(2)COCH(2)COPh)(PMe(2)Ph)(3)] (R = Me (3), Ph) via the condensation between the hydrazido(2-) ligand and one terminal carbonyl group in the triketone. By contrast, the reaction of the hydrazido(2-) complex cis,trans-[WCl(2)(NNH(2))(CO)(PMe(2)Ph)(2)] with PhCOCH(2)COCH(2)COPh resulted in the formation of a dinuclear mu-bis(diazoalkane) complex [WCl(2)(CO)(PMe(2)Ph)(2)(NN=CPhCH(2)COCH(2)CPh=NN)WCl(2)(CO)(PMe(2)Ph)(2)] (5). The structures of 3 and 5 in the solid state have been determined unequivocally by X-ray analysis. (C) 1999 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Hidai, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Hongo, Tokyo 1138656, Japan.	hidai@chembio.t.u-tokyo.ac.jp					HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; BAZHENOVA TA, 1995, COORDIN CHEM REV, V144, P69, DOI 10.1016/0010-8545(95)01139-G; AOSHIMA T, 1992, J ORGANOMET CHEM, V435, P85, DOI 10.1016/0022-328X(92)83462-Q; Beurskens P. T., 1992, DIRDIF PROGRAM SYSTE; BEVAN PC, 1978, J ORGANOMET CHEM, V160, P165, DOI 10.1016/S0022-328X(00)91210-5; DUDEK GO, 1962, J AM CHEM SOC, V84, P2691, DOI 10.1021/ja00873a009; GAMBAROTTA S, 1995, J ORGANOMET CHEM, V500, P117, DOI 10.1016/0022-328X(95)00522-R; HARADA Y, IN PRESS B CHEM SOC; HIDAI M, 1986, J AM CHEM SOC, V108, P1562, DOI 10.1021/ja00267a027; HIDAI M, 1978, J AM CHEM SOC, V100, P5740, DOI 10.1021/ja00486a026; Hidai M, 1996, B CHEM SOC JPN, V69, P819, DOI 10.1246/bcsj.69.819; HIDAI M, 1993, ACS SYM SER, V535, P346; MILES ML, 1965, J ORG CHEM, V30, P1007, DOI 10.1021/jo01015a013; MIZOBE Y, 1980, B CHEM SOC JPN, V53, P1781, DOI 10.1246/bcsj.53.1781; *MOL STRUCT COOP, 1985, TEXSAN CRYST STRUCT; *MOL STRUCT COOP, 1992, TEXSAN CRYST STRUCT; NISHIBAYASHI Y, IN PRESS J AM CHEM S; OSHITA H, 1993, J ORGANOMET CHEM, V461, P43, DOI 10.1016/0022-328X(93)83272-W; Richards RL, 1996, COORDIN CHEM REV, V154, P83, DOI 10.1016/0010-8545(96)01186-1	19	8	8	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	FEB 8	1999	574	1					24	31		10.1016/S0022-328X(98)00976-0		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	173FF	WOS:000078970000005		
J	Hanaguri, T; Tsuboi, T; Tsuchiya, Y; Sasaki, K; Maeda, A				Hanaguri, T; Tsuboi, T; Tsuchiya, Y; Sasaki, K; Maeda, A			Reduction of the superfluid density in the vortex-liquid phase of Bi2Sr2CaCu2Oy	PHYSICAL REVIEW LETTERS			English	Article							YBA2CU3O7-DELTA; STATE; SUPERCONDUCTORS; CROSSOVER; LINES	In-plane complex surface impedance of a Bi2Sr2CaCu2Oy Single crystal was measured in the mixed state at 40.8 GHz. The surface reactance, which is proportional to the real part of thr effective penetration depth, increased rapidly just above the first-order vortex-lattice melting transition field and the: second magnetization peak field. This increase is ascribed to the decrease in the superfluid density rather than the loss of pinning. This result indicates that the vortex melting transition changes the electronic structure as well as the vortex structure. [S0031-9007(99)08428-8].	Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Hanaguri, T (reprint author), Univ Tokyo, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Hanaguri, Tetsuo/I-6710-2012; Tsuchiya, Yoshishige/B-6127-2013	Hanaguri, Tetsuo/0000-0003-2896-0081; 			WANG Y, 1995, PHYS REV B, V52, pR3876; VOLOVIK GE, 1993, JETP LETT+, V58, P469; MAGGIOAPRILE I, 1995, PHYS REV LETT, V75, P2754, DOI 10.1103/PhysRevLett.75.2754; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; Renner C, 1998, PHYS REV LETT, V80, P3606, DOI 10.1103/PhysRevLett.80.3606; IKUTA H, 1993, PHYS REV LETT, V70, P2166, DOI 10.1103/PhysRevLett.70.2166; COFFEY MW, 1991, PHYS REV LETT, V67, P386, DOI 10.1103/PhysRevLett.67.386; Krishana K, 1997, SCIENCE, V277, P83, DOI 10.1126/science.277.5322.83; Laughlin RB, 1998, PHYS REV LETT, V80, P5188, DOI 10.1103/PhysRevLett.80.5188; Franz M, 1998, PHYS REV LETT, V80, P4763, DOI 10.1103/PhysRevLett.80.4763; Himeda A, 1997, J PHYS SOC JPN, V66, P3367, DOI 10.1143/JPSJ.66.3367; BARDEEN J, 1965, PHYS REV, V140, P1197, DOI 10.1103/PhysRev.140.A1197; BERNHARD C, 1995, PHYS REV B, V52, pR7050; Golosovsky M, 1996, SUPERCOND SCI TECH, V9, P1, DOI 10.1088/0953-2048/9/1/001; ICHIOKA M, 1996, PHYS REV B, V53, P15136; Kubert C, 1998, PHYS REV LETT, V80, P4963, DOI 10.1103/PhysRevLett.80.4963; Mallozzi R, 1998, PHYS REV LETT, V81, P1485, DOI 10.1103/PhysRevLett.81.1485; MATSUDA Y, 1994, PHYS REV B, V49, P4380, DOI 10.1103/PhysRevB.49.4380; OWLIAEI J, 1992, PHYS REV LETT, V69, P3366, DOI 10.1103/PhysRevLett.69.3366; Vekhter I, 1999, PHYS REV B, V59, P1417, DOI 10.1103/PhysRevB.59.1417	20	22	22	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 8	1999	82	6					1273	1276		10.1103/PhysRevLett.82.1273		4	Physics, Multidisciplinary	Physics	164HV	WOS:000078458500049		
J	Ohkoshi, S; Abe, Y; Fujishima, A; Hashimoto, K				Ohkoshi, S; Abe, Y; Fujishima, A; Hashimoto, K			Design and preparation of a novel magnet exhibiting two compensation temperatures based on molecular field theory	PHYSICAL REVIEW LETTERS			English	Article							PRUSSIAN BLUE; MAGNETIZATION; CYANIDE	We show the design and preparation of a novel type of magnet exhibiting two compensation temperatures; i.e., the spontaneous magnetization changes its sign twice with changing temperature. The key to obtaining this unusual behavior is the simultaneous incorporation of one antiferromagnetic and two different ferromagnetic interactions through the use of four different spin sources, as predicted by a calculation based on molecular field theory. As a prototype exemplifying this idea, we have prepared a Prussian blue analog, ((Ni0.22Mn0.60Fe0.18II)-Mn-II-Fe-II)(1.5)[Cr-III(CN)(6)] . 7.6H(2)O, which exhibits magnetization reversals at 35 and 53 K. [S0031-9007(98)08379-3].	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Kanagawa Acad Sci & Technol, Atsugi, Kanagawa 2430297, Japan	Hashimoto, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012	Hashimoto, Kazuhito/0000-0002-8384-8749			MALLAH T, 1993, SCIENCE, V262, P1554, DOI 10.1126/science.262.5139.1554; FERLAY S, 1995, NATURE, V378, P701, DOI 10.1038/378701a0; Ohkoshi S, 1997, PHYS REV B, V56, P11642, DOI 10.1103/PhysRevB.56.11642; NEEL L, 1948, ANN PHYS-PARIS, V3, P137; Ren Y, 1998, NATURE, V396, P441; Palacio F, 1997, PHYS REV LETT, V79, P2336, DOI 10.1103/PhysRevLett.79.2336; Sato O, 1996, SCIENCE, V271, P49, DOI 10.1126/science.271.5245.49; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851; Chavan SA, 1996, J APPL PHYS, V79, P5260, DOI 10.1063/1.361304; GORTER EW, 1954, PHILIPS RES REP, V9, P403; ENTLEY WR, 1994, INORG CHEM, V33, P5165, DOI 10.1021/ic00101a003; Babel D., 1986, COMMENTS INORG CHEM, V5, P285, DOI 10.1080/02603598608081849; BUCHANAN WE, 1997, ADV MAT, V9, P645; Gatteschi D., 1991, MAGNETIC MOL MAT; GORTER EW, 1954, PHILIPS RES REP, V9, P295; GORTER EW, 1954, PHILIPS RES REP, V9, P321; GRIEBLER WD, 1982, Z NATURFORSCH B, V87, P832; Kahn O., 1993, MOL MAGNETISM; Lotgering F.K., 1956, Philips Research Reports, V11; Ludi A., 1973, STRUCT BOND, V14, P1; MATHONIERE C, 1994, J CHEM SOC CHEM COMM, P1551, DOI 10.1039/c39940001551; Ohkoshi S, 1998, J AM CHEM SOC, V120, P5349, DOI 10.1021/ja980732f; Ohkoshi S, 1997, INORG CHEM, V36, P268, DOI 10.1021/ic960978q; Ohkoshi S, 1997, APPL PHYS LETT, V70, P1040, DOI 10.1063/1.118475; OHKOSHI S, UNPUB; PAUTHENET R, 1958, J APPL PHYS, V29, P253, DOI 10.1063/1.1723094; WILLIAM RE, 1995, SCIENCE, V268, P397; 1970, LANDOLTBORNSTEIN	29	247	248	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 8	1999	82	6					1285	1288		10.1103/PhysRevLett.82.1285		4	Physics, Multidisciplinary	Physics	164HV	WOS:000078458500052		
J	Osafune, T; Motoyama, N; Eisaki, H; Uchida, S; Tajima, S				Osafune, T; Motoyama, N; Eisaki, H; Uchida, S; Tajima, S			Pseudogap and collective mode in the optical conductivity spectra of hole-doped ladders in Sr14-xCaxCu24O41	PHYSICAL REVIEW LETTERS			English	Article							C-AXIS; CHARGE; SUPERCONDUCTIVITY; SR14CU24O41; DENSITY; SYSTEM; PLANE; STATE	Anisotropic optical conductivity spectra have been investigated for the hole-doped two-leg ladder system Sr14-xCaxCu24O41. As in the case of the underdoped high-T-c cuprates, upon cooling a pseudogap opens in the spectrum for the transverse (a-axis) polarization, and concurrently a peak develops in the far infrared region of the longitudinal (c-axis) spectrum. A possible interpretation for these results is that the pseudogap signals a formation of hole pairs on the ladders and the peak might correspond to a pinned collective mode of a regular array of hole pairs. [S0031-9007(99)08340-9].	Univ Tokyo, Dept Superconduct, Bunkyo Ku, Tokyo 1138656, Japan; ISTEC, Superconduct Res Lab, Koto Ku, Tokyo 1350062, Japan	Osafune, T (reprint author), Univ Tokyo, Dept Superconduct, Bunkyo Ku, Tokyo 1138656, Japan.						ANDERSON PW, 1991, PHYS REV LETT, V67, P3844, DOI 10.1103/PhysRevLett.67.3844; EMERY VJ, 1995, NATURE, V374, P434, DOI 10.1038/374434a0; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; Motoyama N, 1997, PHYS REV B, V55, pR3386; Uehara M, 1996, J PHYS SOC JPN, V65, P2764, DOI 10.1143/JPSJ.65.2764; Osafune T, 1997, PHYS REV LETT, V78, P1980, DOI 10.1103/PhysRevLett.78.1980; MCCARRON EM, 1988, MATER RES BULL, V23, P1355, DOI 10.1016/0025-5408(88)90124-9; Nagata T, 1998, PHYS REV LETT, V81, P1090, DOI 10.1103/PhysRevLett.81.1090; Arai M, 1997, PHYS REV B, V56, pR4305; Basov DN, 1998, PHYS REV LETT, V81, P2132, DOI 10.1103/PhysRevLett.81.2132; Eccleston RS, 1998, PHYS REV LETT, V81, P1702, DOI 10.1103/PhysRevLett.81.1702; HOMES CC, 1995, PHYSICA C, V254, P265, DOI 10.1016/0921-4534(95)00579-X; HOMES CC, 1993, PHYS REV LETT, V71, P1645, DOI 10.1103/PhysRevLett.71.1645; Magishi K, 1998, PHYS REV B, V57, P11533, DOI 10.1103/PhysRevB.57.11533; MAYAFFRE H, 1998, SCIENCE, V279, P375; NAGAOSA N, 1992, PHYS REV B, V45, P966, DOI 10.1103/PhysRevB.45.966; ONG NP, 1996, SCIENCE, V273, P32; PUCHKOV AV, 1995, PHYS REV B, V51, P3312, DOI 10.1103/PhysRevB.51.3312; REEDYK M, 1994, PHYS REV B, V49, P15984, DOI 10.1103/PhysRevB.49.15984; TAKENAKA K, 1992, PHYS REV B, V46, P5833, DOI 10.1103/PhysRevB.46.5833; TRAVAGLINI G, 1984, PHYS REV B, V30, P1971, DOI 10.1103/PhysRevB.30.1971; Tsuji S, 1996, J PHYS SOC JPN, V65, P3474, DOI 10.1143/JPSJ.65.3474; TSUNETSUGU H, 1995, PHYS REV B, V51, P16456, DOI 10.1103/PhysRevB.51.16456; Uchida S, 1996, PHYS REV B, V53, P14558, DOI 10.1103/PhysRevB.53.14558; WHEATLEY JM, 1988, PHYS REV B, V37, P5897, DOI 10.1103/PhysRevB.37.5897	25	55	56	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 8	1999	82	6					1313	1316		10.1103/PhysRevLett.82.1313		4	Physics, Multidisciplinary	Physics	164HV	WOS:000078458500059		
J	Murashita, J; Kato, T; Shioiri, T; Inubushi, T; Kato, N				Murashita, J; Kato, T; Shioiri, T; Inubushi, T; Kato, N			Age-dependent alteration of metabolic response to photic stimulation in the human brain measured by P-31 MR-spectroscopy	BRAIN RESEARCH			English	Article						phosphorus-31 magnetic resonance spectroscopy; brain energy metabolism; creatine phosphate; intracellular pH; membrane phospholipid; photic stimulation	MAGNETIC-RESONANCE SPECTROSCOPY; MUSCLE METABOLISM; VISUAL-CORTEX; IN-VIVO; REDUCTION; DISORDER; LACTATE; OXYGEN; YOUNG; H-1	Effects of photic stimulation (PS) on energy metabolism were examined in the occipital cortex of 25 healthy volunteers aged 23-69 years old using phosphorus-31 magnetic resonance spectroscopy (P-31-MRS). A significant effect of photic stimulation was found only for intracellular pH (p < 0.05 by repeated measures analysis of variance) but not for any peak area ratios, An interaction between intracellular pH and age were statistically significant (p < 0.005), and the interaction between phosphocreatine and age was close to significance (p =0.06). In subjects aged more than 40 years old, phosphocreatine was significantly decreased during the photic stimulation (p < 0.05, multiple comparison by Dunnett's method), and intracellular pH tended to be elevated just after the stimulation (p = 0.07). There were no significant changes in these values in younger subjects. These results suggest that no significant effect of photic stimulation on brain energy metabolism was found in younger subjects, and that significant effects of photic stimulation on intracellular pH and phosphocreatine were found in middle-aged subjects. Metabolic response of the human brain to photic stimulation may be dependent on age. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Fac Med, Dept Neuropsychiat, Tokyo 1138655, Japan; Shiga Univ Med Sci, Dept Psychiat, Shiga 5202121, Japan; Shiga Univ Med Sci, Mol Neurobiol Res Ctr, Shiga 5202121, Japan	Kato, T (reprint author), Univ Tokyo, Fac Med, Dept Neuropsychiat, Hongo 7-3-1, Tokyo 1138655, Japan.		Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952			LEENDERS KL, 1990, BRAIN, V113, P27, DOI 10.1093/brain/113.1.27; YAMAGUCHI T, 1986, STROKE, V17, P1220; SAPPEYMARINIER D, 1992, J CEREBR BLOOD F MET, V12, P584; Chen W, 1997, MAGN RESON MED, V38, P551, DOI 10.1002/mrm.1910380408; COGGAN AR, 1993, J APPL PHYSIOL, V75, P2125; LONGO R, 1993, NMR BIOMED, V6, P53, DOI 10.1002/nbm.1940060109; MCCULLY KK, 1993, J APPL PHYSIOL, V75, P813; KATO T, 1994, PSYCHIAT RES-NEUROIM, V55, P41, DOI 10.1016/0925-4927(94)90010-8; Kato T, 1996, J NEUROPSYCH CLIN N, V8, P417; KATO T, 1994, J AFFECT DISORDERS, V31, P125, DOI 10.1016/0165-0327(94)90116-3; ROSS B, 1994, MAGN RESON QUART, V10, P191; CHANCE B, 1980, P NATL ACAD SCI-BIOL, V77, P7430, DOI 10.1073/pnas.77.12.7430; MCCULLY KK, 1991, J BIOMECH, V24, P153, DOI 10.1016/0021-9290(91)90385-Z; SAPPEYMARINIER D, 1992, RADIOLOGY, V183, P247; SMITH CD, 1995, ANN NEUROL, V38, P194, DOI 10.1002/ana.410380211; VANRIJEN PC, 1989, MAGNET RESON MED, V10, P182, DOI 10.1002/mrm.1910100204; VIONDURY J, 1994, J NEUROL, V241, P354, DOI 10.1007/BF02033352	17	10	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	FEB 6	1999	818	1					72	76		10.1016/S0006-8993(98)01285-2		5	Neurosciences	Neurosciences & Neurology	163BC	WOS:000078381500008		
J	Nakamura, J; Nishida, T; Hayashi, K; Kawada, N; Ueshima, S; Sugiyama, Y; Ito, T; Sobue, K; Matsuda, H				Nakamura, J; Nishida, T; Hayashi, K; Kawada, N; Ueshima, S; Sugiyama, Y; Ito, T; Sobue, K; Matsuda, H			Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; LIVER; CHOLESTASIS; ENDOTOXIN; PROTEIN; ALPHA; INACTIVATION; MACROPHAGES; CYTOKINES	Lipopolysaccharides (LPS) induces intrahepatic cholestasis and canalicular multispecific organic anion transporter (CMOAT/MRP2) plays a central role in hepatic bilirubin transport. This study examined the role of Kupffer cell in LPS-induced cholestasis. Rats were injected intravenously with LPS. Kupffer cells were inactivated with gadolinium chloride (Gd). CMOAT/MRP2 mRNA expression was time- and dose-dependently decreased by LPS injection with a decrease in bile dow and an increase in serum bilirubin level. Gd pretreatment inhibited decrease in CMOAT/MRP2 mRNA and bile dow, and increase in serum bilirubin. Kupffer cell-conditioned medium decreased CMOAT/MRP2 expression. Addition of anti-IL-l or anti-TNF alpha antibody restored CMOAT/MRP2 expression, whereas IL-1 and TNF alpha decreased the expression. MAP kinases were activated by addition of the conditioned medium, and addition of PD98059 or SB203580 restored CMOAT/MRP2 expression. These results suggest that LPS activates Kupffer cells to secrete IL-1 and TNF alpha, which in turn activate MAP kinases and decrease CMOAT/MRP2 expression. (C) 1999 Academic Press.	Osaka Univ, Sch Med, Dept Surg 1, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Neurochem & Neuropharmacol, Ctr Biomed Res, Suita, Osaka 5650871, Japan; Osaka City Univ, Sch Med, Dept Internal Med 3, Osaka 5650871, Japan; Univ Tokyo, Fac Pharmaceut Sci, Dept Pharmaceut, Bunkyo Ku, Tokyo 1130033, Japan	Nakamura, J (reprint author), Osaka Univ, Sch Med, Dept Surg 1, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.						Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Read MA, 1997, J BIOL CHEM, V272, P2753; CHENSUE SW, 1991, AM J PATHOL, V138, P395; Paulusma CC, 1997, HEPATOLOGY, V25, P1539, DOI 10.1002/hep.510250635; Keppler D, 1997, FASEB J, V11, P15; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1016/0270-9139(94)90199-6; Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Kumar A, 1998, J BIOL CHEM, V273, P15742, DOI 10.1074/jbc.273.25.15742; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; LAZAR G, 1973, J RETICULOENDOTH SOC, V13, P231; Hayashi K, 1998, J BIOL CHEM, V273, P28860, DOI 10.1074/jbc.273.44.28860; Trautwein C, 1996, J BIOL CHEM, V271, P22262; Bohlinger I, 1996, AM J PATHOL, V149, P1381; DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Guan ZH, 1997, J BIOL CHEM, V272, P8083; Kauffmann HM, 1998, BIOCHEM BIOPH RES CO, V245, P325, DOI 10.1006/bbrc.1998.8340; KAWADA N, 1992, GASTROENTEROLOGY, V103, P1026; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; Moseley RH, 1997, GASTROENTEROLOGY, V112, P302, DOI 10.1016/S0016-5085(97)70250-6; Moseley RH, 1996, AM J PHYSIOL-GASTR L, V271, pG137; PLAULUSMA CC, 1996, SCIENCE, V271, P1126; Rizzardini M, 1998, HEPATOLOGY, V27, P703, DOI 10.1002/hep.510270311; ROELOFSEN H, 1994, GASTROENTEROLOGY, V107, P1075; ROELOFSEN H, 1995, AM J PHYSIOL-GASTR L, V269, pG427; Sarphie TG, 1996, HEPATOLOGY, V23, P788, DOI 10.1002/hep.510230420; TAUNER M, 1998, J CLIN INVEST, V101, P2092; WHITING JF, 1995, HEPATOLOGY, V22, P1273, DOI 10.1016/0270-9139(95)90639-8; ZIMMERMAN HJ, 1979, GASTROENTEROLOGY, V77, P362	34	52	52	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 5	1999	255	1					143	149		10.1006/bbrc.1999.0160		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	166WA	WOS:000078599700026		
J	Miyazaki, H; Uchida, S; Takei, Y; Hirano, T; Marumo, F; Sasaki, S				Miyazaki, H; Uchida, S; Takei, Y; Hirano, T; Marumo, F; Sasaki, S			Molecular cloning of CLC chloride channels in Oreochromis mossambicus and their functional complementation of yeast CLC gene mutant	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							SACCHAROMYCES-CEREVISIAE; SALINE WATERS; HUMAN KIDNEY; EXPRESSION; PROTEIN; REGION; FAMILY; CELLS; RAT; NEPHROLITHIASIS	We have cloned two members of the CLC chloride channel family (OmCLC-3 and OmCLC-5) from gill cDNA libraries of the euryhaline tilapia Oreochromis mosammbicus. At the amino acid level, OmCLC-3 is 90.5% identical to rat CLC-3 and OmCLC-5 is 79.2% identical to rat CLC-5. Ribonuclease protection assay revealed that OmCLC-5 was mainly expressed in the gill, kidney, and intestine in both freshwater- (FW) and seawater- (SW) adapted tilapia. Although the mRNA of OmCLC-3 was broadly expressed in tissues of FW- and SW-adapted tilapia, the most intense signals were observed in the gill, kidney, intestine, and brain. Injection of OmCLC-3 and OmCLC-5 cRNAs into Xenopus oocytes did not elicit chloride currents, but these clones did functionally complement the gef1 phenotype of YPH250(gef), a yeast strain in which a single CLC channel (GEF1) has been disrupted by homologous recombination. These results clearly indicated that CLC channels closely related to the mammalian CLC-3, -4, and -5 subfamily exist also in tilapia and that OmCLC-3 and OmCLC-5 function as intracellular chloride channels. (C) 1999 Academic Press.	Tokyo Med & Dent Univ, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138519, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Miyazaki, H (reprint author), Tokyo Med & Dent Univ, Dept Internal Med 2, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.		Uchida, Shinichi/D-1111-2013				KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; Duan D, 1997, NATURE, V390, P417; Gaxiola RA, 1998, P NATL ACAD SCI USA, V95, P4046, DOI 10.1073/pnas.95.7.4046; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Hiroi J, 1998, ZOOL SCI, V15, P447, DOI 10.2108/0289-0003(1998)15[447:IOVHIT]2.0.CO;2; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; VERNET T, 1987, GENE, V52, P225, DOI 10.1016/0378-1119(87)90049-7; ADACHI S, 1994, J BIOL CHEM, V269, P17677; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; FISHER SE, 1995, GENOMICS, V29, P598; FUJITA N, 1994, NUCLEIC ACIDS RES, V22, P1637, DOI 10.1093/nar/22.9.1637; GREENE JR, 1993, MOL GEN GENET, V241, P542, DOI 10.1007/BF00279896; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; Hechenberger M, 1996, J BIOL CHEM, V271, P33632; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; JENTSCH TJ, 1995, J PHYSIOL-LONDON, V482P, pS19; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; LAURENT P, 1994, ARCH INT PHYSIOL BIO, V102, P77, DOI 10.3109/13813459408996110; Lindenthal S, 1997, AM J PHYSIOL-CELL PH, V273, pC1176; Lurin C, 1996, PLANT CELL, V8, P701; Morimoto T, 1998, J AM SOC NEPHROL, V9, P811; Sakamoto H, 1996, J BIOL CHEM, V271, P10210; SIKORSKI RS, 1995, GENE, V155, P51, DOI 10.1016/0378-1119(94)00915-F; STEINMEYER K, 1991, NATURE, V354, P301, DOI 10.1038/354301a0; STICKNEY RR, 1986, PROG FISH CULT, V48, P161, DOI 10.1577/1548-8640(1986)48<161:TTOSW>2.0.CO;2; SURESH AV, 1992, AQUACULTURE, V106, P201, DOI 10.1016/0044-8486(92)90253-H; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0	30	28	29	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	FEB 5	1999	255	1					175	181		10.1006/bbrc.1999.0166		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	166WA	WOS:000078599700031		
J	Nakayama, K; Hirao, K; Lindh, R				Nakayama, K; Hirao, K; Lindh, R			Different bases for different correlation effects: multireference Moller-Plesset perturbation theory in the extended basis function space	CHEMICAL PHYSICS LETTERS			English	Article							LYING SINGLET-STATES; EXCITED-STATES; BARRIER HEIGHT; BASIS-SETS; SCF METHOD; BUTADIENE; ABINITIO; FORMALDEHYDE; EXCITATION; HEXATRIENE	A method to improve virtual orbitals of CASSCF theory has been proposed by expanding the virtual orbital space through the addition of basis functions without disturbing already established CASSCF function space. It is a natural extension of work used in Hartree-Fock calculations. The improved virtual orbitals are then used to estimate the dynamical correlation. That is, a moderate basis set is used in CASSCF to include nondynamical correlation and a sufficiently large basis set is used in multireference Moller-Plesset perturbation theory to estimate the slowly convergent dynamical correlation. The present formalism is tested on the barrier height of the H2CO --> H-2 + CO reaction, singlet-triplet energy separation in CH2 and valence pi-pi* excitation energies in butadiene. Numerical results show that good accuracy can be obtained. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; Univ Lund, Dept Chem Phys, S-22100 Lund, Sweden	Hirao, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hirao@qcl.u-tokyo.ac.jp	Lindh, Roland/F-3471-2012	Lindh, Roland/0000-0001-7567-8295			KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; NAKANO H, 1993, J CHEM PHYS, V99, P7983, DOI 10.1063/1.465674; JANKOWSKI K, 1985, J CHEM PHYS, V82, P1413, DOI 10.1063/1.448464; KUTZELNIGG W, 1985, THEOR CHIM ACTA, V68, P445, DOI 10.1007/BF00527669; COMEAU DC, 1989, J CHEM PHYS, V90, P6491, DOI 10.1063/1.456315; HIRAO K, 1992, CHEM PHYS LETT, V196, P397, DOI 10.1016/0009-2614(92)85710-R; Nakano H, 1997, J CHEM PHYS, V106, P4912, DOI 10.1063/1.473540; HIRAO K, 1993, CHEM PHYS LETT, V201, P59, DOI 10.1016/0009-2614(93)85034-L; HIRAO K, 1992, CHEM PHYS LETT, V190, P374, DOI 10.1016/0009-2614(92)85354-D; POLIK WF, 1990, J CHEM PHYS, V92, P3453, DOI 10.1063/1.457857; Nakayama K, 1998, INT J QUANTUM CHEM, V66, P157; ANDERSSON K, 1995, THEOR CHIM ACTA, V91, P31, DOI 10.1007/s002140050085; ROOS BO, 1980, CHEM PHYS, V48, P157, DOI 10.1016/0301-0104(80)80045-0; SERRANOANDRES L, 1993, J CHEM PHYS, V98, P3151; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; HUZINAGA S, 1977, J CHEM PHYS, V66, P2157, DOI 10.1063/1.434130; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3629, DOI 10.1063/1.455821; BAUSCHLICHER CW, 1986, J CHEM PHYS, V85, P6510, DOI 10.1063/1.451431; CAVE RJ, 1987, J PHYS CHEM-US, V91, P4481, DOI 10.1021/j100301a013; CAVE RJ, 1988, CHEM PHYS LETT, V148, P190, DOI 10.1016/0009-2614(88)80297-5; DUPUIS M, 1992, NATO ADV STUD I SER; FLICKER WM, 1978, CHEM PHYS, V30, P307, DOI 10.1016/0301-0104(78)87002-5; FLICKER WM, 1977, CHEM PHYS LETT, V45, P492, DOI 10.1016/0009-2614(77)80073-0; GRAHAM RL, 1992, J CHEM PHYS, V96, P1304, DOI 10.1063/1.462166; HAUGEN W, 1966, ACTA CHEM SCAND, V20, P1726, DOI 10.3891/acta.chem.scand.20-1726; HIRAO K, 1992, INT J QUANTUM CHEM S, V26, P517; JOHNSON PM, 1976, J CHEM PHYS, V64, P4638, DOI 10.1063/1.432048; KUPPERMANN A, 1979, CHEM REV, V79, P77, DOI 10.1021/cr60317a006; MCDIARMID R, 1992, CHEM PHYS LETT, V188, P423, DOI 10.1016/0009-2614(92)80841-X; NAKANO H, 1995, MR2D VERSION 2; Roos B. O., 1980, INT J QUANTUM CHEM S, V18, P175; SIEGBAHN P, 1980, PHYS SCRIPTA, V21, P323, DOI 10.1088/0031-8949/21/3-4/014; YAMANISHI M, UNPUB	33	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	FEB 5	1999	300	3-4					303	311		10.1016/S0009-2614(98)01371-2		9	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	163XJ	WOS:000078431800006		
J	Nakabayashi, S; Tryk, DA; Fujishima, A; Ohta, N				Nakabayashi, S; Tryk, DA; Fujishima, A; Ohta, N			Electrochemical reduction of Cu2+ without surface trapping on synthetic conductive diamond electrodes	CHEMICAL PHYSICS LETTERS			English	Article							THIN-FILM ELECTRODES; RAMAN-SPECTROSCOPY	The electrochemical reduction of metal ions is commonly referred to as 'electrodeposition' because the reduced metal is trapped on the surface, and a new solid phase is formed. We present evidence for a clear deviation from this general concept on the conductive boron-doped CVD diamond electrode, where the electrochemical reduction of copper proceeds with negligible deposition of the metal on the electrode and the product is a colloid composed of the metal clusters. (C) 1999 Elsevier Science B.V. All rights reserved.	Saitama Univ, Fac Sci, Dept Chem, Urawa, Saitama 3388570, Japan; Univ Tokyo, Sch English, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Nakabayashi, S (reprint author), Saitama Univ, Fac Sci, Dept Chem, Urawa, Saitama 3388570, Japan.	sei@chem.saitama-u.ac.jp	Ohta, Narumi/B-7239-2008; Tryk, Donald/D-5931-2012; Fujishima, Akira/G-7701-2012	Ohta, Narumi/0000-0002-6353-4806; Tryk, Donald/0000-0003-4660-9674; 			ADZIC GD, 1988, J ELECTROANAL CHEM, V241, P353, DOI 10.1016/0022-0728(88)85138-6; ALTERMAT.JA, 1968, ANAL CHEM, V40, P655, DOI 10.1021/ac60259a030; SWAIN GM, 1993, ANAL CHEM, V65, P345, DOI 10.1021/ac00052a007; MASSARANI B, 1978, PHYS REV B, V17, P1758, DOI 10.1103/PhysRevB.17.1758; Chen QY, 1997, J ELECTROCHEM SOC, V144, P3806, DOI 10.1149/1.1838096; GUNAWARDENA G, 1982, J ELECTROANAL CHEM, V138, P241, DOI 10.1016/0022-0728(82)85081-X; Goeting CH, 1998, J ELECTROANAL CHEM, V442, P207, DOI 10.1016/S0022-0728(97)00456-7; ALEHASHEM S, 1995, ANAL CHEM, V67, P2812, DOI 10.1021/ac00113a014; Gonon P, 1995, J APPL PHYS, V78, P7059, DOI 10.1063/1.360410; Yano T, 1998, J ELECTROCHEM SOC, V145, P1870, DOI 10.1149/1.1838569; AGER JW, 1995, APPL PHYS LETT, V66, P616, DOI 10.1063/1.114031; EDWARDS PP, 1978, PHYS REV B, V17, P2575, DOI 10.1103/PhysRevB.17.2575; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; KNIGHT DS, 1989, J MATER RES, V4, P385, DOI 10.1557/JMR.1989.0385; AWADA M, 1995, J ELECTROCHEM SOC, V142, pL42, DOI 10.1149/1.2048579; BARRADAS RG, 1977, CAN J CHEM, V55, P4037, DOI 10.1139/v77-572; Bertocci U., 1974, ENCY ELECTROCHEMISTR, V2; BOONMA L, 1997, J ELECTROCHEM SOC, V144, P6142; Bouamrane F, 1998, J PHYS CHEM B, V102, P134, DOI 10.1021/jp971516g; Budevski E.B., 1996, ELECTROCHEMICAL PHAS; Everett D. H., 1989, BASIC PRINCIPLES COL; Li LF, 1998, J ELECTROCHEM SOC, V145, pL85, DOI 10.1149/1.1838495; LOCHER R, 1995, DIAM RELAT MATER, V4, P678, DOI 10.1016/0925-9635(94)05297-2; Losev V.V., 1972, MOD ASPECT ELECTROC, V7, P314; VINOKUR N, 1997, ELECTROCHEMICAL SOC, V1; Zare R. N., 1995, LASER EXPT BEGINNERS	26	25	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	FEB 5	1999	300	3-4					409	413		10.1016/S0009-2614(98)01372-4		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	163XJ	WOS:000078431800021		
J	Harada, K; Komuro, I; Sugaya, T; Murakami, K; Yazaki, Y				Harada, K; Komuro, I; Sugaya, T; Murakami, K; Yazaki, Y			Vascular injury causes neointimal formation in angiotensin II type 1a receptor knockout mice	CIRCULATION RESEARCH			English	Article						angiotensin; angioplasty; stenosis; carotid artery	CONVERTING ENZYME-INHIBITION; SMOOTH-MUSCLE CELLS; RAT ARTERIAL-WALL; MYOINTIMAL HYPERPLASIA; BALLOON ANGIOPLASTY; CAROTID-ARTERY; DNA-SYNTHESIS; EXPRESSION; PROLIFERATION; RESTENOSIS	Many studies using small-animal models suggest that angiotensin II (Ang II) plays an important role in neointimal formation after vascular injury. In the present study, we examined whether Ang II type 1 receptor (AT(1))-mediated Ang II signaling is indispensable for the development of injury-induced neointimal formation using AT(1a) knockout (KO) mice. Reverse transcriptase-polymerase chain re action analysis revealed that AT(1) mRNA was not detectable in both uninjured and injured carotid arteries of KO mice, whereas the AT(1) gene was expressed in uninjured carotid arteries of wild-type (WT) mice. At 14 days after injury, AT(1) mRNA levels were increased by 1.5-fold in injured arteries of WT mice. Although AT(2) mRNA was not detectable in uninjured arteries, expression of AT(2) gene was induced in both animal groups at 2 weeks after injury. Vascular injury induced neointimal formation in KO mice as well as in WT mice. There were no significant differences between WT and KO mice in the extent of histological findings such as increased cross-sectional areas of the neointima and the media, the number of proliferating smooth muscle cells, and the amount of collagen and fibronectin. Treatment with subpressor doses of Ang II after injury enhanced the growth of neointima in WT mice but not in KO mice. Moreover, treatment with the selective AT(1) antagonist CV-11974 before injury significantly decreased the formation of neointima in only WT mice, whereas treatment with the selective AT(2) antagonist PD-123319 before injury had no effects in both animal groups. These results suggest that AT(1)-mediated Ang II signaling is not essential for the development of neointimal formation, although it may modify it.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 113, Japan; Tanabe Seiyaku Co Ltd, Lead Generat Res Labs, Osaka, Japan; Univ Tsukuba, Inst Appl Biochem, Ibaraki, Osaka, Japan	Komuro, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	komuro-tky@umin.u-tokyo.ac.jp					BALCON R, 1992, CIRCULATION, V86, P100; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; Kijima K, 1996, CIRC RES, V79, P887; SCHWARTZ SM, 1995, CIRC RES, V77, P445; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; GRADY EF, 1991, J CLIN INVEST, V88, P921, DOI 10.1172/JCI115395; GIBBONS GH, 1992, J CLIN INVEST, V90, P456, DOI 10.1172/JCI115881; JANIAK P, 1992, HYPERTENSION, V20, P737; DAEMEN MJAP, 1991, CIRC RES, V68, P450; URATA H, 1990, J BIOL CHEM, V265, P22348; Harada K, 1998, CIRC RES, V82, P779; LINDNER V, 1993, CIRC RES, V73, P792; deBlois D, 1996, ARTERIOSCL THROM VAS, V16, P1122; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; Harada K, 1998, CIRCULATION, V97, P1952; SUGAYA T, 1995, J BIOL CHEM, V270, P18719; DOUGLAS SA, 1994, CIRC RES, V75, P190; DZAU VJ, 1991, HYPERTENSION, V18, P100; FAXON DP, 1995, J AM COLL CARDIOL, V25, P362, DOI 10.1016/0735-1097(94)00368-Z; HANSON SR, 1991, HYPERTENSION, V18, P70; HUBER KC, 1993, AM HEART J, V125, P695, DOI 10.1016/0002-8703(93)90160-B; Huckle WR, 1996, CIRCULATION, V93, P1009; INAGAMI T, 1994, J HYPERTENS, V12, pS83; ITO H, 1993, J CLIN INVEST, V91, P2268; Iwai N, 1997, HYPERTENSION, V29, P1044; JACKSON CL, 1992, HYPERTENSION, V20, P712; KIM SK, 1995, CIRCULATION, V92, P88; LINDNER V, 1993, CIRC RES, V73, P589; PRATT RE, 1992, HYPERTENSION, V20, P432; PRESCOTT MF, 1991, AM J PATHOL, V139, P1291; RAKUGI H, 1994, CIRCULATION, V90, P449; RAKUGI H, 1993, CIRCULATION, V87, P283; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Su EJ, 1998, CIRC RES, V82, P321; VANKLEEF EM, 1992, CIRC RES, V70, P1122; VISWANATHAN M, 1992, J CLIN INVEST, V90, P1707, DOI 10.1172/JCI116043	38	24	27	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7330			CIRC RES	Circ.Res.	FEB 5	1999	84	2					179	185				7	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	166ZA	WOS:000078607000007		
J	Amano, K; Hori, M; Ozaki, H; Karaki, H				Amano, K; Hori, M; Ozaki, H; Karaki, H			Agonist-dependent difference in the relationship between cytosolic Ca2+ level and release of vascular relaxing factors in the endothelium of rabbit aortic valve	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						ATP; thapsigargin; carbachol; endothelium; EDRF (endothelium-derived relaxing factor); Ca2+ level; cytosolic	NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE; TYROSINE PHOSPHORYLATION; CALCIUM; CELLS; RECEPTOR; MOBILIZATION; TOXIN	The correlation between changes in cytosolic Ca2+ levels ([Ca2+](i)) and the release of vascular relaxing factor(s) was investigated in the endothelium of rabbit aortic valve. ATP, carbachol and thapsigargin increased endothelial [Ca2+](i) in rabbit aortic valve loaded with a leakage resistant, fluorescent Ca2+ indicator, fura-PE3. Release of relaxing factors was bioassayed using the 'sandwich' preparation in which contraction was measured in the endothelium-denuded rabbit aorta attached to the endothelial surface of the valve. Addition of ATP, carbachol and thapsigargin induced sustained relaxation of the phenylephrine-induced contraction of the aorta in the 'sandwich' preparation, N-G-monomethyl-L-arginine (L-NMMA) greatly attenuated the relaxation induced by carbachol, and combined treatment with tetra-n-butylammonium completely inhibited the relaxation. These results suggest that the endothelial relaxing factors released from aortic valve are nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDHF). When the increase in endothelial [Ca2+](i) was plotted against the relaxation, the carbachol-induced increase in [Ca2+](i) elicited greater relaxation than did ATP or thapsigargin at a given [Ca2+](i). This suggests that various agonists differently modulate the relationship between [Ca2+](i) and release of NO. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Tokyo 1138657, Japan	Ozaki, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aozaki@hongo.ecc.u-tokyo.ac.jp					ADAMS DJ, 1989, FASEB J, V3, P2389; Amano K, 1997, N-S ARCH PHARMACOL, V355, P751, DOI 10.1007/PL00005009; AMANO K, 1994, J PHARMACOL EXP THER, V271, P1359; Karaki H, 1997, PHARMACOL REV, V49, P157; Corson MA, 1996, CIRC RES, V79, P984; AOKI H, 1994, BRIT J PHARMACOL, V111, P989; BUSSE R, 1990, FEBS LETT, V265, P133, DOI 10.1016/0014-5793(90)80902-U; CHEN GF, 1990, J PHYSIOL-LONDON, V421, P521; CHINELLATO A, 1994, J PHARM PHARMACOL, V46, P337; CHINELLATO A, 1992, GEN PHARMACOL, V23, P1067, DOI 10.1016/0306-3623(92)90288-U; DOLOR RJ, 1992, AM J PHYSIOL, V262, P171; NETLAND PA, 1985, HISTOCHEM J, V17, P1309, DOI 10.1007/BF01002528; Omote M, 1996, BRIT J PHARMACOL, V118, P233; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; SATO K, 1990, J PHARMACOL EXP THER, V255, P114; SCHILLING WP, 1992, BIOCHEM J, V284, P521; SUTTORP N, 1985, AM J PHYSIOL, V248, pC127; THURINGER D, 1992, J MEMBRANE BIOL, V130, P139; VACA L, 1994, AM J PHYSIOL-CELL PH, V267, pC920; VACA L, 1995, AM J PHYSIOL-CELL PH, V269, pC733; Venema VJ, 1996, BIOCHEM BIOPH RES CO, V226, P703, DOI 10.1006/bbrc.1996.1417; Venema VJ, 1997, BIOCHEM BIOPH RES CO, V236, P155, DOI 10.1006/bbrc.1997.6921; Vorndran C, 1995, BIOPHYS J, V69, P2112	23	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 5	1999	366	2-3					215	221		10.1016/S0014-2999(98)00913-3		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	166EV	WOS:000078564000011		
J	Yamawaki, H; Sato, K; Hori, M; Ozaki, H; Karaki, H				Yamawaki, H; Sato, K; Hori, M; Ozaki, H; Karaki, H			Impairment of endothelium-dependent relaxation in the arteries cultured with fetal bovine serum	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						endothelium-dependent relaxation; nitric oxide (NO); endothelial NO synthase; fetal bovine serum; organ culture	VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE SYNTHASE; OBLIGATORY ROLE; MESSENGER-RNA; CELLS	Effects of chronic treatment with fetal bovine serum on the function of vascular endothelium were examined using an organ culture system. Ln the rabbit mesenteric arteries cultured with 10% fetal bovine serum for 7 days, the substance P- or ionomycin-induced endothelium-dependent relaxation was significantly attenuated compared to the arteries cultured in the serum-free condition. The effects of the serum were concentration- and time-dependent. By the treatment with the serum, the amounts of nitric oxide (NO) production and total mRNA for endothelial NO synthase were reduced, whereas the sodium nitroprusside-induced relaxation was rather augmented. These results suggest that chronic treatment of rabbit mesenteric artery with fetal bovine serum decreases endothelial NO synthase mRNA, reduces NO production and impairs endothelium-dependent relaxation. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Radio Isotope Ctr, Bunkyo Ku, Tokyo 1138657, Japan	Yamawaki, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pharmacol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						YOSHIZUMI M, 1993, CIRC RES, V73, P205; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRYGLEWSKI RJ, 1988, HYPERTENSION, V12, P530; Hood JD, 1998, AM J PHYSIOL, V274, P1054; INOUE N, 1995, THROMB VASC BIOL, V15, P1255; KARAKI H, 1988, EUR J PHARMACOL, V156, P259, DOI 10.1016/0014-2999(88)90329-9; KOSTYK SK, 1995, AM J PHYSIOL-HEART C, V269, pH1583; MONCADA S, 1991, PHARMACOL REV, V43, P109; RAPOPORT RM, 1983, CIRC RES, V52, P352; ROGERS MJ, 1993, AM J PHYSIOL, V265, pC1433; SATO K, 1997, JPN J PHARMACOL, V73, P95; SESSA WC, 1992, J BIOL CHEM, V267, P15274; VANHOUTTE PM, 1986, ANNU REV PHYSIOL, V48, P307; ZAWADZKI JV, 1981, FED PROC, V40, P689	18	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	FEB 5	1999	366	2-3					237	242		10.1016/S0014-2999(98)00969-8		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	166EV	WOS:000078564000014		
J	Igarashi, K; Verhagen, MFJM; Samejima, M; Schulein, M; Eriksson, KEL; Nishino, T				Igarashi, K; Verhagen, MFJM; Samejima, M; Schulein, M; Eriksson, KEL; Nishino, T			Cellobiose dehydrogenase from the fungi Phanerochaete chrysosporium and Humicola insolens - A flavohemoprotein from Humicola insolens contains 6-hydroxy-FAD as the dominant active cofactor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPOROTRICHUM-PULVERULENTUM; QUINONE OXIDOREDUCTASE; OXIDIZING ENZYMES; OXIDASE; CELLULOSE; PURIFICATION; DEGRADATION; OXIDATION; BREAKDOWN; CULTURES	Cellobiose dehydrogenases (CDH) were purified from cellulose-grown cultures of the fungi Phanerochaete chrysosporium and Humicola insolens, The pH optimum of the cellobiose cytochrome c oxidoreductase activity of P, chrysosporium CDH was acidic, whereas that of H, insolens CDH was neutral. The absorption spectra of the two CDHs showed them to be typical hemoproteins, but there was a small. difference in the visible region. Limited proteolysis between the heme and flavin domains was performed to investigate the cofactors, There was no difference in absorption spectrum between the heme domains of P, chrysosporium and H, insolens CDHs. The midpoint potentials of heme at pH 7.0 were almost identical, and no difference in pH dependence was observed over the range of pH 3-9, The pH dependence of cellobiose oxidation by the flavin domains was similar to that of the native CDHs, indicating that the difference in the pH dependence of the catalytic activity between the two CDHs is because of the flavin domains. The absorption spectrum of the flavin domain from H, insolens CDH has absorbance maxima at 343 and 426 and a broad absorption peak at 660 nm, whereas that of P, chrysosporium CDH showed a normal flavoprotein spectrum. Flavin cofactors were extracted from the flavin domains and analyzed by high-performance liquid chromatography. The flavin cofactor from H. insolens was found to be a mixture of 60% 6-hydroxy-FAD and 40% FAD, whereas that from P, chrysosporium CDH was normal FAD, After reconstitution of the deflavo-proteins it was found that flavin domains containing B-hydroxy-FAD were clearly active but their cellobiose oxidation rates were lower than those of flavin domains containing normal FAD, Reconstitution of flavin cofactor had no effect on the optimum pH, From these results, it is concluded that the pH dependence is not because of the flavin cofactor but is because of the protein molecule.	Univ Tokyo, Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark; Nippon Med Sch, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1138602, Japan	Samejima, M (reprint author), Univ Tokyo, Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan.	amsam@hongo.ecc.u-tokyo.ac.jp					WOOD TM, 1972, BIOCHEM J, V128, P1183; ANDER P, 1994, FEMS MICROBIOL REV, V13, P297, DOI 10.1016/0168-6445(94)90087-6; ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; ERIKSSON KEL, 1993, ENZYME MICROB TECH, V15, P1002, DOI 10.1016/0141-0229(93)90046-5; RENGANATHAN V, 1990, APPL MICROBIOL BIOT, V32, P609; HABU N, 1993, FEBS LETT, V327, P161, DOI 10.1016/0014-5793(93)80162-N; AYERS AR, 1978, EUR J BIOCHEM, V90, P171, DOI 10.1111/j.1432-1033.1978.tb12588.x; BAO WJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P705, DOI 10.1006/abbi.1993.1098; ERIKSSON KE, 1975, EUR J BIOCHEM, V51, P213, DOI 10.1111/j.1432-1033.1975.tb03921.x; HAGEN WR, 1989, EUR J BIOCHEM, V182, P523, DOI 10.1111/j.1432-1033.1989.tb14859.x; HENRIKSSON G, 1995, COMPREHENSIVE SUMMAR, V112, P35; HENRIKSSON G, 1991, EUR J BIOCHEM, V196, P101, DOI 10.1111/j.1432-1033.1991.tb15791.x; Igarashi K, 1997, FUNGAL GENET BIOL, V21, P214, DOI 10.1006/fgbi.1996.0954; KOMAI H, 1969, J BIOL CHEM, V244, P1692; KREMER SM, 1992, FEMS MICROBIOL LETT, V92, P187, DOI 10.1111/j.1574-6968.1992.tb05257.x; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWE HJ, 1956, J BIOL CHEM, V221, P983; MASSEY V, 1991, FLAVINS AND FLAVOPROTEINS 1990, P59; MAYHEW SG, 1974, EUR J BIOCHEM, V44, P579, DOI 10.1111/j.1432-1033.1974.tb03515.x; MORPETH FF, 1986, BIOCHEM J, V236, P221; Radola B. J., 1980, ELECTROPHORESIS, V1, P43, DOI 10.1002/elps.1150010109; SAMEJIMA M, 1992, EUR J BIOCHEM, V207, P103, DOI 10.1111/j.1432-1033.1992.tb17026.x; SAMEJIMA M, 1992, FEBS LETT, V306, P165, DOI 10.1016/0014-5793(92)80991-O; Samejima M, 1997, BIOTECHNOL APPL BIOC, V25, P135; Schou C, 1998, BIOCHEM J, V330, P565; Schulein M, 1993, FDN BIOTECH IND FERM, V8, P109; WESTERMARK U, 1975, ACTA CHEM SCAND B, V29, P419, DOI 10.3891/acta.chem.scand.29b-0419; WESTERMA.U, 1974, ACTA CHEM SCAND B, VB 28, P209, DOI 10.3891/acta.chem.scand.28b-0209; WOOD JD, 1992, BIOCHIM BIOPHYS ACTA, V1119, P90, DOI 10.1016/0167-4838(92)90239-A	30	50	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1999	274	6					3338	3344		10.1074/jbc.274.6.3338		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	163VZ	WOS:000078428200015		
J	Zhu, CC; Furuichi, T; Mikoshiba, R; Wojcikiewicz, RJH				Zhu, CC; Furuichi, T; Mikoshiba, R; Wojcikiewicz, RJH			Inositol 1,4,5-trisphosphate receptor down-regulation is activated directly by inositol 1,4,5-trisphosphate binding - Studies with binding-defective mutant receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SH-SY5Y NEUROBLASTOMA-CELLS; TRISPHOSPHATE RECEPTOR; PHOSPHOINOSITIDASE-C; CA2+ MOBILIZATION; DESENSITIZATION; FIBROBLASTS; DEGRADATION; EXPRESSION; INVOLVEMENT; STIMULATION	Activation of certain phosphoinositidase C-linked cell surface receptors is known to cause an acceleration of the proteolysis of inositol 1,4,5-trisphosphate (InsP(3)) receptors and, thus, lead to InsP(3) receptor down-regulation. To gain insight into this process, we examined whether or not InsP(3) receptor degradation is a direct consequence of InsP(3) binding by analyzing the downregulation of exogenous wild-type and binding-defective mutant InsP(3) receptors expressed in SH-SY5Y human neuroblastoma cells. Stimulation of these cells with carbachol showed that wild-type exogenous receptors could be down-regulated but that the binding-defective mutant exogenous receptors were not. Thus, InsP(3) binding appears to mediate down-regulation. To validate this conclusion, a comprehensive analysis of the effects of the exogenous receptors was undertaken. This showed that exogenous receptors (i) are localized appropriately within the cell, (ii) enhance InsP(3)-induced Ca2+ release in permeabilized cells, presumably by increasing the number of InsP(3)-sensitive Ca2+ channels, (iii) have minimal effects on Ca2+ mobilization and InsP(3) formation in intact cells, (iv) form heteromers with endogenous receptors, and (v) do not alter the down-regulation of endogenous receptors, In total, these data show that the introduction of exogenous receptors into SH-SY5Y cells does not compromise intracellular signaling or the down-regulatory process. We can thus conclude that InsP(3) binding directly activates InsP(3) receptor degradation. Because InsP(3) binding induces a conformational change in the InsP(3) receptor, these data suggest that this change provides the signal for accelerated proteolysis.	SUNY Hlth Sci Ctr, Coll Med, Dept Pharmacol, Syracuse, NY 13210 USA; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 108, Japan	Wojcikiewicz, RJH (reprint author), SUNY Hlth Sci Ctr, Coll Med, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	wojcikir@vax.cs.hscsyr.edu					BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; YAMADA N, 1994, BIOCHEM J, V302, P781; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Mackrill JJ, 1996, BIOCHEM J, V318, P871; Sipma H, 1998, CELL CALCIUM, V23, P11, DOI 10.1016/S0143-4160(98)90070-7; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Bokkala S, 1997, J BIOL CHEM, V272, P12454, DOI 10.1074/jbc.272.19.12454; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; MIYAWAKI A, 1990, NEURON, V5, P11, DOI 10.1016/0896-6273(90)90029-F; BLONDEL O, 1994, J BIOL CHEM, V269, P27167; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; BEZPROZVANNY I, 1991, NATURE, V351, P751; BLONDEL O, 1993, J BIOL CHEM, V268, P11356; DeSmedt H, 1997, BIOCHEM J, V322, P575; FISCHER GA, 1994, J BIOL CHEM, V269, P19216; FISHER SK, 1995, EUR J PHARM-MOLEC PH, V288, P231, DOI 10.1016/0922-4106(95)90035-7; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HONDA Z, 1995, J BIOL CHEM, V270, P4840; Joseph SK, 1996, CELL SIGNAL, V8, P1, DOI 10.1016/0898-6568(95)02012-8; KINGSTON R, 1987, CURRENT PROTOCOLS MO; [Anonymous], 1991, METHOD ENZYMOL; Lievremont JP, 1996, BIOCHEM J, V317, P755; Lobaugh LA, 1996, MOL PHARMACOL, V50, P493; MIGNERY GA, 1990, EMBO J, V9, P3893; MIYAWAKI A, 1991, P NATL ACAD SCI USA, V88, P4911, DOI 10.1073/pnas.88.11.4911; MIYAZAKI S, 1992, SCIENCE, V257, P251, DOI 10.1126/science.1321497; NAKADE S, 1991, BIOCHEM J, V277, P125; NAKAGAWA T, 1991, P NATL ACAD SCI USA, V88, P6244, DOI 10.1073/pnas.88.14.6244; Quick MW, 1996, J BIOL CHEM, V271, P32021; SAMBROOK J, 1989, MOL CLONING LAB MANU; SUDHOF TC, 1991, EMBO J, V10, P3199; WATRAS J, 1991, J NEUROSCI, V11, P3239; WOJCIKIEWICZ RJH, 1993, TRENDS PHARMACOL SCI, V14, P279, DOI 10.1016/0165-6147(93)90131-3; WOJCIKIEWICZ RJH, 1991, J BIOL CHEM, V266, P22234; Wojcikiewicz RJH, 1996, J BIOL CHEM, V271, P16652; WOJCIKIEWICZ RJH, 1992, J NEUROCHEM, V59, P383, DOI 10.1111/j.1471-4159.1992.tb08916.x; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Yoshida Y, 1997, JPN J PHARMACOL, V74, P125, DOI 10.1254/jjp.74.125	43	38	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	1999	274	6					3476	3484		10.1074/jbc.274.6.3476		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	163VZ	WOS:000078428200033		
J	Tamaru, M; Narumi, S				Tamaru, M; Narumi, S			E-selectin gene expression is induced synergistically with the coexistence of activated classic protein kinase C and signals elicited by interleukin-1 beta but not tumor necrosis factor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MURINE PERITONEAL-MACROPHAGES; ISCHEMIA-REPERFUSION INJURY; TISSUE-SPECIFIC EXPRESSION; CELL-ADHESION MOLECULE-1; LEUKOCYTE ADHESION; ENDOTHELIAL-CELLS; TRANSCRIPTIONAL REGULATION; GROWTH-FACTOR; IFN-GAMMA	We have examined the effect of protein kinase C (PKC) on the expression of the E-selectin and intercellular adhesion molecule-1 (ICAM-1) mRNAs in human umbilical vein endothelial cells. The lower classic PKC activity on pretreatment with phorbol ester (phorbol 12-myristate 13-acetate (PMA)) for 24 h markedly decreased IL-1 beta-induced E-selectin mRNA expression in the presence of fetal calf serum and basic fibroblast growth factor, although the induction of ICAM-1 mRNA expression was only influenced a little by the PKC down-regulation. On the other hand, tumor necrosis factor-alpha (TNF alpha)-induced gene expression of these adhesion molecules was unaffected by such PKC modulation. The intracellular signals generated by interleukin (IL)-1 beta and TNF alpha themselves are not mediated through classic PKC activation, because the response to neither stimulant was inhibited by the PKC down-regulation in the absence of fetal calf serum and basic fibroblast growth factor. Simultaneous treatment with IL-1 beta and PMA synergistically induced E-selectin gene expression but not when TNFa was substituted for IL-1 beta. ICAM-1 mRNA expression was only additively induced on the cotreatment. The synergistic effect on E-selectin mRNA induction was independent of de novo protein synthesis and mediated by elevated transcriptional activity. Promoter analysis of E-selectin indicated that the NF-ELAM1/activating transcription factor element is critical for the synergistic effect of the cotreatment with IL-1 beta and PMA.	Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; Japan Tobacco Inc, Cent Pharmaceut Res Inst, Pharmaceut Frontier Res Labs, Kanagawa 2360004, Japan	Narumi, S (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Stein B, 1997, J BIOL CHEM, V272, P19509, DOI 10.1074/jbc.272.31.19509; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420; SLUSS HK, 1994, MOL CELL BIOL, V14, P8376; SWERLICK RA, 1992, J IMMUNOL, V149, P698; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; NEISH AS, 1992, J EXP MED, V176, P1583, DOI 10.1084/jem.176.6.1583; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820; CYBULSKY MI, 1991, SCIENCE, V251, P788, DOI 10.1126/science.1990440; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; CARLOS TM, 1994, BLOOD, V84, P2068; COLLINS T, 1995, FASEB J, V9, P899; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; VORABERGER G, 1991, J IMMUNOL, V147, P2777; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Jiang Y, 1996, J BIOL CHEM, V271, P17920; COLLETTI LM, 1990, J CLIN INVEST, V85, P1936, DOI 10.1172/JCI114656; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DELUCA LG, 1994, J BIOL CHEM, V269, P19193; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOUKAS J, 1990, J IMMUNOL, V145, P1727; DREYER WJ, 1991, CIRCULATION, V84, P400; FARRAR WL, 1985, NATURE, V315, P235, DOI 10.1038/315235a0; GIMOND C, 1992, EXP CELL RES, V203, P365, DOI 10.1016/0014-4827(92)90010-6; GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090; GROUDINE M, 1981, MOL CELL BIOL, V1, P281; HA KS, 1993, J BIOL CHEM, V268, P10534; HAMILTON TA, 1986, J CELL PHYSIOL, V128, P9, DOI 10.1002/jcp.1041280103; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; HORGAN MJ, 1990, AM J PHYSIOL, V259, pL315; INTRONA M, 1987, J CELL PHYSIOL, V131, P36, DOI 10.1002/jcp.1041310107; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180; LEWIS H, 1994, MOL CELL BIOL, V14, P5701; MONTGOMERY KF, 1991, P NATL ACAD SCI USA, V88, P6523, DOI 10.1073/pnas.88.15.6523; NARUMI S, 1992, J LEUKOCYTE BIOL, V52, P27; NARUMI S, 1992, J IMMUNOL, V149, P529; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; OHMORI Y, 1993, AM J PATHOL, V142, P861; Perbal B, 1988, PRACTICAL GUIDE MOL; PRESTA M, 1989, J CELL BIOL, V109, P1877, DOI 10.1083/jcb.109.4.1877; REPINE JE, 1987, AM REV RESPIR DIS, V136, P483; RITCHIE AJ, 1991, J IMMUNOL, V146, P3056; SIMPSON PJ, 1988, J CLIN INVEST, V81, P624, DOI 10.1172/JCI113364; SMITH RJ, 1992, J LEUKOCYTE BIOL, V52, P17; Tamaru M, 1998, ARTERIOSCL THROM VAS, V18, P1292; THOMAS PS, 1983, METHOD ENZYMOL, V100, P255; VANHUIJSDUIJNEN RH, 1992, J BIOL CHEM, V267, P22385; VYAS S, 1990, EMBO J, V9, P3707; WHITLEY MZ, 1994, MOL CELL BIOL, V14, P6464	52	17	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 5	1999	274	6					3753	3763		10.1074/jbc.274.6.3753		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	163VZ	WOS:000078428200068		
J	Ibuka, A; Taguchi, A; Ishiguro, M; Fushinobu, S; Ishii, Y; Kamitori, S; Okuyama, K; Yamaguchi, K; Konno, M; Matsuzawa, H				Ibuka, A; Taguchi, A; Ishiguro, M; Fushinobu, S; Ishii, Y; Kamitori, S; Okuyama, K; Yamaguchi, K; Konno, M; Matsuzawa, H			Crystal structure of the E166A mutant of extended-spectrum beta-lactamase Toho-1 at 1.8 angstrom resolution	JOURNAL OF MOLECULAR BIOLOGY			English	Article						Toho-1; beta-lactamase; expanded cephems; X-ray structure; molecular replacement	ACYL-ENZYME INTERMEDIATE; BACILLUS-LICHENIFORMIS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; PROTEIN; PENICILLIN; SEQUENCE; PROGRAM; GENE; CEFTAZIDIME	Bacterial resistance to beta-lactams is mainly due to the production of beta-lactamase. Especially through the production of extended-spectrum beta-lactamases (ESBLs), bacteria have acquired resistance not only to penicillins, but also to expanded-spectrum cephems. Here, we describe the crystal structure of the E166A mutant of class A beta-lactamase Toho-1 at 1.8 Angstrom resolution, the first reported tertiary structure of an ESBL. Instead of the wild-type enzyme, a mutant Toho-1, in which Glu166 was replaced with alanine, was used for this study, because of the strong tendency of the wild-type enzyme to form twinned crystals. The overall structure of Toho-1 is similar to the crystal structures of non-ESBLs, with no pronounced backbone rearrangement of the framework. However, there are some notable local changes. First, a difference in the disposition of an arginine residue, which is at position 244 in non-ESBLs but at position 276 in Toho-1 and other ESBLs, was revealed and the role of this arginine residue is discussed. Moreover, changes in the hydrogen-bonding pattern and in the formation of the hydrophobic core were also observed near the Omega loop. In particular, the lack of hydrogen bonds in the vicinity of the Omega loop could be a cause of the extended substrate specificity of Toho-1. Through the generation of a model for the enzyme-substrate complex, a conformational change of Toho-1 occurring on complex formation is discussed based on the active-site cleft structure and the substrate profile. (C) 1999 Academic Press.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Univ Shizuoka, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; Suntory Inst Bioorgan Res, Shimamoto, Osaka 6188503, Japan; Toho Univ, Sch Med, Dept Microbiol, Ota Ku, Tokyo 1438540, Japan; Tokyo Univ Agr & Technol, Fac Technol, Tokyo 1848588, Japan; Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Integrated Sci, Bunkyo Ku, Tokyo 1228610, Japan	Matsuzawa, H (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.		Fushinobu, Shinya/E-4987-2011	Fushinobu, Shinya/0000-0003-1346-6435			ADACHI H, 1991, J BIOL CHEM, V266, P3186; Arlet G, 1997, FEMS MICROBIOL LETT, V152, P163, DOI 10.1111/j.1574-6968.1997.tb10423.x; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; BOLES MO, 1976, ACTA CRYSTALLOGR B, V32, P2279, DOI 10.1107/S0567740876007590; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; AMBLER RP, 1991, BIOCHEM J, V276, P269; Ghuysen Jean-Marie, 1994, Trends in Microbiology, V2, P372, DOI 10.1016/0966-842X(94)90614-9; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; BLANEY JM, 1990, DGEOM GEOMETRY; Bonomo RA, 1997, FEMS MICROBIOL LETT, V152, P275, DOI 10.1111/j.1574-6968.1997.tb10439.x; BRUNGER T, 1992, XPLOR VERSION 3 1 MA; Cantu C, 1996, J BIOL CHEM, V271, P22538; DIDEBERG O, 1987, BIOCHEM J, V245, P911; DU BS, 1995, J ANTIMICROB CHEMOTH, V35, P7; GEWIRTH D, 1995, MACDENZO MANUAL; Gniadkowski M, 1998, ANTIMICROB AGENTS CH, V42, P827; HERZBERG O, 1987, SCIENCE, V236, P694, DOI 10.1126/science.3107125; ISHII Y, 1995, ANTIMICROB AGENTS CH, V39, P2269; JONES TA, 1995, OTHE MANUAL VERSION; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMIYA K, 1981, ACTA CRYSTALLOGR B, V37, P1626, DOI 10.1107/S0567740881006730; KNOX JR, 1991, J MOL BIOL, V220, P435, DOI 10.1016/0022-2836(91)90023-Y; KNOX JR, 1993, PROTEIN ENG, V6, P11, DOI 10.1093/protein/6.1.11; KNOX JR, 1995, ANTIMICROB AGENTS CH, V39, P2593; KUZIN AP, 1995, BIOCHEMISTRY-US, V34, P9532, DOI 10.1021/bi00029a030; LOBKOVSKY E, 1993, P NATL ACAD SCI USA, V90, P11257, DOI 10.1073/pnas.90.23.11257; Ma L, 1998, ANTIMICROB AGENTS CH, V42, P1181; MATAGNE A, 1990, BIOCHEM J, V265, P131; MATAGNE A, 1995, BBA-PROTEIN STRUCT M, V1246, P109, DOI 10.1016/0167-4838(94)00177-I; NEUGEBAUER K, 1981, NUCLEIC ACIDS RES, V9, P2577, DOI 10.1093/nar/9.11.2577; Peduzzi J, 1997, BBA-PROTEIN STRUCT M, V1341, P58, DOI 10.1016/S0167-4838(97)00020-4; SAKABE N, 1983, J APPL CRYSTALLOGR, V16, P542, DOI 10.1107/S0021889883010973; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; TAMAKI M, 1994, BIOCHEMISTRY-US, V33, P10200, DOI 10.1021/bi00199a049; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016; Zawadzke LE, 1995, PROTEIN ENG, V8, P1275, DOI 10.1093/protein/8.12.1275	40	65	71	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-2836			J MOL BIOL	J. Mol. Biol.	FEB 5	1999	285	5					2079	2087		10.1006/jmbi.1998.2432		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	164DQ	WOS:000078447500014		
J	Matsumori, N; Kaneno, D; Murata, M; Nakamura, H; Tachibana, K				Matsumori, N; Kaneno, D; Murata, M; Nakamura, H; Tachibana, K			Stereochemical determination of acyclic structures based on carbon-proton spin-coupling constants. A method of configuration analysis for natural products	JOURNAL OF ORGANIC CHEMISTRY			English	Article							DIMENSIONAL NMR-SPECTROSCOPY; SYMBIOTIC DINOFLAGELLATE; ZOOXANTHELLATOXIN-A; RELATIVE CONFIGURATION; MARINE DINOFLAGELLATE; AMPHIDINIUM-KLEBSII; SIDE-CHAIN; HETERONUCLEAR; MAITOTOXIN; ASSIGNMENT	A method for elucidating the relative configuration of acyclic organic compounds was developed on the basis of carbon-proton spin-coupling constants ((2,3)J(C,H)) and interproton spin-coupling constants ((3)J(H,H)). This method is based on the theory that, in acyclic systems, the conformation of adjacent asymmetric centers is represented by staggered rotamers, and their relative stereochemistry can be determined using (2,3)J(C,H) and (3)J(H,H), because the combined use of these J values enables the identification of the predominant staggered rotamer(s) out of the six possible derived from threo and erythro configurations. Detailed conformational analysis for model compounds 1-4 revealed that this method is useful in most cases for assignment of the configuration of acyclic structures occurring in natural products, in which stereogenic methine carbons are often substituted with a methyl or a hydroxy (alkoxy) group. This J-based configuration analysis was applied to the stereochemical elucidation of carboxylic acid 5 derived from zooxanthellatoxin and proven to be a practical method even for natural products with complicated structures.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan	Murata, M (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	murata@chem.s.u-tokyo.ac.jp					Zheng WJ, 1996, J AM CHEM SOC, V118, P7946, DOI 10.1021/ja961230+; Igarashi T, 1996, J AM CHEM SOC, V118, P479, DOI 10.1021/ja9534112; HAASNOOT CAG, 1980, TETRAHEDRON, V36, P2783, DOI 10.1016/0040-4020(80)80155-4; HANSEN PE, 1981, PROG NUCL MAG RES SP, V14, P175, DOI 10.1016/0079-6565(81)80001-5; SCHWARCZ JA, 1975, CAN J CHEM, V53, P1872, DOI 10.1139/v75-262; MUELLER L, 1987, J MAGN RESON, V72, P191, DOI 10.1016/0022-2364(87)90188-0; NAKAMURA H, 1995, J AM CHEM SOC, V117, P550, DOI 10.1021/ja00106a071; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; OTTING G, 1990, Q REV BIOPHYS, V23, P39; SATAKE M, 1991, J AM CHEM SOC, V113, P9859, DOI 10.1021/ja00026a027; PAUL GK, 1995, TETRAHEDRON LETT, V36, P6279, DOI 10.1016/0040-4039(95)01259-K; Wang AC, 1996, J AM CHEM SOC, V118, P2483, DOI 10.1021/ja9535524; KURZ M, 1991, ANGEW CHEM INT EDIT, V30, P1329, DOI 10.1002/anie.199113291; KITAGAWA I, 1990, J AM CHEM SOC, V112, P3710, DOI 10.1021/ja00165a094; GRIESINGER C, 1985, J AM CHEM SOC, V107, P6394, DOI 10.1021/ja00308a042; NAKAMURA H, 1995, TETRAHEDRON LETT, V36, P7255, DOI 10.1016/0040-4039(95)01503-A; Sakuda S, 1996, J AM CHEM SOC, V118, P7855, DOI 10.1021/ja960899d; PARELLA T, 1994, MAGN RESON CHEM, V32, P657, DOI 10.1002/mrc.1260321105; EBERSTADT M, 1995, ANGEW CHEM INT EDIT, V34, P1671, DOI 10.1002/anie.199516711; SCHWARCZ JA, 1972, CAN J CHEMISTRY, V50, P3667, DOI 10.1139/v72-581; BRUSCHWEILER R, 1987, J MAGN RESON, V73, P380, DOI 10.1016/0022-2364(87)90215-0; GANIS P, 1971, J AM CHEM SOC, V93, P4560, DOI 10.1021/ja00747a037; CHA JK, 1982, J AM CHEM SOC, V104, P7369, DOI 10.1021/ja00389a101; DUKER JM, 1993, CARBOHYD RES, V249, P281, DOI 10.1016/0008-6215(93)84096-O; ELIEL EL, 1965, CONFORMATIONAL ANAL, P13; Falk M, 1996, J COMPUT CHEM, V17, P409, DOI 10.1002/(SICI)1096-987X(199603)17:4<409::AID-JCC3>3.0.CO;2-Y; FUJITA K, 1996, 38 S CHEM NAT PROD O, P379; HANSEN PE, 1991, BIOCHEMISTRY-US, V30, P10457, DOI 10.1021/bi00107a014; HARMANGE JC, 1994, TETRAHEDRON LETT, V35, P6819, DOI 10.1016/0040-4039(94)85013-5; Hayakawa Y, 1998, J AM CHEM SOC, V120, P3524, DOI 10.1021/ja9732643; HINES JV, 1994, J AM CHEM SOC, V116, P5823, DOI 10.1021/ja00092a037; KATO Y, 1986, J AM CHEM SOC, V108, P2780, DOI 10.1021/ja00270a061; KESSLER H, 1987, J AM CHEM SOC, V109, P6927, DOI 10.1021/ja00257a004; KOBAYASHI M, 1994, TETRAHEDRON LETT, V35, P1243, DOI 10.1016/0040-4039(94)88034-4; KOBAYASHI M, 1996, 38 S CHEM NAT PROD, P61; Kock M, 1997, J ORG CHEM, V62, P8614, DOI 10.1021/jo970930+; LEMIEUX RU, 1972, CAN J CHEMISTRY, V50, P773, DOI 10.1139/v72-120; Marino JP, 1996, J AM CHEM SOC, V118, P4388, DOI 10.1021/ja953554o; MATSUMORI N, 1995, TETRAHEDRON, V51, P12229, DOI 10.1016/0040-4020(95)00790-F; Matsumori N, 1996, TETRAHEDRON LETT, V37, P1269, DOI 10.1016/0040-4039(95)02413-1; MECHLINS.W, 1970, TETRAHEDRON LETT, P3873; MURATA M, 1994, J AM CHEM SOC, V116, P7098, DOI 10.1021/ja00095a013; Murata M, 1997, NIPPON KAGAKU KAISHI, P749; NAKAMURA H, 1993, J ORG CHEM, V58, P313, DOI 10.1021/jo00054a009; NAKAMURA H, 1997, 72 ANN M JAP SOC CHE, P1048; Nonomura T, 1996, ANGEW CHEM INT EDIT, V35, P1675, DOI 10.1002/anie.199616751; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Sakai R, 1997, J AM CHEM SOC, V119, P4112, DOI 10.1021/ja963953z; Sasaki M, 1996, ANGEW CHEM INT EDIT, V35, P1672, DOI 10.1002/anie.199616721; UEMURA D, 1980, TETRAHEDRON LETT, V21, P4861, DOI 10.1016/0040-4039(80)80160-2; WASYLISH.R, 1973, CAN J CHEM, V51, P961, DOI 10.1139/v73-142; WOLLBORN U, 1992, J MAGN RESON, V98, P142, DOI 10.1016/0022-2364(92)90117-P; ZHU G, 1994, J AM CHEM SOC, V116, P8370, DOI 10.1021/ja00097a056	53	394	397	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0022-3263			J ORG CHEM	J. Org. Chem.	FEB 5	1999	64	3					866	876		10.1021/jo981810k		11	Chemistry, Organic	Chemistry	165XY	WOS:000078548200035		
J	Hitoshi, S; Kusunoki, S; Murayama, S; Tsuji, S; Kanazawa, I				Hitoshi, S; Kusunoki, S; Murayama, S; Tsuji, S; Kanazawa, I			Rabbit experimental sensory ataxic neuropathy: anti-GD1b antibody-mediated trkC downregulation of dorsal root ganglia neurons	NEUROSCIENCE LETTERS			English	Article						ganglioside; immunization; sensory neuron; peripheral nerve; neurotrophic factor receptor; macrophage	RECEPTOR MESSENGER-RNA; TYROSINE KINASE RECEPTOR; GUILLAIN-BARRE-SYNDROME; NEUROTROPHIN; GANGLIOSIDES; EXPRESSION; PROTEIN; INJURY; BINDS; GD1B	We previously reported experimental sensory neuropathy in rabbit induced by the immunization of ganglioside GD1b. The major pathological change in diseased rabbits was degeneration of primary sensory neurons with central axons extending to the dorsal column of the spinal cord. The loss of primary sensory neurons that mediate proprioceptive sensation prompted us to investigate the expression of trkC in dorsal root ganglia (DRG) because this type of neuron is thought depend mainly on neurotrophin-3-mediated trkC signaling. Northern blotting analysis revealed markedly reduced expression of trkC in DRG of diseased rabbits in acute phase. This result together with the absence of lymphocytic infiltration in DRG of diseased rabbits at any stage suggests the anti-GD1b antibody-mediated down regulation of trkC expression could be one of the pathogenesis of this experimental sensory ataxic neuropathy. (C) 1999 Elsevier Science Ireland Ltd. Ail rights reserved.	Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; RIKEN, Inst Phys & Chem Res, Frontier Res Program, Wako, Saitama, Japan	Kusunoki, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414; Kusunoki S, 1996, ANN NEUROL, V39, P424, DOI 10.1002/ana.410390404; CHIBA A, 1993, NEUROLOGY, V43, P1911; SEBERT ME, 1993, J NEUROSCI RES, V36, P357, DOI 10.1002/jnr.490360402; Arai S, 1996, NEUROSCI LETT, V211, P57, DOI 10.1016/0304-3940(96)12720-8; BENGZON J, 1993, NEUROSCIENCE, V53, P433, DOI 10.1016/0306-4522(93)90207-V; DAUNE GC, 1992, ANN NEUROL, V31, P683, DOI 10.1002/ana.410310621; HARTUNG HP, 1995, MUSCLE NERVE, V18, P137, DOI 10.1002/mus.880180202; ILYAS AA, 1985, ANN NEUROL, V18, P655, DOI 10.1002/ana.410180605; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Krekoski CA, 1996, J NEUROSCI RES, V43, P1, DOI 10.1002/jnr.490430102; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Oka N, 1996, MUSCLE NERVE, V19, P528, DOI 10.1002/(SICI)1097-4598(199604)19:4<528::AID-MUS15>3.0.CO;2-L; PESTRONK A, 1991, MUSCLE NERVE, V14, P927; SADIQ SA, 1990, NEUROLOGY, V40, P1067; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; VERGE VMK, 1992, J NEUROSCI, V12, P4011; VERGE VMK, 1989, J NEUROSCI, V9, P914	18	11	11	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	FEB 5	1999	260	3					157	160		10.1016/S0304-3940(98)00985-9		4	Neurosciences	Neurosciences & Neurology	168EB	WOS:000078677400003		
J	Hiyagon, H; Hashimoto, A				Hiyagon, H; Hashimoto, A			(16)O excesses in Olivine inclusions in Yamato-86009 and Murchison chondrites and their relation to CAIs	SCIENCE			English	Article							CARBONACEOUS CHONDRITES; ALLENDE METEORITE; ISOTOPE; OXYGEN; CONSEQUENCES; COMPONENT	In situ ion microprobe analyses of oxygen isotopes in Yamato-86009 and Murchison chondrites show that they contain abundant olivine-rich inclusions that have large oxygen-16 ((16)O) excesses, similar to those in spinel grains in calcium-aluminium-rich inclusions in Allende and other carbonaceous chondrites. The existence of (16)O-enriched olivine-rich inclusions suggests that oxygen isotopic anomalies were more extensive in the early solar system than was previously thought a nd that their origin may be attributed to a nebular chemical process rather than to an unidentified (16)O-rich carrier of presolar origin.	Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Dept Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan	Hiyagon, H (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan.	hiyagon@geoph.s.u-tokyo.ac.jp					CLAYTON RN, 1976, EARTH PLANET SC LETT, V30, P10, DOI 10.1016/0012-821X(76)90003-0; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; CLAYTON RN, 1984, EARTH PLANET SC LETT, V67, P151, DOI 10.1016/0012-821X(84)90110-9; CLAYTON RN, 1973, SCIENCE, V182, P485, DOI 10.1126/science.182.4111.485; CLAYTON RN, 1977, EARTH PLANET SC LETT, V34, P209, DOI 10.1016/0012-821X(77)90005-X; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; CLAYTON DD, 1988, ASTROPHYS J, V334, P191, DOI 10.1086/166829; CLAYTON DD, 1989, ASTROPHYS J, V346, P531, DOI 10.1086/168035; GREENWOOD RC, 1994, GEOCHIM COSMOCHIM AC, V58, P1913, DOI 10.1016/0016-7037(94)90424-3; GROSSMAN L, 1976, GEOCHIM COSMOCHIM AC, V40, P149, DOI 10.1016/0016-7037(76)90172-1; HASHIMOTO A, 1997, ANTARCTIC METEORITES, V22, P49; HASHIMOTO A, 1987, GEOCHIM COSMOCHIM AC, V51, P1685, DOI 10.1016/0016-7037(87)90348-6; HASHIMOTO A, 1997, 22 S ANT MET NAT I P; HIYAGON H, 1997, ANTARCT METEORITE RE, V10, P249; HIYAGON H, 1998, LUNAR PLANET SCI, V29; Jabeen I., 1998, ANTARCT METEORITE RE, V11, P122; KIMURA M, 1993, GEOCHIM COSMOCHIM AC, V57, P2329, DOI 10.1016/0016-7037(93)90573-F; LATTIMER JM, 1978, ASTROPHYS J, V219, P230, DOI 10.1086/155771; LIFFMAN K, 1988, P LUN PLAN SCI C, V18, P657; MACPHERSON GJ, 1984, J GEOPHYS RES, V89, pC299, DOI 10.1029/JB089iS01p0C299; MACPHERSON GJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2267, DOI 10.1016/0016-7037(85)90227-3; MACPHERSON GJ, 1981, P LUNAR PLANET SCI, V12, P1079; MCKEEGAN KD, 1998, METEORIT PLANET SC S, V32; Nittler LR, 1997, AIP CONF PROC, P59, DOI 10.1063/1.53320; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; Thiemens M. H., 1996, CHONDRULES PROTOPLAN, P107; Wark D. A., 1977, P LUNAR PLANET SCI, P95; WEN J, 1993, J GEOPHYS RES-ATMOS, V98, P12801, DOI 10.1029/93JD00565; WOOD JA, 1993, GEOCHIM COSMOCHIM AC, V57, P2377, DOI 10.1016/0016-7037(93)90575-H	30	55	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	1999	283	5403					828	831		10.1126/science.283.5403.828		4	Multidisciplinary Sciences	Science & Technology - Other Topics	165AT	WOS:000078496800039		
J	Yamabe, Y; Yokoi, A; Imamura, O; Matsui, M; Matsunaga, A; Taketo, M; Sugawara, M; Furuichi, Y				Yamabe, Y; Yokoi, A; Imamura, O; Matsui, M; Matsunaga, A; Taketo, M; Sugawara, M; Furuichi, Y			Structures of mouse Rep-8 cDNA and genomic clones	GENE			English	Article						amplification; cDNA cloning; leucine zipper motif; marathon-ready cDNA; promoter	POLYOMAVIRUS ENHANCER; TRANSLATION; ACTIVATION; PROTEINS	A mouse homologue of the human Rep-8 gene was cloned by PCR methods using degenerate oligonucleotide primers corresponding to highly conserved regions between human and mouse genes, and by the Marathon-Ready cDNA amplification method. The full-length mouse Rep-8 contains 1422 nucleotides and codes for a protein of 277 amino acids with a calculated mel. wt, of 31,519. The overall amino acid sequence homology between mouse and human Rep-8 proteins was 73%, and the overall nucleic acid sequence similarity was 65%. The predicted amino acid sequence of mouse Rep-8 has leucine zipper-like motifs in the N-terminal region, similar to the human Rep-8 protein. Rep-8 exists as a single-copy gene and is expressed in both the early and late embryonic stages of mouse development, suggesting that the Rep-8 gene product has an important role in embryogenesis. The genomic structure of the mouse Rep-8 gene was characterized extensively so that a gene targeting strategy could be used to develop an understanding of the biological function(s) of this interesting gene and its product. (C) 1999 Elsevier Science B.V. All rights reserved.	AGENE Res Inst, Kamakura, Kanagawa 2470063, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Bunkyo Ku, Tokyo 1130033, Japan	Furuichi, Y (reprint author), AGENE Res Inst, 200 Kajiwara, Kamakura, Kanagawa 2470063, Japan.	furuichi@a.gene.co.jp					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; IMAGAWA M, 1987, CELL, V51, P251, DOI 10.1016/0092-8674(87)90152-8; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; THOMPSON CC, 1991, SCIENCE, V253, P762, DOI 10.1126/science.1876833; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Ichikawa K, 1998, DNA Res, V5, P103, DOI 10.1093/dnares/5.2.103; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; Yamabe Y, 1997, GENOMICS, V39, P198, DOI 10.1006/geno.1996.4480; Yu M, 1997, J BIOL CHEM, V272, P29060, DOI 10.1074/jbc.272.46.29060	14	1	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119			GENE	Gene	FEB 4	1999	227	1					39	47		10.1016/S0378-1119(98)00598-8		9	Genetics & Heredity	Genetics & Heredity	166BT	WOS:000078556900005		
J	Zhang, YK; Fujita, N; Tsuruo, T				Zhang, YK; Fujita, N; Tsuruo, T			Caspase-mediated cleavage of p21(Wafl)/(Cip1) converts cancer cells from growth arrest to undergoing apoptosis	ONCOGENE			English	Article						p21; apoptosis; caspases; DNA damage; p53	CYCLIN-DEPENDENT KINASES; P53-MEDIATED G(1) ARREST; DNA-REPLICATION; P53-INDUCED APOPTOSIS; PROTEASE ACTIVATION; NUCLEAR ANTIGEN; CYTOCHROME-C; IN-VIVO; INHIBITION; P21	The cyclin-dependent kinase inhibitor p21(Waf1/Cip1) is a downstream effector of the p53-dependent cell growth arrest. We report herein that p21 was cleaved by caspase-3/CPP32 at the site of (DHVDL)-L-112 down arrow during the DNA damage-induced apoptosis of cancer cells. The cleaved p21 fragment could no more arrest the cells in G(1) phase nor suppress the cells undergoing apoptosis because it failed to bind to the proliferating cell nuclear antigen (PCNA) and lost its capability to localize in the nucleus. Thus, caspase-3-mediated cleavage and inactivation of p21 protein may convert cancer cells from growth arrest to undergoing apoptosis, leading to the acceleration of chemotherapy-induced apoptotic process in cancer cells.	Univ Tokyo, Lab Biomed Sci, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1700012, Japan	Tsuruo, T (reprint author), Univ Tokyo, Lab Biomed Sci, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Adams PD, 1996, MOL CELL BIOL, V16, P6623; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; KING KL, 1995, J CELL BIOCHEM, V58, P175, DOI 10.1002/jcb.240580206; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; WALDMAN T, 1995, CANCER RES, V55, P5187; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; MIYASHITA T, 1995, CELL, V80, P293; HARPER JW, 1995, MOL BIOL CELL, V6, P387; Rosse T, 1998, NATURE, V391, P496; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Chen IT, 1996, ONCOGENE, V12, P595; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; HARPER JW, 1993, CELL, V75, P805; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Talanian RV, 1997, J BIOL CHEM, V272, P9677; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Ball KL, 1997, CURR BIOL, V7, P71, DOI 10.1016/S0960-9822(06)00029-7; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; FOTEDAR R, 1995, MOL CELL BIOL, V15, P932; Fujita N, 1998, ONCOGENE, V17, P1295, DOI 10.1038/sj.onc.1202065; Gorospe M, 1996, CANCER RES, V56, P475; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Lee SH, 1996, ONCOGENE, V13, P2131; LEHMAN TA, 1991, CANCER RES, V51, P4090; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MASHIMA T, 1995, BIOCHEM BIOPH RES CO, V209, P907, DOI 10.1006/bbrc.1995.1584; Mashima T, 1997, ONCOGENE, V14, P1007, DOI 10.1038/sj.onc.1200919; MEIKRANTZ W, 1995, J CELL BIOCHEM, V58, P160, DOI 10.1002/jcb.240580205; Meikrantz W, 1996, J BIOL CHEM, V271, P10205; NAKANISHI M, 1995, J BIOL CHEM, V270, P17060; NAKANISHI M, 1995, EMBO J, V14, P555; Poluha W, 1996, MOL CELL BIOL, V16, P1335; SHI L, 1994, SCIENCE, V263, P1143, DOI 10.1126/science.8108732; SHIMIZU T, 1995, CANCER RES, V55, P228; TOMIDA A, 1996, ONCOGENE, V13, P299; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0	51	174	182	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB 4	1999	18	5					1131	1138		10.1038/sj.onc.1202426		8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	165FU	WOS:000078510700001		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, F; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hoch, M; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybycien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, F; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hoch, M; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybycien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D		OPAL Collaboration	A measurement of the tau(-)-> e(-)(nu)over-bar(e)nu(tau) branching ratio	PHYSICS LETTERS B			English	Article							ELECTROWEAK RADIATIVE-CORRECTIONS; 2-PHOTON PRODUCTION PROCESSES; OPAL JET CHAMBER; MONTE-CARLO; TAU-LEPTON; HIGH-ENERGY; MICROVERTEX DETECTOR; BHABHA SCATTERING; DECAY; QCD	The branching ratio for the decay tau(-) --> e(-) <(nu)over bar>(e)nu(tau) has been measured using Z(0) decay data collected by the OPAL experiment at LEP. In total 33 073 tau(-) --> e(-) <(nu)over bar>(e)nu(tau) candidates were identified from a sample of 186 197 selected tau. decays, giving a branching ratio of B(tau(-) --> e(-) <(nu)over bar>(e)nu(tau)) = (17.81 +/- 0.09 (stat) +/- 0.06 (syst))%. This result is combined with other measurements to test e - mu and mu - tau universality in charged-current weak interactions. Additionally, the strong coupling constant alpha(s)(m(tau)(2)) has been extracted from B(tau(-) --> e(-) <(nu)over bar>(e)nu(tau)) and evolved to the Z(0) mass scale, giving alpha(s)(m(Z)(2)) = 0.1204 +/- 0.0011 (exp) +/- 0.0019 (theory). (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Lab Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Phys Expt, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Duke Univ, Dept Phys, Durham, NC 27708 USA; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Hungarian Acad Sci, Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Lajos Kossuth Univ, Dept Expt Phys, Debrecen, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary	Abbiendi, G (reprint author), Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Palinkas, Jozsef/B-2993-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Schmitt, Bernd/H-9365-2013; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Schmitt, Bernd/0000-0002-5778-0680; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348			ACKERSTAFF K, UNPUB EUR PHYS J; ACTON PD, 1992, PHYS LETT B, V288, P373, DOI 10.1016/0370-2693(92)91117-R; AKERS R, 1995, Z PHYS C PART FIELDS, V66, P543; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; Alexander G, 1996, PHYS LETT B, V369, P163, DOI 10.1016/0370-2693(95)01600-7; ALEXANDER G, 1991, PHYS LETT B, V266, P201, DOI 10.1016/0370-2693(91)90768-L; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; Alexander G, 1996, PHYS LETT B, V374, P341; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; Jadach S, 1997, PHYS LETT B, V390, P298, DOI 10.1016/S0370-2693(96)01382-2; BRAATEN E, 1988, PHYS REV LETT, V60, P1606, DOI 10.1103/PhysRevLett.60.1606; JADACH S, 1994, COMPUT PHYS COMMUN, V79, P503, DOI 10.1016/0010-4655(94)90190-2; Rodrigo G, 1998, PHYS LETT B, V424, P367, DOI 10.1016/S0370-2693(98)00219-6; LEDIBERDER F, 1992, PHYS LETT B, V286, P147, DOI 10.1016/0370-2693(92)90172-Z; LEDIBERDER F, 1992, PHYS LETT B, V289, P165, DOI 10.1016/0370-2693(92)91380-R; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; JADACH S, 1993, COMPUT PHYS COMMUN, V76, P361, DOI 10.1016/0010-4655(93)90061-G; Bai JZ, 1996, PHYS REV D, V53, P20, DOI 10.1103/PhysRevD.53.20; MARCIANO WJ, 1988, PHYS REV LETT, V61, P1815, DOI 10.1103/PhysRevLett.61.1815; TSAI YS, 1971, PHYS REV D, V4, P2821, DOI 10.1103/PhysRevD.4.2821; Barate R, 1998, EUR PHYS J C, V4, P409, DOI 10.1007/s100520050217; BERENDS FA, 1988, NUCL PHYS B, V304, P712, DOI 10.1016/0550-3213(88)90651-7; BHATTACHARYA R, 1977, PHYS REV D, V15, P3267, DOI 10.1103/PhysRevD.15.3267; BIEBEL O, 1992, NUCL INSTRUM METH A, V323, P169, DOI 10.1016/0168-9002(92)90284-B; BRAATEN E, 1992, NUCL PHYS B, V373, P581, DOI 10.1016/0550-3213(92)90267-F; BRAATEN E, 1990, PHYS REV D, V42, P3888, DOI 10.1103/PhysRevD.42.3888; Braaten E., 1997, Nuclear Physics B, Proceedings Supplements, V55, DOI 10.1016/S0920-5632(97)00233-8; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; HILGART J, 1993, COMPUT PHYS COMMUN, V75, P191, DOI 10.1016/0010-4655(93)90175-C; ICH A, 1997, NUCL PHYS C S, V55, P3; LAM CS, 1977, PHYS REV D, V16, P703, DOI 10.1103/PhysRevD.16.703; NARISON S, 1995, NUCL PHYS B, P47, DOI 10.1016/0920-5632(95)00129-W; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x; PICH A, 1996, 20 J HOPK WORKSH CUR; PICH A, 1997, FTUV9703; Raczka PA, 1998, PHYS REV D, V57, P6862, DOI 10.1103/PhysRevD.57.6862; vanRitbergen T, 1997, PHYS LETT B, V400, P379, DOI 10.1016/S0370-2693(97)00370-5; SHIFMAN MA, 1979, NUCL PHYS B, V147, P385, DOI 10.1016/0550-3213(79)90022-1; SMITH J, 1977, PHYS REV D, V15, P3280, DOI 10.1103/PhysRevD.15.3280	41	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693	1873-2445		PHYS LETT B	Phys. Lett. B	FEB 4	1999	447	1-2					134	146		10.1016/S0370-2693(98)01553-6		13	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	167XM	WOS:000078660200019		
J	Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hoch, M; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybycien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Alexander, G; Allison, J; Altekamp, N; Anderson, KJ; Anderson, S; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Ball, AH; Barberio, E; Barlow, RJ; Bartoldus, R; Batley, JR; Baumann, S; Bechtluft, J; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Betts, S; Biebel, O; Biguzzi, A; Bird, SD; Blobel, V; Bloodworth, IJ; Bock, P; Bohme, J; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Conboy, JE; Cooke, OC; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Davis, R; De Jong, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Eatough, D; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Faust, AA; Fiedler, F; Fierro, M; Fleck, I; Folman, R; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gascon, J; Gascon-Shotkin, SM; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gibson, V; Gibson, WR; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, W; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Hartmann, C; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Herndon, M; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hoch, M; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kluth, S; Kobayashi, T; Kobel, M; Koetke, DS; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lauber, J; Lautenschlager, SR; Lawson, I; Layter, JG; Lazic, D; Lee, AM; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Ludwig, J; Liu, D; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Markopoulos, C; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; Mckigney, EA; McMahon, TJ; McPherson, RA; Meijers, F; Menke, S; Merritt, FS; Mes, H; Meyer, J; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mir, R; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nellen, B; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oreglia, MJ; Orito, S; Palinkas, J; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Petzold, S; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poffenberger, P; Polok, J; Przybycien, M; Rembser, C; Rick, H; Robertson, S; Robins, SA; Rodning, N; Roney, JM; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharf, F; Scharff-Hansen, P; Schieck, J; Schmitt, B; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Sittler, A; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Steuerer, J; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tanaka, S; Taras, P; Tarem, S; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; von Torne, E; Torrence, E; Towers, S; Trigger, I; Trocsanyi, Z; Tsur, E; Turcot, AS; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Wackerle, F; Wagner, A; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wermes, N; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Yekutieli, G; Zacek, V; Zer-Zion, D		OPAL Collaboration	Search for baryon and lepton number violating Z(0) decays	PHYSICS LETTERS B			English	Article							PARTICLE IDENTIFICATION; RADIATIVE-CORRECTIONS; MICROVERTEX DETECTOR; PHOTON CORRECTIONS; BHABHA SCATTERING; HIGH-ENERGIES; OPAL; SPHALERON; PROGRESS; Z0	Using data collected with the OPAL detector at LEP, we have searched for the processes e(+)e(-) --> Z(0) --> pe(-),p mu(-) and the charge conjugate final-states. These would violate the conservation of the baryon-number B, lepton-number L and the fermion-number n = (B + L). No evidence for such decays has been found, and the 95% confidence level upper limits on the partial widths Gamma(Z(0) --> pe) and Gamma(Z(0) --> p mu) are found to be 4.6 and 4.4 keV respectively. (C) 1999 Published by Elsevier Science B.V. All rights reserved.	Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Lab Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Univ Heidelberg, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Univ London Queen Mary & Westfield Coll, London E1 4NS, England; Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Brunel Univ, Inst Phys & Environm Sci, Uxbridge UB8 3PH, Middx, England; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Duke Univ, Dept Phys, Durham, NC 27708 USA; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Lajos Kossuth Univ, Dept Expt Phys, Debrecen, Hungary; Nucl Res Inst, Debrecen, Hungary	Abbiendi, G (reprint author), Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Palinkas, Jozsef/B-2993-2011; Stahl, Achim/E-8846-2011; Giacomelli, Paolo/B-8076-2009; Montanari, Alessandro/J-2420-2012; Schmitt, Bernd/H-9365-2013; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; spagnolo, stefania/A-6359-2012	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Montanari, Alessandro/0000-0003-2748-6373; Schmitt, Bernd/0000-0002-5778-0680; Grandi, Claudio/0000-0001-5998-3070; spagnolo, stefania/0000-0001-7482-6348			ADRIANI O, 1996, PHYS LETT B, V316, P467; AKERS R, 1994, Z PHYS C PART FIELDS, V61, P19; AKERS R, 1995, Z PHYS C PART FIELDS, V67, P555; AKRAWY MZ, 1990, PHYS LETT B, V235, P379, DOI 10.1016/0370-2693(90)91982-H; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ANDERSON BE, 1994, IEEE T NUCL SCI, V41, P845, DOI 10.1109/23.322818; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; ARNOLD P, 1988, PHYS REV D, V37, P1020, DOI 10.1103/PhysRevD.37.1020; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; COHEN AG, 1993, ANNU REV NUCL PART S, V43, P27; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; KLINKHAMER FR, 1984, PHYS REV D, V30, P2212, DOI 10.1103/PhysRevD.30.2212; KUZMIN VA, 1985, PHYS LETT B, V155, P36, DOI 10.1016/0370-2693(85)91028-7; JADACH S, 1991, COMPUT PHYS COMMUN, V66, P276, DOI 10.1016/0010-4655(91)90077-X; Abreu P, 1997, Z PHYS C PART FIELDS, V73, P243, DOI 10.1007/s002880050313; 't Hooft G., 1976, PHYS REV LETT, V37, P8; BARNETT RM, 1996, PHYS REV D, V45, pS1; BERENDS FA, 1988, NUCL PHYS B, V304, P712, DOI 10.1016/0550-3213(88)90651-7; BOHM M, 1988, NUCL PHYS B, V304, P687, DOI 10.1016/0550-3213(88)90650-5; CARSON L, 1990, PHYS REV D, V42, P2127, DOI 10.1103/PhysRevD.42.2127; CHANG CY, 1988, NUCL INSTRUM METH A, V264, P194, DOI 10.1016/0168-9002(88)90908-4; COUSINS RD, 1992, NUCL INSTRUM METH A, V320, P331, DOI 10.1016/0168-9002(92)90794-5; DECAMP D, 1992, PHYS REP, V216, P253; DOLGOV AD, 1993, P 3 INT WORKSH THEOR, P28; FISHER HM, 1986, NUCL I METH A, V252, P331; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; Hauschild M, 1996, NUCL INSTRUM METH A, V379, P436, DOI 10.1016/0168-9002(96)00607-9; SAKHAROV AD, 1967, JETP LETT, V6, P6; SJOSTRAND T, CERNTH648892; t Hooft G., 1976, PHYS REV D, V14, P3432, DOI 10.1103/PhysRevD.14.3432	33	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	FEB 4	1999	447	1-2					157	166		10.1016/S0370-2693(98)01570-6		10	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	167XM	WOS:000078660200021		
J	Hara, S; Kitamura, J; Okushi, H; Misawa, S; Yoshida, S; Kajimura, K; Yeom, HW; Uhrberg, RIG				Hara, S; Kitamura, J; Okushi, H; Misawa, S; Yoshida, S; Kajimura, K; Yeom, HW; Uhrberg, RIG			Perfect cellular disorder in a two-dimensional system: Si cells on the 3C-SiC(001) surface	SURFACE SCIENCE			English	Letter						angle resolved photoemission; ising models; scanning tunneling microscopy; silicon carbide; surface electronic phenomena; surface structure, morphology, roughness and topography; surface thermodynamics	ANGLE-RESOLVED-PHOTOEMISSION; SCANNING-TUNNELING-MICROSCOPY; ELECTRONIC-STRUCTURE	Using scanning tunneling microscopy, we have observed a random orientation of the two possible inter-dimer buckling directions without any intercell correlation on a vacancy-free 3C-SiC(001)-(3 x 2) surface. The very small surface state dispersions observed by photoemission support the picture of essentially non-interacting (3 x 2) cells. The perfect cellular disorder, with no intercell correlation, originates from the electron localization that can be inferred from the weak surface state dispersions. Our experimental findings indicate a zero dimensionality of this system. (C) 1999 Elsevier Science B.V. All rights reserved.	Electrotech Lab, Tsukuba, Ibaraki 3058568, Japan; Univ Tokyo, Res Ctr Spectrochem, Bukyo Ku, Tokyo 113, Japan; Linkoping Univ, Dept Phys & Measurement Technol, S-58183 Linkoping, Sweden	Hara, S (reprint author), Electrotech Lab, 1-1-4 Umezono, Tsukuba, Ibaraki 3058568, Japan.	shara@etl.go.jp					BECKER RS, 1987, NATURE, V325, P419, DOI 10.1038/325419a0; SCHMID M, 1993, PHYS REV LETT, V70, P1441, DOI 10.1103/PhysRevLett.70.1441; MERMIN ND, 1968, PHYS REV, V176, P250, DOI 10.1103/PhysRev.176.250; ENTA Y, 1990, PHYS REV LETT, V65, P2704, DOI 10.1103/PhysRevLett.65.2704; Hakansson MC, 1997, SURF SCI, V374, P73, DOI 10.1016/S0039-6028(96)00745-5; Hara S, 1996, SURF SCI, V357, P436, DOI 10.1016/0039-6028(96)00195-1; HARA S, 1994, PHYS REV B, V50, P4548, DOI 10.1103/PhysRevB.50.4548; IHM J, 1983, PHYS REV LETT, V51, P1872, DOI 10.1103/PhysRevLett.51.1872; JOHANSSON LSO, 1990, PHYS REV B, V42, P1305, DOI 10.1103/PhysRevB.42.1305; KOBAYASHI A, 1993, SCIENCE, V259, P1724, DOI 10.1126/science.259.5102.1724; LARSEN PK, 1982, PHYS REV B, V26, P3222, DOI 10.1103/PhysRevB.26.3222; Semond F, 1996, PHYS REV LETT, V77, P2013, DOI 10.1103/PhysRevLett.77.2013; SWALIN RA, 1972, THERMODYNAMICS SOLID, pCH7; Yeom HW, 1998, PHYS REV B, V58, P10540, DOI 10.1103/PhysRevB.58.10540; Yeom HW, 1997, PHYS REV B, V56, pR15525; YOSHIDA S, 1985, APPL PHYS LETT, V46, P766, DOI 10.1063/1.95502; ZIMAN JM, 1979, MODELS DISORDER, pCH1	17	14	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0039-6028			SURF SCI	Surf. Sci.	FEB 4	1999	421	1-2					L143	L149		10.1016/S0039-6028(98)00874-7		7	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	168JX	WOS:000078689400001		
J	Takano, M; Yamato, T; Higo, J; Suyama, A; Nagayama, K				Takano, M; Yamato, T; Higo, J; Suyama, A; Nagayama, K			Molecular dynamics of a 15-residue poly(L-alanine) in water: Helix formation and energetics	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ALANINE-BASED PEPTIDES; SPECIAL-PURPOSE COMPUTER; ALPHA-HELIX; AMINO-ACIDS; FORMING TENDENCIES; FAST EVENTS; RELAXATION DYNAMICS; FOLDING DYNAMICS; COIL TRANSITIONS; SIMULATIONS	We present a molecular dynamics study of the alpha-helix formation in a system consisting of a 15-residue poly(L-alanine) and surrounding water molecules. By applying a relatively high temperature, we observed the alpha-helix formation several times during a 17-ns run, and reversible helix-coil transitions were also observed. The alpha-helix formations were usually initiated by the beta-tum structures. A crank-shaft-like motion of the peptide was included in the folding process. In the formed alpha-helical domains, substantial 3(10)-helix formations were found especially at the termini, as observed by the NMR study. The folding time scale at room temperature estimated from our simulation was found to lie in the range of 100ns, which is in accord with the time scale of the T-jump experiments. The total energy of the whole system was lower in the alpha-helix state than in the random-coil state by 20.4 +/- 4.8 kcal/mol, which is consistent with the experimental value obtained by calorimetry. This energy decrease in forming the alpha-helix was mainly caused by the Coulombic energy and the torsional energy.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; Nagoya Univ, Grad Sch Sci, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Biomol Engn Res Inst, Suita, Osaka 5650874, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	Takano, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	takano@santa.c.u-tokyo.ac.jp	de Sousa, Miguel/A-3877-2009				ALBERTY RA, 1987, PHYSICAL CHEM; TIRADORIVES J, 1991, BIOCHEMISTRY-US, V30, P3864, DOI 10.1021/bi00230a009; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; Duan Y, 1998, P NATL ACAD SCI USA, V95, P9897, DOI 10.1073/pnas.95.17.9897; Ballew RM, 1996, P NATL ACAD SCI USA, V93, P5759, DOI 10.1073/pnas.93.12.5759; Avbelj F, 1998, J MOL BIOL, V279, P665, DOI 10.1006/jmbi.1998.1792; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; KOVACS H, 1995, J MOL BIOL, V247, P808, DOI 10.1016/S0022-2836(05)80156-1; Gilmanshin R, 1997, P NATL ACAD SCI USA, V94, P3709, DOI 10.1073/pnas.94.8.3709; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; VANBUUREN AR, 1993, BIOPOLYMERS, V33, P1159, DOI 10.1002/bip.360330802; CHAKRABARTTY A, 1994, PROTEIN SCI, V3, P843; ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Gilmanshin R, 1997, BIOCHEMISTRY-US, V36, P15006, DOI 10.1021/bi970634r; Bashford D, 1997, J AM CHEM SOC, V119, P4964, DOI 10.1021/ja963516k; Berendsen H.J.C., 1981, INTERMOLECULAR FORCE, P331; BRAXENTHALER M, 1995, J MOL BIOL, V250, P239, DOI 10.1006/jmbi.1995.0374; Brooks CL, 1996, J PHYS CHEM-US, V100, P2546, DOI 10.1021/jp952674f; DAGGETT V, 1992, J MOL BIOL, V223, P1121, DOI 10.1016/0022-2836(92)90264-K; Daura X, 1998, J MOL BIOL, V280, P925, DOI 10.1006/jmbi.1998.1885; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; DELOOF H, 1992, J AM CHEM SOC, V114, P4028, DOI 10.1021/ja00037a002; DICAPUA FM, 1991, J AM CHEM SOC, V113, P6145, DOI 10.1021/ja00016a034; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Gilmanshin R, 1998, NAT STRUCT BIOL, V5, P363, DOI 10.1038/nsb0598-363; Haar L., 1984, NBS NRC STEAM TABLES; HELFAND E, 1984, SCIENCE, V226, P647, DOI 10.1126/science.226.4675.647; HIGO J, 1994, J COMPUT CHEM, V15, P1372, DOI 10.1002/jcc.540151207; HIRST JD, 1995, BIOCHEMISTRY-US, V34, P7614, DOI 10.1021/bi00023a007; Hockney R.W., 1970, METHODS COMPUTATIONA, V9, P135; Karplus M, 1997, FOLD DES, V2, pS69, DOI 10.1016/S1359-0278(97)00067-9; Klein CT, 1996, THEOCHEM-J MOL STRUC, V370, P33; Komeiji Y, 1997, J COMPUT CHEM, V18, P1546, DOI 10.1002/(SICI)1096-987X(199709)18:12<1546::AID-JCC11>3.0.CO;2-I; Krynicki K., 1978, Faraday Discussions of the Chemical Society; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; Millhauser GL, 1997, J MOL BIOL, V267, P963, DOI 10.1006/jmbi.1997.0923; MORIKAMI K, 1992, COMPUT CHEM, V16, P243, DOI 10.1016/0097-8485(92)80010-W; OKAMOTO Y, 1994, PROTEINS, V19, P14, DOI 10.1002/prot.340190104; OKAMOTO Y, 1995, J PHYS CHEM-US, V99, P11276, DOI 10.1021/j100028a031; OOI T, 1988, J BIOCHEM-TOKYO, V103, P114; PADMANABHAN S, 1994, BIOCHEMISTRY-US, V33, P8604, DOI 10.1021/bi00194a027; PEAR MR, 1981, BIOPOLYMERS, V20, P629, DOI 10.1002/bip.1981.360200314; PRESS WH, 1996, NUMERICAL RECIPES FO, P655; RIPOLL DR, 1988, BIOPOLYMERS, V27, P1283, DOI 10.1002/bip.360270808; SHEINERMAN FB, 1995, J AM CHEM SOC, V117, P10098, DOI 10.1021/ja00145a022; Shirley WA, 1997, PROTEINS, V28, P59, DOI 10.1002/(SICI)1097-0134(199705)28:1<59::AID-PROT6>3.0.CO;2-E; SOMAN KV, 1991, BIOPOLYMERS, V31, P1351, DOI 10.1002/bip.360311202; STEINFELD JI, 1989, CHEM KINETICS DYNAMI, P410; Sung SS, 1996, PROTEINS, V25, P202, DOI 10.1002/(SICI)1097-0134(199606)25:2<202::AID-PROT6>3.0.CO;2-J; SUNG SS, 1995, BIOPHYS J, V68, P826; Takano M, 1998, PHYS REV LETT, V80, P5691, DOI 10.1103/PhysRevLett.80.5691; Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764; TOBIAS DJ, 1991, BIOCHEMISTRY-US, V30, P6054, DOI 10.1021/bi00238a032; Wang L, 1996, BIOPOLYMERS, V39, P479, DOI 10.1002/(SICI)1097-0282(199610)39:4<479::AID-BIP1>3.0.CO;2-U; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p; YANG AS, 1995, J MOL BIOL, V252, P351, DOI 10.1006/jmbi.1995.0502; Young WS, 1996, J MOL BIOL, V259, P560, DOI 10.1006/jmbi.1996.0339	65	71	73	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 3	1999	121	4					605	612		10.1021/ja982919c		8	Chemistry, Multidisciplinary	Chemistry	164PB	WOS:000078471800002		
J	Tanaka, H; Kobayashi, A; Sato, A; Akutsu, H; Kobayashi, H				Tanaka, H; Kobayashi, A; Sato, A; Akutsu, H; Kobayashi, H			Chemical control of electrical properties and phase diagram of a series of lambda-type BETS superconductors, lambda-(BETS)(2)GaBrxCl4-x	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							ELECTRONIC BAND-STRUCTURE; ORGANIC SUPERCONDUCTOR; TRANSITION; CONDUCTOR; METALS; STATE; CL; BETS=BIS(ETHYLENEDITHIO)TETRASELENAFULVALENE; BR	lambda-(BETS)(2)GaBrxCl4-(x) [BETS = bis(ethylenedithio)tetraselenafulvalene; 0 less than or equal to x less than or equal to 2] is a molecular superconductor with strongly correlated conduction electrons. The electrical transport properties of lambda(BETS)(2)GaBrx- Cl4-x are drastically changed by varying the bromine content x or by applying pressure. At ambient pressure, the superconducting transition could be observed for x < 0.75. The pressure and x dependencies of T-c were examined. The M-H curve (M = magnetization; H = magnetic field) at 2 K indicated the almost perfect Meissner state of the superconducting phase of lambda-(BETS)(2)CaCl4. The H-cl is similar to 8 Oe for H-perpendicular to and 12 Oe for H-parallel to where H-perpendicular to and H-parallel to are the magnetic fields perpendicular and parallel to the c axis, respectively. The magnetic susceptibility of lambda-(BETS)(2)GaBrxCl4-x increases with decreasing temperature to similar to 60 K, below which the susceptibility becomes x-dependent and tends to be suppressed with increasing x. The isotropic decrease of the static susceptibility at lower temperature observed in the insulating system with x > 1.0 indicates the insulating ground state seems not to be antiferromagnetic but probably nonmagnetic. The crystal structure determinations of a series of lambda-(BETS)(2)GaBrxCl4-x and the calculations of the intermolecular overlap integrals of the highest occupied molecular orbital of BETS were made to elucidate a key factor of the superconducting transition mechanism. The x-dependence of intermolecular overlap integrals seems to suggest that the magnitude of the "spin gap" of the nonmagnetic insulating state tends to be diminished with decreasing x. There exists one intermolecular overlap integral exhibiting a large temperature and x-dependence, which seems to play a crucial role in determining the nature of the ground state.	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mol Sci, Okazaki, Aichi 4448585, Japan	Kobayashi, A (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.						Akutsu H, 1997, J AM CHEM SOC, V119, P12681, DOI 10.1021/ja9733853; Akutsu H, 1998, PHYS REV B, V58, P9294, DOI 10.1103/PhysRevB.58.9294; Brossard L, 1998, EUR PHYS J B, V1, P439, DOI 10.1007/s100510050207; KOBAYASHI H, 1995, SYNTHETIC MET, V70, P867, DOI 10.1016/0379-6779(94)02683-P; JEROME D, 1991, SCIENCE, V252, P1509, DOI 10.1126/science.252.5012.1509; Troyer M, 1997, PHYS REV B, V55, pR6117; GRANT PM, 1982, PHYS REV B, V26, P6888, DOI 10.1103/PhysRevB.26.6888; CASSOUX P, 1991, COORDIN CHEM REV, V110, P115, DOI 10.1016/0010-8545(91)80024-8; MIYAGAWA K, 1995, PHYS REV LETT, V75, P1174, DOI 10.1103/PhysRevLett.75.1174; WILLIAMS JM, 1990, INORG CHEM, V29, P3272, DOI 10.1021/ic00343a003; Kobayashi H, 1996, J AM CHEM SOC, V118, P368, DOI 10.1021/ja9523350; KOBAYASHI A, 1988, SYNTHETIC MET, V27, pB339; GEISER U, 1993, SYNTHETIC MET, V56, P2314, DOI 10.1016/0379-6779(93)90416-T; GOZE F, 1995, PHYSICA B, V211, P290, DOI 10.1016/0921-4526(94)01043-Z; HASEGAWA Y, 1987, J PHYS SOC JPN, V56, P877, DOI 10.1143/JPSJ.56.877; JEROME D, 1980, J PHYS LETT-PARIS, V41, pL95; KATO R, 1991, SYNTHETIC MET, V41, P2093; KOBAYASHI A, 1993, CHEM LETT, P2179, DOI 10.1246/cl.1993.2179; KOBAYASHI H, 1993, CHEM LETT, P1559, DOI 10.1246/cl.1993.1559; KOBAYASHI H, 1995, J CHEM SOC CHEM COMM, P1225, DOI 10.1039/c39950001225; Kobayashi H, 1997, SYNTHETIC MET, V85, P1463, DOI 10.1016/S0379-6779(97)80317-7; KOBAYASHI H, 1995, J MATER CHEM, V5, P1681, DOI 10.1039/jm9950501681; Kobayashi H, 1997, J AM CHEM SOC, V119, P12392, DOI 10.1021/ja973068w; MCGARVEY BR, 1981, INORG CHEM, V20, P2010, DOI 10.1021/ic50221a015; Montgomery LK, 1996, MOL CRYST LIQ CRYS A, V284, P73, DOI 10.1080/10587259608037912; MONTGOMERY LK, 1994, PHYSICA C, V219, P490, DOI 10.1016/0921-4534(94)90404-9; OGURA F, 1997, ORGANIC CONDUCTIVE M, P234; PAPAVASSILIOU GC, 1997, ORGANIC CONDUCTIVE M, P173; Seo H, 1997, J PHYS SOC JPN, V66, P3352, DOI 10.1143/JPSJ.66.3352; TANAKA N, 1996, ADV MATER, V8, P812; *TEXS, 1992, CRYST STRUCT AN PACK; TOKUMOTO M, 1988, SYNTHETIC MET, V27, pA251, DOI 10.1016/0379-6779(88)90408-0; URAYAMA H, 1988, CHEM LETT, P55, DOI 10.1246/cl.1988.55; WHANGBO MH, 1982, SOLID STATE COMMUN, V43, P637, DOI 10.1016/0038-1098(82)90480-X; Williams J M, 1992, ORGANIC SUPERCONDUCT	35	63	63	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 3	1999	121	4					760	768		10.1021/ja9827806		9	Chemistry, Multidisciplinary	Chemistry	164PB	WOS:000078471800019		
J	Murata, M; Matsuoka, S; Matsumori, N; Paul, GK; Tachibana, K				Murata, M; Matsuoka, S; Matsumori, N; Paul, GK; Tachibana, K			Absolute configuration of amphidinol 3, the first complete structure determination from amphidinol homologues: Application of a new configuration analysis based on carbon-hydrogen spin-coupling constants	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							MARINE DINOFLAGELLATE; COMPOUND; KLEBSII		Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Murata, M (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.						SCHWARCZ JA, 1975, CAN J CHEM, V53, P1872, DOI 10.1139/v75-262; LANCELIN JM, 1989, TETRAHEDRON LETT, V30, P4521, DOI 10.1016/S0040-4039(01)80734-6; SATAKE M, 1991, J AM CHEM SOC, V113, P9859, DOI 10.1021/ja00026a027; PAUL GK, 1995, TETRAHEDRON LETT, V36, P6279, DOI 10.1016/0040-4039(95)01259-K; KURZ M, 1991, ANGEW CHEM INT EDIT, V30, P1329, DOI 10.1002/anie.199113291; Doi Y, 1997, J ORG CHEM, V62, P3820, DOI 10.1021/jo970273l; GRIESINGER C, 1985, J AM CHEM SOC, V107, P6394, DOI 10.1021/ja00308a042; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Matsumori N, 1996, TETRAHEDRON LETT, V37, P1269, DOI 10.1016/0040-4039(95)02413-1; Paul G. K., 1996, HARMFUL TOXIC ALGAL, P503; Satake M, 1997, J AM CHEM SOC, V119, P11325, DOI 10.1021/ja972482t; SCHREIBER SL, 1987, TETRAHEDRON LETT, V28, P6001, DOI 10.1016/S0040-4039(00)96847-3; ZHU G, 1994, J AM CHEM SOC, V116, P8370, DOI 10.1021/ja00097a056	13	142	145	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 3	1999	121	4					870	871		10.1021/ja983655x		2	Chemistry, Multidisciplinary	Chemistry	164PB	WOS:000078471800039		
J	Enomoto, M; Aida, T				Enomoto, M; Aida, T			Self-assembly of a copper-ligating dendrimer that provides a new non-heme metalloprotein mimic: "Dendrimer effects" on stability of the bis(mu-oxo)dicopper(III) core	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							SPHERICAL SUPRAMOLECULAR DENDRIMERS; COMPLEXES; CHEMISTRY; MACROMOLECULES; DIOXYGEN; ACTIVATION		Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Aida, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Aida, Takuzo/I-9117-2012				HAWKER CJ, 1990, J AM CHEM SOC, V112, P7638, DOI 10.1021/ja00177a027; Mahapatra S, 1996, J AM CHEM SOC, V118, P11575, DOI 10.1021/ja962304k; Gitsov I, 1996, J AM CHEM SOC, V118, P3785, DOI 10.1021/ja9542348; Mahapatra S, 1996, J AM CHEM SOC, V118, P11555, DOI 10.1021/ja962305c; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Zimmerman SC, 1996, SCIENCE, V271, P1095, DOI 10.1126/science.271.5252.1095; Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; TOMALIA DA, 1994, ADV MATER, V6, P529, DOI 10.1002/adma.19940060703; Halfen JA, 1996, SCIENCE, V271, P1397, DOI 10.1126/science.271.5254.1397; Zeng FW, 1997, CHEM REV, V97, P1681, DOI 10.1021/cr9603892; BEISSEL T, 1990, INORG CHEM, V29, P1736, DOI 10.1021/ic00334a029; Chow HF, 1996, CHEM-EUR J, V2, P1085, DOI 10.1002/chem.19960020908; Huck WTS, 1997, ANGEW CHEM INT EDIT, V36, P1006, DOI 10.1002/anie.199710061; Huck WTS, 1996, ANGEW CHEM INT EDIT, V35, P1213, DOI 10.1002/anie.199612131; Mahadevan V, 1997, J AM CHEM SOC, V119, P11996, DOI 10.1021/ja972946n; NEWKOME GR, 1995, ANGEW CHEM INT EDIT, V34, P2023, DOI 10.1002/anie.199520231; Que L, 1996, ACCOUNTS CHEM RES, V29, P190; Tomioka N, 1998, ANGEW CHEM INT EDIT, V37, P1531, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1531::AID-ANIE1531>3.3.CO;2-K	18	105	105	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	FEB 3	1999	121	4					874	875		10.1021/ja982282x		2	Chemistry, Multidisciplinary	Chemistry	164PB	WOS:000078471800041		
J	Kasai, H; Kishimoto, T; Liu, TT; Miyashita, Y; Podini, P; Grohovaz, F; Meldolesi, J				Kasai, H; Kishimoto, T; Liu, TT; Miyashita, Y; Podini, P; Grohovaz, F; Meldolesi, J			Multiple and diverse forms of regulated exocytosis in wild-type and defective PC12 cells	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							FROG NEUROMUSCULAR-JUNCTIONS; PLASMA-MEMBRANE; FREEZE-FRACTURE; CALCIUM; RELEASE; VESICLES; NEUROTRANSMITTER; STIMULATION; FROZEN; FUSION	Regulated exocytosis triggered by the photolysis of a caged Ca2+ compound, DM-nitrophen, was investigated by patch-clamp capacitance measurements in two clones of PC12, the first wild-type and the second (PC12-27) defective of both types of classical secretory vesicles together with the neuronal-type receptors for the attachment proteins of the N-ethylmaleimide-sensitive fusion protein, the so called SNAREs. Moreover, the electrophysiological data were correlated with the ultrastructure of resting quick-frozen-freeze-dried cells of the two clones. Wild-type PC12 exhibited two-component capacitance responses, time constants of 30-100 ms and >10 s, that previous studies had suggested to reflect primarily the fusion of the small and large secretory vesicles, each contributing cell surface increases of approximate to 10%. Both of these components were largely and specifically inhibited whether cells previously were microinjected with tetanus toxin light chain. In the defective clone, large responses also were recorded (approximate to 19% surface expansion; time constant, approximate to 1 s) that, in contrast to those of the wild-type, were entirely resistant to the toxin, Although ecretory organelles, i.e., large vesicles and also profiles of small vesicles, were abundant at the cell periphery and often docked to the plasmalemma of resting wild-type PC12, in the defective clone, no superficial accumulation of vesicles was observed. Our coordinate structural and functional results have revealed diversities between the two classical forms of regulated secretion in wild-type PC12 and have provided evidence of a toxin-insensitive form of Ca2+-induced exocytosis, prominent in the defective clone, that may play an important role(s) in cellular physiology.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Tokyo, Dept Physiol, Bunkyo Ku, Tokyo 113, Japan; Univ Milan, B Ceccarelli Ctr, Dept Pharmacol, Ctr Cellular & Mol Pharmacol,CNR, I-20132 Milan, Italy	Meldolesi, J (reprint author), San Raffaele Sci Inst, DIBIT, Via Olgettina 58, I-20132 Milan, Italy.	meldolesi.jacopo@hsr.it		Kasai, Haruo/0000-0003-2327-9027			Ninomiya Y, 1996, J BIOL CHEM, V271, P17751; Terasaki M, 1997, J CELL BIOL, V139, P63, DOI 10.1083/jcb.139.1.63; HEUSER JE, 1974, J NEUROCYTOL, V3, P109, DOI 10.1007/BF01111936; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Passafaro M, 1996, J BIOL CHEM, V271, P30096; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Bi GQ, 1995, J CELL BIOL, V131, P1747, DOI 10.1083/jcb.131.6.1747; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Coorssen JR, 1996, EMBO J, V15, P3787; Pezzati R, 1997, MOL BIOL CELL, V8, P1501; KELLENBERGER E, 1992, J MICROSC-OXFORD, V168, P181; Banerjee A, 1996, J BIOL CHEM, V271, P20227; BAUMERT M, 1990, J CELL BIOL, V110, P1285, DOI 10.1083/jcb.110.4.1285; BREWER PA, 1986, NEUROSCIENCE, V17, P881, DOI 10.1016/0306-4522(86)90052-7; CECCARELLI B, 1979, J CELL BIOL, V81, P178, DOI 10.1083/jcb.81.1.178; CHUNG KN, 1996, MOL BIOL CELL, V7, P277; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; Corradi N, 1996, J BIOL CHEM, V271, P27116; Goda Y, 1997, P NATL ACAD SCI USA, V94, P769, DOI 10.1073/pnas.94.3.769; Gotte M, 1998, TRENDS CELL BIOL, V8, P215, DOI 10.1016/S0962-8924(98)01272-0; Grohovaz F, 1996, P NATL ACAD SCI USA, V93, P4799, DOI 10.1073/pnas.93.10.4799; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; KELLY R B, 1991, Current Opinion in Cell Biology, V3, P654, DOI 10.1016/0955-0674(91)90037-Y; Montecucco C, 1995, Q REV BIOPHYS, V28, P423; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	33	53	53	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 2	1999	96	3					945	949		10.1073/pnas.96.3.945		5	Multidisciplinary Sciences	Science & Technology - Other Topics	164VK	WOS:000078484100028		
J	Nakasako, M; Kimura, M; Yamaguchi, I				Nakasako, M; Kimura, M; Yamaguchi, I			Crystallization and preliminary X-ray diffraction studies of blasticidin S deaminase from Aspergillus terreus	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							PYRICULARIA-ORYZAE; GENE BSD; TRANSFORMATION; MARKER	Blasticidin S deaminase from Aspergillus terreus was crystallized with polyethylene glycol 8000. Two types of crystals were grown under the same crystallization conditions. One type grew as thin plates, while the other had a rhombic shape. The rhombic shaped crystal was suitable for high-resolution crystal structure analysis. Precession photographs and diffraction data showed that the crystal belonged to orthorhombic space group P2(1)2(1)2(1), With unit-cell dimensions a = 70.33, b = 146.56 and c = 56.48 Angstrom. The calculated V-m value was acceptable when a tetramer of the enzyme was contained in an asymmetric unit. Preliminary diffraction data were collected to a resolution of 2.0 Angstrom with good statistics.	Japan Sci & Technol Corp, PRESTO, Tokyo 1130032, Japan; Univ Tokyo, Tokyo 1130032, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan	Nakasako, M (reprint author), Japan Sci & Technol Corp, PRESTO, 1-1-1 Bunkyoku, Tokyo 1130032, Japan.		KIMURA, Makoto/I-6906-2014	KIMURA, Makoto/0000-0001-5310-2893			BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; TAKEUCHI S, 1958, J ANTIBIOT, V11, P1; YAMAGUCHI I, 1975, J ANTIBIOT, V28, P7; KIMURA M, 1995, BIOSCI BIOTECH BIOCH, V59, P1177; KIMURA M, 1994, BBA-GENE STRUCT EXPR, V1219, P653, DOI 10.1016/0167-4781(94)90224-0; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; MISATO T., 1959, Ann. phytopath. Soc., V24, P302; SETO H, 1966, AGR BIOL CHEM TOKYO, V30, P877; Tamura K, 1995, BIOSCI BIOTECH BIOCH, V59, P2336; YAMAGUCH.H, 1966, J BIOCHEM-TOKYO, V60, P632; YAMAGUCH.I, 1972, AGR BIOL CHEM TOKYO, V36, P1719	12	8	9	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0907-4449			ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	FEB	1999	55		2				547	548		10.1107/S0907444998011809		2	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	165UU	WOS:000078540900032		
J	Shioda, T; Terasoma, T				Shioda, T; Terasoma, T			Existence of simple Jacobian varieties of genus g with rank at least 4g+5	AMERICAN JOURNAL OF MATHEMATICS			English	Article								We prove the existence of infinitely many curves of genus g over the rational number field which have absolutely simple Jacobian varieties with Mordell-Weil rank at least 4g + 5.	Rikkyo Univ, Dept Math, Tokyo 171, Japan; Univ Tokyo, Inst Math Sci, Tokyo, Japan	Shioda, T (reprint author), Rikkyo Univ, Dept Math, Tokyo 171, Japan.						SILVERMAN JH, 1983, J REINE ANGEW MATH, V342, P197; BLOCH S, 1985, ADV STUD PURE MATH, V10, P717; Hamm H. A., 1973, ANN SCIENT EC NORM S, V6, P317; Lang S., 1983, FUNDAMENTALS DIOPHAN; MORI S, 1977, JAPAN J MATH, V3, P105; SERRE JP, 1989, LECT MORDELLWEIL THE; Shioda T, 1998, AM J MATH, V120, P551, DOI 10.1353/ajm.1998.0025; TERASOMA T, 1985, MATH Z, V189, P289, DOI 10.1007/BF01175050; TSUYUMINE S, 1991, MATH Z, V207, P539, DOI 10.1007/BF02571407	9	0	0	JOHNS HOPKINS UNIV PRESS	BALTIMORE	JOURNALS PUBLISHING DIVISION, 2715 NORTH CHARLES ST, BALTIMORE, MD 21218-4319 USA	0002-9327			AM J MATH	Am. J. Math.	FEB	1999	121	1					65	72				8	Mathematics	Mathematics	163JH	WOS:000078401900004		
J	Nakada, M; Nakamura, H; Ikeda, E; Fujimoto, N; Yamashita, J; Sato, H; Seiki, M; Okada, Y				Nakada, M; Nakamura, H; Ikeda, E; Fujimoto, N; Yamashita, J; Sato, H; Seiki, M; Okada, Y			Expression and tissue localization of membrane-type 1, 2, and 3 matrix metallotoproteinases in human astrocytic tumors	AMERICAN JOURNAL OF PATHOLOGY			English	Article							HUMAN GASTRIC CARCINOMAS; GELATINASE-A; EXTRACELLULAR-MATRIX; MESSENGER-RNA; MT-MMP; DEGRADING ACTIVITY; GLIOMA INVASION; CDNA LIBRARY; IN-VITRO; METALLOPROTEINASE	Three different membrane-type matrix metalloproteinases (MT1-, MT2-, and MT3-MMPs) are known to activate in vitro the zymogen of MMP-2 (pro-MMP-2, progelatinase A), which is one of the key MMPs in invasion and metastasis of various cancers. In the present study, we have examined production and activation of pro-MMP-2, expression of MT1-, MT2-, and MT3-MMPs and their correlation with pro-MMP-2 activation, and localization of MMP-2, MT1-MMP, and MT2-MMP in human astrocytic tumors. The sandwich enzyme immunoassay demonstrates that the production levels of pro-MMP-2 in the anaplastic astrocytomas and glioblastomas are significantly higher than that in the low-grade astrocytomas (P < 0.05 and P < 0.01, respectively), metastatic brain tumors (P < 0.05), or normal brains (P < 0.01). Gelatin zymography indicates that the pro-MMP-2 activation ratio is significantly higher in the glioblastomas than in other astrocytic tumors (P < 0.01), metastatic brain tumors (P < 0.01), and normal brains (P < 0.01). The quantitative reverse transcription polymerase chain reaction analyses demonstrate that MT1-MMP and MT2-MMP are expressed predominantly in glioblastoma tissues (17/17 and 12/17 cases, respectively), and their expression levels increase significantly as tumor grade increases. MT3-MMP is detectable in both astrocytic tumor and normal brain tissues, but the mean expression level is approximately 50-fold lower compared with that of MT1-MMP and MT2-MMP in the glioblastomas, The activation ratio of pro-MMP-2 correlates directly with the expression levels of MT1-MMP and MT2-MMP but not MT3-MMP. In situ hybridization indicates that neoplastic astrocytes express MT1-MMP and MT2-MMP in the glioblastoma tissues (5/5 cases and 5/5 cases, respectively). Immunohistochemically, MT1-MMP and MT2-MMP are localized to the neoplastic astrocytes in glioblastoma samples (17/17 cases and 12/17 cases, respectively),which are also positive for MMP-2. In situ zymography shows gelatinolytic activity in the glioblastoma tissues but not in the normal brain tissues. These results suggest that both MT1-MMP and MT2-MMP play a key role in the activation of pro-MMP-2 in the human malignant astrocytic tumors and that the gelatinolytic activity is involved in the astrocytic tumor invasion.	Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1060016, Japan; Kanazawa Univ, Canc Res Inst, Dept Mol Immunol & Pathol, Kanazawa, Ishikawa 920, Japan; Kanazawa Univ, Canc Res Inst, Dept Virol & Oncol, Kanazawa, Ishikawa 920, Japan; Kanazawa Univ, Sch Med, Dept Neurosurg, Kanazawa, Ishikawa 920, Japan; Fuji Chem Ind Ltd, Biopharmaceut Dept, Takaoka, Toyama, Japan; Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Tokyo, Japan	Okada, Y (reprint author), Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1060016, Japan.		Nakamura, Hiroyuki DDS PhD/A-2953-2013; Okada, Yasunori/B-5550-2014; Seiki, Motoharu/K-9443-2015; SATO, Hiroshi/D-8454-2015	Okada, Yasunori/0000-0001-9208-4755; 			NOMURA H, 1995, CANCER RES, V55, P3263; Yamamoto M, 1996, CANCER RES, V56, P384; Ueno H, 1997, CANCER RES, V57, P2055; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; Ohuchi E, 1997, J BIOL CHEM, V272, P2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; TAKINO T, 1995, J BIOL CHEM, V270, P23013; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Nakagawa T, 1996, J NEURO-ONCOL, V28, P13, DOI 10.1007/BF00300442; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Nagase H, 1997, BIOL CHEM, V378, P151; TOKURAKU M, 1995, INT J CANCER, V64, P355, DOI 10.1002/ijc.2910640513; Nomura H, 1996, INT J CANCER, V69, P9, DOI 10.1002/(SICI)1097-0215(19960220)69:1<9::AID-IJC3>3.0.CO;2-8; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; AUTIOHARMAINEN H, 1993, LAB INVEST, V69, P312; Fishman DA, 1996, INVAS METAST, V16, P150; FUJIMOTO N, 1993, CLIN CHIM ACTA, V221, P91, DOI 10.1016/0009-8981(93)90024-X; Gilles C, 1996, INT J CANCER, V65, P209; Imai K, 1996, CANCER RES, V56, P2707; Kitagawa Y, 1998, J UROLOGY, V160, P1540, DOI 10.1016/S0022-5347(01)62609-0; Matsumoto SI, 1997, BBA-GENE STRUCT EXPR, V1354, P159, DOI 10.1016/S0167-4781(97)00120-6; Nagase H, 1997, TXB RHEUMATOLOGY, P323; OKADA Y, 1995, LAB INVEST, V72, P311; Pei DQ, 1996, J BIOL CHEM, V271, P9135; Puente XS, 1996, CANCER RES, V56, P944; RUSSEL DS, 1989, PATHOL TUMOURS NER, P834; Sawaya RE, 1996, CLIN EXP METASTAS, V14, P35, DOI 10.1007/BF00157684; Scheithauer BW, 1993, HISTOLOGICAL TYPING, P11; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Tanaka M, 1997, FEBS LETT, V402, P219, DOI 10.1016/S0014-5793(96)01537-2; Uhm JH, 1996, CLIN EXP METASTAS, V14, P421, DOI 10.1007/BF00128958; WILL H, 1995, EUR J BIOCHEM, V231, P602, DOI 10.1111/j.1432-1033.1995.0602d.x; YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112; Yoshizaki T, 1997, CANCER, V79, P139, DOI 10.1002/(SICI)1097-0142(19970101)79:1<139::AID-CNCR20>3.0.CO;2-4	35	154	157	AMER SOC INVESTIGATIVE PATHOLOGY, INC	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202-3993 USA	0002-9440			AM J PATHOL	Am. J. Pathol.	FEB	1999	154	2					417	428		10.1016/S0002-9440(10)65288-1		12	Pathology	Pathology	166KU	WOS:000078575900012		
J	Kataoka, H; Uchino, H; Iwamura, T; Seiki, M; Nabeshima, K; Koono, M				Kataoka, H; Uchino, H; Iwamura, T; Seiki, M; Nabeshima, K; Koono, M			Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of alpha 1-proteinase inhibitor generated by matrix metalloproteinases - A possible modulatory role in natural killer cytotoxicity	AMERICAN JOURNAL OF PATHOLOGY			English	Article							PROTEASE PROTECTION PEPTIDE; CARCINOMA CELL-LINES; IMMUNEDEFENSE SUPPRESSION; PROTEOLYTIC INACTIVATION; SEC RECEPTOR; PROGNOSTIC-SIGNIFICANCE; SCM-RECOGNITION; NUDE-MICE; MATRILYSIN; EXPRESSION	Matrix metalloproteinases (MMPs) are believed to contribute to the complex process of cancer progression. They also exhibit an alpha 1-proteinase inhibitor (alpha PI)-degrading activity generating a carboxyl-terminal fragment of similar to 5 kd (alpha PI-C). This study reports that overexpression of alpha PI-C in S2-020, a cloned subline derived from the human pancreas adenocarcinoma cell line SUIT-2, potentiates the growth capability of the cells in nude mice. After stable transfection of a vector containing a chimeric cDNA encoding a signal peptide sequence of tissue inhibitor of metalloproteinase-1 followed by cDNA for alpha PI-C into S2-020 cells, three clones that stably secrete alpha PI-C were obtained. The ectopic expression of alpha PI-C did not alter in vitro cellular growth. However, subcutaneous injection of the alpha PI-C-secreting clones resulted in tumors that mere 1.5 to 3-fold larger than those of control clones with an increased tendency to invasiveness and lymph node metastasis. These effects could be a result of modulation of natural killer (NK) cell-mediated control of tumor growth in nude mice, as the growth advantage of alpha PI-C-secreting clones was not observed in NK-depleted mice, and alpha PI-C-secreting clones showed decreased NK sensitivity ta vitro. In addition, production of alpha PI and generation of the cleaved form of alpha PI by MMP mere observed in various human tumor cell lines and in a highly metastatic subline of SUIT-2 in vitro. These results provide experimental evidence that the alpha PI-degrading activity of MMPs may play a role in tumor progression not only via the inactivation of alpha PI but also via the generation of alpha PI-C.	Miyazaki Med Coll, Dept Pathol 2, Miyazaki 8891692, Japan; Miyazaki Med Coll, Dept Surg 2, Miyazaki 8891692, Japan; Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Tokyo, Japan	Koono, M (reprint author), Miyazaki Med Coll, Dept Pathol 2, 5200 Kihara, Miyazaki 8891692, Japan.		Seiki, Motoharu/K-9443-2015				HIGASHIYAMA M, 1992, BRIT J CANCER, V65, P300, DOI 10.1038/bjc.1992.60; Ahmad A, 1998, AM J PATHOL, V152, P721; PEI DQ, 1994, J BIOL CHEM, V269, P25849; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; JOSLIN G, 1992, J CLIN INVEST, V90, P1150, DOI 10.1172/JCI115934; IWAMURA T, 1992, J GASTROEN HEPATOL, V7, P512, DOI 10.1111/j.1440-1746.1992.tb01030.x; HABU S, 1981, J IMMUNOL, V127, P34; MULLER D, 1993, CANCER RES, V53, P165; ADES EW, 1982, SCAND J IMMUNOL, V15, P109, DOI 10.1111/j.1365-3083.1982.tb00628.x; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Brittenden J, 1996, CANCER, V77, P1226, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G; Allgayer H, 1998, CLIN EXP METASTAS, V16, P62; MCDONNELL S, 1991, MOL CARCINOGEN, V4, P527, DOI 10.1002/mc.2940040617; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; ARORA PK, 1978, NATURE, V274, P589, DOI 10.1038/274589a0; BASSET P, 1990, NATURE, V348, P699, DOI 10.1038/348699a0; Bolon I, 1997, AM J PATHOL, V150, P1619; CERCEK L, 1992, CANCER DETECT PREV, V16, P305; CERCEK L, 1995, CANCER DETECT PREV, V19, P325; CERCEK L, 1981, EUR J CANCER, V17, P167, DOI 10.1016/0014-2964(81)90032-3; CERCEK L, 1993, CANCER DETECT PREV, V17, P433; CERCEK L, 1975, BRIT J CANCER, V31, P252, DOI 10.1038/bjc.1975.33; DESROCHERS PE, 1991, J CLIN INVEST, V87, P2258, DOI 10.1172/JCI115262; Ishihara S, 1996, MICROBIOL IMMUNOL, V40, P39; Joslin G, 1991, J BIOL CHEM, V266, P11281; KARASHIMA S, 1990, INT J CANCER, V45, P244, DOI 10.1002/ijc.2910450207; KATAOKA H, 1993, FEBS LETT, V328, P291, DOI 10.1016/0014-5793(93)80946-R; KATAOKA H, 1989, VIRCHOWS ARCH B, V57, P157, DOI 10.1007/BF02899077; KATAOKA H, 1995, INT J CANCER, V60, P123, DOI 10.1002/ijc.2910600118; Kataoka H, 1997, ONCOL RES, V9, P101; Keppler D, 1996, BIOL CHEM H-S, V377, P301, DOI 10.1515/bchm3.1996.377.5.301; Knox JD, 1996, MOL CARCINOGEN, V15, P57; LAINE A, 1990, CLIN CHIM ACTA, V190, P163, DOI 10.1016/0009-8981(90)90170-W; MALLYA SK, 1994, ANN NY ACAD SCI, V732, P303, DOI 10.1111/j.1749-6632.1994.tb24745.x; Noel AC, 1996, J CLIN INVEST, V97, P1924, DOI 10.1172/JCI118624; PERIMUTTER DH, 1990, P NATL ACAD SCI USA, V87, P3753; PERLMUTTER DH, 1994, PEDIATR RES, V36, P271, DOI 10.1203/00006450-199409000-00001; SIRES UI, 1994, BIOCHEM BIOPH RES CO, V204, P613, DOI 10.1006/bbrc.1994.2503; StetlerStevenson WG, 1996, SEMIN CANCER BIOL, V7, P147, DOI 10.1006/scbi.1996.0020; TAHARA E, 1984, HUM PATHOL, V15, P957, DOI 10.1016/S0046-8177(84)80125-2; TAKENOUCHI T, 1995, PEPTIDES, V16, P1019, DOI 10.1016/0196-9781(95)00084-W; TANIGUCHI S, 1992, CLIN EXP METASTAS, V10, P259; WINYARD PG, 1991, FEBS LETT, V279, P91, DOI 10.1016/0014-5793(91)80258-5; WITTY JP, 1994, CANCER RES, V54, P4805; ZHANG Z, 1994, BBA-GEN SUBJECTS, V1199, P224, DOI 10.1016/0304-4165(94)90119-8	45	51	51	AMER SOC INVESTIGATIVE PATHOLOGY, INC	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202-3993 USA	0002-9440			AM J PATHOL	Am. J. Pathol.	FEB	1999	154	2					457	468		10.1016/S0002-9440(10)65292-3		12	Pathology	Pathology	166KU	WOS:000078575900016		
J	Hamai, Y; Fujii, T; Yamashita, T; Miki, A; Hyodo, H; Kozuma, S; Geraghty, DE; Taketani, Y				Hamai, Y; Fujii, T; Yamashita, T; Miki, A; Hyodo, H; Kozuma, S; Geraghty, DE; Taketani, Y			The expression of human leukocyte antigen-G on trophoblasts abolishes the growth-suppressing effect of interleukin-2 towards them	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						cell growth; human leukocyte antigen-G; interleukin-2; interleukin-2 receptor; preeclampsia; trophoblast	HLA-G; CLASS-I; RETROVIRAL VECTORS; GENE-TRANSFER; PREECLAMPSIA; CELLS; ASSOCIATION; RECEPTORS	PROBLEM: We have shown the attenuated human leukocyte antigen (HLA)-G expression on trophoblasts and an aberrant expression of interleukin (IL)-2, a cytotoxic cytokine, in decidual tissue in preeclampsia, where deteriorated trophoblastic invasion into decidual layers may constitute a crucial pathogenesis. We hypothesized that the absence of HLA-G might make trophoblasts susceptible to compromise by IL-2. METHOD OF STUDY: We analyzed the growth of HLA-G-negative and -positive cell lines, all of which possessed IL-2 receptors, in the culture with or without IL-2 supplementation. RESULTS: The proliferation of HLA-G-positive trophoblastic cell lines (BeWo and JEG-3) was not influenced by the addition of IL-2, whereas a HLA-G-negative trophoblastic eel line (JAR) exhibited significantly decreased proliferation when cultured with IL-2. Interestingly, the transfection of JAR cells with HLA-G completely eliminates the growth-inhibitory effect of IL-2. CONCLUSION: The expression of HLA-G may commit trophoblasts to evade cell damage by IL-2, which may be relevant to maternal tolerance of the fetus during pregnancy and its derangement as exemplified by preeclampsia.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Fujii, T (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Yang YP, 1996, J IMMUNOL, V156, P4224; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; ROBERTSON WB, 1986, AM J OBSTET GYNECOL, V155, P401; Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P89; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Maejima M, 1997, AM J REPROD IMMUNOL, V38, P79; ISHITANI A, 1992, P NATL ACAD SCI USA, V89, P3947, DOI 10.1073/pnas.89.9.3947; Hara N, 1996, AM J REPROD IMMUNOL, V36, P349; ELLIS SA, 1990, J IMMUNOL, V144, P731; FUJII T, 1994, J IMMUNOL, V153, P5516; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Hamai Y, 1997, AM J REPROD IMMUNOL, V38, P83; HARA N, 1995, AM J REPROD IMMUNOL, V34, P44; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; Lim KJH, 1998, MOL HUM REPROD, V4, P77, DOI 10.1093/molehr/4.1.77; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MILLER AD, 1993, METHOD ENZYMOL, V217, P581; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; SHARON M, 1988, J IMMUNOL, V141, P3512; TROWSDALE J, 1980, J EXP MED, V152, P11; Yamashita T, 1996, IMMUNOGENETICS, V44, P186, DOI 10.1007/s002510050110; YASUMURA S, 1994, INT J CANCER, V59, P225, DOI 10.1002/ijc.2910590215	23	22	27	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	8755-8920			AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	FEB	1999	41	2					153	158				6	Immunology; Reproductive Biology	Immunology; Reproductive Biology	175HG	WOS:000079086900005		
J	Yamashita, T; Fujii, T; Tokunaga, K; Tadokoro, K; Hamai, Y; Miki, A; Kozuma, S; Juji, T; Taketani, Y				Yamashita, T; Fujii, T; Tokunaga, K; Tadokoro, K; Hamai, Y; Miki, A; Kozuma, S; Juji, T; Taketani, Y			Analysis of human leukocyte antigen-G polymorphism including intron 4 in Japanese couples with habitual abortion	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						habitual abortion; human leukocyte antigen-G; polymerase chain reaction; polymorphism; single-strand conformation polymorphism	RECURRENT SPONTANEOUS-ABORTION; HLA-G GENE; MISCARRIAGE; POPULATION; CYTOKINES	PROBLEM: The purpose of this study was to clarify whether there is a difference between the allele frequency of human leukocyte antigen (HLA)-G in healthy Japanese people and that of Japanese couples with habitual abortion. METHOD OF STUDY: Exons 2, 3, 4, and intron 4 of the HLA-G gene were analyzed in 20 couples with habitual abortion, using polymerase chain reaction (PCR)-single-strand conformation polymorphism (SSCP) analysis. Intron 3 of the HLA-G gene was also analyzed in 54 healthy individuals. The nucleotide sequence of the PCR product of intron 4 was further determined by direct sequencing. RESULTS: Two kinds of nucleotide sequence were identified in intron 4 of the HLA-G gene, one of which was identical to that of HLA-G*01011, and the other was identical to that of HLA-G*01012, G*01013, and G*0104. The frequency of each allele in affected women and their husbands did not significantly differ from that of healthy individuals, and no mutation was found in any affected couple. CONCLUSION: HLA-G allelic abnormality seemed to have little, if any, implication in the pathogenesis of habitual abortion.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Dept Human Genet, Sch Int Hlth, Tokyo, Japan; Japanese Red Cross, Cent Blood Ctr, Dept Res, Tokyo, Japan	Fujii, T (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						HILL JA, 1995, JAMA-J AM MED ASSOC, V273, P1933, DOI 10.1001/jama.273.24.1933; Lim KJH, 1996, HUM REPROD UPDATE, V2, P469, DOI 10.1093/humupd/2.6.469; FUJII T, 1994, J IMMUNOL, V153, P5516; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; Raghupathy R, 1997, AM J REPROD IMMUNOL, V37, P478; BANNAI M, 1994, EUR J IMMUNOGENET, V21, P1, DOI 10.1111/j.1744-313X.1994.tb00170.x; Bodmer JG, 1997, TISSUE ANTIGENS, V49, P297, DOI 10.1111/j.1399-0039.1997.tb02759.x; Christiansen OB, 1996, HUM REPROD UPDATE, V2, P271, DOI 10.1093/humupd/2.4.271; Hamai Y, 1998, AM J REPROD IMMUNOL, V40, P63; HIGUCHI K, 1995, AM J REPROD IMMUNOL, V33, P221; Hviid TVF, 1997, J REPROD IMMUNOL, V35, P31; Karhukorpi J, 1997, BRIT J OBSTET GYNAEC, V104, P1212, DOI 10.1111/j.1471-0528.1997.tb10951.x; Ober C, 1997, J REPROD IMMUNOL, V36, P1, DOI 10.1016/S0165-0378(97)00062-4; Ober C, 1996, J REPROD IMMUNOL, V32, P111, DOI 10.1016/S0165-0378(96)01000-5; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Sambrook J., 1989, MOL CLONING LAB MANU; Shaarawy M, 1997, ACTA OBSTET GYN SCAN, V76, P205, DOI 10.1111/j.1600-0412.1997.tb07846.x; Suarez MB, 1997, IMMUNOGENETICS, V45, P464, DOI 10.1007/s002510050235; VANDERVEN K, 1994, J IMMUNOL, V153, P5628; Yamashita T, 1996, IMMUNOGENETICS, V44, P186, DOI 10.1007/s002510050110; Yamashita T, 1997, TISSUE ANTIGENS, V49, P673, DOI 10.1111/j.1399-0039.1997.tb02823.x	21	30	34	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	8755-8920			AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	FEB	1999	41	2					159	163				5	Immunology; Reproductive Biology	Immunology; Reproductive Biology	175HG	WOS:000079086900006		
J	Hosoi, Y; Yasuhara, H; Shigematsu, H; Komiyama, T; Onozuka, A; Muto, T				Hosoi, Y; Yasuhara, H; Shigematsu, H; Komiyama, T; Onozuka, A; Muto, T			Influence of popliteal vein thrombosis on subsequent ambulatory venous function measured by near infrared spectroscopy	AMERICAN JOURNAL OF SURGERY			English	Article							POSTTHROMBOTIC-SYNDROME; VALVULAR INCOMPETENCE; FOLLOW-UP; POSTPHLEBITIC SYNDROME; REFLUX; ULCERATION; SEQUELAE; INSUFFICIENCY; DISEASE; LYSIS	BACKGROUND: TO determine the influence of the site affected by thrombi on the subsequent venous physiology, we examined patients with postthrombotic syndrome (PTS) with respect to ambulatory venous function using near-infrared spectroscopy (NIRS). METHODS: Fifty-one limbs of 45 patients, for whom more than 1 year had passed since an acute episode of deep vein thrombosis, were studied. Seventeen limbs were asymptomatic, 27 had mild symptoms (edema only), and 7 showed severe symptoms (skin changes). The mean duration of PTS was 8.2 years. All of the patients underwent a treadmill walking test with simultaneous NIRS. Deoxygenated hemoglobin was continuously measured during exercise. The ambulatory venous retention index (AVRI) obtained from the serial deoxygenated hemoglobin changes was calculated in each patient. The location of thrombi at the onset of deep vein thrombosis was identified by venography. RESULTS: The calculated AVRI was apparently related to the clinical symptoms of PTS. The limbs initially involved with popliteal vein thrombosis showed significantly higher AVRI values than those without popliteal vein thrombosis. CONCLUSIONS: The clinical severity of PTS is correlated well with the degree of venous retention during exercise, Initial involvement of the popliteal vein is an important factor determining subsequent venous hemodynamics in patients with PTS. (C) 1999 by Excerpta Medica, Inc.	Univ Tokyo, Dept Surg, Div Vasc Surg, Tokyo, Japan	Hosoi, Y (reprint author), Univ Tokyo, Dept Surg 1, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ODONNELL TF, 1977, J SURG RES, V22, P483, DOI 10.1016/0022-4804(77)90030-0; Franzeck UK, 1996, CIRCULATION, V93, P74; SHULL KC, 1979, ARCH SURG-CHICAGO, V114, P1304; MEISSNER MH, 1993, J VASC SURG, V18, P596; MEISSNER MH, 1995, J VASC SURG, V22, P558, DOI 10.1016/S0741-5214(95)70038-2; PORTER JM, 1995, J VASC SURG, V21, P635, DOI 10.1016/S0741-5214(95)70195-8; WELKIE JF, 1992, J VASC SURG, V16, P733; HARADA RN, 1995, J VASC SURG, V22, P532, DOI 10.1016/S0741-5214(95)70033-1; LABROPOULOS N, 1994, J VASC SURG, V20, P20; [Anonymous], 1989, J VASC SURG; COMEROTA AJ, 1995, INT ANGIOL, V14, P45; BAUER G, 1942, ACTA CHIR SCAND S74, V86, P1; Brittenden J, 1998, BRIT J SURG, V85, P60; GOOLEY NA, 1988, J VASC SURG, V7, P50, DOI 10.1067/mva.1988.avs0070050; HANRAHAN LM, 1991, J VASC SURG, V13, P805; Hosoi Y, 1997, J VASC SURG, V26, P53, DOI 10.1016/S0741-5214(97)70147-2; JOHNSON BF, 1995, J VASC SURG, V21, P307, DOI 10.1016/S0741-5214(95)70271-7; KAKKAR VV, 1985, AM J SURG, V150, P54; KILLEWICH LA, 1985, ARCH SURG-CHICAGO, V120, P424; LINDNER DJ, 1986, J VASC SURG, V4, P436, DOI 10.1067/mva.1986.avs0040436; MARKEL A, 1992, J VASC SURG, V15, P377; MONREAL M, 1993, J INTERN MED, V233, P233; MOORE DJ, 1986, J VASC SURG, V3, P49; ODONNELL TF, 1987, ARCH SURG-CHICAGO, V122, P474; SCHMIDT C, 1987, INT ANGIOL, V6, P187; STRANDNESS DE, 1983, JAMA-J AM MED ASSOC, V250, P1289, DOI 10.1001/jama.250.10.1289; VANRAMSHORST B, 1994, J VASC SURG, V20, P1059	27	11	11	CAHNERS PUBL CO	NEW YORK	249 WEST 17 STREET, NEW YORK, NY 10011 USA	0002-9610			AM J SURG	Am. J. Surg.	FEB	1999	177	2					111	116		10.1016/S0002-9610(98)00314-6		6	Surgery	Surgery	178VM	WOS:000079289900004		
J	Nishiyama, T; Hanaoka, K				Nishiyama, T; Hanaoka, K			Anesthesia induction with the combination of midazolam and barbiturate: Changes of heart rate variability	ANESTHESIA AND ANALGESIA			English	Meeting Abstract									Univ Tokyo, Dept Anesthesiol, Tokyo, Japan							PAGANI M, 1986, CIRC RES, V59, P178; Nishiyama T, 1996, CAN J ANAESTH, V43, P1134; 1989, AM J PHYSL, V256, pH1573; 1994, JPN J ANESTHESIOL, V43, P818	4	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	FEB	1999	88	2		S		S22						1	Anesthesiology	Anesthesiology	165EN	WOS:000078507400023		
J	Eguchi, T; Harii, K; Sugawara, Y				Eguchi, T; Harii, K; Sugawara, Y			Repair of a large "coup de sabre" with soft-tissue expansion and artificial bone graft	ANNALS OF PLASTIC SURGERY			English	Article								The authors present a case of a "coup de sabre"-a linear form of scleroderma-in an 18-year-old woman treated by means of an expanded forehead and scalp flap, a hydroxyapatite implant, and an autologous iliac bone graft. Hydroxyapatite was implanted to augment a depressive bony deformity. The nasal deformity was repaired with an expanded forehead flap and an autologous iliac bone graft. This is the first reported case in which a deformity of scleroderma was treated with a combination of an expanded skin flap and a hydroxyapatite implant.	Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan	Eguchi, T (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						APESOS J, 1993, ANN PLAS SURG, V30, P411, DOI 10.1097/00000637-199305000-00004; CRAMER LM, 1961, PLAST RECONSTR SURG, V28, P166; CRIKELAIR G F, 1962, Plast Reconstr Surg Transplant Bull, V29, P5, DOI 10.1097/00006534-196201000-00002; DILLEY JJ, 1968, ARCH DERMATOL, V97, P688, DOI 10.1001/archderm.97.6.688; KIYOKAWA K, 1997, J JPN PLAST RECONSTR, V17, P822; LEVER WF, 1983, HISTOPATHOLOGY SKIN, P461; LOSKEN HW, 1973, PLAST RECONSTR SURG, V51, P212, DOI 10.1097/00006534-197302000-00038; NAKAHARA M, 1991, BRIT J PLAST SURG, V44, P575, DOI 10.1016/0007-1226(91)90092-X; SALYER KE, 1989, PLAST RECONSTR SURG, V84, P236, DOI 10.1097/00006534-198908000-00008; Sengezer M, 1996, ANN PLAS SURG, V37, P428, DOI 10.1097/00000637-199610000-00015	10	15	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043			ANN PLAS SURG	Ann. Plast. Surg.	FEB	1999	42	2					207	210				4	Surgery	Surgery	165LG	WOS:000078521800019		
J	Shinzato, N; Matsumoto, T; Yamaoka, I; Oshima, T; Yamagishi, A				Shinzato, N; Matsumoto, T; Yamaoka, I; Oshima, T; Yamagishi, A			Phylogenetic diversity of symbiotic methanogens living in the hindgut of the lower termite Reticulitermes speratus analyzed by PCR and in situ hybridization	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							ARCHAEA	A phylogenetic analysis of the sequences of 60 clones of archaeal small-subunit rRNA genes amplified from the termite Reticulitermes speratus revealed that most of them (56 clones) clustered in the genus Methanobrevibacter. Three clones were classified in the order Thermoplasmales. The Methanobrevibacter-related symbionts were detected by in situ hybridization analysis.	Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, Tokyo 1920392, Japan; Univ Tokyo, Sch Arts & Sci, Dept Biol, Meguro Ku, Tokyo 1530041, Japan; Yamaguchi Univ, Fac Sci, Inst Biol, Yamaguchi 7530841, Japan	Shinzato, N (reprint author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Dept Mol Biol, 1432-1 Horinouchi, Tokyo 1920392, Japan.	shinzato@nibh.go.jp					DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; DELONG EF, 1994, NATURE, V371, P695, DOI 10.1038/371695a0; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Leadbetter JR, 1996, APPL ENVIRON MICROB, V62, P3620; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; MESSER AC, 1989, MICROBIAL ECOL, V18, P275, DOI 10.1007/BF02075814; OBRIEN RW, 1982, AUST J BIOL SCI, V35, P239; OHKUMA M, 1995, FEMS MICROBIOL LETT, V134, P45, DOI 10.1111/j.1574-6968.1995.tb07912.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sambrook J., 1989, MOL CLONING LAB MANU; SHINZATO N, 1993, ENDOCYTOBIOLOGY, V5, P161; Stahl D. A., 1995, P111	14	52	53	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0099-2240			APPL ENVIRON MICROB	Appl. Environ. Microbiol.	FEB	1999	65	2					837	840				4	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	165AC	WOS:000078495200072		
J	Zhu, CX; Misawa, S; Tsukahara, S; Kawazu, A; Pang, SJ				Zhu, CX; Misawa, S; Tsukahara, S; Kawazu, A; Pang, SJ			Adsorption and growth of Al on Si(100) in the initial stage	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							SCANNING-TUNNELING-MICROSCOPY; LOW-COVERAGE PHASES; ELECTRONIC-STRUCTURE; SURFACE-STRUCTURES; ROOM-TEMPERATURE; ALUMINUM; SI(111); RECONSTRUCTION; SPECTROSCOPY; SINGLE	The adsorption structures and growth of Al on Si(100) have been intensively studied using scanning tunneling microscope (STM). The high-resolution STM images are presented to demonstrate that the Al-adsorbed Si(100) surface is accurately described by the parallel-dimer model, The structures at the ends of Al dimer rows are further discussed by means of the illustration of STM images taken from the occupied and unoccupied electronic state surfaces. The dimer termination is confirmed to be a stable structure at the end of an Al dimer row. Moreover, the growth behavior of Al on the Si(100) surface with coverages over 0.5 monolayer (ML) are also investigated on the basis of STM observations as a function of the Al coverage up to 1.4 ML. The STM images reveal that once a well-ordered Al 2 x 2 adlayer is formed at 0.5 ML, further deposition of Al results in the disappearance of the Al 2 x 2 phase without disruption of the Si 2 x 1 reconstruction.	Chinese Acad Sci, Beijing Lab Vacuum Phys, Beijing 100080, Peoples R China; Ulvac Japan Ltd, Tsukuba Inst Super Mat, Tsukuba, Ibaraki 30026, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan	Zhu, CX (reprint author), Chinese Acad Sci, Beijing Lab Vacuum Phys, POB 2724, Beijing 100080, Peoples R China.						AIZAWA T, 1987, PHYS REV B, V36, P9107, DOI 10.1103/PhysRevB.36.9107; NOGAMI J, 1991, PHYS REV B, V44, P1415, DOI 10.1103/PhysRevB.44.1415; LANDER JJ, 1964, SURF SCI, V2, P553, DOI 10.1016/0039-6028(64)90099-8; HAMERS RJ, 1989, J VAC SCI TECHNOL A, V7, P2854, DOI 10.1116/1.576158; APPELBAUM JA, 1976, PHYS REV B, V14, P588, DOI 10.1103/PhysRevB.14.588; BRILLSON LJ, 1984, J VAC SCI TECHNOL A, V2, P551, DOI 10.1116/1.572443; BROCKS G, 1993, PHYS REV LETT, V70, P2786, DOI 10.1103/PhysRevLett.70.2786; BROCKS G, 1994, J VAC SCI TECHNOL B, V12, P2705, DOI 10.1116/1.587235; HAMERS RJ, 1989, PHYS REV B, V40, P1657, DOI 10.1103/PhysRevB.40.1657; HASAN MA, 1990, SURF SCI, V236, P53, DOI 10.1016/0039-6028(90)90761-V; IDE T, 1989, SURF SCI, V209, P335, DOI 10.1016/0039-6028(89)90079-4; ITOH H, 1994, SURF SCI, V302, P295, DOI 10.1016/0039-6028(94)90834-6; ITOH H, 1993, PHYS REV B, V48, P14663, DOI 10.1103/PhysRevB.48.14663; MURAKAMI K, 1992, APPL SURF SCI, V60-1, P146, DOI 10.1016/0169-4332(92)90408-P; NORTHRUP JE, 1984, PHYS REV LETT, V53, P683, DOI 10.1103/PhysRevLett.53.683; NORTHRUP JE, 1991, PHYS REV B, V44, P13799, DOI 10.1103/PhysRevB.44.13799; QIAN Y, 1994, PHYS REV LETT, V73, P1521, DOI 10.1103/PhysRevLett.73.1521; SAGAWA T, 1985, PHYS REV B, V32, P2714; SAKURAI T, 1990, J VAC SCI TECHNOL A, V8, P324, DOI 10.1116/1.577098; STEELE BE, 1993, PHYS REV B, V47, P9925, DOI 10.1103/PhysRevB.47.9925; UHRBERG RIG, 1985, PHYS REV B, V31, P3805, DOI 10.1103/PhysRevB.31.3805; YEOM HW, 1995, SURF SCI, V341, P328, DOI 10.1016/0039-6028(95)00688-5	22	6	6	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0947-8396			APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	FEB	1999	68	2					145	151		10.1007/s003390050869		7	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	162MF	WOS:000078350100005		
J	Togashi, T; Nabekawa, Y; Sekikawa, T; Watanabe, S				Togashi, T; Nabekawa, Y; Sekikawa, T; Watanabe, S			High-peak-power femtosecond Cr : forsterite laser system	APPLIED PHYSICS B-LASERS AND OPTICS			English	Article							CHROMIUM-DOPED FORSTERITE; UP-CONVERTED LUMINESCENCE; POCKELS CELL; 5 FS; PULSES; GENERATION; AMPLIFICATION; COMPRESSION; SPECTROSCOPY; PERFORMANCE	We have developed a high-peak-power Cr:forsterite laser based on a regenerative amplifier. The output energy was 0.4 mJ with a pulse duration of 77 fs at a 10 Hz repetition ratio, resulting in a peak power of 5.2 GW, which as far as we know is the highest power ever obtained from Cr:forsterite laser. To switch the regenerative amplifier rapidly, we developed a Pockels cell driver based on fast high-voltage transistor switches. We also investigated the effects of excited-state absorption on the gain numerically and experimentally. The way to optimize the regenerative amplifier is indicated by the analytical results obtained using a model including absorption in the crystal and excited-state absorption.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Togashi, T (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1068666, Japan.		sekikawa, taro/A-5211-2012				Zhang ZG, 1997, IEEE J QUANTUM ELECT, V33, P1975; Chambaret JP, 1996, OPT LETT, V21, P1921, DOI 10.1364/OL.21.001921; FRANTZ LM, 1963, J APPL PHYS, V34, P2346, DOI 10.1063/1.1702744; Nisoli M, 1997, OPT LETT, V22, P522, DOI 10.1364/OL.22.000522; STRICKLAND D, 1985, OPT COMMUN, V56, P219, DOI 10.1016/0030-4018(85)90120-8; Baltuska A, 1997, OPT LETT, V22, P102, DOI 10.1364/OL.22.000102; Backus S, 1997, OPT LETT, V22, P1256, DOI 10.1364/OL.22.001256; BADO P, 1985, REV SCI INSTRUM, V56, P1744, DOI 10.1063/1.1138086; BECKER K, 1994, REV SCI INSTRUM, V65, P1496, DOI 10.1063/1.1144881; Boyer GR, 1997, OPT COMMUN, V133, P205, DOI 10.1016/S0030-4018(96)00427-0; CARRIG TJ, 1991, OPT LETT, V16, P1662, DOI 10.1364/OL.16.001662; DAVIS SJ, 1978, APPL OPTICS, V17, P3184, DOI 10.1364/AO.17.003184; DEMOS SG, 1992, PHYS REV B, V46, P8811, DOI 10.1103/PhysRevB.46.8811; DEMOS SG, 1993, OPT LETT, V18, P522, DOI 10.1364/OL.18.000522; DEMOS SG, 1995, PHYS REV B, V52, P1544, DOI 10.1103/PhysRevB.52.1544; EVANS JM, 1996, CLEO 96, V9, P127; Fujii T, 1996, IEEE J QUANTUM ELECT, V32, P1497, DOI 10.1109/3.511563; Itatani J, 1997, OPT COMMUN, V134, P134, DOI 10.1016/S0030-4018(96)00588-3; MATSUSHIMA I, 1981, REV SCI INSTRUM, V52, P1860, DOI 10.1063/1.1136528; McKinnie IT, 1996, APPL OPTICS, V35, P4159, DOI 10.1364/AO.35.004159; McKinnie IT, 1997, OPT COMMUN, V141, P157, DOI 10.1016/S0030-4018(97)00243-5; McKinnie IT, 1996, OPT COMMUN, V129, P49, DOI 10.1016/0030-4018(96)00094-6; ONISHCHUKOV G, 1993, OPT COMMUN, V100, P137, DOI 10.1016/0030-4018(93)90569-Q; PANG Y, 1993, OPT LETT, V18, P1168, DOI 10.1364/OL.18.001168; PETRICEVIC V, 1988, APPL PHYS LETT, V53, P2590; PETRICEVIC V, 1988, APPL PHYS LETT, V52, P1040; PETRICEVIC V, 1989, OPT LETT, V14, P612, DOI 10.1364/OL.14.000612; SEAS A, 1992, OPT LETT, V17, P937, DOI 10.1364/OL.17.000937; SEAS A, 1993, OPT LETT, V18, P891, DOI 10.1364/OL.18.000891; SENNAROGLU A, 1994, IEEE J QUANTUM ELECT, V30, P1851, DOI 10.1109/3.301649; SQUIER J, 1993, OPT LETT, V18, P625, DOI 10.1364/OL.18.000625; STROHKENDL FP, 1994, J OPT SOC AM B, V11, P742, DOI 10.1364/JOSAB.11.000742; TILLEMAN MM, 1987, APPL PHYS LETT, V50, P121, DOI 10.1063/1.97690; VERDUN HR, 1988, APPL PHYS LETT, V53, P2593, DOI 10.1063/1.100537	34	12	12	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0946-2171			APPL PHYS B-LASERS O	Appl. Phys. B-Lasers Opt.	FEB	1999	68	2					169	175		10.1007/s003400050602		7	Optics; Physics, Applied	Optics; Physics	162MD	WOS:000078349900003		
J	Yoon, JW; Miyayama, M				Yoon, JW; Miyayama, M			Formation of n-p-n structure on an insulating SrTiO3 single crystal using excimer laser irradiation	APPLIED PHYSICS LETTERS			English	Article							TITANATE THIN-FILMS; ELECTRICAL-PROPERTIES; STRONTIUM-TITANATE; LAYER CAPACITORS; BARIUM-TITANATE; CHEMISTRY	An n-p-n semiconducting structure, similar to a p-type grain boundary between n-type grains in ceramics, was realized on an insulating SrTiO3 single crystal by using CuO diffusion and KrF excimer laser irradiation. P- and n-type semiconductivity was confirmed by Hall coefficient measurements for the laser-irradiated surface with and without CuO diffusion, respectively. Laser irradiation on the surface including a CuO-diffused line (1 mu m width) gave an n-p-n structure, which showed nonlinear I-V characteristics with a nonlinear coefficient of 7. The present fabrication process is suggested to be effective for developing new oxide microelectronic devices as well as for fundamental study on grain-boundary functions of semiconducting ceramics. (C) 1999 American Institute of Physics. [S0003-6951(99)03805-X].	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Yoon, JW (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						KOFFYBERG FP, 1982, J APPL PHYS, V53, P1173, DOI 10.1063/1.330567; WASER R, 1991, J AM CERAM SOC, V74, P1934, DOI 10.1111/j.1151-2916.1991.tb07812.x; CHIANG YM, 1990, J AM CERAM SOC, V73, P3278, DOI 10.1111/j.1151-2916.1990.tb06450.x; FUJIMOTO M, 1985, J AM CERAM SOC, V68, P169, DOI 10.1111/j.1151-2916.1985.tb15292.x; DAVIS GM, 1989, APPL PHYS LETT, V55, P112, DOI 10.1063/1.102393; DijIckamp D., 1987, APPL PHYS LETT, V51, P619; Frederikse H. P. R., 1964, PHYS REV A, V134, P442; FUJIMOTO M, 1985, J AM CERAM SOC, V68, pC300; IGARASHI K, 1989, J AM CERAM SOC, V72, P2367, DOI 10.1111/j.1151-2916.1989.tb06092.x; MAFFEI N, 1992, APPL PHYS LETT, V60, P781, DOI 10.1063/1.106518; ROY D, 1992, APPL PHYS LETT, V61, P2057, DOI 10.1063/1.108305; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; WAKU S, 1971, REV ELEC COMMUN LAB, V19, P665; WERNICKE R, 1981, ADV CERAMICS; YOON JW, IN PRESS JPN J APPL; YOON JW, 1988, ELECTROCERAMICS JAPA	16	2	2	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	FEB 1	1999	74	5					738	740		10.1063/1.123108		3	Physics, Applied	Physics	163AG	WOS:000078379600036		
J	Fukui, K; Onishi, H; Iwasawa, Y				Fukui, K; Onishi, H; Iwasawa, Y			Imaging of atomic-scale structure of oxide surfaces and adsorbed molecules by noncontact atomic force microscopy	APPLIED SURFACE SCIENCE			English	Article; Proceedings Paper	1st International Workshop on Noncontact Atomic Force Microscopy (NC-AFM 98)	JUL 21-23, 1998	OSAKA UNIV, OSAKA, JAPAN		OSAKA UNIV	noncontact AFM; TiO2(110); atom-resolved images; adsorbed carboxylates	TIO2(110) SURFACE; DIFFRACTION; ADSORPTION; RESOLUTION; FORMATE; IMAGES	Atom-resolved images of a TiO2(110)-(1 x 1) surface and individual formate and acetate ions adsorbed on the surface were obtained by noncontact atomic force microscopy (NC-AFM) in ultrahigh vacuum. In contrast to previous scanning tunneling microscopic studies imaging five-fold coordinated Ti atoms, outermost atoms of bridge-bound oxygen ridges of the surface were resolved as protruding rows by NC-AFM. High-resolution image of the surface revealed that the bridging oxygen atoms on terraces ordered in a (1 X 1) periodicity. Randomly distributed point and multiple defects of oxygen atoms were also imaged as dark spots. The (2 X I) overlayer of formate and acetate ions were resolved as ordered bright spots. Dispersed formate ions at a low coverage were also observed as bright spots between the bridging oxygen ridges along the [001] direction. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan	Iwasawa, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	iwasawa@chem.s.u-tokyo.ac.jp	Fukui, Ken-ichi/E-1455-2011				OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451; Fukui K, 1997, CHEM PHYS LETT, V280, P296, DOI 10.1016/S0009-2614(97)01143-3; ABRAHAM FF, 1989, SURF SCI, V209, pL125, DOI 10.1016/0039-6028(89)90053-8; Onishi H, 1996, PHYS REV LETT, V76, P791, DOI 10.1103/PhysRevLett.76.791; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; RAMAMOORTHY M, 1994, PHYS REV B, V49, P16721, DOI 10.1103/PhysRevB.49.16721; Diebold U, 1996, PHYS REV LETT, V77, P1322, DOI 10.1103/PhysRevLett.77.1322; KURTZ RL, 1989, SURF SCI, V218, P178, DOI 10.1016/0039-6028(89)90626-2; PAN JM, 1992, J VAC SCI TECHNOL A, V10, P2470, DOI 10.1116/1.577986; WEISENHORN AL, 1990, SCIENCE, V247, P1330, DOI 10.1126/science.247.4948.1330; CAI H, 1994, SCIENCE, V266, P1551, DOI 10.1126/science.266.5190.1551; Chambers SA, 1997, CHEM PHYS LETT, V267, P51, DOI 10.1016/S0009-2614(97)00070-5; Charlton G, 1997, PHYS REV LETT, V78, P495, DOI 10.1103/PhysRevLett.78.495; Fukui K, 1997, PHYS REV LETT, V79, P4202, DOI 10.1103/PhysRevLett.79.4202; Guo Q, 1996, PHYS REV LETT, V77, P3851, DOI 10.1103/PhysRevLett.77.3851; Henrich V, 1994, SURFACE SCI METAL OX; HOWALD L, 1995, PHYS REV B, V51, P5484, DOI 10.1103/PhysRevB.51.5484; KIM KS, 1990, J CATAL, V125, P353, DOI 10.1016/0021-9517(90)90309-8; Kitamura S, 1996, JPN J APPL PHYS 2, V35, pL668, DOI 10.1143/JJAP.35.L668; Komiyama M, 1996, JPN J APPL PHYS 1, V35, P3775, DOI 10.1143/JJAP.35.3775; Komiyama M, 1996, J PHYS CHEM-US, V100, P15198, DOI 10.1021/jp960537s; MASCHHOFF BL, 1991, SURF SCI, V259, P190, DOI 10.1016/0039-6028(91)90537-3; Ng KO, 1997, PHYS REV B, V56, P10544, DOI 10.1103/PhysRevB.56.10544; ONISHI H, 1994, CHEM PHYS LETT, V226, P111, DOI 10.1016/0009-2614(94)00712-8; ONISHI H, 1994, J CATAL, V146, P557, DOI 10.1006/jcat.1994.1094; Onishi H, 1996, J PHYS CHEM-US, V100, P9582, DOI 10.1021/jp960861n; ONISHI H, 1997, MONOGRAPH CHEM 21 CE, P57; Sarid D., 1994, SCANNING FORCE MICRO; Sugawara Y, 1997, APPL SURF SCI, V113, P364, DOI 10.1016/S0169-4332(96)00877-X	29	27	27	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332			APPL SURF SCI	Appl. Surf. Sci.	FEB	1999	140	3-4					259	264		10.1016/S0169-4332(98)00537-6		6	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	171QX	WOS:000078876200005		
J	Sasaki, N; Tsukada, M				Sasaki, N; Tsukada, M			Theory for the effect of the tip-surface interaction potential on atomic resolution in forced vibration system of noncontact AFM	APPLIED SURFACE SCIENCE			English	Article; Proceedings Paper	1st International Workshop on Noncontact Atomic Force Microscopy (NC-AFM 98)	JUL 21-23, 1998	OSAKA UNIV, OSAKA, JAPAN		OSAKA UNIV	atomic-force microscopy; perturbation theory; resonance curve; frequency shift; bistability; image	FREQUENCY-MODULATION DETECTION; MICROSCOPY	We present a perturbation theory which enables us to understand the physics of the cantilever-forced vibration in noncontact atomic-force microscopy (nc-AFM). Analytical expressions of the resonance curve and frequency shift are given. This theory is applied to the model system with a van der Waals tip-surface interaction potential. Based on this case study, it is elucidated how the resonance frequency shift is analytically described by an integral of the tip-surface interaction force. Then nc-AFM image of Si(lll) 7 x 7 surface is calculated by the present theory. It is examined that this theory works as an algorithm for nc-AFM image simulator. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Sasaki, N (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Tsukada, Masaru/E-5182-2010				Anczykowski B, 1996, PHYS REV B, V53, P15485, DOI 10.1103/PhysRevB.53.15485; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; GLEYZES P, 1991, APPL PHYS LETT, V58, P2989, DOI 10.1063/1.104690; Perez R, 1997, PHYS REV LETT, V78, P678, DOI 10.1103/PhysRevLett.78.678; Bammerlin M., 1997, PROBE MICROSC, V1, P3; Bogoliubov N N, 1961, ASYMPTOTIC METHODS T; Boisgard R, 1998, SURF SCI, V401, P199, DOI 10.1016/S0039-6028(97)01079-0; Erlandsson R, 1996, PHYS REV B, V54, pR8309; GIESSIBL FJ, 1995, SCIENCE, V267, P67; KITAMURA S, 1995, JPN J APPL PHYS 2, V34, pL145, DOI 10.1143/JJAP.34.L145; Kuhle A, 1997, J APPL PHYS, V81, P6562, DOI 10.1063/1.365194; Nakagiri N, 1997, SURF SCI, V373, pL329, DOI 10.1016/S0039-6028(96)01276-9; Sasaki N, 1998, JPN J APPL PHYS 2, V37, pL533, DOI 10.1143/JJAP.37.L533; Sasaki N, 1997, SCI REP RES TOHOKU A, V44, P1; SPATZ JP, 1995, NANOTECHNOLOGY, V6, P40, DOI 10.1088/0957-4484/6/2/002; Tsukada M, 1998, SURF SCI, V401, P355, DOI 10.1016/S0039-6028(98)00022-3; Uchihashi T, 1997, J VAC SCI TECHNOL B, V15, P1543, DOI 10.1116/1.589396; UEYAMA H, 1995, JPN J APPL PHYS 2, V34, pL1086; Zhong Q., 1993, SURF SCI LETT, V290, P688	21	68	68	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-4332			APPL SURF SCI	Appl. Surf. Sci.	FEB	1999	140	3-4					339	343		10.1016/S0169-4332(98)00551-0		5	Chemistry, Physical; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	171QX	WOS:000078876200019		
J	Lee, HJ; Tomioka, S; Kinbara, K; Masumoto, H; Jeong, SY; Sorimachi, H; Ishiura, S; Suzuki, K				Lee, HJ; Tomioka, S; Kinbara, K; Masumoto, H; Jeong, SY; Sorimachi, H; Ishiura, S; Suzuki, K			Characterization of a human digestive tract-specific calpain, nCL-4, expressed in the baculovirus system	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						recombinant human nCL-4; calpain; baculovirus system; protease; immunofluorescence analysis	ACTIVATED NEUTRAL PROTEASE; CHICKEN SKELETAL-MUSCLE; CALCIUM-DEPENDENT PROTEASE; DROSOPHILA-MELANOGASTER; NUCLEOTIDE-SEQUENCE; MOLECULAR-CLONING; PURIFICATION; FAMILY; P94; AUTOLYSIS	Human nCL-4, a digestive tract-specific calpain, was stably produced with 30K, a regulatory subunit for ubiquitous calpain as a fully active form using the baculovirus-expression system. nCL-4 showed an activity only when it was coexpressed with 30K, Expressed heterodimeric recombinant nCL-4 was purified to near homogeneity by sequential column chromatographies. Purified nCL-4 showed a calcium-dependent activity (calcium concentration at 50% maximum activity (K-a): 0.125 mM) with a sp act of 21 U/mg, which is distinct from those of ubiquitous calpains. nCL-4 exhibited calcium-dependent autolysis, but the cleavage pattern of nCL-4 was clearly different from ubiquitous calpains. Although it was inhibited by leupeptin, E-64, and calpastatin, and exhibited an optimal pH at 7.3 like other ubiquitous calpains, its optimal temperature was much lower. When overexpressed in COS-7 cells, clear asymmetric juxtanuclear, and/or nuclear staining rather than typical cytoplasmic staining was observed. Moreover, a translation product of nCL-4 was detected in rat stomach tissue by immunofluorescence analysis. In conclusion, human nCL-4 resembles ubiquitous calpain in some enzymatic properties and interacts with 30K for its activity. This is the first report on biochemical and enzymatic properties of a fully active tissue-specific calpain species expressed in the baculovirus system. (C) 1999 Academic Press.	Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol Biol, Bunkyo Ku, Tokyo 1130032, Japan	Suzuki, K (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol Biol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727			Sorimachi H, 1995, J BIOL CHEM, V270, P31158; EMORI Y, 1994, J BIOL CHEM, V269, P25137; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Tsukita S, 1997, CURR OPIN CELL BIOL, V9, P70, DOI 10.1016/S0955-0674(97)80154-8; DELANEY SJ, 1991, P NATL ACAD SCI USA, V88, P7214, DOI 10.1073/pnas.88.16.7214; SAIDO TC, 1994, FASEB J, V8, P814; SORIMACHI H, 1994, FEBS LETT, V343, P1, DOI 10.1016/0014-5793(94)80595-4; Sorimachi H, 1996, ADV BIOPHYS, V33, P101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CROALL DE, 1991, PHYSIOL REV, V71, P813; DENISON SH, 1995, J BIOL CHEM, V270, P28519; ISHIURA S, 1978, J BIOCHEM-TOKYO, V84, P225; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; MASUMOTO H, 1998, IN PRESS J BIOCH; Meyer SL, 1996, BIOCHEM J, V314, P511; OHNO S, 1988, CELL, V53, P731, DOI 10.1016/0092-8674(88)90091-8; OHNO S, 1986, NUCLEIC ACIDS RES, V14, P5559; PINTER M, 1992, BIOCHEMISTRY-US, V31, P8201, DOI 10.1021/bi00150a012; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; SARGIANOS N, 1994, J EXP ZOOL, V269, P95, DOI 10.1002/jez.1402690203; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1997, BIOCHEM J, V328, P721; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SUZUKI K, 1979, FEBS LETT, V104, P355, DOI 10.1016/0014-5793(79)80851-0; SUZUKI K, 1981, J BIOCHEM-TOKYO, V90, P1787; THEOPOLD U, 1995, MOL CELL BIOL, V15, P824; WATERSTON R, 1992, NAT GENET, V1, P114, DOI 10.1038/ng0592-114; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; WOLFE FH, 1989, BIOCHIM BIOPHYS ACTA, V998, P236, DOI 10.1016/0167-4838(89)90280-X; Yao X., 1993, AM J PHYSIOL, V265, P36	33	31	31	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-9861			ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	FEB 1	1999	362	1					22	31		10.1006/abbi.1998.1021		10	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	162MN	WOS:000078350900003		
J	Murashima, R; Nakamura, K; Matsushita, T; Kurokawa, T				Murashima, R; Nakamura, K; Matsushita, T; Kurokawa, T			Remission of idiopathic thrombocytopenic purpura after femoral lengthening - Clinical case followed for 5 years	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article								We report on a patient with chronic idiopathic thrombocytopenic purpura (ITP) who went into remission after femoral Lengthening. Although it is possible that spontaneous remission (frequency 5%-10%) of chronic ITP coincided with the femoral lengthening, limb lengthening could also have caused the thrombocytosis. This case suggests a close relationship between osteogenesis and hematopoiesis during regenerate bone formation. Limb lengthening can therefore be defined as the formation not only of bone and soft tissue but also of hematopoietic tissue.	Hiro O Metropolitan Hosp, Dept Orthopaed Surg, Shibuya Ku, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan	Murashima, R (reprint author), Hiro O Metropolitan Hosp, Dept Orthopaed Surg, Shibuya Ku, 2-34-10 Ebisu, Tokyo, Japan.						STASI R, 1995, AM J MED, V98, P436, DOI 10.1016/S0002-9343(99)80342-8; Aronson J., 1991, OPERATIVE PRINCIPLES, P42; BUNTING RW, 1991, J BONE JOINT SURG BR, V73, P687; ILIZAROV GA, 1992, TRANSOSSEOUS OSTEOSY, P279; SCHIAVOTTO C, 1995, ANN HEMATOL, V70, P89, DOI 10.1007/BF01834386	5	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	1999	119	1-2					100	102		10.1007/s004020050366		3	Orthopedics; Surgery	Orthopedics; Surgery	171AL	WOS:000078839800022		
J	Morita, H; Kurihara, H; Sugiyama, T; Hamada, C; Kurihara, Y; Shindo, T; Oh-hashi, Y; Yazaki, Y				Morita, H; Kurihara, H; Sugiyama, T; Hamada, C; Kurihara, Y; Shindo, T; Oh-hashi, Y; Yazaki, Y			Polymorphism of the methionine synthase gene - Association with homocysteine metabolism and late-onset vascular diseases in the Japanese population	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						homocysteine; methionine synthase; methylenetetrahydrofolate reductase; genetics	CORONARY-ARTERY DISEASE; THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE; INDEPENDENT RISK FACTOR; MYOCARDIAL-INFARCTION; COMMON MUTATION; PLASMA HOMOCYST(E)INE; STROKE; CBLG; HYPERHOMOCYSTEINEMIA; HETEROGENEITY	Methionine synthase and 5,10-methylenetetrahydrofolate reductase (MTHFR) sequentially catalyze the remethylation of homocysteine to methionine. A point mutation in the encoding region of the methionine synthase gene, which results in substitution of an aspartic acid for a glycine residue (D919G), has been identified in patients of the cblG genetic complementation group; these patients exhibit significantly decreased methionine synthase activity. Nevertheless, the D919G mutation has also been reported to be common in the general population. In this study, we analyzed the distribution of methionine synthase DIG polymorphism in the Japanese population and examined the extent to which it is associated with altered homocysteine metabolism and late-onset vascular diseases. We studied 215 patients with coronary artery disease, 251 patients with histories of ischemic stroke, and 257 control subjects. The methionine synthase genotype was analyzed by polymerase chain reaction followed by HaeIII digestion; allele frequencies for the D919G variant of the enzyme proved to be similar in all 3 subject groups (control subjects, 0.17; coronary artery disease patients, 0.17; and ischemic stroke patients, 0.19). Furthermore, in patients with ischemic stroke, plasma levels of homocyst(e)ine and folate were similar, irrespective of methionine synthase genotype, Thus, the methionine synthase D919G mutation was found to be common in the Japanese general population, and it appears unlikely that this polymorphism has a major effect on homocysteine metabolism and/or the onset of vascular diseases.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Pharmacoepidemiol, Tokyo 1138655, Japan; Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan	Kurihara, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Deloughery TG, 1996, CIRCULATION, V94, P3074; Jacques PF, 1996, CIRCULATION, V93, P7; Morita H, 1998, ARTERIOSCL THROM VAS, V18, P1465; MALINOW MR, 1989, CIRCULATION, V79, P1180; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; KANG SS, 1991, AM J HUM GENET, V48, P536; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; PERRY IJ, 1995, LANCET, V346, P1395, DOI 10.1016/S0140-6736(95)92407-8; BOERS GHJ, 1985, NEW ENGL J MED, V313, P709, DOI 10.1056/NEJM198509193131201; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Markus HS, 1997, STROKE, V28, P1739; Ma J, 1996, CIRCULATION, V94, P2410; ARAKI A, 1987, J CHROMATOGR-BIOMED, V422, P43, DOI 10.1016/0378-4347(87)80438-3; BRATTSTROM L, 1992, EUR J CLIN INVEST, V22, P214, DOI 10.1111/j.1365-2362.1992.tb01829.x; COULL BM, 1990, STROKE, V21, P572; denHeijer M, 1996, NEW ENGL J MED, V334, P759, DOI 10.1056/NEJM199603213341203; DUDMAN NPB, 1993, ARTERIOSCLER THROMB, V13, P1253; FENTON WA, 1995, METABOLIC MOL BASES, P3129; Gallagher PM, 1996, CIRCULATION, V94, P2154; Kluijtmans LAJ, 1997, CIRCULATION, V96, P2573; Loehrer FMT, 1996, ARTERIOSCL THROM VAS, V16, P727; Morita H, 1997, CIRCULATION, V95, P2032; Press Richard D., 1997, Stroke, V28, P265; *SAS I INC, 1990, SAS STAT US GUID VER, P2; Schmitz C, 1996, CIRCULATION, V94, P1812; SELHUB J, 1995, NEW ENGL J MED, V332, P286, DOI 10.1056/NEJM199502023320502; WATKINS D, 1989, AM J MED GENET, V34, P427, DOI 10.1002/ajmg.1320340320; WATKINS D, 1988, J CLIN INVEST, V81, P1690, DOI 10.1172/JCI113507; WHISNANT J P, 1990, Stroke, V21, P637; Wilcken DEL, 1996, ARTERIOSCL THROM VAS, V16, P878	31	54	56	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642			ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	FEB	1999	19	2					298	302				5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	168EV	WOS:000078679300014		
J	Kanda, N; Tsuchida, T; Tamaki, K				Kanda, N; Tsuchida, T; Tamaki, K			Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus	ARTHRITIS AND RHEUMATISM			English	Article							B-LYMPHOCYTE HYPERACTIVITY; MONOCLONAL-ANTIBODIES; AUTO-IMMUNITY; SEX-HORMONES; T-CELLS; MICE; INTERLEUKIN-10; DIFFERENTIATION; EXPRESSION; ACTIVATION	Objective. To study the in vitro effect of estrogen on IgG anti-double-stranded DNA (anti-dsDNA) antibody and total IgG production in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE), in order to elucidate its regulatory role in SLE. Methods. PBMC from SLE patients and normal donors were cultured with 17 beta-estradiol (E-2). IgG anti-dsDNA antibodies, total IgG, and cytokine activity in the culture supernatants were measured by enzyme-linked immunosorbent assay. Results, E-2 enhanced production of IgG anti-dsDNA antibodies as well as total IgG in PBMC from SLE patients. Anti-dsDNA production in patients with inactive disease was less responsive to E-2 than that in patients with active disease. E-2 also enhanced total IgG, but not anti-dsDNA, production in the PBMC of normal donors. Antibody production was increased by E-2 to a lesser extent in patients' B cells than in their PBMC. Anti-interleukin-10 (anti-IL-10) antibodies partially blocked the E-2-induced increase in antibody production in patients' PBMC, but anti-IL-10 had no effect on B cells, E-2 increased IL-10 production by patients' monocytes, Exogenous IL-10 acted additively with E-2 in increasing antibody production in patients' B cells. Conclusion. These results suggest that E-2 may polyclonally increase the production of IgG, including IgG anti-dsDNA, in SLE patients' PBMC by enhancing B cell activity and by promoting IL-10 production in monocytes, These findings support the involvement of E-2 in the pathogenesis of SLE.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1130033, Japan; Saitama Med Sch, Moroyama, Saitama 35004, Japan	Kanda, N (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; NAGAFUCHI H, 1993, J IMMUNOL, V151, P6525; FOX HS, 1991, J IMMUNOL, V146, P4362; STEINBERG AD, 1979, ARTHRITIS RHEUM, V22, P1170, DOI 10.1002/art.1780221103; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; STHOEGER ZM, 1988, J IMMUNOL, V141, P91; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; LIN H, 1993, J IMMUNOL, V151, P4562; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; BAIOCCHI RA, 1995, BLOOD, V85, P1063; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; DZIARSKI R, 1988, IMMUNOL TODAY, V9, P340, DOI 10.1016/0167-5699(88)91333-3; PELTON BK, 1991, CLIN EXP IMMUNOL, V83, P274; KITANI A, 1992, CLIN EXP IMMUNOL, V88, P75; Ansar A. S., 1989, J IMMUNOL, V142, P2647; ANSARAHMED S, 1988, FASEB J, V2, pA894; ANSARAHMED S, 1993, DUBOIS LUPUS ERYTHEM, P148; BATRA S, 1978, J CLIN ENDOCR METAB, V46, P622; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BLANK M, 1990, J RHEUMATOL, V17, P311; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; CAIRNS E, 1989, J CLIN INVEST, V83, P1002, DOI 10.1172/JCI113941; CARLSTEN H, 1990, CLIN EXP IMMUNOL, V80, P467; COFFMAN RL, 1990, IMMUNOPHYSIOLOGY, P88; DANEL L, 1985, LEUKEMIA RES, V9, P1373, DOI 10.1016/0145-2126(85)90125-0; DANEL L, 1988, J STEROID BIOCHEM, V30, P363, DOI 10.1016/0022-4731(88)90124-0; DATTA SK, 1983, P NATL ACAD SCI-BIOL, V80, P2723, DOI 10.1073/pnas.80.9.2723; FARRANT J, 1985, CLIN EXP IMMUNOL, V61, P189; FORMBY B, 1995, ENDOCRIN METAB CLIN, V24, P187; GEE AP, 1987, BONE MARROW TRANSPL, V2, P155; GHARAVI AE, 1989, CLIN EXP IMMUNOL, V78, P233; Hahn Bevra H., 1993, P195; ISENBERG DA, 1994, ARTHRITIS RHEUM-US, V37, P169, DOI 10.1002/art.1780370204; JAKOB F, 1992, J ENDOCRINOL, V134, P397, DOI 10.1677/joe.0.1340397; Kanda N, 1997, ARTHRITIS RHEUM, V40, P1703, DOI 10.1002/art.1780400921; KANDA N, IN PRESS J ALLERGY C; KERL JH, 1992, ANN NY ACAD SCI, V651, P220; KIMATA H, 1991, CLIN EXP IMMUNOL, V85, P151; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; LLORENTE L, 1994, ARTHRITIS RHEUM, V37, P1647, DOI 10.1002/art.1780371114; MACKWORTHYOUNG C, 1987, J CLIN INVEST, V79, P572, DOI 10.1172/JCI112849; MISHELL DR, 1977, AM J OBSTET GYNECOL, V111, P60; RAVECHE ES, 1976, NATURE, V263, P415, DOI 10.1038/263415a0; ROSEN ST, 1983, BLOOD, V62, P996; ROUBINIAN J, 1979, ARTHRITIS RHEUM, V22, P1162; STEINBERG AD, 1980, CLIN IMMUNOL IMMUNOP, V17, P562, DOI 10.1016/0090-1229(80)90152-X; TAKI S, 1992, EUR J IMMUNOL, V22, P987, DOI 10.1002/eji.1830220417; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; VERTHELYI D, 1994, ENDOCRINOLOGY, V135, P2615, DOI 10.1210/en.135.6.2615; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611	54	108	119	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0004-3591			ARTHRITIS RHEUM	Arthritis Rheum.	FEB	1999	42	2					328	337		10.1002/1529-0131(199902)42:2<328::AID-ANR16>3.0.CO;2-#		10	Rheumatology	Rheumatology	164MW	WOS:000078469000016		
J	White, GJ; Nelson, RP; Holland, WS; Robson, EI; Greaves, JS; McCaughrean, MJ; Pilbratt, GL; Balser, DS; Oka, T; Sakamoto, S; Hasegawa, T; McCutcheon, WH; Matthews, HE; Fridlund, CVM; Tothill, NFH; Huldtgren, M; Deane, JR				White, GJ; Nelson, RP; Holland, WS; Robson, EI; Greaves, JS; McCaughrean, MJ; Pilbratt, GL; Balser, DS; Oka, T; Sakamoto, S; Hasegawa, T; McCutcheon, WH; Matthews, HE; Fridlund, CVM; Tothill, NFH; Huldtgren, M; Deane, JR			The Eagle Nebula's fingers - pointers to the earliest stages of star formation?	ASTRONOMY & ASTROPHYSICS			English	Article						infrared : ISM : continuum; ISM : molecules; ISM : individual objects : Eagle Nebula; ISM : H II regions; ISM : general ISM : clouds	YOUNG STELLAR OBJECTS; COMETARY GLOBULES; MOLECULAR CLOUDS; DUST EMISSION; PROTOSTELLAR CONDENSATIONS; INTERSTELLAR CLOUDS; HIGH-RESOLUTION; ROSETTE NEBULA; SUBMILLIMETER; CORES	Molecular line, millimetre/submillimetre continuum, and mid-IR observations are reported of the opaque fingers which cross the Eagle Nebula. The fingers are surprisingly warm when viewed in the CO J= 3-2 lines, with kinetic temperatures approaching 60 K, although the lines are relatively narrow. Most of the mass in the fingers is concentrated in cores which lie at the tips of the fingers, and contain from similar to 10 to 60 M., representing 55-80% of the mass of the individual fingers. The integrated mass contained in the three fingers and the nearby extended material is similar to 200 M.. The velocity fields of the gas are complex and the material is very clumpy. The best evidence for coherent velocity structure is seen running along the central finger, which has a velocity gradient similar to 1.7 km s(-1) pc(-1). The fingers contain several embedded submm continuum cores, with the most intense located at the tips of the fingers. The continuum spectra of these cores shows that they are much cooler, T-dust similar to 20 K, than T-gas similar to 60 K of their respective fingers. A simple thermal and chemical model of a finger was developed to study the physical environment, which takes into account the external UV illumination (similar to 1700 G(0)), and the chemical and thermal structure of a finger. The model predictions are consistent with all of the available observations. The fingers appear to have been formed after primordial dense clumps in the original cloud were irradiated by the light of its OB stars. These clumps then shielded material lying behind from the photoevaporative dispersal of the cloud, and facilitated the formation of the finger structures. The cores in the tips of the fingers appear to be at a very early stage of pre-protostellar development: there are no embedded infrared sources or molecular outflows present. The pressure inside the cores is just less than that of the surrounding gas, allowing them to be compressed by the external pressure. The cores are probably just starting the final stages of collapse, which will lead to the formation of a condensed, warm object. It is well known that such characteristics are expected from the earliest stages of objects popularly known as 'protostars'. The cores in the tips of the Eagle Nebula's fingers have characteristics similar to those expected to occur in the earliest stages of protostellar formation.	Univ London Queen Mary & Westfield Coll, Dept Phys, London E1 4NS, England; Univ London Queen Mary & Westfield Coll, Astron Unit, London E1 4NS, England; Joint Astron Ctr, Hilo, HI 96720 USA; Inst Astrophys, D-14482 Potsdam, Germany; European Space Agcy, Estec, Dept Space Sci, Div Astrophys, NL-2200 AG Noordwijk, Netherlands; NRAO, Green Bank, WV 24944 USA; RIKEN, Cosm Radio Observ, Wako, Saitama 35101, Japan; Nobeyama Radio Observ, Minamisa Ku, Nagano 38413, Japan; Univ Tokyo, Astron Inst, Tokyo 181, Japan; Univ British Columbia, Dept Phys, Vancouver, BC V6T 2A6, Canada; Stockholm Observ, SE-13336 Saltsjobaden, Sweden	White, GJ (reprint author), Univ London Queen Mary & Westfield Coll, Dept Phys, Mile End Rd, London E1 4NS, England.	g.j.white@qmw.ac.uk		Tothill, Nicholas/0000-0002-9931-5162			ANDRE P, 1994, ASTROPHYS J, V420, P837, DOI 10.1086/173608; ANDRE P, 1996, MEM SOC ASTRON ITAL, V67, P901; Andre P, 1996, ASTRON ASTROPHYS, V314, P625; Hester JJ, 1996, ASTRON J, V111, P2349, DOI 10.1086/117968; ISRAEL FP, 1995, ASTRON ASTROPHYS, V302, P343; BECKWITH SVW, 1991, ASTROPHYS J, V381, P250, DOI 10.1086/170646; GOLDSMITH PF, 1978, ASTROPHYS J, V222, P881, DOI 10.1086/156206; MATHIS JS, 1989, ASTROPHYS J, V341, P808, DOI 10.1086/167538; OORT JH, 1955, ASTROPHYS J, V121, P6, DOI 10.1086/145958; WARDTHOMPSON D, 1994, MON NOT R ASTRON SOC, V268, P276; LEFLOCH B, 1994, ASTRON ASTROPHYS, V289, P559; MINCHIN NR, 1995, ASTRON ASTROPHYS, V302, pL25; WHITE GJ, 1995, ASTRON ASTROPHYS, V299, P179; BALSER DS, 1995, ASTROPHYS J SUPPL S, V100, P371, DOI 10.1086/192224; BERTOLDI F, 1990, ASTROPHYS J, V354, P529, DOI 10.1086/168713; BERTOLDI F, 1989, ASTROPHYS J, V346, P735, DOI 10.1086/168055; BOWERS R, 1984, ASTROPHYSICS, V2, P410; CHANDLER CJ, 1995, ASTROPHYS J, V449, pL139, DOI 10.1086/309644; CHIEZE JP, 1987, ASTRON ASTROPHYS, V183, P98; EIROA C, 1998, IN PRESS A A; Gammie CF, 1996, ASTROPHYS J, V466, P814, DOI 10.1086/177556; GENZEL R, 1991, PHYSICS STAR FORMATI; Gibb AG, 1998, MON NOT R ASTRON SOC, V295, P299, DOI 10.1046/j.1365-8711.1998.01270.x; HABING HJ, 1968, B ASTRON I NETH, V19, P421; Henriksen R, 1997, ASTRON ASTROPHYS, V323, P549; HILLENBRAND LA, 1906, AJ, P106; HOGERHEIJDE M, 1998, THESIS U LEIDEN; HOLLENBACH DJ, 1991, ASTROPHYS J, V377, P192, DOI 10.1086/170347; ISRAEL FP, 1995, A A, V317, P299; KEENE J, 1987, P SETI C CARB BAL; KURUCZ RL, 1979, ASTROPHYS J SUPPL S, V40, P1, DOI 10.1086/190589; Launhardt R, 1997, MON NOT R ASTRON SOC, V288, pL45; LEFLOCH B, 1995, A A, V301, P552; Lefloch B, 1997, ASTRON ASTROPHYS, V324, P249; MCCAUGHREAN MJ, 1997, P IAU S, V182, P551; MCKEE CF, 1995, ASTROPHYS J, V440, P686, DOI 10.1086/175306; Megeath ST, 1997, ASTRON J, V114, P1106, DOI 10.1086/118541; MEZGER PG, 1988, ASTRON ASTROPHYS, V191, P44; MEZGER PG, 1992, ASTRON ASTROPHYS, V256, P631; MUFSON SL, 1981, ASTROPHYS J, V248, P992, DOI 10.1086/159228; MYERS PC, 1988, ASTROPHYS J, V329, P392, DOI 10.1086/166385; Nelson RP, 1997, ASTROPHYS J, V482, P796, DOI 10.1086/304167; Pilbratt GL, 1998, ASTRON ASTROPHYS, V333, pL9; Pound MW, 1998, ASTROPHYS J, V493, pL113, DOI 10.1086/311131; SCHNEPS MH, 1980, ASTROPHYS J, V240, P84, DOI 10.1086/158209; Spitzer Jr L., 1968, DIFFUSE MATTER SPACE; TUCHOLKE HJ, 1986, ASTRON ASTROPHYS SUP, V66, P311; WARDTHOMPSON D, 1997, P IAU S, V182, P257; WARDTHOMPSON D, 1995, MON NOT R ASTRON SOC, V274, P1219; WHITE GJ, 1991, NATURE, V354, P511, DOI 10.1038/354511a0; WHITE GJ, 1995, ASTRON ASTROPHYS, V298, P594; White GJ, 1997, ASTRON ASTROPHYS, V323, P931; Wiesemeyer H, 1997, ASTRON ASTROPHYS, V320, P287	53	61	61	EDP SCIENCES S A	LES ULIS CEDEX A	17, AVE DU HOGGAR, PA COURTABOEUF, BP 112, F-91944 LES ULIS CEDEX A, FRANCE	0004-6361			ASTRON ASTROPHYS	Astron. Astrophys.	FEB	1999	342	1					233	256				24	Astronomy & Astrophysics	Astronomy & Astrophysics	164LJ	WOS:000078465400025		
J	Mori, M; Yoshii, Y; Nomoto, K				Mori, M; Yoshii, Y; Nomoto, K			Dissipative process as a mechanism of differentiating internal structures between dwarf and normal elliptical galaxies in a cold dark matter universe	ASTROPHYSICAL JOURNAL			English	Article						dark matter; galaxies : abundances; galaxies : formation; galaxies : structure; methods : numerical	SMOOTHED PARTICLE HYDRODYNAMICS; SURFACE PHOTOMETRY; STAR-FORMATION; VIRGO CLUSTER; METALLICITY GRADIENTS; STELLAR POPULATIONS; SPHERICAL GALAXIES; EVOLUTION; SYSTEMS; ORIGIN	We simulate the dynamical, chemical, and spectrophotometric evolution of dwarf and normal elliptical galaxies embedded in a dark matter halo using a three-dimensional N-body/smoothed particle hydrodynamics simulation code. For the forming dwarf elliptical galaxies, supernova-driven winds propagating outward from inside the system collide with the infalling gas and produce the supershell in which stars are formed. The resulting stellar system forms a loosely bound virialized system due to the significant mass loss and has a large velocity dispersion and a large core. Consequently the surface brightness distribution shows an exponential profile and the color distribution shows a positive gradient such that the colors become redder away from the galaxy center in agreement with observations. On the other hand, for the normal elliptical galaxies with deep gravitational potential, the mass loss out of the system does not have a significant dynamical effect on the stellar system. The resulting surface brightness distribution has a large central concentration like de Vaucouleurs' r(1/4) profile and the color distribution shows a negative gradient as observed. Our simulation shows that different features between dwarf and normal elliptical galaxies stem from different cooling efficiencies for their respective protogalaxies in a standard cold dark matter universe.	Univ Tokyo, Astron Inst, Mitaka, Tokyo 1818588, Japan; Univ Tokyo, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Mori, M (reprint author), Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany.		Nomoto, Ken'ichi/A-4393-2011				SALPETER EE, 1955, ASTROPHYS J, V121, P161, DOI 10.1086/145971; SANDAGE A, 1985, ASTRON J, V90, P1759, DOI 10.1086/113875; Navarro JF, 1996, MON NOT R ASTRON SOC, V283, pL72; MARLOWE AT, 1995, ASTROPHYS J, V438, P563, DOI 10.1086/175101; Fukushige T, 1997, ASTROPHYS J, V477, pL9, DOI 10.1086/310516; THEIS C, 1992, ASTRON ASTROPHYS, V265, P465; MEURER GR, 1992, ASTRON J, V103, P60, DOI 10.1086/116041; MONAGHAN JJ, 1985, ASTRON ASTROPHYS, V149, P135; KORMENDY J, 1989, ANNU REV ASTRON ASTR, V27, P235; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; DUBINSKI J, 1991, ASTROPHYS J, V378, P496, DOI 10.1086/170451; SUGIMOTO D, 1990, NATURE, V345, P33, DOI 10.1038/345033a0; MIHOS JC, 1994, ASTROPHYS J, V437, P611, DOI 10.1086/175025; TSUJIMOTO T, 1995, MON NOT R ASTRON SOC, V277, P945; COLE S, 1994, MON NOT R ASTRON SOC, V271, P781; THOUL AA, 1995, ASTROPHYS J, V442, P480, DOI 10.1086/175455; ARIMOTO N, 1986, ASTRON ASTROPHYS, V164, P260; LACEY C, 1991, ASTROPHYS J, V381, P14, DOI 10.1086/170625; VANALBADA TS, 1982, MON NOT R ASTRON SOC, V201, P939; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; HERNQUIST L, 1990, ASTROPHYS J, V356, P359, DOI 10.1086/168845; Binggeli B, 1998, ASTRON ASTROPHYS, V333, P17; BESSELL MS, 1988, PUBL ASTRON SOC PAC, V100, P1134, DOI 10.1086/132281; STEINMETZ M, 1994, ASTRON ASTROPHYS, V281, pL97; NAVARRO JF, 1993, MON NOT R ASTRON SOC, V265, P271; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375; WHITE SDM, 1991, ASTROPHYS J, V379, P52, DOI 10.1086/170483; DEKEL A, 1986, ASTROPHYS J, V303, P39, DOI 10.1086/164050; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Babul A, 1996, ASTROPHYS J, V458, P100, DOI 10.1086/176795; BESSELL MS, 1990, PUBL ASTRON SOC PAC, V102, P1181, DOI 10.1086/132749; BINGGELI B, 1991, ASTRON ASTROPHYS, V252, P27; BINNEY J, 1987, GALACTIC DYNAMICS, P232; CALDWELL N, 1987, ASTRON J, V94, P1126, DOI 10.1086/114550; CAROLLO CM, 1993, MON NOT R ASTRON SOC, V265, P553; Chaboyer B., 1994, ESO/OHP Workshop. Dwarf Galaxies. Proceedings; CHIBA M, 1994, ASTROPHYS J, V436, P618, DOI 10.1086/174937; DAVID LP, 1990, ASTROPHYS J, V359, P29, DOI 10.1086/169030; De Vaucouleurs G., 1948, Annales d'Astrophysique, V11; Durrell PR, 1996, ASTROPHYS J, V463, P543, DOI 10.1086/177269; Efstathiou G., 1992, MNRAS, V256, P43; FABER SM, 1983, ASTROPHYS J, V266, pL17, DOI 10.1086/183970; Hunter DA, 1996, ASTROPHYS J, V457, P671, DOI 10.1086/176762; ICHIKAWA SI, 1986, ASTROPHYS J SUPPL S, V60, P475, DOI 10.1086/191094; Katz N, 1996, ASTROPHYS J SUPPL S, V105, P19, DOI 10.1086/192305; KATZ N, 1992, ASTROPHYS J, V391, P502, DOI 10.1086/171366; Kodama T, 1997, ASTRON ASTROPHYS, V320, P41; KORMENDY J, 1977, ASTROPHYS J, V218, P333, DOI 10.1086/155687; Loveday J, 1997, ASTROPHYS J, V489, P29, DOI 10.1086/304778; Mao S, 1998, MON NOT R ASTRON SOC, V296, P847, DOI 10.1046/j.1365-8711.1998.01406.x; MORI M, 1999, UNPUB; Mori M, 1997, ASTROPHYS J, V478, pL21, DOI 10.1086/310547; Nakasato N, 1997, ASTROPHYS J, V484, P608, DOI 10.1086/304352; Patterson RJ, 1996, ASTROPHYS J SUPPL S, V107, P103, DOI 10.1086/192357; Puche D., 1994, ESO/OHP Workshop. Dwarf Galaxies. Proceedings; SAITO M, 1979, PUBL ASTRON SOC JPN, V31, P193; SHULL JM, 1979, ASTROPHYS J, V234, P427, DOI 10.1086/157511; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Trentham N, 1998, MON NOT R ASTRON SOC, V294, P193, DOI 10.1046/j.1365-8711.1998.01084.x; VADER JP, 1988, ASTRON ASTROPHYS, V203, P217; VIGROUX L, 1988, ASTRON ASTROPHYS SUP, V73, P1; Westpfahl D., 1994, ESO/OHP Workshop. Dwarf Galaxies. Proceedings; WHITE SDM, 1979, MON NOT R ASTRON SOC, V189, P831; YOSHII Y, 1987, ASTRON ASTROPHYS, V188, P13; YOUNG CK, 1994, MON NOT R ASTRON SOC, V268, pL11	66	45	45	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 1	1999	511	2	1				585	594		10.1086/306724		10	Astronomy & Astrophysics	Astronomy & Astrophysics	176NN	WOS:000079158100007		
J	Funato, Y; Makino, J				Funato, Y; Makino, J			Change in mass and energy of galaxies through mutual encounters	ASTROPHYSICAL JOURNAL			English	Article						galaxies : elliptical and lenticular, cD; galaxies : evolution; galaxies : interactions; galaxies : kinematics and dynamics; methods : numerical	N-BODY SIMULATIONS; MERGER REMNANTS; SPHERICAL GALAXIES; VIOLENT RELAXATION; RICH CLUSTERS; EVOLUTION; DYNAMICS; SYSTEMS; HALOS	We present the result of a systematic study of the evolution of galaxies through their encounters. We performed a series of numerical experiments of encounters of two galaxies and determined how the change of mass and binding energy depends on galaxy models and collision parameters. Using both numerical experiments and analytic theory, we found that the relation between the relative change of energy delta(E) and that of mass delta(M) of one galaxy per unit time is expressed as delta(E) similar or equal to 1.5 delta(M) if the evolution is solely due to encounters. This result suggests that when galaxies in a cluster evolve mainly through frequent encounters with each other, a relation sigma(4) similar to M develops between the mass M and the velocity dispersion sigma of the galaxies. If we assume that M/L is constant, this relation is equivalent to the Faber-Jackson relation, sigma(4) similar to L, which is observed for elliptical galaxies in a cluster of galaxies. This agreement with observations suggests that the encounters of galaxies play an important role in the evolution of galaxies in clusters.	Univ Tokyo, Grad Div Int & Interdisciplinary Studies, Tokyo, Japan	Funato, Y (reprint author), Univ Tokyo, Grad Div Int & Interdisciplinary Studies, Tokyo, Japan.		Makino, Junichiro/A-9525-2014				AGUILAR LA, 1985, ASTROPHYS J, V295, P374, DOI 10.1086/163382; SPITZER L, 1971, ASTROPHYS J, V166, P483, DOI 10.1086/150977; BARNES JE, 1992, ANNU REV ASTRON ASTR, V30, P705; FABER SM, 1976, ASTROPHYS J, V204, P668, DOI 10.1086/154215; Makino J, 1997, ASTROPHYS J, V481, P83, DOI 10.1086/304013; HERNQUIST L, 1990, ASTROPHYS J, V356, P359, DOI 10.1086/168845; Makino J, 1997, ASTROPHYS J, V480, P432, DOI 10.1086/303972; Moore B, 1996, NATURE, V379, P613, DOI 10.1038/379613a0; Athanassoula E, 1997, MON NOT R ASTRON SOC, V286, P825; BAHCALL NA, 1994, ASTROPHYS J, V426, P513, DOI 10.1086/174087; BARNES J, 1985, MON NOT R ASTRON SOC, V215, P517; BARNES JE, 1992, ASTROPHYS J, V393, P484, DOI 10.1086/171522; BARNES JE, 1988, ASTROPHYS J, V331, P699, DOI 10.1086/166593; BINNEY J, 1982, MON NOT R ASTRON SOC, V201, P1; De Vaucouleurs G., 1948, Annales d'Astrophysique, V11; DEKEL A, 1980, ASTROPHYS J, V241, P946, DOI 10.1086/158409; FAROUKI RT, 1983, ASTROPHYS J, V271, P11, DOI 10.1086/161171; FUNATO Y, 1993, PUBL ASTRON SOC JPN, V45, P289; FUNATO Y, 1992, PUBL ASTRON SOC JPN, V44, P613; Heggie D. C., 1986, USE SUPERCOMPUTERS S, P233; HERNQUIST L, 1992, ASTROPHYS J, V400, P460, DOI 10.1086/172009; HERNQUIST L, 1993, APJ, V409, P54; HERNQUIST L, 1993, ASTROPHYS J, V416, P415, DOI 10.1086/173247; Jaffe W., 1987, IAU S, P511; MAKINO J, 1990, PUBL ASTRON SOC JPN, V42, P205; Makino J, 1996, ASTROPHYS J, V465, P527, DOI 10.1086/177439; MERRITT D, 1984, ASTROPHYS J, V276, P26, DOI 10.1086/161590; MERRITT D, 1983, ASTROPHYS J, V264, P24, DOI 10.1086/160571; Morganti R, 1997, ASTRON J, V113, P937, DOI 10.1086/118311; OKUMURA SK, 1991, PUBL ASTRON SOC JPN, V43, P781; Pizzella A, 1995, ASTR SOC P, V86, P53; Plummer H.C., 1911, Monthly Notices of the Royal Astronomical Society, V71; Quinlan G. D., 1996, New Astronomy, V1, DOI 10.1016/S1384-1076(96)00018-8; RICHSTONE DO, 1975, ASTROPHYS J, V200, P535, DOI 10.1086/153820; Spitzer L., 1987, DYNAMICAL EVOLUTION; TAIJI M, 1996, IAU S, V174, P141; Weil ML, 1996, ASTROPHYS J, V460, P101, DOI 10.1086/176955; WHITMORE BC, 1990, CLUSTERS GALAXIES, P139, DOI 10.1017/CBO9780511600135.007	38	10	10	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	FEB 1	1999	511	2	1				625	638		10.1086/306688		14	Astronomy & Astrophysics	Astronomy & Astrophysics	176NN	WOS:000079158100010		
J	Kawaii, S; Yamashita, K; Nakai, M; Takahashi, M; Fusetani, N				Kawaii, S; Yamashita, K; Nakai, M; Takahashi, M; Fusetani, N			Calcium dependence of settlement and nematocyst discharge in actinulae of the hydroid Tubularia mesembryanthemum	BIOLOGICAL BULLETIN			English	Article							CALLIACTIS-PARASITICA; INDUCE METAMORPHOSIS; ION CHANNELS; ACONTIA; GADOLINIUM; MECHANORECEPTORS; HYDRACTINIA; TRANSIENTS; ACTIVATION	The influence of Ca2+ and Mg2+ ions on both atrichous isorhiza (AI) discharge and settlement of actinular larvae of the hydroid Tubularia mesembryanthemum was investigated. Mg2+-supplemented artificial seawater (ASW) completely inhibited both events at a concentration of 206 mM, whereas lowered Mg2+ concentrations enhanced them. Ca2+ ions in the bathing solution highly regulated Al discharge and settlement, and Mg2+ ions may down-regulate these events. The effect of inorganic Ca2+-channel blockers, including Gd3+ and La3+, was also examined. Larval settlement was inhibited by Co2+, Ni2+, Cd2+, La3+, and Gd3+, with half inhibitory concentrations (IC50) of 5800, 260, 53, 45, and 7 mu M, respectively; AI discharge was also inhibited by these ions, with IC50 values of 6600, 500, 78, 41, and 5 mu M respectively. These results suggest possible involvement of stretch-activated Ca2+ channels in the signal transmission of both AI discharge and larval settlement.	Res Dev Corp Japan, ERATO, Biofouling Project, Yokohama R&D Ctr ,Niigata Engn Co Ltd,Isogo Ku, Yokohama, Kanagawa 235, Japan	Fusetani, N (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 113, Japan.						FREEMAN G, 1990, ROUX ARCH DEV BIOL, V199, P63, DOI 10.1007/BF02029553; Pantin CFA, 1942, J EXP BIOL, V19, P294; WATSON GM, 1989, SCIENCE, V243, P1589, DOI 10.1126/science.2564698; Kawaii S, 1997, J EXP ZOOL, V278, P299, DOI 10.1002/(SICI)1097-010X(19970801)278:5<299::AID-JEZ4>3.0.CO;2-K; BERKING S, 1988, ROUX ARCH DEV BIOL, V197, P1, DOI 10.1007/BF00376035; ENDO M, 1977, PHYSIOL REV, V57, P71; Freeman G., 1987, Roux's Archives of Developmental Biology, V196, P30, DOI 10.1007/BF00376020; GITTER AH, 1994, J COMP PHYSIOL A, V175, P115; MCKAY MC, 1988, BIOL BULL, V174, P47, DOI 10.2307/1541758; MULLER WA, 1985, DIFFERENTIATION, V29, P216, DOI 10.1111/j.1432-0436.1985.tb00319.x; RUSSELL TJ, 1995, J EXP ZOOL, V273, P175, DOI 10.1002/jez.1402730302; SADOSHIMA J, 1992, P NATL ACAD SCI USA, V89, P9905, DOI 10.1073/pnas.89.20.9905; SALLEO A, 1993, COMP BIOCHEM PHYS A, V104, P565, DOI 10.1016/0300-9629(93)90465-G; SALLEO A, 1994, EXPERIENTIA, V50, P148, DOI 10.1007/BF01984954; SALLEO A, 1994, J EXP BIOL, V187, P201; SANTORO G, 1991, EXPERIENTIA, V47, P701, DOI 10.1007/BF01958819; SANTORO G, 1991, J EXP BIOL, V156, P173; Tardent P., 1988, P309; Thorington G.U., 1988, P233; THORINGTON GU, 1988, BIOL BULL, V174, P163, DOI 10.2307/1541783; WATSON GM, 1991, J CELL SCI, V99, P307; YAMASHITA K, 1997, P 6 ICCB, P512; Yanagita T.M., 1973, Publications Seto Mar Biol Lab, V20, P675; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333	24	7	7	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185			BIOL BULL	Biol. Bull.	FEB	1999	196	1					45	51		10.2307/1543165		7	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	170YT	WOS:000078835400005		
J	Hirose, E; Kimura, S; Itoh, T; Nishikawa, J				Hirose, E; Kimura, S; Itoh, T; Nishikawa, J			Tunic morphology and cellulosic components of pyrosomas, doliolids, and salps (Thaliacea, Urochordata)	BIOLOGICAL BULLETIN			English	Article							ASCIDIAN APLIDIUM-YAMAZII; CLAVELINA-MINIATA; ANIMAL CELLULOSE; JET PROPULSION; PROTRUSIONS; CONTRACTION; CUTICLE; CELLS	The morphology and cellulosic composition of the tunic was studied in pelagic tunicates (3 pyrosomas, 2 doliolids, and 13 salps). The tunic is transparent and gelatinous, consisting of an electron-dense cuticular layer with a fibrous tunic matrix. The thickness and density of the cuticular layer and of the tunic matrix differ from species to species. In some salps, the cuticular layer has numerous minute protrusions that are structurally identical to those found in several ascidians. Free mesenchymal cells (tunic cells) are distributed in the tunic. Whereas the number of tunic cells in the pyrosomas is similar to that in ascidians, there are many fewer tunic cells in doliolids and salps. These differences may be caused by the different functions of the tunic in each group. The existence of cellulose in the tunic was confirmed using electron diffraction in all of the species studied thus far. Their diffractograms indicate that the cellulose microfibrils consist of nearly pure I beta of the allomorph. These results show that tunic morphology and cellulosic composition are similar in ascidians and thaliaceans (pyrosomas, doliolids, and salps). The tunic is considered to be a homologous tissue in these animals, and their most recent common ancestor would have possessed this tissue.	Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan; Kyoto Univ, Wood Res Inst, Uji 611, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Hirose, E (reprint author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, Nishihara, Okinawa 9030213, Japan.		Hirose, Euichi/I-5009-2013	Hirose, Euichi/0000-0001-7002-4524			YAMAMOTO H, 1989, MACROMOLECULES, V22, P4130, DOI 10.1021/ma00200a058; BELTON PS, 1989, MACROMOLECULES, V22, P1615, DOI 10.1021/ma00194a019; Kimura S, 1996, PROTOPLASMA, V194, P151, DOI 10.1007/BF01882023; BONE Q, 1984, J EXP MAR BIOL ECOL, V76, P105, DOI 10.1016/0022-0981(84)90059-5; Hirose E, 1996, INVERTEBR BIOL, V115, P343, DOI 10.2307/3227023; AOKI M, 1989, BIOL BULL, V176, P57, DOI 10.2307/1541889; Chiba K, 1998, J EXP ZOOL, V281, P546, DOI 10.1002/(SICI)1097-010X(19980815)281:6<546::AID-JEZ2>3.0.CO;2-N; Bone Q., 1998, BIOL PELAGIC TUNICAT; BONE Q, 1983, J ZOOL, V201, P481; DELEO G, 1977, ACTA ZOOL-STOCKHOLM, V58, P135; DELEO G, 1981, ACTA ZOOL-STOCKHOLM, V62, P259; Fenaux R., 1998, P151; HIROSE E, 1995, BIOL BULL, V189, P29, DOI 10.2307/1542198; Hirose E, 1997, ZOOL SCI, V14, P683, DOI 10.2108/zsj.14.683; HIROSE E, 1994, ZOOL SCI, V11, P203; HIROSE E, 1990, J MORPHOL, V204, P67, DOI 10.1002/jmor.1052040108; Hirose E, 1997, DEV COMP IMMUNOL, V21, P25, DOI 10.1016/S0145-305X(97)00002-5; Hirose E, 1996, ZOOL SCI, V13, P519, DOI 10.2108/zsj.13.519; Hirose E, 1997, BIOL BULL, V192, P53, DOI 10.2307/1542575; Hirose Euchi, 1992, Hiyoshi Review of Natural Science, V12, P108; HIROSE E, 1992, ZOOL SCI, V9, P397; MACKIE GO, 1987, BIOL BULL, V173, P188, DOI 10.2307/1541872; Nishiakwa Jun, 1994, Bulletin of Plankton Society of Japan, V41, P170; Okamoto Takashi, 1996, Wood Research, V83, P27; VANDAELE Y, 1992, BIOL CELL, V76, P87, DOI 10.1016/0248-4900(92)90198-A; WELSCH U, 1984, BIOL INTEGUMENT INVE, V1, P800	26	31	32	MARINE BIOLOGICAL LABORATORY	WOODS HOLE	7 MBL ST, WOODS HOLE, MA 02543 USA	0006-3185			BIOL BULL	Biol. Bull.	FEB	1999	196	1					113	120		10.2307/1543173		8	Biology; Marine & Freshwater Biology	Life Sciences & Biomedicine - Other Topics; Marine & Freshwater Biology	170YT	WOS:000078835400013		
J	Shimazawa, R; Miyachi, H; Takayama, H; Kuroda, K; Kato, F; Kato, M; Hashimoto, Y				Shimazawa, R; Miyachi, H; Takayama, H; Kuroda, K; Kato, F; Kato, M; Hashimoto, Y			Antiangiogenic activity of tumor necrosis factor-alpha production regulators derived from thalidomide	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						thalidomide; antiangiogenesis; phthalimide; tumor necrosis factor-alpha	BIDIRECTIONAL REGULATION; ENANTIO-DEPENDENCE; ANGIOGENESIS; GROWTH; INHIBITION; HEPARIN; PHENYLPHTHALIMIDES; DISEASE; ANALOGS	Recently, we developed novel tumor necrosis factor (TNF)-alpha production regulators with a phthalimide skeleton derived from thalidomide, We show here that some of these compounds are more potent inhibitors than thalidomide of angiogenesis induced by basic fibroblast growth factor in a murine angiogenesis assay.	Univ Tokyo, Dept Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Ishihara Sangyo Kaisha Ltd, Cent Res Res, R&D Grp Pharmaceut, Shiga 5250025, Japan	Hashimoto, Y (reprint author), Univ Tokyo, Dept Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						PASSANITI A, 1992, LAB INVEST, V67, P519; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Shibata Y, 1996, CHEM PHARM BULL, V44, P156; SAMPAIO EP, 1991, J EXP MED, V173, P699, DOI 10.1084/jem.173.3.699; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; TAMARGO RJ, 1991, CANCER RES, V51, P672; CRUM R, 1985, SCIENCE, V230, P1375, DOI 10.1126/science.2416056; FOLKMAN J, 1971, NEW ENGL J MED, V285, P82; Hashimoto Y, 1998, CURR MED CHEM, V5, P163; KAPLAN G, 1994, IMMUNOBIOLOGY, V191, P564; LEE JK, 1990, J NEUROSURG, V73, P429, DOI 10.3171/jns.1990.73.3.0429; MAKONKAWKEYOON S, 1993, P NATL ACAD SCI USA, V90, P5974, DOI 10.1073/pnas.90.13.5974; Miyachi H, 1996, BIOCHEM BIOPH RES CO, V226, P439, DOI 10.1006/bbrc.1996.1374; Miyachi H, 1997, BIOORGAN MED CHEM, V5, P2095, DOI 10.1016/S0968-0896(97)00148-X; Miyachi H, 1996, CHEM PHARM BULL, V44, P1980; Miyachi H, 1997, J MED CHEM, V40, P2858, DOI 10.1021/jm970109q; Miyachi H, 1996, BIOORG MED CHEM LETT, V6, P2293, DOI 10.1016/0960-894X(96)00409-X; MIYATA H, 1995, J GEN APPL MICROBIOL, V41, P63, DOI 10.2323/jgam.41.63; Nguyen M, 1997, INT J ONCOL, V10, P965; NISHIMURA K, 1994, CHEM PHARM BULL, V42, P1157; NISHIMURA K, 1994, BIOCHEM BIOPH RES CO, V199, P455, DOI 10.1006/bbrc.1994.1250; SAKAMOTO N, 1991, CANCER RES, V51, P903; SASAKI K, 1995, BIOL PHARM BULL, V18, P1228; SHIBATA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1992, DOI 10.1006/bbrc.1994.2904; SHIMAZAWA R, IN PRESS J ENZYME IN	26	28	30	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	FEB	1999	22	2					224	226				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	169PU	WOS:000078758400024		
J	Kizu, J; Watanabe, S; Yasuno, N; Arakawa, Y; Uzu, S; Kanda, S; Komoda, F; Iwata, T; Hayakawa, H; Hayakawa, T; Imai, K				Kizu, J; Watanabe, S; Yasuno, N; Arakawa, Y; Uzu, S; Kanda, S; Komoda, F; Iwata, T; Hayakawa, H; Hayakawa, T; Imai, K			Development and clinical application of high performance liquid chromatography for the simultaneous determination of plasma levels of theophylline and its metabolites without interference from caffeine	BIOMEDICAL CHROMATOGRAPHY			English	Article							DISPOSITION	A high performance liquid chromatography (HPLC) method has been developed for the simultaneous determination of plasma levels of theophylline and its metabolites without interference from caffeine or caffeine metabolites. The method is simple and of practical use because it is applicable even to plasma samples from patients who take caffeine-containing beverages. The method was also reproducible with a coefficient of variation of less than 5% for each analyte. The levels of theophylline, determined by HPLC, were validated by their high correlation to the levels obtained by fluorescence polarization immunoassay. HPLC was used to determine theophylline levels in patients with bronchial asthma. The data revealed that the ratio of 1,3-dimethyluric acid, the major metabolite of theophylline, to theophylline concentration in the plasma was within a narrow range in most patients (0.055 +/- 0.01, n = 66), regardless of the method of theophylline administration or the time of blood sampling. Conversely, this ratio was as low as 0.027 +/- 0.005 in the patient with a long plasma half-life of theophylline. These results suggest that it may be possible to predict the plasma half-life of theophylline for each patient from a single blood sample. This may be useful when planning theophylline administration, especially in patients with abnormal theophylline metabolism. Copyright (C) 1999 John Wiley & Sons, Ltd.	Univ Tokyo, Fac Med, Branch Hosp, Dept Pharm,Bunkyo Ku, Tokyo 112, Japan; Mitsui Mem Hosp, Dept Pharm, Chiyoda Ku, Tokyo 101, Japan; Univ Tokyo, Fac Med, Branch Hosp, Dept Pediat,Bunkyo Ku, Tokyo 112, Japan; Natl Sagamihara Hosp, Ctr Rheumatoallergol, Dept Res, Sagamihara, Kanagawa 228, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Bioanalyt Chem, Bunkyo Ku, Tokyo 113, Japan	Kizu, J (reprint author), Univ Tokyo, Fac Med, Branch Hosp, Dept Pharm,Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 112, Japan.						WILLIAMS JF, 1978, BIOCHEM PHARMACOL, V27, P1545, DOI 10.1016/0006-2952(78)90483-5; TANGLIU DD, 1983, J PHARMACOL EXP THER, V224, P180; BECKMANN J, 1987, EUR J CLIN PHARMACOL, V33, P227, DOI 10.1007/BF00637553; Hamasaki Y., 1986, JAP J CLIN CHEM, V15, P44; HENDELES L, 1978, CLIN PHARMACOKINET, V3, P294, DOI 10.2165/00003088-197803040-00003; HURWITZ A, 1991, CLIN PHARMACOL THER, V50, P299; KAWAKATSU K, 1988, THER RES, V8, P34; KAWAKATSU K, 1985, JPN PHARMACOL THER, V13, P4509; KODERA H, 1985, ALLERGY, V34, P33; LEAKEY TEB, 1991, CLIN PHARMACOKINET, V21, P400, DOI 10.2165/00003088-199121050-00007; MUIR KT, 1982, J CHROMATOGR, V231, P73, DOI 10.1016/S0378-4347(00)80510-1; NALINE E, 1987, J CHROMATOGR-BIOMED, V419, P177, DOI 10.1016/0378-4347(87)80276-1; RICHER M, 1993, CLIN PHARMACOKINET, V25, P283; SAITO K, 1987, MED PRACTICE S, V4, P252; SARKAR MA, 1992, DRUG METAB DISPOS, V20, P31; TANGLIU DDS, 1982, CLIN PHARMACOL THER, V31, P358; TSERNG KY, 1981, CLIN PHARMACOL THER, V29, P594	17	19	20	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0269-3879			BIOMED CHROMATOGR	Biomed. Chromatogr.	FEB	1999	13	1					15	23		10.1002/(SICI)1099-0801(199902)13:1<15::AID-BMC766>3.3.CO;2-4		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	165JW	WOS:000078518500003		
J	Prados, P; Matsunaga, H; Mori, T; Santa, T; Fukushima, T; Homma, H; Kasai, C; Imai, K				Prados, P; Matsunaga, H; Mori, T; Santa, T; Fukushima, T; Homma, H; Kasai, C; Imai, K			Changes of plasma L-arginine levels in spontaneously hypertensive rats under induced hypotension	BIOMEDICAL CHROMATOGRAPHY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; NITRIC-OXIDE; BLOOD-PRESSURE; RELAXING FACTOR; AMINO-ACIDS; ENDOTHELIUM; RESPONSES; 7-FLUORO-4-NITROBENZO-2-OXA-1,3-DIAZOLE; STRESS; SODIUM	Nicardipine, a dihydropyridine type calcium channel blocker, was infused at two flow-rates into spontaneously hypertensive (SH) and control normotensive Wistar-Kyoto (WKY) rats (young, 6-week-old and adult, 23-week-old, n = 5) under pentobarbital anesthesia, to cause hypotension. Mean arterial blood pressure and the concentrations of plasma amino acids and norepinephrine (NE) were measured before infusion and at each step of the infusion. The reduction in blood pressure caused by nicardipine induced a decrease in plasma L-arginine concentration in both young and adult SH rats, this effect being larger in adult rats. There was no significant change in plasma levels of L-arginine in age-matched WKY rats. The concentration of other amino acids did not change in both rat strains. On the contrary, there was an increase in plasma NE concentration in both SH and WKY rats after infusion with nicardipine. Plasma L-arginine concentration showed a good inverse correlation with the logarithm of plasma NE concentration in SH and WKY rats and the correlation was expressed as Y = -alpha log(X) + m (Y, plasma L-arginine concentration (nmol/mL); X, plasma NE concentration (pmol/mL); alpha, a slope; and m, an intercept). alpha, 43.0 and 4.35 for 23-week-old SH and WKY rats, respectively, and 17.0 and 4.0 for 6-week-old SH and WKY rats, respectively. The present data together with previous data suggest a direct noradrenergic stimulation of the synthesis of nitric oxide (NO) from L-arginine. The findings also indicate an impairment of the L-arginine metabolism or pools in SH rats compared with WKY rats. The deficiency of L-arginine increases with the age of SH rats and could be related to the development and maintenance of hypertension due to inefficient production of NO. Copyright (C) 1999 John Wiley & Sons, Ltd.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Yamanouchi Seiyaku Co Ltd, Pharmacol Res Lab, Tsukuba, Ibaraki 3050841, Japan	Imai, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						HASEGAWA T, 1992, BIOCHEM INT, V26, P653; SAKUMA I, 1988, P NATL ACAD SCI USA, V85, P8664, DOI 10.1073/pnas.85.22.8664; ZEBALLOS GA, 1995, CIRCULATION, V91, P2982; KORTH HG, 1994, J AM CHEM SOC, V116, P2767, DOI 10.1021/ja00086a010; De Champlain J, 1972, Circ Res, V31, P617; DONALD DE, 1980, ANNU REV PHYSIOL, V42, P429, DOI 10.1146/annurev.ph.42.030180.002241; FEATHERS.WR, 1973, AM J PHYSIOL, V224, P127; GONZALEZ C, 1992, BIOCHEM BIOPH RES CO, V186, P150, DOI 10.1016/S0006-291X(05)80787-9; HALLBACK M, 1974, ACTA PHYSIOL SCAND, V90, P684, DOI 10.1111/j.1748-1716.1974.tb05636.x; HASEGAWA T, 1992, DOMYAKU KOUKA, V20, P1017; HIGASHIDATE S, 1994, BIOMED CHROMATOGR, V8, P19, DOI 10.1002/bmc.1130080105; HISHIKAWA K, 1992, J CARDIOVASC PHARM, V20, pS196; IMAI K, 1994, BIOL PHARM BULL, V17, P907; JONES MR, 1988, J NUTR, V118, P579; JUDDY WV, 1976, CIRC RES S2, V38, P21; KHARITONOV SA, 1995, CLIN SCI, V88, P135; KIKUCHI K, 1993, J BIOL CHEM, V268, P23106; KOEPKE JP, 1985, HYPERTENSION, V7, P357; LOCKETTE W, 1986, HYPERTENSION, V8, P61; LUSCHER TF, 1986, HYPERTENSION, V8, P344; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Prados P, 1997, BIOL PHARM BULL, V20, P341; Prados P, 1998, HYPERTENS RES-CLIN E, V21, P147, DOI 10.1291/hypres.21.147; PRADOS P, 1994, BIOMED CHROMATOGR, V8, P1, DOI 10.1002/bmc.1130080102; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; TAKAHASHI H, 1992, J CARDIOVASC PHARM, V20, pS214; THIENPONT LM, 1995, J CHROMATOGR A, V706, P443, DOI 10.1016/0021-9673(95)00152-D; Watanabe N, 1987, Biomed Chromatogr, V2, P99, DOI 10.1002/bmc.1130020304; WATANABE Y, 1982, J CHROMATOGR, V239, P723, DOI 10.1016/S0021-9673(00)82032-4; WATANABE Y, 1983, ANAL CHEM, V55, P1786, DOI 10.1021/ac00261a032; WATANABE Y, 1981, ANAL BIOCHEM, V116, P471, DOI 10.1016/0003-2697(81)90390-0	32	9	10	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0269-3879			BIOMED CHROMATOGR	Biomed. Chromatogr.	FEB	1999	13	1					27	32		10.1002/(SICI)1099-0801(199902)13:1<27::AID-BMC807>3.0.CO;2-6		6	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy	165JW	WOS:000078518500005		
J	Ito, K; Liu, X; Katayama, E; Uyeda, TQP				Ito, K; Liu, X; Katayama, E; Uyeda, TQP			Cooperativity between two heads of Dictyostelium myosin II in in vitro motility and ATP hydrolysis	BIOPHYSICAL JOURNAL			English	Article							SMOOTH-MUSCLE MYOSIN; PHOSPHORYLATION-DEPENDENT REGULATION; ACTIN-FILAMENTS; SLIDING MOVEMENT; HEAVY-MEROMYOSIN; 2 HEADS; INVITRO; MOTOR; SUBFRAGMENT-1; CONTRACTION	To elucidate the significance of the two-headed structure of myosin II, we have engineered and characterized recombinant single-headed myosin II. A tail segment of a myosin II heavy chain fused with a His-tag was expressed in wild-type Dictyostelium cells. Single-headed myosin, which consists of a full length myosin heavy chain and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and actin. Actin sliding velocity by the single-headed myosin was about half of the two-headed, whereas the minimum density of the heads to support continuous movement was twofold higher. Actin-activated MgATPase activity of the single-headed myosin in solution in the presence of 24 mu M actin was less than half of the two headed. This decrease is primarily because of fourfold-elevated Kapp for actin and secondary to 40% lower Vmax, These results suggest that the two heads of a Dictyostelium myosin II molecule act cooperatively on an actin filament. We propose a mechanism by which two heads move actin efficiently based on the cooperativity.	Natl Inst Adv Interdisciplinary Res, Biomol Res Grp, Tsukuba, Ibaraki 3058562, Japan; Univ Tokyo, Inst Med Sci, Dept Fine Morphol, Tokyo 1088639, Japan	Uyeda, TQP (reprint author), Natl Inst Adv Interdisciplinary Res, Biomol Res Grp, Higashi 1-1-4, Tsukuba, Ibaraki 3058562, Japan.	uyeda@nair.go.jp					Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; Cuda G, 1997, J MUSCLE RES CELL M, V18, P275, DOI 10.1023/A:1018613907574; Anson M, 1996, EMBO J, V15, P6069; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Katayama E, 1998, J MOL BIOL, V278, P349, DOI 10.1006/jmbi.1998.1715; AUSUBEL FM, 1993, CURRENT PROTOCOLS MO; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Bobkov AA, 1996, P NATL ACAD SCI USA, V93, P2285, DOI 10.1073/pnas.93.6.2285; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BRENNER B, 1982, P NATL ACAD SCI-BIOL, V79, P7288, DOI 10.1073/pnas.79.23.7288; BURNS CG, 1995, P NATL ACAD SCI USA, V92, P8244, DOI 10.1073/pnas.92.18.8244; COOKE R, 1978, J MOL BIOL, V120, P361, DOI 10.1016/0022-2836(78)90424-2; CREMO CR, 1995, J BIOL CHEM, V270, P2171; DANTZIG JA, 1991, J PHYSIOL-LONDON, V432, P639; EGELHOFF TT, 1990, DEV BIOL, V137, P359, DOI 10.1016/0012-1606(90)90260-P; EISENBERG E, 1980, ANNU REV PHYSIOL, V42, P209; GRIFFITH LM, 1987, J CELL BIOL, V104, P1309, DOI 10.1083/jcb.104.5.1309; GUILFORD WH, 1998, BIOPHYS J, V74, pA255; HARADA Y, 1987, NATURE, V326, P805, DOI 10.1038/326805a0; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255; ITAKURA S, 1993, BIOCHEM BIOPH RES CO, V196, P1504, DOI 10.1006/bbrc.1993.2422; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; [Anonymous], 1991, METHOD ENZYMOL; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MANSTEIN DJ, 1989, SCIENCE, V246, P656, DOI 10.1126/science.2530629; MARGOSSI.SS, 1973, J MOL BIOL, V74, P313, DOI 10.1016/0022-2836(73)90376-8; MATSUURA M, 1995, FEBS LETT, V363, P246, DOI 10.1016/0014-5793(95)00326-5; ONISHI H, 1990, J BIOL CHEM, V265, P19362; ONISHI H, 1989, BIOCHEMISTRY-US, V28, P1898, DOI 10.1021/bi00430a070; PERRIE WT, 1970, BIOCHEM J, V119, P31; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Shimada Takashi, 1996, Cell Structure and Function, V21, P598; Smith JL, 1996, EMBO J, V15, P6075; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Titus MA, 1993, CURR OPIN CELL BIOL, V5, P77, DOI 10.1016/S0955-0674(05)80011-0; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Trybus KM, 1997, P NATL ACAD SCI USA, V94, P48, DOI 10.1073/pnas.94.1.48; UYEDA TQP, 1991, NATURE, V352, P307, DOI 10.1038/352307a0; UYEDA TQP, 1993, SCIENCE, V262, P1867, DOI 10.1126/science.8266074; WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115; WARSHAW DM, 1990, J CELL BIOL, V111, P453, DOI 10.1083/jcb.111.2.453	46	29	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0006-3495	1542-0086		BIOPHYS J	Biophys. J.	FEB	1999	76	2					985	992		10.1016/S0006-3495(99)77262-0		8	Biophysics	Biophysics	162VZ	WOS:000078368800036		
J	Tanaka, K; Adachi, H; Konishi, H; Iwamatsu, A; Ohkawa, K; Shirai, T; Nagata, S; Kikkawa, U; Fukui, Y				Tanaka, K; Adachi, H; Konishi, H; Iwamatsu, A; Ohkawa, K; Shirai, T; Nagata, S; Kikkawa, U; Fukui, Y			Identification of protein kinase B (PKB) as a phosphatidylinositol 3,4,5-trisphosphate binding protein in Dictyostelium discoideum	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						phosphatidylinositol 3,4,5-trisphosphate; PI-3 kinase; protein kinase B; Dictyostelium discoideum; phosphatidylinositol 3,4,5-trisphosphate binding protein	PLECKSTRIN HOMOLOGY DOMAIN; 3-KINASE; ACTIVATION; GROWTH; PRODUCT; PATHWAY; CELLS; P110; AKT	We have searched for phosphatidylinositol (PI)-3,4,5-trisphosphate (PIP3) binding proteins in Dictyostelium discoideum using beads bearing a PIP3 analogue, PIP3-APB. One of the binding proteins with a molecular mass of 55 kDa was purified and its amino acid sequence was partially amalyzed. Database searches showed that the analyzed sequence was identical to that of protein kinase B (PKB) of D. discoideum. The specific activity of D. discoideum PKB, when expressed together with constitutively active PI-3 kinase in mammalian cells, was elevated by about three-fold, suggesting that PKB could also act downstream of PI-3 kinase in Dictyostelium cells.	Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Biol Chem Lab,Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanazawa Ku, Kanagawa 2360004, Japan	Fukui, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Biol Chem Lab,Bunkyo Ku, 1-1-1 Yayoi Cho, Tokyo 1130032, Japan.	ayfukui@hongo.ecc.u-tokyo.ac.jp	Fukui, Yasuhisa/E-8806-2010				Akimoto K, 1996, EMBO J, V15, P788; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Frech M, 1997, J BIOL CHEM, V272, P8474; Klippel A, 1997, MOL CELL BIOL, V17, P338; James SR, 1996, BIOCHEM J, V315, P709; Konishi H, 1996, P NATL ACAD SCI USA, V93, P7639, DOI 10.1073/pnas.93.15.7639; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; ZHOU KM, 1995, MOL CELL BIOL, V15, P5645; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Tanaka K, 1997, EUR J BIOCHEM, V245, P512, DOI 10.1111/j.1432-1033.1997.00512.x; WATTS DJ, 1970, BIOCHEM J, V119, P171; Shirai T, 1998, BBA-MOL CELL RES, V1402, P292, DOI 10.1016/S0167-4889(98)00014-7; Buczynski G, 1997, J CELL BIOL, V136, P1271, DOI 10.1083/jcb.136.6.1271; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; IWAMATSU A, 1992, ELECTROPHORESIS, V13, P142, DOI 10.1002/elps.1150130129; Kabuyama Y, 1996, EUR J BIOCHEM, V238, P350, DOI 10.1111/j.1432-1033.1996.0350z.x; Kita Y, 1998, J CELL SCI, V111, P907; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Takayanagi J, 1996, BIOCHEM MOL BIOL INT, V39, P721	24	12	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB	1999	63	2					368	372		10.1271/bbb.63.368		5	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	173QK	WOS:000078991100021		
J	Tanaka, T; Matsuzawa, H; Ohta, T				Tanaka, T; Matsuzawa, H; Ohta, T			Substrate specificity of aqualysin I altered by an organic solvent, DMSO	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						aqualysin I; alkaline serine protease; DMSO; substrate specificity; Thermus aquaticus YT-1	ALKALINE SERINE PROTEASE; THERMUS-AQUATICUS YT-1; ESCHERICHIA-COLI; SUBTILISIN BPN'; PRO-SEQUENCE; RESOLUTION	Aqualysin I is the alkaline serine protease isolated from an extreme thermophile, Thermus aquaticus YT-1. We have analyzed the kinetic properties of aqualysin I, using thirty-one kinds of chromogenic succinyl-tripeptide p-nitroanilides as substrates in the presence of 10% dimethylsulfoxide (DMSO). Aqualysin I hydrolyzed many peptides in a DMSO-containing mixture, however the substrate specificity was different from that in the absence of DMSO. The K-m for each peptide was raised by the addition of 10% DMSO. Also, the P3- as well as P2-specificity of aqualysin I was altered. These results suggested that the side chains of the P2 and P3 residues are exposed to the solvent, and the hydrophobic interactions between the side chain of the substrate and the solvent may take a part in the substrate recognition of the enzyme.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Ohta, T (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.						BETZEL C, 1988, EUR J BIOCHEM, V178, P155, DOI 10.1111/j.1432-1033.1988.tb14440.x; BODE W, 1987, EUR J BIOCHEM, V166, P673, DOI 10.1111/j.1432-1033.1987.tb13566.x; SIEZEN RJ, 1991, PROTEIN ENG, V4, P719, DOI 10.1093/protein/4.7.719; KWON ST, 1988, J BIOCHEM-TOKYO, V104, P557; KWON ST, 1988, EUR J BIOCHEM, V173, P491, DOI 10.1111/j.1432-1033.1988.tb14025.x; LEE YC, 1991, AGR BIOL CHEM TOKYO, V55, P3027; LEE YC, 1992, FEMS MICROBIOL LETT, V92, P73, DOI 10.1016/0378-1097(92)90544-X; MATSUZAWA H, 1983, AGR BIOL CHEM TOKYO, V47, P25; MATSUZAWA H, 1988, EUR J BIOCHEM, V171, P441, DOI 10.1111/j.1432-1033.1988.tb13809.x; MATTHEWS DA, 1975, J BIOL CHEM, V250, P7120; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P2439, DOI 10.1021/bi00763a009; Tanaka T, 1998, BIOSCI BIOTECH BIOCH, V62, P1806, DOI 10.1271/bbb.62.1806; Tanaka T, 1998, BIOSCI BIOTECH BIOCH, V62, P2161, DOI 10.1271/bbb.62.2161; Tanaka T, 1998, BIOSCI BIOTECH BIOCH, V62, P2035, DOI 10.1271/bbb.62.2035; Tanaka T, 1998, BIOCHEMISTRY-US, V37, P17402, DOI 10.1021/bi981533b; TERADA I, 1990, J BIOL CHEM, V265, P6576; WRIGHT CS, 1972, J MOL BIOL, V66, P283, DOI 10.1016/0022-2836(72)90479-2	17	3	3	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	FEB	1999	63	2					446	448		10.1271/bbb.63.446		3	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	173QK	WOS:000078991100038		
J	Kuwana, Y; Nagasawa, S; Shimoyama, I; Kanzaki, R				Kuwana, Y; Nagasawa, S; Shimoyama, I; Kanzaki, R			Synthesis of the pheromone-oriented behaviour of silkworm moths by a mobile robot with moth antennae as pheromone sensors	BIOSENSORS & BIOELECTRONICS			English	Article						pheromone sensor; pheromone-guided mobile robot; silkworm moth; antennae; pheromone-oriented behavior; EAG	BOMBYX-MORI; INTERNEURONS	The authors have studied the emergent mechanism in insect behavior by using a robotic system. Since insects have a simpler nervous system than humans, it is an appropriate model for clarifying the above mechanism. In this study, the pheromone oriented behavior of male silkworm moths was shown by a pheromone-guided mobile robot which had male moth antennae that can detect sex pheromones. This study focuses on the pheromone sensor that used antennae from a living moth. Since the antennae of silkworm moths are very sensitive as compared to artificial gas sensors, they can be used as living gas sensors that can detect pheromone molecules. (C) 1999 Elsevier Science S.A. All rights reserved.	NISES, Lab Biomimet, Tsukuba, Ibaraki 3058634, Japan; Univ Tokyo, Fac Engn, Dept Mechanoinformat, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tsukuba, Inst Biol Sci, Tsukuba, Ibaraki 3050006, Japan	Kuwana, Y (reprint author), NISES, Lab Biomimet, 1-2 Ohwashi, Tsukuba, Ibaraki 3058634, Japan.		Marion-Poll, Frederic/D-8882-2011	Marion-Poll, Frederic/0000-0001-6824-0180			KANZAKI R, 1992, ZOOL SCI, V9, P515; KANZAKI R, 1994, J COMP PHYSIOL A, V175, P1; OLBERG RM, 1983, J COMP PHYSIOL, V152, P297; Arbas Edmund A., 1993, P159; Farbert P, 1996, PHEROMONE RES NEW DI, P347; KANZAKI R, 1994, OLFACTION TASTE, V11, P851; KANZAKI R, 1994, OLFACTION TASTE, V11, P831; Kramer E., 1986, P59; Kramer E, 1996, PHEROMONE RES NEW DI, P232; Kramer E, 1975, MECH INSECT OLFACTIO, P329; Kuwana Y., 1995, Proceedings. 1995 IEEE/RSJ International Conference on Intelligent Robots and Systems. Human Robot Interaction and Cooperative Robots (Cat. No.95CB35836), DOI 10.1109/IROS.1995.526267; KUWANA Y, 1996, P ARTIFICIAL LIFE, V5, P337; KUWANA Y, 1997, IN PRESS INT J ROBOT; Kuwana Y., 1996, Proceedings of the 1996 IEEE/RSJ International Conference on Intelligent Robots and Systems. IROS 96. Robotic Intelligence Interacting with Dynamic Worlds (Cat. No.96CH35908), DOI 10.1109/IROS.1996.569043; SAUER AE, 1992, CHEM SENSES, V17, P543, DOI 10.1093/chemse/17.5.543; SCHNEIDE.D, 1969, SCIENCE, V163, P1031, DOI 10.1126/science.163.3871.1031; Shepherd GM, 1988, NEUROBIOLOGY; VANDERPERS JNC, 1996, PHEROMONE RES NEW DI, P359	18	54	54	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	FEB 1	1999	14	2					195	202		10.1016/S0956-5663(98)00106-7		8	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	168UA	WOS:000078710000010		
J	Kurooka, Y; Moriyama, N; Nasu, K; Kameyama, S; Fukasawa, R; Yano, J; Kawabe, K				Kurooka, Y; Moriyama, N; Nasu, K; Kameyama, S; Fukasawa, R; Yano, J; Kawabe, K			Distribution of alpha 1-adrenoceptor subtype mRNAs in human renal cortex	BJU INTERNATIONAL			English	Article						alpha 1-adrenoceptor subtypes; human renal cortex; in situ hybridization; RT-PCR; RNase protection assay	ADRENERGIC-RECEPTOR SUBTYPES; HUMAN PROSTATE; MESSENGER-RNAS; EXPRESSION; ALPHA(1)-ADRENOCEPTOR; QUANTIFICATION; CLONING; RAT; CLASSIFICATION; TISSUE	Objective To determine the quantity and distribution of alpha 1-adrenoceptor subtype mRNAs in human renal cortex. Materials and methods Specimens of renal cortex tissue were obtained at the time of radical nephrectomy or total nephroureterectomy from 46 patients (mean age 59.0 years, SD 14.7) with renal cell carcinoma, renal pelvic or ureteric tumour. Using the reverse-transcriptase polymerase chain reaction (RT-PCR), the RNase protection assay and in situ hybridization, the presentation, quantity and distribution of alpha 1-adrenoceptor subtype mRNAs were determined. Results Expression of the three alpha 1-adrenoceptor subtype mRNAs (alpha 1a, alpha 1b and alpha 1d) was confirmed in the arteries of the renal cortex (arciform, interlobular, arteriole), but among the three subtypes, the alpha 1b was less apparent by in situ hybridization, Intense alpha 1-mRNA staining was apparent especially in the smooth muscle of arterial walls. In both proximal and distal renal tubules, each of the alpha 1-mRNAs was less marked in cytoplasm than in the arteries. In the glomeruli weak staining was detected in the endothelium but there was no obvious staining in the veins. RT-PCR showed all three subtypes of alpha 1-adrenoceptor. The RNase protection assay showed that the predominant alpha 1-adrenoceptor subtype mRNA in human renal cortex was alpha 1a. However, the abundance of alpha 1a-mRNA in human kidney was much less than in the prostate. Conclusion Three alpha 1-adrenoceptor subtype mRNAs were recognized in human renal cortex and detected particularly in the smooth muscle of the arteries, There was more alpha 1a-adrenoceptor subtype in human renal cortex than the other subtypes. It is not known how each subtype operates against adrenergic stimulation; further studies are needed to examine receptor density or receptor function.	Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; Nippon Shinyaku Co Ltd, Dept Mol Biol, Res Labs, Kyoto 601, Japan	Kurooka, Y (reprint author), Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						HIEBLE JP, 1995, PHARMACOL REV, V47, P267; PRICE DT, 1993, J UROLOGY, V150, P546; Nasu K, 1996, BRIT J PHARMACOL, V119, P797; BLUE DR, 1995, BRIT J PHARMACOL, V115, P283; CHEN K, 1996, EUR J PHARMACOL, V284, P281; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DELEEUW PW, 1988, J HYPERTENS, V6, pS21; FORD APDW, 1994, TRENDS PHARMACOL SCI, V15, P167, DOI 10.1016/0165-6147(94)90136-8; Giordano M, 1996, NEPHRON, V72, P447; HIRASAWA A, 1993, BIOCHEM BIOPH RES CO, V195, P902, DOI 10.1006/bbrc.1993.2130; Kawabe K, 1998, BRIT J UROL, V81, P48; MORIYAMA N, 1995, GEN PHARMACOL, V26, P347, DOI 10.1016/0306-3623(94)00176-N; Moriyama N, 1996, HISTOCHEM J, V28, P283, DOI 10.1007/BF02409016; Moriyama N, 1997, BRIT J PHARMACOL, V122, P1009, DOI 10.1038/sj.bjp.0701485; Muramatsu I, 1995, PHARM COMMUN, V6, P23; Neumann P., 1993, International Urology and Nephrology, V25, P19, DOI 10.1007/BF02552250; PRICE DT, 1994, MOL PHARMACOL, V46, P221; RAMARAO CS, 1992, J BIOL CHEM, V267, P21936; SCHWINN DA, 1995, J PHARMACOL EXP THER, V272, P134; SNAVELY MD, 1982, MOL PHARMACOL, V22, P532; STUDER JA, 1993, J CLIN PHARMACOL, V33, P2; Testa R, 1996, J PHARMACOL EXP THER, V277, P1237; UMEMURA S, 1986, J HYPERTENS, V4, pS222; WEINBERG DH, 1994, BIOCHEM BIOPH RES CO, V201, P1296, DOI 10.1006/bbrc.1994.1845	24	3	3	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1464-4096			BJU INT	BJU Int.	FEB	1999	83	3					299	304				6	Urology & Nephrology	Urology & Nephrology	187FN	WOS:000079776400021		
J	Tanaka, M; Hara, T; Copeland, NG; Gilbert, DJ; Jenkins, NA; Miyajima, A				Tanaka, M; Hara, T; Copeland, NG; Gilbert, DJ; Jenkins, NA; Miyajima, A			Reconstitution of the functional mouse oncostatin M (OSM) receptor: Molecular cloning of the mouse OSM receptor beta subunit	BLOOD			English	Article							LEUKEMIA-INHIBITORY FACTOR; COLONY-STIMULATING FACTOR; SIGNAL-TRANSDUCTION; CYTOKINE RECEPTORS; GROWTH-REGULATOR; CELL-LINE; INTERLEUKIN-6; GP130; FAMILY; BINDING	Oncostatin M (OSM) is a member of the interleukin-6 (IL-6) family of cytokines that share the gp130 receptor subunit. Of these family members, leukemia inhibitory factor (LIF) is most closely related to OSM, and various overlapping biologic activities have been described between human LIF and OSM (hLIF and hOSM). Two types of functional hOSM receptors are known: the type I OSM receptor is identical to the LIF receptor that consists of gp130 and the LIF receptor beta subunit (LIFR beta), and the type II OSM receptor consists of gp130 and the OSM receptor beta subunit (OSMR beta). It is thus conceivable that common biologic activities between hLIF and hOSM are mediated by the shared type I receptor and OSM-specific activities are mediated by the type II receptor. However, in contrast to the human receptors, recent studies have demonstrated that mouse OSM (mOSM) does not activate the type I receptor and exhibits unique biologic activity. To elucidate the molecular structure of the functional mOSM receptor, we cloned a cDNA encoding mOSMR beta, which is 55.5% identical to the hOSMR beta at the amino acid level, mOSM-responsive cell lines express high-affinity mOSM receptors, as well as mOSMR beta, whereas embryonic stem cells, which are responsive to LIF but not to mOSM, do not express mOSMR beta. mOSMR beta alone binds mOSM with low affinity (kd = 13.0 nmol/L) and forms a high-affinity receptor (kd = 606 pmol/L) with gp130. Ba/F3 transfectants expressing both mOSMR beta and gp130 proliferated in response to mOSM, but failed to respond to LIF and human OSM. Thus, the cloned mOSMR beta constitutes an essential and species-specific receptor component of the functional mOSM receptor. Reminiscent of the colocalization of the mOSM and mLIF genes, the mOSMR beta gene was found to be located in the vicinity of the LIFR beta locus in the proximal end of chromosome 15. (C) 1999 by The American Society of Hematology.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; NCI, Mammalian Genet Lab, Adv Biosci Labs, Basic Res Program,Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA	Miyajima, A (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	miyajima@ims.u-tokyo.ac.jp					THOMA B, 1994, J BIOL CHEM, V269, P6215; DAVIS S, 1993, SCIENCE, V260, P1805, DOI 10.1126/science.8390097; KISHIMOTO T, 1995, BLOOD, V86, P1243; Pennica D, 1996, NEURON, V17, P63, DOI 10.1016/S0896-6273(00)80281-0; Kuropatwinski KK, 1997, J BIOL CHEM, V272, P15135, DOI 10.1074/jbc.272.24.15135; ROSE TM, 1991, P NATL ACAD SCI USA, V88, P8641, DOI 10.1073/pnas.88.19.8641; DU XX, 1994, BLOOD, V83, P2023; Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; ROSE TM, 1994, CYTOKINE, V6, P48, DOI 10.1016/1043-4666(94)90007-8; MURAKAMI M, 1991, P NATL ACAD SCI USA, V88, P11349, DOI 10.1073/pnas.88.24.11349; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Hara T, 1998, DEV BIOL, V201, P144, DOI 10.1006/dbio.1998.8990; BAZAN JF, 1990, P NATL ACAD SCI USA, V87, P6934, DOI 10.1073/pnas.87.18.6934; SPORENO E, 1994, J BIOL CHEM, V269, P10991; TANIGUCHI T, 1995, SCIENCE, V268, P251, DOI 10.1126/science.7716517; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Cichy J, 1997, J BIOL CHEM, V272, P8250; GEARING DP, 1992, SCIENCE, V255, P1434, DOI 10.1126/science.1542794; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; Mosley B, 1996, J BIOL CHEM, V271, P32635; JEFFERY E, 1993, CYTOKINE, V5, P107, DOI 10.1016/1043-4666(93)90048-A; BAZAN JF, 1989, BIOCHEM BIOPH RES CO, V164, P788, DOI 10.1016/0006-291X(89)91528-3; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357; MALIK N, 1989, MOL CELL BIOL, V9, P2847; JENKINS NA, 1982, J VIROL, V43, P26; COLOSI P, 1993, J BIOL CHEM, V268, P12617; Ichihara M, 1997, BLOOD, V90, P165; Yoshimura A, 1996, EMBO J, V15, P1055; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; BAUMANN H, 1994, MOL CELL BIOL, V14, P138; BAUMANN H, 1993, J BIOL CHEM, V268, P8414; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; BRUCE AG, 1992, J IMMUNOL, V149, P1271; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90085-5; COSMAN D, 1993, CYTOKINE, V5, P95, DOI 10.1016/1043-4666(93)90047-9; DAMELL JE, 1994, SCIENCE, V264, P1415; GASCAN H, 1989, LYMPHOKINE RES, V8, P79; GEARING DP, 1993, GENOMICS, V18, P148, DOI 10.1006/geno.1993.1441; HARA T, 1992, EMBO J, V11, P1875; Hasson T, 1996, GENOMICS, V36, P431, DOI 10.1006/geno.1996.0488; LIU JW, 1992, J BIOL CHEM, V267, P16763; Maruyama K, 1990, MED IMMUNOL, V20, P27; MCDONALD VL, 1993, GROWTH FACTORS, V9, P167; MILES SA, 1992, SCIENCE, V255, P1432, DOI 10.1126/science.1542793; MIYAJIMA A, 1987, GENE, V58, P273, DOI 10.1016/0378-1119(87)90382-9; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MUNSON PJ, 1983, METHOD ENZYMOL, V92, P543; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; Schreurs J, 1990, Growth Factors, V2, P221, DOI 10.3109/08977199009071508; SCHREURS J, 1989, J IMMUNOL, V142, P819; THOMA B, 1995, CYTOKINE, V7, P607; ZARLING JM, 1986, P NATL ACAD SCI USA, V83, P9739, DOI 10.1073/pnas.83.24.9739; ZIEGLER SF, 1993, MOL CELL BIOL, V13, P2384	56	67	71	AMER SOC HEMATOLOGY	WASHINGTON	1200 19TH ST, NW, STE 300, WASHINGTON, DC 20036-2422 USA	0006-4971			BLOOD	Blood	FEB 1	1999	93	3					804	815				12	Hematology	Hematology	161YX	WOS:000078319100005		
J	Yamagata, M; Mori, M; Mimori, K; Mafune, KI; Tanaka, Y; Ueo, H; Akiyoshi, T				Yamagata, M; Mori, M; Mimori, K; Mafune, KI; Tanaka, Y; Ueo, H; Akiyoshi, T			Expression of pyrimidine nucleoside phosphorylase mRNA plays an important role in the prognosis of patients with oesophageal cancer	BRITISH JOURNAL OF CANCER			English	Article						pyrimidine nucleoside phosphorylase; oesophagus; carcinoma; human; reverse transcription polymerase chain reaction	CELL GROWTH-FACTOR; HUMAN GASTRIC-CARCINOMA; THYMIDINE PHOSPHORYLASE; COLORECTAL-CARCINOMA; ANGIOGENIC FACTOR; TUMOR-CELLS; 5'-DEOXY-5-FLUOROURIDINE; TISSUES; XENOGRAFTS	To clarity the significance of the expression of pyrimidine nucleoside phosphorylase (PyNPase) mRNA as a predictive factor for the prognosis of patients with oesophageal carcinoma, the PyNPase mRNA in the tumours and normal tissues from 55 resected cases of oesophageal carcinoma was examined by a reverse transcript on polymerase chain reaction (RT-PCR). As a result, a positive correlation was observed between the tumour/normal (TIN) ratio of the expression of PyNPase mRNA by RT-PCR and that or the enzyme activity of PyNPase based on the findings of an enzyme linked immunosolvent assay (r= 0.594, P = 0.009). The T/N ratio of the expression of PyNPase mRNA was significantly higher in the cases with lymph Vessel invasion (P = 0.013), lymph node metastasis (P= 0.0016), and an advanced stage of the disease (P = 0.021) than those without these factors. The patients with a higher T/N ratio of PyNPase mRNA showed significantly worse prognosis than those with a lower T/N ratio (P = 0.023 with log-rank tests). A multivariate analysis for the cumulative survival rates revealed that a high T/N ratio of the expression of PyNPase mRNA was independently related to a poor prognosis. These findings suggested that the determination of PyNPase mRNA by RT-PCR thus appears to be a new useful parameter for identifying both a poor prognosis and a highly malignant potential of oesophageal carcinoma.	Kyushu Univ, Dept Surg, Med Inst Bioregulat, Beppu, Oita 874, Japan; Tokyo Univ Hosp, Dept Surg, Tokyo 113, Japan; Suita Canc Ctr Hosp, Dept Surg, Suita, Osaka, Japan; Oita Prefectural Hosp, Dept Surg, Oita, Japan	Yamagata, M (reprint author), Kyushu Univ, Dept Surg, Med Inst Bioregulat, Beppu, Oita 874, Japan.		Mori, Masaki/A-4501-2011				FURUKAWA T, 1992, NATURE, V356, P668, DOI 10.1038/356668a0; COX DR, 1972, J R STAT SOC B, V34, P187; Mori M, 1996, INT J CANCER, V68, P739; EDA H, 1993, CANCER CHEMOTH PHARM, V32, P333, DOI 10.1007/BF00735915; Takebayashi Y, 1996, EUR J CANCER, V32A, P1227, DOI 10.1016/0959-8049(96)00061-5; ISHIKAWA F, 1989, NATURE, V338, P557, DOI 10.1038/338557a0; Takebayashi Y, 1996, J NATL CANCER I, V88, P1110, DOI 10.1093/jnci/88.16.1110; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Giatromanolaki A, 1997, J PATHOL, V181, P196; HIROKOSHI T, 1992, CANCER RES, V52, P108; Imazono Y, 1997, J CLIN ONCOL, V15, P2570; ISHITSUKA H, 1980, GANN, V71, P112; Japanese Society for Esophageal Disease, 1992, GUID CLIN PATH STUD; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KONO A, 1983, CHEM PHARM BULL, V31, P175; Kubota Y, 1997, CLIN CANCER RES, V3, P973; LUCCIONI C, 1994, INT J CANCER, V58, P517, DOI 10.1002/ijc.2910580411; Maeda K, 1996, BRIT J CANCER, V73, P884, DOI 10.1038/bjc.1996.177; Mimori K, 1997, INT J ONCOL, V10, P493; Mori M, 1997, NAT MED, V3, P593, DOI 10.1038/nm0697-593; MORI M, 1995, CANCER RES, V55, P3417; NIO Y, 1992, ANTICANCER RES, V12, P1141; Nishida M, 1996, BIOL PHARM BULL, V19, P1407; Petro R, 1973, BIOMETRICS, V29, P579; SUGIMACHI K, 1994, J AM COLL SURGEONS, V178, P363; Takebayashi Y, 1996, JPN J CANCER RES, V87, P288; Tanigawa N, 1996, CANCER LETT, V108, P281, DOI 10.1016/S0304-3835(96)04482-5; WEBER G, 1983, CANCER RES, V43, P3466	28	5	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0007-0920			BRIT J CANCER	Br. J. Cancer	FEB	1999	79	3-4					565	569		10.1038/sj.bjc.6690089		5	Oncology	Oncology	159GZ	WOS:000078165200030		
J	Nakagawa, S; Yoshikawa, H; Kimura, M; Kawana, K; Matsumoto, K; Onda, T; Kino, N; Yamada, M; Yasugi, T; Taketani, Y				Nakagawa, S; Yoshikawa, H; Kimura, M; Kawana, K; Matsumoto, K; Onda, T; Kino, N; Yamada, M; Yasugi, T; Taketani, Y			A possible involvement of aberrant expression of the FHIT gene in the carcinogenesis of squamous cell carcinoma of the uterine cervix	BRITISH JOURNAL OF CANCER			English	Article						FHIT gene expression; cervical carcinoma; cervical intraepithelial neoplasia; squamous cell carcinoma; carcinogenesis; human papillomavirus	HUMAN PAPILLOMAVIRUS TYPE-16; E6 ONCOPROTEIN; CHROMOSOME 3P; P53; CANCER; LINES; ASSOCIATION; MUTATIONS; INFECTION; PROTEINS	To investigate involvement of an aberrant expression of the FHIT(fragile histidine triad) gene in the process of carcinogenesis and progression in cervical carcinoma, we examined its expression by the reverse transcriptase polymerase chain reaction (RT-PCR) and cDNA sequence method in 32 cervical invasive carcinomas (25 squamous cell carcinomas and seven adeno- or adenosquamous carcinomas) and 18 of its precursor lesions [four low-grade and 14 high-grade cervical intraepithelial[ neoplasias (CINs)]. We also examined a link between the occurrence of the aberrant expression and human papillomavirus (HPV). We detected the aberrant FHIT transcripts in 11 of 25 (44%) cervical invasive squamous cell carcinomas and in 5 of 14 (36%) high-grade CINs (CIN 2 or 3), whereas they were not found in seven non-squamous type and four low-grade CINs (CIN 1). The alteration patterns of the FHIT gene expression in high-grade CINs Ms were virtually similar to those found in invasive carcinomas, such that the exons 5-7 were consistently deleted associated or unassociated with loss of the exon 4 and/or 8. The incidence of the aberrant expression was not related to the presence of HPV and its type. These data indicate that the aberrant expression of the FHIT gene is observed in precursor lesions of cervical carcinoma as well as invasive carcinomas, with its incidence not increasing with advance of clinical stage. Given the squamous cell type dominant expression, the aberrant expression may play a critical role in the generation of squamous cell carcinoma of the uterine cervix, but not the consequence of the progression of the cancer.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 113, Japan	Yoshikawa, H (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						CROOK T, 1992, EMBO J, V11, P3935; Ohta M, 1996, CELL, V84, P587, DOI 10.1016/S0092-8674(00)81034-X; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524; FUJITA M, 1992, CANCER RES, V52, P5323; Hendricks DT, 1997, CANCER RES, V57, P2112; MUNGER K, 1989, EMBO J, V8, P4099; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; HUIBREGTSE JM, 1991, EMBO J, V10, P4129; CHOO KB, 1993, VIROLOGY, V193, P1042; CROOK T, 1991, ONCOGENE, V6, P873; Fong KM, 1997, CANCER RES, V57, P2256; Gemma A, 1997, CANCER RES, V57, P1435; Greenspan DL, 1997, CANCER RES, V57, P4692; HELLAND A, 1993, J PATHOL, V171, P105, DOI 10.1002/path.1711710207; Larson AA, 1997, CANCER RES, V57, P4082; Mao L, 1996, CANCER RES, V56, P5128; MIWA K, 1995, BRIT J CANCER, V71, P219, DOI 10.1038/bjc.1995.47; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sozzi G, 1996, CELL, V85, P17, DOI 10.1016/S0092-8674(00)81078-8; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Wistuba II, 1997, CANCER RES, V57, P3154	21	22	29	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0007-0920			BRIT J CANCER	Br. J. Cancer	FEB	1999	79	3-4					589	594		10.1038/sj.bjc.6690093		6	Oncology	Oncology	159GZ	WOS:000078165200034		
J	Kizu, R; Nakanishi, T; Hayakawa, K; Matsuzawa, A; Eriguchi, M; Takeda, Y; Akiyama, N; Tashiro, T; Kidani, Y				Kizu, R; Nakanishi, T; Hayakawa, K; Matsuzawa, A; Eriguchi, M; Takeda, Y; Akiyama, N; Tashiro, T; Kidani, Y			A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine)(oxalato)platinum(IV)	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						antitumor platinum complex; orally active agent; oxaliplatin derivative	PLATINUM COMPLEX; OXALATO-PLATINUM; PHASE-I; CISPLATIN; ANALOGS; BIOTRANSFORMATION; PHARMACOKINETICS; TETRAPLATIN; OXALIPLATIN; DRUG	Purpose: The authors have previously reported that trans-bis(n-valerato)(1R,2R-cyclohexanediamine) (oxalato)platinum(IV) (C5-OHP), an oxaliplatin derivative, is an orally active antitumor agent in an intraperitoneal (i.p.) L1210 murine leukemia model. In this study, several oxaliplatin derivatives of the general formula trans-(carboxylato)chloro(1R,2R-cyclohexanediamine)(oxalato)platinum(IV) were synthesized in order to find new derivatives with greater oral activity than C5-OHP in a clinically predictive tumor model. In the formula, the carboxylate and chloride ligands are situated in axial positions. Methods: Four complexes with the axial carboxylate ligands il-butyrate? n-valerate, n-caproate or n-heptanoate were synthesized and designated C4-OHP-Cl, C5-OHP-Cl, C6-OHP-Cl and C7-OHP-Cl, respectively. The oral antitumor activity of the complexes was evaluated against the murine reticulosarcoma M5076 implanted subcutaneoulsy (s.c.) in to male BDF(1) mice. The complexes were administered orally daily for 5 days in two cycles initiated on days 5 and 12 postimplantation. The physicochemical properties were examined by measuring the concentrations of the complexes in test solutions at intervals by HPLC. The pharmacokinetic behaviors of C5-OHP-Cl, C6-OHP-Cl and C5-OHP following a single oral administration were studied in non-tumor-bearing male BDF(1) mice. Results: Of the complexes synthesized in this study, C5-OHP-Cl, which exhibited high activity in the i.p. L1210 model, was found to be orally active in the s.c. M5076 model while C5-OHP was not. The in vitro reduction of the complexes by ascorbate was much more rapid than that of C5-OHP, while the complexes were more stable than C5-OHP in HCl-acidic and alkaline solutions. Pharmacokinetic study showed that C(max) and AUC(0 24h) values of plasma total and filterable platinum of C5-OHP-Cl were four to six times greater than those of C5-OHP, indicating that C5-OHP-Cl was absorbed more than C5-OHP. Conclusion: C5-OHP-Cl was found to be a superior 1-OHP derivative C5-OHP, exhibiting significant oral antitumor activity in the s.c. M5076 model. The enhanced activity of C5-OHP-Cl was considered to be due in part to increased susceptibility to reduction and increased gastrointestinal absorption. C5-OHP-Cl is a suitable candidate for further study as an oral cancer chemotherapy agent.	Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1080071, Japan; Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Toshima Ku, Tokyo 1700012, Japan; Nagoya City Univ, Fac Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4670027, Japan	Kizu, R (reprint author), Kanazawa Univ, Fac Pharmaceut Sci, 13-1 Takara Machi, Kanazawa, Ishikawa 9200934, Japan.		Nakanishi, Takeo/C-3891-2015	Nakanishi, Takeo/0000-0002-6561-7138			ALBERTS DS, 1996, PLATINUM OTHER METAL, V2, P303; KELLAND LR, 1993, CRIT REV ONCOL HEMAT, V15, P191, DOI 10.1016/1040-8428(93)90042-3; MATHE G, 1989, BIOMED PHARMACOTHER, V43, P237, DOI 10.1016/0753-3322(89)90003-6; TASHIRO T, 1989, BIOMED PHARMACOTHER, V43, P251, DOI 10.1016/0753-3322(89)90004-8; BURCHENAL JH, 1979, CANCER TREAT REP, V63, P1493; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; LOEHRER PJ, 1984, ANN INTERN MED, V100, P704; KELLAND LR, 1993, CANCER RES, V53, P2581; KIDANI Y, 1980, GANN, V71, P637; MATHE G, 1986, BIOMED PHARMACOTHER, V40, P372; AYRES GH, 1951, ANAL CHEM, V23, P299, DOI 10.1021/ac60050a020; BURCHENAL JH, 1980, RECENT RES CANCER, V74, P146; CHANEY SG, 1990, CANCER RES, V50, P4539; CHRISTIAN MC, 1992, SEMIN ONCOL, V19, P720; Cleare MJ, 1980, CISPLATIN CURRENT ST, P149; GIANDOMENICO CM, 1991, PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY, P93; KIDANI Y, 1977, Journal of Clinical Hematology and Oncology, V7, P197; KIZU R, 1993, CANCER CHEMOTH PHARM, V31, P475, DOI 10.1007/BF00685038; Kizu R, 1998, ANTI-CANCER DRUG, V9, P167, DOI 10.1097/00001813-199802000-00008; Kizu R, 1996, ANTI-CANCER DRUG, V7, P248, DOI 10.1097/00001813-199605000-00003; MATHE G, 1985, CANCER LETT, V27, P135, DOI 10.1016/0304-3835(85)90102-8; MAULDIN SK, 1988, CANCER RES, V48, P5136; MCKEAGE MJ, 1995, CANCER CHEMOTH PHARM, V36, P451, DOI 10.1007/BF00685793; NOJI M, 1988, NIPPON KAGAKU KAISHI, P675; PENDYALA L, 1993, CANCER RES, V53, P5970; RAYNAUD FI, 1995, CONTR ONCOL, V49, P100; Rose WC, 1997, CANCER CHEMOTH PHARM, V40, P51, DOI 10.1007/s002800050624; ROSE WC, 1993, CANCER CHEMOTH PHARM, V32, P197, DOI 10.1007/BF00685835; ROSE WC, 1986, ANTICANCER RES, V6, P557; Soulie P, 1996, PLATINUM AND OTHER METAL COORDINATION COMPOUNDS IN CANCER CHEMOTHERAPY 2, P165; TASHIRO T, 1988, NIPPON KAGAKU KAISHI, P684; YARBO JW, 1992, SEMIN ONCOL, V19, P72	32	15	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704			CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	FEB	1999	43	2					97	105				9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	145AJ	WOS:000077348500001		
J	Sakabe, T; Shinomiya, T; Mori, T; Ariyama, Y; Fukuda, Y; Fujiwara, T; Nakamura, Y; Inazawa, J				Sakabe, T; Shinomiya, T; Mori, T; Ariyama, Y; Fukuda, Y; Fujiwara, T; Nakamura, Y; Inazawa, J			Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization	CANCER RESEARCH			English	Article							BINDING-PROTEIN COMPLEX; SOFT-TISSUE SARCOMAS; ACID-LABILE SUBUNIT; PROGNOSTIC FACTORS; ADENYLATE-CYCLASE; DNA-SEQUENCE; HUMAN-SERUM; GLYCOSAMINOGLYCANS; EXPRESSION; TUMORS	We used comparative genomic hybridization to study malignant fibrous histiocytomas (MFHs) from 19 patients to detect changes in the copy number of DNA sequences along entire chromosomes, Together with losses and gains in various chromosomal regions, distinct high-level amplifications were found at six loci (4q12-21, 8p21-pter, 8q24.1-qter, 9q12-13, 12p11.2-pter, and 15q11.2-15), suggesting that those regions may contain unknown (proto) oncogenes, We focused on the 8p amplicon, where detailed characterization allowed us to determine that the minimal common amplified region lay between markers D8S1819 and D8S550 at 8p23.1. A novel gene designated MASL1 (MFH-amplified sequences with leucine-rich tandem repeats 1) was isolated from within this narrowly defined region. Expression of the MASL1 gene was enhanced significantly in MFH tumors bearing the 8p amplicon, The primary structure of its deduced product revealed an ATP/GTP-binding site, three leucine zipper domains, and a leucine-rich tandem repeat, all of which are important structural or functional elements for interactions among proteins related to the cell cycle. These features suggest that overexpression of MASL1 might well be oncogenic with respect to MFH.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 1088639, Japan; Kyoto Prefectural Univ Med, Dept Orthoped Surg, Kyoto 6020841, Japan; Otsuka Pharmaceut Co Ltd, Otsuka GEN Res Inst, Tokushima 7710192, Japan; Tokyo Med & Dent Univ, Med Res Inst, Div Genet, Dept Mol Cytogenet, Tokyo 1138519, Japan	Inazawa, J (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, Shirokanedai 4-6-1, Tokyo 1088639, Japan.						NILBERT M, 1995, CANCER GENET CYTOGEN, V83, P32, DOI 10.1016/S0165-4608(95)00016-X; Larramendy ML, 1997, AM J PATHOL, V151, P1153; BAXTER RC, 1989, J BIOL CHEM, V264, P11843; HOOK M, 1984, ANNU REV BIOCHEM, V53, P847; WADAYAMA B, 1993, BRIT J CANCER, V68, P1134, DOI 10.1038/bjc.1993.493; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; KALLIONIEMI OP, 1994, GENE CHROMOSOME CANC, V10, P231, DOI 10.1002/gcc.2870100403; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; BAXTER RC, 1990, BIOCHEM J, V271, P773; BINOUX M, 1988, J CLIN ENDOCR METAB, V67, P509; Delhanty P, 1996, BIOCHEM BIOPH RES CO, V227, P897, DOI 10.1006/bbrc.1996.1602; Delhanty Patric J. D., 1995, Progress in Growth Factor Research, V6, P141, DOI 10.1016/0955-2235(95)00011-9; ENZINGER FM, 1995, MALIGNANT FIBROHISTI, P351; INAZAWA J, 1994, CYTOGENET CELL GENET, V65, P130, DOI 10.1159/000133618; Ishikawa S, 1997, DNA Res, V4, P35, DOI 10.1093/dnares/4.1.35; JOOS S, 1993, HUM GENET, V90, P584; KATAOKA T, 1985, CELL, V43, P493, DOI 10.1016/0092-8674(85)90179-5; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LeDoussal V, 1996, CANCER, V77, P1823; Moskaluk CA, 1998, GENE CHROMOSOME CANC, V22, P305, DOI 10.1002/(SICI)1098-2264(199808)22:4<305::AID-GCC6>3.0.CO;2-Z; PEZZI CM, 1992, CANCER, V69, P2098, DOI 10.1002/1097-0142(19920415)69:8<2098::AID-CNCR2820690815>3.0.CO;2-9; SAKAKURA C, 1999, IN PRESS GENES CHROM; Sambrook J., 1989, MOL CLONING LAB MANU; TAN FL, 1990, J BIOL CHEM, V265, P13; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; Weiss SW, 1994, HISTOLOGICAL TYPING; WUNDER JS, 1991, J NATL CANCER I, V83, P194, DOI 10.1093/jnci/83.3.194	28	41	42	AMER ASSOC CANCER RESEARCH	BIRMINGHAM	PO BOX 11806, BIRMINGHAM, AL 35202 USA	0008-5472			CANCER RES	Cancer Res.	FEB 1	1999	59	3					511	515				5	Oncology	Oncology	163EU	WOS:000078390900003		
J	Peters, TJ; Albieri, A; Bevilacqua, E; Chapman, BM; Crane, LH; Hamlin, GP; Seiki, M; Soares, MJ				Peters, TJ; Albieri, A; Bevilacqua, E; Chapman, BM; Crane, LH; Hamlin, GP; Seiki, M; Soares, MJ			Differentiation-dependent expression of gelatinase B/matrix metalloproteinase-9 in trophoblast cells	CELL AND TISSUE RESEARCH			English	Article						trophoblast giant cell; placenta; gelatinase; B/MMP-9/92-kDa gelatinase; ectoplacental cone outgrowths; invasion, trophoblast; rat (Sprague Dawley)	PLACENTAL-LACTOGEN-I; MOUSE EMBRYO IMPLANTATION; PROLACTIN-RELATED PROTEIN; EPIDERMAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; TRANSCRIPTIONAL ACTIVATION; COLLAGENASE GENE; RAT PLACENTA; FACTOR-BETA; INVASION	The purpose of this study was to evaluate the Rcho-1 trophoblast culture system as a model for studying trophoblast invasion and to examine stage-specific expression of enzyme(s) potentially participating in rat trophoblast giant cell invasive behavior. The invasive behavior of the differentiating Rcho-1 trophoblast cells was demonstrated using Matrigel invasion chambers. Gelatin zymography and Western blot analysis of conditioned medium from differentiating Rcho-1 trophoblast cell cultures and rat ectoplacental cone outgrowths revealed a differentiation-dependent increase in gelatinase B/matrix metalloproteinase (MMP-9). Nothern blot and reverse transcriptase polymerase chain reaction (RT-PCR) analyses of Rcho-1 trophoblast or ectoplacental cone cells also showed increasing expression of MMP-9 accompanying cell differentiation. Rcho-1 trophoblast cells stably transfected with MMP-9 promoter/luciferase reporter constructs exhibited a differentiation-dependent increase in MMP-9 promoter activation. In conclusion, trophoblast giant cell differentiation is characterized by transcriptional activation of the MMP-9 gene and appearance of the invasive phenotype.	Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; Univ Sao Paulo, ICB, Dept Histol & Embryol, Sao Paulo, Brazil; Univ Tokyo, Inst Med Sci, Dept Canc Res, Minato Ku, Tokyo 108, Japan	Soares, MJ (reprint author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.	msoares@kumc.edu	Seiki, Motoharu/K-9443-2015; BEVILACQUA, ESTELA/H-3354-2011	BEVILACQUA, ESTELA/0000-0003-4178-4625			Albieri A, 1996, PLACENTA, V17, P507, DOI 10.1016/S0143-4004(96)90033-8; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; BASS KE, 1994, DEV BIOL, V164, P550, DOI 10.1006/dbio.1994.1223; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1<44::AID-DVG5>3.0.CO;2-8; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; SHIDA MM, 1993, MOL ENDOCRINOL, V7, P181, DOI 10.1210/me.7.2.181; Soares MJ, 1996, PLACENTA, V17, P277, DOI 10.1016/S0143-4004(96)90051-X; DAMSKY C, 1993, FASEB J, V7, P1320; SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331; Alexander CM, 1996, DEVELOPMENT, V122, P1723; RINGLER GE, 1990, ENDOCR REV, V11, P105; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hulboy DL, 1997, MOL HUM REPROD, V3, P27, DOI 10.1093/molehr/3.1.27; Gum R, 1996, J BIOL CHEM, V271, P10672; LEI HQ, 1995, BIOL REPROD, V53, P339, DOI 10.1095/biolreprod53.2.339; HAMLIN GP, 1994, ENDOCRINOLOGY, V134, P2390, DOI 10.1210/en.134.6.2390; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895; SATO H, 1993, J BIOL CHEM, V268, P23460; OKADA Y, 1992, J BIOL CHEM, V267, P21712; SATO H, 1993, ONCOGENE, V8, P395; YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923; APLIN JD, 1991, J CELL SCI, V99, P681; BABIARZ BS, 1992, IN VITRO CELL DEV-AN, V28A, P500; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197; Bischof P, 1997, Early Pregnancy, V3, P81; CANETESOLER R, 1995, DEV DYNAM, V204, P30; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Dai GL, 1996, ENDOCRINOLOGY, V137, P5020, DOI 10.1210/en.137.11.5020; ENDERS AC, 1993, J EXP ZOOL, V266, P578, DOI 10.1002/jez.1402660608; FARIA TN, 1990, DEV BIOL, V141, P279, DOI 10.1016/0012-1606(90)90384-U; FARIA TN, 1990, ENDOCRINOLOGY, V127, P3131; Gardner R L, 1988, J Cell Sci Suppl, V10, P11; GRAHAM CH, 1994, EXP CELL RES, V214, P93, DOI 10.1006/excr.1994.1237; HAMLIN GP, 1995, ENDOCRINOLOGY, V136, P322, DOI 10.1210/en.136.1.322; HARVEY MB, 1995, DEVELOPMENT, V121, P1005; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; KEPPEL G, 1973, DESIGN ANAL; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lala PK, 1996, PLACENTA, V17, P545, DOI 10.1016/S0143-4004(96)80071-3; Leco KJ, 1996, MOL REPROD DEV, V45, P458, DOI 10.1002/(SICI)1098-2795(199612)45:4<458::AID-MRD8>3.3.CO;2-2; LYONS JG, 1991, BIOCHEMISTRY-US, V30, P1449, DOI 10.1021/bi00220a001; Nagase H, 1992, Matrix Suppl, V1, P421; NG YK, 1994, DEVELOPMENT, V120, P3257; OKADA A, 1995, GENE, V164, P317, DOI 10.1016/0378-1119(95)00447-E; Orwig KE, 1997, ENDOCRINOLOGY, V138, P2491, DOI 10.1210/en.138.6.2491; PETERS TJ, 1998, TROPHOBLAST DIFFEREN; PIJNENBORG R, 1981, PLACENTA, V2, P71; Rasmussen CA, 1997, BIOL REPROD, V56, P647, DOI 10.1095/biolreprod56.3.647; REPONEN P, 1995, DEV DYNAM, V202, P388; Rinkenberger JL, 1997, DEV GENET, V21, P6, DOI 10.1002/(SICI)1520-6408(1997)21:1<6::AID-DVG2>3.0.CO;2-B; SALAMONSEN LA, 1994, CELL BIOL INT, V18, P1139, DOI 10.1006/cbir.1994.1040; Sharkey ME, 1996, AM J REPROD IMMUNOL, V36, P72; Shi FL, 1997, EXP CELL RES, V234, P147, DOI 10.1006/excr.1997.3603; SOARES MJ, 1995, DEV GROWTH DIFFER, V37, P355; SOARES MJ, 1987, DEV BIOL, V124, P134, DOI 10.1016/0012-1606(87)90466-0; Suenaga A, 1996, PLACENTA, V17, P583, DOI 10.1016/S0143-4004(96)80075-0; Tanaka SS, 1998, PLACENTA, V19, P41, DOI 10.1016/S0143-4004(98)90097-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VALENZUELA R, 1981, HUM PATHOL, V12, P355, DOI 10.1016/S0046-8177(81)80145-1; VERSTUYF A, 1992, AM J REPROD IMMUNOL, V28, P6; YAMAMOTO T, 1994, J BIOL CHEM, V269, P6517	64	27	30	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0302-766X			CELL TISSUE RES	Cell Tissue Res.	FEB	1999	295	2					287	296		10.1007/s004410051235		10	Cell Biology	Cell Biology	161DJ	WOS:000078272900012		
J	Minoura, I; Yagi, T; Kamiya, R				Minoura, I; Yagi, T; Kamiya, R			Direct measurement of inter-doublet elasticity in flagellar axonemes	CELL STRUCTURE AND FUNCTION			English	Article						nexin; eukaryotic flagella; elasticity; Chlamydomonas; mutants; dynein	SEA-URCHIN SPERM; NANOMETER-SCALE VIBRATION; CENTRAL-PAIR MICROTUBULES; DYNEIN ARMS; SLIDING DISINTEGRATION; FLEXURAL RIGIDITY; TETRAHYMENA CILIA; INNER-ARM; CHLAMYDOMONAS; MUTANTS	The outer doublet microtubules in ciliary and flagellar axonemes are presumed to be connected with each other by elastic Links called the inter-doublet links or the nexin Links, but it is not known whether there actually are such elastic links. In this study, to detect the elasticity of the putative inter-doublet links, shear force was applied to Chlamydomonas axonemes with a fine glass needle and the longitudinal elasticity was determined from the deflection of the needle. Wild-type axonemes underwent a high-frequency, nanometer-scale vibration in the presence of ATP. When longitudinal shear force was applied, the average position of the needle tip attached to the axoneme moved linearly with the force applied, yielding an estimate of spring constant of 2.0 (S.D.: 0.8) pN/nm for 1 mu m of axoneme. This value did not change in the presence of vanadate, i.e., when dynein does not form strong cross bridges. In contrast, it was at least five times larger when ATP was absent, i.e., when dynein forms strong cross bridges. The measured elasticity did not significantly differ in various mutant axonemes lacking the central-pair microtubules, a subset of inner-arm dynein, outer-arm dynein, or the radial spokes, although it was somewhat smaller in the latter two mutants. It was also observed that the shear displacement in an axoneme in the presence of ATP often took place in a stepwise manner. This suggests that the inter-doublet Links can reversibly detach from and reattach to the outer doublets in a cooperative manner. This study thus provides the first direct measure of the elasticity of inter-doublet links and also demonstrates its dynamic nature.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan	Kamiya, R (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan.	kamiyar@biol.s.u-tokyo.ac.jp					KAMIMURA S, 1989, NATURE, V340, P476, DOI 10.1038/340476a0; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; YAGI T, 1995, CELL MOTIL CYTOSKEL, V31, P207, DOI 10.1002/cm.970310304; BROKAW CJ, 1980, SCIENCE, V207, P1365; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; GIBBONS IR, 1978, P NATL ACAD SCI USA, V75, P2220, DOI 10.1073/pnas.75.5.2220; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; BROKAW CJ, 1971, J EXP BIOL, V55, P289; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; OKUNO M, 1979, J EXP BIOL, V79, P235; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; BROKAW CJ, 1989, SCIENCE, V243, P1593, DOI 10.1126/science.2928796; BABA SA, 1972, J EXP BIOL, V56, P459; BOZKURT HH, 1993, CELL MOTIL CYTOSKEL, V24, P109; GIBBONS I. R., 1965, ARCH BIOL, V76, P317; HARRIS EH, 1988, CHLAMYDOMONAS SOURCE; HIGUCHI H, 1993, BIOPHYS J, V65, P1906; HIRAKAWA E, 1998, CELL STRUCT FUNCT S, V23, P199; Ishijima A, 1996, BIOPHYS J, V70, P383; ISHIJIMA S, 1994, CELL STRUCT FUNCT, V19, P349; KAMIMURA S, 1992, J CELL BIOL, V116, P1443, DOI 10.1083/jcb.116.6.1443; KAMIYA R, 1991, J CELL BIOL, V112, P441, DOI 10.1083/jcb.112.3.441; KOBAYASHI T, 1978, BIOCHEM BIOPH RES CO, V81, P1313, DOI 10.1016/0006-291X(78)91279-2; KOJIMA H, 1998, CELL STRUCT FUNCT S, V23, P199; KURIMOTO E, 1991, CELL MOTIL CYTOSKEL, V19, P275, DOI 10.1002/cm.970190406; LINDEMANN CB, 1994, CELL MOTIL CYTOSKEL, V29, P141, DOI 10.1002/cm.970290206; OIWA K, 1988, CELL STRUCT FUNCT, V13, P193; OKAGAKI T, 1986, J CELL BIOL, V103, P1895, DOI 10.1083/jcb.103.5.1895; OKUNO M, 1980, J CELL BIOL, V85, P712, DOI 10.1083/jcb.85.3.712; OLSON GE, 1977, J ULTRA MOL STRUCT R, V61, P21, DOI 10.1016/S0022-5320(77)90004-1; Omoto CK, 1996, CELL MOTIL CYTOSKEL, V33, P88; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; STEPHENS RE, 1970, BIOL BULL, V139, P438; STEPHENS RE, 1976, PHYSIOL REV, V56, P709; SUMMERS KE, 1973, J CELL BIOL, V58, P618, DOI 10.1083/jcb.58.3.618; TANAKA M, 1988, CELL MOTIL CYTOSKEL, V9, P191, DOI 10.1002/cm.970090302; Tani T, 1998, J EXP BIOL, V201, P1493; WARNER FD, 1983, CELL MOTIL CYTOSKEL, V3, P321; WARNER FD, 1976, J CELL SCI, V20, P101; WARNER FD, 1980, J CELL BIOL, V86, P436, DOI 10.1083/jcb.86.2.436; YAGI T, 1994, CELL MOTIL CYTOSKEL, V29, P177, DOI 10.1002/cm.970290209	43	28	28	JAPAN SOC CELL BIOLOGY	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	0386-7196	1347-3700		CELL STRUCT FUNCT	Cell Struct. Funct.	FEB	1999	24	1					27	33		10.1247/csf.24.27		7	Cell Biology	Cell Biology	181WM	WOS:000079465900005		
J	Yoshimura, M; Shingyoji, C				Yoshimura, M; Shingyoji, C			Effects of the central pair apparatus on microtubule sliding velocity in sea urchin sperm flagella	CELL STRUCTURE AND FUNCTION			English	Article						dynein; flagella; microtubule; central pair; sperm; sea urchin	CHLAMYDOMONAS-REINHARDTII IDENTIFY; DYNEIN REGULATORY COMPLEX; INNER-ARM DYNEIN; HEAVY-CHAIN; RADIAL SPOKES; AXONEMES; MOVEMENT; MUTATIONS; PHOSPHORYLATION; TRANSLOCATION	To produce oscillators bending movement in cilia and flagella, the activity of dynein arms must be regulated. The central-pair microtubules, located at the centre of the axoneme, are often thought to be involved in the regulation, but this has not been demonstrated definitively. In order to determine whether the central-pair apparatus are directly involved in the regulation of the dynein arm activity, we analyzed the movement of singlet microtubules that were brought into contact with dynein arms on bundles of doublets obtained by sliding disintegration of elastase-treated flagellar axonemes. An advantage of this new assay system was that we could distinguish the bundles that contained the central pair apparatus from those that did not, the former being clearly thicker than the latter. We found that microtubule sliding occurred along both the thinner and the thicker bundles, but its velocity differed between the two kinds of bundles in an ATP concentration dependent manner. At high ATP concentrations, such as 0.1 and 1 mM, the sliding velocity on the thinner bundles was significantly higher than that on the thicker bundles, while at lower ATP concentrations the sliding velocity did not change between the thinner and the thicker bundles. We observed similar bundle width-related differences in sliding velocity after removal of the outer arms. These results provide first evidence suggesting that the central pair and its associated structures may directly regulate the activity of the inner (and probably also the outer) arm dynein.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan	Shingyoji, C (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan.	chikako@biol.s.u-tokyo.ac.jp					GIBBONS IR, 1987, NATURE, V325, P351, DOI 10.1038/325351a0; YOKOTA E, 1994, J CELL SCI, V107, P353; Shingyoji C, 1998, NATURE, V393, P711, DOI 10.1038/31520; MOSS AG, 1992, J CELL BIOL, V118, P1177, DOI 10.1083/jcb.118.5.1177; PORTER ME, 1992, J CELL BIOL, V118, P1163, DOI 10.1083/jcb.118.5.1163; Habermacher G, 1997, J CELL BIOL, V136, P167, DOI 10.1083/jcb.136.1.167; VALE RD, 1989, CELL, V59, P915, DOI 10.1016/0092-8674(89)90614-4; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; SMITH EF, 1991, CELL MOTIL CYTOSKEL, V18, P258, DOI 10.1002/cm.970180403; SALE WS, 1988, J CELL BIOL, V107, P1793, DOI 10.1083/jcb.107.5.1793; SATIR P, 1989, CELL MOTIL CYTOSKEL, V14, P345, DOI 10.1002/cm.970140305; HASEGAWA E, 1987, CELL MOTIL CYTOSKEL, V8, P302, DOI 10.1002/cm.970080403; Bre MH, 1996, J CELL SCI, V109, P727; PIPERNO G, 1994, J CELL BIOL, V125, P1109, DOI 10.1083/jcb.125.5.1109; Johnson KA, 1998, J CELL SCI, V111, P313; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; HUANG B, 1982, CELL, V28, P115, DOI 10.1016/0092-8674(82)90381-6; OMOTO CK, 1979, NATURE, V279, P532, DOI 10.1038/279532a0; TAKAHASHI D, 1985, CELL STRUCT FUNCT, V10, P327; Bre MH, 1998, MOL BIOL CELL, V9, P2655; BROKAW CJ, 1985, CELL MOTIL CYTOSKEL, V5, P195; BROKAW CJ, 1982, J CELL BIOL, V92, P722, DOI 10.1083/jcb.92.3.722; GIBBONS BH, 1973, J CELL SCI, V13, P337; GIBBONS BH, 1985, CELL MOTIL CYTOSKEL, V5, P333; GIBBONS IR, 1961, J BIOPHYS BIOCHEM CY, V11, P179, DOI 10.1083/jcb.11.1.179; Habermacher G, 1996, J CELL SCI, V109, P1899; HABERMACHER G, 1995, CELL MOTIL CYTOSKEL, V32, P106, DOI 10.1002/cm.970320207; HAWARD DR, 1994, J CELL BIOL, V127, P1683; HOSOKAWA Y, 1987, J CELL BIOL, V105, P1297, DOI 10.1083/jcb.105.3.1297; ISHIGURO K, 1982, J CELL BIOL, V92, P777, DOI 10.1083/jcb.92.3.777; KAGAMI O, 1992, J CELL SCI, V103, P653; Kamiya R., 1982, CELL MOTIL S, P169; KURIMOTO E, 1991, CELL MOTIL CYTOSKEL, V19, P275, DOI 10.1002/cm.970190406; MORI M, 1992, EXP CELL RES, V203, P483, DOI 10.1016/0014-4827(92)90024-3; Multigner L, 1996, BIOCHEMISTRY-US, V35, P10862, DOI 10.1021/bi961057u; MUROFUSHI H, 1986, CELL MOTIL CYTOSKEL, V6, P83, DOI 10.1002/cm.970060203; OKUNO M, 1981, CELL MOTIL CYTOSKEL, V1, P349; OMOTO CK, 1981, NATURE, V290, P708, DOI 10.1038/290708a0; Omoto CK, 1996, CELL MOTIL CYTOSKEL, V33, P88; OMOTO CK, 1980, J CELL BIOL, V87, P33, DOI 10.1083/jcb.87.1.33; PORTER ME, 1994, J CELL BIOL, V126, P1495, DOI 10.1083/jcb.126.6.1495; Sakakibara H, 1998, J CELL SCI, V111, P1155; SALE WS, 1986, J CELL BIOL, V102, P2042, DOI 10.1083/jcb.102.6.2042; SHIMIZU T, 1991, J CELL BIOL, V112, P1189, DOI 10.1083/jcb.112.6.1189; SHINGYOJI C, 1995, J CELL SCI, V108, P1359; SHINGYOJI C, 1991, J CELL SCI, V98, P175; SHINGYOJI C, 1995, J EXP BIOL, V198, P645; SMITH EF, 1992, SCIENCE, V257, P1557, DOI 10.1126/science.1387971; TAMM SL, 1970, PROC R SOC SER B-BIO, V175, P219, DOI 10.1098/rspb.1970.0020; TANAKA M, 1988, CELL MOTIL CYTOSKEL, V9, P191, DOI 10.1002/cm.970090302; VALE RD, 1989, J CELL BIOL, V108, P2327, DOI 10.1083/jcb.108.6.2327; Yamada A, 1998, J CELL SCI, V111, P93; YANO Y, 1981, J CELL SCI, V48, P223; YOKOTA E, 1994, J CELL SCI, V107, P345	55	34	34	JAPAN SOC CELL BIOLOGY	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	0386-7196	1347-3700		CELL STRUCT FUNCT	Cell Struct. Funct.	FEB	1999	24	1					43	54		10.1247/csf.24.43		12	Cell Biology	Cell Biology	181WM	WOS:000079465900007		
J	Chida, K; Nagamori, S; Kuroki, T				Chida, K; Nagamori, S; Kuroki, T			Nuclear translocation of Fos is stimulated by interaction with Jun through the leucine zipper	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Article						b-ZIP; Jun; Fos; NLS; nuclear import	DNA-BINDING DOMAIN; C-FOS; TRANSCRIPTION FACTOR; TARGETING SEQUENCE; HETERODIMER FORMATION; LOCALIZATION SIGNALS; GENE-PRODUCT; VIRAL JUN; V-JUN; PROTEINS	Jun and Fos, b-ZIP transcription factors, form a heterodimer and bind to DNA enhancer elements, thereby regulating the expression of target genes. The present study was undertaken to investigate the molecular mechanism underlying nuclear translocation of the Jun/Fos complex. For this pul pose, normal rat kidney cells were microinjected with a DNA expression vector containing wild-type or mutant c- or v-jun together with c- or v-fos, followed by detection of the subcellular localization of Jun or Fos by immunofluorescence staining. The nuclear accumulation of Fos was markedly enhanced by the presence of wildtype Jun, but not by Jun mutants lacking nuclear targeting or zipper dimerization functions, implying that Jun and Fos mutually interact via their leucine zippers and translocate from the cytoplasm to the nucleus using the markedly stronger nuclear localization signal of Jun.	Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Minato Ku, Tokyo 1088639, Japan; Showa Univ, Inst Mol Oncol, Shinagawa Ku, Tokyo 1428555, Japan	Chida, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Canc Cell Res, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	chida@ims.u-tokyo.ac.jp	Kuroki, Toshio/A-9500-2011				ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; KATAOKA K, 1995, MOL CELL BIOL, V15, P2180; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; KRYLOV D, 1995, EMBO J, V14, P5329; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565; Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; BENBROOK DM, 1990, ONCOGENE, V5, P295; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; BOS TJ, 1989, ONCOGENE, V4, P123; CHIDA K, 1992, P NATL ACAD SCI USA, V89, P4290, DOI 10.1073/pnas.89.10.4290; CHIU R, 1988, CELL, V54, P541, DOI 10.1016/0092-8674(88)90076-1; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; HIRAI SI, 1989, EMBO J, V8, P1433; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; KATAOKA K, 1994, MOL CELL BIOL, V14, P700; MACGREGOR PF, 1990, ONCOGENE, V5, P451; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; MIKAELIAN I, 1993, J VIROL, V67, P734; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; TAGAWA T, 1995, J CELL BIOL, V130, P255, DOI 10.1083/jcb.130.2.255; TAKEMOTO Y, 1994, FEBS LETT, V350, P55, DOI 10.1016/0014-5793(94)00733-0; TRATNER I, 1991, ONCOGENE, V6, P2049; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; Vogt P K, 1990, Adv Cancer Res, V55, P1, DOI 10.1016/S0065-230X(08)60466-2; VRIZ S, 1992, MOL CELL BIOL, V12, P3548; Williams SC, 1997, GENE EXPRESSION, V6, P371	32	20	21	BIRKHAUSER VERLAG AG	BASEL	VIADUKSTRASSE 40-44, PO BOX 133, CH-4010 BASEL, SWITZERLAND	1420-682X			CELL MOL LIFE SCI	Cell. Mol. Life Sci.	FEB	1999	55	2					297	302		10.1007/s000180050291		6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	177NU	WOS:000079217100011		
J	Boldyrev, A; Abe, H				Boldyrev, A; Abe, H			Metabolic transformation of neuropeptide carnosine modifies its biological activity	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						carnosine; antioxidant activity; free radical species	HISTIDINE-CONTAINING DIPEPTIDES; ANTIOXIDATIVE PROPERTIES; OXYGEN; ANSERINE; PEPTIDES; MUSCLE	1. The ability of carnosine and carnosine-related compounds (CRCs) to interact with several free oxygen radicals is analyzed. 2. Carnosine, the CRCs (imidazole, histidine, anserine), and ergothioneine were found to be equally efficient in singlet oxygen quenching. During generation of hydroxyl radicals from hydrogen peroxide in the Fenton reaction, carnosine was found to be more effective than the CRCs tested. 3. By measuring the chemiluminescence produced by carnosine and CRCs in rabbit leukocytes in the presence of luminol or lucigenin, we conclude that carnosine and other CRCs play a stimulating role in superoxide oxygen production while suppressing the myeloperoxidase system. 4. ADP-induced aggregation of human platelets is slightly stimulated by carnosine but is inhibited by acetylanserine. 5. The following rank order of efficiency of CRCs was demonstrated while measuring the oxidation of human serum lipoproteins: acetylcarnosine < acetylanserine < homocarnosine = ophidine < carnosine < anserine. 6. The results obtained demonstrate that metabolic transformation of carnosine into CRCs in tissues may play an important role in regulating the native antioxidant status of the organism.	Moscow MV Lomonosov State Univ, Int Biotechnol Ctr, Moscow 119899, Russia; Univ Tokyo, Marine Biochem Lab, Bunkyo Ku, Tokyo 1138657, Japan	Abe, H (reprint author), Moscow MV Lomonosov State Univ, Int Biotechnol Ctr, Moscow 119899, Russia.						YOSHIKAWA T, 1991, BIOCHIM BIOPHYS ACTA, V1115, P15, DOI 10.1016/0304-4165(91)90005-2; BOLDYREV AA, 1990, INT J BIOCHEM, V22, P129, DOI 10.1016/0020-711X(90)90173-Z; BOLDYREV AA, 1988, COMP BIOCHEM PHYS B, V89, P245, DOI 10.1016/0305-0491(88)90218-0; NAGAI K, 1986, SURGERY, V100, P815; ARUOMA OI, 1989, BIOCHEM J, V264, P863; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; PAVLOV AR, 1993, BIOCHIM BIOPHYS ACTA, V1157, P304, DOI 10.1016/0304-4165(93)90114-N; Stvolinsky SL, 1999, CELL MOL NEUROBIOL, V19, P45, DOI 10.1023/A:1006960407008; DAHL TA, 1988, PHOTOCHEM PHOTOBIOL, V47, P357, DOI 10.1111/j.1751-1097.1988.tb02737.x; HARTMAN PE, 1990, PHOTOCHEM PHOTOBIOL, V51, P59, DOI 10.1111/j.1751-1097.1990.tb01684.x; BATE SMITH E. C., 1938, JOUR PHYSIOL, V92, P336; BAUER K, 1982, J BIOL CHEM, V257, P3593; BIFFO S, 1990, BRAIN RES, V528, P353, DOI 10.1016/0006-8993(90)91682-7; BOGARDUS SI, 1992, FASEB J, V6, pA138; BOLDYREV A, 1995, COMP BIOCHEM PHYS B, V112, P481, DOI 10.1016/0305-0491(95)00084-4; Boldyrev A.A., 1994, PATHOPHYSIOLOGY, V1, P215, DOI 10.1016/0928-4680(94)90040-X; Boldyrev A. A., 1992, Biokhimiya, V57, P1360; BOLDYREV AA, 1978, J GEN PHARM, V9, P17; BOLDYREV AA, 1990, ADV ENZYME REGUL, V30, P175; BROWN CE, 1980, BIOCHEM BIOPH RES CO, V92, P470, DOI 10.1016/0006-291X(80)90357-5; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403; CHASOVNIKOVA LV, 1990, BIOCHEM INT, V20, P1097; CZAPSKI G, 1984, METHOD ENZYMOL, V105, P209; DAVEY CL, 1960, ARCH BIOCHEM BIOPHYS, V89, P303, DOI 10.1016/0003-9861(60)90059-X; Dupin A M, 1984, Biull Eksp Biol Med, V98, P186; EVSTIGNEEVA RP, 1993, DOKL AKAD NAUK+, V333, P104; FITZPATRICK JC, 1991, NEPHRON, V59, P299; Formazyuk V. E., 1992, Biokhimiya, V57, P1324; GIRALT E, 1986, BIOORG CHEM, V14, P405, DOI 10.1016/0045-2068(86)90005-2; Gulewitsch W, 1900, BER DTSCH CHEM GES, V33, P1902, DOI 10.1002/cber.19000330275; GULYAEVA N V, 1987, Biokhimiya, V52, P1216; GYLLENHAMMAR H, 1987, J IMMUNOL METHODS, V97, P209, DOI 10.1016/0022-1759(87)90461-3; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3174; LI KI, 1990, BIOFIZIKA+, V35, P82; Nikitenko N. Yu., 1995, Voprosy Meditsinskoi Khimii, V41, P41; ODOWD A, 1992, J CHROMATOGR-BIOMED, V577, P347, DOI 10.1016/0378-4347(92)80257-Q; OKUMA E, 1992, COMP BIOCHEM PHYS A, V102, P37, DOI 10.1016/0300-9629(92)90008-E; RAGHAVAN M, 1992, EUR J BIOCHEM, V210, P311, DOI 10.1111/j.1432-1033.1992.tb17423.x; Rebrova O. Yu., 1995, Byulleten' Eksperimental'noi Biologii i Meditsiny, V119, P152; Severin S.E., 1964, P PLEN SESS 7 INT BI, P45; SKULACHEV VP, 1978, FEBS LETT, V87, P171, DOI 10.1016/0014-5793(78)80326-3; YEGOROV S, 1997, BIOCHEM MOL BIOL INT, V41, P687	42	24	27	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340			CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	FEB	1999	19	1					163	175		10.1023/A:1006914028195		13	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	166YK	WOS:000078605400015		
J	Li, M; Yoneya, T				Li, M; Yoneya, T			Short-distance space-time structure and black holes in string theory: A short review of the present status	CHAOS SOLITONS & FRACTALS			English	Article							MATRIX MODEL; QUANTUM-GRAVITY; PLANCK-SCALE; DUAL MODELS; P-BRANES; ABSORPTION; DYNAMICS; LENGTH; WORLD	We briefly review the present status of string theory From the viewpoint of its implications on the short-distance space-time structure and black hole physics. Special emphases are given on two closely related issues in recent developments towards nonperturbative string theory, namely, the role of the space-time uncertainty relation as a qualitative but universal characterization of the short-distance structure of string theory and the microscopic formulation of black-hole entropies. We will also suggest that the space-time uncertainty relation can be an underlying principle for the holographic property of M theory, by showing that the space-time uncertainty relation naturally explains the UV/IR relation used in a recent derivation of the holographic bound for D3 brane by Susskind and Witten. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Tokyo, Inst Phys, Meguro Ku, Tokyo 153, Japan	Li, M (reprint author), Univ Chicago, Enrico Fermi Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	mli@curie.uchicago.edu; tam@hep1.c.u-tokyo.ac.jp					AMELIOCAMELIN G, HEPTH9701144; Horowitz GT, 1997, PHYS REV D, V55, P6189, DOI 10.1103/PhysRevD.55.6189; AMATI D, 1987, PHYS LETT B, V197, P81, DOI 10.1016/0370-2693(87)90346-7; Polchinski J, 1996, REV MOD PHYS, V68, P1245, DOI 10.1103/RevModPhys.68.1245; SUSSKIND L, 1994, PHYS REV D, V49, P6606, DOI 10.1103/PhysRevD.49.6606; Banks T, 1998, PHYS REV LETT, V80, P226, DOI 10.1103/PhysRevLett.80.226; GROSS DJ, 1988, NUCL PHYS B, V303, P407, DOI 10.1016/0550-3213(88)90390-2; Douglas MR, 1997, NUCL PHYS B, V485, P85, DOI 10.1016/S0550-3213(96)00619-0; Strominger A, 1996, PHYS LETT B, V379, P99, DOI 10.1016/0370-2693(96)00345-0; Becker K, 1997, NUCL PHYS B, V506, P48, DOI 10.1016/S0550-3213(97)00518-X; Ishibashi N, 1997, NUCL PHYS B, V498, P467, DOI 10.1016/S0550-3213(97)00290-3; Li M, 1997, PHYS REV LETT, V78, P1219, DOI 10.1103/PhysRevLett.78.1219; GLIOZZI F, 1977, NUCL PHYS B, V122, P253, DOI 10.1016/0550-3213(77)90206-1; SEN A, 1994, INT J MOD PHYS A, V9, P3707, DOI 10.1142/S0217751X94001497; Seiberg N, 1997, PHYS REV LETT, V79, P3577, DOI 10.1103/PhysRevLett.79.3577; Witten E, 1996, NUCL PHYS B, V460, P335, DOI 10.1016/0550-3213(95)00610-9; Horowitz GT, 1998, PHYS REV D, V57, P4935, DOI 10.1103/PhysRevD.57.4935; YONEYA T, 1974, PROG THEOR PHYS, V51, P1907, DOI 10.1143/PTP.51.1907; GARAY LJ, 1995, INT J MOD PHYS A, V10, P145, DOI 10.1142/S0217751X95000085; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; SUSSKIND L, 1995, J MATH PHYS, V36, P6377, DOI 10.1063/1.531249; Polchinski J, 1995, PHYS REV LETT, V75, P4724, DOI 10.1103/PhysRevLett.75.4724; HOROWITZ GT, 1991, NUCL PHYS B, V360, P197, DOI 10.1016/0550-3213(91)90440-9; ATICK JJ, 1988, NUCL PHYS B, V310, P291, DOI 10.1016/0550-3213(88)90151-4; SCHERK J, 1974, NUCL PHYS B, VB 81, P118, DOI 10.1016/0550-3213(74)90010-8; KIKKAWA K, 1984, PHYS LETT B, V149, P357, DOI 10.1016/0370-2693(84)90423-4; DOPLICHER S, 1994, PHYS LETT B, V331, P39, DOI 10.1016/0370-2693(94)90940-7; Dijkgraaf R, 1997, NUCL PHYS B, V500, P43, DOI 10.1016/S0550-3213(97)00326-X; BANKS T, HEPTH9711005; Becker K, 1997, PHYS REV D, V56, pR3174; BERGMAN O, 1995, NUCL PHYS B, V441, P441; BIGATTI D, HEPTH9712072; CONNE A, HEPTH9711262; DINE M, HEPTH9710174; DINE M, HEPTH9805007; DOPLICHER S, 1995, COMMUN MATH PHYS, V172, P187, DOI 10.1007/BF02104515; Douglas M. R., HEPTH9610041; ECHOLS R, HEPTH9806109; FABBRICHESI M, HEPTH9806018; GIDDINGS SB, HEPTH9804121; Green MB, 1987, SUPERSTRING THEORY, VII; Green MB, 1987, SUPERSTRING THEORY, Vl; GUBSER S, 1996, PHYS REV D, V54, P3916; Gubser SS, 1997, NUCL PHYS B, V499, P217, DOI 10.1016/S0550-3213(97)00325-8; Gubser S.S., HEPTH9802109; HATA H, 1988, PROG THEOR PHYS, V80, P80; Hirano S, 1997, PROG THEOR PHYS, V98, P1371, DOI 10.1143/PTP.98.1371; ITZHAKI N, HEPTH9802042; JEVICKI A, 1994, NUCL PHYS B, V411, P64, DOI 10.1016/0550-3213(94)90054-X; JEVICKI A, HEPTH9309115; JEVICKI A, 1995, NUCL PHYS B, V448, P277, DOI 10.1016/0550-3213(95)00312-G; JEVICKI A, HEPTH9805069; JEVICKI A, IN PRESS; KABAT D, HEPTH9806214; KLEBANOV I, 1991, P TRIEST SPRING SCH; Klebanov IR, 1997, NUCL PHYS B, V496, P231, DOI 10.1016/S0550-3213(97)00235-6; Li M., HEPTH9801070; LI M, HEPTH9710226; LI MS, IN PRESS; LIU H, HEPTH9712063; LOWE D, HEPTH9802173; MALDACENA JM, HEPTH9607235; MALDACENA JM, HEPTH9711200; MCCARTHY J, HEPTH9806136; MINIC D, COMMUNICATION; MYERS RC, 1988, NUCL PHYS B, V310, P25, DOI 10.1016/0550-3213(88)90052-1; Nambu Y., 1969, P INT C SYMM QUARK M; NIELSEN HB, 1970, 15 C HIGH EN PHYS KI; Oda I, 1998, NUCL PHYS B, V516, P160, DOI 10.1016/S0550-3213(98)00058-3; OKAWA Y, HEPTH9806108; PABAN S, HEPTH9805018; PEET A, HEPTH9712253; POLCHINSKI J, HEPTH9411028; SCHERK J, 1975, PHYS LETT B, V57, P463, DOI 10.1016/0370-2693(75)90269-5; SEN A, HEPTH9709220; SHAPIRO JA, 1975, PHYS REV D, V11, P2937, DOI 10.1103/PhysRevD.11.2937; Shenker S.H., HEPTH9509132; SUSSKIND L, HEPTH9511227; SUSSKIND L, 1970, NUOVO CIMENTO A, V69, P457, DOI 10.1007/BF02726485; Susskind L., HEPTH9805114; SUSSKIND L, HEPTH9704080; t Hooft G., GRQC9310026; TAYLOR W, HEPTH9806066; VENEZIAN.G, 1968, NUOVO CIMENT A, V57, P190, DOI 10.1007/BF02824451; Witten E., HEPTH9802150; WITTEN E, 1995, NUCL PHYS B, V443, P85, DOI 10.1016/0550-3213(95)00158-O; YONEYA T, IN PRESS P APCPT ICT; YONEYA T, 1996, P 6 WORKSH GEN REL G; YONEYA T, 1989, MOD PHYS LETT A, V4, P1587, DOI 10.1142/S0217732389001817; YONEYA T, 1976, PROG THEOR PHYS, V56, P1310, DOI 10.1143/PTP.56.1310; YONEYA T, 1973, LETT NUOVO CIMENTO, V8, P951, DOI 10.1007/BF02727806; Yoneya T., 1987, WANDERING FIELDS, P419; Yoneya T, 1997, PROG THEOR PHYS, V97, P949, DOI 10.1143/PTP.97.949; YONEYA T, 1987, PHYS LETT B, V197, P76, DOI 10.1016/0370-2693(87)90345-5; Yoneya T., 1988, Quantum String Theory. Proceedings of the Second Yukawa Memorial Symposium; Yoneya T., 1996, Frontiers in Quantum Field Theory	96	14	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779			CHAOS SOLITON FRACT	Chaos Solitons Fractals	FEB-MAR	1999	10	2-3					423	443		10.1016/S0960-0779(98)00198-2		21	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	179BB	WOS:000079302700021		
J	Tokitoh, N; El-Sayed, IE; Okazaki, R				Tokitoh, N; El-Sayed, IE; Okazaki, R			Unusual oxidation reaction of an overcrowded thiagermacyclohexene derivative	CHEMISTRY LETTERS			English	Article							REARRANGEMENT; SULFOXIDES	Oxidation of extremely overcrowded 1,2-thiagermacyclohex-4-ene derivatives with m-chloroperbenzoic acid resulted in competitive formation of the ring expanded 1,2,7-oxathiagermacyclohept-4-ene derivatives and the ring contracted 1,2,3-oxathiagermacyclopentane derivatives. The latter reaction products are found to isomerize into the former ones very slowly at room temperature not only in solution but also in the crystalline state.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; El Menoufeia Univ, Fac Sci, Dept Chem, Shebin, El Kom, Egypt	Tokitoh, N (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						TOKITOH N, 1993, J AM CHEM SOC, V115, P8855, DOI 10.1021/ja00072a055; MCKILLOP KL, 1992, J AM CHEM SOC, V114, P5203, DOI 10.1021/ja00039a035; Bonini BF, 1997, CHEM COMMUN, P1011, DOI 10.1039/a701942d; MATSUMOTO T, 1994, THESIS U TOKYO TOKYO; Okazaki R., 1996, SYNTHETIC METHODS OR, V2, P260; TANG R, 1970, J AM CHEM SOC, V92, P2100, DOI 10.1021/ja00710a051; Tokitoh N, 1998, J AM CHEM SOC, V120, P433, DOI 10.1021/ja973295y; TOKITOH N, 1995, MAIN GROUP CHEM NEWS, V3, P4	8	3	3	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB	1999		2					129	130				2	Chemistry, Multidisciplinary	Chemistry	171AT	WOS:000078840400016		
J	Tanaka, H; Kobayashi, A; Kobayashi, H				Tanaka, H; Kobayashi, A; Kobayashi, H			Electrical and magnetic properties of BETS conductor with modified lambda-type structure, lambda '-(BETS)(2)GaBr4	CHEMISTRY LETTERS			English	Article							Y=F; CL	The resistivity and the magnetic susceptibility of BETS conductor with modified ii-type structure, lambda'-(BETS)(2)GaBr4 are 0.06 Omega cm and 4x10(-4) emu mol(-1) at room temperature. In contrast to the semimetal-to-insulator transition at ambient pressure, the system showed an unusual high-pressure resistivity behavior below 50 K. Very sensitive pressure dependence of the resistivities will be consistent with the semimetallic Fermi surface obtained by extended Huckel tight-binding band calculation.	Univ Tokyo, Dept Chem, Sch Med, Bunkyo Ku, Tokyo 113, Japan; Grad Univ Adv Studies, Okazaki, Aichi 444, Japan; Inst Mol Sci, Okazaki, Aichi 444, Japan	Kobayashi, A (reprint author), Univ Tokyo, Dept Chem, Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						KOBAYASHI H, 1993, CHEM LETT, P1559, DOI 10.1246/cl.1993.1559; Kobayashi H, 1997, PHYS REV B, V56, pR8526; Kobayashi H, 1997, J AM CHEM SOC, V119, P12392, DOI 10.1021/ja973068w; MONTGOMERY LK, 1994, PHYSICA C, V219, P490, DOI 10.1016/0921-4534(94)90404-9; TANAKA H, IN PRESS J AM CHEM S; TANAKA N, 1996, ADV MATER, V8, P812	6	7	7	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB	1999		2					133	134				2	Chemistry, Multidisciplinary	Chemistry	171AT	WOS:000078840400018		
J	Saitoh, T; Ohkubo, S; Matsubara, C				Saitoh, T; Ohkubo, S; Matsubara, C			Polymer-mediated extraction of porphirinato chelates for a spectrophotometric approach to sub-ppt level detection of metal ions	CHEMISTRY LETTERS			English	Article							REVERSIBLE POLYMER; PHASE; CHROMATOGRAPHY; PHOSPHATE; WATER; HPLC	Negatively charged copper(II) and zinc(II) chelates with 5, 10, 15, 20-tetrakis(4-carboxyphenyl)-21H, 23H-porphine were incorporated into the precipitates formed from the aqueous solutions of thermo-responsive polymer; poly(N-isopropylacrylamide). In the presence of an appropriate kind and amount of quaternary ammonium ion, the recovery of the chelate was quantitatively. Sub-ppt level zinc(II) in water by the photometric detection in HPLC was successfully achieved, because of the highly efficient concentration.	Univ Tokyo, Sch Life Sci, Tokyo 1920392, Japan	Saitoh, T (reprint author), Univ Tokyo, Sch Life Sci, 1432-1 Horinouchi, Tokyo 1920392, Japan.						CHEN GH, 1994, J BIOMAT SCI-POLYM E, V5, P371; DSIYOH Y, 1998, TALANTA, V46, P541; HOSHINO H, 1984, CHEM LETT, P1445, DOI 10.1246/cl.1984.1445; HOSHINO H, 1978, BUNSEKI KAGAKU, V27, P315; Igarashi S, 1997, BUNSEKI KAGAKU, V46, P1; IGARASHI S, 1986, BUNSEKI KAGAKU, V35, P829; ISHII H, 1980, NIPPON KAGAKU KAISHI, P1919; MATSUBARA C, 1993, CHEM LETT, P849, DOI 10.1246/cl.1993.849; MATSUBARA C, 1995, BUNSEKI KAGAKU, V44, P311; MATSUBARA C, 1993, ANALYST, V118, P553, DOI 10.1039/an9931800553; OHYAMA T, 1997, BUNSEKI KAGAKU, V45, P59; SAITOH M, 1998, ANAL SCI, V14, P929; Saitoh T, 1997, ANAL SCI, V13, P1, DOI 10.2116/analsci.13.1; UEHARA N, 1989, ANAL SCI, V5, P111, DOI 10.2116/analsci.5.111	14	15	15	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	FEB	1999		2					151	152				2	Chemistry, Multidisciplinary	Chemistry	171AT	WOS:000078840400027		
J	Teramoto, S; Matsuse, T; Ouchi, Y				Teramoto, S; Matsuse, T; Ouchi, Y			Clinical significance of cough as a defense mechanism or a symptom in elderly patients with aspiration and diffuse aspiration bronchiolitis	CHEST			English	Letter									Tokyo Univ Hosp, Dept Geriatr Med, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Dept Geriatr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						PONTOPPIDAN H, 1960, JAMA-J AM MED ASSOC, V174, P2209; Gleeson K, 1997, CHEST, V111, P1266, DOI 10.1378/chest.111.5.1266; HUXLEY EJ, 1978, AM J MED, V64, P564, DOI 10.1016/0002-9343(78)90574-0; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Matsuse T, 1996, CHEST, V110, P1289, DOI 10.1378/chest.110.5.1289; Matsuse T, 1998, CHEST, V114, P350, DOI 10.1378/chest.114.1.350-a; SEKIZAWA K, 1990, LANCET, V335, P1228, DOI 10.1016/0140-6736(90)92758-A; Teramoto S, 1998, CHEST, V113, P1733, DOI 10.1378/chest.113.6.1733	9	10	10	AMER COLL CHEST PHYSICIANS	NORTHBROOK	3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA	0012-3692			CHEST	Chest	FEB	1999	115	2					602	602		10.1378/chest.115.2.602		1	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	166BK	WOS:000078556200054		
J	Hoshino, Y; Kurokawa, T; Hongo, T; Sasaki, S				Hoshino, Y; Kurokawa, T; Hongo, T; Sasaki, S			Abnormally large evoked potentials arising from dorsal column fibers in the region of chronically compressed spinal cord	CLINICAL NEUROPHYSIOLOGY			English	Article						evoked potential; spinal cord; chronic compression; dorsal column; cat	LYSOPHOSPHATIDYL CHOLINE; NERVE-FIBERS; CONDUCTION	Objective: To understand the origin and mechanism of the large evoked potentials known to occur in chronically compressed spinal cord. Methods: Electrophysiological analysis was made of evoked potentials produced in the cervical cord compressed for more than 1 year by rotating a screw in the vertebral body, in 4 adult cats. Results: In all cats, manifesting no motor disturbance, large positive or negative evoked potentials were recorded from the cord dorsum at the compressed region following lumbar cord stimulation. These potentials followed high-frequency stimulation and were judged as conducting volleys of directly activated fibers. Intraspinally, single fiber spikes, normally barely recordable with the glass microelectrodes, were recorded extracellularly from localized areas within the dorsal column restricted to the compressed region. Such single fibers showed slowed conduction at the compressed region without a conduction block. Histologically, demyelinated fibers were observed in localized areas in the dorsal column of the compressed region. Conclusion: We concluded that the large abnormal surface potentials originated from the dorsal column and were attributed to an increase in action current in affected fibers, which presumably occurred associated with demyelination. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Fac Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 113, Japan; Tokyo Metropolitan Inst Neurosci, Fuchu, Tokyo 183, Japan	Hoshino, Y (reprint author), Jichi Med Sch, Dept Orthoped, 3311-1 Yakushiji, Minami Kawachi, Tochigi 32904, Japan.						HALL SM, 1971, J CELL SCI, V9, P769; SMITH KJ, 1982, J NEUROL SCI, V54, P13, DOI 10.1016/0022-510X(82)90215-5; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273; MEIRI H, 1985, BRAIN RES, V359, P326, DOI 10.1016/0006-8993(85)91444-1; BRISMAR T, 1981, ACTA PHYSIOL SCAND, V113, P167, DOI 10.1111/j.1748-1716.1981.tb06878.x; GE XX, 1982, LARYNGOSCOPE, V92, P1; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; IMAI T, 1976, J JPN ORTHOP ASSOC, V50, P1037; KUROKAWA T, 1985, NICHIDOKUIHOU, V30, P527; KUROKAWA T, 1975, J JAP ORTHOP ASS, V49, P769; Lux H D, 1986, Adv Neurol, V44, P619; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; MEIRI H, 1986, J MEMBRANE BIOL, V92, P47, DOI 10.1007/BF01869015; NAKAMURA K, 1981, Journal of the Japanese Orthopaedic Association, V55, P747; RASMINSK.M, 1972, J PHYSIOL-LONDON, V227, P323; SATO K, 1991, SPINE, V16, P1283, DOI 10.1097/00007632-199111000-00007; SEKI H, 1978, INT ORTHOP, V2, P25; TANAKA H, 1980, Journal of the Japanese Orthopaedic Association, V54, P161; WAXMAN SG, 1992, J NEUROTRAUM, V9, pS105; WAXMAN SG, 1994, CLIN NEUROSCI, V2, P202	20	3	3	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1388-2457			CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	1999	110	2					305	316		10.1016/S1388-2457(98)00010-8		12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	193CL	WOS:000080118200012		
J	Kuramoto, E; Tsutsumi, T; Ueno, K; Ohmura, M; Kamimura, Y				Kuramoto, E; Tsutsumi, T; Ueno, K; Ohmura, M; Kamimura, Y			Positron lifetime calculations on vacancy clusters and dislocations in Ni and Fe	COMPUTATIONAL MATERIALS SCIENCE			English	Article						positron lifetime calculation; nickel; iron; vacancy; stacking fault tetrahedron; dislocation; dislocation-vacancy complex	ANNIHILATION; DEFECT	Positron lifetime calculations have been performed on vacancy clusters (stacking fault tetrahedra (SFT), vacancy loops), such clusters on dislocation line, interstitial clusters, such clusters on a dislocation line and dislocation line itself in order to investigate the so-called intermediate lifetimes observed in the experiments, namely, positron lifetimes between that at a matrix and that at a single vacancy. Before lifetime calculations, various defects were constructed in the model lattices and were relaxed completely to obtain the stable atomic structure by using N-body potentials. Then positron lifetime calculation was carried out for each defect. It was shown that positron lifetime for a SFT in Ni dependes on its size and becomes smaller with increasing the size. The positron wave function is mainly localized at the corner of a SFT, which gives rather lifetime, e.g., 130 ps for V-28, but when the cluster size is small, e.g., less than 10 vacancies, it gives a rather longer lifetime, e.g., 177 ps for V-6 because of the wave function localized at the inner space of a cluster. These behaviours are consistent with the experimental results. It was also found that the positron lifetime on a dislocation line and that at a jog are short (113 and 119 ps, respectively for Ni, 117 and 117 ps, respectively for Fe), close to the lifetime at matrix(110 ps for both Ni and Fe) and in these cases trapping potentials for a positron are shallow both for Ni and Fe. (C) 1999 Elsevier Science B.V. All rights reserved.	Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 816, Japan; Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 816, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo, Japan	Kuramoto, E (reprint author), Kyushu Univ, Appl Mech Res Inst, 6-1 Kasuga Koen, Kasuga, Fukuoka 816, Japan.	kuramoto@himiko.riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				PUSKA MJ, 1983, J PHYS F MET PHYS, V13, P333, DOI 10.1088/0305-4608/13/2/009; BORONSKI E, 1986, PHYS REV B, V34, P3820, DOI 10.1103/PhysRevB.34.3820; FINNIS MW, 1984, PHILOS MAG A, V50, P45; DOYAMA M, 1979, P 5 INT C POS ANN, P13; ELDRUP M, 1976, J PHYS F MET PHYS, V6, P499, DOI 10.1088/0305-4608/6/4/011; GAO F, 1993, PHILOS MAG A, V67, P275; HAUTOJARVI P, 1979, P 5 INT C POS ANN LA, P737; Kamimura Y, 1996, PHYS REV B, V54, P12595, DOI 10.1103/PhysRevB.54.12595; Kamimura Y, 1997, J PHYS SOC JPN, V66, P3090, DOI 10.1143/JPSJ.66.3090; Kuramoto E., 1992, MATER SCI FORUM, V105-110, P1125; Kuramoto E, 1996, J NUCL MATER, V239, P54, DOI 10.1016/S0022-3115(96)00432-1; Shirai Y, 1992, MATER SCI FORUM, V105-110, P1225; Ueno K, 1997, MATER SCI FORUM, V255-2, P430	13	47	48	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256			COMP MATER SCI	Comput. Mater. Sci.	FEB	1999	14	1-4					28	35		10.1016/S0927-0256(98)00068-8		8	Materials Science, Multidisciplinary	Materials Science	178AK	WOS:000079243100007		
J	Suzuki, A; Kamiko, M; Yamamoto, R; Tateizumi, Y; Hashimoto, M				Suzuki, A; Kamiko, M; Yamamoto, R; Tateizumi, Y; Hashimoto, M			Molecular simulations in the virtual material laboratory	COMPUTATIONAL MATERIALS SCIENCE			English	Article						virtual material laboratory; virtual reality; computer graphics; force feedback; molecular dynamics simulation; superplastic deformation	TEMPERATURE	A virtual reality system for atomic behavior in materials testing is developed. The system is called the virtual material laboratory (VML). VML aims to help scientists make discoveries by improving their perception of data describing the atomic world and of predictions of computer simulation in atomic scale. This paper describes the VML system under developing which consists of a force display, a visual display, and simulator. Each component of VML is connected with network and exchanged data such as atomic positions from each other. We have developed a control algorithm between each component to make a real-time simulation. A molecular dynamics (MD) simulation was carried out as an example to investigate atomic behaviors and to prove the feasibility of the VML constructed. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan; Tokyo Natl Coll Technol, Hachioji, Tokyo 193, Japan; Kagoshima Univ, Kagoshima 890, Japan	Suzuki, A (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 106, Japan.						Allen M. P., 1987, COMPUTER SIMULATION, P385; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; DVELDI A, 1990, PHIL MAG Z, V61, P1; HASHIMOTO M, 1997, IEEE INT C ROB AUT; NOSE S, 1984, J CHEM PHYS, V81, P511; WAGNER NJ, 1992, PHYS REV A, V45, P45; WAKAI F, 1994, ACTA METALL MATER, V42, P1163, DOI 10.1016/0956-7151(94)90133-3; WAKAI F, 1986, CERAMIC MAT COMPONEN, P315	8	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-0256			COMP MATER SCI	Comput. Mater. Sci.	FEB	1999	14	1-4					227	231		10.1016/S0927-0256(98)00135-9		5	Materials Science, Multidisciplinary	Materials Science	178AK	WOS:000079243100043		
J	Gregorio, CC; Granzier, H; Sorimachi, H; Labeit, S				Gregorio, CC; Granzier, H; Sorimachi, H; Labeit, S			Muscle assembly: a titanic achievement?	CURRENT OPINION IN CELL BIOLOGY			English	Article							SARCOMERIC M-BAND; ALPHA-ACTININ; IMMUNOELECTRON MICROSCOPY; MYOFIBRIL FORMATION; CARDIAC MYOCYTES; SKELETAL-MUSCLE; TERMINAL REGION; M-LINE; TITIN; PROTEIN	The formation of perfectly aligned myofibrils in striated muscle represents a dramatic example of supramolecular assembly in eukaryotic cells. Recently, considerable progress has been made in deciphering the roles that titin, the third most abundant protein in muscle, has in this process. An increasing number of sarcomeric proteins (ligands) are being identified that bind to specific titin domains. Titin may serve as a molecular blueprint for sarcomere assembly and turnover by specifying the precise position of its ligands within each half-sarcomere in addition to functioning as a molecular spring that maintains the structural integrity of the contracting myofibrils.	Univ Arizona, Dept Cell Biol, Tucson, AZ 85724 USA; Univ Arizona, Dept Anat, Tucson, AZ 85724 USA; Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; European Mol Biol Lab, D-69012 Heidelberg, Germany	Gregorio, CC (reprint author), Univ Arizona, Dept Cell Biol, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	gregorio@u.arizona.edu; granzier@wsunix.wsu.edu; sorimach@iam.u-tokyo.ac.jp; Siegfried.Labeit@embl-hedelberg.de	Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727			Holtzer H, 1997, CELL STRUCT FUNCT, V22, P83; Millevoi S, 1998, J MOL BIOL, V282, P111, DOI 10.1006/jmbi.1998.1999; Sorimachi H, 1995, J BIOL CHEM, V270, P31158; Granzier H, 1997, BIOPHYS J, V73, P2043; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Dabiri GA, 1997, P NATL ACAD SCI USA, V94, P9493, DOI 10.1073/pnas.94.17.9493; FURST DO, 1989, J CELL BIOL, V109, P517, DOI 10.1083/jcb.109.2.517; MONCMAN CL, 1995, CELL MOTIL CYTOSKEL, V32, P205, DOI 10.1002/cm.970320305; Littlefield R, 1998, ANNU REV CELL DEV BI, V14, P487, DOI 10.1146/annurev.cellbio.14.1.487; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; HOUMEIDA A, 1995, J CELL BIOL, V131, P1471, DOI 10.1083/jcb.131.6.1471; Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441; Mayans O, 1998, NATURE, V395, P863; Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614; VIGOREAUX JO, 1994, J MUSCLE RES CELL M, V15, P237; Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853; Schiaffino S, 1996, PHYSIOL REV, V76, P371; EPSTEIN HF, 1991, SCIENCE, V251, P1039, DOI 10.1126/science.1998120; Fulton AB, 1997, CELL STRUCT FUNCT, V22, P51; FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563; GAUTEL M, 1993, EMBO J, V12, P3827; Gautel M, 1996, J CELL SCI, V109, P2747; GOLL DE, 1972, J MOL BIOL, V67, P469, DOI 10.1016/0022-2836(72)90464-0; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Gregorio CC, 1996, TRENDS CARDIOVAS MED, V6, P136, DOI 10.1016/1050-1738(96)00022-9; Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028; Kolmerer B, 1996, J MOL BIOL, V256, P556, DOI 10.1006/jmbi.1996.0108; LABEIT S, 1992, EMBO J, V11, P1711; Lin Z, 1998, DEV BIOL, V199, P291, DOI 10.1006/dbio.1998.8920; Linke WA, 1998, P NATL ACAD SCI USA, V95, P8052, DOI 10.1073/pnas.95.14.8052; Linke WA, 1998, J CELL SCI, V111, P1567; Linke WA, 1997, BIOPHYS J, V73, P905; Liu FZ, 1997, CELL STRUCT FUNCT, V22, P155; Liu FZ, 1998, J CELL BIOL, V140, P347, DOI 10.1083/jcb.140.2.347; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; MUHLEGOLL C, 1998, STRUCTURE, V0006; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441; Ohtsuka H, 1997, FEBS LETT, V401, P65, DOI 10.1016/S0014-5793(96)01432-9; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Peckham M, 1997, CELL STRUCT FUNCT, V22, P95; Pelin K, 1997, EUR J HUM GENET, V5, P229; Shimada Y, 1996, ADV BIOPHYS, V33, P223; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; Squire JM, 1997, CURR OPIN STRUC BIOL, V7, P247, DOI 10.1016/S0959-440X(97)80033-4; TOKUYASU KT, 1987, J CELL BIOL, V105, P2795, DOI 10.1083/jcb.105.6.2795; Trinick J, 1996, CURR BIOL, V6, P258, DOI 10.1016/S0960-9822(02)00472-4; Trombitas K, 1997, AM J PHYSIOL-CELL PH, V273, pC662; Turnacioglu KK, 1996, CELL MOTIL CYTOSKEL, V34, P108, DOI 10.1002/(SICI)1097-0169(1996)34:2<108::AID-CM3>3.3.CO;2-N; WITT CC, 1998, J STRUCT BIOL, V122, P1	54	230	235	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0955-0674			CURR OPIN CELL BIOL	Curr. Opin. Cell Biol.	FEB	1999	11	1					18	25		10.1016/S0955-0674(99)80003-9		8	Cell Biology	Cell Biology	167CA	WOS:000078614000002		
J	Sugiyama, M				Sugiyama, M			Organogenesis in vitro	CURRENT OPINION IN PLANT BIOLOGY			English	Review							SHOOT APICAL MERISTEM; MAIZE HOMEOBOX GENE; CULTURED IN-VITRO; ARABIDOPSIS-THALIANA; CELL-CYCLE; NICOTIANA-TABACUM; WILD-TYPE; EXPRESSION; INVITRO; MUTANT	Organogenesis in vitro consists of many aspects such as phytohormone perception, dedifferentiation of differentiated cells to acquire organogenic competence, re-entry of quiescent cells into cell cycle, and organization of cell division to form specific organ primordia and meristems, Some of elementary processes and essential genes involved in this composite phenomenon are being identified largely through genetic analysis with various types of mutants including temperature-sensitive and activation-tagged ones.	Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Tokyo 1120001, Japan	Sugiyama, M (reprint author), Univ Tokyo, Grad Sch Sci, Bot Gardens, Bunkyo Ku, Hakusan 3-7-1, Tokyo 1120001, Japan.		SUGIYAMA, MUNETAKA/G-4922-2014				YASUTANI I, 1994, PLANT PHYSIOL, V105, P815; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; Magyar Z, 1997, PLANT CELL, V9, P223; CHRISTIANSON ML, 1983, DEV BIOL, V95, P288, DOI 10.1016/0012-1606(83)90029-5; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; VOLLBRECHT E, 1991, NATURE, V350, P241, DOI 10.1038/350241a0; BARTON MK, 1993, DEVELOPMENT, V119, P823; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; HEMERLY AS, 1993, PLANT CELL, V5, P1711, DOI 10.1105/tpc.5.12.1711; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; ATTFIELD EM, 1991, J EXP BOT, V42, P59, DOI 10.1093/jxb/42.1.59; Burritt DJ, 1996, J EXP BOT, V47, P557, DOI 10.1093/jxb/47.4.557; CHRISTIANSON ML, 1985, DEV BIOL, V112, P494, DOI 10.1016/0012-1606(85)90423-3; Fobert PR, 1996, PLANT CELL, V8, P1465, DOI 10.1105/tpc.8.9.1465; Fuerst RAUA, 1996, PLANT PHYSIOL, V112, P1023, DOI 10.1104/pp.112.3.1023; HAYASHI H, 1992, SCIENCE, V258, P1350, DOI 10.1126/science.1455228; HICKS GS, 1994, IN VITRO CELL DEV-PL, V30P, P10; Lakshmanan P, 1997, PLANT CELL PHYSIOL, V38, P59; Lo KH, 1997, PLANT CELL REP, V16, P416, DOI 10.1007/s002990050251; Lund ST, 1997, PLANT PHYSIOL, V114, P1197; Lund ST, 1996, PHYSIOL PLANTARUM, V97, P372, DOI 10.1034/j.1399-3054.1996.970223.x; MARTINEZ MC, 1992, P NATL ACAD SCI USA, V89, P7360, DOI 10.1073/pnas.89.16.7360; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; MULLER JF, 1985, MOL GEN GENET, V199, P194, DOI 10.1007/BF00330259; Ozawa S, 1998, DEVELOPMENT, V125, P135; Segers G, 1996, PLANT J, V10, P601, DOI 10.1046/j.1365-313X.1996.10040601.x; Shaul O, 1996, ANN BOT-LONDON, V78, P283, DOI 10.1006/anbo.1996.0122; SINHA NR, 1993, GENE DEV, V7, P787, DOI 10.1101/gad.7.5.787; SONI R, 1995, PLANT CELL, V7, P85, DOI 10.1105/tpc.7.1.85; White DWR, 1998, PLANT PHYSIOL, V116, P913, DOI 10.1104/pp.116.3.913; Zhang SB, 1998, PLANTA, V204, P542, DOI 10.1007/s004250050289	37	110	123	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	1369-5266			CURR OPIN PLANT BIOL	Curr. Opin. Plant Biol.	FEB	1999	2	1					61	64		10.1016/S1369-5266(99)80012-0		4	Plant Sciences	Plant Sciences	162TA	WOS:000078361800011		
J	Torii, MA; Matsuzaki, F; Osumi, N; Kaibuchi, K; Nakamura, S; Casarosa, S; Guillemot, F; Nakafuku, M				Torii, MA; Matsuzaki, F; Osumi, N; Kaibuchi, K; Nakamura, S; Casarosa, S; Guillemot, F; Nakafuku, M			Transcription factors Mash-1 and Prox-1 delineate early steps in differentiation of neural stem cells in the developing central nervous system	DEVELOPMENT			English	Article						neural development; stem cell; neuron; glia; Mash-1; prospero	EMBRYONIC MOUSE FOREBRAIN; ACHAETE-SCUTE HOMOLOG-1; ZONE PROGENITOR CELLS; RAT CEREBRAL-CORTEX; RESTRICTED EXPRESSION; PRECURSOR CELLS; CNS; NEUROGENESIS; LINEAGE; PROTEIN	Like other tissues and organs in vertebrates, multipotential stem cells serve as the origin of diverse cell types during genesis of the mammalian central nervous system (CNS), During early development, stem cells self-renew and increase their total cell numbers without overt differentiation. At later stages, the cells withdraw from this self-renewal mode, and are fated to differentiate into neurons and glia in a spatially and temporally regulated manner. However, the molecular mechanisms underlying this important step in cell differentiation remain poorly understood. In this study, we present evidence that the expression and function of the neural-specific transcription factors Mash-1 and Prox-1 are involved in this process. In vivo, Mash-1- and Prox-1-expressing cells were defined as a transient proliferating population that was molecularly distinct from self-renewing stem cells. By taking advantage of in vitro culture systems, we showed that induction of Mash-1 and Prox-1 coincided with an initial step of differentiation of stem cells. Furthermore, forced expression of Mash-1 led to the down-regulation of nestin, a marker for undifferentiated neuroepithelial cells, and upregulation of Prox-1, suggesting that Mash-1 positively regulates cell differentiation. In support of these observations in vitro, we found specific defects in cellular differentiation and loss of expression of Prox-1 in the developing brain of Mash-1 mutant mice in vivo. Thus, we propose that induction of Mash-1 and Prox-1 is one of the critical molecular events that control early development of the CNS.	Univ Tokyo, Grad Sch Med, Div Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Neurol & Psychiat, Inst Neurosci, Div Mol Genet, Tokyo, Japan; Natl Inst Neurol & Psychiat, Inst Neurosci, Div Biochem & Cellular Biol, Tokyo, Japan; Nara Adv Inst Sci & Technol, Grad Sch Biol Sci, Div Signal Transduct, Nara, Japan; Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, CU Strasbourg, France	Nakafuku, M (reprint author), Univ Tokyo, Grad Sch Med, Div Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan.	nakafuku@m.u-tokyo.ac.jp		Casarosa, Simona/0000-0002-7744-8183			Altman J., 1995, ATLAS PRENATAL RAT B; ANGEVINE JB, 1970, ANAT REC, V166, P257, DOI 10.1002/ar.1091660214; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Saito T, 1996, DEV BIOL, V180, P143, DOI 10.1006/dbio.1996.0291; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Cau E, 1997, DEVELOPMENT, V124, P1611; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; BULFONE A, 1993, J NEUROSCI, V13, P3155; STOYKOVA A, 1994, J NEUROSCI, V14, P1395; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Casarosa S, 1999, DEVELOPMENT, V126, P525; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Bhide PG, 1996, J COMP NEUROL, V374, P506; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; ANGEVINE JB, 1970, J COMP NEUROL, V139, P129, DOI 10.1002/cne.901390202; Qian XM, 1998, DEVELOPMENT, V125, P3143; Osumi N, 1997, DEVELOPMENT, V124, P2961; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Hirsch MR, 1998, DEVELOPMENT, V125, P599; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; CEPKO C, 1995, METHOD ENZYMOL, V254, P387; DOE CQ, 1993, TRENDS NEUROSCI, V16, P510, DOI 10.1016/0166-2236(93)90195-R; GORDON RD, 1995, NAT GENET, V11, P6, DOI 10.1038/ng0995-6; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; HALL PA, 1989, DEVELOPMENT, V106, P619; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; KILPATRICK TJ, 1995, MOL CELL NEUROSCI, V6, P2, DOI 10.1006/mcne.1995.1002; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LO L, 1995, NEURON, V15, P517; Lo LC, 1998, DEVELOPMENT, V125, P609; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; NAKAFUKU M, 1995, J NEUROSCI RES, V41, P153, DOI 10.1002/jnr.490410203; Nakagawa Y, 1996, DEVELOPMENT, V122, P2449; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; REDIES C, 1991, J NEUROSCI RES, V30, P601, DOI 10.1002/jnr.490300403; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Temple S, 1996, CURR OPIN NEUROBIOL, V6, P11, DOI 10.1016/S0959-4388(96)80003-1; Verma-Kurvari S, 1998, DEV BIOL, V197, P106, DOI 10.1006/dbio.1998.8873; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WILLIAMS BP, 1995, NEURON, V14, P1181, DOI 10.1016/0896-6273(95)90265-1; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	54	161	162	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS, ENGLAND CB4 4DL	0950-1991			DEVELOPMENT	Development	FEB	1999	126	3					443	456				14	Developmental Biology	Developmental Biology	168VK	WOS:000078713700003		
J	Nishina, H; Vaz, C; Billia, P; Nghiem, M; Sasaki, T; De la Pompa, JL; Furlonger, K; Paige, C; Hui, CC; Fischer, KD; Kishimoto, H; Iwatsubo, T; Katada, T; Woodgett, JR; Penninger, JM				Nishina, H; Vaz, C; Billia, P; Nghiem, M; Sasaki, T; De la Pompa, JL; Furlonger, K; Paige, C; Hui, CC; Fischer, KD; Kishimoto, H; Iwatsubo, T; Katada, T; Woodgett, JR; Penninger, JM			Defective liver formation and liver cell apoptosis in mice lacking the stress signaling kinase SEK1/MKK4	DEVELOPMENT			English	Article						SEK1/MKK4; stress kinase signaling; hepatogenesis; mouse	ACTIVATED PROTEIN-KINASE; JUN NH2-TERMINAL KINASE; RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; N-TERMINAL KINASE; HUMAN T-CELLS; C-JUN; GENE-EXPRESSION; IN-VITRO; TRANSCRIPTIONAL ACTIVITY	The stress signaling kinase SEK1/MKK4 is a direct activator of stress-activated protein kinases (SAPKs; also called Jun-N-terminal kinases, JNKs) in response to a variety of cellular stresses, such as changes in osmolarity, metabolic poisons, DNA damage, heat shock or inflammatory cytokines. We have disrupted the sek1 gene in mice using homologous recombination, Sek1(-/-) embryos display severe anemia and die between embryonic day 10.5 (E10.5) and E12.5. Haematopoiesis from yolk sac precursors and vasculogenesis are normal in sek1(-/-) embryos, However, hepatogenesis and liver formation were severely impaired in the mutant embryos and E11.5 and E12.5 sek1(-/-) embryos had greatly reduced numbers of parenchymal hepatocytes. Whereas formation of the primordial liver from the visceral endoderm appeared normal, sek1(-/-) liver cells underwent massive apoptosis, These results provide the first genetic link between stress-responsive kinases and organogenesis in mammals and indicate that SEK1 provides a crucial and specific survival signal for hepatocytes.	Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Wuerzburg, Inst Radiat & Cell Res, D-97078 Wuerzburg, Germany	Penninger, JM (reprint author), Univ Toronto, Ontario Canc Inst, Amgen Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.	Jpenning@amgen.com	Woodgett, Jim/F-1087-2010; Penninger, Josef/I-6860-2013; De La Pompa Minguez, Jose Luis/F-9719-2014	Woodgett, Jim/0000-0003-3731-5797; De La Pompa Minguez, Jose Luis/0000-0001-6761-7265			ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; NALDINI L, 1991, EMBO J, V10, P2867; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Bardelli A, 1996, EMBO J, V15, P6205; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Sasaki H, 1997, DEVELOPMENT, V124, P1313; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Gualdi R, 1996, GENE DEV, V10, P1670, DOI 10.1101/gad.10.13.1670; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Tokiwa G, 1996, SCIENCE, V273, P792, DOI 10.1126/science.273.5276.792; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Chen YR, 1996, J BIOL CHEM, V271, P631; Ganju RK, 1998, BLOOD, V91, P791; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Diehl AM, 1996, FASEB J, V10, P215; Lenczowski JM, 1997, MOL CELL BIOL, V17, P170; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Woodgett JR, 1996, CANCER SURV, V27, P127; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689; Latinis KM, 1996, BLOOD, V87, P871; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; DARBY C, 1994, J IMMUNOL, V152, P5429; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Chen YR, 1996, J BIOL CHEM, V271, P31929; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Yang D, 1997, P NATL ACAD SCI USA, V94, P3004, DOI 10.1073/pnas.94.7.3004; Zeitlinger J, 1997, EMBO J, V16, P7393, DOI 10.1093/emboj/16.24.7393; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; MINDEN A, 1994, MOL CELL BIOL, V14, P6683; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; MARTI E, 1995, DEVELOPMENT, V121, P2537; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; Bachmaier K, 1997, CIRCULATION, V95, P655; COBB MH, 1995, J BIOL CHEM, V270, P14843; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; CUMANO A, 1993, P NATL ACAD SCI USA, V90, P6429, DOI 10.1073/pnas.90.14.6429; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DieterlenLievre F, 1995, COLLOQ INSE, V235, P5; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Holland PM, 1997, J BIOL CHEM, V272, P24994, DOI 10.1074/jbc.272.40.24994; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; Li YS, 1996, MOL CELL BIOL, V16, P5947; Longati P, 1996, CELL DEATH DIFFER, V3, P23; Lu XH, 1997, J BIOL CHEM, V272, P24751, DOI 10.1074/jbc.272.40.24751; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; MITTRUCKER HW, 1996, STEM CELLS, V14, P250; Nishina H, 1997, J EXP MED, V186, P941, DOI 10.1084/jem.186.6.941; Orkin SH, 1997, ANNU REV GENET, V31, P33, DOI 10.1146/annurev.genet.31.1.33; PRASAD MVVSV, 1995, J BIOL CHEM, V270, P18655; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Riese J, 1997, DEVELOPMENT, V124, P3353; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Rodrigues GA, 1997, EMBO J, V16, P2634, DOI 10.1093/emboj/16.10.2634; SANCHEZ I, 1994, NATURE, V372, P794; SLADEK FM, 1993, RECEPTOR, V3, P223; SU B, 1994, CELL, V77, P727, DOI 10.1016/0092-8674(94)90056-6; Toyoshima F, 1997, J CELL BIOL, V139, P1005, DOI 10.1083/jcb.139.4.1005; Wilson DJ, 1996, EUR J IMMUNOL, V26, P989, DOI 10.1002/eji.1830260505; Wu ZG, 1997, MOL CELL BIOL, V17, P7407; YAN MH, 1994, NATURE, V372, P798; Yao ZB, 1997, J BIOL CHEM, V272, P32378, DOI 10.1074/jbc.272.51.32378	84	123	125	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE, CAMBS, ENGLAND CB4 4DL	0950-1991			DEVELOPMENT	Development	FEB	1999	126	3					505	516				12	Developmental Biology	Developmental Biology	168VK	WOS:000078713700008		
J	Miyanaga, Y; Shiurba, R; Asashima, M				Miyanaga, Y; Shiurba, R; Asashima, M			Blood cell induction in Xenopus animal cap explants: Effects of fibroblast growth factor, bone morphogenetic proteins, and activin	DEVELOPMENT GENES AND EVOLUTION			English	Article						amphibian haematopoiesis; leukocytes; activin; basic fibroblast growth factor; bone morphogenetic proteins	ERYTHROID-DIFFERENTIATION FACTOR; MESODERM INDUCTION; VENTRAL MESODERM; EMBRYOS; LAEVIS; RECEPTOR; SIGNALS; ERYTHROPOIESIS; BMP-2; GENE	Cultures of Xenopus blastula animal caps were used to explore the haematopoietic effects of three candidate inducers of mesoderm: basic fibroblast growth factor (bFGF), bone morphogenetic proteins (BMPs) and activin A. In response to either bFGF or activin A, explants expanded into egg-shaped structures, and beneath an outer layer of epidermis, a ventral mesodermal lining surrounded a fluid-filled cavity containing "blood-like cells". Immunocytochemistry identified some of these cells as early leukocytes, but erythrocytes were rare. BMP-2 or BMP-4 induced primitive erythrocytes as well as leukocytes, and a high concentration was required for these cells to differentiate in only a small proportion of explants. BMP-2 but not BMP-4 induced ventral mesoderm concomitantly. High concentrations of activin A dorsalized explants, which contained infrequent leukocytes, and an optimal combination of activin A and bFGF caused differentiation of muscle with few blood cells. By contrast, BMP-2 or BMP-4! plus activin A synergistically increased the numbers of both leukocytes and erythrocytes. Explants treated with BMPs plus activin contained a well organized cell mass in which yolk-rich cells mixed with blood cells and pigment-ed cells did not. BMP-2 plus bFGF also induced numerous leukocytes and fewer erythrocytes, but BMP-4 antagonized the leukopoietic effect of bFGF The data suggest that the signalling pathways these three factors use to induce leukopoiesis overlap and that erythropoiesis may be activated when inducers are present in combination.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; Misato Plaheat Mfg Ltd, Satte, Saitama 3400124, Japan	Miyanaga, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; MURATA M, 1988, P NATL ACAD SCI USA, V85, P2434, DOI 10.1073/pnas.85.8.2434; Mead PE, 1996, NATURE, V382, P357, DOI 10.1038/382357a0; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4; ARIIZUMI T, 1991, ROUX ARCH DEV BIOL, V200, P230, DOI 10.1007/BF00361342; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; CLEMENT JH, 1995, MECH DEVELOP, V52, P357, DOI 10.1016/0925-4773(95)00413-U; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; GREEN JBA, 1990, DEVELOPMENT, V108, P173; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; JONES CM, 1992, DEVELOPMENT, V115, P639; Kaufmann E, 1996, EMBO J, V15, P6739; KNOCHEL W, 1994, ANN NY ACAD SCI, V718, P125; KOSTER M, 1991, MECH DEVELOP, V33, P191, DOI 10.1016/0925-4773(91)90027-4; MAENO M, 1994, P NATL ACAD SCI USA, V91, P10260, DOI 10.1073/pnas.91.22.10260; Mangia F, 1970, Acta Embryol Exp (Palermo), V2, P163; Miyanaga Y, 1998, DEV GENES EVOL, V207, P417, DOI 10.1007/s004270050132; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; OHINATA H, 1991, DEV GROWTH DIFFER, V33, P299; PLESSOW S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P280, DOI 10.1016/0167-4781(91)90026-I; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; Thomsen GH, 1996, DEVELOPMENT, V122, P2359; Tracey WD, 1998, DEVELOPMENT, V125, P1371; Vize PD, 1996, DEV BIOL, V177, P226, DOI 10.1006/dbio.1996.0158; Watabe T, 1995, GENE DEV, V9, P3038, DOI 10.1101/gad.9.24.3038; Zhang CH, 1996, DEV GENET, V18, P267, DOI 10.1002/(SICI)1520-6408(1996)18:3<267::AID-DVG7>3.0.CO;2-7	27	27	27	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0949-944X			DEV GENES EVOL	Dev. Genes Evol.	FEB	1999	209	2					69	76		10.1007/s004270050229		8	Cell Biology; Evolutionary Biology; Developmental Biology	Cell Biology; Evolutionary Biology; Developmental Biology	171UU	WOS:000078883100001		
J	Tamai, K; Yokota, C; Ariizumi, T; Asashima, M				Tamai, K; Yokota, C; Ariizumi, T; Asashima, M			Cytochalasin B inhibits morphogenetic movement and muscle differentiation of activin-treated ectoderm in Xenopus	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						activin A; cytochalasin B; morphogenetic movement; muscle differentiation; Xenopus	MESODERM INDUCTION; EARLY RESPONSE; NEURAL INDUCTION; GASTRULATION MOVEMENTS; HOMEOBOX GENE; ANIMAL CAPS; C-CADHERIN; EMBRYOS; LAEVIS; EXPRESSION	Xenopus ectodermal explants (animal caps) begin to elongate after treatment with the mesoderm inducing factor activin A. This phenomenon mimics the convergent extension of dorsal mesoderm during gastrulation. To analyze the relationship between elongation movement and muscle differentiation, animal caps were treated with colchicine, taxol, cytochalasin B and hydroxyurea (HUA)/aphidicolin following activin treatment. Cytochalasin B disrupted the organization of actin filaments and inhibited the elongation of the activin-treated explants. Muscle differentiation was also inhibited in these explants at the histologic and molecular levels. Colchicine and taxol, which are known to affect microtubule organization, had little effect on elongation of the activin-treated explants. Go-treatment with HUA and aphidicolin caused serious damage on the explants and they did not undergo elongation. These results suggest that actin filaments play an important role in the elongation movement that leads to muscle differentiation of activin-treated explants.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1138654, Japan; Univ Tokyo, Grad Sch Arts & Sci, CREST Project, Dept Life Sci,Meguro Ku, Tokyo 1538902, Japan	Asashima, M (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.						SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; ARIIZUMI T, 1991, ROUX ARCH DEV BIOL, V200, P230, DOI 10.1007/BF00361342; ASASHIMA M, 1994, DEV GROWTH DIFFER, V36, P343; ASASHIMA M, 1990, ROUX ARCH DEV BIOL, V198, P330, DOI 10.1007/BF00383771; BRIEHER WM, 1994, J CELL BIOL, V126, P519, DOI 10.1083/jcb.126.2.519; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; HATADA S, 1995, FEBS LETT, V371, P287, DOI 10.1016/0014-5793(95)00913-T; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HOPWOOD ND, 1989, EMBO J, V8, P3409; Horb ME, 1997, DEVELOPMENT, V124, P1689; HOWARD JE, 1992, MECH DEVELOP, V38, P109, DOI 10.1016/0925-4773(92)90003-3; HOWARD JE, 1993, MECH DEVELOP, V43, P37, DOI 10.1016/0925-4773(93)90021-O; ITOH K, 1994, DEVELOPMENT, V120, P2703; KELLER R, 1992, GASTRULATION DEV S, P81; KINTNER CR, 1987, DEVELOPMENT, V99, P311; LABONNE C, 1994, DEVELOPMENT, V120, P463; Ladher R, 1996, DEVELOPMENT, V122, P2385; LAI CJ, 1995, DEVELOPMENT, V121, P2349; Lane MC, 1997, DEVELOPMENT, V124, P895; LEE CH, 1995, DEV BIOL, V171, P363, DOI 10.1006/dbio.1995.1288; MITANI S, 1989, DEVELOPMENT, V107, P423; NAKATSUJI N, 1979, DEV BIOL, V68, P140, DOI 10.1016/0012-1606(79)90249-5; Nieuwkoop P.D., 1956, NORMAL TABLE XENOPUS; PANNESE M, 1995, DEVELOPMENT, V121, P707; PERRY MM, 1975, J EMBRYOL EXP MORPH, V33, P127; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Sasai Y, 1996, EMBO J, V15, P4547; SCHAEFFE.HE, 1973, DEV BIOL, V34, P163, DOI 10.1016/0012-1606(73)90346-1; Selchow A, 1997, CELL MOTIL CYTOSKEL, V36, P12; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; SMITH JC, 1990, NATURE, V345, P729, DOI 10.1038/345729a0; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; STUTZ F, 1986, J MOL BIOL, V187, P349, DOI 10.1016/0022-2836(86)90438-9; SYMES K, 1994, DEVELOPMENT, V120, P2339; SYMES K, 1987, DEVELOPMENT, V101, P339; Takahashi S, 1998, ZOOL SCI, V15, P231, DOI 10.2108/zsj.15.231; Wacker S, 1998, DEVELOPMENT, V125, P1931; WILSON PA, 1994, CURR BIOL, V4, P676, DOI 10.1016/S0960-9822(00)00152-4; WINKLBAUER R, 1990, DEV BIOL, V142, P155, DOI 10.1016/0012-1606(90)90159-G; Winklbauer R, 1996, DEV BIOL, V177, P413, DOI 10.1006/dbio.1996.0174; WRIGHT CVE, 1990, DEVELOPMENT, V109, P225; Yokota C, 1998, J BIOCHEM-TOKYO, V123, P339	48	12	12	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0012-1592			DEV GROWTH DIFFER	Dev. Growth Diff.	FEB	1999	41	1					41	49				9	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	223MF	WOS:000081844300005		
J	Oshima, Y; Kishi, MJ; Sugimoto, T				Oshima, Y; Kishi, MJ; Sugimoto, T			Evaluation of the nutrient budget in a seagrass bed	ECOLOGICAL MODELLING			English	Article						physical-biological coupled model; Zostera marina; nutrient budget	ZOSTERA-MARINA-L; ORGANIC PRODUCTION; TEMPERATE WATERS; NITROGEN UPTAKE; PACIFIC COAST; GROWTH; MODEL; JAPAN; LEAVES; ROOTS	Seagrass bed has an important role in the marine ecosystem of estuarine areas. To conserve and manage these seagrass beds, understanding the system and the role of seagrass is necessary. A three-dimensional physical-biological coupled model (MK-3) was modified to include a seagrass bed and it was applied to Akkeshi lake, on the Pacific coast of Hokkaido in the northern part of Japan. Nitrogen and phosphorus fluxes were evaluated to investigate the role of seagrass on the nutrient cycle. First, a simple box model was developed. We divided the lake into three boxes to estimate the characteristics of the nutrient cycle from observed data. The box model revealed that nitrate is supplied to the lake through physical processes, i.e. river discharge and advection from outer regions and is consumed biologically inside the lake. On the other hand: phosphate is supplied from inside the lake and flows out. Second, to explain this different behavior of nitrate and phosphate, the three-dimensional physical-biological coupled model was applied. The model was run under average meteorological conditions of April for IO days, then a calculation was continued using actual conditions (wind, precipitation, etc.) during 16-27 April 1996. The calculation was carried out for two cases: (I) with eelgrass; and (2) without eelgrass. In the case without eelgrass, nitrate and phosphate were both reduced by biological and chemical processes inside the lake. In the case with eelgrass, nitrate was reduced, but phosphate was produced inside the lake, which was estimated by the box model. Furthermore, the eelgrass was more important than phytoplankton to produce particulate organic matter. The daily variation in chlorophyll a and nitrate, which was observed during 16-27 April 1996, could not be reproduced in the model results, although the average values coincided with the observed values. This may be because of the effect of melting snow in the river discharge (data not shown). (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Hokkaido Univ, Fac Fisheries, Hakodate, Hokkaido 0418611, Japan							AIOI K, 1980, Japanese Journal of Ecology, V30, P189; AIOI K, 1981, PRODUCTION EELGRASS; ATKINSON MJ, 1983, LIMNOL OCEANOGR, V28, P568; Stapel J, 1996, MAR ECOL PROG SER, V134, P195, DOI 10.3354/meps134195; PACANOWSKI RC, 1981, J PHYS OCEANOGR, V11, P1443, DOI 10.1175/1520-0485(1981)011<1443:POVMIN>2.0.CO;2; IIZUMI H, 1982, AQUAT BOT, V12, P245, DOI 10.1016/0304-3770(82)90020-1; BACH HK, 1993, ECOL MODEL, V65, P31, DOI 10.1016/0304-3800(93)90125-C; HOKKAIDO, 1981, REP COMPR DEV PLAN C; IIZUMI H, 1996, NO JAP SEAGR BIOL P, P143; Iizumi Hitoshi, 1995, Bulletin of the Hokkaido National Fisheries Research Institute, V59, P43; Jorgensen S.E, 1979, HDB ENV DATA ECOLOGI; Kawamiya Michio, 1995, Journal of Oceanography, V51, P635, DOI 10.1007/BF02235457; Kawamiya M, 1996, CONT SHELF RES, V16, P1683, DOI 10.1016/0278-4343(96)00007-6; Kishi MJ, 1995, FISH OCEANOGR, V4, P303, DOI 10.1111/j.1365-2419.1995.tb00075.x; KISHI MJ, 1993, P 2 INT C FISH OC IN, P23; KISHI MJ, 1993, NUMERICAL MODEL TOKY, P139; MCROY CP, 1972, LIMNOL OCEANOGR, V17, P58; MUKAI H, 1979, AQUAT BOT, V7, P47, DOI 10.1016/0304-3770(79)90006-8; *RES DEV COAST COM, 1991, EX COND FISH ENV AKK; SHORT FT, 1984, BOT MAR, V27, P547, DOI 10.1515/botm.1984.27.12.547; TAKAHASHI Y, 1978, HYDROLOGY RIVERS, P70; WETZEL RL, 1986, AQUAT BOT, V26, P307, DOI 10.1016/0304-3770(86)90029-X; Zupo V, 1997, ESTUAR COAST SHELF S, V44, P483, DOI 10.1006/ecss.1996.0137	23	13	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-3800			ECOL MODEL	Ecol. Model.	FEB 1	1999	115	1					19	33		10.1016/S0304-3800(98)00155-0		15	Ecology	Environmental Sciences & Ecology	173VR	WOS:000079000900002		
J	Miyoshi, T; Tanaka, Y				Miyoshi, T; Tanaka, Y			Optimal hierarchical structure of broadcast network	ELECTRONICS AND COMMUNICATIONS IN JAPAN PART I-COMMUNICATIONS			English	Article						network; B-ISDN; broadcast; hierarchical structure; optimization		With the realization of broadband integrated service digital networks (B-ISDN), broadcast services will occupy a large part of the network traffic. In these services, the same information is distributed to many subscribers through the point-to-multipoint connection paths. This connection form is quite different from that of conventional point-to-point services. Since the conventional network structure is designed for point-to-point services, the current network topology may lower the quality of service or may increase construction costs. In this paper, the hierarchical broadcast network topology is optimized under certain assumptions: the cost functions, the population distribution, and the percentage of broadcast services are treated as parameters. The result shows that the ring-star-star or ring-ring-star topologies can be better than the conventional mesh-star topology in some cases, and can be much better when the viewing ratio of broadcast services increases. (C) 1998 Scripta Technica, Electron Comm Jpn Pt 1, 82(2): 48-56, 1999.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Waseda Univ, Global Informat & Telecommun Inst, Tokyo 1698555, Japan	Miyoshi, T (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo 1068558, Japan.						TANAKA T, 1995, IN9521 IEICE; *TEL TECHN COUNC, 1996, TECHN ISS NETW ER CO; YAMASHITA M, 1981, T IEICE B, V64, P305	3	3	3	SCRIPTA TECHNICA-JOHN WILEY & SONS	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158 USA	8756-6621			ELECTRON COMM JPN 1	Electron. Commun. Jpn. Pt. I-Commun.	FEB	1999	82	2					48	56				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	135CY	WOS:000076783900006		
J	Crawford, DJG; Ito, K; Nakamura, Y; Tate, WP				Crawford, DJG; Ito, K; Nakamura, Y; Tate, WP			Indirect regulation of translational termination efficiency at highly expressed genes and recoding sites by the factor recycling function of Escherichia coli release factor RF3	EMBO JOURNAL			English	Article						recoding; release factors; RF3; ribosome; translational termination	TRANSFER-RNA; RIBOSOME BINDING; FACTOR RF-3; STOP CODON; FACTOR RRF	Prokaryotic release factor RF3 is a stimulatory protein that increases the rate of translational termination by the decoding release factors RF1 and RF2, The favoured model for RF3 function is the recycling of RF1 and RF2 after polypeptide release by displacing the factors from the ribosome. In this study, we have demonstrated that RF3 also plays an indirect role in the decoding of stop signals of highly expressed genes and recoding sites by accentuating the influence of the base following the stop codon (+4 base) on termination signal strength. The efficiency of decoding strong stop signals (e.g. UAAU and UAAG) in vivo is markedly improved with increased RF3 activity, while weak signals (UGAC and UAGC) are only modestly affected. However, RF3 is not responsible for the +4 base influence on termination signal strength, since prfC(-) strains lacking the protein still exhibit the same qualitative effect. The differential effect of RF3 at stop signals can be mimicked by modest overexpression of decoding RF. These findings can be interpreted according to current views of RF3 as a recycling factor, which functions to maintain the concentration of free decoding RF at stop signals, some of which are highly responsive to changes in RF levels.	Univ Otago, Dept Biochem, Dunedin, New Zealand; Univ Otago, Ctr Gene Res, Dunedin, New Zealand; Univ Tokyo, Inst Med Sci, Dept Tumour Biol, Tokyo, Japan	Tate, WP (reprint author), Univ Otago, Dept Biochem, POB 56, Dunedin, New Zealand.						Tate WP, 1995, BIOCHEM CELL BIOL, V73, P1095; PEDERSEN WT, 1991, J MOL BIOL, V219, P231, DOI 10.1016/0022-2836(91)90564-M; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; ATKINS JF, 1990, CELL, V62, P413, DOI 10.1016/0092-8674(90)90007-2; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469; CRAIGEN WJ, 1985, P NATL ACAD SCI USA, V82, P3616, DOI 10.1073/pnas.82.11.3616; Dalphin ME, 1998, NUCLEIC ACIDS RES, V26, P335, DOI 10.1093/nar/26.1.335; FARABAUGH PJ, 1993, CELL, V74, P591, DOI 10.1016/0092-8674(93)90507-M; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; GOLDSTEI.JL, 1970, P NATL ACAD SCI USA, V67, P537, DOI 10.1073/pnas.67.2.537; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; GRENTZMANN G, 1995, J BIOL CHEM, V270, P10595; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; KAWAZU Y, 1995, J BACTERIOL, V177, P5547; Matsumura K, 1996, J MOL BIOL, V258, P588, DOI 10.1006/jmbi.1996.0271; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Nakamura Y, 1995, BIOCHEM CELL BIOL, V73, P1113; Pavlov MY, 1997, J MOL BIOL, V273, P389, DOI 10.1006/jmbi.1997.1324; Pel HJ, 1998, RNA, V4, P47; POOLE ES, 1995, EMBO J, V14, P151; TATE WP, 1992, BIOCHEMISTRY-US, V31, P2443, DOI 10.1021/bi00124a001	26	26	26	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0261-4189			EMBO J	Embo J.	FEB 1	1999	18	3					727	732		10.1093/emboj/18.3.727		6	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	166VC	WOS:000078597500023		
J	Okazaki, T				Okazaki, T			Gene regulation by extracellular calcium, vitamin D and osmolarity	ENDOCRINE JOURNAL			English	Review							PARATHYROID-HORMONE GENE; DNA-BINDING ACTIVITY; RESPONSE ELEMENT; KU AUTOANTIGEN; MAMMALIAN-CELLS; D-RECEPTOR; PROTEIN; EXPRESSION; TRANSCRIPTION; REPAIR		Univ Tokyo, Sch Med, Dept Internal Med 4, Endocrine Genet & Hypertens Unit,Bunkyo Ku, Tokyo 1128688, Japan	Okazaki, T (reprint author), Univ Tokyo, Sch Med, Dept Internal Med 4, Endocrine Genet & Hypertens Unit,Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Chung U, 1996, J BIOL CHEM, V271, P8593; Brenza HL, 1998, P NATL ACAD SCI USA, V95, P1387, DOI 10.1073/pnas.95.4.1387; OKAZAKI T, 1994, J BIOL CHEM, V269, P27855; Yacoub A, 1997, CANCER RES, V57, P5457; Jayaraman L, 1997, GENE DEV, V11, P558, DOI 10.1101/gad.11.5.558; Chen SC, 1998, HYPERTENSION, V31, P1338; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Reddy SV, 1998, BLOOD, V91, P1793; Bell NH, 1998, J BONE MINER RES, V13, P350, DOI 10.1359/jbmr.1998.13.3.350; BROWN EM, 1995, NEW ENGL J MED, V333, P234; Brown EM, 1998, ANNU REV MED, V49, P15; DEMAY MB, 1992, P NATL ACAD SCI USA, V89, P8097, DOI 10.1073/pnas.89.17.8097; GENERSCH E, 1995, EMBO J, V14, P791; GRIFFIN W, 1996, NATURE, V380, P265; GRIFFIN W, 1997, J BIOL CHEM, V272, P5647; HOFF CM, 1994, P NATL ACAD SCI USA, V91, P762, DOI 10.1073/pnas.91.2.762; Izumi T, 1996, BIOCHEMISTRY-US, V35, P14679, DOI 10.1021/bi961995u; Jhappan C, 1997, NAT GENET, V17, P483, DOI 10.1038/ng1297-483; KIM D, 1995, J BIOL CHEM, V270, P15277; KNUTH MW, 1990, J BIOL CHEM, V265, P17911; Kronenberg Henry M., 1994, P125; KRONENBERG HM, 1986, RECENT PROG HORM RES, V42, P641; LI GC, 1995, P NATL ACAD SCI USA, V92, P4512, DOI 10.1073/pnas.92.10.4512; MCHAFFIE GS, 1995, BONE, V17, P11, DOI 10.1016/8756-3282(95)00131-V; Meira LB, 1997, NAT GENET, V17, P145, DOI 10.1038/ng1097-145; MESSIER H, 1993, P NATL ACAD SCI USA, V90, P2685, DOI 10.1073/pnas.90.7.2685; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Murayama A, 1998, BIOCHEM BIOPH RES CO, V249, P11, DOI 10.1006/bbrc.1998.9098; Nishishita T, 1998, J BIOL CHEM, V273, P10901, DOI 10.1074/jbc.273.18.10901; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; NUSSBAUM SR, 1990, NEW ENGL J MED, V323, P324; OKAZAKI T, 1991, J BIOL CHEM, V266, P21903; Okazaki T, 1997, J BIOL CHEM, V272, P32274, DOI 10.1074/jbc.272.51.32274; OKAZAKI T, 1992, J CLIN INVEST, V89, P1268, DOI 10.1172/JCI115711; ROBERTS MR, 1994, P NATL ACAD SCI USA, V91, P6354, DOI 10.1073/pnas.91.14.6354; ROBSON CN, 1991, NUCLEIC ACIDS RES, V19, P5519, DOI 10.1093/nar/19.20.5519; SCHAFFNER W, 1989, TRENDS GENET, V5, P37, DOI 10.1016/0168-9525(89)90017-6; VANSANT G, 1995, P NATL ACAD SCI USA, V92, P8229, DOI 10.1073/pnas.92.18.8229; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323; YAMAMOTO M, 1989, J CLIN INVEST, V83, P1053, DOI 10.1172/JCI113946; ZHOU C, 1996, CELL, V86, P379	51	0	0	JAPAN ENDOCRINE SOCIETY	TOKYO	C/O DEPT VETERINARY PHYSIOL, VET MED SCI, UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 113, JAPAN	0918-8959			ENDOCR J	Endocr. J.	FEB	1999	46	1					1	9		10.1507/endocrj.46.1		9	Endocrinology & Metabolism	Endocrinology & Metabolism	181YV	WOS:000079471800001		
J	Hiroi, H; Momoeda, M; Inoue, S; Tsuchiya, F; Matsumi, H; Tsutsumi, O; Muramatsu, M; Taketani, Y				Hiroi, H; Momoeda, M; Inoue, S; Tsuchiya, F; Matsumi, H; Tsutsumi, O; Muramatsu, M; Taketani, Y			Stage-specific expression of estrogen receptor subtypes and estrogen responsive finger protein in preimplantational mouse embryos	ENDOCRINE JOURNAL			English	Article						estrogen receptor subtypes; estrogen-responsive finger protein; preimplantation embryos; mouse	BETA-MESSENGER-RNA; MOLECULAR-CLONING; ER-ALPHA; GENE; SEQUENCE; CDNA; IMPLANTATION; RING; DNA	In hope of understanding possible roles of estrogen during early embryogenesis, we examined the expression of both estrogen receptor alpha (ER alpha) and ER beta, a recently cloned novel subtype, in mouse oocytes and preimplantation embryos by means of reverse transcription polymerase chain reaction (RT-PCR). To investigate whether estrogen actually exerts its action, we further determined the expression of efp (estrogen-responsive finger protein), a newly characterized estrogen responsive gene belonging to the RING finger family. ER alpha mRNA was detected in whole ovaries, cumulus-oocyte complexes, denuded oocytes, 2-cell and 4-cell embryos, whereas it was undetected in 8-cell embryos. Interestingly it reappeared in morulae and blastocysts. ER beta mRNA was detected similarly to ER alpha except for the absence of ER beta mRNA in morulae. The efp mRNA was detected in whole ovaries, cumulus-oocyte complexes, 4-cell embryos, morulae and blastocysts. The stage specific expression of ER alpha and ER beta along with detection of the product of the estrogen responsive gene in early preimplantation embryos may indicate the possible physiological roles of estrogen in early embryogenesis.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; Saitama Med Sch, Dept Biochem, Kawagoe, Saitama 3500495, Japan	Hiroi, H (reprint author), Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; ORIMO A, 1995, J BIOL CHEM, V270, P24406; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Arts J, 1997, ENDOCRINOLOGY, V138, P5067, DOI 10.1210/en.138.11.5067; BACHVAROVA R, 1980, DEV BIOL, V74, P1, DOI 10.1016/0012-1606(80)90048-2; Brandenberger AW, 1997, J CLIN ENDOCR METAB, V82, P3509, DOI 10.1210/jc.82.10.3509; CHAN YL, 1987, J BIOL CHEM, V262, P1111; Das N, 1997, MOL REPROD DEV, V46, P499, DOI 10.1002/(SICI)1098-2795(199704)46:4<499::AID-MRD8>3.0.CO;2-J; GUPTA JS, 1977, STEROIDS, V29, P863; Hou Q, 1996, P NATL ACAD SCI USA, V93, P2376, DOI 10.1073/pnas.93.6.2376; HOU Q, 1993, P NATL ACAD SCI USA, V90, P9460, DOI 10.1073/pnas.90.20.9460; KASTNER P, 1990, EMBO J, V9, P1603; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; PEACH K, 1997, SCIENCE, V277, P1508; Saunders P.T., 1997, J ENDOCRINOL, V154, P13; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; SENGUPTA J, 1982, J REPROD FERTIL, V66, P63; Shughrue PJ, 1996, STEROIDS, V61, P678, DOI 10.1016/S0039-128X(96)00222-X; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Watanabe T, 1997, BIOCHEM BIOPH RES CO, V236, P140, DOI 10.1006/bbrc.1997.6915; WU TCJ, 1992, MOL REPROD DEV, V33, P407, DOI 10.1002/mrd.1080330406	32	38	39	JAPAN ENDOCRINE SOCIETY	TOKYO	C/O DEPT VETERINARY PHYSIOL, VET MED SCI, UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 113, JAPAN	0918-8959			ENDOCR J	Endocr. J.	FEB	1999	46	1					153	158		10.1507/endocrj.46.153		6	Endocrinology & Metabolism	Endocrinology & Metabolism	181YV	WOS:000079471800018		
J	Tsuchida, T; Ohnishi, H; Tanaka, Y; Mine, T; Fujita, T				Tsuchida, T; Ohnishi, H; Tanaka, Y; Mine, T; Fujita, T			Inhibition of stimulated amylase secretion by adrenomedullin in rat pancreatic acini	ENDOCRINOLOGY			English	Article							GENE-RELATED PEPTIDE; SMOOTH-MUSCLE-CELLS; HYPOTENSIVE PEPTIDE; IMMUNOREACTIVE ADRENOMEDULLIN; EXOCRINE PANCREAS; CYCLIC-AMP; INSULIN; CAMP; SOMATOSTATIN; RECEPTORS	Adrenomedullin is a novel hypotensive peptide originally isolated from human pheochromocytoma and recently localized to PP cells of the pancreatic islets of Langerhans. Based on the pancreatic islet-acinar axis model, we investigated the effect of adrenomedullin on regulated exocytosis of exocrine pancreas. Using rat [I-125]-adrenomedullin, specific binding sites were localized to rat pancreatic acini. We next examined the effect of adrenomedullin on 100 pM cholecystokinin (CCK)-stimulated amylase release from pancreatic acini. Adrenomedullin inhibited amylase secretion in a dose-dependent manner by approximately 50% at maximum, and the IC50 was 1.1 pM. However, adrenomedullin did not affect rat [I-125] CCK binding to isolated acini or reduce the intracellular free Ca2+ concentration increased by CCK. Adrenomedullin also inhibited amylase secretion induced by 1 mu M calcium ionophore A23187, suggesting that adrenomedullin inhibits stimulated amylase secretion by functioning at a step(s) distal to the ligand-receptor binding system and intracellular calcium mobilizing mechanism. In streptolysin-O permeabilized acini, 10 nM adrenomedullin shifted the calcium dose-response curve to the right, indicating that adrenomedullin inhibits calcium-induced amylase secretion by reducing calcium sensitivity of the pancreatic exocytotic machinery. In addition, pretreatment of pancreatic acini with pertussis toxin abolished the inhibitory effect of adrenomedullin on CCK-stimulated amylase secretion. These results indicate that adrenomedullin inhibits stimulated amylase secretion by reducing the calcium sensitivity of the exocytotic machinery of the pancreatic acini. A pertussis toxin-sensitive GTP-binding protein(s) is also involved in this mechanism.	Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, Tokyo 1128688, Japan	Ohnishi, H (reprint author), Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.	hohnishi-tky@umin.ac.jp					ICHIKI Y, 1994, FEBS LETT, V338, P6, DOI 10.1016/0014-5793(94)80106-1; KAPAS S, 1995, J BIOL CHEM, V270, P25344; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412; OWJI AA, 1995, ENDOCRINOLOGY, V136, P2127, DOI 10.1210/en.136.5.2127; EGUCHI S, 1994, FEBS LETT, V340, P226, DOI 10.1016/0014-5793(94)80143-6; SAKATA J, 1993, BIOCHEM BIOPH RES CO, V195, P921, DOI 10.1006/bbrc.1993.2132; ISHIZAKA Y, 1994, BIOCHEM BIOPH RES CO, V200, P642, DOI 10.1006/bbrc.1994.1496; Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; BURNHAM DB, 1982, J BIOL CHEM, V257, P523; CHINI EN, 1995, BIOCHEM BIOPH RES CO, V215, P868, DOI 10.1006/bbrc.1995.2544; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; HALL JM, 1995, BRIT J PHARMACOL, V114, P592; ICHIKI Y, 1995, J BIOCHEM-TOKYO, V118, P765; ISHIYAMA Y, 1993, EUR J PHARMACOL, V241, P271, DOI 10.1016/0014-2999(93)90214-3; MATOZAKI M, 1998, AM J PHYSIOL, V255, pE652; MATSUSHITA K, 1993, GASTROENTEROLOGY, V104, P1146; MATSUSHITA K, 1994, GASTROENTEROLOGY, V106, P200; OHNISHI H, 1994, BIOCHEM J, V304, P531; Ohnishi H, 1997, J BIOL CHEM, V272, P16056, DOI 10.1074/jbc.272.25.16056; Padfield PJ, 1997, BIOCHEM BIOPH RES CO, V237, P235, DOI 10.1006/bbrc.1997.7120; PIPER A, 1997, GASTROENTEROLOGY, V113, P1747; Rossowski WJ, 1997, EUR J PHARMACOL, V336, P51, DOI 10.1016/S0014-2999(97)01252-1; SAMSON WK, 1995, ENDOCRINOLOGY, V136, P2349, DOI 10.1210/en.136.5.2349; STRYJEKKAMINSKA D, 1995, PEPTIDES, V16, P123, DOI 10.1016/0196-9781(94)00164-2; WILLIAMS JA, 1985, DIABETES, V34, P980, DOI 10.2337/diabetes.34.10.980; Withers DJ, 1996, FEBS LETT, V378, P83, DOI 10.1016/0014-5793(95)01427-6; Yamaguchi Tatsuyuki, 1995, Life Sciences, V56, P379	28	17	17	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	1999	140	2					865	870		10.1210/en.140.2.865		6	Endocrinology & Metabolism	Endocrinology & Metabolism	158ZX	WOS:000078148300042		
J	Matsuzaki, K; Katayama, K; Takahashi, Y; Nakamura, I; Udagawa, N; Tsurukai, T; Nishinakamura, R; Toyama, Y; Yabe, Y; Hori, M; Takahashi, N; Suda, T				Matsuzaki, K; Katayama, K; Takahashi, Y; Nakamura, I; Udagawa, N; Tsurukai, T; Nishinakamura, R; Toyama, Y; Yabe, Y; Hori, M; Takahashi, N; Suda, T			Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene	ENDOCRINOLOGY			English	Article							COLONY-STIMULATING FACTOR; BONE-MARROW CULTURES; OSTEOBLASTIC CELLS; SOLUBLE INTERLEUKIN-6; MULTINUCLEATED CELLS; STROMAL CELLS; IN-VITRO; MOUSE; RESORPTION; DIFFERENTIATION	Subclones of the human osteosarcoma cell line SaOS-2 were established by transfecting with an expression vector containing the human PTH/PTH-related protein (PTHrP) receptor, and their abilities to support osteoclast-like multinucleated cell (OCL) formation were examined in coculture with mouse or human hemopoietic cells. Of four subclones examined, SaOS-2/4 and SaOS-4/3 bound high levels of [I-125]-PTH and produced a significant amount of cAMP in response to PTH. OCLs were formed in response to PTH in the cocultures of mouse bone marrow cells with either SaOS-2/4 cells or SaOS-4/3 cells. Human OCLs were also formed in response to PTH in the coculture of SaOS-4/3 cells and human peripheral blood mononuclear cells. Adding dexamethasone together with PTH greatly enhanced PTH-induced human OCL formation. Like mouse OCLs, human OCLs formed in response to PTH were tartrate-resistant acid phosphatase positive, expressed abundant calcitonin receptors and vitronectin receptors, and formed resorption pits on dentine slices. Other osteotropic factors such as 1 alpha,25-dihydroxyviitamin D-3, prostaglandin E-2, and interleukin 6 plus soluble interleukin 6 receptors failed to induce mouse and human OCLs in cocultures with SaOS-4/3 cells. Both mouse and human OCL formation supported by SaOS-4/3 cells were inhibited by either adding an antibody against macrophage-colony stimulating factor or adding granulocyte/macrophage-colony stimulating factor. Thus, it is likely that human and mouse OCL formation supported by SaOS-4/3 cells are similarly regulated. These results indicate that the target cells of PTH for inducing osteoclast formation are osteoblast/stromal cells but not osteoclast progenitor cells in the coculture. This coculture model will be useful for investigating the abnormalities of osteoclast differentiation and function in human metabolic bone diseases.	Asahi Chem Ind Co Ltd, Lab Bone Metab, Ohito, Shizuoka 4102321, Japan; Showa Univ, Sch Dent, Dept Biochem, Shinagawa Ku, Tokyo 1428555, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1080071, Japan; Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1600016, Japan	Takahashi, Y (reprint author), Asahi Chem Ind Co Ltd, Lab Bone Metab, 632-1 Mifuku, Ohito, Shizuoka 4102321, Japan.	a7911076@ut.asahi-kasei.co.jp	Toyama, Yoshiaki/K-5743-2013				AKATSU T, 1992, J BONE MINER RES, V7, P1297; AKATSU T, 1989, ENDOCRINOLOGY, V125, P20; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; KURIHARA N, 1989, BLOOD, V74, P1295; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; MACDONALD BR, 1986, J BONE MINER RES, V1, P227; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Purton LE, 1996, BLOOD, V87, P1802; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; RODAN SB, 1987, CANCER RES, V47, P4961; UDAGAWA N, 1995, J EXP MED, V182, P1461, DOI 10.1084/jem.182.5.1461; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; TAMURA T, 1993, J BONE MINER RES, V8, P953; Fujikawa Y, 1996, ENDOCRINOLOGY, V137, P4058, DOI 10.1210/en.137.9.4058; Liu BY, 1998, ENDOCRINOLOGY, V139, P1952, DOI 10.1210/en.139.4.1952; AKATSU T, 1989, J BONE MINER RES, V4, P29; Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096; Chambers Timothy J., 1992, P105; FELIX R, 1990, ENDOCRINOLOGY, V127, P2592; GRAHAM FL, 1973, VIROLOGY, V5, P456; HAKEDA Y, 1989, BIOCHEM BIOPH RES CO, V163, P1481, DOI 10.1016/0006-291X(89)91146-7; HORTON MA, 1985, CANCER RES, V45, P5663; Kato S, 1998, J BONE MINER METAB, V16, P65, DOI 10.1007/s007740050028; KODAMA H, 1991, J EXP MED, V173, P269, DOI 10.1084/jem.173.1.269; Kotake S, 1996, J BONE MINER RES, V11, P88; LEE MY, 1991, P NATL ACAD SCI USA, V88, P8500, DOI 10.1073/pnas.88.19.8500; MARTIN TJ, 1995, ENDOCRINOLOGY, V2, P967; Matayoshi A, 1996, P NATL ACAD SCI USA, V93, P10785, DOI 10.1073/pnas.93.20.10785; METCALF D, 1986, BLOOD, V67, P37; NISHINAKAMURA R, 1995, IMMUNITY, V2, P211, DOI 10.1016/1074-7613(95)90046-2; POTTS JT, 1995, ENDOCRINOLOGY, V2, P920; Sarma U, 1996, BLOOD, V88, P2531; Sarma U, 1998, J CELL PHYSIOL, V175, P99, DOI 10.1002/(SICI)1097-4652(199804)175:1<99::AID-JCP11>3.0.CO;2-J; Segre Gino V., 1996, P377; SHINAR DM, 1990, ENDOCRINOLOGY, V126, P1728; SHUPNIK MA, 1982, J BIOL CHEM, V257, P2161; SHUTO T, 1994, ENDOCRINOLOGY, V134, P1121, DOI 10.1210/en.134.3.1121; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; TAKAHASHI N, 1991, ENDOCRINOLOGY, V128, P1792	41	39	40	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	1999	140	2					925	932		10.1210/en.140.2.925		8	Endocrinology & Metabolism	Endocrinology & Metabolism	158ZX	WOS:000078148300050		
J	Takeda, S; Yoshizawa, T; Nagai, Y; Yamato, H; Fukumoto, S; Sekine, K; Kato, S; Matsumoto, T; Fujita, T				Takeda, S; Yoshizawa, T; Nagai, Y; Yamato, H; Fukumoto, S; Sekine, K; Kato, S; Matsumoto, T; Fujita, T			Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: Studies using VDR knockout mice	ENDOCRINOLOGY			English	Article							CALCIUM-TRANSPORT; GENE-EXPRESSION; DIFFERENTIATION; OSTEOPROTEGERIN; MODULATION; RAT	Previous studies have shown that 1,25-dihydroxyvitamin D [1,25(OH)(2)D] plays important roles in the formation of osteoclasts through its actions on osteoblastic cells. We have generated mice lacking vitamin D receptor (VDR) by gene targeting (VDR-/-). These mice had tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts, and exhibited similar levels of parameters for bone resorption to those in wild type mice. The present studies were undertaken to clarify whether effects of 1,25(OH)(2)D on osteoclast formation require VDR in osteoblasts, and to examine mechanisms of the formation of osteoclasts without VDR-mediated actions using VDR-/- mice. When wild-type calvarial osteoblasts and spleen cells were co-cultured with 1,25(OH)(2)D, TRAP-positive osteoclasts were formed regardless of the genotypes of spleen cells. In contrast, when osteoblasts from VDR-/- mice were cocultured, no osteoclasts could be formed even with wild-type spleen cells. Parathyroid hormone and interleukin-1 alpha stimulated osteoclast formation by co-cultures from VDR-/- mice, and the generated osteoclasts showed resorbing activity. These results demonstrate that VDR-mediated actions of 1,25(OH)(2)D in osteoblasts are essential for osteoclast formation by 1,25(OH)(2)D, and that functionally intact osteoclasts can be formed without 1,25(OH)(2)D actions under stimulations by other agents. It is suggested that osteoclastic bone resorption can be maintained without 1,25(OH)(2)D actions by other stimulatory agents.	Univ Tokushima, Sch Med, Dept Internal Med 1, Tokushima 7708503, Japan; Univ Tokyo, Dept Internal Med 4, Tokyo, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; Kureha Chem Co, Tokyo, Japan	Matsumoto, T (reprint author), Univ Tokushima, Sch Med, Dept Internal Med 1, 3-18-15 Juramoto Cho, Tokushima 7708503, Japan.		takeda, shu/B-5195-2012				Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; KURIHARA N, 1989, BLOOD, V74, P1295; OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600; PARFITT AM, 1987, J BONE MINER RES, V2, P595; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; DEBOLAND AR, 1994, CELL SIGNAL, V6, P717, DOI 10.1016/0898-6568(94)00042-5; NORMAN A W, 1992, Current Opinion in Rheumatology, V4, P375, DOI 10.1097/00002281-199206000-00016; Sims NA, 1997, MOL ENDOCRINOL, V11, P1695, DOI 10.1210/me.11.11.1695; SUDA T, 1995, ENDOCRINE REV MONOGR, V4, P266; WASSERMAN RH, 1995, J NUTR, V125, pS1971; YAMAMOTO M, 1984, J CLIN INVEST, V74, P507, DOI 10.1172/JCI111448; YAMASHITA T, 1990, J CELL PHYSIOL, V145, P587, DOI 10.1002/jcp.1041450327; YAMATO H, 1993, CALCIFIED TISSUE INT, V52, P255, DOI 10.1007/BF00298729	17	91	94	ENDOCRINE SOC	CHEVY CHASE	8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	FEB	1999	140	2					1005	1008		10.1210/en.140.2.1005		4	Endocrinology & Metabolism	Endocrinology & Metabolism	158ZX	WOS:000078148300060		
J	Komatsu, Y; Kawabe, T; Shiratori, Y; Omata, M				Komatsu, Y; Kawabe, T; Shiratori, Y; Omata, M			Endoscopic papillary balloon dilation for the management of common bile duct stones: The two faces of sphincter preservation - Reply to Myung et al.	ENDOSCOPY			English	Letter							RANDOMIZED TRIAL; FOLLOW-UP; MANOMETRY; REMOVAL; ODDI		Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan	Komatsu, Y (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Minami A, 1995, DIGEST DIS SCI, V40, P2550, DOI 10.1007/BF02220440; Hakamada K, 1997, SURGERY, V121, P488, DOI 10.1016/S0039-6060(97)90101-X; Bergman JJGHM, 1997, LANCET, V349, P1124, DOI 10.1016/S0140-6736(96)11026-6; Sato H, 1997, GUT, V41, P541; Bergman JJGHM, 1997, GASTROINTEST ENDOSC, V45, P400, DOI 10.1016/S0016-5107(97)70151-2; Komatsu Y, 1998, ENDOSCOPY, V30, P12, DOI 10.1055/s-2007-993721; KOZAREK RA, 1988, ENDOSCOPY, V20, P207, DOI 10.1055/s-2007-1018177; MACMATHUNA P, 1995, GASTROINTEST ENDOSC, V42, P468	8	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0013-726X			ENDOSCOPY	Endoscopy	FEB	1999	31	2					210	210				1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	185HE	WOS:000079661600017		
J	Komatsu, Y; Kawabe, T; Shiratori, Y; Omata, M				Komatsu, Y; Kawabe, T; Shiratori, Y; Omata, M			Reply to the letter by Misra et al. (Endoscopic papillary balloon dilation has sufficient potential to replace endoscopic sphincterotomy for the removal of common bile duct stones)	ENDOSCOPY			English	Letter							MANAGEMENT; MANOMETRY		Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan	Komatsu, Y (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Minami A, 1995, DIGEST DIS SCI, V40, P2550, DOI 10.1007/BF02220440; Hakamada K, 1997, SURGERY, V121, P488, DOI 10.1016/S0039-6060(97)90101-X; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Sato H, 1997, GUT, V41, P541; Bergman JJGHM, 1998, ENDOSCOPY, V30, P43, DOI 10.1055/s-2007-993728; Bergman JJGHM, 1997, GASTROINTEST ENDOSC, V45, P400, DOI 10.1016/S0016-5107(97)70151-2; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P83; DiSario J. A., 1997, GASTROINTEST ENDOSC, V45, pAB129; IBUKI Y, 1992, GASTROINTEST ENDOSC, V38, P178, DOI 10.1016/S0016-5107(92)70387-3; Komatsu Y, 1998, ENDOSCOPY, V30, P12, DOI 10.1055/s-2007-993721; Uchida N, 1997, AM J GASTROENTEROL, V92, P1440	11	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0013-726X			ENDOSCOPY	Endoscopy	FEB	1999	31	2					212	212				1	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	185HE	WOS:000079661600019		
J	Ito, K; Haga, T; Lameh, J; Sadee, W				Ito, K; Haga, T; Lameh, J; Sadee, W			Sequestration of dopamine D2 receptors depends on coexpression of G-protein-coupled receptor kinases 2 or 5	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						desensitization; dopamine D2 receptor; G protein-coupled receptor kinase; internalization; sequestration	MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA-ADRENERGIC-RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; PHOSPHORYLATION SITES; BETA-2-ADRENERGIC RECEPTOR; SYNERGISTIC REGULATION; CHOLINERGIC RECEPTORS; COATED VESICLES; INTERNALIZATION; DESENSITIZATION	We examined the agonist-dependent sequestration/internalization of dopamine D2 receptor (the lone form D2L and short form D2S), which were transiently expressed in COS-7 and HEK 293 cells with or without G-protein-coupled receptor kinases (GRK2 or GRK5). Sequestration was assessed quantitatively by loss of [M-3] sulpiride-binding activity from the cell surface and by transfer of [H-3] spiperone-binding activity from the membrane fraction to the light vesicle fraction in sucrose-density gradients. In COS-7 cells expressing D2 receptors alone, virtually no sequestration was observed with or without dopamine (< 4%). When GRK2 was coexpressed 50% of D2S receptors and 36% of D2L receptors were sequestered by treatment with 10(-4) M dopamine for 2 h. whereas no sequestration was observed in cells expressing the dominant negative form of GRK2 (DN-GRK2). When GRK5 was coexpressed, 36% of D2S receptors were sequestered following the same treatment. The agonist-dependent and GRK2-dependent sequestration of D2S receptors was reduced markedly in the presence of hypertonic medium containing 0.45 M sucrose, suggesting that the sequestration follows the clathrin pathway. internalization of D2S receptors was also assessed by immunofluorescence confocal microscopy. Translocation of D2 receptors from the cell membrane to intracellular vesicles was observed following the treatment with dopamine from HEK 293 cells only when GRK2 was coexpressed. D2S receptors expressed in HEK 293 cells were shown to be phosphorylated by GRK2 in an agonist-dependent manner. These results indicate that the sequestration of D2 receptors occurs only through a GRK-mediated pathway.	Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	Haga, T (reprint author), Univ Tokyo, Fac Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.						DAUKAS G, 1985, J CELL BIOL, V101, P1673, DOI 10.1083/jcb.101.5.1673; Menard L, 1996, BIOCHEMISTRY-US, V35, P4155, DOI 10.1021/bi952961+; KONG GH, 1994, J BIOL CHEM, V269, P13084; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; ROETTGER BF, 1995, J CELL BIOL, V128, P1029, DOI 10.1083/jcb.128.6.1029; Seibold A, 1998, J BIOL CHEM, V273, P7637, DOI 10.1074/jbc.273.13.7637; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; LOHSE MJ, 1993, BIOCHIM BIOPHYS ACTA, V1179, P171, DOI 10.1016/0167-4889(93)90139-G; PALSRYLAARSDAM R, 1995, J BIOL CHEM, V270, P29004; YU SS, 1993, J BIOL CHEM, V268, P337; Bohm SK, 1997, BIOCHEM J, V322, P1; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; BOUVIER M, 1988, NATURE, V333, P370, DOI 10.1038/333370a0; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Menard L, 1997, MOL PHARMACOL, V51, P800; WINDERICKX J, 1992, NATURE, V356, P431, DOI 10.1038/356431a0; Krueger KM, 1997, J BIOL CHEM, V272, P5; PIPPIG S, 1995, MOL PHARMACOL, V47, P666; Ishii I, 1998, J BIOL CHEM, V273, P9878, DOI 10.1074/jbc.273.16.9878; Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; BOUVIER C, 1986, J NEUROCHEM, V47, P1653, DOI 10.1111/j.1471-4159.1986.tb00809.x; CAMPBELL PT, 1991, MOL PHARMACOL, V39, P192; COMBEST WL, 1988, J NEUROCHEM, V51, P1581, DOI 10.1111/j.1471-4159.1988.tb01128.x; EVAN GI, 1985, MOL CELL BIOL, V5, P3610; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/cjpp-74-10-1095; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782; GUREVICH VV, 1995, J BIOL CHEM, V270, P720; HARDEN TK, 1985, J BIOL CHEM, V260, P3060; Itokawa M, 1996, MOL PHARMACOL, V49, P560; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)90643-X; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; LEW JY, 1984, J NEUROCHEM, V42, P1298, DOI 10.1111/j.1471-4159.1984.tb02787.x; NAKATA H, 1994, EUR J BIOCHEM, V220, P29, DOI 10.1111/j.1432-1033.1994.tb18595.x; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P23682, DOI 10.1074/jbc.272.38.23682; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; RAPOSO G, 1987, BIOL CELL, V60, P117; RAPOSO G, 1989, EUR J CELL BIOL, V50, P340; RuizGomez A, 1997, J BIOL CHEM, V272, P9601; SAKATA M, 1992, BRAIN RES, V575, P309, DOI 10.1016/0006-8993(92)90095-Q; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; STRADER CD, 1987, CELL, V49, P855, DOI 10.1016/0092-8674(87)90623-4; Tolbert LM, 1996, J BIOL CHEM, V271, P17335; TSUGA H, 1994, J BIOL CHEM, V269, P32522; Tsuga H, 1998, J BIOL CHEM, V273, P5323, DOI 10.1074/jbc.273.9.5323; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Wang ZJ, 1996, FEBS LETT, V387, P53, DOI 10.1016/0014-5793(96)00467-X; WILLIAMSON RA, 1988, EMBO J, V7, P4129; YANG J, 1995, MOL PHARMACOL, V48, P477	49	77	78	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	FEB	1999	260	1					112	119		10.1046/j.1432-1327.1999.00125.x		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	172LZ	WOS:000078926900014		
J	Song, J; Murakami, H; Tsutsui, H; Ugai, H; Geltinger, C; Murata, T; Matsumura, M; Itakura, K; Kanazawa, I; Sun, KL; Yokoyama, KK				Song, J; Murakami, H; Tsutsui, H; Ugai, H; Geltinger, C; Murata, T; Matsumura, M; Itakura, K; Kanazawa, I; Sun, KL; Yokoyama, KK			Structural organization and expression of the mouse gene for Pur-1, a highly conserved homolog of the human MAZ gene	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						cis elements; expression; genome organization; MAZ; Pur-1	ZINC-FINGER PROTEIN; KI-RAS PROMOTER; C-MYC; TRANSCRIPTION FACTORS; RECEPTOR GENE; START SITES; SEQUENCES; CELLS; DNA; SP1	We have characterized the genomic structure and expression of the mouse gene for Pur-1. The cloned Pur-1 gene spans a 5-kb region encompassing the promoter, five exons, four introns and the 3'-untranslated region. All exon-intron junction sequences conform to the GT/AG rule. The promoter region has typical features of a housekeeping gene: a high G + C content (77.5%); a high frequency of CpG dinucleotides, in particular within the region 0.5 kb upstream of the site of initiation of translation; and the absence of canonical TATA and CAAT boxes. S1 nuclease protection assay demonstrated the presence of multiple sites for initiation of transcription around a site 108 nucleotides upstream of the ATG codon. Comparison of Pur-1 with the human gene for MAZ (Myc-associated zinc finger protein) revealed a striking homology of both their nucleotide and deduced protein sequences, an identical genomic organization and high similarity in promoter architecture and mRNA expression pattern. Sequence analysis of the 5'-flanking region of Pur-1 revealed numerous potential binding sites for transcription factors Sp1, AP-2 and Pur-1/MAZ itself. An element required for basal Pur-1 expression was mapped from nucleotide - 258 to + 43. This region also mediated stimulation of basal transcription by ectopically expressed MAZ protein. We conclude that the Pur-1 gene is the murine homolog of human MAZ and, like it, belongs to the family of housekeeping genes.	Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Ibaraki, Osaka 3050074, Japan; China Med Univ, Dept Med Genet, Shenyang, Peoples R China; Univ Tsukuba, Inst Appl Biochem, Ibaraki, Osaka, Japan; GSF, Natl Res Ctr Environm & Hlth, Munich, Germany; City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Genet, Duarte, CA 91010 USA; Univ Tokyo, Fac Med, Inst Brain Res, Dept Neurol, Tokyo, Japan	Yokoyama, KK (reprint author), Inst Phys & Chem Res, Tsukuba Life Sci Ctr, 3-1-1 Koyadai, Ibaraki, Osaka 3050074, Japan.	kazunari@rtc.riken.go.jp					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160; Azizkhan Jane C., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P229; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; MELTON DW, 1984, P NATL ACAD SCI-BIOL, V81, P2147, DOI 10.1073/pnas.81.7.2147; KENNEDY GC, 1992, P NATL ACAD SCI USA, V89, P11498, DOI 10.1073/pnas.89.23.11498; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Parks CL, 1997, J VIROL, V71, P9600; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Parks CL, 1996, J BIOL CHEM, V271, P4417; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; SINGERSAM J, 1984, GENE, V32, P409, DOI 10.1016/0378-1119(84)90016-7; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; ARAKI E, 1988, NUCLEIC ACIDS RES, V16, P1627, DOI 10.1093/nar/16.4.1627; ARONOW B, 1989, GENE DEV, V3, P1384, DOI 10.1101/gad.3.9.1384; ASHFIELD R, 1994, EMBO J, V13, P5656; Ausubel F.M., 1987, CURRENT PROTOCOLS MO; BONHAM K, 1993, ONCOGENE, V8, P1973; CECI JD, 1991, ONCOGENE, V6, P323; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; DESJARDINS E, 1993, MOL CELL BIOL, V13, P5710; DUNCAN DD, 1995, MOL CELL BIOL, V15, P3179; EVANS T, 1988, J MOL BIOL, V199, P61, DOI 10.1016/0022-2836(88)90379-8; FEINBERG AP, 1983, ANAL BIOCHEM, V133, P6; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044; GOU LH, 1983, METHOD ENZYMOL, V100, P60; HOFFMAN EK, 1990, P NATL ACAD SCI USA, V87, P2705, DOI 10.1073/pnas.87.7.2705; JOHNSON AC, 1988, MOL CELL BIOL, V8, P4174; KARLSSON O, 1987, P NATL ACAD SCI USA, V84, P8819, DOI 10.1073/pnas.84.24.8819; KATOH S, 1990, EMBO J, V9, P127; KITABAYASHI I, 1992, EMBO J, V11, P167; Komatsu M, 1997, ONCOGENE, V15, P1123, DOI 10.1038/sj.onc.1201283; KOYANONAKAGAWA N, 1994, MOL CELL BIOL, V14, P5099; LAVIA P, 1987, EMBO J, V6, P2773; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; MAVROTHALASSITIS GJ, 1990, ONCOGENE, V5, P1337; PATEL M, 1990, ONCOGENE, V5, P201; PESTOV DG, 1991, NUCLEIC ACIDS RES, V19, P6527, DOI 10.1093/nar/19.23.6527; PYRE JJ, 1992, BIOCHEMISTRY-US, V31, P4102; SAMBROOK DJ, 1989, MOL CLONING LAB MANU; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; Song J, 1998, J BIOL CHEM, V273, P20603, DOI 10.1074/jbc.273.32.20603; STEPHENS RM, 1992, J MOL BIOL, V228, P1124, DOI 10.1016/0022-2836(92)90320-J; Tsutsui H, 1996, BIOCHEM BIOPH RES CO, V226, P801, DOI 10.1006/bbrc.1996.1432	47	12	13	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	FEB	1999	259	3					676	683		10.1046/j.1432-1327.1999.00081.x		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	169FN	WOS:000078737000016		
J	Sakaki, T; Sawada, N; Takeyama, KI; Kato, S; Inouye, K				Sakaki, T; Sawada, N; Takeyama, KI; Kato, S; Inouye, K			Enzymatic properties of mouse 25-hydroxyvitamin D-3 1 alpha-hydroxylase expressed in Escherichia coli	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						1 alpha-hydroxylase; CYP27B1; E-coli; P450; vitamin D	CALCIUM-METABOLISM; CLONING; KIDNEY; 1,25-DIHYDROXYCHOLECALCIFEROL; CYTOCHROME-P450; 24-HYDROXYLASE; CDNA; IDENTIFICATION; PURIFICATION; MITOCHONDRIA	Renal 25-hydroxyvitamin D-3 1 alpha-hydroxylase cDNA cloned from the kidneys of mice lacking the vitamin D receptor was expressed in Escherichia coli JM109. As expected, the bacterially-expressed enzyme catalyzes the 1 alpha- hydroxylation of 25-hydroxyvitamin D-3 With a Michaelis constant, K-m, value of 2.7 mu M. Unexpectedly, the enzyme also hydroxylates the 1 alpha-position of 24,25-dihydroxyvitamin D-3 With a K-m Of 1.3 mu M, and a fourfold higher V-max/K-m compared with the 25-hydroxyvitamin D-3 hydroxylase activity, suggesting that 24,25-dihydroxyvitamin D-3 is a better substrate than 25-hydroxyvitamin D-3 for 1 alpha-hydroxylase. In addition, the enzyme showed 1 alpha-hydroxylase activity toward 24-oxo-25-hydroxyvitamin D-3. However, it showed only slight activity towards 23,25-dihydroxy-vitamin D-3 and 24-oxo-23,25-dihydroxyvitamin D-3, and no detectable activity towards vitamin D-3 and 24,25,26,27-tetranor-23-hydroxyvitamin D-3. These results suggest that the 25-hydroxyl group of vitamin D-3 is essential for the 1 alpha-hydroxylase activity and the 24-hydroxyl group enhances the activity, but the 23-hydroxyl group greatly reduced the activity. Another remarkable finding is that living recombinant E. coli cells can convert the substrates into the 1 alpha-hydroxylated products, suggesting the presence of a redox partner of 1 alpha-hydroxylase in E. coli cells.	Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Inouye, K (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Sakyo Ku, Kyoto 6068502, Japan.	inouye@kais.kyoto-u.ac.jp					AKIYOSHISHIBATA M, 1994, EUR J BIOCHEM, V224, P335, DOI 10.1111/j.1432-1033.1994.00335.x; Monkawa T, 1997, BIOCHEM BIOPH RES CO, V239, P527, DOI 10.1006/bbrc.1997.7508; LAWSON DEM, 1971, NATURE, V230, P228, DOI 10.1038/230228a0; NORMAN AW, 1971, SCIENCE, V173, P51, DOI 10.1126/science.173.3991.51; Sakaki T, 1996, J BIOL CHEM, V271, P26209; BISHOP JE, 1994, J BONE MINER RES, V9, P1277; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; AXWEN E, 1994, P NATL ACAD SCI USA, V91, P10014; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; BOYLE IT, 1971, P NATL ACAD SCI USA, V68, P2131, DOI 10.1073/pnas.68.9.2131; GRAY RW, 1989, BIOCHEM J, V259, P561; HAGENFELDT Y, 1988, BIOCHEM J, V250, P521; HARVEY JA, 1989, J CLIN ENDOCR METAB, V69, P467; HAYS SJ, 1984, J MED CHEM, V27, P15, DOI 10.1021/jm00367a004; HIWATASHI A, 1982, BIOCHEM BIOPH RES CO, V105, P320, DOI 10.1016/S0006-291X(82)80047-8; HOLICK MF, 1971, P NATL ACAD SCI USA, V68, P803, DOI 10.1073/pnas.68.4.803; HOLLANDER D, 1990, SCAND J GASTROENTERO, V25, P1, DOI 10.3109/00365529009091917; ISHIDA M, 1987, ENDOCRINOLOGY, V121, P443; KUMAR R, 1982, AM J PHYSIOL, V243, P370; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Nakamura Y, 1997, FEBS LETT, V419, P45, DOI 10.1016/S0014-5793(97)01432-4; OHYAMA Y, 1991, FEBS LETT, V278, P195, DOI 10.1016/0014-5793(91)80115-J; Pikuleva IA, 1997, ARCH BIOCHEM BIOPHYS, V343, P123, DOI 10.1006/abbi.1997.0142; Shinki T, 1997, P NATL ACAD SCI USA, V94, P12920, DOI 10.1073/pnas.94.24.12920; TAKEUCHI A, 1994, COMP BIOCHEM PHYS C, V109, P1, DOI 10.1016/0742-8413(94)00046-D; WADA A, 1991, ARCH BIOCHEM BIOPHYS, V290, P376, DOI 10.1016/0003-9861(91)90554-V; Wakino S, 1996, GERONTOLOGY, V42, P67; WECKSLER WR, 1980, J STEROID BIOCHEM, V13, P977, DOI 10.1016/0022-4731(80)90173-9	32	33	34	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	FEB	1999	259	3					731	738		10.1046/j.1432-1327.1999.00096.x		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	169FN	WOS:000078737000022		
J	Yamaguchi, S; Homma, K; Natori, S				Yamaguchi, S; Homma, K; Natori, S			A novel egg-derived tyrosine phosphatase, EDTP, that participates in the embryogenesis of Sarcophaga peregrina (flesh fly)	EUROPEAN JOURNAL OF BIOCHEMISTRY			English	Article						cathepsin L; embryogenesis; oogenesis; Sarcophaga peregrina; tyrosine phosphatase	EMBRYONIC-CELL LINE; DROSOPHILA EMBRYO; IMAGINAL DISKS; CDC25 HOMOLOG; CDNA CLONING; PROTEIN; EXPRESSION; DIFFERENTIATION; PURIFICATION; GENE	We have previously reported that cathepsin L mRNA is present in unfertilized eggs of Sarcophaga peregrina (flesh fly) as a maternal mRNA, which suggests that cathepsin L is required for embryogenesis. Now we have identified an egg protein, with a molecular mass of 100 kDa, that is extremely susceptible to cathepsin L digestion and which disappears rapidly as the embryos develop. We purified this protein to homogeneity, cloned its cDNA, and found that it contained a consensus sequence for the active site of tyrosine phosphatase. in fact this protein showed tyrosine phosphatase activity, indicating that it is a novel tyrosine phosphatase. The expression and subsequent disappearance of this protein, which we have named egg-derived tyrosine phosphatase (EDTP), may be indispensable for embryogenesis of Sarcophaga.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Natori, S (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						PERKINS LA, 1992, CELL, V70, P225, DOI 10.1016/0092-8674(92)90098-W; ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; TONKS NK, 1988, J BIOL CHEM, V263, P6731; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; YANG Q, 1991, P NATL ACAD SCI USA, V88, P5949, DOI 10.1073/pnas.88.14.5949; JIANG YP, 1993, MOL CELL BIOL, V13, P2942; TIAN SS, 1991, CELL, V67, P675, DOI 10.1016/0092-8674(91)90063-5; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COURTOT C, 1992, DEVELOPMENT, V116, P405; Denu JM, 1996, CELL, V87, P361, DOI 10.1016/S0092-8674(00)81356-2; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; FITZPATRICK KA, 1995, MECH DEVELOP, V53, P171, DOI 10.1016/0925-4773(95)00432-Z; GORDBERG DA, 1980, P NATL ACAD SCI USA, V77, P5794; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HOMMA K, 1994, J BIOL CHEM, V269, P15258; Homma K, 1996, J BIOL CHEM, V271, P13770; Homma K, 1996, EUR J BIOCHEM, V240, P443, DOI 10.1111/j.1432-1033.1996.0443h.x; Hong CC, 1996, GENETICS, V143, P1653; JOMORI H, 1991, J BIOL CHEM, V266, P1318; KURAMA T, 1995, EUR J BIOCHEM, V228, P229, DOI 10.1111/j.1432-1033.1995.tb20254.x; KURATA S, 1992, DEV BIOL, V153, P115, DOI 10.1016/0012-1606(92)90096-Y; LEPAGE T, 1992, DEVELOPMENT, V114, P147; LOWRY OH, 1951, J BIOL CHEM, V266, P13318; MARUO LJ, 1994, J BIOL CHEM, V269, P30659; MCCAULEY R, 1973, MOL CELL BIOCHEM, V1, P73, DOI 10.1007/BF01659940; Nakajima Y, 1997, J BIOL CHEM, V272, P23805, DOI 10.1074/jbc.272.38.23805; OHTAKI T, 1966, JPN J MED SCI BIOL, V19, P97; OHTSUKI S, 1994, J BIOCHEM-TOKYO, V115, P449; SANGER F, 1977, P NATL ACAD SCI USA, V77, P5794; Smith CL, 1995, DEVELOPMENT, V121, P4127; TAKAHASHI H, 1986, J INSECT PHYSIOL, V32, P771, DOI 10.1016/0022-1910(86)90080-6; TAKAHASHI SY, 1993, J BIOCHEM-TOKYO, V114, P267; TATIBANA K, 1997, EMBO J, V16, P4333; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; Ursuliak Z, 1997, MECH DEVELOP, V65, P19, DOI 10.1016/S0925-4773(97)00046-4; WILLIAM GD, 1991, CELL, V67, P189; YANO T, 1995, EUR J BIOCHEM, V234, P39, DOI 10.1111/j.1432-1033.1995.039_c.x	39	13	13	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0014-2956			EUR J BIOCHEM	Eur. J. Biochem.	FEB	1999	259	3					946	953		10.1046/j.1432-1327.1999.00143.x		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	169FN	WOS:000078737000050		
J	Kumagai, F; Hasezawa, S; Nagata, T				Kumagai, F; Hasezawa, S; Nagata, T			Putative involvement of a 49 kDa protein in microtubule assembly in vitro	EUROPEAN JOURNAL OF CELL BIOLOGY			English	Article						microtubule organizing center; tobacco BY-2 cells; elongation factor 1 alpha	ELONGATION-FACTOR 1-ALPHA; TOBACCO BY-2 CELLS; ASTER FORMATION INVITRO; SEA-URCHIN EGGS; ORGANIZING CENTERS; MITOTIC APPARATUS; MAMMALIAN CENTROSOMES; DYNAMIC INSTABILITY; BINDING PROTEIN; GAMMA-TUBULIN	In higher plant cells, thus far only a few molecules have been inferred to be involved in microtubule organizing centers (MTOCs). Examination of a 49 kDa tobacco protein, homologous to a 51 kDa protein involved in sea urchin MTOCs, showed that it also accumulated at the putative MTOC sites in tobacco BY-2 cells. In this report, we show that the 49 kDa protein is likely to play a significant role in microtubule organization in vitro. We have established a system prepared from BY-2 cells, capable of organizing microtubules in vitro. The fraction, which was partially purified from homogenized miniprotoplasts (evacuolated protoplasts) by salt extraction and subsequent ion exchange chromatography, contained many particles of diameters about 1 mu m after desalting by dialysis, When this fraction was incubated with purified porcine brain tubulin, microtubules were elongated radially from the particles and organized into structures similar to the asters observed in animal cells, and therefore also termed "asters" here. Since we could hardly detect BY-2 tubulin molecules in this fraction, the microtubules in "asters" seemed to be solely composed of the added porcine tubulin. Tubulin molecules were newly polymerized at the ends of the microtubules distal to the particles, and the elongation rate of microtubules was more similar to the reported rate of the plus-ends than that of the minus-ends in vitro. By fluorescence microscopy, the 49 kDa protein was shown to be located at the particles. Thus, its location at the centers of the "asters" suggests that the protein plays a role in microtubule organization in vitro.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kumagai, F (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						SHIINA N, 1994, SCIENCE, V266, P282, DOI 10.1126/science.7939665; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; MARCHESI VT, 1993, P NATL ACAD SCI USA, V90, P3028, DOI 10.1073/pnas.90.7.3028; Chan J, 1996, PLANT J, V10, P251, DOI 10.1046/j.1365-313X.1996.10020251.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; TORIYAMA M, 1988, CELL MOTIL CYTOSKEL, V9, P117, DOI 10.1002/cm.970090204; RIIS B, 1990, TRENDS BIOCHEM SCI, V15, P420, DOI 10.1016/0968-0004(90)90279-K; DURSO NA, 1994, PLANT CELL, V6, P893; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; BRINKLEY BR, 1985, ANNU REV CELL BIOL, V1, P145, DOI 10.1146/annurev.cb.01.110185.001045; CASSIMERIS L, 1988, CYTOSKELETON, V26, P275; CHEVRIER V, 1992, J CELL SCI, V101, P823; ENDO S, 1985, CELL MOTILITY MECHAN, P403; HASEZAWA S, 1993, PROTOPLASMA, V176, P64, DOI 10.1007/BF01378940; Hasezawa S, 1997, PROTOPLASMA, V198, P202, DOI 10.1007/BF01287569; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; ITANO N, 1991, CELL MOTIL CYTOSKEL, V19, P244, DOI 10.1002/cm.970190403; JIANG CJ, 1992, PLANT CELL PHYSIOL, V33, P497; Kumagai F, 1995, BOT ACTA, V108, P467; Kurasawa Y, 1996, ZOOL SCI, V13, P371, DOI 10.2108/zsj.13.371; KURIYAMA R, 1990, J CELL SCI, V95, P231; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert AM, 1993, CURR OPIN CELL BIOL, V5, P116, DOI 10.1016/S0955-0674(05)80016-X; LINSMAIE.EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; LIU B, 1993, J CELL SCI, V104, P1217; MAZIA D, 1987, INT REV CYTOL, V100, P49; MIZUNO K, 1993, PROTOPLASMA, V173, P77, DOI 10.1007/BF01378864; Moore RC, 1997, CELL MOTIL CYTOSKEL, V38, P278, DOI 10.1002/(SICI)1097-0169(1997)38:3<278::AID-CM6>3.0.CO;2-1; NAGATA T, 1994, PLANTA, V193, P567, DOI 10.1007/BF02411563; Numata O, 1996, Int Rev Cytol, V164, P1; OHTA K, 1990, J BIOL CHEM, V265, P3240; OHTA K, 1988, Protoplasma Supplementum, V1, P113; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; SMIRNOVA EA, 1994, CELL MOTIL CYTOSKEL, V27, P219, DOI 10.1002/cm.970270304; Stoppin V, 1996, EUR J CELL BIOL, V69, P11; STOPPIN V, 1994, PLANT CELL, V6, P1099; TODOROV IT, 1992, EXP CELL RES, V199, P398, DOI 10.1016/0014-4827(92)90452-E; TORIYAMA M, 1984, CELL STRUCT FUNCT, V9, P213; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANG WN, 1993, J BIOL CHEM, V268, P392	40	10	12	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-9335	1618-1298		EUR J CELL BIOL	Eur. J. Cell Biol.	FEB	1999	78	2					109	116				8	Cell Biology	Cell Biology	177PT	WOS:000079220100004		
J	Maciel, P; Gasper, C; Guimaraes, L; Goto, J; Lopez-Cendes, I; Hayes, S; Arvidsson, K; Dias, A; Sequeiros, J; Sousa, A; Rouleau, GA				Maciel, P; Gasper, C; Guimaraes, L; Goto, J; Lopez-Cendes, I; Hayes, S; Arvidsson, K; Dias, A; Sequeiros, J; Sousa, A; Rouleau, GA			Study of three intragenic polymorphisms in the Machado-Joseph disease gene (MJD1) in relation to genetic instability of the (CAG)(n) tract	EUROPEAN JOURNAL OF HUMAN GENETICS			English	Article						ataxia; neurodegenerative disorder; polyglutamine; trinucleotide repeats; dynamic mutations; haplotypes; origin of mutation	FRAGILE-X SYNDROME; MYOTONIC-DYSTROPHY; CAG REPEAT; HUNTINGTONS-DISEASE; HAPLOTYPE ANALYSIS; DYNAMIC MUTATION; SIZE; ORIGIN; POPULATIONS; MECHANISMS	Intergenerational instability is one of the most important features of the disease-associated trinucleotide expansions, leading to variation in size of the repeat among and,within families, which manifests as variable age at onset and severity, and is probably the basis for the occurrence of anticipation. Several factors are known to affect the degree of instability, namely the type of repeated sequence, its initial size, the presence or absence of interruptions in the repetitive tract and the gender of the transmitting parent. A recent study demonstrated the effect of an intragenic polymorphism (C(987)GG/G(987)GG) in the Machado-Joseph disease causative gene, immediately downstream of the CAG repeat, on the intergenerational instability of the expanded repeat. Surprisingly, there was an effect not only of the specific allele in cis to the disease chromosome, but also of the allele on the normal chromosome, suggesting the existence of an interaction between the normal and expanded alleles that affects the fidelity of replication of the (CAG)(n) tract. This effect could be a direct effect of the polymorphism studied or, alternatively, this polymorphism could be in disequilibrium with some other flanking sequence which affects the instability of the repetitive (CAG)(n) tract. In order to confirm the previous results in a different population and to distinguish between a direct and indirect effect of the CGG/GGG polymorphism, we typed 70 parent-progeny pairs for which the variation in the (CAG)(n) length in the MJD1 gene was known, for three intragenic polymorphisms: C(987)GG/G(987)GG and two additional, newly described ones, TA (A) under bar(1118)/TA (C) under bar(1118) and (A) under bar(669)TG/(G) under bar(669)TG. We also typed a control population of 125 individuals for the (A) under bar(669)TG/(G) under bar(669)TG, (C) under bar(987)GG/(G) under bar(987)GG and TA (A) under bar(1118)/TA (C) under bar(1118) polymorphisms, in an attempt to identify any association between haplotype and (CAG)(n) length in normal chromosomes, suggestive of an instability-predisposing effect of the repeat-flanking sequences, which could have led to the origin of the MJD mutation in the human population. We confirmed the effect of the (C) under bar(987)GG/(G) under bar(987)GG polymorphism on intergenerational instability when present in trans, Our results suggest that this effect is restricted to a small region of the gene, immediately downstream of the CAG repeat, which includes this particular nucleotide substitution and the stop codon of the MJD1 cDNA, and is not a more widespread chromosomal effect, The lack of a significant association of any specific intragenic haplotype with larger CAG repeats in normal chromosomes, together with the absence of an effect of the intragenic haplotype in cis on the intergenerational instability of the expanded (CAG)(n) in MJD families does not indicate the existence of an instability-predisposing haplotype.	Univ Porto, IBMC, UNIGENE, P-4050 Porto, Portugal; Univ Porto, ICBAS, P-4050 Porto, Portugal; McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Univ Tokyo, Sch Med, Dept Neurol, Tokyo 113, Japan	Maciel, P (reprint author), Univ Porto, IBMC, UNIGENE, R Campo Alegre 823, P-4050 Porto, Portugal.		Lopes-Cendes, Iscia/B-9416-2013; Maciel, Patricia/B-5989-2009; Sousa, Alda/K-4372-2013; Guimaraes, Laura/A-6759-2011	Lopes-Cendes, Iscia/0000-0002-6221-6822; Maciel, Patricia/0000-0002-0920-6350; Sousa, Alda/0000-0001-5441-1815; Sequeiros, Jorge/0000-0002-9846-1037; Guimaraes, Laura/0000-0003-3360-3783			Almqvist E., 1996, American Journal of Human Genetics, V59, pA48; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; SNOW K, 1993, AM J HUM GENET, V53, P1217; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P510; RUBINSZTEIN DC, 1995, HUM MOL GENET, V4, P203, DOI 10.1093/hmg/4.2.203; SQUITIERI F, 1994, HUM MOL GENET, V3, P2103, DOI 10.1093/hmg/3.12.2103; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; MACIEL P, 1995, AM J HUM GENET, V57, P54; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; ROSENBERG RN, 1976, NEUROLOGY, V26, P703; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; ALMQVIST E, 1995, HUM MOL GENET, V4, P207, DOI 10.1093/hmg/4.2.207; YU S, 1992, AM J HUM GENET, V50, P968; COUTINHO P, 1978, NEUROLOGY, V28, P703; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; MCMURRAY CT, 1995, CHROMOSOMA, V104, P2; COUTINHO P, 1981, J GENET HUM, V29, P203; MARUYAMA H, 1995, HUM MOL GENET, V4, P807, DOI 10.1093/hmg/4.5.807; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; DEROOIJ KE, 1993, J MED GENET, V30, P996, DOI 10.1136/jmg.30.12.996; FISCH GS, 1995, AM J HUM GENET, V56, P1147; GASPAR C, 1997, 1 INT S INH AT MONTR; GOLDBERG YP, 1993, NAT GENET, V5, P174, DOI 10.1038/ng1093-174; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Igarashi S, 1996, HUM MOL GENET, V5, P923, DOI 10.1093/hmg/5.7.923; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; KUNST CB, 1994, CELL, V77, P853, DOI 10.1016/0092-8674(94)90134-1; LEEFLANG EP, 1995, HUM MOL GENET, V4, P135; Limprasert P, 1996, HUM MOL GENET, V5, P207, DOI 10.1093/hmg/5.2.207; LOESCH D, 1995, AM J HUM GENET, V57; Maciel P, 1997, AM J HUM GENET, V61, pA314; MACPHERSON JN, 1994, HUM MOL GENET, V3, P399, DOI 10.1093/hmg/3.3.399; MONCKTON DG, 1994, NAT GENET, V8, P162, DOI 10.1038/ng1094-162; Murray A, 1997, HUM MOL GENET, V6, P173, DOI 10.1093/hmg/6.2.173; NANCARROW JK, 1995, HUM MOL GENET, V4, P367, DOI 10.1093/hmg/4.3.367; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; NICOL K, 1996, AM J HUM GENET, V59, P1590; Pianese L, 1997, AM J HUM GENET, V60, P460; RANEN NG, 1995, AM J HUM GENET, V57, P593; RICHARDS RI, 1992, NAT GENET, V1, P257, DOI 10.1038/ng0792-257; RUBINSZTEIN DC, 1994, HUM MOL GENET, V3, P2031; Sambrook J., 1989, MOL CLONING LAB MANU; Snow K., 1994, American Journal of Human Genetics, V55, pA243; Stevanin G, 1997, AM J HUM GENET, V60, P1548; Takiyama Y, 1997, NEUROLOGY, V49, P604; WARNER JP, 1996, AM J HUM GENET, V59, P1697; Yanagisawa H, 1996, HUM MOL GENET, V5, P373, DOI 10.1093/hmg/5.3.373	49	15	16	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	1018-4813			EUR J HUM GENET	Eur. J. Hum. Genet.	FEB-MAR	1999	7	2					147	156		10.1038/sj.ejhg.5200264		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	183BY	WOS:000079535200007		
J	Nishimura, Y; Miyazawa, T; Ikeda, Y; Izumiya, Y; Nakamura, K; Cai, JS; Sato, E; Kohmoto, M; Mikami, T				Nishimura, Y; Miyazawa, T; Ikeda, Y; Izumiya, Y; Nakamura, K; Cai, JS; Sato, E; Kohmoto, M; Mikami, T			Molecular cloning and sequencing of feline CD56 (N-CAM)	EUROPEAN JOURNAL OF IMMUNOGENETICS			English	Article							CELL-ADHESION MOLECULE; CDNA CLONE; DOMAINS; ANTIGEN		Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	Mikami, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						LANIER LL, 1986, J IMMUNOL, V136, P4480; LANIER LL, 1989, J EXP MED, V169, P2233, DOI 10.1084/jem.169.6.2233; LANIER LL, 1991, J IMMUNOL, V146, P4421; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; HEMPERLY JJ, 1986, P NATL ACAD SCI USA, V83, P3037, DOI 10.1073/pnas.83.9.3037; MURRAY BA, 1984, P NATL ACAD SCI-BIOL, V81, P5584, DOI 10.1073/pnas.81.17.5584; OWENS GC, 1987, P NATL ACAD SCI USA, V84, P294, DOI 10.1073/pnas.84.1.294; SMALL SJ, 1987, J CELL BIOL, V105, P2335, DOI 10.1083/jcb.105.5.2335	8	1	2	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0960-7420			EUR J IMMUNOGENET	Eur. J. Immunogenet.	FEB	1999	26	1					29	32		10.1046/j.1365-2370.1999.00121.x		4	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	166VZ	WOS:000078599600005		
J	Nicoletti, A; Caligiuri, G; Tornberg, I; Kodama, T; Stemme, S; Hansson, GK				Nicoletti, A; Caligiuri, G; Tornberg, I; Kodama, T; Stemme, S; Hansson, GK			The macrophage scavenger receptor type A directs modified proteins to antigen presentation	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						T cell; antigen presentation; lipoprotein; monocyte/macrophage; protein modification	LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; ATHEROSCLEROTIC LESIONS; OXIDATIVE MODIFICATION; INTERFERON-GAMMA; DENDRITIC CELLS; EXPRESSION; RECOGNITION; BINDING; INVIVO	Scavenger receptors constitute a family of cell surface receptors that internalize endotoxins, oxidized low-density lipoproteins (oxLDL) and other proteins with clustered negative charges for degradation in macrophages. They were recently proposed to play a role in antigen presentation but the type of scavenger receptor involved in this process has not been known. In this report, we have examined the cellular immune responses to modified proteins in mice lacking the SR-A scavenger receptor (SRAKO) and their wild-type (ICR) controls. White spleen cells of ICR mice immunized with maleylated murine serum albumin (Mal-MSA) exhibit strong proliferative responses to the antigen, no such responses were found in SRAKO mice. However, addition of SR-A(+) antigen-presenting cells from ICR mice unmasked proliferative responses to Mal-MSA in spleen cultures of immunized SRAKO mice. Similarly, addition of SR-A(+) antigen-presenting cells was necessary to detect T cell responses in spleen cultures of oxLDL-immunized SRAKO mice. This indicates that SR-A can mediate uptake of modified antigens for presentation to antigen-specific T cells. The fact that cellular immunity developed in SRAKO mice implies that other scavenger receptor(s) also internalize modified antigens for presentation in vivo. These observations show that scavenger receptors participate in immune recognition of oxidized protein antigens; this system may be important for recognition of damaged macromolecules but could also play a role in autoimmunity.	Karolinska Hosp, Ctr Mol Med L803, S-17176 Stockholm, Sweden; Hop Broussais, INSERM U430, F-75674 Paris, France; Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo, Japan	Nicoletti, A (reprint author), Karolinska Hosp, Ctr Mol Med L803, S-17176 Stockholm, Sweden.		Hansson, Goran/B-7423-2012; Nicoletti, Antonino/A-9460-2015; Caligiuri, Giuseppina/G-4810-2015	Nicoletti, Antonino/0000-0002-2623-0897; 			ABRAHAM R, 1995, J IMMUNOL, V154, P1; ADACHI H, 1997, J BIOL CHEM, V272, P31317; GENG YJ, 1992, J CLIN INVEST, V89, P1322, DOI 10.1172/JCI115718; Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; PALINSKI W, 1990, ARTERIOSCLEROSIS, V10, P325; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; FRASER I, 1993, NATURE, V364, P343, DOI 10.1038/364343a0; PALINSKI W, 1989, P NATL ACAD SCI USA, V86, P1372, DOI 10.1073/pnas.86.4.1372; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; VANBERKEL TJC, 1991, J BIOL CHEM, V266, P2282; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Abraham R, 1997, J IMMUNOL, V158, P4029; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; CATHCART MK, 1985, J LEUKOCYTE BIOL, V38, P341; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; EMI M, 1993, J BIOL CHEM, V268, P2120; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Pierre P, 1997, NATURE, V388, P787; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707; Butler P J, 1972, Methods Enzymol, V25, P191, DOI 10.1016/S0076-6879(72)25016-9; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Fogelman A M, 1988, J Cell Sci Suppl, V9, P135; GENG YJ, 1995, SCAND J IMMUNOL, V42, P289, DOI 10.1111/j.1365-3083.1995.tb03658.x; GENG YJ, 1995, ARTERIOSCL THROM VAS, V15, P1995; GENG YJ, 1994, ARTERIOSCLER THROMB, V14, P798; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P168; HABERLAND ME, 1986, J CLIN INVEST, V77, P681, DOI 10.1172/JCI112362; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; LIAO F, 1991, J CLIN INVEST, V87, P2253, DOI 10.1172/JCI115261; LOUGHEED M, 1997, J BIOL CHEM, V272, P12944; OTTNAD E, 1995, P NATL ACAD SCI USA, V92, P1391, DOI 10.1073/pnas.92.5.1391; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; STEINBRECHER UP, 1987, ARTERIOSCLEROSIS, V7, P135; STEINBRECHER UP, 1987, J BIOL CHEM, V262, P3603; Terpstra V, 1997, P NATL ACAD SCI USA, V94, P8127, DOI 10.1073/pnas.94.15.8127; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; VANLENTEN BJ, 1992, J IMMUNOL, V148, P112; WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0; Yokota T, 1998, EXP CELL RES, V239, P16, DOI 10.1006/excr.1997.3876	48	72	75	WILEY-V C H VERLAG GMBH	BERLIN	MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY	0014-2980			EUR J IMMUNOL	Eur. J. Immunol.	FEB	1999	29	2					512	521		10.1002/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y		10	Immunology	Immunology	167XD	WOS:000078658700015		
J	Kume, H; Kameyama, S; Kasuya, Y; Tajima, A; Kawabe, K				Kume, H; Kameyama, S; Kasuya, Y; Tajima, A; Kawabe, K			Surgical treatment of renal cell carcinoma associated with Budd-Chiari syndrome: report of four cases and review of the literature	EUROPEAN JOURNAL OF SURGICAL ONCOLOGY			English	Article						renal cell carcinoma; Budd-Chiari syndrome; surgical treatment; tumour thrombus	VENA-CAVA; MANAGEMENT	Aims: Renal cell carcinoma is sometimes associated. with inferior vena caval tumour thrombus, but occlusion of hepatic veins by the tumour thrombus causing liver dysfunction, the so-called Budd-Chiari syndrome, is relatively uncommon. There are only a few reports in the literature which discuss this condition. Methods: Four cases admitted to our hospital over a 7-year period and eight cases reported in detail in the English and the Japanese literature were included in this study. They are classified into two groups: mild/silent, without liver failure, and severe, with liver failure. Results: Five patients were classified as mild/silent and sec en as severe. Clinical manifestations were mild in the former cases and acute in the latter. Surgery was performed in four of the former cases but only in one case of the latter cases. Conclusions: In mild cases, surgical treatment seems to avoid imminent hepatic failure effectively and should be performed as soon as possible. In such cases Budd-Chiari syndrome in itself does not affect the prognosis. In severe cases, however, surgical treatment is very difficult and risky due to the existing hepatic failure.	Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 113, Japan	Kume, H (reprint author), Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						SCHRAUT WH, 1985, GASTROENTEROLOGY, V88, P576; KINMOND S, 1990, ARCH DIS CHILD, V65, P542; AOKI K, 1978, JPN J INT MED, V67, P103; HATCHER PA, 1991, J UROLOGY, V145, P20; HAYASHIDA M, 1978, JPN J INT MED, V67, P220; MARSHALL FF, 1988, J UROLOGY, V139, P1166; NAKAJIMA Y, 1989, UROL INT, V44, P173; Okada Y, 1996, J UROLOGY, V155, P444, DOI 10.1016/S0022-5347(01)66413-9; OKULSKI TA, 1977, AM J ROENTGENOL, V128, P140; REYNOLDS TB, 1993, DIS LIVER, P1091; SMITH KC, 1984, CAN MED ASSOC J, V130, P12; SPAPEN HDM, 1988, BRIT J UROL, V62, P274, DOI 10.1111/j.1464-410X.1988.tb04337.x; UENO Y, 1972, JPN J INT MED, V61, P1363; Wanless I. R., 1994, P535; YANO Y, 1966, JPN J INT MED, V55, P84	15	9	12	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0748-7983			EUR J SURG ONCOL	Eur. J. Surg. Oncol.	FEB	1999	25	1					71	75		10.1053/ejso.1998.0603		5	Oncology; Surgery	Oncology; Surgery	169FH	WOS:000078736500013		
J	Teramoto, S; Ouchi, Y				Teramoto, S; Ouchi, Y			Inhaled oxitropium bromide is currently used as the first-line therapy of patients with chronic pulmonary disease in Japan	EUROPEAN RESPIRATORY JOURNAL			English	Letter							BRONCHODILATOR RESPONSE; ANTICHOLINERGIC DRUG; EXERCISE; DYSPNEA		Tokyo Univ Hosp, Fac Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan	Teramoto, S (reprint author), Tokyo Univ Hosp, Fac Med, Dept Geriatr Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						CONNOLLY MJ, 1995, CHEST, V108, P401, DOI 10.1378/chest.108.2.401; Cazzola M, 1998, EUR RESPIR J, V11, P1337, DOI 10.1183/09031936.98.11061337; GROSS NJ, 1984, NEW ENGL J MED, V311, P421, DOI 10.1056/NEJM198408163110701; HAY JG, 1992, EUR RESPIR J, V5, P659; IKEDA A, 1995, THORAX, V50, P62, DOI 10.1136/thx.50.1.62; KRADJAN WA, 1992, CHEST, V101, P1545, DOI 10.1378/chest.101.6.1545; TERAMOTO S, 1995, AGE AGEING, V24, P278, DOI 10.1093/ageing/24.4.278; Teramoto S, 1996, INTERNAL MED, V35, P772, DOI 10.2169/internalmedicine.35.772; Teramoto S, 1997, CURR THER RES CLIN E, V58, P78, DOI 10.1016/S0011-393X(97)80116-6; TERAMOTO S, 1993, CHEST, V103, P1774, DOI 10.1378/chest.103.6.1774	10	1	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0903-1936			EUR RESPIR J	Eur. Resp. J.	FEB	1999	13	2					473	474		10.1183/09031936.99.13247399		2	Respiratory System	Respiratory System	169XY	WOS:000078776000045		
J	Matsuoka, M; Nishimoto, I; Asano, S				Matsuoka, M; Nishimoto, I; Asano, S			Interferon-gamma impairs physiologic downregulation of cyclin-dependent kinase inhibitor, p27(Kip1), during G1 phase progression in macrophages	EXPERIMENTAL HEMATOLOGY			English	Article						p27(Kip1); interferon-gamma	CELL-CYCLE; GROWTH ARREST; CARCINOMA CELLS; CDK INHIBITOR; ACTIVATION; EXPRESSION; CDC25A; BETA; P21	Cell cycle progression of mouse macrophage cells was impaired by interferon-gamma (IFN-gamma), The blockage of G1/S transition was associated with diminution of cyclin-dependent kinase-2 (CDK2)-associated kinase activities. The expression of p21(Cip1) was not upregulated by IFN-gamma, Instead, the physiologic downregulation of p27(Kip1) necessary for normal cell cycle progression did not take place sufficiently in the presence of IFN-gamma. During normal cell cycle progression, the levels of p27(Kip1) were maximal at early G1 and then decreased gradually. In the presence of IFN-gamma, however, the levels of p27(Kip1) discontinued to decrease at a late mid G1 point and were consistently as high as, or higher than, levels observed there. The steady, relatively high-level attachment of p27(Kip1) to CDK2 contributed to the insufficient formation of active cyclin/CDK2, possibly deferring cells from entering S phase. (C) 1999 International Society for Published by Elsevier Science Inc.	Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, Tokyo 160, Japan; Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Tokyo, Japan	Matsuoka, M (reprint author), Keio Univ, Sch Med, Dept Pharmacol, Shinjuku Ku, 35 Shinanomachi, Tokyo 160, Japan.						Tiefenbrun N, 1996, MOL CELL BIOL, V16, P3934; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; Gorospe M, 1996, MOL CELL BIOL, V16, P762; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; LI Y, 1994, ONCOGENE, V9, P2261; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Selleri C, 1996, BLOOD, V87, P4149; ZHANG H, 1994, GENE DEV, V8, P1750, DOI 10.1101/gad.8.15.1750; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066; Hara E, 1996, MOL CELL BIOL, V16, P859; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; KATO JY, 1994, CELL, V79, P487, DOI 10.1016/0092-8674(94)90257-7; GU Y, 1992, EMBO J, V11, P3995; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Harvat BL, 1997, ONCOGENE, V14, P2111, DOI 10.1038/sj.onc.1201055; JINNO S, 1994, EMBO J, V13, P1549; KATO JY, 1994, MOL CELL BIOL, V14, P2713; Lloyd AC, 1997, GENE DEV, V11, P663, DOI 10.1101/gad.11.5.663; Matsuoka M, 1998, ONCOGENE, V16, P2075, DOI 10.1038/sj.onc.1201745; NOURSE J, 1994, NATURE, V368, P753; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; TUSHINSKI RJ, 1985, J CELL PHYSIOL, V122, P221, DOI 10.1002/jcp.1041220210; VAIRO G, 1995, ONCOGENE, V10, P1969	29	13	15	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0301-472X			EXP HEMATOL	Exp. Hematol.	FEB	1999	27	2					203	209		10.1016/S0301-472X(98)00034-4		7	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	166GF	WOS:000078567300002		
J	Kitagawa, M; Aizawa, S; Kamisaku, H; Hirokawa, K; Ikeda, H				Kitagawa, M; Aizawa, S; Kamisaku, H; Hirokawa, K; Ikeda, H			Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector	EXPERIMENTAL HEMATOLOGY			English	Article						retrovirus; Fv-4 resistance gene; Env; bone marrow transplantation; gene therapy	MURINE LEUKEMIA-VIRUS; FV-4 RESISTANCE GENE; FOCUS-FORMING VIRUS; INFECTION IN-VITRO; FRIEND-LEUKEMIA; ENVELOPE PROTEIN; HIV-INFECTION; MICE; RECEPTOR; GLYCOPROTEIN	Fv-4 is a mouse gene that dominantly confers resistance to infection by ecotropic murine leukemia virus (MuLV), We have demonstrated previously that bone marrow chimeras in which hematopoietic cells were replaced with cells expressing Fv-4 resistant (Fv-4(r)) gene product became refractory to Friend leukemia virus (FLV)-induced leukemogenesis. To induce in vivo resistance against retrovirus-induced diseases by retroviral vector-mediated gene transduction, me introduced Fv-4(r) env gene into bone marrow cells of FLV-susceptible C3H/He (C3H) mice with retroviral vector (pLSF) derived from murine Friend spleen focus forming virus (SFFV) and the cells were transplanted into lethally irradiated C3H mice. After the bone marrow transplantation, Fv-4(r) gene product was successfully expressed on erythroid and myeloid cells, while lymphoid cells were only weakly expressing Fv-4(r) gene product, The C3H mice expressing relatively higher amounts of Fv-4(r) gene product were rendered resistant to FLV-induced erythroleukemia, while mice expressing lower amounts of the Fv-4 gene product were still susceptible. Effective protection of FLV-induced leukemia in these mice suggested that the Fv-4(r) gene expression by erythroid cells that were the major target of FLV infection might be critical for resisting FLV-induced leukemia. Thus, gene therapy model by transducing Fv-4 env gene using bone marrow transplantation would provide a useful protection model system of retrovirus-induced diseases, (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.	Natl Inst Radiol Sci, Div Biol & Oncol, Chiba 260, Japan; Natl Inst Anim Hlth, Immunogenet Lab, Ibaraki, Osaka, Japan; Univ Tokyo, Fac Med, Dept Pathol & Immunol, Bunkyo Ku, Tokyo 113, Japan	Kitagawa, M (reprint author), Univ Tokyo, Fac Med, Dept Pathol & Immunol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 113, Japan.						AMANUMA H, 1989, J VIROL, V63, P4824; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; STECK FT, 1966, VIROLOGY, V29, P628, DOI 10.1016/0042-6822(66)90287-X; IKEDA H, 1989, J VIROL, V63, P5405; JENKINS NA, 1982, J VIROL, V43, P26; AUCHINCLOSS H, 1993, TRANSPLANTATION, V36, P436; BATTINI JL, 1995, J VIROL, V69, P713; EARL PL, 1986, SCIENCE, V234, P728, DOI 10.1126/science.3490689; HUNSMANN G, 1974, VIROLOGY, V62, P307, DOI 10.1016/0042-6822(74)90394-8; IKEDA H, 1985, J VIROL, V55, P768; IRWIN MJ, 1994, J VIROL, V68, P5036; KAI K, 1976, J VIROL, V20, P436; KITAGAWA M, 1994, LEUKEMIA, V8, P2200; Kitagawa M, 1996, EXP HEMATOL, V24, P1423; KITAGAWA M, 1995, BLOOD, V86, P1557; KURIU A, 1989, LEUKEMIA RES, V13, P77, DOI 10.1016/0145-2126(89)90034-9; LIMJOCO T, 1995, VIROLOGY, V208, P75, DOI 10.1006/viro.1995.1131; LIMJOCO TI, 1993, J VIROL, V67, P4163; MACIEJEWSKI JP, 1995, NAT MED, V1, P667, DOI 10.1038/nm0795-667; MATANO T, 1993, J VIROL, V67, P2026; Nihrane A, 1996, J VIROL, V70, P1882; Nihrane A, 1997, IMMUNOLOGY, V90, P219, DOI 10.1046/j.1365-2567.1997.00157.x; Nihrane A, 1997, J GEN VIROL, V78, P785; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; SADO T, 1985, J IMMUNOL, V134, P704; SPRENT J, 1992, BONE MARROW TRANSPL, V10, P5; SUZUKI S, 1975, JPN J EXP MED, V45, P473; TAKAHARA Y, 1992, J VIROL, V66, P3725; TOZAWA H, 1970, VIROLOGY, V40, P530, DOI 10.1016/0042-6822(70)90196-0; Tumas DB, 1996, BLOOD, V87, P509; YU M, 1994, GENE THER, V1, P13	33	8	8	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0301-472X			EXP HEMATOL	Exp. Hematol.	FEB	1999	27	2					234	241		10.1016/S0301-472X(98)00040-X		8	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	166GF	WOS:000078567300007		
J	Sato, K; Nagayama, H; Tadokoro, K; Juji, T; Takahashi, TA				Sato, K; Nagayama, H; Tadokoro, K; Juji, T; Takahashi, TA			Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells	EXPERIMENTAL HEMATOLOGY			English	Article						dendritic cells; interleukin-13; monocytes; differentiation; antigen presentation	COLONY-STIMULATING FACTOR; CD4+ T-CELLS; TNF-ALPHA; LANGERHANS CELLS; IFN-GAMMA; GM-CSF; IL-13; EXPRESSION; RECEPTOR; ANTIGEN	Dendritic cells (DCs) are professional antigen presenting cells (APCs) that are required for the initiation of the immune response. DCs have been shown to be generated from hematopoietic stem cells, but relatively little is known about the regulation underlying differentiation and activation of DCs, Here, we report that recombinant human (rh)IL-13 induces functional maturation of rhGM-CSF plus rhIL-4 generated monocyte-derived immature DCs, Incubation of these immature DCs with rhIL-13 or rhTNF-alpha for 2 days resulted in increased surface expression of CD1a, CD11c, CD86 and HLA-DR, The DCs treated with rhIL-13 or rhTNF-alpha, but not rhIL-4, for 2 days were more efficient than unstimulated DCs in the primary autologous/allogeneic T-cell response whereas the antigen (Ag)specific T-cell response was suppressed. The treatment of DCs with rhIL-13 as well as rhTNF-alpha for 4 days down-modulated endocytic capacity for FITC-dextran (FITC-DX) and lucifer yellow (LY), and induced surface expression of CD83, Morphological, phenotypical, and functional analyses revealed that the monocytes cultured with rhGM-CSF plus rhIL-13 gave rise to a DC type more mature than rhGM-CSF plus rhIL-4-induced DCs, These findings revealed a new role for rhIL-13 in regulating both the maturation and activation of DCs, (C) 1999 International Society for Experimental Hematology. Published by Elsevier Science Inc.	Univ Tokyo, Inst Med Sci, Dept Cell Proc, Tokyo, Japan; Japanese Red Cross Cent Blood Ctr, Tokyo, Japan	Takahashi, TA (reprint author), Univ Tokyo, Inst Med Sci, Dept Cell Proc, Tokyo, Japan.	takahasi@ims.u-tokyo.ac.jp					SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; LARSEN CP, 1990, J EXP MED, V171, P307, DOI 10.1084/jem.171.1.307; Verhasselt V, 1997, J IMMUNOL, V158, P2919; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Aman MJ, 1996, J BIOL CHEM, V271, P29265; CAUX C, 1992, NATURE, V360, P258, DOI 10.1038/360258a0; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; DEFRANCE T, 1994, J EXP MED, V179, P135, DOI 10.1084/jem.179.1.135; MCKENZIE ANJ, 1993, P NATL ACAD SCI USA, V90, P3735, DOI 10.1073/pnas.90.8.3735; Piemonti L, 1995, EUR CYTOKINE NETW, V6, P245; Austyn J M, 1992, Semin Immunol, V4, P227; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; CAUX C, 1994, J EXP MED, V180, P1263, DOI 10.1084/jem.180.4.1263; CELLA M, 1996, J EXP MED, V184, P742; DEG HJ, 1998, BLOOD, V71, P1138; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; Herbst B, 1996, BLOOD, V88, P2541; KANNER SB, 1992, J IMMUNOL, V149, P3482; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; Lopez M, 1997, J IMMUNOL METHODS, V208, P117, DOI 10.1016/S0022-1759(97)00133-6; Muchamuel T, 1997, J IMMUNOL, V158, P2898; Murata T, 1997, INT J CANCER, V70, P230, DOI 10.1002/(SICI)1097-0215(19970117)70:2<230::AID-IJC15>3.0.CO;2-M; OBIRI NI, 1995, J BIOL CHEM, V270, P8797; Ozawa H, 1996, EUR J IMMUNOL, V26, P648, DOI 10.1002/eji.1830260321; Pinchuk LM, 1996, J IMMUNOL, V157, P4363; Rosenzwajg M, 1998, EXP HEMATOL, V26, P63; Sallusto F, 1996, J EXP MED, V184, P2411, DOI 10.1084/jem.184.6.2411; SMEDT TD, 1997, EUR J IMMUNOL, V27, P1229; Steinman R M, 1991, ANNU REV IMMUNOL, V9, P271; SZABOLCS P, 1995, J IMMUNOL, V154, P5851; ZHOU LJ, 1995, J IMMUNOL, V58, P2898	37	35	35	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0301-472X			EXP HEMATOL	Exp. Hematol.	FEB	1999	27	2					326	336		10.1016/S0301-472X(98)00046-0		11	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	166GF	WOS:000078567300017		
J	Hou, YY; Suzuki, Y; Aida, K				Hou, YY; Suzuki, Y; Aida, K			Effects of steroid hormones on immunoglobulin M (IgM) in rainbow trout, Oncorhynchus mykiss	FISH PHYSIOLOGY AND BIOCHEMISTRY			English	Article						cortisol; estradiol-17 beta; 11-ketotestosterone; mucus; plasma; testosterone	SALMO-TRUTTA-L; BROWN TROUT; CORTISOL; GAIRDNERI; STRESS; SUSCEPTIBILITY	The immunosuppressive effects of steroid hormones were evaluated as the response against implanted steroid hormones, cortisol (F), testosterone (T), estradiol-17 beta (E-2), and 11-ketotestosterone (11-KT), in juvenile rainbow trout. In long term experiments (5 weeks), fish were given a single intraperitoneal implant of F or T. A clear suppressive effect of plasma IgM levels with F and T was not necessarily obtained, although mucus IgM levels were reduced corresponding to the elevated plasma steroid hormone levels. In short term experiments (1 week), intraperitoneal implantation of T, 11-KT and E2 suppressed plasma and mucus IgM levels, although the effects were not dose-dependent. When administered through diet, F and T caused a suppression of plasma IgM levels; F administration at both high and low dosages caused a significant decrease in plasma IgM levels, while only a high dose of T caused the suppression. These results suggest that sex steroid hormones, as well as F, have immunosuppressive functions in rainbow trout.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 113, Japan	Suzuki, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo 113, Japan.	ayuzuru@hongo.ecc.u-tokyo.ac.jp					AIDA K, 1984, B JAP SOC SCI FISH, V50, P561; SLATER CH, 1993, GEN COMP ENDOCR, V89, P291, DOI 10.1006/gcen.1993.1035; PICKERING AD, 1983, J FISH BIOL, V23, P163, DOI 10.1111/j.1095-8649.1983.tb02891.x; FLOS R, 1988, AQUACULTURE, V71, P99, DOI 10.1016/0044-8486(88)90277-3; PICKERING AD, 1982, J FISH BIOL, V20, P229, DOI 10.1111/j.1095-8649.1982.tb03923.x; NAGAE M, 1994, FISH PHYSIOL BIOCHEM, V13, P41, DOI 10.1007/BF00004118; BALM PHM, 1993, CAN J FISH AQUAT SCI, V50, P2532; Hou Y, 1998, THESIS U TOKYO TOKYO; LOU SW, 1986, GEN COMP ENDOCR, V64, P212, DOI 10.1016/0016-6480(86)90006-7; LOU SW, 1984, AQUACULTURE, V43, P13, DOI 10.1016/0044-8486(84)90005-X; Maulik D, 1996, J MATERN-FETAL INVES, V6, P1; OOUTH DD, 1980, DEV COMP IMMUNOL, V4, P65; PELETEIRO MC, 1985, J FISH DIS, V8, P161, DOI 10.1111/j.1365-2761.1985.tb01211.x; PELETEIRO MC, 1988, J FISH BIOL, V32, P845, DOI 10.1111/j.1095-8649.1988.tb05428.x; PICKERING AD, 1981, GEN COMP ENDOCR, V44, P487, DOI 10.1016/0016-6480(81)90337-3; PICKERING AD, 1985, J FISH BIOL, V27, P611, DOI 10.1111/j.1095-8649.1985.tb03206.x; POTTINGER TG, 1985, J FISH BIOL, V26, P745, DOI 10.1111/j.1095-8649.1985.tb04315.x; Schreck CB., 1996, FISH IMMUNE SYSTEM O, P311; SUMPTER JP, 1986, GEN COMP ENDOCR, V62, P377, DOI 10.1016/0016-6480(86)90047-X; Suzuki Y, 1997, FISH PHYSIOL BIOCHEM, V17, P415, DOI 10.1023/A:1007795827112	20	50	61	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0920-1742			FISH PHYSIOL BIOCHEM	Fish Physiol. Biochem.	FEB	1999	20	2					155	162		10.1023/A:1007799617597		8	Biochemistry & Molecular Biology; Fisheries; Physiology	Biochemistry & Molecular Biology; Fisheries; Physiology	186GX	WOS:000079721500006		
J	Utagawa, K; Taniuchi, T				Utagawa, K; Taniuchi, T			Age and growth of the black rockfish Sebastes inermis in eastern Sagami Bay off Miura Peninsula, central Japan	FISHERIES SCIENCE			English	Article						Sebastes inermis; age; growth; otolith	OCEAN	Age and growth of the black rockfish Sebastes inermis off Miura Peninsula in central Japan were estimated from otoliths of 359 fish. Most of otoliths had a translucent margin from April to September and an opaque margin from October to May. The translucent zone was formed once a year and hence it can be used as an annulus. Growth of S. inermis was expressed by von Bertalanffy growth equation as L-t=211.5[1-exp {-0.277(t+0.991)} for males and L-t=282.2[1-exp {-0.166(t+1.291)}] for females, where L-t is standard length in mm and t is age in years. The maximum age in the sample was 6 years old for males and 7 years old for females. At ages up to 3 years old there was little difference in length by sex, but females over 3 years old grew faster than males.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan	Utagawa, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Yayoi, Tokyo 1138657, Japan.						AKAMINE T, 1986, B JAP SEA REG FISH R, V36, P77; AMAOKA K, 1984, FISHES JAPANESE ARCH, P297; Andrew TG, 1996, J ZOOL, V238, P125; SHINOMIYA A, 1991, ENVIRON BIOL FISH, V30, P15, DOI 10.1007/BF02296872; BEAMISH RJ, 1979, J FISH RES BOARD CAN, V36, P1395; BOEHLERT GW, 1980, MAR ECOL PROG SER, V3, P1, DOI 10.3354/meps003001; Fujimura H, 1997, B YAMAGUCHI PREF NAI, V26, P87; Harada E., 1962, Publications of the Seto Marine Biological Laboratory, V10, P307; HATANAKA M, 1962, NIPPON SUISAN GAKK, V28, P155; Hatanaka M., 1962, Bulletin of the Japanese Society of Scientific Fisheries, V28, P305; Hatanaka M., 1962, Bulletin of the Japanese Society of Scientific Fisheries, V28, P5; LENARZ WH, 1980, MAR FISH REV, V42, P34; MATSUKIYO K, 1963, YAMAGUCHIKEN KAISUIS, V13, P29; MIO S, 1961, SCI B AGR KYUSHU U, V1, P419; MIZUE K, 1959, B FAC FISH NAGASAKI, V8, P84; OCHIAI A, 1986, ICHTHYOLOGY KOUSEISH, P377; SHINOHARA M, 1977, B FISH EXP STA OKAYA, P85; SIX LD, 1977, FISH B-NOAA, V75, P405; STEWART NE, 1967, J FISH RES BOARD CAN, V24, P475; TANITA S, 1956, B TOHOKU NATL FISH R, V6, P106; WESTRHEI.SJ, 1973, J FISH RES BOARD CAN, V30, P235; WILKINS ME, 1980, MAR FISH REV, V42, P48; Yokogawa Koji, 1992, Suisan Zoshoku, V40, P139; Yokogawa Koji, 1992, Suisan Zoshoku, V40, P235	24	13	15	JAPAN SOC SCI FISHERIES SCI	TOKYO	C/O TOKYO UNIV FISHERIES, 5-7, 4-CHOME, KONAN, MINATO-KU, TOKYO, 108, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	FEB	1999	65	1					73	78				6	Fisheries	Fisheries	184NX	WOS:000079619200013		
J	Atsuta, S; Watanabe, T; Nakamura, H; Kono, M; Furukawa, K				Atsuta, S; Watanabe, T; Nakamura, H; Kono, M; Furukawa, K			Well developed splenic ellipsoids in Japanese conger Conger myriaster	FISHERIES SCIENCE			English	Article						anguilliformes; macrophage; reticular cell; reticular fiber; phagocytosis; fish; teleost	TROUT ONCORHYNCHUS-MYKISS; CYPRINUS-CARPIO L; CHICKEN SPLEEN; ANTIGEN; LOCALIZATION; CELLS	The histological examination of the spleen of Japanese conger Conger myriaster revealed that there were many eosinophilic island-like structures in splenic hematopoietic tissues, which consisted of large square cells and fibrous structure, when stained with hematoxylin and eosin. Silver stain showed these fibrous structures were composed of abundant reticular fibers that occasionally formed lattice structures. Electron microscopically, these structures consisted of cuboidal endothelial cells, reticular cells, and reticular fibers. In neighboring tissues, there were abundant thrombocytes, lymphoid cells, and macrophages (or monocytes). Basement membranes were poorly developed. When carbon suspensions were injected into the aortic bulb, carbon particles were ingested by macrophages and/or reticular cells in the islands, and were also observed on the bundles of reticular fibers. These data indicate that the eosinophilic island-like structures observed in Japanese conger spleens are well developed splenic ellipsoids, and suggest that such tissues provide a good model for the investigation of trapping foreign antigenic and non-antigenic substances in fish.	Kitasato Univ, Sch Fisheries Sci, Lab Fish Pathol, Sanriku, Iwate 0220101, Japan; Tokyo Dent Coll, Biol Lab, Chiba 2618502, Japan; Univ Tokyo, Fisheries Res Lab, Shizuoka 4310211, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Atsuta, S (reprint author), Kitasato Univ, Sch Fisheries Sci, Lab Fish Pathol, Sanriku, Iwate 0220101, Japan.						KASAI K, 1995, CELL TISSUE RES, V281, P135, DOI 10.1007/BF00307967; ESPENES A, 1995, CELL TISSUE RES, V282, P41, DOI 10.1007/s004410050457; ELLIS AE, 1980, J FISH DIS, V3, P413, DOI 10.1111/j.1365-2761.1980.tb00425.x; SECOMBES CJ, 1980, J FISH DIS, V3, P399, DOI 10.1111/j.1365-2761.1980.tb00424.x; ESPENES A, 1995, CELL TISSUE RES, V279, P469, DOI 10.1007/s004410050307; FAENGE R, 1985, EXPERIENTIA, V41, P152; LAMERS CHJ, 1985, CELL TISSUE RES, V242, P499; SECOMBES CJ, 1982, IMMUNOLOGY, V47, P101; SUZUKI Y, KAIYO MONTHLY, V286, P288; TISCHENDORF F, 1985, EXPERIENTIA, V41, P145, DOI 10.1007/BF02002606; WATANABE T, 1998, IN PRESS FISHERIES S, V64; Watanabe T, 1995, FISHERIES SCI, V61, P937; WEISS L, 1990, IMMUNOL LETT, V25, P165, DOI 10.1016/0165-2478(90)90109-4; WHITE RG, 1970, J MED MICROBIOL, V3, P65; WOLF BC, 1989, DISORDER SPLEEN; ZAPATA AG, 1990, IMMUNE SYSTEM COMP H, P150	16	3	3	JAPAN SOC SCI FISHERIES SCI	TOKYO	C/O TOKYO UNIV FISHERIES, 5-7, 4-CHOME, KONAN, MINATO-KU, TOKYO, 108, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	FEB	1999	65	1					79	83				5	Fisheries	Fisheries	184NX	WOS:000079619200014		
J	Kojima, S; Matsuki, O; Nomura, T; Yamaoka, K; Takahashi, M; Niki, E				Kojima, S; Matsuki, O; Nomura, T; Yamaoka, K; Takahashi, M; Niki, E			Elevation of antioxidant potency in the brain of mice by low-dose gamma-ray irradiation and its effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						gamma-ray; glutathione; thioredoxin; mouse brain; MPTP; neurodegenerative disorders; free radical	SUPEROXIDE-DISMUTASE ACTIVITY; NF-KAPPA-B; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE SYNTHESIS; PARKINSONS-DISEASE; HYDROGEN-PEROXIDE; HUMAN THIOREDOXIN; OXIDATIVE STRESS; TRANSGENIC MICE; IN-VIVO	The elevation of endogenous thiol-related antioxidants and free radical scavenging enzymes in the brain of C57BL/6 female mice after low-dose gamma-ray irradiation and its inhibitory effect on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced brain damage were investigated. The brain level of the reduced form of glutathione (GSH) increased soon after irradiation with 50 cGy of gamma-rays, reached a maximum at 3 h post-treatment, and remained elevated until 12 h. Thioredoxin (TRX) was also transiently increased after irradiation. The activities of free radical scavenging enzymes, including Cu/Zn-superoxide dismutase, catalase and glutathione peroxidase, were significantly induced after irradiation as well. Cerebral malondialdehyde was remarkably elevated by MPTP treatment, and this elevation was suppressed by pre- irradiation (50 cGy). The contents of GSH and TRX were significantly decreased by MPTP treatment in comparison with those of the control group. These reductions both seemed to be attenuated by pre-irradiation with gamma-rays. These results suggest that low-dose gamma-ray irradiation induces endogenous antioxidative potency in the brain of mice and might be effective for the prevention and/or therapy of various reactive oxygen species-related neurodegenerative disorders, such as Parkinson's disease and Alzheimer's disease. (C) 1998 Elsevier Science Inc.	Sci Univ Tokyo, Res Inst Biol Sci, Noda, Chiba 2780022, Japan; Cent Res Inst Elect Power Ind, Abiko Res Lab, Dept Biosci, Komae Branch, Tokyo 201, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan	Kojima, S (reprint author), Sci Univ Tokyo, Res Inst Biol Sci, 2669 Yamazaki, Noda, Chiba 2780022, Japan.						Acuna-Castroviejo D., 1997, LIFE SCI, V60, P23; ADAMS JD, 1993, FREE RADICAL BIO MED, V15, P181, DOI 10.1016/0891-5849(93)90057-2; AEBI HE, 1983, METHODS ENZYME ANAL, V3, P273; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Kojima S, 1997, BIOL PHARM BULL, V20, P601; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SCHENK H, 1994, P NATL ACAD SCI USA, V91, P1672, DOI 10.1073/pnas.91.5.1672; Sriram K, 1997, BRAIN RES, V749, P44, DOI 10.1016/S0006-8993(96)01271-1; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; JELLINGER K, 1990, J NEURAL TRANSM-PARK, V2, P327, DOI 10.1007/BF02252926; OKAMOTO T, 1992, INT IMMUNOL, V4, P811, DOI 10.1093/intimm/4.7.811; Simonian NA, 1996, ANNU REV PHARMACOL, V36, P83, DOI 10.1146/annurev.pa.36.040196.000503; JAIN A, 1991, P NATL ACAD SCI USA, V88, P1913, DOI 10.1073/pnas.88.5.1913; JESBERGER JA, 1991, INT J NEUROSCI, V57, P1, DOI 10.3109/00207459109150342; SONSALLA PK, 1986, EUR J PHARMACOL, V129, P339, DOI 10.1016/0014-2999(86)90444-9; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; CADET JL, 1995, MOL NEUROBIOL, V11, P155, DOI 10.1007/BF02740692; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; FLATTERYOBRIEN J, 1993, J GEN MICROBIOL, V139, P501; FLOHE L, 1976, GLUTATHIONE METABOLI, V6, P187; GALIAZZO F, 1987, BIOCHEM BIOPH RES CO, V147, P1200, DOI 10.1016/S0006-291X(87)80197-3; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; JAMIESON DJ, 1992, J BACTERIOL, V174, P6678; JAMIESON DJ, 1994, MICROBIOL-UK, V140, P3277; KIMBALL RE, 1976, AM J PHYSIOL, V230, P1425; KITAOKA Y, 1994, IMMUNOL LETT, V41, P155, DOI 10.1016/0165-2478(94)90126-0; Kojima S, 1998, BBA-GEN SUBJECTS, V1381, P312, DOI 10.1016/S0304-4165(98)00043-9; Kojima S, 1998, ANTICANCER RES, V18, P2471; LANGSTON JW, 1984, BRAIN RES, V292, P390; LASH LH, 1986, P NATL ACAD SCI USA, V83, P4641, DOI 10.1073/pnas.83.13.4641; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARTENSSON J, 1991, P NATL ACAD SCI USA, V88, P9360, DOI 10.1073/pnas.88.20.9360; Meister A, 1983, ANNU REV BIOCHEM, V52, P611; MEYER M, 1993, EMBO J, V12, P2005; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Oberly L. W., 1986, FREE RADICALS AGING, P325; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; QUINTILIANI M, 1986, INT J RADIAT BIOL, V50, P573, DOI 10.1080/09553008614550981; RAMSAY RR, 1987, BIOCHEM BIOPH RES CO, V146, P53, DOI 10.1016/0006-291X(87)90689-9; SHIRAISHI N, 1983, RADIAT RES, V95, P298, DOI 10.2307/3576256; SINGER TP, 1993, ADV NEUROL, V60, P300; SZEKELY JG, 1983, HEALTH PHYS, V45, P699, DOI 10.1097/00004032-198309000-00012; WILLIAMS RS, 1993, J CLIN INVEST, V92, P503, DOI 10.1172/JCI116594; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323; YAMAMOTO Y, 1993, ARCH BIOCHEM BIOPHYS, V86, P271	47	46	49	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0891-5849			FREE RADICAL BIO MED	Free Radic. Biol. Med.	FEB	1999	26	3-4					388	395		10.1016/S0891-5849(98)00200-7		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	151BL	WOS:000077701000019		
J	Wu, HZ; Watanabe, N; Gohshi, Y; Kotama, R				Wu, HZ; Watanabe, N; Gohshi, Y; Kotama, R			Mixture of HIBA and glycolic acid as eluent for effective separation of yttrium and dysprosium by HPLC	FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY			English	Article							RARE-EARTH ELEMENTS; ION-INTERACTION CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; ISOTACHOPHORETIC SEPARATION; EMISSION-SPECTROMETRY; MASS-SPECTROMETRY; TARTARIC ACID; EXCHANGE; COMPLEXES; BEHAVIOR	A mixture of 2-hydroxy-2-methylpropanoic acid (HIBA) and glycolic acid, with 1-octanesulfonate (OS) as hydrophobic ion proved to be successful for the separation of rare-earth elements (REE), UI the ratio of HIBA and glycolic acid is suitably adjusted, it is possible to separate Y from Dy. The resolution of Y and Dy was further improved by controlling the concentration of HIBA and glycolic acid. The technique was applied successfully to the separation and analysis of highly pure Y2O3 and DY2O3.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 113, Japan; Sumitomo Met Min Co Ltd, Cent Res Lab, Chiba 272, Japan	Wu, HZ (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						KURODA R, 1993, TALANTA, V40, P237, DOI 10.1016/0039-9140(93)80328-O; KNIGHT CH, 1984, ANAL CHEM, V56, P474, DOI 10.1021/ac00267a041; KAWABATA K, 1991, ANAL CHEM, V63, P2137, DOI 10.1021/ac00019a013; BRAVERMAN DS, 1992, J ANAL ATOM SPECTROM, V7, P43, DOI 10.1039/ja9920700043; CASSIDY RM, 1988, CHEM GEOL, V67, P185, DOI 10.1016/0009-2541(88)90127-1; HIROKAWA T, 1995, J CHROMATOGR A, V689, P149, DOI 10.1016/0021-9673(94)00872-7; HIROKAWA T, 1994, J CHROMATOGR A, V663, P245, DOI 10.1016/0021-9673(94)85251-0; KUBAN V, 1991, ANAL CHIM ACTA, V254, P21, DOI 10.1016/0003-2670(91)90004-O; KUBAN V, 1992, FRESEN J ANAL CHEM, V324, P706; KURODA R, 1991, CHROMATOGRAPHIA, V32, P265; OGUMA K, 1993, CHROMATOGRAPHIA, V37, P319, DOI 10.1007/BF02278641; SAWTARI H, 1995, B CHEM SOC JPN, V68, P898; SISSON DH, 1972, J CHROMATOGR, V66, P129, DOI 10.1016/S0021-9673(01)82936-8; STIJFHOORN DE, 1993, SPECTROCHIM ACTA B, V48, P507, DOI 10.1016/0584-8547(93)80055-Y; YOSHIDA K, 1984, ANAL CHEM, V56, P2580, DOI 10.1021/ac00277a069	15	9	10	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0937-0633			FRESEN J ANAL CHEM	Fresenius J. Anal. Chem.	FEB	1999	363	4					424	426		10.1007/s002160051214		3	Chemistry, Analytical	Chemistry	171ZR	WOS:000078895300017		
J	Katayama, T				Katayama, T			Heavy ion inertial fusion experiments planned at MUSES project at RIKEN	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	IAEA Technical Committee Meeting on Drivers and Ignition Facilities for Inertial Fusion	FEB 10-MAR 14, 1997	OSAKA UNIV, OSAKA, JAPAN	IAEA	OSAKA UNIV				Univ Tokyo, Sch Sci, Ctr Nucl Study, Tokyo, Japan	Katayama, T (reprint author), Univ Tokyo, Sch Sci, Ctr Nucl Study, Tokyo, Japan.						INABE N, 1996, P 5 EPAC SITG JUN; KATAYAMA T, 1996, P 3 INT C PHYS STOR; RAO YN, 1996, P 5 EPAC SITG JUN; YANO Y, 1996, P 5 EPAC SITG JUN; YUAN YJ, 1996, P 5 EPAC SITG JUN	5	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796			FUSION ENG DES	Fusion Eng. Des.	FEB	1999	44						313	317		10.1016/S0920-3796(98)00293-2		5	Nuclear Science & Technology	Nuclear Science & Technology	170EM	WOS:000078793400058		
J	Gorbman, A; Nozaki, M; Kubokawa, K				Gorbman, A; Nozaki, M; Kubokawa, K			A brain-Hatschek's pit connection in amphioxus	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						amphioxus; Branchiostoma; gonadotropin release; Hatschek's pit; infundibulum; lancelet		In the adult lancelet, Branchiostoma belcheri, there is a lobe of the right ventral margin of the brain that extends around the right side of the notochord and makes contact with Hatschek's pit, which also is to the right of the midline. This structural system resembles the hypothalamo-adenohypophyseal system of vertebrates and appears to make possible seasonal nervous regulation of the release of gonadotropin, (C) 1999 Academic Press.	Univ Washington, Dept Zool, Seattle, WA 98195 USA; Niigata Univ, Sado Marine Biol Stn, Niigata 9522135, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1640014, Japan	Gorbman, A (reprint author), Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA.						OLSSON R, 1994, CELL TISSUE RES, V277, P107, DOI 10.1007/BF00303086; Boeke J, 1908, ANAT ANZEIGER, V32, P473; Boeke J, 1913, ANAT ANZEIGER, V44, P460; Chang C, 1982, KEXUE TONGBAO, V27, P1233; GORBMAN A, 1995, GEN COMP ENDOCR, V97, P171, DOI 10.1006/gcen.1995.1016; KUBOKAWA K, 1998, IN PRESS ZOOL SCI, V15; Light S. F., 1923, Science New York NY, V58, P57, DOI 10.1126/science.58.1491.57; NOZAKI M, 1992, ZOOL SCI, V9, P387; OBERMUELLER-WILEN H, 1976, Acta Zoologica (Stockholm), V57, P211	9	41	41	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480			GEN COMP ENDOCR	Gen. Comp. Endocrinol.	FEB	1999	113	2					251	254		10.1006/gcen.1998.7193		4	Endocrinology & Metabolism	Endocrinology & Metabolism	168CX	WOS:000078674400008		
J	Matsui, M; Araki, Y; Karasawa, H; Matsubara, N; Taketo, MM; Seldin, MF				Matsui, M; Araki, Y; Karasawa, H; Matsubara, N; Taketo, MM; Seldin, MF			Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes	GENES & GENETIC SYSTEMS			English	Article							PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; PROGRESSIVE MOTOR NEURONOPATHY; CILIARY NEUROTROPHIC FACTOR; RAT-BRAIN; CHOLINERGIC RECEPTORS; FUNCTIONAL EXPRESSION; EL MOUSE; SEQUENCE; CLONING; MUTANT	Muscarinic acetylcholine receptors in mammals consist of five subtypes (M-1-M-5) encoded by distinct genes. They are widely expressed throughout the body and play a variety of roles in the peripheral and central nervous systems. Although their pharmacological properties have been studied extensively in. vitro, colocalization of the multiple subtypes in each tissue and lack of subtype-specific ligands have hampered characterization of the respective subtypes in vivo. We have mapped mouse genomic loci for all five genes (Chrm1-5) by restriction fragment length variant (RFLV) analyses in interspecific backcross mice. Chrm1, Chrm2, and Chrm3 were mapped to chromosome (Chr) 19, 6, and 13, respectively. Both Chrm4 and Chrm5 were mapped to Chr 2. Although a comparison of their map positions with other mutations in their vicinities suggested a possibility that the El2 (epilepsy 2) allele might be a mutation in Chrm5, sequencing analyses of the Chrm5 gene in the El2 mutant mice did not support such a hypothesis.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Tokyo 1130033, Japan; Univ Calif Davis, Dept Biol Chem, Rowe Programs Genet, Davis, CA 95616 USA	Taketo, MM (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Tokyo 1130033, Japan.						ANDRE C, 1994, EUR J NEUROSCI, V6, P1691, DOI 10.1111/j.1460-9568.1994.tb00561.x; YASUDA RP, 1993, MOL PHARMACOL, V43, P149; PERALTA EG, 1987, SCIENCE, V236, P600, DOI 10.1126/science.3107123; GIRALDO E, 1988, MOL PHARMACOL, V33, P617; Caulfield MP, 1998, PHARMACOL REV, V50, P279; LIAO CF, 1989, J BIOL CHEM, V264, P7328; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Kim D, 1997, NATURE, V389, P290; LEVEY AI, 1993, LIFE SCI, V52, P441, DOI 10.1016/0024-3205(93)90300-R; EHLERT FJ, 1990, J PHARMACOL EXP THER, V255, P1148; BONNER TI, 1988, NEURON, V1, P403, DOI 10.1016/0896-6273(88)90190-0; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; PERALTA EG, 1987, EMBO J, V6, P3923; SCHMALBRUCH H, 1991, J NEUROPATH EXP NEUR, V50, P192; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; KUBO T, 1986, NATURE, V323, P411, DOI 10.1038/323411a0; BARTON DE, 1989, GENOMICS, V5, P91, DOI 10.1016/0888-7543(89)90091-8; BISHOP D T, 1985, Genetic Epidemiology, V2, P349; BONNER TI, 1991, CYTOGENET CELL GENET, V58, P1850; BRAUN T, 1987, BIOCHEM BIOPH RES CO, V149, P125, DOI 10.1016/0006-291X(87)91613-5; BRYAN JHD, 1977, VIRCHOWS ARCH A, V374, P205, DOI 10.1007/BF00427115; CACCIA N, 1984, CELL, V37, P1091, DOI 10.1016/0092-8674(84)90443-4; CHERRY M, 1973, MOUSE NEWS LETT, V49, P33; Courseaux A., 1996, GENOMICS, V37, P345, DOI 10.1006/geno.1996.0570; CUNNINGHAM E, 1995, CURR BIOL, V5, P775, DOI 10.1016/S0960-9822(95)00154-0; DEAN M, 1987, Genomics, V1, P167, DOI 10.1016/0888-7543(87)90009-7; Du Y, 1996, GENOMICS, V32, P113, DOI 10.1006/geno.1996.0083; FRANKEL WN, 1995, MAMM GENOME, V6, P839, DOI 10.1007/BF00292432; GOCAYNE J, 1987, P NATL ACAD SCI USA, V84, P8296, DOI 10.1073/pnas.84.23.8296; Hamilton BA, 1997, NEURON, V18, P711, DOI 10.1016/S0896-6273(00)80312-8; Imaizumi K, 1964, MOUSE NEWS LETT, V31, P57; Ishizaka N, 1998, BRAIN RES, V787, P344, DOI 10.1016/S0006-8993(97)01554-0; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; JENKINS NA, 1991, GENOMICS, V9, P401, DOI 10.1016/0888-7543(91)90275-J; JOHNSON DR, 1971, J EMBRYOL EXP MORPH, V25, P223; KAUFFMANNZEH A, 1995, SCIENCE, V268, P1188, DOI 10.1126/science.7761838; Kha H, 1996, GENOMICS, V37, P242, DOI 10.1006/geno.1996.0550; Klett CPR, 1998, MAMM GENOME, V9, P476, DOI 10.1007/s003359900801; KUBO T, 1986, FEBS LETT, V209, P367, DOI 10.1016/0014-5793(86)81144-9; LEVY MN, 1994, VAGAL CONTROL HEART, P241; LI M, 1991, MOL PHARMACOL, V40, P28; LOBACH DF, 1993, GENOMICS, V17, P194, DOI 10.1006/geno.1993.1301; MAK JCW, 1993, LIFE SCI, V53, P1501, DOI 10.1016/0024-3205(93)90624-C; MULLERGARTNER HW, 1993, ANN NEUROL, V34, P235, DOI 10.1002/ana.410340221; Perou CM, 1997, GENOMICS, V39, P136, DOI 10.1006/geno.1996.4478; POTTS JF, 1993, BIOCHEM BIOPH RES CO, V197, P100, DOI 10.1006/bbrc.1993.2446; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; ROBERT JL, 1996, PHARMACOL BASIS THER, P105; ROCHELLE JM, 1992, GENOMICS, V14, P26, DOI 10.1016/S0888-7543(05)80278-2; Rosoff ML, 1996, P NATL ACAD SCI USA, V93, P14889, DOI 10.1073/pnas.93.25.14889; Sambrook J., 1989, MOL CLONING LAB MANU; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SELDIN MF, 1995, IMMUNOGENETICS, V42, P422; SENDTNER M, 1992, NATURE, V358, P502, DOI 10.1038/358502a0; SHAPIRO RA, 1988, J BIOL CHEM, V263, P18397; SUZUKI J, 1982, EXP NEUROL, V75, P440, DOI 10.1016/0014-4886(82)90172-8; SUZUKI J, 1976, EXPERIENTIA, V32, P336, DOI 10.1007/BF01940824; TEDDER TF, 1988, J IMMUNOL, V141, P4388; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; VANKOPPEN CJ, 1993, BIOCHIM BIOPHYS ACTA, V1173, P342, DOI 10.1016/0167-4781(93)90135-Z; WALL SJ, 1991, MOL PHARMACOL, V40, P783; WATSON ML, 1994, METH MOL G, V5, P369; WEIMAR WR, 1982, BRAIN RES, V251, P357, DOI 10.1016/0006-8993(82)90754-5; WESSLER I, 1987, N-S ARCH PHARMACOL, V335, P605, DOI 10.1007/BF00166975; YACHOU A, 1991, GENOMICS, V9, P204, DOI 10.1016/0888-7543(91)90240-F	65	6	6	GENETICS SOC JAPAN	SHIZUOKA-KEN	NATIONAL INST GENETICS YATA 1111, MISHIMA, SHIZUOKA-KEN, 411-8540, JAPAN	1341-7568	1880-5779		GENES GENET SYST	Genes Genet. Syst.	FEB	1999	74	1					15	21		10.1266/ggs.74.15		7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	230QA	WOS:000082260800003		
J	Innan, H; Tajima, F				Innan, H; Tajima, F			The effect of selection on the amounts of nucleotide variation within and between allelic classes	GENETICAL RESEARCH			English	Article							DROSOPHILA-MELANOGASTER; FINITE POPULATION; POLYMORPHISM; MODELS; GENE; RECOMBINATION; IN(3L)PAYNE; GENEALOGY; SEQUENCES; DNA	The effect of selection on the amounts of nucleotide variation within and between allelic classes was studied when two allelic classes exist in a population. Two selection models - the genic selection model and the overdominant selection model - were used. The average numbers of pairwise nucleotide differences within two allelic classes were investigated by computer simulation and the average number of pairwise differences between two allelic classes was obtained analytically. It was indicated that selection largely affects the amounts of variation within and between allelic classes. However, the sum of the average numbers of pairwise differences within two allelic classes is nearly constant and always close to theta(theta = 4N mu), even when selection is acting, where N is the effective population size and mu is the mutation rate per sequence per generation. This result suggests that the sum of the average numbers of pairwise differences within two allelic classes can be used to estimate theta. It may be useful for a region where selection may be acting. As examples, several gene regions of Drosophila melanogaster and a region of Mus domesticus were analysed. The effect of recombination on the sum of the average numbers of pairwise differences within two allelic classes was discussed.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan	Tajima, F (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan.	ftajima@biol.s.u-tokyo.ac.jp					AGUADE M, 1992, GENETICS, V132, P755; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Rand DM, 1996, MOL BIOL EVOL, V13, P735; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; KIMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P522, DOI 10.1073/pnas.77.1.522; Neuhauser C, 1997, GENETICS, V145, P519; KIMURA M, 1969, GENETICS, V61, P763; Wright S, 1931, GENETICS, V16, P0097; KIMURA M, 1962, GENETICS, V47, P713; NACHMAN MW, 1994, GENETICS, V136, P1105; HUDSON RR, 1983, EVOLUTION, V37, P203, DOI 10.2307/2408186; LEWONTIN RC, 1966, GENETICS, V54, P595; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HUBBY JL, 1966, GENETICS, V54, P577; MARUYAMA T, 1974, GENET RES, V23, P137; KREITMAN M, 1983, NATURE, V304, P412, DOI 10.1038/304412a0; Hasson E, 1996, GENETICS, V144, P1565; GRIFFITHS RC, 1980, THEOR POPUL BIOL, V17, P37, DOI 10.1016/0040-5809(80)90013-1; KIMURA M, 1969, GENETICS, V61, P893; WESLEY CS, 1994, P NATL ACAD SCI USA, V91, P3132, DOI 10.1073/pnas.91.8.3132; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; TAKAHATA N, 1990, GENETICS, V124, P967; Clark AG, 1996, MOL BIOL EVOL, V13, P471; DENNISTON C, 1990, GENETICS, V125, P201; Dobzhansky T., 1970, GENETICS EVOLUTIONAR; Dobzhansky TG, 1937, GENETICS ORIGIN SPEC; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Innan H, 1997, GENETICS, V147, P1431; KAPLAN NL, 1988, GENETICS, V120, P819; Kimura M., 1983, NEUTRAL THEORY MOL E; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P1048, DOI 10.1073/pnas.80.4.1048; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; LI WH, 1975, AM J HUM GENET, V27, P274; TAJIMA F, 1983, GENETICS, V105, P437; WATTERSON WA, 1977, THEORETICAL POPULATI, V12, P179	36	15	15	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	0016-6723			GENET RES	Genet. Res.	FEB	1999	73	1					15	28		10.1017/S0016672398003632		14	Genetics & Heredity	Genetics & Heredity	180ET	WOS:000079373200003		
J	Onda, M; Hanada, K; Kawachi, H; Ikeda, H				Onda, M; Hanada, K; Kawachi, H; Ikeda, H			Escherichia coli MutM suppresses illegitimate recombination induced by oxidative stress	GENETICS			English	Article							BIO TRANSDUCING PHAGE; HYDROGEN-PEROXIDE; DNA-DAMAGE; G.C->T.A TRANSVERSIONS; GENE-PRODUCT; GLYCOSYLASE; BASE; IRON; 8-OXOGUANINE; MUTAGENESIS	DNA damage by oxidative stress is one of the causes of mutagenesis. However, whether or not DNA damage induces illegitimate recombination has not been determined. To study the effect of oxidative stress on illegitimate recombination, we examined the frequency of lambda bio transducing phage in the presence of hydrogen peroxide and found that this reagent enhances illegitimate recombination. To clarify the types of illegitimate recombination, we examined the effect of mutations in mutM and related genes on the process. The frequency of lambda bio transducing phage was 5- to 12-fold higher in the mutM mutant than in the wild type, while the frequency in the mutY and mutT mutants was comparable to that of the wild type. Because 7,8-dihydro-8-oxoguanine (8-oxoG) and formamido pyrimidine (Fapy) lesions can be removed from DNA by MutM protein, these lesions are thought to induce illegitimate recombination. Analysis of recombination junctions showed that the recombination at Hotspot I accounts for 22 or 4% of total lambda bio transducing phages in the wild type or in the mutM mutant, respectively. The preferential increase of recombination at nonhotspot sites with hydrogen peroxide in the mutM mutant was discussed on the basis of a new model, in which 8-oxoG and/or Fapy residues may introduce double-strand breaks into DNA.	Univ Tokyo, Inst Med Sci, Dept Mol Biol, Tokyo 1088639, Japan	Onda, M (reprint author), Univ Tokyo, Inst Med Sci, Dept Mol Biol, PO Takanawa, Tokyo 1088639, Japan.						AMES BN, 1989, MUTAT RES, V250, P3; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Henle ES, 1997, J BIOL CHEM, V272, P19095, DOI 10.1074/jbc.272.31.19095; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TAJIRI T, 1995, MUTAT RES-DNA REPAIR, V336, P257, DOI 10.1016/0921-8777(94)00062-B; DIZDAROGLU M, 1992, MUTAT RES, V275, P331, DOI 10.1016/0921-8734(92)90036-O; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; YANOFSKY C, 1966, P NATL ACAD SCI USA, V55, P274, DOI 10.1073/pnas.55.2.274; MICHAELS ML, 1991, NUCLEIC ACIDS RES, V19, P3629, DOI 10.1093/nar/19.13.3629; AU KG, 1989, P NATL ACAD SCI USA, V86, P8877, DOI 10.1073/pnas.86.22.8877; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; FARRINGTON WHH, 1991, FOOD ADDIT CONTAM, V8, P55; FRANKLIN NC, 1967, GENETICS, V55, P699; FRANKLIN NC, 1971, BACTERIOPHAGE LAMBDA, P175; IKEDA H, 1995, ADV BIOPHYS, V31, P197, DOI 10.1016/0065-227X(95)99392-3; KASAI H, 1986, CARCINOGENESIS, V7, P1840; LARRAMENDY M, 1987, MUTAT RES, V178, P57, DOI 10.1016/0027-5107(87)90086-8; MASSIE HR, 1972, BIOCHIM BIOPHYS ACTA, V272, P539, DOI 10.1016/0005-2787(72)90509-6; Muller H J, 1927, Science, V66, P84, DOI 10.1126/science.66.1699.84; NGHIEM Y, 1988, P NATL ACAD SCI USA, V85, P2709, DOI 10.1073/pnas.85.8.2709; Ouchane S, 1997, EMBO J, V16, P4777, DOI 10.1093/emboj/16.15.4777; OYA Y, 1986, MUTAT RES, V172, P245, DOI 10.1016/0165-1218(86)90062-5; POVIRK LF, 1989, MUTAT RES, V214, P13, DOI 10.1016/0027-5107(89)90193-0; Shanado Y, 1997, J BACTERIOL, V179, P4239; Shimizu H, 1997, J MOL BIOL, V266, P297, DOI 10.1006/jmbi.1996.0794; SHIMIZU H, 1995, GENETICS, V140, P889; TCHOU J, 1993, MUTAT RES, V299, P277, DOI 10.1016/0165-1218(93)90104-L; TESSMAN I, 1962, J MOL BIOL, V5, P442; Ukita T, 1996, J BACTERIOL, V178, P2362; YAMAGUCHI H, 1995, MOL GEN GENET, V248, P637, DOI 10.1007/BF02191702	37	10	10	GENETICS	BALTIMORE	428 EAST PRESTON ST, BALTIMORE, MD 21202 USA	0016-6731			GENETICS	Genetics	FEB	1999	151	2					439	446				8	Genetics & Heredity	Genetics & Heredity	164KF	WOS:000078462500003		
J	Tasaki, Y; Fukuda, S; Iio, M; Miura, R; Imai, T; Sugano, S; Yoshie, O; Hughes, AL; Nomiyama, H				Tasaki, Y; Fukuda, S; Iio, M; Miura, R; Imai, T; Sugano, S; Yoshie, O; Hughes, AL; Nomiyama, H			Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1 alpha/LD78 alpha-like genes	GENOMICS			English	Article							LD78	Two loci in the human genome, chromosomes 4q12-q21 and 17q11.2, contain clusters of CXC and CC chemokine subfamily genes, respectively. Since mice appear to contain fewer chemokine genes than humans, numerous gene duplications might have occurred in each locus of the human genome. Here we describe the genomic organization of the human pulmonary and activation-regulated CC chemokine (PARC), also known as DC-CK1 and AMAC-1, Despite high sequence similarity to a CC chemokine macrophage inflammatory protein-1 alpha (MIP-1 alpha)/LD78 alpha, PARC is chemotactic for lymphocytes and not for monocytes and does not share its receptor with MIP-1 alpha. Analyses of the BAC clones containing the human PARC gene indicated that the gene is located most closely to MIP-1 alpha (HGMW-approved symbol SCYA3) and MIP-1 beta (HGMW-approved symbol SCYA4) on chromosome 17q11.2. Dot-plot comparison suggested that the PARC gene had been generated by fusion of two MIP-1 alpha-like genes with deletion and selective usage of exons, Base changes accumulated before and after the fusion might have adapted the gene to a new function. Since there are variably duplicated copies of the MIP-1 alpha gene called LD78 beta (HGMW-approved symbol SCYA3L) in the vicinity of the MIP-1 alpha gene, the locus surrounding the MIP-1 alpha gene seems to be a "hot spring" that continuously produces new family genes. This evidence provides a new model, duplication and fusion, of the molecular basis for diversity within a gene family (C) 1999 Academic Press.	Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan; Prefectural Univ Kumamoto, Fac Human Life Sci, Dept Food Sci & Nutr, Kumamoto 8628502, Japan; Shionogi Inst Med Sci, Osaka 5660022, Japan; Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; Kinki Univ, Sch Med, Dept Bacteriol, Osaka 5898511, Japan; Penn State Univ, Eberly Coll Sci, Dept Biol, University Pk, PA 16802 USA	Nomiyama, H (reprint author), Kumamoto Univ, Sch Med, Dept Biochem, Honjo 2-2-1, Kumamoto 8600811, Japan.		Nomiyama, Hisayuki/F-2840-2013	Nomiyama, Hisayuki/0000-0002-2716-4043			Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; YOSHIDA T, 1995, FEBS LETT, V360, P155, DOI 10.1016/0014-5793(95)00093-O; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Rollins BJ, 1997, BLOOD, V90, P909; HASKILL S, 1990, P NATL ACAD SCI USA, V87, P7732, DOI 10.1073/pnas.87.19.7732; MARUYAMA K, 1994, GENE, V138, P171; Kodelja V, 1998, J IMMUNOL, V160, P1411; Hieshima K, 1997, J IMMUNOL, V159, P1140; Hirashima M, 1992, DNA Seq, V3, P203, DOI 10.3109/10425179209034019; Hughes AL, 1997, BIOESSAYS, V19, P777, DOI 10.1002/bies.950190907; IRVING SG, 1990, NUCLEIC ACIDS RES, V18, P3261, DOI 10.1093/nar/18.11.3261; Modi WS, 1998, GENOMICS, V47, P136, DOI 10.1006/geno.1997.5100; NAKAO M, 1990, MOL CELL BIOL, V10, P3646; Naruse K, 1996, GENOMICS, V34, P236, DOI 10.1006/geno.1996.0274; Ohno S., 1970, EVOLUTION GENE DUPLI; WIDMER U, 1991, J IMMUNOL, V146, P4031	17	33	35	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543			GENOMICS	Genomics	FEB 1	1999	55	3					353	357		10.1006/geno.1998.5670		5	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	169WD	WOS:000078771400015		
J	Alibo, DS; Nozaki, Y				Alibo, DS; Nozaki, Y			Rare earth elements in seawater: Particle association, shale-normalization, and Ce oxidation	GEOCHIMICA ET COSMOCHIMICA ACTA			English	Article							NORTH PACIFIC; FALLOUT RADIONUCLIDES; NEODYMIUM ISOTOPES; MARINE-ENVIRONMENT; THORIUM ISOTOPES; CERIUM OXIDATION; SARGASSO SEA; WATER COLUMN; DEEP OCEAN; DISTRIBUTIONS	Dissolved (<0.03 mu m, not <0.4 mu m) and total acid-soluble concentrations of rare earth elements (REEs) and yttrium were measured by using ICP mass spectrometry in the seawaters obtained from various depths in the western North Pacific near Japan. The difference, i.e., acid-soluble particulate fraction, was found to be small, 2-5% for all tri-valent light and middle REEs and less than 18 for heavy REEs and yttrium. The high particulate fraction of 31% for Ce is consistent with its predicted oxidation state of tetra-valence. Elevated particulate fraction of all REEs was found within similar to 80 m above the bottom due to contribution of flocculated resuspended particles. The vertical profiles of REE(III)s show smoothly increasing convex curves with depth similar to those reported previously. Dissolved Ce concentration decreases from similar to 6 pmol/kg near the surface to a minimum at 2.5 pmol/kg around 400 m where the North Pacific Intermediate Water penetrates, and then approaches to nearly constant value of similar to 4 pmol/kg below 800 m. Particulate Ce concentration significantly increases from the surface to 200 m depth suggesting oxidation of Ce(In) to Ce(IV) and subsequent scavenging in the upper water column. However, there is no evidence in our data showing that Ce oxidation is continuously taking place even in the deep sea. Shale-normalized patterns of dissolved REEs were examined in detail, based on three datasets of composite shales available in the literature. Distinctively positive La and only slightly positive Gd anomalies were identified together with well-documented negative Ce-anomaly as common features of seawater. These anomalies systematically change with depth. Rapid changes occur in the upper several hundred meters suggesting that their distributions are largely governed by ocean circulation and biogeochemical cycling. Copyright (C) 1999 Elsevier Science Ltd.	Univ Tokyo, Ocean Res Inst, Marine Inorgan Chem Div, Nakano Ku, Tokyo 164, Japan	Nozaki, Y (reprint author), Univ Tokyo, Ocean Res Inst, Marine Inorgan Chem Div, Nakano Ku, 1-15-1 Minamidai, Tokyo 164, Japan.						BERTRAM CJ, 1993, GEOCHIM COSMOCHIM AC, V57, P1957, DOI 10.1016/0016-7037(93)90087-D; HASKIN MA, 1966, SCIENCE, V154, P507; NOZAKI Y, 1981, EARTH PLANET SC LETT, V54, P203, DOI 10.1016/0012-821X(81)90004-2; PIPER DZ, 1974, CHEM GEOL, V14, P285, DOI 10.1016/0009-2541(74)90066-7; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V89, P35, DOI 10.1016/0012-821X(88)90031-3; DEBAAR HJW, 1985, GEOCHIM COSMOCHIM AC, V49, P1943, DOI 10.1016/0016-7037(85)90089-4; DEBAAR HJW, 1985, GEOCHIM COSMOCHIM AC, V49, P1961, DOI 10.1016/0016-7037(85)90090-0; Zhang J, 1998, GEOCHIM COSMOCHIM AC, V62, P1307, DOI 10.1016/S0016-7037(98)00073-8; Lerche D, 1998, EARTH PLANET SC LETT, V159, P71, DOI 10.1016/S0012-821X(98)00066-1; SHOLKOVITZ ER, 1991, GEOCHIM COSMOCHIM AC, V55, P2737, DOI 10.1016/0016-7037(91)90440-G; GOLDBERG ED, 1963, J GEOPHYS RES, V68, P4209; ZHANG J, 1994, GEOPHYS RES LETT, V21, P2677, DOI 10.1029/94GL02404; [Anonymous], 1996, HANDB PHYSI, DOI 10.1016/S0168-1273(96)23009-0; JEANDEL C, 1995, GEOCHIM COSMOCHIM AC, V59, P535, DOI 10.1016/0016-7037(94)00367-U; MOFFETT JW, 1990, NATURE, V345, P421, DOI 10.1038/345421a0; BYRNE RH, 1993, GEOCHIM COSMOCHIM AC, V57, P519, DOI 10.1016/0016-7037(93)90364-3; BOWEN VT, 1980, EARTH PLANET SC LETT, V49, P411, DOI 10.1016/0012-821X(80)90083-7; Zhang J, 1996, GEOCHIM COSMOCHIM AC, V60, P4631, DOI 10.1016/S0016-7037(96)00276-1; PIEPGRAS DJ, 1992, GEOCHIM COSMOCHIM AC, V56, P1851, DOI 10.1016/0016-7037(92)90315-A; Nozaki Y, 1997, EARTH PLANET SC LETT, V148, P329, DOI 10.1016/S0012-821X(97)00034-4; PIEPGRAS DJ, 1982, SCIENCE, V217, P207, DOI 10.1126/science.217.4556.207; ELDERFIELD H, 1982, NATURE, V296, P214, DOI 10.1038/296214a0; NOZAKI Y, 1984, NATURE, V310, P486, DOI 10.1038/310486a0; GERMAN CR, 1995, GEOCHIM COSMOCHIM AC, V59, P1551, DOI 10.1016/0016-7037(95)00061-4; BACON MP, 1982, J GEOPHYS RES-OC ATM, V87, P2045, DOI 10.1029/JC087iC03p02045; BYRNE RH, 1990, GEOCHIM COSMOCHIM AC, V54, P2654; GROMET LP, 1984, GEOCHIM COSMOCHIM AC, V48, P2469, DOI 10.1016/0016-7037(84)90298-9; HASKIN LA, 1968, PHYSICS CHEM EARTH; LERCHE D, 1997, THESIS U TOKYO; LIVINGSTON HD, 1983, NATURE, V303, P228, DOI 10.1038/303228a0; MASUDA A, 1979, GEOCHEM J, V13, P16; MOFFETT JW, 1994, LIMNOL OCEANOGR, V39, P1309; Nozaki Y., 1997, EOS T AM GEOPHYS UN, V78, P221, DOI [10.1029/97EO00148, DOI 10.1029/97EO00148]; NOZAKI Y, 1987, J GEOPHYS RES-OCEANS, V92, P772, DOI 10.1029/JC092iC01p00772; SHABANI MB, 1990, ANAL CHEM, V62, P2709, DOI 10.1021/ac00223a012; TACHIKAWA K, IN PRESS DEEP SEA RE; Tachikawa K, 1997, DEEP-SEA RES PT I, V44, P1769, DOI 10.1016/S0967-0637(97)00057-5; Taylor S., 1985, CONTINENTAL CRUST IT	38	214	250	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0016-7037			GEOCHIM COSMOCHIM AC	Geochim. Cosmochim. Acta	FEB	1999	63	3-4					363	372		10.1016/S0016-7037(98)00279-8		10	Geochemistry & Geophysics	Geochemistry & Geophysics	207ZD	WOS:000080964900005		
J	Ikeda, T; Tajika, E				Ikeda, T; Tajika, E			A study of the energy balance climate model with CO2-dependent outgoing radiation: implication for glaciation during the Cenozoic	GEOPHYSICAL RESEARCH LETTERS			English	Article							EARTH; OCEAN	We analyze the energy balance climate model with CO2-dependent outgoing radiation, and obtain the steady-state solution for very wide range of the atmospheric CO2 partial pressure and the thermal diffusion coefficient. We propose a phase diagram of the climate on the parameter space of the atmospheric CO2 and the thermal diffusion coefficient for the latitudinal heat transport, which may be useful to understand the climate change through the history of the Earth. It is shown that the formation of polar ice caps can be caused by decrease in the atmospheric CO2 and the latitudinal heat transport. The different history of glaciation in each hemisphere through the Cenozoic might be the result of difference in the heat transport in each hemisphere. Understanding of the small ice cap instability might be important to interpret the oxygen isotope record at the Eocene-Oligocene boundary.	Univ Tokyo, Inst Geol, Bunkyo Ku, Tokyo, Japan	Ikeda, T (reprint author), Univ Tokyo, Inst Geol, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.		Tajika, Eiichi/H-3519-2013				KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; SHACKLETON N, 1981, J GEOL SOC LONDON, V138, P153, DOI 10.1144/gsjgs.138.2.0153; NORTH GR, 1975, J ATMOS SCI, V32, P1301, DOI 10.1175/1520-0469(1975)032<1301:ASTASC>2.0.CO;2; Maier-Reimer E, 1990, PALEOCEANOGRAPHY, V5, P349, DOI 10.1029/PA005i003p00349; CALDEIRA K, 1992, NATURE, V359, P226, DOI 10.1038/359226a0; NORTH GR, 1984, J ATMOS SCI, V41, P3390, DOI 10.1175/1520-0469(1984)041<3390:TSICII>2.0.CO;2; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571; BUDYKO MI, 1969, TELLUS, V21, P611; NORTH GR, 1981, REV GEOPHYS, V19, P91, DOI 10.1029/RG019i001p00091; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; CROWLEY J, 1995, PALEOCLIMATOLOGY; DAWSON MR, 1976, SCIENCE, V192, P781, DOI 10.1126/science.192.4241.781; Frakes L.A., 1992, CLIMATE MODES PHANER; Kennett J.P., 1990, Proceedings of the Ocean Drilling Program Scientific Results, V113, P937; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Leg 113 Shipboard Scientific Party, 1987, NATURE, V328, P115; ROBERT C, 1992, ANTARCTIC PALEOENVIR, P97; Sellers WD, 1969, J APPL METEOROL, V8, P392, DOI [10.1175/1520-0450(1969)008&LT;0392:AGCMBO&GT;2.0.CO;2, DOI 10.1175/1520-0450(1969)008<0392:AGCMB0>2.0.C0;2]; Tajika E, 1998, EARTH PLANET SC LETT, V160, P695, DOI 10.1016/S0012-821X(98)00121-6	20	12	13	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0094-8276			GEOPHYS RES LETT	Geophys. Res. Lett.	FEB 1	1999	26	3					349	352		10.1029/1998GL900298		4	Geosciences, Multidisciplinary	Geology	163YK	WOS:000078434300018		
J	Miura, A				Miura, A			A quantitative test of the self-organization hypothesis of the magnetopause Kelvin-Helmholtz instability as an inverse problem	GEOPHYSICAL RESEARCH LETTERS			English	Article							MAGNETIC-FIELD; BOUNDARY-LAYER; MAGNETOSHEATH; OSCILLATIONS; PLASMA	The self-organization hypothesis of the magnetopause Kelvin-Helmholtz (K-H) instability is tested against observations by two-dimensional (2-D) magnetohydrodynamic (MHD) simulations for two different initial seed perturbations. The linear relationships are obtained by the simulations between the period of the magnetopause oscillation caused by the K-H instability and the distance along the magnetopause from the subsolar point. The comparison of the linear relationships with that obtained from reported observations of the magnetopause oscillations gives,a reasonable thickness of the velocity shear layer near the subsolar point of 1570km-3010km and a reasonable average magnetosheath flow speed along the magnetopause of 399km/sec-766km/sec. This suggests that the self-organization of the magnetopause K-H instability, i.e., the successive pairings of vortices, really occurs along the magnetopause. The present comparison provides a useful method to determine the thickness of the velocity shear layer near the subsolar point as an inverse problem.	Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	Miura, A (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Miura, Akira/A-2871-2009	Miura, Akira/0000-0003-3477-6512			SPREITER JR, 1966, PLANET SPACE SCI, V14, P223, DOI 10.1016/0032-0633(66)90124-3; CHEN SH, 1993, J GEOPHYS RES, V98, P5727, DOI 10.1029/92JA02263; EASTMAN TE, 1976, GEOPHYS RES LETT, V3, P685, DOI 10.1029/GL003i011p00685; BELMONT G, 1989, PHYS SCRIPTA, V40, P124, DOI 10.1088/0031-8949/40/1/018; KOKUBUN S, 1994, GEOPHYS RES LETT, V21, P2883, DOI 10.1029/94GL02103; LEPPING RP, 1979, J GEOPHYS RES-SPACE, V84, P7099, DOI 10.1029/JA084iA12p07099; MANUEL JR, 1993, J GEOPHYS RES, V98, P17367, DOI 10.1029/93JA01524; Miura A, 1997, PHYS PLASMAS, V4, P2871, DOI 10.1063/1.872419; Miura A., 1995, GEOPHYS MONOGR SER, V90, P285; MIURA A, 1982, J GEOPHYS RES-SPACE, V87, P7431, DOI 10.1029/JA087iA09p07431; MIURA A, 1998, IN PRESS J GEOPHYS R; MIURA A, 1995, GEOPHYS RES LETT, V22, P2993, DOI 10.1029/95GL02793; SEON J, 1995, J GEOPHYS RES, V100, P11907, DOI 10.1029/94JA03314; SIBECK DG, 1987, MAGNETOTAIL PHYSICS, P73; WILLIAMS DJ, 1979, J GEOPHYS RES-SPACE, V84, P101, DOI 10.1029/JA084iA01p00101; WU CC, 1986, J GEOPHYS RES, V91, P3042, DOI 10.1029/JA091iA03p03042	16	10	10	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0094-8276			GEOPHYS RES LETT	Geophys. Res. Lett.	FEB 1	1999	26	3					409	412		10.1029/1998GL900300		4	Geosciences, Multidisciplinary	Geology	163YK	WOS:000078434300033		
J	Masaki, T; Okada, M; Tokuda, M; Shiratori, Y; Hatase, O; Shirai, M; Nishioka, M; Omata, M				Masaki, T; Okada, M; Tokuda, M; Shiratori, Y; Hatase, O; Shirai, M; Nishioka, M; Omata, M			Reduced C-terminal Src kinase (Csk) activities in hepatocellular carcinoma	HEPATOLOGY			English	Article							PP60C-SRC PROTEIN-KINASE; HUMAN-COLON CARCINOMA; TYROSINE PHOSPHORYLATION; CELL-TRANSFORMATION; HEREDITARY HEPATITIS; FAMILY KINASES; GENE-PRODUCT; ACTIVATION; DEPHOSPHORYLATION; EXPRESSION	The proto-oncogene product pp60(c-src) is the cellular homologue of the Rous sarcoma transforming gene, and it is a non-receptor-linked and membrane-associated tyrosine kinase, There is a close correlation between elevated pp60(c-src) activity and cell transformation. We have recently reported that pp60(c-src) was activated in hepatocellular carcinoma (HCC) of human and Long-Evans cinnamon (LEC) rats. However, the mechanisms involved in this process remain unknown. C-terminal Src kinase (Csk) is a novel cytoplasmic protein tyrosine kinase that inactivates the members of the Src family protein tyrosine kinase in vitro. We investigated the role of Csk in hepatocarcinogenesis by analyzing the location, amount of Csk, and its kinase activity levels in nontumorous cirrhotic and tumorous sections of HCC of patients and an animal model of LEC rats. Csk tyrosine kinase activity was significantly reduced in tumorous tissues compared with nontumorous sections of patients as well as LEC rats. A single immunoreactive band at 50 kd was detected with Csk antibody in normal liver (NL), chronic hepatitis (CH), and nontumorous cirrhotic (NTC) segments of HCC of patients and LEC rats. In human tumorous tissues, Western blot revealed a 53-kd immunoreactive band, which was slightly larger than the usual 50-kd band of Csk, These results suggest that the reduced activity of tyrosine kinase of Csk may play an important role in the malignant transformation of hepatocytes in human and IEC rat, and the appearance of 53-kd Csk-related protein may be closely involved in the progression of cirrhosis to HCC in humans, and that 50-kd Csk may act as an antioncogene through the negative regulation of pp60(c-src) in the development of human HCC.	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan; Kagawa Med Sch, Dept Internal Med 3, Kagawa, Japan; Kagawa Med Sch, Dept Physiol, Kagawa, Japan; Osaka Univ, Inst Prot Res, Div Prot Metab, Osaka, Japan; Yamaguchi Univ, Sch Med, Dept Microbiol, Yamaguchi, Japan	Shiratori, Y (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; PIWNICAWORMS H, 1987, CELL, V49, P75, DOI 10.1016/0092-8674(87)90757-4; JOVE R, 1987, ANNU REV CELL BIOL, V3, P31, DOI 10.1146/annurev.cb.03.110187.000335; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; COOPER JA, 1986, SCIENCE, V231, P1431, DOI 10.1126/science.2420005; BARNEKOW A, 1987, CANCER RES, V47, P235; BENNETT BD, 1994, J BIOL CHEM, V269, P1068; BOLEN JB, 1984, CELL, V38, P767, DOI 10.1016/0092-8674(84)90272-1; BOLEN JB, 1993, ONCOGENE, V8, P2025; BOLEN JB, 1985, P NATL ACAD SCI USA, V82, P7275, DOI 10.1073/pnas.82.21.7275; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; CARTWRIGHT CA, 1987, CELL, V49, P83, DOI 10.1016/0092-8674(87)90758-6; COOPER JA, 1986, MOL CELL BIOL, V6, P4467; COOPER JA, 1984, J BIOL CHEM, V259, P7835; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; COURTNEIDGE SA, 1985, EMBO J, V4, P1471; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1016/0270-9139(94)90250-X; KANG JH, 1993, HEPATOLOGY, V18, P614; KLAGES S, 1994, P NATL ACAD SCI USA, V91, P2597, DOI 10.1073/pnas.91.7.2597; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; OKADA M, 1989, J BIOL CHEM, V264, P20887; OKADA M, 1991, J BIOL CHEM, V266, P24249; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; PARKER RC, 1984, CELL, V37, P131, DOI 10.1016/0092-8674(84)90308-8; ROSEN N, 1986, J BIOL CHEM, V261, P3754; SAKI M, 1985, RAT NEWS LETT, V14, P4; SOBE H, 1992, MOL CELL BIOL, V12, P4706; TAKEICHI N, 1988, ACTA PATHOL JAPON, V38, P1369; Towbin H., 1979, P NATL ACAD SCI USA, V76, P350; YOSHIDA MC, 1987, J HERED, V78, P361; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0	38	49	52	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	FEB	1999	29	2					379	384		10.1002/hep.510290239		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	162FB	WOS:000078333900010		
J	Suzuki, MG; Shimada, T; Kobayashi, M				Suzuki, MG; Shimada, T; Kobayashi, M			Bm kettin, homologue of the Drosophila kettin gene, is located on the Z chromosome in Bombyx mori and is not dosage compensated	HEREDITY			English	Article						Bombyx mori; dosage compensation; female heterogamety; kettin; sex-linked gene; Z chromosome	SEX-LINKED ENZYME; PROTEIN; INHERITANCE; BUTTERFLIES; SEQUENCE; MUSCLE	In Bombyx mori, the female is the heterogametic sex and the sex determining system is referred to as ZZ/ZW. In a previous study, we found that this insect does not show dosage compensation at the transcriptional level. To confirm the validity of our conclusion, we investigated whether or not another sex-linked gene is dosage compensated. To identify new Z-linked genes, total RNA from reciprocal hybrid females between the silkworm strains p50 and C108 was compared using the differential display technique. Nine cDNA fragments corresponding to several differentially expressed mRNAs were cloned and sequenced. The analysis of nucleotide sequence polymorphisms confirmed that one of these cDNAs, ZDD4, originated from the Z chromosome. The amino acid sequence deduced from ZDD4 has homology with kettin, a modular protein in the Z-disc of Drosophila melanogaster muscles. On immunoblots of Bombyx larval muscle proteins a polypeptide of 380 kDa was labelled with antibody to the ZDD4 peptide. We considered that the gene corresponding to ZDD4 encodes a kettin homologue in the silkworm, and denote it as Bm kettin. By a three-point cross, Bm kettin was mapped at 40.0 CM on the Z chromosome. Southern blot analysis revealed that Bm kettin was present at one copy in the genome. Northern blot analysis showed that Bm kettin mRNA was 9.1kb in length, and that the level of the mRNA in males was two times greater than that of females. Taken together with our previous observations, the present data suggest that lack of dosage compensation is a general rule in B. mori. Moreover, the twofold difference in Bm kettin expression between males and females may help explain the sexual difference in the wing flapping activity observed in some groups of Lepidoptera.	Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan	Shimada, T (reprint author), Univ Tokyo, Dept Agr & Environm Biol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 113, Japan.	shimada@ss.ab.a.u-tokyo.ac.jp	Shimada, Toru/A-2033-2011	Shimada, Toru/0000-0002-5791-0000			Alschul SF, 1990, J MOL BIOL, V215, P403; KONGSUWAN K, 1985, NATURE, V317, P555, DOI 10.1038/317555a0; KACSER H, 1981, GENETICS, V97, P639; HOMYK T, 1988, GENETICS, V119, P105; BAVERSTOCK PR, 1982, NATURE, V296, P763, DOI 10.1038/296763a0; LAKEY A, 1993, EMBO J, V12, P2863; BAKER BS, 1994, ANNU REV GENET, V28, P491; Borsani Giuseppe, 1993, Seminars in Developmental Biology, V4, P129, DOI 10.1006/sedb.1993.1015; BULLARD B, 1985, J MOL BIOL, V182, P443, DOI 10.1016/0022-2836(85)90203-7; CHANDRA HS, 1991, J GENET, V70, P137, DOI 10.1007/BF02927864; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOK AG, 1964, GENET RES, V5, P354; Doira H., 1992, GENETICAL STOCKS MUT; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.2307/2408022; Hashimoto H, 1933, JAP J GENET, V8, P245; HEBBERT DR, 1984, HEREDITY, V53, P361, DOI 10.1038/hdy.1984.93; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; Hsu David R., 1993, Seminars in Developmental Biology, V4, P93, DOI 10.1006/sedb.1993.1012; Inoue H, 1982, MOTHS JAPAN, V2; Inoue H., 1982, MOTHS JAPAN, VI.; JOHNSON MS, 1979, HEREDITY, V43, P71, DOI 10.1038/hdy.1979.60; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAST RL, 1987, GENETICS, V117, P619; MOUNIER N, 1987, NUCLEIC ACIDS RES, V15, P2781, DOI 10.1093/nar/15.6.2781; Ohno S., 1967, SEX CHROMOSOMES SEX; REGAN CL, 1988, GENE DEV, V2, P82, DOI 10.1101/gad.2.1.82; SPERLING FAH, 1994, CAN ENTOMOL, V126, P807; STEHR G, 1959, EVOLUTION, V13, P537, DOI 10.2307/2406135; SUZUKI GM, 1998, HEREDITY, V81, P275; WANG K, 1989, METHOD ENZYMOL, V172, P687, DOI 10.1016/S0076-6879(89)72038-3; WANG K, 1982, METHOD ENZYMOL, V85, P264	31	30	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0018-067X	1365-2540		HEREDITY	Heredity	FEB	1999	82		2				170	179		10.1038/sj.hdy.6884570		10	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	176JD	WOS:000079147200008		
J	Smyth, I; Narang, MA; Evans, T; Heimann, C; Nakamura, Y; Chenevix-Trench, G; Pietsch, T; Wicking, C; Wainwright, BJ				Smyth, I; Narang, MA; Evans, T; Heimann, C; Nakamura, Y; Chenevix-Trench, G; Pietsch, T; Wicking, C; Wainwright, BJ			Isolation and characterization of human Patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32	HUMAN MOLECULAR GENETICS			English	Article							HUMAN HOMOLOG; SONIC HEDGEHOG; MUTATIONS; PHENOTYPE; TISSUES; PROTEIN; SKIN	mutations of the human Patched gene (PTCH) have been identified in individuals with the nevoid basal cell carcinoma syndrome (NBCCS) as well as in sporadic basal cell carcinomas and medulloblastomas, We have isolated a homologue of this tumour suppressor gene and localized it to the short arm of chromosome 1 (1p32.1-32.3). Patched 2(PTCH2) comprises 22 coding exons and spans similar to 15 kb of genomic DNA, The gene encodes a 1203 amino acid putative transmembrane protein which is highly homologous to the PTCH product. We have characterized the genomic structure of PTCH2 and have used single-stranded conformational polymorphism analysis to search for mutations in PTCH2 in NBCCS patients, basal cell carcinomas and in medulloblastomas, To date, we have identified one truncating mutation in a medulloblastoma and a change in a splice donor site in a basal cell carcinoma, suggesting that the gene plays a role in the development of some tumours.	Univ Queensland, Ctr Mol & Cellular Biol, Brisbane, Qld 4072, Australia; Univ Queensland, Dept Biochem, Brisbane, Qld 4072, Australia; Univ Bonn, Med Ctr, Dept Neuropathol, D-53105 Bonn, Germany; Univ Tokyo, Mol Med Lab, Tokyo, Japan; Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Wainwright, BJ (reprint author), Univ Queensland, Ctr Mol & Cellular Biol, Res Rd, Brisbane, Qld 4072, Australia.	b.wainwright@cmcb.uq.edu.au					Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Hahn H, 1996, J BIOL CHEM, V271, P12125; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Wicking C, 1997, AM J HUM GENET, V60, P21; Xie JW, 1998, NATURE, V391, P90; Raffel C, 1997, CANCER RES, V57, P842; Wolter M, 1997, CANCER RES, V57, P2581; GORLIN RJ, 1995, DERMATOL CLIN, V13, P113; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Pietsch T, 1997, CANCER RES, V57, P2085; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Motoyama J, 1998, NAT GENET, V18, P104, DOI 10.1038/2392; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; IOANNOU PA, 1994, NAT GENET, V6, P84; Sambrook J., 1989, MOL CLONING LAB MANU; Sidransky D, 1996, NAT GENET, V14, P7, DOI 10.1038/ng0996-7; SteilenGimbel H, 1996, HUM GENET, V97, P87; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; Wicking C, 1997, AM J MED GENET, V73, P304	24	103	106	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906			HUM MOL GENET	Hum. Mol. Genet.	FEB	1999	8	2					291	297		10.1093/hmg/8.2.291		7	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	166BV	WOS:000078557100015		
J	Kyo, K; Parkes, M; Takei, Y; Nishimori, H; Vyas, P; Satsangi, J; Simmons, J; Nagawa, H; Baba, S; Jewell, D; Muto, T; Lathrop, GM; Nakamura, Y				Kyo, K; Parkes, M; Takei, Y; Nishimori, H; Vyas, P; Satsangi, J; Simmons, J; Nagawa, H; Baba, S; Jewell, D; Muto, T; Lathrop, GM; Nakamura, Y			Association of ulcerative colitis with rare VNTR alleles of the human intestinal mucin gene, MUC3	HUMAN MOLECULAR GENETICS			English	Article							INFLAMMATORY BOWEL-DISEASE; MOLECULAR-CLONING; MONOCLONAL-ANTIBODIES; EPITHELIAL MUCIN; CROHNS-DISEASE; COLONIC MUCIN; POLYMORPHISM; PREVALENCE; REGION; LOCUS	Ulcerative colitis (UC), a common form of inflammatory bowel disease, is a multifactorial disorder with significant genetic influence. Recently, evidence of linkage on chromosome 7q near the intestinal mucin gene MUC3 was reported by an affected sib-pair analysis. Previous reports indicate a possible mucin abnormality in UC patients, but whether genetic differences in a specific mucin gene are associated with UC is unknown. Here we analysed polymorphisms of variable number of tandem repeats (VNTRs) within this gene using DNAs obtained from 243 Japanese (75 patients with UC and 168 controls), and to confirm the result we undertook a two-stage examination using 328 Caucasian samples (72 and 85 with UC in the first and second stages, respectively, and 171 controls). When the frequency of patients carrying one or two rare VNTR alleles was compared with that of controls, a significant increase was found first in Japanese patients (odds ratio 2.72, 95% CI 1.17-6.32, P = 0.0308). In Caucasians, the odds ratio was 2.80 (95% CI 1.36-5.75, P = 0.0079) in the first stage, 2.43 (95% CI 1.20-4.92, P = 0.0196) in the second stage and 2.60 (95% CI 1.41-4.80, P = 0.0024) in total. The overall odds ratio was 2.64 (95% CI 1.60-4.33, P = 0.0001), This result suggests that rare alleles of the MUGS gene may confer genetic predisposition to UC.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Hamamatsu Univ Sch Med, Dept Surg 2, Shizuoka 4313192, Japan; Univ Tokyo, Dept Surg 1, Bunkyo Ku, Tokyo 1138655, Japan; Radcliffe Infirm, Dept Gastroenterol, Oxford OX2 6HE, England	Nakamura, Y (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp					SNYDER JD, 1987, INT ARCH ALLER A IMM, V82, P351; PODOLSKY DK, 1983, J CLIN INVEST, V72, P142, DOI 10.1172/JCI110952; Agrawal B, 1998, NAT MED, V4, P43, DOI 10.1038/nm0198-043; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607; Apostolopoulos V, 1998, NAT MED, V4, P315, DOI 10.1038/nm0398-315; STEVENS TRJ, 1992, CLIN EXP IMMUNOL, V90, P271; TORIBARA NW, 1991, J CLIN INVEST, V88, P1005, DOI 10.1172/JCI115360; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; BREGMAN ELAZAR, 1965, PROC SOC EXP BIOL MED, V118, P727; Calkins BM, 1995, INFLAMM BOWEL DIS, P31; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; DONALDSON RM, 1964, NEW ENGL J MED, V270, P938, DOI 10.1056/NEJM196404302701806; FIOCCHI C, 1989, ANN INTERN MED, V110, P786; GUM JR, 1990, BIOCHEM BIOPH RES CO, V171, P407, DOI 10.1016/0006-291X(90)91408-K; Gum JR, 1997, J BIOL CHEM, V272, P26678; KRONTIRIS TG, 1985, NATURE, V313, P369, DOI 10.1038/313369a0; LAMBLIN G, 1991, AM REV RESP DIS S, V144, P19; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396; MADARA JL, 1985, GASTROENTEROLOGY, V88, P13; Merry DE, 1998, HUM MOL GENET, V7, P693, DOI 10.1093/hmg/7.4.693; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Phelan CM, 1996, NAT GENET, V12, P309, DOI 10.1038/ng0396-309; PODOLSKY DK, 1985, GASTROENTEROLOGY, V88, P20; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; PODOLSKY DK, 1988, GASTROENTEROLOGY, V95, P371; PODOLSKY DK, 1988, GASTROENTEROLOGY, V95, P379; TANAKA T, 1994, HUM GENET, V94, P380; TEAGUE RH, 1973, BRIT MED J, V2, P645; TYSK C, 1991, GASTROENTEROLOGY, V100, P419; VanKlinken BJW, 1997, BIOCHEM BIOPH RES CO, V238, P143, DOI 10.1006/bbrc.1997.7258; Walter P., 1994, MOL BIOL CELL, P599; YANG H, 1994, INFLAMM BOWEL DIS, P32	35	64	64	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0964-6906			HUM MOL GENET	Hum. Mol. Genet.	FEB	1999	8	2					307	311		10.1093/hmg/8.2.307		5	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	166BV	WOS:000078557100017		
J	Hayakawa, H; Hirata, Y; Kakoki, M; Suzuki, Y; Nishimatsu, H; Nagata, D; Suzuki, E; Kikuchi, K; Nagano, T; Kangawa, K; Matsuo, H; Sugimoto, T; Omata, M				Hayakawa, H; Hirata, Y; Kakoki, M; Suzuki, Y; Nishimatsu, H; Nagata, D; Suzuki, E; Kikuchi, K; Nagano, T; Kangawa, K; Matsuo, H; Sugimoto, T; Omata, M			Role of nitric oxide cGMP pathway in adrenomedullin-induced vasodilation in the rat	HYPERTENSION			English	Article						adrenomedullin; nitric oxide; cyclic GMP; endothelium; phosphodiesterase inhibitors; rats	VASCULAR SMOOTH-MUSCLE; PHOSPHODIESTERASE INHIBITOR; MOLECULAR-CLONING; PHOSPHOLIPASE-C; CYCLIC-AMP; PEPTIDE; CELLS; RECEPTOR; HYPERTENSION; CIRCULATION	We previously reported that adrenomedullin (AM), a potent vasodilator peptide discovered in pheochromocytoma cells, stimulates nitric oxide (NO) release in the rat kidney. To further investigate whether the NO-cGMP pathway is involved in the mechanisms of AM-induced vasodilation, we examined the effects of E-4021, a cGMP-specific phosphodiesterase inhibitor, on AM-induced vasorelaxation in aortic rings and perfused kidneys isolated from Wistar rats. We also measured NO release from the kidneys using a chemiluminescence assay. AM (10(-10) to 10(-7) mol/L) relaxed the aorta precontracted with phenylephrine in a dose-dependent manner. Denudation of endothelium (E) attenuated the vasodilatory action of AM (10(-7) mol/L AM: intact (E+) -25.7 +/- 5.2% versus denuded (E-) -7.8 +/- 0.6%, P < 0.05), On the other hand, pretreatment with 10(-8) mol/L E-4021 augmented AM-induced vasorelaxation in the intact aorta (-49.0 +/- 7.9%, P < 0.05) but not in the denuded one. E-4021 also enhanced acetylcholine (ACh)-induced vasorelaxation in the rat intact aorta (10(-7) mol/L ACh -36.6 +/- 8.4% versus 10(-8) mol/L E-4021 + 10(-7) mol/L ACh -62.7 +/- 3.1%, P < 0.05). In perfused kidneys, AM-induced vasorelaxation was also augmented by preincubation with E-4021 (10(-9) mol/L AM - 15.4 +/- 0.6% versus 10(-8) mol/L E-4021 + 10(-9) mol/L AM -23.6 +/- 1.2%, P < 0.01). AM significantly increased NO release from rat kidneys (Delta NO: +11.3 +/- 0.8 fmol min(-1) g(-1) kidney at 10-9 mol/L AM), which was not affected by E-4021. E-4021 enhanced ACh-induced vasorelaxation (10(-9) mol/L ACh -9.7 +/- 1.7% versus 10(-8) mol/L E-4021 + 10(-9) mol/L ACh -18.8 +/- 2.9%, P < 0.01) but did not affect ACh-induced NO release from the kidneys. In the aorta and the kidney, 10(-4) moI/L of N-G-nitro-L-arginine methyl ester, an NO synthase inhibitor, and 10(-5) mol/L of methylene blue, a guanylate cyclase inhibitor, reduced the vasodilatory effect of AM. These results suggest that the NO-cGMP pathway is involved in the mechanism of AM-induced vasorelaxation, at least in the rat aorta and kidney.	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Kanto Cent Hosp, Dept Internal Med 3, Tokyo 113, Japan; Univ Tokyo, Fac Pharmaceut Sci, Tokyo 113, Japan; Natl Cardiovasc Ctr, Res Inst, Osaka, Japan	Hirata, Y (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		Kikuchi, Kazuya/D-2370-2009				McLatchie LM, 1998, NATURE, V393, P333; HEATON J, 1995, AM J PHYSIOL-HEART C, V268, pH2211; Hayakawa H, 1997, CIRCULATION, V96, P2407; KAPAS S, 1995, J BIOL CHEM, V270, P25344; EGUCHI S, 1994, ENDOCRINOLOGY, V135, P2454, DOI 10.1210/en.135.6.2454; SHIMEKAKE Y, 1995, J BIOL CHEM, V270, P4412; FORCE T, 1992, AM J PHYSIOL, V262, pF1110; Cohen AH, 1996, J CLIN INVEST, V97, P172, DOI 10.1172/JCI118386; NISHIDA K, 1992, J CLIN INVEST, V90, P2092, DOI 10.1172/JCI116092; ISHIZAKA Y, 1994, BIOCHEM BIOPH RES CO, V200, P642, DOI 10.1006/bbrc.1994.1496; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; HIRATA Y, 1995, CIRCULATION, V91, P1229; BASKAYA MK, 1995, J CEREBR BLOOD F MET, V15, P827; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Champion HC, 1997, AM J PHYSIOL-REG I, V272, pR234; CRAVEN PA, 1978, J BIOL CHEM, V253, P8433; GARDINER SM, 1995, BRIT J PHARMACOL, V114, P584; GUO J, 1995, ENDOCRINOLOGY, V136, P3884, DOI 10.1210/en.136.9.3884; HIRATA Y, 1995, HYPERTENSION, V25, P790; KATO J, 1995, EUR J PHARM-MOLEC PH, V289, P383, DOI 10.1016/0922-4106(95)90117-5; KIKUCHI K, 1993, J BIOL CHEM, V268, P23106; KOHNO M, 1995, METABOLISM, V44, P10, DOI 10.1016/0026-0495(95)90282-1; KUREISHI Y, 1995, BIOCHEM BIOPH RES CO, V212, P572, DOI 10.1006/bbrc.1995.2008; LAMAS S, 1992, P NATL ACAD SCI USA, V89, P6348, DOI 10.1073/pnas.89.14.6348; Majid DSA, 1996, AM J PHYSIOL-RENAL, V270, pF200; MIURA K, 1995, BRIT J PHARMACOL, V115, P917; OSAJIMA A, 1995, LIFE SCI, V57, P457, DOI 10.1016/0024-3205(95)00279-F; SAEKI T, 1995, J PHARMACOL EXP THER, V272, P825; THUSU KG, 1995, AM J RESP CRIT CARE, V152, P1605	30	97	103	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X			HYPERTENSION	Hypertension	FEB	1999	33	2					689	693				5	Peripheral Vascular Disease	Cardiovascular System & Cardiology	168CM	WOS:000078673300017		
J	Takushima, Y; Kikuchi, K				Takushima, Y; Kikuchi, K			Gain spectrum equalization of all-optical gain-clamped erbium-doped fiber amplifier	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						erbium materials/devices; optical fiber amplifiers; optical fiber communication; optical filters; wavelength-division multiplexing	NM	We experimentally investigate the gain spectrum of erbium-doped fiber amplifiers whose gain is clamped by internal laser oscillation. The gain is ideally clamped and immune to the input signal power in the wavelength range of 17 nm. The clamped gain spectrum is equalized by a Mach-Zehnder interferometer, and we achieve the 17-nm-wide uniform gain, which is not dependent on input optical power levels.	Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan	Takushima, Y (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan.						Wysocki PF, 1997, IEEE PHOTONIC TECH L, V9, P1343, DOI 10.1109/68.623257; FUKUSHIMA M, 1997, C OPT FIB COMM OFC 9; HWANG ST, 1998, C OPT FIB COMM OFC 9; KASHYAP R, 1993, ELECTRON LETT, V29, P1025, DOI 10.1049/el:19930685; KIM HY, 1998, C OPT FIB COMM OFC 9; Lee YW, 1996, IEEE PHOTONIC TECH L, V8, P1612, DOI 10.1109/68.544694; Ohishi Y, 1998, OPT LETT, V23, P274, DOI 10.1364/OL.23.000274; OKAMURA H, 1992, J LIGHTWAVE TECHNOL, V10, P1110, DOI 10.1109/50.156852; Park N, 1996, IEEE PHOTONIC TECH L, V8, P1148, DOI 10.1109/68.531818; SRIVASTAVA AK, 1996, C OPT FIB COMM OFC 9; Sulhoff JW, 1997, IEEE PHOTONIC TECH L, V9, P1578, DOI 10.1109/68.643268; Takushima Y, 1998, ELECTRON LETT, V34, P458, DOI 10.1049/el:19980269; WYSOCKI PF, 1997, C OPT FIB COMM OFC 9; WYSOCKI PF, 1998, C OPT FIB COMM OFC 9; ZIRNGIBL M, 1991, ELECTRON LETT, V27, P560, DOI 10.1049/el:19910353	15	5	5	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1041-1135			IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	FEB	1999	11	2					176	178		10.1109/68.740695		3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	160ZV	WOS:000078264000008		
J	Ma, BJ; Nakano, Y				Ma, BJ; Nakano, Y			Realization of all-optical wavelength converter based on directionally coupled semiconductor optical amplifiers	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						all-optical; conversion efficiency; digital response; directional coupler; semiconductor optical amplifiers		We propose a novel all-optical wavelength converter based on directionally coupled (DC) semiconductor optical amplifiers (SOA) and simulate its characteristics using a simple model to find out such advantages as extinction enhancement and digital response. We then fabricate devices in the 1.55-mu m band, and successfully demonstrate the wavelength conversion operation with the above-mentioned advantages, Very compact size and no need of active/passive integration are other significant merits of DC SOA's.	Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Ma, BJ (reprint author), Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan.						Joergensen C, 1996, IEEE PHOTONIC TECH L, V8, P521, DOI 10.1109/68.491213; LIU JM, 1987, APPL PHYS LETT, V50, P1625, DOI 10.1063/1.97748; MA B, 1998, C LAS EL OPT CLEO 98, P477; MA B, 1998, INT PHOT RES IPR 98, P164; PAN X, 1995, IEEE PHOTONIC TECH L, V7, P995, DOI 10.1109/68.414680; Spiekman LH, 1997, IEEE PHOTONIC TECH L, V9, P1349, DOI 10.1109/68.623259; Spiekman LH, 1998, IEEE PHOTONIC TECH L, V10, P1115, DOI 10.1109/68.701520	7	15	21	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1041-1135			IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	FEB	1999	11	2					188	190				3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	160ZV	WOS:000078264000012		
J	Hayakawa, K; Matsumoto, K; Yamashita, M; Suzuki, Y; Fujimori, K; Kimura, H				Hayakawa, K; Matsumoto, K; Yamashita, M; Suzuki, Y; Fujimori, K; Kimura, H			Robust H-infinity-output feedback control of decoupled automobile active suspension systems	IEEE TRANSACTIONS ON AUTOMATIC CONTROL			English	Article						active suspension; automobile; decoupling; H-infinity control; output feedback		H-infinity-output feedback control is applied to the control of automobile active suspensions based on a dynamic model of the full vehicle. The output feedback control is desirable from the viewpoint of implementation in the sense that it reduces the number of measurements drastically compared with state feedback used currently in suspension control. In this paper, the authors show that a linearized moder can be block-decoupled by a similarity transformation, which reduces the controller complexity significantly. The uncertainties of the vehicle model rue properly taken into account in the derivation of the Hm controller. The controller is actually Implemented in a commercial car, and the performance is evaluated both by simulations and experiments. The performance obtained proves to be quite satisfactory.	Toyota Cent Res & Dev Labs Inc, Syst Control Lab, Nagakute, Aichi 48011, Japan; Komatsu Ltd, Hirakata, Osaka 573, Japan; Toyota Motor Corp, Toyota, Aichi 471, Japan; Univ Tokyo, Fac Engn, Dept Math Engn & Informat, Bunkyo Ku, Tokyo 113, Japan	Hayakawa, K (reprint author), Toyota Cent Res & Dev Labs Inc, Syst Control Lab, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.						Alexandridis A. A., 1984, Proceedings of the 1984 American Control Conference (IEEE Cat. No. 84CH2024-8); Aoyama Y., 1990, 901747 SAE; BARAK P, 1985, THESIS WAYNE STATE U; BARAK P, 1988, P INT C ADV SUSP LON; CHALASANI RM, 1986, T ASME, V80, P205; DOYLE J, 1982, IEE PROC-D, V129, P242; HAYAKAWA K, 1993, THESIS OSAKA U OSAKA; HAYAKAWA K, 1993, PROCEEDINGS OF THE 32ND IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P2931, DOI 10.1109/CDC.1993.325738; Kane T.R., 1985, DYNAMICS THEORY APPL; KAWAKAMI H, 1991, TOYOTA TECH REV, V41, P64; KIMURA H, 1991, IEEE T AUTOMAT CONTR, V36, P653, DOI 10.1109/9.86940; KRTOLICA R, 1992, IEEE T AUTOMAT CONTR, V37, P528, DOI 10.1109/9.126592; Malek KM, 1986, VEH SYST DYN S, V15, P383, DOI DOI 10.1080/00423118608969149; MORAN A, 1992, JSME INT J III-VIB C, V35, P427; ULSOY AG, 1994, J DYN SYST-T ASME, V116, P123, DOI 10.1115/1.2900666; Ulsoy A. G., 1990, Proceedings of the 1990 American Control Conference (IEEE Cat. No.90CH2896-9); YAMASHITA M, 1990, PROCEEDINGS OF THE 29TH IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-6, P2244, DOI 10.1109/CDC.1990.204024; Yamashita M, 1993, P IFAC 12 WORLD C IN, V3, P143; Yue C., 1989, ASME, V111, P286	19	42	48	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9286			IEEE T AUTOMAT CONTR	IEEE Trans. Autom. Control	FEB	1999	44	2					392	396		10.1109/9.746274		5	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	166TX	WOS:000078594200025		
J	Panda, PR; Nakamura, H; Dutt, ND; Nicolau, A				Panda, PR; Nakamura, H; Dutt, ND; Nicolau, A			Augmenting loop tiling with data alignment for improved cache performance	IEEE TRANSACTIONS ON COMPUTERS			English	Article						loop tiling; data cache; data alignment; cache conflict		Loop blocking (tiling) is a well-known compiler optimization that helps improve cache performance by dividing the loop iteration space into smaller blocks (tiles); reuse of array elements within each tile is maximized by ensuring that the working set for the tile fits into the data cache. Padding is a data alignment technique that involves the insertion of dummy elements into a data structure for improving cache performance. In this work, we present DAT, a technique that augments loop tiling with data alignment, achieving improved efficiency (by ensuring that the cache is never under-utilized) as well as improved flexibility (by eliminating self-interference cache conflicts independent of the tile size). This results in a more stable and better cache performance than existing approaches, in addition to maximizing cache utilization, eliminating Self-interference, and minimizing cross-interference conflicts. Further, while all previous efforts are targetted at programs characterized by the reuse of a single array, we also address the issue of minimizing conflict misses when several tiled arrays are involved. To validate our technique, we ran extensive experiments using both simulations as well as actual measurements on SUN Sparc5 and Sparc10 workstations. The results on benchmarks exhibiting varying memory access patterns demonstrate the effectiveness of our technique through consistently high hit ratios and improved performance across varying problem sizes.	Synopsys Inc, Mt View, CA 94043 USA; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92697 USA	Panda, PR (reprint author), Synopsys Inc, 700 E Middlefield Rd, Mt View, CA 94043 USA.						Carr S., 1992, Proceedings. Supercomputing '92. (Cat. No.92CH3216-9), DOI 10.1109/SUPERC.1992.236704; COLEMAN S, 1995, P ACM SIGPLAN C PROG, P279, DOI 10.1145/207110.207162; EMBREE P, 1991, C LANGUAGE ALGORITHM; ESSEGHIR K., 1993, THESIS RICE U; Lam M.D., 1991, P 4 INT C ARCH SUPP, P63, DOI 10.1145/106972.106981; LEBECK AR, 1994, COMPUTER, V27; MILENKOVIC A, 1988, P 31 HAW INT C SYST, V7; PANDA PR, 1997, SOLVING IRREGULARLY, V1253; Press W.H., 1992, NUMERICAL RECIPES C; *SUN MICR LAB INC, 1993, SHAD US MAN; TEMAM O, 1993, P SUP NOV; Wolf M. E., 1991, P ACM SIGPLAN 91 C P, P30, DOI 10.1145/113445.113449; WOLFE M, 1989, PROCEEDINGS : SUPERCOMPUTING 89, P655, DOI 10.1145/76263.76337	13	38	39	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340			IEEE T COMPUT	IEEE Trans. Comput.	FEB	1999	48	2					142	149		10.1109/12.752655		8	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	174WV	WOS:000079060200006		
J	Ishii, M; Michishita, K; Hongo, Y				Ishii, M; Michishita, K; Hongo, Y			Experimental study of lightning-induced voltage on an overhead wire over lossy ground	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						electromagnetic transients; lightning; overhead distribution lines; surges	HORIZONTAL ELECTRIC-FIELDS; 2 COUPLING MODELS; POWER-LINES; STROKES	Experiments on the lightning-induced voltage on an overhead wire with a simulated lightning channel and a 1/20 reduced-scale model have been carried out on a lossy ground. This method is quite useful in testing various coupling models as repeated measurement along with a simple simulated lightning channel is possible. The electrical characteristics of the ground, indispensable in the calculation of the induced voltage over lossy ground, are evaluated through the comparison of the measured and the calculated horizontal electric field waveforms. The coupling model adopted in the numerical calculation of the induced voltage, including the terminations of a finite line, is verified by the good agreement of the measured and the calculated voltage waveforms. This result also verifies the usefulness of the measurement of the horizontal electric field waveform in assessing the ground conductivity in the frequency range of interest.	Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan; Shizuoka Univ, Dept Elect & Elect Engn, Hamamatsu, Shizuoka 4328561, Japan; Tohoku Elect Power Co Inc, Elect Technol R&D Ctr, Sendai, Miyagi 9810952, Japan	Ishii, M (reprint author), Univ Tokyo, Inst Ind Sci, 7-22-1 Roppongi, Tokyo 1068558, Japan.						AGRAWAL AK, 1980, IEEE T ELECTROMAGN C, V22, P119, DOI 10.1109/TEMC.1980.303824; Rachidi F, 1996, IEEE T ELECTROMAGN C, V38, P250, DOI 10.1109/15.536054; Norton KA, 1937, P IRE, V25, P1203, DOI 10.1109/JRPROC.1937.228544; SAKAKIBARA A, 1989, IEEE T POWER DELIVER, V4, P683, DOI 10.1109/61.19261; Michishita K, 1996, IEEE T ELECTROMAGN C, V38, P507, DOI 10.1109/15.536083; THOMSON EM, 1988, J GEOPHYS RES-ATMOS, V93, P2429, DOI 10.1029/JD093iD03p02429; DIENDORFER G, 1990, IEEE T ELECTROMAGN C, V32, P292, DOI 10.1109/15.59889; TAYLOR CD, 1965, IEEE T ANTENN PROPAG, VAP13, P987, DOI 10.1109/TAP.1965.1138574; COORAY V, 1994, IEEE T ELECTROMAGN C, V36, P179, DOI 10.1109/15.305462; GUERRIERI S, 1997, P 10 INT S HIGH VOLT, V5, P119; HONGO Y, 1996, P 23 INT C LIGHTN PR, P310; ISHII M, 1994, IEEE T POWER DELIVER, V9, P109, DOI 10.1109/61.277685; KOGA H, 1980, T IECE JAPAN E, V62, P216; MASTER MJ, 1984, IEEE T POWER AP SYST, V103, P2502, DOI 10.1109/TPAS.1984.318405; Michishita K, 1996, J GEOPHYS RES-ATMOS, V101, P3861, DOI 10.1029/95JD03069; MICHISHITA K, 1997, P 10 INT C HIGH VOLT, V5, P75; MICHISHITA K, 1993, 10 INT S EL COMP ZUR; NUCCI CA, 1995, IEEE T POWER DELIVER, V10, P330, DOI 10.1109/61.368381; RUBINSTEIN M, 1994, IEEE T ELECTROMAGN C, V36, P134, DOI 10.1109/15.293277; Rusck S., 1958, T ROYAL I TECHNOL; Stratton J. A., 1941, ELECTROMAGNETIC THEO; Vance E. F., 1987, COUPLING SHIELDED CA; YOKOYAMA S, 1984, IEEE T POWER AP SYST, V103, P100, DOI 10.1109/TPAS.1984.318583; Zeddam A., 1987, Electromagnetics, V7, DOI 10.1080/02726348708908197	24	23	23	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9375			IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	FEB	1999	41	1					39	45		10.1109/15.748135		7	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	169VV	WOS:000078770500006		
J	Hori, Y; Sawada, H; Chun, YH				Hori, Y; Sawada, H; Chun, YH			Slow resonance ratio control for vibration suppression and disturbance rejection in torsional system	IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS			English	Article						disturbance observer; disturbance rejection; observer pole design; resonance ratio; robust control; speed control; suppression; torsional system; vibration	FEEDBACK; 2-MASS	In the resonance ratio control, which we proposed for vibration suppression and disturbance rejection in a torsional system, the estimation speed of the disturbance observer should have been much faster than the resonance frequency of the controlled system, However, a too fast disturbance observer sometimes causes an implementation problem, In this paper, we give the optimal speed of the disturbance observer and propose a novel technique named "slow resonance ratio control," It does not have any fast part in the controller, It also enables us to design the speed control and the vibration suppression control almost completely independently.	Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Hori, Y (reprint author), Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan.						HORI Y, 1994, IEEE T IND APPL, V30, P889, DOI 10.1109/28.297904; Ji JK, 1995, IEEE T IND ELECTRON, V42, P564; Sugiura K, 1996, IEEE T IND ELECTRON, V43, P56, DOI 10.1109/41.481408; CHUN Y, 1995, P IFAC WORKSH MOT CO, P165; HARA S, 1994, P ASCC, P313; HORI Y, 1994, P ASCC 94, P741; HORI Y, 1992, P 2 INT WORKSH ADV M, P409; HORI Y, 1996, P PEMC 96, V1, P120; HORI Y, 1995, P IPEC YOK 95, P440; Hori Y., 1995, P IFAC WORKSH MOT CO, P41; HORI Y, 1997, P ASCC 97, V1, P177; IWATA M, 1994, P 3 INT WORKSH AMC B, P51; MANABE S, 1994, P ASCC 94, P329; SCHAFER U, 1991, P EPE 91, P596; UMIDA H, 1994, C REC I EL ENG JPN I; Wie B., 1990, Proceedings of the 1990 American Control Conference (IEEE Cat. No.90CH2896-9); Yuki K., 1993, Transactions of the Institute of Electrical Engineers of Japan, Part D, V113-D	17	117	124	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0278-0046			IEEE T IND ELECTRON	IEEE Trans. Ind. Electron.	FEB	1999	46	1					162	168		10.1109/41.744407		7	Automation & Control Systems; Engineering, Electrical & Electronic; Instruments & Instrumentation	Automation & Control Systems; Engineering; Instruments & Instrumentation	164UF	WOS:000078481400019		
J	Chen, Q; Aoyagi, PH; Katsurai, M				Chen, Q; Aoyagi, PH; Katsurai, M			Numerical analysis of surface wave excitation in a planar-type nonmagnetized plasma processing device	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						FDTD; plasma processing; surface wave propagation	MICROWAVE PLASMA; PROPAGATION; COLUMNS; GENERATION; LAUNCHER; FIELD	Two-dimensional numerical simulations based on the finite-difference time-domain approximation to Maxwell's equations coupled with nonmagnetized cold electron plasma equations are used to study surface wave propagation in a four-layer planar type surface wave plasma processing structure (Komachi et al.) under the assumption that the plasma is overdense, Simulations are used to verify the existence of surface waves along the plasma-dielectric window interface as well as to investigate the excitation mechanism of surface waves, In addition, simulations are used to study the effect of the air gap on the electric field distribution at the plasma-dielectric window interface. It is found that metal edges located along the processing chamber wall sufficiently close to the interface are needed to excite surface waves along the interface. It is also found that the air gap layer helps achieve a more uniform electric field distribution over the processing chamber.	Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Chen, Q (reprint author), Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan.						KOMACHI K, 1989, J MICROWAVE POWER EE, V24, P140; TRIVELPIECE AW, 1959, J APPL PHYS, V30, P1784, DOI 10.1063/1.1735056; MOISAN M, 1991, J PHYS D APPL PHYS, V24, P1025, DOI 10.1088/0022-3727/24/7/001; MOISAN M, 1974, PHYS LETT A, VA 50, P125, DOI 10.1016/0375-9601(74)90903-7; KIMURA T, 1995, JPN J APPL PHYS 2, V34, pL1076; MOISAN M, 1984, IEEE T PLASMA SCI, V12, P203, DOI 10.1109/TPS.1984.4316320; SHIVAROVA A, 1978, PLASMA PHYS CONTR F, V20, P1049, DOI 10.1088/0032-1028/20/10/007; KOMACHI K, 1993, J VAC SCI TECHNOL A, V11, P164, DOI 10.1116/1.578284; MOISAN M, 1979, J PHYS D APPL PHYS, V12, P219, DOI 10.1088/0022-3727/12/2/008; MOISAN M, 1982, PLASMA PHYS CONTR F, V24, P1331, DOI 10.1088/0032-1028/24/11/001; MOISAN M, 1987, REV SCI INSTRUM, V58, P1895, DOI 10.1063/1.1139539; Chen Q, 1998, IEEE T ANTENN PROPAG, V46, P1739, DOI 10.1109/8.736632; COLLIN RE, 1986, FIELD THEORY GUIDED; Ghanashev I, 1997, JPN J APPL PHYS 1, V36, P337, DOI 10.1143/JJAP.36.337; Harrington R. F., 1961, TIME HARMONIC ELECTR; KOMACHI K, 1994, J VAC SCI TECHNOL A, V12, P769, DOI 10.1116/1.578821; KOMACHI K, 1991, J ELECTROCHEM SOC, V138, pL76, DOI 10.1149/1.2085514; KOMACHI K, 1990, J MICROWAVE POWER EE, V25, P236; KOMACHI K, 1998, THESIS U TOKYO JAPAN; Kong JA, 1985, ELECTROMAGNETIC WAVE; LIEBERMAN M, 1994, PRINCIPLES PLASMA DI; LUEBBERS RJ, 1990, IEEE T ELECTOMAGN CO, V32, P22; MARGOT J, 1993, J PLASMA PHYS, V49, P357; MOISAN M, 1974, PLASMA PHYS CONTR F, V16, P1, DOI 10.1088/0032-1028/16/1/001; MOISAN M, 1975, IEEE T PLASMA SCI, VPS 3, P55, DOI 10.1109/TPS.1975.4316875; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; ODROBINA I, 1996, TECH REP I ELECT INF, P23; Oppenheim A., 1983, SIGNALS SYSTEMS; Taflove A., 1995, COMPUTATIONAL ELECTR; TUMA DR, 1970, REV SCI INSTRUM, V44, P1519; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; YOUNG JL, 1994, RADIO SCI, V29, P1513, DOI 10.1029/94RS01921; ZAKRZEWSKI Z, 1977, PLASMA PHYS CONTR F, V19, P77, DOI 10.1088/0032-1028/19/2/001	33	25	27	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0093-3813			IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	FEB	1999	27	1					164	170		10.1109/27.763108		7	Physics, Fluids & Plasmas	Physics	197MX	WOS:000080369700076		
J	Paterni, P; Vitet, S; Bena, M; Yokoyama, A				Paterni, P; Vitet, S; Bena, M; Yokoyama, A			Optimal location of phase shifters in the French network by genetic algorithm	IEEE TRANSACTIONS ON POWER SYSTEMS			English	Article						FACTS; phase shifter; power flow control; OFF; optimal location; return on investment		Series FACTS such as series capacitors or phase shifters, by controlling the power flows in a network, can help reduce the flows in heavily loaded lines, resulting in an increased loadability of the network and a reduced cost of production. The influence of multiple phase shifters on the network flows is complex, because they interact on one another, and the problem of the optimal location is essential. This paper proposes an index for measuring the benefit of a given set of phase shifters. The best location for a set of phase shifters is found by a genetic algorithm for a 36 line test case and for the French network.	EDF, DER, Dept Power Syst, F-92141 Clamart, France; Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 113, Japan	Paterni, P (reprint author), EDF, DER, Dept Power Syst, F-92141 Clamart, France.						Lie TT, 1997, INT J ELEC POWER, V19, P125, DOI 10.1016/S0142-0615(96)00036-1; DAVRIU A, CIGRE TOKYO 1995; DAVRIU A, 1995, P IEEE KTH STOCKH PO; Goldberg D. E., 1989, GENETIC ALGORITHMS S; PATERNI P, 1997, INT C EL ENG MATS JA; PATERNI P, 1997 NATL CONV REC I	6	66	71	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0885-8950			IEEE T POWER SYST	IEEE Trans. Power Syst.	FEB	1999	14	1					37	42		10.1109/59.744481		6	Engineering, Electrical & Electronic	Engineering	162YF	WOS:000078374500008		
J	Matsunaga, T; Nakano, Y				Matsunaga, T; Nakano, Y			Joint special issue on photonics in switching: Systems and devices - Foreword	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Editorial Material									NTT, Musashino, Tokyo, Japan; Univ Tokyo, Tokyo, Japan	Matsunaga, T (reprint author), NTT, Musashino, Tokyo, Japan.							0	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8516	1745-1345		IEICE T COMMUN	IEICE Trans. Commun.	FEB	1999	E82B	2					207	208				2	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	171CR	WOS:000078845300001		
J	Yasui, T; Nakano, Y				Yasui, T; Nakano, Y			Switching node consideration from the aspect of transmission characteristics in wavelength assignment photonic network (WAPN)	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						photonic network; switching matrix; transmission characteristics; traffic performance		By adopting a network architecture in which not only a calling but also a called terminal can select a wavelength, a novel WDM network becomes possible. This we call Wavelength Assignment Photonic Network (WAPN). In this network wavelengths are a kind of network resources and according to requests from terminals, wavelengths are allocated or assigned to cans. In the system a wavelength used for a call is to be used for another call after the call is terminated. By supplying wavelengths to the home, a bitrate-free, protocol free or even transmission method free network can be realized. In this paper, from a viewpoint of S/N or Q factor, WAPN is evaluated with special focus on the node architectur-i.e., from the view-point of node size, number of switching stages, crosstalk level,and losses, because the allowable node size is the crucial issue to decide the whole network capacity. After brief explanations of this proposed system, the model for system evaluations will be established and a node system is to be evaluated for some practical parameter values considering especially traffic characteristics of a node. As a result of this study a node system with capacity more than 100 thousands erl (about 20 Tbps throughput) can be constructed using present available technologies, which will enable us to construct large WAPN network with radius of 2,000 km and subscribers of about 50 millions.	Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan; Univ Tokyo, Fac Elect Engn, Tokyo 1138654, Japan	Yasui, T (reprint author), Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan.						ALEXANDER SB, 1997, SPIE TUTORIAL TEX TT, V22; Chang GK, 1996, J LIGHTWAVE TECHNOL, V14, P1320; HIMENO A, 1996, P ECOC 96 OSL NORW S, V4, P149; ISHIO H, 1992, OPTICAL AMPLIFIER IT; Johansson S, 1996, J LIGHTWAVE TECHNOL, V14, P1341, DOI 10.1109/50.511665; KIKUCHI K, 1993, FIBER INTEGRATED OPT, V12, P369, DOI 10.1080/01468039308204237; KIKUCHI K, 1997, FDN OPTICAL FIBER CO; KOGA M, 1996, IEEE J LIGHTWAVE TEC, V14, P1106; MOTOSHIMA K, 1997, IEICE T COMMUN B, V80; Smith DA, 1996, J LIGHTWAVE TECHNOL, V14, P1005, DOI 10.1109/50.511601; SOULAGE G, 1996, P ECOC 96 OSL; TESHIMA M, 1997, P IOOC ECOC 97 ED UK, V3, P59; YAMASHITA S, 1990, OCS9020 IEICE; YASUI T, 1994, IEICE T COMMUN, VE77B, P174	14	7	7	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8516	1745-1345		IEICE T COMMUN	IEICE Trans. Commun.	FEB	1999	E82B	2					306	316				11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	171CR	WOS:000078845300013		
J	Matsunaga, T; Nakano, Y				Matsunaga, T; Nakano, Y			Joint special issue on photonic's in switching: Systems and devices	IEICE TRANSACTIONS ON ELECTRONICS			English	Editorial Material									NTT, Musashino, Tokyo, Japan; Univ Tokyo, Tokyo, Japan	Matsunaga, T (reprint author), NTT, Musashino, Tokyo, Japan.							0	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	FEB	1999	E82C	2					155	156				2	Engineering, Electrical & Electronic	Engineering	171CM	WOS:000078844900001		
J	Yasui, T; Nakano, Y				Yasui, T; Nakano, Y			Switching node consideration from the aspect of transmission characteristics in wavelength assignment photonic network (WAPN)	IEICE TRANSACTIONS ON ELECTRONICS			English	Article						photonic network; switching matric; transmission characteristics; traffic performance		By adopting a network architecture in which not only a calling but also a called terminal can select a wavelength, a novel WDM network becomes possible. This we call Wavelength Assignment Photonic Network (WAPN). In this network wavelengths are a kind of network resources and according to requests from terminals, wavelengths are allocated or assigned to calls. In the system a wavelength used for a call is to be used for another call after the call is terminated. By supplying wavelengths to the home, a bitrate-free, protocol free or even transmission method free network can be realized. In this paper, from a viewpoint of S/N or Q factor, WAPN is evaluated with special focus on the node architecture-i.e., from the viewpoint of node size, number of switching stages, crosstalk level,and losses, because the allowable node size is the crucial issue to decide the whole network capacity. After brief explanations of this proposed system, the model for system evaluations will be established and a node system is to be evaluated for some practical parameter values considering especially traffic characteristics of a node. As a result of this study a node system with capacity more than 100 thousands erl (about 20 Tbps throughput) can be constructed using present available technologies, which will enable us to construct large WAPN network with radius of 2,000 km and subscribers of about 50 millions.	Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan; Univ Tokyo, Fac Elect Engn, Tokyo 1138654, Japan	Yasui, T (reprint author), Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan.	tayasui@opt.isl.melco.co.jp; nakano@ee.t.u-tokyo.ac.jp					Alexander S. B., 1997, SPIE TUTORIAL TEXTS, VTT22; Chang GK, 1996, J LIGHTWAVE TECHNOL, V14, P1320; HIMENO A, 1996, P ECOC 96 OSL NORW S, V4, P149; ISHIO H, 1992, OPTICAL AMPLIFIER IT; Johansson S, 1996, J LIGHTWAVE TECHNOL, V14, P1341, DOI 10.1109/50.511665; KIKUCHI K, 1993, FIBER INTEGRATED OPT, V12, P369, DOI 10.1080/01468039308204237; KIKUCHI K, 1997, FDN OPTICAL FIBER CO; KOGA M, 1996, IEEE J LIGHTWAVE TEC, V14, P1106; MOTOSHIMA K, 1997, IEICE T COMMUN B, V80; Smith DA, 1996, J LIGHTWAVE TECHNOL, V14, P1005, DOI 10.1109/50.511601; SOULAGE G, 1996, P ECOC 96; TESHIMA M, 1997, P IOOC ECOC 97 ED UK, V3, P59; YAMASHITA S, 1990, OCS9020 IEICE; YASUI T, 1994, IEICE T COMMUN, VE77B, P174	14	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	FEB	1999	E82C	2					254	264				11	Engineering, Electrical & Electronic	Engineering	171CM	WOS:000078844900013		
J	Vilen, BJ; Nakamura, T; Cambier, JC				Vilen, BJ; Nakamura, T; Cambier, JC			Antigen-stimulated dissociation of BCR mig from Ig-alpha/Ig-beta: Implications for receptor desensitization	IMMUNITY			English	Article							LYMPHOCYTE CYTOSKELETAL MATRIX; TYROSINE KINASE ACTIVATION; LIGAND-INDUCED ASSOCIATION; REACTIVE B-CELLS; MOLECULAR MECHANISMS; MEMBRANE-PROTEINS; TCR-CD3 COMPLEX; SELF-TOLERANCE; T-CELLS; IMMUNOGLOBULIN	B cell antigen receptor (BCR) ligation leads to receptor desensitization wherein BCR remain competent to bind antigen and yet fail to transduce signals. Desensitized BCR exhibit a defect at the most proximal level of signal transduction, consistent with failed transmission of signals through the receptor complex. We report that antigen stimulation leads to dissociation or destabilization of the BCR reflected by inability to coimmunoprecipitate Ig-alpha/Ig-beta with mIg. This destabilization is temporally correlated with desensitization and occurs in BCR containing mIgM and mIgD. Induction of BCR destabilization requires tyrosine kinase activation but is not induced by phosphatase inhibitors. BCR destabilization occurs at the cell surface and "dissociated" Ig-alpha/Ig-beta complexes remain responsive to anti-Ig-beta stimulation, suggesting that mIg-transducer uncoupling may mediate receptor desensitization.	Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA; Univ Tokyo, Inst Med Sci, Dept Infect Dis & Appl Immunol, Minato Ku, Tokyo 108, Japan	Cambier, JC (reprint author), Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80206 USA.						ALBRECHT DL, 1988, J IMMUNOL, V141, P3915; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; HO WY, 1994, J EXP MED, V179, P1539, DOI 10.1084/jem.179.5.1539; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; BRAUN J, 1982, J IMMUNOL, V128, P1198; ONO S, 1995, IMMUNITY, V2, P639, DOI 10.1016/1074-7613(95)90008-X; Hertz M, 1997, IMMUNITY, V6, P429, DOI 10.1016/S1074-7613(00)80286-1; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; RETH M, 1987, EMBO J, V6, P3299; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; JOHNSON SA, 1995, J IMMUNOL, V155, P4596; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; Lang J, 1996, J EXP MED, V184, P1685, DOI 10.1084/jem.184.5.1685; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; KIM KJ, 1979, J IMMUNOL, V122, P549; Rathmell JC, 1996, CELL, V87, P319, DOI 10.1016/S0092-8674(00)81349-5; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; Koyama M, 1997, INT IMMUNOL, V9, P1767, DOI 10.1093/intimm/9.11.1767; BRUNSWICK M, 1994, CELL IMMUNOL, V156, P240, DOI 10.1006/cimm.1994.1168; CAMBIER JC, 1990, J IMMUNOL, V145, P13; CAMBIER J, 1988, P NATL ACAD SCI USA, V85, P6493, DOI 10.1073/pnas.85.17.6493; Campbell K S, 1994, Semin Immunol, V6, P393, DOI 10.1006/smim.1994.1049; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Jugloff LS, 1997, J IMMUNOL, V159, P1096; KIM KM, 1993, IMMUNOL REV, V132, P125, DOI 10.1111/j.1600-065X.1993.tb00840.x; KISHIMOTO H, 1995, J EXP MED, V182, P1997, DOI 10.1084/jem.182.6.1997; PAO L, 1997, LYMPHOCYTE SIGNALLIN, P3; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; SPARKS AB, 1995, METHOD ENZYMOL, V255, P498; Vilen BJ, 1997, J IMMUNOL, V159, P231; WODA BA, 1983, J IMMUNOL, V131, P1917; WODA BA, 1984, J IMMUNOL, V133, P2767	40	71	71	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	1999	10	2					239	248		10.1016/S1074-7613(00)80024-2		10	Immunology	Immunology	173GF	WOS:000078972200011		
J	Flajnik, MF; Ohta, Y; Namikawa-Yamada, C; Nonaka, M				Flajnik, MF; Ohta, Y; Namikawa-Yamada, C; Nonaka, M			Insight into the primordial MHC from studies in ectothermic vertebrates	IMMUNOLOGICAL REVIEWS			English	Review							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I GENES; AMPHIBIAN XENOPUS; CARTILAGINOUS FISH; LINKAGE ANALYSIS; EVOLUTIONARY ORIGIN; MOLECULAR-CLONING; COMPLEMENTARY-DNA; IMMUNE-RESPONSE; TOAD XENOPUS	MHC classical class I and class II genes have been identified in representative species from all major jawed vertebrate taxa, the oldest group being the cartilaginous fish, whereas no class I/II genes of any type have been detected in animals from older taxa. Among ectothermic vertebrate classes, studies of MHC architecture have been done in cartilaginous fish (sharks), bony fish (several teleost species), and amphibians (the frog Xenopus). The Xenopus MHC contains class I, class II, and class III genes, demonstrating that all of these genes were linked in the ancestor of the tetrapods, but the gene order is not the same as that in mouse/man. Studies of polyploid Xenopus suggest that MHC genes can be differentially silenced when multiple copies are present; i.e. MHC 'subregions' can be silenced. Surprisingly, in all teleosts examined to date class I and class II genes are not linked. Likewise, class III genes like the complement genes factor B (Bf) and C4 are scattered throughout the genome of teleosts. However, the presumed classical class I genes are closely linked to the 'immune' proteasome genes, LMP2 and LMP7, and to the peptide-transporter genes (TAP), implying that a true 'class I region' exists in this group. A similar type of linkage group is found in chickens and perhaps Xenopus, and thus it may reveal the ancestral organization of class I-associated genes. In cartilaginous fish, classical and non-classical class I genes have been isolated from three shark species, and class II A and B chain genes from nurse sharks. Studies of MHC Linkage in sharks are being carried out to provide further understanding of the putative primordial organization of MHC. Segregation studies in one shark family point to linkage of classical class I and class II genes, suggesting that the non-linkage of these genes in teleosts is a derived characteristic.	Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Nagoya City Univ, Sch Med, Dept Biochem, Nagoya, Aichi 467, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	Flajnik, MF (reprint author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 655 W Baltimore St,Room 3-056, Baltimore, MD 21201 USA.		NONAKA, MASARU/G-4929-2014				Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; FLAJNIK MF, 1993, EMBO J, V12, P4385; Seeger A, 1996, MOL IMMUNOL, V33, P511, DOI 10.1016/0161-5890(96)00002-8; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Flajnik MF, 1996, VET IMMUNOL IMMUNOP, V54, P145, DOI 10.1016/S0165-2427(96)05685-1; SATO K, 1993, J IMMUNOL, V150, P2831; SHUM BP, 1993, J IMMUNOL, V151, P5376; WILSON MR, 1990, NUCLEIC ACIDS RES, V18, P5227, DOI 10.1093/nar/18.17.5227; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Kasahara M, 1999, IMMUNOL REV, V167, P17, DOI 10.1111/j.1600-065X.1999.tb01379.x; HASHIMOTO K, 1990, P NATL ACAD SCI USA, V87, P6863, DOI 10.1073/pnas.87.17.6863; Tanaka K, 1998, IMMUNOL REV, V163, P161; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; SMITH LC, 1992, IMMUNOL TODAY, V13, P356, DOI 10.1016/0167-5699(92)90172-4; Kaattari S, 1998, IMMUNOL REV, V166, P133, DOI 10.1111/j.1600-065X.1998.tb01258.x; Bartl S, 1998, IMMUNOL REV, V166, P317, DOI 10.1111/j.1600-065X.1998.tb01272.x; BARTL S, 1994, P NATL ACAD SCI USA, V91, P262, DOI 10.1073/pnas.91.1.262; Bartl S, 1997, J IMMUNOL, V159, P6097; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; CAMPBELL RD, 1997, IMMUNOL TODAY, V18, P43; Chretien I, 1998, EUR J IMMUNOL, V28, P4094; DEY A, 1992, MOL CELL BIOL, V12, P3590; DUPASQUIER L, 1975, IMMUNOGENETICS, V1, P482; DUPASQUIER L, 1977, IMMUNOGENETICS, V5, P129; DUPASQUIER L, 1982, IMMUNOGENETICS, V15, P251; Elliott T, 1997, ADV IMMUNOL, V65, P47, DOI 10.1016/S0065-2776(08)60741-5; FLAJNIK MF, 1984, IMMUNOGENETICS, V20, P433, DOI 10.1007/BF00345617; FLAJNIK MF, 1991, P NATL ACAD SCI USA, V88, P537, DOI 10.1073/pnas.88.2.537; Gongora R, 1998, IMMUNOGENETICS, V48, P141, DOI 10.1007/s002510050414; Graser R, 1998, IMMUNOGENETICS, V47, P318, DOI 10.1007/s002510050364; Joly E, 1998, CURR BIOL, V8, P169, DOI 10.1016/S0960-9822(98)70065-X; KAASTRUP P, 1989, IMMUNOGENETICS, V30, P284, DOI 10.1007/BF02421332; Kandil E, 1996, J IMMUNOL, V156, P4245; KASAHARA M, 1992, P NATL ACAD SCI USA, V89, P6688, DOI 10.1073/pnas.89.15.6688; Kasahara M, 1996, P NATL ACAD SCI USA, V93, P9096, DOI 10.1073/pnas.93.17.9096; KASAHARA M, 1993, EUR J IMMUNOL, V23, P2160, DOI 10.1002/eji.1830230917; Kasahara M, 1995, Transpl Immunol, V3, P1, DOI 10.1016/0966-3274(95)80001-8; KATO Y, 1994, J IMMUNOL, V153, P4546; KATO Y, 1995, IMMUNOGENETICS, V42, P196; Kaufman J, 1996, CURR TOP MICROBIOL, V212, P129; KAUFMAN JF, 1985, J IMMUNOL, V134, P3258; KAUFMAN JF, 1985, J IMMUNOL, V134, P3248; Klein J, 1998, SCAND J IMMUNOL, V47, P199; KOBARI F, 1995, IMMUNOGENETICS, V42, P376; Kuroda N, 1996, IMMUNOGENETICS, V44, P459, DOI 10.1007/s002510050153; MARCHALONIS JJ, 1990, SCAND J IMMUNOL, V32, P13, DOI 10.1111/j.1365-3083.1990.tb02886.x; McConnell TJ, 1998, GENETICS, V149, P1921; McConnell TJ, 1998, IMMUNOL REV, V166, P294, DOI 10.1111/j.1600-065X.1998.tb01270.x; Miller KM, 1998, IMMUNOL REV, V166, P279, DOI 10.1111/j.1600-065X.1998.tb01269.x; Mo RR, 1996, IMMUNOGENETICS, V43, P360, DOI 10.1007/BF02199804; MOLLER G, 1990, IMMUNOL REV, V113, P1; NAKAMURA T, 1986, IMMUNOGENETICS, V23, P181, DOI 10.1007/BF00373819; NAMIKAWA C, 1995, J IMMUNOL, V155, P1964; NamikawaYamada C, 1997, IMMUNOGENETICS, V46, P431, DOI 10.1007/s002510050298; Nelson JS, 1994, FISHES WORLD; Nonaka M, 1997, P NATL ACAD SCI USA, V94, P5789, DOI 10.1073/pnas.94.11.5789; Nonaka M, 1997, J IMMUNOL, V159, P734; Nonaka M, 1998, IMMUNOL REV, V166, P59, DOI 10.1111/j.1600-065X.1998.tb01252.x; Ohno S., 1970, EVOLUTION GENE DUPLI; OHTA Y, IN PRESS IMMUNOGENET; Okamura K, 1997, IMMUNITY, V7, P777, DOI 10.1016/S1074-7613(00)80396-9; PILSTROM I, 1998, IMMUNOL REV, V166, P123; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; Rast JP, 1997, IMMUNITY, V6, P1, DOI 10.1016/S1074-7613(00)80237-X; Rodrigues PNS, 1998, DEV COMP IMMUNOL, V22, P493, DOI 10.1016/S0145-305X(97)00059-1; Salter-Cid L, 1998, J IMMUNOL, V160, P2853; SALTERCID L, 1994, IMMUNOGENETICS, V39, P1; SalterCid L, 1996, IMMUNOGENETICS, V44, P397, DOI 10.1007/s002510050143; Smith SL, 1998, IMMUNOL REV, V166, P67, DOI 10.1111/j.1600-065X.1998.tb01253.x; Stet R. J. M., 1997, Hereditas (Lund), V127, P169; Stet RJM, 1998, IMMUNOL REV, V166, P301, DOI 10.1111/j.1600-065X.1998.tb01271.x; Takami K, 1997, J IMMUNOL, V159, P6052; Thorpe KL, 1996, IMMUNOGENETICS, V44, P391, DOI 10.1007/s002510050142; Trachtulec Z, 1997, GENOMICS, V44, P1, DOI 10.1006/geno.1997.4839; WADA H, 1995, MOL MAR BIOL BIOTECH, V4, P269; WIEGERTJES GF, 1997, DEV COMP IMMUNOL, V21, P105, DOI 10.1016/S0145-305X(97)88544-8	77	65	65	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0105-2896			IMMUNOL REV	Immunol. Rev.	FEB	1999	167						59	67		10.1111/j.1600-065X.1999.tb01382.x		9	Immunology	Immunology	188MP	WOS:000079851100005		
J	Takahashi, Y; Ametani, A; Totsuka, M; Kaminogawa, S				Takahashi, Y; Ametani, A; Totsuka, M; Kaminogawa, S			Autocrine B-cell stimulation by interleukin-2 during a cognate interaction with T-cells	IMMUNOLOGY LETTERS			English	Article						interleukin-2; autocrine; cognate interaction	CROSS-LINKING; GROWTH-FACTOR; CD40; LINES; ACTIVATION; SECRETION; RECEPTORS; LYMPHOMA; ANTIGEN; LIGAND	Interleukin-2 (IL-2) secretion as well as expression of IL-2 receptor has been demonstrated for B-cells in response to several activating stimuli. However, the exact role of B-cell-derived IL-2 in the T-cell-dependent antibody response remains to be determined. Here, we have examined the autocrine regulatory roles of IL-2 secreted from B-cells. Splenic resting B-cells were stimulated with a fixed pre-activated Th1 clone, G1.19, in the presence of a single amino acid-substituted peptide (pD129A; Ala-129 substituted for Asp-129), an analog of the original ligand (p119-133, derived from bovine beta-lactoglobulin) recognized by G1.19 cells. pD129A allowed a cognate interaction between B-cells and fixed pre-activated G1.19 T-cells, but pD129A had no agonistic activity against G1.19 T-cells. Thus, the level of expression of B-cell-activating molecules on T-cells remained unchanged after stimulation with pD129A. Regardless of the lack of ability to induce IL-2 secretion in the case of T-cells, pD129A significantly enhanced antibody secretion from B-cells, and this was partially blocked by anti-IL-2 antibody. Furthermore, IL-2 secretion from B-cells was modestly upregulated in response to added pD129A. Taken together, these data suggest that helper signals from interacting cognate T-cells induce IL-2 secretion by B-cells, which can enhance antibody secretion in an autocrine manner. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Kaminogawa, S (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Beatty PR, 1997, J IMMUNOL, V158, P4045; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; JUSTEMENT LB, 1989, J IMMUNOL, V143, P881; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; BARUT B, 1993, J CLIN INVEST, V92, P2346, DOI 10.1172/JCI116839; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; GRABSTEIN KH, 1993, J IMMUNOL, V150, P3141; KINDLER V, 1995, EUR J IMMUNOL, V25, P1239, DOI 10.1002/eji.1830250516; LEVY Y, 1991, J CLIN INVEST, V88, P696, DOI 10.1172/JCI115355; MAINO VC, 1985, J IMMUNOL, V134, P2419; NONOYAMA S, 1993, J EXP MED, V178, P1097, DOI 10.1084/jem.178.3.1097; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331; POUDRIER J, 1994, J EXP MED, V179, P1417, DOI 10.1084/jem.179.5.1417; ROTH M, 1995, P NATL ACAD SCI USA, V92, P1312, DOI 10.1073/pnas.92.5.1312; TAIRA S, 1987, J IMMUNOL, V139, P2957; Takahashi Y, 1998, IMMUNOL LETT, V61, P97, DOI 10.1016/S0165-2478(98)00002-9; Totsuka M, 1997, CYTOTECHNOLOGY, V25, P115, DOI 10.1023/A:1007934832359; WADE WF, 1993, IMMUNOL TODAY, V14, P539, DOI 10.1016/0167-5699(93)90184-M; WALKER E, 1988, J IMMUNOL, V140, P859	20	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-2478			IMMUNOL LETT	Immunol. Lett.	FEB	1999	65	3					183	188		10.1016/S0165-2478(98)00108-4		6	Immunology	Immunology	168FN	WOS:000078681200006		
J	Kaminuma, O; Mori, A; Ogawa, K; Nakata, A; Kikkawa, H; Ikezawa, K; Okudaira, H				Kaminuma, O; Mori, A; Ogawa, K; Nakata, A; Kikkawa, H; Ikezawa, K; Okudaira, H			Cloned Th cells confer eosinophilic inflammation and bronchial hyperresponsiveness	INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY			English	Article; Proceedings Paper	22nd Symposium of the Collegium-Internationale-Allergologicum - From Molecular Science to the Treatment of Allergy	SEP 12-16, 1998	CORFU, GREECE	Collegium Int Allergologicum		T cell; interleukin 5; asthma; eosinophilic inflammation	BRONCHOALVEOLAR LAVAGE; CYCLOSPORINE-A; AIRWAY HYPERRESPONSIVENESS; ASTHMA; ACTIVATION	Background: The essential role of Th cells and T cell cytokines in eosinophilic inflammation has been established. Methods: To determine whether Th cells are sufficient for the development of airway eosinophilic inflammation, ovalbumin-reactive murine Th clones were established and infused into unprimed mice. Results: Eosinophilic infiltration into the lung was induced upon antigen inhalation in parallel with the rise in bronchoalveolar lavage fluid (BALF) eosinophil peroxidase activity. Neither IgG, IgA, nor IgE antibodies were present in this model. Pathological examination showed swelling and desquamation of epithelial cells, mucous plugs, and goblet cell hyperplasia, all of which well resemble human asthma. Fluorescent probe labeled Th clones migrated into the lung prior to the eosinophil accumulation. Bronchial hyperresponsiveness (BHR) was clearly induced upon antigen inhalation. Anti-IL-5 monoclonal antibody abrogated the responses. Dexamethasone and cyclosporin A suppressed cytokine production by Th cells both in vitro and in vivo, BALF eosinophilia, and BHR. The number of eosinophils recovered in the BALF correlated with the intensity of BHR. Conclusion: The results clearly indicated that monoclonal Th cells are sufficient for the development of both airway eosinophilia and BHR. Agents capable of downregulating IL-5 production seem promising for the treatment of bronchial asthma.	Tanabe Seiyaku Co Ltd, Discovery Res Lab, Toda, Saitama 335, Japan; Univ Tokyo, Fac Med, Dept Med & Phys Therapy, Tokyo 113, Japan; Natl Sagamihara Hosp, Res Ctr Allergy & Rheumatol, Kanagawa, Japan	Kaminuma, O (reprint author), Tanabe Seiyaku Co Ltd, Discovery Res Lab, 2-2-50 Kawagishi, Toda, Saitama 335, Japan.						ROBINSON D, 1993, J ALLERGY CLIN IMMUN, V92, P313, DOI 10.1016/0091-6749(93)90175-F; FUKUDA T, 1995, ANN ALLERG ASTHMA IM, V75, P65; WALKER C, 1992, AM REV RESPIR DIS, V146, P109; BurkeGaffney A, 1996, AM J PHYSIOL-CELL PH, V270, pC552; DAERON M, 1982, J IMMUNOL, V129, P1212; Druilhe A, 1996, BLOOD, V87, P2822; KRISHNASWAMY G, 1993, AM J RESP CELL MOL, V9, P279; MARONE G, 1992, INT ARCH ALLERGY IMM, V99, P279; MORI A, 1997, J ALLERGY CLIN IMM S, V100, P56; MORI A, 1995, INT IMMUNOL, V7, P449, DOI 10.1093/intimm/7.3.449; NAGAI H, 1995, INT ARCH ALLERGY IMM, V108, P189; NAKAJIMA H, 1992, AM REV RESPIR DIS, V146, P374	12	10	11	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1018-2438			INT ARCH ALLERGY IMM	Int. Arch. Allergy Immunol.	FEB-APR	1999	118	2-4					136	139		10.1159/000024050		4	Allergy; Immunology	Allergy; Immunology	193LE	WOS:000080137100015		
J	Mori, A; Kaminuma, O; Ogawa, K; Kobayashi, N; Akiyama, K; Okudaira, H				Mori, A; Kaminuma, O; Ogawa, K; Kobayashi, N; Akiyama, K; Okudaira, H			Regulatory mechanisms of human T cell IL-5 synthesis: Differential roles of the proximal promoter-binding proteins in IL-5 gene transcription	INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY			English	Article; Proceedings Paper	22nd Symposium of the Collegium-Internationale-Allergologicum - From Molecular Science to the Treatment of Allergy	SEP 12-16, 1998	CORFU, GREECE	Collegium Int Allergologicum		IL-5; gene transcription; promoter; T cell; NF-AT	CYCLOSPORINE-A; INTERLEUKIN-5; ASTHMA; FK506; EOSINOPHILS; CLONES	Background: IL-5 is crucially involved in eosinophilic inflammation. We have previously reported that IL-5 syn thesis by atopic and nonatopic asthmatics is significantly enhanced compared to control subjects. T cell IL-5 synthesis is regulated at the transcriptional level. The proximal human IL-5 promoter (-62 to -46) homologous to the conserved lymphokine element 0 (CLE0) is essential for activation-induced gene transcription by Th cells, Methods: Luciferase reporter analysis and gel shift analysis were performed. Results: The CLE0 homologous element is the overlapping binding site for a constitutive and an inducible binding factor. Site-directed mutagenesis successfully differentiated the two bindings, and revealed that the transcriptional induction was ascribed to the inducible binding, while the constitutive binding was rather inhibitory. A mutant element which lost the constitutive binding, but retained the inducible binding, exerted 3 times more transcriptional activity compared to the wild-type element. In contrast, another mutant element which lost the inducible binding and retained the constitutive binding exhibited no transcriptional induction. Gel shift analysis was performed to clarify that the inducible binding was more prominent and the constitutive binding was less in IL-5 producing Th clones compared to IL-5-nonproducing clones. Conclusion: The ratio of the inducible/constitutive binding to the CLE0 homologous element may determine the capacity of human Th cells to transcribe the IL-5 gene.	Natl Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa 228, Japan; Tanabe Seiyaku Co Ltd, Discovery Res Lab, Toda, Saitama, Japan; Tokyo Tech Coll, Dept Biotechnol, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Med & Phys Therapy, Tokyo, Japan	Mori, A (reprint author), Natl Sagamihara Hosp, Clin Res Ctr Allergy & Rheumatol, 18-1 Sakuradai, Sagamihara, Kanagawa 228, Japan.						CORRIGAN CJ, 1992, IMMUNOL TODAY, V13, P501, DOI 10.1016/0167-5699(92)90026-4; ARAI K, 1990, ANNU REV BIOCHEM, V59, P783, DOI 10.1146/annurev.biochem.59.1.783; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; KAY AB, 1992, AM REV RESPIR DIS, V145, pS22; Mori A, 1996, INT IMMUNOL, V8, P1889, DOI 10.1093/intimm/8.12.1889; Mori A, 1997, J IMMUNOL, V158, P3659; Mori A, 1997, INT ARCH ALLERGY IMM, V113, P272; MORI A, 1995, INT ARCH ALLERGY IMM, V107, P366; Mori A, 1997, J ALLERGY CLIN IMMUN, V100, pS56, DOI 10.1016/S0091-6749(97)70006-X; MORI A, IN PRESS J ALLERGY C; MORI A, 1995, J IMMUNOL, V156, P2391; MORI A, 1995, INT IMMUNOL, V7, P449, DOI 10.1093/intimm/7.3.449; MORI A, 1994, INT ARCH ALLERGY IMM, V104, P32; SANDERSON CJ, 1988, IMMUNOL REV, V102, P29, DOI 10.1111/j.1600-065X.1988.tb00740.x; Schwenger GTF, 1998, LEUKEMIA LYMPHOMA, V28, P443; YAMAGATA T, 1995, MOL CELL BIOL, V15, P3830	16	3	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1018-2438			INT ARCH ALLERGY IMM	Int. Arch. Allergy Immunol.	FEB-APR	1999	118	2-4					271	274		10.1159/000024097		4	Allergy; Immunology	Allergy; Immunology	193LE	WOS:000080137100062		
J	Mukasa, R; Homma, T; Ohtsuki, T; Hosono, O; Souta, A; Kitamura, T; Fukuda, M; Watanabe, S; Morimoto, C				Mukasa, R; Homma, T; Ohtsuki, T; Hosono, O; Souta, A; Kitamura, T; Fukuda, M; Watanabe, S; Morimoto, C			Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells	INTERNATIONAL IMMUNOLOGY			English	Article						CD4; CD43; cell surface molecules; core 2 beta-1,6-N-acetylglucosaminyltransferase; O-glycan; selectin ligand	SELECTIN GLYCOPROTEIN LIGAND-1; CUTANEOUS LYMPHOCYTE ANTIGEN; WISKOTT-ALDRICH SYNDROME; MONOCLONAL-ANTIBODY; P-SELECTIN; LINKED OLIGOSACCHARIDES; IMMUNOREGULATORY FUNCTIONS; MAJOR SIALOGLYCOPROTEIN; DIFFERENTIAL EXPRESSION; ADHESION MOLECULES	Human CD4 T cells can be divided into two functionally distinct subsets: a CD45RO(+) memory subset and a CD45RA(+) naive subset. In an attempt to identify novel cell surface molecules on these cells, we have developed a mAb, anti-1D4, The antigen defined by anti-1D4 was preferentially expressed on the memory subset of freshly isolated peripheral Ca4 T cells and 1D4(+) CD4 T cells functionally corresponded to memory T cells. Retrovirus-mediated expression cloning revealed that the 1D4 antigen is human CD43, Transfection of CHO-leu cells, which stably express human CD43, with core 2 beta-1,6-N-acetylslucosaminyltransferase (C2GnT) conferred expression of the 1D4 antigen and mRNA of C2GnT was detected by RT-PCR only In 1D4(+) T cells but not in 1D4(-) T cells, implying that the 1D4 antigen is composed of core 2-containing O-glycans on CD43. Reactivity with anti-1D4 was completely abolished when cells were treated with neuraminidase, while there remained weak binding of anti-T305, a previously described mAb which also reacts with CD43 modified with core 2-containing O-glycans, Moreover, anti-1D4 markedly reacted with NIH-3T3 cells expressing human CD43 and low levels of endogenous C2GnT; whereas anti-T305 reacted slightly. These results indicate that the 1D4 antigen is distinct from the epitope defined by anti-T305 and anti-1D4 is a more sensitive probe to detect core 2-containing O-glycans than anti-T305, Taken together, our results indicate that core 2-containing O-glycans, whose expression can easily be detected with anti-1D4, are preferentially expressed in the CD45RO(+) memory subset of CD4 T cells.	Univ Tokyo, Dept Clin Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, AIDS Res Ctr, Inst Med Sci,Dept Hematopoiet Growth Factors, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, AIDS Res Ctr, Inst Med Sci,Dept Mol & Dev Biol, Minato Ku, Tokyo 1088639, Japan; Burnham Inst, La Jolla Canc Res Ctr, Glycobiol Program, La Jolla, CA 92037 USA	Morimoto, C (reprint author), Univ Tokyo, Dept Clin Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						ALON R, 1994, J CELL BIOL, V127, P1485, DOI 10.1083/jcb.127.5.1485; ANDERSSON LC, 1978, BLOOD, V52, P57; PICKER LJ, 1990, AM J PATHOL, V136, P1053; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Snapp KR, 1998, BLOOD, V91, P154; Fox DA, 1997, ARTHRITIS RHEUM, V40, P598, DOI 10.1002/art.1780400403; MAEMURA K, 1992, J BIOL CHEM, V267, P24379; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Onishi M, 1996, EXP HEMATOL, V24, P324; THOMAS ML, 1988, IMMUNOL TODAY, V9, P320, DOI 10.1016/0167-5699(88)91326-6; Fuhlbrigge RC, 1997, NATURE, V389, P978; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; REINHERZ EL, 1980, P NATL ACAD SCI-BIOL, V77, P1588, DOI 10.1073/pnas.77.3.1588; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; MORIMOTO C, 1988, AM J MED, V84, P817, DOI 10.1016/0002-9343(88)90058-7; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; VACHINO G, 1995, J BIOL CHEM, V270, P21966; Deng HK, 1997, NATURE, V388, P296; Skrincosky D, 1997, J BIOL CHEM, V272, P22695, DOI 10.1074/jbc.272.36.22695; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; BIERHUIZEN MFA, 1994, J BIOL CHEM, V269, P4473; BROWN WRA, 1981, NATURE, V289, P456, DOI 10.1038/289456a0; CARLSSON SR, 1986, J BIOL CHEM, V261, P2779; CARLSSON SR, 1986, J BIOL CHEM, V261, P2787; CUSH JJ, 1992, ARTHRITIS RHEUM, V35, P1434, DOI 10.1002/art.1780351206; DESMET W, 1993, IMMUNOLOGY, V79, P46; FOX RI, 1983, J IMMUNOL, V131, P762; FUKUDA M, 1986, J BIOL CHEM, V261, P2796; FUKUDA M, 1991, Glycobiology, V1, P347, DOI 10.1093/glycob/1.4.347; GRIFFIN JD, 1981, J CLIN INVEST, V68, P932, DOI 10.1172/JCI110348; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Kumar R, 1996, BLOOD, V88, P3872; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEDBETTER JA, 1985, J IMMUNOL, V135, P1819; Li FG, 1996, J BIOL CHEM, V271, P3255; MOORE K, 1987, IMMUNOLOGY, V61, P159; MORIMOTO C, 1989, J IMMUNOL, V143, P3430; MORIMOTO C, 1985, J IMMUNOL, V134, P1508; MORIMOTO C, 1985, J IMMUNOL, V134, P3762; NOJIMA Y, 1993, CELL IMMUNOL, V152, P249, DOI 10.1006/cimm.1993.1285; PILLER F, 1991, J EXP MED, V173, P1501, DOI 10.1084/jem.173.6.1501; PILLER F, 1988, J BIOL CHEM, V263, P15146; REMOLDODONNELL E, 1984, J EXP MED, V159, P1705, DOI 10.1084/jem.159.6.1705; RUDD CE, 1987, J EXP MED, V166, P1758, DOI 10.1084/jem.166.6.1758; SAITOH O, 1991, BLOOD, V77, P1491; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SAWADA R, 1994, J BIOL CHEM, V269, P1425; SMITH SH, 1986, IMMUNOLOGY, V58, P63; STROSS WP, 1989, J CLIN PATHOL, V42, P953, DOI 10.1136/jcp.42.9.953; SUGITA K, 1992, J IMMUNOL, V149, P3208; TAKAHASHI H, 1992, EUR J IMMUNOL, V22, P2879, DOI 10.1002/eji.1830221119; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.iy.07.040189.002011; TODD RF, 1984, HUM IMMUNOL, V10, P23, DOI 10.1016/0198-8859(84)90083-1; TORIMOTO Y, 1992, J IMMUNOL, V148, P388; TORIMOTO Y, 1991, J IMMUNOL, V146, P2176	55	23	23	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178			INT IMMUNOL	Int. Immunol.	FEB	1999	11	2					259	268		10.1093/intimm/11.2.259		10	Immunology	Immunology	169FD	WOS:000078736100015		
J	Yoshida, Y; Bowler, JR				Yoshida, Y; Bowler, JR			Computation of eddy current probe response due to a long crack based on a vector potential integral formulation	INTERNATIONAL JOURNAL OF APPLIED ELECTROMAGNETICS AND MECHANICS			English	Article							IDEAL CRACK; INVERSION	A volume integral formulation utilizing the vector potential dyadic Green's function is applied to the computation of eddy current probe response due to a long crack. In addition to the ideal crack model, a thin crack model is proposed which takes into account the effect of crack opening on the measurement signal. To deal with the infinitely long crack, the spatial Fourier transform is applied to the boundary integral equation based on the vector potential integral formulation and then the method of moments is used to discretize the resultant equation. The proposed method is validated through the comparison of the computed results with measurements.	Univ Tokyo, Nucl Engn Res Lab, Naka, Ibaraki 31911, Japan; Univ Surrey, Dept Phys, Guildford GU2 5XH, Surrey, England			Bowler, John/J-8955-2012				Takagi T., 1994, International Journal of Applied Electromagnetics in Materials, V5; BOWLER JR, 1994, J APPL PHYS, V75, P8138, DOI 10.1063/1.356512; BOWLER JR, 1994, J APPL PHYS, V75, P8128, DOI 10.1063/1.356511; Bowler JR, 1997, IEEE T MAGN, V33, P4287, DOI 10.1109/20.620437; BOWLER JR, 1991, J APPL PHYS, V70, P1107, DOI 10.1063/1.349615; BURKE SK, 1994, J APPL PHYS, V76, P3072, DOI 10.1063/1.358454; DODD CV, 1968, J APPL PHYS, V39, P2829, DOI 10.1063/1.1656680; Harfield N, 1996, J APPL PHYS, V80, P4090, DOI 10.1063/1.363280; McKirdy D. McA., 1989, Journal of Nondestructive Evaluation, V8, DOI 10.1007/BF00566587; NOBLE B, 1958, METHODS BASED WIENER, P31; PAVO J, 1994, IEEE T MAGN, V30, P3407, DOI 10.1109/20.312670; Press W. H., 1992, NUMERICAL RECIPES FO; SABBAGH HA, 1986, IEEE T MAGN, V22, P282, DOI 10.1109/TMAG.1986.1064305	13	4	4	IOS PRESS	AMSTERDAM	VAN DIEMENSTRAAT 94, 1013 CN AMSTERDAM, NETHERLANDS	1383-5416			INT J APPL ELECTROM	Int. J. Appl. Electromagn. Mech.	FEB	1999	10	1					77	89				13	Engineering, Electrical & Electronic; Mechanics; Physics, Applied	Engineering; Mechanics; Physics	154TW	WOS:000077906000006		
J	Ohata, J; Matsuoka, M; Yamashita, T; Tojo, A; Tani, K; Asano, S				Ohata, J; Matsuoka, M; Yamashita, T; Tojo, A; Tani, K; Asano, S			CD4/CD8 double-positive adult T cell leukemia with preceding cytomegaloviral gastroenterocolitis	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						adult T cell leukemia; CD4/CD8 double-positive cells; cytomegalovirus gastroenterocolitis	GASTROINTESTINAL-TRACT; INFECTION; AIDS	We present a rare case of adult T cell leukemia (ATL) in which leukemic T cells simultaneously expressed CD4 and CD8 surface antigens and refractory cytomegalovirus (CMV)-induced gastroenterocolitis preceded its clinical onset. A 40-year-old male was admitted to our hospital with abdominal pain and bloody stool. Biopsy specimens of the gastric and rectal mucosa indicated CMV-induced gastroenterocolitis. The patient also proved to be seropositive for human T lymphotropic virus type I (HTLV-I). While being administered gancyclovir for CMV infection, he presented hepatomegaly and systemic lymphadenopathy. Monoclonal expansion of lymphoid cells integrated with HTLV-I genome was observed. He underwent a LSG15 regimen and hepatomegaly and lymphadenopathy improved markedly. Gastroenterocolitis also improved, but the symptoms did not disappear completely. CMV-induced diseases are prevalent among immunosuppressed patients. Although there was no evidence that this patient had ATL on admission, it is likely that he was severely immunodeficient. CMV can easily infect damaged mucosa. ATL cells often infiltrate gastrointestinal mucosa and may have triggered CMV gastroenterocolitis in this case. (C) 1999 The Japanese Society of Hematology.	Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Minato Ku, Tokyo 1088639, Japan	Ohata, J (reprint author), Univ Tokyo, Inst Med Sci, Dept Hematol & Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						KAMIHIRA S, 1992, LEUKEMIA RES, V16, P435, DOI 10.1016/0145-2126(92)90168-7; WINGARD JR, 1988, BLOOD, V71, P1432; SUZUSHIMA H, 1993, BLOOD, V81, P1032; BUCKNER FS, 1993, CLIN INFECT DIS, V17, P644; DIETERICH DT, 1993, J INFECT DIS, V167, P278; DIETERICH DT, 1991, J ACQ IMMUN DEF SYND, V4, pS29; MATTHEW EF, 1996, AM J GASTROENTEROL, V91, P168; NABESHIMA K, 1992, ACTA PATHOL JAPON, V42, P267; OTSUKA M, 1989, ACTA HAEMATOL JAPON, V52, P623; ROSEN P, 1973, ARCH INTERN MED, V132, P274, DOI 10.1001/archinte.132.2.274; VAKIL N, 1989, ENDOSCOPY, V21, P22, DOI 10.1055/s-2007-1012888; YAMADA Y, 1984, BLOOD, V64, P440	12	8	8	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903 USA	0925-5710			INT J HEMATOL	Int. J. Hematol.	FEB	1999	69	2					92	95				4	Hematology	Hematology	284RQ	WOS:000085346600006		
J	Kawamuro, K				Kawamuro, K			Central sequence subfactors and double commutant properties	INTERNATIONAL JOURNAL OF MATHEMATICS			English	Article							FINITE VONNEUMANN-ALGEBRAS; STAR-SUBALGEBRAS; INDEX	First, we construct the Jones tower and tunnel of the central sequence subfactor arising from a hyperfinite type II1 subfactor with finite-index and finite depth, and prove each algebra has the double commutant property in the ultraproduct of the enveloping II1 factor. Next, we show the equivalence between Popa's strong amenability and the double commutant property of the central sequence factor for subfactors as above without assuming the finite depth condition.	Univ Tokyo, Dept Math Sci, Tokyo 153, Japan	Kawamuro, K (reprint author), Univ Tokyo, Dept Math Sci, Tokyo 153, Japan.						PIMSNER M, 1986, ANN SCI ECOLE NORM S, V19, P57; JONES VFR, 1983, INVENT MATH, V72, P1, DOI 10.1007/BF01389127; BISCH D, 1994, PAC J MATH, V163, P201; LONGO R, 1995, REV MATH PHYS, V7, P567, DOI 10.1142/S0129055X95000232; POPA S, 1983, J OPERAT THEOR, V9, P253; HAAGERUP U, 1979, J FUNCT ANAL, V33, P339, DOI 10.1016/0022-1236(79)90072-7; KOSAKI H, 1986, J FUNCT ANAL, V66, P123, DOI 10.1016/0022-1236(86)90085-6; BAILLET M, 1988, COMPOS MATH, V66, P199; Evans D E, 1998, QUANTUM SYMMETRIES O; Goodman F., 1989, MSRI PUBLICATIONS, V14; JOLISSAINT P, 1991, MATH SCAND, V68, P221; JONES VFR, 1983, J OPERAT THEOR, V10, P61; LONGO R, 1989, COMMUN MATH PHYS, V126, P217, DOI 10.1007/BF02125124; Ocneanu A, 1991, U TOKYO SEMINARY NOT, V45; Ocneanu Adrian, 1988, LONDON MATH SOC LECT, V2, P119; POPA S, 1994, ACTA MATH-DJURSHOLM, V172, P163, DOI 10.1007/BF02392646; POPA S, 1981, INVENT MATH, V65, P269, DOI 10.1007/BF01389015; Popa S., 1995, CBMS REGIONAL C SERI, V86; POPA S, 1989, CR ACAD SCI I-MATH, V309, P771; Stratila S, 1981, MODULAR THEORY OPERA	20	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE	0129-167X			INT J MATH	Int. J. Math.	FEB	1999	10	1					53	77		10.1142/S0129167X99000033		25	Mathematics	Mathematics	173VU	WOS:000079001100002		
J	Gorenflo, R; Yamamoto, M				Gorenflo, R; Yamamoto, M			Operator theoretic treatment of linear Abel integral equations of first kind	JAPAN JOURNAL OF INDUSTRIAL AND APPLIED MATHEMATICS			English	Article						Abel integral equation; III-posedness; singular values; conditional stability; Tikhonov's regularization	SINGULAR-VALUES; TIKHONOV REGULARIZATION; ASYMPTOTICS	We consider a linear Abel integral operator A(alpha): L-2(0, 1) --> L-2(0, 1) defined by (A(alpha)y)(t) = 1/Gamma(alpha) integral(0)(t) (t - s)Kalpha-1(t, s)y(s)ds, 0 less than or equal to t less than or equal to 1, 0 < alpha less than or equal to 1. We construct a scale {X-beta}(beta is an element of R) of Hilbert spaces of functions in (0, 1) and relate it with a Hilbert scale of Sobolev spaces. Under suitable assumptions on K, we prove that \\A alpha u\\(L2)(0,1) gives an equivalent norm in X-alpha. On the basis of this equivalence, we find a lower and upper estimate for the singular values of A(alpha) and, furthermore a Holder estimate for \\u\\(L2(0,1)) by \\A(alpha)u\\(L2(0,1)) provided that \\u\\(Xq) with q > 0 is uniformly bounded. Finally we discuss convergence rates of regularized solutions obtained by a Tikhonov method.	Free Univ Berlin, Dept Math & Comp Sci, D-14195 Berlin, Germany; Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 153, Japan	Gorenflo, R (reprint author), Free Univ Berlin, Dept Math & Comp Sci, Arnimallee 2-6, D-14195 Berlin, Germany.						Abramowitz M., 1965, HDB MATH FUNCTIONS; Adams R.A, 1975, SOBOLEV SPACES; ANG DD, 1992, APPL ANAL, V45, P321, DOI 10.1080/00036819208840105; FUJIWARA D, 1967, P JPN ACAD, V43, P82; NATTERER F, 1984, APPL ANAL, V18, P29, DOI 10.1080/00036818408839508; Hille E, 1930, ANN MATH, V31, P479, DOI 10.2307/1968241; Baumeister J., 1987, STABLE SOLUTION INVE; Colton D, 1992, INVERSE ACOUSTIC ELE; DOSTANIC MR, 1993, J MATH ANAL APPL, V175, P380, DOI 10.1006/jmaa.1993.1177; FABER V, 1986, J MATH ANAL APPL, V120, P745, DOI 10.1016/0022-247X(86)90195-2; Fattorini H. O., 1983, CAUCHY PROBLEM; GORELENKOV NN, 1995, PHYS PLASMAS, V2, P1; GORENFLO R, FACTORIZATION METHOD; Gorenflo R., 1991, ABEL INTEGRAL EQUATI; GORENFLO R, 1995, P INT C AN MECH CONT, P162; Groetsch C. W., 1984, THEORY TIKHONOV REGU; HAI DD, 1987, P ROY SOC EDINB A, V107, P165; Henry D, 1981, LECT NOTES MATH, V840; Hofmann B., 1986, REGULARIZATION APPL; Kress R., 1989, LINEAR INTEGRAL EQUA; LEVITAN BM, 1975, INTRO SPECTRAL THEOR; Lions J. L., 1972, NONHOMOGENEOUS BOUND, V1; NATTERER F, 1986, MATH COMPUTERIZED TO; Samko S., 1993, FRACTIONAL INTEGRALS; Tanabe H., 1979, EQUATIONS EVOLUTION; TUAN VK, 1994, INVERSE PROBL, V10, P949, DOI 10.1088/0266-5611/10/4/013; TUAN VK, 1995, P INT WORKSH INV PRO, P174; Tuan VK, 1996, NUMER FUNC ANAL OPT, V17, P453, DOI 10.1080/01630569608816704; Yamamoto M, 1996, J MATH KYOTO U, V36, P825	29	12	13	KINOKUNIYA CO LTD	TOKYO	17-7 SHINJUKU 3-CHOME, SHINJUKU-KU, TOKYO, 163-8636, JAPAN	0916-7005			JPN J IND APPL MATH	Jpn. J. Ind. Appl. Math.	FEB	1999	16	1					137	161				25	Mathematics, Applied	Mathematics	283KC	WOS:000085273900008		
J	Yoon, JW; Miyayama, M				Yoon, JW; Miyayama, M			Electrical properties of a semiconducting layer formed on SrTiO3 single crystal by excimer laser irradiation	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF COMMUNICATIONS & REVIEW PAPERS			English	Article						excimer laser; strontium titanate; semiconducting properties; oxygen vacancy; XPS analysis	CONDUCTIVITY; TITANATE; BEHAVIOR; OXYGEN; XPS	Effects of excimer laser irradiation on electrical properties were investigated for insulating SrTiO3 single crystals, and the mechanism was discussed. A drastic drop of surface resistance from >10(13) Ohm/cm(2) to about 10(4) Ohm/cm(2) was observed after irradiation by KrF and XeCl laser light with fluences of about 100 and 200 mJ/cm(2), respectively. For laser irradiation with a fluence above these critical values, the surface resistance remained at almost the same, low values. Traces of local melting, in the form of microcracks, were recognized on the surfaces with low resistance. Thr low-resistance surface had n-type semiconductivity, and the resistivity, electron concentration and mobility were estimated to be 0.2 Ohm cm, 5.4 x 10(18) cm(-3), 5.3 cm(2) V-1 s(-1), respectively, by the Hall coefficient measurement assuming a semiconductive layer thickness of 0.3 mu m. On the basis of the result of X-ray photoelectron spectroscopic analysis, the drastic decrease in resistivity is attributed to the generation of oxygen vacancies.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Dept Appl Chem, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Yoon, JW (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						FIERRO JLG, 1987, APPL SURF SCI, V27, P453, DOI 10.1016/0169-4332(87)90154-1; KOONCE CS, 1967, PHYS REV, V163, P380, DOI 10.1103/PhysRev.163.380; ODEKIRK B, 1982, MATER RES BULL, V17, P199, DOI 10.1016/0025-5408(82)90146-5; BALACHANDRAN U, 1982, J ELECTROCHEM SOC, V129, P1021, DOI 10.1149/1.2124008; FREDERIKSE HPR, 1964, PHYS REV, V134, pA442, DOI 10.1103/PhysRev.134.A442; CARDONA M, 1965, PHYS REV, V140, pA651, DOI 10.1103/PhysRev.140.A651; COHEN MI, 1968, PHYS REV, V168, P929, DOI 10.1103/PhysRev.168.929; DijIckamp D., 1987, APPL PHYS LETT, V51, P619; DOLLE P, 1992, SURF SCI, V269, P687, DOI 10.1016/0039-6028(92)91333-7; DREYFUS RW, 1987, APPL PHYS LETT, V50, P1491, DOI 10.1063/1.97809; GANDY HW, 1959, PHYS REV, V113, P795, DOI 10.1103/PhysRev.113.795; GOTO K, 1995, J SOLID STATE CHEM, V119, P76, DOI 10.1016/0022-4596(95)80011-D; HUGHES AE, 1988, J ELECTRON SPECTROSC, V46, P31, DOI 10.1016/0368-2048(88)80003-3; IGARASHI K, 1989, J AM CERAM SOC, V72, P2367, DOI 10.1111/j.1151-2916.1989.tb06092.x; ISHIBASHI H, 1994, JPN J APPL PHYS, V33, P4791; LONOV AI, 1980, AKAD NAUK SSSR NEORG, V16, P1076; MAFFEI N, 1992, APPL PHYS LETT, V60, P718; MIZUSAKI J, 1989, J ELECTROCHEM SOC, V136, P2082, DOI 10.1149/1.2097187; PENA MA, 1987, J COLLOID INTERF SCI, V119, P100, DOI 10.1016/0021-9797(87)90248-7; PLADINO AE, 1965, J PHYS CHEM SOLIDS, V26, P391; ROY D, 1992, APPL PHYS LETT, V61, P2057, DOI 10.1063/1.108305; SCOOLEY F, 1965, PHYS REV LETT, V14, P305; SCOOLEY F, 1965, PHYS REV LETT, V12, P474; SHIMOYAMA J, 1986, THESIS U TOKYO TOKYO; SMIRL AL, 1986, J APPL PHYS, V60, P1169, DOI 10.1063/1.337362; STRUPP PG, 1992, J VAC SCI TECHNOL A, V10, P508, DOI 10.1116/1.578180; WEIMER WA, 1988, APPL PHYS LETT, V52, P2171, DOI 10.1063/1.99759; YAMAZOE N, 1981, CHEM LETT, P1767, DOI 10.1246/cl.1981.1767	28	11	11	JAPAN SOC APPLIED PHYSICS	TOKYO	KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.	FEB	1999	38	2A					894	898		10.1143/JJAP.38.894		5	Physics, Applied	Physics	182BC	WOS:000079477800059		
J	Okajima, K; Wen, CJ; Ihara, M; Sakata, I; Yamada, K				Okajima, K; Wen, CJ; Ihara, M; Sakata, I; Yamada, K			Optical and electrical properties of beta-FeSi2/Si, beta-FeSi2/InP heterojunction prepared by RF-sputtering deposition	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						RF-sputtering; beta-FeSi2; X-ray diffraction; optical absorption; open-circuit photovoltage; short-circuit photocurrent density; photoelectric yield	ION-BEAM SYNTHESIS; IRON DISILICIDE; THIN-FILMS	The composition dependence of the optical absorption and the photoelectric measurements of beta-FeSiX thin films prepared by RF-sputtering were studied, where X was in the range of 1.9-2.3. The absorption coefficient increased steeply at photon energies near 0.9 eV. The photovoltaic properties and the I-V characteristics of beta-FeSiX/n-Si heterojunctions were measured. The open-circuit photovoltage (V-OC) was about 40 mV, and independent of X and the substrate temperature. The photoelectric yields of a beta-FeSiX/n-Si heterojunctions were measured and the photoemission thresholds phi(1) and phi(2) were determined to be 0.64 and 0.96 eV for X = 2.1. It was suggested that a deep trap level existed on the interface and a large discontinuity of the conduction band (Delta E-c) was formed. The value of Delta E-c decreased from 0.35 eV to 0.30 eV as the value of X increased. In addition, the photovoltaic properties of beta-FeSi2/InP heterojunctions were investigated to obtain Delta E-c, lower and V-OC higher than that of beta-FeSiX/n-Si. For beta-FeSiX/p-InP, a maximum V-OC of 450 mV was obtained under concentrated illumination.	Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; Electrotech Lab, Tsukuba, Ibaraki 3058568, Japan	Okajima, K (reprint author), Shizuoka Univ, Dept Mat Sci & Chem Engn, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.						CHRISTENSEN NE, 1990, PHYS REV B, V42, P7148, DOI 10.1103/PhysRevB.42.7148; KANE EO, 1962, PHYS REV, V127, P131, DOI 10.1103/PhysRev.127.131; DIMITRIADIS CA, 1990, J APPL PHYS, V68, P1726, DOI 10.1063/1.346601; Fowler RH, 1931, PHYS REV, V38, P45, DOI 10.1103/PhysRev.38.45; Leong D, 1997, NATURE, V387, P686; LEFKI K, 1991, J APPL PHYS, V69, P352, DOI 10.1063/1.347720; BOST MC, 1988, J APPL PHYS, V64, P2034, DOI 10.1063/1.341735; BOST MC, 1985, J APPL PHYS, V58, P2969; Chen IS, 1996, J APPL PHYS, V79, P8470, DOI 10.1063/1.362522; Dusausoy P. Y., 1971, ACTA CRYSTALLOGR B, V27, P1209; ERLESAND U, 1995, SOLID STATE ELECTRON, V38, P1143, DOI 10.1016/0038-1101(94)00232-5; Erlesand U, 1996, APPL PHYS LETT, V68, P105, DOI 10.1063/1.116770; Grob Erwin, 1995, J MATER RES, V10, P34, DOI 10.1557/JMR.1995.0034; Katsumata H, 1997, JPN J APPL PHYS 1, V36, P2802, DOI 10.1143/JJAP.36.2802; KOMABAYASHI M, 1990, JPN J APPL PHYS 1, V29, P1118, DOI 10.1143/JJAP.29.1118; LEFKI K, 1993, APPL SURF SCI, V65-6, P772, DOI 10.1016/0169-4332(93)90754-Y; Libezny M., 1995, P 13 EUR PHOT SOL EN, P1326; OOSTRA DJ, 1993, J APPL PHYS, V74, P4347, DOI 10.1063/1.354401; POWALLA M, 1993, APPL SURF SCI, V65-6, P482, DOI 10.1016/0169-4332(93)90706-H; REGOLINI JL, 1992, IEEE T ELECTRON DEV, V39, P200, DOI 10.1109/16.108230; WATANABE T, 1994, J JPN I MET, V58, P353	21	17	17	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	FEB	1999	38	2A					781	786		10.1143/JJAP.38.781		6	Physics, Applied	Physics	182BC	WOS:000079477800035		
J	Mitsui, T; Kinugawa, T; Sakurai, K				Mitsui, T; Kinugawa, T; Sakurai, K			Spectral narrowing of atomic resonance by recurrent excitation spectroscopy: Feedback from atom to radiation field via digital-data processing	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						recurrent excitation; optical pumping; spectroscopy; Rb; laser diode; magnetometer; spectral narrowing		We describe the theoretical analysis and experimental detail of recurrent excitation spectroscopy (RES), which contributes to precise determination of atomic resonance frequency. The basic idea of RES lies in the iterative excitation of the atomic system by radiation. During the preceding excitation, the output held emitted from the atom is recorded in the form of digital data, and the next excitation field is generated in accordance with these data. This recurrent interaction between the atomic system and the radiation field significantly reduces the spectral width of the atomic resonance, while the signal-to-noise ratio remains sufficiently high. To reflect the actual experimental situation, we present a theoretical model in the presence of background white noise, and using this model, analytical and numerical calculations are performed. We find that RES gives a better signal-to-noise ratio compared to the conventional averaging technique until spectral narrowing is terminated. The combination of RES and the digital-data processing technique has been successfully applied to the magnetic resonance of Rb atoms in the sub-MHz region, where our theoretical findings are experimentally confirmed.	Keio Univ, Sch Med, Dept Phys, Yokohama, Kanagawa 2238521, Japan; Univ Tokyo, Dept Basic Sci, Tokyo 1538902, Japan	Mitsui, T (reprint author), Keio Univ, Sch Med, Dept Phys, Yokohama, Kanagawa 2238521, Japan.						DEHMELT HG, 1957, PHYS REV, V105, P1924, DOI 10.1103/PhysRev.105.1924; MLYNEK J, 1983, PHYS REV LETT, V50, P993, DOI 10.1103/PhysRevLett.50.993; DEHMELT HG, 1957, PHYS REV, V105, P1487, DOI 10.1103/PhysRev.105.1487; WINELAND DJ, 1978, PHYS REV LETT, V40, P1639, DOI 10.1103/PhysRevLett.40.1639; BLOOM AL, 1962, APPL OPTICS, V1, P61, DOI 10.1364/AO.1.000061; BREWER RG, 1971, PHYS REV LETT, V27, P631, DOI 10.1103/PhysRevLett.27.631; BELL WE, 1957, PHYS REV, V107, P1559, DOI 10.1103/PhysRev.107.1559; DEMTRODER W, 1982, LASER SPECTROSCOPY, P100; Kinugawa T, 1998, REV SCI INSTRUM, V69, P2796, DOI 10.1063/1.1148980; Mitsui T, 1997, J PHYS B-AT MOL OPT, V30, P2395, DOI 10.1088/0953-4075/30/10/013; PAUL W, 1955, Z PHYS, V140, P262, DOI 10.1007/BF01328923; PHILLIPS WO, 1982, PHYS LETT, V49, P1982; RAMSEY NF, 1950, PHYS REV, V78, P625; SCHENCK P, 1973, PHYS REV LETT, V31, P189, DOI 10.1103/PhysRevLett.31.189; SHIMIZU F, 1981, PHYS REV LETT, V47, P825, DOI 10.1103/PhysRevLett.47.825; USHER MJ, 1964, J SCI INSTRUM, V41, P544, DOI 10.1088/0950-7671/41/9/305	16	3	3	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	FEB	1999	38	2A					923	930		10.1143/JJAP.38.923		8	Physics, Applied	Physics	182BC	WOS:000079477800067		
J	Seto, H; Okuhara, D; Nagao, M; Komura, S; Takeda, T				Seto, H; Okuhara, D; Nagao, M; Komura, S; Takeda, T			A pressure-induced phase transition in a ternary microemulsion with an assembly of a new high-pressure cell and small-angle X-ray scattering apparatus	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						high-pressure; small angle X-ray scattering; complex fluids; microemulsion; phase transition	WATER; PERCOLATION; INTERFACES; REGION; SYSTEM	A small-angle X-ray scattering (SAXS) apparatus for use at high pressure was developed in order to investigate pressure-induced phase transition in a ternary microemulsion consisting of dioctyl sulfosuccinate sodium salt (AOT), water and n-decane. A high-pressure cell was designed to study structural phase transitions in complex fluids, and a SAXS software was developed to measure dynamical structural change of the sub-second order or a successive structural change with temperature variation. The observed SAXS profiles were explained by combining two models for small-angle neutron scattering (SANS), and the results obtained from SANS were reproduced. A pressure jump experiment from the high-pressure lamellar phase to the low-pressure phase was also carried out.	Hiroshima Univ, Fac Integrated Arts & Sci, Higashihiroshima 7398521, Japan; Univ Tokyo, Neutron Scattering Lab, Inst Solid State Phys, Tokai, Ibaraki 3191106, Japan; Ochanomizu Univ, Fac Sci, Tokyo 1128610, Japan	Seto, H (reprint author), Hiroshima Univ, Fac Integrated Arts & Sci, Higashihiroshima 7398521, Japan.	seto@mls.ias.hiroshima-u.ac.jp					DEGENNES PG, 1982, J PHYS CHEM-US, V86, P2294, DOI 10.1021/j100210a011; CHEN SH, 1990, J CHEM PHYS, V93, P1907, DOI 10.1063/1.459068; TEUBNER M, 1987, J CHEM PHYS, V87, P3195, DOI 10.1063/1.453006; LEE DD, 1994, PHYS REV LETT, V73, P106, DOI 10.1103/PhysRevLett.73.106; CAMETTI C, 1990, PHYS REV LETT, V64, P1461, DOI 10.1103/PhysRevLett.64.1461; EASTOE J, 1994, J CHEM SOC FARADAY T, V90, P3121, DOI 10.1039/ft9949003121; Gelbart WM, 1994, MICELLES MEMBRANES M; Gompper G., 1994, SELF ASSEMBLING AMPH, V16; GOMPPER G, 1994, PHYS REV E, V49, P1478, DOI 10.1103/PhysRevE.49.1478; KATO M, 1995, REV SCI INSTRUM, V66, P4333, DOI 10.1063/1.1145323; KOTLARCHYK M, 1992, PHYS REV A, V46, P928, DOI 10.1103/PhysRevA.46.928; KOTLARCHYK M, 1984, PHYS REV A, V29, P2054, DOI 10.1103/PhysRevA.29.2054; KOTLARCHYK M, 1984, PHYS REV LETT, V53, P941, DOI 10.1103/PhysRevLett.53.941; LORENZEN M, 1993, J PHYS IV, V3, P487, DOI 10.1051/jp4:19938101; NAGAO M, 1998, PHYSICA B, V241, P970; NAGAO M, IN PRESS J PHYS CHEM; NAGAO M, IN PRESS PHYS REV E; Nagao M, 1997, PROG COLL POL SCI S, V106, P86, DOI 10.1007/BF01189498; NALLET F, 1990, J PHYS-PARIS, V51, P2333, DOI 10.1051/jphys:0199000510200233300; NODA Y, 1983, NIHONKESSHO GAKKAISH, V25, P222; SAIDI Z, 1995, J PHYS D APPL PHYS, V28, P2108, DOI 10.1088/0022-3727/28/10/017; SETO H, UNPUB; Ueno S, 1997, J PHYS CHEM B, V101, P6847, DOI 10.1021/jp9715639	23	6	6	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	FEB	1999	38	2A					951	956		10.1143/JJAP.38.951		6	Physics, Applied	Physics	182BC	WOS:000079477800073		
J	Bouda, M; Nakano, Y				Bouda, M; Nakano, Y			Development of metal-organic vapor phase diffusion enhanced selective area epitaxy, a novel metal-organic vapor phase epitaxy selective area growth technique, and its application to multi-mode interference device fabrication	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article; Proceedings Paper	International Conference on Indium Phosphide and Related Materials	MAY 11-15, 1998	UNIV TSUKUBA, UNIV HALL TSUKUBA, IBARAKI, JAPAN	Japan Soc Appl Phys, IEEE, Lasers & Electro Optics Soc, IEEE, Electron Devices Soc, Inst Electr Informat & Commun Engineers, Optoelectr Ind & Technol Dev Assoc, Res & Dev Assoc Future Electron Devices, Commemorat Assoc Japan World Exposit, Marubun Res Promot Fdn, Nippon Sheet Glass Fdn Mat Sci & Engn, Ogasawara Fdn Promot Sci & Engn, Aixtron AG, Epichem, Epitaxial Prod Int Ltd	UNIV TSUKUBA, UNIV HALL TSUKUBA	metalorganic vapor phase epitaxy; MOVPE; vapor phase diffusion enhanced selective area growth; SAG; multimode interference; MMI; photonic integration	MOVPE	For the first time Multi-Mode Interference (MMI) power splitters have been fabricated directly by selective area growth, using a novel metal-organic vapor phase diffusion enhanced selective area epitaxy (MOVE2) process. The MOVE2 process features extremely wide-range in-plane bandgap control, high design flexibility and good uniformity under conventional growth pressure and therefore is very suitable for photonic integration. For bulk InGaAs material in-plane bandgap shifts as large as 200 nm have been obtained. The general incorporation characteristics of both group-III and group-V species in selective area grown InGaAsP have also been determined. The MMI power splitter excess losses were as low as 2 dB, including S-bend losses.	Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Bouda, M (reprint author), Fujitsu Labs Ltd, 10-1 Morinosato Wakamiya, Kanagawa 2430197, Japan.						SOLDANO LB, 1995, J LIGHTWAVE TECHNOL, V13, P615, DOI 10.1109/50.372474; FUJII T, 1995, J CRYST GROWTH, V146, P475, DOI 10.1016/0022-0248(94)00498-6; SAKATA Y, 1998, P INT C IND PHOSPH R, P317; SAKATA Y, 1997, P INT C IND PHOSPH R, P602; Sasaki T, 1997, IEICE T ELECTRON, VE80C, P654	5	7	7	JAPAN J APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG 24-8 SHINBASHI 4-CHOME, MINATO-KU TOKYO, 105, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	FEB	1999	38	2B					1029	1033		10.1143/JJAP.38.1029		5	Physics, Applied	Physics	186YM	WOS:000079758900018		
J	Iwao, K; Miyoshi, Y; Nawa, G; Yoshikawa, H; Ochi, T; Nakamura, Y				Iwao, K; Miyoshi, Y; Nawa, G; Yoshikawa, H; Ochi, T; Nakamura, Y			Frequent beta-catenin abnormalities in bone and soft-tissue tumors	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						beta-catenin; mutation; bone tumor; soft-tissue tumor	FAMILIAL ADENOMATOUS POLYPOSIS; DESMOID TUMORS; APC GENE; XENOPUS EMBRYOS; CELL-LINES; MUTATIONS; SARCOMAS; AMPLIFICATION; P53; ACTIVATION	We have screened mutations of the beta-catenin gene by using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method in 62 malignant bone and soft-tissue tumors, including malignant fibrous histiocytomas (MFHs), osteosarcomas, synovial sarcomas, liposarcomas, malignant schwannomas, and other types of tumors, as well as 11 benign tumors, beta-Catenin-activating missense mutations were found in two malignant tumors. One found in MFH occurred at codon 45 and caused an amino acid substitution from serine (one of the GSK3 beta-targeted phosphorylation sites) to phenylalanine. The other, detected in synovial sarcoma at codon 32, resulted in an amino acid change from aspartic acid (located adjacent to the phosphorylation target, serine, encoded by codon 33) to tyrosine, Furthermore, we found accumulation of beta-catenin by western-blotting analysis in 12 of 19 malignant tumors in which we found no mutation involving exon 3, Our results suggested the possible involvement of beta-catenin activation, by beta-catenin gene mutation or alteration of other factor(s), in the formation and/or progression of various types of bone and soft-tissue tumors.	Osaka Univ, Sch Med, Ctr Biomed Res, Dept Med Genet,Div Clin Genet, Suita, Osaka 5650871, Japan; Osaka Univ, Sch Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Osaka Med Ctr Canc & Cardiovasc Dis, Dept Orthoped Surg, Higashinari Ku, Osaka 5370025, Japan	Iwao, K (reprint author), Osaka Univ, Sch Med, Ctr Biomed Res, Dept Med Genet,Div Clin Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.						Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; TOGUCHIDA J, 1992, CANCER RES, V52, P6194; WILKE W, 1993, MODERN PATHOL, V6, P129; LEACH FS, 1993, CANCER RES, V53, P2231; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Alman BA, 1997, AM J PATHOL, V151, P329; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Palacios J, 1998, CANCER RES, V58, P1344; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; WHITEHEAD I, 1995, MOL CELL BIOL, V15, P704; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; MIYAKI M, 1993, CANCER RES, V53, P5079; BARRIOS C, 1994, ONCOLOGY, V51, P13; Bohle RM, 1996, AM J PATHOL, V148, P731; ENZINGER FM, 1969, INT CLASSIFICATION T, V3; GURBUZ AK, 1994, GUT, V35, P377, DOI 10.1136/gut.35.3.377; Iwao K, 1998, CANCER RES, V58, P1021; Kitaeva MN, 1997, CANCER RES, V57, P4478; Miller CW, 1996, J CANCER RES CLIN, V122, P559, DOI 10.1007/BF01213553; OZAKI T, 1993, CELL MOL BIOL, V39, P235; PALMIROTTA R, 1995, HUM MOL GENET, V4, P1979; REISSMANN PT, 1989, ONCOGENE, V4, P839; SENGUPTA S, 1993, LANCET, V342, P552, DOI 10.1016/0140-6736(93)91677-E; SOLER AP, 1993, EXP CELL RES, V208, P84, DOI 10.1006/excr.1993.1225; Young CS, 1998, MOL CELL BIOL, V18, P2474	28	43	44	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	FEB	1999	90	2					205	209				5	Oncology	Oncology	173EA	WOS:000078967200011		
J	Sugiura, W; Matsuda, M; Abumi, H; Yamada, K; Taki, M; Ishikawa, M; Miura, T; Fukutake, K; Gouchi, K; Ajisawa, A; Iwamoto, A; Hanabusa, H; Mimaya, J; Takamatsu, J; Takada, N; Kakishita, E; Yoshioka, A; Kashiwagi, S; Shirahata, A; Nagai, Y				Sugiura, W; Matsuda, M; Abumi, H; Yamada, K; Taki, M; Ishikawa, M; Miura, T; Fukutake, K; Gouchi, K; Ajisawa, A; Iwamoto, A; Hanabusa, H; Mimaya, J; Takamatsu, J; Takada, N; Kakishita, E; Yoshioka, A; Kashiwagi, S; Shirahata, A; Nagai, Y			Prevalence of drug resistance-related mutations among HIV-1s in Japan	JAPANESE JOURNAL OF INFECTIOUS DISEASES			English	Article									Natl Inst Infect Dis, AIDS Res Ctr, Musashimurayama, Tokyo, Japan; St Marianna Univ, Sch Med, Inst Med Sci, Miyamae Ku, Kawasaki, Kanagawa, Japan; St Marianna Univ, Sch Med, Dept Pediat, Miyamae Ku, Kawasaki, Kanagawa, Japan; Tohoku Univ, Sch Med, Dept Internal Med 3, Aoba Ku, Sendai, Miyagi 980, Japan; Haga Red Cross Hosp, Dept Pediat, Mooka, Tochigi, Japan; Tokyo Med Univ, Dept Clin Pathol, Shinjuku Ku, Tokyo, Japan; Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 173, Japan; Tokyo Metropolitan Komagome Hosp, Dept Infect Dis, Bunkyo Ku, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis, Minato Ku, Tokyo, Japan; Ogikubo Hosp, Dept Hematol, Suginami Ku, Tokyo, Japan; Childrens Hosp Shizuoka Prefecture, Div Hematol Oncol, Shizuoka, Japan; Nagoya Univ Hosp, Dept Blood Transfus, Syowa Ku, Nagoya, Aichi, Japan; Hiroshima Univ, Hosp Med, Div Blood Transfus Serv, Minami Ku, Hiroshima, Japan; Hyogo Coll Med, Dept Internal Med 2, Nishinomiya, Hyogo, Japan; Nara Med Univ, Dept Pediat, Kashihara, Nara, Japan; Kyushu Univ Hosp, Dept Gen Med, Higashi Ku, Fukuoka 812, Japan; Univ Occupat & Environm Hlth, Dept Pediat, Yahatanishi Ku, Kitakyushu, Fukuoka 807, Japan	Sugiura, W (reprint author), Natl Inst Infect Dis, AIDS Res Ctr, 4-7-1 Gakuen, Musashimurayama, Tokyo, Japan.	wsugiura@nih.go.jp					Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; HIRSH MS, 1990, ANTIVIRAL THERAPY S4, V2, P19; JENNIFER H, 1997, HUMAN RETROVIRUSES A, V3, P207; Kitsutani PT, 1998, AIDS RES HUM RETROV, V14, P1099, DOI 10.1089/aid.1998.14.1099	5	12	12	NATL INST INFECTIOUS DISEASES	TOKYO	JPN J INFECT DIS ED OFF NATL INST INFECTIOUS DISEASES TOYAMA 1-23-1, SHINJUKU-KU, TOKYO, 162-8640, JAPAN	1344-6304	1884-2836		JPN J INFECT DIS	Jpn. J. Infect. Dis.	FEB	1999	52	1					21	22				2	Infectious Diseases	Infectious Diseases	216CK	WOS:000081423100007		
J	Wu, J; Kusuhara, K; Ishizaki, S; Kato, Y; Fukashiro, S				Wu, J; Kusuhara, K; Ishizaki, S; Kato, Y; Fukashiro, S			Longitudinal study of annual change of bone mass at weight-bearing and non-weight-bearing sites in college women	JAPANESE JOURNAL OF PHYSICAL FITNESS AND SPORTS MEDICINE			Japanese	Article						annual changes of BMD and BMC; weight-bearing and non-weight-bearing bone; rhythmic sports gymnastics; sports practice; college women	PROFESSIONAL BALLET DANCERS; MINERAL DENSITY; YOUNG-WOMEN; GYMNASTS; EXERCISE; FEMALES; SPORTS	To examine the relationship between sports activity and bone mass acquisition, we observed one-year changes in the bone mineral content and density (BMC and BMD) of weight-bearing and non-weight-bearing bone in 68 college women who had participated in various sports since the age of 18.5 years on average. Based on their sports experience, the subjects were divided into four groups :Group A: 18 students who have not had participated in any kind of sports activity since junior high school days;Group B:8 students who had participated in team sports at junior and senior high school, then stopped practicing after entering college;Group C:14 students who had participated in team sports since junior high school;Group D:28 rhythmic sports gymnasts. Whole-body and regional BMC in the head, trunk, arms and legs, and BMD of the lumbar spine and proximal femur were measured using an XR-26 DXA scanner. Height, weight and calcium intake were similar among the four groups. and during the experiment their values changed little. With regard to annual changes in BMC and BMD for weight-bearing regions: 1) In Group A, no significant increases were observed in any of the body regions: 2) In Groups B and C, only the lumbar spine showed a significant increase. Comparing the changes in BMD in these two groups, Group C showed a larger increase than Group B, although the value did not reach statistical significance; 3) In Group D, significant increases in BMD for the lumbar spine and femoral neck and in BMC for the trunk and legs were found. The annual changes in BMD were significantly higher than Group A. As to annual changes in non-weight-bearing bones such as those in the head and arms, there were not significant differences among the groups. These data indicate that sports practice may affect changes in bone mass in weight-bearing regions in female college students. Furthermore, it is possible that the amount and quality of sports training may influence the peak bone mass and its timing.	Univ Tokyo, Dept Life Sci, Lab Sports Sci, Meguro Ku, Tokyo 153001, Japan; Japan Womens Coll Phys Educ, Setagaya Ku, Tokyo 1570061, Japan; Tokyo Womens Christian Univ, Suginami Ku, Tokyo 1678585, Japan	Wu, J (reprint author), Univ Tokyo, Dept Life Sci, Lab Sports Sci, Meguro Ku, Komaba 3-8-1, Tokyo 153001, Japan.						Alfredson H, 1997, CALCIFIED TISSUE INT, V60, P338, DOI 10.1007/s002239900239; TOMMERUP LJ, 1993, J BONE MINER RES, V8, P1053; MATKOVIC V, 1994, J CLIN INVEST, V93, P799, DOI 10.1172/JCI117034; ROBINSON TL, 1995, J BONE MINER RES, V10, P26; Alfredson H, 1996, CALCIFIED TISSUE INT, V59, P438, DOI 10.1007/BF00369207; TAAFFE DR, 1995, J BONE MINER RES, V10, P586; BAILEY D, 1994, SCI MED SPORT, V26, P3; CALABRESE LH, 1983, CLIN SPORT MED, V2, P539; Cuesta A, 1996, CALCIFIED TISSUE INT, V58, P150, DOI 10.1007/BF02526880; FEHLING PC, 1995, BONE, V17, P205, DOI 10.1016/8756-3282(95)00171-9; Heinonen A, 1996, J BONE MINER RES, V11, P490; Kannus P, 1996, BONE, V18, pS1, DOI 10.1016/8756-3282(95)00372-X; KARLSSON MK, 1993, BONE MINER, V21, P163, DOI 10.1016/S0169-6009(08)80227-9; Khan KM, 1996, J BONE MINER RES, V11, P1566; NICHOLS DL, 1994, MED SCI SPORTS EXERC, V26, P220; RICO H, 1993, OSTEOPOROSIS INT, V3, P154, DOI 10.1007/BF01623277; SLEMENDA CW, 1993, BONE MINER, V20, P125, DOI 10.1016/S0169-6009(08)80021-9; WELTEN DC, 1994, J BONE MINER RES, V9, P1089; Wu J, 1998, J BONE MINER RES, V13, P900, DOI 10.1359/jbmr.1998.13.5.900; YOUNG N, 1994, J CLIN ENDOCR METAB, V78, P449, DOI 10.1210/jc.78.2.449	20	0	0	JAPANESE SOC PHYSICAL FITNESS SPORTS MEDICINE	TOKYO	C/O BUSINESS CENTER ACAD SOC JAPAN, 5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113, JAPAN	0039-906X			JPN J PHYS FIT SPORT	Jpn. J. Phys. Fit. Sports Med.	FEB	1999	48	1					211	218				8	Physiology; Sport Sciences	Physiology; Sport Sciences	187DM	WOS:000079771700015		
J	Kitamura, Y; Ishikawa, T; Okui, N; Kobayashi, N; Kanda, T; Shimada, T; Miyake, K; Yoshiike, K				Kitamura, Y; Ishikawa, T; Okui, N; Kobayashi, N; Kanda, T; Shimada, T; Miyake, K; Yoshiike, K			Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase	JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY			English	Article						inhibition; replication; HIV-1; single-chain antibodies; integrase	HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 REVERSE-TRANSCRIPTASE; DNA-BINDING DOMAIN; VARIABLE FRAGMENTS; INTRACELLULAR EXPRESSION; IN-VITRO; BETA-GALACTOSIDASE; RETROVIRAL DNA; GENE-THERAPY; PROTEIN	Retroviruses including HIV-1 integrates a DNA copy of their RNA genome into cellular DNA of the infected cell. This reaction, essential and unique to replication of retroviruses, is mediated by the viral enzyme, integrase (IN). We constructed a recombinant gene encoding a single-chain, antigen-binding peptide (scAb2-19), which interacted with a carboxyl terminal part of HIV-I IN. HeLa CD4 cells expressing scAb2-19 localized in either cytoplasmic of nuclear compartment were resistant to HIV-1 infection at an multiplicity of infection (MOI) of 0.25 or 0.063, but the resistance was overcome when MOI was increased to 1. To determine whether this resistance was due to inhibition of the early events, transduction experiments were performed with a replication-incompetent HIV-1 vector carrying bacterial lacZ driven by an internal Tat-independent cytomegalovirus immediate early promoter. Both cytoplasmic and nuclear expressions of scAb2-19 resulted in decrease in the transduction efficiency on HeLa CD4 cells. This implies that an early step of replication-before or during integration-was affected by the scAb2-19. Furthermore, cytoplasmic expression of scAb2-19 did not affect the viral amount released from the cells transfected with HIV-I infectious clone DNA (pLAI). However, infectivity relative to reverse transcriptase activity was lower for virions released from the 293T cells cotransfected with pLAI and the cytoplasmic scAb2-19 expression plasmid than for those released from the 293T cells transfected with pLAI alone. This implies that scAb2-19 reduced infectivity of released virions by interfering a late step of the viral replication. The single-chain, antigen-binding peptide molecule may prove useful not only for studies of the functions of IN and its role in the viral life cycle but also for developing a gene therapy strategy against AIDS.	Natl Inst Infect Dis, Div Mol Genet, Tokyo 2080011, Japan; Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo, Japan; Nippon Med Coll, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 113, Japan	Kitamura, Y (reprint author), Natl Inst Infect Dis, Div Mol Genet, 4-7-1 Gakuen, Tokyo 2080011, Japan.	yochan@nih.go.jp					GALLAY P, 1995, CELL, V83, P569, DOI 10.1016/0092-8674(95)90097-7; ENGELMAN A, 1994, J VIROL, V68, P5911; ENGELMAN A, 1995, J VIROL, V69, P2729; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; LUTZKE RAP, 1994, NUCLEIC ACIDS RES, V22, P4125; NIWA H, 1991, GENE, V108, P193; BOWERMAN B, 1989, GENE DEV, V3, P469, DOI 10.1101/gad.3.4.469; WINTER G, 1991, NATURE, V349, P293, DOI 10.1038/349293a0; Levin R, 1997, MOL MED, V3, P96; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; FARNET CM, 1991, J VIROL, V65, P1910; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; KIMPTON J, 1992, J VIROL, V66, P2232; Leavitt AD, 1996, J VIROL, V70, P721; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; ADACHI A, 1986, J VIROL, V59, P284; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; BROWN PO, 1990, RETROVIRUSES STRATEG, P19; Cannon PM, 1996, J VIROL, V70, P651; CHEN SY, 1994, HUM GENE THER, V5, P595, DOI 10.1089/hum.1994.5.5-595; Duan LX, 1995, HUM GENE THER, V6, P1561, DOI 10.1089/hum.1995.6.12-1561; DUAN LX, 1994, HUM GENE THER, V5, P1315, DOI 10.1089/hum.1994.5.11-1315; DUAN LX, 1994, P NATL ACAD SCI USA, V91, P5075, DOI 10.1073/pnas.91.11.5075; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Gargano N, 1996, J VIROL, V70, P7706; Harlow E.D., 1988, ANTIBODIES LAB MANUA; Ishiyama M., 1995, In Vitro Toxicology, V8, P187; IZUMI M, 1991, EXP CELL RES, V197, P229, DOI 10.1016/0014-4827(91)90427-V; LevyMintz P, 1996, J VIROL, V70, P8821; MACIEJEWSKI JP, 1995, NAT MED, V1, P667, DOI 10.1038/nm0795-667; MADDON PJ, 1986, CELL, V47, P33; MARASCO WA, 1993, P NATL ACAD SCI USA, V90, P7889, DOI 10.1073/pnas.90.16.7889; Miyake K, 1996, HUM GENE THER, V7, P2281, DOI 10.1089/hum.1996.7.18-2281; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nilsen BM, 1996, J VIROL, V70, P1580; NORTON PA, 1985, MOL CELL BIOL, V5, P281; Obaru K, 1996, HUM GENE THER, V7, P2203, DOI 10.1089/hum.1996.7.18-2203; Okui N, 1998, J VIROL, V72, P6960; PEDEN KWC, 1995, HIV PRACTICAL APPROA, V1, P21; RIGGS P, 1996, CURRENT PROTOCOLS MO, P1; Shaheen F, 1996, J VIROL, V70, P3392; VANDEREB AJ, 1977, GENE, V2, P115, DOI 10.1016/0378-1119(77)90012-9; Varmus H, 1989, MOBILE DNA, P53; VINK C, 1993, NUCLEIC ACIDS RES, V21, P1419, DOI 10.1093/nar/21.6.1419; Wu Y, 1996, J VIROL, V70, P3290	49	22	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1077-9450			J ACQ IMMUN DEF SYND	J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.	FEB 1	1999	20	2					105	114				10	Immunology; Infectious Diseases	Immunology; Infectious Diseases	163ET	WOS:000078390800001		
J	Kanda, N; Tamaki, K				Kanda, N; Tamaki, K			Estrogen enhances immunoglobulin production by human PBMCs	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						estrogen; immunoglobulin; IL-10; B cell; monocyte	SYSTEMIC LUPUS-ERYTHEMATOSUS; HUMAN PERIPHERAL-BLOOD; IMMUNE-RESPONSE; LYMPHOCYTES-B; STROMAL CELLS; AUTO-IMMUNITY; LPR/LPR MICE; SEX-HORMONES; ANTIBODIES; INVITRO	Background: It has been suggested that estrogen may enhance humoral immune responses and may be involved in the pathogenesis of autoimmune diseases, Objective: We studied the in vitro effects of 17 beta-estradiol (E-2) on spontaneous immunoglobulin production by human PBMCs. Methods: PBMCs from healthy human volunteers were cultured with E-2. Levels of IgG and IgM and cytokine activity were measured by ELISA, proliferation was determined by [H-3]-thymidine uptake. The cell viability was assessed by a trypan blue exclusion test. Results: E-2 enhanced IgG and IgM production of PBMCs both from men and women without altering cell viability and proliferation, The stimulatory effect of E-2 was revealed at 10(-10) mol/L, increased in a dose-dependent fashion, and was maximized at 10(-8) mol/L, IgG production of PBMCs in the presence of E-2 (10(-8) mol/L) was 220% of control cells, and that of IgM was 211%. Immunoglobutin production of E-2-treated B cells was slightly higher than that of control cells; IgG production was 161% of control cells, and that of IgM was 157%. Anti-IL-10 antibody partially blocked the E-2 effect on immunoglobulin production of PBMCs; anti-IL-10 reduced IgG production in the presence of E-2 from 206% to 151% of control cells, and that of IgM from 206% to 152%. E-2 increased IL-10 production of monocytes up to 250% of control level, but it did not affect that of T cells or B cells. Exogenous IL-10 (1 U/mL) further enhanced E-2-induced increase of immunoglobulin production by B cells, although this level of IL-10 alone was ineffective for B cells. Conclusion: These results suggest that E2 may increase immunoglobulin production of human PBMCs mainly by increasing IL-10 production of monocytes, The results also support that E-2 may act as an important stimulator for human humoral immunity.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1130033, Japan	Kanda, N (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						AHMED SA, 1989, J IMMUNOL, V142, P2647; AHMED SA, 1988, FASEB J, V2, pA894; FOX HS, 1991, J IMMUNOL, V146, P4362; ABRAHAM GE, 1969, J CLIN ENDOCR METAB, V29, P866; PAAVONEN T, 1981, J EXP MED, V154, P1935, DOI 10.1084/jem.154.6.1935; STEINBERG AD, 1979, ARTHRITIS RHEUM, V22, P1170, DOI 10.1002/art.1780221103; ROUBINIAN JR, 1978, J EXP MED, V147, P1568, DOI 10.1084/jem.147.6.1568; ROUSSET F, 1992, P NATL ACAD SCI USA, V89, P1890, DOI 10.1073/pnas.89.5.1890; Kanda N, 1996, CLIN EXP IMMUNOL, V106, P410, DOI 10.1046/j.1365-2249.1996.d01-842.x; STHOEGER ZM, 1988, J IMMUNOL, V141, P91; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; LIN H, 1993, J IMMUNOL, V151, P4562; POLAN ML, 1988, FERTIL STERIL, V49, P964; Ahmed S. Ansar, 1993, P148; ARIGA H, 1989, CLIN IMMUNOL IMMUNOP, V53, P499, DOI 10.1016/0090-1229(89)90011-1; BATRA S, 1978, J CLIN ENDOCR METAB, V46, P622; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BLANK M, 1990, J RHEUMATOL, V17, P311; Boyum A., 1968, SCAND J CLIN LAB INV, V97, P7; BURDIN N, 1993, J EXP MED, V177, P295, DOI 10.1084/jem.177.2.295; CARLSTEN H, 1990, CLIN EXP IMMUNOL, V80, P467; DE M, 1992, DEV BIOL, V151, P297; FARRANT J, 1985, CLIN EXP IMMUNOL, V61, P189; FERRE F, 1980, AM J OBSTET GYNECOL, V138, P500; FORMBY B, 1995, ENDOCRIN METAB CLIN, V24, P187; GEE AP, 1987, BONE MARROW TRANSPL, V2, P155; GIRASOLE G, 1992, J CLIN INVEST, V89, P883, DOI 10.1172/JCI115668; KIMATA H, 1991, CLIN EXP IMMUNOL, V85, P151; LINKERISRAELI M, 1990, ARTHRITIS RHEUM, V33, P1216; MILLER MH, 1983, MEDICINE, V62, P327, DOI 10.1097/00005792-198309000-00005; MISHELL DR, 1971, AM J OBSTET GYNECOL, V111, P60; MORI H, 1991, J IN VITRO FERTIL EM, V8, P329, DOI 10.1007/BF01133023; RAVECHE ES, 1976, NATURE, V263, P415, DOI 10.1038/263415a0; ROUBINIAN J, 1979, ARTHRITIS RHEUM, V22, P1162; STEINBERG AD, 1980, CLIN IMMUNOL IMMUNOP, V17, P562, DOI 10.1016/0090-1229(80)90152-X; TABIBZADEH SS, 1989, J IMMUNOL, V142, P3134; WALKER P, 1984, NUCLEIC ACIDS RES, V12, P8611, DOI 10.1093/nar/12.22.8611	37	112	119	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0091-6749			J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	FEB	1999	103	2	1				282	288		10.1016/S0091-6749(99)70503-8		7	Allergy; Immunology	Allergy; Immunology	167JW	WOS:000078630100016		
J	Tomoda, H; Matsushima, C; Tabata, N; Namatame, I; Tanaka, H; Bamberger, MJ; Arai, H; Fukazawa, M; Inoue, K; Omura, S				Tomoda, H; Matsushima, C; Tabata, N; Namatame, I; Tanaka, H; Bamberger, MJ; Arai, H; Fukazawa, M; Inoue, K; Omura, S			Structure-specific inhibition of cholesteryl ester transfer protein by azaphilones	JOURNAL OF ANTIBIOTICS			English	Article							LIPID TRANSFER PROTEIN; HIGH-DENSITY LIPOPROTEINS; TRANSGENIC MICE; HUMAN-PLASMA; BINDING-SITES; ATHEROSCLEROSIS; PURIFICATION; METABOLISM; DEFICIENCY; CYSTEINE	The effect of thirteen different fungal azaphilones, which have a common 6-isochromane-like ring, was tested on cholesteryl ester transfer protein (CETP) activity bi vitro. Chaetoviridin B showed the most potent inhibitory activity with an TC,, value of < 6.2 mu M, followed by sclerotiorin with an IC50 value of 19.4 mu M. Rotiorin, chaetoviridin A and rubrorotiorin had moderate inhibitory activity (IC50; 30 similar to 40 mu M), but others showed very weak or no inhibitory activity. The relationship between the structures and their inhibitory activity indicated that the presence of an electrophilic ketone(s) and/or enone(s) at both C-6 and C-8 positions in the isochromane-like ring is essential for eliciting CETP inhibitory activity. The transfer activity of both CE and TG was inhibited by sclerotiorin to approximately the same extent (IC50: 14.4 and 10.3 mu M, respectively). A model of the reaction suggested that sclerotiorin reacts with a primary amine of amino acids such as lysine in the protein to form a covalent bond.	Kitasato Inst, Res Ctr Biol Funct, Minato Ku, Tokyo 1088641, Japan; Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; Pfizer Inc, Groton, CT 06340 USA; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 103, Japan	Tomoda, H (reprint author), Kitasato Inst, Res Ctr Biol Funct, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.		Jansen, Nils/G-1835-2011				ARAI N, 1995, J ANTIBIOT, V48, P696; KUO MS, 1995, J AM CHEM SOC, V117, P10629, DOI 10.1021/ja00148a004; AGELLON LB, 1991, J BIOL CHEM, V266, P10796; BARTER P, 1994, CLIN EXP PHARMACOL P, V21, P663, DOI 10.1111/j.1440-1681.1994.tb02569.x; TAKAHASHI F, 1995, BBA-LIPID LIPID MET, V1258, P70, DOI 10.1016/0005-2760(95)00102-I; NISHIDA HI, 1993, J BIOL CHEM, V268, P16352; TALL AR, 1993, J LIPID RES, V34, P1255; KATO H, 1989, J BIOL CHEM, V264, P4082; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; DRAYNA D, 1987, NATURE, V327, P632, DOI 10.1038/327632a0; Kim YK, 1996, J ANTIBIOT, V49, P815; BISGAIER CL, 1994, LIPIDS, V29, P811, DOI 10.1007/BF02536247; BRESLOW JL, 1993, P NATL ACAD SCI USA, V90, P8314, DOI 10.1073/pnas.90.18.8314; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; BUSCH SJ, 1990, LIPIDS, V25, P216, DOI 10.1007/BF02535750; CHACKALAMANNIL S, 1995, BIOORG MED CHEM LETT, V5, P2005, DOI 10.1016/0960-894X(95)00342-Q; Cho KH, 1998, BBA-LIPID LIPID MET, V1391, P133, DOI 10.1016/S0005-2760(97)00197-5; Connolly DT, 1996, BIOCHEM BIOPH RES CO, V223, P42, DOI 10.1006/bbrc.1996.0843; COVAL SJ, 1995, BIOORG MED CHEM LETT, V5, P605, DOI 10.1016/0960-894X(95)00081-4; Curtin TP, 1940, BIOCHEM J, V34, P1419; EADE RA, 1957, J CHEM SOC, P4913, DOI 10.1039/jr9570004913; EPPS DE, 1995, BIOCHEMISTRY-US, V34, P12560, DOI 10.1021/bi00039a010; FUJIMOTO H, 1990, HETEROCYCLES, V30, P607; FUKASAWA M, 1992, J BIOCHEM-TOKYO, V111, P696; HESLER CB, 1987, J BIOL CHEM, V262, P2275; HOPKINS GJ, 1985, J LIPID RES, V26, P218; JARNAGIN AS, 1987, P NATL ACAD SCI USA, V84, P1854, DOI 10.1073/pnas.84.7.1854; JIANG XC, 1995, BIOCHEMISTRY-US, V34, P7258, DOI 10.1021/bi00021a042; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Kotake H, 1997, BBA-LIPID LIPID MET, V1347, P69, DOI 10.1016/S0005-2760(97)00054-4; Kothari HV, 1997, ATHEROSCLEROSIS, V128, P59, DOI 10.1016/S0021-9150(96)05981-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGROST L, 1994, BBA-LIPID LIPID MET, V1215, P209, DOI 10.1016/0005-2760(94)90047-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAROTTI KR, 1992, ARTERIOSCLER THROMB, V12, P736; MELCHIOR GW, 1995, J BIOL CHEM, V270, P21068; NAKAMURA M, 1990, Patent No. 255615; OMURA S, 1993, J ANTIBIOT, V46, P1908; SAMMETT D, 1985, J BIOL CHEM, V260, P6687; SHIN J, 1995, J ORG CHEM, V60, P7582, DOI 10.1021/jo00128a034; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; SWENSON TL, 1989, J BIOL CHEM, V264, P14318; SWENSON TL, 1988, J BIOL CHEM, V263, P5150; YASUKAWA K, 1994, ONCOLOGY, V51, P108	44	29	30	JAPAN ANTIBIOTICS RESEARCH ASSOC	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	FEB	1999	52	2					160	170				11	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	171RZ	WOS:000078879000012		
J	Teii, K; Yoshida, T				Teii, K; Yoshida, T			Lower pressure limit of diamond growth in inductively coupled plasma	JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; SURFACE; ENERGY; NUCLEATION; SILICON; FILMS	A study of diamond growth at pressures below 20 mTorr by using an inductively coupled radio frequency plasma is presented. Emissive and Langmuir probes, and optical emission spectroscopy were used to examine the plasma, and deposits were obtained on single crystalline silicon and diamond substrates with controlling the bombarding ion energy by the sheath potential (V-sheath). A higher threshold of V-sheath that allowed diamond growth was found in the range of 11-19 V above 20 mTorr, while a shift down of the V-sheath threshold was observed below 10 mTorr, as confirmed by Raman spectroscopy and electron diffraction. The growth at 10 mTorr was successful only when V-sheath was reduced to 2 V, however, the growth at 5 mTorr was no longer possible even when V-sheath was reduced to 2 V. Effects of the pressure decrease on the suppression of diamond growth below 10 mTorr were interpreted in terms of an increase in ion flux relative to radical flux as well as low radical density corresponding to the plasma density of approximately 2 x 10(10) cm(-3). (C) 1999 American Institute of Physics. [S0021-8979(99)00203-0].	Univ Tokyo, Grad Sch, Dept Met & Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Fac Engn, Bunkyo Ku, Tokyo 1138656, Japan	Teii, K (reprint author), Nagoya Univ, Grad Sch, Dept Quantum Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	teii@nuee.nagoya-u.ac.jp					PETROV I, 1993, APPL PHYS LETT, V63, P36, DOI 10.1063/1.109742; GOODWIN DG, 1993, J APPL PHYS, V74, P6888, DOI 10.1063/1.355063; STONER BR, 1992, PHYS REV B, V45, P11067, DOI 10.1103/PhysRevB.45.11067; YOSHIKAWA M, 1995, APPL PHYS LETT, V67, P694, DOI 10.1063/1.115206; FRENKLACH M, 1991, PHYS REV B, V43, P1520, DOI 10.1103/PhysRevB.43.1520; EDDY CR, 1992, J MATER RES, V7, P3255, DOI 10.1557/JMR.1992.3255; HIRAKI A, 1990, SURF COAT TECH, V43-4, P10, DOI 10.1016/0257-8972(90)90055-H; IHARA M, 1994, APPL PHYS LETT, V65, P1192, DOI 10.1063/1.112105; *JCDPS, 1990, 60675 JCDPS INT CTR; KOIZUMI S, 1990, J CRYST GROWTH, V99, P1188, DOI 10.1016/S0022-0248(08)80105-4; LEE NE, 1994, APPL PHYS LETT, V65, P3236, DOI 10.1063/1.112423; Loh KP, 1996, DIAM RELAT MATER, V5, P231, DOI 10.1016/0925-9635(95)00421-1; MAKOWSKI MA, 1983, REV SCI INSTRUM, V54, P830, DOI 10.1063/1.1137486; Nishimori T, 1997, DIAM RELAT MATER, V6, P463, DOI 10.1016/S0925-9635(96)00763-7; Pearse R. W. B., 1976, IDENTIFICATION MOL S; Smith BA, 1997, APPL PHYS LETT, V70, P1950, DOI 10.1063/1.118788; Stiegler J, 1997, APPL PHYS LETT, V70, P173, DOI 10.1063/1.118348; Stockel R, 1996, J APPL PHYS, V79, P768; SUGAI H, 1994, JPN J APPL PHYS 1, V33, P2189, DOI 10.1143/JJAP.33.2189; TEII K, IN PRESS J VAC SCI A; TEII K, 1998, T I ELECT ENG JPN A, V118, P895; Teii K, 1998, THIN SOLID FILMS, V316, P24, DOI 10.1016/S0040-6090(98)00382-4; Wiese W. L., 1966, NATL STANDARD REFERE, V1; Wolden CA, 1996, DIAM RELAT MATER, V5, P1503, DOI 10.1016/S0925-9635(96)00574-2; YOUCHISON DL, 1993, J VAC SCI TECHNOL A, V11, P103, DOI 10.1116/1.578275	25	33	33	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0021-8979			J APPL PHYS	J. Appl. Phys.	FEB 1	1999	85	3					1864	1870		10.1063/1.369311		7	Physics, Applied	Physics	158VB	WOS:000078137100088		
J	Takahashi, S; Kuzuyama, T; Seto, H				Takahashi, S; Kuzuyama, T; Seto, H			Purification, characterization, and cloning of a eubacterial 3-hydroxy-3-methylglutaryl coenzyme A reductase, a key enzyme involved in biosynthesis of terpenoids	JOURNAL OF BACTERIOLOGY			English	Article							HMG-COA REDUCTASE; ACTIVATED PROTEIN-KINASE; A REDUCTASE; PSEUDOMONAS-MEVALONII; ESCHERICHIA-COLI; RAT-LIVER; ENDOPLASMIC-RETICULUM; ISOPRENOID SYNTHESIS; HALOFERAX-VOLCANII; CATALYTIC DOMAIN	The eubacterial 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase (EC 1.1.1.34) was purified 3,000-fold from Streptomyces sp. strain CL190 to apparent homogeneity with an overall yield of 2.1%. The purification procedure consisted of (NEI,),SO, precipitation, heat treatment and anion exchange, hydrophobic interaction, and affinity chromatographies, The molecular mass of the enzyme was estimated to be 41 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and 100 to 105 kDa by gel filtration chromatography, suggesting that the enzyme is most likely to be a dimer, The enzyme showed a pH optimum of around 7.2, with apparent K-m values of 62 mu M for NADPH and 7.7 mu M for HMG-CoA. A gene from CL190 responsible for HMG-CoA reductase aas cloned by the colony hybridization method with an oligonucleotide probe synthesized on the basis of the N-terminal sequence of the purified enzyme. The amino acid sequence of the CL190 HMG-CoA reductase revealed several limited motifs which were highly conserved and common to the eucaryotic and archaebacterial enzymes. These sequence conservations suggest a strong evolutionary pressure to maintain amino acid residues at specific positions, indicating that the conserved motifs might play important roles in the structural conformation and/or catalytic properties of the enzyme.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Seto, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.						DALE S, 1995, EUR J BIOCHEM, V233, P506, DOI 10.1111/j.1432-1033.1995.506_2.x; BACH TJ, 1986, EUR J BIOCHEM, V154, P103, DOI 10.1111/j.1432-1033.1986.tb09364.x; DARNAY BG, 1992, J BIOL CHEM, V267, P15064; ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; CLARKE PR, 1990, EMBO J, V9, P2439; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; AMEMIYA Y, 1988, NATURE, V336, P89, DOI 10.1038/336089a0; SHIOMI K, 1987, J ANTIBIOT, V40, P1740; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; DARNAY BG, 1993, J BIOL CHEM, V268, P8429; BROWN MS, 1980, J LIPID RES, V21, P505; OMKUMAR RV, 1994, J BIOL CHEM, V269, P6810; WOESE CR, 1987, MICROBIOL REV, V51, P221; BEACH MJ, 1989, J BACTERIOL, V171, P2994; BISCHOFF KM, 1997, PROTEIN SCI, V6, P1; Bischoff KM, 1996, J BACTERIOL, V178, P19; Bochar DA, 1997, J BACTERIOL, V179, P3632; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CABRERA JA, 1986, J BIOL CHEM, V261, P3578; Friesen JA, 1997, BIOCHEMISTRY-US, V36, P1157, DOI 10.1021/bi962104l; Friesen JA, 1997, BIOCHEMISTRY-US, V36, P2173, DOI 10.1021/bi962254w; FRIMPONG K, 1993, PROTEIN EXPRES PURIF, V4, P337, DOI 10.1006/prep.1993.1044; FRIMPONG K, 1994, J BIOL CHEM, V269, P11478; FUNAYAMA S, 1990, J ORG CHEM, V55, P1132, DOI 10.1021/jo00291a003; GILL JF, 1985, J BIOL CHEM, V260, P9393; HORBACH S, 1993, FEMS MICROBIOL LETT, V111, P135, DOI 10.1111/j.1574-6968.1993.tb06375.x; ISSHIKI K, 1986, J ANTIBIOT, V39, P1634; KIRTLEY ME, 1967, BIOCHEMISTRY-US, V6, P230, DOI 10.1021/bi00853a036; KLEINSEK DA, 1979, J BIOL CHEM, V254, P7591; KLEINSEK DA, 1977, P NATL ACAD SCI USA, V74, P1431, DOI 10.1073/pnas.74.4.1431; KRISTIN TC, 1992, J BIOL CHEM, V267, P4236; LAM WL, 1992, J BIOL CHEM, V267, P5829; LAWRENCE CM, 1995, SCIENCE, V268, P1758, DOI 10.1126/science.7792601; LISCUM L, 1985, J BIOL CHEM, V260, P522; LISCUM L, 1983, P NATL ACAD SCI-BIOL, V80, P7165, DOI 10.1073/pnas.80.23.7165; MAYER RJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P110, DOI 10.1016/0003-9861(88)90014-8; NESS GC, 1979, ARCH BIOCHEM BIOPHYS, V197, P493, DOI 10.1016/0003-9861(79)90272-8; OMKUMAR RV, 1994, J BIOL CHEM, V269, P16862; OTENDER EH, 1992, J BIOL CHEM, V267, P4223; PERSON WR, 1988, P NATL ACAD SCI USA, V85, P2444; Rodwell V W, 1976, Adv Lipid Res, V14, P1; Sambrook J., 1989, MOL CLONING LAB MANU; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; SETO H, 1996, TETRAHEDRON LETRT, V12, P4411; SHIN-YA K, 1990, Tetrahedron Letters, V31, P6025, DOI 10.1016/S0040-4039(00)98019-5; TORMANEN CD, 1976, BIOCHEM BIOPH RES CO, V68, P754, DOI 10.1016/0006-291X(76)91209-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P1350; WANG YL, 1990, J BIOL CHEM, V265, P21634	49	42	42	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0021-9193			J BACTERIOL	J. Bacteriol.	FEB	1999	181	4					1256	1263				8	Microbiology	Microbiology	166XG	WOS:000078602700024		
J	Muneyuki, E; Shibazaki, C; Ohtani, H; Okuno, D; Asaumi, M; Mogi, T				Muneyuki, E; Shibazaki, C; Ohtani, H; Okuno, D; Asaumi, M; Mogi, T			Time-resolved measurements of photovoltage generation by bacteriorhodopsin and halorhodopsin adsorbed on a thin polymer film	JOURNAL OF BIOCHEMISTRY			English	Article						bacteriorhodopsin; halobacteria; halorhodopsin; photocycle; photovoltage	CHLORIDE-ION TRANSPORT; SCHIFF-BASE; NATRONOBACTERIUM-PHARAONIS; PROTON TRANSLOCATION; PUMP HALORHODOPSIN; ASPARTIC ACID-96; ELECTRIC-CURRENT; INTERMEDIATE; RECONSTITUTION; PHOTOCYCLE	We constructed a time-resolved photovoltage measurement system and examined the photovoltage kinetics of wild-type bacteriorhodopsin, its D96N mutant, and halorhodopsins from Halobacterium salinarum and Natronobacterium pharaonis. Upon illumination with a laser hash, wild-type bacteriorhodopsin showed photovoltage generation with fast (10-100 mu s range) and slow (ms range) components while D96N lacked the latter, as reported previously [Holz, M., Drachev, L.A., Mogi, T., Otto, H., Kaulen, A.D., Heyn, M.P., Skulachev, V.P., and Khorana, H.G. (1989) Proc. Natl. Acad. Sci. USA 86, 2167-2171]. In contrast, photovoltage generation in halorhodopsins from H. salinarum and N. pharaonis was significant only in the ms time range. On the basis of the photovoltage kinetics and photocycle, we conclude that major charge (chloride) movements within halorhodopsin occur during the formation and decay of the N intermediate in the ms range. These observations are discussed in terms of the "Energization-Relaxation Channel Model" [Muneyuki, E., Ikematsu, M., and Yoshida, M. (1996) J. Phys. Chem. 100, 19687-19691].	Tokyo Inst Technol, Resources Utilizat Res Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Tokyo Inst Technol, Fac Biosci & Biotechnol, Dept Biomol Engn, Midori Ku, Yokohama, Kanagawa 2268503, Japan; Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan	Muneyuki, E (reprint author), Tokyo Inst Technol, Resources Utilizat Res Lab, Midori Ku, Nagatsuta 4259, Yokohama, Kanagawa 2268503, Japan.	emuneyuk@res.titech.ac.jp					AMES JB, 1992, BIOCHEMISTRY-US, V31, P12546, DOI 10.1021/bi00165a002; VARO G, 1995, BIOCHEMISTRY-US, V34, P14500, DOI 10.1021/bi00044a028; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; OTTO H, 1990, P NATL ACAD SCI USA, V87, P1018, DOI 10.1073/pnas.87.3.1018; VARO G, 1995, BIOCHEMISTRY-US, V34, P14490, DOI 10.1021/bi00044a027; VARO G, 1995, BIOPHYS J, V68, P2062; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; Nagel G, 1998, BIOPHYS J, V74, P403; BAMBERG E, 1984, BIOCHIM BIOPHYS ACTA, V773, P53, DOI 10.1016/0005-2736(84)90549-2; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; BRAIMAN MS, 1994, BIOCHEMISTRY-US, V33, P1629, DOI 10.1021/bi00173a003; DER A, 1985, FEBS LETT, V187, P233, DOI 10.1016/0014-5793(85)81248-5; DICKOPF S, 1995, P NATL ACAD SCI USA, V92, P11519, DOI 10.1073/pnas.92.25.11519; DRACHEV LA, 1981, EUR J BIOCHEM, V117, P461; DRACHEV LA, 1974, NATURE, V249, P321, DOI 10.1038/249321a0; DRACHEV LA, 1979, ANAL BIOCHEM, V96, P250, DOI 10.1016/0003-2697(79)90580-3; DRACHEV LA, 1976, J BIOL CHEM, V251, P7059; DRACHEV LA, 1978, FEBS LETT, V87, P161, DOI 10.1016/0014-5793(78)80157-4; HOLZ M, 1988, BIOPHYS J, V53, P623; Kalaidzidis IV, 1998, FEBS LETT, V427, P59, DOI 10.1016/S0014-5793(98)00394-9; LANYI JK, 1990, PHYSIOL REV, V70, P319; Muneyuki E, 1996, J PHYS CHEM-US, V100, P19687, DOI 10.1021/jp961514g; Muneyuki E, 1998, FEBS LETT, V427, P109, DOI 10.1016/S0014-5793(98)00404-9; Oesterhelt D, 1974, Methods Enzymol, V31, P667; Oesterhelt D, 1995, ISR J CHEM, V35, P475; OHTANI H, 1994, PHOTOCHEM PHOTOBIOL, V60, P394, DOI 10.1111/j.1751-1097.1994.tb05122.x; PANDE C, 1989, BIOPHYS J, V55, P425; Rudiger M, 1997, EMBO J, V16, P3813, DOI 10.1093/emboj/16.13.3813; SCHOBERT B, 1986, BIOCHEMISTRY-US, V25, P4163, DOI 10.1021/bi00362a026; WALTER TJ, 1994, BIOCHEMISTRY-US, V33, P1724, DOI 10.1021/bi00173a015	33	12	12	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	FEB	1999	125	2					270	276				7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	170MG	WOS:000078809000008		
J	Namatame, I; Tomoda, H; Arai, H; Inoue, K; Omura, S				Namatame, I; Tomoda, H; Arai, H; Inoue, K; Omura, S			Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C	JOURNAL OF BIOCHEMISTRY			English	Article						acyl-CoA synthetase inhibitor; cholesteryl ester; macrophage-derived foam cell formation; triacsin; triacylglycerol	LOW-DENSITY-LIPOPROTEIN; ACYL-COA SYNTHETASE; COENZYME-A SYNTHASE; ACAT INHIBITORS; CHOLESTEROL ESTERIFICATION; ANTIATHEROSCLEROTIC AGENTS; PERITONEAL-MACROPHAGES; BIOLOGICAL PROPERTIES; J774 MACROPHAGES; ACCUMULATION	Primary mouse peritoneal macrophages effectively take up and metabolize phosphatidylcholine/cholesterol liposomes containing a small amount of phosphatidylserine, which results in the massive accumulation in the cytoplasm of oil red O positive lipid droplets consisting of cholesteryl ester (CE) and triacylglycerol (TG) [Nishikawa ct al. (1990) J. Biol. Chen. 265, 5226-5231], A number of inhibitors of CE synthesis have been reported, but their effects on the lipid droplet formation have not been fully examined, Furthermore, the contribution of TG synthesis to lipid droplet formation has been poorly investigated. We have investigated the relationship between CE and TG syntheses and cytosolic lipid droplet formation in macrophages cultured in the presence of inhibitors with different modes of action. When macrophages were cultured with liposomes and [C-14] oleic acid in the presence of triacsin C, a potent inhibitor of long chain acyl-CoA synthetase, both [C-14]CE and [C-14]TG syntheses were inhibited to similar extents with IC50 values of 0.19 and 0.10 mu M, respectively, On the other hand, pregnenolone, a well-known inhibitor of cellular cholesterol transport, and CL-283,546, a potent inhibitor of acyl-CoA:cholesterol acyltransferase, inhibited [C-14] CE synthesis specifically with IC50 values of 5.0 and 0.038 mu M, respectively, Microscopic observation revealed that the inhibitors of cholesterol metabolism produce only a partial decrease in cytosolic lipid droplets even at the highest doses which cause almost complete inhibition of [C-14] CE synthesis, However, the triacsin C-dose dependent inhibition of lipid droplet formation was almost complete at 0.59 mu M, a concentration that inhibits [C-14]CE and [C-14] TG syntheses by about 90%. These results show that inhibiton of acyl-CoA synthetase by triacsin C causes a decrease in the cellular levels of acyl-CoA, the common substrate for CE and TG syntheses, leading to an inhibiton of neutral lipid synthesis and eventually to the complete disappearance of cytosolic lipid droplets from macrophages, These findings suggest that TG synthesis, as well as CE synthesis, is responsible for macrophage-derived foam cell formation, and is therefore a potential target for new antiatherosclerotic agents.	Kitasato Univ, Biol Funct Res Ctr, Minato Ku, Tokyo 1088642, Japan; Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088642, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Omura, S (reprint author), Kitasato Univ, Biol Funct Res Ctr, Minato Ku, Tokyo 1088642, Japan.						AIKAWA K, 1994, BBA-LIPID LIPID MET, V1213, P127; TABAS I, 1986, J BIOL CHEM, V261, P3147; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; NAGANUMA S, 1992, BIOCHIM BIOPHYS ACTA, V1126, P41, DOI 10.1016/0005-2760(92)90214-G; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; ENDO A, 1985, J MED CHEM, V28, P401, DOI 10.1021/jm00382a001; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; Fujino T, 1996, J BIOL CHEM, V271, P16748; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; NISHIKAWA K, 1990, J BIOL CHEM, V265, P5226; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; LISCUM L, 1989, J BIOL CHEM, V264, P11796; Debry P, 1997, J BIOL CHEM, V272, P1026; BUTLER JD, 1992, J BIOL CHEM, V267, P23797; BELL RM, 1983, ENZYMES, V16, P87; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; FUJINO T, 1992, J BIOCHEM-TOKYO, V111, P197; GERRITY RG, 1981, AM J PATHOL, V103, P181; GOLDSTEIN JL, 1978, P NATL ACAD SCI USA, V75, P1877, DOI 10.1073/pnas.75.4.1877; HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x; HUANG XH, 1995, J ANTIBIOT, V48, P1; INOUE K, 1974, BIOCHIM BIOPHYS ACTA, V339, P390, DOI 10.1016/0005-2736(74)90166-7; ISHII I, 1995, J LIPID RES, V36, P2303; KATOCS AS, 1988, FASEB J, V2, pA1219; KNOLL LJ, 1995, J BIOL CHEM, V270, P20090; KNOLL LJ, 1994, J BIOL CHEM, V269, P16348; KORCHAK HM, 1994, J BIOL CHEM, V269, P30281; MISHINA M, 1978, EUR J BIOCHEM, V82, P347, DOI 10.1111/j.1432-1033.1978.tb12029.x; Morikawa Y, 1996, J BIOL CHEM, V271, P2868; NICHOLSON AC, 1995, LIPIDS, V30, P771, DOI 10.1007/BF02537805; NISHIKAWA K, 1993, BIOCHIM BIOPHYS ACTA, V1169, P257; Omura S, 1981, Methods Enzymol, V72, P520; OMURA S, 1986, J ANTIBIOT, V39, P1211; PFANNER N, 1989, CELL, V59, P95, DOI 10.1016/0092-8674(89)90872-6; SANO Y, 1963, J ANTIBIOT, V20, P344; SATO Y, 1995, BBA-LIPID LIPID MET, V1257, P38, DOI 10.1016/0005-2760(95)00053-F; SCAFFNER T, 1980, AM J PATHOL, V100, P57; Sliscovic D.R., 1994, CURR MED CHEM, V1, P204; SLISKOVIC DR, 1991, TRENDS PHARMACOL SCI, V12, P194, DOI 10.1016/0165-6147(91)90546-5; SUZUKI H, 1990, J BIOL CHEM, V265, P8681; TABAS I, 1985, P NATL ACAD SCI USA, V82, P416, DOI 10.1073/pnas.82.2.416; TIJBURG LBM, 1989, BIOCHIM BIOPHYS ACTA, V269, P16348; TOMODA H, 1988, J ANTIBIOT, V41, P247; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V921, P595; TOMODA H, 1991, J BIOL CHEM, V266, P4214; TOMODA H, 1992, J ANTIBIOT, V45, P1626; TOMODA H, 1987, BIOCHIM BIOPHYS ACTA, V922, P351; Underwood KW, 1998, J BIOL CHEM, V273, P4266, DOI 10.1074/jbc.273.7.4266; WU XJ, 1994, J BIOL CHEM, V269, P12375	49	49	50	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	FEB	1999	125	2					319	327				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	170MG	WOS:000078809000014		
J	Furuse, H; Toda, K				Furuse, H; Toda, K			Analysis of flow behavior of non-Newtonian fluids based on a concept of traveling force	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						non-Newtonian fluid; contact particles; traveling force; shear stress; viscosity equation	UNIFORM COLLOIDAL SPHERES; RHEOLOGICAL PROPERTIES; CYANOSPIRA-CAPSULATA; KINETIC-THEORY; POLYMER MELTS; VISCOSITY; POLYSACCHARIDES; CYANOBACTERIA; DISPERSIONS; SUSPENSIONS	The non-Newtonian flow behavior of a culture fluid with suspended adhesive particles of microbes and polysaccharides is analyzed in this study based on a new concept. The concept assumes that the force generated by the contact between particles under shearing flow due to mixing is decreasingly transmitted through the fluid in radial directions. A viscosity equation that includes the degree of force transmisson is derived by considering the shear stress to the force. On the other hand, the shear stress dependence on the concentration of bound particles is expressed in an equation by introducing an effective shear stress that works on the contact sites of the bindings and varies the concentration. Relating the degree of force transmission to the concentration derives a non-Newtonian viscosity equation in terms of shear stress (or shear rate), in which zero-shear viscosity is correlated with both the particle concentration and molecular weight of polymers. It is confirmed that calculations based on the equation are in good agreement with experimental results previously reported for aqueous solutions of several polysaccharides.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138657, Japan	Furuse, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						FREED KF, 1974, J CHEM PHYS, V61, P3626, DOI 10.1063/1.1682545; HOFFMAN RL, 1972, T SOC RHEOL, V16, P155; NAVARINI L, 1990, CARBOHYD POLYM, V12, P169, DOI 10.1016/0144-8617(90)90017-M; ALLEN DG, 1990, CHEM ENG SCI, V45, P37; AXELOS MAV, 1989, INT J BIOL MACROMOL, V11, P186, DOI 10.1016/0141-8130(89)90066-4; BUECHE F, 1956, J CHEM PHYS, V25, P599, DOI 10.1063/1.1742998; CHOI GN, 1986, J COLLOID INTERF SCI, V113, P101, DOI 10.1016/0021-9797(86)90210-9; CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X; CURTISS CF, 1981, J CHEM PHYS, V74, P2026, DOI 10.1063/1.441247; DOI M, 1981, J POLYM SCI POL LETT, V19, P265, DOI 10.1002/pol.1981.130190507; Dreveton E, 1996, J FERMENT BIOENG, V82, P272, DOI 10.1016/0922-338X(96)88819-2; FOX G, 1956, RHEOLOGY, V1, P431; FURUSE H, 1981, KAGAKU KOGAKU RONBUN, V7, P315; Gillespie T., 1960, Journal of Colloid Science, V15, DOI 10.1016/0095-8522(60)90024-6; KIM JH, 1983, EUR J APPL MICROBIOL, V18, P11, DOI 10.1007/BF00508123; Kouda T, 1996, J FERMENT BIOENG, V82, P382, DOI 10.1016/0922-338X(96)89155-0; LAPASIN R, 1992, CARBOHYD POLYM, V17, P1, DOI 10.1016/0144-8617(92)90017-K; LAUN HM, 1979, RHEOL ACTA, V18, P478, DOI 10.1007/BF01736954; METZNER AB, 1958, T SOC RHEOL, V2, P239; MORRIS ER, 1990, CARBOHYD POLYM, V13, P85, DOI 10.1016/0144-8617(90)90053-U; Morris E. R., 1981, Carbohydrate Polymers, V1, P5, DOI 10.1016/0144-8617(81)90011-4; PEDERSEN AG, 1993, BIOTECHNOL BIOENG, V41, P162, DOI 10.1002/bit.260410121; POVOLO F, 1992, POLYM J, V24, P497, DOI 10.1295/polymj.24.497; SCHIEBER JD, 1987, J CHEM PHYS, V87, P4917, DOI 10.1063/1.452804; Toda K, 1998, J FERMENT BIOENG, V85, P410, DOI 10.1016/S0922-338X(98)80085-8; TODA K, 1998, J JPN SOC BIORHEOL, V12, P74; Toda K, 1997, NIHON REOROJI GAKK, V25, P43; WHITCOMB PJ, 1978, J RHEOL, V22, P493, DOI 10.1122/1.549485; WOODS ME, 1970, J COLLOID INTERF SCI, V34, P91, DOI 10.1016/0021-9797(70)90262-6	29	2	2	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723			J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	1999	87	2					218	223		10.1016/S1389-1723(99)89016-1		6	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	209CQ	WOS:000081030500016		
J	Yao, SL; Shen, XC; Terada, S; Nagamune, T; Suzuki, E				Yao, SL; Shen, XC; Terada, S; Nagamune, T; Suzuki, E			A new method of ATP regeneration rate measurement using a pH meter	JOURNAL OF BIOSCIENCE AND BIOENGINEERING			English	Article						ATP regeneration; creatine phosphate; creatine kinase; pH measurement	FREE PROTEIN-SYNTHESIS; WHEAT-GERM EXTRACT; SYSTEM; KINASE; LEVEL	A new method was developed for measuring the ATP regeneration tate by creatine kinase from creatine phosphate and ADP. The ATP regeneration rate was calculated to be 0.20 mM . s(-1) at room temperature from the pH change of the regeneration mixture.	Res Inst Innovat Technol Earth, Kyoto 6190292, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan	Suzuki, E (reprint author), Res Inst Innovat Technol Earth, 9-2 Kizugawadai, Kyoto 6190292, Japan.						SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; CLARK JF, 1995, J VASC RES, V32, P24, DOI 10.1159/000159074; FELIPO V, 1987, BIOCHEM BIOPH RES CO, V146, P1079, DOI 10.1016/0006-291X(87)90757-1; HUCUL JA, 1985, J BIOL CHEM, V260, P5585; KANTOR HL, 1984, BIOCHIM BIOPHYS ACTA, V789, P128, DOI 10.1016/0167-4838(84)90196-1; KAWARASAKI Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1911; MAHOWALD TA, 1962, J BIOL CHEM, V237, P1535; Matveev SV, 1996, BBA-PROTEIN STRUCT M, V1293, P207, DOI 10.1016/0167-4838(95)00244-8; NEEMAN M, 1987, BIOCHIM BIOPHYS ACTA, V930, P179, DOI 10.1016/0167-4889(87)90030-9; WALTER E, 1992, J BIOL CHEM, V267, P14084; Yamamoto YI, 1996, J CHEM ENG JPN, V29, P1047, DOI 10.1252/jcej.29.1047; Yao SL, 1997, J FERMENT BIOENG, V84, P7, DOI 10.1016/S0922-338X(97)82779-1	12	0	0	SOC BIOSCIENCE BIOENGINEERING JAPAN	OSAKA	OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871, JAPAN	1389-1723			J BIOSCI BIOENG	J. Biosci. Bioeng.	FEB	1999	87	2					238	240		10.1016/S1389-1723(99)89020-3		3	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	209CQ	WOS:000081030500020		
J	Sasaki-Iwaoka, H; Maruyama, K; Endoh, H; Komori, T; Kato, S; Kawashima, H				Sasaki-Iwaoka, H; Maruyama, K; Endoh, H; Komori, T; Kato, S; Kawashima, H			A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in Osteoblasts	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article							RALOXIFENE LY139481 HCL; RECEPTOR MESSENGER-RNA; POSTMENOPAUSAL WOMEN; RESPONSE ELEMENT; TARGET-CELLS; CLEIDOCRANIAL DYSPLASIA; BONE; RAT; IDENTIFICATION; ACTIVATION	The presence of bone-specific estrogen agonists and discovery of the osteoblast-specific transcription factor (TF), Cbfa1, together with the discovery of synergism between a TF Pit-1 and estrogen receptor alpha (FR alpha) on rat prolactin gene, led to investigation of Cbfa1 in the modulation of osteoblast-specific actions of estrogen, Reverse transcribed-polymerase chain reaction demonstrated expression of Cbfa1 in the osteoblastic cell lines, MG63, ROS17/2,8, and MC3T3E1, but not in nonosteoblastic cell lines, MCF7, C3H10T1/2, and HeLa. An ER expression vector and a series of luciferase (Luc) reporter plasmids harboring the Cbfa1 binding site OSE2 (the osteoblast-specific cis element in the osteocalcin promoter) and palindromic estrogen response elements (EREs) were cotransfected into both osteoblastic and nonosteoblastic cells. OSE2 worked as a cis-acting element in osteoblastic cells but not nonosteoblastic cells, whereas EREs were cis-acting in all cell lines. Synergistic transactivation was observed in osteoblastic cells only when both ERE and OSE2 were placed in juxtaposition to the promoter. Forced expression of Cbfa1 in C3H10T1/2 cells also induced synergism. Tamoxifen, a partial agonist/antagonist of estrogen, acted as an osteoblast-specific agonist in cells transfected with a promoter containing ERF and acted synergistically with a promoter containing the ERE-OSE2 enhancer combination. These results support the idea that bane-specific TFs modulate the actions of estrogen in a tissue-specific manner.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki, Japan; Osaka Univ, Sch Med, Dept Med 3, Osaka, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Kawashima, H (reprint author), Niigata Univ, Sch Dent, Dept Pharmacol, 5274 2 Bancho Gakkocho Dori, Niigata 951, Japan.						WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; TURNER RT, 1994, ENDOCR REV, V15, P275, DOI 10.1210/er.15.3.275; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; HOROWITZ MC, 1993, SCIENCE, V260, P626, DOI 10.1126/science.8480174; BRAIDMAN IP, 1995, J BONE MINER RES, V10, P74; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; KATO S, 1992, CELL, V68, P731, DOI 10.1016/0092-8674(92)90148-6; PFAFF D, 1973, J COMP NEUROL, V151, P121, DOI 10.1002/cne.901510204; DUCY P, 1995, MOL CELL BIOL, V15, P1858; BROWN TJ, 1988, ENDOCRINOLOGY, V123, P1761; Draper MW, 1996, J BONE MINER RES, V11, P835; Grodstein F, 1997, NEW ENGL J MED, V336, P1769, DOI 10.1056/NEJM199706193362501; ORIMO A, 1993, BIOCHEM BIOPH RES CO, V195, P730, DOI 10.1006/bbrc.1993.2106; NABULSI AA, 1993, NEW ENGL J MED, V328, P1069, DOI 10.1056/NEJM199304153281501; KOMM BS, 1988, SCIENCE, V241, P81, DOI 10.1126/science.3164526; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; BLACK LJ, 1994, J CLIN INVEST, V93, P63, DOI 10.1172/JCI116985; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; LOVE RR, 1992, NEW ENGL J MED, V326, P852, DOI 10.1056/NEJM199203263261302; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; deMedeiros SRB, 1997, J BIOL CHEM, V272, P18250, DOI 10.1074/jbc.272.29.18250; Chuang FM, 1997, MOL ENDOCRINOL, V11, P1332, DOI 10.1210/me.11.9.1332; DAY RN, 1990, MOL ENDOCRINOL, V4, P1964; Endoh H, 1997, BIOCHEM BIOPH RES CO, V235, P99, DOI 10.1006/bbrc.1997.6746; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GEORGE G, 1997, ENDOCRINOLOGY, V138, P863; GURA T, 1995, SCIENCE, V269, P771, DOI 10.1126/science.7543696; HESKETH R, 1994, ONCOGENE HDB; Horwitz KB, 1996, MOL ENDOCRINOL, V10, P1167, DOI 10.1210/me.10.10.1167; HORWITZ KB, 1978, J BIOL CHEM, V253, P8185; KATO S, 1995, MOL CELL BIOL, V15, P5858; KE HZ, 1995, ENDOCRINOLOGY, V136, P2435, DOI 10.1210/en.136.6.2435; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Mano H, 1996, BIOCHEM BIOPH RES CO, V223, P637, DOI 10.1006/bbrc.1996.0947; MCCABE LR, 1995, EXP CELL RES, V218, P255, DOI 10.1006/excr.1995.1154; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; OURSLER MJ, 1991, P NATL ACAD SCI USA, V88, P6613, DOI 10.1073/pnas.88.15.6613; SCHULE R, 1991, TRENDS GENET, V7, P377, DOI 10.1016/0168-9525(91)90259-S; STUMPF WE, 1977, SCIENCE, V196, P319, DOI 10.1126/science.847474; UMEYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Watanabe T, 1997, BIOCHEM BIOPH RES CO, V236, P140, DOI 10.1006/bbrc.1997.6915; XING H, 1995, BIOCHEMISTRY-US, V34, P3956, DOI 10.1021/bi00012a013; Yang NN, 1996, SCIENCE, V273, P1222, DOI 10.1126/science.273.5279.1222	47	22	22	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	FEB	1999	14	2					248	255		10.1359/jbmr.1999.14.2.248		8	Endocrinology & Metabolism	Endocrinology & Metabolism	161NE	WOS:000078294700012		
J	Hoshi, K; Kemmotsu, S; Takeuchi, Y; Amizuka, N; Ozawa, H				Hoshi, K; Kemmotsu, S; Takeuchi, Y; Amizuka, N; Ozawa, H			The primary calcification in bones follows removal of decorin and fusion of collagen fibrils	JOURNAL OF BONE AND MINERAL RESEARCH			English	Article							GROWTH-FACTOR-BETA; DERMATAN SULFATE; MATRIX VESICLES; PROTEOGLYCAN; ULTRASTRUCTURE; LOCALIZATION; MORPHOLOGY; CARTILAGE; INVITRO; CULTURE	To elucidate the mechanisms of primary calcification in bone, ultrastructural changes in collagen fibrils, as well as cytochemical alteration of proteoglycan, especially decorin, were investigated morphologically in 19-day post-coitum embryonic rat calvariae, Below the osteoblast layer, calcification of the osteoid area increased in direct proportion to its distance from the osteoblasts, In the uncalcified osteoid area, collagen fibrils near matrix vesicles possessed sharp contours and were a uniform 50 mn in diameter. Immunoelectron microscopy revealed decorin to be abundantly localized in the vicinity of the collagen fibrils, In the osteoid area undergoing the process of calcification, collagen fibrils tended to fuse side by side, Where calcification was progressed, this: fusion was even more so, Some very large fribrils exhibited complicated contours, 400 nm or more in diameter, Although the calcification at this stage affected areas both inside and outside of the collagen fibrils, the interior areas manifested a lower density of calcification, The immunolocalization of decorin was also much decreased around these fibrils. Thus, primary calcification in bone matrix follows the removal of decorin and fusion of collagen fibrils. This phenomenon may aid in the process of calcification and bone formation, because (1) inhibitors of calcification, such as decorin, are removed, (2) the fusion of collagen fibrils provides the room necessary for rapid growth of mineral crystals, and (3) the soft elastic bone matrix containing abundant fused collagen fibrils less subjective to calcification is safe for both maternal and embryonic bodies and is convenient for subsequent bone remodeling.	Niigata Univ, Sch Dent, Dept Oral Anat 1, Niigata 9518514, Japan; Univ Tokyo, Sch Med, Dept Internal Med 4, Tokyo 112, Japan	Hoshi, K (reprint author), Niigata Univ, Sch Dent, Dept Oral Anat 1, 2-5274 Gakkacho Dori, Niigata 9518514, Japan.						ANDERSON HC, 1967, J CELL BIOL, V35, P81, DOI 10.1083/jcb.35.1.81; Weiner S, 1997, BONE, V20, P509, DOI 10.1016/S8756-3282(97)00053-7; TOKUYASU KT, 1989, HISTOCHEM J, V21, P163, DOI 10.1007/BF01007491; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229; SCOTT JE, 1988, BIOCHEM J, V252, P313; TAKEUCHI Y, 1994, J BIOL CHEM, V269, P32634; BIRK DE, 1995, DEV DYNAM, V202, P229; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FLEISCHMAJER R, 1981, P NATL ACAD SCI-BIOL, V78, P7360, DOI 10.1073/pnas.78.12.7360; SCOTT JE, 1981, BIOCHEM J, V197, P213; CHEN CC, 1985, CALCIFIED TISSUE INT, V37, P395, DOI 10.1007/BF02553709; FISHER LW, 1987, J BIOL CHEM, V262, P9702; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549; BIRK DE, 1990, J CELL SCI, V95, P649; Birk DE, 1991, CELL BIOL EXTRACELLU, P221; BONUCCI E, 1967, J ULTRA MOL STRUCT R, V20, P33, DOI 10.1016/S0022-5320(67)80034-0; DEAN DD, 1994, CALCIFIED TISSUE INT, V54, P399, DOI 10.1007/BF00305527; Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61; FISHER LW, 1983, J BIOL CHEM, V258, P6588; FLEISCHMAJER R, 1983, P NATL ACAD SCI-BIOL, V80, P3354, DOI 10.1073/pnas.80.11.3354; Hoshi K, 1997, ACTA HISTOCHEM CYTOC, V30, P371; IKEDA H, 1984, J ELECTRON MICROSC, V33, P242; KATZ EP, 1969, BIOCHIM BIOPHYS ACTA, V194, P121, DOI 10.1016/0005-2795(69)90187-1; FLEISH H, 1961, AM J PHYSIOL, V200, P1296; OZAWA H, 1972, P 4 INT C HIST CYT K, P311; Schmitz JP, 1996, J CELL BIOCHEM, V61, P375, DOI 10.1002/(SICI)1097-4644(19960601)61:3<375::AID-JCB5>3.0.CO;2-Q; SCOTT JE, 1984, BIOCHEM J, V218, P229; SELA J, 1979, VIRCHOWS ARCH A, V382, P1, DOI 10.1007/BF01102736; SHEPARD N, 1976, J HISTOCHEM CYTOCHEM, V24, P621; TAKEUCHI Y, 1990, BIOCHEM J, V266, P15; VOGEL KG, 1987, COLLAGEN REL RES, V7, P105	31	63	67	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0884-0431			J BONE MINER RES	J. Bone Miner. Res.	FEB	1999	14	2					273	280		10.1359/jbmr.1999.14.2.273		8	Endocrinology & Metabolism	Endocrinology & Metabolism	161NE	WOS:000078294700015		
J	Liu, YK; Seki, M; Furusaki, S				Liu, YK; Seki, M; Furusaki, S			Plant cell immobilization in loofa sponge using two-way bubble circular system	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						biochemical engineering; plant cell immobilization; loofa sponge; Luffa cylindrica; bubble circular system	LUFFA-CYLINDRICA SPONGE; 2,3,5-TRIPHENYLTETRAZOLIUM CHLORIDE; VIABILITY ASSAY; TISSUE CULTURE; COFFEA-ARABICA; BIOTECHNOLOGY	In this study, we investigated the immobilization of loofa sponge as a carrier for plant cells using a novel immobilization reactor, namely, a two-way bubble circular (TBC) reactor, for analyzing the effects of medium flow pattern. A TBC reactor, in which two-way circular flow prevailed and was controlled by bubble flow and sparger adjustment, was developed as a suitable system for plant cell immobilization using loofa sponge. In this system, relatively small aggregates of cultured plant cells could be immobilized, and the entrapped cells grew quickly, avoiding cell leakage from the sponge throughout 31 days of incubation. The optimum immobilization conditions and immobilization mechanism in this system were investigated using Coffea arabica cells as a model cell line. By changing the flow direction of culture medium in the circular reactor periodically between downflow and up-flow, cell immobilization efficiency of the loofa sponge was improved as compared with reactors using one-directional flows, The specific respiration activity of cells immobilized in loofa sponge was also studied, Uniform distribution of cell density and specific respiration activity were obtained along the axial direction of the loofa sponge. In the same reactor system, loofa sponge exhibited high immobilized cell concentration and specific respiration activity not less than those of polyurethane foam.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Seki, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan.						BRODELIUS P, 1979, FEBS LETT, V103, P93, DOI 10.1016/0014-5793(79)81257-0; FACCHINI PJ, 1990, APPL MICROBIOL BIOT, V33, P36; FURUYA T, 1988, PHYTOCHEMISTRY, V27, P803, DOI 10.1016/0031-9422(88)84096-2; HOOKER BS, 1989, ENZYME MICROB TECH, V11, P484, DOI 10.1016/0141-0229(89)90028-8; HULST AC, 1989, APPL MICROBIOL BIOT, V30, P18; Iborra JL, 1992, BIOTECHNOL TECH, V6, P319, DOI 10.1007/BF02439319; LANG JA, 1990, BIOTECHNOL PROGR, V6, P447, DOI 10.1021/bp00006a007; LINDSEY K, 1983, FEBS LETT, V155, P143, DOI 10.1016/0014-5793(83)80227-0; Liu YK, 1998, J FERMENT BIOENG, V85, P416, DOI 10.1016/S0922-338X(98)80086-X; NAKAJIMA H, 1986, APPL MICROBIOL BIOT, V24, P266; Ogbonna JC, 1997, J FERMENT BIOENG, V84, P271, DOI 10.1016/S0922-338X(97)82069-7; OGBONNA JC, 1994, J FERMENT BIOENG, V78, P437, DOI 10.1016/0922-338X(94)90043-4; Ogbonna JC, 1996, PROCESS BIOCHEM, V31, P737, DOI 10.1016/S0032-9592(96)00036-2; PARR AJ, 1989, J BIOTECHNOL, V10, P1, DOI 10.1016/0168-1656(89)90089-8; PRENOSIL JE, 1987, ENZYME MICROB TECH, V9, P450, DOI 10.1016/0141-0229(87)90096-2; STAFFORD A, 1986, ENZYME MICROB TECH, V8, P578, DOI 10.1016/0141-0229(86)90114-6; TATICEK RA, 1991, PLANT CELL TISS ORG, V24, P139, DOI 10.1007/BF00039742; TOWILL LE, 1975, CAN J BOT, V53, P1097; TYLER RT, 1995, PLANT CELL TISS ORG, V42, P81	19	7	7	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	FEB	1999	32	1					8	14		10.1252/jcej.32.8		7	Engineering, Chemical	Engineering	170VA	WOS:000078826700002		
J	Watanabe, M; Nitta, T				Watanabe, M; Nitta, T			Decadal changes in the atmospheric circulation and associated surface climate variations in the Northern Hemisphere winter	JOURNAL OF CLIMATE			English	Article							LOW-FREQUENCY VARIABILITY; SEA-LEVEL PRESSURE; TEMPERATURE-VARIATIONS; ATLANTIC OSCILLATION; SOUTHERN OSCILLATION; HEAT-FLUX; PACIFIC; PATTERNS; OCEAN; ANOMALIES	This study attempts to investigate decadal-scale climate changes in the mid- and high latitudes of the Northern Hemisphere in winter 1989 by using various observational data for atmospheric parameters, sea surface temperature (SST), and snow cover. Decadal-scale changes in the winter atmosphere after 1989 are characterized as follows: a dipole pattern of height anomalies between midlatitudes and polar regions with an equivalent barotropic structure, temperature changes with cooling in the polar region and warming in midlatitudes in the middle troposphere, and associated reduction of the subtropical jet stream. Statistical tests applied to the 500-hPa height field reveal that the changes in 1989 are a distinct discontinuity or shift on the decadal scale with hemispheric extent. The spatial structure is interpreted as a linear combination of three teleconnections: the North Atlantic oscillation, Pacific-North American, and Eurasian patterns, in addition to the zonally symmetric dipole. On the other hand, the sharpness of decadal changes in 1989 arises from synchronous phase shifts of interdecadal variations over the Pacific Ocean and quasi-decadal variations over the North Atlantic. Similar concurrence is also found in winter 1977. In agreement with previous studies, the interdecadal atmospheric variations over the North Pacific reveal a strong coupling with tropical/extratropical SST anomalies in the Pacific Ocean. A relationship between the quasi-decadal variability of the North Atlantic atmosphere and underlying SST anomalies is relatively tenuous. Surface air temperatures show a warming over all of Eurasia after winter 1989. It is shown by the analysis of snow cover in the Northern Hemisphere derived from NOAA satellites that a large decrease (increase) of the snow extent over the eastern part of the Eurasian continent occurred in autumn 1988 (1976) prior to winter 1989 (1977). It is suggested that the anomalies in the Eurasian snow cover during autumn play a role as an amplifier in the atmospheric shifts. These snow anomalies may be as important for the atmospheric changes as changes in SSTs.	Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, Tokyo 153, Japan	Watanabe, M (reprint author), Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.						LATIF M, 1994, SCIENCE, V266, P634, DOI 10.1126/science.266.5185.634; GROISMAN PY, 1994, J CLIMATE, V7, P1633, DOI 10.1175/1520-0442(1994)007<1633:COSCTA>2.0.CO;2; KUSHNIR Y, 1989, J ATMOS SCI, V46, P3122, DOI 10.1175/1520-0469(1989)046<3122:LFVITN>2.0.CO;2; TRENBERTH KE, 1994, CLIM DYNAM, V9, P303, DOI 10.1007/BF00204745; Latif M, 1996, J CLIMATE, V9, P2407, DOI 10.1175/1520-0442(1996)009<2407:DCVOTN>2.0.CO;2; NORTH GR, 1982, MON WEATHER REV, V110, P699, DOI 10.1175/1520-0493(1982)110<0699:SEITEO>2.0.CO;2; JAMES IN, 1989, NATURE, V342, P53, DOI 10.1038/342053a0; CHENG XH, 1995, J CLIMATE, V8, P1709, DOI 10.1175/1520-0442(1995)008<1709:ROLFCP>2.0.CO;2; ROGERS JC, 1984, MON WEATHER REV, V112, P1999, DOI 10.1175/1520-0493(1984)112<1999:TABTNA>2.0.CO;2; NITTA T, 1989, J METEOROL SOC JPN, V67, P375; Zhang Y, 1997, J CLIMATE, V10, P1004, DOI 10.1175/1520-0442(1997)010<1004:ELIV>2.0.CO;2; KIMOTO M, 1993, J ATMOS SCI, V50, P2625, DOI 10.1175/1520-0469(1993)050<2625:MFRITN>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; WALLACE JM, 1992, J CLIMATE, V5, P561, DOI 10.1175/1520-0442(1992)005<0561:SVDOWS>2.0.CO;2; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Ting MF, 1996, J CLIMATE, V9, P2614, DOI 10.1175/1520-0442(1996)009<2614:NHTPDE>2.0.CO;2; HOLTON JR, 1980, J ATMOS SCI, V37, P2200, DOI 10.1175/1520-0469(1980)037<2200:TIOTEQ>2.0.CO;2; DESER C, 1995, J CLIMATE, V8, P1677, DOI 10.1175/1520-0442(1995)008<1677:OTRBTA>2.0.CO;2; Trenberth KE, 1996, GEOPHYS RES LETT, V23, P57, DOI 10.1029/95GL03602; GRAHAM NE, 1994, CLIM DYNAM, V10, P135, DOI 10.1007/BF00210626; Hurrell JW, 1996, GEOPHYS RES LETT, V23, P665, DOI 10.1029/96GL00459; KAWAMURA R, 1994, J PHYS OCEANOGR, V24, P707, DOI 10.1175/1520-0485(1994)024<0707:AREAOG>2.0.CO;2; YONETANI T, 1992, J METEOROL SOC JPN, V70, P95; WALLACE JM, 1995, SCIENCE, V270, P780, DOI 10.1126/science.270.5237.780; WALLACE JM, 1990, J CLIMATE, V3, P990, DOI 10.1175/1520-0442(1990)003<0990:SPOAOI>2.0.CO;2; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; DESER C, 1993, J CLIMATE, V6, P1743, DOI 10.1175/1520-0442(1993)006<1743:SCVOTN>2.0.CO;2; BRETHERTON CS, 1992, J CLIMATE, V5, P541, DOI 10.1175/1520-0442(1992)005<0541:AIOMFF>2.0.CO;2; Nakamura H, 1997, B AM METEOROL SOC, V78, P2215, DOI 10.1175/1520-0477(1997)078<2215:DCVITN>2.0.CO;2; TANIMOTO Y, 1993, J CLIMATE, V6, P1153, DOI 10.1175/1520-0442(1993)006<1153:CVOSST>2.0.CO;2; Bjerknes J, 1964, ADV GEOPHYS, P1, DOI DOI 10.1016/S0065-2687(08)60005-9; CAYAN DR, 1992, J CLIMATE, V5, P354, DOI 10.1175/1520-0442(1992)005<0354:LASHFA>2.0.CO;2; IWASAKA N, 1995, J METEOROL SOC JPN, V73, P781; JONES PD, 1986, J CLIM APPL METEOROL, V25, P161, DOI 10.1175/1520-0450(1986)025<0161:NHSATV>2.0.CO;2; Kitoh A, 1996, GEOPHYS RES LETT, V23, P543, DOI 10.1029/96GL00158; KUSHNIR Y, 1994, J CLIMATE, V7, P141, DOI 10.1175/1520-0442(1994)007<0141:IVINAS>2.0.CO;2; LANZANTE JR, 1984, MON WEATHER REV, V112, P2270, DOI 10.1175/1520-0493(1984)112<2270:AREOTC>2.0.CO;2; MANN ME, 1994, J GEOPHYS RES-ATMOS, V99, P25819, DOI 10.1029/94JD02396; Maslanik JA, 1996, GEOPHYS RES LETT, V23, P1677, DOI 10.1029/96GL01426; RICHMAN MB, 1986, J CLIMATOL, V6, P293; Tachibana Y, 1996, J METEOROL SOC JPN, V74, P579; Tanaka HL, 1996, J METEOROL SOC JPN, V74, P947; TRENBERTH KE, 1990, B AM METEOROL SOC, V71, P988, DOI 10.1175/1520-0477(1990)071<0988:ROICCI>2.0.CO;2; TRENBERTH KE, 1981, MON WEATHER REV, V109, P1169, DOI 10.1175/1520-0493(1981)109<1169:CPOVOS>2.0.CO;2; Walsh JE, 1996, J CLIMATE, V9, P480, DOI 10.1175/1520-0442(1996)009<0480:RDOSLP>2.0.CO;2; Watanabe M, 1998, J CLIMATE, V11, P2837, DOI 10.1175/1520-0442(1998)011<2837:RIOSAS>2.0.CO;2; Wiesnet D. R., 1987, IAHS PUBL, V166, P291	48	117	124	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755			J CLIMATE	J. Clim.	FEB	1999	12	2					494	510		10.1175/1520-0442(1999)012<0494:DCITAC>2.0.CO;2		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	174LY	WOS:000079037700012		
J	Tanaka, S; Mori, M; Sakamoto, Y; Makuuchi, M; Sugimachi, K; Wands, JR				Tanaka, S; Mori, M; Sakamoto, Y; Makuuchi, M; Sugimachi, K; Wands, JR			Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma	JOURNAL OF CLINICAL INVESTIGATION			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; TIE2 RECEPTOR; ANGIOGENESIS; LIGAND; TEK	Human hepatocellular carcinoma (HCC) is generally a highly vascular tumor, but the mechanisms of neovascularization that permit rapid growth have not been defined. Angiopoietins (Ang) recently have been identified as ligands for vascular endothelial-specific Tie2 receptor tyrosine kinase and may be important growth factors in the generation of new blood vessels. We investigated Ang expression in 23 samples of HCC and paired adjacent uninvolved liver samples to determine if these genes have a potential role in the growth and spread of this disease. The full coding sequence of a variant angiopoietin-2 (Ang2) cDNA was obtained from HCC specimens, and the biologic consequences of overexpression on tumor formation and hemorrhage were determined in an animal model system. Angiopoietin-1 (Ang1) was equally expressed in HCC and adjacent noncarcinomatous liver tissue. Surprisingly, Ang2 was found to be highly expressed only in tumor tissue. In addition, Ang2 was expressed in 10 of 12 hypervascular HCC, but only in 2 of 11 hypovascular HCC. Ectopic expression of Ang2 in nonexpressing HCC cells promotes the rapid development of human hepatomas and produces hemorrhage within tumors in nude mice. These results suggest a role for Ang2 in the neovascularization of HCC. This enhanced gene expression may contribute to the clinical hypervascular phenotype, as well as tumor formation and progression.	Kyushu Univ, Med Inst Bioregulat, Dept Surg, Beppu, Oita 8740838, Japan; Univ Tokyo, Fac Med, Dept Surg, Tokyo 1130033, Japan; Kyushu Univ, Fac Med, Dept Surg 2, Fukuoka 8148582, Japan; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Canc Ctr,Mol Hepatol Lab, Boston, MA 02114 USA	Tanaka, S (reprint author), Kyushu Univ, Med Inst Bioregulat, Dept Surg, 4546 Tsurumibaru, Beppu, Oita 8740838, Japan.		Mori, Masaki/A-4501-2011; 幕内, 雅敏/A-2140-2012				SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Kontos CD, 1998, MOL CELL BIOL, V18, P4131; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; RUNTING AS, 1993, GROWTH FACTORS, V9, P99; FIDLER IJ, 1994, CELL, V79, P185, DOI 10.1016/0092-8674(94)90187-2; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; HUANG LW, 1995, ONCOGENE, V11, P2097; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; DUMONT DJ, 1993, ONCOGENE, V8, P1293; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Beck L, 1997, FASEB J, V11, P365; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Jones N, 1998, ONCOGENE, V17, P1097, DOI 10.1038/sj.onc.1202115; Liver Cancer Study Group of J, 1990, ANN SURG, V211, P277; MORADPOUR D, 1996, HEPATOLOGY TXB LIVER, V2, P1490; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tanaka S, 1998, P NATL ACAD SCI USA, V95, P10164, DOI 10.1073/pnas.95.17.10164; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016	21	188	205	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	ROOM 4570 KRESGE I, 200 ZINA PITCHER PLACE, ANN ARBOR, MI 48109-0560 USA	0021-9738			J CLIN INVEST	J. Clin. Invest.	FEB	1999	103	3					341	345		10.1172/JCI4891		5	Medicine, Research & Experimental	Research & Experimental Medicine	166MX	WOS:000078581400006		
J	Fukuda, T; Morimoto, Y; Morishita, S; Tokuyama, T				Fukuda, T; Morimoto, Y; Morishita, S; Tokuyama, T			Mining optimized association rules for numeric attributes	JOURNAL OF COMPUTER AND SYSTEM SCIENCES			English	Article; Proceedings Paper	15th ACM SIGACT-SIGMOD-SIGART Symposium on Principles of Database Systems	JUN 03-05, 1996	MONTREAL, CANADA	SIGACT, SIGMOD, SIGART				Given a huge database, we address the problem of finding association rules for numeric attributes, such as (Balance is an element of l) double right arrow (CardLoan = yes), which implies that bank customers whose balances fall in a range l are likely to use card loan with a probability greater than p. The above rule is interesting only if the range l has some special feature with respect to the interrelation between Balance and CardLoan. It is required that the number of customers whose balances are contained in l (called the support of l) is sufficient and also that the probability p of the condition CardLoan = yes being met (called the confidence ratio) be much higher than the average probability of the condition over all the data. Our goal is to realize a system that finds such appropriate ranges automatically. We mainly focus on computing two optimized ranges: one that maximizes the support on the condition that the confidence ratio is at least a given threshold value, and another that maximizes the confidence ratio on the condition that the support is at least a given threshold number. Using techniques from computational geometry, we present novel algorithms that compute the optimized ranges in linear time if the data are sorted. Since sorting data with respect to each numeric attribute is expensive in the case of huge databases that occupy much more space than the main memory, we instead apply randomized bucketing as the preprocessing method and thus obtain an efficient rule-finding system. Tests show that our implementation is fast not only in theory but also in practice. The efficiency of our algorithm enables us to compute optimized rules for all combinations of hundreds of numeric and Boolean attributes in a reasonable time. (C) 1999 Academic Press.	IBM Corp, Res, Tokyo Res Lab, Yamato, Kanagawa 242, Japan; Univ Tokyo, Inst Med Sci, Tokyo 108, Japan	Fukuda, T (reprint author), IBM Corp, Res, Tokyo Res Lab, 1623-14 Shimo Tsuruma, Yamato, Kanagawa 242, Japan.		Morimoto, Yasuhiko/D-8282-2011	Morimoto, Yasuhiko/0000-0001-7130-2864			Agrawal R., 1993, P 1993 ACM SIGMOD IN, V22, P207, DOI DOI 10.1145/170035.170072; AGRAWAL R, 1993, IEEE T KNOWL DATA EN, V5, P914, DOI 10.1109/69.250074; AGRAWAL R, 1992, PROC INT CONF VERY L, P560; Agrawal R, 1994, P 20 INT C VER LARG, P487; Bentley J., 1984, Communications of the ACM, V27, DOI 10.1145/358234.381162; Breiman L., 1984, CLASSIFICATION REGRE; Fukuda T., 1996, P 1996 ACM SIGMOD IN, P13, DOI 10.1145/233269.233313; HAN JW, 1992, PROC INT CONF VERY L, P547; Mehta M., 1996, P 5 INT C EXT DAT TE; Morimoto Y., 1997, Constraints, V2, DOI 10.1023/A:1009755828992; Motwani R., 1995, RANDOMIZED ALGORITHM; Ng R.T., 1994, P 20 INT C VER LARG, P144; Park J. S., 1995, P ACM SIGMOD INT C M, P175, DOI 10.1145/223784.223813; PIATETSKYSHAPIR.G, 1991, KNOWLEDGE DISCOVERY; Piatetsky-Shapiro G., 1991, Knowledge discovery in databases; Preparata F. P., 1985, COMPUTATIONAL GEOMET; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Srikant R, 1996, P ACM SIGMOD C MAN D; STONEBRAKER M, 1993, P 19 VLDB C, P688; Yoda K., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining	20	23	23	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-0000			J COMPUT SYST SCI	J. Comput. Syst. Sci.	FEB	1999	58	1					1	12		10.1006/jcss.1998.1595		12	Computer Science, Hardware & Architecture; Computer Science, Theory & Methods	Computer Science	170AN	WOS:000078783100002		
J	Wu, J; Yaguchi, H; Onabe, K; Shiraki, Y				Wu, J; Yaguchi, H; Onabe, K; Shiraki, Y			Stimulated emission from optically pumped cubic GaN/AlGaN double heterostructures	JOURNAL OF CRYSTAL GROWTH			English	Article						stimulated emission; MOVPE; cubic GaN; cubic AlGaN; heterostructures; cleaved cavity	MOLECULAR-BEAM EPITAXY; VAPOR-PHASE EPITAXY; ROOM-TEMPERATURE; GALLIUM NITRIDE; VERTICAL-CAVITY; HEXAGONAL GAN; GROWTH; LASER; GAAS; SAPPHIRE	Cubic GaN/AlGaN heterostructures were grown on semi-insulating GaAs(1 0 0) substrates by metalorganic vapor-phase epitaxy. Optical pumping experiments were performed on cubic GaN/AlGaN cavities, which were formed simply by cleaving the substrate. Strong stimulated emission at a wavelength of 394 nm was observed from the cleaved edge of the optically pumped cubic GaN/AlGaN heterostructures at 15 K. The stimulated emission was demonstrated by the superlinear increase of the output intensity and the highly TE-polarized nature. Besides this strong stimulated emission, an additional stimulated emission centered at 383 nm is also observed from some samples. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Wu, J (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Yaguchi, Hiroyuki/B-3902-2012	Yaguchi, Hiroyuki/0000-0003-0621-3501			AGGARWAL RL, 1995, APPL PHYS LETT, V79, P2148; AMANO H, 1994, APPL PHYS LETT, V64, P1377, DOI 10.1063/1.111942; PAISLEY MJ, 1989, J VAC SCI TECHNOL A, V7, P701, DOI 10.1116/1.575869; DINGLE R, 1971, APPL PHYS LETT, V19, P5, DOI 10.1063/1.1653730; Wu J, 1997, JPN J APPL PHYS 1, V36, P4241, DOI 10.1143/JJAP.36.4241; Wu J, 1997, APPL PHYS LETT, V71, P2067, DOI 10.1063/1.119344; Khan MA, 1996, APPL PHYS LETT, V69, P2418, DOI 10.1063/1.117656; KHAN MA, 1991, APPL PHYS LETT, V58, P1515, DOI 10.1063/1.105163; Klann R, 1997, APPL PHYS LETT, V70, P1076, DOI 10.1063/1.118489; Menniger J, 1996, PHYS REV B, V53, P1881, DOI 10.1103/PhysRevB.53.1881; MIYOSHI S, 1992, J CRYST GROWTH, V124, P439, DOI 10.1016/0022-0248(92)90497-7; MIZUTA M, 1986, JPN J APPL PHYS 2, V25, pL945, DOI 10.1143/JJAP.25.L945; Mullhauser JR, 1997, APPL PHYS LETT, V71, P909, DOI 10.1063/1.119685; Nakadaira A, 1997, APPL PHYS LETT, V71, P812, DOI 10.1063/1.119654; Nakadaira A, 1997, APPL PHYS LETT, V70, P2720, DOI 10.1063/1.119003; Nakamura S, 1996, JPN J APPL PHYS PT 1, V35, P74; OKUMURA H, 1994, J CRYST GROWTH, V136, P361, DOI 10.1016/0022-0248(94)90440-5; PANKOVE JI, 1990, MATER RES SOC SYMP P, V162, P515; Redwing JM, 1996, APPL PHYS LETT, V69, P1, DOI 10.1063/1.118104; STRITE S, 1991, J VAC SCI TECHNOL B, V9, P1924, DOI 10.1116/1.585381; Wu J, 1998, APPL PHYS LETT, V73, P193, DOI 10.1063/1.121752; YANG XH, 1995, APPL PHYS LETT, V66, P1, DOI 10.1063/1.114222; Zhang X, 1996, J APPL PHYS, V80, P6544, DOI 10.1063/1.363674	23	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	FEB	1999	197	1-2					73	77		10.1016/S0022-0248(98)00945-2		5	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	162PG	WOS:000078355300012		
J	Bera, LK; Ray, SK; Nayak, DK; Usami, N; Shiraki, Y; Maiti, CK				Bera, LK; Ray, SK; Nayak, DK; Usami, N; Shiraki, Y; Maiti, CK			Gas source molecular beam epitaxy grown strained-Si films on step-graded relaxed Si1-xGex for MOS applications	JOURNAL OF ELECTRONIC MATERIALS			English	Article						band offset; heterostructure MOSFET; gas source molecular beam epitaxy (GSMBE); silicon-germanium; strained-Si	MOBILITY ENHANCEMENT; ELECTRON-MOBILITY; BAND OFFSETS; HETEROSTRUCTURES; LAYER; DISCONTINUITIES; SUPERLATTICES; SPECTROSCOPY; DEVICE; FIELD	Gas source molecular beam epitaxy has been employed for the growth of a high quality strained-Si layer on a completely relaxed step-graded Si1-xGex buffer layer. As-grown strained-Si layers have been characterized using secondary ion mass spectroscopy, Rutherford backscattering spectroscopy, atomic force microscopy, and spectroscopic ellipsometry for the determination of composition, thickness, crystalline quality, and surface roughness. Heterojunction conduction and valence band offsets (Delta E-c, Delta E-v) of strained-Si/SiGe heterostructure have been determined from measured threshold voltages of a strained-Si channel p-metal oxide semiconductor field effect transistor (MOSFET) fabricated using grown films. MOS capacitance-voltage profiling has been employed for the extraction of strained-Si layer thickness and apparent doping profile in the device.	Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India; Altera Corp, Fremont, CA 94555 USA; Univ Tokyo, RCAST, Meguro Ku, Tokyo 153, Japan	Bera, LK (reprint author), Indian Inst Technol, Dept Elect & Elect Commun Engn, Kharagpur 721302, W Bengal, India.	ckm@ece.iitkgp.ernet.in	Usami, Noritaka/C-1720-2009				WELSER J, 1994, IEEE ELECTR DEVICE L, V15, P100, DOI 10.1109/55.285389; SCHMALZ K, 1994, PHYS REV B, V50, P14287, DOI 10.1103/PhysRevB.50.14287; Armstrong GA, 1998, SOLID STATE ELECTRON, V42, P487, DOI 10.1016/S0038-1101(98)00060-4; LEGOUES FK, 1991, PHYS REV LETT, V66, P2903, DOI 10.1103/PhysRevLett.66.2903; HUMLICEK J, 1989, J APPL PHYS, V65, P2827, DOI 10.1063/1.342720; ABSTREITER G, 1985, PHYS REV LETT, V54, P2441, DOI 10.1103/PhysRevLett.54.2441; VAN DE WALLE CG, 1986, PHYS REV B, V34, P5621, DOI 10.1103/PhysRevB.34.5621; MEYERSON BS, 1988, APPL PHYS LETT, V53, P2555, DOI 10.1063/1.100206; ISMAIL K, 1995, APPL PHYS LETT, V66, P1077, DOI 10.1063/1.113577; BRIGHTEN JC, 1993, J APPL PHYS, V74, P1894, DOI 10.1063/1.354799; Chretien O, 1997, THIN SOLID FILMS, V294, P198, DOI 10.1016/S0040-6090(96)09247-4; FITZGERALD EA, 1991, APPL PHYS LETT, V59, P811, DOI 10.1063/1.105351; FUKATSU S, 1992, APPL PHYS LETT, V61, P804, DOI 10.1063/1.107770; Harame D, 1995, INTERNATIONAL ELECTRON DEVICES MEETING, 1995 - IEDM TECHNICAL DIGEST, P731, DOI 10.1109/IEDM.1995.499322; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Humlicek J., 1995, PROPERTIES STRAINED, P121; ICHII A, 1993, J APPL PHYS, V74, P2112, DOI 10.1063/1.354734; INIEWSKI K, 1993, SOLID STATE ELECTRON, V36, P775, DOI 10.1016/0038-1101(93)90249-P; ISMAIL K, 1993, APPL PHYS LETT, V63, P660, DOI 10.1063/1.109949; Ismail K, 1995, INTERNATIONAL ELECTRON DEVICES MEETING, 1995 - IEDM TECHNICAL DIGEST, P509, DOI 10.1109/IEDM.1995.499249; JOHN S, 1996, P MAT RES SOC SPRING; KATO Y, 1995, J VAC SCI TECHNOL B, V13, P111, DOI 10.1116/1.588002; KOH J, 1995, APPL PHYS LETT, V67, P2669, DOI 10.1063/1.114287; Maiti CK, 1997, SOLID STATE ELECTRON, V41, P1863, DOI 10.1016/S0038-1101(97)00152-4; Nayak DK, 1996, IEEE T ELECTRON DEV, V43, P1709, DOI 10.1109/16.536817; NI WX, 1990, PHYS REV B, V42, P3030, DOI 10.1103/PhysRevB.42.3030; PEOPLE R, 1986, APPL PHYS LETT, V48, P538, DOI 10.1063/1.96499; PEOPLE R, 1986, IEEE J QUANTUM ELECT, V22, P1696, DOI 10.1109/JQE.1986.1073152; Rim K, 1995, INTERNATIONAL ELECTRON DEVICES MEETING, 1995 - IEDM TECHNICAL DIGEST, P517, DOI 10.1109/IEDM.1995.499251; SAARILATHI J, 1992, USERS GUIDE GISA 3 9; SPANOS L, 1994, J VAC SCI TECHNOL A, V12, P2653, DOI 10.1116/1.579085; VAN DE WALLE CG, 1985, J VAC SCI TECHNOL B, V3, P1256, DOI 10.1116/1.583051; VESCAN L, 1993, J APPL PHYS, V73, P271; VOINIGESCU SP, 1994, SOLID STATE ELECTRON, V37, P1491, DOI 10.1016/0038-1101(94)90157-0; WELSER J, 1994, JPN J APPL PHYS 1, V33, P2419, DOI 10.1143/JJAP.33.2419; WELSER J, 1993, P INT C SSDM, P377; WELSER JJ, 1994, THESIS STANFORD U	37	4	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0361-5235	1543-186X		J ELECTRON MATER	J. Electron. Mater.	FEB	1999	28	2					98	104		10.1007/s11664-999-0225-5		7	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Applied	Engineering; Materials Science; Physics	164NE	WOS:000078469800004		
J	Gunn, MD; Kyuwa, S; Tam, C; Kakiuchi, T; Matsuzawa, A; Williams, LT; Nakano, H				Gunn, MD; Kyuwa, S; Tam, C; Kakiuchi, T; Matsuzawa, A; Williams, LT; Nakano, H			Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization	JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						CC chemokines; cellular immunity; leukocyte chemotaxis; T lymphocytes; mutation	C-C CHEMOKINE; IMMUNE-RESPONSES; T-LYMPHOCYTE; CONTACT SENSITIZERS; MIGRATION PATTERNS; IN-VITRO; MOUSE; ANTIGEN; ACTIVATION; MATURATION	Secondary lymphoid organ chemokine (SLC) is expressed in high endothelial venules and in T cell zones of spleen and lymph nodes (LNs) and strongly attracts naive T cells. In mice homozygous for the paucity of lymph node T cell (plt) mutation, naive T cells fail to home to LNs or the lymphoid regions of spleen. Here we demonstrate that expression of SLC is undetectable in pit mice. In addition to the defect in T cell homing, we demonstrate that dendritic cells (DCs) fail to accumulate in spleen and LN T cell zones of plt mice. DC migration to LNs after contact sensitization is also substantially reduced. The physiologic significance of these abnormalities in pit mice is indicated by a markedly increased sensitivity to infection with murine hepatitis virus. The pit mutation maps to the :SLC locus; however, the sequence of SLC introns and exons in plt mice is normal. These findings suggest that the abnormalities in pit mice are due to a genetic defect in the expression of SLC and that SLC mediates the entry of naive T cells and antigen-stimulated DCs into the T cell zones of secondary lymphoid organs.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1088639, Japan; Toho Univ, Sch Med, Dept Immunol, Tokyo 1438540, Japan	Gunn, MD (reprint author), Duke Univ, Med Ctr, Div Cardiol, Box 3547, Durham, NC 27710 USA.	michael.gunn@duke.edu		Gunn, Michael/0000-0003-4602-0667			Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; AGGER R, 1992, J LEUKOCYTE BIOL, V52, P34; Gretz JE, 1996, J IMMUNOL, V157, P495; Nakano H, 1998, BLOOD, V91, P2886; Gunn MD, 1998, NATURE, V391, P799; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Vremec D, 1997, J IMMUNOL, V159, P565; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; HILL S, 1990, IMMUNOLOGY, V71, P277; Yoshie O, 1997, J LEUKOCYTE BIOL, V62, P634; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Taub DD, 1996, J IMMUNOL, V156, P2095; Hedrick JA, 1997, J IMMUNOL, V159, P1589; DeSmedt T, 1996, J EXP MED, V184, P1413, DOI 10.1084/jem.184.4.1413; Kim CH, 1998, J IMMUNOL, V160, P2418; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; KAST WM, 1986, J EXP MED, V164, P723, DOI 10.1084/jem.164.3.723; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Tanabe S, 1997, J IMMUNOL, V159, P5671; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Sozzani S, 1998, J IMMUNOL, V161, P1083; KUPIECWEGLINSKI JW, 1988, J EXP MED, V167, P632, DOI 10.1084/jem.167.2.632; Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518; AUSTYN JM, 1988, J EXP MED, V167, P646, DOI 10.1084/jem.167.2.646; MACATONIA SE, 1987, J EXP MED, V166, P1654, DOI 10.1084/jem.166.6.1654; Campbell JJ, 1998, J CELL BIOL, V141, P1053, DOI 10.1083/jcb.141.4.1053; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; BACON KB, 1995, SCIENCE, V269, P1727, DOI 10.1126/science.7569902; Catalina MD, 1996, J EXP MED, V184, P2341, DOI 10.1084/jem.184.6.2341; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; DRISCOLL MC, 1989, P NATL ACAD SCI USA, V86, P7470, DOI 10.1073/pnas.86.19.7470; FORSTER R, 1996, CELL, V87, P1; Goodnow CC, 1997, CURR BIOL, V7, pR219, DOI 10.1016/S0960-9822(06)00105-9; HART D N J, 1990, International Reviews of Immunology, V6, P127, DOI 10.3109/08830189009056624; Hromas R, 1997, J IMMUNOL, V159, P2554; KNIGHT SC, 1985, CELL IMMUNOL, V94, P427, DOI 10.1016/0008-8749(85)90266-7; KNIGHT SC, 1985, CELL IMMUNOL, V94, P435, DOI 10.1016/0008-8749(85)90267-9; Kyuwa S, 1997, EXP ANIM TOKYO, V46, P311, DOI 10.1538/expanim.46.311; LARSEN CP, 1990, J EXP MED, V172, P1483, DOI 10.1084/jem.172.5.1483; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Nakano H, 1997, EUR J IMMUNOL, V27, P215, DOI 10.1002/eji.1830270132; Okumura A, 1996, J VIROL, V70, P4146; Pachynski RK, 1998, J IMMUNOL, V161, P952; SPANGRUDE GJ, 1984, J IMMUNOL, V132, P354; SPRINGER GF, 1995, CRIT REV ONCOGENESIS, V6, P57; Steinman R M, 1991, ANNU REV IMMUNOL, V9, P271; Tangemann K, 1998, J IMMUNOL, V161, P6330; VANEWIJK W, 1985, EXPERIENTIA, V41, P199	53	719	744	ROCKEFELLER UNIV PRESS	NEW YORK	1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA	0022-1007			J EXP MED	J. Exp. Med.	FEB 1	1999	189	3					451	460		10.1084/jem.189.3.451		10	Immunology; Medicine, Research & Experimental	Immunology; Research & Experimental Medicine	164NK	WOS:000078470300002		
J	Kwon, JY; Chang, YJ; Sohn, YC; Aida, K				Kwon, JY; Chang, YJ; Sohn, YC; Aida, K			Plasma and ovarian thyroxine levels in relation to sexual maturation and gestation in female Sebastes inermis	JOURNAL OF FISH BIOLOGY			English	Article						thyroxine; sex steroids; reproduction; viviparous fish; Sebastes inermis	THYROID-HORMONE LEVELS; TROUT ONCORHYNCHUS-MYKISS; WILD ATLANTIC SALMON; RAINBOW-TROUT; MASU SALMON; REPRODUCTIVE-CYCLE; STEROID-HORMONES; SERUM THYROXINE; FRESH-WATER; COHO SALMON	Plasma T-4 (L-thyroxine) concentrations in the viviparous rockfish Sebastes inermis showed a peak (119.3 +/- 27.8 ng ml(-1)) during the development of embryos. Ovarian T-4 concentrations increased during vitellogenesis and final maturation and decreased during embryogenesis. However, total T-4 content within the ovary increased continuously up to the larval stages. Plasma oestradiol-17 beta (E-2) concentrations peaked at the final maturation stage and then recovered to the level seen during the non-reproductive periods. Plasma testosterone (T) concentrations showed a peak (5.33 +/- 1.08 ng ml(-1)) at the embryo stage and high levels were maintained throughout the gestation period. Plasma T-4 concentrations during the embryo stage and ovarian T-4 content during vitellogenesis were much higher than the levels reported in oviparous fishes. These data suggest that in viviparous rockfish, T-4 may be required for sustaining gestation or embryo development within the maternal body. In addition, the high content of total T-4 in the ovary implies that there probably does exist a maternal embryo relationship during gestation as well as during vitellogenesis. (C) 1999 The Fisheries Society of the British Isles.	Pukyong Natl Univ, Coll Fisheries Sci, Dept Aquaculture, Pusan 608737, South Korea; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Tokyo, Japan	Chang, YJ (reprint author), Pukyong Natl Univ, Coll Fisheries Sci, Dept Aquaculture, 599-1 Daeyeon 3 Dong,Nam Gu, Pusan 608737, South Korea.						TAGAWA M, 1990, FISH PHYSIOL BIOCHEM, V8, P515, DOI 10.1007/BF00003409; Cyr DG, 1996, REV FISH BIOL FISHER, V6, P165; MANIRE CA, 1995, GEN COMP ENDOCR, V97, P366, DOI 10.1006/gcen.1995.1036; Hobby AC, 1997, FISH PHYSIOL BIOCHEM, V16, P65, DOI 10.1007/BF00004541; Brown DD, 1997, P NATL ACAD SCI USA, V94, P13011, DOI 10.1073/pnas.94.24.13011; AIDA K, 1984, B JPN SOC SCI FISH, V50, P565; AYSON FG, 1993, AQUACULTURE, V109, P83, DOI 10.1016/0044-8486(93)90488-K; BOEHLERT GW, 1991, ENVIRON BIOL FISH, V30, P81, DOI 10.1007/BF02296879; BROMAGE NR, 1968, J ENDOCRINOL, V41, P303, DOI 10.1677/joe.0.0410303; BROWN CL, 1989, FISH PHYSIOL BIOCHEM, V7, P295, DOI 10.1007/BF00004720; EALES JG, 1991, CAN J FISH AQUAT SCI, V48, P2443, DOI 10.1139/f91-286; GREENBLATT M, 1989, FISH PHYSIOL BIOCHEM, V6, P261, DOI 10.1007/BF01881680; Lam T. J., 1994, Journal of the World Aquaculture Society, V25, P2, DOI 10.1111/j.1749-7345.1994.tb00798.x; LAM TJ, 1985, GEN COMP ENDOCR, V60, P324, DOI 10.1016/0016-6480(85)90330-2; LEATHERLAND JF, 1985, GEN COMP ENDOCR, V60, P343, DOI 10.1016/0016-6480(85)90067-X; LEATHERLAND JF, 1989, CAN J FISH AQUAT SCI, V46, P2146; Lee Taek-Yuil, 1992, Bulletin of the Korean Fisheries Society, V25, P413; MACKENZIE DS, 1989, AQUACULTURE, V78, P63, DOI 10.1016/0044-8486(89)90006-9; MIWA S, 1987, GEN COMP ENDOCR, V67, P356, DOI 10.1016/0016-6480(87)90190-0; MUNEHARA H, 1989, NIPPON SUISAN GAKK, V55, P423; NAGAHAMA Y, 1991, ENVIRON BIOL FISH, V30, P31, DOI 10.1007/BF02296874; Pankhurst NW, 1996, AQUACULTURE, V146, P277, DOI 10.1016/S0044-8486(96)01374-9; PAVLIDIS M, 1991, AQUACULTURE, V99, P365, DOI 10.1016/0044-8486(91)90256-7; SHIMIZU M, 1991, ENVIRON BIOL FISH, V30, P155, DOI 10.1007/BF02296886; SOWER SA, 1992, GEN COMP ENDOCR, V85, P278, DOI 10.1016/0016-6480(92)90012-9; SOYANO K, 1993, FISH PHYSIOL BIOCHEM, V11, P265, DOI 10.1007/BF00004574; TAGAWA M, 1987, GEN COMP ENDOCR, V68, P129, DOI 10.1016/0016-6480(87)90068-2; TAGAWA M, 1994, FISH PHYSIOL BIOCHEM, V13, P233, DOI 10.1007/BF00004361; WEBER GM, 1992, GEN COMP ENDOCR, V85, P392, DOI 10.1016/0016-6480(92)90084-W; WOURMS JP, 1991, ENVIRON BIOL FISH, V30, P111, DOI 10.1007/BF02296882; YAMADA H, 1993, FISH PHYSIOL BIOCHEM, V12, P1, DOI 10.1007/BF00004317; YAMADA H, 1993, ZOOL SCI, V10, P587; YOUNGSON AF, 1984, J FISH BIOL, V24, P29, DOI 10.1111/j.1095-8649.1984.tb04773.x; YOUNGSON AF, 1993, J FISH BIOL, V42, P293, DOI 10.1111/j.1095-8649.1993.tb00329.x; Zar JH, 1984, BIOSTATISTICAL ANAL	35	2	3	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0022-1112			J FISH BIOL	J. Fish Biol.	FEB	1999	54	2					370	379		10.1006/jfbi.1998.0871		10	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	164HQ	WOS:000078457900010		
J	Sakiyama, T; Akutsu, M; Miyawaki, O; Yano, T				Sakiyama, T; Akutsu, M; Miyawaki, O; Yano, T			Effective thermal diffusivity of food gels impregnated with air bubbles	JOURNAL OF FOOD ENGINEERING			English	Article							CONDUCTIVITY; BREAD	A predictive model of the effective thermal diffusivity of food gels impregnated with air bubbles was proposed. The model included the effect of latent heat transport accompanied by water vapor diffusion within the bubbles in addition to heat conduction. To discuss the reliability of the model, the effective thermal diffusivities of several air-impregnated gels were measured and compared with the predicted values. For air-impregnated gels of low water content, the effective thermal diffusivities measured at 20 degrees C were in good agreement with the predicted values. For air-impregnated gels of high water content, the effective thermal diffusivities were well approximated by the predicted values up to 50 degrees C. At higher temperatures, the model tended to overestimate the effective thermal diffusivity especially for the gels of high porosity. (C) 1999 Elsevier Science Ltd. All rights reserved.	Okayama Univ, Fac Engn, Dept Biosci & Biotechnol, Okayama 7008530, Japan; Univ Tokyo, Dept Appl Biol Chem, Div Agr & Agr Life Sci, Tokyo 1138657, Japan	Sakiyama, T (reprint author), Okayama Univ, Fac Engn, Dept Biosci & Biotechnol, Okayama 7008530, Japan.						CARSLAW HS, 1959, CONDUCTION HEAT SOLI, P198; DICKERSO.RW, 1965, FOOD TECHNOL-CHICAGO, V19, P880; DICKERSON RW, 1965, ASHRAE T, V81, P356; KERRISK JF, 1971, J APPL PHYS, V42, P267, DOI 10.1063/1.1659581; KONG JY, 1982, AGR BIOL CHEM TOKYO, V46, P783; KONG JY, 1979, THESIS U TOKYO JAPAN; LEE HJ, 1976, J APPL PHYS, V47, P148, DOI 10.1063/1.322335; LEE TYR, 1978, J HEAT TRANS-T ASME, V100, P720; MAGEE TRA, 1995, J FOOD ENG, V25, P223, DOI 10.1016/0260-8774(94)00025-5; POULSEN KP, 1982, J FOOD ENG, V1, P115; RASK C, 1989, Journal of Food Engineering, V9, P167, DOI 10.1016/0260-8774(89)90039-3; SAKIYAMA T, 1990, AGR BIOL CHEM TOKYO, V54, P1375; SAKIYAMA T, 1990, Journal of Food Engineering, V11, P317, DOI 10.1016/0260-8774(90)90045-A; SAKIYAMA T, 1994, J CHEM ENG JPN, V27, P291, DOI 10.1252/jcej.27.291; Vargaftik N. B., 1975, TABLES THERMOPHYSICA; YAMADA E, 1993, P 4 JAP S THERM PROP, P141; ZANONI B, 1995, J FOOD ENG, V26, P497, DOI 10.1016/0260-8774(94)00073-I	17	14	16	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0260-8774			J FOOD ENG	J. Food Eng.	FEB	1999	39	3					323	328		10.1016/S0260-8774(99)00021-7		6	Engineering, Chemical; Food Science & Technology	Engineering; Food Science & Technology	180FZ	WOS:000079376600014		
J	Tamura, M; Kawasaki, H; Sugiyama, J				Tamura, M; Kawasaki, H; Sugiyama, J			Identity of the xerophilic species Aspergillus penicillioides: Integrated analysis of the genotypic and phenotypic characters	JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY			English	Article						Aspergillus penicillioides; DNA base composition; DNA relatedness; electrophoretic comparison of enzymes; internal transcribed spacer; phylogeny; ribosomal RNA genes; xerophilic fungus	PERFORMANCE LIQUID-CHROMATOGRAPHY; PHYLOGENETIC-RELATIONSHIPS; DEOXYRIBONUCLEIC-ACID; 18S; SEQUENCES; SAITOELLA; ORIGINS; GENERA; FLAVUS; ORYZAE	We examined the identity of Aspergillus penicillioides, the typical xerophilic and strictly anamorphic species, using an integrated analysis of the genotypic and phenotypic characters. Our experimental methods on two genotypic characters, i.e., DNA base composition using the HPLC method and DNA relatedness using the nitrocellulose filter hybridization technique between A. flavus, A. oryzae, and their close relations revealed a good agreement with the values by buoyant density (for DNA base composition) and spectrophotometric determination (for DNA relatedness) reported by Kurtzman et al, in 1986, On the basis of these comparisons, we examined DNA base composition and DNA relatedness of six selected strains of A. penicillioides, including IFO 8155 (originally described as A. vitricola), one strain of A. restrictus, and the respective strains from Eurotium amstelodami, E. repens, and E. rubrum, As a result, five strains within A, penicillioides, including the neotype strain NRRL 4548, had G+C contents of 46 to 49 mol%, whereas IFO 8155 had 50 mol%. A. restrictus had 52 mol%, and three Eurotium species ranged from 46 to 49 mol%, The DNA relatedness between A. penicillioides (five strains), except for IFO 8155, exhibited values greater than 70%, but the DNA complementarity between four strains and IFO 8155 in A. penicillioides revealed values of less than 40%, DNA relatedness values between three species of Eurotium were 65 to 72%. We determined 18S, 5.8S, and ITS rDNA sequences as other genotypic characters from A. penicillioides (six strains), A. restrictus, and related teleomorphic species of Eurotium, In three phylogenetic trees inferred from these sequences, five strains of A. penicillioides, including the neotype strain, were closely related to each other, whereas IFO 8155 was distantly related and grouped with other xerophilic species. Our results have suggested that A. penicillioides typified by NRRL 4548 and A. penicillioides IFO 8155 (ex holotype df A. vitricola) are not conspecific. The enzyme patterns as a genotypic character and general morphology and conidial ornamentation types as phenotypic characters supported this conclusion. Therefore the name A. vitricola Ohtsuki, typified by the holotype strain IFO 8155, should be revived. Evolutionary affinities among Aspergillus species and related teleomorphs, including the xerophilic taxa, are discussed.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Sugiyama, J (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1 Yayoi 1 Chome, Tokyo 1130032, Japan.						ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; KURTZMAN CP, 1986, MYCOLOGIA, V78, P955, DOI 10.2307/3807436; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; MALLOCH D, 1972, CAN J BOT, V50, P2613; ARAI H, 1990, BIODETERIORATION CUL; CASTELLANI A, 1964, MYCOPATHOL MYCOL APP, V23, P153; CHANG JM, 1991, J GEN APPL MICROBIOL, V37, P289, DOI 10.2323/jgam.37.289; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; GOTO S, 1987, J GEN APPL MICROBIOL, V33, P75, DOI 10.2323/jgam.33.75; HAMAMOTO M, 1995, ANTON LEEUW INT J G, V67, P151, DOI 10.1007/BF00871210; Heng Z., 1993, NUCLEIC ACIDS RES, V21, P5279; HOCKING AD, 1988, MYCOLOGIA, V80, P82, DOI 10.2307/3807497; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozakiewicz Z, 1989, MYCOL PAP, V161, P1; KURAISHI H, 1990, NATO ADV SCI I A-LIF, V185, P407; LOBUGLIO KF, 1994, MYCOL RES, V98, P250; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; Nikkuni S, 1998, J GEN APPL MICROBIOL, V44, P225, DOI 10.2323/jgam.44.225; Nikkuni S, 1996, J GEN APPL MICROBIOL, V42, P181, DOI 10.2323/jgam.42.181; Nishida Hiromi, 1994, Mycoscience, V35, P361, DOI 10.1007/BF02268506; NISHIDA H, 1993, MOL BIOL EVOL, V10, P431; Ogawa H, 1997, MYCOLOGIA, V89, P756, DOI 10.2307/3761132; OHTSUKI T, 1992, J ELECTRON MICROSC, V41, P270; OHTSUKI T., 1962, Bot. Mag., V75, P436; PETERSON SW, 1997, P 3 INT WORKSH PEN A; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SAMSON RA, 1978, MYCOPATHOLOGIA, V64, P13, DOI 10.1007/BF00443082; Sugiyama J., 1991, Japanese Journal of Medical Mycology, V32, P39; SUGIYAMA J, 1990, NATO ADV SCI I A-LIF, V185, P385; SUGIYAMA J, 1993, FUNGAL HOLOMORPH : MITOTIC, MEIOTIC AND PLEOMORPHIC SPECIATION IN FUNGAL SYSTEMATICS, P261; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; TAMAOKA J, 1984, FEMS MICROBIOL LETT, V25, P125, DOI 10.1111/j.1574-6968.1984.tb01388.x; TAMURA M, 1997, P 3 INT WORKSH PEN A; TAMURA M, 1996, J GEN APPL MICROBIOL, V42, P253; Thompson J.D., 1994, NUCLEIC ACIDS RES, V22, P2673; White T J, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; YAMATOYA K, 1990, NATO ADV SCI I A-LIF, V185, P395	37	10	10	MICROBIOL RES FOUNDATION	TOKYO	JAPAN ACAD SOC CENTER BLDG 4-16 YAYOI 2-CHOME, TOKYO, 113-0032, JAPAN	0022-1260	1349-8037		J GEN APPL MICROBIOL	J. Gen. Appl. Microbiol.	FEB	1999	45	1					29	37		10.2323/jgam.45.29		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	206CJ	WOS:000080858600005		
J	Ohtani, S; Rostoker, G; Takahashi, K; Angelopoulos, V; Nakamura, M; Waters, C; Singer, H; Kokubun, S; Tsuruda, K; Hughes, WJ; Potemra, TA; Zanetti, LJ; Gary, JB; Lui, ATY; Williams, DJ				Ohtani, S; Rostoker, G; Takahashi, K; Angelopoulos, V; Nakamura, M; Waters, C; Singer, H; Kokubun, S; Tsuruda, K; Hughes, WJ; Potemra, TA; Zanetti, LJ; Gary, JB; Lui, ATY; Williams, DJ			Coordinated ISTP satellite and ground observations of morningside Pc5 waves	JOURNAL OF GEOPHYSICAL RESEARCH-SPACE PHYSICS			English	Article							KELVIN-HELMHOLTZ INSTABILITY; LATITUDE BOUNDARY-LAYER; FIELD LINE RESONANCES; INTERPLANETARY MAGNETIC-FIELD; UPSTREAM PRESSURE VARIATIONS; MAGNETOSPHERIC BOUNDARY; MAGNETOPAUSE-BOUNDARY; EARTHS MAGNETOPAUSE; PC-5 PULSATIONS; PARTICLE OBSERVATIONS	This paper reports the result of a coordinated data analysis of a morningside Pc5 event observed at different altitudes in the magnetosphere and also on the ground. The event took place during 1400-1500 UT of April 29, 1993. The Geotail satellite was located in the boundary region and observed a 5-min quasi-periodic magnetic oscillation. The oscillation was mostly transverse to the background magnetic field. A 90 degrees phase lag between the magnetic field and electric field variations was not clear, suggesting that the oscillation was not a standing wave and that Geotail was located in or close to the excitation region. The plasma flow vector rotated clockwise on the equatorial plane viewed from the north as expected for a magnetospheric surface wave on the morningside. At geosynchronous altitude, the GOES satellites also observed a 5-min magnetic oscillation but with a significantly smaller amplitude than at the Geotail position. Five-minute magnetic oscillations were also detected at Canadian Auroral Network for the OPEN Program Unified Study (CANOPUS) and Magnetometer Array for Cusp and Cleft Studies (MACCS) ground stations in the same local time sector as the satellites, even equatorward of a region 2 field-aligned current observed by the Freja magnetometer data. From the phase analysis of ground signatures, the wave is inferred to propagate westward (antisunward) at a velocity of 18 degrees in longitude per minute. The propagation speed mapped to the equator, 400 km/s, is in the range of the expected flow speed of the magnetosheath. It is inferred that in the present event, the Kelvin-Helmholtz instability at the magnetopause, rather than at the inner edge of the boundary layer, excited an oscillation at the single frequency in a large area from the boundary region to deep inside the magnetosphere.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Boston Univ, Dept Astron, Boston, MA 02215 USA; Nagoya Univ, Solar Terr Environm Lab, Toyokawa 442, Japan; Univ Tokyo, Dept Earth & Planetary Phys, Tokyo 113, Japan; Univ Alberta, Dept Phys, Edmonton, AB T6G 21, Canada; NOAA, RESE, Boulder, CO 80303 USA; Inst Space & Astronaut Sci, Sagamihara, Kanagawa 229, Japan; Univ New Castle, Dept Phys, Callaghan, NSW 2308, Australia	Ohtani, S (reprint author), Johns Hopkins Univ, Appl Phys Lab, 11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	ohtani@fluxgate.jhuapl.edu; kazue.takahashi@jhuapl.edu; vassilis@ssl.berkeley.edu; kokubun@stelab.ngoya-u.ac.jp; hughes@buasta.bu.edu; ZANETLJ1@jhuapl.edu; GARYJB1@aplmail.jhuapl.edu; LUIAT1@jhuapl.edu; WILLIDJ1@jhuaapl.edu	Waters, Colin/B-3086-2011	Waters, Colin/0000-0003-2121-6962			ANDERSON BJ, 1994, GEOPH MONOG SERIES, V81, P25; ANDERSON BJ, 1990, J GEOPHYS RES, V95, P10495, DOI 10.1029/JA095iA07p10495; EASTMAN TE, 1979, J GEOPHYS RES-SPACE, V84, P2019, DOI 10.1029/JA084iA05p02019; SCKOPKE N, 1981, J GEOPHYS RES-SPACE, V86, P2099, DOI 10.1029/JA086iA04p02099; TAKAHASHI K, 1984, PLANET SPACE SCI, V32, P1343; CUMMINGS WD, 1969, J GEOPHYS RES, V74, P778, DOI 10.1029/JA074i003p00778; KOKUBUN S, 1989, J GEOPHYS RES, V94, P6607, DOI 10.1029/JA094iA06p06607; GREENWALD RA, 1980, GEOPHYS RES LETT, V7, P745, DOI 10.1029/GL007i010p00745; WILLIAMS DJ, 1994, J GEOMAGN GEOELECTR, V46, P39; SAMSON JC, 1971, J GEOPHYS RES, V76, P3675, DOI 10.1029/JA076i016p03675; SINGER HJ, 1979, J GEOPHYS RES-SPACE, V84, P7213, DOI 10.1029/JA084iA12p07213; CHEN SH, 1993, J GEOPHYS RES, V98, P5727, DOI 10.1029/92JA02263; EASTMAN TE, 1976, GEOPHYS RES LETT, V3, P685, DOI 10.1029/GL003i011p00685; TAKAHASHI K, 1982, J GEOPHYS RES-SPACE, V87, P1504, DOI 10.1029/JA087iA03p01504; CHEN L, 1974, J GEOPHYS RES, V79, P1024, DOI 10.1029/JA079i007p01024; TAKAHASHI K, 1991, J GEOPHYS RES, V96, P9503, DOI 10.1029/91JA00612; BAKER KB, 1989, J GEOPHYS RES, V94, P9139, DOI 10.1029/JA094iA07p09139; WATERS CL, 1995, J GEOPHYS RES, V100, P7987, DOI 10.1029/94JA02712; Atkinson G., 1966, Earth and Planetary Science Letters, V1, DOI 10.1016/0012-821X(66)90112-9; AUBRY MP, 1971, J GEOPHYS RES, V76, P1673, DOI 10.1029/JA076i007p01673; Bendat J. S., 1971, RANDOM DATA ANAL MEA, P407; CAHILL LJ, 1986, J GEOPHYS RES, V91, P8895, DOI 10.1029/JA091iA08p08895; CHEN SH, 1993, GEOPHYS RES LETT, V20, P2699, DOI 10.1029/93GL02622; Clauer CR, 1997, J GEOPHYS RES-SPACE, V102, P4585, DOI 10.1029/96JA02929; COUZENS D, 1985, J GEOPHYS RES-SPACE, V90, P6343, DOI 10.1029/JA090iA07p06343; ELIASSON L, 1994, SPACE SCI REV, V70, P563, DOI 10.1007/BF00756886; FAIRFIEL.DH, 1971, J GEOPHYS RES, V76, P6700, DOI 10.1029/JA076i028p06700; FAIRFIELD DH, 1990, J GEOPHYS RES, V95, P3773, DOI 10.1029/JA095iA04p03773; HASEGAWA A, 1975, PLASMA INSTABILITIES, P125; HONES EW, 1978, GEOPHYS RES LETT, V5, P2069; Kivelson M. G., 1995, GEOPHYS MONOGR SER, V90, P257, DOI DOI 10.1029/GM090P0257; KOKUBUN S, 1985, J GEOMAGN GEOELECTR, V37, P759; KOKUBUN S, 1976, J GEOPHYS RES-SPACE, V81, P5141, DOI 10.1029/JA081i028p05141; KOKUBUN S, 1994, GEOPHYS RES LETT, V21, P2883, DOI 10.1029/94GL02103; LEE LC, 1981, J GEOPHYS RES-SPACE, V86, P54, DOI 10.1029/JA086iA01p00054; LEPPING RP, 1979, J GEOPHYS RES-SPACE, V84, P7099, DOI 10.1029/JA084iA12p07099; LUNDIN R, 1994, SPACE SCI REV, V70, P465; MITCHELL DG, 1990, J GEOPHYS RES, V95, P967, DOI 10.1029/JA095iA02p00967; MIURA A, 1992, J GEOPHYS RES, V97, P10655, DOI 10.1029/92JA00791; MIURA A, 1982, J GEOPHYS RES-SPACE, V87, P7431, DOI 10.1029/JA087iA09p07431; NAKAMURA M, 1994, GEOPHYS RES LETT, V21, P2903, DOI 10.1029/94GL02110; OGILVIE KW, 1989, J GEOPHYS RES, V94, P15113, DOI 10.1029/JA094iA11p15113; OLSON JV, 1978, J GEOPHYS RES-SPACE, V83, P2481, DOI 10.1029/JA083iA06p02481; Potemra TA, 1996, J GEOPHYS RES-SPACE, V101, P24801, DOI 10.1029/97JA02405; POTEMRA TA, 1989, J GEOPHYS RES, V94, P2543, DOI 10.1029/JA094iA03p02543; ROELOF EC, 1993, J GEOPHYS RES, V98, P21421, DOI 10.1029/93JA02362; ROSTOKER G, 1992, GEOPHYS RES LETT, V19, P613, DOI 10.1029/91GL02784; ROSTOKER G, 1984, J GEOPHYS RES-SPACE, V89, P6749, DOI 10.1029/JA089iA08p06749; Samson J. C., 1991, GEOMAGN AERON, V4, P481; SARAFOPOULOS DV, 1993, ANN GEOPHYS, V11, P990; SEON J, 1995, J GEOPHYS RES, V100, P11907, DOI 10.1029/94JA03314; SIBECK DG, 1989, J GEOPHYS RES, V94, P2505, DOI 10.1029/JA094iA03p02505; SINGER HJ, 1982, J GEOPHYS RES-SPACE, V87, P3519, DOI 10.1029/JA087iA05p03519; SONG P, 1988, GEOPHYS RES LETT, V15, P744, DOI 10.1029/GL015i008p00744; SOUTHWOO.DJ, 1974, PLANET SPACE SCI, V22, P483, DOI 10.1016/0032-0633(74)90078-6; TAKAHASHI K, 1984, J GEOPHYS RES-SPACE, V89, P6758, DOI 10.1029/JA089iA08p06758; Tamao T., 1965, SCI REP TOHOKU U 5, V17, P43; THOMAS VA, 1993, J GEOPHYS RES, V98, P11425, DOI 10.1029/93JA00604; TRAVER DP, 1991, J GEOPHYS RES, V96, P21025, DOI 10.1029/91JA02136; TSURUDA K, 1994, J GEOMAGN GEOELECTR, V46, P693; WALKER ADM, 1981, PLANET SPACE SCI, V38, P213; WEI CQ, 1990, J GEOPHYS RES, V95, P20793, DOI 10.1029/JA095iA12p20793; WILLIAMS DJ, 1985, J GEOPHYS RES-SPACE, V90, P5097, DOI 10.1029/JA090iA06p05097; WINNINGHAM JD, 1975, J GEOPHYS RES-SPACE, V80, P3148, DOI 10.1029/JA080i022p03148; WOLFE A, 1980, J GEOPHYS RES-SPACE, V85, P114, DOI 10.1029/JA085iA01p00114; WU CC, 1986, J GEOPHYS RES, V91, P3042, DOI 10.1029/JA091iA03p03042; ZANETTI L, 1994, SPACE SCI REV, V70, P465; ZIESOLLECK CWS, 1994, J GEOPHYS RES, V99, P5817, DOI 10.1029/93JA02903	68	10	10	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0148-0227			J GEOPHYS RES-SPACE	J. Geophys. Res-Space Phys.	FEB 1	1999	104	A2					2381	2397		10.1029/1998JA900037		17	Astronomy & Astrophysics	Astronomy & Astrophysics	170TX	WOS:000078823900006		
J	Kobayashi, T; Kubota, K; Sudo, K; Mori, M; Sano, K; Yotsuyanagi, H; Makuuchi, M				Kobayashi, T; Kubota, K; Sudo, K; Mori, M; Sano, K; Yotsuyanagi, H; Makuuchi, M			Cholinesterase-producing hepatocellular carcinoma	JOURNAL OF HEPATOLOGY			English	Letter									Univ Tokyo, Fac Med, Dept Surg, Hepatobiliary Pancreat Div, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Pathol, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Internal Med 1, Tokyo 113, Japan; Jikei Univ, Daisan Hosp, Dept Lab Med, Tokyo 201, Japan	Kobayashi, T (reprint author), Univ Tokyo, Fac Med, Dept Surg, Hepatobiliary Pancreat Div, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				BECKER DJ, 1963, JAMA-J AM MED ASSOC, V186, P1018; Brown SS, 1981, ADV CLIN CHEM, V22, P82; Drews U, 1975, Prog Histochem Cytochem, V7, P1; KODAMA T, 1980, ACTA HEPATOL JPN, V21, P1393; MARGOLIS S, 1972, MEDICINE, V51, P381; MCFADZEA.AJ, 1967, BLOOD-J HEMATOL, V29, P808; ORD MG, 1952, BIOCHEM J, V51, P245; Tajiri J, 1983, Gastroenterol Jpn, V18, P137	8	1	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0168-8278			J HEPATOL	J. Hepatol.	FEB	1999	30	2					348	349		10.1016/S0168-8278(99)80087-7		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	165HB	WOS:000078514300028		
J	Minami, M; Atarashi, K; Ishiyama, A; Hirata, Y; Goto, A; Omata, M				Minami, M; Atarashi, K; Ishiyama, A; Hirata, Y; Goto, A; Omata, M			Pressor hyperreactivity to mental and hand-grip stresses in patients with hypercholesterolemia	JOURNAL OF HYPERTENSION			English	Article						pressor hyperreactivity; stress; hypercholesterolemia; intracellular Ca2+ concentration; nitric oxide	LOW-DENSITY-LIPOPROTEIN; NITRIC-OXIDE; ESSENTIAL-HYPERTENSION; CORONARY MICROCIRCULATION; SERUM-CHOLESTEROL; RELAXING FACTOR; L-ARGININE; ENDOTHELIUM; ATHEROSCLEROSIS; CELLS	Objective To investigate the role of hypercholesterolemia in the regulation of blood pressure. Subjects and methods We compared blood pressure responses to arithmetic stress and hand-grip tests in normotensive patients with hypercholesterolemia n = 15) and a mean (+/-SEM) age of 49 +/- 3 years, and normal cholesterolemic controls (n = 22) aged 48 +/- 1 years. Blood pressure and heart rate were measured throughout the tests. We examined the intracellular Ca2+ concentration in platelets with or without low-density-lipoprotein stimulation (2.9 nmol/l, 10 mg/ml). The plasma nitrite plus nitrate and cyclic GMP were determined before and at the end of each test to evaluate nitric oxide production and activity. Results Both tests showed that systolic/diastolic blood pressure was higher in the hypercholesterolemic patients than in the normal controls (stress test: 139 +/- 3/91 +/- 4 versus 127 +/- 2/80 +/- 3 mmHg, P < 0.01/P < 0.05; handgrip test: 164 +/- 5/106 +/- 5 versus 144 +/- 3/88 +/- 3 mmHg, P < 0.01/P < 0.01). The intracellular Ca2+ concentration in platelets and the increase in response to low-density-lipoprotein stimulation were higher in the hypercholesterolemic patients (without stimulation: 72 +/- 3 versus 64 +/- 3 nmol/l, P < 0.01; with 2.9 nmol/l stimulation: 145 +/- 21 versus 89 +/- 6 nmol/l, P < 0.01). The increase in Ca2+ in response to 2.9 nmol/ml stimulation with low-density lipoprotein was positively related to the increase in mean blood pressure in response to the stress test (r = 0.56, P < 0.002). Nitric oxide production appeared to be increased in the hypercholesterolemic patients (65 +/- 5 versus 51 +/- 4 mmol/l, P < 0.05), and was not affected significantly by the tests. In contrast, cyclic GMP was lower in the patients and was increased significantly in the normal controls by the hand-grip test (P < 0.05). As a result, plasma cyclic GMP was lower in the patients (1.9 +/- 0.2 versus 2.5 +/- 0.1 nmol/l, P < 0.01). The ratio of plasma cyclic GMP to nitric oxide was also lower in the hypercholesterolemic patients at rest (P < 0.05), and at the end of the mental stress (P < 0.02) and hand-grip (P < 0.001) tests. Conclusions Patients with hypercholesterolemia showed an exaggerated blood pressure response to both mental stress and exercise, even if resting blood pressure was normal. Increases in the intracellular Ca2+ concentration can contribute to these excessive responses. A disproportionately lower level of cyclic GMP to nitric oxide in plasma may also be involved in these abnormal responses. (C) Lippincott Williams & Wilkins.	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138655, Japan	Minami, M (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						GALLE J, 1991, ARTERIOSCLER THROMB, V11, P198; BURSTEIN M, 1970, J LIPID RES, V11, P583; STAMLER J, 1986, AM J MED, V80, P33, DOI 10.1016/0002-9343(86)90158-0; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; ALLAIN CC, 1974, CLIN CHEM, V20, P470; FOTI A, 1987, CLIN CHEM, V33, P2209; Forte P, 1997, LANCET, V349, P837, DOI 10.1016/S0140-6736(96)07631-3; SULLIVAN DR, 1985, CLIN CHEM, V31, P1227; FALKNER B, 1979, HYPERTENSION, V1, P23; EGASHIRA K, 1994, CIRCULATION, V89, P2519; Sung BH, 1997, AM J HYPERTENS, V10, P592, DOI 10.1016/S0895-7061(97)00050-2; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; BLOCK LH, 1988, P NATL ACAD SCI USA, V85, P885, DOI 10.1073/pnas.85.3.885; BOCHKOV VN, 1991, THROMB RES, V61, P403, DOI 10.1016/0049-3848(91)90654-F; BOIJERSEN A, 1998, THROMB HAEMOST, V79, P268; BROD J, 1959, CLIN SCI, V18, P269; Brooker G, 1979, Adv Cyclic Nucleotide Res, V10, P1; CHIN JH, 1992, J CLIN INVEST, V89, P10, DOI 10.1172/JCI115549; CHOWIENCZYK PJ, 1992, LANCET, V340, P1430, DOI 10.1016/0140-6736(92)92621-L; DREXLER H, 1991, LANCET, V338, P1546, DOI 10.1016/0140-6736(91)92372-9; Eliasson K, 1983, J Hypertens, V1, P131, DOI 10.1097/00004872-198308000-00004; FALKNER B, 1981, HYPERTENSION, V3, P521; FOLKOW B, 1982, PHYSL REV, V62, P371; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; GOODE GK, 1995, LANCET, V345, P362, DOI 10.1016/S0140-6736(95)90345-3; GROSSMAN E, 1989, AM J CARDIOL, V64, P42, DOI 10.1016/0002-9149(89)90650-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAMA N, 1991, CLIN REP, V25, P4205; HENRY JP, 1990, J HYPERTENS, V8, P783, DOI 10.1097/00004872-199009000-00001; INOUE N, 1992, CIRC RES, V71, P1410; JULIUS S, 1991, J HYPERTENS, V9, P983, DOI 10.1097/00004872-199111000-00001; KUO L, 1992, CIRC RES, V70, P465; LAURENZI M, 1990, J HYPERTENS, V8, pS7, DOI 10.1097/00004872-199003001-00003; MINOR RL, 1990, J CLIN INVEST, V86, P2109, DOI 10.1172/JCI114949; MONCADA S, 1991, PHARMACOL REV, V43, P109; MUGGE A, 1991, CIRC RES, V69, P1293; MYERS PR, 1994, J LAB CLIN MED, V124, P672; OHISHI N, 1985, BIOCHEM INT, V10, P205; RAPOPORT RM, 1988, RELAXING CONTRACTING, P219; ROSTRUP M, 1993, HYPERTENSION, V22, P891; SACHINIDIS A, 1990, HYPERTENSION, V15, P704; SHERWOOD A, 1995, HYPERTENSION, V25, P384; VALLANCE P, 1989, LANCET, V2, P997; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634	44	12	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0263-6352			J HYPERTENS	J. Hypertens.	FEB	1999	17	2					185	192		10.1097/00004872-199917020-00002		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	177XE	WOS:000079235700002		
J	Hyodo, Y; Matsui, K; Hayashi, N; Tsutsui, H; Kashiwamura, S; Yamauchi, H; Hiroishi, K; Takeda, K; Tagawa, Y; Iwakura, Y; Kayagaki, N; Kurimoto, M; Okamura, H; Hada, T; Yagita, H; Akira, S; Nakanishi, K; Higashino, K				Hyodo, Y; Matsui, K; Hayashi, N; Tsutsui, H; Kashiwamura, S; Yamauchi, H; Hiroishi, K; Takeda, K; Tagawa, Y; Iwakura, Y; Kayagaki, N; Kurimoto, M; Okamura, H; Hada, T; Yagita, H; Akira, S; Nakanishi, K; Higashino, K			IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor	JOURNAL OF IMMUNOLOGY			English	Article							GAMMA-INDUCING FACTOR; NATURAL-KILLER-CELLS; IFN-GAMMA; MACROPHAGE ACTIVATION; FAS LIGAND; SCID MICE; T-CELLS; MOLECULAR MECHANISMS; INDEPENDENT PATHWAY; CYTOKINE	IL-18 is a powerful inducer of IFN-gamma production, particularly in collaboration with IL-12, IL-18, like IL-12, also augments NK activity. Here we investigated the molecular mechanism underlying the up-regulation of killing activity of NK cells by IL-18, IL-18, like IL-12, dose dependently enhanced NK activity of splenocytes. This action was further enhanced by costimulation with IL-12. Treatment with anti-IL-2R Ab did not affect IL-18- and/or IL-12-augmented NK activity, and splenocytes from IFN-gamma-deficient mice showed enhanced NK activity. following stimulation with IL-12 and/or IL-18. Splenocytes from the mice deficient in both IL-12 and IL-18 normally responded to IL-18 and/or IL-12 with facilitated NK activity, suggesting that functional NK cells develop in the absence of IL-12 and IL-18. IL-18R, as well as IL-12R mRNA, was constitutively expressed in splenocytes from SCID mice, which lack T cells and B cells but have intact NK cells, and in those from IL-12 and IL-18 double knockout mice. NK cells isolated from SCID splenocytes expressed IL-18R on their surface. IL-18, in contrast to IL-12, did not enhance mRNA expression of perforin, a key molecule for exocytosis-mediated cytotoxicity. However, pretreatment with concanamycin A completely inhibited this IL-18- and/or IL-12-augmented NK activity. Furthermore, IL-18, like IL-12, failed to enhance NK activity of splenocytes from perforin-deficient mice. These data suggested that NK cells develop and express IL-12R and IL-18R in the absence of IL-12 or IL-18, and that both IL-18 and IL-12 directly and independently augment perforin-mediated cytotoxic activity of NK cells.	Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Internal Med 3, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Biochem, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan; Hayashibara Biochem Labs, Fujisaki Inst, Okayama, Japan; Univ Tokyo, Inst Med Sci, Ctr Expt Med, Tokyo, Japan; Juntendo Univ, Sch Med, Dept Immunol, Tokyo, Japan	Nakanishi, K (reprint author), Hyogo Coll Med, Dept Immunol & Med Zool, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.		Akira, Shizuo/C-3134-2009; Takeda, Kiyoshi/C-9331-2009; Tagawa, Yoh-ichi/F-7216-2011; Iwakura, Yoichiro/E-5457-2011				ABRAHAM E, 1990, J IMMUNOL, V144, P2117; Ahn HJ, 1997, J IMMUNOL, V159, P2125; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Ushio S, 1996, J IMMUNOL, V156, P4274; Kayagaki N, 1997, P NATL ACAD SCI USA, V94, P3914, DOI 10.1073/pnas.94.8.3914; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; CHUA AO, 1994, J IMMUNOL, V153, P128; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Micallef MJ, 1996, EUR J IMMUNOL, V26, P1647, DOI 10.1002/eji.1830260736; Tsutsui H, 1997, J IMMUNOL, V159, P3961; Okamura H, 1998, ADV IMMUNOL, V70, P281, DOI 10.1016/S0065-2776(08)60389-2; Trinchieri G, 1998, IMMUNOL RES, V17, P269, DOI 10.1007/BF02786451; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; FLEISHER G, 1982, J PEDIATR-US, V100, P727, DOI 10.1016/S0022-3476(82)80572-6; YOKOYAMA WM, 1993, ANNU REV IMMUNOL, V11, P613, DOI 10.1146/annurev.immunol.11.1.613; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Ye WG, 1996, J EXP MED, V184, P2405, DOI 10.1084/jem.184.6.2405; Tagawa Y, 1997, J IMMUNOL, V159, P1418; Torigoe K, 1997, J BIOL CHEM, V272, P25737, DOI 10.1074/jbc.272.41.25737; BANCROFT GJ, 1991, IMMUNOL REV, V124, P5, DOI 10.1111/j.1600-065X.1991.tb00613.x; BANCROFT GJ, 1989, CURR TOP MICROBIOL, V152, P235; BANCROFT GJ, 1989, J IMMUNOL, V143, P127; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BOSMA MJ, 1989, CURR TOP MICROBIOL, V152, P3; CESANO A, 1993, J IMMUNOL, V151, P2943; GEORGE A, 1990, J EXP MED, V171, P929, DOI 10.1084/jem.171.3.929; KANEDA K, 1983, CELL TISSUE RES, V233, P485; KAUFMAN DS, 1992, P NATL ACAD SCI USA, V89, P8337, DOI 10.1073/pnas.89.17.8337; KAYANO T, 1990, J IMMUNOL METHODS, V130, P25; LOWREY DM, 1989, P NATL ACAD SCI USA, V86, P247, DOI 10.1073/pnas.86.1.247; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; PORTNOY DA, 1992, CURR OPIN IMMUNOL, V4, P20, DOI 10.1016/0952-7915(92)90118-X; PRENDERGAST JA, 1992, J BIOL CHEM, V267, P5090; RAULET DH, 1992, NATURE, V358, P21, DOI 10.1038/358021a0; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187; Tsutsui H, 1996, J IMMUNOL, V157, P3967; VANTOL EAF, 1992, EUR J IMMUNOL, V22, P23, DOI 10.1002/eji.1830220105; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948	45	175	178	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	FEB 1	1999	162	3					1662	1668				7	Immunology	Immunology	160YM	WOS:000078261000056		
J	Hara, M				Hara, M			A note on the phrase dharma-ksetre kuru-ksetre ('Bhagavad-gita', semantics)	JOURNAL OF INDIAN PHILOSOPHY			English	Article									Univ Tokyo, Tokyo, Japan	Hara, M (reprint author), Univ Tokyo, Tokyo, Japan.						ALSDORF L, 1974, KLEINE SCHRIFTEN; BHARADWAJ OP, 1991, ANCIENT KURUKSETRA S; BOHTLINGK O, 1966, INDISCHE SPRUCHE; BUHLER G, 1886, LAW MANU; CUNNINGHAM A, 1975, ANCIENT GEOGRAPHY IN; DIKSHITAR VRR, 1951, PURANIC INDEX; EDGERTON F, 1952, BHAGAVAD GITA; Garbe R., 1921, BHAGAVADGITA; GUPTA AS, 1967, VAMANA PURANA; HARA M, 1997, INDIA BEYOND ESSYAS, P226; HARA M, 1975, FS A HIRAKAWA, P507; HARA M, 1968, TOYO GAKUHO, V51; HARA M, 1993, INDOLOGICA TAURINENS, V19, P147; HERTEL J, 1908, PANCHATANTRA RECENSI; JULIEN S, 1858, MEMOIRES CONTREES OC; KANE PV, 1973, HIST DHARMASASTRA; KLOPPENBACH R, 1964, PACCEKABUDDHA; LAW BC, 1947, SK BELVALKAR GELICIT, P249; LEVI S, 1938, BHAGAVAD-GITA; Lingat Robert, 1967, SOURCES DROIT SYSTEM; MACDONELL AA, 1958, VEDIC INDEX NAMES SU; PANSIKAR WLS, 1978, SRIMADBHAGAVADGITA; PURANE V, SAROMAHATMYA; Radhakrishnan S., 1948, BHAGAVADGITA; RHYSDAVIDS TW, 1962, PTS PALI ENGLISH DIC; ROSENBERG, 1916, INTRO STUDY BUDDHISM; SCHRADER FO, 1912, MINOR UPANISADS; SCHREINER P, 1991, BHAGAVAD-GITA; SENART E, 1922, BHAGAVADGITA; Sharma Arvind, 1986, HINDU GITA ANCIENT C; SPROCKHOFF, 1976, SAMNYASA; TAISHO, 1928, SHINSHU DAIZOKYO; Van Buitenen J. A. B., 1988, STUDIES INDIAN LIT P; Watters Thomas, 1904, YUAN CHWANGS TRAVELS; WEZLER A, 1979, WIENER Z KUNDE SUDAS, V23, P29; Zaehner R.C., 1969, BHAGAVADGITA	36	1	1	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0022-1791			J INDIAN PHILOS	J. Indian Philos.	FEB-APR	1999	27	1-2					49	66		10.1023/A:1004321823723		18	Asian Studies; Philosophy	Asian Studies; Philosophy	197TJ	WOS:000080381500006		
J	Saida, T; Hotate, K				Saida, T; Hotate, K			General formula describing drift of interferometer fiber-optic gyro due to Faraday effect: Reduction of the drift in twin-depo-I-FOG	JOURNAL OF LIGHTWAVE TECHNOLOGY			English	Article						degree of depolarization; Faraday effect; fiberoptic gyro (FOG); optical fiber sensor; state of polarization	GYROSCOPE	The drift of an interferometer fiber-optic gyro (I-FOG) by the magnetic field through the Faraday effect is generally formulated. By the derived formula, the drift reduction mechanism in the interferometer fiber-optic gyro using ordinary single-mode fiber as a sensing coil and two depolarizers (twin-depo-I-FOG) is clarified, as well as that in the interferometer fiber-optic gyro using polarization maintaining fiber (PM-I-FOG). Degradation factors in the practical twin-depo-I-FOG are evaluated by using the derived equation, and methods for further drift reduction are discussed.	Univ Tokyo, Sch Engn, Dept Elect Engn, Tokyo 1138656, Japan	Saida, T (reprint author), Univ Tokyo, Sch Engn, Dept Elect Engn, Tokyo 1138656, Japan.						SZAFRANIEC B, 1995, P SOC PHOTO-OPT INS, V2510, P37, DOI 10.1117/12.221716; HOTATE K, 1987, J LIGHTWAVE TECHNOL, V5, P997, DOI 10.1109/JLT.1987.1075591; OKAMOTO K, 1984, ELECTRON LETT, V20, P429, DOI 10.1049/el:19840297; Blake J., 1990, P SOC PHOTO-OPT INS, V1367, P81; BOHM K, 1983, J LIGHTWAVE TECHNOL, V1, P71; CARRARA SLA, 1987, OPT LETT, V12, P214, DOI 10.1364/OL.12.000214; HOTATE K, 1986, APPL OPTICS, V25, P1086; Hotate K, 1996, P SOC PHOTO-OPT INS, V2837, P33; Hotate K., 1997, OPTICAL FIBER SENSOR, P167; Kozel S. M., 1986, Optics and Spectroscopy, V61; Lefevre H. C., 1993, FIBER OPTIC GYROSCOP; MOTOHARA S, 1992, P 8 INT C OPT FIB SE, P30; USUI R, 1993, P SOC PHOTO-OPT INS, V2070, P152	13	21	32	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0733-8724			J LIGHTWAVE TECHNOL	J. Lightwave Technol.	FEB	1999	17	2					222	228		10.1109/50.744228		7	Engineering, Electrical & Electronic; Optics; Telecommunications	Engineering; Optics; Telecommunications	164YX	WOS:000078492100010		
J	Golhen, S; Ouahab, L; Lebeuze, A; Bouayed, M; Delhaes, P; Kashimura, Y; Kato, R; Binet, L; Fabre, JM				Golhen, S; Ouahab, L; Lebeuze, A; Bouayed, M; Delhaes, P; Kashimura, Y; Kato, R; Binet, L; Fabre, JM			Preparation, crystal structures, EHT band calculations and physical properties of kappa-(EDS-EDT-TTF)(2)[Ag-2(CN)(3)] and alpha(BETS)(2)Ag(CN)(2)	JOURNAL OF MATERIALS CHEMISTRY			English	Article							CHARGE-TRANSFER SALT; BEDT-TTF; ORGANIC SUPERCONDUCTOR; ELECTRONIC-STRUCTURES; ELECTRICAL-PROPERTIES; ANIONS; METAL; BETS=BIS(ETHYLENEDITHIO)TETRASELENAFULVALENE; AG(CN)2	Preparation, crystal structures, EHT band calculations and physical properties of a semi-conducting kappa-( EDS-EDT-TTF)(2)[Ag-2(CN)(3)] (1) and a new metallic-like species alpha-(BETS)(2)Ag(CN)(2) (2) are reported. kappa-(EDS-EDTTTF)(2)[Ag-2(CN)(3)] 1: M-r = 625.3, monoclinic space group P2(1)/c, a = 15.157(9), b = 8.732(2), c = 13.51(2) Angstrom, beta = 90.94(3)degrees, V = 1788 Angstrom(3), Z = 2, D-c = 2.324 g cm(-3), R = 0.055 for 2572 reflections with F-2 greater than or equal to 2 sigma(F-2). In this compound the organic molecules adopt the so-called K type of packing. In the inorganic sublattice the [Ag-2(CN)(3)](-) units form an infinite two-dimensional polymeric sheet. This compound shows a semi conducting behaviour, with sigma(300) (K) = 3.0 x 10(-4) S cm(-1) and E-a = 120 meV. alpha-(BETS)(2)Ag(CN)(2) 2: M-r = 1304.4, orthorhombic space group P2(1)2(1)2(1) a = 9.5839(8), b = 4.983(3), c = 34.645(6), V = 1654 Angstrom(3), Z = 2, D-c = 2.618 g cm(-3), R = 0.057 for 1136 reflections with F-2 greater than or equal to 2 sigma(F-2). Its crystal structure consists of two-dimensional organic sheets separated by linear Ag(CN)(2)(-) anions. The organic molecules adopt the so-called alpha type of packing with a dihedral angle between two molecules belonging to two adjacent chains of ca. 78 degrees. This compound shows metallic behaviour in the range 300-2 K, with sigma(300) (K) =100 S cm(-1).	Univ Rennes 1, Chim Solide & Inorgan Mol Lab, CNRS, UMR 6511,Grp Mat Mol, F-35042 Rennes, France; CNRS, Ctr Rech Paul Pascal, F-33600 Pessac, France; Univ Tokyo, Inst Solid State Phys, Tokyo 106, Japan; Univ Montpellier 2, Chim Organ Struct Lab, Minato Ku, F-34095 Montpellier, France	Golhen, S (reprint author), Univ Rennes 1, Chim Solide & Inorgan Mol Lab, CNRS, UMR 6511,Grp Mat Mol, F-35042 Rennes, France.		Kato, Reizo/I-1073-2014				GEISER U, 1985, J AM CHEM SOC, V107, P8305, DOI 10.1021/ja00312a106; MORI T, 1984, B CHEM SOC JPN, V57, P627, DOI 10.1246/bcsj.57.627; NORTH ACT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P351, DOI 10.1107/S0567739468000707; YAMOCHI H, 1993, J AM CHEM SOC, V115, P11319, DOI 10.1021/ja00077a034; KATO R, 1991, SYNTHETIC MET, V42, P2093, DOI 10.1016/0379-6779(91)92024-C; Kobayashi H, 1996, J AM CHEM SOC, V118, P368, DOI 10.1021/ja9523350; BENO MA, 1986, SOLID STATE COMMUN, V57, P735, DOI 10.1016/0038-1098(86)90849-5; Binet L, 1997, SYNTHESIS-STUTTGART, P26; BOCHGAARD K, 1980, SOLID STATE COMMUN, V33, P1119; BU XH, 1991, SOLID STATE COMMUN, V79, P1053, DOI 10.1016/0038-1098(91)90009-K; DELHAES P, 1990, J PHYS-PARIS, V51, P1179, DOI 10.1051/jphys:0199000510110117900; DUCASSE L, 1993, SYNTHETIC MET, V56, P1995, DOI 10.1016/0379-6779(93)90361-Y; GEISER U, 1987, SYNTHETIC MET, V19, P599, DOI 10.1016/0379-6779(87)90422-X; GEISER U, 1991, INORG CHEM, V30, P2586, DOI 10.1021/ic00012a005; GEISER U, 1986, INORG CHEM, V25, P401, DOI 10.1021/ic00224a001; KANODA K, 1989, SOLID STATE COMMUN, V69, P415, DOI 10.1016/0038-1098(89)90699-6; KOBAYASHI A, 1993, CHEM LETT, P2179, DOI 10.1246/cl.1993.2179; NAITO T, 1991, CHEM LETT, P1945, DOI 10.1246/cl.1991.1945; KOBAYASHI H, 1995, J CHEM SOC CHEM COMM, P1225, DOI 10.1039/c39950001225; KURMOO M, 1993, J MATER CHEM, V3, P1161, DOI 10.1039/jm9930301161; KURMOO M, 1996, B CHEM SOC JPN, V69, P1; KURMOO M, 1990, ACTA CRYSTALLOGR B, V46, P348, DOI 10.1107/S0108768189013145; KURMOO M, 1988, SYNTHETIC MET, V27, pA177, DOI 10.1016/0379-6779(88)90398-0; MOUSDIS GA, 1992, SYNTHETIC MET, V48, P219, DOI 10.1016/0379-6779(92)90063-O; Ouahab L, 1997, CHEM MATER, V9, P1909, DOI 10.1021/cm9701217; PAPAVASSILIOU GC, 1992, MATER RES SOC SYMP P, V247, P535, DOI 10.1557/PROC-247-535; PAPAVASSILIOU GC, 1993, SYNTHETIC MET, V61, P267, DOI 10.1016/0379-6779(93)91272-4; PAPAVASSILIOU GC, 1997, HDB ORGANIC CONDUCTI, V1, P151; Sheldrick G. M., SHELXL 97 PROGRAM RE, P199; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; STRINGER AM, 1988, THESIS U BRISTOL UK; Williams J M, 1992, ORGANIC SUPERCONDUCT; WILLIAMS JM, 1987, PROG INORG CHEM, V35, P51, DOI 10.1002/9780470166369.ch2; 1997, P INT C SYNTH MET IC, V86	34	9	9	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD,, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	0959-9428			J MATER CHEM	J. Mater. Chem.	FEB	1999	9	2					387	393		10.1039/a804995e		7	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	166JR	WOS:000078572900012		
J	Yagi, Y; Hirano, S; Ujihira, Y; Miyayama, M				Yagi, Y; Hirano, S; Ujihira, Y; Miyayama, M			Analysis of the sintering process of 2 mol % yttria-doped zirconia by positron annihilation lifetime measurements	JOURNAL OF MATERIALS SCIENCE LETTERS			English	Article									Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Yagi, Y (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0; ITO K, 1998, RADIOISOTOPES, V47, P12; Kingerg W.D., 1976, INTRO CERAMICS; LIU J, 1993, MACROMOLECULES, V26, P7149, DOI 10.1021/ma00078a006; NAKANISHI H, 1982, J PHYS CHEM-US, V86, P4446, DOI 10.1021/j100219a035; Nakanishi H., 1988, POSITRON ANNIHILATIO, P292; NAKANISHI N, 1988, POSITRON POSITRONIUM, pCH5; OGAI M, 1992, NEW CERAMICS, P43; ROOSEN A, 1984, ADV CERAM, V12, P714; UJIHIRA Y, 1992, RADIOISOTOPES, V41, P281; Wakabayashi Y, 1997, MATER SCI FORUM, V255-2, P357	11	16	16	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0261-8028			J MATER SCI LETT	J. Mater. Sci. Lett.	FEB 1	1999	18	3					205	207		10.1023/A:1006616030469		3	Materials Science, Multidisciplinary	Materials Science	190DD	WOS:000079945900009		
J	Fujii, T; Taguchi, H; Katano, H; Mori, S; Nakamura, T; Nojiri, N; Nakajima, K; Tadokoro, K; Juji, T; Iwamoto, A				Fujii, T; Taguchi, H; Katano, H; Mori, S; Nakamura, T; Nojiri, N; Nakajima, K; Tadokoro, K; Juji, T; Iwamoto, A			Seroprevalence of human herpesvirus 8 in human immunodeficiency virus 1-positive and human immunodeficiency virus 1-negative populations in Japan	JOURNAL OF MEDICAL VIROLOGY			English	Article						human herpesvirus 8; Kaposi's sarcoma; seroprevalence	SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; DNA-SEQUENCES; CASTLEMANS DISEASE; ANTIBODIES; INFECTION	To determine the seroprevalence of human herpesvirus 8 (HHV8) among human immunodeficiency virus 1 (HIV-1)-positive (HIV-1(+)) and HIV-1-negative (HIV-1(-)) populations in Japan, 276 HIV-1(+) patients and 1,000 HIV-1- blood donors were enrolled in this study. Antibodies against HHV8 latency-associated nuclear antigen (LANA) were examined through indirect immunofluorescent assay by using a B-cell line that was infected latently with HHV8 (body cavity-based lymphoma 1). An HHV8(-) and Epstein-Barr virus-negative B-cell line (Ramos) was used as a control. Thirty-two seropositive cases against LANA (anti-LANA(+)) were identified among the 276 HIV-1(+) patients who were studied. Five cases were foreigners living in Japan. The risk factor of all 27 Japanese cases was unprotected sexual intercourse, and the great majority of these cases (23 in 27; 85%) reported homosexual/bisexual behavior. Anti-LANA(+) status correlated with the presence of sexually transmitted diseases, such as amoeba and HBV infection, further suggesting male homosexual behavior as the main route of HHV8 transmission in Japan. Only two LANA(+) cases were identified among 1,000 HIV- blood donors in Japan; thus, seroprevalence of HHV8 identified by LANA was estimated to be 0.2% among HIV-1(-) populations in this country. (C) 1999 Wiley-Liss, Inc.	Univ Tokyo, Inst Med Sci, Dept Infect Dis, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol & Infect Dis, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Appl Immunol, Tokyo, Japan; Japanese Red Cross, Cent Blood Ctr, Tokyo, Japan	Iwamoto, A (reprint author), Univ Tokyo, Inst Med Sci, Dept Infect Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						KLEIN G, 1975, INTERVIROLOGY, V5, P319; Gao SJ, 1996, NAT MED, V2, P925, DOI 10.1038/nm0896-925; Kedes DH, 1996, NAT MED, V2, P918, DOI 10.1038/nm0896-918; Lennette ET, 1996, LANCET, V348, P858, DOI 10.1016/S0140-6736(96)03240-0; SOULIER J, 1995, BLOOD, V86, P1276; Simpson GR, 1996, LANCET, V348, P1133, DOI 10.1016/S0140-6736(96)07560-5; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; KARCHER DS, 1995, NEW ENGL J MED, V333, P797; TACHIKAWA N, 1996, J INFECT CHEMOTHER, V1, P190, DOI 10.1007/BF02350647	10	40	47	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0146-6615			J MED VIROL	J. Med. Virol.	FEB	1999	57	2					159	162		10.1002/(SICI)1096-9071(199902)57:2<159::AID-JMV12>3.0.CO;2-A		4	Virology	Virology	154DJ	WOS:000077873100012		
J	Hiroi, H; Inoue, S; Watanabe, T; Goto, W; Orimo, A; Momoeda, M; Tsutsumi, O; Taketani, Y; Muramatsu, M				Hiroi, H; Inoue, S; Watanabe, T; Goto, W; Orimo, A; Momoeda, M; Tsutsumi, O; Taketani, Y; Muramatsu, M			Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus	JOURNAL OF MOLECULAR ENDOCRINOLOGY			English	Article							MESSENGER-RIBONUCLEIC-ACID; BABOON PAPIO-ANUBIS; PROGESTERONE RECEPTORS; GRANULOSA-CELLS; ER-BETA; IMMUNOCYTOCHEMICAL LOCALIZATION; GLUCOCORTICOID RECEPTOR; MOLECULAR-CLONING; FINGER PROTEIN; EXPRESSION	In order to investigate the localization of estrogen receptor (ER) alpha and ER beta in the reproductive organs in the rat, polyclonal antibodies were raised to each specific amino acid sequence. The Western blot with anti-ER alpha antibody showed a 66 kDa band in rat ovary and uterus, while that with anti-ER beta antibody detected a 55 kDa band in rat ovary, uterus and prostate. The ligand-independent nuclear localization of the two receptors was verified by immunocytochemistry. By immunohistochemistry, the nuclei of glandular and luminal epithelial cells in the uterus were stained with anti-ER alpha antibody, whereas only the nuclei of glandular epithelium cells were stained with anti-ER beta antibody. In rat ovary, positive signals were shown with anti-ER beta antibody in the nuclei of granulosa cells. No specific immunostaining was observed with anti-ER alpha antibody. Although ER beta was immunostained at the proestrous, metestrous and diestrous stages, the immunoreactivity of ER beta was hardly detected at the estrous stage in rat ovary. Thus, we show differential expression of ER alpha and ER beta in rat uterus and ovary at the protein level, which may provide a clue for understanding the roles of the two receptors in reproductive organs.	Saitama Med Sch, Dept Biochem, Moroyama, Saitama 3500495, Japan; Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Tokyo 1130033, Japan	Muramatsu, M (reprint author), Saitama Med Sch, Dept Biochem, 38 Morohongo, Moroyama, Saitama 3500495, Japan.						Tremblay GB, 1997, MOL ENDOCRINOL, V11, P353, DOI 10.1210/me.11.3.353; Couse JF, 1997, ENDOCRINOLOGY, V138, P4613, DOI 10.1210/en.138.11.4613; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; ORIMO A, 1995, J BIOL CHEM, V270, P24406; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; GREEN S, 1986, NATURE, V320, P134, DOI 10.1038/320134a0; BILLIAR RB, 1992, J CLIN ENDOCR METAB, V75, P1159, DOI 10.1210/jc.75.4.1159; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V243, P122, DOI 10.1006/bbrc.1997.7893; GREENE GL, 1986, SCIENCE, V231, P1150, DOI 10.1126/science.3753802; INOUE S, 1993, P NATL ACAD SCI USA, V90, P11117, DOI 10.1073/pnas.90.23.11117; YANG J, 1994, MOL CELL BIOL, V14, P5088; Byers M, 1997, MOL ENDOCRINOL, V11, P172, DOI 10.1210/me.11.2.172; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Dotzlaw H, 1997, J CLIN ENDOCR METAB, V82, P2371, DOI 10.1210/jc.82.7.2371; HILDPETITO S, 1988, ENDOCRINOLOGY, V123, P2896; HILDPETITO S, 1992, ENDOCRINOLOGY, V130, P2343, DOI 10.1210/en.130.4.2343; IKEGAMI A, 1994, ENDOCRINOLOGY, V135, P782, DOI 10.1210/en.135.2.782; INOUE S, 1993, ARTERIOSCLER THROMB, V13, P1859; IWAI T, 1991, ENDOCRINOLOGY, V129, P1840; Katzenellenbogen BS, 1997, ENDOCRINOLOGY, V138, P861, DOI 10.1210/en.138.3.861; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; KOJI T, 1993, ENDOCRINOLOGY, V132, P382, DOI 10.1210/en.132.1.382; KUDOLO GB, 1984, J ENDOCRINOL, V102, P83, DOI 10.1677/joe.0.1020083; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Onoe Y, 1997, ENDOCRINOLOGY, V138, P4509, DOI 10.1210/en.138.10.4509; Pace P, 1997, J BIOL CHEM, V272, P25832, DOI 10.1074/jbc.272.41.25832; PEACH K, 1997, SCIENCE, V277, P1508; RICHARDS JS, 1975, ENDOCRINOLOGY, V97, P1174; Sackey FNA, 1996, MOL ENDOCRINOL, V10, P1191, DOI 10.1210/me.10.10.1191; Saunders P.T., 1997, J ENDOCRINOL, V154, P13; Shughrue PJ, 1996, STEROIDS, V61, P678, DOI 10.1016/S0039-128X(96)00222-X; Watanabe T, 1997, BIOCHEM BIOPH RES CO, V236, P140, DOI 10.1006/bbrc.1997.6915; WELSHONS WV, 1984, NATURE, V307, P747, DOI 10.1038/307747a0; ZAINO RJ, 1989, ENDOCRINOLOGY, V125, P2728	38	117	126	SOC ENDOCRINOLOGY	BRISTOL	17/18 THE COURTYARD, WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4NQ, ENGLAND	0952-5041			J MOL ENDOCRINOL	J. Mol. Endocrinol.	FEB	1999	22	1					37	44		10.1677/jme.0.0220037		8	Endocrinology & Metabolism	Endocrinology & Metabolism	164EP	WOS:000078450000005		
J	Charles, H; Ishikawa, H				Charles, H; Ishikawa, H			Physical and genetic map of the genome of Buchnera, the primary endosymbiont of the pea aphid Acyrthosiphon pisum	JOURNAL OF MOLECULAR EVOLUTION			English	Article						Buchnera; Acyrthosiphon pisum; pea aphid; pulse-field gel electrophoresis; genome size; genetic map; symbiosis	WEEVIL-SITOPHILUS-ORYZAE; INTRACELLULAR SYMBIONT; OPERON; SIZE; EXPRESSION; ELECTROPHORESIS; BACTERIA; SEQUENCE; DNA	The genome of Buchnera, an endosymbiotic bacterium of the pea aphid Acyrthosiphon pisum, was characterized by pulse-field gel electrophoresis (PFGE) as a circular DNA molecule of 657 kb. The enzymes I-CeuI, CpoI, ApaI, SmaI, NaeI, SacII, MluI, FspI, and NruI were used to cleave the DNA of Buchnera into fragments of suitable size for PFGE analysis. A physical map of the Buchnera genome, including restriction fragments from seven of these enzymes, was constructed using double cutting, partial digestion, and hybridization with linking fragments, and 29 genes and operons were localized on the map. In addition, the genomic map of Buchnera was compared with those of Escherichia coli and Haemophilus influenzae. The gene order in Buchnera is more similar to that of E. coli than to H. influenzae. The dramatic shrinkage of the Buchnera genome compared with those of other members of the closely related Enterobacteriaceae family is discussed in terms of evolution under the influence of the intracellular symbiotic association.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan	Ishikawa, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan.		CHARLES, Hubert/B-9392-2011				HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Sato S, 1997, J BACTERIOL, V179, P2300; GU X, 1995, J MOL EVOL, V40, P464, DOI 10.1007/BF00164032; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; FEBVAY G, 1995, ARCH INSECT BIOCHEM, V29, P45, DOI 10.1002/arch.940290106; ISHIKAWA H, 1989, INT REV CYTOL, V116, P1, DOI 10.1016/S0074-7696(08)60637-3; Nakabachi A, 1997, INSECT BIOCHEM MOLEC, V27, P1057, DOI 10.1016/S0965-1748(97)00092-1; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Baumann L, 1998, CURR MICROBIOL, V36, P85, DOI 10.1007/s002849900284; BRACHO AM, 1995, J MOL EVOL, V41, P67; Buchner P, 1965, ENDOSYMBIOSIS ANIMAL; Charles H, 1997, INSECT BIOCHEM MOLEC, V27, P345, DOI 10.1016/S0965-1748(97)00005-2; Clark MA, 1998, CURR MICROBIOL, V36, P158, DOI 10.1007/PL00006760; HEDDI A, 1998, IN PRESS J MOL EVOL; HEDDI A, 1991, ENDOCYTOBIOSIS CELL, V8, P61; HERDMAN M, 1977, FEMS MICROBIOL LETT, V1, P7, DOI 10.1111/j.1574-6968.1977.tb00568.x; ISHIKAWA H, 1987, J MOL EVOL, V24, P205, DOI 10.1007/BF02111233; ISHIKAWA H, 1982, COMP BIOCHEM PHYS B, V72, P239, DOI 10.1016/0305-0491(82)90041-4; KRAWIEC S, 1990, MICROBIOL REV, V54, P502; LAI CY, 1994, P NATL ACAD SCI USA, V91, P3819, DOI 10.1073/pnas.91.9.3819; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; MORAN N, 1996, P NATL ACAD SCI USA, V48, P644; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; NAKABACHI A, 1998, IN PRESS J INSECT PH; OHTAKA C, 1992, J BACTERIOL, V174, P1869; OHTAKA C, 1993, J MOL EVOL, V36, P121, DOI 10.1007/BF00166247; PYLE LE, 1988, NUCLEIC ACIDS RES, V16, P6015, DOI 10.1093/nar/16.13.6015; ROUHBAKHSH D, 1995, GENE, V155, P107, DOI 10.1016/0378-1119(94)00910-K; SASAKI T, 1993, ZOOL SCI, V10, P779; Sato S, 1997, J BIOCHEM-TOKYO, V122, P41; Smith C.L., 1988, P41; SOLDO AT, 1983, J GEN MICROBIOL, V129, P1317; UNTERMAN BM, 1989, J BACTERIOL, V171, P2970; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052	38	61	63	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0022-2844			J MOL EVOL	J. Mol. Evol.	FEB	1999	48	2					142	150		10.1007/PL00006452		9	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Evolutionary Biology; Genetics & Heredity	162BP	WOS:000078325600003		
J	Chang, KA; Kim, SH; Y-Sakaki; Kim, HS; Park, CW; Suh, YH				Chang, KA; Kim, SH; Y-Sakaki; Kim, HS; Park, CW; Suh, YH			Inhibition of the NGF and IL-1 beta-induced expression of Alzheimer's amyloid precursor protein by antisense oligonucleotides	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Alzheimer's disease; amyloid precursor protein; nerve growth factor; interleukin-1 beta; antisense oligonucleotides; Down syndrome	DOWNS-SYNDROME; MESSENGER-RNA; DISEASE; GENE; CELLS; INTERLEUKIN-1; BRAIN	Alzheimer's disease (AD) is a neurodegenerative disorder of the brain characterized by the extracellular deposition of amyloid in senile plaques and along the walls of the cerebral vasculature. The principal constituent of amyloid deposit is amyloid beta peptide (AP) derived from its larger precursor protein, amyloid precursor protein (APP). The overexpression of APP is known to be a risk factor for AP deposit in AD and in Down syndrome (DS). The inhibition of APP expression has been thought to be beneficial to patients with AD and DS. In this study, we investigated the effects of antisense oligonucleotide (AO) on the overexpression of APP induced by IL-1 beta and NGF. Using phosphorothioate-oligonucleotides against initiation codon significantly reduced the protein levels of APP induced by NGF and IL-1 beta to basal level in PC12 cell culture systems. These results showed that these antisense oligonucleotides may have a potential to be a therapeutic agent for some patients with AD and DS.	Seoul Natl Univ, MRC, Neurosci Res Inst, Coll Med,Dept Pharmacol,Chongno Gu, Seoul 110799, South Korea; Univ Tokyo, Inst Med Sci, Tokyo, Japan	Suh, YH (reprint author), Seoul Natl Univ, MRC, Neurosci Res Inst, Coll Med,Dept Pharmacol,Chongno Gu, Yongon Dong 28, Seoul 110799, South Korea.		Kim, Hye Sun/J-2752-2012; Suh, Yoo-Hun/J-2761-2012				Cosgaya JM, 1996, J NEUROCHEM, V67, P98; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; LEBLANC AC, 1992, J NEUROSCI RES, V31, P635, DOI 10.1002/jnr.490310407; BEYREUTHER K, 1993, ANN NY ACAD SCI, V695, P91, DOI 10.1111/j.1749-6632.1993.tb23035.x; Grilli M, 1996, J BIOL CHEM, V271, P15002; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; GOLDGABER D, 1989, P NATL ACAD SCI USA, V86, P7606, DOI 10.1073/pnas.86.19.7606; NEVE RL, 1988, NEURON, V1, P669, DOI 10.1016/0896-6273(88)90166-3; ALLINQUANT B, 1995, J CELL BIOL, V128, P919, DOI 10.1083/jcb.128.5.919; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; JOHNSON SA, 1988, EXP NEUROL, V102, P264, DOI 10.1016/0014-4886(88)90104-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; TANAKA S, 1992, MOL BRAIN RES, V15, P303, DOI 10.1016/0169-328X(92)90122-R; WAHLESTEDT C, 1994, TRENDS PHARMACOL SCI, V15, P42, DOI 10.1016/0165-6147(94)90107-4	20	6	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	FEB	1999	12	1					69	74		10.1385/JMN:12:1:69		6	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	231PG	WOS:000082318500006		
J	Koike, K; Kudo, M; Jia, ZH; Nikaido, T; Ide, Y; Sakura, T				Koike, K; Kudo, M; Jia, ZH; Nikaido, T; Ide, Y; Sakura, T			New triterpenoid saponins from Maesa japonica	JOURNAL OF NATURAL PRODUCTS			English	Article							HOST DEFENSE STIMULANT; LANCEOLATA	New triterpenoid saponins, maejaposides A, B, C, D, and E, were isolated from the roots of Maesa japonica and were, respectively, defined to be 3-O-[beta-D-xylopyranosyl-(1-->2)-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-galactopyranosyl-(1-->3)] [beta-D-galactopyranosyl-(1-->2)]beta-D-glucuronopyranosides of 22 alpha-[(Z)-2-hexenoyloxy]-13 beta,28-oxido-olean-16 alpha,28 alpha-diol (1); 22 alpha-[2 '-methylbutanoyl]-13 beta,28-oxido-olean-16 alpha,28 alpha-diol (2a) and 22 alpha-angeloyloxy-13 beta, 28-oxido-olean-16 alpha,28 alpha-diol (2b); 21 beta,22 alpha-diangeloyloxy-13 beta,28-oxido-olean-16 alpha,28 alpha-diol (3); 21 beta-angeloyloxy,22 alpha-(2 '-methylbutanoyl)-13 beta,28-oxido-olean-16 alpha,28 alpha-diol (4), and 21 beta-angeloyloxy,22 alpha-[(Z)-2 '-hexenoyl]- 13 beta,28-oxido-olean-16 alpha,28 alpha-diol (5). Their structures were established on the basis of extensive NMR (DEPT, COSY, HOHAHA, HETCOR, HMBC, and NOESY) and ESIMS/MS studies, along with chemical degradation.	Toho Univ, Sch Pharmaceut Sci, Dept Pharmacognosy, Funabashi, Chiba 2748510, Japan; Univ Tokyo, Fac Agr, Univ Forest Chiba, Amatsu Kominato, Chiba 2995503, Japan	Nikaido, T (reprint author), Toho Univ, Sch Pharmaceut Sci, Dept Pharmacognosy, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.						ALIOTTA G, 1992, PHYTOCHEMISTRY, V31, P929; CHAKRAVARTY AK, 1987, PHYTOCHEMISTRY, V26, P2345, DOI 10.1016/S0031-9422(00)84716-0; GLOMBITZA KW, 1987, PLANTA MED, V53, P548, DOI 10.1055/s-2006-962809; *JIANGS NEW MED CO, 1977, ZHONG YAO DA CI DIAN, P1035; KUBO I, 1987, TETRAHEDRON, V43, P2653, DOI 10.1016/S0040-4020(01)86870-8; KUBO I, 1983, TETRAHEDRON LETT, V24, P3825, DOI 10.1016/S0040-4039(00)94285-0; OGAWA H, 1968, PHYTOCHEMISTRY, V7, P773, DOI 10.1016/S0031-9422(00)84831-1; Sindambiwe JB, 1996, PHYTOCHEMISTRY, V41, P269, DOI 10.1016/0031-9422(95)00552-8; Tuntiwachwuttikul P, 1997, PHYTOCHEMISTRY, V44, P491, DOI 10.1016/S0031-9422(96)00556-0	9	13	15	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864			J NAT PROD	J. Nat. Prod.	FEB	1999	62	2					228	232		10.1021/np980235c		5	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	173BJ	WOS:000078960800006		
J	Hu, K; Yao, XS; Dong, AJ; Kobayashi, H; Iwasaki, S; Jing, YK				Hu, K; Yao, XS; Dong, AJ; Kobayashi, H; Iwasaki, S; Jing, YK			A new pregnane glycoside from Dioscorea collettii var. hypoglauca	JOURNAL OF NATURAL PRODUCTS			English	Article							ANTINEOPLASTIC AGENTS; RHIZOMES	During further bioactivity-guided fractionation, a new pregnane glycoside, hypoglaucin G (1), and a known compound, pregna-5,16-dien-3 beta-ol-20-one 3-O-alpha-L-rhamnopyranosyl-(1-->2)-[alpha-L-rhamnopyranosyl-(1-->4)]-beta-D-glucopyranoside (2), were isolated from the EtOH extract of Dioscorea collettii var. hypoglauca rhizomes, which induced morphological deformation of Pyricularia oryzae mycelia with minimum morphological deformation concentration values of 135 mu M and 236 mu M, respectively. The structure of 1 was established as 16 beta-(4 '-methyl-5 '-O-beta-D-glucopyranosyl-pentanoxyl) 3-O-alpha-L- rhamnopyranosyl-(1-->2)-[alpha-L-rhamnopyranosyl-(1-->4)]-beta-D-glucoptranoside on the basis of chemical evidence and spectral analysis, especially by 2D NMR techniques.	Shenyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang 110015, Peoples R China; NE Pharmaceut Corp, Inst Drug Res & Dev, Shenyang 110026, Peoples R China; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	Yao, XS (reprint author), Shenyang Pharmaceut Univ, Dept Nat Prod Chem, 103 Wenhua Rd, Shenyang 110015, Peoples R China.	xsyao@ihw.com.cn					TSURUO T, 1986, CANCER RES, V46, P381; KOBAYASHI H, 1995, J ANTIBIOT, V48, P42; AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; ABISCH E, 1960, HELV CHIM ACTA, V43, P1844, DOI 10.1002/hlca.19600430646; BETINA V, 1973, Z ALLG MIKROBIOL, V13, P287, DOI 10.1002/jobm.3630130402; Hu K, 1996, PLANTA MED, V62, P573, DOI 10.1055/s-2006-957978; HU K, 1996, J SHENYANG PHARM UNI, V12, P146; Hu K, 1997, PLANTA MED, V63, P161, DOI 10.1055/s-2006-957636; JU Y, 1994, LANZHOU DAXUE XUEBAO, V30, P64; Kobayashi H, 1996, J ANTIBIOT, V49, P873; LI TL, 1981, ANAL CHEM, V9, P295; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Richmond D V, 1975, Adv Appl Microbiol, V19, P289, DOI 10.1016/S0065-2164(08)70432-5	13	37	42	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0163-3864			J NAT PROD	J. Nat. Prod.	FEB	1999	62	2					299	301		10.1021/np980101z		3	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	173BJ	WOS:000078960800024		
J	Watanabe, T; Sukegawa, J; Sukegawa, I; Tomita, S; Iijima, K; Oguchi, S; Suzuki, T; Nairn, AC; Greengard, P				Watanabe, T; Sukegawa, J; Sukegawa, I; Tomita, S; Iijima, K; Oguchi, S; Suzuki, T; Nairn, AC; Greengard, P			A 127-kDa protein (UV-DDB) binds to the cytoplasmic domain of the Alzheimer's amyloid precursor protein	JOURNAL OF NEUROCHEMISTRY			English	Article						amyloid precursor protein; UV-damaged DNA binding protein; DNA repair	PIGMENTOSUM GROUP-E; DNA-REPAIR; PRIMATE CELLS; BETA-PROTEIN; DAMAGED DNA; DISEASE; SYSTEM; FE65; PHOSPHORYLATION; PURIFICATION	Alzheimer amyloid precursor protein (APP) is an integral membrane protein with a short cytoplasmic domain of 47 amino acids. It is hoped that identification of proteins that interact with the cytoplasmic domain will provide new insights into the physiological function of APP and, in turn, into the pathogenesis of Alzheimer's disease. To identify proteins that interact with the cytoplasmic domain of APP, we employed affinity chromatography using an immobilized synthetic peptide corresponding to residues 645-694 of APP(695), and identified a protein of similar to 130 kDa in rat brain cytosol. Amino acid sequencing of the protein revealed the protein to be a rat homologue of monkey UV-DDB (UV-damaged DNA-binding protein, calculated molecular mass of 127 kDa), UV-DDB/p127 co-immunoprecipitated with APP using an anti-APP antibody from PC12 cell lysates. APP also coimmunoprecipitated with UV-DDB/p127 using an anti-UV-DDB/p127 antibody. These results indicate that UV-DDB/p127, which is present in the cytosolic fraction, forms a complex with APP through its cytoplasmic domain. In vitro binding experiments using a glutathione S-transferase-APP cytoplasmic domain fusion protein and several mutants indicated that the YENPTY motif within the APP cytoplasmic domain, which is important in the internalization of APP and amyloid beta protein secretion, may be involved in the interaction between UV-DDB/p127 and APP.	Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Tohoku Univ, Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan; Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Tokyo, Japan	Nairn, AC (reprint author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA.		Suzuki, Toshiharu/B-5342-2013; 	Nairn, Angus/0000-0002-7075-0195			ABRAMIC M, 1991, J BIOL CHEM, V266, P22493; LAI A, 1995, J BIOL CHEM, V270, P3565; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; NISHIMOTO I, 1993, NATURE, V362, P75, DOI 10.1038/362075a0; Hayes S, 1998, MOL CELL BIOL, V18, P240; TAKAO M, 1993, NUCLEIC ACIDS RES, V21, P4111, DOI 10.1093/nar/21.17.4111; McLoughlin DM, 1996, FEBS LETT, V397, P197; MU D, 1995, J BIOL CHEM, V270, P2415; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Borg JP, 1996, MOL CELL BIOL, V16, P6229; KEENEY S, 1993, J BIOL CHEM, V268, P21293; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; KOO EH, 1994, J BIOL CHEM, V269, P17386; Fiore F, 1995, J BIOL CHEM, V270, P30853; ATHERTON D, 1993, TECHNIQUES PROTEIN C, V4, P409; BARTLETT WP, 1984, J NEUROSCI, V4, P1944; BOERRIGTER METI, 1992, J GERONTOL, V47, pB177; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chow NW, 1996, J BIOL CHEM, V271, P11339; DAS HK, 1988, J BIOL CHEM, V263, P11452; [Anonymous], 1990, METHOD ENZYMOL; DUALAN R, 1995, GENOMICS, V29, P62, DOI 10.1006/geno.1995.1215; FERNANDEZ J, 1994, ANAL BIOCHEM, V218, P112, DOI 10.1006/abio.1994.1148; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; HIRSCHFELD S, 1990, MOL CELL BIOL, V10, P2041; JONES SK, 1989, MUTAT RES, V219, P247, DOI 10.1016/0921-8734(89)90007-6; Kazantsev A, 1996, P NATL ACAD SCI USA, V93, P5014, DOI 10.1073/pnas.93.10.5014; KEENEY S, 1994, P NATL ACAD SCI USA, V91, P4053, DOI 10.1073/pnas.91.9.4053; Krishnamoorthy RR, 1997, BIOCHEMISTRY-US, V36, P960, DOI 10.1021/bi961407c; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAZZARELLO P, 1992, J NEUROL SCI, V112, P4, DOI 10.1016/0022-510X(92)90125-5; Neve RL, 1996, TRENDS NEUROSCI, V19, P371, DOI 10.1016/S0166-2236(96)30011-8; Oishi M, 1997, MOL MED, V3, P111; Parshad R, 1996, P NATL ACAD SCI USA, V93, P5146, DOI 10.1073/pnas.93.10.5146; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yamatsuji T, 1996, SCIENCE, V272, P1349, DOI 10.1126/science.272.5266.1349; Zambrano N, 1997, J BIOL CHEM, V272, P6399; ZHUANG HM, 1992, MOL CELL BIOL, V12, P3183	44	36	39	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	FEB	1999	72	2					549	556		10.1046/j.1471-4159.1999.0720549.x		8	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	159FR	WOS:000078161800011		
J	Kurita, N; Kawamoto, S; Kirino, T				Kurita, N; Kawamoto, S; Kirino, T			Radiosurgically treated acromegaly	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article									Univ Tokyo, Fac Med, Dept Neurosurg, Bunkyo Ku, Tokyo, Japan	Kurita, N (reprint author), Univ Freiburg, Neurochirurg Klin, Breisacher Str 64, D-79106 Freiburg, Germany.		Kawamoto, Shunsuke/E-9947-2013	Kawamoto, Shunsuke/0000-0002-1388-1287				0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	1999	66	2					244	244				1	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	164EX	WOS:000078450800023		
J	Abe, H; Oka, Y				Abe, H; Oka, Y			Characterization of K+ currents underlying pacemaker potentials of fish gonadotropin-releasing hormone cells	JOURNAL OF NEUROPHYSIOLOGY			English	Article							MIDBRAIN DOPAMINE NEURONS; GOURAMI COLISA-LALIA; TERMINAL NERVE; DWARF GOURAMI; GNRH NEURONS; BRAIN; RHYTHMICITY; MODULATION; CHANNELS; INVITRO	Endogenous pacemaker activities are important for the putative neuromodulator functions of the gonadotropin-releasing hormone (GnRH)-immunoreactive terminal nerve (TN) cells. We analyzed several types of voltage-dependent K+ currents to investigate the ionic mechanisms underlying the repolarizing phase of pacemaker potentials of TN-GnRH cells by using the whole brain in vitro preparation of fish (dwarf gourami, Colisa lalia). TN-GnRH cells have at least four types of voltage-dependent K+ currents: 1) 4-aminopyridine (4AP)-sensitive K+ current, 2) tetraethylammonium (TEA)-sensitive K+ current, and 3) and 4) two types of TEA- and 4AP-resistant K+ currents. A transient, low-threshold K+ current, which was 4AP sensitive and showed significant steady-state inactivation in the physiological membrane potential range (-40 to -60 mV), was evoked from a holding potential of -100 mV. This current thus cannot contribute to the repolarizing phase of pacemaker potentials. TEA-sensitive K+ current evoked from a holding potential of -100 mV was slowly activating, long lasting, and showed comparatively low threshold of activation. This current was only partially inactivated at steady slate of -60 to -40 mV, which is equivalent to the resting membrane potential. TEA- and 4AP-resistant sustained K+ currents were evoked from a holding potential of -100 mV and were suggested to consist of two types, based on the analysis of activation curves. From the inactivation and activation curves, it was suggested that one of them with low threshold of activation may be partly involved in the repolarizing phase of pacemaker potentials. Bath application of TEA together with tetrodotoxin reversibly blocked the pacemaker potentials in current-clamp recordings. We conclude that the TEA-sensitive K+ current is the most likely candidate that contributes to the repolarizing phase of the pacemaker potentials of TN-GnRH cells.	Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan	Oka, Y (reprint author), Univ Tokyo, Grad Sch Sci, Misaki Marine Biol Stn, Kanagawa 2380225, Japan.		Oka, Yoshitaka/C-9670-2010; Abe, Hideki/D-2791-2011	Oka, Yoshitaka/0000-0002-3482-3051; Abe, Hideki/0000-0002-8931-5767			ALZHEIMER C, 1994, J PHYSIOL-LONDON, V479, P199; OKA Y, 1990, J COMP NEUROL, V300, P511, DOI 10.1002/cne.903000406; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Gold MS, 1996, J NEUROPHYSIOL, V75, P2629; GRACE AA, 1991, SYNAPSE, V7, P221, DOI 10.1002/syn.890070307; BOSMA MM, 1993, J MEMBRANE BIOL, V136, P85; CONNOR JA, 1985, ANNU REV PHYSIOL, V47, P17; GRACE AA, 1988, ANN NY ACAD SCI, V537, P51, DOI 10.1111/j.1749-6632.1988.tb42096.x; KACZMAREK LK, 1978, P NATL ACAD SCI USA, V75, P5200, DOI 10.1073/pnas.75.10.5200; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P3918, DOI 10.1073/pnas.92.9.3918; OKA Y, 1993, J NEUROSCI, V13, P2161; OKA Y, 1992, NEUROSCI LETT, V142, P119, DOI 10.1016/0304-3940(92)90353-9; Oka Y, 1996, J NEUROPHYSIOL, V75, P2397; OKA Y, 1995, J PHYSIOL-LONDON, V482, P1; OKA Y, 1992, PERSPECTIVES NEUROET, P37; OKA Y, 1991, J COMP NEUROL, V304, P161, DOI 10.1002/cne.903040202; Oka Y, 1997, GNRH NEURONS GENE BE, P245; OYAMA Y, 1991, BRAIN RES, V568, P350, DOI 10.1016/0006-8993(91)91425-Z; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; Spergel DJ, 1996, NEUROENDOCRINOLOGY, V63, P101, DOI 10.1159/000126946; STRONG JA, 1987, NEUROMODULATION BIOC, P119; STRONG JA, 1985, J NEUROSCI, V6, P819; Wang XY, 1996, J PHYSIOL-LONDON, V490, P63; YAMAMOTO N, 1995, J COMP NEUROL, V355, P354, DOI 10.1002/cne.903550303	24	17	17	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	FEB	1999	81	2					643	653				11	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	170XR	WOS:000078832800023		
J	Akiyama, M; Kouzu, Y; Takahashi, S; Wakamatsu, H; Moriya, T; Maetani, M; Watanabe, S; Tei, H; Sakaki, Y; Shibata, S				Akiyama, M; Kouzu, Y; Takahashi, S; Wakamatsu, H; Moriya, T; Maetani, M; Watanabe, S; Tei, H; Sakaki, Y; Shibata, S			Inhibition of light- or glutamate-induced mPer1 expression represses the phase shifts into the mouse circadian locomotor and suprachiasmatic firing rhythms	JOURNAL OF NEUROSCIENCE			English	Article						antisense oligonucleotide; circadian rhythm; firing rhythm; mPer1; phase shift; suprachiasmatic nucleus	NUCLEUS IN-VITRO; PROTEIN-SYNTHESIS; NEURONAL-ACTIVITY; RAT; CLOCK; PACEMAKER; GENE; SCN; FOS	mPer1, a mouse gene, is a homolog of the Drosophila clock gene period and has been shown to be closely associated with the light-induced resetting of a mammalian circadian clock. To investigate whether the rapid induction of mPer1 after light exposure is necessary for light-induced phase shifting, we injected an antisense phosphotioate oligonucleotide (ODN) to mPer1 mRNA into the cerebral ventricle. Light-induced phase delay of locomotor activity at CT16 was significantly inhibited when the mice were pretreated with mPer1 antisense ODN 1 hr before light exposure. mPer1 sense ODN or random ODN treatment had little effect on phase delay induced by light pulses. In addition, glutamate-induced phase delay of suprachiasmatic nucleus (SCN) firing rhythm was attenuated by pretreatment with mPer1 antisense ODN, but not by random ODN. The present results demonstrate that induction of mPer1 mRNA is required for light- or glutamate-induced phase shifting, suggesting that the acute induction of mPer1 mRNA in the SCN after light exposure is involved in light-induced phase shifting of the overt rhythm.	Waseda Univ, Sch Human Sci, Dept Pharmacol & Brain Sci, Tokorozawa, Saitama 3591192, Japan; Waseda Univ, Sch Human Sci, ARCHS, Tokorozawa, Saitama 3591192, Japan; Kyushu Univ, Fac Pharmaceut Sci, Dept Pharmacol, Fukuoka 81282, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	Shibata, S (reprint author), Waseda Univ, Sch Human Sci, Dept Pharmacol & Brain Sci, Tokorozawa, Saitama 3591192, Japan.	shibata@human.waseda.ac.jp					Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; SHIBATA S, 1994, AM J PHYSIOL, V267, pR360; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Watanabe A, 1996, BRAIN RES, V740, P329, DOI 10.1016/S0006-8993(96)00881-5; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; DAAN S, 1976, J COMP PHYSIOL, V106, P253; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4; AGRAWAL S, 1991, P NATL ACAD SCI USA, V88, P7595, DOI 10.1073/pnas.88.17.7595; COLWELL CS, 1990, BRAIN RES, V523, P117, DOI 10.1016/0006-8993(90)91643-U; DEVRIES MJ, 1993, BRAIN RES, V612, P231, DOI 10.1016/0006-8993(93)91665-F; Edmunds L. N., 1988, CELLULAR MOL BASIS B; Fukushima T, 1997, NEUROSCI LETT, V227, P45, DOI 10.1016/S0304-3940(97)00297-8; Hall JC, 1998, ADV GENET, V38, P135, DOI 10.1016/S0065-2660(08)60143-1; Hastings MH, 1997, TRENDS NEUROSCI, V20, P459, DOI 10.1016/S0166-2236(97)01087-4; INOUYE ST, 1988, AM J PHYSIOL, V255, pR1055; Kashihara N, 1998, EXP NEPHROL, V6, P84; Morris ME, 1998, SCIENCE, V279, P1544, DOI 10.1126/science.279.5356.1544; Ono M, 1996, NEUROSCIENCE, V72, P213, DOI 10.1016/0306-4522(95)00500-5; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; SHIBATA S, 1992, BRAIN RES, V597, P257, DOI 10.1016/0006-8993(92)91482-T; SHIBATA S, 1993, BRAIN RES, V615, P95, DOI 10.1016/0006-8993(93)91118-C; SHIRAKAWA T, 1994, NEUROSCI LETT, V178, P47, DOI 10.1016/0304-3940(94)90286-0; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; TAKAHASHI JS, 1987, BRAIN RES, V405, P199, DOI 10.1016/0006-8993(87)91010-9; TAKEUCHI J, 1993, NEURON, V11, P825, DOI 10.1016/0896-6273(93)90112-5; Talamo BR, 1998, CHEM SENSES, V23, P243; WATANABE A, 1994, BRAIN RES, V646, P161, DOI 10.1016/0006-8993(94)90071-X; WOLLNIK F, 1995, EUR J NEUROSCI, V7, P388, DOI 10.1111/j.1460-9568.1995.tb00334.x; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135	34	205	206	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 1	1999	19	3					1115	1121				7	Neurosciences	Neurosciences & Neurology	161JQ	WOS:000078285800024		
J	Sano, K				Sano, K			Pathogenesis of intracranial germ cell tumors reconsidered	JOURNAL OF NEUROSURGERY			English	Article						embryogenesis; germinoma; germ cell tumor; survival rate	NEOPLASMS; ORIGIN	Object. To determine the pathogenesis of intracranial germ cell tumors (GCTs), the author studied 153 cases of these tumors encountered through 1994, 62.7% of which showed monotypic histological patterns and 37.3% of which were shown to be mixed tumors. Methods. Six patients died soon after admission and underwent autopsy; the other patients underwent surgery followed by radio- and/or chemotherapy. One hundred thirty-four cases were followed through the end of 1997. All patients with a choriocarcinoma died within 1 year. Patients with a yolk sac tumor (endodermal sinus tumor) or an embryonal carcinoma also had poor outcomes. Patients with a mature teratoma had 5- and 10-year survival rates of 93% each. Patients with an immature teratoma had 5- and 10-year survival rates of 86% each, whereas patients who had a teratoma with malignant transformation had a 3-year survival rate of 50%. Patients with a germinoma had a 5-year survival rate of 96% and a 10-year survival rate of 93%. These results may bring into question the validity of the germ cell theory because germinoma, which should be the most undifferentiated tumor according to the theory, was the most benign and choriocarcinoma and yolk sac tumor (endodermal sinus tumor), which should be the most differentiated tumors, were the most malignant according to results obtained during the follow-up study. Conclusions. Germ cell tumors other than germinomas may not originate from one single type of cell (primordial germ cells). The embryonic cells of various stages of embryogenesis may perhaps be misplaced in the bilaminar embryonic disc at the time of the primitive streak formation, becoming involved in the stream of lateral mesoderm and carried to the neural plate area to become incorrectly enfolded into the brain at the time of neural tube formation. The author propounds the following hypothesis: tumors composed of cells resembling the cells that appear in the earlier stages of embryogenesis (ontogenesis) are more malignant than those composed of cells resembling the cells that appear in the later stages of embryogenesis.	Teikyo Univ, Sch Med, Dept Neurosurg, Itabashi Ku, Tokyo 1738605, Japan; Univ Tokyo, Dept Neurosurg, Fuji Brain Inst, Tokyo 113, Japan	Sano, K (reprint author), Teikyo Univ, Sch Med, Dept Neurosurg, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.						STEVENS LC, 1964, P NATL ACAD SCI USA, V52, P654, DOI 10.1073/pnas.52.3.654; BRODEUR GM, 1981, CANCER, V48, P1890, DOI 10.1002/1097-0142(19811015)48:8<1890::AID-CNCR2820480830>3.0.CO;2-D; DIXON FJ, 1953, CANCER, V6, P427, DOI 10.1002/1097-0142(195305)6:3<427::AID-CNCR2820060302>3.0.CO;2-U; TEILUM G, 1959, CANCER, V12, P1092, DOI 10.1002/1097-0142(195911/12)12:6<1092::AID-CNCR2820120606>3.0.CO;2-V; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Matsutani M, 1997, J NEUROSURG, V86, P446, DOI 10.3171/jns.1997.86.3.0446; JENNINGS MT, 1985, J NEUROSURG, V63, P155, DOI 10.3171/jns.1985.63.2.0155; ZALOUDEK CJ, 1981, AM J SURG PATHOL, V5, P361, DOI 10.1097/00000478-198106000-00006; ARIASBER.L, 1968, AM J OBSTET GYNECOL, V100, P785; ASHLEY DJB, 1973, CANCER, V32, P390, DOI 10.1002/1097-0142(197308)32:2<390::AID-CNCR2820320216>3.0.CO;2-W; Askanazy M, 1907, VERHANDL DTSCH PATH, V11, P39; COHNHEIM JF, 1882, VORLESUNGEN ALLGEMEI, V1, P723; *COMM BRAIN TUM RE, 1992, NEUROL MED CHIR, V32, P396; FRIEDMAN NB, 1951, CANCER, V4, P265, DOI 10.1002/1097-0142(195103)4:2<265::AID-CNCR2820040211>3.0.CO;2-X; FRIEDMAN NB, 1947, CANCER RES, V7, P363; FRIEDMAN N B, 1946, Mil Surg, V99, P573; GUTHKELC.AN, 1970, ARCH DIS CHILD, V45, P104; Mintz B, 1981, Adv Cancer Res, V34, P211, DOI 10.1016/S0065-230X(08)60243-2; Moore KL, 1993, DEV HUMAN CLIN ORIEN; MOSTOFI FK, 1980, CANCER, V45, P1735; RUBINSTEIN LJ, 1981, HUM PATHOL, V12, P441, DOI 10.1016/S0046-8177(81)80024-X; Russell DS, 1944, J PATHOL BACTERIOL, V56, P145, DOI 10.1002/path.1700560202; Sano K, 1983, Clin Neurosurg, V30, P59; SANO K, 1989, Neurological Research, V11, P118; SANO K, 1995, BRIT J NEUROSURG, V9, P391, DOI 10.1080/02688699550041395; SANO K, 1998, NEUROSURG FOCUS, V5; STEVENS LC, 1960, DEV BIOL, V2, P285, DOI 10.1016/0012-1606(60)90010-5; TAKEI Y, 1981, CANCER, V48, P2038, DOI 10.1002/1097-0142(19811101)48:9<2038::AID-CNCR2820480921>3.0.CO;2-M; TEILUM G, 1965, ACTA PATHOL MIC SC, V64, P407; UEDA G, 1972, AM J OBSTET GYNECOL, V114, P748; WOODRUFF JD, 1968, OVARY, P82; ZULCH KJ, 1986, BRAIN TUMORS THEIR B, P414	33	71	80	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	FEB	1999	90	2					258	264		10.3171/jns.1999.90.2.0258		7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	168RU	WOS:000078707100010		
J	Kobayashi, H; Narumi, S; Tamatani, T; Lane, GJ; Miyano, T				Kobayashi, H; Narumi, S; Tamatani, T; Lane, GJ; Miyano, T			Serum IFN-Inducible protein-10: A new clinical prognostic predictor of hepatocyte death in biliary atresia	JOURNAL OF PEDIATRIC SURGERY			English	Article; Proceedings Paper	45th Annual International Congress of the British Association of Paediatric Surgeons	JUL 21-24, 1998	BRISTOL, ENGLAND	British Assoc Paediat Surgeons		biliary atresia; interferon-inducible protein-10; hepatocyte death; prognosis	INFLAMMATORY RESPONSE; IP-10; EXPRESSION; DISEASE; MIG	Purpose: The aim of this study was to determine whether chemokines such as serum IP-10 levels in patients with biliary atresia (BA) correlate with liver function and histology and assess its value as a medium to long-term prediction of prognosis in postoperative BA patients. Methods: Thirty postoperative BA patients (mean age, 10.8 +/- 3.5 years) and eight normal controls (mean age, 10.3 +/- 3.3 years) were studied. The BA patients were divided into three groups according to liver function. Group I (n = 8) was jaundice free, had normal liver function and no evidence of severe cholangitis or portal hypertension. Group II (n = 12) had moderate liver dysfunction. Group Ill (n = 10), had severe liver dysfunction. Hepatic histology was assessed using conventional needle biopsy. Serum IP-10 levels were determined using a specific enzyme-linked immunosorbent assay (ELISA). Results: Serum levels of IP-10 in group ill (458.0 +/- 240.0 pg/mL) were significantly higher than those in group Il (233.6 +/- 126.9 pg/mL; P <.0001). Levels in group fl were also significantly higher than those in group 1 (144.8 +/- 23.4 pg/ mL; P <.05), but there was no significant difference between group I and controls (107.9 +/- 34.0 pg/mL). Liver biopsy findings showed a progression of fibrosis and mononuclear cell infiltration from group I to group Ill. There was intimal hyperplasia and swelling of endothelial cells of branches of the hepatic artery in the portal area in group III. Conclusion: Because IP-10 levels correlate closely with histological findings in postoperative BA patients, it would appear to play a specific role in hepatocyte death and hepatic artery changes, thus providing important information about progressive fibrosis in BA patients that facilitates treatment decision making and prediction of prognosis.	Juntendo Univ, Sch Med, Dept Pediat Surg, Bunkyo Ku, Tokyo 1138421, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo, Japan; Japan Tobacco Inc, Pharmaceut Basic Res Labs, Tokyo, Japan	Miyano, T (reprint author), Juntendo Univ, Sch Med, Dept Pediat Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.						Narumi S, 1997, J IMMUNOL, V158, P5536; RANSOHOFF RM, 1993, FASEB J, V7, P592; Balistreri WF, 1996, HEPATOLOGY, V23, P1682, DOI 10.1002/hep.510230652; Kobayashi H, 1997, J PEDIATR SURG, V32, P590, DOI 10.1016/S0022-3468(97)90714-4; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246; Wang XK, 1996, J BIOL CHEM, V271, P24286; Valayer J, 1996, J PEDIATR SURG, V31, P1546, DOI 10.1016/S0022-3468(96)90174-8; BROUGH AJ, 1969, PEDIATRICS, V43, P519; HO CW, 1993, J PEDIATR GASTR NUTR, V16, P53, DOI 10.1097/00005176-199301000-00010; TeruyaFeldstein J, 1997, BLOOD, V90, P4099; Tracy TF, 1996, J PEDIATR SURG, V31, P121, DOI 10.1016/S0022-3468(96)90333-4	11	19	22	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0022-3468			J PEDIATR SURG	J. Pediatr. Surg.	FEB	1999	34	2					308	311		10.1016/S0022-3468(99)90197-5		4	Pediatrics; Surgery	Pediatrics; Surgery	166XC	WOS:000078602300017		
J	Koyaguchi, T; Kaneko, K				Koyaguchi, T; Kaneko, K			A two-stage thermal evolution model of magmas in continental crust	JOURNAL OF PETROLOGY			English	Article						magma chamber; continental crust; crustal melting; magma residence times; fluid dynamics experiments	LONG RESIDENCE TIMES; COMPOSITIONAL CONVECTION; PRECALDERA LAVAS; RHYOLITIC MAGMA; ISOTOPIC RECORD; GRANITIC MAGMAS; GLASS MOUNTAIN; CHAMBER; FLUID; DIFFERENTIATION	When a basaltic magma is emplaced In a continental crust, a silicic magna is generated by melting of the crust. nle light silicic magma forms a separate magma layer with little chemical interaction with the underlying dense basaltic magma layer Extensive melting occurs at the boundary between the silicic magma and the crust while the basalt acts a heat source. The mass and heat transfer at the boundary between the silicic magma and the dust controls the thermal evolution of the silicic magma. nle thermal evolution of the silicic magma after the basalt emplacement is divided into two stages. In the first stage, the temperature in the silicic magma rises above and then decays back to the melting temperature of the crust on a short timescale (10(2) years). The results of fluid dynamics experiments suggest that rite silicic magma generally has a lower melting temperature than the crust because of fractional crystallization and mixing of partial melts during the first stage, and that it can be effectively liquid at the end of the first stage. In the second stage, the silicic magma cools slowly by heat conduction on a much longer timescale (10(5) years). Petrological features of the magma in rite second stage are strongly constrained by petrological features of the surrounding crust as well as those of the supplied magma itself its temperature remains at or just below the melting temperature of the crust for a long time because of the the slow cooling rate; its phenocryst content reflects the difference in the melt fraction vs temperature relationships between the magma and the crust. Judging from the distinct cooling rate between the two stages, erupted magmas ale statistically mole likely to reflect the characteristics of magmas in the second stage.	Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan	Koyaguchi, T (reprint author), Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan.						HUPPERT HE, 1988, J PETROL, V29, P599; MARTIN D, 1988, NATURE, V332, P534, DOI 10.1038/332534a0; TAIT S, 1989, NATURE, V338, P571, DOI 10.1038/338571a0; MARSH BD, 1981, CONTRIB MINERAL PETR, V78, P85, DOI 10.1007/BF00371146; Hort M, 1997, J VOLCANOL GEOTH RES, V76, P297, DOI 10.1016/S0377-0273(96)00079-0; MARSH BD, 1989, J PETROL, V30, P479; SPARKS RSJ, 1990, EARTH PLANET SC LETT, V99, P387, DOI 10.1016/0012-821X(90)90143-L; SPARKS RSJ, 1984, PHILOS T R SOC A, V310, P511, DOI 10.1098/rsta.1984.0006; WORSTER MG, 1991, J FLUID MECH, V224, P335, DOI 10.1017/S0022112091001787; HALLIDAY AN, 1989, EARTH PLANET SC LETT, V94, P274, DOI 10.1016/0012-821X(89)90146-5; HUPPERT HE, 1988, J FLUID MECH, V188, P107, DOI 10.1017/S0022112088000655; BERGANTZ GW, 1995, J GEOPHYS RES-SOL EA, V100, P17603, DOI 10.1029/95JB01240; BROWN M, 1995, J GEOPHYS RES-SOL EA, V100, P15551, DOI 10.1029/95JB01253; CAMPBELL IH, 1987, J GEOL, V95, P155; EWART A, 1982, ANDESITES, P25; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; HALLIDAY AN, 1990, EARTH PLANET SC LETT, V99, P390, DOI 10.1016/0012-821X(90)90144-M; HUPPERT HE, 1981, EARTH PLANET SC LETT, V54, P144, DOI 10.1016/0012-821X(81)90075-3; KANEKO K, 1996, THESIS U TOKYO; KANEKO K, 1996, MEMOIRS GEOLOGICAL S, V46, P29; KERR RC, 1994, J FLUID MECH, V280, P255, DOI 10.1017/S0022112094002922; KOYAGUCHI T, 1995, TOD S ROL MAGM EV EA, P36; KOYAGUCHI T, 1961, ENCLAVES GRANITIC PE, P415; MAHOOD GA, 1990, EARTH PLANET SC LETT, V99, P395, DOI 10.1016/0012-821X(90)90145-N; MCBIRNEY AR, 1980, J VOLCANOL GEOTH RES, V7, P357, DOI 10.1016/0377-0273(80)90038-4; PIWINSKI.AJ, 1970, J GEOL, V78, P52; PIWINSKI.AJ, 1968, J GEOL, V76, P205; RUTTER EH, 1995, J GEOPHYS RES-SOL EA, V100, P15697, DOI 10.1029/94JB03388; SISSON TW, 1993, CONTRIB MINERAL PETR, V113, P143, DOI 10.1007/BF00283225; SPERA FJ, 1979, SCIENCE, V207, P299; TAIT S, 1992, J GEOPHYS RES-SOL EA, V97, P6735, DOI 10.1029/92JB00016; Turcotte D., 1982, GEODYNAMICS APPL CON; Turner J. S., 1973, BUOYANCY EFFECTS FLU; WOLF MB, 1995, J GEOPHYS RES-SOL EA, V100, P15611, DOI 10.1029/95JB00660; WOODS AW, 1991, PHYS FLUIDS A-FLUID, V3, P1393, DOI 10.1063/1.858018	35	56	59	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-3530			J PETROL	J. Petrol.	FEB	1999	40	2					241	254		10.1093/petrology/40.2.241		14	Geochemistry & Geophysics	Geochemistry & Geophysics	170XH	WOS:000078832000001		
J	Radecka, H; Nakanishi, J; Hirano, A; Sugawara, M; Umezawa, Y				Radecka, H; Nakanishi, J; Hirano, A; Sugawara, M; Umezawa, Y			A method for evaluating chemical selectivity of agonists for glutamate receptor channels incorporated in liposomes based on an agonist-induced ion flux measured by ion-selective electrodes	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Article						NMDA receptor; liposome; selectivity of agonist; Ca2+ ion flux; ion-selective electrode; thin-layer potentiometry	RAT HIPPOCAMPAL-NEURONS; D-ASPARTATE; QUISQUALATE RECEPTORS; DIVALENT-CATIONS; CALCIUM; ACID; BINDING; BRAIN; PERMEATION; RESPONSES	A new method for evaluating chemical selectivity of agonists for the NMDA subtype of glutamate receptor (GluR) channels is described. The method is based on the magnitude of Ca2+ release from GluR-incorporated liposomes, which is measured by a Ca2+ ion-selective electrode with a thin-layer mode. The partially purified GluRs from rat whole brain were reconstituted into Ca2+-loaded liposomes. Small aliquots (each 50 mu l) of the proteoliposomes, in the presence of an antagonist DNQX for blocking non-NMDA subtype, were subjected to potentiometric measurements of Ca2+ release under stimulation by three kinds of agonists, i.e. NMDA, L-glutamate and L-CCG-IV. The amount of the Ca2+-ion flux through the GluR channel induced by the agonists was found to increase in the order of NMDA < L-glutamate < L-CCG-IV, which was consistent with that of binding affinity of the agonists toward the NMDA subtype. However, the range of selectivity of the relevant agonists was much smaller compared with results based on binding affinities. The present method provides physiologically more relevant values for the agonist selectivity of GluRs as compared to that of the conventional binding assay in the sense that the selectivity is based on the very magnitude of Ca2+ flux through the NMDA receptor, i.e. the extent of signal transduction by a given agonist. The evaluation of agonist selectivity based on Na+ release was also investigated by using a Na+ ion-selective electrode, but agonist-induced Na+ release was not detected, because of low permeability of Na+ through the NMDA subtype. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Sch Sci, Dept Chem, Tokyo 113, Japan	Umezawa, Y (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Tokyo 113, Japan.	umezawa@chem.s.u-tokyo.ac.jp	NAKANISHI, Jun/H-2616-2011	NAKANISHI, Jun/0000-0003-4457-6581			ABE H, 1986, ANAL SCI, V2, P523, DOI 10.2116/analsci.2.523; IINO M, 1990, J PHYSIOL-LONDON, V424, P151; ANKER P, 1981, ANAL CHEM, V53, P1970, DOI 10.1021/ac00236a005; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; RORABACHER DB, 1991, ANAL CHEM, V63, P139, DOI 10.1021/ac00002a010; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BENAVIDES J, 1988, J NEUROSCI, V8, P3607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; BRAMMER MJ, 1991, NEUROSCI LETT, V128, P231, DOI 10.1016/0304-3940(91)90267-W; CHIBA K, 1980, ANAL CHEM, V52, P596, DOI 10.1021/ac50053a059; CULLCANDY SG, 1983, SINGLE CHANNEL RECOR, P389; GRATION KAF, 1983, SINGLE CHANNEL RECOR, P377; Jane D. E., 1994, NMDA RECEPTOR, P31; KAWAI M, 1992, EUR J PHARMACOL, V211, P195; KUDO Y, 1991, BRAIN RES, V567, P342, DOI 10.1016/0006-8993(91)90817-F; Kyle D. J., 1992, EXCITATORY AMINO ACI, P121; LESTER RAJ, 1994, NMDA RECEPTOR, P206; LY AM, 1991, BIOCHEMISTRY-US, V30, P4307, DOI 10.1021/bi00231a029; MACBAIN CJ, 1994, PHYSIOL REV, V74, P723; MURPHY DE, 1987, J PHARMACOL EXP THER, V240, P778; OKU N, 1982, BIOCHIM BIOPHYS ACTA, V691, P332, DOI 10.1016/0005-2736(82)90422-9; RADECKA H, 1997, METHODS MOL BIOL, pCH32; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SHIBA K, 1980, ANAL CHEM, V52, P1610, DOI 10.1021/ac50061a018; Sugawara M, 1997, BIOSENS BIOELECTRON, V12, P425, DOI 10.1016/S0956-5663(97)00005-5; UMEZAWA Y, 1988, CHEM SENSOR TECHNOLO, V1, P141; UMEZAWA Y, 1983, P INT M CHEM SENS KO, P705; UMEZAWA Y, 1984, TALANTA, V31, P375, DOI 10.1016/0039-9140(84)80100-9; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575	33	8	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0731-7085			J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	FEB	1999	19	1-2					205	216		10.1016/S0731-7085(98)00146-0		12	Chemistry, Analytical; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	157YD	WOS:000078088500020		
J	Hanada, E; Ohtani, H; Kotaki, H; Sawada, Y; Sato, H; Iga, T				Hanada, E; Ohtani, H; Kotaki, H; Sawada, Y; Sato, H; Iga, T			Pharmacodynamic analysis of the electrocardiographic interaction between disopyramide and erythromycin in rats	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article							TORSADES-DE-POINTES; N-DEALKYLATED DISOPYRAMIDE; LONG QT SYNDROME; CLASS-I; PURKINJE-FIBERS; METABOLITE; REPOLARIZATION; PROLONGATION; MECHANISMS; MUSCLE	Disopyramide (DP) is known to induce QT prolongation and Torsades de Pointes (TdP) when administered concomitantly with erythromycin (EM). To define and evaluate quantitatively the arrhythmogenic risk of the concomitant administration of DP and EM, we investigated the influence of EM on the pharmacokinetics and pharmacodynamics of DP in rats. The time profiles of change in QT interval and plasma concentration of each drug were evaluated during and after constant intravenous infusion of DP (6.0 or 15.0 mg/kg/h), EM (4.0 or 8.0 mg/kg/h), and coadministration of DP and EM (DP 6.0 mg/kg/h plus EM 4.0 mg/kg/h). Each agent induced QT prolongation at plasma concentrations within the therapeutic range in humans. DP-induced QT prolongation was proportional to its plasma concentration. In the case of EM, the E-max model with an "effect compartment" could explain the relationship between plasma EM concentrations and changes in QT interval. Although coadministration of EM with DP gave enhanced QT prolongation compared to dosing with DP alone, EM did not affect the pharmacokinetics of DP. In conclusion, it was shown that a pharmacodynamic interaction contributes to the electrocardiographic adverse reaction (i.e., QT prolongation) induced by coadministration of DP and EM in rats.	Univ Tokyo, Fac Med, Tokyo Univ Hosp, Dept Pharm,Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pharm,Minato Ku, Tokyo 1088639, Japan; Kyushu Univ, Fac Pharmaceut Sci, Higashi Ku, Fukuoka 8120054, Japan	Iga, T (reprint author), Univ Tokyo, Dept Pharm, Tokyo, Japan.						Antzelevitch C, 1996, J AM COLL CARDIOL, V28, P1836; HOLFORD NHG, 1981, CLIN PHARMACOKINET, V6, P429; PERITI P, 1992, CLIN PHARMACOKINET, V23, P106; HAYES E, 1994, J PHARMACOL TOXICOL, V32, P201, DOI 10.1016/1056-8719(94)90088-4; BRANDRISS MW, 1994, CLIN INFECT DIS, V18, P995; BERGFELDT L, 1992, CARDIOVASC DRUG THER, V6, P529, DOI 10.1007/BF00055612; BOUCHER M, 1992, LIFE SCI, V50, pPL161; CAMPBELL TJ, 1983, CARDIOVASC RES, V17, P344, DOI 10.1093/cvr/17.6.344; COOK CS, 1982, DRUG METAB DISPOS, V10, P116; CORABOEUF E, 1988, CARDIOVASC RES, V22, P375, DOI 10.1093/cvr/22.6.375; CORRE P, 1991, EUR J DRUG METAB PH, V3, P233; DALEAU P, 1995, CIRCULATION, V91, P3010; DELAFORGE M, 1984, CHEM-BIOL INTERACT, V15, P371; ECHIZEN H, 1993, J PHARMACOL EXP THER, V264, P1425; ECHIZEN H, 1994, J PHARMACOL EXP THER, V268, P1518; ENDRESEN K, 1988, EUR J CLIN PHARMACOL, V35, P467, DOI 10.1007/BF00558240; FREEDMAN RA, 1987, AM J CARDIOL, V59, P168, DOI 10.1016/S0002-9149(87)80096-6; GITLER B, 1994, CHEST, V105, P368, DOI 10.1378/chest.105.2.368; GRANT AM, 1978, EUR J PHARMACOL, V49, P389, DOI 10.1016/0014-2999(78)90313-8; Hanada E, 1997, J CHROMATOGR B, V692, P478, DOI 10.1016/S0378-4347(97)00011-X; HIRAOKA M, 1989, AM J CARDIOL, V64, pJ15, DOI 10.1016/0002-9149(89)91191-0; ITO T, 1992, YAKUGAKU ZASSHI, V112, P336; KARIM A, 1975, ANGIOLOGY, V26, P85; KARIM A, 1972, J PHARM SCI, V61, P888, DOI 10.1002/jps.2600610612; KAWAMOTO T, 1993, SHINZOU, V25, P696; KEREN A, 1981, CIRCULATION, V64, P1167; KUS T, 1975, CIRC RES, V37, P844; LIMA JJ, 1981, J PHARMACOL EXP THER, V219, P741; Lin JC, 1997, PHARMACOTHERAPY, V17, P626; LONGMORE J, 1990, EUR J CLIN PHARMACOL, V39, P305, DOI 10.1007/BF00315118; MAYER F, 1991, J CHROMATOGR-BIOMED, V572, P339, DOI 10.1016/0378-4347(91)80501-3; Ohtani H, 1996, BIOL PHARM BULL, V19, P1189; ORBAN Z, 1995, AM J CARDIOL, V75, P859, DOI 10.1016/S0002-9149(99)80434-2; PISCITELLI DA, 1994, J CLIN PHARMACOL, V34, P823; RAGOSTA M, 1989, AM J MED, V86, P465, DOI 10.1016/0002-9343(89)90346-X; RUBART M, 1993, CIRCULATION, V88, P1832; SADANAGA T, 1993, AM HEART J, V126, P114, DOI 10.1016/S0002-8703(07)80017-2; SCHANNE OF, 1986, CAN J PHYSIOL PHARM, V64, P487; VANHOUTTE F, 1991, N-S ARCH PHARMACOL, V344, P662; WAGNER JG, 1975, FUNDAMENTALS CLIN PH, P90; WHITING B, 1980, BRIT J CLIN PHARMACO, V9, P67	41	11	12	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0022-3549			J PHARM SCI	J. Pharm. Sci.	FEB	1999	88	2					234	240		10.1021/js980256r		7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	165LN	WOS:000078522600013		
J	Kato, Y; Akhteruzzaman, S; Hisaka, A; Sugiyama, Y				Kato, Y; Akhteruzzaman, S; Hisaka, A; Sugiyama, Y			Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							BILE-ACID TRANSPORTER; CYCLIC PENTAPEPTIDE ENDOTHELIN; ET(A) RECEPTOR ANTAGONIST; MEDIATED HEPATIC-UPTAKE; TISSUE DISTRIBUTION; HEPATOCELLULAR TRANSPORT; CEREBRAL VASOSPASM; BILIARY-EXCRETION; LIVER-CELLS; IN-VIVO	The overall disposition and hepatobiliary transport of BQ-123, an anionic cyclopentapeptide, and three analogs were examined in rats in vivo. Total body clearance (CLtotal) and biliary excretion clearance (CLbile, p) exhibited 4- to 8-fold differences between the compounds, with those for BQ-485 and compound A having the highest and lowest values, respectively. The CL values of BQ-485, BQ-123, and BQ-518 were almost equal to the CLtotal, suggesting that hepatobiliary transport is the major elimination pathway for these compounds. Hepatic uptake clearance (CLuptake, vivo) and biliary excretion clearance (CLbile, (h)/f(T)), which was defined for the hepatic unbound concentration, were separately determined to examine the hepatic uptake and excretion processes, respectively. Both the CLuptake, vivo and CLbile, (h)/f(T) of BQ-485 were higher than those of BQ-123, whereas the corresponding values for BQ-518 were similar to those for BQ-123. The CLuptake, vivo and CLbile, h/f(T) of compound A were, respectively, approximately two thirds and one half those of BQ-123, suggesting that the lower CLbile, p value is due to the low efficiency of both the uptake and excretion processes. The CLuptake, vivo of these four peptides in vivo was similar to the extrapolated values based on the carrier-mediated transport activity previously assessed in vitro in isolated rat hepatocytes. The primary active transport previously assessed in an in vitro study in canalicular membrane Vesicles was also highest for BQ-485 and lowest for compound A, similar to CLbile, h/f(T), in vivo. Thus, the transporters on both the sinusoidal and canalicular membranes determine the efficiency of the peptide overall elimination from the circulation.	Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Bunkyo Ku, Tokyo 1130033, Japan; Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan	Kato, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kato@seizai.f.u-tokyo.ac.jp	KATO, Yukio/D-8396-2015				Akhteruzzaman S, 1999, J PHARMACOL EXP THER, V288, P575; LEMAIRE M, 1989, DRUG METAB DISPOS, V17, P699; Yamazaki M, 1996, PHARMACEUT RES, V13, P497, DOI 10.1023/A:1016077517241; GORES GJ, 1989, AM J PHYSIOL, V257, pG242; Meier PJ, 1997, HEPATOLOGY, V26, P1667; Yamada T, 1997, DRUG METAB DISPOS, V25, P536; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285; YAMAZAKI M, 1993, AM J PHYSIOL, V264, pG36; Yamada T, 1996, J PHARMACOL EXP THER, V279, P1357; BERTRAMS A, 1991, BIOCHIM BIOPHYS ACTA, V1091, P337, DOI 10.1016/0167-4889(91)90198-7; BERTRAMS AA, 1991, BIOCHIM BIOPHYS ACTA, V1073, P213, DOI 10.1016/0304-4165(91)90205-U; CATHAPERMAL SS, 1991, DRUG METAB DISPOS, V19, P735; Eckhardt U, 1996, HEPATOLOGY, V24, P380; FUKAMI T, 1995, J MED CHEM, V38, P4309, DOI 10.1021/jm00021a021; Fukami T, 1996, CHEM PHARM BULL, V44, P609; GORES GJ, 1986, AM J PHYSIOL, V250, pG344; GREENFIELD JC, 1989, DRUG METAB DISPOS, V17, P518; ITOH S, 1993, BIOCHEM BIOPH RES CO, V195, P969, DOI 10.1006/bbrc.1993.2139; Keppler D, 1997, BIOL CHEM, V378, P787; LABMERTS SWJ, 1985, NEW ENGL J MED, V313, P1576; Lomri N, 1996, SEMIN LIVER DIS, V16, P201, DOI 10.1055/s-2007-1007232; MIYAUCHI S, 1993, PHARMACEUT RES, V10, P434, DOI 10.1023/A:1018952709120; MORELAND S, 1994, CAN J PHYSIOL PHARM, V72, P1469; Nakamura T, 1996, J PHARMACOL EXP THER, V278, P564; NIREI H, 1993, LIFE SCI, V52, P1869, DOI 10.1016/0024-3205(93)90007-P; NISHIKIBE M, 1993, LIFE SCI, V52, P717, DOI 10.1016/0024-3205(93)90233-S; ONDETTI MA, 1981, J MED CHEM, V24, P355, DOI 10.1021/jm00136a001; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; Shin HC, 1996, J PHARMACOL EXP THER, V278, P607; Shin HC, 1997, AM J PHYSIOL-GASTR L, V272, pG979; Takahashi H, 1997, J PHARMACOL EXP THER, V281, P297; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; ZIEGLER K, 1988, BIOCHIM BIOPHYS ACTA, V945, P263, DOI 10.1016/0005-2736(88)90488-9; ZIEGLER K, 1991, BIOCHIM BIOPHYS ACTA, V1061, P287, DOI 10.1016/0005-2736(91)90294-I; ZIEGLER K, 1994, BBA-BIOMEMBRANES, V1196, P209, DOI 10.1016/0005-2736(94)00228-2	35	12	12	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	1999	288	2					568	574				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	161KA	WOS:000078286700024		
J	Akhteruzzaman, S; Kato, Y; Hisaka, A; Sugiyama, Y				Akhteruzzaman, S; Kato, Y; Hisaka, A; Sugiyama, Y			Primary active transport of peptidic endothelin antagonists by rat hepatic canalicular membrane	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							BILE-ACID TRANSPORTER; ACUTE-RENAL-FAILURE; BILIARY-EXCRETION; TISSUE DISTRIBUTION; RECEPTOR ANTAGONIST; PLASMA-MEMBRANE; METABOLITES; LIVER; DISPOSITION; IRINOTECAN	The biliary excretion mechanism of three derivatives of BQ-123, an anionic cyclopentapeptide, was examined using isolated canalicular membrane vesicles (CMVs) from Sprague-Dawley rats. The uptake by CMV of BQ-485, a linear peptide, BQ-518, a cyclic peptide, and compound A, a cyclic peptide with a cationic moiety, was stimulated by ATP. An "overshoot" phenomenon and saturation were observed for the ATP-dependent uptake of these three peptides. The Michaelis-Menten constants (K-m) for the uptake of BQ-485 and BQ-518 were comparable to the inhibition constants (Ki) for their inhibitory effects on ATP-dependent [H-3]BQ-123 uptake. The uptake of BQ-485 showed the highest Value and was inhibited by BQ-123 with a K-i that was comparable to the K-m for BQ-123 uptake. The ATP-dependent uptake of BQ-123, BQ-485, and BQ-518 was much lower in CMVs from Eisai hyperbilirubinemic rats, a strain having a hereditary defect of the canalicular multispecific organic anion transporter (cMOAT). These results suggest that both BQ-485 and BQ-518 principally share the cMOAT transporter with BQ-123. Compound A almost completely inhibited BQ-123 uptake, although its ATP-dependent uptake was much lower than that of the other three peptides. The ATP-dependent uptake of compound A was not very different in Sprague-Dawley rats and Eisai hyperbilirubinemic rats and was not inhibited by S-(2,4-dinitrophenyl)-glutathione, a typical substrate for cMOAT. Thus, although compound A inhibits cMOAT-mediated transport, its own transport by cMOAT is minimal and mediated by another transporter. This low degree of primary active transport by cMOAT may be the principal reason for its relatively longer residence in the circulation.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Banyu Pharmaceut Co Ltd, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		KATO, Yukio/D-8396-2015				LEMAIRE M, 1989, DRUG METAB DISPOS, V17, P699; Yamazaki M, 1996, PHARMACEUT RES, V13, P497, DOI 10.1023/A:1016077517241; YACHI K, 1989, BIOCHIM BIOPHYS ACTA, V978, P1, DOI 10.1016/0005-2736(89)90490-2; Chu XY, 1997, CANCER RES, V57, P1934; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285; Yamada T, 1996, J PHARMACOL EXP THER, V279, P1357; Chu XY, 1997, J PHARMACOL EXP THER, V281, P304; BERTRAMS AA, 1991, BIOCHIM BIOPHYS ACTA, V1073, P213, DOI 10.1016/0304-4165(91)90205-U; BOHME M, 1993, FEBS LETT, V333, P193, DOI 10.1016/0014-5793(93)80403-H; CATHAPERMAL SS, 1991, DRUG METAB DISPOS, V19, P735; CHAN L, 1994, AM J PHYSIOL, V266, pF135; DOHERTY AM, 1992, J MED CHEM, V35, P1493, DOI 10.1021/jm00087a001; GREENFIELD JC, 1989, DRUG METAB DISPOS, V17, P518; Gupta E, 1996, CANCER RES, V56, P1309; IHARA M, 1991, BIOCHEM BIOPH RES CO, V178, P132, DOI 10.1016/0006-291X(91)91789-F; ISHIKAWA T, 1992, TRENDS BIOCHEM SCI, V17, P463, DOI 10.1016/0968-0004(92)90489-V; Kato Y, 1999, J PHARMACOL EXP THER, V288, P568; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; KOJIRI K, 1991, J ANTIBIOT, V44, P1342; MINO N, 1992, EUR J PHARMACOL, V221, P77; Nakamura T, 1996, J PHARMACOL EXP THER, V278, P564; Niinuma K, 1997, J PHARMACOL EXP THER, V282, P866; SCHONER W, 1967, EUR J BIOCHEM, V1, P334, DOI 10.1111/j.1432-1033.1967.tb00078.x; Shin HC, 1996, J PHARMACOL EXP THER, V278, P607; Shin HC, 1997, AM J PHYSIOL-GASTR L, V272, pG979; Takahashi H, 1997, J PHARMACOL EXP THER, V281, P297; TERASAKI T, 1995, PHARMACEUT RES, V12, P11; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374; ZIEGLER K, 1988, BIOCHIM BIOPHYS ACTA, V945, P263, DOI 10.1016/0005-2736(88)90488-9; ZIEGLER K, 1991, BIOCHIM BIOPHYS ACTA, V1061, P287, DOI 10.1016/0005-2736(91)90294-I; ZIEGLER K, 1994, BBA-BIOMEMBRANES, V1196, P209, DOI 10.1016/0005-2736(94)00228-2	32	6	6	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	1999	288	2					575	581				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	161KA	WOS:000078286700025		
J	Kouzuki, H; Suzuki, H; Ito, K; Ohashi, R; Sugiyama, Y				Kouzuki, H; Suzuki, H; Ito, K; Ohashi, R; Sugiyama, Y			Contribution of organic anion transporting polypeptide to uptake of its possible substrates into rat hepatocytes	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							CARRIER-MEDIATED TRANSPORT; BILE-ACID; FUNCTIONAL-CHARACTERIZATION; EXPRESSION CLONING; ACTIVE-TRANSPORT; HEPATIC-UPTAKE; HUMAN LIVER; CULTURES; TAUROCHOLATE; COTRANSPORT	Organic anion transporting polypeptide (oatp1) has been cloned from rat fiver as one of the transporters responsible for the hepatic uptake of ligands, and its substrate specificity has been determined. However, the contribution of oatp1 to the Na+-independent uptake of ligands into rat hepatocytes remains to be investigated. in the present study, we determined the contribution of oatp1 and examined the uptake of ligands into primary cultured hepatocytes (cultured for 4 h) and into COS-7 cells transiently expressing oatp1 and normalized using estradiol-17 beta-D-glucuronide as a reference compound. Western blot analysis indicated that oatp1 was less extensively glycosylated in transfected COS-7 cells, and the expression level in transfectant was one-seventh that in rat liver. The K-m values for the uptake of estradiol-17 beta-D-glucuronide were similar for cultured hepatocytes and oatp1-transfected COS-7 cells (K-m = 12.3 versus 20.4 mu M), although the V-max value for oatp1-transfected COS-7 cells was one-seventh that for cultured hepatocytes (V-max = 1.30 versus 0.175 nmol/min/mg protein). The contribution of oatp1 to the Na+-independent uptake of taurocholic acid and cholic acid into rat hepatocytes was more than 50 to 60%, whereas the corresponding values for the sulfate-conjugates of estrone and 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole were 20 to 30%. In addition, the analysis indicated that the contribution of oatp1 to the Na+-independent uptake of several ligands [glucuronide-conjugate of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole, ibuprofen, pravastatin, ouabain, and 2,4-dinitrophenyl-S-glutathione] was minimal. Collectively, the transfected COS-7 cells may be used to quantitatively predict oatp1 activity in hepatocytes after correction of its expressed amount. it is also suggested that multiple transport mechanisms are responsible for the Na+-independent uptake of organic anions into hepatocytes.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						NIWA H, 1991, GENE, V108, P193; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; YAMAZAKI M, 1993, AM J PHYSIOL, V264, pG36; Bossuyt X, 1996, J PHARMACOL EXP THER, V276, P891; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Kanai N, 1996, AM J PHYSIOL-RENAL, V270, pF326; Bergwerk AJ, 1996, AM J PHYSIOL-GASTR L, V271, pG231; BLITZER BL, 1982, AM J PHYSIOL, V243, pG48; BLOM A, 1981, BIOCHEM PHARMACOL, V30, P1809, DOI 10.1016/0006-2952(81)90015-0; BROUWER KLR, 1987, MOL PHARMACOL, V32, P519; EATON DL, 1978, J PHARMACOL EXP THER, V205, P480; GANT TW, 1991, MOL CARCINOGEN, V4, P499, DOI 10.1002/mc.2940040614; Hagenbuch B, 1996, BIOCHEM J, V316, P901; HIBI S, 1994, J MED CHEM, V37, P3062, DOI 10.1021/jm00045a011; ISHIGAMI M, 1995, PHARMACEUT RES, V12, P1741, DOI 10.1023/A:1016226024587; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16; JACQUEMIN E, 1994, P NATL ACAD SCI USA, V91, P133, DOI 10.1073/pnas.91.1.133; Kouzuki H, 1998, J PHARMACOL EXP THER, V286, P1043; KULLAKUBLICK GA, 1994, HEPATOLOGY, V20, P411; LIANG D, 1993, HEPATOLOGY, V18, P1162; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEIER PJ, 1988, SEMIN LIVER DIS, V8, P293, DOI 10.1055/s-2008-1040551; Meier PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG801; Nakamura T, 1996, J PHARMACOL EXP THER, V278, P564; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215; PAUMGARTNER G, 1976, CLIN SCI MOL MED, V51, P169; PETZINGER E, 1989, AM J PHYSIOL, V256, pG78; Petzinger E, 1996, J HEPATOL, V24, P42; SAXENA M, 1995, J BIOL CHEM, V270, P5312; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7477; SUGIYAMA Y, 1983, J PHARM SCI, V72, P871, DOI 10.1002/jps.2600720809; Takenaka O, 1997, J PHARMACOL EXP THER, V280, P948; Torchia EC, 1996, HEPATOLOGY, V24, P206, DOI 10.1002/hep.510240133; TSUJI A, 1986, BIOCHEM PHARMACOL, V35, P151; VORE M, 1994, AM J PHYSIOL-GASTR L, V267, pG546; WOLKOFF AW, 1987, J CLIN INVEST, V79, P1259, DOI 10.1172/JCI112946; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879; YAMAZAKI M, 1993, AM J PHYSIOL, V264, pG693	40	39	39	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	1999	288	2					627	634				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	161KA	WOS:000078286700032		
J	Chu, XY; Suzuki, H; Ueda, K; Kato, Y; Akiyama, SI; Sugiyama, Y				Chu, XY; Suzuki, H; Ueda, K; Kato, Y; Akiyama, SI; Sugiyama, Y			Active efflux of CPT-11 and its metabolites in human KB-derived cell lines	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							RESISTANCE-ASSOCIATED PROTEIN; ORGANIC ANION TRANSPORTER; MULTIDRUG-RESISTANCE; BILIARY-EXCRETION; P-GLYCOPROTEIN; CANALICULAR ISOFORM; MEMBRANE-VESICLES; CAMPTOTHECIN; RATS; GENE	To investigate the possible involvement of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP), and/or other glutathione S-conjugate export pump (GS-X pump) family members on the active efflux of irinotecan [(7-ethyl-10-[4-(1-piperidino)-1-pipertidino)-1-piperidino]carbonyloxy camptothecin (CPT-11)] and its metabolites, as well as their contribution to the acquisition of resistance, we studied the uptake of CPT-11, its active metabolite SN-38, and glucuronide conjugate (SN38-Glu) using membrane vesicles from human epidermoid KB-3-1-derived cell lines. These lines included KB-C2, C-A500, and KCP-4, which overexpress P-gp, MRP, and the unidentified GS-X pump, respectively. The carboxylate form of SN-38 exhibited significant ATP-dependent transport, with a Michaelis constant of 17 mu M, into membrane vesicles from C-A500 but not from other cell lines. Among these KB-derived cells, significant ATP-dependent uptake of the carboxylate form of CPT-11 was only observed in KB-C2 vesicles. In addition, the uptake of the lactone and carboxylate forms of SN38-Glu into membrane vesicles from C-A500 and KB-C2, but not KCP-4, was ATP dependent, although the transport activity in C-A500 was much higher than that in KB-C2. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed that the resistance of KB-C2 to CPT-11 and SN-38, compared with that of KB-3-1, was 6.3- and 6.8-fold, respectively; the corresponding figures for C-A500 were 12- and 27-fold, respectively, whereas those for KCP-4 were 2.3- and 20-fold, respectively. These results suggest that MRP and P-gp are involved in the active efflux of SN-38 and CPT-11, respectively, from human KB-derived cells. In addition, a difference in substrate specificity among GS-X pump members was demonstrated.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kagoshima Univ, Canc Res Inst, Kagoshima, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	sugiyama@seizai.f.u-tokyo.ac.jp	KATO, Yukio/D-8396-2015				Gottesman MM, 1996, CURR OPIN GENET DEV, V6, P610, DOI 10.1016/S0959-437X(96)80091-8; Ito K, 1998, J BIOL CHEM, V273, P1684, DOI 10.1074/jbc.273.3.1684; Buchler M, 1996, J BIOL CHEM, V271, P15091; Yamazaki M, 1996, PHARMACEUT RES, V13, P497, DOI 10.1023/A:1016077517241; Evers R, 1998, J CLIN INVEST, V101, P1310, DOI 10.1172/JCI119886; Taniguchi K, 1996, CANCER RES, V56, P4124; Chu XY, 1998, CANCER RES, V58, P5137; Chu XY, 1997, CANCER RES, V57, P1934; AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; MINATO K, 1990, CANCER CHEMOTH PHARM, V26, P313, DOI 10.1007/BF02897284; Kool M, 1997, CANCER RES, V57, P3537; HASEGAWA S, 1995, BRIT J CANCER, V71, P907, DOI 10.1038/bjc.1995.177; Muller M, 1997, AM J PHYSIOL-GASTR L, V272, pG1285; Keppler D, 1997, FASEB J, V11, P509; Paulusma CC, 1996, SCIENCE, V271, P1126, DOI 10.1126/science.271.5252.1126; Paulusma CC, 1997, J MOL MED-JMM, V75, P420, DOI 10.1007/s001090050127; Sugiyama Y, 1998, CANCER CHEMOTH PHARM, V42, pS44, DOI 10.1007/s002800051078; Borst P, 1997, SEMIN CANCER BIOL, V8, P205, DOI 10.1006/scbi.1997.0071; CARMICHAEL J, 1987, CANCER RES, V47, P936; Lautier D, 1996, BIOCHEM PHARMACOL, V52, P967, DOI 10.1016/0006-2952(96)00450-9; Chu XY, 1997, J PHARMACOL EXP THER, V281, P304; Chuman Y, 1996, BIOCHEM BIOPH RES CO, V226, P158, DOI 10.1006/bbrc.1996.1326; FASSBERG J, 1992, J PHARM SCI, V81, P676, DOI 10.1002/jps.2600810718; FUJII R, 1994, J NATL CANCER I, V86, P1781, DOI 10.1093/jnci/86.23.1781; Hirohashi T, 1998, MOL PHARMACOL, V53, P1068; Hoki Y, 1997, CANCER CHEMOTH PHARM, V40, P433, DOI 10.1007/s002800050682; Ishikawa T., 1996, GLUTATHIONE S TRANSF, P199; Ito K, 1997, AM J PHYSIOL-GASTR L, V272, pG16; Koike K, 1997, CANCER RES, V57, P5475; Loe D. W., 1996, European Journal of Cancer, V32A, P945, DOI 10.1016/0959-8049(96)00046-9; Madon J, 1997, FEBS LETT, V406, P75, DOI 10.1016/S0014-5793(97)00245-7; Masuda M, 1997, CANCER RES, V57, P3506; Meier PJ, 1996, J HEPATOL, V24, P29; Muller M, 1996, SEMIN LIVER DIS, V16, P211, DOI 10.1055/s-2007-1007233; ELFERINK RPJO, 1995, BBA-REV BIOMEMBRANES, V1241, P215; SLICHENMYER WJ, 1993, J NATL CANCER I, V85, P271, DOI 10.1093/jnci/85.4.271; SUMIZAWA T, 1994, SOMAT CELL MOLEC GEN, V20, P423, DOI 10.1007/BF02257459; TAKIGAWA N, 1992, ACTA MED OKAYAMA, V46, P203; TANIZAWA A, 1993, J BIOL CHEM, V268, P25463; van Aubel RAMH, 1998, MOL PHARMACOL, V53, P1062; Vore M, 1996, AM J PHYSIOL-GASTR L, V271, pG791; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	42	78	80	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	1999	288	2					735	741				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	161KA	WOS:000078286700047		
J	Suzuki, K; Susaki, H; Okuno, S; Yamada, H; Watanabe, HK; Sugiyama, Y				Suzuki, K; Susaki, H; Okuno, S; Yamada, H; Watanabe, HK; Sugiyama, Y			Specific renal delivery of sugar-modified low-molecular-weight peptides	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							EPIDERMAL GROWTH-FACTOR; PROTEIN-CARBOHYDRATE INTERACTIONS; KINETIC-ANALYSIS; RAT-KIDNEY; IN-VIVO; BINDING; INVIVO; OLIGOSACCHARIDES; NARTOGRASTIM; VASOPRESSIN	To develop a novel delivery system for peptides involving sugar modification, Arg-vasopressin (AVP) was modified by linking it to a variety of sugars via an octamethylene group and the subsequent tissue uptake by rats was then monitored after administration by i.v, injection. The glucosyl, mannosyl, and 2-deoxyglucosyl derivatives of AVP exhibited selective renal uptake. These derivatives were found to be distributed in the proximal tubules of the renal cortex. In addition, they exhibited specific binding to the kidney microsomal fraction in vitro (K-d = similar to 60 nM), suggesting that they are taken up by a specific recognition mechanism located in the kidneys. From the results of the uptake study of glucosyl derivatives, the following points are clear: 1) renal uptake in vivo becomes saturated with increasing dose, and the K-m from the uptake study is almost the same as the K-d obtained in the binding assay in vitro and 2) because the renal first-pass uptake extraction is about 70% at a low dose (10 nmol/kg), there is an effective mechanism for uptake from blood. Furthermore. glucosyl and mannosyl derivatives of oxytocin, a neutral peptide, unlike AVP that is basic, also have high renal uptake clearances Thus, the renal uptake may not be dependent on derivatives having a cationic nature. We conclude that there is a novel transport mechanism in the kidneys that can be used for the specific renal delivery of glycosylated peptides.	Drug Delivery Syst Inst Ltd, Noda, Chiba, Japan; Univ Tokyo, Fac Pharmaceut Sci, Bunkyo Ku, Tokyo 113, Japan	Suzuki, K (reprint author), Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Kohoku Ku, 760 Morooka Cho, Yokohama, Kanagawa 2228567, Japan.						MONSIGNY M, 1994, ADV DRUG DELIVER REV, V14, P1, DOI 10.1016/0169-409X(94)90003-5; Saito H, 1996, J BIOL CHEM, V271, P20719; PRICER WE, 1971, J BIOL CHEM, V246, P4825; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; FRANSSEN EJF, 1992, J MED CHEM, V35, P1246, DOI 10.1021/jm00085a012; CHIU MH, 1994, J BIOL CHEM, V269, P16195; Susaki H, 1998, CHEM PHARM BULL, V46, P1530; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Elgavish S, 1997, TRENDS BIOCHEM SCI, V22, P462, DOI 10.1016/S0968-0004(97)01146-8; BOURNE Y, 1993, CURR OPIN STRUC BIOL, V3, P681, DOI 10.1016/0959-440X(93)90050-U; CHAUDHURI G, 1987, J ENDOCRINOL INVEST, V10, P283; ELFARRA AA, 1995, J PHARMACOL EXP THER, V274, P1298; HEDIGER MA, 1994, PHYSIOL REV, V74, P993; HORI R, 1991, J PHARMACOKINET BIOP, V19, P51, DOI 10.1007/BF01062192; HORTON D, 1990, CARBOHYD RES, V205, P71, DOI 10.1016/0008-6215(90)80129-Q; KANN N, 1990, J ORG CHEM, V55, P5312, DOI 10.1021/jo00306a006; KARLSSON KA, 1991, TRENDS PHARMACOL SCI, V12, P265, DOI 10.1016/0165-6147(91)90568-D; KIM DC, 1991, AM J PHYSIOL, V261, pF988; KIM DC, 1988, J PHARM SCI, V77, P200, DOI 10.1002/jps.2600770304; KOJIMA K, 1992, J BIOL CHEM, V267, P20536; Kojima K, 1996, J BIOL CHEM, V271, P7679; KUWABARA T, 1995, J PHARMACOL EXP THER, V273, P1114; KUWABARA T, 1995, AM J PHYSIOL-ENDOC M, V269, pE1; KUWABARA T, 1994, J PHARMACOL EXP THER, V271, P1535; LIU KX, 1992, AM J PHYSIOL, V263, pG643; MATSUMOTO I, 1986, CARBOHYD RES, V151, P261, DOI 10.1016/S0008-6215(00)90346-X; PAGER AM, 1996, AM J PHYSIOL, V270, pF642; PALOMINO E, 1994, ADV DRUG DELIVER REV, V13, P311, DOI 10.1016/0169-409X(94)90017-5; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P625, DOI 10.1007/BF01059688; Sadee W, 1995, PHARMACEUT RES, V12, P1823, DOI 10.1023/A:1016211015926; SASAKI A, 1995, BIOL PHARM BULL, V18, P740; STASSEN FL, 1982, J PHARMACOL EXP THER, V223, P50; SUSAKI H, 1994, CHEM PHARM BULL, V42, P2090; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541; Vyas N.K., 1991, CURR OPIN STRUC BIOL, V1, P732, DOI 10.1016/0959-440X(91)90172-P; YANAI S, 1990, AM J PHYSIOL, V258, pC593	36	29	32	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0022-3565			J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB	1999	288	2					888	897				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	161KA	WOS:000078286700067		
J	Sonoike, K				Sonoike, K			The different roles of chilling temperatures in the photoinhibition of photosystem I and photosystem II	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY			English	Article; Proceedings Paper	ESF Workshop on Adverse Effects of Visible and Ultraviolet Light in Plants and Algae, as a Satellite Meeting of the XIth International Congress on Photosynthesis	AUG 13-17, 1998	SZEGED, HUNGARY			chilling damage; cyclic electron transfer; excitation pressure; photoinhibition; photosynthesis; photosystems I and II	CUCUMIS-SATIVUS L; PSAB GENE-PRODUCT; REDOX STATE; LEAVES; PHOTOSYNTHESIS; LIGHT; ILLUMINATION; DEGRADATION; THYLAKOIDS; MECHANISM	The role of chilling temperatures on photoinhibition of photosystems I and II (PSI and PSII) under weak light has been examined in cucumber, a chilling-sensitive plant. The extent of PSII photoinhibition, determined by pulse-modulated fluorescence in vivo, is closely related to the redox state of the PSII electron acceptor Q(A), measured as a fluorescence parameter, 1-q(P). On the other hand, the extent of PSI photoinhibition, which is only observed in chilling-sensitive plants at chilling temperatures, cannot be related to the redox state of Q(A), suggesting that the underlying mechanism is different from that of PSII photoinhibition. Chilling treatment at low photon flux densities is found to enhance cyclic electron flow around PSI. Both PSI photoinhibition and enhanced cyclic electron flow show similar temperature dependence, with the threshold temperature at 10 degrees C. (C) 1999 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Sonoike, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1130033, Japan.	sonoike@biol.s.u-tokyo.ac.jp	Sonoike, Kintake/E-3699-2010	Sonoike, Kintake/0000-0002-5327-473X			HAVAUX M, 1994, PHOTOSYNTH RES, V40, P75, DOI 10.1007/BF00019047; SONOIKE K, 1995, PLANT CELL PHYSIOL, V36, P825; Sonoike K, 1997, PHOTOSYNTH RES, V53, P55, DOI 10.1023/A:1005852330671; MOON BY, 1995, P NATL ACAD SCI USA, V92, P6219, DOI 10.1073/pnas.92.14.6219; TERASHIMA I, 1991, PLANT CELL PHYSIOL, V32, P1275; SONOIKE K, 1990, PLANT CELL PHYSIOL, V31, P1079; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; Huner NPA, 1996, PHYSIOL PLANTARUM, V98, P358, DOI 10.1034/j.1399-3054.1996.980218.x; Sonoike K, 1998, J PLANT RES, V111, P121, DOI 10.1007/BF02507158; Sonoike K, 1996, PLANT SCI, V115, P157, DOI 10.1016/0168-9452(96)04341-5; TERASHIMA I, 1994, PLANTA, V193, P300; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; SONOIKE K, 1995, FEBS LETT, V362, P235, DOI 10.1016/0014-5793(95)00254-7; SONOIKE K, 1994, PLANTA, V194, P287, DOI 10.1007/BF01101690; Tjus SE, 1998, PLANT PHYSIOL, V116, P755; Ivanov AG, 1998, FEBS LETT, V430, P288, DOI 10.1016/S0014-5793(98)00681-4; BAKER NR, 1988, SYM SOC EXP BIOL, V42, P347; Herbert Stephen K., 1997, Plant Physiology (Rockville), V114, P219; Krause G.H., 1994, PHOTOINHIBITION PHOT, P331; OQUIST G, 1993, PLANT PHYSIOL BIOCH, V31, P683; Schreiber U., 1993, ECOL STUD, P45; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; SHEN JR, 1990, PLANT PHYSIOL, V93, P1345; SONOIKE K, 1999, IN PRESS PHOTOSYNTHE; SONOIKE K, 1995, PHOTOSYNTHESIS LIGHT, V4, P853; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239; TERASHIMA I, 1989, PLANT CELL PHYSIOL, V30, P841; TERASHIMA I, 1991, PLANT CELL PHYSIOL, V32, P1267; Terashima I, 1998, PHYSIOL PLANTARUM, V103, P295, DOI 10.1034/j.1399-3054.1998.1030301.x; TJUS SE, 1993, BIOCHIM BIOPHYS ACTA, V1183, P315, DOI 10.1016/0005-2728(93)90233-6	31	49	59	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1011-1344			J PHOTOCH PHOTOBIO B	J. Photochem. Photobiol. B-Biol.	FEB	1999	48	2-3					136	141		10.1016/S1011-1344(99)00030-5		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	193WY	WOS:000080161800008		
J	Nozaki, H; Ohta, N; Takano, H; Watanabe, MM				Nozaki, H; Ohta, N; Takano, H; Watanabe, MM			Reexamination of phylogenetic relationships within the colonial Volvocales (Chlorophyta): An analysis of atpB and rbcL gene sequences	JOURNAL OF PHYCOLOGY			English	Article						atpB gene; Chlorophyta; Gonium; molecular phylogeny; rbcL gene; Volvocaceae; volvocine series; Volvox	NUCLEOTIDE-SEQUENCES; LARGE SUBUNIT; ULTRASTRUCTURE; YAMAGISHIELLA; CARBOXYLASE; EUDORINA; POSITION; MATRIX	The chloroplast-encoded atpB gene was sequenced from 33 strains representing 28 species of the colonial Volvocales (the Volvocaceae and its relatives) to reexamine phylogenetic relationships as previously deduced by morphological data and rbcL gene sequence data.1128 base pairs in the coding regions of the atpB gene were analyzed by MP, NJ, and ML analyses, Although supported with relatively low bootstrap values (75% and 65% in the NJ and ML analyses, respectively), three anisogamous/oogamous volvocacean genera-Eudorina, Pleodorina, and Volvox, excluding the section Volvox(= Euvolvox, illegitimate name), constituted a large monophyletic group (Eudorina group), Outside the Eudorina group, a robust Lineage composed of three species of Volvox sect, Volvox was resolved as in the rbcL gene trees, rejecting the hypothesis of the previous cladistic analysis based on morphological data that the genus Volvox is monophyletic, In addition, the NJ and ML trees suggested that Eudorina is a non-monophyletic genus as inferred from the morphological data and rbcL gene sequences. Although phylogenetic status of the genus Gonium is ambiguous in the rbcL gene trees and the paraphyly of this genus is resolved in the cladistic analysis based on morphological data, the atpB gene sequence data suggest monophyly of Gonium with relatively low bootstrap values (56-61%) in the NJ and ML trees. On the basis of the combined sequence data (2256 base pairs) from atpB and rbcL genes, Gonium was resolved as a robust monophyletic genus in the NJ and ML trees (with 68-86% bootstrap values), and Eudorina elegans Ehrenberg represented a paraphyletic species positioned most basally within the Eudorina group, However, phylogenetic status and relationships of the families of the colonial Volvocales were still almost ambiguous even in the combined analysis.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan; Waseda Univ, Dept Basic Human Sci, Tokorozawa, Saitama 3591164, Japan; Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan	Nozaki, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan.	nozaki@biol.s.u-tokyo.ac.jp		Takano, Hiroyoshi/0000-0003-4720-5057			Hepperle D, 1998, J MOL EVOL, V47, P420, DOI 10.1007/PL00006399; Strimmer K, 1996, MOL BIOL EVOL, V13, P964; HOOT SB, 1995, ANN MO BOT GARD, V82, P194, DOI 10.2307/2399877; Nozaki H, 1997, J PHYCOL, V33, P272, DOI 10.1111/j.0022-3646.1997.00272.x; NOZAKI H, 1994, J PHYCOL, V30, P353, DOI 10.1111/j.0022-3646.1994.00353.x; Nozaki H, 1995, J PHYCOL, V31, P970, DOI 10.1111/j.0022-3646.1995.00970.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; BATKO A, 1970, Acta Mycologica, V6, P407; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; CROW WB, 1918, NEW PHYTOL, V17, P151, DOI 10.1111/j.1469-8137.1918.tb07276.x; DRON M, 1982, J MOL BIOL, V162, P775, DOI 10.1016/0022-2836(82)90547-2; FELSENSTEIN J, 1984, EVOLUTION, V38, P16, DOI 10.2307/2408542; FRITSCH FE, 1935, STRUCTURE REPRO ALGA, V1; GOLDSTEIN M, 1964, J PROTOZOOL, V11, P317, DOI 10.1111/j.1550-7408.1964.tb01762.x; GREUTER W, 1994, INT CODE BOTANICAL N; HOOPS HJ, 1984, J PHYCOL, V20, P20, DOI 10.1111/j.0022-3646.1984.00020.x; Hoot S. B., 1995, PL SYST EVOL S, V9, P241; HOOT SB, 1995, PL SYST EVOL S, V9, P119; HOOT SB, 1995, PLANT SYSTEMATICS S, V9, P195; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirk DL, 1998, VOLVOX MOL GENETIC O; LARSON A, 1992, MOL BIOL EVOL, V9, P85; LOCKHART PJ, 1992, P NATL ACAD SCI USA, V89, P2742, DOI 10.1073/pnas.89.7.2742; Nozaki H, 1997, J PHYCOL, V33, P859, DOI 10.1111/j.0022-3646.1997.00859.x; NOZAKI H, 1998, IN PRESS J PHYCOL, V34; Nozaki H, 1997, J PHYCOL, V33, P864, DOI 10.1111/j.0022-3646.1997.00864.x; Nozaki H, 1996, EUR J PHYCOL, V31, P67, DOI 10.1080/09670269600651211a; Pickett-Heaps J, 1975, GREEN ALGAE STRUCTUR; POCOCK M. A., 1955, MADRONO, V13, P49; PRINTZ H, 1927, NATURALICHEN PFLANZF; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schagerl M, 1998, PHYCOLOGIA, V37, P79, DOI 10.2216/i0031-8884-37-2-79.1; Shaw W. R, 1922, PHYLIP J SCI, V20, p[477, 1]; Shaw WR, 1916, BOT GAZ, V61, P253, DOI 10.1086/331765; SHAW WR, 1919, PHYLIP J SCI, V15, P439; Shaw W. R., 1922, Philippine Journal of Science, V21, P87; SHAW WR, 1922, PHILIPP J SCI, V21, P207; Smith Gilbert M., 1944, TRANS AMER MICROSC SOC, V63, P265, DOI 10.2307/3223302; Smith G. M., 1950, FRESH WATER ALGAE US; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; STARR RC, 1980, PHYTOFLAGELLATES DEV, V2, P147; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; THOMPSON AS, 1988, CULTURE COLLECTION A; Watanabe M.M., 1997, NIES COLLECTION LIST; WOESSNER JP, 1986, GENE, V44, P17; Wolf PG, 1997, AM J BOT, V84, P1429, DOI 10.2307/2446141; YANG RCA, 1986, GENE, V50, P259, DOI 10.1016/0378-1119(86)90330-6	48	34	37	PHYCOLOGICAL SOC AMER INC	LAWRENCE	810 EAST 10TH ST, LAWRENCE, KS 66044 USA	0022-3646			J PHYCOL	J. Phycol.	FEB	1999	35	1					104	112		10.1046/j.1529-8817.1999.3510104.x		9	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	172LU	WOS:000078926400015		
J	Onodera, A; Mimasaka, M; Sakamoto, I; Okumura, J; Sakamoto, K; Uehara, S; Takemura, K; Shimomura, O; Ohtani, T; Fujii, Y				Onodera, A; Mimasaka, M; Sakamoto, I; Okumura, J; Sakamoto, K; Uehara, S; Takemura, K; Shimomura, O; Ohtani, T; Fujii, Y			Structural and electrical properties of NiAs-type compounds under pressure	JOURNAL OF PHYSICS AND CHEMISTRY OF SOLIDS			English	Article						equations-of-state; inorganic compounds; high pressure; phase transitions; X-ray diffraction	PHASE-TRANSITIONS; THERMAL-EXPANSION; TRANSFORMATION; TEMPERATURE; STABILITY; CRYSTAL; STATE; SEMICONDUCTORS; CALIBRATION; EQUATION	High pressure X-ray diffraction and electrical resistivity measurements were carried out at room temperature on some NiAs-type compounds; CrSb, NiTe, TiS and the high-pressure phase of AlAs. The axial ratio of each compound was found to deviate with pressure from the ideal value for the hexagonal close-packed geometry. Structural phase transition was observed in CrSb at 17 GPa, whereas the NiAs-type structure persisted in AlAs (between 14 and at least 39 GPa), TiS (to at least 41 cpa) and NiTe (to at least 69 GPa). The electrical resistivity of CrSb showed simply a slight pressure-induced decrease without exhibiting any discontinuity in the vicinity of the pressure of phase transition. In TiS, drops in the resistivity were observed at 25 and 27 GPa. General trends in the pressure dependence of the axial ratio as well as in the bulk modulus are discussed. (C) 1998 Elsevier Science Ltd. All rights reserved.	Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; Natl Inst Res Inorgan Mat, Ibaraki, Osaka 3050044, Japan; Japan Atom Energy Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan; Okayama Univ Sci, Lab Solid State Chem, Okayama 7000005, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1060032, Japan	Onodera, A (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.						Albers W, 1965, SOLID STATE COMMUN, V3, P417, DOI 10.1016/0038-1098(65)90268-1; OHTA S, 1993, J PHYS-CONDENS MAT, V5, P2759, DOI 10.1088/0953-8984/5/17/010; FEI YW, 1994, SCIENCE, V266, P1678, DOI 10.1126/science.266.5191.1678; MAO HK, 1978, J APPL PHYS, V49, P3276, DOI 10.1063/1.325277; GREENE RG, 1994, PHYS REV LETT, V72, P2045, DOI 10.1103/PhysRevLett.72.2045; Narayana C, 1997, PHYS REV B, V56, P14338, DOI 10.1103/PhysRevB.56.14338; BIRCH F, 1978, J GEOPHYS RES, V83, P1257, DOI 10.1029/JB083iB03p01257; GREENE RG, 1994, J APPL PHYS, V76, P7296, DOI 10.1063/1.358015; MUJICA A, 1995, PHYS REV B, V52, P8881, DOI 10.1103/PhysRevB.52.8881; ANZAI S, 1968, J PHYS SOC JPN, V24, P271, DOI 10.1143/JPSJ.24.271; CAMPBELL AJ, 1993, J PHYS CHEM SOLIDS, V54, P5, DOI 10.1016/0022-3697(93)90106-2; Cemic L., 1972, High Temperatures - High Pressures, V4; FROYEN S, 1983, PHYS REV B, V28, P3258, DOI 10.1103/PhysRevB.28.3258; GOODENOU.JB, 1967, PHYS REV, V157, P389, DOI 10.1103/PhysRev.157.389; HATAKEYAMA K, 1990, J MAGN MAGN MATER, V90-1, P175; KANEKO T, 1974, J PHYS SOC JPN, V37, P1465, DOI 10.1143/JPSJ.37.1465; Kjekshus A., 1964, PROGR SOLID STATE CH, V1, P83, DOI 10.1016/0079-6786(64)90004-4; LAMBERTANDRON B, 1978, J PHYS LETT-PARIS, V39, pL43; LAWAETZ P, 1972, PHYS REV B, V5, P4039, DOI 10.1103/PhysRevB.5.4039; LIU GC, 1995, PHYS REV B, V51, P16789; LIU L, 1981, HIGH TEMP HIGH PRESS, V13, P387; LUO H, 1995, PHYS REV B, V52, P7958; MAJEWSKI JA, 1987, PHYS REV B, V35, P9666, DOI 10.1103/PhysRevB.35.9666; Mazin II, 1998, AM MINERAL, V83, P451; MCWHAN DB, 1972, PHYS REV B-SOLID ST, V5, P2552, DOI 10.1103/PhysRevB.5.2552; MIMASAKA M, 1987, J PHYS C SOLID STATE, V20, P4689, DOI 10.1088/0022-3719/20/29/007; NAVROTSKY A, 1981, J GEOPHYS RES, V86, P3689, DOI 10.1029/JB086iB05p03689; Ohta S, 1996, J MAGN MAGN MATER, V163, P117, DOI 10.1016/S0304-8853(96)00315-0; Onodera A., 1989, HIGH PRESSURE SCI TE, V1, P114; Onodera A., 1987, High Temperatures - High Pressures, V19; ONODERA A, 1980, J APPL PHYS, V51, P315, DOI 10.1063/1.327374; ONODERA A, 1980, J APPL PHYS, V51, P2581, DOI 10.1063/1.327984; OZAWA K, 1966, PHYS LETT, V20, P132, DOI 10.1016/0031-9163(66)90903-6; RODORIQUEZHERNA.P, 1996, PHYS STATE SOLIDS B, V198, P455; SHIMOMURA O, 1992, REV SCI INSTRUM, V63, P967, DOI 10.1063/1.1143793; SUGIURA H, 1979, J PHYS CHEM SOLIDS, V40, P701, DOI 10.1016/0022-3697(79)90183-5; Takagaki M, 1998, J MAGN MAGN MATER, V177, P1385, DOI 10.1016/S0304-8853(97)00433-2; Takagaki M, 1998, J PHYS SOC JPN, V67, P1014, DOI 10.1143/JPSJ.67.1014; Takemura K., 1979, High Temperatures - High Pressures, V11; WANG CY, 1970, PHYS EARTH PLANET IN, V3, P213, DOI 10.1016/0031-9201(70)90059-2; WEINSTEIN BA, 1987, PHYS REV LETT, V58, P781, DOI 10.1103/PhysRevLett.58.781; WEIR ST, 1986, PHYS REV B, V33, P4221, DOI 10.1103/PhysRevB.33.4221; Wyckoff R. W. G., 1963, CRYSTAL STRUCTURES, V1	43	16	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3697			J PHYS CHEM SOLIDS	J. Phys. Chem. Solids	FEB	1999	60	2					167	179		10.1016/S0022-3697(98)00278-9		13	Chemistry, Multidisciplinary; Physics, Condensed Matter	Chemistry; Physics	158UM	WOS:000078135500004		
J	Yokoyama, T; Matsumoto, Y; Meshitsuka, G				Yokoyama, T; Matsumoto, Y; Meshitsuka, G			The role of peroxide species in carbohydrate degradation during oxygen bleaching. Part III. Effect of metal ions on the reaction selectivity between lignin and carbohydrate model compounds	JOURNAL OF PULP AND PAPER SCIENCE			English	Article									Univ Tokyo, Grad Sch Agr & Agr Life Sci, Dept Biomat Sci, Wood Chem Lab,Bunkyo Ku, Tokyo 113, Japan	Yokoyama, T (reprint author), Univ Tokyo, Grad Sch Agr & Agr Life Sci, Dept Biomat Sci, Wood Chem Lab,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 113, Japan.						ABBOT J, 1990, CAN J CHEM, V68, P1537, DOI 10.1139/v90-237; Gierer J, 1997, HOLZFORSCHUNG, V51, P34, DOI 10.1515/hfsg.1997.51.1.34; ERICSSON B, 1971, SVEN PAPPERSTIDN, V74, P757; BROWN KD, 1995, GENET ENG NEWS, V15, P1; COLODETTE JL, 1989, J PULP PAP SCI, V15, pJ45; Gyenge EL, 1997, TAPPI J, V80, P194; LACHENAL D, 1996, P 1996 INT PULP BLEA, V1, P275; SAMUELSON O, 1994, NORD PULP PAPER RES, V9, P259; YANG E, 1995, THESIS ROYAL I TECHN; Yasumoto M, 1996, J WOOD CHEM TECHNOL, V16, P95, DOI 10.1080/02773819608545785; YOKOYAMA T, 1996, 46 ANN M JAP WOOD RE, P388; Yokoyama T, 1996, J PULP PAP SCI, V22, pJ151; YOKOYAMA T, 1997, P 9 INT S WOOD PULP	13	14	15	PULP & PAPER TECHNICAL ASSOCIATION CANADA	MONTREAL	740 NOTRE DAME WEST, STE 810, MONTREAL, QC H3C 3X6, CANADA	0826-6220			J PULP PAP SCI	J. Pulp Pap. Sci.	FEB	1999	25	2					42	46				5	Materials Science, Paper & Wood	Materials Science	178XT	WOS:000079295000002		
J	Sakai, Y; Ohshita, K; Kubo, MK; Yonezawa, C; Matsue, H; Sawahata, H; Ito, Y; Iwama, S				Sakai, Y; Ohshita, K; Kubo, MK; Yonezawa, C; Matsue, H; Sawahata, H; Ito, Y; Iwama, S			Mossbauer characterization and prompt gamma-ray analysis of the products of thermit reactions	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article								Iron and boron species in the products of thermit reaction of aluminum, iron oxide, and boron oxide were characterized by Mossbauer spectroscopy, X-ray diffraction, and prompt gamma-ray analysis. It was revealed that iron and boron products of the thermit reaction are composed of intermetallic compounds with aluminum.	Daido Inst Technol, Dept Chem, Nagoya, Aichi 4578532, Japan; Univ Tokyo, Sch Sci, Tokyo 1130033, Japan; Japan Atom Energy Res Inst, Dept Chem & Fuel Res, Tokai, Ibaraki 3191106, Japan; Univ Tokyo, Nucl Sci & Technol Res Ctr, Tokai, Ibaraki 3191106, Japan; Daido Inst Technol, Dept Appl Elect, Nagoya, Aichi 4578531, Japan	Sakai, Y (reprint author), Daido Inst Technol, Dept Chem, Hakusui Cho, Nagoya, Aichi 4578532, Japan.	yocsakai@daido-it.ac.jp					Lindhard J., 1963, MAT FYS MEDD DAN VID, V33, P1, DOI DOI 10.1002/ADMA.200904153; MULLER F, 1991, MAT SCI ENG A-STRUCT, V134, P900, DOI 10.1016/0921-5093(91)90887-S; SAKAI Y, IN PRESS RADIOCHIM A; Sakai Y, 1996, J RADIOAN NUCL CH AR, V207, P275, DOI 10.1007/BF02071233; Sakai Y, 1996, RADIOCHIM ACTA, V72, P45; SAKAI Y, 1994, NUCL INSTRUM METH A, V353, P699, DOI 10.1016/0168-9002(94)91755-8; Wagman D. D., 1982, J PHYS CHEM REF DA S, V11; YONEZAWA C, 1993, ANAL SCI, V9, P185, DOI 10.2116/analsci.9.185; YONEZAWA C, 1993, NUCL INSTRUM METH A, V329, P207, DOI 10.1016/0168-9002(93)90938-E	9	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	1999	239	2					263	266		10.1007/BF02349494		4	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	168QB	WOS:000078702800009		
J	Homonnay, Z; Nomura, K; Juhasz, G; Vertes, A; Ujihira, Y				Homonnay, Z; Nomura, K; Juhasz, G; Vertes, A; Ujihira, Y			The microenvironment of iron in (Ba,Ca)(Fe,Co)O3-delta catalyst system: A Mossbauer study	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article							NONSTOICHIOMETRIC PEROVSKITE; METHANE; OXIDES	Perovskite type oxides of BaxCa1-xFe0.8Co0.2O3-delta with x = 0.95, 0.8, 0.6 and 0.4 have been studied by Fe-57 transmission Mossbauer spectroscopy. The microenvironment of Fe was found to be sensitively dependent on the Ba to Ca ratio and, more importantly, on the oxygen content. At high Ba concentration, magnetic relaxation is indicated by the Mossbauer spectra. identification of the various sextets and doublets in the Mossbauer spectra is attempted by the help of thermal treatments of the samples in air and methane as well as by quenching experiments and low temperature measurements.	Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 113, Japan; Eotvos Lorand Univ, Dept Nucl Chem, H-1518 Budapest 112, Hungary; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan	Nomura, K (reprint author), Univ Tokyo, Sch Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 113, Japan.		Juhasz, Gergely/A-3394-2012; 	Juhasz, Gergely/0000-0002-6359-1333; Nomura, Kiyoshi/0000-0003-0625-1778			Nomura K, 1996, APPL CATAL A-GEN, V137, P25, DOI 10.1016/0926-860X(95)00317-7; TAKANO M, 1988, J SOLID STATE CHEM, V73, P140, DOI 10.1016/0022-4596(88)90063-1; GAL M, COMMUNICATION; GALLAGHE.PK, 1966, J CHEM PHYS, V45, P2466, DOI 10.1063/1.1727962; Nomura K, 1998, HYPERFINE INTERACT, V112, P7, DOI 10.1023/A:1011003719888; NOMURA K, 1991, HYPERFINE INTERACT, V69, P879; NOMURA K, 1993, APPL CATAL A-GEN, V101, P63, DOI 10.1016/0926-860X(93)80138-G; NOMURA K, 1991, HYPERFINE INTERACT, V69, P835	8	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	1999	239	2					291	296		10.1007/BF02349499		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	168QB	WOS:000078702800014		
J	Oshima, N; Hamada, E; Suzuki, T; Kondo, K; Kanazawa, I; Ito, Y				Oshima, N; Hamada, E; Suzuki, T; Kondo, K; Kanazawa, I; Ito, Y			Application of a pulsed slow-positron beam to polymers	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article							THIN-FILMS; ANNIHILATION; SURFACES	Pulsed slow positrons were produced using a time-varying moderator bias with an interval of 82 ns; 97% of the positrons were compressed within 2 ns width at the target position. Both the positron annihilation lifetime and Doppler broadening of the positron annihilation radiation (DBPR) of polytetrafluoroethylene (PTFE) were measured as a function of the incident energy of slow positrons. It was shown that the lifetime and intensity of the long-lived component of positron annihilation are independent of the positron incident energy above 1.2 keV. However, the width of the Doppler-broadened annihilation gamma-ray increased in the energy region below 1.2 keV.	Grad Univ Adv Studies, High Energy Accelerator Res Org, KEK, Dept Accelerator Sci, Ibaraki, Osaka 305, Japan; KEK, High Energy Accelerator Res Org, Radiat Sci Ctr, Tsukuba, Ibaraki 305, Japan; Tokyo Gakugei Univ, Dept Phys, Tokyo 184, Japan; Univ Tokyo, Nucl Sci & Technol Res Ctr, Tokai, Ibaraki 31911, Japan	Oshima, N (reprint author), Grad Univ Adv Studies, High Energy Accelerator Res Org, KEK, Dept Accelerator Sci, Ibaraki, Osaka 305, Japan.						SCHULTZ PJ, 1988, REV MOD PHYS, V60, P701, DOI 10.1103/RevModPhys.60.701; DeMaggio GB, 1997, PHYS REV LETT, V78, P1524, DOI 10.1103/PhysRevLett.78.1524; ELDRUP M, 1981, CHEM PHYS, V63, P51, DOI 10.1016/0301-0104(81)80307-2; TAO SJ, 1972, J CHEM PHYS, V56, P5499, DOI 10.1063/1.1677067; JEAN YC, 1997, APPL SURF SCI, V251, P116; KINDL P, 1981, PHYS STATUS SOLIDI A, V66, P627, DOI 10.1002/pssa.2210660227; KIRKEGAARD P, RISOM2740; KOBAYASHI Y, 1995, PHYS REV B, V52, P823, DOI 10.1103/PhysRevB.52.823; MOGENSEN OE, 1995, CHEM PHYSICS, V58; Oshima N, 1997, APPL SURF SCI, V116, P82, DOI 10.1016/S0169-4332(96)01033-1; OSHIMA N, 1997, ICPA11, P629; OSHIMA N, MAT SCI FORUM, P255; Suzuki T, 1996, POLYMER, V37, P5521, DOI 10.1016/S0032-3861(96)00459-4; XIE L, 1995, PHYS REV LETT, V74, P4947, DOI 10.1103/PhysRevLett.74.4947	14	4	4	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	1999	239	2					329	333		10.1007/BF02349506		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	168QB	WOS:000078702800021		
J	Takahashi, Y; Kimura, T; Kato, Y; Minai, Y; Makide, Y; Tominaga, T				Takahashi, Y; Kimura, T; Kato, Y; Minai, Y; Makide, Y; Tominaga, T			Laser-induced fluorescence study on the interaction of Eu(III) with polycarboxylates	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article							POLY-ELECTROLYTE SOLUTIONS; ION-BINDING; POLY(METHACRYLIC ACID); POLY(ACRYLIC ACID); EUROPIUM(III); LUMINESCENCE; PROBES; METAL	Laser-induced fluorescence spectroscopy was applied to obtaining hydration structure of Eu(III) complexes with synthetic polycarboxylates of poly(acrylic acid), poly(maleic acid), poly(methacrylic acid), and poly(a-hydroxyacrylic acid). Dependence of N-H2O (the number of water molecules in the first coordination sphere of Eu(III) ion) on pH and supporting electrolyte concentration was obtained for these complexes. The spectroscopic results show that Eu(III) is surrounded by the "cage" of polycarboxylate ligands. The pH-induced transition in conformation of poly(methacrylic acid) ligand was clearly observed in the N-H2O plot VS. pH.	Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 113, Japan; Japan Atom Energy Res Inst, Tokai, Ibaraki 31911, Japan; Musashi Univ, Ctr Arts & Sci, Nerima Ku, Tokyo 176, Japan	Takahashi, Y (reprint author), Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 113, Japan.		Takahashi, Yoshio/F-6733-2011				Miyajima T, 1997, J COLLOID INTERF SCI, V187, P259, DOI 10.1006/jcis.1996.4694; YOON TH, 1994, ENVIRON SCI TECHNOL, V28, P2139, DOI 10.1021/es00061a023; RICHARDSON FS, 1982, CHEM REV, V82, P541, DOI 10.1021/cr00051a004; CHOPPIN GR, 1988, RADIOCHIM ACTA, V44-5, P23; Lis S, 1995, INORG CHIM ACTA, V239, P139, DOI 10.1016/0020-1693(95)04736-0; LEYTE JC, 1964, J POLYM SCI PART A, V2, P1879, DOI 10.1002/pol.1964.100020429; TORRES RA, 1984, RADIOCHIM ACTA, V35, P143; Anufrieva EV, 1968, J POLYM SCI C, V16, P3519; CRESCENZ.V, 1972, J POLYM SCI A2, V10, P357, DOI 10.1002/pol.1972.160100215; HORROCKS WD, 1983, PROGR INORGANIC CHEM, V31; KIM JI, 1992, RADIOCHIM ACTA, V58-9, P147; KOPPOLD FX, 1987, RADIOCHIM ACTA, V42, P29; MARINSKY JA, 1976, COORDIN CHEM REV, V19, P125, DOI 10.1016/S0010-8545(00)80314-8; NAGATA I, 1983, MACROMOLECULES, V16, P749, DOI 10.1021/ma00239a009; SAKURAI M, 1993, POLYM J, V25, P1247, DOI 10.1295/polymj.25.1247; Smith R.M., 1982, CRITICAL STABILITY C; TAKAHASHI Y, 1997, THESIS U TOKYO; Takahashi Y, 1996, J RADIOAN NUCL CH LE, V212, P11, DOI 10.1007/BF02165446; TIPPING E, 1993, RADIOCHIM ACTA, V62, P141; WARWICK P, 1994, RADIOCHIM ACTA, V66-7, P133; YAMASHITA F, 1987, J POLYM SCI POL PHYS, V25, P1395, DOI 10.1002/polb.1987.090250703	21	15	15	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	1999	239	2					335	340		10.1007/BF02349507		6	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	168QB	WOS:000078702800022		
J	Nogawa, N; Momose, S; Miyazawa, K; Makide, Y; Oohashi, K; Hashimoto, K; Morikawa, N				Nogawa, N; Momose, S; Miyazawa, K; Makide, Y; Oohashi, K; Hashimoto, K; Morikawa, N			Synthesis of Re-186-DMSA and its biodistributions in mice	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article							DIMERCAPTOSUCCINIC ACID; MEDULLARY CARCINOMA; IMAGING AGENT; RHENIUM; COMPLEX; RE-188	Optimum conditions were determined for high-yield synthesis of Re-186- and Re-188-meso-2,3-dimercaptosuccinic acid complexes applicable to animal injection. The yield was more than 95% under the conditions used. The bone accumulation of the complexes was remarkable in the biodistributions in mice.	Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 113, Japan; Chiba Univ, Fac Pharmaceut Sci, Lab Radiopharmaceut Chem, Inage Ku, Chiba 263, Japan; Japan Atom Energy Res Inst, Tokai, Ibaraki 31911, Japan	Nogawa, N (reprint author), Univ Tokyo, Radioisotope Ctr, Bunkyo Ku, Tokyo 113, Japan.						ANDO A, 1975, RADIOISOTOPES, V24, P46; SINGH J, 1993, NUCL MED COMMUN, V14, P197, DOI 10.1097/00006231-199303000-00009; BLAUENSTEIN P, 1990, NEW J CHEM, V14, P405; CLARKE SEM, 1988, J NUCL MED, V29, P33; CALLAHAN AP, 1992, APPL RADIAT ISOTOPES, V43, P801; CALLAHAN AP, 1989, NUC COMPACT, V20, P3; LIN TH, 1974, J NUCL MED, V15, P512; OHTA H, 1984, J NUCL MED, V25, P323; OHTA H, 1988, NUCL MED COMMUN, V9, P105; SINGH J, 1991, J CHEM SOC CHEM COMM, P1115, DOI 10.1039/c39910001115; YOKOYAMA A, 1985, INT J NUCL MED BIOL, V12, P273, DOI 10.1016/0047-0740(85)90180-9	11	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	FEB	1999	239	2					385	389		10.1007/BF02349517		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	168QB	WOS:000078702800032		
J	De Benedetti, F; Pignatti, P; Bernasconi, S; Gerloni, V; Matsushima, K; Caporali, R; Montecucco, CM; Sozzani, S; Fantini, F; Martini, A				De Benedetti, F; Pignatti, P; Bernasconi, S; Gerloni, V; Matsushima, K; Caporali, R; Montecucco, CM; Sozzani, S; Fantini, F; Martini, A			Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes	JOURNAL OF RHEUMATOLOGY			English	Article						interleukin 8; monocyte chemoattractant protein-1; juvenile rheumatoid arthritis	TUMOR-NECROSIS-FACTOR; ANTIRHEUMATIC DRUGS; MONONUCLEAR-CELLS; CYTOKINE LEVELS; MESSENGER-RNA; RECEPTOR; CHEMOKINES; METHOTREXATE; SERUM; IL-6	Objective. To measure serum and synovial fluid (SF) levels of interleukin 8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) in patients with juvenile rheumatoid arthritis (JRA) and to compare them with adult rheumatoid factor-positive rheumatoid arthritis (RA), Methods. IL-8 and MCP-I were measured by immunoassay (1) in sera obtained from 55 children with JRA and from 16 adults with RA, and (2) in SF obtained from 30 children with JRA and II adults with RA. Results, Patients with active systemic JRA had serum levels of IL-8 and MCP-I higher than in controls (p < 0.01) and in patients with active polyarticular or pauciarticular JRA (p < 0.05), In patients with RA serum MCP-1 levels were higher than in patients with the 3 JRA onset types, while no difference was found for IL-8 levels. Patients with systemic JRA and with current systemic features had serum levels of IL-8 and MCP-1 higher (p = 0.03 and p = 0.04, respectively) than patients in which systemic features had subsided, No significant differences in SF IL-8 or MCP-I levels were found among the 3 JRA onset types or adults with RA. In patients with JRA SF leukocyte counts were correlated with SF IL-8 levels (p = 0.002), but not with MCP-1 levels. Moreover, SF levels of both IL-8 and MCP-1 were correlated with those of IL-1 beta (p < 0.001) and IL-6 (p<0.01), but not with those of TNF-alpha, Conclusion. Elevated serum levels of IL-8 and MCP-1 in patients with systemic JRA with current systemic features at sampling suggest systemic production of the 2 chemokines during systemic phases of the disease. Similar SF levels of IL-8 and MCP-1 among the 3 JRA onset-types and RA suggest comparable local production of the 2 chemokines.	Policlin San Matteo, Pediat Clin, Dipartimento Assistenziale Med Interna & Nefrol, Serv Reumatol,IRCCS, I-27100 Pavia, Italy; Ist Ric Farmacol Mario Negri, Milan, Italy; Univ Milan, Chair Rheumatol, Ist Gaetano Pini, Milan, Italy; Univ Tokyo, Dept Mol Prevent Med, Tokyo, Japan	Martini, A (reprint author), Policlin San Matteo, Pediat Clin, Dipartimento Assistenziale Med Interna & Nefrol, Serv Reumatol,IRCCS, Piazzale Golgi 2, I-27100 Pavia, Italy.		Sozzani, Silvano/C-1447-2009	Sozzani, Silvano/0000-0002-3144-8743			Amett FC, 1988, ARTHRITIS RHEUM, V31, P315; ENDO H, 1991, LYMPHOKINE CYTOK RES, V10, P245; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; SEITZ M, 1991, J CLIN INVEST, V87, P463, DOI 10.1172/JCI115018; LOETSCHER P, 1994, CYTOKINE, V6, P162, DOI 10.1016/1043-4666(94)90038-8; BERTAZZOLO N, 1994, AGENTS ACTIONS, V41, P90, DOI 10.1007/BF01986402; BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97; Badolato R, 1996, SEMIN ARTHRITIS RHEU, V26, P526, DOI 10.1016/S0049-0172(96)80041-2; VILLIGER PM, 1992, J IMMUNOL, V149, P722; ENDO H, 1994, CLIN EXP IMMUNOL, V96, P31; RAVELLI A, 1993, J RHEUMATOL, V20, P1573; POLI V, 1994, EMBO J, V13, P1189; LEDUR A, 1995, J IMMUNOL METHODS, V186, P171, DOI 10.1016/0022-1759(95)00184-C; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; AKAHOSHI T, 1993, ARTHRITIS RHEUM, V36, P762, DOI 10.1002/art.1780360605; SEITZ M, 1995, BRIT J RHEUMATOL, V34, P602; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; DEBENEDETTI F, 1991, ARTHRITIS RHEUM, V34, P1158, DOI 10.1002/art.1780340912; MANGGE H, 1995, ARTHRITIS RHEUM, V38, P211, DOI 10.1002/art.1780380209; DIEZRUIZ A, 1995, EUR J HAEMATOL, V54, P1; Barrera P, 1996, SEMIN ARTHRITIS RHEU, V25, P234, DOI 10.1016/S0049-0172(96)80035-7; BRENNAN FM, 1990, EUR J IMMUNOL, V20, P2141, DOI 10.1002/eji.1830200938; Brewer E J Jr, 1977, Arthritis Rheum, V20, P195; CASSIDY JT, 1995, TXB PEDIAT RHEUMATOL, P133; De Benedetti Fabrizio, 1997, Current Opinion in Rheumatology, V9, P428, DOI 10.1097/00002281-199709000-00009; DeBenedetti F, 1997, BRIT J RHEUMATOL, V36, P581; DeBenedetti F, 1997, J RHEUMATOL, V24, P1403; DEKOSSODO S, 1995, J IMMUNOL METHODS, V182, P197; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2; DELEURAN B, 1992, CYTOKINE, V4, P403, DOI 10.1016/1043-4666(92)90085-6; GROM AA, 1994, ARTHRITIS RHEUM, V37, P601, DOI 10.1002/art.1780370501; HARIGAI M, 1993, CLIN IMMUNOL IMMUNOP, V69, P83, DOI 10.1006/clin.1993.1153; KO YC, 1992, J IMMUNOL METHODS, V149, P227, DOI 10.1016/0022-1759(92)90254-Q; KOCK AE, 1991, J IMMUNOL, V147, P2187; KOCK AE, 1992, J CLIN INVEST, V90, P772; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; MILTENBURG AMM, 1991, BRIT J RHEUMATOL, V30, P186; Ozen S, 1997, CLIN RHEUMATOL, V16, P173, DOI 10.1007/BF02247847; PAKER M, 1995, CIRCULATION, V92, P1379; PEICHL P, 1991, SCAND J IMMUNOL, V34, P333, DOI 10.1111/j.1365-3083.1991.tb01554.x; PERI G, 1994, J IMMUNOL METHODS, V174, P249, DOI 10.1016/0022-1759(94)90029-9; RAMPART M, 1992, LAB INVEST, V66, P512; SEITZ M, 1992, RHEUMATOL INT, V12, P159, DOI 10.1007/BF00274936; Sozzani S, 1996, Prog Drug Res, V47, P53; VANLEEUWEN MA, 1995, ANN RHEUM DIS, V54, P33, DOI 10.1136/ard.54.1.33	45	36	37	J RHEUMATOL PUBL CO	TORONTO	920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA	0315-162X			J RHEUMATOL	J. Rheumatol.	FEB	1999	26	2					425	431				7	Rheumatology	Rheumatology	162CJ	WOS:000078327600030		
J	Yoshimura, K; Harii, K				Yoshimura, K; Harii, K			A regenerative change during muscle adaptation to denervation in rats	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	7th Annual Meeting of the American-Society-for-Peripheral-Nerve	JUN 05-07, 1997	WILLIAMSBURG, VIRGINIA	Amer Soc Peripheral Nerve		satellite cell; myoblast; rat; regeneration; myosin heavy chain; apoptosis; MyoD; BrdU	MYOSIN HEAVY-CHAIN; SATELLITE CELLS; SKELETAL-MUSCLE; MYOD1	The purpose of this study is to examine the cellular and molecular events coincident with muscle denervation, especially the regenerative changes seen following muscle denervation, the role of satellite cells in this process, and the possibility of apoptotic degeneration of myonuclei as a mechanism of myonuclei loss during muscle denervation atrophy. Myosin heavy chain (MHC) isoform expression during muscle denervation was examined using pyrophosphate acrylamide gel electrophoresis and immunohistochemistry. DNA fragmentation (apoptosis) in myonuclei of denervated fibers was investigated using agarose gel electrophoresis, the TUNEL technique and ELISA for cytoplasmic histone-associated DNA fragmentation. Immunohistochemistry for MyoD and BrdU was also performed. Following muscle denervation, embryonic MHC, which is not expressed in adult healthy muscles, was expressed in some denervated fibers as well as in small activated satellite cells; maximal expression was observed 2 to 3 weeks after denervation. Activation and proliferation of satellite cells were observed, while few typical regenerating fibers were identified. It is speculated that most activated satellite cells fused to the denervated maternal fibers in order to repair them instead of fusing to each other to form new fibers as a mechanism that compensates for the atrophic changes after denervation. Although DNA ladder formation was not observed with agarose gel electrophoresis, DNA fragmentation was detected by the TUNEL technique and ELISA, suggesting that apoptotic degeneration contributes to the loss of myonuclei associated with denervation atrophy. (C) 1999 Academie Press.	Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 113, Japan	Yoshimura, K (reprint author), Univ Tokyo, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	yoshimura-pla@h.u-tokyo.ac.jp	Yoshimura, Kotaro/C-8524-2009				ANDERSON JE, 1991, MUSCLE NERVE, V14, P268, DOI 10.1002/mus.880140311; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; ADAMS L, 1995, J CELL BIOL, V131, P1341, DOI 10.1083/jcb.131.5.1341; DIAS P, 1992, CANCER RES, V52, P6431; Viguie CA, 1997, ANAT REC, V248, P346; Allen DL, 1997, AM J PHYSIOL-CELL PH, V273, pC579; Lu DX, 1997, ANAT REC, V248, P355; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; MOSS FP, 1971, ANAT REC, V170, P421, DOI 10.1002/ar.1091700405; SNOW MH, 1983, ANAT REC, V207, P593, DOI 10.1002/ar.1092070407; BORIEK AM, 1995, FASEB J, V9, pA825; Davis C E, 1991, Neuromuscul Disord, V1, P411, DOI 10.1016/0960-8966(91)90004-C; Eberstein A, 1996, MED SCI SPORT EXER, V28, P1463, DOI 10.1097/00005768-199612000-00004; ECOBPRINCE M, 1989, J NEUROL SCI, V91, P71, DOI 10.1016/0022-510X(89)90076-2; FIDZIANSKA A, 1991, Pediatric Pathology, V11, P421; FIDZIANSKA A, 1990, BRAIN, V113, P433, DOI 10.1093/brain/113.2.433; HOH JFY, 1976, BIOCHEM J, V157, P87; KOISHI K, 1995, DEV DYNAM, V202, P244; MCGEACHIE JK, 1986, BIBL ANAT, V29, P173; Ochi M, 1996, PLAST RECONSTR SURG, V97, P577, DOI 10.1097/00006534-199603000-00014; ONTELL M, 1974, ANAT REC, V178, P211, DOI 10.1002/ar.1091780206; RODRIGUES AD, 1995, ANAT REC, V243, P430; SCHMALBRUCH H, 1994, J MUSCLE RES CELL M, V15, P256; SCHMID U, 1991, MAT SCI ENG B-SOLID, V9, P233, DOI 10.1016/0921-5107(91)90178-X; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Terzis JK, 1988, P 6 INT S FAC NERV R, P525; TINBALL JG, 1996, J LEUKOCYTE BIOL, V59, P380; WHALEN RG, 1981, NATURE, V292, P805, DOI 10.1038/292805a0; WINCHESTER PK, 1991, AM J PHYSIOL, V260, pC206; Yoshimura K, 1998, J SURG RES, V75, P135, DOI 10.1006/jsre.1998.5271; Zhang F, 1997, PLAST RECONSTR SURG, V99, P803, DOI 10.1097/00006534-199703000-00029	32	35	43	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	FEB	1999	81	2					139	146		10.1006/jsre.1998.5504		8	Surgery	Surgery	166NG	WOS:000078582700004		
J	Fukatsu, K; Saito, H; Han, I; Inoue, T; Furukawa, S; Matsuda, T; Ikeda, S; Yasuhara, H; Muto, T				Fukatsu, K; Saito, H; Han, I; Inoue, T; Furukawa, S; Matsuda, T; Ikeda, S; Yasuhara, H; Muto, T			Concomitant increase in neutrophil adhesion to inflammatory peritoneum and remote organs during peritonitis	JOURNAL OF SURGICAL RESEARCH			English	Article						peritonitis; neutrophil adhesion; fluorescent microscopic method; myeloperoxidase	ESCHERICHIA-COLI; INTRAABDOMINAL INFECTION; BACTEROIDES-FRAGILIS; ENDOTHELIAL-CELL; INJURY; FAILURE; ACTIVATION; MECHANISM; SITE	Background. Neutrophils contribute to the host defense mechanism, but they can cause remote organ injury in peritonitis. The purpose of this study was to examine neutrophil adhesion to the peritoneum and remote organs simultaneously in peritonitis using a fluorescence microscopic method. Study design. Experiment 1: Sprague-Dawley rats (n = 16) were injected intraperitoneally (ip) with saline solution or 10(5), 10(7), or 10(9) Escherichia coli. Five hours after challenge, 1 x 10(6) fluorescein-labeled neutrophils were infused, Two minutes after neutrophil injection, five peritoneal samples (the greater omentum, mesentery, parietal peritoneum, colon, and ileum), both lungs, the liver, and the right kidney were harvested for counting of labeled neutrophils under epifluorescent microscopy. Lung myeloperoxidase (MPO) activity was also determined. Experiment 2: Rats (n = 23) were given 10(9) E. coli ip. Before challenge (6 h) or at 1, 5, or 10 h after challenge, labeled neutrophils were infused. Then, the labeled neutrophil numbers in organs and lung MPO activities were assessed as described for Experiment 1. Hemodynamic and arterial blood gas data were also obtained in another set of rats before and at 1, 5, 8 and 10 h after 10(9) E, coli ip challenge. Results. Experiment 1: The labeled neutrophil numbers in the peritoneum, lungs, and kidney showed significant positive correlations with the injected bacterial numbers. Lung MFO also positively correlated with E. coli number and labeled neutrophil number in the lungs. Experiment 2: Labeled neutrophil numbers in the peritoneum and kidney peaked at 5 h. The pulmonary labeled neutrophil number rose, reaching a plateau at 5 h. No remarkable change was observed in the hepatic labeled neutrophil number, There was a positive correlation between lung MPO activity and pulmonary labeled neutrophil number. Hemodynamic and blood gas data reflected a hyperdynamic state. Conclusions. Concomitant dose-dependent increases in neutrophil adhesion in the peritoneum, lungs, and kidney were observed in this peritonitis model. Increased neutrophil adhesion was transient in the peritoneum and kidney but persistent in the lungs. Strategies modulating neutrophil adhesion in organs are anticipated to be useful for the treatment of peritonitis. (C) 1999 Academic Press.	Univ Tokyo, Dept Surg, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Surg Ctr, Bunkyo Ku, Tokyo 113, Japan	Fukatsu, K (reprint author), Univ Tokyo, Dept Surg, Bunkyo Ku, 731 Hongo, Tokyo 113, Japan.						ALLISON F, 1955, J EXP MED, V102, P655, DOI 10.1084/jem.102.6.655; ANDERSON BO, 1991, J SURG RES, V51, P170, DOI 10.1016/0022-4804(91)90090-9; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; Wickel DJ, 1997, ANN SURG, V225, P744, DOI 10.1097/00000658-199706000-00012; MADDAUS MA, 1988, SURG CLIN N AM, V68, P431; GOYA T, 1994, SURGERY, V115, P145; JOHNSON RJ, 1987, J CLIN INVEST, V79, P1379, DOI 10.1172/JCI112965; BOYCE NW, 1986, KIDNEY INT, V30, P813, DOI 10.1038/ki.1986.260; Chen XW, 1996, ARCH SURG-CHICAGO, V131, P1148; Downey G P, 1995, New Horiz, V3, P219; DUNN DL, 1985, INFECT IMMUN, V49, P257; Fukatsu K, 1997, J SURG RES, V68, P79, DOI 10.1006/jsre.1997.5018; Fukatsu K, 1998, J SURG RES, V74, P119, DOI 10.1006/jsre.1997.5234; Fukatsu K, 1996, J AM COLL SURGEONS, V183, P450; GRISHAM MB, 1990, METHOD ENZYMOL, V186, P729; Hau T, 1979, Curr Probl Surg, V16, P1, DOI 10.1016/S0011-3840(79)80011-8; HOLMAN JM, 1988, J LEUKOCYTE BIOL, V43, P193; ISHIZAKA A, 1988, AM REV RESPIR DIS, V137, P783; JOYCE LD, 1978, SURGERY, V83, P717; Marcus BC, 1997, SURGERY, V122, P420, DOI 10.1016/S0039-6060(97)90035-0; Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955; RICHARDSON DJ, 1982, ANN SURG, V195, P732; STEPHENS KE, 1988, AM REV RESPIR DIS, V138, P1300; TIGHE D, 1989, CLIN SCI, V76, P269; VARANI J, 1989, AM J PATHOL, V135, P435; VERWEIJ WR, 1993, J GEN MICROBIOL, V139, P1739; VERWEIJ WR, 1993, J MED MICROBIOL, V38, P13; Watson RWG, 1996, J IMMUNOL, V156, P3986	28	9	9	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	FEB	1999	81	2					156	163		10.1006/jsre.1998.5454		8	Surgery	Surgery	166NG	WOS:000078582700006		
J	Yoshimura, K; Asato, H; Cederna, PS; Urbanchek, MG; Kuzon, WM				Yoshimura, K; Asato, H; Cederna, PS; Urbanchek, MG; Kuzon, WM			The effect of reinnervation on force production and power output in skeletal muscle	JOURNAL OF SURGICAL RESEARCH			English	Article						reinnervated muscle; force production; power output	SOLEUS FIBER FORCE; MOTOR UNITS; WEIGHT-BEARING; RAT SOLEUS; VELOCITY; HINDLIMB; ARCHITECTURE; RECOVERY; SLOW; TRANSPLANTATION	Failure to fully restore contractile function after denervation and reinnervation of skeletal muscle engenders significant disability in patients suffering peripheral nerve injuries. This work tested the hypothesis that skeletal muscle denervation and reinnervation result in a deficit in normalized power (W/kg), which exceeds the deficit in specific force (N/cm(2)), and that the mechanisms responsible for these deficits are independent. Adult Lewis rats underwent either transection and epineurial repair of the left peroneal nerve (denervation-reinnervation, n = 13) or SHAM: exposure of the peroneal nerve (SHAM, n = 13). After a 4-month recovery period, isometric force, peak power, and maximum sustained power output were measured in the left extensor digitorum longus (EDL) muscle from each animal. Isometric force measurements revealed a specific force deficit of 14.3% in the reinnervated muscles. Power measurements during isovelocity shortening contractions demonstrated a normalized peak power deficit of 25.8% in the reinnervated muscles, which is accounted for by decreases in both optimal velocity (10.5%) and average force curing shortening (13.7%). Maximum sustained power was similar in both groups. These data support our working hypothesis that both whole muscle force production and power output can be impaired in reinnervated muscle and that the relative deficits in power output exceed the deficits in force production. The mechanisms responsible for the deficits in force production appear to be independent of those that result in changes in peak power output. The measurement of muscle power output may represent a clinically relevant variable for studies of the recovery of mechanical function after motor nerve injury and repair. (C) 1999 Academic Press.	Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; Univ Tokyo, Dept Plast & Reconstruct Surg, Tokyo, Japan; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	Cederna, PS (reprint author), Univ Michigan, Med Ctr, Dept Surg, 2130 Taubman Ctr,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	cederna@umich.edu	Yoshimura, Kotaro/C-8524-2009				ALBANI M, 1988, J NEUROL SCI, V88, P195, DOI 10.1016/0022-510X(88)90217-1; NACHLAS MM, 1957, J HISTOCHEM CYTOCHEM, V5, P420; GORDON T, 1982, J NEUROPHYSIOL, V48, P1175; CLOSE RI, 1972, PHYSIOL REV, V52, P129; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369; SEGAL SS, 1986, J APPL PHYSIOL, V61, P660; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; JACOBSON MD, 1992, J HAND SURG-AM, V17A, P804, DOI 10.1016/0363-5023(92)90446-V; LIEBER RL, 1989, J MORPHOL, V199, P93, DOI 10.1002/jmor.1051990108; BLOMSTRAND E, 1982, ACTA PHYSIOL SCAND, V116, P437, DOI 10.1111/j.1748-1716.1982.tb07163.x; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Carlson BM, 1996, RESTOR NEUROL NEUROS, V10, P77, DOI 10.3233/RNN-1996-10203; LIEBER RL, 1992, J HAND SURG-AM, V17A, P787, DOI 10.1016/0363-5023(92)90444-T; ASATO H, 1995, P 4 INT MUSCL S ZUR, P82; Bangart JJ, 1997, J APPL PHYSIOL, V82, P1905; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; BLOMSTRAND E, 1984, ACTA PHYSIOL SCAND, V122, P545, DOI 10.1111/j.1748-1716.1984.tb07543.x; Brooks S. V., 1991, J GERONTOL, V46, P28; BROOKS SV, 1991, J PHYSIOL-LONDON, V436, P701; BROOKS SV, 1990, J APPL PHYSIOL, V68, P1282; CHENG NX, 1994, ANN PLAS SURG, V33, P166, DOI 10.1097/00000637-199408000-00008; CLAFLIN DR, 1989, J PHYSIOL-LONDON, V411, P627; CLOSE R, 1967, J PHYSIOL-LONDON, V193, P45; DAS SK, 1986, PLAST RECONSTR SURG, V77, P804, DOI 10.1097/00006534-198605000-00020; DETTBARN WD, 1981, EXP NEUROL, V74, P33, DOI 10.1016/0014-4886(81)90147-3; DUBOWITZ V, 1967, J PHYSIOL-LONDON, V193, P481; EISEN A, 1974, NEUROLOGY, V24, P878; FAULKNER JA, 1986, AM REV RESPIR DIS, V134, P1081; FOEHRING RC, 1986, J NEUROPHYSIOL, V55, P931; FREY M, 1983, PLAST RECONSTR SURG, V71, P689, DOI 10.1097/00006534-198305000-00021; FRIEDERICH JA, 1990, J BIOMECH, V23, P91, DOI 10.1016/0021-9290(90)90373-B; Gans C, 1982, Exerc Sport Sci Rev, V10, P160; GREEN HJ, 1982, HISTOCHEMISTRY, V76, P21, DOI 10.1007/BF00493282; GUELINCKX P, 1976, 2 VIENN MUSCL S P AU, P75; GUELINCKX PJ, 1988, MUSCLE NERVE, V11, P745, DOI 10.1002/mus.880110710; Halkjaer-Kristensen J, 1985, Scand J Rehabil Med Suppl, V13, P5; HARRISON IW, 1992, CORNELL VET, V82, P59; HEMS TEJ, 1992, BRIT J PLAST SURG, V45, P497, DOI 10.1016/0007-1226(92)90141-J; HOWALD H, 1982, INT J SPORTS MED, V3, P1, DOI 10.1055/s-2008-1026053; JOLESZ F, 1981, ANNU REV PHYSIOL, V43, P531, DOI 10.1146/annurev.ph.43.030181.002531; Jones NL, 1986, HUMAN MUSCLE POWER; KARPATI G, 1968, NEUROLOGY, V18, P447; Klueber K M, 1987, Anat Rec, V219, P370; KUYPERS PDL, 1995, EXP NEUROL, V132, P77, DOI 10.1016/0014-4886(95)90060-8; KUZON WM, 1991, MICROSURG, V12, P352, DOI 10.1002/micr.1920120507; Kuzon William M. Jr., 1994, Surgical Forum, V45, P630; LEWIS DM, 1982, J PHYSIOL-LONDON, V325, P393; Mackinnon S., 1988, SURG PERIPHERAL NERV; MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P833, DOI 10.1097/00006534-198506000-00013; MAXWELL LC, 1978, J APPL PHYSIOL, V44, P431; MCDONALD KS, 1994, J APPL PHYSIOL, V77, P1609; MENDEZ J, 1984, METABOLISM, V9, P1960; PODOLIN RA, 1986, J GEN PHYSIOL, V87, P607, DOI 10.1085/jgp.87.4.607; ROSENBLATT J, 1988, STAIN TECHNOL, V62, P263; SEGAL SS, 1985, AM J PHYSIOL, V248, pC265; STENANOVIC MV, 1986, MICROSURG, V7, P105; Terzis J K, 1978, J Hand Surg Am, V3, P37; WICKIEWICZ TL, 1983, CLIN ORTHOP RELAT R, P275; Widrick JJ, 1996, J APPL PHYSIOL, V80, P981	59	39	40	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	FEB	1999	81	2					201	208		10.1006/jsre.1998.5498		8	Surgery	Surgery	166NG	WOS:000078582700013		
J	Shimazawa, R; Takayama, H; Hashimoto, Y				Shimazawa, R; Takayama, H; Hashimoto, Y			Development of novel biological response modifiers derived from thalidomide	JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN			Japanese	Article						thalidomide; cyclic imides; tumor necrosis factor-alpha; androgen antagonist; protease inhibitor; aminopeptidase N; structure-activity relationship; angiogenesis	NECROSIS-FACTOR-ALPHA; ESTER-INDUCED PRODUCTION; BIDIRECTIONAL REGULATION; ENANTIO-DEPENDENCE; PHENYLPHTHALIMIDES; ENHANCEMENT; PHTHALIMIDES; RECEPTORS; SKELETON; ANALOGS	There has been a resurgence of interest in thalidomide (N-alpha-phthalimidoglutarimide), a teratogenic hypnotic/sedative agent, in recent gears due to its potential usefulness of the treatment of various deseases. The effectiveness of the drug has been attributed to its regulating activity on tumor necrosis factor alpha production. The regulating activity has been found to be bidirectional, depending on both cell-type and the cell-stimulator. The bidirectional activity was separated by structural development of the drug, resulting in navel, potent, and structurally new thalidomides. By further structural development, novel types of androgen antagonists and nonpeptide protease inhibitors have been derived. Some of the developed compounds have been found to elicit potent antiangiogenic activity and/or potent inhibitory activity on tumor cell invasion. The studies on these structural development and the expansion of: biological activities is reviewed in relation to the structure-activity relationships.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Shimazawa, R (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Miyachi H, 1997, BIOORG MED CHEM LETT, V7, P1483, DOI 10.1016/S0960-894X(97)00249-7; HASHIMOTO Y, 1991, CELL STRUCT FUNCT, V16, P113; HASHIMOTO Y, 1991, CELL BIOL REV, V25, P209; Shibata Y, 1996, CHEM PHARM BULL, V44, P156; Miyachi H, 1996, BIOCHEM BIOPH RES CO, V224, P426, DOI 10.1006/bbrc.1996.1043; Azuma A, 1996, BIOL PHARM BULL, V19, P1001; HASHIMOTO Y, 1984, ACCOUNTS CHEM RES, V17, P403, DOI 10.1021/ar00107a005; Hashimoto Y, 1998, CURR MED CHEM, V5, P163; Miyachi H, 1996, BIOCHEM BIOPH RES CO, V226, P439, DOI 10.1006/bbrc.1996.1374; Miyachi H, 1997, BIOORGAN MED CHEM, V5, P2095, DOI 10.1016/S0968-0896(97)00148-X; Miyachi H, 1996, CHEM PHARM BULL, V44, P1980; Miyachi H, 1998, J MED CHEM, V41, P263, DOI 10.1021/jm970624o; Miyachi H, 1997, J MED CHEM, V40, P2858, DOI 10.1021/jm970109q; Miyachi H, 1996, BIOORG MED CHEM LETT, V6, P2293, DOI 10.1016/0960-894X(96)00409-X; Miyachi H, 1998, CHEM PHARM BULL, V46, P1165; NISHIMURA K, 1994, CHEM PHARM BULL, V42, P1157; NISHIMURA K, 1994, BIOCHEM BIOPH RES CO, V199, P455, DOI 10.1006/bbrc.1994.1250; Niwayama S, 1998, BIOORG MED CHEM LETT, V8, P1071, DOI 10.1016/S0960-894X(98)00171-1; SASAKI K, 1994, BIOL PHARM BULL, V17, P1313; SASAKI K, 1995, BIOL PHARM BULL, V18, P1228; SHIBATA Y, 1994, BIOL PHARM BULL, V17, P1532; SHIBATA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1992, DOI 10.1006/bbrc.1994.2904; SHIBATA Y, 1995, CHEM PHARM BULL, V43, P177	23	7	7	SOC SYNTHETIC ORGANIC CHEM JPN	TOKYO	CHEMISTRY HALL, 1-5 KANDA-SURUGADAI, CHIYODA-KU, TOKYO, 101, JAPAN	0037-9980			J SYN ORG CHEM JPN	J. Synth. Org. Chem. Jpn.	FEB	1999	57	2					92	104				13	Chemistry, Organic	Chemistry	169PB	WOS:000078756800004		
J	Brand, KP; Jang, CJ; Park, JH; Serrano, PI; Weker, RA; Lee, K; Yanagisawa, Y				Brand, KP; Jang, CJ; Park, JH; Serrano, PI; Weker, RA; Lee, K; Yanagisawa, Y			Residual perchloroethylene in dry-cleaned acetate: The effect of pressing and extent of inter-dry-cleaner variability	JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION			English	Article							UNCERTAINTY ANALYSIS; EXPOSURE; CHEMICALS; EMISSIONS	Measurements of residual perchloroethylene (PCE), a dry-cleaning solvent associated with human health effects, were made in dry-cleaned acetate cloth to enable improved characterizations of both occupational and environmental exposure. A limited sample size (25 acetate cloths) was used to explore the extent of inter-dry-cleaner variability in residual PCE and to characterize the effect of the pressing operation on residual PCE. A new method, which uses carbon-disulfide as the direct extracting agent, proved effective in the analysis of residual PCE, with a recovery-efficiency approximate to 75%. Inter-dry-cleaner variability of residual PCE, although marginally statistically significant, was relatively low, showing only a fourfold range compared to a 5-order-of-magnitude range obtained from Kawauchi and Nishiyama(1). Pairwise comparison of residual PCE in nonpressed versus pressed acetate samples revealed a statistically significant reduction (p < 0.008), which amounted to a consistent (among dry-cleaners) pressing-related removal efficiency of 75 +/- 4%. A preliminary assessment of the source term associated with the pressing operation (mass PCE liberated per kg cloth dry-cleaned, S-PCE approximate to 30 mg/kg) indicates a minor contribution to the average ambient air concentrations within dry-cleaning establishments.	Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; Queensland Univ Technol, Sch Publ Hlth, Kelvin Grove, Qld 4059, Australia; Univ Tokyo, Tokyo, Japan	Brand, KP (reprint author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.						SOLET D, 1990, AM IND HYG ASSOC J, V51, P566, DOI 10.1202/0002-8894(1990)051<0566:PEAADC>2.0.CO;2; MCKONE TE, 1989, ENVIRON SCI TECHNOL, V23, P1154, DOI 10.1021/es00067a014; TICHENOR BA, 1990, ATMOS ENVIRON A-GEN, V24, P1219, DOI 10.1016/0960-1686(90)90087-4; BRODMANN GL, 1975, J AM ASS TEXTILE CHE, V7, P20; DRYE E, 1991, HARNESSING SCI ENV R; FINKEL AM, 1994, RISK ANAL, V14, P751, DOI 10.1111/j.1539-6924.1994.tb00285.x; GULYAS H, 1990, ENVIRON RES, V53, P90, DOI 10.1016/S0013-9351(05)80132-X; KAWAUCHI T, 1989, ENVIRON RES, V48, P296, DOI 10.1016/S0013-9351(89)80042-8; MATERNA BL, 1985, AM IND HYG ASSOC J, V46, P268, DOI 10.1202/0002-8894(1985)046<0268:OETPIT>2.3.CO;2; MORGAN G, 1990, UNCERTAINTY GUIDE DE; MOSCHANDREAS DJ, 1995, J AIR WASTE MANAGE, V45, P111; *NAT I OCC SAF HLT, 1991, NIOSH MAN AN METH NM; RAO VR, 1993, REGUL TOXICOL PHARM, V18, P233, DOI 10.1006/rtph.1993.1056; SCHREIBER JS, 1993, RISK ANAL, V13, P335, DOI 10.1111/j.1539-6924.1993.tb01085.x; THOMPSON KM, 1995, THESIS HARVARD SCH P; THOMPSON KM, 1997, GREENING IND RISK MA; THOMPSON KM, 1992, RISK ANAL, V12, P53, DOI 10.1111/j.1539-6924.1992.tb01307.x; US EPA (US Environmental Protection Agency), 1996, FED REG, V61, P17960; WALLACE L, 1990, RISK ANAL, V10, P59, DOI 10.1111/j.1539-6924.1990.tb01020.x	19	1	1	AIR & WASTE MANAGEMENT ASSOC	PITTSBURGH	ONE GATEWAY CENTER, THIRD FL, PITTSBURGH, PA 15222 USA	1047-3289			J AIR WASTE MANAGE	J. Air Waste Manage. Assoc.	FEB	1999	49	2					213	218				6	Engineering, Environmental; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	167PL	WOS:000078642400013		
J	Yoon, JW; Miyayama, M				Yoon, JW; Miyayama, M			Formation and electrical properties of pn and n-p-n structures on SrTiO3 single crystal by CuO diffusion and excimer laser irradiation	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						SrTiO3 single crystal; KrF excimer laser irradiation; pn junction; n-p-n structure; CuO deposition; nonlinear I-V characteristics	SENSING PROPERTIES; LAYER CAPACITORS; THIN-FILMS; FABRICATION; ABLATION; TITANATE	N-type and p-type semiconducting regions were formed on an insulating SrTiO3 single crystal by KrF excimer laser irradiation at non-treated and CuO-diffused surfaces, respectively. The n-type and p-type semiconductivity was confirmed using Hall coefficient measurement. The pn junction showed rectifying characteristics. An n-p-n structure was formed by laser-irradiation on a surface including a thin (1 mu m in width) CuO-diffused layer. It shows nonlinear I-V characteristics with a nonlinear coefficient of 7, as observed in semiconducting SrTiO3 ceramics with acceptor-diffused grain boundaries. This fabrication method was found to be effective for realizing the pn and n-p-n electrical properties at desired positions on insulating oxides.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Miyayama, M (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						YAN MF, 1982, APPL PHYS LETT, V40, P536, DOI 10.1063/1.93134; KOFFYBERG FP, 1982, J APPL PHYS, V53, P1173, DOI 10.1063/1.330567; WASER R, 1991, J AM CERAM SOC, V74, P1934, DOI 10.1111/j.1151-2916.1991.tb07812.x; USHIO Y, 1993, SENSOR ACTUAT B-CHEM, V12, P135, DOI 10.1016/0925-4005(93)80009-Z; YAMAMOTO N, 1980, SURF SCI, V92, P400, DOI 10.1016/0039-6028(80)90212-5; FUJIMOTO M, 1985, J AM CERAM SOC, V68, P169, DOI 10.1111/j.1151-2916.1985.tb15292.x; CHO SG, 1995, P 12 JAP KOR SEM CER, P129; DAVIS GM, 1989, APPL PHYS LETT, V55, P112, DOI 10.1063/1.102393; Frederikse H. P. R., 1964, PHYS REV A, V134, P442; FUJIMOTO M, 1985, J AM CERAM SOC, V68, pC300; Greuter F., 1989, ADV VARISTOR TECHNOL, V3, P31; IGARASHI K, 1989, J AM CERAM SOC, V72, P2367, DOI 10.1111/j.1151-2916.1989.tb06092.x; MAFFEI N, 1992, APPL PHYS LETT, V60, P781, DOI 10.1063/1.106518; MIYAYAMA M, 1987, J CERAM SOC JPN, V95, P1145; MUKAE K, 1994, CERAMIC T, V41, P195; Pike G. E., 1982, Grain Boundaries in Semiconductors. Proceedings of the Materials Research Society Annual Meeting; PLATEN W, 1988, J APPL PHYS, V64, P218, DOI 10.1063/1.341466; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sze S. M, 1969, PHYSICS SEMICONDUCTO, P96; Uozumi G, 1997, J MATER SCI, V32, P2991, DOI 10.1023/A:1018653323658; WAKU S, 1971, REV ELEC COMMUN LAB, V19, P665; WEIMER WA, 1988, APPL PHYS LETT, V52, P2171, DOI 10.1063/1.99759; Wernicke R., 1981, ADV CERAM, P272; YOON JW, IN PRESS J J APPL PH; YOON JW, 1999, ELECTROCERAMICS JAPA, V1, P213	25	2	2	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	1999	107	2					103	108		10.2109/jcersj.107.103		6	Materials Science, Ceramics	Materials Science	174UL	WOS:000079054100002		
J	Ito, K; Yagi, Y; Hirano, S; Miyayama, M; Kudo, T; Kishimoto, A; Ujihira, Y				Ito, K; Yagi, Y; Hirano, S; Miyayama, M; Kudo, T; Kishimoto, A; Ujihira, Y			Estimation of pore size of porous materials by positron annihilation lifetime measurement	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			English	Article						porous material; meso pore; micro pore; positronium; positron annihilation; pore size; nondestructive analysis	MESOPOROUS MOLECULAR-SIEVES; SCATTERING; POLYMERS; SOLIDS	Pore size of several porous materials such as zeolites (MCM-41 and MCM-48) and highly fined grain aggregates of zirconia was estimated by means of positron annihilation lifetime measurement. Observed lifetimes of ortho-positronium (over similar to 20 ns, tau(4) and tau(5)) correspond to the meso-pore sizes assessed by conventional porosimetries due to a nitrogen physisorption and a mercury porosimetry. The long-lived lifetime components included an unassigned lifetime component (tau(5)), which was not detected by the other porosimetry. The observed ortho-positronium lifetimes are correlated to the mean size of pores. A relation between relative intensities of the long-lived ortho-positronium components (I-4 and I-5) and specific surface areas is discussed and a variation of a numerical concentration of pores is correlated to the change of the particle sizes of the zirconia aggregates.	Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Ito, K (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						SIEGEL RW, 1980, ANNU REV MATER SCI, V10, P393, DOI 10.1146/annurev.ms.10.080180.002141; Koyano KA, 1997, J PHYS CHEM B, V101, P9436, DOI 10.1021/jp9724941; BRANDT W, 1968, PHYS REV LETT, V21, P193, DOI 10.1103/PhysRevLett.21.193; VENKATESWARAN K, 1984, J PHYS CHEM-US, V88, P2465, DOI 10.1021/j150656a010; [Anonymous], 1972, PURE APPL CHEM, V31, P578; DOLLIMORE D, 1964, J APPL CHEM, V14, P109; BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; ENDO M, 1997, 10 FALL M CER SOC JA, P352; FURUSAKI N, 1993, KOBUNSHI RONBUNSHU, V50, P969; GALLEGOS DP, 1987, J COLLOID INTERF SCI, V119, P127, DOI 10.1016/0021-9797(87)90251-7; GOLDANSK.VI, 1970, DOKL AKAD NAUK SSSR+, V191, P855; Goworek T, 1997, MATER SCI FORUM, V255-2, P296; HALL PG, 1985, J COLLOID INTERF SCI, V104, P151, DOI 10.1016/0021-9797(85)90020-7; ITO K, 1998, RADIOISOTOPES, V47, P206; ITO Y, 1975, CANCER, V2, P323; JEAN YC, 1988, POSITIRON POSITRONIU; KIRKEGAARD P, 1989, RISOM2740 RIS NAT LA; KOBAYASHI Y, 1992, B CHEM SOC JPN, V65, P160, DOI 10.1246/bcsj.65.160; MOGENSEN OE, 1995, POSITRON ANNIHILATIO, P54; NAKANISHI H, 1982, J PHYS CHEM-US, V86, P4446, DOI 10.1021/j100219a035; Nakanishi H., 1988, POSITRON ANNIHILATIO, P292; PLANK CJ, 1947, J COLL SCI IMP U TOK, V2, P399, DOI 10.1016/0095-8522(47)90043-3; ROOSEN A, 1984, ADV CERAM, V12, P714; SETOYAMA N, 1993, LANGMUIR, V9, P2612, DOI 10.1021/la00034a021; Shantarovich V.P., 1994, KHIM VYS ENERG, V28, P53; Tatsumi T, 1997, CHEM LETT, P469, DOI 10.1246/cl.1997.469; UJIHIRA Y, 1978, APPL PHYS, V16, P71, DOI 10.1007/BF00931424; UJIHIRA Y, 1993, RADIOISOTOPES, V42, P43; Wang SJ, 1996, J RADIOAN NUCL CH AR, V210, P407, DOI 10.1007/BF02056380; Wu CN, 1996, MICROPOROUS MATER, V7, P173, DOI 10.1016/0927-6513(96)00049-1; Yagi Y, 1997, MATER SCI FORUM, V255-2, P433	31	24	24	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	1999	107	2					123	127		10.2109/jcersj.107.123		5	Materials Science, Ceramics	Materials Science	174UL	WOS:000079054100006		
J	Tohyama, N; Kim, BN; Enoki, M; Kishi, T				Tohyama, N; Kim, BN; Enoki, M; Kishi, T			Oxidation mechanisms of Si-Ti-C-O fiber-bonded ceramics	JOURNAL OF THE CERAMIC SOCIETY OF JAPAN			Japanese	Article						Si-Ti-C-O fiber-bonded ceramics; oxidation; thermogravimetry; free carbon; cristobalite coat	MATRIX COMPOSITES; HIGH-TEMPERATURE; ELEVATED-TEMPERATURES; SILICON-CARBIDE; BEHAVIOR; INTERFACE; NITRIDE	The oxidation mechanisms of Si-Ti-C-O fiber-bonded ceramics had been investigated through thermogravimetric analysis, electron microscopy and X-ray diffraction. The influence of temperatures ranging from 773 to 1773 K in air is discussed. The materials showed mass loss due to oxidation of the carbon interface and free carbon in the fibers at the beginning of the oxidation tests. Then, mass gain due to the formation of silica on the surface of the fibers was observed. When heat-treated below 1023 K, most of the free carbon was oxidized and flexural strength decreased to almost zero. The free carbon contained in the materials was about 7.7 mass% and oxidized along the fiber direction. On the other hand, upon heat treatment above 1073 K, the oxidation of carbon was strongly inhibited due to a cristobalite coat formed on the surface of the specimen which maintained its initial strength even after oxidized for 100h. After the formation of the cristobalite coating, the materials showed an excellent oxidation resistance even if oxidized at 973 K.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Tohyama, N (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						Hsueh CH, 1996, ACTA MATER, V44, P2211, DOI 10.1016/1359-6454(95)00369-X; FILIPUZZI L, 1994, J AM CERAM SOC, V77, P467, DOI 10.1111/j.1151-2916.1994.tb07016.x; VAUGHN WL, 1990, J AM CERAM SOC, V73, P1540, DOI 10.1111/j.1151-2916.1990.tb09793.x; CAO HO, 1990, J AM CERAM SOC, V73, P2091, DOI 10.1111/j.1151-2916.1990.tb05273.x; CURTIN WA, 1991, J AM CERAM SOC, V74, P2837, DOI 10.1111/j.1151-2916.1991.tb06852.x; CHAIM R, 1987, ADV CERAM MATER, V2, P154; Cutard T, 1996, J AM CERAM SOC, V79, P957, DOI 10.1111/j.1151-2916.1996.tb08531.x; Evans AG, 1996, J AM CERAM SOC, V79, P2345, DOI 10.1111/j.1151-2916.1996.tb08982.x; KAKIMOTO K, 1995, J CERAM SOC JPN, V103, P557, DOI 10.2109/jcersj.103.557; MATSUNAGA K, 1995, J CERAM SOC JPN, V103, P288, DOI 10.2109/jcersj.103.288; Singh D, 1996, J AM CERAM SOC, V79, P591; Sun EY, 1996, J AM CERAM SOC, V79, P1521, DOI 10.1111/j.1151-2916.1996.tb08760.x; THOULESS MD, 1989, J AM CERAM SOC, V72, P525, DOI 10.1111/j.1151-2916.1989.tb06171.x; XU HHK, 1995, J AM CERAM SOC, V78, P388, DOI 10.1111/j.1151-2916.1995.tb08812.x	14	3	3	CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI	TOKYO	22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN	1882-0743	1348-6535		J CERAM SOC JPN	J. Ceram. Soc. Jpn.	FEB	1999	107	2					147	152		10.2109/jcersj.107.147		6	Materials Science, Ceramics	Materials Science	174UL	WOS:000079054100010		
J	Takeuchi, T; Miyoshi, H; Egashira, Y; Komiyama, H				Takeuchi, T; Miyoshi, H; Egashira, Y; Komiyama, H			Chemical vapor deposition of silicon carbide titanium carbide composite films from dichlorodimethylsilane, titanium tetrachloride, and methane	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							C-CL-H; FUNCTIONALLY GRADIENT MATERIALS; TI-SI-C; MECHANICAL-PROPERTIES; SIC/TIC COMPOSITES; GAS-MIXTURES; CVD; SYSTEM; FABRICATION; TI3SIC2	Composite films of silicon carbide (SiC) and titanium carbide (TiC) were prepared from mixtures of dichlorodimethylsilane (DDS), titanium tetrachloride (TiCl4), and methane (CH4) at 1273 K by atmospheric-pressure chemical vapor deposition (APCVD), The addition of DDS significantly increased TiC deposition at a temperature where insignificant deposition of TiC Occurred from TiCl4 and CH4 in the absence of DDS. The composition of the composite films strongly depended on the feed ratio of DDS to TiCl4. SiC/TiC composites formed for DDS/TiCl4 > 1.5, and pure TiC formed for DDS/TiCl4 < 1. A reaction model was developed where gas-phase reactions and decomposition of DDS form highly reactive CH3-SiCl2 and CH3 that react with TiCl4 to form TiCl3 and/or TiCl2. The combination of DDS, TiCl4, and CH4 is a promising precursor system for SiC/TiC chemical vapor deposition to form either composites or pure TiC. (C) 1999 The Electrochemical Society, S0013-4651(98)03-100-0. All rights reserved.	Univ Tokyo, Fac Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 113, Japan; Osaka Univ, Grad Sch Engn Sci, Dept Sci & Chem Engn, Div Chem Engn, Toyonaka, Osaka 560, Japan	Takeuchi, T (reprint author), Yokohama Natl Univ, Dept Mat Sci & Chem Engn, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan.						ADACHI M, 1992, JPN J APPL PHYS 2, V31, pL1439; ALLENDORF MD, 1991, J ELECTROCHEM SOC, V138, P841, DOI 10.1149/1.2085688; SCHLICHTING J, 1980, POWDER METALL INT, V12, P141; BECHER PF, 1991, NIPPON SERAM KYO GAK, V99, P993; COLTRIN ME, 1989, J ELECTROCHEM SOC, V136, P819, DOI 10.1149/1.2096750; FISCHMAN GS, 1985, J AM CERAM SOC, V68, P185, DOI 10.1111/j.1151-2916.1985.tb15295.x; GOTO T, 1987, ELECTROCHEMICAL S PV, V878, P1070; Hitchman M. L., 1993, CHEM VAPOR DEPOSITIO; HONG LS, 1992, J ELECTROCHEM SOC, V139, P3652, DOI 10.1149/1.2069138; JENSEN KF, 1983, J ELECTROCHEM SOC, V130, P1950, DOI 10.1149/1.2120129; Kawai C., 1992, Journal of the Ceramic Society of Japan, V100; KAWAI C, 1994, J MATER SCI LETT, V13, P860, DOI 10.1007/BF00273230; KAWAI C, 1991, NIPPON SERAM KYO GAK, V99, P1088; Kim H. J., 1992, Journal of Chemical Vapor Deposition, V1; Kim Y, 1996, MATER LETT, V26, P249, DOI 10.1016/0167-577X(95)00228-6; LIN BW, 1992, NIPPON SERAM KYO GAK, V100, P509; Lin TT, 1996, J CERAM SOC JPN, V104, P174, DOI 10.2109/jcersj.104.174; Liu YJ, 1996, KAGAKU KOGAKU RONBUN, V22, P1429; MALINE M, 1992, J MATER SCI, V27, P6187, DOI 10.1007/BF01133769; ALLENDORF MD, 1993, J PHYS CHEM-US, V97, P720, DOI 10.1021/j100105a031; Nakano J, 1997, J AM CERAM SOC, V80, P2897, DOI 10.1111/j.1151-2916.1997.tb03209.x; OSTERHELD TH, 1994, J PHYS CHEM-US, V98, P6995, DOI 10.1021/j100079a018; RACAULT C, 1994, J MATER SCI, V29, P3941, DOI 10.1007/BF00355952; RACAULT C, 1994, J MATER SCI, V29, P5023, DOI 10.1007/BF01151093; SASAKI M, 1991, NIPPON SERAM KYO GAK, V99, P1002; SASAKI M, 1994, J EUR CERAM SOC, V14, P257, DOI 10.1016/0955-2219(94)90094-9; Stinton D.P., 1985, CERAM ENG SCI P, V6, P707; Stinton D.P., 1984, CERAM ENG SCI P, V5, P668; Tago T, 1998, J ELECTROCHEM SOC, V145, P2516, DOI 10.1149/1.1838671; Takeuchi T, 1998, J ELECTROCHEM SOC, V145, P1277, DOI 10.1149/1.1838451; TOUANEN M, 1993, J AM CERAM SOC, V76, P1473, DOI 10.1111/j.1151-2916.1993.tb03928.x; TOUANEN M, 1989, J MATER SCI LETT, V8, P98, DOI 10.1007/BF00720264; TOUANEN M, 1991, MAT SCI ENG A-STRUCT, V147, P239, DOI 10.1016/0921-5093(91)90851-D; WEI GC, 1984, J AM CERAM SOC, V67, P571, DOI 10.1111/j.1151-2916.1984.tb19174.x; 1985, J PHYS CHEM DATA S1, V14	35	6	6	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651			J ELECTROCHEM SOC	J. Electrochem. Soc.	FEB	1999	146	2					564	569		10.1149/1.1391644		6	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	171LZ	WOS:000078866400023		
J	Rao, TN; Tryk, DA; Hashimoto, K; Fujishima, A				Rao, TN; Tryk, DA; Hashimoto, K; Fujishima, A			Band-edge movements of semiconducting diamond in aqueous electrolyte induced by anodic surface treatment	JOURNAL OF THE ELECTROCHEMICAL SOCIETY			English	Article							THIN-FILMS; HYDROGEN; INTERFACE; NITRATE; NITRIDE; OXYGEN	Photoelectrochemical characterization of semiconducting, diamond was carried out in a weakly UV-absorbing aqueous electrolyte using suprabandgap illumination in order to examine the influence of electrochemical oxidative surface treatment on the energetic positions of bandedges. Anodic treatment of diamond photoelectrodes resulted in a positive shift in both the photocurrent onset potential and the flatband potential obtained from Mott-Schottky plots, indicating the displacement of the bandedges. A corresponding increase in the photovoltage was also observed.. The pH dependence of the flatband potential of anodically treated diamond indicates an acid-base equilibrium at the interface, suggesting the formation of oxygen-containing groups. The presence of the latter was confirmed using X-ray photoelectron spectroscopy. These results suggest that the changes in the potential drop in the Helmholtz layer are due to oxygen functional groups, and the loss of surface and subsurface hydrogen are mainly responsible for the observed shifts in the flatband potentials. (C) 1999 The Electrochemical Society. S0013-4651(98)06-102-3. All rights reserved.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Rao, TN (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.		Tryk, Donald/D-5931-2012; Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012	Tryk, Donald/0000-0003-4660-9674; Hashimoto, Kazuhito/0000-0002-8384-8749			Kawarada H, 1996, SURF SCI REP, V26, P205, DOI 10.1016/S0167-5729(97)80002-7; Martin HB, 1996, J ELECTROCHEM SOC, V143, pL133, DOI 10.1149/1.1836901; THOMAS RE, 1992, J VAC SCI TECHNOL A, V10, P2451, DOI 10.1116/1.577983; SWAIN GM, 1994, ADV MATER, V6, P388, DOI 10.1002/adma.19940060511; VANDERWEIDE J, 1994, PHYS REV B, V49, P13629, DOI 10.1103/PhysRevB.49.13629; Baumann PK, 1998, J APPL PHYS, V83, P2072, DOI 10.1063/1.366940; Nemanich RJ, 1996, DIAM RELAT MATER, V5, P790, DOI 10.1016/0925-9635(95)00485-8; KOCHA SS, 1995, J ELECTROCHEM SOC, V142, P2625, DOI 10.1149/1.2050065; Miller JB, 1996, LANGMUIR, V12, P5809, DOI 10.1021/la9407166; Popa E, 1999, ELECTROCHEM SOLID ST, V2, P49, DOI 10.1149/1.1390730; TENNE R, 1993, J ELECTROANAL CHEM, V347, P409, DOI 10.1016/0022-0728(93)80105-Q; BOOMMA L, 1997, J ELECTROCHEM SOC, V144, pL142; Bouamrane P, 1996, J ELECTROANAL CHEM, V405, P95; FRESE KW, 1979, J ELECTROCHEM SOC, V126, P1235, DOI 10.1149/1.2129248; GROT SA, 1990, IEEE ELECTR DEVICE L, V11, P100, DOI 10.1109/55.46942; Hayashi K, 1997, J APPL PHYS, V81, P744, DOI 10.1063/1.364299; Jolley S, 1997, ANAL CHEM, V69, P4099, DOI 10.1021/ac961269x; Kocha SS, 1995, J ELECTROCHEM SOC, V142, pL238, DOI 10.1149/1.2048511; Kocha SS, 1996, ELECTROCHIM ACTA, V41, P1295, DOI 10.1016/0013-4686(95)00450-5; Modestov AD, 1997, RUSS J ELECTROCHEM+, V33, P55; MORRISON SR, 1980, ELECTROCHEMISTRY SEM, P166; PATEL K, 1992, J PHOTOCH PHOTOBIO A, V65, P419, DOI 10.1016/1010-6030(92)80023-O; RAO TR, UNPUB; SAKHAROVA AY, 1995, J ELECTROCHEM SOC, V142, P2704, DOI 10.1149/1.2050078; SHIRAFUJI J, 1995, DIAM RELAT MATER, V4, P984, DOI 10.1016/0925-9635(94)00267-3; TRYK DA, UNPUB; TURNER JA, 1983, J ELECTROANAL CHEM, V150, P611, DOI 10.1016/S0022-0728(83)80240-X; Wagner C. D., 1978, HDB XRAY PHOTOELECTR; Xu JZ, 1998, ANAL CHEM, V70, P1502, DOI 10.1021/ac970959d	29	69	70	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	0013-4651			J ELECTROCHEM SOC	J. Electrochem. Soc.	FEB	1999	146	2					680	684		10.1149/1.1391662		5	Electrochemistry; Materials Science, Coatings & Films	Electrochemistry; Materials Science	171LZ	WOS:000078866400041		
J	Itsubo, N; Yamamoto, R				Itsubo, N; Yamamoto, R			Application of life cycle assessment to manufacturing of nonferrous metals	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						life cycle assessment; inventory analysis; impact assessment; valuation; abiotic resource depletion; global warming; acidification; eutrophication; human toxicological impacts; nonferrous metals		Life cycle assessment (LCA) is a broad topic that is currently being discussed. However, little is known about the assessment method of environmental impacts expressing a single index, especially in Japan. Non ferrous metals are one of the basic materials for industrial products. The establishment of the assessment for these materials is important to improve the quality of LCA for products. We have proposed a method of assessment for total impact in Japan, and a case study of LCA is performed concerning the nonferrous metals in this paper. The stages considered in this LCA study are: goal and scope of the inventory analysis and impact assessment. The inventory data include the consumption of raw materials and the emissions through the mining, transport and manufacturing. Resource depletion, global warming, acidification, eutrophication and air pollution have been considered as impact categories. The main results of this study are summarized as follows, (1) The impacts of eutrophication, air pollution and resource depletion are serious for the production of aluminum. (2) The stages of the consumption of non oil and that of the production of non oil are serious for the production of zinc, because the large quantity of non oil such as cokes are consumed. (3) We have showed that the interpretation will differ if the criteria of materials for assessment are changed from weight (per kg) to tensile strength (per MN).	Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan							BUBAL, 1990, OEKOBILANZ PAKCSTOFF; GOEDKOOP MJ, 1995, ECO INDICATOR 95, P80; Heijungs R., 1992, ENV LIFE CYCLE ASSES; 1995, OECD ENV DATA COMPEN, P43	4	2	3	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	FEB	1999	63	2					208	214				7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	184LM	WOS:000079613700010		
J	Ninomiya, K; Kobayashi, C				Ninomiya, K; Kobayashi, C			Precipitation and moisture balance of the Asian summer monsoon in 1991 Part II: Moisture transport and moisture balance	JOURNAL OF THE METEOROLOGICAL SOCIETY OF JAPAN			English	Article							WATER-VAPOR TRANSPORT; TIBETAN PLATEAU; INDIAN-OCEAN; BUDGETS; HEAT	Features of the moisture transport and the moisture balance within the Asian summer monsoon region in 1991 are studied utilizing the 24-hour prediction data by a global weather prediction model in relation to changes of precipitation and the major circulation systems (CSs) defined in Part I of the present paper. The change during May, June and July is characterized by a shift of the intense rainfall areas, with the strong moisture sink from the equatorial zone over the Indian Ocean and Indonesia, to the subtropical area of the Indian subcontinent and East Asia. The southwesterly moisture transport in 30-80 degrees E is mainly due to CS-3 (the clockwise circulation over the Indian Ocean), whereas the southwesterly moisture transport in 80-110 degrees E and 110-140 degrees E is mainly due to CS-4 (clockwise circulation around Indonesia) and CS-5 (circulation around the Pacific subtropical anticyclone), respectively. The confluence between the adjacent CSs yields strong southerly moisture transport into the monsoon rainfall areas and large moisture-flux convergence. It is an important fact that the seasonal variation of the moisture flux crossing the boundary of a large domain, which is bounded by 10 degrees S, 40 degrees N, 35 degrees E and 140 degrees E, and the variation of cross equatorial moisture transport from the southern hemisphere, are significantly smaller than the variations of the moisture transport within the domain. The moisture balance calculation also indicates that the essential feature of the summer monsoon is the formation of a pair of moisture source region, and the adjacent moisture sink region, within the large domain. The moisture source regions form under the subsidence and convective stable stratification. The moisture sink regions appear under the ascent motion and convective unstable stratification. Several parameters such as "moisture influx ratio" and "rainfall production ratio" are defined to discern the characteristics of the moisture balance. The temporal and spatial variations of these parameters depict well the features of moisture balance within the Asia summer monsoon region.	Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, Tokyo 1538904, Japan; Japan Meteorol Agcy, Climate Div, Tokyo 1008122, Japan	Ninomiya, K (reprint author), Univ Tokyo, Ctr Climate Syst Res, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	nmiya@ccsr.u-tokyo.ac.jp					AKIYAMA T, 1975, J METEOR SOC JAPAN, V53, P304; AKIYAMA T, 1973, PAP METEOROL GEOPHYS, V24, P157; NINOMIYA K, 1992, J METEOROL SOC JPN, V70, P467; NINOMIYA K, 1984, J METEOROL SOC JPN, V62, P880; MURAKAMI T, 1984, J METEOROL SOC JPN, V62, P469; YANAI MH, 1992, J METEOROL SOC JPN, V70, P319; CADET DL, 1987, MON WEATHER REV, V115, P653, DOI 10.1175/1520-0493(1987)115<0653:WVTOTI>2.0.CO;2; CADET DL, 1987, MON WEATHER REV, V115, P2358, DOI 10.1175/1520-0493(1987)115<2358:WVTOTI>2.0.CO;2; Ding Y.-H., 1991, MONSOON CHINA; HE HY, 1987, MON WEATHER REV, V115, P1966, DOI 10.1175/1520-0493(1987)115<1966:OOTASM>2.0.CO;2; LUO H, 1984, MON WEATHER REV, V112, P966, DOI 10.1175/1520-0493(1984)112<0966:TLSCAH>2.0.CO;2; Ninomiya K, 1987, MONSOON METEOROLOGY, P93; Ninomiya K, 1998, J METEOROL SOC JPN, V76, P855; NINOMIYA K, 1976, TENKI, V23, P45; *NUM PRED DIV JA M, 1993, OUTL OP NUM WEATH PR; PEARCE RP, 1992, J METEOROL SOC JPN, V70, P303; Tao S., 1987, MONSOON METEOROLOGY, P50	17	35	46	METEOROLOGICAL SOC JAPAN	TOKYO	C/O JAPAN METEOROLOGICAL AGENCY 1-3-4 OTE-MACHI, CHIYODA-KU, TOKYO, 100-0004, JAPAN	0026-1165	2186-9057		J METEOROL SOC JPN	J. Meteorol. Soc. Jpn.	FEB	1999	77	1					77	99				23	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	184PC	WOS:000079619900006		
J	Iwata, A; Koike, F; Arasaki, K; Tamaki, M				Iwata, A; Koike, F; Arasaki, K; Tamaki, M			Blood brain barrier destruction in hyperglycemic chorea in a patient with poorly controlled diabetes	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						hemichorea; hyperglycemia; diabetes mellitus; blood-brain barrier	BASAL GANGLIA; NONKETOTIC HYPERGLYCEMIA; HEMICHOREA; HEMORRHAGE; HEMIBALLISMUS; CHOREOATHETOSIS; MELLITUS	A case of hemichorea in a patient with poorly controlled diabetes is reported. T1-weighted magnetic resonance imaging (MRT) showed an unusual homogeneous high-intensity area in the corpus striatum. Of interest in the case was the fact that the globus pallidus, which was enhanced with gadolinium at the onset of hemichorea, showed homogeneous high-intensity on a subsequent T1-weighted image. This indicated that blood brain barrier destruction preceded the signal intensity change in the basal ganglia. As far as the authors could determine, this is the first reported case showing such enhancement during the course of diabetic hemichorea. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Med, Div Neurosci, Dept Neurol,Bunkyo Ku, Tokyo, Japan; Tokyo Womens Med Univ, Dept Neurol, Shinjuku Ku, Tokyo, Japan; Kanto Teishin Hosp, Dept Neurol, Shinagawa Ku, Tokyo, Japan	Iwata, A (reprint author), Univ Tokyo, Grad Sch Med, Div Neurosci, Dept Neurol,Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.		Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314			ALTAFULLAH I, 1990, STROKE, V21, P1093; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BRADLEY WG, 1993, RADIOLOGY, V189, P15; BRODERICK JP, 1995, STROKE, V26, P484; Chang MH, 1997, J NEUROL NEUROSUR PS, V63, P300, DOI 10.1136/jnnp.63.3.300; GOLDBLAT.D, 1974, ARCH NEUROL-CHICAGO, V31, P51; HO VB, 1993, AM J NEURORADIOL, V14, P163; JONES HR, 1985, STROKE, V16, P130; KASE CS, 1981, NEUROLOGY, V31, P452; Lai PH, 1996, AM J NEURORADIOL, V17, P1057; LIN JJ, 1994, J NEUROL NEUROSUR PS, V57, P748, DOI 10.1136/jnnp.57.6.748; NABATAME H, 1994, INTERNAL MED, V33, P472, DOI 10.2169/internalmedicine.33.472; NAGAI C, 1995, AM J NEURORADIOL, V16, P1243; NAKAGAWA T, 1994, CLIN NEUROL, V34, P52; RECTOR WG, 1982, ARCH INTERN MED, V142, P154, DOI 10.1001/archinte.142.1.154; SANFIELD JA, 1986, DIABETES CARE, V9, P100; SHWARTZ GA, 1960, ARCH NEUROL-CHICAGO, V2, P420; YAHIKOZAWA H, 1994, J NEUROL SCI, V124, P208, DOI 10.1016/0022-510X(94)90328-X	18	27	30	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X			J NEUROL SCI	J. Neurol. Sci.	FEB 1	1999	163	1					90	93		10.1016/S0022-510X(98)00325-6		4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	182RV	WOS:000079512700019		
J	Itoh, K				Itoh, K			Exact ground states in spin systems with orbital degeneracy	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						orbital degeneracy; spin systems; valence bond state; orbital order	LONG-RANGE ORDER; INSULATING PHASE; XXZ MODEL; ANTIFERROMAGNETS; V2O3; FERROMAGNETISM; EXISTENCE	We present exact ground states ill spin models with orbital degeneracy in one and higher dimensions. A method to obtain the exact ground states of the models when the Hamiltonians are composed of the products of two commutable operators is proposed. For the case of the spin-1/2 model with two-fold degeneracy some exact ground states are given, such as the Valence-Bond (VB), the magnetically ordered, and the orbitally ordered states under particular parameter regimes. We also find models with the higher spin and degeneracy which have the new type VB ground states in the spin and the orbital sectors.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Itoh, K (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan.	kzitoh@taka2.jssp.u-tokyo.ac.jp					AFFLECK I, 1987, PHYS REV LETT, V59, P799, DOI 10.1103/PhysRevLett.59.799; AFFLECK I, 1988, COMMUN MATH PHYS, V115, P477, DOI 10.1007/BF01218021; MAJUMDAR CK, 1969, J MATH PHYS, V10, P1399, DOI 10.1063/1.1664979; CASTELLANI C, 1978, PHYS REV B, V18, P4967, DOI 10.1103/PhysRevB.18.4967; YANG CN, 1966, PHYS REV, V150, P321, DOI 10.1103/PhysRev.150.321; CASTELLANI C, 1978, PHYS REV B, V18, P4945, DOI 10.1103/PhysRevB.18.4945; NISHIMORI H, 1989, J STAT PHYS, V55, P259, DOI 10.1007/BF01042599; CASTELLANI C, 1978, PHYS REV B, V18, P5001, DOI 10.1103/PhysRevB.18.5001; KUGEL KI, 1982, USP FIZ NAUK+, V136, P621, DOI 10.3367/UFNr.0136.198204c.0621; KUGEL KI, 1973, ZH EKSP TEOR FIZ+, V64, P1429; Feiner LF, 1997, PHYS REV LETT, V78, P2799, DOI 10.1103/PhysRevLett.78.2799; AROVAS DP, 1995, PHYS REV B, V52, P10114, DOI 10.1103/PhysRevB.52.10114; Blinc R, 1996, PHYS REV LETT, V76, P523, DOI 10.1103/PhysRevLett.76.523; FRISCHMUTH B, CONDMAT9807179; GUIDONI L, CONDMAT9809013; HULTHEN L, 1938, ARK MATH ASTRON FY A, V26; INAGAKI S, 1975, J PHYS SOC JPN, V39, P596, DOI 10.1143/JPSJ.39.596; KENNEDY T, 1988, J STAT PHYS, V53, P1019, DOI 10.1007/BF01023854; Kolezhuk AK, 1998, PHYS REV LETT, V80, P2709, DOI 10.1103/PhysRevLett.80.2709; KUBO K, 1988, PHYS REV LETT, V61, P2585, DOI 10.1103/PhysRevLett.61.2585; LI YQ, CONDMAT9804157; MAJUMDER CK, 1970, J PHYS C SOLID STATE, V30, P911; OHKAWA FJ, 1983, J PHYS SOC JPN, V52, P3897, DOI 10.1143/JPSJ.52.3897; OHKAWA FJ, 1985, J PHYS SOC JPN, V54, P3909, DOI 10.1143/JPSJ.54.3909; PATI SK, CONDMAT9807270; Santoro G, 1997, PHYS REV B, V55, P16168, DOI 10.1103/PhysRevB.55.16168; SHINA R, 1997, J PHYS SOC JPN, V66, P1741; Ueda K, 1996, PHYS REV LETT, V76, P1932, DOI 10.1103/PhysRevLett.76.1932; YAMASHITA Y, CONDMAT9804128; Yamaura K, 1996, J SOLID STATE CHEM, V127, P109, DOI 10.1006/jssc.1996.0363	30	11	11	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					322	325		10.1143/JPSJ.68.322		4	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400002		
J	Ishihara, M; Ogata, M				Ishihara, M; Ogata, M			Spectral functions of one-dimensional electron systems with Ising-like spin gap	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Letter						1D t-J(xxz) model; spin-charge separation; photoemission; spectral function; spin gap	HUBBARD-MODEL; MOMENTUM DISTRIBUTION; U->+INFINITY LIMIT; WAVE-FUNCTION; SEPARATION; INSULATORS	The effect of a spin gap on the photoemission spectral functions is studied in the one-dimensional t-Jxxz model. The find that spinon hands show up in the spectral functions but holon hands are obscured in the spin-gap cases. The reason for this is studied using a simple interpretation of the spectral functions, which is a convolution between the spectral Function of spinless fermions and a spin excitation weight Z(Q). The spin gap suppresses the singularity of Z(Q), and as a result, only the holon bands are obscured. It is also shown that the spinon peaks lie along a cosine band and extend over the region \k\ > k(F). Finally, the momentum-dependent critical exponents of the power-law singularity at the spinon bands are determined.	Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1530041, Japan	Ishihara, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1530041, Japan.						Sorella S, 1996, PHYS REV LETT, V76, P4604, DOI 10.1103/PhysRevLett.76.4604; SOLYOM J, 1979, ADV PHYS, V28, P201, DOI 10.1080/00018737900101375; OGATA M, 1990, PHYS REV B, V41, P2326, DOI 10.1103/PhysRevB.41.2326; Penc K, 1997, PHYS REV B, V55, P15475, DOI 10.1103/PhysRevB.55.15475; SORELLA S, 1992, J PHYS-CONDENS MAT, V4, P3589, DOI 10.1088/0953-8984/4/13/020; Tohyama T, 1996, J PHYS SOC JPN, V65, P1902, DOI 10.1143/JPSJ.65.1902; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Favand J, 1997, PHYS REV B, V55, pR4859, DOI 10.1103/PhysRevB.55.R4859; Fujii T, 1997, J PHYS SOC JPN, V66, P2552, DOI 10.1143/JPSJ.66.2552; Fujisawa H, 1998, SOLID STATE COMMUN, V106, P543, DOI 10.1016/S0038-1098(98)00099-4; JOHNSON JD, 1972, PHYS REV A-GEN PHYS, V6, P1613, DOI 10.1103/PhysRevA.6.1613; MEDEN V, 1992, PHYS REV B, V46, P15753, DOI 10.1103/PhysRevB.46.15753; PAROLA A, 1992, PHYS REV B, V45, P13156, DOI 10.1103/PhysRevB.45.13156; PENC K, 1995, PHYS REV LETT, V75, P894, DOI 10.1103/PhysRevLett.75.894; SHIBA H, 1991, INT J MOD PHYS B, V5, P31, DOI 10.1142/S0217979291000031; Tohyama T, 1998, J PHYS CHEM SOLIDS, V59, P1864, DOI 10.1016/S0022-3697(98)00126-7; Voit J, 1996, J PHYS-CONDENS MAT, V8, pL779, DOI 10.1088/0953-8984/8/50/002; VOIT J, 1993, PHYS REV B, V47, P6740, DOI 10.1103/PhysRevB.47.6740	18	1	1	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					350	353		10.1143/JPSJ.68.350		4	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400009		
J	Hikami, K; Inoue, R				Hikami, K; Inoue, R			The quantum Volterra model and the lattice sine-Gordon system. Construction of the Baxter Q operator and the integrals of motion	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						integrable system; Volterra model; Virasoro algebra; Baxter equation; sine-Gordon theory; vertex operator	W-ALGEBRAS; VIRASORO ALGEBRA; EQUATION	We investigate the integrable structure of the quantum Volterra model, which is a discretization of the Korteweg-de Vries equation. Based on Sklyanin's method we derive the Baxter equation, and then clarify a role of the "fundamental transfer matrix". We show that the fundamental transfer matrix also generates the integrals of motion for a lattice analogue of the sine-Gordon system.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Hikami, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	hikami@phys.s.u-tokyo.ac.jp; inoue@monet.phys.s.u-tokyo.ac.jp					Frenkel E, 1998, COMMUN MATH PHYS, V192, P605, DOI 10.1007/s002200050311; Dickey LA, 1997, ACTA APPL MATH, V47, P243, DOI 10.1023/A:1017903416906; VOLKOV AY, 1992, PHYS LETT A, V167, P345, DOI 10.1016/0375-9601(92)90270-V; FADDEEV L, 1993, PHYS LETT B, V315, P311, DOI 10.1016/0370-2693(93)91618-W; SKLYANIN EK, 1985, LECT NOTES PHYS, V226, P196; FADDEEV LD, 1994, MOD PHYS LETT A, V9, P427, DOI 10.1142/S0217732394000447; IZERGIN AG, 1982, NUCL PHYS B, V205, P401, DOI 10.1016/0550-3213(82)90365-0; GOEL NS, 1971, REV MOD PHYS, V43, P231, DOI 10.1103/RevModPhys.43.231; Antonov A, 1997, PHYS LETT B, V392, P115, DOI 10.1016/S0370-2693(96)01526-2; Antonov A, 1997, J GEOM PHYS, V22, P298, DOI 10.1016/S0393-0440(96)00040-X; Antonov AV, 1997, THEOR MATH PHYS+, V113, P1520, DOI 10.1007/BF02634512; Baxter R. J., 1982, EXACTLY SOLVED MODEL; BELOV AA, 1993, PHYS LETT B, V317, P73; BELOV AA, 1993, PHYS LETT B, V309, P268, DOI 10.1016/0370-2693(93)90932-8; Faddeev L, 1996, P INT SCH PHYS, V127, P117; Faddeev L. D., 1986, LECT NOTE PHYS, V246, P166, DOI 10.1007/3-540-16452-9_10; FADDEEV LD, 1995, INT J MOD PHYS A, V10, P1845, DOI 10.1142/S0217751X95000905; Faddeev L.D., 1987, HAMILTONIAN METHODS; FADDEEV LD, 1998, DISCRETE INTEGRABLE, P301; Feigin B, 1996, COMMUN MATH PHYS, V178, P653, DOI 10.1007/BF02108819; GUTZWILLER MC, 1981, ANN PHYS-NEW YORK, V133, P304, DOI 10.1016/0003-4916(81)90253-0; Hikami K, 1997, J PHYS A-MATH GEN, V30, P6911, DOI 10.1088/0305-4470/30/19/026; Hikami K, 1997, NUCL PHYS B, V505, P749, DOI 10.1016/S0550-3213(97)00578-6; HIKAMI K, 1998, PHYS LETT B, V443, P202; Hikami K, 1998, CHAOS SOLITON FRACT, V9, P853, DOI 10.1016/S0960-0779(98)00054-X; Hikami K, 1998, CHAOS SOLITON FRACT, V9, P1773, DOI 10.1016/S0960-0779(97)00142-2; Hikami K, 1998, PHYS REV LETT, V80, P4374, DOI 10.1103/PhysRevLett.80.4374; HIKAMI K, 1997, J PHYS SOC JPN, V66, P2756; Inoue R, 1998, J PHYS SOC JPN, V67, P87, DOI 10.1143/JPSJ.67.87; KIRILLOV AN, 1995, PROG THEOR PHYS SUPP, P61; Korepin V. E., 1993, QUANTUM INVERSE SCAT; KRYUKOV SV, 1996, THEOR MATH PHYS, V105, P1359; PUGAY YP, 1994, THEOR MATH PHYS+, V100, P900, DOI 10.1007/BF01017329; Shiraishi JI, 1996, LETT MATH PHYS, V38, P33, DOI 10.1007/BF00398297; SKLYANIN EK, 1995, PROG THEOR PHYS SUPP, P35; Volkov AY, 1997, LETT MATH PHYS, V39, P313, DOI 10.1023/A:1007390915590; ZAKHAROV VE, 1974, JETP LETT+, V19, P151	37	0	0	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					380	385		10.1143/JPSJ.68.380		6	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400013		
J	Inoue, R; Hikami, K				Inoue, R; Hikami, K			Lattice W currents with discrete time	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						Bogoyavlensky lattice; lattice W algebra; lattice W currents; difference-difference equation	VOLTERRA SYSTEM; ALGEBRAS; EQUATION	Studied are the integrable difference-difference equations for the lattice W currents. which can be regarded as the full-discretized (reduced) KP equations. We find explicit forms of the time-discretization for the lowest equations of the hierarchy by making use of the relation with the Bogoyavlensky lattice.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Inoue, R (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	inoue@monet.phys.s.u-tokyo.ac.jp; hikami@phys.s.u-tokyo.ac.jp					BOGOYAVLENSKII OI, 1991, RUSS MATH SURV+, V46, P1, DOI 10.1070/RM1991v046n03ABEH002801; VOLKOV AY, 1992, PHYS LETT A, V167, P345, DOI 10.1016/0375-9601(92)90270-V; NIJHOFF F, 1995, ACTA APPL MATH, V39, P133, DOI 10.1007/BF00994631; Tokihiro T, 1996, PHYS REV LETT, V76, P3247, DOI 10.1103/PhysRevLett.76.3247; Antonov A, 1997, J GEOM PHYS, V22, P298, DOI 10.1016/S0393-0440(96)00040-X; BELOV AA, 1993, PHYS LETT B, V309, P268, DOI 10.1016/0370-2693(93)90932-8; BOGOYAVLENSKY OI, 1988, PHYS LETT A, V134, P34, DOI 10.1016/0375-9601(88)90542-7; Bonora L, 1996, PHYS LETT B, V387, P759, DOI 10.1016/0370-2693(96)01106-9; Faddeev L. D., 1986, LECT NOTE PHYS, V246, P166, DOI 10.1007/3-540-16452-9_10; Hikami K, 1997, J PHYS A-MATH GEN, V30, P6911, DOI 10.1088/0305-4470/30/19/026; HIKAMI K, 1998, CHAOS SOLITON FRACT, V9, P1783; Hikami K, 1997, J PHYS SOC JPN, V66, P3756, DOI 10.1143/JPSJ.66.3756; HIKAMI K, 1999, IN PRESS J PHYS SOC, V68; HIROTA R, 1994, DIRECT METHOD SOLITO; HIROTA R, 1994, RIMS KOKYUROKU, V868, P31; Inoue R, 1998, J PHYS SOC JPN, V67, P87, DOI 10.1143/JPSJ.67.87; Inoue R, 1998, J PHYS SOC JPN, V67, P3729, DOI 10.1143/JPSJ.67.3729; ITOH Y, 1987, PROG THEOR PHYS, V78, P507, DOI 10.1143/PTP.78.507; ITOH Y, 1988, PROG THEOR PHYS, V80, P749, DOI 10.1143/PTP.80.749; NARITA K, 1985, J PHYS SOC JPN, V54, P1217, DOI 10.1143/JPSJ.54.1217; NARITA K, 1982, J PHYS SOC JPN, V51, P1682, DOI 10.1143/JPSJ.51.1682; SURIS YB, SOLVINT9709005; ZAMOLODCHIKOV AB, 1985, THEOR MATH PHYS+, V65, P1205, DOI 10.1007/BF01036128	23	1	1	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					386	390		10.1143/JPSJ.68.386		5	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400014		
J	Ujino, H; Wadati, M				Ujino, H; Wadati, M			Rodrigues formula for the nonsymmetric multivariable Hermite polynomial	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						nonsymmetric multivariable Hermite polynomial; Calogero model; Dunkl-Cherednik operator formulation; Rodrigues formula	CALOGERO-SUTHERLAND MODEL; FRACTIONAL STATISTICS; JACK POLYNOMIALS; OPERATOR; SYMMETRY	Applying a method developed by Takamura and Takano for the nonsymmetric Jack polynomial, we present the Rodrigues formula for the nonsymmetric multivariable Hermite polynomial.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Ujino, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	ujino@monet.phys.s.u-tokyo.ac.jp					DUNKL CF, 1989, T AM MATH SOC, V311, P167, DOI 10.2307/2001022; POLYCHRONAKOS AP, 1992, PHYS REV LETT, V69, P703, DOI 10.1103/PhysRevLett.69.703; Knop F, 1997, INVENT MATH, V128, P9, DOI 10.1007/s002220050134; KATO Y, 1995, PHYS REV LETT, V74, P1222, DOI 10.1103/PhysRevLett.74.1222; CHEREDNIK I, 1991, INVENT MATH, V106, P411, DOI 10.1007/BF01243918; STANLEY RP, 1989, ADV MATH, V77, P76, DOI 10.1016/0001-8708(89)90015-7; CALOGERO F, 1971, J MATH PHYS, V12, P419, DOI 10.1063/1.1665604; BAKER TH, IN PRESS DUKE J MATH; HA ZNC, 1994, PHYS REV LETT, V73, P1574, DOI 10.1103/PhysRevLett.73.1574; HA ZNC, 1995, NUCL PHYS B, V435, P604, DOI 10.1016/0550-3213(94)00537-O; JACK H, 1970, PROC R SOC EDIN A-MA, V69, P1; Lapointe L, 1996, COMMUN MATH PHYS, V178, P425, DOI 10.1007/BF02099456; LAPOINTE L, 1995, IMRN, V9, P425; Macdonald I. G., 1995, SYMMETRIC FUNCTIONS; SAHI S, 1996, IMRN, V20, P997; SUTHERLAND B, 1970, PHYS REV A, V4, P1; Takamura A, 1998, J PHYS A-MATH GEN, V31, pL473, DOI 10.1088/0305-4470/31/25/002; Takemura K, 1997, J PHYS A-MATH GEN, V30, P3685, DOI 10.1088/0305-4470/30/10/039; Takemura K, 1997, J PHYS A-MATH GEN, V30, P6185, DOI 10.1088/0305-4470/30/17/025; Uglov D, 1998, COMMUN MATH PHYS, V191, P663, DOI 10.1007/s002200050283; Ujino H, 1996, J PHYS SOC JPN, V65, P653, DOI 10.1143/JPSJ.65.653; UJINO H, 1995, J PHYS SOC JPN, V64, P2703, DOI 10.1143/JPSJ.64.2703; Ujino H, 1996, J PHYS SOC JPN, V65, P2423, DOI 10.1143/JPSJ.65.2423; Ujino H, 1997, J PHYS SOC JPN, V66, P345, DOI 10.1143/JPSJ.66.345; vanDiejen JF, 1997, COMMUN MATH PHYS, V188, P467, DOI 10.1007/s002200050174; YAMAMOTO T, 1995, PHYS LETT A, V208, P293, DOI 10.1016/0375-9601(95)00775-4	26	7	7	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					391	395		10.1143/JPSJ.68.391		5	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400015		
J	Nakanishi, T; Ando, T				Nakanishi, T; Ando, T			Numerical study of impurity scattering in carbon nanotubes	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						graphite; carbon nanotube; fullerene tube; impurity scattering; recursive Green's function technique	MAGNETIC-FIELDS; QUANTUM TRANSPORT; GRAPHENE TUBULES; CONDUCTANCE; JUNCTIONS; MICROTUBULES	The transmission and reflection coefficients of a carbon nanotube with a scatterer are calculated in a tight-binding model. The result obtained in a k . p scheme is shown to be essentially valid, including the complete absence of back scattering for scatterers with range larger than the lattice constant, unless the strength of the potential becomes comparable to the band width. When the potential strength is comparable to the band width, a resonant enhancement of back scattering appears and the result becomes completely different from that in the k . p scheme.	RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Nakanishi, T (reprint author), RIKEN, Inst Phys & Chem Res, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.						Ando T, 1997, J PHYS SOC JPN, V66, P3558, DOI 10.1143/JPSJ.66.3558; TIAN WD, 1994, PHYS REV B, V49, P5097, DOI 10.1103/PhysRevB.49.5097; ANDO T, 1991, PHYS REV B, V44, P8017, DOI 10.1103/PhysRevB.44.8017; Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; Tamura R, 1997, SOLID STATE COMMUN, V101, P601, DOI 10.1016/S0038-1098(96)00761-2; Shon NH, 1998, J PHYS SOC JPN, V67, P2421, DOI 10.1143/JPSJ.67.2421; BETHUNE DS, 1993, NATURE, V363, P605, DOI 10.1038/363605a0; AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; Ando T, 1998, J PHYS SOC JPN, V67, P1704, DOI 10.1143/JPSJ.67.1704; Langer L, 1996, PHYS REV LETT, V76, P479, DOI 10.1103/PhysRevLett.76.479; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Bezryadin A, 1998, PHYS REV LETT, V80, P4036, DOI 10.1103/PhysRevLett.80.4036; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; KATAYAMA F, 1996, THESIS U TOKYO; Matsumura H, 1998, J PHYS SOC JPN, V67, P3542, DOI 10.1143/JPSJ.67.3542; Miyamoto Y, 1996, PHYS REV LETT, V76, P2121, DOI 10.1103/PhysRevLett.76.2121; Nakanishi T, 1997, J PHYS SOC JPN, V66, P2973, DOI 10.1143/JPSJ.66.2973; Saito R, 1996, PHYS REV B, V53, P2044, DOI 10.1103/PhysRevB.53.2044; Seri T, 1997, J PHYS SOC JPN, V66, P169, DOI 10.1143/JPSJ.66.169; SONG SN, 1994, PHYS REV LETT, V72, P697, DOI 10.1103/PhysRevLett.72.697; Tamura R, 1997, PHYS REV B, V55, P4991, DOI 10.1103/PhysRevB.55.4991	24	59	59	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					561	566		10.1143/JPSJ.68.561		6	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400035		
J	Maeda, A; Yasuda, H; Hanaguri, T				Maeda, A; Yasuda, H; Hanaguri, T			Field dependence of penetration depth in an electron-doped cuprate superconductor Nd2-xCexCuO4 with x = 0.16	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						non-linear Meissner effect; electron-doped superconductor; symmetry of the pair wave function; penetration depth	TEMPERATURE-DEPENDENCE	We investigated the magnetic-field dependence of penetration depth in the Meissner state in an electron-doped cuprate superconductor Nd2-xCexCuO4 with x = 016, to clarify the symmetry of the order parameter of the superconducting state of these materials. We found that the results are consistent with a gap with lines of nodes. Thus, it is speculated that the d(x2-y2) symmetry is common to all the cuprate superconductors, both for hole-doped and electron-doped materials.	Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Maeda, A (reprint author), Univ Tokyo, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.		Hanaguri, Tetsuo/I-6710-2012	Hanaguri, Tetsuo/0000-0003-2896-0081			ANDREONE A, 1994, PHYS REV B, V49, P6392, DOI 10.1103/PhysRevB.49.6392; YIP SK, 1992, PHYS REV LETT, V69, P2264, DOI 10.1103/PhysRevLett.69.2264; WU DH, 1993, PHYS REV LETT, V70, P85, DOI 10.1103/PhysRevLett.70.85; HUANG Q, 1990, NATURE, V347, P369, DOI 10.1038/347369a0; Betouras JJ, 1998, PHYS REV B, V57, P11752, DOI 10.1103/PhysRevB.57.11752; BIDINOSTI CP, CONDMAT9808231; CARRINGTON A, UNPUB; Cooper JR, 1996, PHYS REV B, V54, pR3753; Harlingen D J V, 1995, REV MOD PHYS, V67, P515; HIDAKA Y, 1989, NATURE, V338, P635, DOI 10.1038/338635a0; KASHIWAYA S, 1998, PHYS REV B, V57, P7997; Li MR, 1998, PHYS REV LETT, V81, P5640, DOI 10.1103/PhysRevLett.81.5640; Maeda A, 1996, J PHYS SOC JPN, V65, P3638, DOI 10.1143/JPSJ.65.3638; Maeda A, 1998, SUPERCOND REV, V3, P1; MAEDA A, 1995, PHYS REV LETT, V74, P1202, DOI 10.1103/PhysRevLett.74.1202; MASUOKA S, 1998, M ABSTR PHYS SOC J 3, V53, P633; STADLOBER B, 1995, PHYS REV LETT, V74, P4911, DOI 10.1103/PhysRevLett.74.4911; STOJKOVIC BP, 1995, PHYS REV B, V51, P6049, DOI 10.1103/PhysRevB.51.6049; XU D, 1995, PHYS REV B, V51, P16233, DOI 10.1103/PhysRevB.51.16233; YASUDA H, 1997, M ABSTR PHYS SOC J 3, V52, P9577; Yasuda H., UNPUB	21	9	9	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					594	598		10.1143/JPSJ.68.594		5	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400039		
J	Katoh, K; Takabatake, T; Oguro, I; Ochiai, A; Uesawa, A; Suzuki, T				Katoh, K; Takabatake, T; Oguro, I; Ochiai, A; Uesawa, A; Suzuki, T			Anisotropic behavior of magnetic and transport properties in CePdSb and CePtSb	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						electrical resistivity; Hall coefficient; magnetic susceptibility; magnetization; specific heat; CePdSb; CePtSb	TEMPERATURE; CESB	Measurements of resistivity rho, Hall coefficient R-H, magnetic susceptibility chi, magnetization, specific heat C and magnetoresistance have been performed on the hexagonal ferromagnets CeTSb (T = Pd,Pt) and the isostructural compounds LaTSb using single crystalline samples. Strong anisotropy in rho, rho(c) > rho(a), was observed for both the Ce compounds as well as the La compounds. However, R-H(T) for CeTSb does not exhibit strong anisotropy between H//a and H//c. The anisotropic behavior of chi(T) for the Ce compounds is well reproduced by the crystalline electronic-field model. The analysis of chi(T) suggests that the ferromagnetic exchange interaction along the c axis in CePdSb is much stronger than that in CePtSb. Magnetization measurements reveal that the saturated magnetic moments of 1.32 mu(B) and 0.91 mu(B) for CePdSb and CePtSb lie within the c plane in the ferromagnetic state. The C(T) for CePdSb shows a clear jump at T-C = 17.5 K in addition to a broad peak around 10K. These results suggest that one dimensional magnetic order along the c axis occurs in CePdSb at T-C = 17.5 K and three-dimensional order develops only below 10 K. It is found that rho(c) increases below 8 K and 6 K for CePdSb and CePtSb, respectively, and R-H(H//a; I//c) also increases below 10 K for both compounds. Unlike usual ferromagnets, the transverse and longitudinal magnetoresistances in the ferromagnetic states are largely positive for H//a. These unusual transport properties may be ascribed to the anomalous spin dynamics in the ferromagnetic state of the present systems.	Hiroshima Univ, Fac Sci, Higashihiroshima 7398526, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan; Niigata Univ, Fac Engn, Niigata 9502100, Japan; Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9807700, Japan	Katoh, K (reprint author), Natl Def Acad, Yokosuka, Kanagawa 2398686, Japan.	katok@cc.nda.ac.jp	Takabatake, Toshiro/L-2882-2014	Takabatake, Toshiro/0000-0002-3293-8592			AKUURA M, COMMUNICATIONS; Kasuya T, 1996, J PHYS SOC JPN, V65, P160, DOI 10.1143/JPSJ.65.160; FERT A, 1987, PHYS REV B, V36, P1907, DOI 10.1103/PhysRevB.36.1907; DONOFRIO L, 1991, PHYSICA B, V171, P266, DOI 10.1016/0921-4526(91)90528-M; FUJITA T, 1992, J MAGN MAGN MATER, V108, P35, DOI 10.1016/0304-8853(92)91338-T; HURD CM, 1980, HALL EFFECT ITD APPL, P44; Isikawa Y., 1996, J PHYS SOC JPN, V65, P117; KASAYA M, 1992, J PHYS SOC JPN, V61, P4187, DOI 10.1143/JPSJ.61.4187; Lord JS, 1996, J PHYS-CONDENS MAT, V8, P5475, DOI 10.1088/0953-8984/8/29/020; MALIK SK, 1991, PHYS REV B, V43, P6295, DOI 10.1103/PhysRevB.43.6295; Marazza R., 1980, J LESS-COMMON MET, V75, P25; Neville AJ, 1996, PHYSICA B, V223-24, P271, DOI 10.1016/0921-4526(96)00097-X; RAINFORD BD, 1994, PHYSICA B, V194, P365, DOI 10.1016/0921-4526(94)90512-6; Rainford B. D., 1995, Physica B, V206-207, DOI 10.1016/0921-4526(94)00410-W; RAINFORD BD, 1994, PHYSICA B, V199, P556, DOI 10.1016/0921-4526(94)91903-8; RIEDI PC, 1994, PHYSICA B, V199, P558, DOI 10.1016/0921-4526(94)91904-6; ROSSATMIGNOD J, 1985, J MAGN MAGN MATER, V52, P111, DOI 10.1016/0304-8853(85)90235-5; ROSSI D, 1981, J LESS-COMMON MET, V78, P1; Thornton MJ, 1996, PHYS REV B, V54, P4189, DOI 10.1103/PhysRevB.54.4189; TROVARELLI O, 1994, PHYS REV B, V49, P15179, DOI 10.1103/PhysRevB.49.15179; Ziman J.M., 1972, PRINCIPLE THEORY SOL	21	10	10	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					613	619		10.1143/JPSJ.68.613		7	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400041		
J	Chen, W; Hida, K; Nakano, H				Chen, W; Hida, K; Nakano, H			Magnetization plateaus in one dimensional S=1/2 Heisenberg model with dimerization and quadrumerization	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						Heisenberg chain; spin gap; exact diagonalization; magnetization plateau; conformal field theory; central charge; scaling dimension; dimer gas model	CONFORMAL-INVARIANCE; CRITICAL EXPONENTS; SPIN CHAINS; FIELD	The one dimensional S = 1/2 Heisenberg model with dimerization (1 - j) and quadrumerization (delta) in the magnetic field is studied by means of the numerical exact diagonalization of finite size systems and the conformal field theory. It is found that the magnetization plateau at half of the saturation value exists for delta not equal 0. For delta = 0, this model is described by the conformal field theory with central charge c = 1 at this value of magnetization. The critical exponent upsilon which characterizes the delta-dependence of the width of the plateau is calculated using the level spectroscopy method. The j-dependence of the critical exponent upsilon is found to be non-monotonic and discontinuous at j = 0. The effective theory of the magnetization plateau is also presented for various limiting cases.	Saitama Univ, Dept Phys, Urawa, Saitama 3388570, Japan; Univ Tokyo, Inst Solid State Phys, Tokyo 1068666, Japan	Chen, W (reprint author), Saitama Univ, Dept Phys, Urawa, Saitama 3388570, Japan.	chenwei@riron.ged.saitama-u.ac.jp	Hida, Kazuo/B-2770-2012				AFFLECK I, 1986, NUCL PHYS B, V270, P186; Shiramura W, 1998, J PHYS SOC JPN, V67, P1548, DOI 10.1143/JPSJ.67.1548; BLOTE HWJ, 1986, PHYS REV LETT, V56, P742, DOI 10.1103/PhysRevLett.56.742; HIDA K, 1994, J PHYS SOC JPN, V63, P2359, DOI 10.1143/JPSJ.63.2359; AFFLECK I, 1986, PHYS REV LETT, V56, P746, DOI 10.1103/PhysRevLett.56.746; Narumi Y, 1998, PHYSICA B, V246, P509, DOI 10.1016/S0921-4526(97)00974-5; LUTHER A, 1975, PHYS REV B, V12, P3908, DOI 10.1103/PhysRevB.12.3908; Totsuka K, 1997, PHYS LETT A, V228, P103, DOI 10.1016/S0375-9601(97)00087-X; SAKAI T, 1991, J PHYS SOC JPN, V60, P3615, DOI 10.1143/JPSJ.60.3615; Tonegawa T, 1996, J PHYS SOC JPN, V65, P3317, DOI 10.1143/JPSJ.65.3317; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Oshikawa M, 1997, PHYS REV LETT, V78, P1984, DOI 10.1103/PhysRevLett.78.1984; CARDY JL, 1984, J PHYS A-MATH GEN, V17, pL385, DOI 10.1088/0305-4470/17/7/003; BOGOLIUBOV NM, 1986, NUCL PHYS B, V275, P687, DOI 10.1016/0550-3213(86)90579-1; CABRA DC, CONDMAT9803368; CABRA DC, CONDMAT9802935; Chen W, 1998, J PHYS SOC JPN, V67, P2910, DOI 10.1143/JPSJ.67.2910; Fukuyama H., 1985, ELECT PROPERTIES I 1; Hida K, 1998, J PHYS SOC JPN, V67, P1416, DOI 10.1143/JPSJ.67.1416; Kitazawa A, 1997, J PHYS SOC JPN, V66, P3944, DOI 10.1143/JPSJ.66.3944; KOLEZHUK AK, CONDMAT9806292; Nakano H, 1998, J PHYS SOC JPN, V67, P1126, DOI 10.1143/JPSJ.67.1126; NOMURA K, 1995, J PHYS A-MATH GEN, V28, P5451, DOI 10.1088/0305-4470/28/19/003; Sakai T, 1998, PHYS REV B, V57, pR3201, DOI 10.1103/PhysRevB.57.R3201; SAKAI T, 1995, J PHYS SOC JPN, V64, P251; Shanks D., 1955, J MATH PHYS, V34, P1; TAKANO K, CONDMAT9804055; Totsuka K, 1998, PHYS REV B, V57, P3454, DOI 10.1103/PhysRevB.57.3454; Zvyagin A. A., 1990, Soviet Physics - Solid State, V32; ZVYAGIN AA, 1991, PHYS LETT A, V158, P333, DOI 10.1016/0375-9601(91)90992-H; ZVYAGIN AA, 1992, SOV J LOW TEMP PHYS, V18, P558	31	19	19	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					625	630		10.1143/JPSJ.68.625		6	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400043		
J	Okada, K; Kotani, A				Okada, K; Kotani, A			Large-cluster effects on core-level photoabsorption spectrum of LaCuO3	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						core level photoabsorption; photoemission; LaCuO3; orbital degeneracy; metal insulator transition; large-cluster effect	X-RAY PHOTOEMISSION; TRANSITION-METAL COMPOUNDS; ELECTRONIC-STRUCTURE; CU COMPOUNDS; SPECTROSCOPY; OXIDES	In order to investigate the influence of Cu-Cu interaction on the Cu 2p core-level x-ray absorption spectrum of LaCuO3, the Lanczos calculations are performed for (Cu3O16)(23-) and (CuO16)(29-) cluster models. The Cu 2p XAS is calculated as a function of the charge-transfer energy (Delta) between the Cu 3d and O 2p states. With decreasing Delta, the spin state of the ground state changes from magnetic to nonmagnetic. Around the critical Delta, the main line of the XAS splits by about 1.5 eV, reproducing the experimental result of LaCuO3 well. In such low Delta cases; half the valence holes occupy the O 2p states, mediating the strong Cu-Cu coupling, and the photoabsorption at a particular Cu site inevitably affects the electronic states around the neighboring Cu sites, in contrast to divalent Cu compounds. This inter-site coupling is enhanced, when the tetragonal distortion of CuO6 units is small. In other words, the 3d orbital degeneracy is important in discussing the Cu 2p XAS of LaCuO3. The Cu 2p photoemission spectrum is also calculated.	Okayama Univ, Fac Sci, Dept Phys, Okayama 7008530, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Okada, K (reprint author), Okayama Univ, Fac Sci, Dept Phys, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	okada@science.okayama-u.ac.jp	OKADA, Kozo/B-1464-2011				VANVEENENDAAL MA, 1993, PHYS REV LETT, V70, P2459, DOI 10.1103/PhysRevLett.70.2459; BOCQUET AE, 1992, PHYS REV B, V46, P3771, DOI 10.1103/PhysRevB.46.3771; VANDERMAREL D, 1988, PHYS REV B, V37, P10674, DOI 10.1103/PhysRevB.37.10674; ZAANEN J, 1986, PHYS REV B, V33, P8060, DOI 10.1103/PhysRevB.33.8060; CZYZYK MT, 1994, PHYS REV B, V49, P14211, DOI 10.1103/PhysRevB.49.14211; Mizokawa T, 1998, PHYS REV B, V57, P9550, DOI 10.1103/PhysRevB.57.9550; SARMA DD, 1988, PHYS REV B, V37, P9784, DOI 10.1103/PhysRevB.37.9784; MIZOKAWA T, 1994, PHYS REV B, V49, P7193, DOI 10.1103/PhysRevB.49.7193; Mizokawa T, 1998, J ELECTRON SPECTROSC, V92, P97, DOI 10.1016/S0368-2048(98)00108-X; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; SAITOH T, 1995, PHYS REV B, V52, P7934, DOI 10.1103/PhysRevB.52.7934; VANVEENENDAAL MA, 1994, PHYS REV B, V49, P3473, DOI 10.1103/PhysRevB.49.3473; BRINGLEY JF, 1993, PHYS REV B, V47, P15269, DOI 10.1103/PhysRevB.47.15269; ESEKS H, 1988, PHYS REV LETT, V61, P1415; FUJIMORI A, 1989, PHYS REV B, V39, P793, DOI 10.1103/PhysRevB.39.793; Harrision W. A., 1980, ELECT STRUCTURE PROP; Heine V., 1980, SOLID STATE PHYS, V35, P87; KARLSSON K, 1992, J PHYS-CONDENS MAT, V4, P2801, DOI 10.1088/0953-8984/4/11/009; LEE G, 1991, PHYS REV B, V43, P14674, DOI 10.1103/PhysRevB.43.14674; MAEKAWA S, 1992, PHYSICS HIGH TEMPERA; OKADA K, 1991, SOLID STATE COMMUN, V77, P835, DOI 10.1016/0038-1098(91)90815-D; OKADA K, 1995, PHYS REV B, V52, P4794, DOI 10.1103/PhysRevB.52.4794; Okada K, 1997, J ELECTRON SPECTROSC, V86, P119, DOI 10.1016/S0368-2048(97)00056-X; OKADA K, 1992, J ELECTRON SPECTROSC, V58, P325, DOI 10.1016/0368-2048(92)85018-3; Okada K, 1996, J PHYS SOC JPN, V65, P1844, DOI 10.1143/JPSJ.65.1844	25	8	8	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					666	673		10.1143/JPSJ.68.666		8	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400050		
J	Svirko, YP; Shirane, M; Suzuura, H; Kuwata-Gonokami, M				Svirko, YP; Shirane, M; Suzuura, H; Kuwata-Gonokami, M			Four-wave mixing theory at the excitonic resonance: Weakly interacting boson model	JOURNAL OF THE PHYSICAL SOCIETY OF JAPAN			English	Article						four-wave mixing; exciton; semiconductor microcavity; normal mode splitting; four-particle correlation	NONLINEAR-OPTICAL RESPONSE; CAVITY POLARITONS; MICROCAVITY; GAAS	A theory of degenerate four-wave mixing (DFWM) in the low density excitation limit at the semiconductor band edge is developed on the basis of the bosonic representation of the electron-hole Hamiltonian. By accounting for the exciton-exciton interactions of the lowest order we arrive at the practical few-level density matrix description of the third-order excitonic nonlinearity. The developed theory accounts phenomenologically for the phase space filling, and excitation induced dephasing effects and well reproduces the results of the recent DFWM experiments in high- and low-fineness microcavity. We show that polarization-sensitive four-wave mixing measurements enable to discriminate the contributions to the DFWM signal from the exciton-exciton interactions of different symmetry.	Japan Sci & Technol Corp JST, Cooperat Excitat Project ERATO, Takatsu Ku, Kanagawa 2130012, Japan; Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Kuwata-Gonokami, M (reprint author), Japan Sci & Technol Corp JST, Cooperat Excitat Project ERATO, Takatsu Ku, KSP Bldg D 8th,3-2-1 Sakato, Kanagawa 2130012, Japan.		SUZUURA, Hidekatsu/F-7605-2012				AKIMOTO O, 1972, J PHYS SOC JPN, V33, P1537, DOI 10.1143/JPSJ.33.1537; Axt VM, 1998, REV MOD PHYS, V70, P145, DOI 10.1103/RevModPhys.70.145; WANG HL, 1993, PHYS REV LETT, V71, P1261, DOI 10.1103/PhysRevLett.71.1261; WEISBUCH C, 1992, PHYS REV LETT, V69, P3314, DOI 10.1103/PhysRevLett.69.3314; HANAMURA E, 1970, J PHYS SOC JPN, V29, P50, DOI 10.1143/JPSJ.29.50; HANAMURA E, 1974, J PHYS SOC JPN, V37, P1553, DOI 10.1143/JPSJ.37.1553; AOKI T, 1998, OSA TECHICAL DIGEST, V7, P60; AXT VM, 1994, Z PHYS B CON MAT, V93, P195, DOI 10.1007/BF01316963; FAN X, 1998, OSA TECHNICAL DIGEST, V7, P31; Fan XD, 1997, PHYS REV A, V56, P3233, DOI 10.1103/PhysRevA.56.3233; HAUG H, 1994, QUNTUM THEORY OPTICA; Inoue J, 1998, J PHYS SOC JPN, V67, P3384, DOI 10.1143/JPSJ.67.3384; ISHIHARA H, 1993, PHYS REV B, V48, P7960, DOI 10.1103/PhysRevB.48.7960; IVANOV AL, 1993, PHYS REV B, V48, P1490, DOI 10.1103/PhysRevB.48.1490; KIRA M, 1997, PHYS REV LETT, V79, P2170; Kner P, 1997, PHYS REV LETT, V78, P1319, DOI 10.1103/PhysRevLett.78.1319; KUWATAGONOKAMI M, 1992, NONLINEAR OPTICS FUN, P239; KuwataGonokami M, 1997, PHYS REV LETT, V79, P1341, DOI 10.1103/PhysRevLett.79.1341; LINDBERG M, 1994, PHYS REV B, V50, P18060, DOI 10.1103/PhysRevB.50.18060; NORRIES TB, 1994, PHYS REV B, V59, P663; Pau S, 1996, PHYS REV A, V54, pR1789; SAIKI T, 1994, PHYS REV B, V49, P7817, DOI 10.1103/PhysRevB.49.7817; SHIMANO R, 1995, JPN J APPL PHYS PT 2, V34, P817; Shirane M, 1998, PHYS REV B, V58, P7978, DOI 10.1103/PhysRevB.58.7978; Suzuura H, 1998, SOLID STATE COMMUN, V108, P289, DOI 10.1016/S0038-1098(98)00382-2; Victor K, 1996, Z PHYS B CON MAT, V99, P197, DOI 10.1007/s002570050028	26	9	9	PHYSICAL SOC JAPAN	TOKYO	YUSHIMA URBAN BUILDING 5F, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN	0031-9015			J PHYS SOC JPN	J. Phys. Soc. Jpn.	FEB	1999	68	2					674	682		10.1143/JPSJ.68.674		9	Physics, Multidisciplinary	Physics	173EC	WOS:000078967400051		
J	Perfumo, CJ; Petruccelli, MA; Itagaki, S				Perfumo, CJ; Petruccelli, MA; Itagaki, S			Pulmonary lesions in guinea pigs experimentally infected with Actinobacillus pleuropneumoniae (Ap) serovar 1	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						Actinobacillus pleuropneumoniae serovar 1; fibrinonecrotic pleuropneumonia; guinea pig	HEMOPHILUS-PLEUROPNEUMONIAE; MICE	Pathological studies were carried out on the lungs of guinea pigs intratracheally inoculated with 4.6 x 10(6-8) colony forming units (CFU)/head of Actinobacillus pleuropneumoniae serovar I. All animals in the highest dose group died within 24 hr post inoculation (hpi) and showed pulmonary lesions being hemorrhagic an nature while all animals in the lowest dose group were killed as scheduled at 11 days post inoculation (dpi) and showed only hyperplasia of peribronchial lymphoid tissues. In the middle dose group, two died within 24 hpi, two died at 9 dpi, and the remaining one was killed at 11 dpi. Two guinea pigs which died at 9 dpi showed fibrinonecrotic pleuropneumonia which is the most characteristic acute pulmonary lesion in swine, and has not yet been reproduced in laboratory animals up to the present time. This suggests that guinea pigs may be a useful laboratory animal far studying the pathogenesis of Actinobacillus pleuropneumoniae infection in swine.	Natl Univ La Plata, Fac Vet Sci, Inst Pathol, RA-1900 La Plata, Argentina; Univ Tokyo, Fac Agr, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan	Perfumo, CJ (reprint author), Natl Univ La Plata, Fac Vet Sci, Inst Pathol, CC 296, RA-1900 La Plata, Argentina.						FREY J, 1995, TRENDS MICROBIOL, V3, P257, DOI 10.1016/S0966-842X(00)88939-8; BERTRAM TA, 1988, CAN VET J, V29, P574; FENWICK BW, 1986, INFECT IMMUN, V53, P474; IDRIS UEA, 1993, VET PATHOL, V30, P234; NAKAI T, 1984, JPN J VET SCI, V45, P851; PERFUMO CJ, 1984, ZBL VET MED, V30, P678; SEBUNYA TNK, 1982, AM J VET RES, V43, P1799; SEBUNYA TNK, 1982, AM J VET RES, V43, P1793	8	0	1	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250			J VET MED SCI	J. Vet. Med. Sci.	FEB	1999	61	2					163	165				3	Veterinary Sciences	Veterinary Sciences	173CH	WOS:000078963300012		
J	Uema, M; Ikeda, Y; Miyazawa, T; Lin, JA; Chen, MC; Kuo, TF; Kai, C; Mikami, T; Takahashi, E				Uema, M; Ikeda, Y; Miyazawa, T; Lin, JA; Chen, MC; Kuo, TF; Kai, C; Mikami, T; Takahashi, E			Feline immunodeficiency virus subtype C is prevalent in northern part of Taiwan	JOURNAL OF VETERINARY MEDICAL SCIENCE			English	Article						feline immunodeficiency virus; subtype; Taiwan	NUCLEOTIDE-SEQUENCE; CATS; INFECTIONS; FIV	The seroepidemiological survey of cats conducted in northern part of Taiwan in 1998 revealed that the positive rate of feline immunodeficiency virus (FIV)-infection was 21.9% (7/32) and the rate was much higher than those of previous reports. We succeeded in isolation of three strains of FIV from peripheral blood mononuclear cells of the blood samples. Nucleotide sequences of the env variable V3 to V5 region of the strains revealed that the isolates from distinct areas belong to subtype C. These data together with our previous report (Inada et al. 1997. Arch. Virol., 142: 1459-1467) indicate that FIV subtype C is prevalent in northern part of Taiwan.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; Obihiro Univ Agr & Vet Med, Res Ctr Protozoan Mol Immunol, Obihiro, Hokkaido 0808555, Japan; Natl Chung Hsing Univ, Dept Vet Med, Taichung 40227, Taiwan; Taiwan Prov Res Inst Anim Hlth, Tam Sui, Taiwan; Natl Taiwan Univ, Dept Vet Med, Taipei 10764, Taiwan	Takahashi, E (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.			KUO, TZONG-FU/0000-0002-6328-8967			PEDERSEN NC, 1987, SCIENCE, V235, P790, DOI 10.1126/science.3643650; KAKINUMA S, 1995, J VIROL, V69, P3639; SODORA DL, 1994, J VIROL, V68, P2230; DIEHL LJ, 1995, J VIROL, V69, P6149; GRAIL A, 1993, VET MICROBIOL, V36, P369, DOI 10.1016/0378-1135(93)90103-E; Inada G, 1997, ARCH VIROL, V142, P1459, DOI 10.1007/s007050050172; LIN DS, 1990, BRIT VET J, V146, P468; LIN JA, 1995, J VET MED SCI, V57, P161; MAKI N, 1992, ARCH VIROL, V123, P29, DOI 10.1007/BF01317136; MIYAZAWA T, 1989, ARCH VIROL, V108, P59, DOI 10.1007/BF01313743; MIYAZAWA T, 1993, J VET MED SCI, V55, P519; MIYAZAWA T, 1989, ARCH VIROL, V108, P131, DOI 10.1007/BF01313750; OLMSTED RA, 1989, P NATL ACAD SCI USA, V86, P8088, DOI 10.1073/pnas.86.20.8088; Pecoraro MR, 1996, J GEN VIROL, V77, P2031, DOI 10.1099/0022-1317-77-9-2031; VERSCHOOR EJ, 1995, J VIROL, V69, P4752	15	16	17	JAPAN SOC VET SCI	TOKYO	UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 103, JAPAN	0916-7250			J VET MED SCI	J. Vet. Med. Sci.	FEB	1999	61	2					197	199		10.1292/jvms.61.197		3	Veterinary Sciences	Veterinary Sciences	173CH	WOS:000078963300021		
J	Gromeier, M; Bossert, B; Arita, M; Nomoto, A; Wimmer, E				Gromeier, M; Bossert, B; Arita, M; Nomoto, A; Wimmer, E			Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence	JOURNAL OF VIROLOGY			English	Article							5' NONTRANSLATED REGION; HUMAN NEURO-BLASTOMA; HEPATITIS-C VIRUS; ATTENUATION PHENOTYPE; TYPE-1 POLIOVIRUS; NONCODING REGION; TRANSLATION INITIATION; 5'-UNTRANSLATED REGION; INVITRO TRANSLATION; SECONDARY STRUCTURE	In the human central nervous system, susceptibility to poliovirus (PV) infection is largely confined to a specific subpopulation of neuronal cells. PV tropism is likely to be determined by cell-external components such as the PV receptor CD155, as well as cell-internal constraints such as the availability of a suitable microenvironment for virus propagation. We reported previously that the exchange of the cognate internal ribosomal entry site (IRES) within the 5' nontranslated region of PV with its counterpart from human rhinovirus type 2 (HRV2) can eliminate the neuropathogenic phenotype in a transgenic mouse model for poliomyelitis without diminishing the growth properties in HeLa cells. We now show that attenuation of neurovirulence of PV/HRV2 chimeras is not confined to CD155 transgenic mice but is evident also after intraspinal inoculation into Cynomolgus monkeys. We have dissected the PV and HRV2 IRES elements to determine those structures responsible for neurovirulence (or attenuation) of these chimeric viruses. We report that two adjacent stem loop structures within the IRES cooperatively determine neuropathogenicity.	SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; Univ Tokyo, Inst Med Sci, Dept Microbiol, Tokyo, Japan	Gromeier, M (reprint author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.						AGOL VI, 1989, J VIROL, V63, P4034; ALEXANDER L, 1994, P NATL ACAD SCI USA, V91, P1406, DOI 10.1073/pnas.91.4.1406; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; MOLLA A, 1992, NATURE, V356, P255, DOI 10.1038/356255a0; EVANS DMA, 1985, NATURE, V314, P548, DOI 10.1038/314548a0; MCGOLDRICK A, 1995, J VIROL, V69, P7601; BOUCHARD MJ, 1995, J VIROL, V69, P4972; OMATA T, 1986, J VIROL, V58, P348; WIMMER E, 1993, ANNU REV GENET, V27, P353; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; Hyypia T, 1997, J GEN VIROL, V78, P1; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; JANG SK, 1988, J VIROL, V62, P2636; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476; KITAMURA N, 1981, NATURE, V291, P547, DOI 10.1038/291547a0; Belov G A, 1995, Mol Biol (Mosk), V29, P294; Bodian D., 1972, PATHOLOGY NERVOUS SY, P2323; HALLER AA, 1995, VIROLOGY, V206, P923, DOI 10.1006/viro.1995.1015; Haller AA, 1996, J VIROL, V70, P1467; HELLEN CUT, 1994, J VIROL, V68, P6312; IIZUKA N, 1991, J VIROL, V65, P4867; JANG SK, 1989, J VIROL, V63, P1651; KAWAMURA N, 1989, J VIROL, V63, P1302; KUGE S, 1987, J VIROL, V61, P1478; LAMONICA N, 1989, J VIROL, V63, P2357; LE SY, 1992, VIROLOGY, V191, P858, DOI 10.1016/0042-6822(92)90261-M; Lu HH, 1996, P NATL ACAD SCI USA, V93, P1412, DOI 10.1073/pnas.93.4.1412; MUELLEN S, UNPUB; MURRAY MG, 1988, SCIENCE, V241, P213, DOI 10.1126/science.2838906; PILIPENKO EV, 1989, VIROLOGY, V168, P201, DOI 10.1016/0042-6822(89)90259-6; PILIPENKO EV, 1989, NUCLEIC ACIDS RES, V17, P5701, DOI 10.1093/nar/17.14.5701; RODRIGO MJ, 1995, J MOL EVOL, V40, P362, DOI 10.1007/BF00164022; Sabin A. B., 1973, J BIOL STAND, V1, P115, DOI 10.1016/0092-1157(73)90048-6; SABIN AB, 1956, SCIENCE, V123, P1151, DOI 10.1126/science.123.3209.1151; SKERN T, 1985, NUCLEIC ACIDS RES, V13, P2111, DOI 10.1093/nar/13.6.2111; SKINNER MA, 1989, J MOL BIOL, V207, P379, DOI 10.1016/0022-2836(89)90261-1; Slobodskaya OR, 1996, VIROLOGY, V221, P141, DOI 10.1006/viro.1996.0360; SVITKIN YV, 1985, VIROLOGY, V147, P243, DOI 10.1016/0042-6822(85)90127-8; SVITKIN YV, 1988, VIROLOGY, V166, P394, DOI 10.1016/0042-6822(88)90510-7; SVITKIN YV, 1990, VIROLOGY, V175, P103, DOI 10.1016/0042-6822(90)90190-3; *WHO, 1983, WHO TECH REP SER, V687, P130; WIMMER E, 1997, SEMINARS VIROLOGY, V8; WITHERELL GW, 1993, VIRUS STRATEGIES, P237	43	92	94	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0022-538X			J VIROL	J. Virol.	FEB	1999	73	2					958	964				7	Virology	Virology	156TE	WOS:000078017500011		
J	Arita, M; Horie, H; Arita, M; Nomoto, A				Arita, M; Horie, H; Arita, M; Nomoto, A			Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor	JOURNAL OF VIROLOGY			English	Article							AMINO-ACID-RESIDUES; FUNCTIONAL DOMAINS; MOLECULAR-CLONING; VIRUS-INFECTION; CELL RECEPTORS; REPLICATION; ANTIBODY; BINDING; ENHANCEMENT; RHINOVIRUS	Poliovirus infects susceptible cells through the poliovirus receptor (PVR), which functions to bind virus and to change its conformation. These two activities are thought to be necessary for efficient poliovirus infection. How binding and conformation conversion activities contribute to the establishment of poliovirus infection was investigated. Mouse L cells expressing mouse high-affinity Fc gamma receptor molecules were established and used to study poliovirus infection mediated by mouse antipoliovirus monoclonal antibodies (MAbs) (immunoglobulin G2a [IgG2a] subtypes) or FVR-IgG2a, a chimeric molecule consisting of the extracellular moiety of PVR and the hinge and Fc portion of mouse IgG2a. The antibodies and PVR-IgG2a showed the same degree of affinity fur poliovirus, but the infectivities mediated by these molecules were different. Among the. molecules tested, PVR-IgG2a mediated the infection most efficiently, showing 50- to 100-fold-higher efficiency than that attained with the different MAbs, A conformational change of poliovirus was induced only by PVR-IgG2a. These results strongly suggested that some specific interaction(s) between poliovirus and the PVR is required for high-level infectivity of poliovirus in this system.	Univ Tokyo, Inst Med Sci, Dept Microbiol, Minato Ku, Tokyo 1088639, Japan; Japan Poliomyelitis Res Inst, Tokyo 1890003, Japan; Natl Inst Hlth, Dept Viral Dis & Vaccine Control, Tokyo 2080011, Japan	Nomoto, A (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol, Minato Ku, 4-6-1 Shiroganedai, Tokyo 1088639, Japan.						HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465, DOI 10.1038/icb.1964.44; ROSSMANN MG, 1985, NATURE, V317, P145, DOI 10.1038/317145a0; Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774; HULETT MD, 1991, J IMMUNOL, V147, P1863; SEARS DW, 1990, J IMMUNOL, V144, P371; PACE CN, 1995, PROTEIN SCI, V4, P2411; GREVE JM, 1991, J VIROL, V65, P6015; Yang WX, 1997, VIROLOGY, V229, P421, DOI 10.1006/viro.1997.8450; ISMAILCASSIM N, 1990, J GEN VIROL, V71, P2283, DOI 10.1099/0022-1317-71-10-2283; HOOVERLITTY H, 1993, J VIROL, V67, P390; KAPLAN G, 1990, J VIROL, V64, P4697; LI QH, 1994, J VIROL, V68, P3965; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P4104, DOI 10.1073/pnas.88.10.4104; FRICKS CE, 1990, J VIROL, V64, P1934; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; HOGLE JM, 1985, SCIENCE, V229, P1358, DOI 10.1126/science.2994218; Miller KL, 1996, J EXP MED, V183, P2227, DOI 10.1084/jem.183.5.2227; LEWIS VA, 1986, NATURE, V324, P372, DOI 10.1038/324372a0; DAVIS W, 1995, EMBO J, V14, P432; KIM KH, 1993, J MOL BIOL, V230, P206, DOI 10.1006/jmbi.1993.1137; VANDEWINKEL JGJ, 1993, IMMUNOL TODAY, V14, P215, DOI 10.1016/0167-5699(93)90166-I; AOKI J, 1994, J BIOL CHEM, V269, P8431; Arita M, 1998, J VIROL, V72, P3578; BERNHARDT G, 1994, VIROLOGY, V203, P344, DOI 10.1006/viro.1994.1493; Bouchard MJ, 1997, J VIROL, V71, P2793; Curry S, 1996, J VIROL, V70, P7125; Dove AW, 1997, J VIROL, V71, P4728; FOX MP, 1986, ANTIMICROB AGENTS CH, V30, P110; Freistadt MS, 1996, VIROLOGY, V224, P542, DOI 10.1006/viro.1996.0561; GROMEIER M, 1990, J VIROL, V64, P3590; GUTTMAN N, 1977, VIROLOGY, V82, P25, DOI 10.1016/0042-6822(77)90029-0; Harber J, 1995, VIROLOGY, V214, P559, DOI 10.1006/viro.1995.0067; HARLOW E, 1988, ANTIBODIES LAB MANUA, P673; INADA T, 1985, J GEN VIROL, V66, P871, DOI 10.1099/0022-1317-66-4-871; KING AA, 1984, J GEN VIROL, V65, P1091, DOI 10.1099/0022-1317-65-6-1091; KOIKE S, 1990, EMBO J, V9, P3217; LEE WM, 1993, J VIROL, V67, P2110; LONBERGHOLM K, 1975, J GEN VIROL, V27, P329, DOI 10.1099/0022-1317-27-3-329; MASON PW, 1993, VIROLOGY, V192, P568, DOI 10.1006/viro.1993.1073; MORRISON ME, 1994, J VIROL, V68, P2578; PEREZ L, 1993, J VIROL, V67, P4543; PORTERFIELD JS, 1986, ADV VIRUS RES, V31, P335, DOI 10.1016/S0065-3527(08)60268-7; RAVETCH JV, 1986, SCIENCE, V234, P718, DOI 10.1126/science.2946078; Rueckert R., 1996, FIELDS VIROLOGY, V1, P609; SELINKA HC, 1991, P NATL ACAD SCI USA, V88, P3598, DOI 10.1073/pnas.88.9.3598; SHEPARD DA, 1993, J VIROL, V67, P2245; SHEPLEY MP, 1994, J VIROL, V68, P1301; SHIROKI K, 1995, J VIROL, V69, P6825; Tosteson MT, 1997, J VIROL, V71, P507; UNKELESS JC, 1988, ANNU REV IMMUNOL, V6, P251; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5; YAFAL AG, 1993, VIROLOGY, V197, P501, DOI 10.1006/viro.1993.1621; ZIBERT A, 1992, VIRUS RES, V25, P51, DOI 10.1016/0168-1702(92)90099-U	53	25	25	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0022-538X			J VIROL	J. Virol.	FEB	1999	73	2					1066	1074				9	Virology	Virology	156TE	WOS:000078017500022		
J	Enomoto, H; Kato, H; Tsue, M; Kono, M				Enomoto, H; Kato, H; Tsue, M; Kono, M			An numerical simulation of effect of surface diffusion on hydrogen-oxygen reaction over platinum catalytic surface	JSME INTERNATIONAL JOURNAL SERIES B-FLUIDS AND THERMAL ENGINEERING			English	Article						chemical reaction; gaseous fuel; catalyst; numerical simulation; surface diffusion		An numerical simulation of hydrogen-oxygen reaction over platinum catalytic surface was carried out and the effect of surface diffusion velocity on catalytic reaction was studied. In this simulation, no convection is assumed to simplify the analysis. The numerical model is as follows; A spherical platinum of 0.75 mm in radius is surrounded with the mixture. Three based partial differential equations, which govern mass, energy and species concentrations, are stated in one-dimensional polar coordinates. Axial symmetry, zero azimuthal velocity, and no gradient along the axis are assumed. Because of low Mach numbers, constant pressure is assumed, and therefore, momentum equation is not used. The Langmuir-Hinshelwood mechanism was used for the catalytic reaction model. The adsorbed species are H, O, OH and H2O and 3 elementary surface reactions are used. As the results, a steady state is observed. The surface temperatures at the steady state do not depend on surface diffusion velocities but on adsorption rates and desorption rates. The catalytic ignition temperatures increase as H(s) surface diffusion velocity decrease. They are independent on surface diffusion velocities of O(s) and OH(s).	Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, Tokyo 1138656, Japan	Enomoto, H (reprint author), Univ Tokyo, Dept Aeronaut & Astronaut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						MONCHICK L, 1961, J CHEM PHYS, V35, P1676, DOI 10.1063/1.1732130; ANTON AB, 1990, SURF SCI, V239, pL548, DOI 10.1016/0039-6028(90)90217-V; ATKINS PW, 1990, PHYSICAL CHEM; Deutschmann O, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P1747; ENOMOTO H, 1995, JIE, V74, P1046; Hirschfelder J.O., 1964, MOL THEORY GASES LIQ; KEE RJ, 1988, 22 S INT COMB COMB I, P1479; LJUNGSTROM S, 1989, SURF SCI, V216, P63, DOI 10.1016/0039-6028(89)90644-4; Stull D., 1986, JANAF THERMOCHEMICAL; WARNATZ J, 1994, COMBUST FLAME, V96, P393, DOI 10.1016/0010-2180(94)90107-4	10	1	1	JAPAN SOC MECHANICAL ENGINEERS	TOKYO	SHINANOMACHI-RENGAKAN BLDG, SHINANOMACHI 35, SHINJUKU-KU, TOKYO, 160, JAPAN	1340-8054			JSME INT J B-FLUID T	JSME Int. J. Ser. B-Fluids Therm. Eng.	FEB	1999	42	1					71	77				7	Thermodynamics; Engineering, Mechanical	Thermodynamics; Engineering	190GE	WOS:000079953800010		
J	Lee, DJ; Lee, TJ; Kim, HD; Uryu, T				Lee, DJ; Lee, TJ; Kim, HD; Uryu, T			Effect of shearing on the liquid crystallinity of polymer blends containing thermotropic liquid crystalline polyurethane	KOREA POLYMER JOURNAL			English	Article							X-RAY-DIFFRACTION; POLYETHYLENE TEREPHTHALATE; POLYPHENYLENE SULFIDE; MECHANICAL-PROPERTIES; EXTRUDED BLENDS; MORPHOLOGY; POLYPROPYLENE; BEHAVIOR	Thermotropic polyurethanes (PUnT: n=2, 6, 8, 11) were synthesized from 4,4'-bis(omega-hydroxyalkoxy)biphenyls (BPn: n=2, 6, 8, 11) and 2,5-tolylene diisocyate (2,5-TDI). Polymer blends (PU6T/PU8T, PU8T/PU11T, and PU2T/PU11T) were prepared from the DMF solutions of various compositions. The effect of shearing on the liquid crystallinity of the polymer blends was investigated through differential scanning calorimetry (DSC) measurement, polarized optical microscope observation, and X-ray diffractometry. The liquid crystallinity was shown in the polymers PU6T, PU8T and PU11T but it was not in PU2T. Polymer blends PU6T/PU8T and PU8T/PU11T showed a monotropic liquid crystallinity, however, PU2T/PU11T did not.	Pusan Natl Univ, Dept Text Engn, Pusan 609735, South Korea; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan							SEPPALA J, 1992, J APPL POLYM SCI, V44, P1051, DOI 10.1002/app.1992.070440614; SUKHADIA AM, 1990, POLYM ENG SCI, V30, P519, DOI 10.1002/pen.760300904; BAFNA SS, 1993, POLYMER, V28, P2130; BAFNA SS, 1995, POLYMER, V36, P259, DOI 10.1016/0032-3861(95)91312-U; BAIRD DG, 1993, POLYM COMPOSITE, V14, P214, DOI 10.1002/pc.750140306; BALLAUF M, 1990, POLYM ADVAN TECHNOL, V1, P109, DOI 10.1002/pat.1990.220010113; BASSETT BR, 1990, POLYM COMPOSITE, V11, P10, DOI 10.1002/pc.750110103; BLIZARD KG, 1990, POLYM ENG SCI, V30, P1442, DOI 10.1002/pen.760302205; FRANCESCANGELI O, 1995, J POLYM SCI POL PHYS, V33, P699, DOI 10.1002/polb.1995.090330419; Gray G.W., 1974, LIQUID CRYSTALS PLAS, V1, P20; GREVECOEUR G, 1990, POLYM ENG SCI, V30, P532; HEINO MT, 1992, J APPL POLYM SCI, V44, P2185, DOI 10.1002/app.1992.070441215; HIRATA T, 1994, MACROMOL CHEM PHYSIC, V195, P2267, DOI 10.1002/macp.1994.021950632; KIM WN, 1992, J RHEOL, V36, P1477, DOI 10.1122/1.550269; KOHLI A, 1989, POLYM ENG SCI, V29, P573, DOI 10.1002/pen.760290902; Lee DJ, 1998, MACROMOLECULES, V31, P975, DOI 10.1021/ma970866y; Lee DJ, 1998, MACROMOLECULES, V31, P7142, DOI 10.1021/ma971878m; Lee DJ, 1998, SEN-I GAKKAISHI, V54, P246; LEE JB, 1995, POLYM J, V27, P664, DOI 10.1295/polymj.27.664; LEE JB, 1995, MACROMOLECULES, V28, P2165, DOI 10.1021/ma00111a010; LEE JB, 1993, MACROMOLECULES, V26, P4986; POLLACK SK, 1989, MACROMOLECULES, V22, P551, DOI 10.1021/ma00192a007; SCHLEEH T, 1993, MAKROMOL CHEM, V194, P2771; SIEGMANN A, 1985, POLYMER, V26, P1325, DOI 10.1016/0032-3861(85)90307-6; SMYTH G, 1990, MACROMOLECULES, V23, P3389, DOI 10.1021/ma00216a001; TAESLER C, 1996, INNOVATIONS MAT RES, V1, P89; TAESLER C, 1994, J MATER SCI, V29, P3017, DOI 10.1007/BF01117614; ZHONG Y, 1992, POLYM J, V24, P999, DOI 10.1295/polymj.24.999	28	7	7	POLYMER SOC KOREA	SEOUL	ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792, SOUTH KOREA	1225-5947			KOREA POLYM J	Korea Polym. J.	FEB	1999	7	1					58	63				6	Polymer Science	Polymer Science	179BF	WOS:000079303100009		
J	Ono, K; Matsumori, A; Furukawa, Y; Igata, H; Shioi, T; Matsushima, K; Sasayama, S				Ono, K; Matsumori, A; Furukawa, Y; Igata, H; Shioi, T; Matsushima, K; Sasayama, S			Prevention of myocardial reperfusion injury in rats by an antibody against monocyte chemotactic and activating factor monocyte chemoattractant protein-1	LABORATORY INVESTIGATION			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE CELLS; CANINE MYOCARDIUM; ISCHEMIA-REPERFUSION; MONOCLONAL-ANTIBODY; INFARCT SIZE; INDUCTION; HEART; LINE	MCAF(monocyte chemotactic and activating factor)/MCP-1 (monocyte chemoattractant protein-1) is an important mediator of monocyte recruitment to inflammatory sites. However, its pathophysiologic role in myocardial reperfusion injury remains unknown. Male Wistar rats were anesthetized, and the left anterior descending coronary artery was ligated for an hour, after which the ligature was released. Northern blotting analysis revealed that MCAF/MCP-1 mRNA expression increased 16-fold in the reperfused region at 12 hours after reperfusion. MCAF/MCP-1 concentration in plasma and the heart was already elevated after hour of ischemia in this model. Goat polyclonal antibodies were prepared by repeated immunization of animals with purified, recombinant rat MCAF/MCP-1, and the neutralizing activities of this antibody were confirmed by monocyte chemotaxis assay and administration to rats with crescentic glomerulonephritis. Intravenous injection of anti-MCAF/MCP-1 antibody significantly reduced the infarct size at 24 hours after reperfusion compared with the injection of control IgG (33.9 +/- 5.1% vs 49.4 +/- 2.7% of ischemic area, mean +/- SEM). Administration of this antibody markedly decreased the intercellular adhesion molecule-1 mRNA expression and infiltration of macrophages, which suggested the pathophysiologic role of MCAF/MCP-1. Neutralization of MCAF/MCP-1 is beneficial by preventing reperfusion injury in a rat model of myocardial ischemia and reperfusion.	Kyoto Univ, Dept Cardiovasc Med, Sakyo Ku, Kyoto 606, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 113, Japan; Kanazawa Univ, Canc Res Inst, Dept Pharmacol, Tokyo, Japan	Matsumori, A (reprint author), Kyoto Univ, Dept Cardiovasc Med, Sakyo Ku, 54 Kawaracho Shogoin, Kyoto 606, Japan.						HANSEN PR, 1995, CIRCULATION, V91, P1872; Matsumori A, 1997, J MOL CELL CARDIOL, V29, P419, DOI 10.1006/jmcc.1996.0285; Meldrum DR, 1998, ANN THORAC SURG, V65, P439, DOI 10.1016/S0003-4975(97)01297-6; Mallory GK, 1939, AM HEART J, V18, P647; Kumar AG, 1997, CIRCULATION, V95, P693; KASAHARA T, 1991, IMMUNOLOGY, V74, P60; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; HORWITZ LD, 1994, CIRCULATION, V89, P1792; Birdsall HH, 1997, CIRCULATION, V95, P684; OPIE LH, 1989, CIRCULATION, V80, P1049; KUKIELKA GL, 1993, J CLIN INVEST, V92, P1504, DOI 10.1172/JCI116729; Simoons ML, 1997, LANCET, V349, P1429; HERSKOWITZ A, 1995, AM J PATHOL, V146, P419; Wada T, 1996, FASEB J, V10, P1418; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; ROBINSON EA, 1989, P NATL ACAD SCI USA, V86, P1850, DOI 10.1073/pnas.86.6.1850; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; BAN K, 1994, CARDIOVASC RES, V28, P1258, DOI 10.1093/cvr/28.8.1258; COCHRAN BH, 1983, CELL, V33, P939, DOI 10.1016/0092-8674(83)90037-5; Gurevitch J, 1996, J AM COLL CARDIOL, V28, P247, DOI 10.1016/0735-1097(96)00105-2; HARTMAN JC, 1995, CARDIOVASC RES, V30, P47, DOI 10.1016/S0008-6363(95)00015-1; IKEDA U, 1993, ATHEROSCLEROSIS, V104, P61, DOI 10.1016/0021-9150(93)90176-U; INTRONA M, 1987, J IMMUNOL, V138, P3891; IOCULANO M, 1994, EUR J PHARMACOL, V264, P143, DOI 10.1016/0014-2999(94)00452-8; KAROLLE BL, 1991, CIRCULATION S, V84, P2; ROLLINS BJ, 1989, MOL CELL BIOL, V9, P4687; Schaper W, 1984, THERAPEUTIC APPROACH, P79; SIMPSON PJ, 1988, J CLIN INVEST, V81, P624, DOI 10.1172/JCI113364; Topol EJ, 1997, NEW ENGL J MED, V336, P1689; TILLMANS H, 1984, THERAPEUTIC APPROACH, P107; YAMAZAKI T, 1993, AM J PATHOL, V143, P410; YOUKER KA, 1994, CIRCULATION, V89, P2736; ZACHARIAE COC, 1990, J EXP MED, V171, P2177, DOI 10.1084/jem.171.6.2177	35	70	79	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0023-6837			LAB INVEST	Lab. Invest.	FEB	1999	79	2					195	203				9	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	171DU	WOS:000078847900015		
J	Kawamura, M; Ohnishi, H; Guo, SX; Sheng, XM; Minegishi, M; Hanada, R; Horibe, K; Hongo, T; Kaneko, Y; Bessho, F; Yanagisawa, M; Sekiya, T; Hayashi, Y				Kawamura, M; Ohnishi, H; Guo, SX; Sheng, XM; Minegishi, M; Hanada, R; Horibe, K; Hongo, T; Kaneko, Y; Bessho, F; Yanagisawa, M; Sekiya, T; Hayashi, Y			Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia	LEUKEMIA RESEARCH			English	Article						p53, p21, p16, p15 and RAS genes; childhood; T-cell acute lymphoblastic leukemia	ACUTE LYMPHOCYTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; DEPENDENT KINASE INHIBITORS; HUMAN LYMPHOID MALIGNANCIES; HOMOZYGOUS DELETIONS; CLINICAL-SIGNIFICANCE; FREQUENT MUTATIONS; ONCOGENE MUTATIONS; MYELOID-LEUKEMIA; CLONAL EXPANSION	We investigated the alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia (T-ALL) and T-ALL cell lines by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis and direct sequencing. Mutations of the p53 gene were found in three of 57 (5%) patients at diagnosis, one of 14 (7%) patients at relapse and in 12 of 18 (67%) cell lines. In these 12 cell lines, four had more than two mutations of the p53 gene. The p53 mutations were found in four of five cell lines whose original fresh leukemic cells were simultaneously examined original fresh leukemic cells. However, only one of the four fresh leukemic cells had the same mutation. All patients with p53 mutations in the course of disease died. Mutations of the p21 gene were not identified in 71 fresh samples and in 18 cell lines. N-RAS mutations were found in two of 57 (4%) fresh T-ALL patients at diagnosis, and four of 18 cell lines (22%), whereas no mutations were detected in any samples at relapse. Alterations of the p16 gene were found in 18 of 47 (38%) patients at diagnosis and in seven of 14 (50%) at relapse. These differences were not statistically significant. There were no differences in the frequency of alteration of the p16 and p15 genes between event-free patients and the remaining patients. Furthermore, we found the methylation of p16 gene in three of seven patients lacking homozygous deletions, suggesting higher frequency of p16 inactivation than previous reports in T-ALL. Interestingly, we found that one allele is inactivated by methylation and another allele had nonsense mutation in one cell line (KOPT-K1), resulting in loss of protein expression of p16. This type of p16 inactivation has not been so far reported in leukemia. We conclude that, (1) p53 mutations are infrequent at diagnosis but tend to be associated with poor clinical outcome; (2) RAS and p21 mutations may not be involved in the pathogenesis of T-ALL; (3) not only frequent alterations of p16 and p15 genes but also methylation of p16 gene are involved in initiating the leukemogenesis of T-ALLs, and (4) these 5 genes are independently involved in T-ALL. (C) 1999 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 113, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Pediat Oncol, Sendai, Miyagi 980, Japan; Saitama Childrens Med Ctr, Div Hematol Oncol, Moroyama, Saitama, Japan; Nagoya Univ, Sch Med, Fac Med, Dept Pediat, Aichi, Japan; Hamamatsu Univ Sch Med, Dept Pediat, Shizuoka, Japan; Saitama Canc Ctr, Dept Canc Chemotherapy, Ina, Saitama, Japan; Natl Canc Ctr, Res Inst, Div Oncogene, Tokyo 104, Japan	Hayashi, Y (reprint author), Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; OHNISHI H, 1995, BLOOD, V86, P1269; FIZZOTTI M, 1995, BLOOD, V85, P2685; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; PUI CH, 1993, BLOOD, V82, P343; NERI A, 1988, P NATL ACAD SCI USA, V85, P9268, DOI 10.1073/pnas.85.23.9268; HIRAMA T, 1995, BLOOD, V86, P841; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; CHEDID M, 1994, ONCOGENE, V9, P3021; KAWAMURA M, 1995, BLOOD, V85, P2546; CHENG J, 1990, MOL CELL BIOL, V10, P5502; Batova A, 1997, CANCER RES, V57, P832; NERI A, 1993, BLOOD, V81, P128; Lo KW, 1996, CANCER RES, V56, P2721; SIDRANSKY D, 1992, NATURE, V355, P846, DOI 10.1038/355846a0; KASTAN MB, 1991, CANCER RES, V51, P6304; HARPER JW, 1993, CELL, V75, P805; HEBERT J, 1994, BLOOD, V84, P4038; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SHIOHARA M, 1994, BLOOD, V84, P3781; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; MERLO A, 1995, NAT MED, V1, P686, DOI 10.1038/nm0795-686; ELDEIRY WS, 1994, CANCER RES, V54, P1169; TAKEUCHI S, 1995, BLOOD, V86, P755; FEINSTEIN E, 1991, P NATL ACAD SCI USA, V88, P6293, DOI 10.1073/pnas.88.14.6293; KOMURO H, 1993, CANCER RES, V53, P5284; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; IMAMURA J, 1994, BLOOD, V84, P2412; BOS JL, 1989, CANCER RES, V49, P4682; CHEN Q, 1990, EMBO J, V9, P415; DICCIANNI MB, 1994, BLOOD, V84, P3105; FENAUX P, 1992, LEUKEMIA, V6, P246; GREAVES MF, 1981, BRIT J HAEMATOL, V48, P179, DOI 10.1111/j.1365-2141.1981.tb02704.x; HAYASHI Y, 1988, BLOOD, V72, P15; HAYASHI Y, 1993, INT J HEMATOL, V57, P124; HAYASHI Y, 1990, BLOOD, V76, P1926; HORIBE K, 1994, JPN J CLIN HEMATOL R, V35, P657; HSIAO MH, 1994, BLOOD, V83, P2922; ICHIKAWA A, 1992, BLOOD, V79, P2701; Jagasia AA, 1996, LEUKEMIA, V10, P624; JONVEAUX P, 1991, ONCOGENE, V6, P2243; JONVEAUX P, 1991, LEUKEMIA, V5, P839; KAMB A, 1994, SCIENCE, V264, P436, DOI 10.1126/science.8153634; KANEKO Y, 1989, LEUKEMIA, V3, P1989; KIKUCHI A, 1993, LEUKEMIA, V7, P933; LEMAISTRE A, 1989, BLOOD, V73, P889; LUBBERT M, 1990, BLOOD, V75, P1163; MINEGISHI M, 1988, LEUKEMIA RES, V12, P227, DOI 10.1016/0145-2126(88)90140-3; MINEGISHI M, 1995, LEUKEMIA RES, V19, P433, DOI 10.1016/0145-2126(95)00016-H; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Ohnishi H, 1996, LEUKEMIA, V10, P1104; PUI CH, 1990, BLOOD, V75, P174; PULLEN DJ, 1981, CANCER RES, V41, P4802; QUESNEL B, 1995, BLOOD, V85, P657; RAIMONDI SC, 1988, BLOOD, V72, P1560; RASOOL O, 1995, BLOOD, V85, P3431; RIVERA GK, 1991, LANCET, V337, P61, DOI 10.1016/0140-6736(91)90733-6; RODENHUIS S, 1986, BLOOD, V67, P1698; SALLAN SE, 1980, BLOOD, V55, P395; SENN H, 1989, INT J CANCER, V41, P59; Sheng XM, 1997, LEUKEMIA RES, V21, P697, DOI 10.1016/S0145-2126(97)00036-2; Shimizu T, 1996, JPN J CANCER RES, V87, P275; SHUSTER JJ, 1990, BLOOD, V75, P166; SLINGERLAND JM, 1991, BLOOD, V77, P1500; SPRUCK CH, 1994, NATURE, V370, P183, DOI 10.1038/370183a0; SUGIMOTO K, 1992, BLOOD, V79, P2378; Takita J, 1997, CANCER RES, V57, P907; Tsuchida M, 1991, Acta Paediatr Jpn, V33, P522; WADA H, 1994, LEUKEMIA, V8, P53; WU JK, 1993, AM J HUM GENET, V52, P1273	72	73	77	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	FEB	1999	23	2					115	126		10.1016/S0145-2126(98)00146-5		12	Oncology; Hematology	Oncology; Hematology	166CU	WOS:000078559300004		
J	Hibino, A; Kiuchi, M				Hibino, A; Kiuchi, M			Pressureless combustion synthesis of dense TiAl intermetallic compounds by Ni/Al powder addition	MATERIALS TRANSACTIONS JIM			English	Article						combustion synthesis; self propagating high temperature synthesis; reaction sintering; TiAl; Ni3Al; intermetallic compound		In this paper, the fabrication of dense TiAl by the pressureless combustion synthesis has been attempted, and the synthesis conditions were investigated. The Ti and Al powders were mixed (Ti:Al=1:1 in atomic ratio), and press formed to a compact. It was heated in a vacuum furnace, and the synthesis reaction with the thermal explosion mode was generated. For the products obtained, the density, microstructure and phases present were analyzed. The Ni/Al pow der was mixed into the Ti/Al powder and the same experiment was attempted as well. The products synthesized became porous, and full dense TiAl could not be synthesized. It was guessed that the liquid quantity was insufficient to promote the densification and too small heat of formation would result in the poor densification. Therefore the Ni/Al powder was mixed into the Ti/Al powder as a sintering additive. When the Ni/Al powder was added to the Ti/Al powder, the product density reached more than 98%. The products consisted of TiAl, Ti3Al and solidified Ti-Ni-Al melt with the grain size of about 20 mu m. The Vickers hardness and compressive strength of the products were compared to those of the TiAl produced by the fusion process. The synthesis condition for the dense TiAl intermetallic compound by the combustion synthesis route could be determined in this study.	Univ Electrocommun, Dept Mech & Control Engn, Chofu, Tokyo 182, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Hibino, A (reprint author), Univ Electrocommun, Dept Mech & Control Engn, Chofugaoka 1-5-1, Chofu, Tokyo 182, Japan.						Barin I., 1995, THERMOCHEMICAL DATA; BOSE A, 1988, POWDER METALL INT, V20, P25; HIBINO A, 1996, J JAPAN SOC POWDER P, V43, P1208; Hibino A, 1997, J JPN I MET, V61, P128; HIBINO A, 1992, J JPN I MET, V56, P1435; HIBINO A, 1995, J JAPAN SOC POWDER P, V42, P1264; Merzhanov A. G., 1980, INT CHEM ENG, V20, P150; PHILPOT KA, 1987, J MATER SCI, V22, P159, DOI 10.1007/BF01160566; TSUJIMOTO T, 1984, J JPN I MET, V48, P435	9	3	4	JAPAN INST METALS	SENDAI	AOBA ARAMAKI, SENDAI, 980, JAPAN	0916-1821			MATER T JIM	Mater. Trans. JIM	FEB	1999	40	2					92	99				8	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	184NL	WOS:000079618200002		
J	Freund, RW; Jarre, F; Mizuno, S				Freund, RW; Jarre, F; Mizuno, S			Convergence of a class of inexact interior-point algorithms for linear programs	MATHEMATICS OF OPERATIONS RESEARCH			English	Article						linear program; infeasible-interior-point method; inexact search direction; linear system; residual; convergence	SYMMETRICAL INDEFINITE SYSTEMS	We present a convergence analysis for a class of inexact infeasible-interior-point methods for solving linear programs. The main feature of inexact methods is that the linear systems defining the search direction at each interior-point interation need not be solved to high accuracy More precisely, we allow that these linear systems are only solved to a moderate accuracy in the residual, but no assumptions are made on the accuracy of the search direction in the search space. In particular, our analysis does not require that feasibility is maintained even if the initial iterate happened to be a feasible solution of the linear program. We also present a few numerical examples to illustrate the effect of using inexact search direction on the number of interior-point iterations.	Lucent Technol, Bell Labs, Murray Hill, NJ 07974 USA; Univ Wurzburg, Inst Angew Math & Stat, D-97074 Wurzburg, Germany; Univ Tokyo, Inst Stat Math, Dept Predict & Control, Minato Ku, Tokyo 106, Japan	Freund, RW (reprint author), Lucent Technol, Bell Labs, 700 Mt Ave,Room 2C-420, Murray Hill, NJ 07974 USA.						KOJIMA M, 1993, MATH PROGRAM, V61, P263, DOI 10.1007/BF01582151; MIZUNO S, 1994, MATH PROGRAM, V67, P109, DOI 10.1007/BF01582216; KARMARKAR N, 1984, COMBINATORICA, V4, P373, DOI 10.1007/BF02579150; LUSTIG IJ, 1991, LINEAR ALGEBRA APPL, V152, P191, DOI 10.1016/0024-3795(91)90275-2; Andersen ED, 1995, MATH PROGRAM, V71, P221, DOI 10.1007/BF01586000; FREUND RW, 1991, NUMER MATH, V60, P315, DOI 10.1007/BF01385726; MONTEIRO RDC, 1989, MATH PROGRAM, V44, P27, DOI 10.1007/BF01587075; FOURER R, 1993, MATH PROGRAM, V62, P15, DOI 10.1007/BF01585158; FREUND RW, 1996, 9616 BELL LAB; FREUND RW, 1999, UNPUB NUMERCAL EXPER; FREUND RW, 1996, MATH PROGRAMMING B, V76, P183; FREUND RW, 1996, MATH PROGRAMMING; Gay D.M., 1985, MATH PROGRAMMING SOC, V13, P10; GONDZIO J, 1994, 9473 DELFT U TECHN F; Kojima M, 1989, PROGR MATH PROGRAMMI, P29; Lustig IJ, 1992, SIAM J OPTIMIZ, V2, P435, DOI 10.1137/0802022; Megiddo N., 1989, PROGR MATH PROGRAMMI, P131; Mizuno S, 1996, ANN OPER RES, V62, P59, DOI 10.1007/BF02206811; MIZUNO S, 1996, 605 I STAT MATH; PORTUGAL LF, 1994, TRUNCATED PRIMAL INF; Stoer J., 1993, INTRO NUMERICAL ANAL; TANABE K., 1988, SYSTEM MODELLING OPT, P197; VANDERBEI RJ, 1993, MATH PROGRAM, V58, P1, DOI 10.1007/BF01581257	23	18	19	INST OPERATIONS RESEARCH  MANAGEMENT SCIENCES	LINTHICUM HTS	901 ELKRIDGE LANDING RD, STE 400, LINTHICUM HTS, MD 21090-2909 USA	0364-765X			MATH OPER RES	Math. Oper. Res.	FEB	1999	24	1					50	71		10.1287/moor.24.1.50		22	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	217JY	WOS:000081497200004		
J	Kikuchi, A; Hanada, R; Yamamoto, K; Hayashi, Y				Kikuchi, A; Hanada, R; Yamamoto, K; Hayashi, Y			Detection of minimal residual disease by PCR in childhood T-cell acute lymphoblastic leukemia with TAL1 gene rearrangement: A preliminary report	MEDICAL AND PEDIATRIC ONCOLOGY			English	Article						T-ALL; TAL1; minimal residual disease; PCR			Saitama Childrens Med Ctr, Div Hematol Oncol, Iwatsuki, Saitama, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 113, Japan	Kikuchi, A (reprint author), Univ Tokyo, Inst Med Sci, Dept Clin Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 108, Japan.						BROWN L, 1990, EMBO J, V9, P3343; KIKUCHI A, 1993, LEUKEMIA, V7, P933	2	0	0	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0098-1532			MED PEDIATR ONCOL	Med. Pediatr. Oncol.	FEB	1999	32	2					148	148		10.1002/(SICI)1096-911X(199902)32:2<148::AID-MPO15>3.0.CO;2-A		1	Oncology; Pediatrics	Oncology; Pediatrics	159VK	WOS:000078195600015		
J	Matsuse, T; Ozawa, T; Orimo, H; Fukuchi, Y; Ouchi, Y; Iriki, M				Matsuse, T; Ozawa, T; Orimo, H; Fukuchi, Y; Ouchi, Y; Iriki, M			The difference between Japan and other countries, in particular the United Kingdom, in views regarding the teaching of geriatrics to undergraduate medical students	MEDICAL EDUCATION			English	Article						education, medical, undergraduate, methods; geriatrics, education; Great Britain; health service, aged; Japan		Objectives To examine differences in views on geriatrics education at the undergraduate level between Japan and other industrialized countries, including the United Kingdom. Design We conducted a nationwide survey of professorial staff responsible for undergraduate education in all medical schools in Japan, and an international survey of 37 medical schools and geriatric institutes in other industrialized countries, including 16 medical schools in the United Kingdom. Results The results indicate that undergraduate education in geriatrics in Japan emphasizes the theoretical aspects of the aging process and the features of diseases in the elderly, and lacks attention to the practical aspects of care. In contrast, geriatrics education in the United Kingdom and other countries places emphasis on practical aspects of the care of the elderly. Conclusions The introduction of practical aspects of management and care of the elderly to the undergraduate education programme in geriatrics in each medical school in Japan is strongly recommended. This is especially important to meet the needs of the rapid demographic shift towards an older population in this country.	Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, Tokyo 113, Japan; Tokyo Metropolitan Geriatr Hosp, Tokyo 173, Japan; Yamanashi Med Univ, Yamanashi 40938, Japan	Matsuse, T (reprint author), Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						STAHELIN HB, 1994, AGE AGEING, V23, P179, DOI 10.1093/ageing/23.3.179; *DEP STAT INF MIN, 1994, VIT STAT JAP, V1, P422; EVANS JG, 1994, AGE AGEING, V23, P177, DOI 10.1093/ageing/23.3.177; FUKUCHI Y, 1992, JAPAN J GERIATR, V29, P368; MARSHALL J, 1990, MED EDUC, V24, P528; PAWLSON LG, 1995, J AM GERIATR SOC, V43, P707; REUBEN DB, 1993, J AM GERIATR SOC, V41, P560	7	3	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0308-0110			MED EDUC	Med. Educ.	FEB	1999	33	2					140	144		10.1046/j.1365-2923.1999.00262.x		5	Education, Scientific Disciplines; Health Care Sciences & Services	Education & Educational Research; Health Care Sciences & Services	169UA	WOS:000078765900011		
J	Tanaka, H; Tanaka, K; Murakami, H; Okayama, H				Tanaka, H; Tanaka, K; Murakami, H; Okayama, H			Fission yeast Cdc24 is a replication factor C- and proliferating cell nuclear antigen-interacting factor essential for S-phase completion	MOLECULAR AND CELLULAR BIOLOGY			English	Article							DNA-POLYMERASE-DELTA; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL REPLICATION; LARGE SUBUNIT; CATALYTIC SUBUNIT; MAMMALIAN-CELLS; PROTEIN COMPLEX; GENE ENCODES; MCM PROTEIN	At the nonpermissive temperature the fission yeast cdc24-M38 mutant arrests in the cell cycle with incomplete DNA replication as indicated by pulsed-field gel electrophoresis. The cdc24(+) gene encodes a 501-amino-acid protein with no significant homolog to any known proteins. The temperature-sensitive cdc24 mutant is effectively rescued by pcn1(+), rfc1(+) (a fission yeast homologue of RFC1), and hhp1(+), which encode the proliferating cell nuclear antigen (PCNA), the large subunit of replication factor C (RFC), and a casein kinase I involved in DNA damage repair, respectively. The Cdc24 protein binds PCNA and RFC1 in vivo, and the domains essential for Cdc24 function and for RFC1 and PCNA binding colocalize in the N-terminal two-thirds of the molecule. In addition, cdc24(+) genetically interacts with the gene encoding the catalytic subunit of DNA polymerase epsilon, which is stimulated by PCNA. and RFC, and with those encoding the fission yeast counterparts of Mcm2, Mcm4, and Mcm10. These results indicate that Cdc24 is an RFC- and PCNA-interacting factor required for DNA replication and might serve as a target for regulation.	Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan	Okayama, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okayama@m.u-tokyo.ac.jp					ALKHODAIRY F, 1992, EMBO J, V11, P1343; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; FORSBURG SL, 1994, J CELL SCI, V107, P2779; Gould KL, 1998, GENETICS, V149, P1221; COXON A, 1992, NUCLEIC ACIDS RES, V20, P5571, DOI 10.1093/nar/20.21.5571; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; COSTELLO G, 1986, CURR GENET, V11, P119, DOI 10.1007/BF00378203; WASEEM NH, 1992, EMBO J, V11, P5111; OKAYAMA H, 1987, METHOD ENZYMOL, V154, P3; Warbrick E, 1997, ONCOGENE, V14, P2313, DOI 10.1038/sj.onc.1201072; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; CULLMANN G, 1995, MOL CELL BIOL, V15, P4661; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Merchant AM, 1997, MOL CELL BIOL, V17, P3261; DAMAGNEZ V, 1991, MOL GEN GENET, V226, P182, DOI 10.1007/BF00273602; MacNeill SA, 1996, EMBO J, V15, P4613; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1961; [Anonymous], 1991, METHOD ENZYMOL; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; BUNZ F, 1993, P NATL ACAD SCI USA, V90, P11014, DOI 10.1073/pnas.90.23.11014; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; DHILLON N, 1994, EMBO J, V13, P2777; DUrso G, 1997, P NATL ACAD SCI USA, V94, P12491, DOI 10.1073/pnas.94.23.12491; Fotedar R, 1996, EMBO J, V15, P4423; [Anonymous], 1974, HDB GENETICS; HIRANO T, 1986, EMBO J, V5, P2973; HOWELL EA, 1994, MOL CELL BIOL, V14, P255; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; Iino Y, 1997, MOL GEN GENET, V254, P93; KAWASAKI Y, UNPUB; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Leatherwood J, 1996, NATURE, V379, P360, DOI 10.1038/379360a0; LEE SH, 1991, J BIOL CHEM, V266, P22707; LEE SH, 1991, J BIOL CHEM, V266, P594; Maiorano D, 1996, EMBO J, V15, P861; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MCALEAR MA, 1994, MOL CELL BIOL, V14, P4390; MIYAKE S, 1993, MOL BIOL CELL, V4, P1003; NAGATA A, 1991, NEW BIOL, V3, P959; NISHIDA C, 1988, J BIOL CHEM, V263, P501; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; PIGNEDE G, 1991, J MOL BIOL, V222, P209, DOI 10.1016/0022-2836(91)90207-M; PRELICH G, 1987, NATURE, V326, P471, DOI 10.1038/326471a0; ROWLEY R, 1992, EMBO J, V11, P1335; Shivji K K, 1992, Cell, V69, P367; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tye Bik-Kwoon, 1994, Trends in Cell Biology, V4, P160, DOI 10.1016/0962-8924(94)90200-3; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; YAN H, 1993, GENE DEV, V7, P2149, DOI 10.1101/gad.7.11.2149; Zlotkin T, 1996, EMBO J, V15, P2298; Zuo SJ, 1997, P NATL ACAD SCI USA, V94, P11244, DOI 10.1073/pnas.94.21.11244	64	29	33	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0270-7306	1098-5549		MOL CELL BIOL	Mol. Cell. Biol.	FEB	1999	19	2					1038	1048				11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	158WR	WOS:000078140900008		
J	Takeyama, KI; Masuhiro, Y; Fuse, H; Endoh, H; Murayama, A; Kitanaka, S; Suzawa, M; Yanagisawa, J; Kato, S				Takeyama, KI; Masuhiro, Y; Fuse, H; Endoh, H; Murayama, A; Kitanaka, S; Suzawa, M; Yanagisawa, J; Kato, S			Selective interaction of vitamin D receptor with transcriptional coactivators by a vitamin D analog	MOLECULAR AND CELLULAR BIOLOGY			English	Article							NUCLEAR RECEPTORS; ESTROGEN-RECEPTOR; ACTIVATION FUNCTION-2; GENE-EXPRESSION; BINDING-PROTEIN; IN-VITRO; HORMONE; DOMAIN; AF-2; SUPERFAMILY	The nuclear vitamin D receptor (VDR) is a member of a nuclear receptor superfamily and acts as a ligand-dependent transcription factor. A family of cotranscriptional activators (SRC-1, TIF2, and AIB-1) interacts with and activates the transactivation function of nuclear receptors in a ligand-dependent way. We examined interaction of VDR with these coactivators that was induced by several vitamin D analogs, since they exert differential subsets of the biological action of vitamin D through unknown mechanisms. Unlike other vitamin D analogs tested, OCT (22-oxa-1 alpha,25-dihydroxyvitamin D-3) induced interaction of VDR with TIF2 but not with SRC-1 or AIB-1. Consistent with these interactions, only TIF2 was able to potentiate the transactivation function of VDR bound to OCT. Thus, the present findings suggest that the structure of VDR is altered in a vitamin D analog-specific way, resulting in selective interactions of VDR with coactivators. Such selective interaction of coactivators with VDR may specify the array of biological actions of a vitamin D analog like OCT, possibly through activating a particular set of target gene promoters.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol Corp, Core Res Evolution Sci & Technol, Saitama 332, Japan	Kato, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 113, Japan.	uskato@hongo.ecc.u-tokyo.ac.jp					ABE J, 1986, CANCER RES, V53, P2534; ABE J, 1991, ENDOCRINOLOGY, V129, P832; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; BIKLE DD, 1993, ENDOCR REV, V14, P3, DOI 10.1210/er.14.1.3; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; OKANO T, 1989, BIOCHEM BIOPH RES CO, V163, P1444, DOI 10.1016/0006-291X(89)91140-6; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; Heery DM, 1997, NATURE, V387, P733; Feng WJ, 1998, SCIENCE, V280, P1747, DOI 10.1126/science.280.5370.1747; CAVAILLES V, 1995, EMBO J, V14, P3741; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ONATE SA, 1995, SCIENCE, V270, P1354; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Imai T, 1997, BIOCHEM BIOPH RES CO, V233, P765, DOI 10.1006/bbrc.1997.6531; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Spencer TE, 1997, NATURE, V389, P194; TANAKA Y, 1984, ARCH BIOCHEM BIOPHYS, V229, P348, DOI 10.1016/0003-9861(84)90161-9; Voegel JJ, 1996, EMBO J, V15, P3667; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; CHAKRAVARTI D, 1996, P NATL ACAD SCI USA, V93, P4948; Chen LY, 1997, J AM COLL CARDIOL, V30, P569, DOI 10.1016/S0735-1097(97)00158-7; Darwish Hisham, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P89; DURAND B, 1994, EMBO J, V13, P5370; Ebihara K, 1996, MOL CELL BIOL, V16, P3393; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gill RK, 1998, MOL ENDOCRINOL, V12, P57; HALACHMI S, 1994, SCIENCE, V264, P1455, DOI 10.1126/science.8197458; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; HAUSSLER MR, 1988, RECENT PROG HORM RES, V44, P263; HENRY HL, 1978, SCIENCE, V201, P835, DOI 10.1126/science.684411; IKEDA T, 1992, BIOCHEM BIOPH RES CO, V189, P1231, DOI 10.1016/0006-291X(92)92336-V; Jurutka PW, 1997, J BIOL CHEM, V272, P14592, DOI 10.1074/jbc.272.23.14592; Kalkhoven E, 1998, EMBO J, V17, P232, DOI 10.1093/emboj/17.1.232; KATO S, 1995, MOL CELL BIOL, V15, P5858; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Masuyama H, 1997, MOL ENDOCRINOL, V11, P1507, DOI 10.1210/me.11.10.1507; May M, 1996, EMBO J, V15, P3093; MURAYAMA E, 1986, CHEM PHARM BULL, V34, P4410; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; SASAKI H, 1995, BIOCHEMISTRY-US, V34, P370, DOI 10.1021/bi00001a045; Songyang Z, 1993, Cell, V72, P767; TANAKA Y, 1982, ARCH BIOCHEM BIOPHYS, V218, P134, DOI 10.1016/0003-9861(82)90328-9; Tansey WP, 1997, CELL, V88, P729, DOI 10.1016/S0092-8674(00)81916-9; vom B. E., 1996, EMBO J, V15, P110	53	174	175	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	FEB	1999	19	2					1049	1055				7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	158WR	WOS:000078140900009		
J	Takuwa, N; Fukui, Y; Takuwa, Y				Takuwa, N; Fukui, Y; Takuwa, Y			Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts	MOLECULAR AND CELLULAR BIOLOGY			English	Article							PROTEIN-KINASE-C; P70 S6 KINASE; INITIATION-FACTOR 4E; VASCULAR ENDOTHELIAL-CELLS; DNA-SYNTHESIS; PHOSPHOINOSITIDE 3-KINASE; INDUCED ACTIVATION; CATALYTIC SUBUNIT; AKT PROTOONCOGENE; GLUCOSE-TRANSPORT	Phosphatidylinositol (PT) 3-kinase is required for G(1) to S phase cell cycle progression stimulated by a variety of growth factors and is implicated in the activation of several downstream effectors, including p70(S6K). However, the molecular mechanisms by which PI 3-kinase is engaged in activation of the cell cycle machinery are not well understood. Here we report that the expression of a dominant negative (DN) form of either the p110 alpha catalytic or the p85 regulatory subunit of heterodimeric PI 3-kinase strongly inhibited epidermal growth factor (EGF)-induced upregulation of cyclin D1 protein in NIH 3T3(M17) fibroblasts. The PI 3-kinase inhibitors LY29-4002 and wortmannin completely abrogated increases in both mRNA and protein levels of cyclin D1 and phosphorylation of pRb, inducing G(1) arrest in EGF-stimulated cells. By contrast, rapamycin, which potently suppressed p70(S6K) activity throughout the G(1) phase, had little inhibitory effect, if any, on either of these events. PI 3-kinase, but not rapamycin-sensitive pathways, was also indispensable for upregulation of cyclin D1 mRNA and protein by other mitogens in NIH 3T3 (M17) cells and in wild-type NIH 3T3 cells as well. We also found that an enforced expression of wild-type p110 was sufficient to induce cyclin D1 protein expression in growth factor-deprived NIH 3T3 (M17) cells. The p110 induction of cyclin D1 in quiescent cells was strongly inhibited by coexpression of either of the PI 3-kinase DN forms, and by LY294002, but was independent of the Ras-MEK-ERK pathway. Unlike mitogen stimulation, the p110 induction of cyclin D1 was sensitive to rapamycin. These results indicate that the catalytic activity of PI 3-kinase is necessary, and could also be sufficient, for upregulation of cyclin D1, with mTOR signaling being differentially required depending upon cellular conditions.	Univ Tokyo, Grad Sch Med, Dept Cellular & Mol Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Div Appl Biol Chem, Lab Biol Chem,Bunkyo Ku, Tokyo 1138657, Japan; Fdn Advancement Int Sci, Ibaraki, Osaka 3050005, Japan	Takuwa, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Cellular & Mol Physiol, Bunkyo Ku, Tokyo 1130033, Japan.	ntakuwa@m.u-tokyo.ac.jp	Fukui, Yasuhisa/E-8806-2010				Akimoto K, 1996, EMBO J, V15, P788; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; KLIPPEL A, 1993, MOL CELL BIOL, V13, P5560; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Brunn GJ, 1996, EMBO J, V15, P5256; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; ALBANESE C, 1995, J BIOL CHEM, V270, P23589; Klippel A, 1997, MOL CELL BIOL, V17, P338; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358; Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656; Beretta L, 1996, EMBO J, V15, P658; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Moscatello DK, 1998, J BIOL CHEM, V273, P200, DOI 10.1074/jbc.273.1.200; Dennis PB, 1996, MOL CELL BIOL, V16, P6242; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Lavoie JN, 1996, J BIOL CHEM, V271, P20608; Withers DJ, 1997, J BIOL CHEM, V272, P2509; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Kobayashi M, 1997, J BIOL CHEM, V272, P16089, DOI 10.1074/jbc.272.26.16089; Mendez R, 1996, MOL CELL BIOL, V16, P2857; COUGHLIN SR, 1989, SCIENCE, V243, P1191; Aktas H, 1997, MOL CELL BIOL, V17, P3850; WHITMAN M, 1988, NATURE, V332, P644, DOI 10.1038/332644a0; CHUNG JK, 1994, NATURE, V370, P71, DOI 10.1038/370071a0; TAKUWA N, 1993, J BIOL CHEM, V268, P138; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Proud CG, 1996, TRENDS BIOCHEM SCI, V21, P181, DOI 10.1016/S0968-0004(96)10016-5; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Westwick JK, 1997, MOL CELL BIOL, V17, P1324; BOS JL, 1995, TRENDS BIOCHEM SCI, V20, P441, DOI 10.1016/S0968-0004(00)89097-0; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; CAI H, 1990, MOL CELL BIOL, V10, P5314; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; FANTL WJ, 1992, CELL, V69, P413, DOI 10.1016/0092-8674(92)90444-H; Frevert EU, 1997, MOL CELL BIOL, V17, P190; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; HU P, 1994, MOL CELL BIOL, V14, P2577; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; HU SW, 1996, J BIOL CHEM, V271, P8977; JHUN BH, 1994, MOL CELL BIOL, V14, P7466; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; KIMURA K, 1994, J BIOL CHEM, V269, P18961; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Logan SK, 1997, MOL CELL BIOL, V17, P5784; McIlroy J, 1997, MOL CELL BIOL, V17, P248; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; Mitsui H, 1997, J BIOL CHEM, V272, P4904; MONFAR M, 1995, MOL CELL BIOL, V15, P326; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; PRICE DJ, 1990, P NATL ACAD SCI USA, V87, P7944, DOI 10.1073/pnas.87.20.7944; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; ROSENTHAL K, 1995, SEMIN AVIAN EXOT PET, V4, P1, DOI 10.1016/S1055-937X(05)80002-7; Takayanagi J, 1996, BIOCHEM MOL BIOL INT, V39, P721; TAKUWA N, UNPUB; Takuwa N, 1997, MOL CELL BIOL, V17, P5348; TOKER A, 1994, J BIOL CHEM, V269, P32358; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; VEMURI GS, 1994, BIOCHEM BIOPH RES CO, V202, P1619, DOI 10.1006/bbrc.1994.2118; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426; WENG QP, 1995, P NATL ACAD SCI USA, V92, P5744, DOI 10.1073/pnas.92.12.5744; WENG QP, 1995, MOL CELL BIOL, V15, P2333; Yao R, 1996, ONCOGENE, V13, P343; ZHOU W, 1993, J BIOL CHEM, V268, P23041; ZHOU W, 1994, BIOCHEM BIOPH RES CO, V199, P191, DOI 10.1006/bbrc.1994.1213	86	134	136	AMER SOC MICROBIOLOGY	WASHINGTON	1325 MASSACHUSETTS AVENUE, NW, WASHINGTON, DC 20005-4171 USA	0270-7306			MOL CELL BIOL	Mol. Cell. Biol.	FEB	1999	19	2					1346	1358				13	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	158WR	WOS:000078140900037		
J	Noma, K; Ohtsubo, E; Ohtsubo, H				Noma, K; Ohtsubo, E; Ohtsubo, H			Non-LTR retrotransposons (LINEs) as ubiquitous components of plant genomes	MOLECULAR AND GENERAL GENETICS			English	Article						plant kingdom; non-LTR retrotransposons; LINEs endonuclease gene; phylogeny	REVERSE-TRANSCRIPTASE; ARABIDOPSIS-THALIANA; DNA-SEQUENCES; BOMBYX-MORI; RICE; ELEMENT; FAMILY; IDENTIFICATION; ALIGNMENT; SILKWORM	During the course of work aimed at isolating a rice gene from Oryza australiensis by PCR, the oligonucleotide primers used were found to generate a fragment that showed sequence homology to the endonuclease (EN) region of the maize non-LTR retrotransposon (LINE) Cin4. We carried out further PCRs using oligonucleotide primers that hybridized to these sequences, and found that they amplified several fragments, each with homology to the EN regions, from Oryza sativa cv. Nipponbare as well as O. australiensis. We mapped the approximate locations of two rice LINE homologues by screening clones in a YAC library made from a rice (O. sativa) genome, and found that each homologue was present in a low copy number apparently at nonspecific regions on rice chromosomes. We then carried out PCR using degenerate oligonucleotide primers which hybridized to the rice LINE homologues and Cin4 to ascertain whether LINE homologues are present in a variety of members of the plant kingdom, including angiosperms, gymnosperms, bracken, horsetail and liverwort. Cloning and nucleotide sequencing revealed that 53 clones obtained from 27 out of 33 plant species contained LINE homologues. In addition to these homologues, we identified four homologues with EN regions in the Arabidopsis thaliana genome by a computer search of databases. The nucleotide sequences of almost all the LINE homologues were greatly diverged, but the derived amino acid sequences were well conserved, and all contained glutamic acid and tyrosine residues at almost the same relative positions as in the the active site regions of AP (apurinic/apyrimidinic) endonucleases. The EN regions in the LINE homologues from closely related plant species show a closer phylogenetic relationship, indicating that sequence divergence during Vertical transmission has been a major influence upon the evolution of plant LINEs.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Ohtsubo, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	hohtsubo@ims.u-tokyo.ac.jp					ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; MESSING J, 1983, METHOD ENZYMOL, V101, P20; LEETON PRJ, 1993, MOL GEN GENET, V237, P97; Harushima Y, 1998, GENETICS, V148, P479; OKAZAKI S, 1995, MOL CELL BIOL, V15, P4545; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; XIONG Y, 1990, EMBO J, V9, P3353; Kubis SE, 1998, PLANT MOL BIOL, V36, P821, DOI 10.1023/A:1005973932556; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; HATTORI M, 1986, NATURE, V321, P625, DOI 10.1038/321625a0; Berg DE, 1989, MOBILE DNA; Felsenstein J, 1995, PHYLIP PHYLOGENY INF; Feng QH, 1998, P NATL ACAD SCI USA, V95, P2083, DOI 10.1073/pnas.95.5.2083; GABRIEL A, 1993, REVERSE TRANSCRIPTAS, P275; GABRIEL A, 1991, P NATL ACAD SCI USA, V88, P9794, DOI 10.1073/pnas.88.21.9794; Higashiyama T, 1997, EMBO J, V16, P3715, DOI 10.1093/emboj/16.12.3715; HIROCHIKA H, 1993, JPN J GENET, V68, P35, DOI 10.1266/jjg.68.35; Hutchison III C.A, 1989, MOBILE DNA, P593; IVANOV VA, 1991, EMBO J, V10, P2489; Knoop V, 1996, GENETICS, V142, P579; Kumekawa N, 1999, MOL GEN GENET, V260, P593; Kurata N, 1997, PLANT MOL BIOL, V35, P101, DOI 10.1023/A:1005760717474; KURATA N, 1994, NAT GENET, V8, P365, DOI 10.1038/ng1294-365; LOEB DD, 1986, MOL CELL BIOL, V6, P168; MOCHIZUKI K, 1993, JPN J GENET, V68, P205, DOI 10.1266/jjg.68.205; Nakajima R, 1996, GENES GENET SYST, V71, P373, DOI 10.1266/ggs.71.373; OHTSUBO H, 1991, JPN J GENET, V66, P241, DOI 10.1266/jjg.66.241; Olivares M, 1997, J BIOL CHEM, V272, P25224, DOI 10.1074/jbc.272.40.25224; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Quigley F, 1996, NUCLEIC ACIDS RES, V24, P4313, DOI 10.1093/nar/24.21.4313; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHWARZSOMMER Z, 1987, EMBO J, V6, P3873; Takahashi H, 1997, NUCLEIC ACIDS RES, V25, P1578, DOI 10.1093/nar/25.8.1578; Wright DA, 1996, GENETICS, V142, P569	39	36	43	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0026-8925			MOL GEN GENET	Mol. Gen. Genet.	FEB	1999	261	1					71	79				9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	167LM	WOS:000078634300009		
J	Ogura, T; Inoue, K; Tatsuta, T; Suzaki, T; Karata, K; Young, K; Su, LH; Fierke, CA; Jackman, JE; Raetz, CRH; Coleman, J; Tomoyasu, T; Matsuzawa, H				Ogura, T; Inoue, K; Tatsuta, T; Suzaki, T; Karata, K; Young, K; Su, LH; Fierke, CA; Jackman, JE; Raetz, CRH; Coleman, J; Tomoyasu, T; Matsuzawa, H			Balanced biosynthesis of major membrane components through regulated degradation of the committed enzyme of lipid A biosynthesis by the AAA protease FtsH (HflB) in Escherichia coli	MOLECULAR MICROBIOLOGY			English	Article							FATTY-ACID BIOSYNTHESIS; UDP-N-ACETYLGLUCOSAMINE; ATP-DEPENDENT PROTEASE; ENDOTOXIN BIOSYNTHESIS; INNER MEMBRANE; A BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; BACTERIOPHAGE-LAMBDA; 1ST STEP; GENE	The suppressor mutation, named sfhC21, that allows Escherichia coli ftsH null mutant cells to survive was found to be an allele of fabZ encoding R-3-hydroxyacyl-ACP dehydrase, involved in a key step of fatty acid biosynthesis, and appears to upregulate the dehydrase. The ffsH1(Ts) mutation increased the amount of lipopolysaccharide at 42 degrees C. This was accompanied by a dramatic increase in the amount of UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase [the IpxC (envA) gene product] involved in the committed step of lipid A biosynthesis. Pulse-chase experiments and in vitro assays with purified components showed that FtsH, the AAA-type membrane-bound metalloprotease, degrades the deacetylase. Genetic evidence also indicated that the FtsH protease activity for the deacetylase might be affected when acyl-ACP pools were altered. The biosynthesis of phospholipids and the lipid A moiety of lipopolysaccharide, both of which derive their fatty acyl chains from the same R-3-hydroxyacyl-ACP pool, is regulated by FtsH.	Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8620976, Japan; Saitama Univ, Fac Sci, Dept Mol Biol, Urawa, Saitama 3388570, Japan; Kobe Univ, Fac Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; Merck Res Labs, Dept Microbiol, Rahway, NJ 07065 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Louisiana State Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Ogura, T (reprint author), Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Mol Cell Biol, Kumamoto 8620976, Japan.	ogura@gpo.kumamoto-u.ac.jp	Jackman, Jane/G-7167-2012				Akiyama Y, 1996, J BIOL CHEM, V271, P31196; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5218; Akiyama Y, 1998, J BIOL CHEM, V273, P22326, DOI 10.1074/jbc.273.35.22326; ANDERSON MS, 1988, BIOCHEMISTRY-US, V27, P1908, DOI 10.1021/bi00406a017; ANDERSON MS, 1985, J BIOL CHEM, V260, P5536; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; HEATH RJ, 1995, J BIOL CHEM, V270, P26538; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; AKIYAMA Y, 1995, J BIOL CHEM, V270, P23485; ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Heath RJ, 1996, J BIOL CHEM, V271, P27795; Young K, 1995, J BIOL CHEM, V270, P30384; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; KELLY TM, 1993, J BIOL CHEM, V268, P19866; AMES GF, 1968, J BACTERIOL, V95, P833; GALLOWAY SM, 1990, J BIOL CHEM, V265, P6394; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; DITTMER JC, 1964, J LIPID RES, V5, P126; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Deuerling E, 1997, MOL MICROBIOL, V23, P921, DOI 10.1046/j.1365-2958.1997.2721636.x; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; GAMER J, 1992, CELL, V69, P833, DOI 10.1016/0092-8674(92)90294-M; TOMOYASU T, 1993, J BACTERIOL, V175, P1352; MAGNUSON K, 1993, MICROBIOL REV, V57, P522; Shotland Y, 1997, MOL MICROBIOL, V24, P1303, DOI 10.1046/j.1365-2958.1997.4231796.x; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Tatsuta T, 1998, MOL MICROBIOL, V30, P583, DOI 10.1046/j.1365-2958.1998.01091.x; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; AKIYAMA Y, 1994, J BIOL CHEM, V269, P5225; BEGG KJ, 1992, J BACTERIOL, V174, P2416; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; EGAN AF, 1973, GENET RES, V21, P139; GANONG BR, 1982, J BIOL CHEM, V257, P389; Granger LL, 1998, J BACTERIOL, V180, P1920; Guelin E, 1996, FEBS LETT, V381, P42, DOI 10.1016/0014-5793(96)00074-9; Herman C, 1997, J BACTERIOL, V179, P358; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; HERMAN C, 1993, P NATL ACAD SCI USA, V90, P10861, DOI 10.1073/pnas.90.22.10861; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; KIDO N, 1990, J BACTERIOL, V172, P1145; Kihara A, 1996, EMBO J, V15, P6122; Kleerebezem M, 1996, RES MICROBIOL, V147, P609, DOI 10.1016/0923-2508(96)84016-2; Kloser A, 1998, MOL MICROBIOL, V27, P1003, DOI 10.1046/j.1365-2958.1998.00746.x; KORNITZER D, 1989, J BACTERIOL, V171, P2563; KUNAU WH, 1993, BIOCHIMIE, V75, P209, DOI 10.1016/0300-9084(93)90079-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonhard K, 1996, EMBO J, V15, P4218; Makino S, 1997, MOL GEN GENET, V254, P578; MATSUZAWA H, 1984, J BACTERIOL, V160, P733; Miller J. H., 1972, EXPT MOL GENETICS; NAKAI T, 1995, MOL CELL BIOL, V15, P4441; NICHOLS BW, 1963, BIOCHIM BIOPHYS ACTA, V70, P417, DOI 10.1016/0926-6542(63)90060-X; Paul Elizabeth S, 1995, Soc Anim, V3, P1, DOI 10.1163/156853095X00017; POSTBEITTENMILLER D, 1991, J BIOL CHEM, V266, P1858; PRADEL E, 1991, J BACTERIOL, V173, P6428; Qu JN, 1996, J BACTERIOL, V178, P3457; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Shirai Y, 1996, J BACTERIOL, V178, P1141; Sorensen PG, 1996, J BIOL CHEM, V271, P25898; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; TAUER R, 1994, FEBS LETT, V353, P197, DOI 10.1016/0014-5793(94)01045-5; TOMOYASU T, 1993, J BACTERIOL, V175, P1344; TOMOYASU T, 1995, EMBO J, V14, P2551; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826; Wang RF, 1998, J BACTERIOL, V180, P1929; Weber ER, 1996, MOL BIOL CELL, V7, P307; WIJSMAN HJW, 1972, J BACTERIOL, V110, P789	73	111	115	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	FEB	1999	31	3					833	844		10.1046/j.1365-2958.1999.01221.x		12	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	168TG	WOS:000078708300009		
J	Yang, YL; Guo, L; Xu, SA; Holland, CA; Kitamura, T; Hunter, K; Cunningham, JM				Yang, YL; Guo, L; Xu, SA; Holland, CA; Kitamura, T; Hunter, K; Cunningham, JM			Receptors for polytropic and xenotropic mouse leukaemia viruses encoded by a single gene at Rmc1	NATURE GENETICS			English	Article							MURINE LEUKEMIA-VIRUS; ENVELOPE GLYCOPROTEINS; CELLULAR RECEPTOR; PROTEIN; LEUKEMOGENESIS; CHROMOSOME-1; BINDING; SUSCEPTIBILITY; CONSTRUCTION; RETROVIRUSES	The onset of leukaemia caused by type C retroviruses (MLV) in mice is accelerated by the emergence of recombinant polytropic or mink cell focus-forming (MCF) viruses(1-4). Susceptibility to infection by polytropic/MCF and also by closely related xenotropic MLV has been mapped to Rmc1 on mouse chromosome 1 (refs 5-7). To identify this gene, we introduced an expression cDNA library prepared from mouse NIH3T3 fibroblasts into nonpermissive hamster cells and screened these cells for acquired susceptibility to MCF viruses encoding beta-galactosidase and G418 resistance. From hamster cell clones identified in the screen, we recovered a mouse cDNA that maps to Rmc1 and confers MCF MLV infection when expressed in nonpermissive cell lines. It encodes a membrane protein related to Syg1p (suppressor of yeast G alpha deletion; ref. 8), The receptor-binding domain of the MCF MLV envelope protein binds specifically to Xenopus laevis oocytes that express mouse Syg1, suggesting it functions as a receptor that mediates virus entry. We also obtained the cDNA encoding human SYG1. When expressed in hamster cells, it establishes infectivity by MCF MLV as well as xenotropic MLV, which do not infect laboratory mice.	Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Natl Med Ctr, Ctr Virol Immunol & Infect Dis Res, Washington, DC 20010 USA; Univ Tokyo, Inst Med Sci, Tokyo 108, Japan; Fox Chase Canc Ctr, Dept Mol Biol, Philadelphia, PA 19111 USA	Cunningham, JM (reprint author), Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.		Loewen, Nils/E-9946-2014	Loewen, Nils/0000-0001-7167-1213			ADAMS RM, 1992, P NATL ACAD SCI USA, V89, P8981, DOI 10.1073/pnas.89.19.8981; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; STOYE JP, 1991, J VIROL, V65, P1273; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; CHESEBRO B, 1985, VIROLOGY, V141, P119, DOI 10.1016/0042-6822(85)90188-6; Lyu MS, 1996, J VIROL, V70, P830; BATTINI JL, 1992, J VIROL, V66, P1468; Brojatsch J, 1996, CELL, V87, P845, DOI 10.1016/S0092-8674(00)81992-3; KOZAK CA, 1983, J VIROL, V48, P300; KOZAK CA, 1985, J VIROL, V55, P690; Fan H, 1997, TRENDS MICROBIOL, V5, P74, DOI 10.1016/S0966-842X(96)10076-7; BATTINI JL, 1995, J VIROL, V69, P713; Davey RA, 1997, J VIROL, V71, P8096; Fass D, 1997, SCIENCE, V277, P1662, DOI 10.1126/science.277.5332.1662; FLUBACHER MM, 1994, J VIROL, V68, P7709; HERR W, 1984, J VIROL, V50, P155; HUNTER K, 1991, SOMAT CELL MOLEC GEN, V17, P169, DOI 10.1007/BF01232974; HUNTER KW, 1994, MAMM GENOME, V5, P597, DOI 10.1007/BF00411453; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LI JP, 1991, J VIROL, V65, P2408; Loiler SA, 1997, J VIROL, V71, P4825; OTT D, 1992, J VIROL, V66, P4632; RUSCETTI S, 1981, J EXP MED, V154, P907, DOI 10.1084/jem.154.3.907; SPAIN BH, 1995, J BIOL CHEM, V270, P25435; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0	26	100	102	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					216	219				4	Genetics & Heredity	Genetics & Heredity	163MH	WOS:000078399500027		
J	Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T				Terauchi, Y; Tsuji, Y; Satoh, S; Minoura, H; Murakami, K; Okuno, A; Inukai, K; Asano, T; Kaburagi, Y; Ueki, K; Nakajima, H; Hanafusa, T; Matsuzawa, Y; Sekihara, H; Yin, YX; Barrett, JC; Oda, H; Ishikawa, T; Akanuma, Y; Komuro, I; Suzuki, M; Yamamura, K; Kodama, T; Suzuki, H; Koyasu, S; Aizawa, S; Tobe, K; Fukui, Y; Yazaki, Y; Kadowaki, T			Increased insulin sensitivity and hypoglycaemia in mice lacking the P85 alpha subunit of phosphoinositide 3-kinase	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASES; RAT ADIPOSE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; REGULATORY SUBUNIT; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; GROWTH-FACTOR; PROTEIN; SUBSTRATE-1; TRANSLOCATION	The hallmark of type 2 diabetes, the most common metabolic disorder, is a defect in insulin-stimulated glucose transport in peripheral tissues. Although a role for phosphoinositide-3-kinase (PI3K) activity in insulin-stimulated glucose transport and glucose transporter isoform 4 (Glut4) translocation has been suggested in vitro(1,2), its role in vive and the molecular link between activation of PI3K and translocation has not yet been elucidated. To determine the role of PI3K in glucose homeostasis, we generated mice with a targeted disruption of the gene encoding the p85 alpha regulatory subunit of PI3K (Pik3r1; refs 3-5). Pik3r1(-/-) mice showed increased insulin sensitivity and hypoglycaemia due to increased glucose transport in skeletal muscle and adipocytes. Insulin-stimulated PI3K activity associated with insulin receptor substrates (IRSs) was mediated via full-length p85 alpha in wild-type mice, but via the p50 alpha alternative splicing isoform of the same gene(6,7) in Pik3r1(-/-) mice. This isoform switch was associated with an increase in insulin-induced generation of phosphatidylinositol(3, 4, 5)triphosphate (PtdIns(3, 4, 5)P-3) in Pik3r1(-/-) adipocytes and facilitation of Glut4 translocation from the law-density microsome (LDM) fraction to the plasma membrane (PM). This mechanism seems to be responsible for the phenotype of Pik3r1(-/-) mice, namely increased glucose transport and hypoglycaemia. Our work provides the first direct evidence that PI3K and its regulatory subunit have a role in glucose homeostasis in vive.	Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Pathol, Tokyo 1138655, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1138655, Japan; Univ Tokyo, Dept Appl Biol Chem, Biol Chem Lab, Tokyo 1138655, Japan; Osaka Univ, Dept Internal Med 2, Suita, Osaka 565, Japan; Yokohama City Univ, Dept Internal Med, Yokohama, Kanagawa 236, Japan; NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; Asahi Life Fdn, Inst Diabet Care & Res, Tokyo 100, Japan; Kumamoto Univ, Sch Med, Lab Transgen Technol, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Dept Dev Genet, Kumamoto 860, Japan; Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Morphogenesis, Kumamoto 860, Japan; Keio Univ, Sch Med, Dept Immunol, Tokyo 160, Japan	Kadowaki, T (reprint author), Univ Tokyo, Dept Internal Med, Tokyo 1138655, Japan.		Fukui, Yasuhisa/E-8806-2010; Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361			CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Yamauchi T, 1996, MOL CELL BIOL, V16, P3074; HARANO Y, 1981, J CLIN ENDOCR METAB, V52, P982; PONS S, 1995, MOL CELL BIOL, V15, P4453; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; SATOH S, 1993, J BIOL CHEM, V268, P17820; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; SKOLNIK EY, 1991, CELL, V65, P83, DOI 10.1016/0092-8674(91)90410-Z; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; SUN XJ, 1995, NATURE, V377, P173, DOI 10.1038/377173a0; Holman GD, 1997, DIABETOLOGIA, V40, P991, DOI 10.1007/s001250050780; Antonetti DA, 1996, MOL CELL BIOL, V16, P2195; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; ESCOBEDO JA, 1991, CELL, V65, P75, DOI 10.1016/0092-8674(91)90409-R; Fruman DA, 1996, GENOMICS, V37, P113, DOI 10.1006/geno.1996.0527; Inukai K, 1996, J BIOL CHEM, V271, P5317; Inukai K, 1997, J BIOL CHEM, V272, P7873; Kaburagi Y, 1997, J BIOL CHEM, V272, P25839, DOI 10.1074/jbc.272.41.25839; KADOWAKI T, 1996, ENDOCR J, V43, P533; KELLY KL, 1993, J BIOL CHEM, V268, P4391; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Lavan BE, 1997, J BIOL CHEM, V272, P11439; Nave BT, 1996, BIOCHEM J, V318, P55; Ricort JM, 1996, EUR J BIOCHEM, V239, P17, DOI 10.1111/j.1432-1033.1996.0017u.x; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0	28	277	282	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	1999	21	2					230	235				6	Genetics & Heredity	Genetics & Heredity	163MH	WOS:000078399500030		
J	Hirawa, N; Uehara, Y; Suzuki, T; Kawabata, Y; Numabe, A; Gomi, T; Ikeda, T; Kizuki, K; Omata, M				Hirawa, N; Uehara, Y; Suzuki, T; Kawabata, Y; Numabe, A; Gomi, T; Ikeda, T; Kizuki, K; Omata, M			Regression of glomerular injury by kallikrein infusion in Dahl salt-sensitive rats is a bradykinin B-2-receptor-mediated event	NEPHRON			English	Article						kallikrein; bradykinin; Dahl salt-sensitive rats; renal injury; bradykinin antagonist; glomerulosclerosis; arterial injury; nitric oxide	SPONTANEOUSLY HYPERTENSIVE RATS; NITRIC-OXIDE SYNTHESIS; URINARY KALLIKREIN; BLOOD-PRESSURE; RENAL PROTECTION; PROLIFERATION; ARTERIOLES; GENERATION; AFFERENT; DISEASES	Aims: We investigated whether kallikrein infusion attenuates renal injury in Dahl salt-sensitive rats with hypertension and assessed the role of bradykinin-nitric oxide axis in the renal protection using HOE-140, the bradykinin type-2 (B-2) receptor specific antagonist. Methods: Subdepressor dose of purified rat urinary kallikrein (RUK) (400 ng/day) was continuously infused through the jugular vein by an osmotic mini-pump for 4 weeks in Dahl salt-sensitive (Dahl S) rats fed a high-salt (2% NaCl) diet. Results: Blood pressure increased in a time-dependent manner in Dahl S rats fed a high-salt diet. The RUK infusion did not influence the elevation of blood pressure in Dahl S rats. However, the RUK infusion significantly decreased urinary protein excretion, and increased glomerular filtration rate, as compared with untreated high-salt Dahl S rats. Morphological investigation disclosed that the RUK infusion significantly attenuated glomerulosclerosis and arterial and tubular injuries in the kidney of hypertensive Dahl S rats. The RUK infusion produced an increase in urinary excretions of nitric oxide and cyclic guanosine monophosphate. In addition, the RUK infusion enhanced the generation of nitric oxide from the kidney slices. The functional and morphological effects of the RUK infusion on the kidney were completely lessened by co-administration of the bradykinin B-2-receptor antagonist, HOE-140. Conclusion: Long-term infusion of subdepressor close of rat urinary kallikrein attenuates functionally and morphologically the progression of renal injury in Dahl rats susceptible to salt-induced hypertension, and that the protection is mediated by stimulation of bradykinin B-2 receptor.	Univ Tokyo, Dept Med 2, Bunkyo Ku, Tokyo 113, Japan; Asahi Hosp, Dept Nephrol, Yokohama, Kanagawa, Japan; Sci Univ Tokyo, Fac Pharmaceut Sci, Dept Biochem, Tokyo 162, Japan; Dokkyo Univ Hosp, Dept Clin Pathol, Tochigi, Japan; NTT Kantoh Teishin Hosp, Dept Nephrol, Tokyo, Japan	Uehara, Y (reprint author), Univ Tokyo, Dept Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						YANG WD, 1994, BIOCHEM BIOPH RES CO, V203, P1160, DOI 10.1006/bbrc.1994.2304; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; BAYLIS C, 1992, J CLIN INVEST, V90, P278, DOI 10.1172/JCI115849; CHEN PY, 1993, HYPERTENSION, V22, P812; RAIJ L, 1984, KIDNEY INT, V26, P137, DOI 10.1038/ki.1984.147; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; ARBEIT LA, 1985, KIDNEY INT, V28, P440, DOI 10.1038/ki.1985.150; ARIMA S, 1995, KIDNEY INT, V48, P683, DOI 10.1038/ki.1995.338; Chao J, 1997, PHARMACOL RES, V35, P517, DOI 10.1006/phrs.1997.0179; CHEN PY, 1993, LAB INVEST, V68, P174; CHURCHILL PC, 1995, AM J PHYSIOL-RENAL, V269, pF710; FRIEDMAN M, 1946, P SOC EXP BIOL MED, V70, P670; GARG UC, 1989, AM J PHYSIOL, V257, P60; HIRAWA N, 1995, J HYPERTENS, V13, P81; HIRAWA N, 1991, CLIN SCI, V81, P499; HIRAWA N, 1994, J HYPERTENS, V12, P909; IDEISHI M, 1994, J HYPERTENS, V12, P653; IKEKITA M, 1987, CHEM PHARM BULL, V35, P2071; Ito S, 1997, CLIN EXP PHARMACOL P, V24, P532, DOI 10.1111/j.1440-1681.1997.tb01241.x; KATORI M, 1992, AGENT ACTION SUPPL, V38, P235; KIZUKI K, 1990, J ENDOCRINOL, V127, P317, DOI 10.1677/joe.0.1270317; Kotake Y, 1996, BBA-GEN SUBJECTS, V1289, P362, DOI 10.1016/0304-4165(95)00172-7; MARGOLIUS HS, 1989, ANNU REV PHARMACOL, V29, P343; OGAWA K, 1985, KLIN WOCHENSCHR, V63, P332, DOI 10.1007/BF01731977; OHISHI K, 1992, AM J PHYSL F, V263, P900; REID GM, 1988, HYPERTENSION, V11, P179; ROSEN S, 1990, KIDNEY INT, V37, P1067, DOI 10.1038/ki.1990.87; SARKAR R, 1995, SURGERY, V118, P274, DOI 10.1016/S0039-6060(05)80334-4; SHULTZ PJ, 1990, AM J PHYSIOL, V258, P162; TAKAOKA M, 1984, BIOCHEM BIOPH RES CO, V122, P1282, DOI 10.1016/0006-291X(84)91231-2; TOBIAN L, 1982, HYPERTENSION, V4, P149; UEHARA Y, 1991, J HYPERTENS, V9, P719, DOI 10.1097/00004872-199108000-00005; UEHARA Y, 1987, PROSTAGLANDINS, V33, P727, DOI 10.1016/0090-6980(87)90038-4; UEHARA Y, 1994, HYPERTENSION, V24, P770; WANG C, 1995, J CLIN INVEST, V95, P1710, DOI 10.1172/JCI117847; WATANABE Y, 1993, OUYO YAKURI, V45, P445; WIEMER G, 1991, HYPERTENSION, V18, P558; Yoshida H, 1997, AM J HYPERTENS, V10, pS73	38	24	25	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-2766			NEPHRON	Nephron	FEB	1999	81	2					183	193		10.1159/000045275		11	Urology & Nephrology	Urology & Nephrology	170JN	WOS:000078802700010		
J	Hirose, A; Onishi, H				Hirose, A; Onishi, H			Proposal of relative-minimization learning for behavior stabilization of complex-valued recurrent neural networks	NEUROCOMPUTING			English	Article						learning; recurrent network; complex-valued network; stability; Lyapunov exponent	BACKPROPAGATION; TIME	Relative-minimization learning using additional random teacher signal points is proposed for behavior stabilization of complex-valued recurrent neural networks. Although recurrent neural networks can deal with time-sequential data, they tend to show an unstable behavior after a large number of iterations, The proposed method superimposes a type of basin upon a dynamics-determining hypersurface in an information vector field. It is shown that this process is equivalent to the relative minimization of the error function in the input-signal partial space. Experiments demonstrate that the relative-minimization learning suppresses positive values of Lyapunov exponents down to zero or negative. It is shown that the network behavior becomes stable successfully. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 153, Japan	Hirose, A (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.						AIHARA K, 1990, CHAOS SCI; HIROSE A, 1992, ELECTRON LETT, V28, P1492, DOI 10.1049/el:19920948; Bersini H, 1997, IEEE T NEURAL NETWOR, V8, P437, DOI 10.1109/72.557698; HIROSE A, P IEEE INT C NEUR NE, V2, P657; Hirose A, 1996, APPL OPTICS, V35, P836, DOI 10.1364/AO.35.000836; WERBOS PJ, 1990, P IEEE, V78, P1550, DOI 10.1109/5.58337	6	7	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-2312			NEUROCOMPUTING	Neurocomputing	FEB	1999	24	1-3					163	171		10.1016/S0925-2312(98)00093-9		9	Computer Science, Artificial Intelligence	Computer Science	173KJ	WOS:000078979500007		
J	Uchida, I; Kikyo, H; Nakajima, K; Konishi, S; Sekihara, K; Miyashita, Y				Uchida, I; Kikyo, H; Nakajima, K; Konishi, S; Sekihara, K; Miyashita, Y			Activation of lateral extrastriate areas during orthographic processing of Japanese characters studied with fMRI	NEUROIMAGE			English	Article							POSITRON EMISSION TOMOGRAPHY; CEREBRAL BLOOD-FLOW; BRAIN ACTIVITY; KANJI; DURATION; CORTEX; WORDS; PET	We investigated the early orthographic processing in the occipital cortex using Japanese morphogram by functional magnetic resonance imaging. Kanji (Japanese morphogram) is one system of character used in the Japanese language, each character of which has a specific meaning and pronunciations. To ensure that the effects of the general visual properties of Kanji were excluded from Kanji-related activation, we created strict control stimuli, the "scrambled Kanji" that had the same luminance, contrast, and retinotopical size as those of the original Kanji. In the Kanji vs scrambled Kanji task, we found significant activation in the left inferior occipital gyrus. However, we found no activation in earlier visual cortices, including the primary visual cortex, indicating that the scrambled Kanji served as an effective control stimulus for this task. In the Kanji vs blank screen task, much more areas, including earlier visual cortices, were activated. The activation that we found in the Kanji vs scrambled Kanji task was compatible with the results of previous studies of English letter strings by other groups, suggesting that the left inferior occipital gyrus plays an essential role in orthographic processing common to these two different writing systems. (C) 1999 Academic Press.	Univ Tokyo, Sch Med, Dept Physiol, Tokyo 1130033, Japan; Japan Sci & Technol Corp, ICORP, Mind Articulat Project, Tokyo 1130034, Japan; Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan	Uchida, I (reprint author), Univ Tokyo, Sch Med, Dept Physiol, Tokyo 1130033, Japan.						Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Puce A, 1996, J NEUROSCI, V16, P5205; PRICE CJ, 1994, BRAIN, V117, P1255, DOI 10.1093/brain/117.6.1255; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; LABERGE D, 1974, COGNITIVE PSYCHOL, V6, P293, DOI 10.1016/0010-0285(74)90015-2; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; COLTHEART M, 1993, PSYCHOL REV, V100, P589, DOI 10.1037//0033-295X.100.4.589; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; DAMASIO AR, 1983, NEUROLOGY, V33, P1573; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; SAKAI K, 1995, P ROY SOC B-BIOL SCI, V261, P89, DOI 10.1098/rspb.1995.0121; SAKURAI Y, 1993, NEUROREPORT, V4, P327, DOI 10.1097/00001756-199303000-00026; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; KIYOSAWA M, 1995, JPN J OPHTHALMOL, V39, P198; Konishi S, 1996, NEUROREPORT, V8, P19, DOI 10.1097/00001756-199612200-00005; Law I., 1991, J NEUROLINGUIST, V6, P243, DOI 10.1016/0911-6044(91)90020-J; Makabe T., 1997, Society for Neuroscience Abstracts, V23, P2227; MAKABE T, 1997, NEUROIMAGE, V5, pS556; Price CJ, 1996, NEUROIMAGE, V3, P40, DOI 10.1006/nimg.1996.0005; SAKAI K, 1995, MAGNET RESON MED, V33, P736, DOI 10.1002/mrm.1910330521; SAKURAI Y, 1992, NEUROREPORT, V3, P445, DOI 10.1097/00001756-199205000-00017; SOMA Y, 1989, BRAIN, V112, P1549, DOI 10.1093/brain/112.6.1549; SUGISHITA M, 1987, NEUROPSYCHOLOGIA, V25, P329, DOI 10.1016/0028-3932(87)90022-4; SUGISHITA M, 1978, NEUROPSYCHOLOGIA, V16, P417, DOI 10.1016/0028-3932(78)90065-9; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	30	40	41	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119			NEUROIMAGE	Neuroimage	FEB	1999	9	2					208	215		10.1006/nimg.1999.0400		8	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	166ZW	WOS:000078608900003		
J	Kirino, T				Kirino, T			Molecular biology and cerebrovascular diseases	NEUROLOGICAL SURGERY			Japanese	Article						molecular biology; gene therapy; apoptosis; genetics; vascular biology	ISCHEMIC BRAIN INJURY; INTERLEUKIN-1-BETA CONVERTING-ENZYME; HEREDITARY CEREBRAL-HEMORRHAGE; TRANSGENIC MICE; GENE-THERAPY; INTRACRANIAL ANEURYSMS; CELL-DEATH; NERVOUS-SYSTEM; NITRIC-OXIDE; IN-VIVO		Univ Tokyo, Fac Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan							Chen J, 1998, J NEUROSCI, V18, P4914; Bennett MVL, 1996, COLD SPRING HARB SYM, V61, P373; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Collen D, 1998, NAT MED, V4, P279, DOI 10.1038/nm0398-279; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; OHNO T, 1994, SCIENCE, V265, P781, DOI 10.1126/science.8047883; Morishita R, 1997, NAT MED, V3, P894, DOI 10.1038/nm0897-894; Namura S, 1998, J NEUROSCI, V18, P3659; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Ronkainen A, 1997, LANCET, V349, P380, DOI 10.1016/S0140-6736(97)80009-8; Murakami K, 1998, J NEUROSCI, V18, P205; Plumier JCL, 1997, CELL STRESS CHAPERON, V2, P162, DOI 10.1379/1466-1268(1997)002<0162:TMETHI>2.3.CO;2; Schielke GP, 1998, J CEREBR BLOOD F MET, V18, P180, DOI 10.1097/00004647-199802000-00009; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Zhang FY, 1997, J NEUROSCI, V17, P7655; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Iadecola C, 1997, J NEUROSCI, V17, P9157; Connolly ES, 1997, CIRC RES, V81, P304; Barinaga M, 1996, SCIENCE, V272, P664; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; Xu DG, 1997, NAT MED, V3, P997, DOI 10.1038/nm0997-997; Anderson WF, 1998, NATURE, V392, P25; CRUMRINE RC, 1994, J CEREBR BLOOD F MET, V14, P887; Jeffs B, 1997, NAT GENET, V16, P364, DOI 10.1038/ng0897-364; Gorter JA, 1997, J NEUROSCI, V17, P6179; Keller JN, 1998, J NEUROSCI, V18, P687; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Asano T, 1998, CRIT REV NEUROSURG, V8, P176, DOI 10.1007/s003290050075; Bonn D, 1998, LANCET, V352, P119, DOI 10.1016/S0140-6736(98)85026-5; CHANG MW, 1995, SCIENCE, V267, P518, DOI 10.1126/science.7824950; Cornejo C J, 1997, Adv Pharmacol, V39, P99, DOI 10.1016/S1054-3589(08)60070-8; DEGRABA TJ, 1995, CURR OPIN NEUROL, V8, P24, DOI 10.1097/00019052-199502000-00005; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Gage FH, 1998, NATURE, V392, P18; Gibbons GH, 1996, SCIENCE, V272, P689, DOI 10.1126/science.272.5262.689; Graeber MB, 1998, J NEUROL SCI, V153, P251, DOI 10.1016/S0022-510X(97)00295-5; GUNEL M, 1995, P NATL ACAD SCI USA, V92, P6620, DOI 10.1073/pnas.92.14.6620; Hara H, 1997, J CEREBR BLOOD F MET, V17, P370, DOI 10.1097/00004647-199704000-00002; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; Ho DY, 1997, SCI AM, V276, P116; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Karpati G, 1996, TRENDS NEUROSCI, V19, P49; Leblanc R, 1997, CAN J NEUROL SCI, V24, P191; Liu PK, 1996, J NEUROSCI, V16, P6795; MacManus JP, 1997, J CEREBR BLOOD F MET, V17, P815; Morikawa E, 1996, STROKE, V27, P951; MORISHITA R, 1995, P NATL ACAD SCI USA, V92, P5855, DOI 10.1073/pnas.92.13.5855; Muhonen MG, 1997, STROKE, V28, P822; Rastenyte D, 1998, J NEUROL SCI, V153, P132, DOI 10.1016/S0022-510X(97)00286-4; SCHIEVINK WI, 1994, STROKE, V25, P2028; SCHIEVINK WI, 1994, STROKE, V25, P889; Schievink WI, 1997, NEUROSURGERY, V40, P651, DOI 10.1097/00006123-199704000-00001; Sharma P, 1996, J HYPERTENS, V14, P277, DOI 10.1097/00004872-199603000-00002; Soriano SG, 1996, ANN NEUROL, V39, P618, DOI 10.1002/ana.410390511; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; TSUBOKAWA H, 1995, NEUROREPORT, V6, P527, DOI 10.1097/00001756-199502000-00030; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; Zamzami N, 1997, J BIOENERG BIOMEMBR, V29, P185, DOI 10.1023/A:1022694131572	67	1	1	IGAKU-SHOIN LTD	TOKYO	5-24-3 HONGO BUNKYO-KU, TOKYO, 113 91, JAPAN	0301-2603			NEUROL SURG TOKYO	Neurol. Surg.	FEB	1999	27	2					111	118				8	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	174RV	WOS:000079049500002		
J	Kabayama, H; Takei, K; Fukuda, M; Ibata, K; Mikoshiba, K				Kabayama, H; Takei, K; Fukuda, M; Ibata, K; Mikoshiba, K			Functional involvement of synaptotagmin I/II C2A domain in neurite outgrowth of chick dorsal root ganglion neuron	NEUROSCIENCE			English	Letter						synaptotagmin; C2 domains; DRG neuron; neurite outgrowth; exocytosis	HIGH-POLYPHOSPHATE BINDING; TRANSMITTER RELEASE; ANTIBODY INJECTION; AXONAL GROWTH; C-2 DOMAIN; PROTEINS; EXOCYTOSIS; MEMBRANE; RECEPTOR; CALCIUM	Synaptotagmin I or II (Syt I/II) is involved in Ca2+-regulated exocytosis of secretory vesicles, probably serving as a Ca2+-sensor via its C2A domain. Synaptotagmin is also known to be expressed in neuronal growth cone vesicles, but its functional involvement in neurite outgrowth remains largely unknown. In this study,we examined the function of Syt I/II in neurite outgrowth in cultured chick dorsal root ganglion neurons using an anti-synaptotagmin I and II C2A domain (anti-STI/II-C2A) antibody that inhibits Ca2+-regulated exocytosis. Immunoblots confirmed the high specificity of the anti-STI/II-C2A antibody and shelved the expression of synaptotagmin I or II in chick dorsal root ganglion neurons. Immunocytochemistry revealed that synaptotagmin I or II is enriched at the growth cone region of chick dorsal root ganglion neurons, in both lamellipodia and filopodia. Whole or Fab-fragment of the anti-STI/II-C2A antibody loaded into dorsal root ganglion neurons by trituration significantly inhibited neurite outgrowth, whereas preimmune immunoglobulin G had no effect. These results showed that the C2A domain of synaptotagmin I or II plays a crucial role in neurite outgrowth. (C) 1998 IBRO. Published by Elsevier Science Ltd.	RIKEN, Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Mol Neurobiol Lab, Tsukuba, Ibaraki 3050074, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, ERATO, Calciosignal Net Project, Meguro Ku, Tokyo 1530064, Japan	Fukuda, M (reprint author), RIKEN, Inst Phys & Chem Res, Tsukuba Life Sci Ctr, Mol Neurobiol Lab, 3-1-1 Koyadai, Tsukuba, Ibaraki 3050074, Japan.		Ibata, Keiji/L-5802-2013; Fukuda, MItsunori/I-1511-2015				FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667; CLARKE MSF, 1992, J CELL SCI, V102, P533; YOSHIDA A, 1992, J BIOL CHEM, V267, P24925; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; KATER SB, 1991, J NEUROSCI, V11, P891; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; Thompson CC, 1996, J NEUROSCI, V16, P7832; Igarashi M, 1996, J CELL BIOL, V134, P205, DOI 10.1083/jcb.134.1.205; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Schiavo G, 1995, CURR TOP MICROBIOL, V195, P257; Ide C, 1996, NEUROSCI RES, V25, P101; Fukuda M, 1996, J BIOL CHEM, V271, P8430; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; BRAY D, 1995, CULTURING NERVE CELL, P104; FUKUDA M, 1995, J BIOL CHEM, V270, P26523; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Igarashi M, 1997, J NEUROSCI, V17, P1460; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; LOU XJ, 1993, DEV BIOL, V159, P327, DOI 10.1006/dbio.1993.1244; Mochida S, 1997, NEUROSCIENCE, V77, P937; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; PERIN MS, 1991, J BIOL CHEM, V266, P623; Sugimori M, 1998, NEUROSCIENCE, V86, P39, DOI 10.1016/S0306-4522(97)00689-1; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314	32	28	28	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience	FEB	1999	88	4					999	1003		10.1016/S0306-4522(98)00547-8		5	Neurosciences	Neurosciences & Neurology	146PJ	WOS:000077439300002		
J	Tsutsumi, K; Ohno, H; Okada, Y; Fujimaki, T; Kirino, T				Tsutsumi, K; Ohno, H; Okada, Y; Fujimaki, T; Kirino, T			Fenestrated oculomotor nerve caused by meningioma around the cavernous sinus: A surgical pitfall in tumor removal: Case report	NEUROSURGERY			English	Article						fenestration; meningioma; oculomotor nerve		OBJECTIVE AND IMPORTANCE: The preservation of oculomotor nerves is one of the most significant issues regarding the resection of meningiomas around the cavernous sinus. CLINICAL PRESENTATION: We report the case of a patient whose oculomotor nerve was fenestrated, caused by a large meningioma around the cavernous sinus. The nerve function remained intact until surgery. INTERVENTION: During surgery, one trunk of fenestrated nerve behind the tumor was sacrificed. The fenestrated shape of the nerve led us to the misjudgment that the preserved other trunk located along the upper margin of the tumor was the whole nerve. CONCLUSION: Although fenestrated oculomotor nerves may be rare, their possibility should be kept in mind during surgery around the cavernous sinus.	Aizu Chuou Hosp, Dept Neurosurg, Fukushima, Japan; Univ Tokyo, Dept Neurosurg, Tokyo 113, Japan	Tsutsumi, K (reprint author), Aizu Chuou Hosp, Dept Neurosurg, Fukushima, Japan.						SEKHAR LN, 1992, J NEUROSURG, V76, P935, DOI 10.3171/jns.1992.76.6.0935	1	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-396X			NEUROSURGERY	Neurosurgery	FEB	1999	44	2					395	397		10.1097/00006123-199902000-00089		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	163FR	WOS:000078394000076		
J	Watanabe, H				Watanabe, H			Synthetic studies on the insect antifeedant terpenes: Azadirachtin and tanabalin	NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY			Japanese	Review						insect antifeedant; azadirachtin; clerodane; tanabalin	DIELS-ALDER REACTION; CLERODANE DITERPENOIDS; SESTERTERPENOID (+/-)-PALAUOLIDE; ANTIBACTERIAL CLERODANE; ASYMMETRIC-SYNTHESIS; AJUGARIN-IV; CONSTRUCTION; INDICA; CHEMISTRY; NMR		Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Watanabe, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.						Watanabe H, 1997, TETRAHEDRON LETT, V38, P4429, DOI 10.1016/S0040-4039(97)00923-4; MORDUE AJ, 1993, J INSECT PHYSIOL, V39, P903, DOI 10.1016/0022-1910(93)90001-8; Tokoroyama T, 1998, J ORG CHEM, V63, P4151, DOI 10.1021/jo980188t; BILTON JN, 1987, TETRAHEDRON, V43, P2805, DOI 10.1016/S0040-4020(01)86886-1; BROUGHTON HB, 1986, J CHEM SOC CHEM COMM, P46, DOI 10.1039/c39860000046; Butterworth JH, 1968, J CHEM SOC CHEM COMM, P23; Cunat AC, 1996, J CHEM SOC PERK T 1, P611, DOI 10.1039/p19960000611; GOLDSMITH DJ, 1995, SYNLETT, P495; HAGIWARA H, 1994, TETRAHEDRON LETT, V35, P8189, DOI 10.1016/0040-4039(94)88279-7; HAGIWARA H, 1995, J CHEM SOC PERK T 1, P757, DOI 10.1039/p19950000757; HENRY KJ, 1994, J ORG CHEM, V59, P5128, DOI 10.1021/jo00097a007; IIO H, 1987, J CHEM SOC CHEM COMM, P358, DOI 10.1039/c39870000358; JONES PS, 1986, TETRAHEDRON, V42, P6519, DOI 10.1016/S0040-4020(01)88114-X; KANOH N, 1995, SYNLETT, P895; Kanoh N, 1997, SYNLETT, P737; KENDE AS, 1982, TETRAHEDRON LETT, V23, P1751, DOI 10.1016/S0040-4039(00)86731-3; KOLB HC, 1992, J CHEM SOC PERK T 1, P2763, DOI 10.1039/p19920002763; KOLB HC, 1992, J CHEM SOC PERK T 1, P2735, DOI 10.1039/p19920002735; KOOT WJ, 1995, TETRAHEDRON, V51, P2077, DOI 10.1016/0040-4020(94)01071-7; KRAUS W, 1985, TETRAHEDRON LETT, V26, P6435, DOI 10.1016/S0040-4039(00)99020-8; KRAUS W, 1987, TETRAHEDRON, V43, P2817, DOI 10.1016/S0040-4020(01)86887-3; Kubo I, 1996, CHEM LETT, P441, DOI 10.1246/cl.1996.441; LEY SV, 1983, J CHEM SOC CHEM COMM, P503, DOI 10.1039/c39830000503; LEY SV, 1993, NAT PROD REP, P109; Liu HJ, 1997, CAN J CHEM, V75, P646, DOI 10.1139/v97-079; Liu WC, 1998, SYNLETT, P912; LOPEZ JC, 1997, J CHEM SOC CHEM COMM, P2251; MERRITT AT, 1992, NAT PROD REP, V9, P243, DOI 10.1039/np9920900243; PIERS E, 1992, TETRAHEDRON LETT, V33, P6923, DOI 10.1016/S0040-4039(00)60896-1; PIERS E, 1988, J CHEM SOC CHEM COMM, P1245, DOI 10.1039/c39880001245; PIERS E, 1995, J CHEM SOC PERK T 1, P963, DOI 10.1039/p19950000963; PIERS E, 1987, J CHEM SOC CHEM COMM, P1342, DOI 10.1039/c39870001342; PIERS E, 1994, CAN J CHEM, V72, P146; Seaman F., 1990, DITERPENES FLOWERING; SHARMA AS, 1985, TETRAHEDRON, V41, P4581, DOI 10.1016/S0040-4020(01)82353-X; TAKAHASHI S, 1979, CHEM LETT, P515, DOI 10.1246/cl.1979.515; TOKOROYAMA T, 1980, TETRAHEDRON, V36, P3377, DOI 10.1016/0040-4020(80)80188-8; TOKOROYAMA T, 1990, B CHEM SOC JPN, V63, P1720, DOI 10.1246/bcsj.63.1720; TOKOROYAMA T, 1983, J CHEM SOC CHEM COMM, P1516, DOI 10.1039/c39830001516; TOKOROYAMA T, 1988, TETRAHEDRON, V44, P6607, DOI 10.1016/S0040-4020(01)90099-7; TOKOROYAMA T, 1987, TETRAHEDRON LETT, V28, P6645, DOI 10.1016/S0040-4039(00)96935-1; TOKOROYAMA T, 1978, TETRAHEDRON, V34, P1907, DOI 10.1016/0040-4020(78)80096-9; TURNER CJ, 1987, TETRAHEDRON, V43, P2789, DOI 10.1016/S0040-4020(01)86885-X; Watanabe H, 1996, TETRAHEDRON, V52, P13939, DOI 10.1016/0040-4020(96)00856-3; WATANABE H, TETRAHEDRON LETT	45	0	0	JAPAN SOC BIOSCI BIOTECHN AGROCHEM	TOKYO	JAPAN ACAD SOC CTR BLDG, 2-4-6 YAYOI BUNKYO-KU, TOKYO, 113, JAPAN	0002-1407			NIPPON NOGEIK KAISHI	Nippon Nogeikagaku Kaishi-J. Jpn. Soc. Biosci. Biotechol. Agrochem.	FEB	1999	73	2					117	123				7	Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics	Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology; Nutrition & Dietetics	163YN	WOS:000078434600002		
J	Murakawa, Y; Yamashita, T; Kanese, Y; Sezaki, K; Omata, M				Murakawa, Y; Yamashita, T; Kanese, Y; Sezaki, K; Omata, M			Is ventricular fibrillation interval an indicator of electrical defibrillation threshold?	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						ventricular fibrillation; defibrillation; electrocardiogram	ENERGY-REQUIREMENTS; DOGS; CARDIOVERSION; FREQUENCY; SUCCESS	To clarify whether peak-to-peak interval of the fibrillation wave (VF interval) during VF is an independent indicator of defibrillation efficacy, we measured the transcardiac DFT, SF intervals of the surface and local ECGs (lead ii and the right ventricle), and the ERP in 82 open-chest dogs. Both VF intervals showed a negative correlation with heart weight (surface: r = -0.358 [P < 0.005]; local: r = -0.349 [P < 0.005]). DFT was 2.0 +/- 0.7 A and positively correlated with heart rr eight (r = 0.453 [P < 0.0001]). ERP did not show a significant correlation with heart weight. DFT rr as negatively correlated with VF interval (vs surface VF interval: r = -0.568 [P < 0.0001]; rs local VF interval: r = -0.504 [P < 0.0001]), but showed only a weak negative correlation with ERP (r = -0.314 [P < 0.005]). Er en after allowing for the dependency of DFT and VF intervals on heart weight (normalized to a 100-g heart), the correlation between VF interval and DFT was still significant (vs surface VF interval: r = -0.487 [P < 0.0001]; vs local VF interval: r = -0.414 [P < 0.0002]). These results suggest that VF interval is an indicator of DFT in intact hearts that have not received pharmacological intervention.	Univ Tokyo, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan	Murakawa, Y (reprint author), Univ Tokyo, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ECHT DS, 1989, CIRCULATION, V79, P1106; JOSEPHSON ME, 1979, AM J CARDIOL, V44, P623, DOI 10.1016/0002-9149(79)90279-0; BROWN CG, 1991, ANN EMERG MED, V20, P787, DOI 10.1016/S0196-0644(05)80843-1; KERBER RE, 1992, CIRCULATION, V85, P158; Herlitz J, 1997, RESUSCITATION, V34, P17, DOI 10.1016/S0300-9572(96)01064-7; STROHMENGER HU, 1994, ANESTH ANALG, V79, P434; OPTHOF T, 1991, CIRC RES, V68, P1204; BABBS CF, 1978, AM HEART J, V95, P331, DOI 10.1016/0002-8703(78)90364-2; Bollmann Andreas, 1997, Circulation, V96, pI529; CHAPMAN PD, 1987, AM HEART J, V114, P274, DOI 10.1016/0002-8703(87)90490-X; Dorian P, 1996, CAN J CARDIOL, V12, P399; DORIAN P, 1994, CAN J CARDIOL, V10, P193; ECHT DS, 1988, PACE, V11, P1315, DOI 10.1111/j.1540-8159.1988.tb03994.x; GASCHO JA, 1979, CIRCULATION, V60, P231; KUELZ KW, 1994, IEEE T BIO-MED ENG, V41, P782, DOI 10.1109/10.310093; MURAKAWA Y, 1997, J AM COLL CARDIOL, V21, P102; OUYANG P, 1981, AM J CARDIOL, V48, P455, DOI 10.1016/0002-9149(81)90072-2; RUFFY R, 1986, CIRCULATION, V73, P374; SCHRADER R, 1992, J CARDIOVASC PHARM, V19, P839, DOI 10.1097/00005344-199206000-00001; TASHIRO N, 1992, CLIN CARDIOL, V15, P733; WAGNER G S, 1969, Progress in Cardiovascular Diseases, V11, P431, DOI 10.1016/0033-0620(69)90030-9; WINKLE RA, 1984, CIRCULATION, V69, P766	22	8	8	FUTURA PUBL CO	ARMONK	135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418 USA	0147-8389			PACE	PACE-Pacing Clin. Electrophysiol.	FEB	1999	22	2					302	306		10.1111/j.1540-8159.1999.tb00442.x		5	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	171WM	WOS:000078887200009		
J	Shiraishi, H; Kikuchi, Y; Momoi, MY; Yanagisawa, M				Shiraishi, H; Kikuchi, Y; Momoi, MY; Yanagisawa, M			Hemodynamic effect of rapid atrial pacing in fetal lambs	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						fetal lamb; cardiac output; atrial pacing; hydrops fetalis; supraventricular tachyarrhythmia	SUPRAVENTRICULAR TACHYCARDIA; VENTRICULAR OUTPUT; HYDROPS-FETALIS; MANAGEMENT; DIAGNOSIS; DIGOXIN; SHEEP; TACHYARRHYTHMIAS; ECHOCARDIOGRAPHY	To determine the threshold at which rapid atrial pacing brings on fetal circulatory failure, rte made a fetal supraventricular tachyarrhythmia model and measured the central venous pressure, aortic pressure, and right and left ventricular outputs in five fetal lambs. Under maternal anesthesia, the uterus rr as opened, and under local anesthesia, polyvinyl catheters were inserted into the fetal superior vena car a and ascending aorta through a neck incision. Pacing leads (Medtronic model 6492) were then sutured onto the fetal right atrial appendage via right thoracotomy. Ventricular output rr as estimated using a Toshiba SSH-65A echocardiography by a transuterine approach. Fetal hemodynamics rr-ere observed without pacing (control), and at the atrial pacing rates of 200, 300, 350, and 400/min. Central venous pressure (CVP) increased and the aortic pressure decreased when the right atrium was paced at 350/min or more. Right ventricular output decreased rr hen the right atrium was paced at 300/min or more. The left ventricular output, however, remained constant. The right ventricular output rt as 382 +/- 106 mL/kg/min at control, and 391 +/- 117 mL/kg/min rt hen paced at 200/min, but decreased to 210 +/- 138 mL/kg/min rt hen paced at 300/min, to 223 +/- 102 mL/kg/min rr hen paced at 350/min, and to 186 +/- 86 mL/kg/min rt hen paced at 400/min. Fetal circulatory failure occurred when the right atrium rt as paced at 300/min or more.	Jichi Med Sch, Dept Pediat, Minami Kawachi, Tochigi 32904, Japan; Univ Tokyo, Tokyo, Japan	Shiraishi, H (reprint author), Jichi Med Sch, Dept Pediat, Minami Kawachi, Tochigi 32904, Japan.						ANDERSON PAW, 1984, AM J PHYSIOL, V247, pH371; Naheed ZJ, 1996, J AM COLL CARDIOL, V27, P1736, DOI 10.1016/0735-1097(96)00054-X; Shinbane JS, 1997, J AM COLL CARDIOL, V29, P709; AZANCOTBENISTY A, 1992, J PEDIATR-US, V121, P608, DOI 10.1016/S0022-3476(05)81156-4; GEMBRUCH U, 1993, AM HEART J, V125, P1290, DOI 10.1016/0002-8703(93)90997-N; IGARASHI H, 1994, AM HEART J, V127, P1336, DOI 10.1016/0002-8703(94)90053-1; KIKUCHI Y, 1995, PACE, V18, P417, DOI 10.1111/j.1540-8159.1995.tb02540.x; KLEINMAN CS, 1997, 2 WORLD C PED CARD C; KLEINMAN CS, 1985, SEMIN PERINATOL, V9, P113; KOHL T, 1995, OBSTET GYNECOL, V85, P873, DOI 10.1016/0029-7844(94)00314-4; MAXWELL DJ, 1988, BRIT MED J, V297, P107; NEWBURGER JW, 1997, J PEDIAT 1, V95, P780; NIMROD C, 1987, AM J OBSTET GYNECOL, V157, P655; OWEN J, 1988, AM J OBSTET GYNECOL, V158, P1169; RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183; SHIRAISHI H, 1993, AM J OBSTET GYNECOL, V168, P947; SILVERMAN NH, 1985, J CLIN ULTRASOUND, V13, P255, DOI 10.1002/jcu.1870130405; STEVENS DC, 1982, AM J OBSTET GYNECOL, V142, P316; VALERIUS NH, 1978, ACTA OBSTET GYN SCAN, V57, P407; VANENGELEN AD, 1994, J AM COLL CARDIOL, V24, P1371; WEINER CP, 1988, AM J OBSTET GYNECOL, V158, P570; WIGGINS JW, 1986, AM J DIS CHILD, V140, P202; YOUNIS JS, 1987, AM J OBSTET GYNECOL, V157, P1268	23	6	6	FUTURA PUBL CO	ARMONK	135 BEDFORD RD, PO BOX 418, ARMONK, NY 10504-0418 USA	0147-8389			PACE	PACE-Pacing Clin. Electrophysiol.	FEB	1999	22	2					320	325		10.1111/j.1540-8159.1999.tb00445.x		6	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	171WM	WOS:000078887200012		
J	Yang, JH; Shikata, N; Yasuda, T; Matsuzawa, A; Tsubura, A				Yang, JH; Shikata, N; Yasuda, T; Matsuzawa, A; Tsubura, A			Sjogren's syndrome in mice carrying the Ipr(cg) gene and the therapeutic efficacy of an immunosuppressive agent FK506	PATHOLOGY INTERNATIONAL			English	Article						autoimmunity; immunotherapy; Ipr(cg) gene; Sjogren's syndrome; superantigen	TUMOR VIRUS MMTV; LPR MICE; AUTOIMMUNE-DISEASE; MOUSE MODEL; T-CELLS; SIALADENITIS; FK-506; GLANDS; SUPERANTIGEN; INDUCTION	The influence of the Ipr(cg) gene on the development of Sjogren's syndrome was followed up to 5 months of age in male and female mice of MRL, CBA and C3H strains. In MRL-Ipr(cg) mice, focal mononuclear cell infiltration started at 2 months and became conspicuous after 3 months of age in the lacrimal and submandibular glands but was minimal in the parotid and sublingual glands, even at 5 months of age, without any apparent sex effects found. In CBA and C3H mice carrying the Ipr(cg) gene, this manifestation of Sjogren's syndrome was much less prominent, indicating that the participation of some genes of the MRL strain may be indispensable for the development of Sjogren's syndrome in mice carrying this gene. In MRL-Ipr(cg) mice, an immunosuppressive agent, FK506, improved the serological abnormalities (decreased levels of anti-double-stranded DNA antibody of IgG2a and IgG3 subclasses) and proteinuria. It also reduced the manifestations of Sjogren's syndrome when it was intraperitoneally administered three times weekly at a dose of 2 mg/kg from 6 weeks (before disease onset) until 5 months of age (the termination of the experiment). Although V beta 8.2(+) T cells have been demonstrated to be responsible for causing several autoimmune diseases, the selective deletion of V beta 8.2(+) T cells with the superantigen encoded by mouse mammary tumor virus did not affect the disease severity at all, suggesting that this T cell repertoire may not play a crucial role in induction of Sjogren's syndrome.	Kansai Med Univ, Dept Pathol, Moriguchi, Osaka 5708506, Japan; Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo, Japan	Tsubura, A (reprint author), Kansai Med Univ, Dept Pathol, Moriguchi, Osaka 5708506, Japan.	tsubura@takii.kmu.ac.jp					MATSUZAWA A, 1990, J EXP MED, V171, P519, DOI 10.1084/jem.171.2.519; KINO T, 1987, J ANTIBIOT, V40, P1249; CHISHOLM DM, 1968, J CLIN PATHOL, V21, P656, DOI 10.1136/jcp.21.5.656; IZUI S, 1984, J IMMUNOL, V133, P227; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; FURUKAWA F, 1995, ARCH DERMATOL RES, V287, P558, DOI 10.1007/BF00374076; HAYASHI Y, 1994, EUR J IMMUNOL, V24, P2826, DOI 10.1002/eji.1830241137; HAYASHI Y, 1995, ARTHRITIS RHEUM, V38, P1077, DOI 10.1002/art.1780380809; HOFFMAN RW, 1984, ARTHRITIS RHEUM, V27, P157, DOI 10.1002/art.1780270206; JABS DA, 1985, INVEST OPHTH VIS SCI, V26, P1223; JABS DA, 1994, ADV EXP MED BIOL, V350, P623; JONSSON R, 1987, IMMUNOLOGY, V60, P611; KIMURA M, 1992, IMMUNOLOGY, V76, P498; Kimura M, 1994, Int Rev Immunol, V11, P193, DOI 10.3109/08830189409061727; KIMURA M, 1990, CLIN EXP IMMUNOL, V79, P123; MATSUZAWA A, 1995, CANCER LETT, V90, P3, DOI 10.1016/0304-3835(94)03671-5; MOUNTZ J D, 1991, Current Opinion in Rheumatology, V3, P738, DOI 10.1097/00002281-199110000-00004; NAKANO H, 1993, EUR J IMMUNOL, V23, P2434, DOI 10.1002/eji.1830231009; Ono M, 1995, EXP EYE RES, V61, P659, DOI 10.1016/S0014-4835(05)80016-8; SCOTT J, 1990, J ORAL PATHOL MED, V19, P131, DOI 10.1111/j.1600-0714.1990.tb00811.x; SKARSTEIN K, 1995, SCAND J IMMUNOL, V42, P529, DOI 10.1111/j.1365-3083.1995.tb03691.x; TAKABAYASHI K, 1989, CLIN IMMUNOL IMMUNOP, V51, P110, DOI 10.1016/0090-1229(89)90211-0; TAKAHASHI S, 1993, MOL IMMUNOL, V30, P177; TANAKA S, 1987, JPN J EXP MED, V57, P241; THOMSON AW, 1992, AUTOIMMUNITY, V12, P303, DOI 10.3109/08916939209148473; TSUBURA A, 1987, JPN J EXP MED, V57, P255; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; YAMAMOTO K, 1990, IMMUNOLOGY, V69, P222; Yamano S, 1997, J CLIN PATHOL, V50, P223, DOI 10.1136/jcp.50.3.223; Yoshimoto T, 1996, VIROLOGY, V223, P387, DOI 10.1006/viro.1996.0492; YOSHIMOTO T, 1994, EUR J IMMUNOL, V24, P1612, DOI 10.1002/eji.1830240724	32	5	5	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1320-5463			PATHOL INT	Pathol. Int.	FEB	1999	49	2					133	140		10.1046/j.1440-1827.1999.00834.x		8	Pathology	Pathology	185MJ	WOS:000079672500006		
J	Liaw, J; Aoyagi, T; Kataoka, K; Sakurai, Y; Okano, T				Liaw, J; Aoyagi, T; Kataoka, K; Sakurai, Y; Okano, T			Permeation of PEO-PBLA-FITC polymeric micelles in aortic endothelial cells	PHARMACEUTICAL RESEARCH			English	Article						polymeric micelles; FITC; endothelial; endocytosis	MACROMOLECULAR PERMEABILITY; ELECTRICAL-RESISTANCE; MOLECULAR-WEIGHT; BLOCK-COPOLYMER; IN-VITRO; TRANSPORT; NANOSPHERES; ADRIAMYCIN; CAPILLARY; LIPOSOMES	Purpose. To determine aortic endothelial cells permeation ability and mechanisms of the aqueous block copolymeric micelles, poly(ethylene oxide)-poly (beta-benzyl L-aspartate) (PEO-PBLA) chemically conjugated with fluroescein isothiocyanate (FITC) by transport study and confocal laser scanning microscopy. Methods, The block copolymers' PEO-PBLA-FITC was first synthesized and characterized by gel permeation chromatography (GPC) reflect index, UV, fluorescence detectors, and critical micelles concentrations (CMC). and atomic force microscopy (AFM). Permeation ability and mechanisms of polymeric micelles in aortic endothelial cells were evaluated by incubating with NaF NaN3, wortmannin, cytochalasin B inhibitors, at 20 degrees C, and under reverse conditions. FITC and latex panicles (40 nm) were also used for comparison of transport ability. The extent of localization of uptake polymeric micelles was established by confocal laser scanning microscopy. Results. The size of the aqueous PEO-PBLA-FITC polymeric micelles was detected at around 56 nm with unimodal distribution by AFM. The CMC test revealed the fluorescence intensity increased to around 0.01 similar to 0.05 mg/ml. NaF, NaN3, wortmannin, cytochalasin B, 20 degrees C, and reverse experiments inhibited the absorption of polymeric micelles through aortic endothelial cells with apparent permeability coefficients (P) of 18.07 +/- 1.03 to 12.98 +/- 0.93, 11.31 +/- 0.77, 12.44 +/- 1.23, 6.40 +/- 0.23, 11.11 +/- 0.46, and 10.22 +/- 1.09 x 10(-7) cm/sec, respectively. Also, the permeation of FITC and latex on aortic endothelial cells was 70.02 +/- 4.71, and 2.05 +/- 0.41 x 10(-7) cm/sec, respectively. Confocal laser microscopy showed that fluorescent compounds were distributed in the intracellular cytoplasm and nucleus. Conclusions. PEO-PBLA-FITC copolymeric micelles in an aqueous system were transported by energy-dependent endocytosis with 18.07 x 10(-7) cm/sec penetrated range and were localized on intracellular and nucleus endothelial cells.	Taipei Med Coll, Sch Pharm, Dept Pharmaceut, Taipei, Taiwan; Tokyo Womens Med Univ, Inst Biomed Engn, Shinjuku Ku, Tokyo 162, Japan; Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 113, Japan	Liaw, J (reprint author), Taipei Med Coll, Sch Pharm, Dept Pharmaceut, Taipei, Taiwan.	jhorng@tmc.edu.tw	Okano, Teruo/J-4028-2012; Kataoka, Kazunori/K-7108-2012	Kataoka, Kazunori/0000-0002-8591-413X			Mooren FC, 1998, PHARMACEUT RES, V15, P58, DOI 10.1023/A:1011996619500; JANI P, 1989, J PHARM PHARMACOL, V41, P809; LIU SM, 1993, J CELL PHYSIOL, V156, P311, DOI 10.1002/jcp.1041560213; YOKOYAMA M, 1990, CANCER RES, V50, P1693; NINOMIYA N, 1994, J BIOL CHEM, V269, P22732; LUM H, 1994, AM J PHYSIOL, V267, pL223; RUTTEN MJ, 1987, BRAIN RES, V425, P301, DOI 10.1016/0006-8993(87)90513-0; Hrkach JS, 1997, BIOMATERIALS, V18, P27, DOI 10.1016/S0142-9612(96)00077-4; Torchilin VP, 1998, J MICROENCAPSUL, V15, P1, DOI 10.3109/02652049809006831; Miller DW, 1997, BIOCONJUGATE CHEM, V8, P649, DOI 10.1021/bc970118d; MIZUGUCHI H, 1994, BIOL PHARM BULL, V17, P1385; Dunn SE, 1997, J CONTROL RELEASE, V44, P65, DOI 10.1016/S0168-3659(96)01504-0; GILLIES MC, 1995, CURR EYE RES, V14, P435, DOI 10.3109/02713689509003753; KWON GS, 1995, PHARMACEUT RES, V12, P192, DOI 10.1023/A:1016266523505; Lacasse FX, 1998, PHARMACEUT RES, V15, P312, DOI 10.1023/A:1011935222652; LEE KD, 1993, BIOCHEMISTRY-US, V32, P889, DOI 10.1021/bi00054a021; Liaw J, 1998, PHARMACEUT RES, V15, P1721, DOI 10.1023/A:1011908728838; LIAW J, 1992, INT J PHARM, V88, P125, DOI 10.1016/0378-5173(92)90309-P; MAEDA H, 1992, BIOCONJUGATE CHEM, V3, P351, DOI 10.1021/bc00017a001; Martys JL, 1996, J BIOL CHEM, V271, P10953; Molema G, 1997, PHARMACEUT RES, V14, P2, DOI 10.1023/A:1012038930172; OKADA K, 1988, J IMMUNOL, V140, P878; PLEYER U, 1995, SURV OPHTHALMOL, V39, pS3, DOI 10.1016/S0039-6257(05)80068-2; RATYCH RE, 1987, SURGERY, V102, P122; VertutDoi A, 1996, BBA-BIOMEMBRANES, V1278, P19, DOI 10.1016/0005-2736(95)00185-9; WALTROUSPELTIER N, 1992, PHARMACEUT RES, V9, P1177; ZALIPSKY S, 1995, ADV DRUG DELIVER REV, V16, P157, DOI 10.1016/0169-409X(95)00023-Z	27	26	26	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741			PHARMACEUT RES	Pharm. Res.	FEB	1999	16	2					213	220		10.1023/A:1012157906528		8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	176HL	WOS:000079145600007		
J	Ito, K; Kusuhara, H; Sugiyama, Y				Ito, K; Kusuhara, H; Sugiyama, Y			Effects of intestinal CYP3A4 and P-glycoprotein on oral drug absorption - Theoretical approach	PHARMACEUTICAL RESEARCH			English	Article						oral absorption; CYP3A4; P-glycoprotein; diffusion model; drug interaction	HUMAN SMALL-BOWEL; CACO-2 CELLS; METABOLISM; CYCLOSPORINE; RAT; BIOAVAILABILITY; PREDICTION; TRANSPORT; LIVER; MODEL	Purpose. To evaluate the effects of gut metabolism and efflux on drug absorption by simulation studies using a pharmacokinetic model involving diffusion in epithelial cells. Methods. A pharmacokinetic model for drug absorption was constructed including metabolism by CYP3A4 inside the epithelial cells, P-gp-mediated efflux into the lumen, intracellular diffusion from the luminal side to the basal side, and subsequent permeation through the basal membrane. Partial differential equations were solved to yield an equation for the fraction absorbed from gut to the blood. Effects of inhibition of CYP3A4 and/or P-gp on the fraction absorbed were simulated for a hypothetical substrate for both CYP3A4 and P-gp. Results. The fraction absorbed after oral administration was shown to increase following inhibition of P-gp. This increase was more marked when the efflux clearance of the drug was greater than the sum of the metabolic and absorption clearances and when the intracellular diffusion constant was small. Furthermore, it was demonstrated that the fraction absorbed was synergistically elevated by simultaneous inhibition of both CYP3A4 and P-gp. Conclusions. The analysis using our present diffusion model is expected to allow the prediction of in vivo intestinal drug absorption and related drug interactions from in vitro studies using human intestinal microsomes, gut epithelial cells, CYP3A4-expressed Caco-2 cells, etc.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Ito K, 1998, ANNU REV PHARMACOL, V38, P461, DOI 10.1146/annurev.pharmtox.38.1.461; KOLARS JC, 1991, LANCET, V338, P1488, DOI 10.1016/0140-6736(91)92302-I; Ito K, 1998, PHARMACOL REV, V50, P387; WU CY, 1995, CLIN PHARMACOL THER, V58, P492, DOI 10.1016/0009-9236(95)90168-X; Iwatsubo T, 1997, PHARMACOL THERAPEUT, V73, P147, DOI 10.1016/S0163-7258(96)00184-2; Thummel KE, 1996, CLIN PHARMACOL THER, V59, P491, DOI 10.1016/S0009-9236(96)90177-0; Schuetz EG, 1996, MOL PHARMACOL, V49, P311; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; ARTURSSON P, 1991, BIOCHEM BIOPH RES CO, V175, P880, DOI 10.1016/0006-291X(91)91647-U; KOMIYA I, 1980, INT J PHARM, V4, P249, DOI 10.1016/0378-5173(80)90140-4; LEVITT MD, 1990, J CLIN INVEST, V86, P1540, DOI 10.1172/JCI114873; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387; Iwatsubo T, 1996, BIOPHARM DRUG DISPOS, V17, P273, DOI 10.1002/(SICI)1099-081X(199605)17:4<273::AID-BDD961>3.0.CO;2-R; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741; Chiba M, 1997, BIOCHEM PHARMACOL, V53, P1187, DOI 10.1016/S0006-2952(97)00100-7; Crespi CL, 1996, PHARMACEUT RES, V13, P1635, DOI 10.1023/A:1016428304366; GOMEZ DY, 1995, CLIN PHARMACOL THER, V58, P15, DOI 10.1016/0009-9236(95)90067-5; GUPTA SK, 1989, BRIT J CLIN PHARMACO, V27, P475; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; SAITOH H, 1995, PHARMACEUT RES, V12, P1304, DOI 10.1023/A:1016217505990; SATHIRAKUL K, 1993, BIOL PHARM BULL, V16, P273; STOCK RJ, 1989, HEPATOLOGY, V9, P75, DOI 10.1002/hep.1840090112; Sugiyama Yuichi, 1996, Journal of Toxicological Sciences, V21, P309; Terao T, 1996, J PHARM PHARMACOL, V48, P1083; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; Yamashita S, 1997, PHARMACEUT RES, V14, P486, DOI 10.1023/A:1012103700981; Zhang YC, 1998, DRUG METAB DISPOS, V26, P360	30	98	103	KLUWER ACADEMIC/PLENUM PUBL	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0724-8741			PHARMACEUT RES	Pharm. Res.	FEB	1999	16	2					225	231		10.1023/A:1018872207437		7	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Chemistry; Pharmacology & Pharmacy	176HL	WOS:000079145600009		
J	Nagai, H; Matsuura, S; Bouda, K; Takaoka, Y; Wang, T; Niwa, S; Shudo, K				Nagai, H; Matsuura, S; Bouda, K; Takaoka, Y; Wang, T; Niwa, S; Shudo, K			Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice	PHARMACOLOGY			English	Article						retinoid; Am-80; collagen-induced arthritis; IL-6	COLLAGEN-INDUCED ARTHRITIS; II COLLAGEN; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; PASSIVE TRANSFER; BINDING-PROTEIN; ACID; CELLS; RECEPTOR; RATS	Am-80 is a newly snythesized retinoid with the structure of one aromatic amide among retinobenzoic acids. It exhibits specific biological activities of retinoic acid such as the activation of cellular differentiation and proliferation. We investigated the effect of Am-80 on collagen-induced arthritis (CIA) in mice and the immunopharmacological action on the production of several cytokines in the in vitro and in vivo models. Am-80, at doses of 0.3, 1 and 3 mg/kg, significantly inhibited the severity and development of the arthritis index, progression of foot pad swelling, bone damage and histopathological alterations. Am-80 also inhibited the production of antitype II collagen (CII) IgG antibody, but did not affect the delayed-type hypersensitivity (DTH) response in arthritic mice. To determine the inhibitory mechanism of Am-80, we studied the effect of Am-80 on the production of cytokines. Am-80 did not affect the production of IFN-gamma by Th1 cells (1E10.H2 cells) and IL-4 by Th2 cells (D10.G4.1 cells), respectively. Am-80 selectively inhibited bacterial lipopolysaccharide (LPS)-induced IL-6, but not TNF-alpha and IL-1 beta, production in mice. Moreover Am-80 inhibited IL-1 beta induced IL-6 production and IL-6 mRNA expression in human osteoblast-like cells (MG-63). The inhibition of IL-6 production by Am-80 was due to down regulation of the pretranscription or the transcription of IL-6 in MG 63 cells. These findings suggest that the inhibitory effect of Am-80 on CIA is partially by modulating the production of the proinflammatory cytokine, IL-6.	Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 502, Japan; Univ Tokyo, Sch Pharm, Tokyo, Japan	Nagai, H (reprint author), Gifu Pharmaceut Univ, Dept Pharmacol, 5-6-1 Mitahora-higashi, Gifu 502, Japan.						PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; WENDLING D, 1993, J RHEUMATOL, V20, P259; COURTENAY JS, 1980, NATURE, V283, P666, DOI 10.1038/283666a0; Tobita T, 1997, BLOOD, V90, P967; SILVERMAN AK, 1987, J AM ACAD DERMATOL, V16, P1027, DOI 10.1016/S0190-9622(87)70133-9; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; WOOLEY PH, 1981, J EXP MED, V154, P688, DOI 10.1084/jem.154.3.688; BLOMHOFF HK, 1992, J BIOL CHEM, V267, P23988; BRINCKERHOFF CE, 1980, NEW ENGL J MED, V303, P432, DOI 10.1056/NEJM198008213030805; CARBE A, 1992, J EXP MED, V176, P109; DENNERT G, 1978, EUR J IMMUNOL, V8, P23, DOI 10.1002/eji.1830080106; GERD RB, 1997, ARTHRITIS RHEUM, V40, P5; HASHIMOTO Y, 1988, JPN J CANCER RES, V79, P473; HIROFUJI T, 1985, CLIN EXP IMMUNOL, V62, P159; HOLMDAHL R, 1985, SCAND J IMMUNOL, V22, P295, DOI 10.1111/j.1365-3083.1985.tb01884.x; KAGECHIKA H, 1994, YAKUGAKU ZASSHI, V114, P847; Kagechika H, 1997, BIOCHEM BIOPH RES CO, V231, P243, DOI 10.1006/bbrc.1997.6087; KOGA T, 1982, ENSHO, V2, P503; Kuwabara K, 1996, FEBS LETT, V378, P153, DOI 10.1016/0014-5793(95)01440-3; MCCUNE WJ, 1980, ARTHRITIS RHEUM, V23, P932; PANOSIAN N, 1986, J IMMUNOPHARMACOL, V8, P347; STUART JM, 1982, J EXP MED, V155, P1, DOI 10.1084/jem.155.1.1; STUART JM, 1982, J CLIN INVEST, V69, P673, DOI 10.1172/JCI110495; TOBITA T, 1997, CANC CHEMOTHER PHA S, V40, pS36; TRENTHAM DE, 1978, J CLIN INVEST, V62, P359, DOI 10.1172/JCI109136; TRENTHAM DE, 1983, J IMMUNOL, V130, P2689; Zhou YH, 1996, ENDOCRINOLOGY, V137, P975, DOI 10.1210/en.137.3.975	31	28	28	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0031-7012			PHARMACOLOGY	Pharmacology	FEB	1999	58	2					101	112		10.1159/000028272		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	159JG	WOS:000078168400004		
J	Takeuchi, S; Shinoda, K; Edagawa, K				Takeuchi, S; Shinoda, K; Edagawa, K			Dislocation migration and phason strain relaxation in a quasicrystal	PHILOSOPHICAL MAGAZINE A-PHYSICS OF CONDENSED MATTER STRUCTURE DEFECTS AND MECHANICAL PROPERTIES			English	Article							DECAGONAL QUASI-CRYSTALS; PLASTIC-DEFORMATION; SHEAR-STRESS; SIMULATION; MODEL	Phason flips accompanying the glide of a perfect dislocation has been examined using the Burkov model of the decagonal quasicrystal which is a pseudobinary alloy of Al and transition metals. It is shown that the glide of a perfect dislocation is difficult without producing chemical disorder. There are three extreme cases in the glide of a dislocation in quasicrystal: firstly conservative glide at a very high temperature where the complete phason relaxation occurs; secondly, glide producing chemical disorder; thirdly glide producing a stacking fault with the fault vector of the phason component of the Burgers vector.	Sci Univ Tokyo, Dept Mat Sci & Technol, Noda, Chiba 278, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Takeuchi, S (reprint author), Sci Univ Tokyo, Dept Mat Sci & Technol, Noda, Chiba 278, Japan.						WOLLGARTEN M, 1995, PHIL MAG LETT, V71, P99, DOI 10.1080/09500839508241001; BRESSON L, 1993, J NON-CRYST SOLIDS, V153, P468, DOI 10.1016/0022-3093(93)90397-G; BURKOV SE, 1991, PHYS REV LETT, V67, P614, DOI 10.1103/PhysRevLett.67.614; Dilger C, 1997, PHILOS MAG A, V75, P425; FEUERBACHER M, 1995, PHIL MAG LETT, V71, P91, DOI 10.1080/09500839508241000; MIKULLA R, 1995, PHILOS MAG B, V71, P981, DOI 10.1080/01418639508243601; SHIBUYA T, 1990, JPN J APPL PHYS, V29, P349; TAKEUCHI S, 1993, JPN J APPL PHYS 1, V32, P2063, DOI 10.1143/JJAP.32.2063; Takeuchi S., 1997, Annales de Physique, V22; TEIOHKAWA T, 1995, J NON-CRYST SOLIDS, V189, P25, DOI 10.1016/0022-3093(95)00195-6; ZHANG Z, 1994, MATER SCI FORUM, V150, P335	11	8	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0141-8610			PHILOS MAG A	Philos. Mag. A-Phys. Condens. Matter Struct. Defect Mech. Prop.	FEB	1999	79	2					317	327				11	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Physics, Applied; Physics, Condensed Matter	Materials Science; Metallurgy & Metallurgical Engineering; Physics	162KZ	WOS:000078346600005		
J	Koizumi, H; Ohno, K; Suzuki, T; Nabarro, FRN				Koizumi, H; Ohno, K; Suzuki, T; Nabarro, FRN			Dynamical expansion of a dislocation loop on a two-dimensional periodic potential	PHILOSOPHICAL MAGAZINE A-PHYSICS OF CONDENSED MATTER STRUCTURE DEFECTS AND MECHANICAL PROPERTIES			English	Article							FCC METALS; PEIERLS; STRESS	The equilibrium shape and the motion of a dislocation loop an two-dimensional periodic potential fields are discussed. The Peierls stress for a straight dislocation along non-close-packed direction as well as the Peierls stress for kink migration can be neglected in comparison with that for a dislocation along close-packed directions, provided that the potential is not high. A dislocation loop can take various stable configurations under an applied stress below a certain critical stress. If the dynamic effect of the motion of a loop is taken into account, the segments along non-close-packed directions which start to move under small stresses gain kinetic energy, and the motion of the segments along close-packed direction is induced. Therefore, reduction in the stress for the infinite expansion of a loop can occur.	Meiji Univ, Sch Sci & Technol, Dept Phys, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Univ Witwatersrand, Condensed Matter Phys Res Unit, Johannesburg, South Africa; CSIR, Div Mat Sci & Technol, ZA-0001 Pretoria, South Africa	Koizumi, H (reprint author), Meiji Univ, Sch Sci & Technol, Dept Phys, Tama Ku, Kawasaki, Kanagawa 2148571, Japan.						Alshits V.I., 1986, DISLOCATIONS SOLIDS, V7, P43; Sedlacek R, 1997, PHIL MAG LETT, V76, P275, DOI 10.1080/095008397179020; FANTOZZI G, 1982, PROG MATER SCI, V27, P311, DOI 10.1016/0079-6425(82)90003-2; BENOIT W, 1987, PHYS STATUS SOLIDI A, V104, P427, DOI 10.1002/pssa.2211040132; HIRTH JP, 1982, THEORY DISLOCATIONS, P174; Landau L. D., 1976, MECHANICS, V3rd, P76; Nabarro FRN, 1997, MAT SCI ENG A-STRUCT, V234, P67, DOI 10.1016/S0921-5093(97)00184-6; NINOMIYA T, 1967, J PHYS SOC JPN, V23, P361, DOI 10.1143/JPSJ.23.361; SCHOECK G, 1994, SCRIPTA METALL MATER, V30, P611, DOI 10.1016/0956-716X(94)90438-3; SCHOECK G, 1994, MAT SCI ENG A-STRUCT, V189, P61, DOI 10.1016/0921-5093(94)90401-4; SEEGER A, 1956, PHILOS MAG, V1, P651, DOI 10.1080/14786435608244000; SUZUKI T, 1993, PHILOS MAG A, V67, P1153; SUZUKI T, 1991, DISLOCATION DYNAMICS, P77; TAKEUCHI S, 1995, J PHYS SOC JPN, V64, P1858, DOI 10.1143/JPSJ.64.1858	14	2	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0141-8610			PHILOS MAG A	Philos. Mag. A-Phys. Condens. Matter Struct. Defect Mech. Prop.	FEB	1999	79	2					467	484				18	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Physics, Applied; Physics, Condensed Matter	Materials Science; Metallurgy & Metallurgical Engineering; Physics	162KZ	WOS:000078346600015		
J	Ohama, T; Yasuoka, H; Isobe, M; Ueda, Y				Ohama, T; Yasuoka, H; Isobe, M; Ueda, Y			Mixed valency and charge ordering in alpha '-NaV2O5	PHYSICAL REVIEW B			English	Article							SPIN-PEIERLS COMPOUND; NAV2O5; NMR; TRANSITION; GAP	We report V-51 NMR measurements in alpha'-NaV2O5, which has been considered as a spin-Peierls (SP) system. Above the transition temperature T-C, only one set of V sites was observed in the NMR spectra, indicating that all the V sites are in a uniform electronic state with the average oxidation of V4.5+. Below T-C, there appear two inequivalent sets of V sites assigned to V4+ and V5+ states. This result indicates that the phase transition in alpha'-NaV2O5 is not a conventional SP transition but a charge ordering. Below T-C, 1/T-1 at the V4+ sites has an activated T dependence, confirming a spin-singlet ground state with the excitation gap similar to 108 K. [S0163-1829(99)11705-3].	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Ohama, T (reprint author), Chiba Univ, Fac Sci, Dept Phys, Chiba 2638522, Japan.		Isobe, Masahiko/B-5616-2015				Abragam A, 1970, ELECT PARAMAGNETIC R; Fujii Y, 1997, J PHYS SOC JPN, V66, P326, DOI 10.1143/JPSJ.66.326; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; TAKANASHI K, 1983, J PHYS SOC JPN, V52, P3953, DOI 10.1143/JPSJ.52.3953; Bonner J. C., 1964, PHYS REV           A, V135, P640; BOULOUX JC, 1976, J SOLID STATE CHEM, V16, P385, DOI 10.1016/0022-4596(76)90055-4; CARPY A, 1975, ACTA CRYSTALLOGR B, V31, P1481, DOI 10.1107/S0567740875005468; Gupta R.R., 1986, DIAMAGNETIC SUSCEPTI, V16; Isobe M, 1997, J ALLOY COMPD, V262, P180, DOI 10.1016/S0925-8388(97)00376-9; Isobe M, 1997, J CRYST GROWTH, V181, P314, DOI 10.1016/S0022-0248(97)00363-1; Isobe M, 1996, J PHYS SOC JPN, V65, P1178, DOI 10.1143/JPSJ.65.1178; Iwase H, 1996, J PHYS SOC JPN, V65, P2397, DOI 10.1143/JPSJ.65.2397; Koppen M, 1998, PHYS REV B, V57, P8466, DOI 10.1103/PhysRevB.57.8466; OGAWA K, 1986, J PHYS SOC JPN, V55, P2129, DOI 10.1143/JPSJ.55.2129; Ohama T, 1997, J PHYS SOC JPN, V66, P23, DOI 10.1143/JPSJ.66.23; OHAMA T, UNPUB; Ohama T, 1997, J PHYS SOC JPN, V66, P3008, DOI 10.1143/JPSJ.66.3008; Ohama T, 1997, J PHYS SOC JPN, V66, P545, DOI 10.1143/JPSJ.66.545; Smolinski H, 1998, PHYS REV LETT, V80, P5164, DOI 10.1103/PhysRevLett.80.5164; Vasilev AN, 1997, PHYS REV B, V56, P5065, DOI 10.1103/PhysRevB.56.5065; von Schnering HG, 1998, Z KRIST-NEW CRYST ST, V213, P246; Weiden M, 1997, Z PHYS B CON MAT, V103, P1, DOI 10.1007/s002570050326; Yoshihama T., 1998, Journal of the Physical Society of Japan, V67	23	162	162	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	5					3299	3302		10.1103/PhysRevB.59.3299		4	Physics, Condensed Matter	Physics	168NN	WOS:000078699300010		
J	Kikuchi, J; Terasaki, I; Machi, T; Tajima, S; Koshizuka, N; Seiji, N; Adachi, S; Tanabe, K; Murayama, C; Mori, N				Kikuchi, J; Terasaki, I; Machi, T; Tajima, S; Koshizuka, N; Seiji, N; Adachi, S; Tanabe, K; Murayama, C; Mori, N			Pressure effect on quasi-one-dimensional charge transport in PrBa2Cu4O8: Magnetotransport study	PHYSICAL REVIEW B			English	Article							COMPOUND; CHAIN	The electrical resistivity and the magnetoresistance of PrBa2Cu4O8 have been measured under hydrostatic pressure up to 1.0 GPa. It was found that magnetoresistance is sensitive to the applied pressure below 100 K where the resistivity shows metallic behavior. This suggests that the interchain hopping energy is increased by pressure, which makes the low-temperature electronic state more two dimensional. [S0163-1829(99)01505-2].	Int Superconduct Technol Ctr, Superconduct Res Lab, Koto Ku, Tokyo 1350062, Japan; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1060032, Japan	Kikuchi, J (reprint author), Int Superconduct Technol Ctr, Superconduct Res Lab, Koto Ku, 1-10-13 Shinonome, Tokyo 1350062, Japan.						FEHRENBACHER R, 1993, PHYS REV LETT, V70, P3471, DOI 10.1103/PhysRevLett.70.3471; KAWAKAMI N, 1990, PHYS LETT A, V148, P359, DOI 10.1016/0375-9601(90)90818-9; Hussey NE, 1998, PHYS REV LETT, V80, P2909, DOI 10.1103/PhysRevLett.80.2909; Hussey NE, 1997, PHYS REV B, V56, P11423; KAGOSHIMA S, 1988, ONE DIMENSIONAL COND; Kikuchi J, 1996, J LOW TEMP PHYS, V105, P437, DOI 10.1007/BF00768425; MATSUSHITA A, 1995, PHYSICA C, V242, P381, DOI 10.1016/0921-4534(94)02444-8; Pippard A. B., 1989, MAGNETORESISTANCE ME; SEIJI N, 1994, PHYSICA C, V227, P377, DOI 10.1016/0921-4534(94)90096-5; Tatsumi T., UNPUB; Terasaki I, 1996, PHYS REV B, V54, P11993, DOI 10.1103/PhysRevB.54.11993; YAMADA Y, 1994, PHYSICA C, V231, P131, DOI 10.1016/0921-4534(94)90152-X	12	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	5					3385	3387		10.1103/PhysRevB.59.3385		3	Physics, Condensed Matter	Physics	168NN	WOS:000078699300032		
J	Iida, K				Iida, K			Backflow and dissipation during the quantum decay of a metastable Fermi liquid	PHYSICAL REVIEW B			English	Article							PHASE-TRANSITIONS; TEMPERATURES; KINETICS	The particle current in a metastable Fermi liquid against a first-order phase transition is calculated at zero temperature. During fluctuations of a droplet of the stable phase, in accordance with the conservation law, not only does an unperturbed current arise from the continuity at the boundary, but a backflow is induced by the density response. Quasiparticles carrying these currents are scattered by the boundary, yielding a dissipative backflow around the droplet. An energy of the hydrodynamic mass flow of the liquid and a friction force exerted on the droplet by the quasiparticles have been obtained in terms of a potential of their interaction with the droplet. [S0163-1829(99)07905-9].	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo, Japan	Iida, K (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.						Iida K, 1998, PHYS REV C, V58, P2538, DOI 10.1103/PhysRevC.58.2538; LANDAUER R, 1957, IBM J RES DEV, V1, P223; CALDEIRA AO, 1981, PHYS REV LETT, V46, P211, DOI 10.1103/PhysRevLett.46.211; BONIG L, 1989, PHYS REV B, V39, P7413, DOI 10.1103/PhysRevB.39.7413; BURMISTROV SN, 1987, ZH EKSP TEOR FIZ+, V93, P733; DYSON FJ, 1971, ANN PHYS-NEW YORK, V63, P1, DOI 10.1016/0003-4916(71)90294-6; Iida K, 1997, PROG THEOR PHYS, V98, P277, DOI 10.1143/PTP.98.277; KORSHUNOV SE, 1988, SOV J LOW TEMP PHYS, V14, P316; LANDAUER R, 1975, Z PHYS B CON MAT, V21, P247, DOI 10.1007/BF01313304; LIFSHITS IM, 1972, ZH EKSP TEOR FIZ+, V62, P385; Pines D., 1966, THEORY QUANTUM LIQUI, VI; SATOH T, 1992, PHYS REV LETT, V69, P335, DOI 10.1103/PhysRevLett.69.335; Zwerger W, 1997, PHYS REV LETT, V79, P5270, DOI 10.1103/PhysRevLett.79.5270	13	1	1	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	5					3798	3801		10.1103/PhysRevB.59.3798		4	Physics, Condensed Matter	Physics	168NN	WOS:000078699300078		
J	Huang, DX; Sasaki, Y; Ikuhara, Y				Huang, DX; Sasaki, Y; Ikuhara, Y			Influence of ion velocity on damage efficiency in the single ion-target irradiation system: Au-Bi2Sr2CaCu2Ox	PHYSICAL REVIEW B			English	Article							ENERGY HEAVY-IONS; RESOLUTION ELECTRON-MICROSCOPY; YTTRIUM-IRON-GARNET; MAGNETIC INSULATORS; LATENT TRACKS; COLUMNAR DEFECTS; RUTHERFORD BACKSCATTERING; RADIAL-DISTRIBUTION; NUCLEAR TRACKS; THIN-FILMS	Based on the cross section measurement of the columnar defect along the ion path using high-resolution electron microscopy, we developed a method to study the influence of ion velocity on ion irradiation damage. The use of a single ion-target irradiation system avoids the influences of the different target materials and the different species of incident ions on the irradiation damage. By investigating the dependence of damage efficiency on the ion velocity, we can minimize the influence of the different ion effective charge on the ion irradiation damage. The application on the Au-Bi2Sr2CaCu2Ox system shows that there is a critical velocity v(c)similar to 0.057c (c, the velocity of light) at which the damage efficiency is maximum. By reanalyzing the previous published data, we have found a similar critical velocity (v(c)similar to 0.055c) in the Xe-YIG (yttrium garnet) irradiation system, indicating it is a quite general phenomenon. From this observation, the irradiation damage process is divided into two stages. In the high ion velocity region the irradiation damage is ion velocity controlled and in the low ion velocity region the irradiation damage is the energy-density threshold controlled. The peak of damage efficiency corresponds to the turning point between two stages. [S0163-1829(99)00605-0].	Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan; Univ Tokyo, Dept Mat Sci, Tokyo 113, Japan	Huang, DX (reprint author), Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan.	dxhuang@iname.com	Ikuhara, Yuichi/F-3066-2010; Ikuhara, Yuichi/N-1001-2015	Ikuhara, Yuichi/0000-0003-3886-005X			COSTANTINI JM, 1992, NUCL INSTRUM METH B, V65, P568, DOI 10.1016/0168-583X(92)95106-2; ZHU YM, 1993, PHYS REV B, V48, P6436, DOI 10.1103/PhysRevB.48.6436; HANSEN P, 1979, PHYS REV LETT, V43, P1444, DOI 10.1103/PhysRevLett.43.1444; COSTANTINI JM, 1993, NUCL INSTRUM METH B, V80-1, P1249, DOI 10.1016/0168-583X(93)90777-4; KONCZYKOWSKI M, 1991, PHYS REV B, V44, P7167, DOI 10.1103/PhysRevB.44.7167; DAI HJ, 1994, SCIENCE, V265, P1552, DOI 10.1126/science.265.5178.1552; TOULEMONDE M, 1994, NUCL INSTRUM METH B, V91, P108, DOI 10.1016/0168-583X(94)96200-6; Hardy V, 1996, PHYSICA C, V257, P16, DOI 10.1016/0921-4534(95)00687-7; MEFTAH A, 1993, PHYS REV B, V48, P920, DOI 10.1103/PhysRevB.48.920; HARDY V, 1991, NUCL INSTRUM METH B, V54, P472, DOI 10.1016/0168-583X(91)95395-T; VANDERBEEK CJ, 1995, PHYS REV LETT, V74, P1214, DOI 10.1103/PhysRevLett.74.1214; CIVALE L, 1991, PHYS REV LETT, V67, P648, DOI 10.1103/PhysRevLett.67.648; WALIGORSKI MPR, 1986, NUCL TRACKS RAD MEAS, V11, P309; KATZ R, 1969, PHYS REV, V186, P344, DOI 10.1103/PhysRev.186.344; ARUGA T, 1988, NUCL INSTRUM METH B, V33, P748, DOI 10.1016/0168-583X(88)90673-8; Barkas W. H., 1963, NUCL RES EMULSIONS, VI; CHENEVIER B, 1992, JPN J APPL PHYS 2, V31, pL777, DOI 10.1143/JJAP.31.L777; COSTANTINI JM, 1989, RADIAT EFF DEFECT S, V110, P193, DOI 10.1080/10420158908214195; GERHAUSER W, 1992, PHYS REV LETT, V68, P879, DOI 10.1103/PhysRevLett.68.879; GROULT D, 1988, SOL STATE PHYS SERIE, V57, P391; HARDY V, 1992, PHYSICA C, V191, P85, DOI 10.1016/0921-4534(92)90633-N; HOUPERT C, 1989, NUCL INSTRUM METH B, V39, P720, DOI 10.1016/0168-583X(89)90882-3; Huang D., UNPUB; Huang DX, 1998, PHYS REV B, V57, P13907, DOI 10.1103/PhysRevB.57.13907; KUMAKURA H, 1993, J APPL PHYS, V74, P451, DOI 10.1063/1.355279; LEGHISSA M, 1992, EUROPHYS LETT, V19, P323, DOI 10.1209/0295-5075/19/4/013; MEFTAH A, 1991, NUCL INSTRUM METH B, V59, P605, DOI 10.1016/0168-583X(91)95286-M; STUDER F, 1992, NUCL INSTRUM METH B, V65, P560, DOI 10.1016/0168-583X(92)95105-Z; STUDER F, 1987, NUCL INSTRUM METH B, V19-20, P856, DOI 10.1016/S0168-583X(87)80171-4; STUDER F, 1991, RADIAT EFF DEFECT S, V116, P59, DOI 10.1080/10420159108221345; STUDER F, 1991, J SOLID STATE CHEM, V91, P238, DOI 10.1016/0022-4596(91)90078-V; STUDER F, 1989, RADIAT EFF DEFECT S, V110, P55, DOI 10.1080/10420158908214160; TIMM A, 1985, NUCL INSTRUM METH B, V12, P479, DOI 10.1016/0168-583X(85)90503-8; TOULEMONDE M, 1990, J APPL PHYS, V68, P1545, DOI 10.1063/1.346631; TOULEMONDE M, 1987, PHYS REV B, V35, P6560, DOI 10.1103/PhysRevB.35.6560; TOULEMONDE M, 1988, PHILOS MAG A, V58, P799; WATANABE H, 1991, PHYSICA C, V179, P75, DOI 10.1016/0921-4534(91)90013-O; Wiesner J, 1996, PHYSICA C, V268, P161, DOI 10.1016/0921-4534(96)00381-4; ZHANG CX, 1985, RADIAT PROT DOSIM, V13, P215	39	14	14	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	5					3862	3869		10.1103/PhysRevB.59.3862		8	Physics, Condensed Matter	Physics	168NN	WOS:000078699300088		
J	Ishii, K; Watanuki, T; Fujiwara, A; Suematsu, H; Iwasa, Y; Shimoda, H; Mitani, T; Nakao, H; Fujii, Y; Murakami, Y; Kawada, H				Ishii, K; Watanuki, T; Fujiwara, A; Suematsu, H; Iwasa, Y; Shimoda, H; Mitani, T; Nakao, H; Fujii, Y; Murakami, Y; Kawada, H			Structural phase transition in the ammoniated alkali C-60 compound (NH3)K3C60	PHYSICAL REVIEW B			English	Article							METAL FULLERIDES; DOPED C-60; SUPERCONDUCTIVITY; INTERCALATION; TEMPERATURE; K3C60; KC60	X-ray diffraction measurements of (NH3)K3C60 have revealed a structural phase transition at T-s = 150 K, which is attributed to the orientational order-disorder transition of the K-NH3 pair at the octahedral site of the C-60 lattice. The low-temperature phase has a face-centered-orthorhombic structure derived by doubling the unit lattice vectors of the high-temperature phase along three axes. The superlattice intensity increases continuously below T-s which means that the transition is second order. At 100 K< T< T-s a negative thermal expansion is observed along the a and b axes. This is closely related to the contraction of K-N interatomic distance. We also discuss the relation between the superconductivity and the local symmetry of C-60 in the crystal.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Japan Adv Inst Sci & Technol, Tatsunokuchi, Ishikawa 9231292, Japan; Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Tokai, Ibaraki 3191106, Japan; High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan	Ishii, K (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Iwasa, Yoshihiro/C-1719-2009; Fujiwara, Akihiko/F-3031-2015	Fujiwara, Akihiko/0000-0002-1319-388X			ZHOU O, 1993, NATURE, V362, P433, DOI 10.1038/362433a0; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; FLEMING RM, 1991, NATURE, V352, P787, DOI 10.1038/352787a0; ZHOU O, 1995, PHYS REV B, V52, P483, DOI 10.1103/PhysRevB.52.483; ROSSEINSKY MJ, 1993, NATURE, V364, P425, DOI 10.1038/364425a0; BROWN CM, 1997, RECENT ADV CHEM PHYS, V4, P1224; HENRY PF, 1995, J CHEM SOC CHEM COMM, P2131, DOI 10.1039/c39950002131; Iwasa Y, 1996, PHYS REV B, V53, pR8836; Izumi F., 1993, RIETVELD METHOD; Kim Y., 1994, Journal of the Ceramic Society of Japan, V102; MANIWA Y, COMMUNICATION; MURPHY DW, 1992, J PHYS CHEM SOLIDS, V53, P1321, DOI 10.1016/0022-3697(92)90230-B; PALSTRA TTM, 1995, SOLID STATE COMMUN, V93, P327; Shimoda H, 1996, PHYS REV B, V54, P15653; STEPHENS PW, 1994, NATURE, V370, P636, DOI 10.1038/370636a0; TANIGAKI K, 1992, NATURE, V356, P419, DOI 10.1038/356419a0; ZHOU O, 1992, SCIENCE, V255, P833, DOI 10.1126/science.255.5046.833; ZHU Q, 1995, PHYS REV B, V51, P3966, DOI 10.1103/PhysRevB.51.3966	18	30	31	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	6					3956	3960		10.1103/PhysRevB.59.3956		5	Physics, Condensed Matter	Physics	168NP	WOS:000078699400008		
J	Bozin, ES; Billinge, SJL; Kwei, GH; Takagi, H				Bozin, ES; Billinge, SJL; Kwei, GH; Takagi, H			Charge-stripe ordering from local octahedral tilts: Underdoped and superconducting La2-xSrxCuO4 (0 <= x <= 0.30)	PHYSICAL REVIEW B			English	Article							HIGH-TEMPERATURE SUPERCONDUCTORS; EARTH-DOPED LA2-XSRXCUO4; T-C SUPERCONDUCTIVITY; PHASE-TRANSITIONS; LA2-XBAXCUO4; DIFFRACTION; HOLES; SPINS; LA1-XCAXMNO3; SCATTERING	The local structure of La2-xSrxCuO4, for 0 less than or equal to x less than or equal to 0.30, has been investigated using the atomic pair distribution function (PDF) analysis of neutron powder-diffraction data. The local octahedral tilts are studied to look for evidence of [110] symmetry [i.e., low-temperature tetragonal (LTT) symmetry] tilts locally, even though the average tilts have [010] symmetry [i.e., low-temperature orthorhombic (LTO) symmetry] in these compounds. We argue that this observation would suggest the presence of local charge-stripe order. We show that the tilts are locally LTO in the undoped phase, in agreement with the average crystal structure. At nonzero doping the PDF data are consistent with the presence of local tilt disorder in the form of a mixture of LTO and LTT local tilt directions and a distribution of local tilt magnitudes. We present topological tilt models which qualitatively explain the origin of tilt disorder in the presence of charge stripes and show that the PDF data are well explained by such a mixture of locally small and large amplitude tilts.	Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; Michigan State Univ, Ctr Fundamental Mat Res, E Lansing, MI 48824 USA; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan	Bozin, ES (reprint author), Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA.		Takagi, Hidenori/B-2935-2010; Bozin, Emil/E-4679-2011				RADAELLI PG, 1994, PHYS REV B, V49, P4163, DOI 10.1103/PhysRevB.49.4163; Tranquada JM, 1996, PHYS REV B, V54, P7489, DOI 10.1103/PhysRevB.54.7489; AXE JD, 1989, PHYS REV LETT, V62, P2751, DOI 10.1103/PhysRevLett.62.2751; Tranquada JM, 1997, PHYS REV LETT, V78, P338, DOI 10.1103/PhysRevLett.78.338; Bianconi A, 1997, SOLID STATE COMMUN, V102, P369, DOI 10.1016/S0038-1098(97)00011-2; Markiewicz RS, 1997, J PHYS CHEM SOLIDS, V58, P1179, DOI 10.1016/S0022-3697(97)00025-5; Salkola MI, 1996, PHYS REV LETT, V77, P155, DOI 10.1103/PhysRevLett.77.155; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; BILLINGE SJL, 1994, PHYS REV LETT, V72, P2282, DOI 10.1103/PhysRevLett.72.2282; BUCHNER B, 1994, PHYS REV LETT, V73, P1841, DOI 10.1103/PhysRevLett.73.1841; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; CRAWFORD MK, 1991, PHYS REV B, V44, P7749, DOI 10.1103/PhysRevB.44.7749; Haskel D, 1996, PHYS REV LETT, V76, P439, DOI 10.1103/PhysRevLett.76.439; Cordero F, 1998, PHYS REV B, V57, P8580, DOI 10.1103/PhysRevB.57.8580; Chen CH, 1996, PHYS REV LETT, V76, P4042, DOI 10.1103/PhysRevLett.76.4042; RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; BABERSKI O, 1998, EUROPHYS LETT, V44, P337; Bar-Yam Y., 1992, LATTICE EFFECTS HIGH; BILLINGE SJL, 1988, LOCAL STRUCTURE DIFF, P137; Billinge SJL, 1996, J PHYS CHEM SOLIDS, V57, P1457, DOI 10.1016/0022-3697(96)00013-3; BILLINGE SJL, 1993, PHYS REV LETT, V71, P1903, DOI 10.1103/PhysRevLett.71.1903; Bozin E S, 1998, PHYSICA B, P241; BRADEN M, 1994, PHYSICA C, V223, P396, DOI 10.1016/0921-4534(94)91284-X; BUCHNER B, 1994, PHYSICA C, V235, P281, DOI 10.1016/0921-4534(94)91369-2; BZIN ES, UNPUB; Chen CH, 1997, J APPL PHYS, V81, P4326, DOI 10.1063/1.364758; COX DE, 1989, MATER RES SOC SYMP P, V156, P141, DOI 10.1557/PROC-156-141; EGAMI T, 1990, MATER T JIM, V31, P163; Egami T., 1987, REV SOLID STATE SCI, V1, P247; EGAMI T, 1994, PROG MATER SCI, V38, P359, DOI 10.1016/0079-6425(94)90005-1; Egami T, 1997, J SUPERCOND, V10, P323, DOI 10.1007/BF02765712; EGAMI T, 1996, PHYSICAL PROPERTIES, V5; Emery VJ, 1997, PHYS REV B, V56, P6120, DOI 10.1103/PhysRevB.56.6120; Ramirez AP, 1996, PHYS REV LETT, V76, P3188, DOI 10.1103/PhysRevLett.76.3188; HAMMEL PC, 1993, PHYS REV LETT, V71, P440, DOI 10.1103/PhysRevLett.71.440; Hammel PC, 1998, PHYS REV B, V57, pR712, DOI 10.1103/PhysRevB.57.R712; Haskel D, 1997, PHYS REV B, V56, pR521, DOI 10.1103/PhysRevB.56.R521; Krotov YA, 1997, PHYS REV B, V56, P8367, DOI 10.1103/PhysRevB.56.8367; Markiewicz R S, UNPUB; MARKIEWICZ RS, 1992, PHYSICA C, V193, P323, DOI 10.1016/0921-4534(92)90955-C; MARTIN RL, 1995, PHYS REV LETT, V75, P744, DOI 10.1103/PhysRevLett.75.744; Muller K.A., 1993, PHASE SEPARATION CUP; Phillips JC, 1997, P NATL ACAD SCI USA, V94, P12771, DOI 10.1073/pnas.94.24.12771; SACHAN V, 1995, PHYS REV B, V51, P12742, DOI 10.1103/PhysRevB.51.12742; Saini NL, 1997, PHYS REV B, V55, P12759, DOI 10.1103/PhysRevB.55.12759; SALJE E, 1995, POLARONS BIOPOLARONS; Sigmund E., 1994, PHASE SEPARATION CUP; Statt BW, 1995, PHYS REV B, V52, P15575, DOI 10.1103/PhysRevB.52.15575; Tranquada JM, 1997, PHYS REV LETT, V79, P2133, DOI 10.1103/PhysRevLett.79.2133; Vigliante A, 1997, PHYS REV B, V56, P8248, DOI 10.1103/PhysRevB.56.8248; Von Zimmermann M, 1998, EUROPHYS LETT, V41, P629, DOI 10.1209/epl/i1998-00204-2; Warren B. E., 1990, XRAY DIFFRACTION; YVON K, 1989, Z PHYS B CON MAT, V76, P413, DOI 10.1007/BF01307892; Zhou JS, 1997, PHYS REV B, V56, P6288, DOI 10.1103/PhysRevB.56.6288	55	104	104	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	6					4445	4454		10.1103/PhysRevB.59.4445		10	Physics, Condensed Matter	Physics	168NP	WOS:000078699400068		
J	Shiraishi, J; Kohmoto, M; Maki, K				Shiraishi, J; Kohmoto, M; Maki, K			Vortex lattice transition in d-wave superconductors	PHYSICAL REVIEW B			English	Article							QUASI-PARTICLE SPECTRA; FLUX-LINE-LATTICE; TUNNELING SPECTROSCOPY; NEUTRON-SCATTERING; MAGNETIC-FIELD; SINGLE VORTEX; DEPENDENCE; LUNI2B2C; YNI2B2C; ENERGY	Making use of the extended Ginzburg-Landau theory, which includes the fourth-order derivative term, we study the vortex stare in a magnetic field parallel to the c axis. The vortex core structure is distorted due to the higher-order term, which reveals the fourfold symmetry. Further, this distortion gives rise to the core interaction energy which favors a square lattice tilted by 45 degrees from the a axis. The triangular vortex lattice in small field region transforms into the rhombic vortex lattice (i.e., the square vortex lattice tilted 45 degrees from the (a axis) at B = H-cr similar to kappa (-1) H-c2(t), where kappa is the Ginzburg-Landau parameter and H-c2(t) is the upper critical field. Therefore, in most of the B-T phase diagram the vortex lattice is rhombic. The transition is of the second order and the associated jump in the specific heat should be accessible experimentally.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 106, Japan; Univ So Calif, Dept Phys & Astron, Los Angeles, CA 90089 USA	Shiraishi, J (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 106, Japan.						Affleck I, 1997, PHYS REV B, V55, pR704, DOI 10.1103/PhysRevB.55.R704; ANLAGE SM, 1994, PHYS REV B, V50, P523, DOI 10.1103/PhysRevB.50.523; WON H, 1994, PHYS REV B, V49, P1397, DOI 10.1103/PhysRevB.49.1397; MAGGIOAPRILE I, 1995, PHYS REV LETT, V75, P2754, DOI 10.1103/PhysRevLett.75.2754; REN Y, 1995, PHYS REV LETT, V74, P3680, DOI 10.1103/PhysRevLett.74.3680; WU DH, 1993, PHYS REV LETT, V70, P85, DOI 10.1103/PhysRevLett.70.85; SCHOPOHL N, 1995, PHYS REV B, V52, P490, DOI 10.1103/PhysRevB.52.490; FETTER AL, 1966, PHYS REV, V147, P140, DOI 10.1103/PhysRev.147.140; DeWilde Y, 1997, PHYS REV LETT, V78, P4273, DOI 10.1103/PhysRevLett.78.4273; Ekino T, 1996, PHYS REV B, V53, P5640, DOI 10.1103/PhysRevB.53.5640; Enomoto N, 1997, J PHYS SOC JPN, V66, P204, DOI 10.1143/JPSJ.66.204; Eskildsen MR, 1997, PHYS REV LETT, V79, P487, DOI 10.1103/PhysRevLett.79.487; Eskildsen MR, 1997, PHYS REV LETT, V78, P1968, DOI 10.1103/PhysRevLett.78.1968; Ichioka M, 1996, PHYS REV B, V53, P15316, DOI 10.1103/PhysRevB.53.15316; KEIMER B, 1994, PHYS REV LETT, V73, P3459, DOI 10.1103/PhysRevLett.73.3459; Kogan VG, 1997, PHYS REV B, V55, pR8693; Maki K, 1996, CZECH J PHYS, V46, P3151, DOI 10.1007/BF02548123; Maki K, 1998, PHYSICA B, V244, P22, DOI 10.1016/S0921-4526(97)00456-0; Maki K, 1996, J PHYS I, V6, P2317, DOI 10.1051/jp1:1996220; Maki K, 1996, ANN PHYS-BERLIN, V5, P320; Morita Y, 1997, EUROPHYS LETT, V40, P207, DOI 10.1209/epl/i1997-00446-x; Morita Y, 1997, PHYS REV LETT, V78, P4841, DOI 10.1103/PhysRevLett.78.4841; Morita Y, 1997, PHYS REV LETT, V79, P4514, DOI 10.1103/PhysRevLett.79.4514; Nohara M, 1997, J PHYS SOC JPN, V66, P1888, DOI 10.1143/JPSJ.66.1888; SHIRAISHI J, 1998, SYMMETRY PAIRING SUP; STADLOBER B, 1995, PHYS REV LETT, V74, P4911, DOI 10.1103/PhysRevLett.74.4911; Won H, 1996, PHYS REV B, V53, P5927, DOI 10.1103/PhysRevB.53.5927; WON H, 1995, EUROPHYS LETT, V30, P421, DOI 10.1209/0295-5075/30/7/008; Yaron U, 1996, NATURE, V382, P236, DOI 10.1038/382236a0; Yethiraj M, 1997, PHYS REV LETT, V78, P4849, DOI 10.1103/PhysRevLett.78.4849; 1996, CZECH J PHYS, V46, P56; 1997, PHYSICA C, V282, P4	32	40	40	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	FEB 1	1999	59	6					4497	4503		10.1103/PhysRevB.59.4497		7	Physics, Condensed Matter	Physics	168NP	WOS:000078699400074		
J	Park, SH; Kubono, S; Hahn, KI; Lee, CS; Kim, JC; Strasser, P; Jeong, SC; Tanaka, MH; Lee, C; Lee, JH; Kato, S; Miyachi, T; Kawashima, H; Utsunomiya, H; Yasue, M; Kurokawa, M; Fuchi, Y; Liu, X; Abe, K; Kumagai, K; Smith, MS; Parker, PD				Park, SH; Kubono, S; Hahn, KI; Lee, CS; Kim, JC; Strasser, P; Jeong, SC; Tanaka, MH; Lee, C; Lee, JH; Kato, S; Miyachi, T; Kawashima, H; Utsunomiya, H; Yasue, M; Kurokawa, M; Fuchi, Y; Liu, X; Abe, K; Kumagai, K; Smith, MS; Parker, PD			High-resolution study of the Ne-18 excited states relevant to the hot CNO cycle	PHYSICAL REVIEW C			English	Article								The Ne-20(p,r)Ne-18 reaction has been studied in order to investigate the properties of Ne-18 excited states. A missing 3(+) state of Ne-18, which could have a great influence on the F-17(p,gamma)Ne-18 reaction rate, was searched for, but the existence of this state was not clearly verified. The spins and parities of the 5.11- and 5.15-MeV states were assigned tentatively by angular distribution measurements, as 2(+) and 3(-), respectively. We were able to resolve the doublets at 4.5, 5.1, and 6.3 MeV clearly for the first time due to our high precision system, which allowed us to determine the widths of some critical states above the proton threshold of Ne-18 more precisely. [S0556-2813(99)06502-4].	Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea; Univ Tokyo, Ctr Nucl Study, Tokyo 188, Japan; RIKEN, Wako, Saitama 35101, Japan; Chung Ang Univ, Dept Phys, Seoul 156756, South Korea; KEK, IPNP Tanashi, Tokyo 188, Japan; Yamagata Univ, Dept Phys, Yamagata 990, Japan; Konan Univ, Dept Phys, Kobe, Hyogo 658, Japan; Miyagi Univ Educ, Aoba Ku, Sendai, Miyagi 980, Japan; Yamagata Univ, Dept Phys, Yamagata 990, Japan; Tohoku Univ, Dept Phys, Sendai, Miyagi 980, Japan; Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA; Yale Univ, Wright Nucl Struct Lab, New Haven, CT 06520 USA	Kurokawa, M (reprint author), Seoul Natl Univ, Dept Phys, Seoul 151742, South Korea.		Strasser, Patrick/D-8104-2013	Strasser, Patrick/0000-0002-2370-2166			FABRICI E, 1980, PHYS REV C, V21, P844, DOI 10.1103/PhysRevC.21.844; FALK WR, 1970, NUCL PHYS A, VA157, P241, DOI 10.1016/0375-9474(70)90111-9; FUNCK C, 1988, NUCL PHYS A, V480, P188, DOI 10.1016/0375-9474(88)90392-2; GARCIA A, 1991, PHYS REV C, V43, P2012, DOI 10.1103/PhysRevC.43.2012; Hahn KI, 1996, PHYS REV C, V54, P1999, DOI 10.1103/PhysRevC.54.1999; WALLACE RK, 1981, ASTROPHYS J SUPPL S, V45, P389, DOI 10.1086/190717; WIESCHER M, 1988, ASTROPHYS J, V326, P384, DOI 10.1086/166100; WIESCHER M, 1987, ASTROPHYS J, V316, P162, DOI 10.1086/165189	8	23	24	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2813			PHYS REV C	Phys. Rev. C	FEB	1999	59	2					1182	1184		10.1103/PhysRevC.59.1182		3	Physics, Nuclear	Physics	166KZ	WOS:000078576600079		
J	Nakagawa, N; Komatsu, TS				Nakagawa, N; Komatsu, TS			Confined chaotic behavior in collective motion for populations of globally coupled chaotic elements	PHYSICAL REVIEW E			English	Article							NETWORK; MAPS	The Lyapunov exponent for collective motion is defined in order to characterize chaotic properties of collective motion for large populations of chaotic elements. Numerical computations for this quantity suggest that such collective motion is always chaotic, whenever it appears. Chaotic behavior of collective motion is found to be confined within a small scale, whose size is estimated using the value of the Lyapunov exponent. Finally, we conjecture why the collective motion appears low dimensional despite the actual high dimensionality of the dynamics. [S1063-651X(99)06802-6].	RIKEN, Brain Sci Inst, Lab Informat Synthesis, Wako, Saitama 35101, Japan; Univ Tokyo, Coll Arts & Sci, Dept Pure & Appl Sci, Tokyo 153, Japan	Nakagawa, N (reprint author), Ibaraki Univ, Dept Math Sci, Mito, Ibaraki 3108512, Japan.						ERSHOV SV, 1995, PHYSICA D, V86, P523, DOI 10.1016/0167-2789(95)00191-6; NAKAGAWA N, 1993, PROG THEOR PHYS, V89, P313; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; CHATE H, 1992, PROG THEOR PHYS, V87, P1, DOI 10.1143/PTP.87.1; Chawanya T, 1998, PHYSICA D, V116, P44, DOI 10.1016/S0167-2789(97)00254-6; Nakagawa N, 1998, PHYS REV E, V57, P1570, DOI 10.1103/PhysRevE.57.1570; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; HAKIM V, 1992, PHYS REV A, V46, pR7347; Kane T T, 1989, Asian Pac Popul Forum, V3, P1; KANEKO K, 1992, PHYSICA D, V55, P368, DOI 10.1016/0167-2789(92)90066-V; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Morita S, 1996, PHYS LETT A, V211, P258, DOI 10.1016/0375-9601(96)00012-6	12	7	7	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1063-651X			PHYS REV E	Phys. Rev. E	FEB	1999	59	2	A				1675	1682		10.1103/PhysRevE.59.1675		8	Physics, Fluids & Plasmas; Physics, Mathematical	Physics	169ZF	WOS:000078779500054		
J	Kozuma, M; Deng, L; Hagley, EW; Wen, J; Lutwak, R; Helmerson, K; Rolston, SL; Phillips, WD				Kozuma, M; Deng, L; Hagley, EW; Wen, J; Lutwak, R; Helmerson, K; Rolston, SL; Phillips, WD			Coherent splitting of Bose-Einstein condensed atoms with optically induced Bragg diffraction	PHYSICAL REVIEW LETTERS			English	Article							RECOIL-INDUCED RESONANCES; STANDING LIGHT-WAVE; COLD ATOMS; SCATTERING; SPECTROSCOPY; TRAP; GAS	We have observed Bragg diffraction of a Bose-Einstein condensate of sodium atoms by a moving, periodic, optical potential. The coherent process of Bragg diffraction produced a splitting of the condensate with unidirectional momentum transfer. Using the momentum selectivity of the Bragg process, we separated a condensate component with a momentum width narrower than that of the original condensate. By repeatedly pulsing the optical potential while the atoms were trapped, we observed the trajectory of the split atomic wave packets in the confining magnetic potential.	Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Georgia So Univ, Dept Phys, Statesboro, GA 30460 USA	Kozuma, M (reprint author), Univ Tokyo, Dept Phys, 7-3-1 Hongo, Tokyo 1538902, Japan.		Deng, Lu/B-3997-2012; Hagley, Edward/B-4285-2012; Helmerson, Kristian/E-3683-2013; rolston, steven/L-5175-2013	rolston, steven/0000-0003-1671-4190			PETRICH W, 1995, PHYS REV LETT, V74, P3352, DOI 10.1103/PhysRevLett.74.3352; GUO J, 1992, PHYS REV A, V46, P1426, DOI 10.1103/PhysRevA.46.1426; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Kozuma M, 1996, PHYS REV LETT, V76, P2428, DOI 10.1103/PhysRevLett.76.2428; GILTNER DM, 1995, PHYS REV LETT, V75, P2638, DOI 10.1103/PhysRevLett.75.2638; KETTERLE W, 1993, PHYS REV LETT, V70, P2253, DOI 10.1103/PhysRevLett.70.2253; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; GUO J, 1993, PHYS REV A, V47, P4128, DOI 10.1103/PhysRevA.47.4128; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; COURTOIS JY, 1994, PHYS REV LETT, V72, P3017, DOI 10.1103/PhysRevLett.72.3017; GILTNER DM, 1995, PHYS REV A, V52, P3966, DOI 10.1103/PhysRevA.52.3966; [Anonymous], COMMUNICATION; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; MARTIN PJ, 1988, PHYS REV LETT, V60, P515; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; Berman PR, 1997, PHYS REV A, V55, P4382, DOI 10.1103/PhysRevA.55.4382; Kunze S, 1996, EUROPHYS LETT, V34, P343, DOI 10.1209/epl/i1996-00462-x; LUTWAK R, UNPUB; MEACHER DR, 1994, PHYS REV A, V50, pR1992; Mewes MO, 1997, PHYS REV LETT, V78, P582, DOI 10.1103/PhysRevLett.78.582; Oberthaler MK, 1996, PHYS REV LETT, V77, P4980, DOI 10.1103/PhysRevLett.77.4980; 1992, APPL PHYS B, V54, P321	22	335	338	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 1	1999	82	5					871	875		10.1103/PhysRevLett.82.871		5	Physics, Multidisciplinary	Physics	163PA	WOS:000078412900001		
J	Sasa, S; Komatsu, TS				Sasa, S; Komatsu, TS			Thermodynamic entropy and excess information loss in dynamical systems with time-dependent Hamiltonians	PHYSICAL REVIEW LETTERS			English	Article							STATES	The Fermi-Pasta-Ulam model with the time-dependent nonlinear term is used to explore the relation between the thermodynamic entropy change due to irreversible processes and the change of information loss as a chaotic dynamical system. We define a novel quantity called the "excess information loss" and conjecture a quantitative relation between the thermodynamic entropy increase and this new quantity, purely defined by dynamical system theory.	Univ Tokyo, Dept Pure & Appl Sci, Meguro Ku, Tokyo 153, Japan	Sasa, S (reprint author), Univ Tokyo, Dept Pure & Appl Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 153, Japan.						YOSHIDA H, 1990, PHYS LETT A, V150, P262, DOI 10.1016/0375-9601(90)90092-3; SHIMADA I, 1979, PROG THEOR PHYS, V61, P1605, DOI 10.1143/PTP.61.1605; GALLAVOTTI G, 1995, J STAT PHYS, V80, P931, DOI 10.1007/BF02179860; EVANS DJ, 1993, PHYS REV LETT, V71, P2401, DOI 10.1103/PhysRevLett.71.2401; Dzugutov M, 1998, PHYS REV LETT, V81, P1762, DOI 10.1103/PhysRevLett.81.1762; Fermi E., 1965, COLLECTED WORKS ENRI, V2, P978; Gaspard P, 1997, J STAT PHYS, V88, P1215; LEBOWITZ JL, 1993, PHYSICA A, V194, P1, DOI 10.1016/0378-4371(93)90336-3; Oono Y, 1998, PROG THEOR PHYS SUPP, P29; Pesin YB, 1977, RUSS MATH SURV, V32, P55, DOI DOI 10.1070/RM1977V032N04ABEH001639; Ruelle D, 1996, J STAT PHYS, V85, P1, DOI 10.1007/BF02175553	11	14	14	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 1	1999	82	5					912	915		10.1103/PhysRevLett.82.912		4	Physics, Multidisciplinary	Physics	163PA	WOS:000078412900011		
J	Susaki, T; Takeda, Y; Arita, M; Mamiya, K; Fujimori, A; Shimada, K; Namatame, H; Taniguchi, M; Shimizu, N; Iga, F; Takabatake, T				Susaki, T; Takeda, Y; Arita, M; Mamiya, K; Fujimori, A; Shimada, K; Namatame, H; Taniguchi, M; Shimizu, N; Iga, F; Takabatake, T			Temperature-dependent high-resolution photoemission study of the Kondo insulator YbB12	PHYSICAL REVIEW LETTERS			English	Article							PHOTOELECTRON-SPECTROSCOPY; RESONANCE; SPECTRA; YBAL3; GAP; STATES; FESI	We have performed a detailed temperature-dependent photoemission study of the conduction-band states in the Kondo insulator YbB12 using single crystalline samples. Measurements with improved energy resolution have revealed (pseudo)gaps of two energy scales. The size of the narrower gap similar to 10 meV and its disappearance at high temperatures are consistent with the temperature dependence of the electrical resistivity and the magnetic susceptibility. The larger pseudogap of similar to 100 meV depends on temperature even at room temperature. We discuss how the characteristics of the Kondo insulator are reflected in the conduction-band photoemission spectra.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; High Energy Accelerator Res Org, Photon Factory, Ibaraki, Osaka 3050801, Japan; Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 7398526, Japan; Hiroshima Univ, ADSM, Dept Quantum Matters, Higashihiroshima 7398526, Japan	Susaki, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.		Susaki, Tomofumi/E-6394-2014; Takabatake, Toshiro/L-2882-2014	Takabatake, Toshiro/0000-0002-3293-8592			Aeppli G., 1992, COMMENTS COND MAT PH, V16, P155; BICKERS NE, 1985, PHYS REV LETT, V54, P230, DOI 10.1103/PhysRevLett.54.230; SCHLESINGER Z, 1993, PHYS REV LETT, V71, P1748, DOI 10.1103/PhysRevLett.71.1748; HUNDLEY MF, 1990, PHYS REV B, V42, P6842, DOI 10.1103/PhysRevB.42.6842; Susaki T, 1996, PHYS REV LETT, V77, P4269, DOI 10.1103/PhysRevLett.77.4269; Takabatake T, 1998, J MAGN MAGN MATER, V177, P277, DOI 10.1016/S0304-8853(97)00842-1; TJENG LH, 1993, PHYS REV LETT, V71, P1419, DOI 10.1103/PhysRevLett.71.1419; Greber T, 1997, PHYS REV LETT, V79, P4465, DOI 10.1103/PhysRevLett.79.4465; Iga F, 1998, J MAGN MAGN MATER, V177, P337, DOI 10.1016/S0304-8853(97)00493-9; BLUM P, 1954, ACTA CRYSTALLOGR, V7, P81, DOI 10.1107/S0365110X54000151; Breuer K, 1998, EUROPHYS LETT, V41, P565, DOI 10.1209/epl/i1998-00192-1; Breuer K, 1997, PHYS REV B, V56, pR7061; GERKEN F, 1983, J PHYS F MET PHYS, V13, P703, DOI 10.1088/0305-4608/13/3/021; JOYCE JJ, 1994, PHYS REV LETT, V72, P1774, DOI 10.1103/PhysRevLett.72.1774; Joyce JJ, 1997, PHYS REV LETT, V78, P1831, DOI 10.1103/PhysRevLett.78.1831; Joyce JJ, 1996, PHYS REV B, V54, P17515, DOI 10.1103/PhysRevB.54.17515; KASAYA M, 1985, J MAGN MAGN MATER, V47-8, P429, DOI 10.1016/0304-8853(85)90458-5; LIAO PK, 1990, BINARY ALLOY PHASE D, V1, P558; Malterre D, 1996, ADV PHYS, V45, P299, DOI 10.1080/00018739600101507; MURANI AP, 1994, PHYS REV LETT, V72, P4153, DOI 10.1103/PhysRevLett.72.4153; OH SJ, 1988, PHYS REV B, V37, P2861, DOI 10.1103/PhysRevB.37.2861; OKAMURA H, 1998, PHYS REV B, V58, P6211; Susaki T, 1997, PHYS REV B, V56, P13727, DOI 10.1103/PhysRevB.56.13727; Susaki T, 1997, PHYS REV LETT, V78, P1832, DOI 10.1103/PhysRevLett.78.1832; Susaki T, 1998, PHYS REV B, V58, P1197, DOI 10.1103/PhysRevB.58.1197; TAKEDA Y, UNPUB; WOHLLEBEN D, 1985, ADV PHYS, V34, P403, DOI 10.1080/00018738500101781; YEH JJ, 1985, ATOM DATA NUCL DATA, V32, P1, DOI 10.1016/0092-640X(85)90016-6	28	50	50	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	FEB 1	1999	82	5					992	995		10.1103/PhysRevLett.82.992		4	Physics, Multidisciplinary	Physics	163PA	WOS:000078412900031		
J	Aoki, S; Syono, K				Aoki, S; Syono, K			Function of Ngrol genes in the evolution of Nicotiana glauca: Conservation of the function of NgORF13 and NgORF14 after ancient infection by an Agrobacterium rhizogenes-like ancestor	PLANT AND CELL PHYSIOLOGY			English	Article						Agrobacterium rhizogenes; evolution; horizontal gene transfer; Nicotiana; rol genes; root induction	TRANSGENIC TOBACCO PLANTS; ROOT-INDUCING PLASMID; T-DNA; RI-PLASMID; ROLC-GENE; EXPRESSION; TUMORS; TRANSFORMATION; LANGSDORFFII; INDUCTION	Ngrol genes are thought to have resulted from horizontal gene transfer from an Agrobacterium rhizogenes-like ancestor early in the evolution of the genus Nicotiana. Four Ngrol genes (NgrolB, NgrolC, NgORF13 and NgORF14) have been found in the genome of N.glauca, but their functions are not yet known. We have investigated the properties of Ngrol genes and shown that some of them are able to function in tobacco plants. Transgenic analysis revealed that NgORF13 promotes RirolB-mediated adventitious root induction on tobacco leaf segments. NgORF14 also promoted the RirolB-mediated root induction, but the intensity of this promoting effect was weak. These promoting functions of NgORF13 and NgORF14 have much the same efficiency as those of the corresponding genes of A, rhizogenes, RiORF13 and RiORF14, respectively. Overexpression of NgORF13, under control of the cauliflower mosaic virus 35S promoter (P-35S), provoked morphological abnormalities in transgenic tobacco plants. Transgenic plants that harbored the P-35S-NgORF13 had rounded leaves and stout flowers resulting from suppression of the longitudinal growth of leaf and floral leaves such as sepals, petals, stamens and carpels. These results suggest that NgORF13 and NgORF14 in the genome of N.glauca have conserved functional sequences since their original integration event by an A. rhizogenes-like ancestor.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Aoki, S (reprint author), Chiba Univ, Dept Biol, Lab Phylogenet Bot, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.						FURNER IJ, 1986, NATURE, V319, P422, DOI 10.1038/319422a0; CARDARELLI M, 1987, MOL GEN GENET, V209, P475, DOI 10.1007/BF00331152; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49; JEFFERSON RA, 1987, EMBO J, V6, P3901; SCHMULLING T, 1988, EMBO J, V7, P2621; HORSCH RB, 1985, SCIENCE, V227, P1229; WHITE FF, 1985, J BACTERIOL, V164, P33; AOKI S, 1999, PLANT CELL PHYSL, V400; AOKI S, 1994, MOL GEN GENET, V243, P706; CAPONE I, 1989, PLANT MOL BIOL, V13, P43, DOI 10.1007/BF00027334; DAVID C, 1984, BIO-TECHNOL, V2, P73, DOI 10.1038/nbt0184-73; HANSEN G, 1993, PLANT J, V4, P581, DOI 10.1046/j.1365-313X.1993.04030581.x; HEINEMANN JA, 1991, TRENDS GENET, V7, P181, DOI 10.1016/0168-9525(91)90433-Q; HUFFMAN GA, 1984, J BACTERIOL, V157, P269; ICHIKAWA T, 1990, MOL GEN GENET, V220, P177; JOUANIN L, 1984, PLASMID, V12, P91, DOI 10.1016/0147-619X(84)90055-6; MEYER AD, 1995, MOL GEN GENET, V249, P265, DOI 10.1007/BF00290526; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAGATA N, 1995, PLANT CELL PHYSIOL, V36, P1003; Nagata N, 1996, PLANT CELL PHYSIOL, V37, P489; OONO Y, 1990, JPN J GENET, V65, P7, DOI 10.1266/jjg.65.7; OONO Y, 1987, JPN J GENET, V62, P501, DOI 10.1266/jjg.62.501; OONO Y, 1993, PLANT CELL PHYSIOL, V34, P745; SINKAR VP, 1988, PLANT PHYSIOL, V86, P584, DOI 10.1104/pp.86.2.584; SLIGHTOM JL, 1986, J BIOL CHEM, V261, P108; SPENA A, 1987, EMBO J, V6, P3891; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; WHITE FF, 1982, P NATL ACAD SCI-BIOL, V79, P3193, DOI 10.1073/pnas.79.10.3193; WHITE FF, 1983, NATURE, V301, P348, DOI 10.1038/301348a0	30	9	10	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	FEB	1999	40	2					222	230				9	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	168XX	WOS:000078719400013		
J	Terauchi, K; Ohmori, M				Terauchi, K; Ohmori, M			An adenylate cyclase, cya1, regulates cell motility in the cyanobacterium Synechocystis sp. PCC 6803	PLANT AND CELL PHYSIOLOGY			English	Article						adenylate cyclase; cAMP; cyanobacteria; motility; Synechocystis sp. PCC 6803	SPIRULINA-PLATENSIS; ANABAENA-CYLINDRICA; CYCLIC-AMP; PROTEIN; GENE; CLONING; SIGNAL; CAMP	The cyanobacterium Synechocystis sp. PCC 6803 contained two genes, cya1 and cya2, encoding putative adenylate cyclases. The wild type cells are motile, whereas the disruption mutants of cya1, but not cya2, were immotile. Disruption of the cya1 gene also caused reduction of cellular cAMP level. The cya1 mutant cells regained motility when cAMP was added exogenously.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	Ohmori, M (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan.						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Brahamsha B, 1996, P NATL ACAD SCI USA, V93, P6504, DOI 10.1073/pnas.93.13.6504; MacKinney G, 1941, J BIOL CHEM, V140, P315; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1; COHEN P, 1983, PHILOS T ROY SOC B, V302, P13, DOI 10.1098/rstb.1983.0034; STANIER RY, 1971, BACTERIOL REV, V35, P171; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; Castenholz RW, 1982, BIOL CYANOBACTERIA, P413; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Kaneko T, 1996, DNA Res, V3, P109, DOI 10.1093/dnares/3.3.109; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828; Katayama M, 1997, J BACTERIOL, V179, P3588; KATAYAMA M, 1995, J BACTERIOL, V177, P3873; OHMORI K, 1992, PLANT CELL PHYSIOL, V33, P21; OHMORI M, 1988, ARCH MICROBIOL, V150, P203, DOI 10.1007/BF00425163; OHMORI M, 1989, PLANT CELL PHYSIOL, V30, P911; Sambrook J., 1989, MOL CLONING LAB MANU; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; Yashiro K, 1996, PLANT MOL BIOL, V31, P175, DOI 10.1007/BF00020618	22	41	43	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	FEB	1999	40	2					248	251				4	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	168XX	WOS:000078719400016		
J	Aoki, S; Syono, K				Aoki, S; Syono, K			Synergistic function of rolB, rolC, ORF13 and ORF14 of TL-DNA of Agrobacterium rhizogenes in hairy root induction in Nicotiana tabacum	PLANT AND CELL PHYSIOLOGY			English	Article						adventitious root induction; Agrobacterium rhizogenes; hairy root; Nicotiana tabacum; plast gene family; rol genes	RI-PLASMID; IDENTIFICATION; TRANSFORMATION; SEQUENCE; GENOME; GROWTH; PLANTS; MAP	Comparison of the frequency of rooting in the tobacco leaf segments inoculated with Agrobacterium tumefaciens harboring various combinations of rolB, rolC, ORF13 and ORF14 of TL-DNA of Ri plasmid (pRiHRI) revealed that the genes differ in their function to stimulate adventitious root induction. A single gene rolB induced roots, while rolC, ORF13 and ORF14 independently promoted the root induction by the rolB gene. The effects of these genes on the rolB-mediated rooting were in the order of ORF13> rolC greater than or equal to ORF14.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Aoki, S (reprint author), Chiba Univ, Dept Biol, Lab Phylogenet Bot, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.						FURNER IJ, 1986, NATURE, V319, P422, DOI 10.1038/319422a0; CARDARELLI M, 1987, MOL GEN GENET, V208, P457, DOI 10.1007/BF00328139; CHILTON MD, 1982, NATURE, V295, P432, DOI 10.1038/295432a0; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; SCHMULLING T, 1988, EMBO J, V7, P2621; WHITE FF, 1985, J BACTERIOL, V164, P33; Aoki S, 1999, PLANT CELL PHYSIOL, V40, P222; AOKI S, 1994, MOL GEN GENET, V243, P706; CAPONE I, 1989, PLANT MOL BIOL, V13, P43, DOI 10.1007/BF00027334; CARDARELLI M, 1985, PLANT MOL BIOL, V5, P385, DOI 10.1007/BF00037559; HUFFMAN GA, 1984, J BACTERIOL, V157, P269; JOUANIN L, 1984, PLASMID, V12, P91, DOI 10.1016/0147-619X(84)90055-6; LAHNERS K, 1984, PLASMID, V11, P130, DOI 10.1016/0147-619X(84)90018-0; LEVESQUE H, 1988, PLANT MOL BIOL, V11, P731, DOI 10.1007/BF00019514; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; SLIGHTOM JL, 1986, J BIOL CHEM, V261, P108; SPENA A, 1987, EMBO J, V6, P3891; WHITE FF, 1982, P NATL ACAD SCI-BIOL, V79, P3193, DOI 10.1073/pnas.79.10.3193; WILLMITZER L, 1982, MOL GEN GENET, V186, P16, DOI 10.1007/BF00422906	19	19	22	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	FEB	1999	40	2					252	256				5	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	168XX	WOS:000078719400017		
J	Homma, K; Akashi, N; Abe, T; Hasegawa, M; Harada, K; Hirabuki, Y; Irie, K; Kaji, M; Miguchi, H; Mizoguchi, N; Mizunaga, H; Nakashizuka, T; Natume, S; Niiyama, K; Ohkubo, T; Sawada, S; Sugita, H; Takatsuki, S; Yamanaka, N				Homma, K; Akashi, N; Abe, T; Hasegawa, M; Harada, K; Hirabuki, Y; Irie, K; Kaji, M; Miguchi, H; Mizoguchi, N; Mizunaga, H; Nakashizuka, T; Natume, S; Niiyama, K; Ohkubo, T; Sawada, S; Sugita, H; Takatsuki, S; Yamanaka, N			Geographical variation in the early regeneration process of Siebold's Beech (Fagus crenata BLUME) in Japan	PLANT ECOLOGY			English	Article						Fagus crenata; geographic distribution; post-dispersal mortality; pre-dispersal mortality; seedling emergence; snowpack	FOREST; JAPONICA; RODENTS	The causes and timing of seed death in early regeneration process of Siebold's beech (Fagus crenata Blume) was studied at 15 sites along a snowfall gradient in Japan, in order to clarify why the seedling density of the species has geographic difference remarkably. Seed production did not significantly differ along the snowfall gradient. Pre-dispersal seed mortality by insect damage was higher at sites with light snowfall than at sites with heavy snowfall, but this only seemed to be a minor factor influencing the population. A large proportion of the viable nuts that fall in autumn ware killed in winter before germination. Winter mortality was much higher at sites with thin snow cover than that at sites with thick snow cover, and this factor was strongly correlated with the geographic variation of seedling regeneration probability. There was little seed mortality by winter desiccation. The main factor contributing to the geographic difference seemed to be a seed predation by rodents in winter. Deep snow cover may reduce the success of rodents finding seeds in winter. Thus the observed relationship between snowpack depth and early mortality may be due to an indirect effect through the process of seed predation.	Kyoto Univ, Ctr Ecol Res, Sakyo Ku, Kyoto 6068502, Japan; Toyama Forestry & Forest Prod Res Ctr, Forest Expt Stn, Toyama 9301362, Japan; Hyogo Univ Educ, Yashiro, Hyogo 67314, Japan; Miyagi Univ Educ, Aoba Ku, Sendai, Miyagi 9800845, Japan; Niigata Univ, Grad Sch Nat Sci, Niigata 9502181, Japan; Univ Tokyo, Univ Forest, Chichibu, Saitama 368, Japan; Niigata Prefectural Forest Expt Stn, Asahi, Niigata 9580264, Japan; Kamo Highsch Agr & Forestry, Minokamo City, Gifu 5050027, Japan; Okayama Prefecture Forest Expt Stn, Okayama 7094335, Japan; Forestry & Forest Prod Res Inst, Ibaraki, Osaka 305, Japan; Hokkaido Univ Forestry, Kita Ku, Sapporo, Hokkaido 0600809, Japan; Forest & Forest Prod Res Inst, Kyusyu Res Ctr, Kumamoto 860, Japan; Utsunomiya Univ, Fac Agr, Utsunomiya, Tochigi 3218505, Japan; Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; Univ Tokyo, Fac Agr, Bunkyo Ku, Tokyo 113, Japan; Kyoto Univ Forest, Sakyo Ku, Kyoto 6068224, Japan	Homma, K (reprint author), Kyoto Univ, Ctr Ecol Res, Sakyo Ku, Kyoto 6068502, Japan.						JENSEN TS, 1985, OIKOS, V44, P149, DOI 10.2307/3544056; Homma K, 1997, J VEG SCI, V8, P781, DOI 10.2307/3237022; GURNELL J, 1993, FORESTRY, V66, P291, DOI 10.1093/forestry/66.3.291; BARBOUR MG, 1991, J BIOGEOGR, V18, P141, DOI 10.2307/2845288; CRAWLEY M.J., 1992, SEEDS ECOLOGY REGENE, P157; DOLUKHANOV AG, 1978, ARCTIC ALPINE RES, V10, P409, DOI 10.2307/1550771; FANTA J, 1981, VEGETATIO, V44, P13, DOI 10.1007/BF00119797; Fenner M., 1992, SEEDS ECOLOGY REGENE, P349; FUJITA N, 1986, STUDY SPECIES BIOL, V10, P1; GYSEL LW, 1971, J WILDLIFE MANAGE, V35, P516, DOI 10.2307/3799706; HARA M, 1987, VEGETATIO, V71, P67; Hashizume H., 1987, HARDWOOD RES, V4, P271; Higuchi H., 1993, Journal of the Japanese Forestry Society, V75, P56; Howe H.F., 1986, PLANT ECOL, P185; Hukusima Tukasa, 1995, Japanese Journal of Ecology (Sendai), V45, P79; Kaji M., 1995, MODERN ECOLOGY ITS S, P128; Kamitani T, 1984, B NIIGATA U FOR, V17, P1; KUME A, 1993, ECOL RES, V8, P111, DOI 10.1007/BF02348523; MAEDA T, 1988, SPEC B COLL AGR UTSU, V46; Maruta E, 1997, J FOR RES, V2, P45, DOI 10.1007/BF02348262; Miguchi H., 1988, Journal of the Japanese Forestry Society, V70, P472; OHTA Y, 1984, STUDY MICE HOKKAIDO; Ohwi J., 1965, FLORA JAPAN; PETERS R, 1990, J VEG SCI, V1, P499, DOI 10.2307/3235784; SAKAI A, 1976, LOW TEMP SCI B, V34, P47; Shidei T, 1974, FLORA VEGETATION JAP, P87; Shimano Koji, 1993, Japanese Journal of Ecology (Sendai), V43, P13; Shimano Koji, 1994, Japanese Journal of Ecology (Sendai), V44, P283; SHIMANO K, 1995, TECH B FAC HORT CHIB, V49, P111; TAKAHASHI I, 1991, STUDIES MYCOFLORAL S; Tranquillini W, 1979, PHYSL ECOLOGY ALPINE; VONWACHTER H, 1964, FORESTARCHIV, V35, P69; Watkinson AR, 1986, PLANT ECOL, P137; Woodward F. I., 1987, CLIMATE PLANT DISTRI	34	15	16	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1385-0237			PLANT ECOL	Plant Ecol.	FEB	1999	140	2					129	138		10.1023/A:1009725007759		10	Plant Sciences; Ecology; Forestry	Plant Sciences; Environmental Sciences & Ecology; Forestry	170FX	WOS:000078796600001		
J	Higuchi, K; Suzuki, K; Nakanishi, H; Yamaguchi, H; Nishizawa, NK; Mori, S				Higuchi, K; Suzuki, K; Nakanishi, H; Yamaguchi, H; Nishizawa, NK; Mori, S			Cloning of nicotianamine synthase genes, novel genes involved in the biosynthesis of phytosiderophores	PLANT PHYSIOLOGY			English	Article							FE-DEFICIENT BARLEY; MUGINEIC ACID; 2'-DEOXYMUGINEIC ACID; GEL-ELECTROPHORESIS; HORDEUM-VULGARE; IRON-DEFICIENCY; PLANTS; ROOTS; METHIONINE; PROTEINS	Nicotianamine synthase (NAS), the key enzyme in the biosynthetic pathway for the mugineic acid family of phytosiderophores, catalyzes the trimerization of S-adenosylmethionine to Corm one molecule of nicotianamine. We purified NAS protein and isolated the genes nas1, nas2, nas3, nas4, nas5-1, nas5-2, and nas6, which encode NAS and NAS-like proteins from Fe-deficient barley (Hordeum vulgare L. cv Ehimehadaka no. 1) roots. Escherichia coli expressing nas1 showed NAS activity, confirming that this gene encodes a functional NAS. Expression of nas genes as determined by northern-blot analysis was induced by Fe deficiency and was root specific. The NAS genes Corm a multigene family in the barley and rice genomes.	Univ Tokyo, Dept Appl Biol Chem, Lab Plant Mol Physiol, Bunkyo Ku, Tokyo 1138657, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Mori, S (reprint author), Univ Tokyo, Dept Appl Biol Chem, Lab Plant Mol Physiol, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	asmori@hongo.ecc.u-tokyo.ac.jp					Higuchi K, 1996, PLANT SOIL, V178, P171, DOI 10.1007/BF00011580; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; STEPHAN UW, 1994, PLANT SOIL, V165, P181, DOI 10.1007/BF00008060; ROMHELD V, 1986, PLANT PHYSIOL, V80, P175, DOI 10.1104/pp.80.1.175; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; MA JF, 1993, PLANT PHYSIOL, V102, P373; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; KAWAI S, 1988, TETRAHEDRON LETT, V29, P1053, DOI 10.1016/0040-4039(88)85333-4; MARSCHNER H, 1987, PHYSIOL PLANTARUM, V71, P157, DOI 10.1111/j.1399-3054.1987.tb02861.x; ROMHELD V, 1987, PHYSIOL PLANTARUM, V70, P231, DOI 10.1111/j.1399-3054.1987.tb06137.x; DZANDU JK, 1988, ANAL BIOCHEM, V174, P157, DOI 10.1016/0003-2697(88)90531-3; Gross E., 1967, METHOD ENZYMOL, V11, P238; Hashimoto T, 1998, PLANT CELL PHYSIOL, V39, P73; HIGUCHI K, 1995, J EXP BOT, V289, P1061; Higuchi K, 1996, J PLANT NUTR, V19, P1235, DOI 10.1080/01904169609365194; HIGUCHI K, 1994, PLANT SOIL, V165, P173, DOI 10.1007/BF00008059; Kanazawa K., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium on Iron Nutrition and Interactions in Plants, Zaragoza, Spain, 27 June-2 July 1993., P37; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mihashi S., 1989, Biology of Metals, V2, P146, DOI 10.1007/BF01142553; MORI S, 1987, J PLANT NUTR, V10, P1003, DOI 10.1080/01904168709363628; MORI S, 1988, J PLANT NUTR, V11, P653, DOI 10.1080/01904168809363831; NAITO S, 1988, PLANT MOL BIOL, V11, P109, DOI 10.1007/BF00015664; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; Nishizawa N, 1987, J PLANT NUTR, V10, P1012; NISHIZAWA NK, 1990, T 14 INT C SOIL SCI; PAJULA RL, 1979, EUR J BIOCHEM, V101, P619, DOI 10.1111/j.1432-1033.1979.tb19756.x; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SHOJIMA S, 1989, PLANT CELL PHYSIOL, V30, P673; Singh K., 1993, Genetic aspects of plant mineral nutrition. The Fourth International Symposium on Genetic Aspects of Plant Mineral Nutrition, 30 September-4 October 1991, Canberra, Australia., P335; Takagi S, 1976, SOIL SCI PLANT NUTR, V22, P4232; TAKAHASHI M, 1997, PLANT NUTR SUSTAINAB, P279; Takizawa R, 1996, J PLANT NUTR, V19, P1189, DOI 10.1080/01904169609365190; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	36	189	214	AMER SOC PLANT PHYSIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889			PLANT PHYSIOL	Plant Physiol.	FEB	1999	119	2					471	479		10.1104/pp.119.2.471		9	Plant Sciences	Plant Sciences	166PP	WOS:000078586300013		
J	Hu, K; Kobayashi, H; Dong, AJ; Jing, YK; Iwasaki, S; Yao, XS				Hu, K; Kobayashi, H; Dong, AJ; Jing, YK; Iwasaki, S; Yao, XS			Antineoplastic agents III: Steroidal glycosides from Solanum nigrum	PLANTA MEDICA			English	Article						Solanum nigrum; Solanaceae; steroidal glycosides; antineoplastic agents; cytotoxicity; Pyricularia oryzae	COLLETTII VAR HYPOGLAUCA; STRUCTURAL ELUCIDATION; NMR-SPECTROSCOPY; RHIZOMES	By bioactivity-guided fractionation, three known steroidal glycosides, beta(2)-solamargine (1), solamargine (2), and degalactotigonin (3), were isolated from Solanum nigrum. Compounds 1-3 induced morphological abnormality in Pyricularia oryzae mycelia with MMDC (minimum morphological deformation concentration) values of 63.0, 38.5, and 97.2 mu M, respectively. This is the first report on the isolation of 1 from this species and on the cytotoxicity of 1-3 on six cultured human solid tumor cell lines HT-29 (colon), HCT-15 (colon), LNCaP (prostate), PC-3 (prostate), T47D (breast), and MDA-MB-231 (breast) in vitro. The cytotoxic assay indicated that 2 is the main antineoplastic agent in S. nigrum. The structures of 1-3 were elucidated on the basis of chemical evidence and spectral analysis, especially by 2D-NMR analysis.	Shenyang Pharmaceut Univ, Dept Nat Prod Chem, Shenyang 110015, Peoples R China; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo, Japan; NE Pharmaceut Corp, Inst Drug Res & Dev, Shenyang, Peoples R China; Mt Sinai Sch Med, Dept Med, New York, NY USA	Yao, XS (reprint author), Shenyang Pharmaceut Univ, Dept Nat Prod Chem, 103 Wenhua Rd, Shenyang 110015, Peoples R China.						TSURUO T, 1986, CANCER RES, V46, P381; KOBAYASHI H, 1995, J ANTIBIOT, V48, P42; AGRAWAL PK, 1992, PHYTOCHEMISTRY, V31, P3307, DOI 10.1016/0031-9422(92)83678-R; MAHATO SB, 1982, PHYTOCHEMISTRY, V21, P959, DOI 10.1016/S0031-9422(00)82400-0; BETINA V, 1973, Z ALLG MIKROBIOL, V13, P287, DOI 10.1002/jobm.3630130402; Hu K, 1996, PLANTA MED, V62, P573, DOI 10.1055/s-2006-957978; Hu K, 1997, PLANTA MED, V63, P161, DOI 10.1055/s-2006-957636; Kobayashi H, 1996, J ANTIBIOT, V49, P873; LEE YY, 1994, CHEM PHARM BULL, V42, P707; MAHATO SB, 1980, PHYTOCHEMISTRY, V19, P2017, DOI 10.1016/0031-9422(80)83026-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAWWAR MAM, 1989, PHYTOCHEMISTRY, V28, P1755; PENG JP, 1992, ZHONGCAOYAO, V23, P437; Richmond D V, 1975, Adv Appl Microbiol, V19, P289, DOI 10.1016/S0065-2164(08)70432-5; SAIJO R, 1982, YAKUGAKU ZASSHI, V102, P300; TAKEDA K, 1963, J CHEM SOC, P4815, DOI 10.1039/jr9630004815; VALVERDE M, 1993, PLANTA MED, V59, P483	17	55	61	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0032-0943			PLANTA MED	Planta Med.	FEB	1999	65	1					35	38		10.1055/s-1999-13958		4	Plant Sciences; Chemistry, Medicinal; Pharmacology & Pharmacy	Plant Sciences; Pharmacology & Pharmacy	165TY	WOS:000078539000007		
J	Nakatsuka, T; Harii, K; Takushima, A; Yoshimura, K; Ichioka, S; Sugasawa, M; Ichimura, K; Seto, Y; Nagawa, H				Nakatsuka, T; Harii, K; Takushima, A; Yoshimura, K; Ichioka, S; Sugasawa, M; Ichimura, K; Seto, Y; Nagawa, H			Prefabricated free jejunal transfer: A new reconstructive technique for high pharyngeal defects	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							CERVICAL ESOPHAGUS	A new method that uses a prefabricated free jejunal transfer has been applied to three cancer patients with pharyngoesophageal defects with a high pharyngeal deficit extending up to the nasopharynx. In this method, the jejunum harvested in the usual manner is divided into two segments with a single vascular pedicle. Its distal segment is used to reconstruct the cervical esophagus, and its proximal segment is turned over to create a mucosal patch to cover the high pharyngeal defects. The two segments are then co-apted in a side-by-side anastomosis. The esophagus can be reconstructed in a naturally straight shape without a curved portion or blind loop formation, thus leading to good swallowing function. In our series, all grafts survived well and there was no complication directly related to jejunal transfer. All patients could tolerate a soft diet without difficulty. This method is easy to perform and applicable to any shape or size of very high pharyngeal defects that cannot be reconstructed properly by other methods. Although patients with an advanced hypopharyngeal cancer usually have a poor prognosis, this technique allows a better quality of life for a probable short life span.	Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Otorhinolaryngol, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Surg 1, Tokyo 1138655, Japan	Nakatsuka, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		Yoshimura, Kotaro/C-8524-2009				CARLSON GW, 1992, ANN PLAS SURG, V29, P408, DOI 10.1097/00000637-199211000-00005; KOSHIMA I, 1993, PLAST RECONSTR SURG, V92, P421, DOI 10.1097/00006534-199309000-00005; Nakatsuka T, 1998, SCAND J PLAST RECONS, V32, P307; ASATO H, 1990, JPN J PLAST RECONSTR, V10, P340; ENDO T, 1995, PLAST RECONSTR SURG, V95, P400, DOI 10.1097/00006534-199502000-00025; HARASHINA T, 1985, BRIT J PLAST SURG, V38, P483, DOI 10.1016/0007-1226(85)90004-9; Nakatsuka T, 1996, ANN PLAS SURG, V37, P596, DOI 10.1097/00000637-199612000-00005; NOHIRO K, 1988, Japanese Journal of Plastic and Reconstructive Surgery, V31, P223; STEPNICK DW, 1994, OTOLARYNG CLIN N AM, V27, P1151; THEILE DR, 1995, HEAD NECK-J SCI SPEC, V17, P83, DOI 10.1002/hed.2880170202; Yoshida T, 1998, BRIT J PLAST SURG, V51, P103, DOI 10.1016/S0007-1226(97)90183-1	11	12	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0032-1052			PLAST RECONSTR SURG	Plast. Reconstr. Surg.	FEB	1999	103	2					458	464		10.1097/00006534-199902000-00014		7	Surgery	Surgery	162ED	WOS:000078331800014		
J	Takagi, H				Takagi, H			Classification of extremal contractions from smooth fourfolds of (3,1)-type	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY			English	Article						extremal ray; contraction morphism	CALABI-YAU THREEFOLDS; VARIETIES; MANIFOLDS; BUNDLES; CONE	We investigate divisorial contractions of extremal rays from smooth fourfolds. When the exceptional divisor is contracted to a curve, we prove that the divisor is a P-2-bundle or quadric bundle over a smooth curve and the contraction is the blowing up along the curve. Furthermore we determine the local analytic structure of the contraction.	Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 1530041, Japan	Takagi, H (reprint author), Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 1530041, Japan.						ANDO T, 1985, INVENT MATH, V81, P347, DOI 10.1007/BF01389057; ANDREATTA M, 1993, DUKE MATH J, V72, P739, DOI 10.1215/S0012-7094-93-07228-6; Andreatta M., 1997, P S PURE MATH, V62, P153; ANDREATTA M, 1986, TEUBNER TEXTE MATH, V92, P24; Andreatta M, 1998, J ALGEBRAIC GEOM, V7, P253; MORI S, 1979, ANN MATH, V110, P593, DOI 10.2307/1971241; BELTRAMETTI M, 1987, ANN MAT PUR APPL, V147, P151, DOI 10.1007/BF01762415; FUJITA T, 1990, LECT NOTES MATH, V1417, P117; Fujita T., 1990, LONDON MATH SOC LECT, V155; Hartshorne R., 1977, GTM, V52; Kachi Y., 1997, ANN SCUOLA NORM SUP, V24, P63; KAWAMATA Y, 1987, ADV ST PURE MATH, V10, P287; KAWAMATA Y, 1989, MATH ANN, V284, P595, DOI 10.1007/BF01443353; KAWAMATA Y, 1984, ANN MATH, V119, P603, DOI 10.2307/2007087; MORI S, 1982, ANN MATH, V116, P133, DOI 10.2307/2007050; Nakano S., 1971, PUBL RIMS KYOTO U, V6, P483; REID M, 1994, PUBL RES I MATH SCI, V30, P695, DOI 10.2977/prims/1195165581; Reid M., 1980, JOURNEES GEOMETRIE A, P273; Reid M., 1983, ADV STUDIES PURE MAT, V1, P131; SCHLESSI.M, 1971, INVENT MATH, V14, P17, DOI 10.1007/BF01418741; WILSON PMH, 1992, INVENT MATH, V107, P561, DOI 10.1007/BF01231902; Wilson PMH, 1997, J DIFFER GEOM, V45, P611	22	5	5	AMER MATHEMATICAL SOC	PROVIDENCE	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA	0002-9939			P AM MATH SOC	Proc. Amer. Math. Soc.	FEB	1999	127	2					315	321		10.1090/S0002-9939-99-05114-X		7	Mathematics, Applied; Mathematics	Mathematics	163PN	WOS:000078414200001		
J	Hayashi, T; Mizuno, K; Hirose, M; Nakazato, K; Adachi, E; Imamura, Y; Kosugi, H; Yoshikawa, K				Hayashi, T; Mizuno, K; Hirose, M; Nakazato, K; Adachi, E; Imamura, Y; Kosugi, H; Yoshikawa, K			Cell type specific recognition of the reconstituted aggregates from isolated type I collagen, type IV collagen, and type V collagen	PROCEEDINGS OF THE INDIAN ACADEMY OF SCIENCES-CHEMICAL SCIENCES			English	Article; Proceedings Paper	Satellite Symposium on Trends in Collagen, at the XXV Congress of the International-Union-of-Leather-Technologists-and-Chemists-Societies	JAN 27-30, 1999	CHENNAI, INDIA	Int Union Leather Technologists & Chemists Soc		collagen aggregates; collagen types; cell; animal tissues; biological function	LAMINA DENSA; LENS CAPSULE; FIBRILS	The ultrastructure of animal tissues has a graded distribution that is reminiscent of the reconstituted aggregate structures from isolated type I collagen, type V collagen, and type IV collagen aligned in a gradient manner. We can assume that mesenchymal cells with different functions are also located in a graded way in accord with the graded distribution of collagen supramolecular aggregates. It was already known that proliferation, shape, migration, gene expression, and responses to growth factors of the cultured fibroblasts were greatly affected by the type I collagen fibrils. Other differentiated cells such as endothelial cells and smooth muscle cells are surrounded by type IV collagen and/or type V collagen more closely. The reconstituted type IV collagen aggregates in a gel form were tested as culture substrates for these differentiated cells. Of particular interest was the examination of myofibroblasts that are thought responsible for the pathogenesis of fibrotic or cirrhotic tissues. It was found that the type IV collagen gel appeared to restore the behaviors of smooth muscle-related cells including the myofibroblasts into the contractile stage. The whole cells cultured on the type I.V collagen gel were totally quiescent and formed a multicellular network. The findings suggest that interrelationships in a graded way between differentiated cells and the specific collagen aggregates might be involved in the homeostasis of tissue structure and function.	Kitasato Univ, Sch Med, Dept Anat & Cell Biol, Kanagawa 228, Japan; Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Hayashi, T (reprint author), Kitasato Univ, Sch Med, Dept Anat & Cell Biol, Kanagawa 228, Japan.						Adachi E, 1997, INT REV CYTOL, V173, P73; Adachi E, 1997, J ELECTRON MICROSC, V46, P233; YAMATO M, 1995, J BIOCHEM-TOKYO, V117, P940; HAYASHI T, 1993, NEW FUNCTIONALLY MAT, VB, P239; HIROSE M, 1997, ADV POLYMERIC BIOMAT, P153; Mizuno K, 1996, J BIOCHEM-TOKYO, V120, P934; Muraoka M, 1996, J BIOCHEM-TOKYO, V119, P167; Nakazato K, 1996, J BIOCHEM-TOKYO, V120, P889; Yamato M, 1998, EXTRACELLULAR MATRIX-CELL INTERACTION, P123	9	0	0	INDIAN ACADEMY SCIENCES	BANGALORE	P B 8005 C V RAMAN AVENUE, BANGALORE 560 080, INDIA	0253-4134			P INDIAN AS-CHEM SCI	Proc. Indian Acad. Sci.-Chem. Sci.	FEB	1999	111	1					171	177				7	Chemistry, Multidisciplinary	Chemistry	209JZ	WOS:000081045600018		
J	Chuda, T; Kimura, R; Niino, H; Sakajiri, M; Sebori, P				Chuda, T; Kimura, R; Niino, H; Sakajiri, M; Sebori, P			Detection of vertical fine structures in the free atmosphere	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						vertical fine structure; troposphere; radiosonde	LAYERS	Vertical fine structures of temperature and water vapor in the troposphere were detected from radiosonde data between 1 and 8 km MSL. It was found that fluctuations of temperature and specific humidity have a negative correlation in most of the vertical soundings examined. Their mean thickness is about 300 m. The mean amplitudes of fluctuations are 0.4 K for temperature and 0.4 gkg(-1) for specific humidity.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Japan Meteorol Agcy, Aerol Observ, Ibaraki, Osaka 3050052, Japan	Chuda, T (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						NEAL VT, 1969, SCIENCE, V166, P373, DOI 10.1126/science.166.3903.373; DALAUDIER F, 1994, J ATMOS SCI, V51, P237, DOI 10.1175/1520-0469(1994)051<0237:DEOITA>2.0.CO;2; COX C, 1969, B JPN SOC FISH OCEAN, P67; Cunningham J. E., 1993, Semiconductor Heterostructures for Photonic and Electronic Applications Symposium; de Bort LT, 1902, CR HEBD ACAD SCI, V134, P987; Iselin JP, 1997, MON WEATHER REV, V125, P1954, DOI 10.1175/1520-0493(1997)125<1954:WVLISF>2.0.CO;2; MCINTYRE DP, 1972, METEOROLOGICAL CHALL, P1; Muschinski A, 1998, J ATMOS SCI, V55, P2893, DOI 10.1175/1520-0469(1998)055<2893:FISEFC>2.0.CO;2; Newell RE, 1996, J GEOPHYS RES-ATMOS, V101, P1943, DOI 10.1029/95JD02613; SCORER RS, 1978, ENV AERODYNAMICS, P406; TAIT RI, 1971, NATURE, V231, P178, DOI 10.1038/231178a0; THORPE SA, 1982, J FLUID MECH, V124, P391, DOI 10.1017/S0022112082002559; *TREX GROUP, 1998, TENKI, V45, P137; YOSHIZAKI M, 1999, TSUKUBA AREA PRECIPI, P1	14	1	1	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	FEB	1999	75	2					23	28		10.2183/pjab.75.23		6	Multidisciplinary Sciences	Science & Technology - Other Topics	178EM	WOS:000079253400001		
J	Nagahara, H; Ozawa, K				Nagahara, H; Ozawa, K			Mechanism of forsterite evaporation as inferred from surface microstructures	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						evaporation; forsterite; surface reaction; microstructures; dislocation	ETCH PITS; DISSOLUTION; OLIVINE; QUARTZ; CHONDRULES; DIFFUSION; PYROXENE; SOLAR	Evaporation mechanism of synthetic pure forsterite and natural iron-bearing forsterite was experimentally studied in vacuum in the temperature range of 1400-1800 degrees C. Forsterite, which is one of the most important minerals in the planetary system, shows anisotropy of evaporation regarding evaporation rates and surface microstructures. The surfaces develop evaporation pits emanating from dislocation outcrops and smooth or stepped evaporation surface of which evaporation is not enhanced by dislocations. The shape of pits is controlled by anisotropy in evaporation rate and/or that in the surface free energy. Although forsterite and iron-bearing olivine have different type, orientation, and density of dislocation, the characteristics of evaporation pits are common for three crystallographically oriented surfaces. It suggests the larger contribution of anisotropy of surface free energy than the stress energy of dislocations on the shape of the evaporation pits. The estimated evaporation rates, on the contrary, indicate the importance of dislocation, which changes the overall evaporation rate by several factors at the experimental temperature. The change of evaporation rate affects the estimation of timescale of chemical fractionation in the solar nebula.	Univ Tokyo, Inst Geol, Bunkyo Ku, Tokyo 1130033, Japan; Okayama Univ, Inst Study Earths Interior, Tottori 6820193, Japan	Nagahara, H (reprint author), Univ Tokyo, Inst Geol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						MACINNIS IN, 1992, GEOCHIM COSMOCHIM AC, V56, P1113, DOI 10.1016/0016-7037(92)90049-O; HASHIMOTO A, 1990, NATURE, V347, P53, DOI 10.1038/347053a0; BERNER RA, 1980, SCIENCE, V207, P1205, DOI 10.1126/science.207.4436.1205; ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; NAGAHARA H, 1981, NATURE, V292, P135, DOI 10.1038/292135a0; BERNER RA, 1982, AM J SCI, V282, P1214; BLUM AE, 1990, GEOCHIM COSMOCHIM AC, V54, P283, DOI 10.1016/0016-7037(90)90318-F; BRANTLEY SL, 1986, GEOCHIM COSMOCHIM AC, V50, P2349, DOI 10.1016/0016-7037(86)90087-6; BUENING DK, 1973, J GEOPHYS RES, V78, P6852, DOI 10.1029/JB078i029p06852; CASEY WH, 1990, GEOCHIM COSMOCHIM AC, V54, P3369, DOI 10.1016/0016-7037(90)90291-R; CHAKRABORTY S, 1994, PHYS CHEM MINER, V21, P489; Chakraborty S, 1997, J GEOPHYS RES-SOL EA, V102, P12317, DOI 10.1029/97JB00208; Dove P.M., 1995, CHEM WEATHERING RATE, P235; DOWELL MB, 1977, J CHEM PHYS, V66, P1875, DOI 10.1063/1.434185; GRATZ AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P977, DOI 10.1016/0016-7037(93)90034-T; HIRTH JP, 1957, J CHEM PHYS, V26, P1216, DOI 10.1063/1.1743496; INOUE T, 1980, KRIST TECH, V15, P1295, DOI 10.1002/crat.19800151111; LASAGA AC, 1986, GEOCHIM COSMOCHIM AC, V50, P2363, DOI 10.1016/0016-7037(86)90088-8; Lasaga A.C., 1995, CHEM WEATHERING RATE, P23; LIN CC, 1995, GEOCHIM COSMOCHIM AC, V59, P2955, DOI 10.1016/0016-7037(95)00187-5; MISNER DJ, 1974, GEOCHEMICAL TRANSPOR, P117; Nagahara H, 1996, GEOCHIM COSMOCHIM AC, V60, P1445, DOI 10.1016/0016-7037(96)00014-2; RIDEAL R, 1952, P ROYAL SOC A, V210, P291; WANG J, 1991, LUNAR PLANET SCI, V22, P1461; WATANABE S, 1985, EARTH PLANET SC LETT, V72, P87, DOI 10.1016/0012-821X(85)90119-0	26	5	5	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	FEB	1999	75	2					29	34		10.2183/pjab.75.29		6	Multidisciplinary Sciences	Science & Technology - Other Topics	178EM	WOS:000079253400002		
J	Matsui, M; Kitahara, T; Yabuta, G; Yamada, T				Matsui, M; Kitahara, T; Yabuta, G; Yamada, T			Triethyl phosphate as the solvent for the preparation of Grignard reagents	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						Grignard reaction; Grignard reagent; triethyl phosphate		The Grignard reaction successfully proceeds using a Grignard reagent prepared in triethyl phosphate.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Tokyo Univ Agr, Dept Agr, Setagaya Ku, Tokyo 1560054, Japan	Matsui, M (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						LAI YH, 1981, SYNTHESIS-STUTTGART, P585; 1994, ENCY CHEM TECHNOLOGY, V12, P768	2	0	0	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	FEB	1999	75	2					35	36		10.2183/pjab.75.35		2	Multidisciplinary Sciences	Science & Technology - Other Topics	178EM	WOS:000079253400003		
J	Koike, H; Amano, N; Tateno, M; Ohfuku, Y; Suckow, JM; Suzuki, M				Koike, H; Amano, N; Tateno, M; Ohfuku, Y; Suckow, JM; Suzuki, M			Distribution and orientation of genes in the genome of Pyrococcus OT3	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						hyper-thermophile; genome analysis; bacterial evolution; replication; symbiogenesis hypothesis		Novel characteristics of genes identified in the genome of a hyper-thermophilic archaebacterium, Pyrococcus sp. OT3, are described by correlating the 1.74 M bases in the circular genome to the 12 hours in a clock. From 0:00 to 7:00 the bases are used to code more for the genes whose transcription takes place in the clockwise direction, while from 7:00 to 12:00 to code more for the genes whose transcription takes place in the anti-clockwise direction. Genes that are closely related to known eubacterial genes distribute equally through the genome without showing any strong position-preference. In contrast, genes that are closely related to known eukaryotic genes have tendency to cluster from 1:30 to 3:30. On the basis of these findings a possible link between transcription and-replication and the origin of archaebacterial genomes are discussed.	Ctr Struct Biol, CREST, AIST, NIBHT, Tsukuba, Ibaraki 3050046, Japan; Univ Tsukuba, Doctral Program Med Sci, Tsukuba, Ibaraki 3050006, Japan; Univ Tsukuba, Doctral Program Agr Sci, Tsukuba, Ibaraki 3050006, Japan; Univ Tokyo, Grad Sch Human & Environm Sci, Meguro Ku, Tokyo 1530041, Japan	Suzuki, M (reprint author), Ctr Struct Biol, CREST, AIST, NIBHT, 1-1 Higashi, Tsukuba, Ibaraki 3050046, Japan.						BLEASBY AJ, 1994, NUCLEIC ACIDS RES, V22, P3574; Himmelreich R, 1997, NUCLEIC ACIDS RES, V25, P701, DOI 10.1093/nar/25.4.701; Kawarabayasi Y, 1998, DNA Res, V5, P55, DOI 10.1093/dnares/5.2.55; Margulis L., 1970, ORIGIN EUKARYOTIC CE; Ohfuku Y, 1998, P JPN ACAD B-PHYS, V74, P90, DOI 10.2183/pjab.74.90; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SEARCY DG, 1981, ANN NY ACAD SCI, V361, P312, DOI 10.1111/j.1749-6632.1981.tb54373.x; Suckow JM, 1999, P JPN ACAD B-PHYS, V75, P16, DOI 10.2183/pjab.75.16; Suckow JM, 1999, P JPN ACAD B-PHYS, V75, P10, DOI 10.2183/pjab.75.10; Suckow JM, 1998, FEBS LETT, V426, P86, DOI 10.1016/S0014-5793(98)00323-8; Yamasaki T, 1998, P JPN ACAD B-PHYS, V74, P227, DOI 10.2183/pjab.74.227	11	9	9	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	FEB	1999	75	2					37	42		10.2183/pjab.75.37		6	Multidisciplinary Sciences	Science & Technology - Other Topics	178EM	WOS:000079253400004		
J	Hu, Y; Fan, WC; Wang, QA; Kawamora, T; Koseki, N; Akutsu, Y; Tamura, M				Hu, Y; Fan, WC; Wang, QA; Kawamora, T; Koseki, N; Akutsu, Y; Tamura, M			Study on gas phase long-lived radicals in combustion of polyurethane modified by phosphazene	PROGRESS IN NATURAL SCIENCE			English	Article						polyurethane; flame retardant; radical; phosphazene		Combustion and decomposition properties in polyurethane (PU) modified by flame retardant were investigated by using the electron spin resonance (ESR) spin trapping technique and thermogravimetry (TG), the long-lived gas phase radicals in combustion and decomposition products of polyurethane were studied. It was shown that the concentration of radicals in combustion was reduced by adding hexachlorotriphosphazene containing chlorine, and heat decomposition in polyurethane was also accelerated by phosphazene. Appropriate phosphazene compounds could improve name retardant property of PU and inhibit long-lived radicals production in PU combustion.	Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Peoples R China; Univ Tokyo, Sch Engn, Tokyo 113, Japan	Hu, Y (reprint author), Univ Sci & Technol China, State Key Lab Fire Sci, Hefei 230026, Peoples R China.						ALLOCK HR, 1981, MACROMOLECULES, V14, P1616; VANKREVELEN DW, 1975, POLYMER, V16, P615, DOI 10.1016/0032-3861(75)90157-3; HERRINGTON RM, 1979, J FIRE FLAMMABILITY, V10, P308; LOWRY WT, 1985, J FORENSIC SCI, V1, P73; LUND LG, 1960, J CHEM SOC, P2542, DOI 10.1039/jr9600002542; PRAGER FH, 1994, FIRE MATER, V18, P107, DOI 10.1002/fam.810180207; PRYOR WA, 1987, FREE RADICAL BIO MED, V3, P273; PRYOR WA, 1984, J AM CHEM SOC, V106, P5073, DOI 10.1021/ja00330a006; YU YZ, 1990, HDB FLAME RETARDANT, P49	9	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	1002-0071			PROG NAT SCI	Prog. Nat. Sci.	FEB	1999	9	2					103	108				6	Materials Science, Multidisciplinary; Multidisciplinary Sciences	Materials Science; Science & Technology - Other Topics	163FK	WOS:000078393200004		
J	Hashimoto, K; Kurita, H; Haratani, T; Fujii, K; Ishibashi, T				Hashimoto, K; Kurita, H; Haratani, T; Fujii, K; Ishibashi, T			Direct and buffering effects of social support on depressive symptoms of the elderly with home help	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						depressive symptoms; elderly; home help; social support	LIFE EVENTS; STRESS; PEOPLE; ASSOCIATIONS; RECOVERY; HEALTH; MODEL	The purpose of the present study was to examine the prevalence of depressive symptoms on the Center for Epidemiologic Studies Depression Scale (CES-D) and the effect of Life stressors or social support on depressive symptoms in 303 elderly people receiving social services at home. We conducted a questionnaire survey six times with a 1-month interval. In the initial wave of questionnaires, 92 (31%) scored 16 points or above on the CES-D, indicative of a risk for depression. Before life stressors, subjects with low-level support showed significantly more severe depressive symptoms than those with high-level support. Subjects with low-level support were significantly more depressive after life stressors than they had been before, whereas those with middle- and high-level support showed no such difference. The former and latter results seem to suggest the direct and buffering effects of social support on depressive symptoms, respectively.	Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, Tokyo 1130033, Japan; Natl Inst Ind Hlth, Kawasaki, Kanagawa, Japan; Mitsubishi Res Ctr, Chiyoda Ku, Tokyo, Japan; Dia Res Fdn Ageing Soc, Bunkyo Ku, Tokyo, Japan	Hashimoto, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Mental Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ANDREWS G, 1978, J NERV MENT DIS, V166, P307, DOI 10.1097/00005053-197805000-00001; ANESHENSEL CS, 1982, ARCH GEN PSYCHIAT, V39, P1392; BOWLING A, 1991, SOC PSYCH PSYCH EPID, V26, P115, DOI 10.1007/BF00782950; ALLOWAY R, 1987, PSYCHOL MED, V17, P91; LOGSDON RG, 1995, J AM GERIATR SOC, V43, P150; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; OXMAN TE, 1992, AM J EPIDEMIOL, V135, P356; QUITTNER AL, 1990, J PERS SOC PSYCHOL, V59, P1266, DOI 10.1037//0022-3514.59.6.1266; Banerjee S, 1996, BRIT J PSYCHIAT, V168, P750, DOI 10.1192/bjp.168.6.750; Brown GW, 1978, SOCIAL ORIGINS DEPRE; CUMMINGS SR, 1988, J AM GERIATR SOC, V36, P801; Frank E, 1996, PSYCHOL MED, V26, P613; GEORGE LK, 1989, BRIT J PSYCHIAT, V154, P478, DOI 10.1192/bjp.154.4.478; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Ihara K, 1993, Nihon Koshu Eisei Zasshi, V40, P85; ILLIFFE S, 1993, BR J GEN PRACT, V43, P371; KING KB, 1993, HEALTH PSYCHOL, V12, P56, DOI 10.1037/0278-6133.12.1.56; KRAUSE N, 1989, PSYCHOL AGING, V4, P88, DOI 10.1037/0882-7974.4.1.88; KRAUSE N, 1988, BEHAV MED, P101; LINDERSAY J, 1990, THESIS OXFORD U OXFO; MADIANOS MG, 1992, ACTA PSYCHIAT SCAND, V86, P320, DOI 10.1111/j.1600-0447.1992.tb03273.x; MATT GE, 1993, J HEALTH SOC BEHAV, V34, P187, DOI 10.2307/2137201; MCFARLANE AH, 1983, J HEALTH SOC BEHAV, V24, P160, DOI 10.2307/2136642; ORRELL M, 1995, BRIT J PSYCHIAT, V166, P613, DOI 10.1192/bjp.166.5.613; Orrell Martin W., 1994, International Review of Psychiatry, V6, P59, DOI 10.3109/09540269409025243; Oxman TE, 1997, J GERONTOL B-PSYCHOL, V52, P1; RUSSELL DW, 1991, PSYCHOL AGING, V6, P190, DOI 10.1037/0882-7974.6.2.190; SAS Institute Inc, 1990, SAS STAT US GUID VER, V2; Shima S, 1985, CLIN PSYCHIATR, V27, P717; THOITS PA, 1995, J HLTH SOCIAL BEHAV, P53, DOI DOI 10.2307/2626957; WARHEIT G J, 1979, American Journal of Psychiatry, V136, P502; WILCOX VL, 1994, HEALTH PSYCHOL, V13, P170, DOI 10.1037/0278-6133.13.2.170	32	8	11	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1323-1316			PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	FEB	1999	53	1					95	100		10.1046/j.1440-1819.1999.00478.x		6	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	178FW	WOS:000079256400016		
J	Hayashi, N; Ostrom, E; Walker, J; Yamagishi, T				Hayashi, N; Ostrom, E; Walker, J; Yamagishi, T			Reciprocity, trust, and the sense of control - A cross-societal study	RATIONALITY AND SOCIETY			English	Article						trust; reciprocity; experimental; Prisoner's Dilemma	SOCIAL CATEGORIZATION; BEHAVIOR; JAPAN	Most cognitive approaches for explaining cooperation in Prisoner's Dilemma games include the view that many people believe that mutual cooperation is generally a gainful strategy to all parties and will cooperate when they think their partner cooperates. Proceeding along these lines, we argue that many participants treat a Prisoner's Dilemma game as an assurance game, and respond in a reciprocal manner to the choice or expected choice of their partner. We examine two bases for the expectation of a partner's cooperation in one-shot games: 'general trust' and a 'sense of control'. Further, we discuss why we expect general trust and a sense of control to play different roles in societies, particularly in Japanese society and American society. Specifically, we test a general hypothesis that a sense of control plays a relatively more important role as a foundation for expectations in Japanese society and general trust plays the more important role in American society.	Univ Tokyo, Grad Sch Humanities & Sociol, Dept Social Pyschol, Tokyo, Japan; Indiana Univ, Dept Polit Sci, Workshop Polit Theory & Policy Anal, Bloomington, IN USA; Indiana Univ, Dept Econ, Wrokshop Polit Theory & Policy Anal, Bloomington, IN USA; Hokkaido Univ, Fac Letters, Sapporo, Hokkaido 060, Japan	Hayashi, N (reprint author), Univ Tokyo, Grad Sch Humanities & Sociol, Dept Social Pyschol, Tokyo, Japan.		Yamagishi, Toshio/E-2384-2013	Yamagishi, Toshio/0000-0002-8890-1115			ANDREONI J, 1995, AM ECON REV, V85, P891; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V50, P67, DOI 10.1037/0022-3514.50.1.67; BILLIG M, 1973, EUR J SOC PSYCHOL, V3, P27, DOI 10.1002/ejsp.2420030103; TAJFEL H, 1970, SCI AM, V223, P96; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; BEARD TR, 1997, CULTURAL DETERMINANT; Benedict Ruth, 1946, CHRYSANTHEMUM SWORD; Carnevale P. J., 1995, NEGOTIATION SOCIAL P, P309; CHAN D, 1994, COMP NEGOTIATION CUL; CROSON R, 1998, THEORIES ALTRUISM RE; Hayashi C., 1982, STUDY JAPANESE NATL, V4; HECHTER M, 1993, J THEOR POLIT, V5, P455, DOI 10.1177/0951692893005004002; Jin N., 1997, JAPANESE J SOCIAL PS, V12, P190; Jin N, 1996, JPN J PSYCHOL, V67, P77; Karp D., 1993, JAPANESE J EXPT SOCI, V32, P231, DOI 10.2130/jjesp.32.231; KIYONARI T, 1997, UNPUBLISHED EXPT TRU; KIYONARI T, 1997, THESIS HOKKAIDO U SA; KOLLOCK P, 1997, MODELING RATIONAL MO, P186; Kuhlman D, 1986, EXPT SOCIAL DILEMMAS, P151; LIEBRAND WBG, 1984, EUR J SOC PSYCHOL, V14, P239, DOI 10.1002/ejsp.2420140302; SATO M, 1998, J ECON BEHAV ORGAN, V34, P387; Slovic P., 1982, JUDGEMENT UNCERTAINT; Watabe M., 1996, JAPANESE J EXPT SOCI, V36, P183; Yamagishi M, 1989, WORKSH BUR RES PROJ; YAMAGISHI T, 1993, SOC PSYCHOL QUART, V56, P235, DOI 10.2307/2786661; YAMAGISHI T, 1988, SOC PSYCHOL QUART, V51, P265, DOI 10.2307/2786924; Yamagishi T, 1992, SOCIAL DILEMMAS THEO, P267; YAMAMOTO T, 1993, NEUROSCI RES, V18, P129, DOI 10.1016/0168-0102(93)90016-J	30	77	79	SAGE PUBLICATIONS LTD	LONDON	6 BONHILL STREET, LONDON EC2A 4PU, ENGLAND	1043-4631			RATION SOC	Ration. Soc.	FEB	1999	11	1					27	46		10.1177/104346399011001002		20	Sociology	Sociology	167DZ	WOS:000078618500002		
J	Tatsumi, D; Barton, MA; Uchiyama, T; Kuroda, K				Tatsumi, D; Barton, MA; Uchiyama, T; Kuroda, K			Two-dimensional low-frequency vibration attenuator using X pendulums	REVIEW OF SCIENTIFIC INSTRUMENTS			English	Article								We have designed and constructed an improved two-dimensional X pendulum vibration-isolation table. It achieved a lower resonant frequency (7 s) than previous prototypes, and the effects of many parasitic elastic resonances have been reduced by careful balancing, leading to much improved vibration isolation around a few hertz. (C) 1999 American Institute of Physics. [S0034-6748(99)00902-8].	Univ Tokyo, Inst Cosm Ray Res, Tokyo 188, Japan	Tatsumi, D (reprint author), Univ Tokyo, Inst Cosm Ray Res, Tokyo 188, Japan.						BARTON MA, UNPUB REV SCI INSTRU; Barton MA, 1996, REV SCI INSTRUM, V67, P3994, DOI 10.1063/1.1147304; BARTON MA, 1996, M ASTR SOC JAP; BARTON MA, 1996, M PHYS SOC JAP 9 OCT; BARTON MA, 1994, REV SCI INSTRUM, V65, P3775, DOI 10.1063/1.1144506; KANDA N, 1994, REV SCI INSTRUM, V65, P3780, DOI 10.1063/1.1145202; Yuki K, 1996, PHYS LETT A, V223, P149, DOI 10.1016/S0375-9601(96)00723-2	7	3	4	AMER INST PHYSICS	WOODBURY	CIRCULATION FULFILLMENT DIV, 500 SUNNYSIDE BLVD, WOODBURY, NY 11797-2999 USA	0034-6748			REV SCI INSTRUM	Rev. Sci. Instrum.	FEB	1999	70	2					1561	1564		10.1063/1.1149624		4	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	164YD	WOS:000078490400057		
J	Lu, R; Hattori, K; Xia, ZY; Yoshida, T; Yang, JH; Zhang, LN; Du, YM; Miyakoshi, T; Uryu, T				Lu, R; Hattori, K; Xia, ZY; Yoshida, T; Yang, JH; Zhang, LN; Du, YM; Miyakoshi, T; Uryu, T			Structural analysis of polysaccharides in Chinese lacquer by NMR spectroscopy	SEN-I GAKKAISHI			English	Article							RHUS-VERNICIFERA; LAC TREE; ORIENTAL LACQUER; URUSHIOL; SAP	Structural characterization of the Chinese lacquer polysaccharide of Rhus vernicifera was performed by means of high resolution NMR spectroscopy involving two dimensional NMR measurements such as field gradient DQF-COSY, TOCSY, HMQC, and HMBC experiments. Most of complicated proton and carbon absorptions were assigned. It was identified that the lacquer polysaccharide had a 1,3-linked D-galactopyranosidic main chain with complex side chains consisting of D-galactose, 4-O-methyl-D-glucuronic acid, D-glucuronic acid, L-arabinose, and L-rhamnose. The coupling constants (J(1,2)) of anomeric protons in the DQF-COSY spectrum suggested that the galactopyranose residue in the main chain, and 4-O-methyl-D-glucuronic acid and D-glucuronic acid in the terminal of the side-chains (J(1,2) = 7.2, 9.0 Hz and 8.1 Hz) had a beta-linkage, and the terminal D-galactopyranose, L-arabinose and L-rhamnose (J(1,2) less than or equal to 3.6 Hz) in the side-chains had an alpha-linkage. The proportions of the component sugar units were calculated by the intensity of the anomeric carbon signals and were in good agreement with those by the methylation analysis reported previously. These results indicate that the NMR characterization can be widely used to investigate the relationship between the structure of lacquer polysaccharides and specific biological activities.	Hokkaido Univ, Grad Sch Sci, Dept Polymer Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; Wuhan Univ, Dept Environm Sci, Wuhan 430072, Peoples R China; Meiji Univ, Fac Sci & Engn, Dept Ind Chem, Tama Ku, Kawasaki, Kanagawa 2140033, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1060032, Japan			lu, rong/B-2759-2010; Pang, Zh. Y./E-3798-2010				Kumanotani J, 1995, PROG ORG COAT, V26, P163, DOI 10.1016/0300-9440(95)00559-5; BOCK K, 1983, ADV CARBOHYD CHEM BI, V41, P27, DOI 10.1016/S0065-2318(08)60055-4; BARTUS J, 1994, POLYM J, V26, P67, DOI 10.1295/polymj.26.67; BOCK K, 1984, ADV CARBOHYD CHEM, V42, P27; DU Y, 1984, J CHROMATOGR, V295, P179, DOI 10.1016/S0021-9673(01)87609-3; DU YM, 1984, J CHROMATOGR, V284, P463, DOI 10.1016/S0021-9673(01)87848-1; HAKOMORI SI, 1964, J BIOCHEM-TOKYO, V55, P205; LU R, 1997, POLYM PREPR-JAPAN, V46, P3065; MIYAKOSHI T, 1993, P INT S OR LACQ, P65; Niimura N, 1996, J ANAL APPL PYROL, V37, P199, DOI 10.1016/0165-2370(96)00945-X; Niimura N., 1998, J JPN OIL CHEM SOC, V47, P171; Oda Y., 1963, NOGEI KAGAKUKAISHI, V37, P132; ODA Y, 1962, NOGEI KAGAKUKAISHI, V36, P527; OSHIMA R, 1985, J ORG CHEM, V50, P2613, DOI 10.1021/jo00215a002; OSHIMA R, 1984, CARBOHYD RES, V127, P43, DOI 10.1016/0008-6215(84)85105-8; Vogl O, 1994, PROGR PACIFIC POLYM, V3, P423; 张俐娜, 1995, Chinese Journal of Polymer Science, V13, P107	17	18	18	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	1999	55	2					47	56				10	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	168YK	WOS:000078720600007		
J	Enomae, T; Kataoka, H; Onabe, F				Enomae, T; Kataoka, H; Onabe, F			In-plane distribution of paper absorbency measured by liquid absorption profilometer	SEN-I GAKKAISHI			English	Article							SUBMILLIMETER GLOSS VARIATIONS; COATED PAPER; BASESTOCK	A novel apparatus for quantitative evaluation of a liquid, particularly, water absorption profile of paper was developed. The underlying principle for this method is similar to that of Bristow's method. This system is characterized by an applicator head with a small opening scanning a paper surface and by the detection system using an optical sensor pursuing the meniscus of water filled in a glass capillary connected with the applicator head. The level of sheet formation evidently affected the variation of water absorption rate profile, but the effect was observed only when the contact time was sufficiently long. The coefficient of variation for the worse formation was 36 % higher than that for the better formation at a contact time of 3 s, while it was almost the same at a contact time of 0.2 s. However, no distinct correlation such as accordance of peaks was found between the transmitted light profile and the absorption rate profile. The density variation inducing pore size distribution near the surface layer may affect the absorption rate variation. Additionally, the influence of sizing degree was discussed. This novel system might be applied to clarify effects of water absorbency of basepaper on coating and adequate ink absorption in inkjet printing.	Univ Tokyo, Bunkyo Ku, Tokyo 1138657, Japan; ISI Dentsu Amer Inc, New York, NY 10036 USA							MACGREGOR MA, 1991, TAPPI J, V74, P187; TOMIMASU H, 1990, TAPPI J, V73, P179; BRISTOW JA, 1967, SVEN PAPPERSTIDN, V70, P623; ARAI T, 1988, TAPPI COAT C P, P187; DAHLQUIST RW, 1990, TAPPI J, V73, P151; EKLUND DE, 1970, TAPPI, V53, P1925; ENGSTROM G, 1991, P TECH AS P, P169; ENOMAE T, 1999, UNPUB SCIENCE; HOWARTH P, 1985, AERIAL DISTRIBUTION, P483; INOUE M, 1998, COMMUNICATION; KATAOKA H, 1992, SENI GAKKAI PREPRINT, pS228; KENT HJ, 1986, TAPPI J, V69, P78; KOHNO M, 1986, KAMI PA GIKYOSHI, V40, P295; KUGA S, 1994, KAMIPA GIKYOSHI, V48, P730; LEPOUTRE P, 1986, TAPPI J, V69, P66; MACGREGOR MA, 1990, TAPPI J, V73, P161; NORRDAHL PC, 1991, TAPPI COATING C P, P417; SAITO Y, 1992, PAN PACIFIC PULP PAP, P45; TSAI YG, 1997, 1997 JAP TAPP ANN M, P261; WHALENSHAW M, 1991, TAPPI J, V74, P188	20	1	1	SOC FIBER SCIENCE TECHNOLOGY	TOKYO	KAMIOSAKI 3-3-9-208, SHINAGAWA-KU, TOKYO, 141-0025, JAPAN	0037-9875			SEN-I GAKKAISHI	Sen-I Gakkaishi	FEB	1999	55	2					65	72				8	Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	168YK	WOS:000078720600009		
J	Hashimoto, Y; Kimura, G				Hashimoto, Y; Kimura, G			Underplating process from melange formation to duplexing: Example from the Cretaceous Shimanto Belt, Kii Peninsula, southwest Japan	TECTONICS			English	Article							ACCRETIONARY PRISM; SUBDUCTION ZONES; FAULT ZONES; DEFORMATION; HYDROGEOLOGY; CALIFORNIA; SEDIMENTS; TECTONICS; COMPLEX	Accretionary complexes are considered to form through off scraping and underplating, which results in the lateral and vertical growth of an accretionary prism. Accretion of the upper part of the oceanic crust and the formation of melange are important components of the accretionary process, although the origin of melange is considered controversial. In order to better understand the origin of melange and its role in accretion, in particular during underplating. we have studied the relationship between the formation of melange and duplexing in the Miyama Assemblage. Here the melange is composed dominantly of shale, basalt, chert. and sandstone. This study stresses the following features: (1) the structure of the Miyama Assemblage appears to be a composite suits of landward and seaward dipping duplexes: (2) the melange fabric displays a systematic asymmetry, which may have resulted through shearing along the decollement: and (3) facing of horses within duplexes changes from north to south. coinciding with a change in the sense of shear inferred from the melange fabric. which suggests that it formed prior to duplexing.	Univ Tokyo, Inst Geol, Bunkyo Ku, Tokyo 1130033, Japan; Hokkaido Univ, Grad Sch Sci, Dept Earth & Planetary Sci, Sapporo, Hokkaido 060, Japan	Hashimoto, Y (reprint author), Univ Tokyo, Inst Geol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						KIMURA G, 1991, TECTONICS, V10, P31, DOI 10.1029/90TC00799; COWAN DS, 1985, GEOL SOC AM BULL, V96, P451, DOI 10.1130/0016-7606(1985)96<451:SSIMAC>2.0.CO;2; VROLIJK P, 1990, GEOLOGY, V18, P703, DOI 10.1130/0091-7613(1990)018<0703:OTMROS>2.3.CO;2; CHESTER FM, 1987, J STRUCT GEOL, V9, P621, DOI 10.1016/0191-8141(87)90147-7; ISOZAKI Y, 1990, TECTONOPHYSICS, V181, P179, DOI 10.1016/0040-1951(90)90016-2; BOYER SE, 1982, AAPG BULL, V66, P1196; KIMURA G, 1995, GEOLOGY, V23, P217, DOI 10.1130/0091-7613(1995)023<0217:POCISZ>2.3.CO;2; BERTHE D, 1979, J STRUCT GEOL, V1, P31, DOI 10.1016/0191-8141(79)90019-1; RUTTER EH, 1986, PURE APPL GEOPHYS, V124, P3, DOI 10.1007/BF00875717; SILVER EA, 1985, GEOLOGY, V13, P6, DOI 10.1130/0091-7613(1985)13<6:COTGOA>2.0.CO;2; LISTER GS, 1984, J STRUCT GEOL, V6, P617, DOI 10.1016/0191-8141(84)90001-4; Bradley D.C., 1992, US GEOL SURV B, V1999, P17; Byrne T., 1992, ISL ARC, V1, P148, DOI 10.1111/j.1440-1738.1992.tb00066.x; CHATTERJEE KK, 1994, J STRUCT GEOL, V16, P1463, DOI 10.1016/0191-8141(94)90009-4; FISHHER D, 1987, TECTONICS, V6, P775, DOI 10.1029/TC006i006p00775; HSU KJ, 1968, GEOL SOC AM BULL, V79, P1063, DOI 10.1130/0016-7606(1968)79[1063:POMATB]2.0.CO;2; Hyndman R. D., 1994, P OCEAN DRILLING PRO, V146, P399; KANO K, 1991, TECTONOPHYSICS, V185, P375, DOI 10.1016/0040-1951(91)90455-2; KIMURA G, 1997, P OCEAN DRILL PROGRA, V170, P7, DOI DOI 10.2973/ODP.PROC.IR.170.101.1997; Kimura G, 1996, GEOLOGY, V24, P75, DOI 10.1130/0091-7613(1996)024<0075:WPUSOT>2.3.CO;2; *KISHU SHIMANTO RE, 1986, EARTH SCI, V40, P227; KUMON F, 1993, RIDGE TRENCH ENCOUNT, V1, P37; Kumon F., 1988, Modern Geology, V12; KURIMOTO C, 1994, B J GEOL SURV, V45, P235; MCCLAY KR, 1992, THRUST TECTONICS, P419; MOORE GF, 1991, P OCEAN DRILL PROGRA, V131, P15; MOORE JC, 1988, GEOL SOC AM BULL, V100, P1578, DOI 10.1130/0016-7606(1988)100<1578:TAHOTN>2.3.CO;2; MOORE JC, 1987, GEOLOGY, V15, P1040, DOI 10.1130/0091-7613(1987)15<1040:TOFZAM>2.0.CO;2; MOORE JC, 1987, REV GEOPHYS, V25, P1305, DOI 10.1029/RG025i006p01305; MURATA A, 1991, GEOLOGICAL SOC JAPAN, V97, P39; NEEDHAM DT, 1987, GEOL MAG, V124, P311; Onishi CT, 1995, TECTONICS, V14, P1273, DOI 10.1029/95TC01929; Ramsay J.G., 1987, TECHNIQUES MODERN ST, V2, P309; Raymond LA., 1984, GEOL SOC AM SPEC PAP, V198, P7; Scholl D.W., 1987, EARTH SCI SER, V6, P123; SHIPLEY TH, 1992, J GEOPHYS RES-SOL EA, V97, P4439, DOI 10.1029/91JB02999; Taira A., 1980, GEOLOGY PALEONTOLOGY, P319; TAIRA A, 1992, EARTH PLANET SC LETT, V109, P431, DOI 10.1016/0012-821X(92)90104-4; Westbrook G.K., 1994, P OCEAN DRILL PROGRA, V146, P389, DOI 10.2973/odp.proc.ir.146-1.012.1994	39	70	72	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0278-7407			TECTONICS	Tectonics	FEB	1999	18	1					92	107		10.1029/1998TC900014		16	Geochemistry & Geophysics	Geochemistry & Geophysics	168HU	WOS:000078686800006		
J	Ihara, Y; Aoki, K				Ihara, Y; Aoki, K			Sexual selection by male choice in monogamous and polygynous human	THEORETICAL POPULATION BIOLOGY			English	Article							COSTLY MATE PREFERENCES; TO-HIP RATIO; MORMON CRICKETS; PHYSICAL ATTRACTIVENESS; FEMALE ATTRACTIVENESS; REPRODUCTIVE SUCCESS; HANDICAP PRINCIPLE; ROLE REVERSAL; EVOLUTION; COMPETITION	The theoretical possibility of coevolution of a viability-reducing female physical trait and a male mating preference for that trait by Fisherian sexual selection in monogamous and polygynous populations is demonstrated using two-locus haploid models. It is assumed that there is dichotomous variation in male resources, resource-rich males have a wider choice among females than resource-poor males, and a female has greater reproductive success when mated with a resource-rich male than a resource-poor one. Under these assumptions, we find that sexual selection operates effectively when female reproductive success is strongly dependent on male resource, the proportion of females that mate with resource-rich males is neither small nor large, the degree of polygyny is low, and resources are inherited from father to son. We suggest that some human female physical traits may have evolved by sexual selection through male choice. The evolution of skin color by sexual selection is discussed as an example. (C) 1999 Academic Press.	Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	Ihara, Y (reprint author), Univ Tokyo, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.						Alexander RD, 1979, EVOLUTIONARY BIOL HU, P402; GWYNNE DT, 1991, TRENDS ECOL EVOL, V6, P118, DOI 10.1016/0169-5347(91)90089-G; POMIANKOWSKI A, 1991, EVOLUTION, V45, P1422, DOI 10.2307/2409889; ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.2307/2408465; KIRKPATRICK M, 1990, EVOLUTION, V44, P180, DOI 10.2307/2409533; GWYNNE DT, 1993, ECOLOGY, V74, P1406, DOI 10.2307/1940070; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Singh D, 1995, ETHOL SOCIOBIOL, V16, P483, DOI 10.1016/0162-3095(95)00074-7; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LOOMIS WF, 1967, SCIENCE, V157, P501, DOI 10.1126/science.157.3788.501; LALAND KN, 1994, THEOR POPUL BIOL, V45, P1, DOI 10.1006/tpbi.1994.1001; MULDER MB, 1990, BEHAV ECOL SOCIOBIOL, V27, P255; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; ORIANS GH, 1969, AM NAT, V103, P589, DOI 10.1086/282628; GWYNNE DT, 1981, SCIENCE, V213, P779, DOI 10.1126/science.213.4509.779; GWYNNE DT, 1984, EVOLUTION, V38, P1011, DOI 10.2307/2408435; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.2307/2407961; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Aoki K, 1997, P NATL ACAD SCI USA, V94, P13046, DOI 10.1073/pnas.94.24.13046; Barkow J., 1992, ADAPTED MIND; MULDER MB, 1987, J ZOOL, V213, P489; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1; BYARD PJ, 1981, YB PHYS ANTHR, V24, P123; CRONK L, 1991, AM ANTHROPOL, V93, P345, DOI 10.1525/aa.1991.93.2.02a00040; Darwin C., 1871, DESCENT MAN SELECTIO; Fisher R, 1958, GENETICAL THEORY NAT; Hewlett B., 1988, HUMAN REPROD BEHAV D, P263; HULSE FS, 1967, AM J PHYS ANTHROPOL, V27, P143, DOI 10.1002/ajpa.1330270205; Irons W., 1979, EVOLUTIONARY BIOL HU, P257; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Mace R, 1996, BEHAV ECOL SOCIOBIOL, V38, P75, DOI 10.1007/s002650050219; Murray FG, 1934, AM ANTHROPOL, V36, P438, DOI 10.1525/aa.1934.36.3.02a00100; ODONALD P, 1980, HEREDITY, V44, P391, DOI 10.1038/hdy.1980.36; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI 10.2307/2409890; Robins AH., 1991, BIOL PERSPECTIVES HU; ROSENQVIST G, 1990, ANIM BEHAV, V39, P1110, DOI 10.1016/S0003-3472(05)80783-3; TESTART A, 1982, CURR ANTHROPOL, V23, P523, DOI 10.1086/202894; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1111/J.1420-9101.2008.01540.X; VANDENBERGHE PL, 1986, ETHNIC RACIAL STUD, V9, P87; Wallace B., 1968, TOPICS POPULATION GE	40	14	14	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0040-5809			THEOR POPUL BIOL	Theor. Popul. Biol.	FEB	1999	55	1					77	93		10.1006/tpbi.1998.1388		17	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	166DF	WOS:000078560400006		
J	Sakata, Y; Tokunaga, K; Yonehara, Y; Bannai, M; Tsuchiya, N; Susami, T; Takato, T				Sakata, Y; Tokunaga, K; Yonehara, Y; Bannai, M; Tsuchiya, N; Susami, T; Takato, T			Significant association of HLA-B and HLA-DRB1 alleles with cleft lip with or without cleft palate	TISSUE ANTIGENS			English	Article						CL (Cleft lip); CLP (Cleft lip and palate); HLA-B; HLA-DRB1; Japanese	LINKAGE; JAPANESE; GENETICS; H-2; MALFORMATIONS; CHROMOSOME-6; EXCLUSION; DANISH; 6P23; MICE	Nucleotide sequence level typing of HLA-B, -DRB1, and -DPB1 alleles was performed on Japanese patients with cleft lip with or without cleft palate (CL/P). Two HLA-B alleles, B*1501 and B*5101, showed a significant positive association with CLP. The increase of B*1501 was evident in female patients (OR=3.6, P-c=0.003), whereas the increase of B*5101 was evident in male patients (OR=3.7, P-c < 0.001). One HLA-DRB1 allele, HLA-DRB1*D802 also showed an increase in CL/P patients. Conversely, HLA-B*4403 and DRB1*1302 were not observed in the patient group (P-c=0.01 and P-c=0.02, respectively). No HLA-DPB1 alleles showed significant association with CLIP. Thus, the present study indicates that HLA alleles, or closely linked loci, may be involved in the pathogenesis of CL/P.	Univ Tokyo, Fac Med, Dept Oral & Maxillofacial Surg, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; Japanese Red Cross Tokyo, Metropolitan Blood Ctr, Dept Res, Tokyo, Japan	Sakata, Y (reprint author), Univ Tokyo, Fac Med, Dept Oral & Maxillofacial Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yasuaki@m.u-tokyo.ac.jp		Tsuchiya, Naoyuki/0000-0002-6776-5580			Akaza T, 1994, TRANSPLANTATION NO S, V7, P87; CHUNG CS, 1986, AM J HUM GENET, V39, P603; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; Lin L, 1996, TISSUE ANTIGENS, V47, P265, DOI 10.1111/j.1399-0039.1996.tb02553.x; SALOMON DS, 1979, DIFFERENTIATION, V13, P141, DOI 10.1111/j.1432-0436.1979.tb01577.x; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; Tokunaga K, 1997, IMMUNOGENETICS, V46, P199, DOI 10.1007/s002510050262; HU DN, 1982, AM J HUM GENET, V34, P999; Bannai M, 1997, TISSUE ANTIGENS, V49, P376, DOI 10.1111/j.1399-0039.1997.tb02765.x; BIXLER D, 1981, CLEFT PALATE J, V18, P10; Blanton SH, 1996, AM J HUM GENET, V58, P239; BONNER JJ, 1975, IMMUNOGENETICS, V2, P213, DOI 10.1007/BF01572289; BONNER JJ, 1978, TISSUE ANTIGENS, V12, P228, DOI 10.1111/j.1399-0039.1978.tb01328.x; CARINCI F, 1995, AM J HUM GENET, V56, P337; EIBERG H, 1987, CLIN GENET, V32, P129; FRASER FC, 1951, PEDIATRICS, V8, P527; FRASER FC, 1970, AM J HUM GENET, V22, P336; GOLDMAN AS, 1977, NATURE, V265, P643, DOI 10.1038/265643a0; GRANSTROM G, 1990, INT J ORAL MAX SURG, V19, P167, DOI 10.1016/S0901-5027(05)80138-9; HACHT JT, 1993, AM J HUM GENET, V52, P1230; ISHII M, 1991, JAP J ORAL MAXILLOFA, V37, P1114; JASKOLL T, 1995, J CRAN GENET DEV BIO, V15, P57; KALTER H, 1968, TERATOLOGY, V1, P193, DOI 10.1002/tera.1420010208; Kawai S, 1996, EUR J IMMUNOGENET, V23, P471, DOI 10.1111/j.1744-313X.1996.tb00137.x; MEHRA S, 1991, AM J HUM GENET, V49, P150; MELNICK M, 1981, IMMUNOGENETICS, V13, P443, DOI 10.1007/BF00346025; Melnick M, 1986, Am J Med Genet Suppl, V2, P183; OKA T, 1994, NUCLEIC ACIDS RES, V22, P1541, DOI 10.1093/nar/22.9.1541; RAPAPORT FT, 1979, TISSUE ANTIGENS, V14, P407; SALOMON DS, 1976, NATURE, V264, P174, DOI 10.1038/264174a0; Scapoli L, 1997, GENOMICS, V43, P216, DOI 10.1006/geno.1997.4798; SHIELDS ED, 1979, CLEFT PALATE J, V16, P1; TYAN ML, 1978, P SOC EXP BIOL MED, V158, P716; VANDYKE DC, 1980, CLEFT PALATE J, V17, P189; VINTINER GM, 1993, J MED GENET, V30, P773, DOI 10.1136/jmg.30.9.773; WATANABE T, 1984, CLEFT PALATE J, V21, P293	36	6	6	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-2815			TISSUE ANTIGENS	Tissue Antigens	FEB	1999	53	2					147	152		10.1034/j.1399-0039.1999.530204.x		6	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	171HM	WOS:000078857600004		
J	Watanabe, C; Kasanuma, Y; Dejima, Y; Satoh, H				Watanabe, C; Kasanuma, Y; Dejima, Y; Satoh, H			The effect of prenatal methylmercury exposure on the GSH level and lipid peroxidation in the fetal brain and placenta of mice	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						methylmercury; mice; glutathione; lipid peroxidation; fetal brain	SEYCHELLES CHILD-DEVELOPMENT; METHYL MERCURY; MOUSE-BRAIN; DEFICIENCY; DOPAMINE; RATS; ACID	Effect of prenatal exposure to methylmercury (MeHg) on the glutathione (G-SH) levels and lipid peroxidation in the fetal brain was examined. Pregnant ICR mice mere injected with 3 mgHg/kg of:MeHg on gestational day 12, 13 and 14 (G12-14). On the G14 or G17, the fetal brains were removed and their GSH levels and thiobarbituric acid-reactive substances (TBARS) levels were determined. On the G17, GSH level of MeHg-treated fetal brain was significantly higher than that of the control brain; the TEARS level showed the similar trend but the difference was not significant. These results indicated that the prenatal MeHg treatment disturbed the normal GSH level in the fetal brain and warranted further investigation on the significance of this GSH perturbation.	Tohoku Univ, Grad Sch Med, Sendai, Miyagi 9808575, Japan; Kyorin Univ, Fac Hlth Sci, Sch Hlth Sci, Dept Human Ecol, Mitaka, Tokyo 1818611, Japan	Watanabe, C (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Tokyo 1110033, Japan.						COHN VH, 1966, ANAL BIOCHEM, V14, P434, DOI 10.1016/0003-2697(66)90286-7; GRANDJEAN P, 1995, NEUROTOXICOLOGY, V16, P27; CLARKSON TW, 1993, ENVIRON HEALTH PERSP, V100, P31, DOI 10.2307/3431518; Davidson PW, 1998, JAMA-J AM MED ASSOC, V280, P701, DOI 10.1001/jama.280.8.701; Myers GJ, 1997, NEUROTOXICOLOGY, V18, P819; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; SARAFIAN T, 1991, INT J DEV NEUROSCI, V9, P147, DOI 10.1016/0736-5748(91)90005-7; CAGIANO R, 1990, NEUROTOXICOL TERATOL, V12, P23, DOI 10.1016/0892-0362(90)90108-O; Li SN, 1996, TOXICOL APPL PHARM, V140, P180, DOI 10.1006/taap.1996.0211; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; NISHIKIDO N, 1987, TOXICOL APPL PHARM, V88, P322, DOI 10.1016/0041-008X(87)90207-9; OKUSKY JR, 1988, DEV BRAIN RES, V40, P11, DOI 10.1016/0165-3806(88)90003-X; SU MQ, 1976, TOXICOL APPL PHARM, V38, P195, DOI 10.1016/0041-008X(76)90173-3; WAGNER J, 1982, J NEUROCHEM, V38, P1241, DOI 10.1111/j.1471-4159.1982.tb07897.x; WATANABE C, 1998, IN PRESS ENV RES; Watanabe C, 1997, NEUROSCI LETT, V236, P49, DOI 10.1016/S0304-3940(97)00758-1; YASUTAKE A, 1994, ARCH TOXICOL, V68, P512, DOI 10.1007/s002040050104; YEE S, 1993, FASEB J, V7, P211; YEE S, 1994, EXP MOL PATHOL, V60, P188, DOI 10.1006/exmp.1994.1017; YIN K, 1997, NEUROTOXICOL TERATOL, V19, P1; YONAHA M, 1983, LIFE SCI, V32, P1507, DOI 10.1016/0024-3205(83)90917-7	21	6	6	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	FEB	1999	187	2					121	126		10.1620/tjem.187.121		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	183AK	WOS:000079530700004		
J	Umenai, T; Sakano, S; Suzuki, H; Mizuta, K; Yanagiya, T; Hiroi, M; Kikuchi, H; Nakamura, H; Miura, H; Hamada, A				Umenai, T; Sakano, S; Suzuki, H; Mizuta, K; Yanagiya, T; Hiroi, M; Kikuchi, H; Nakamura, H; Miura, H; Hamada, A			Study on Chlamydia trachomatis infection among students and pregnant women in Japan: A step toward developing a reliable method for sexual behavior study	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						C-trachomatis infection; sexual behavior surveillance		2450 sera from students and 5215 sera from pregnant women mere examined for the presence of Chlamydia trachomatis (CT) antibody. CT antibody positive rates were less than 5% with the students and 24. 5%, with the pregnant women suggesting the latter is significantly higher than former. The results provided a base for discussing possibility of using CT infection as a reliable method for studying sexual behavior.	Univ Tokyo, Fac Med, Grad Sch Int Hlth, Dept Hlth Policy & Planning, Tokyo 1130033, Japan; Sendai Natl Hosp, Sendai, Miyagi 9830045, Japan; Niigata Univ, Sch Med, Dept Publ Hlth, Niigata 9518122, Japan; Assoc Prevent Med Miyagi Prefecture, Sendai, Miyagi 9810942, Japan; Yamagata Univ, Sch Med, Yamagata 9909585, Japan	Umenai, T (reprint author), Univ Tokyo, Fac Med, Grad Sch Int Hlth, Dept Hlth Policy & Planning, Tokyo 1130033, Japan.	umenai@m.u-tokyo.ac.jp					KIKUCHI H, 1997, JAPANESE ARCH SEXUAL, V8, P85; MIZOGUCHI J, 1993, CHLAMYDIA TRACHOMATI, P3; UMENAI T, 1996, JAPANESE J CLIN EXPT, V73, P1552; Umenai T, 1996, TOHOKU J EXP MED, V178, P447, DOI 10.1620/tjem.178.447; *WHO, 1986, SEX TRANSM DIS STDS; World Health Organisation (WHO), 1998, WORLD HLTH REP 1998	6	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	FEB	1999	187	2					189	192		10.1620/tjem.187.189		4	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	183AK	WOS:000079530700011		
J	Lei, Z				Lei, Z			Prediction of laminar separation bubbles with algebraic turbulence models	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						separation bubble; turbulence; transition; airfoil	AIRFOILS	The most frequently used turbulence model for the laminar separation bubble may be algebraic models. Algebraic models assume local equilibrium, and empirically describe the turbulence velocity and length scales as algebraic functions of the local mean flow variables. The Boussinesq eddy-viscosity is assumed to be related only to the mean motion. In the present study, two popular algebraic models, Cebeci-Smith model and Baldwin-Lomax model, are employed with combination of transition functions to simulate the process of laminar-turbulent transition. Considering non-equilibrium effects of laminar-turbulent transitional flow, an ordinary differential equation is developed For the transition function instead of the conventional intermittency factor. Numerical results are compared with experimental measurement.	Univ Tokyo, Sch Engn, Dept Aeronaut & Astronaut, Tokyo, Japan	Lei, Z (reprint author), Univ Tokyo, Sch Engn, Dept Aeronaut & Astronaut, Tokyo, Japan.						JOHNSON DA, 1985, AIAA J, V23, P1684, DOI 10.2514/3.9152; Arnal D, 1984, 709 AGARD; Baldwin B.S., 1978, 780257 AIAA; CEBECI T, 1986, J FLUID MECH, V163, P323, DOI 10.1017/S0022112086002318; CRIMI P, 1976, AIAA J, V14, P1548, DOI 10.2514/3.7250; FUJII K, 1989, J AIRCRAFT, V26, P1123, DOI 10.2514/3.45890; GRANVILLE PS, 1987, AIAA J, V25, P1624, DOI 10.2514/3.9834; HORTON H, 1969, 1073 CP AER RES COUN; LEI Z, 1998, THESIS U TOKYO; NITUCH MJ, 1978, AERONAUT QUART, V29, P207; RINOIE K, 1988, THESIS U TOKYO; STOCK HW, 1989, AIAA J, V27, P5, DOI 10.2514/3.10087; Tani I., 1964, PROGRESS AERONAUTICA, V5, P70, DOI DOI 10.1016/0376-0421(64)90004-1; TATSUMI K, 1997, THESIS U TOKYO; ZANG TA, 1990, INSTABILITY TRANSITI, V2, P281	15	0	0	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	FEB	1999	41	134					180	186				7	Engineering, Aerospace	Engineering	169BJ	WOS:000078727400005		
J	Hu, H; Kobayashi, T; Saga, T; Taniguchi, N; Liu, HX; Wu, SS				Hu, H; Kobayashi, T; Saga, T; Taniguchi, N; Liu, HX; Wu, SS			Research on the rectangular lobed exhaust ejector/mixer systems	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						aero-engine exhaust system; exhaust ejector/mixer system; rectangular lobed nozzle; jet mixing enhancement	MIXER	Experimental research of seven rectangular exhaust ejector/mixer systems, which were the combinations of four rectangular lobed nozzles with three rectangular mixing tubes, has been conducted to investigate the effect of the geometry of rectangular lobed nozzles on the aerodynamic performances of exhaust ejector/mixer systems. The experimental results showed that: rectangular aligned lobed nozzles have better pumping and mixing enhancement abilities than rectangular staggered lobed nozzles, while they also cause bigger pressure losses. Scalloping treatment on the lobe structure can improve the pumping ability and mixing enhancement performance of a lobed nozzle, but it will also cause a big extra pressure loss. Among the seven tested exhaust ejector/mixer systems, the exhaust ejector/mixer system which is a combination of the staggered lobed nozzle B and the rectangular mixing tube III has the best aerodynamic performances.	Univ Tokyo, Inst Ind Sci, Tokyo, Japan; Beijing Univ Aeronaut & Astronaut, Dept Jet Propuls, Jet Propusl Lab, Beijing 100083, Peoples R China	Hu, H (reprint author), Univ Tokyo, Inst Ind Sci, 7-22-1 Roppongi, Tokyo, Japan.		Hu, Hui/J-8205-2014				Waitz IA, 1997, PROG AEROSP SCI, V33, P323, DOI 10.1016/S0376-0421(96)00008-5; ECKERLE WA, 1992, J ENG GAS TURB POWER, V114, P63, DOI 10.1115/1.2906308; HU H, 1995, P 1995 YOK INT GAS T; HU H, 1998, P 1998 ASME FLUIDS E; HU H, 1995, 1 C HEL POW; HU H, 1996, THESIS BEIJING U AER; LIU H, 1995, GT95223 ASME; McCormick D, 1993, 930219 AIAA; PATERSON RW, 1984, J ENG GAS TURB POWER, V106, P692; Presz Jr W.M, 1994, 940020 AIAA; Presz W. M., 1987, 871837 AIAA; PRESZ WJ, 1986, 861614 AIAA, P71704; PRESZ WM, 1991, 912234 AIAA; SKEBE SA, 1988, 880188 AIAA; Werle M J, 1987, 870610 AIAA; WU S, 1993, 3 C CHIN SOC AER AST; YU SCM, 1997, J PROPUL POWER, V13, P306	17	11	14	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	FEB	1999	41	134					187	194				8	Engineering, Aerospace	Engineering	169BJ	WOS:000078727400006		
J	Komurasaki, K; Kusamoto, D				Komurasaki, K; Kusamoto, D			Optical measurement of plasma oscillations in a Hall thruster	TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES			English	Article						electric propulsion; Hall thruster; plasmal oscillation; instability		Plasma oscillation phenomena in a Hall thruster were experimentally investigated. The Nagoya University Hall Thruster was tested. Several oscillation frequencies have been observed in a discharge current and in optical emissions from the acceleration channel, and the fluctuations were found propagating in the longitudinal and azimuthal directions in the channel. The oscillations were classified into the ionization oscillation, transit-time oscillation and electron drift oscillation, according to their frequency. The mechanism of each oscillation has been theoretically discussed.	Nagoya Univ, Dept Aerosp Engn, Nagoya, Aichi, Japan	Komurasaki, K (reprint author), Univ Tokyo, Sch Engn, Dept Aeronaut & Astronaut, Tokyo, Japan.						Baranov V. I., 1996, 963192 AIAA; BARANOV VI, 1995, P 24 INT EL PROP C M, P344; BARANOV VI, 1995, P 2J INT EL PROP C M, P445; BARANOV VI, 1995, P 2J INT EL PROP C M, P429; FIFE JM, 1997, 33 JOINT PROP C SEAT; FIFE JM, 1996, 32 JOINT PROP C ORL; KAPULKIN M, 1995, P 2J INT EL PROP C M, P302; KOMURASAKI K, 1996, 32 JOINT PROP C ORL; KOMURASAKI K, 1995, P 24 INT EL PROP C M, P270; KUSAMOTO D, 1997, 25 INT EL PROP C CLE; ZHURIN V, 1993, P 23 INT EL PROP C S, P883	11	1	1	JAPAN SOC AERONAUT SPACE SCI	TOKYO	KOKUKAIKAN-BUNKAN 1-18-2 SHINBASHI MINATO-KU, TOKYO, JAPAN	0549-3811			T JPN SOC AERONAUT S	Trans. Jpn. Soc. Aeronaut. Space Sci.	FEB	1999	41	134					203	208				6	Engineering, Aerospace	Engineering	169BJ	WOS:000078727400008		
J	Wakabayashi, T; Onoda, H; Masunaga, A				Wakabayashi, T; Onoda, H; Masunaga, A		Bone Marrow Transplantation Grp	Fas/Apo-1 expression of human GVHD livers	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	XVIIth World Congress of the Transplantation-Society	JUL 12-17, 1998	MONTREAL, CANADA	Transplantat Soc			TUMOR-NECROSIS-FACTOR; VERSUS-HOST DISEASE; FAS		Univ Tokyo, Inst Med Sci Hosp, Tokyo 108, Japan	Wakabayashi, T (reprint author), Univ Tokyo, Inst Med Sci Hosp, Tokyo 108, Japan.						Via CS, 1996, J IMMUNOL, V157, P5387; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; HOWELL CD, 1992, CELL IMMUNOL, V140, P54, DOI 10.1016/0008-8749(92)90176-P; JAMES FG, 1998, NAT MED, V4, P333; Nishimura M, 1997, BLOOD, V89, P1440	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	FEB-MAR	1999	31	1-2					423	424		10.1016/S0041-1345(98)01689-3		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	173BG	WOS:000078960600180		
J	Bilbao, G; Zhang, H; Contreras, JL; Zhou, T; Feng, M; Saito, I; Mountz, JD; Curiel, DT				Bilbao, G; Zhang, H; Contreras, JL; Zhou, T; Feng, M; Saito, I; Mountz, JD; Curiel, DT			Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/loxp inducible system	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	XVIIth World Congress of the Transplantation-Society	JUL 12-17, 1998	MONTREAL, CANADA	Transplantat Soc			IMMUNE EVASION; CELLS; PRIVILEGE; APOPTOSIS		Univ Alabama, Gene Therapy Program, Birmingham, AL 35294 USA; Univ Alabama, Dept Rheumatol, Birmingham, AL 35294 USA; Univ Alabama, Dept Surg, Birmingham, AL 35294 USA; Univ Tokyo, Inst Med Sci, Genet Mol Lab, Tokyo, Japan	Curiel, DT (reprint author), Univ Alabama, Gene Therapy Program, 1824 6th Ave S,Room WTI 620, Birmingham, AL 35294 USA.						Stuart PM, 1997, J CLIN INVEST, V99, P396, DOI 10.1172/JCI119173; Lau HT, 1996, SCIENCE, V273, P109, DOI 10.1126/science.273.5271.109; Sanberg PR, 1996, NAT BIOTECHNOL, V14, P1692, DOI 10.1038/nbt1296-1692; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Nagata S, 1996, NAT MED, V2, P1306, DOI 10.1038/nm1296-1306; Parks RJ, 1996, P NATL ACAD SCI USA, V93, P13565, DOI 10.1073/pnas.93.24.13565; Berke G, 1997, Curr Opin Hematol, V4, P32; Green DR, 1997, P NATL ACAD SCI USA, V94, P5986, DOI 10.1073/pnas.94.12.5986; Kang SM, 1997, NAT MED, V3, P738, DOI 10.1038/nm0797-738; Larregina AT, 1998, GENE THER, V5, P563, DOI 10.1038/sj.gt.3300615; Zhou T, 1996, J EXP MED, V183, P1879, DOI 10.1084/jem.183.4.1879	12	9	9	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	FEB-MAR	1999	31	1-2					792	793		10.1016/S0041-1345(98)01771-0		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	173BG	WOS:000078960600349		
J	Ono, M; Nakajima, J; Lee, MC; Takamoto, S				Ono, M; Nakajima, J; Lee, MC; Takamoto, S			Influence of cryopreservation on antigen expression and immunogenicity of human vascular endothelial cells	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	XVIIth World Congress of the Transplantation-Society	JUL 12-17, 1998	MONTREAL, CANADA	Transplantat Soc					Univ Tokyo, Fac Med, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan	Ono, M (reprint author), Univ Tokyo, Fac Med, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ANGELL WW, 1989, J THORAC CARDIOV SUR, V98, P48; POBER JS, 1986, TRANSPLANTATION, V41, P141, DOI 10.1097/00007890-198602000-00001; LUPINETTI FM, 1993, J THORAC CARDIOV SUR, V106, P912; BARRATTBOYES BG, 1971, BR HEART J S, V33, P60; BOREN CH, 1978, SURGERY, V85, P382; Hoekstra Franciska, 1995, Annals of Thoracic Surgery, V60, P131; ROSS DN, 1967, LANCET, V58, P859; WAGNER CR, 1985, HUM IMMUNOL, V13, P33, DOI 10.1016/0198-8859(85)90025-4	8	4	5	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	FEB-MAR	1999	31	1-2					985	987		10.1016/S0041-1345(98)01868-5		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	173BG	WOS:000078960600447		
J	Sasaki, S; Karube, I				Sasaki, S; Karube, I			The development of microfabricated biocatalytic fuel cells	TRENDS IN BIOTECHNOLOGY			English	Article							ELECTROCHEMICAL FLOW CELL; SYSTEM	The production of electricity by biocatalytic fuel cells has been feasible for almost two decades and can produce electric power at a practical level, These fuel cells use immobilized microorganisms or enzymes as catalysts, and glucose as a fuel. A microfabricated enzyme battery has recently been made that is designed to function as a power supply for microsurgery robots or artificial organs.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Sasaki, S (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	karube@bio.rcast.u-tokyo.ac.jp					Adlhart OJ, 1997, ASAIO J, V43, P214; KARUBE I, 1988, METHOD ENZYMOL, V137, P668; KAYANO H, 1981, APPL MICROBIOL BIOT, V12, P1; LOWTHER K, 1986, CHEM ENG J, V33, pB69; MURAKAMI Y, 1994, MICROCHEM J, V49, P319, DOI 10.1006/mchj.1994.1043; MURAKAMI Y, 1993, ANAL CHEM, V65, P2731, DOI 10.1021/ac00068a005; MURAKAMI Y, 1994, ELECTROANAL, V6, P735, DOI 10.1002/elan.1140060904; PHADKE RS, 1983, INT J QUANTUM CHEM Q, V10, P251; SASAKI S, 1996, NIHON RINSHOU, V54, P191; SUZUKI S, 1983, ANN NY ACAD SCI, V413, P133, DOI 10.1111/j.1749-6632.1983.tb47884.x; SUZUKI S, 1979, BIOTECHNOL BIOENG S, V8, P501; YAO SJ, 1979, T AM SOC ART INT ORG, V25, P45	12	18	19	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0167-7799			TRENDS BIOTECHNOL	Trends Biotechnol.	FEB	1999	17	2					50	52		10.1016/S0167-7799(98)01243-8		3	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	181AP	WOS:000079418700003		
J	Kasai, H				Kasai, H			Comparative biology of Ca2+-dependent exocytosis: implications of kinetic diversity for secretory function	TRENDS IN NEUROSCIENCES			English	Article							ADRENAL CHROMAFFIN CELLS; PANCREATIC ACINAR-CELLS; PHEOCHROMOCYTOMA CELLS; AMYLASE RELEASE; CAGED CA2+; BETA-CELLS; VESICLES; FUSION; FIBROBLASTS; GRANULES	The application of caged-Ca2+ compounds to the study of Ca2+-dependent exocytosis has begun to reveal kinetic intermediates in this important process. The time course of exocytosis varies greatly among different cell and vesicle types, even in response to Ca2+ 'jumps' of identical amplitude. The kinetics of the binding of Ca2+ to the putative Ca2+ sensor for exocytosis also vary. Theoretical analysis reveals that the kinetic: diversity of exocytotic and Ca2+-binding reactions has distinct roles in determining the probability of exocytosis occurring. it is proposed that both of these reactions are optimized for the secretory function of specific cell types and that the exocytotic reaction includes vesicle translocation in addition to the fusion of vesicles with the plasma membrane.	Univ Tokyo, Fac Med, Dept Physiol, Tokyo 113, Japan	Kasai, H (reprint author), Univ Tokyo, Fac Med, Dept Physiol, Tokyo 113, Japan.			Kasai, Haruo/0000-0003-2327-9027			ANNAERT WG, 1993, J NEUROCHEM, V60, P1746, DOI 10.1111/j.1471-4159.1993.tb13399.x; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Ninomiya Y, 1996, J BIOL CHEM, V271, P17751; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; Trifaro JM, 1997, NEUROCHEM RES, V22, P831, DOI 10.1023/A:1022087910902; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Steyer JA, 1997, NATURE, V388, P474; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; THOMASREETZ AC, 1994, FASEB J, V8, P209; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Martin TFJ, 1997, TRENDS CELL BIOL, V7, P271, DOI 10.1016/S0962-8924(97)01060-X; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Coorssen JR, 1996, EMBO J, V15, P3787; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; HEINEMANN C, 1994, BIOPHYS J, V67, P2546; SMITH SJ, 1988, TRENDS NEUROSCI, V11, P458, DOI 10.1016/0166-2236(88)90199-3; Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; Bakker AC, 1997, J CELL SCI, V110, P2227; BAUERFEIND R, 1993, NEURON, V11, P105, DOI 10.1016/0896-6273(93)90275-V; Calakos N, 1996, PHYSIOL REV, V76, P1; CHER DJ, 1992, AM J PHYSIOL, V262, pG719; Chestkov VV, 1998, J BIOL CHEM, V273, P2445, DOI 10.1074/jbc.273.4.2445; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; Gerasimenko OV, 1996, CELL, V84, P473, DOI 10.1016/S0092-8674(00)81292-1; Haller M, 1998, BIOPHYS J, V74, P2100; Iino M, 1993, EMBO J, V12, P5287; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Kasai H, 1996, J PHYSIOL-LONDON, V494, P53; Kelly RB, 1993, CELL, V72, P45; KIRILLOVA J, 1993, J PHYSIOLOGY-PARIS, V87, P203, DOI 10.1016/0928-4257(93)90031-N; Klingauf J, 1997, BIOPHYS J, V72, P674; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; MCNEIL PL, 1991, AM SCI, V79, P222; MORIMOTO T, 1995, NEURON, V15, P689, DOI 10.1016/0896-6273(95)90156-6; Moser T, 1997, P NATL ACAD SCI USA, V94, P6735, DOI 10.1073/pnas.94.13.6735; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; NANAVATI C, 1992, BIOPHYS J, V63, P1118; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Nishiki T, 1997, BIOCHEM BIOPH RES CO, V239, P57, DOI 10.1006/bbrc.1997.7427; Oberhauser AF, 1996, BIOPHYS J, V71, P1131; Padfield PJ, 1997, AM J PHYSIOL-GASTR L, V273, pG655; STECHER B, 1992, BIOCHEM J, V283, P899; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; TAKAHASHI N, IN PRESS P NATL ACAD; Takahashi N, 1997, J CELL BIOL, V138, P55, DOI 10.1083/jcb.138.1.55; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642	55	145	148	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0166-2236			TRENDS NEUROSCI	Trends Neurosci.	FEB	1999	22	2					88	93		10.1016/S0166-2236(98)01293-4		6	Neurosciences	Neurosciences & Neurology	181AJ	WOS:000079418200010		
J	Adachi, N; Matsumoto, M; Hasegawa, S; Yamamoto, T; Horikoshi, M				Adachi, N; Matsumoto, M; Hasegawa, S; Yamamoto, T; Horikoshi, M			Analysis of TFIIH subunit through isolation of the gene from Schizosaccharomyces pombe corresponding to that of Saccharomyces cerevisiae SSL1, reveals the presence of conserved structural motifs	YEAST			English	Article						TFIIH; SSL1; Sz-pombe; C2H2 zinc finger	MESSENGER-RNA TRANSCRIPTION; NUCLEOTIDE EXCISION-REPAIR; ACTIVATING KINASE CAK; CSB PROTEIN; DNA-REPAIR; DHFR GENE; YEAST; ZINC; INITIATION; SEQUENCE	We isolated a Schizosaccharomyces pombe (Sz, pombe) gene encoding the counterpart of the TFIIH subunit Homo sapiens (H. sapiens) p44 and Saccharomyces cerevisiae (S. cerevisiae) SSL1, and we named this gene product p47. Contrary to the case of SSL1, which is an essential gene of S. cerevisiae, p47 is not essential for the viability of St. pombe. The deduced amino acid sequence revealed that this TFIIH subunit is highly conserved during evolution. Comparison of the primary structures revealed differences in the predicted positions of introns in the Caenorhabditis elegans (C. elegans) gene encoding the p47 counterpart found during the genome project. A charged cluster in the N-terminal region is present in the two yeasts. Two putative zinc-binding motifs, an extended C2H2 zinc finger with a 'C8 motif and a second putative zinc-binding motif common to the two TFIIH subunits, were also found, the former being completely conserved. The latter motif consists of five cysteine residues and is also present in hp44, SSL1 and another TFIIH subunit, human p34 (hp34). Since one zinc atom can bind to four ligands in zinc-binding motifs, the conservation of cysteine residues was given attention. This motif is completely conserved in p47 homologues derived from the four species. As one cysteine residue is not conserved among the homologues of hp34, the consensus of this motif is concluded to be Cys-X2-Cys-X(10,12)-Cys-X2-Cys. This nucleotide sequence has been deposited in the GenBank Data Library under Accession Number AF017646. Copyright (C) 1999 John Wiley & Sons, Ltd.	Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Dept Cellular Biol,Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Corp, Horikoshi Gene Selector Project, Exploratory Res Adv Technol, Tsukuba, Ibaraki 3002635, Japan	Horikoshi, M (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Dev Biol Lab, Dept Cellular Biol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.		Yamamoto, Tohru/A-3801-2012				AITSCHUL SF, 1990, J MOL BIOL, V215, P403; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bohm S, 1997, NUCLEIC ACIDS RES, V25, P2464, DOI 10.1093/nar/25.12.2464; HINDLEY J, 1984, GENE, V31, P129, DOI 10.1016/0378-1119(84)90203-8; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Iyer N, 1996, BIOCHEMISTRY-US, V35, P2157, DOI 10.1021/bi9524124; HENNING KA, 1995, CELL, V82, P555, DOI 10.1016/0092-8674(95)90028-4; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Svejstrup JQ, 1996, TRENDS BIOCHEM SCI, V21, P346, DOI 10.1016/S0968-0004(96)10046-3; Damagnez V, 1995, EMBO J, V14, P6164; Espinoza FH, 1996, SCIENCE, V273, P1714, DOI 10.1126/science.273.5282.1714; HUMBERT S, 1994, EMBO J, V13, P2392; JONES RH, 1988, CELL, V53, P659, DOI 10.1016/0092-8674(88)90581-8; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; RUSSELL PR, 1983, NATURE, V301, P167, DOI 10.1038/301167a0; SCHWABE JWR, 1994, NAT STRUCT BIOL, V1, P345, DOI 10.1038/nsb0694-345; STRUHL K, 1987, MOL CELL BIOL, V7, P104; VANHOFFEN A, 1993, NUCLEIC ACIDS RES, V21, P5890, DOI 10.1093/nar/21.25.5890; WANG ZG, 1995, MOL CELL BIOL, V15, P2288; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; YOON H, 1992, GENE DEV, V6, P2463, DOI 10.1101/gad.6.12b.2463	24	4	5	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0749-503X			YEAST	Yeast	FEB	1999	15	3					255	262				8	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Microbiology; Mycology	170GJ	WOS:000078797700005		
J	Hirai, N; Tagawa, M; Kaneko, T; Seikai, T; Tanaka, M				Hirai, N; Tagawa, M; Kaneko, T; Seikai, T; Tanaka, M			Distributional changes in branchial chloride cells during freshwater adaptation in Japanese sea bass Lateolabrax japonicus	ZOOLOGICAL SCIENCE			English	Article							CHUM SALMON FRY; MITOCHONDRIA-RICH CELLS; GILL EPITHELIUM; ADAPTED TILAPIA; WATER TELEOST; SEAWATER; LOCALIZATION; MECHANISMS; TRANSPORT; PROLACTIN	Distributional changes in branchial chloride cells were examined in Japanese sea bass (Lateolabrax japonicus) juveniles transferred from seawater (SW) to fresh water (FW) during their migration season toward low salinity habitat in nature. Chloride cells were identified by immunocytochemistry with a specific antiserum for Na+,K+-ATPase. In fish reared in SW as controls, branchial chloride cells were localized exclusively in the filaments and absent in the lamellae. When sea bass were transferred from SW to FW, chloride cells emerged in gill lamellae, starting at the proximal part of the lamellae and thereafter spread over the lamellar epithelium. On 7th and 15th days after FW transfer, chloride cells were mostly found on the lamellae, whereas the number of filament chloride cells was decreased. These results suggest that, in Japanese sea bass juveniles, chloride cells in the gill lamellae are important in FW adaptation, and that lamellar chloride cells originated from the filaments and migrated to the lamellae during FW adaptation.	Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Kyoto Univ, Grad Sch Agr, Fisheries Res Stn, Kyoto 6250086, Japan	Hirai, N (reprint author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan.						Uchida K, 1996, J EXP ZOOL, V276, P193, DOI 10.1002/(SICI)1097-010X(19961015)276:3<193::AID-JEZ3>3.0.CO;2-I; FOSKETT JK, 1982, SCIENCE, V215, P164, DOI 10.1126/science.7053566; KARNAKY KJ, 1976, J CELL BIOL, V70, P157, DOI 10.1083/jcb.70.1.157; Flik G, 1996, PHYSIOL ZOOL, V69, P403; PISAM M, 1993, ANAT REC, V235, P275, DOI 10.1002/ar.1092350211; PERRY SF, 1992, CAN J ZOOL, V70, P1775, DOI 10.1139/z92-245; Uchida K, 1996, ZOOL SCI, V13, P655; ZADUNAISKY JA, 1984, FISH PHYSIOL, V10, P129; AVELLA M, 1990, COMP PHYSIOL, V6, P1; AYSON FG, 1995, J EXP ZOOL, V272, P419, DOI 10.1002/jez.1402720603; EVANS DH, 1984, FISH PHYSIOL, V10, P239; Flik G., 1995, CELLULAR MOL APPROAC, P317; FUJITA S, 1988, JPN J ICHTHYOL, V35, P365; HERNDON TM, 1991, GEN COMP ENDOCR, V83, P283, DOI 10.1016/0016-6480(91)90032-2; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; Laurent P, 1980, AM J PHYSIOL, V238, P147; LAURENT P, 1994, FISH PHYSIOL BIOCHEM, V13, P353, DOI 10.1007/BF00003415; Li J, 1997, J EXP BIOL, V200, P1499; Matsumiya Y., 1985, Bulletin of the Japanese Society of Scientific Fisheries, V51, P1955; MATSUMIYA Y, 1982, Nippon Suisan Gakkaishi, V48, P129; McCormick S. D., 1995, CELLULAR MOL APPROAC, P285; McCormick SD, 1990, AM J PHYSIOL, V259, P857; MCCORMICK SD, 1992, P NATL ACAD SCI USA, V89, P3635, DOI 10.1073/pnas.89.8.3635; OCHIAI A, 1986, ICHTHYOLOGY, P675; PISAM M, 1991, INT REV CYTOL, V130, P191, DOI 10.1016/S0074-7696(08)61504-1; PISAM M, 1990, AM J ANAT, V187, P21, DOI 10.1002/aja.1001870104; PISAM M, 1987, AM J ANAT, V179, P40, DOI 10.1002/aja.1001790106; SASAI S, 1998, IN PRESS CAN J ZOOL; TANAKA M, 1997, KAIYO MONTHLY, V29, P199; Uchida K, 1998, GEN COMP ENDOCR, V109, P175, DOI 10.1006/gcen.1997.7019; Ura K, 1996, ZOOL SCI, V13, P219, DOI 10.2108/zsj.13.219	31	54	60	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	FEB	1999	16	1					43	49		10.2108/zsj.16.43		7	Zoology	Zoology	214NG	WOS:000081333600006		
J	Dohra, H; Fujishima, M				Dohra, H; Fujishima, M			Cell structure of the infectious form of Holospora, an endonuclear symbiotic bacterium of the ciliate Paramecium	ZOOLOGICAL SCIENCE			English	Article							MACRONUCLEUS-SPECIFIC BACTERIUM; REPRODUCTIVE SHORT FORM; LONG FORM; MONOCLONAL-ANTIBODIES; CAUDATUM; OBTUSA; DIFFERENTIATION; ELEGANS	Under a phase-contrast microscope, the infectious form of Holospora obtusa appears to consist of three regions in tandem: a dark region, a refractile region, and a small dark tip in the refractile region. By electron microscopy, this bacterium appears to consist of a cytoplasmic region, a periplasmic region, and a small electron-translucent tip in the periplasmic region. It had previously been thought that these three regions in each microscopy respectively corresponded to one another. However, indirect immunofluorescence microscopy with monoclonal antibodies, IF-3-1 and IF-3-2, specific for periplasmic proteins of H. obtusa and an antiserum raised against a cytoplasmic stress protein, the GroEL homologue of aphid endosymbiotic bacterium, showed that the dark region was the periplasm and the refractile region was the cytoplasm. This shows that the small dark tip does not correspond to the small electron-translucent tip, and that the electron-translucent tip should be present at the opposite end. We found that this special tip could be identified with Nomarski- and phase-contrast optics at the end of the dark region when the infectious form was embedded in 30% gelatin. The same correspondences between the light and the electron microscopic structures were also confirmed in the infectious form of the micronucleus-specific bacterium H. recta.	Yamaguchi Univ, Fac Sci, Inst Biol, Yamaguchi 7538512, Japan; Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Tokyo 1130033, Japan	Fujishima, M (reprint author), Yamaguchi Univ, Fac Sci, Inst Biol, Yoshida 1677-1, Yamaguchi 7538512, Japan.						DOHRA H, 1994, EUR J PROTISTOL, V30, P288; DOHRA H, 1992, ENDOCYTOBIOLOGY, V5, P523; Dohra H, 1998, J EUKARYOT MICROBIOL, V45, P71, DOI 10.1111/j.1550-7408.1998.tb05072.x; Dohra H, 1997, ZOOL SCI, V14, P69, DOI 10.2108/zsj.14.69; DRYL S, 1959, J PROTOZOOL, V6, P25; Fokin SI, 1996, EUR J PROTISTOL S1, V32, P19; FOKIN SI, 1991, TSITOLOGIYA+, V33, P135; FUJISHIMA M, 1990, J PROTOZOOL, V37, P123, DOI 10.1111/j.1550-7408.1990.tb05881.x; Fujishima M, 1997, J EUKARYOT MICROBIOL, V44, P636; FUJISHIMA M, 1988, ZOOL SCI, V5, P791; FUJISHIMA M, 1991, EUR J PROTISTOL, V27, P119, DOI 10.1016/S0932-4739(11)80333-0; FUJISHIMA M, 1990, ZOOL SCI, V7, P849; FUJISHIMA M, 1985, J CELL SCI, V76, P179; GORTZ HD, 1990, J BACTERIOL, V172, P5664; GORTZ HD, 1980, PROTISTOLOGICA, V16, P591; GORTZ HD, 1989, J GEN MICROBIOL, V135, P3079; MASON DJ, 1956, J BACTERIOL, V71, P474; SCHMIDT HJ, 1987, MICROBIOS, V49, P189; WIEMANN M, 1991, J BACTERIOL, V173, P4842	19	5	5	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	FEB	1999	16	1					93	98		10.2108/zsj.16.93		6	Zoology	Zoology	214NG	WOS:000081333600013		
J	Ariizumi, T; Komazaki, S; Asashima, M				Ariizumi, T; Komazaki, S; Asashima, M			Activin-treated urodele animal caps: II. Inductive interactions in newt animal caps after treatment with activin A	ZOOLOGICAL SCIENCE			English	Article							NEURAL-INDUCING ACTIVITY; CYNOPS-PYRRHOGASTER; TRUNK ORGANIZER; XENOPUS-LAEVIS; ECTODERM; STATE; MESODERM	The inductive interactions between activin-induced and non-induced cells were investigated in newt animal cap explants. A wide range of concentrations of activin A (0.1-100 ng/ml) induced mesodermal tissues in the animal caps, but at generally low frequencies. Animal caps treated with 100 ng/ml of activin A, on the other hand, differentiated solely into nonspecific endoderm. At this concentration, various mesodermal tissues were induced in addition to endoderm as the animal caps increased in size. They were more frequently induced in explants in which the activin-treated animal caps were combined with untreated animal caps. Central nervous systems were frequently induced in sandwich explants with larger amounts of untreated animal caps. Differentiation of endodermal organs such as the liver, the pancreas and the intestine in the long-term cultured sandwich explants was confirmed by electron microscopy. Lineage tracing of the combination and sandwich explants revealed that the activin-treated animal caps mainly formed the endoderm and induced mesodermal and neural tissues in the untreated animal caps. These results suggest that activin A is capable of inducing the endoderm that can act as an initiator of further inductive interactions in early newt development.	Univ Tokyo, Japan Sci & Technol Corp, JST, CREST,Meguro Ku, Tokyo 1538902, Japan; Saitama Med Sch, Dept Anat 2, Moroyama, Saitama 3500451, Japan; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan	Asashima, M (reprint author), Univ Tokyo, Japan Sci & Technol Corp, JST, CREST,Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; ARIIZUMI T, 1991, ROUX ARCH DEV BIOL, V200, P230, DOI 10.1007/BF00361342; ARIIZUMI T, 1995, ROUX ARCH DEV BIOL, V204, P427, DOI 10.1007/BF00360850; ARIIZUMI T, 1995, ZOOL SCI, V12, P509, DOI 10.2108/zsj.12.509; ARIIZUMI T, 1991, International Journal of Developmental Biology, V35, P407; Ariizumi T, 1998, ZOOL SCI, V15, P887, DOI 10.2108/zsj.15.887; Hamburger V., 1988, HERITAGE EXPT EMBRYO; JONES EA, 1993, ROUX ARCH DEV BIOL, V202, P233, DOI 10.1007/BF02427884; KANEDA T, 1981, DEV GROWTH DIFFER, V23, P553; KANEDA T, 1983, Wilhelm Roux's Archives of Developmental Biology, V192, P8, DOI 10.1007/BF00848763; KANEDA T, 1980, DEV GROWTH DIFFER, V22, P841; KANEDA T, 1979, Wilhelm Roux's Archives of Developmental Biology, V187, P25, DOI 10.1007/BF00848164; KLEIN PS, 1994, ENDOCR REV, V15, P326, DOI 10.1210/er.15.3.326; MORIYA N, 1992, DEV GROWTH DIFFER, V34, P589; NAKAMURA O, 1978, ORG MILESTONE HALF C; Ninomiya H, 1998, DEV GROWTH DIFFER, V40, P199; Okada T. S., 1954, Memoirs of the College of Science Kyoto, V21B, P1; OKADA TS, 1954, MEM COLL SCI U KYO B, V21, P7; OKADA T. S., 1960, WILHELM ROUX ARCH ENTWICKMECH ORGAN, V152, P1, DOI 10.1007/BF00575217; Okada YK, 1947, JPN J EXP MORPHOL, V3, P1; SUZUKI AS, 1986, ROUX ARCH DEV BIOL, V195, P168, DOI 10.1007/BF02439434; TAKATA CHINAMI, 1960, EMBRYOLOGIA, V5, P8, DOI 10.1111/j.1440-169X.1960.tb00263.x; TAKAYA H, 1977, DIFFERENTIATION, V7, P187, DOI 10.1111/j.1432-0436.1977.tb01510.x; YAMADA T, 1961, DEV BIOL, V3, P411, DOI 10.1016/0012-1606(61)90026-4	24	5	5	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	FEB	1999	16	1					115	124		10.2108/zsj.16.115		10	Zoology	Zoology	214NG	WOS:000081333600017		
J	Shiraishi, K; Matsuda, M; Mori, T; Hirano, T				Shiraishi, K; Matsuda, M; Mori, T; Hirano, T			Changes in expression of prolactin- and cortisol-receptor genes during early-life stages of euryhaline tilapia (Oreochromis mossambicus) in fresh water and seawater	ZOOLOGICAL SCIENCE			English	Article							YOLK-SAC MEMBRANE; SALMON ONCORHYNCHUS-KISUTCH; MITOCHONDRION-RICH CELLS; CHLORIDE CELLS; GROWTH-HORMONE; COHO SALMON; GLUCOCORTICOID RECEPTORS; ADAPTED TILAPIA; TELEOST FISH; SAROTHERODON-MOSSAMBICUS	Expression of prolactin receptor (PRLR) and cortisol receptor (CR) mRNAs was examined during early-life stages of euryhaline Mozambique tilapia (Oreochromis mossambicus) by competitive reverse transcription-polymerase chain reaction (cRT-PCR). Concentration of prolactin receptor mRNA was higher in the gills of mature fish reared in fresh water (FW) than in those reared in seawater (SW), whereas no difference was seen in CR mRNA. Whole eggs just after fertilization contained the receptor mRNAs for both prolactin and cortisol. The concentration of PRLR mRNA increased gradually as the embryo grows both in FW and in SW. On the other hand, the concentration of CR mRNA was highest in the egg just after fertilization, decreased rapidly toward hatching, and increased slightly thereafter. When embryos 3 days before hatching were transferred to SW, the levels of PRLR mRNA were significantly lower at the time of hatching and also 3 days after hatching than in the embryo and larvae maintained in FW. Environmental salinity did not affect CR mRNA content at any stage examined. Both PRLR and CR mRNAs were identified in the yolk-sac membrane and in the embryonic body. Significantly more PRLR gene was expressed in the embryonic body developing in FW than in SW, whereas no difference was seen in the yolk-sac membrane. The greater expression of PRLR gene in embryos and larvae developing in FW than in those in SW clearly indicates the presence of regulatory mechanisms of gene expression in early-life stages of tilapia.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Shiraishi, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan.		Perez , Claudio Alejandro/F-8310-2010	Perez , Claudio Alejandro/0000-0001-9688-184X			SANDRA O, 1995, P NATL ACAD SCI USA, V92, P6037, DOI 10.1073/pnas.92.13.6037; MAULE AG, 1990, GEN COMP ENDOCR, V77, P448, DOI 10.1016/0016-6480(90)90236-F; DUCOURET B, 1995, ENDOCRINOLOGY, V136, P3774, DOI 10.1210/en.136.9.3774; AUPERIN B, 1994, J MOL ENDOCRINOL, V12, P13; FOSKETT JK, 1982, SCIENCE, V215, P164, DOI 10.1126/science.7053566; BALM PHM, 1995, FISH PHYSIOL BIOCHEM, V14, P37, DOI 10.1007/BF00004289; Bamberger CM, 1996, ENDOCR REV, V17, P245, DOI 10.1210/er.17.3.245; MAULE AG, 1991, GEN COMP ENDOCR, V84, P83, DOI 10.1016/0016-6480(91)90067-G; [Anonymous], 1994, FISH PHYSIOL; PISAM M, 1993, ANAT REC, V235, P275, DOI 10.1002/ar.1092350211; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; FOSKETT JK, 1983, J EXP BIOL, V106, P255; FOSKETT JK, 1981, J EXP BIOL, V93, P209; YAMAGUCHI K, 1988, J BIOL CHEM, V263, P9113; SPECKER JL, 1985, P NATL ACAD SCI USA, V82, P7490, DOI 10.1073/pnas.82.22.7490; EDERY M, 1984, GEN COMP ENDOCR, V56, P19, DOI 10.1016/0016-6480(84)90056-X; SHRIMPTON JM, 1994, AM J PHYSIOL, V267, pR432; AUPERIN B, 1994, J MOL ENDOCRINOL, V13, P241; AUPERIN B, 1995, J ENDOCRINOL, V145, P213, DOI 10.1677/joe.0.1450213; AYSON FG, 1993, GEN COMP ENDOCR, V89, P138, DOI 10.1006/gcen.1993.1017; AYSON FG, 1994, GEN COMP ENDOCR, V95, P143, DOI 10.1006/gcen.1994.1111; AYSON FG, 1994, J EXP ZOOL, V270, P129, DOI 10.1002/jez.1402700202; AYSON FG, 1995, J EXP ZOOL, V272, P419, DOI 10.1002/jez.1402720603; BERN HA, 1992, AQUACULTURE, V100, P237, DOI 10.1016/0044-8486(92)90384-W; CHAKRABORTI PK, 1987, GEN COMP ENDOCR, V66, P323, DOI 10.1016/0016-6480(87)90241-3; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; DAUDER S, 1990, GEN COMP ENDOCR, V77, P368, DOI 10.1016/0016-6480(90)90226-C; GENTY N, 1994, MOL CELL ENDOCRINOL, V99, P221, DOI 10.1016/0303-7207(94)90011-6; Goss G.G., 1995, CELLULAR MOL APPROAC, P257; Greene MW, 1997, MOL MAR BIOL BIOTECH, V6, P144; HERNDON TM, 1991, GEN COMP ENDOCR, V83, P283, DOI 10.1016/0016-6480(91)90032-2; Hirano T., 1986, COMP ENDOCRINOLOGY D, P53; HWANG PP, 1992, GEN COMP ENDOCR, V86, P189, DOI 10.1016/0016-6480(92)90101-O; HWANG PP, 1993, GEN COMP ENDOCR, V92, P318, DOI 10.1006/gcen.1993.1168; HWANG PP, 1989, B I ZOOL ACAD SINICA, V28, P73; Karabulut AK, 1998, J ANAT, V192, P1, DOI 10.1046/j.1469-7580.1998.19210001.x; KELLY PA, 1991, ENDOCR REV, V12, P235; Kultz D, 1996, AM J PHYSIOL-CELL PH, V271, pC1181; KULTZ D, 1992, COMP BIOCHEM PHYS B, V102, P293, DOI 10.1016/0305-0491(92)90125-B; LI J, 1995, J EXP BIOL, V198, P2177; Marshall WS, 1995, CELLULAR MOL APPROAC, P1; McCormick S. D., 1995, CELLULAR MOL APPROAC, P285; MCCORMICK SD, 1990, AM J PHYSIOL, V259, pR857; MOORE RC, 1993, GENE, V134, P263, DOI 10.1016/0378-1119(93)90104-B; PISAM M, 1981, ANAT REC, V200, P401, DOI 10.1002/ar.1092000403; PISAM M, 1991, INT REV CYTOL, V130, P191, DOI 10.1016/S0074-7696(08)61504-1; RENTIERDELRUE F, 1989, DNA-J MOLEC CELL BIO, V8, P271, DOI 10.1089/dna.1.1989.8.271; SANDOR T, 1984, GEN COMP ENDOCR, V53, P353, DOI 10.1016/0016-6480(84)90262-4; Shiraishi K, 1997, CELL TISSUE RES, V288, P583, DOI 10.1007/s004410050844; SHRIMPTON JM, 1995, GEN COMP ENDOCR, V98, P1, DOI 10.1006/gcen.1995.1039; Tagawa M, 1997, GEN COMP ENDOCR, V108, P132, DOI 10.1006/gcen.1997.6955; Tagawa M, 1996, SURVIVAL STRATEGIES IN EARLY LIFE STAGES OF MARINE RESOURCES, P27; Uchida K, 1998, GEN COMP ENDOCR, V109, P175, DOI 10.1006/gcen.1997.7019; WEISBART M, 1987, GEN COMP ENDOCR, V68, P440, DOI 10.1016/0016-6480(87)90083-9; YOSHIKAWA JSM, 1993, COMP BIOCHEM PHYS A, V105, P311, DOI 10.1016/0300-9629(93)90213-N; Zadunaisky JA, 1984, FISH PHYSIOL BIOCHEM, V10B, P130	57	22	26	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	FEB	1999	16	1					139	146		10.2108/zsj.16.139		8	Zoology	Zoology	214NG	WOS:000081333600020		
J	Maekawa, K; Kitade, O; Matsumoto, T				Maekawa, K; Kitade, O; Matsumoto, T			Molecular phylogeny of orthopteroid insects based on the mitochondrial cytochrome oxidase II gene	ZOOLOGICAL SCIENCE			English	Article							SEQUENCES; DNA; EVOLUTION; ORDERS	Phylogenetic relationships among 18 species of orthopteroid insects (Blattaria: cockroaches, Isoptera: termites, Mantodea: mantids, Grylloblattodea: grylloblattids, Phasmatodea: stick-insects, Orthoptera-Caerifera: locusts, Orthoptera-Ensifera: crickets, and Dermaptera: earwigs), were estimated based on DNA sequencing of the mitochondrial cytochrome oxidase II gene. Our results drew attention to the need for caution in using third codon positions for tree construction, since it was likely that base pair substitutions of third codon positions in the COII gene were saturated among taxa used in the present study. We also detected that there were many phylogenetically informative sites in first codon positions. Phylogenetic trees using first and second codon positions based on both the neighbor-joining method and parsimony analysis indicated that the topology was nearly identical to each other. The phylogenetic relationships among these taxa differ from the current classification based on morphological characters. The inferred trees showed that grylloblattids were not a primitive group, but closely related to the Dictyoptera. Stick-insects were closely related to the Dictyoptera and grylloblattids, not to crickets. Locusts and crickets formed a monophyletic group. Earwigs were only distantly related to the Dictyoptera. Within the Dictyoptera, cockroaches and termites constituted a monophyletic group, with mantids as a sister group to that complex.	Univ Tokyo, Grad Sch Arts & Sci, Dept Biol, Meguro Ku, Tokyo 1538902, Japan; Ibaraki Univ, Dept Biol, Bunkyo Ku, Mito, Ibaraki 3108512, Japan	Maekawa, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Biol, Meguro Ku, Tokyo 1538902, Japan.						Ando H., 1982, P89; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173; KUKALOVAPECK J, 1993, SYST ENTOMOL, V18, P333, DOI 10.1111/j.1365-3113.1993.tb00670.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Whiting MF, 1997, SYST BIOL, V46, P1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Boudreaux H. B, 1979, ARTHROPOD PHYLOGENY; CRAMPTON G. C., 1935, JOUR NEW YORK ENT SOC, V43, P97; Crampton G. C., 1915, Entomological News Philadelphia, V26; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; HENNIG W, 1969, STAMMESGESCHICHTE IN; Hennig W., 1981, INSECT PHYLOGENY; IMMS A. D., 1945, TIIDSCHR ENT, V88, P63; KAMBHAMPATI S, 1995, P NATL ACAD SCI USA, V92, P2017, DOI 10.1073/pnas.92.6.2017; KEVAN DKM, 1986, P 4 TRIENN M PAN AM, P49; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KRISHNAN KN, 1975, INDIAN J TECHNOL, V13, P1; Kristensen N.P., 1991, P125; Kristensen Niels P., 1995, Zoologische Beitraege, V36, P83; KRISTENSEN NP, 1981, ANNU REV ENTOMOL, V26, P135, DOI 10.1146/annurev.en.26.010181.001031; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P2452, DOI 10.1139/z92-330; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P42; Miura T, 1998, ANN ENTOMOL SOC AM, V91, P515; Nagashima T., 1982, P113; RAGGE D. R., 1955, TRANS ROY ENT SOC LONDON, V106, P375; ROSS HERBERT H., 1955, ENT NEWS, V66, P197; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SWOFFORD DL, 1993, PAUP PHYLOGENETIC AN; THORNE BL, 1992, SYST ENTOMOL, V17, P253, DOI 10.1111/j.1365-3113.1992.tb00336.x; Walker E. M., 1933, Annals of the Entomological Society of America, V26, P309; Walker E. M., 1938, ANN ENTOMOL SOC AM, V31, P588; Walker E. M., 1914, Canadian Entomologist, V46	37	33	37	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	FEB	1999	16	1					175	184		10.2108/zsj.16.175		10	Zoology	Zoology	214NG	WOS:000081333600025		
J	Haraguchi, S; Naito, K; Sato, E				Haraguchi, S; Naito, K; Sato, E			Phosphate exposure during the late 1-cell and early 2-cell stages induces a time-specific decrease in cyclin B and cdc25B mRNAs in AKR/N mouse embryos in vitro	ZYGOTE			English	Article						2-cell block; cdc25; cyclin B; mouse embryo; RT-PCR	ONE-CELL; PROTEIN; ACTIVATION; P34CDC2; GLUCOSE; INVITRO; CRABTREE	Phosphate induces 2-cell block in AKR/N mouse embryos in vitro. in an attempt to define the mechanism responsible for the inhibitory effect of phosphate, the critical period for this effect was determined. Then the amounts of the mRNAs for cyclin B and cdc25B, factors related to activation of M-phase promoting factor (MPF), were measured by quantitative reverse transcription-polymerase chain reaction. Exposure to phosphate during the late 1-cell (10-20 h after insemination) and early 2-cell stages (0-12 h after first cleavage) was found to induce 2-cell block in AKR/N mouse embryos. This period corresponds to the initiation of zygotic gene activation (ZGA). The presence of phosphate during second cleavage had no effect on 2-cell block of the embryos. The relative levels of cyclin B and cdc25B mRNAs did not change significantly during the 1-cell stage and decreased during the early 2-cell stage to almost half of the initial levels. When the amounts of mRNA in embryos cultured with and without phosphate were compared they were found to be almost identical even in the 2-cell block embryos, and a significant decrease in mRNA was observed only 33 h after insemination in embryos about to undergo phosphate block at the 2-cell stage. These results show that phosphate does not directly inhibit MPF activity and confirm the presence of cyclin B and cdc25B even in 2-cell block embryos. Furthermore, the fact that the decrease in mRNA levels corresponded to the critical period for the inhibitory effect of phosphate suggests that suppression of initial ZGA induction is involved in the 2-cell block of mouse embryos in vitro.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tsukuba, Ctr TARA, Inst Biol Sci, Tsukuba, Ibaraki 3058572, Japan; Natl Inst Hlth Sci, Cellular & Mol Toxicol Div, Setagaya Ku, Tokyo 1588501, Japan; Tohoku Univ, Fac Agr, Aoba Ku, Sendai, Miyagi 981, Japan	Naito, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Bunkyo Ku, Yayoi 1-1-1, Tokyo 113, Japan.						SOLOMON MJ, 1990, CELL, V63, P1013, DOI 10.1016/0092-8674(90)90504-8; Mitra J, 1996, J CELL SCI, V109, P2407; CHRISTIANS E, 1995, DEVELOPMENT, V121, P113; Crabtree HG, 1929, BIOCHEM J, V23, P536; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; SCHINI SA, 1988, BIOL REPROD, V39, P1183, DOI 10.1095/biolreprod39.5.1183; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; SESHAGIRI PB, 1991, MOL REPROD DEV, V30, P105, DOI 10.1002/mrd.1080300206; AOKI F, 1992, DEV BIOL, V154, P66, DOI 10.1016/0012-1606(92)90048-L; AOKI F, 1997, J MAMM OVA RES, V14, P125, DOI 10.1274/jmor.14.125; Haraguchi S, 1996, BIOL REPROD, V55, P598, DOI 10.1095/biolreprod55.3.598; Haraguchi Seiki, 1996, Journal of Reproduction and Development, V42, P273, DOI 10.1262/jrd.42.273; KOOBS DH, 1972, SCIENCE, V178, P127, DOI 10.1126/science.178.4057.127; LATHAM KE, 1991, DEVELOPMENT, V112, P921; LEVIN B, 1990, CELL, V61, P743; MATSUMOTO K, 1994, MOL REPROD DEV, V39, P136, DOI 10.1002/mrd.1080390203; MIYOSHI K, 1994, J REPROD FERTIL, V100, P21; Nishijima H, 1997, J CELL BIOL, V138, P1105, DOI 10.1083/jcb.138.5.1105; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441; PETTERS RM, 1990, J REPROD FERTIL, V89, P269; PINYOPUMMINTR T, 1991, BIOL REPROD, V45, P736, DOI 10.1095/biolreprod45.5.736; WICKRAMASINGHE D, 1995, DEVELOPMENT, V121, P2047; YOKOI H, 1993, BIOCHEM BIOPH RES CO, V195, P769, DOI 10.1006/bbrc.1993.2112	24	10	13	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH STREET, NEW YORK, NY 10011-4211 USA	0967-1994			ZYGOTE	Zygote	FEB	1999	7	1					87	93		10.1017/S096719949900043X		7	Cell Biology; Developmental Biology; Reproductive Biology	Cell Biology; Developmental Biology; Reproductive Biology	244TC	WOS:000083066000011		
